Psyllid ID: psy11727
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 437 | 2.2.26 [Sep-21-2011] | |||||||
| P49657 | 908 | Serine/threonine-protein | no | N/A | 0.965 | 0.464 | 0.703 | 0.0 | |
| Q63470 | 763 | Dual specificity tyrosine | yes | N/A | 0.931 | 0.533 | 0.709 | 1e-167 | |
| Q61214 | 763 | Dual specificity tyrosine | yes | N/A | 0.931 | 0.533 | 0.709 | 1e-167 | |
| Q9Z188 | 629 | Dual specificity tyrosine | no | N/A | 0.926 | 0.643 | 0.681 | 1e-167 | |
| Q13627 | 763 | Dual specificity tyrosine | yes | N/A | 0.931 | 0.533 | 0.709 | 1e-167 | |
| Q9Y463 | 629 | Dual specificity tyrosine | no | N/A | 0.926 | 0.643 | 0.681 | 1e-167 | |
| Q2TAE3 | 750 | Dual specificity tyrosine | N/A | N/A | 0.938 | 0.546 | 0.699 | 1e-164 | |
| Q0IJ08 | 751 | Dual specificity tyrosine | no | N/A | 0.938 | 0.545 | 0.699 | 1e-158 | |
| Q8WQL7 | 882 | Dual specificity tyrosine | yes | N/A | 0.782 | 0.387 | 0.657 | 1e-130 | |
| A8X4H1 | 904 | Dual specificity tyrosine | N/A | N/A | 0.757 | 0.366 | 0.663 | 1e-128 |
| >sp|P49657|MNB_DROME Serine/threonine-protein kinase minibrain OS=Drosophila melanogaster GN=mnb PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 644 bits (1661), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 309/439 (70%), Positives = 370/439 (84%), Gaps = 17/439 (3%)
Query: 9 SPLYGRLV--ADNSIQNQDIL-------------SMQARIPMQFRDPATAPLRKLSVDLI 53
+PLYGR V D ++D++ +MQARIP FR+PA+ PLRKLSVDLI
Sbjct: 46 APLYGRFVDAEDLPATHRDVMHHHSSPSSSSEVRAMQARIPNHFREPASGPLRKLSVDLI 105
Query: 54 KTYKHINEVYYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYE 113
KTYKHINEVYY KKKR+AQ + + S+ K+++ ++NDG+DD+N+DYIIK+GEKFLDRYE
Sbjct: 106 KTYKHINEVYYAKKKRRAQQTQGDDDSSNKKERKLYNDGYDDDNHDYIIKNGEKFLDRYE 165
Query: 114 IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY- 172
ID+L+GKGSFGQVVKA+DHEE+C VAIKIIKNKKPFLNQAQIEV+LLE +N+AD ++Y
Sbjct: 166 IDSLIGKGSFGQVVKAYDHEEQCHVAIKIIKNKKPFLNQAQIEVKLLEMMNRADAENKYY 225
Query: 173 IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
IVKLK HF W+NHLCLVFELLSYNLY+L+RNTNF GVSLNLT+KFAQQLC AL FLS+PE
Sbjct: 226 IVKLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFAQQLCTALLFLSTPE 285
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDL 292
L+IIHCDLKPENILLC+PKRSAIKI+DFGSSC +GQ +Y YIQSR+YRSPEVLLGI YDL
Sbjct: 286 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYHYIQSRFYRSPEVLLGIQYDL 345
Query: 293 AIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRL-S 351
AIDMWSLGCILVE+HTGEPLFSG NEVDQM KI+EVLGMPP YLL A KT K+FD++ +
Sbjct: 346 AIDMWSLGCILVEMHTGEPLFSGCNEVDQMNKIVEVLGMPPKYLLDQAHKTRKFFDKIVA 405
Query: 352 DNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411
D SYVLKK+ + RK + PGS++L ILGV+ GGPGGRR +EPGHS++DY+KFKDLILRML
Sbjct: 406 DGSYVLKKNQNGRKYKPPGSRKLHDILGVETGGPGGRRLDEPGHSVSDYLKFKDLILRML 465
Query: 412 TYDPKKRISPTNVLRHEFF 430
+DPK R++P L+H FF
Sbjct: 466 DFDPKTRVTPYYALQHNFF 484
|
Role in the specific control of proper proliferation of optic lobe neuronal progeny. Drosophila melanogaster (taxid: 7227) EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 1 |
| >sp|Q63470|DYR1A_RAT Dual specificity tyrosine-phosphorylation-regulated kinase 1A OS=Rattus norvegicus GN=Dyrk1a PE=1 SV=2 | Back alignment and function description |
|---|
Score = 589 bits (1518), Expect = e-167, Method: Compositional matrix adjust.
Identities = 291/410 (70%), Positives = 349/410 (85%), Gaps = 3/410 (0%)
Query: 25 DILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKE 84
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYY KKKR+ Q + S+KKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 85 KKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK 144
+K V+NDG+DD+NYDYI+K+GEK++DRYEID+L+GKGSFGQVVKA+D E+ VAIKIIK
Sbjct: 133 RK-VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK 191
Query: 145 NKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRN 203
NKK FLNQAQIEV+LLE +NK D +Y IV LK HF ++NHLCLVFE+LSYNLY+L+RN
Sbjct: 192 NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRN 251
Query: 204 TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263
TNF GVSLNLT+KFAQQ+C AL FL++PELSIIHCDLKPENILLC+PKRSAIKI+DFGSS
Sbjct: 252 TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 311
Query: 264 CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323
C +GQ +YQYIQSR+YRSPEVLLG+PYDLAIDMWSLGCILVE+HTGEPLFSG NEVDQM
Sbjct: 312 CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 371
Query: 324 KIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE-RLPGSKRLDTILGVDN 382
KI+EVLG+PP ++L A K K+F++L D ++ LKK+ D ++E + PG+++L ILGV+
Sbjct: 372 KIVEVLGIPPAHILDQAPKARKFFEKLPDGTWSLKKTKDGKREYKPPGTRKLHNILGVET 431
Query: 383 GGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432
GGPGGRR E GH++ADY+KFKDLILRML YDPK RI P L+H FF K
Sbjct: 432 GGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 481
|
May play a role in a signaling pathway regulating nuclear functions of cell proliferation. Phosphorylates serine, threonine and tyrosine residues in its sequence and in exogenous substrates. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 2 |
| >sp|Q61214|DYR1A_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 1A OS=Mus musculus GN=Dyrk1a PE=1 SV=1 | Back alignment and function description |
|---|
Score = 588 bits (1517), Expect = e-167, Method: Compositional matrix adjust.
Identities = 291/410 (70%), Positives = 349/410 (85%), Gaps = 3/410 (0%)
Query: 25 DILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKE 84
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYY KKKR+ Q + S+KKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 85 KKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK 144
+K V+NDG+DD+NYDYI+K+GEK++DRYEID+L+GKGSFGQVVKA+D E+ VAIKIIK
Sbjct: 133 RK-VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK 191
Query: 145 NKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRN 203
NKK FLNQAQIEV+LLE +NK D +Y IV LK HF ++NHLCLVFE+LSYNLY+L+RN
Sbjct: 192 NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRN 251
Query: 204 TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263
TNF GVSLNLT+KFAQQ+C AL FL++PELSIIHCDLKPENILLC+PKRSAIKI+DFGSS
Sbjct: 252 TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 311
Query: 264 CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323
C +GQ +YQYIQSR+YRSPEVLLG+PYDLAIDMWSLGCILVE+HTGEPLFSG NEVDQM
Sbjct: 312 CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 371
Query: 324 KIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE-RLPGSKRLDTILGVDN 382
KI+EVLG+PP ++L A K K+F++L D ++ LKK+ D ++E + PG+++L ILGV+
Sbjct: 372 KIVEVLGIPPAHILDQAPKARKFFEKLPDGTWSLKKTKDGKREYKPPGTRKLHNILGVET 431
Query: 383 GGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432
GGPGGRR E GH++ADY+KFKDLILRML YDPK RI P L+H FF K
Sbjct: 432 GGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 481
|
May play a role in a signaling pathway regulating nuclear functions of cell proliferation. Phosphorylates serine, threonine and tyrosine residues in its sequence and in exogenous substrates. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9Z188|DYR1B_MOUSE Dual specificity tyrosine-phosphorylation-regulated kinase 1B OS=Mus musculus GN=Dyrk1b PE=1 SV=3 | Back alignment and function description |
|---|
Score = 588 bits (1517), Expect = e-167, Method: Compositional matrix adjust.
Identities = 278/408 (68%), Positives = 340/408 (83%), Gaps = 3/408 (0%)
Query: 25 DILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKE 84
D+ + R+P+ FRD A+APLRKLSVDLIKTYKHINEVYY KKKR+AQ + + S KKE
Sbjct: 25 DVRLLPRRLPLAFRDAASAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQAPPQDSSTKKE 84
Query: 85 KKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK 144
KK V N G+DD+N+DYI++ GE++L+RYEID+L+GKGSFGQVVKA+DH+ + VAIKIIK
Sbjct: 85 KK-VLNHGYDDDNHDYIVRSGERWLERYEIDSLIGKGSFGQVVKAYDHQTQELVAIKIIK 143
Query: 145 NKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRN 203
NKK FLNQAQIE++LLE +N+ D +Y IV LK HF ++NHLCLVFELLSYNLY+L+RN
Sbjct: 144 NKKAFLNQAQIELRLLELMNQHDTEMKYYIVHLKRHFMFRNHLCLVFELLSYNLYDLLRN 203
Query: 204 TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263
T+F GVSLNLT+K AQQLC AL FL++PELSIIHCDLKPENILLC+PKRSAIKI+DFGSS
Sbjct: 204 THFRGVSLNLTRKLAQQLCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 263
Query: 264 CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323
C +GQ +YQYIQSR+YRSPEVLLG PYDLAIDMWSLGCILVE+HTGEPLFSG NEVDQM+
Sbjct: 264 CQLGQRIYQYIQSRFYRSPEVLLGTPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMS 323
Query: 324 KIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE-RLPGSKRLDTILGVDN 382
+I+EVLG+PP +L A K KYF+RL + L+++ + RK+ + PG++RL +LGV
Sbjct: 324 RIVEVLGIPPAPMLEQAPKARKYFERLPGGGWTLRRTKELRKDYQGPGTRRLQEVLGVQT 383
Query: 383 GGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
GGPGGRR EPGHS ADY++F+DL+LRML Y+P RISP L+H FF
Sbjct: 384 GGPGGRRAGEPGHSPADYLRFQDLVLRMLEYEPAARISPLGALQHGFF 431
|
Dual-specificity kinase which possesses both serine/ threonine and tyrosine kinase activity. Enhances the transcriptional activity of TCF1/HNF1A and FOXO1. Inhibits epithelial cell migration. Mediates colon carcinoma cell survival in mitogen-poor environments. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q13627|DYR1A_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 1A OS=Homo sapiens GN=DYRK1A PE=1 SV=2 | Back alignment and function description |
|---|
Score = 588 bits (1516), Expect = e-167, Method: Compositional matrix adjust.
Identities = 291/410 (70%), Positives = 349/410 (85%), Gaps = 3/410 (0%)
Query: 25 DILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKE 84
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYY KKKR+ Q + S+KKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 85 KKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK 144
+K V+NDG+DD+NYDYI+K+GEK++DRYEID+L+GKGSFGQVVKA+D E+ VAIKIIK
Sbjct: 133 RK-VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK 191
Query: 145 NKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRN 203
NKK FLNQAQIEV+LLE +NK D +Y IV LK HF ++NHLCLVFE+LSYNLY+L+RN
Sbjct: 192 NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRN 251
Query: 204 TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263
TNF GVSLNLT+KFAQQ+C AL FL++PELSIIHCDLKPENILLC+PKRSAIKI+DFGSS
Sbjct: 252 TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 311
Query: 264 CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323
C +GQ +YQYIQSR+YRSPEVLLG+PYDLAIDMWSLGCILVE+HTGEPLFSG NEVDQM
Sbjct: 312 CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 371
Query: 324 KIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE-RLPGSKRLDTILGVDN 382
KI+EVLG+PP ++L A K K+F++L D ++ LKK+ D ++E + PG+++L ILGV+
Sbjct: 372 KIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVET 431
Query: 383 GGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432
GGPGGRR E GH++ADY+KFKDLILRML YDPK RI P L+H FF K
Sbjct: 432 GGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 481
|
May play a role in a signaling pathway regulating nuclear functions of cell proliferation. Phosphorylates serine, threonine and tyrosine residues in its sequence and in exogenous substrates. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9Y463|DYR1B_HUMAN Dual specificity tyrosine-phosphorylation-regulated kinase 1B OS=Homo sapiens GN=DYRK1B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 588 bits (1516), Expect = e-167, Method: Compositional matrix adjust.
Identities = 278/408 (68%), Positives = 339/408 (83%), Gaps = 3/408 (0%)
Query: 25 DILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKE 84
D+ + R+P+ FRD +APLRKLSVDLIKTYKHINEVYY KKKR+AQ + + SNKKE
Sbjct: 25 DVRLLPRRLPLAFRDATSAPLRKLSVDLIKTYKHINEVYYAKKKRRAQQAPPQDSSNKKE 84
Query: 85 KKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK 144
KK V N G+DD+N+DYI++ GE++L+RYEID+L+GKGSFGQVVKA+DH+ + VAIKIIK
Sbjct: 85 KK-VLNHGYDDDNHDYIVRSGERWLERYEIDSLIGKGSFGQVVKAYDHQTQELVAIKIIK 143
Query: 145 NKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRN 203
NKK FLNQAQIE++LLE +N+ D +Y IV LK HF ++NHLCLVFELLSYNLY+L+RN
Sbjct: 144 NKKAFLNQAQIELRLLELMNQHDTEMKYYIVHLKRHFMFRNHLCLVFELLSYNLYDLLRN 203
Query: 204 TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263
T+F GVSLNLT+K AQQLC AL FL++PELSIIHCDLKPENILLC+PKRSAIKI+DFGSS
Sbjct: 204 THFRGVSLNLTRKLAQQLCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 263
Query: 264 CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323
C +GQ +YQYIQSR+YRSPEVLLG PYDLAIDMWSLGCILVE+HTGEPLFSG NEVDQM
Sbjct: 264 CQLGQRIYQYIQSRFYRSPEVLLGTPYDLAIDMWSLGCILVEMHTGEPLFSGSNEVDQMN 323
Query: 324 KIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE-RLPGSKRLDTILGVDN 382
+I+EVLG+PP +L A K KYF+RL + L+++ + RK+ + PG++RL +LGV
Sbjct: 324 RIVEVLGIPPAAMLDQAPKARKYFERLPGGGWTLRRTKELRKDYQGPGTRRLQEVLGVQT 383
Query: 383 GGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
GGPGGRR EPGHS ADY++F+DL+LRML Y+P RISP L+H FF
Sbjct: 384 GGPGGRRAGEPGHSPADYLRFQDLVLRMLEYEPAARISPLGALQHGFF 431
|
Dual-specificity kinase which possesses both serine/ threonine and tyrosine kinase activities. Enhances the transcriptional activity of TCF1/HNF1A and FOXO1. Inhibits epithelial cell migration. Mediates colon carcinoma cell survival in mitogen-poor environments. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q2TAE3|DYR1A_XENLA Dual specificity tyrosine-phosphorylation-regulated kinase 1A OS=Xenopus laevis GN=dyrk1a PE=2 SV=1 | Back alignment and function description |
|---|
Score = 579 bits (1493), Expect = e-164, Method: Compositional matrix adjust.
Identities = 289/413 (69%), Positives = 347/413 (84%), Gaps = 3/413 (0%)
Query: 22 QNQDILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSN 81
Q L Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYY KKKR+ Q + S+
Sbjct: 62 QTPQPLPNQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSH 121
Query: 82 KKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIK 141
KKE+K V+NDG+DD+NYDYI+K+GEK++DRYEID+L+GKGSFGQVVKA+D E+ VAIK
Sbjct: 122 KKERK-VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK 180
Query: 142 IIKNKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNL 200
IIKNKK FLNQAQIEV+LLE +NK D +Y IV LK HF ++NHLCLVFE+LSYNLY+L
Sbjct: 181 IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDL 240
Query: 201 IRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260
+RNTNF GVSLNLT+KFAQQ+C AL FL++PELSIIHCDLKPENILLC+PKRSAIKI+DF
Sbjct: 241 LRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 300
Query: 261 GSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVD 320
GSSC +GQ +YQYIQSR+YRSPEVLLG PYDLAIDMWSLGCILVE+HTGEPLFSG NEVD
Sbjct: 301 GSSCQLGQRIYQYIQSRFYRSPEVLLGTPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 360
Query: 321 QMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE-RLPGSKRLDTILG 379
QM+KI+EVLG+PP ++L A K K+F+++ + ++ LKK+ D +KE + PG+++L ILG
Sbjct: 361 QMSKIVEVLGIPPAHILDQAPKARKFFEKMPEGTWNLKKTKDGKKEYKPPGTRKLHNILG 420
Query: 380 VDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432
V+NGGPGGRR E GH++ADY+KFKD+ILRML YD K RI P L+H FF K
Sbjct: 421 VENGGPGGRRAGESGHTVADYLKFKDVILRMLDYDAKTRIQPYYALQHSFFKK 473
|
May play a role in a signaling pathway regulating nuclear functions of cell proliferation. Phosphorylates serine, threonine and tyrosine residues in its sequence and in exogenous substrates. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q0IJ08|DYR1A_XENTR Dual specificity tyrosine-phosphorylation-regulated kinase 1A OS=Xenopus tropicalis GN=dyrk1a PE=2 SV=1 | Back alignment and function description |
|---|
Score = 559 bits (1440), Expect = e-158, Method: Compositional matrix adjust.
Identities = 289/413 (69%), Positives = 348/413 (84%), Gaps = 3/413 (0%)
Query: 22 QNQDILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSN 81
Q Q L Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYY KKKR+ Q + S+
Sbjct: 62 QIQQPLPNQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSH 121
Query: 82 KKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIK 141
KKE+K V+NDG+DD+NYDYI+K+GEK++DRYEID+L+GKGSFGQVVKA+D E+ VAIK
Sbjct: 122 KKERK-VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRAEQEWVAIK 180
Query: 142 IIKNKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNL 200
IIKNKK FLNQAQIEV+LLE +NK D +Y IV LK HF ++NHLCLVFE+LSYNLY+L
Sbjct: 181 IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDL 240
Query: 201 IRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260
+RNTNF GVSLNLT+KFAQQ+C AL FL++PELSIIHCDLKPENILLC+PKRSAIKI+DF
Sbjct: 241 LRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 300
Query: 261 GSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVD 320
GSSC +GQ +YQYIQSR+YRSPEVLLG+PYDLAIDMWSLGCILVE+HTGEPLFSG NEVD
Sbjct: 301 GSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 360
Query: 321 QMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE-RLPGSKRLDTILG 379
QM+KI+EVLG+PP ++L A K K+F+++ + ++ LKK+ D +KE + PG+++L +LG
Sbjct: 361 QMSKIVEVLGIPPAHILDQAPKARKFFEKMPEGTWNLKKTKDGKKEYKPPGTRKLHNLLG 420
Query: 380 VDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432
V+ GGPGGRR E GH++ADY+KFKDLILRML YD K RI P L+H FF K
Sbjct: 421 VETGGPGGRRGGESGHTVADYLKFKDLILRMLDYDAKTRIQPYYALQHSFFKK 473
|
May play a role in a signaling pathway regulating nuclear functions of cell proliferation. Phosphorylates serine, threonine and tyrosine residues in its sequence and in exogenous substrates. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q8WQL7|MBK1_CAEEL Dual specificity tyrosine-phosphorylation-regulated kinase mbk-1 OS=Caenorhabditis elegans GN=mbk-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 465 bits (1197), Expect = e-130, Method: Compositional matrix adjust.
Identities = 228/347 (65%), Positives = 270/347 (77%), Gaps = 5/347 (1%)
Query: 89 HNDGHDDENYDYIIKHGEKFLDRYEI--DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK 146
+N+G+DD+NYDYI+K+GE F RY I DT +GKGSFGQV KA+D K +VAIKIIKNK
Sbjct: 303 YNNGYDDQNYDYILKNGEIFDKRYVILSDTPVGKGSFGQVTKAYDTLNKEEVAIKIIKNK 362
Query: 147 KPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTN 205
K F +QAQIE+ LLE N D ++Y IV LKGHF + HLCLVFELLSYNLY+L++NT+
Sbjct: 363 KTFFDQAQIEIHLLELTNAHDKDNKYNIVTLKGHFVHRAHLCLVFELLSYNLYDLLKNTS 422
Query: 206 FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265
F GVSLNL +KFAQQL L FLSSPELSIIHCDLKPEN+LL + KRS I++IDFGSSC
Sbjct: 423 FRGVSLNLARKFAQQLGKTLLFLSSPELSIIHCDLKPENVLLVNAKRSQIRVIDFGSSCQ 482
Query: 266 VGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKI 325
G +YQYIQSR+YRSPEVLLGI YD IDMWSLGCILVE+HTGEPLF+G +EVDQM KI
Sbjct: 483 TGHRIYQYIQSRFYRSPEVLLGIAYDTKIDMWSLGCILVEMHTGEPLFAGSSEVDQMMKI 542
Query: 326 IEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE--RLPGSKRLDTILGVDNG 383
+EVLGMPP +L KT KYFD+ D Y KK+ D + + PG+++L ILGV +G
Sbjct: 543 VEVLGMPPKEMLDIGPKTHKYFDKTEDGIYYCKKTRDGYRHTYKAPGARKLHEILGVTSG 602
Query: 384 GPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
GPGGRR EPGHS+ DY KFKDLI RML +DPK+RISP V+RH F
Sbjct: 603 GPGGRRLGEPGHSVEDYSKFKDLIKRMLQFDPKQRISPYYVVRHPFL 649
|
Possible role in the function of olfactory neurons. Caenorhabditis elegans (taxid: 6239) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|A8X4H1|MBK1_CAEBR Dual specificity tyrosine-phosphorylation-regulated kinase mbk-1 OS=Caenorhabditis briggsae GN=mbk-1 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 457 bits (1177), Expect = e-128, Method: Compositional matrix adjust.
Identities = 223/336 (66%), Positives = 263/336 (78%), Gaps = 5/336 (1%)
Query: 89 HNDGHDDENYDYIIKHGEKFLDRYEI--DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK 146
+N+G+DD+NYDYI+K+GE F RY I DT +GKGSFGQV KA+D K +VAIKIIKNK
Sbjct: 342 YNNGYDDQNYDYILKNGEIFDKRYVILSDTPVGKGSFGQVTKAYDTVTKEEVAIKIIKNK 401
Query: 147 KPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTN 205
K F +QAQIE+ LLE N D ++Y IV LKGHF + HLCLVFELLSYNLY+L++NTN
Sbjct: 402 KTFFDQAQIEIHLLELTNAHDKDNKYNIVTLKGHFVHRAHLCLVFELLSYNLYDLLKNTN 461
Query: 206 FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265
F GVSLNL +KFAQQL L FLSSPELSIIHCDLKPEN+LL + KRS I++IDFGSSC
Sbjct: 462 FRGVSLNLARKFAQQLGKTLLFLSSPELSIIHCDLKPENVLLVNAKRSQIRVIDFGSSCQ 521
Query: 266 VGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKI 325
G +YQYIQSR+YRSPEVLLGI YD IDMWSLGCILVE+HTGEPLF+G +EVDQM KI
Sbjct: 522 TGHRIYQYIQSRFYRSPEVLLGIAYDTKIDMWSLGCILVEMHTGEPLFAGSSEVDQMMKI 581
Query: 326 IEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE--RLPGSKRLDTILGVDNG 383
+EVLGMPP +L KT KYFD+ D Y KK+ D + + PG+++L ILGV +G
Sbjct: 582 VEVLGMPPKEMLDIGPKTHKYFDKTEDGIYYCKKTRDGYRHTYKAPGARKLHEILGVTSG 641
Query: 384 GPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419
GPGGRR EPGHS+ DY KFKDLI RML +DPK+RI
Sbjct: 642 GPGGRRLGEPGHSVEDYSKFKDLIKRMLNFDPKQRI 677
|
Possible role in the function of olfactory neurons. Caenorhabditis briggsae (taxid: 6238) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 437 | ||||||
| 347967212 | 1483 | AGAP002119-PB [Anopheles gambiae str. PE | 0.972 | 0.286 | 0.717 | 0.0 | |
| 347967214 | 928 | AGAP002119-PA [Anopheles gambiae str. PE | 0.972 | 0.457 | 0.717 | 0.0 | |
| 347967216 | 1263 | AGAP002119-PD [Anopheles gambiae str. PE | 0.972 | 0.336 | 0.717 | 0.0 | |
| 242012319 | 540 | serine/threonine-protein kinase minibrai | 0.970 | 0.785 | 0.737 | 0.0 | |
| 347967218 | 708 | AGAP002119-PC [Anopheles gambiae str. PE | 0.972 | 0.600 | 0.717 | 0.0 | |
| 156543834 | 706 | PREDICTED: serine/threonine-protein kina | 0.974 | 0.603 | 0.714 | 0.0 | |
| 157136011 | 508 | Dual specificity tyrosine-phosphorylatio | 0.972 | 0.836 | 0.705 | 0.0 | |
| 195041543 | 846 | GH12565 [Drosophila grimshawi] gi|193901 | 0.965 | 0.498 | 0.703 | 0.0 | |
| 328793644 | 704 | PREDICTED: serine/threonine-protein kina | 0.961 | 0.596 | 0.722 | 0.0 | |
| 340710082 | 695 | PREDICTED: serine/threonine-protein kina | 0.961 | 0.604 | 0.722 | 0.0 |
| >gi|347967212|ref|XP_003436034.1| AGAP002119-PB [Anopheles gambiae str. PEST] gi|333469706|gb|EGK97377.1| AGAP002119-PB [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Score = 669 bits (1725), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 318/443 (71%), Positives = 376/443 (84%), Gaps = 18/443 (4%)
Query: 9 SPLYGRLVAD---------------NSIQNQDILSMQARIPMQFRDPATAPLRKLSVDLI 53
+PLYGRLV + + + DI +M+ARIP+ FRDPATAPLRKLSVDLI
Sbjct: 585 APLYGRLVTEEHLPAVHRDIHQRSISPTSSTDIRAMEARIPVLFRDPATAPLRKLSVDLI 644
Query: 54 KTYKHINEVYYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYE 113
KTYKHINEVYY KKKR+AQ + E S+KKE+K ++NDG+DDEN+DYIIK+GEKFLDRYE
Sbjct: 645 KTYKHINEVYYAKKKRRAQQTQGEDTSHKKERK-LYNDGYDDENHDYIIKNGEKFLDRYE 703
Query: 114 IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY- 172
ID+L+GKGSFGQVVKAFDHEE+CQVAIKIIKNKKPFLNQAQIEV+LLE +N+AD ++Y
Sbjct: 704 IDSLIGKGSFGQVVKAFDHEERCQVAIKIIKNKKPFLNQAQIEVKLLEMMNRADAENKYY 763
Query: 173 IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
IVKLK HF W+NHLCLVFELLSYNL++L+RNTNF GVSLNLTKKFAQQLC AL FLS+PE
Sbjct: 764 IVKLKRHFMWRNHLCLVFELLSYNLFDLLRNTNFRGVSLNLTKKFAQQLCTALLFLSTPE 823
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDL 292
L+IIHCDLKPENILLC+PKRSAIKI+DFGSSC +GQ +YQYIQSR+YRSPEVLLGIPYDL
Sbjct: 824 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDL 883
Query: 293 AIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRL-S 351
AIDMWSLGCILVE+HTGEPLFSG NE DQ+ +I+EVLGMPP ++L A KT K+F++L S
Sbjct: 884 AIDMWSLGCILVEMHTGEPLFSGSNEADQINRIVEVLGMPPKHILDQAHKTRKFFEKLPS 943
Query: 352 DNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411
D SYVL+K+ + RK + PGS++L ILGV+ GGPGGRR EPGHS++DY+KFKDLILRML
Sbjct: 944 DGSYVLRKTQNQRKYKPPGSRKLHDILGVETGGPGGRRHGEPGHSVSDYLKFKDLILRML 1003
Query: 412 TYDPKKRISPTNVLRHEFFLKHS 434
YDPK R++P L+H FF + S
Sbjct: 1004 DYDPKTRVTPYYALQHNFFKRTS 1026
|
Source: Anopheles gambiae str. PEST Species: Anopheles gambiae Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|347967214|ref|XP_320918.5| AGAP002119-PA [Anopheles gambiae str. PEST] gi|333469705|gb|EAA43038.5| AGAP002119-PA [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Score = 667 bits (1720), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 318/443 (71%), Positives = 376/443 (84%), Gaps = 18/443 (4%)
Query: 9 SPLYGRLVADNSI---------------QNQDILSMQARIPMQFRDPATAPLRKLSVDLI 53
+PLYGRLV + + + DI +M+ARIP+ FRDPATAPLRKLSVDLI
Sbjct: 30 APLYGRLVTEEHLPAVHRDIHQRSISPTSSTDIRAMEARIPVLFRDPATAPLRKLSVDLI 89
Query: 54 KTYKHINEVYYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYE 113
KTYKHINEVYY KKKR+AQ + E S+KKE+K ++NDG+DDEN+DYIIK+GEKFLDRYE
Sbjct: 90 KTYKHINEVYYAKKKRRAQQTQGEDTSHKKERK-LYNDGYDDENHDYIIKNGEKFLDRYE 148
Query: 114 IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY- 172
ID+L+GKGSFGQVVKAFDHEE+CQVAIKIIKNKKPFLNQAQIEV+LLE +N+AD ++Y
Sbjct: 149 IDSLIGKGSFGQVVKAFDHEERCQVAIKIIKNKKPFLNQAQIEVKLLEMMNRADAENKYY 208
Query: 173 IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
IVKLK HF W+NHLCLVFELLSYNL++L+RNTNF GVSLNLTKKFAQQLC AL FLS+PE
Sbjct: 209 IVKLKRHFMWRNHLCLVFELLSYNLFDLLRNTNFRGVSLNLTKKFAQQLCTALLFLSTPE 268
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDL 292
L+IIHCDLKPENILLC+PKRSAIKI+DFGSSC +GQ +YQYIQSR+YRSPEVLLGIPYDL
Sbjct: 269 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDL 328
Query: 293 AIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRL-S 351
AIDMWSLGCILVE+HTGEPLFSG NE DQ+ +I+EVLGMPP ++L A KT K+F++L S
Sbjct: 329 AIDMWSLGCILVEMHTGEPLFSGSNEADQINRIVEVLGMPPKHILDQAHKTRKFFEKLPS 388
Query: 352 DNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411
D SYVL+K+ + RK + PGS++L ILGV+ GGPGGRR EPGHS++DY+KFKDLILRML
Sbjct: 389 DGSYVLRKTQNQRKYKPPGSRKLHDILGVETGGPGGRRHGEPGHSVSDYLKFKDLILRML 448
Query: 412 TYDPKKRISPTNVLRHEFFLKHS 434
YDPK R++P L+H FF + S
Sbjct: 449 DYDPKTRVTPYYALQHNFFKRTS 471
|
Source: Anopheles gambiae str. PEST Species: Anopheles gambiae Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|347967216|ref|XP_003436035.1| AGAP002119-PD [Anopheles gambiae str. PEST] gi|333469708|gb|EGK97379.1| AGAP002119-PD [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1718), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 318/443 (71%), Positives = 376/443 (84%), Gaps = 18/443 (4%)
Query: 9 SPLYGRLVADNSI---------------QNQDILSMQARIPMQFRDPATAPLRKLSVDLI 53
+PLYGRLV + + + DI +M+ARIP+ FRDPATAPLRKLSVDLI
Sbjct: 585 APLYGRLVTEEHLPAVHRDIHQRSISPTSSTDIRAMEARIPVLFRDPATAPLRKLSVDLI 644
Query: 54 KTYKHINEVYYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYE 113
KTYKHINEVYY KKKR+AQ + E S+KKE+K ++NDG+DDEN+DYIIK+GEKFLDRYE
Sbjct: 645 KTYKHINEVYYAKKKRRAQQTQGEDTSHKKERK-LYNDGYDDENHDYIIKNGEKFLDRYE 703
Query: 114 IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY- 172
ID+L+GKGSFGQVVKAFDHEE+CQVAIKIIKNKKPFLNQAQIEV+LLE +N+AD ++Y
Sbjct: 704 IDSLIGKGSFGQVVKAFDHEERCQVAIKIIKNKKPFLNQAQIEVKLLEMMNRADAENKYY 763
Query: 173 IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
IVKLK HF W+NHLCLVFELLSYNL++L+RNTNF GVSLNLTKKFAQQLC AL FLS+PE
Sbjct: 764 IVKLKRHFMWRNHLCLVFELLSYNLFDLLRNTNFRGVSLNLTKKFAQQLCTALLFLSTPE 823
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDL 292
L+IIHCDLKPENILLC+PKRSAIKI+DFGSSC +GQ +YQYIQSR+YRSPEVLLGIPYDL
Sbjct: 824 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDL 883
Query: 293 AIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRL-S 351
AIDMWSLGCILVE+HTGEPLFSG NE DQ+ +I+EVLGMPP ++L A KT K+F++L S
Sbjct: 884 AIDMWSLGCILVEMHTGEPLFSGSNEADQINRIVEVLGMPPKHILDQAHKTRKFFEKLPS 943
Query: 352 DNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411
D SYVL+K+ + RK + PGS++L ILGV+ GGPGGRR EPGHS++DY+KFKDLILRML
Sbjct: 944 DGSYVLRKTQNQRKYKPPGSRKLHDILGVETGGPGGRRHGEPGHSVSDYLKFKDLILRML 1003
Query: 412 TYDPKKRISPTNVLRHEFFLKHS 434
YDPK R++P L+H FF + S
Sbjct: 1004 DYDPKTRVTPYYALQHNFFKRTS 1026
|
Source: Anopheles gambiae str. PEST Species: Anopheles gambiae Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242012319|ref|XP_002426880.1| serine/threonine-protein kinase minibrain, putative [Pediculus humanus corporis] gi|212511109|gb|EEB14142.1| serine/threonine-protein kinase minibrain, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 664 bits (1712), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 318/431 (73%), Positives = 371/431 (86%), Gaps = 7/431 (1%)
Query: 10 PLYGRLVADNSIQN----QDILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYT 65
PLYGRLV + ++ DI +MQARIP FRDP++APLRKLSVDLIKTYKHINEVYY
Sbjct: 38 PLYGRLVGEEQLETIREPADIQAMQARIPQHFRDPSSAPLRKLSVDLIKTYKHINEVYYA 97
Query: 66 KKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQ 125
KKKR+AQ + E S+KKE+K + N+G+DD+N+DYIIK+GEKFLDRYEID L+GKGSFGQ
Sbjct: 98 KKKRRAQQTQGEDTSHKKERK-IFNEGYDDDNHDYIIKNGEKFLDRYEIDNLIGKGSFGQ 156
Query: 126 VVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKN 184
VVKA+DHEE+CQVAIKIIKNKKPFLNQAQIEV+LLE +N+AD ++Y IV+LK HF W+N
Sbjct: 157 VVKAYDHEEQCQVAIKIIKNKKPFLNQAQIEVKLLEMMNRADADNKYFIVRLKRHFMWRN 216
Query: 185 HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPEN 244
HLCLVFELLSYNLY+L+RNTNF GVSLNLT+KFAQQLC AL FLS+PEL+IIHCDLKPEN
Sbjct: 217 HLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFAQQLCTALLFLSTPELNIIHCDLKPEN 276
Query: 245 ILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILV 304
ILLC+PKRSAIKI+DFGSSC +GQ +YQYIQSR+YRSPEVLLGIPYDLAIDMWSLGCILV
Sbjct: 277 ILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDLAIDMWSLGCILV 336
Query: 305 ELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRL-SDNSYVLKKSTDT 363
E+HTGEPLFSG NEVDQM KIIEVLGMPP ++L A K KYFD+L SD SYVLK+ D
Sbjct: 337 EMHTGEPLFSGTNEVDQMNKIIEVLGMPPKHILDQAHKARKYFDKLPSDGSYVLKRPKDG 396
Query: 364 RKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423
+K R PG++RL ILGVD+GGPGGRR EPGH++ADY+KFKDLILRML +DPK R++P
Sbjct: 397 KKYRSPGTRRLHDILGVDSGGPGGRRLGEPGHTVADYLKFKDLILRMLDFDPKTRVTPYY 456
Query: 424 VLRHEFFLKHS 434
L+ FF + S
Sbjct: 457 ALQQNFFKRTS 467
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|347967218|ref|XP_003436036.1| AGAP002119-PC [Anopheles gambiae str. PEST] gi|333469707|gb|EGK97378.1| AGAP002119-PC [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Score = 663 bits (1711), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 318/443 (71%), Positives = 376/443 (84%), Gaps = 18/443 (4%)
Query: 9 SPLYGRLVADNSI---------------QNQDILSMQARIPMQFRDPATAPLRKLSVDLI 53
+PLYGRLV + + + DI +M+ARIP+ FRDPATAPLRKLSVDLI
Sbjct: 30 APLYGRLVTEEHLPAVHRDIHQRSISPTSSTDIRAMEARIPVLFRDPATAPLRKLSVDLI 89
Query: 54 KTYKHINEVYYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYE 113
KTYKHINEVYY KKKR+AQ + E S+KKE+K ++NDG+DDEN+DYIIK+GEKFLDRYE
Sbjct: 90 KTYKHINEVYYAKKKRRAQQTQGEDTSHKKERK-LYNDGYDDENHDYIIKNGEKFLDRYE 148
Query: 114 IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY- 172
ID+L+GKGSFGQVVKAFDHEE+CQVAIKIIKNKKPFLNQAQIEV+LLE +N+AD ++Y
Sbjct: 149 IDSLIGKGSFGQVVKAFDHEERCQVAIKIIKNKKPFLNQAQIEVKLLEMMNRADAENKYY 208
Query: 173 IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
IVKLK HF W+NHLCLVFELLSYNL++L+RNTNF GVSLNLTKKFAQQLC AL FLS+PE
Sbjct: 209 IVKLKRHFMWRNHLCLVFELLSYNLFDLLRNTNFRGVSLNLTKKFAQQLCTALLFLSTPE 268
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDL 292
L+IIHCDLKPENILLC+PKRSAIKI+DFGSSC +GQ +YQYIQSR+YRSPEVLLGIPYDL
Sbjct: 269 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDL 328
Query: 293 AIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRL-S 351
AIDMWSLGCILVE+HTGEPLFSG NE DQ+ +I+EVLGMPP ++L A KT K+F++L S
Sbjct: 329 AIDMWSLGCILVEMHTGEPLFSGSNEADQINRIVEVLGMPPKHILDQAHKTRKFFEKLPS 388
Query: 352 DNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411
D SYVL+K+ + RK + PGS++L ILGV+ GGPGGRR EPGHS++DY+KFKDLILRML
Sbjct: 389 DGSYVLRKTQNQRKYKPPGSRKLHDILGVETGGPGGRRHGEPGHSVSDYLKFKDLILRML 448
Query: 412 TYDPKKRISPTNVLRHEFFLKHS 434
YDPK R++P L+H FF + S
Sbjct: 449 DYDPKTRVTPYYALQHNFFKRTS 471
|
Source: Anopheles gambiae str. PEST Species: Anopheles gambiae Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|156543834|ref|XP_001606660.1| PREDICTED: serine/threonine-protein kinase minibrain-like [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 655 bits (1689), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 321/449 (71%), Positives = 374/449 (83%), Gaps = 23/449 (5%)
Query: 4 VINAGSPLYGRLVADNSIQN--------------------QDILSMQARIPMQFRDPATA 43
+ G+PLYGRLVA+ + DI +MQARIP +FRDPATA
Sbjct: 61 TVTGGAPLYGRLVAEEPLPGAVCGAGGTGGGSGVMPQETPADIHAMQARIPHRFRDPATA 120
Query: 44 PLRKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIK 103
PLRKLSVDLIKTYKHINEVYY KKKR+AQ E S+KKE+K ++NDG DD+N+DYIIK
Sbjct: 121 PLRKLSVDLIKTYKHINEVYYAKKKRRAQQMQGEDGSHKKERK-LYNDGWDDDNHDYIIK 179
Query: 104 HGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKI 163
+GEKFLDRYEID+L+GKGSFGQVVKAFDHEE+ QVAIKIIKNKKPFLNQAQIEV+LLE +
Sbjct: 180 NGEKFLDRYEIDSLIGKGSFGQVVKAFDHEEQTQVAIKIIKNKKPFLNQAQIEVRLLEMM 239
Query: 164 NKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLC 222
N+AD ++Y IVKLK HF W+NHLCLVFELLSYNLY+L+RNTNF GVSLNLT+KFAQQLC
Sbjct: 240 NRADTDNKYYIVKLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFAQQLC 299
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSP 282
AL FLS+PEL+IIHCDLKPENILLC+PKRSAIKI+DFGSSC +GQ +YQYIQSR+YRSP
Sbjct: 300 TALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSP 359
Query: 283 EVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342
EVLLGIPYDLAIDMWSLGCILVE+HTGEPLFSG NEVDQM KI+EVLGMPP ++L A K
Sbjct: 360 EVLLGIPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGMPPKHILDQAHK 419
Query: 343 TSKYFDRL-SDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYM 401
KYFD++ +D SYVLKKS + +K +LPG++RL ILGV+ GGPGGRR EPGHS++DY+
Sbjct: 420 ARKYFDKVPTDGSYVLKKSKEGKKYKLPGTRRLHDILGVETGGPGGRRHGEPGHSISDYL 479
Query: 402 KFKDLILRMLTYDPKKRISPTNVLRHEFF 430
KFKDLILRML +DPK R++P L+H FF
Sbjct: 480 KFKDLILRMLDFDPKTRVTPYYALQHNFF 508
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|157136011|ref|XP_001656726.1| Dual specificity tyrosine-phosphorylation-regulated kinase [Aedes aegypti] gi|108881094|gb|EAT45319.1| AAEL003370-PA [Aedes aegypti] | Back alignment and taxonomy information |
|---|
Score = 653 bits (1685), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 312/442 (70%), Positives = 370/442 (83%), Gaps = 17/442 (3%)
Query: 9 SPLYGRLVADNSI---------------QNQDILSMQARIPMQFRDPATAPLRKLSVDLI 53
+PLYGRLV + + + DI +MQARIP FRDP TAPLRKLSVDLI
Sbjct: 30 APLYGRLVTEEHLPAAHRDIHQRSISPTSSTDIRAMQARIPSHFRDPTTAPLRKLSVDLI 89
Query: 54 KTYKHINEVYYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYE 113
KTYKHINEVYY KKKR+AQ + E S+KKE+K ++NDG+DDEN+DYIIK+GEKFLDRYE
Sbjct: 90 KTYKHINEVYYAKKKRRAQQTQGEDTSHKKERK-LYNDGYDDENHDYIIKNGEKFLDRYE 148
Query: 114 IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY- 172
ID+L+GKGSFGQVVKA+DHEE+CQVAIKIIKNK+PFL+QAQIEV LLE +N+AD ++Y
Sbjct: 149 IDSLIGKGSFGQVVKAYDHEEECQVAIKIIKNKRPFLSQAQIEVNLLEMMNRADAENKYY 208
Query: 173 IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
IV+LK HF W+NHLCLVFELLSYNLY+L+RNTNF GVSLNLT+KFAQQLC AL FLSS E
Sbjct: 209 IVRLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFAQQLCTALLFLSSQE 268
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDL 292
L+IIHCDLKPENILLC+PKRSAIKI+DFGSSC +GQ +YQYIQSR+YRSPEVLLGIPYDL
Sbjct: 269 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIPYDL 328
Query: 293 AIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSD 352
AIDMWSLGCILVE+HTGEPLFSG NE DQ+ KI+EVLGMPP ++L A KT K+F++L D
Sbjct: 329 AIDMWSLGCILVEMHTGEPLFSGSNEADQINKIVEVLGMPPKHILDQAHKTRKFFEKLPD 388
Query: 353 NSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412
+YVL+K+ + RK + PG+++L ILGV+ GGPGGRR EPGHS++DY+KFKDLILRML
Sbjct: 389 GTYVLRKTQNQRKYKAPGTRKLHDILGVETGGPGGRRHGEPGHSVSDYLKFKDLILRMLD 448
Query: 413 YDPKKRISPTNVLRHEFFLKHS 434
YDPK R +P L+H FF + S
Sbjct: 449 YDPKTRCTPYYALQHNFFKRTS 470
|
Source: Aedes aegypti Species: Aedes aegypti Genus: Aedes Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|195041543|ref|XP_001991277.1| GH12565 [Drosophila grimshawi] gi|193901035|gb|EDV99901.1| GH12565 [Drosophila grimshawi] | Back alignment and taxonomy information |
|---|
Score = 649 bits (1675), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 309/439 (70%), Positives = 370/439 (84%), Gaps = 17/439 (3%)
Query: 9 SPLYGRLVADNSI--QNQDIL-------------SMQARIPMQFRDPATAPLRKLSVDLI 53
+PLYGR V + + ++D++ +MQARIP FRDPA APLRKLSV+LI
Sbjct: 47 APLYGRFVVEEELPATHRDVMHHHSSPSSSSEVRAMQARIPTHFRDPAAAPLRKLSVELI 106
Query: 54 KTYKHINEVYYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYE 113
KTYKHINEVYY KKKR+AQ + + S+ K+++ ++NDG+DD+N+DYIIK+GEKFLDRYE
Sbjct: 107 KTYKHINEVYYAKKKRRAQQTQGDDDSSNKKERKLYNDGYDDDNHDYIIKNGEKFLDRYE 166
Query: 114 IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY- 172
ID+L+GKGSFGQVVKA+DHEE+C VAIKIIKNKKPFLNQAQIEV+LLE +N+AD ++Y
Sbjct: 167 IDSLIGKGSFGQVVKAYDHEEQCHVAIKIIKNKKPFLNQAQIEVKLLEMMNRADAENKYY 226
Query: 173 IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
IVKLK HF W+NHLCLVFELLSYNLY+L+RNTNF GVSLNLT+KFAQQLC AL FLS+PE
Sbjct: 227 IVKLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFAQQLCTALLFLSTPE 286
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDL 292
L+IIHCDLKPENILLC+PKRSAIKI+DFGSSC +GQ +YQYIQSR+YRSPEVLLGI YDL
Sbjct: 287 LNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGIQYDL 346
Query: 293 AIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRL-S 351
AIDMWSLGCILVE+HTGEPLFSG NE DQM KI+EVLGMPP YLL A KT K+FD++ +
Sbjct: 347 AIDMWSLGCILVEMHTGEPLFSGCNEFDQMNKIVEVLGMPPKYLLDQAHKTRKFFDKIVT 406
Query: 352 DNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411
D SYVLKK+ + RK + PGS++L ILGV+ GGP GRR +EPGHS+ADY+KFKDLILRML
Sbjct: 407 DGSYVLKKTLNGRKYKPPGSRKLHDILGVETGGPAGRRLDEPGHSVADYLKFKDLILRML 466
Query: 412 TYDPKKRISPTNVLRHEFF 430
+DPK R++P L+H FF
Sbjct: 467 DFDPKTRVTPYYALQHNFF 485
|
Source: Drosophila grimshawi Species: Drosophila grimshawi Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328793644|ref|XP_392636.3| PREDICTED: serine/threonine-protein kinase minibrain-like isoform 1, partial [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 647 bits (1668), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 320/443 (72%), Positives = 371/443 (83%), Gaps = 23/443 (5%)
Query: 10 PLYGRLVADNSI--------------------QNQDILSMQARIPMQFRDPATAPLRKLS 49
PLYGRLVA+ + DI +MQARIP +FRDPATAPLRKLS
Sbjct: 80 PLYGRLVAEEPLPPTVCGGTGTGGGTGGIPQETPADIHAMQARIPHRFRDPATAPLRKLS 139
Query: 50 VDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFL 109
VDLIKTYKHINEVYY KKKR+AQ E S+KKE+K ++NDG DD+N+DYIIK+GEKFL
Sbjct: 140 VDLIKTYKHINEVYYAKKKRRAQQMQGEDGSHKKERK-LYNDGWDDDNHDYIIKNGEKFL 198
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
DRYEID+L+GKGSFGQVVKAFDHEE+ QVAIKIIKNKKPFLNQAQIEV+LLE +N+AD
Sbjct: 199 DRYEIDSLIGKGSFGQVVKAFDHEEQTQVAIKIIKNKKPFLNQAQIEVRLLEMMNRADTD 258
Query: 170 SRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228
++Y IVKLK HF W+NHLCLVFELLSYNLY+L+RNTNF GVSLNLT+KFAQQLC AL FL
Sbjct: 259 NKYYIVKLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFAQQLCTALLFL 318
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGI 288
S+PEL+IIHCDLKPENILLC+PKRSAIKI+DFGSSC +GQ +YQYIQSR+YRSPEVLLGI
Sbjct: 319 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGI 378
Query: 289 PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFD 348
PYDLAIDMWSLGCILVE+HTGEPLFSG NEVDQM KI+EVLGMPP ++L A K KYFD
Sbjct: 379 PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGMPPKHILDQAHKARKYFD 438
Query: 349 RL-SDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLI 407
++ +D SYVLKKS D +K + PG++RL ILGV++GGPGGRR EPGHS++DY+KFKDLI
Sbjct: 439 KVPTDGSYVLKKSKDGKKYKPPGTRRLHDILGVESGGPGGRRIGEPGHSISDYLKFKDLI 498
Query: 408 LRMLTYDPKKRISPTNVLRHEFF 430
LRML +DPK R++P L+H FF
Sbjct: 499 LRMLDFDPKTRVTPYYALQHNFF 521
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340710082|ref|XP_003393627.1| PREDICTED: serine/threonine-protein kinase minibrain-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 647 bits (1668), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 320/443 (72%), Positives = 371/443 (83%), Gaps = 23/443 (5%)
Query: 10 PLYGRLVADNSI--------------------QNQDILSMQARIPMQFRDPATAPLRKLS 49
PLYGRLVA+ + DI +MQARIP +FRDPATAPLRKLS
Sbjct: 71 PLYGRLVAEEPLPPTVCGGAGTGGGTGGVPQETPADIHAMQARIPHRFRDPATAPLRKLS 130
Query: 50 VDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFL 109
VDLIKTYKHINEVYY KKKR+AQ E S+KKE+K ++NDG DD+N+DYIIK+GEKFL
Sbjct: 131 VDLIKTYKHINEVYYAKKKRRAQQMQGEDGSHKKERK-LYNDGWDDDNHDYIIKNGEKFL 189
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
DRYEID+L+GKGSFGQVVKAFDHEE+ QVAIKIIKNKKPFLNQAQIEV+LLE +N+AD
Sbjct: 190 DRYEIDSLIGKGSFGQVVKAFDHEEQTQVAIKIIKNKKPFLNQAQIEVRLLEMMNRADTD 249
Query: 170 SRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228
++Y IVKLK HF W+NHLCLVFELLSYNLY+L+RNTNF GVSLNLT+KFAQQLC AL FL
Sbjct: 250 NKYYIVKLKRHFMWRNHLCLVFELLSYNLYDLLRNTNFRGVSLNLTRKFAQQLCTALLFL 309
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGI 288
S+PEL+IIHCDLKPENILLC+PKRSAIKI+DFGSSC +GQ +YQYIQSR+YRSPEVLLGI
Sbjct: 310 STPELNIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGI 369
Query: 289 PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFD 348
PYDLAIDMWSLGCILVE+HTGEPLFSG NEVDQM KI+EVLGMPP ++L A K KYFD
Sbjct: 370 PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGMPPKHILDQAHKARKYFD 429
Query: 349 RL-SDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLI 407
++ +D SYVLKKS D +K + PG++RL ILGV++GGPGGRR EPGHS++DY+KFKDLI
Sbjct: 430 KVPTDGSYVLKKSKDGKKYKPPGTRRLHDILGVESGGPGGRRIGEPGHSISDYLKFKDLI 489
Query: 408 LRMLTYDPKKRISPTNVLRHEFF 430
LRML +DPK R++P L+H FF
Sbjct: 490 LRMLDFDPKTRVTPYYALQHNFF 512
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 437 | ||||||
| FB|FBgn0259168 | 908 | mnb "minibrain" [Drosophila me | 0.942 | 0.453 | 0.712 | 3.6e-160 | |
| ZFIN|ZDB-GENE-060503-499 | 751 | dyrk1b "dual-specificity tyros | 0.951 | 0.553 | 0.694 | 1.5e-154 | |
| UNIPROTKB|F1N2J2 | 763 | DYRK1A "Uncharacterized protei | 0.931 | 0.533 | 0.687 | 9.5e-153 | |
| MGI|MGI:1330299 | 763 | Dyrk1a "dual-specificity tyros | 0.931 | 0.533 | 0.687 | 9.5e-153 | |
| RGD|2528 | 763 | Dyrk1a "dual-specificity tyros | 0.931 | 0.533 | 0.687 | 9.5e-153 | |
| UNIPROTKB|F8W9I9 | 541 | DYRK1A "Dual-specificity tyros | 0.931 | 0.752 | 0.687 | 1.2e-152 | |
| UNIPROTKB|Q13627 | 763 | DYRK1A "Dual specificity tyros | 0.931 | 0.533 | 0.687 | 1.2e-152 | |
| UNIPROTKB|E2R722 | 654 | DYRK1A "Uncharacterized protei | 0.931 | 0.622 | 0.685 | 5.2e-152 | |
| UNIPROTKB|I3L9V1 | 764 | LOC100625240 "Uncharacterized | 0.931 | 0.532 | 0.685 | 5.2e-152 | |
| UNIPROTKB|F1P0S9 | 756 | DYRK1A "Uncharacterized protei | 0.933 | 0.539 | 0.686 | 6.7e-152 |
| FB|FBgn0259168 mnb "minibrain" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1560 (554.2 bits), Expect = 3.6e-160, P = 3.6e-160
Identities = 297/417 (71%), Positives = 354/417 (84%)
Query: 23 NQDILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSH-NETRSN 81
+ ++ +MQARIP FR+PA+ PLRKLSVDLIKTYKHINEVYY KKKR+AQ + ++ SN
Sbjct: 75 SSEVRAMQARIPNHFREPASGPLRKLSVDLIKTYKHINEVYYAKKKRRAQQTQGDDDSSN 134
Query: 82 KKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIK 141
KKE+K ++NDG+DD+N+DYIIK+GEKFLDRYEID+L+GKGSFGQVVKA+DHEE+C VAIK
Sbjct: 135 KKERK-LYNDGYDDDNHDYIIKNGEKFLDRYEIDSLIGKGSFGQVVKAYDHEEQCHVAIK 193
Query: 142 IIKNKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNL 200
IIKNKKPFLNQAQIEV+LLE +N+AD ++Y IVKLK HF W+NHLCLVFELLSYNLY+L
Sbjct: 194 IIKNKKPFLNQAQIEVKLLEMMNRADAENKYYIVKLKRHFMWRNHLCLVFELLSYNLYDL 253
Query: 201 IRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260
+RNTNF GVSLNLT+KFAQQLC AL FLS+PEL+IIHCDLKPENILLC+PKRSAIKI+DF
Sbjct: 254 LRNTNFRGVSLNLTRKFAQQLCTALLFLSTPELNIIHCDLKPENILLCNPKRSAIKIVDF 313
Query: 261 GSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVD 320
GSSC +GQ +Y YIQSR+YRSPEVLLGI YDLAIDMWSLGCILVE+HTGEPLFSG NEVD
Sbjct: 314 GSSCQLGQRIYHYIQSRFYRSPEVLLGIQYDLAIDMWSLGCILVEMHTGEPLFSGCNEVD 373
Query: 321 QMTKIIEVLGMPPGYLLHGASKTSKYFDRL-SDNSYVLKKSTDTRKERLPGSKRLDTILG 379
QM KI+EVLGMPP YLL A KT K+FD++ +D SYVLKK+ + RK + PGS++L ILG
Sbjct: 374 QMNKIVEVLGMPPKYLLDQAHKTRKFFDKIVADGSYVLKKNQNGRKYKPPGSRKLHDILG 433
Query: 380 VDXXXXXXXXXXXXXHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHSVD 436
V+ HS++DY+KFKDLILRML +DPK R++P L+H FF K + D
Sbjct: 434 VETGGPGGRRLDEPGHSVSDYLKFKDLILRMLDFDPKTRVTPYYALQHNFF-KRTAD 489
|
|
| ZFIN|ZDB-GENE-060503-499 dyrk1b "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1507 (535.5 bits), Expect = 1.5e-154, P = 1.5e-154
Identities = 291/419 (69%), Positives = 342/419 (81%)
Query: 16 VADNSIQNQDILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSH 75
+AD D+ +Q RIP FRDPA+APLRKLSVDLIKTYKHINEVYYTKKKR+AQ
Sbjct: 16 MADQQQVLSDMTILQRRIPPSFRDPASAPLRKLSVDLIKTYKHINEVYYTKKKRRAQQVP 75
Query: 76 NETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEK 135
E S KKE+K V+NDG+DD+NYDYI+K+GEK+LDRYEID+L+GKGSFGQVVKA+DH E+
Sbjct: 76 PEDSSTKKERK-VYNDGYDDDNYDYIVKNGEKWLDRYEIDSLIGKGSFGQVVKAYDHHEQ 134
Query: 136 CQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLS 194
VAIKIIKNKK FLNQAQIE++LLE +NK D +Y IV LK HF ++NHLCLVFELLS
Sbjct: 135 EWVAIKIIKNKKAFLNQAQIELRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFELLS 194
Query: 195 YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA 254
YNLY+L+RNTNF GVSLNLT+KFAQQLC AL FL++PELSIIHCDLKPENILLC+PKRSA
Sbjct: 195 YNLYDLLRNTNFRGVSLNLTRKFAQQLCTALLFLATPELSIIHCDLKPENILLCNPKRSA 254
Query: 255 IKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFS 314
IKI+DFGSSC +GQ +YQYIQSR+YRSPEVLLG+PYDLAIDMWSLGCILVE+HTGEPLFS
Sbjct: 255 IKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS 314
Query: 315 GKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE-RLPGSKR 373
G NEVDQM KI+EVLG+PP ++L A K KYFD+LSD + +KK+ D +KE + P ++R
Sbjct: 315 GSNEVDQMNKIVEVLGVPPNHMLDQAPKARKYFDKLSDGLWTVKKNKDIKKEYKPPATRR 374
Query: 374 LDTILGVDXXXXXXXXXXXXXHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432
L ILGV+ H+ DY+KFKDLILRML YDPK RI+P L+H FF K
Sbjct: 375 LHEILGVETGGPGGRRAGEQGHAPCDYLKFKDLILRMLDYDPKTRITPFYALQHNFFKK 433
|
|
| UNIPROTKB|F1N2J2 DYRK1A "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1490 (529.6 bits), Expect = 9.5e-153, P = 9.5e-153
Identities = 282/410 (68%), Positives = 340/410 (82%)
Query: 25 DILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKE 84
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYY KKKR+ Q + S+KKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 85 KKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK 144
+K V+NDG+DD+NYDYI+K+GEK++DRYEID+L+GKGSFGQVVKA+D E+ VAIKIIK
Sbjct: 133 RK-VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK 191
Query: 145 NKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRN 203
NKK FLNQAQIEV+LLE +NK D +Y IV LK HF ++NHLCLVFE+LSYNLY+L+RN
Sbjct: 192 NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRN 251
Query: 204 TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263
TNF GVSLNLT+KFAQQ+C AL FL++PELSIIHCDLKPENILLC+PKRSAIKI+DFGSS
Sbjct: 252 TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 311
Query: 264 CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323
C +GQ +YQYIQSR+YRSPEVLLG+PYDLAIDMWSLGCILVE+HTGEPLFSG NEVDQM
Sbjct: 312 CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 371
Query: 324 KIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE-RLPGSKRLDTILGVDX 382
KI+EVLG+PP ++L A K K+F++L D ++ LKK+ D ++E + PG+++L ILGV+
Sbjct: 372 KIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVET 431
Query: 383 XXXXXXXXXXXXHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432
H++ADY+KFKDLILRML YDPK RI P L+H FF K
Sbjct: 432 GGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKSRIQPYYALQHSFFKK 481
|
|
| MGI|MGI:1330299 Dyrk1a "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1490 (529.6 bits), Expect = 9.5e-153, P = 9.5e-153
Identities = 282/410 (68%), Positives = 340/410 (82%)
Query: 25 DILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKE 84
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYY KKKR+ Q + S+KKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 85 KKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK 144
+K V+NDG+DD+NYDYI+K+GEK++DRYEID+L+GKGSFGQVVKA+D E+ VAIKIIK
Sbjct: 133 RK-VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK 191
Query: 145 NKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRN 203
NKK FLNQAQIEV+LLE +NK D +Y IV LK HF ++NHLCLVFE+LSYNLY+L+RN
Sbjct: 192 NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRN 251
Query: 204 TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263
TNF GVSLNLT+KFAQQ+C AL FL++PELSIIHCDLKPENILLC+PKRSAIKI+DFGSS
Sbjct: 252 TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 311
Query: 264 CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323
C +GQ +YQYIQSR+YRSPEVLLG+PYDLAIDMWSLGCILVE+HTGEPLFSG NEVDQM
Sbjct: 312 CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 371
Query: 324 KIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE-RLPGSKRLDTILGVDX 382
KI+EVLG+PP ++L A K K+F++L D ++ LKK+ D ++E + PG+++L ILGV+
Sbjct: 372 KIVEVLGIPPAHILDQAPKARKFFEKLPDGTWSLKKTKDGKREYKPPGTRKLHNILGVET 431
Query: 383 XXXXXXXXXXXXHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432
H++ADY+KFKDLILRML YDPK RI P L+H FF K
Sbjct: 432 GGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 481
|
|
| RGD|2528 Dyrk1a "dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1490 (529.6 bits), Expect = 9.5e-153, P = 9.5e-153
Identities = 282/410 (68%), Positives = 340/410 (82%)
Query: 25 DILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKE 84
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYY KKKR+ Q + S+KKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 85 KKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK 144
+K V+NDG+DD+NYDYI+K+GEK++DRYEID+L+GKGSFGQVVKA+D E+ VAIKIIK
Sbjct: 133 RK-VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK 191
Query: 145 NKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRN 203
NKK FLNQAQIEV+LLE +NK D +Y IV LK HF ++NHLCLVFE+LSYNLY+L+RN
Sbjct: 192 NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRN 251
Query: 204 TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263
TNF GVSLNLT+KFAQQ+C AL FL++PELSIIHCDLKPENILLC+PKRSAIKI+DFGSS
Sbjct: 252 TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 311
Query: 264 CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323
C +GQ +YQYIQSR+YRSPEVLLG+PYDLAIDMWSLGCILVE+HTGEPLFSG NEVDQM
Sbjct: 312 CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 371
Query: 324 KIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE-RLPGSKRLDTILGVDX 382
KI+EVLG+PP ++L A K K+F++L D ++ LKK+ D ++E + PG+++L ILGV+
Sbjct: 372 KIVEVLGIPPAHILDQAPKARKFFEKLPDGTWSLKKTKDGKREYKPPGTRKLHNILGVET 431
Query: 383 XXXXXXXXXXXXHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432
H++ADY+KFKDLILRML YDPK RI P L+H FF K
Sbjct: 432 GGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 481
|
|
| UNIPROTKB|F8W9I9 DYRK1A "Dual-specificity tyrosine-phosphorylation-regulated kinase 1A" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1489 (529.2 bits), Expect = 1.2e-152, P = 1.2e-152
Identities = 282/410 (68%), Positives = 340/410 (82%)
Query: 25 DILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKE 84
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYY KKKR+ Q + S+KKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 85 KKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK 144
+K V+NDG+DD+NYDYI+K+GEK++DRYEID+L+GKGSFGQVVKA+D E+ VAIKIIK
Sbjct: 133 RK-VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK 191
Query: 145 NKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRN 203
NKK FLNQAQIEV+LLE +NK D +Y IV LK HF ++NHLCLVFE+LSYNLY+L+RN
Sbjct: 192 NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRN 251
Query: 204 TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263
TNF GVSLNLT+KFAQQ+C AL FL++PELSIIHCDLKPENILLC+PKRSAIKI+DFGSS
Sbjct: 252 TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 311
Query: 264 CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323
C +GQ +YQYIQSR+YRSPEVLLG+PYDLAIDMWSLGCILVE+HTGEPLFSG NEVDQM
Sbjct: 312 CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 371
Query: 324 KIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE-RLPGSKRLDTILGVDX 382
KI+EVLG+PP ++L A K K+F++L D ++ LKK+ D ++E + PG+++L ILGV+
Sbjct: 372 KIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVET 431
Query: 383 XXXXXXXXXXXXHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432
H++ADY+KFKDLILRML YDPK RI P L+H FF K
Sbjct: 432 GGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 481
|
|
| UNIPROTKB|Q13627 DYRK1A "Dual specificity tyrosine-phosphorylation-regulated kinase 1A" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1489 (529.2 bits), Expect = 1.2e-152, P = 1.2e-152
Identities = 282/410 (68%), Positives = 340/410 (82%)
Query: 25 DILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKE 84
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYY KKKR+ Q + S+KKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 85 KKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK 144
+K V+NDG+DD+NYDYI+K+GEK++DRYEID+L+GKGSFGQVVKA+D E+ VAIKIIK
Sbjct: 133 RK-VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK 191
Query: 145 NKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRN 203
NKK FLNQAQIEV+LLE +NK D +Y IV LK HF ++NHLCLVFE+LSYNLY+L+RN
Sbjct: 192 NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRN 251
Query: 204 TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263
TNF GVSLNLT+KFAQQ+C AL FL++PELSIIHCDLKPENILLC+PKRSAIKI+DFGSS
Sbjct: 252 TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 311
Query: 264 CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323
C +GQ +YQYIQSR+YRSPEVLLG+PYDLAIDMWSLGCILVE+HTGEPLFSG NEVDQM
Sbjct: 312 CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 371
Query: 324 KIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE-RLPGSKRLDTILGVDX 382
KI+EVLG+PP ++L A K K+F++L D ++ LKK+ D ++E + PG+++L ILGV+
Sbjct: 372 KIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVET 431
Query: 383 XXXXXXXXXXXXHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432
H++ADY+KFKDLILRML YDPK RI P L+H FF K
Sbjct: 432 GGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 481
|
|
| UNIPROTKB|E2R722 DYRK1A "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1483 (527.1 bits), Expect = 5.2e-152, P = 5.2e-152
Identities = 281/410 (68%), Positives = 339/410 (82%)
Query: 25 DILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKE 84
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYY KKKR+ Q + S+KKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 85 KKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK 144
+K V+NDG+DD+NYDYI+K+GEK++DRYEID+L+GKGSFGQVVKA+D E+ VAIKIIK
Sbjct: 133 RK-VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK 191
Query: 145 NKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRN 203
NKK FLNQAQIEV+LLE +NK D +Y IV LK HF ++NHLCLVFE+LSYNLY+L+RN
Sbjct: 192 NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRN 251
Query: 204 TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263
TNF GVSLNLT+KFAQQ+C AL FL++PELSIIHCDLKPENILLC+PKRSAIKI+DFGSS
Sbjct: 252 TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 311
Query: 264 CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323
C +GQ +YQYIQSR+YRSPEVLLG+PYDLAIDMWSLGCILVE+HTGEPLFSG NEVDQM
Sbjct: 312 CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 371
Query: 324 KIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE-RLPGSKRLDTILGVDX 382
KI+EVL +PP ++L A K K+F++L D ++ LKK+ D ++E + PG+++L ILGV+
Sbjct: 372 KIVEVLSIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVET 431
Query: 383 XXXXXXXXXXXXHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432
H++ADY+KFKDLILRML YDPK RI P L+H FF K
Sbjct: 432 GGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 481
|
|
| UNIPROTKB|I3L9V1 LOC100625240 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 1483 (527.1 bits), Expect = 5.2e-152, P = 5.2e-152
Identities = 281/410 (68%), Positives = 339/410 (82%)
Query: 25 DILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKE 84
DI+ +Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYY KKKR+ Q + S+KKE
Sbjct: 73 DIVMLQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKKE 132
Query: 85 KKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK 144
+K V+NDG+DD+NYDYI+K+GEK++DRYEID+L+GKGSFGQVVKA+D E+ VAIKIIK
Sbjct: 133 RK-VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK 191
Query: 145 NKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRN 203
NKK FLNQAQIEV+LLE +NK D +Y IV LK HF ++NHLCLVFE+LSYNLY+L+RN
Sbjct: 192 NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRN 251
Query: 204 TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263
TNF GVSLNLT+KFAQQ+C AL FL++PELSIIHCDLKPENILLC+PKRSAIKI+DFGSS
Sbjct: 252 TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 311
Query: 264 CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323
C +GQ +YQYIQSR+YRSPEVLLG+PYDLAIDMWSLGCILVE+HTGEPLFSG NEVDQM
Sbjct: 312 CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 371
Query: 324 KIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE-RLPGSKRLDTILGVDX 382
KI+EVLG+PP ++L A K K+F++L D ++ LKK+ D ++E + P +++L ILGV+
Sbjct: 372 KIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPATRKLHNILGVET 431
Query: 383 XXXXXXXXXXXXHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432
H++ADY+KFKDLILRML YDPK RI P L+H FF K
Sbjct: 432 GGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 481
|
|
| UNIPROTKB|F1P0S9 DYRK1A "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1482 (526.7 bits), Expect = 6.7e-152, P = 6.7e-152
Identities = 282/411 (68%), Positives = 339/411 (82%)
Query: 24 QDILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKK 83
Q L+ Q R+P FRDPATAPLRKLSVDLIKTYKHINEVYY KKKR+ Q + S+KK
Sbjct: 64 QQPLTNQRRMPQTFRDPATAPLRKLSVDLIKTYKHINEVYYAKKKRRHQQGQGDDSSHKK 123
Query: 84 EKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII 143
E+K V+NDG+DD+NYDYI+K+GEK++DRYEID+L+GKGSFGQVVKA+D E+ VAIKII
Sbjct: 124 ERK-VYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII 182
Query: 144 KNKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIR 202
KNKK FLNQAQIEV+LLE +NK D +Y IV LK HF ++NHLCLVFE+LSYNLY+L+R
Sbjct: 183 KNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLR 242
Query: 203 NTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262
NTNF GVSLNLT+KFAQQ+C AL FL++PELSIIHCDLKPENILLC+PKRSAIKI+DFGS
Sbjct: 243 NTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 302
Query: 263 SCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQM 322
SC +GQ +YQYIQSR+YRSPEVLLG+PYDLAIDMWSLGCILVE+HTGEPLFSG NEVDQM
Sbjct: 303 SCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQM 362
Query: 323 TKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE-RLPGSKRLDTILGVD 381
KI+EVLG+PP ++L A K K+F++L D ++ LKK+ D ++E + PG+++L ILGV+
Sbjct: 363 NKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVE 422
Query: 382 XXXXXXXXXXXXXHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432
H++ADY+KFKDLILRML YDPK RI P L+H FF K
Sbjct: 423 TGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 473
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q8WQL7 | MBK1_CAEEL | 2, ., 7, ., 1, 2, ., 1 | 0.6570 | 0.7826 | 0.3877 | yes | N/A |
| Q63470 | DYR1A_RAT | 2, ., 7, ., 1, 2, ., 2 | 0.7097 | 0.9313 | 0.5334 | yes | N/A |
| Q13627 | DYR1A_HUMAN | 2, ., 7, ., 1, 2, ., 1 | 0.7097 | 0.9313 | 0.5334 | yes | N/A |
| Q61214 | DYR1A_MOUSE | 2, ., 7, ., 1, 2, ., 1 | 0.7097 | 0.9313 | 0.5334 | yes | N/A |
| Q76NV1 | DYRK1_DICDI | 2, ., 7, ., 1, 2, ., 1 | 0.6289 | 0.7848 | 0.4102 | yes | N/A |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 437 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-67 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-58 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-57 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-54 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-54 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-48 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-47 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-46 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-44 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-44 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-43 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-43 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-42 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-41 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-40 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-40 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-40 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-39 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-38 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-37 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-37 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-36 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-36 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-35 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-35 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-35 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-35 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-34 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-34 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-34 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-33 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-33 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-33 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-33 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-33 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-32 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-32 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-30 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-30 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-29 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-29 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-29 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-29 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-29 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-29 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-28 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-28 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-27 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-27 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-27 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-26 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-26 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-26 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-26 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-25 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-25 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-24 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-23 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-22 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-21 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-20 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-20 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-20 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-19 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-18 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-17 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-16 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-16 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-14 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-07 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-05 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-05 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 6e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-05 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-04 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-04 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 0.001 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 0.001 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.004 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 213 bits (545), Expect = 8e-67
Identities = 81/220 (36%), Positives = 124/220 (56%), Gaps = 16/220 (7%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIH 169
YEI LG+GSFG+V A D + VAIK+IK KK + E+++L+K+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-----K 55
Query: 170 SRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228
IV+L F ++ L LV E +L++L++ +S + + + +Q+ AL +L
Sbjct: 56 HPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYL 113
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRYYRSPEVLL 286
S I+H DLKPENILL +K+ DFG + + G+ L ++ + Y +PEVLL
Sbjct: 114 HS--KGIVHRDLKPENILLDEDGH--VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169
Query: 287 GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
G Y A+D+WSLG IL EL TG+P F G +++ ++ K I
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKI 209
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 191 bits (489), Expect = 4e-58
Identities = 106/326 (32%), Positives = 152/326 (46%), Gaps = 51/326 (15%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADI 168
YE LG+G++G V KA D + VA+K I+ + A E+ LL+++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK---- 56
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228
H IVKL + L LVFE +L + +S NL K QL LA+
Sbjct: 57 HP-NIVKLLDVIHTERKLYLVFEYCDMDLKKYLDK-RPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY---IQSRYYRSPEVL 285
S I+H DLKP+NIL+ + +K+ DFG + G L Y + + +YR+PE+L
Sbjct: 115 HSH--RILHRDLKPQNILI--NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEIL 170
Query: 286 LGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344
LG Y A+D+WS+GCI E+ TG+PLF G +E+DQ+ KI ++LG P G
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPG----- 225
Query: 345 KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFK 404
+L D K E++ RLD G
Sbjct: 226 --VTKLPDYKPTFPKFPPKDLEKV--LPRLD-----PEG--------------------I 256
Query: 405 DLILRMLTYDPKKRISPTNVLRHEFF 430
DL+ +ML Y+P KRIS L+H +F
Sbjct: 257 DLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 6e-57
Identities = 107/328 (32%), Positives = 153/328 (46%), Gaps = 54/328 (16%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQ-----AQIEVQLLEKINKA 166
Y+ +G+G++G V KA D VAIK K K F ++ A E++LL+++N
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIK--KIKLRFESEGIPKTALREIKLLKELNHP 58
Query: 167 DIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
I+KL F K L LVFE + +LY LI+ G+ +L K + QL LA
Sbjct: 59 -----NIIKLLDVFRHKGDLYLVFEFMDTDLYKLIK-DRQRGLPESLIKSYLYQLLQGLA 112
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG---QTLYQYIQSRYYRSPE 283
F S I+H DLKPEN+L+ + +K+ DFG + G + Y+ +R+YR+PE
Sbjct: 113 FCHSH--GILHRDLKPENLLINTE--GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPE 168
Query: 284 VLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342
+LLG Y +D+WS+GCI EL + PLF GK+E+DQ+ KI LG P +
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTP-------DPE 221
Query: 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMK 402
F L+ N P + N P
Sbjct: 222 VWPKFTSLARNYKF----------SFPKKAGMPLPKLFPNASPQAL-------------- 257
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEFF 430
DL+ +ML YDP KRI+ L H +F
Sbjct: 258 --DLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 2e-54
Identities = 88/230 (38%), Positives = 124/230 (53%), Gaps = 19/230 (8%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK---NKKPFLNQAQIEVQLLEKINKADI 168
YE+ LG GSFG V KA VA+KI+K K A+ E+++L +++
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS---- 56
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
H IV+L F K+HL LV E +L++ + +S + KK A Q+ L +
Sbjct: 57 HP-NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEY 113
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC---HVGQTLYQYIQSRYYRSPEV 284
L S IIH DLKPENILL + +KI DFG + +L ++ + +Y +PEV
Sbjct: 114 LHS--NGIIHRDLKPENILLD--ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEV 169
Query: 285 LL-GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
LL G Y +D+WSLG IL EL TG+P FSG+N +DQ+ I +LG P
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL 219
|
Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 4e-54
Identities = 107/330 (32%), Positives = 154/330 (46%), Gaps = 58/330 (17%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF--------LNQAQIEVQLLEKI 163
Y++ LG G+FG V A + E VAIK K KK F L EV+ L K+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIK--KMKKKFYSWEECMNLR----EVKSLRKL 54
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCC 223
N+ H IVKLK F + L VFE + NLY L+++ S ++ + Q+
Sbjct: 55 NE---H-PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRYYRS 281
LA + H DLKPEN+L+ P+ +KI DFG + + Y+ +R+YR+
Sbjct: 111 GLAHIHK--HGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTDYVSTRWYRA 166
Query: 282 PEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340
PE+LL Y +D+W+LGCI+ EL+T PLF G +E+DQ+ KI VLG P
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTP-------- 218
Query: 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADY 400
T + + Y L R + + L ++ P S
Sbjct: 219 --TKQDWPE----GYKLASKLGFRFPQFAPT-SLHQLI--------------PNASPE-- 255
Query: 401 MKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
DLI ML +DPKKR + + L+H +F
Sbjct: 256 --AIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 2e-48
Identities = 96/333 (28%), Positives = 151/333 (45%), Gaps = 61/333 (18%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF---LNQAQIEVQLLEKINKAD 167
RY+I +G+G+ G V KA D E VA+K + ++ NQA E++ L+
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ--- 57
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
Y+VKL F + LV E + +L ++R+ + K + + L +A+
Sbjct: 58 --HPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAY 114
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG-SSCHVGQTLYQY---IQSRYYRSPE 283
+ I+H DLKP N+L+ + +KI DFG + + Y + +R+YR+PE
Sbjct: 115 MH--ANGIMHRDLKPANLLISA--DGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
Query: 284 VLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP-----PGYLL 337
+L G YD +D+W++GCI EL G PLF G+N+++Q+ + LG P PG
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGL-- 228
Query: 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSL 397
L D + + T E P L+ I P + +L
Sbjct: 229 ----------TSLPDYNKI------TFPESKP--IPLEEIF------P-----DASPEAL 259
Query: 398 ADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
DL+ +L YDP KR+S LRH +F
Sbjct: 260 -------DLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 3e-48
Identities = 103/346 (29%), Positives = 152/346 (43%), Gaps = 80/346 (23%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-------EVQLLEKI 163
RYE+ +G G++G V A D +VAIK I N F I E++LL +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN--VF--DDLIDAKRILREIKLLRHL 56
Query: 164 NKADIHSRYIVKLKGHFTWK-----NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFA 218
H I+ L N + +V EL+ +L+ +I++ LT
Sbjct: 57 R----H-ENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS------PQPLTDDHI 105
Query: 219 Q----QLCCALAFLSSPELSIIHCDLKPENILL---CSPKRSAIKIIDFGSSCHVG---- 267
Q Q+ L +L S ++IH DLKP NIL+ C +KI DFG + V
Sbjct: 106 QYFLYQILRGLKYLHSA--NVIHRDLKPSNILVNSNCD-----LKICDFGLARGVDPDED 158
Query: 268 --QTLYQYIQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTK 324
L +Y+ +R+YR+PE+LL Y AID+WS+GCI EL T +PLF G++ +DQ+
Sbjct: 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL 218
Query: 325 IIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGG 384
I+EVLG P + K+ +Y+ K + P SK
Sbjct: 219 IVEVLGTPS-------EEDLKFITSEKARNYLKSLPK---KPKKPLSKLFPGA------- 261
Query: 385 PGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
+ DL+ +ML +DPKKRI+ L H +
Sbjct: 262 ---------------SPEAIDLLEKMLVFDPKKRITADEALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 1e-47
Identities = 76/196 (38%), Positives = 102/196 (52%), Gaps = 16/196 (8%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKINKADIHSRYIVK 175
LG+G FG V A D + +VAIKIIK + L + E+++L+K+N IVK
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-----HPNIVK 55
Query: 176 LKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELS 234
L G F +NHL LV E +L +L++ N +S + + Q+ L +L S
Sbjct: 56 LYGVFEDENHLYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLHS--NG 112
Query: 235 IIHCDLKPENILLCSPKRSAIKIIDFGSSC---HVGQTLYQYIQSRYYRSPEVLLGIP-Y 290
IIH DLKPENILL S +K+ DFG S L + + Y +PEVLLG Y
Sbjct: 113 IIHRDLKPENILLDSDNGK-VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 291 DLAIDMWSLGCILVEL 306
D+WSLG IL EL
Sbjct: 172 SEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-46
Identities = 99/329 (30%), Positives = 152/329 (46%), Gaps = 57/329 (17%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI----EVQLLEKINKAD 167
Y+I +G+G+F +V+KA + AIK +K F + Q+ E+Q L +++
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKH--FKSLEQVNNLREIQALRRLS--- 55
Query: 168 IHSRYIVKLKGHFTWKNH--LCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCAL 225
I++L + L LVFEL+ NLY LI+ + K + QL +L
Sbjct: 56 -PHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRP-LPEKRVKSYMYQLLKSL 113
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC--HVGQTLYQYIQSRYYRSPE 283
+ I H D+KPENIL+ K +K+ DFGS + +YI +R+YR+PE
Sbjct: 114 DHMHRN--GIFHRDIKPENILI---KDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPE 168
Query: 284 VLL--GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341
LL G Y +D+W++GC+ E+ + PLF G NE+DQ+ KI +VLG P +L
Sbjct: 169 CLLTDGY-YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL---- 223
Query: 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYM 401
K F + +Y T +L + N G
Sbjct: 224 ---KKFRKSRHMNYNFPSKKGTGLRKL-----------LPNASAEGL------------- 256
Query: 402 KFKDLILRMLTYDPKKRISPTNVLRHEFF 430
DL+ ++L YDP +RI+ LRH +F
Sbjct: 257 ---DLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 4e-44
Identities = 101/343 (29%), Positives = 156/343 (45%), Gaps = 80/343 (23%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKP-FLNQAQIEVQLLEKINKADI 168
YE +G+G++GQV KA + + VA+K I+ N+K F A E++LL+K+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR---- 56
Query: 169 HSRYIVKLKGHFT--WKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
H IV+LK T K + +VFE + ++L L+ + + + K + +QL L
Sbjct: 57 H-PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-FTESQIKCYMKQLLEGLQ 114
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR--------- 277
+L S I+H D+K NIL+ + +K+ DFG L + R
Sbjct: 115 YLHSN--GILHRDIKGSNILINN--DGVLKLADFG--------LARPYTKRNSADYTNRV 162
Query: 278 ---YYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
+YR PE+LLG Y +DMWS+GCIL EL G+P+F G E++Q+ KI E+ G P
Sbjct: 163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP- 221
Query: 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEP 393
T + + +S + +R
Sbjct: 222 ---------TDENWPGVSKLPWFENLKPKKPYKR-------------------------- 246
Query: 394 GHSLADYMKFK------DLILRMLTYDPKKRISPTNVLRHEFF 430
L ++ K DL+ ++LT DPKKRIS L+HE+F
Sbjct: 247 --RLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 5e-44
Identities = 94/331 (28%), Positives = 155/331 (46%), Gaps = 53/331 (16%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK---NKKPFLNQAQIEVQLLEKINKA 166
++YE+ ++G+G++G V+K + VAIK K + + A EV++L ++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL--- 57
Query: 167 DIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLI-RNTNFHGVSLNLTKKFAQQLCCAL 225
IV LK F K L LVFE + L L+ + G+ + + + QL A+
Sbjct: 58 --RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPG--GLPPDAVRSYIWQLLQAI 113
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG----SSCHVGQTLYQYIQSRYYRS 281
A+ S +IIH D+KPENIL+ + +K+ DFG L Y+ +R+YR+
Sbjct: 114 AYCHS--HNIIHRDIKPENILV--SESGVLKLCDFGFARALRARPASPLTDYVATRWYRA 169
Query: 282 PEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLG-MPPGYLLHG 339
PE+L+G Y +D+W++GCI+ EL GEPLF G +++DQ+ I + LG +PP H
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPS---HQ 226
Query: 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLAD 399
S N P + +++ R + D
Sbjct: 227 E--------LFSSNPRF-------AGVAFPEPSQPESLE--------RRYPGKVSSPALD 263
Query: 400 YMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
++K L DPK+R++ +L+H +F
Sbjct: 264 FLK------ACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 5e-43
Identities = 98/338 (28%), Positives = 149/338 (44%), Gaps = 70/338 (20%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQI-EVQLLEKINKADI 168
YE +G+G++G V KA D VA+K ++ + + + + E+ LL+++ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE- 59
Query: 169 HSRYIVKL----KGHFTWKN-HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCC 223
H IV+L G T + L LVFE + +L + G+ K +QL
Sbjct: 60 HP-NIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG-----------SSCHVGQTLYQ 272
+ FL S I+H DLKP+NIL+ S + +KI DFG +S V TL+
Sbjct: 119 GVDFLHSH--RIVHRDLKPQNILVTSDGQ--VKIADFGLARIYSFEMALTSVVV--TLW- 171
Query: 273 YIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332
YR+PEVLL Y +DMWS+GCI EL PLF G +E DQ+ KI +V+G+P
Sbjct: 172 ------YRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLP 225
Query: 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNE 392
+ N + + S + + + G
Sbjct: 226 SE-------------EEWPRNVSLPRSSFPSY----TPRSFKSFVPEICEEG-------- 260
Query: 393 PGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
DL+ +MLT++P KRIS L+H +F
Sbjct: 261 -----------LDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 6e-43
Identities = 106/339 (31%), Positives = 160/339 (47%), Gaps = 63/339 (18%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQ--AQI---EVQLLEKI 163
L +YEI LGKG++G V KA D K VA+K I + F N AQ E+ L+++
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA--FRNATDAQRTFREIMFLQEL 63
Query: 164 NKADIHSRYIVKLKGHFTWKNH--LCLVFELLSYNLYNLIRNTNFHGVSLNLTKKF-AQQ 220
IVKL +N + LVFE + +L+ +IR + ++ K++ Q
Sbjct: 64 GDHP----NIVKLLNVIKAENDKDIYLVFEYMETDLHAVIR----ANILEDVHKRYIMYQ 115
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG--------SSCHVGQTLYQ 272
L AL ++ S + IH DLKP NILL S R +K+ DFG L
Sbjct: 116 LLKALKYIHSGNV--IHRDLKPSNILLNSDCR--VKLADFGLARSLSELEENPENPVLTD 171
Query: 273 YIQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331
Y+ +R+YR+PE+LLG Y +DMWS+GCIL E+ G+PLF G + ++Q+ KIIEV+G
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231
Query: 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRN 391
P + S S + + D+ + E LP + D +
Sbjct: 232 PSAEDI--ESIKSPFAATMLDSLPSRPR--KPLDELLPKASD-DAL-------------- 272
Query: 392 EPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
DL+ ++L ++P KR++ L H +
Sbjct: 273 -------------DLLKKLLVFNPNKRLTAEEALEHPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 1e-42
Identities = 99/339 (29%), Positives = 148/339 (43%), Gaps = 73/339 (21%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF-----LNQAQI-EVQLLEKIN 164
RYE LG+G++ V KA D E VAIK IK + +N + E++LL+++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 165 KADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLT----KKFAQQ 220
+I + L F K+++ LVFE + +L +I++ S+ LT K +
Sbjct: 61 HPNI-----IGLLDVFGHKSNINLVFEFMETDLEKVIKDK-----SIVLTPADIKSYMLM 110
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY---IQSR 277
L +L S I+H DLKP N+L+ S +K+ DFG + G + + +R
Sbjct: 111 TLRGLEYLHS--NWILHRDLKPNNLLIAS--DGVLKLADFGLARSFGSPNRKMTHQVVTR 166
Query: 278 YYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP---- 332
+YR+PE+L G Y + +DMWS+GCI EL P G +++DQ+ KI E LG P
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN 226
Query: 333 -PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRN 391
PG S YV K P L I
Sbjct: 227 WPGV--------------TSLPDYVEFKPF-------PP-TPLKQIFPAA---------- 254
Query: 392 EPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
D ++ R+LT +P KRI+ L H +F
Sbjct: 255 --SDDALDLLQ------RLLTLNPNKRITARQALEHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 8e-41
Identities = 100/347 (28%), Positives = 162/347 (46%), Gaps = 65/347 (18%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI---EVQLLEKINKA 166
RY+ +G G++G V A D +VAIK I + A+ E+++L
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 167 DIHS-RYIVKLKG-HFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCA 224
+I + R I++ G F + +V +L+ +L+++I + ++ + F QL
Sbjct: 65 NIIAIRDILRPPGADF---KDVYVVMDLMESDLHHIIHSD--QPLTEEHIRYFLYQLLRG 119
Query: 225 LAFLSSPELSIIHCDLKPENILL---CSPKRSAIKIIDFG-------SSCHVGQTLYQYI 274
L ++ S ++IH DLKP N+L+ C ++I DFG S + +Y+
Sbjct: 120 LKYIHSA--NVIHRDLKPSNLLVNEDCE-----LRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 275 QSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
+R+YR+PE+LL +P Y AIDMWS+GCI E+ LF GKN V Q+ I+ VLG P
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS 232
Query: 334 GYLLH--GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRN 391
+L+ G+ + KY L RK+ +P I P
Sbjct: 233 EEVLNRIGSDRVRKYIQNLP------------RKQPVP----WSKIF------PKASP-- 268
Query: 392 EPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK-HSVDN 437
+L DL+ +ML +DP++RI+ L+H F + H D+
Sbjct: 269 ---EAL-------DLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD 305
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 101/330 (30%), Positives = 153/330 (46%), Gaps = 50/330 (15%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKA 166
D YE + +G++G V +A D + VA+K +K +K F + E+ +L K+
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64
Query: 167 DI-HSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCAL 225
+I + +V + + +V E + ++L +L+ T + K QL +
Sbjct: 65 NIVTVKEVVVGSNL----DKIYMVMEYVEHDLKSLM-ETMKQPFLQSEVKCLMLQLLSGV 119
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ---SRYYRSP 282
A L + I+H DLK N+LL R +KI DFG + G L Y Q + +YR+P
Sbjct: 120 AHLH--DNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAP 175
Query: 283 EVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341
E+LLG Y AIDMWS+GCI EL T +PLF GK+E+DQ+ KI ++LG P
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP--------- 226
Query: 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVD-NGGPGGRRRNEPGHSLADY 400
++ + PG L P + R +
Sbjct: 227 ---------TEKIW-------------PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSD 264
Query: 401 MKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
F DL+ R+LTYDP KRIS + L+H +F
Sbjct: 265 NGF-DLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-40
Identities = 101/337 (29%), Positives = 156/337 (46%), Gaps = 54/337 (16%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQ-----AQIEVQLLEKI 163
L RY+ +G G+ G V A+D VAIK K +PF N A E+ L++ +
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIK--KLSRPFQNVTHAKRAYRELVLMKLV 72
Query: 164 NKADIHSRYIVKLKGHFTWK------NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKF 217
N +I + L FT + + LV EL+ NL +I+ H
Sbjct: 73 NHKNI-----IGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH----ERMSYL 123
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG--SSCHVGQTLYQYIQ 275
Q+ C + L S IIH DLKP NI++ S +KI+DFG + + Y+
Sbjct: 124 LYQMLCGIKHLHSA--GIIHRDLKPSNIVVKS--DCTLKILDFGLARTAGTSFMMTPYVV 179
Query: 276 SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335
+RYYR+PEV+LG+ Y +D+WS+GCI+ E+ G LF G + +DQ KIIE LG P
Sbjct: 180 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS-- 237
Query: 336 LLHGASKTSKYFDRL--SDNSYVLKKSTDTRKERLPGSKRL-DTILGVDNGGPGGRRRNE 392
++ RL + +YV + + + D + D+ + ++
Sbjct: 238 --------DEFMSRLQPTVRNYVENR---PKYAGYSFEELFPDVLFPPDSESHNKLKASQ 286
Query: 393 PGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEF 429
+DL+ +ML DP+KRIS + L+H +
Sbjct: 287 A----------RDLLSKMLVIDPEKRISVDDALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 6e-40
Identities = 97/340 (28%), Positives = 167/340 (49%), Gaps = 64/340 (18%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-------EVQLLEK 162
DRY+ + +G G++GQV AFD + +VAIK K +PF Q+ I E++LL+
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPF--QSAIHAKRTYRELRLLKH 70
Query: 163 INKADIHSRYIVKLKGHFTWKNHL------CLVFELLSYNLYNLIRNTNFHGVSLNLTKK 216
++ H ++ L FT + L LV L+ +L N+++ S + +
Sbjct: 71 MD----H-ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKL---SDDHIQF 122
Query: 217 FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQS 276
Q+ L ++ S IIH DLKP NI + + +KI+DFG + H + Y+ +
Sbjct: 123 LVYQILRGLKYIHSA--GIIHRDLKPSNIAV--NEDCELKILDFGLARHTDDEMTGYVAT 178
Query: 277 RYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335
R+YR+PE++L + Y+ +D+WS+GCI+ EL TG+ LF G + +DQ+ +I+ ++G P
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238
Query: 336 LLHG-ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPG 394
LL +S++++ +Y+ + LP + D + G
Sbjct: 239 LLQKISSESAR--------NYI---------QSLPQMPKKDF------------KEVFSG 269
Query: 395 HSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434
+ DL+ +ML DP KRI+ L H + ++
Sbjct: 270 AN----PLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-39
Identities = 103/320 (32%), Positives = 152/320 (47%), Gaps = 50/320 (15%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIK---NKKPFLNQAQIEVQLLEKINKADIHSRYIV 174
+G+G++G V KA + VA+K I+ + + A E+ LL+++N +I V
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI-----V 62
Query: 175 KLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELS 234
KL +N L LVFE L +L + + G+ L L K + QL LAF S
Sbjct: 63 KLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR-- 120
Query: 235 IIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY---IQSRYYRSPEVLLGIP-Y 290
++H DLKP+N+L+ AIK+ DFG + G + Y + + +YR+PE+LLG Y
Sbjct: 121 VLHRDLKPQNLLI--NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 178
Query: 291 DLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRL 350
A+D+WSLGCI E+ T LF G +E+DQ+ +I LG P + G + Y
Sbjct: 179 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY---- 234
Query: 351 SDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRM 410
K + + R SK + + D G +DL+ +M
Sbjct: 235 --------KPSFPKWARQDFSKVVPPL---DEDG-------------------RDLLSQM 264
Query: 411 LTYDPKKRISPTNVLRHEFF 430
L YDP KRIS L H FF
Sbjct: 265 LHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 7e-38
Identities = 99/325 (30%), Positives = 148/325 (45%), Gaps = 60/325 (18%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQ--------AQIEVQLLEKINKADIH 169
+G+G++G V KA D VA+K I+ L A E+ LL+++N H
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR-----LETEDEGVPSTAIREISLLKELN----H 57
Query: 170 SRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLS 229
IV+L +N L LVFE L +L + ++ G+ L K + QL +A+
Sbjct: 58 PN-IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116
Query: 230 SPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY---IQSRYYRSPEVLL 286
S ++H DLKP+N+L+ + A+K+ DFG + G + Y + + +YR+PE+LL
Sbjct: 117 SHR--VLHRDLKPQNLLI--DREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 172
Query: 287 GIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSK 345
G Y +D+WS+GCI E+ PLF G +E+DQ+ +I LG P + G +
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232
Query: 346 YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKD 405
Y K P R D V N G D
Sbjct: 233 Y------------------KPTFPKWARQDLSKVVPNLDEDGL----------------D 258
Query: 406 LILRMLTYDPKKRISPTNVLRHEFF 430
L+ +ML YDP KRIS L+H +F
Sbjct: 259 LLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 5e-37
Identities = 106/355 (29%), Positives = 159/355 (44%), Gaps = 97/355 (27%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQ--VAIKIIKN---KKPFLNQAQIEVQLLEKINK 165
RYE+ LG+G++G V A + E + VAIK I N KK +A E++LL
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLL----- 55
Query: 166 ADIHSRYIVKLKGHFTWKNHLCL-----VF-----------ELLSYNLYNLIRN----TN 205
H +GH KN CL VF EL+ +L+ +IR+ T+
Sbjct: 56 --RH------FRGH---KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTD 104
Query: 206 FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC- 264
H + F Q+ C L ++ S +++H DLKP N+L+ + +KI DFG +
Sbjct: 105 AH------FQSFIYQILCGLKYIHSA--NVLHRDLKPGNLLVNA--DCELKICDFGLARG 154
Query: 265 -HVGQT-----LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKN 317
+ +Y+ +R+YR+PE++L Y AID+WS+GCIL EL +P+F GK+
Sbjct: 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214
Query: 318 EVDQMTKIIEVLGMPPGYLLH--GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLD 375
VDQ+ +I++VLG P L G+ K Y + L
Sbjct: 215 YVDQLNQILQVLGTPDEETLSRIGSPKAQNYI------------------------RSLP 250
Query: 376 TILGVDNGGPGGRRRNEPGHS-LADYMKFKDLILRMLTYDPKKRISPTNVLRHEF 429
I P + LA DL+ ++L +DP KRIS L H +
Sbjct: 251 NIPKKPFE------SIFPNANPLA-----LDLLEKLLAFDPTKRISVEEALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 7e-37
Identities = 101/334 (30%), Positives = 149/334 (44%), Gaps = 60/334 (17%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK---NKKPFLNQAQIEVQLLEKINKAD 167
+YE +G G++G V KA D VA+K ++ N+ EV LL+++ D
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 168 IHSRYIVKL-----KGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLC 222
H IV+L + + LVFE + +L + G+ K +Q
Sbjct: 61 -HPN-IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG----SSCHVGQTLYQYIQSRY 278
L FL + I+H DLKPENIL+ S +K+ DFG SC + L + + +
Sbjct: 119 RGLDFLHAN--CIVHRDLKPENILVTS--GGQVKLADFGLARIYSCQMA--LTPVVVTLW 172
Query: 279 YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338
YR+PEVLL Y +DMWS+GCI E+ +PLF G +E DQ+ KI +++G+PP
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP----- 227
Query: 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398
++ P D L P G R P S+
Sbjct: 228 --------------------------EDDWP----RDVTLPRGAFSPRGPR---PVQSVV 254
Query: 399 DYMKFK--DLILRMLTYDPKKRISPTNVLRHEFF 430
++ L+L MLT++P KRIS L+H FF
Sbjct: 255 PEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 76/234 (32%), Positives = 115/234 (49%), Gaps = 34/234 (14%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII-------KNKKPFLNQAQIEVQLLEKI 163
+YEI +GKGSFG+V + +K I K ++ A EV++L+K+
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE----DALNEVKILKKL 56
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSL---NLTKKFAQ 219
N H I+K F K LC+V E +L I+ G + F Q
Sbjct: 57 N----HP-NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG------SSCHVGQTLYQY 273
LC AL +L S + I+H D+KP+NI L S +K+ DFG S+ + +T+
Sbjct: 112 -LCLALKYLHSRK--ILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVDLAKTV--- 163
Query: 274 IQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
+ + YY SPE+ PY+ D+WSLGC+L EL T + F G+N ++ KI++
Sbjct: 164 VGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 67/229 (29%), Positives = 112/229 (48%), Gaps = 23/229 (10%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIK---IIKNKKPFLNQAQIEVQLLEKINKADIHSRYI 173
LLG+GSFG V A D + +A+K + + + L + E+++L + I
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-----HPNI 61
Query: 174 VKLKGHFT--WKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSS 230
V+ G KN L + E +S +L +L++ F + + +K+ +Q+ LA+L S
Sbjct: 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 231 PELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLY-----QYIQSRYYRSPEVL 285
I+H D+K NIL+ S +K+ DFG + +G + Y+ +PEV+
Sbjct: 120 --NGIVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 286 LGIPYDLAIDMWSLGCILVELHTGEPLFSG-KNEVDQMTKIIEVLGMPP 333
G Y A D+WSLGC ++E+ TG+P +S N + + KI P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-35
Identities = 78/254 (30%), Positives = 116/254 (45%), Gaps = 43/254 (16%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKI------IKNKKPFLNQAQIEVQLLEKINK 165
++ ++G+GSF VV A + E + AIKI IK KK + +IE ++L ++N
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK--VKYVKIEKEVLTRLN- 59
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCA 224
I+KL F + +L V E L IR + + T+ +A ++ A
Sbjct: 60 ---GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLA 114
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG----------------- 267
L +L S IIH DLKPENILL IKI DFG++ +
Sbjct: 115 LEYLHS--KGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 268 QTLYQYIQSRY------YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ 321
Q + Y SPE+L P + D+W+LGCI+ ++ TG+P F G NE
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230
Query: 322 MTKIIEV-LGMPPG 334
KI+++ PP
Sbjct: 231 FQKILKLEYSFPPN 244
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 73/214 (34%), Positives = 113/214 (52%), Gaps = 11/214 (5%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK 177
LGKGSFG+V+ + A+K++K KK + + ++E L E+ + I+ +IVKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK-KKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 178 GHFTWKNHLCLVFELLSYN-LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSII 236
F + L LV E L++ + S + +A ++ AL +L S L II
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAEIVLALEYLHS--LGII 115
Query: 237 HCDLKPENILLCSPKRSAIKIIDFGSSCHV---GQTLYQYIQSRYYRSPEVLLGIPYDLA 293
+ DLKPENILL + IK+ DFG + + G + + Y +PEVLLG Y A
Sbjct: 116 YRDLKPENILLDA--DGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 294 IDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
+D WSLG +L E+ TG+P F ++ + KI++
Sbjct: 174 VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK 207
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 4e-35
Identities = 126/457 (27%), Positives = 208/457 (45%), Gaps = 59/457 (12%)
Query: 1 MNNVINAGSPLYGRLVADNSIQNQDILSMQARIPMQFRDPATAPLRKLSVDLIKTYKHIN 60
N ++ SP + ++ Q + AR RD TA S D +T H
Sbjct: 23 PVNALSGNSPK--ANNSASTGQTTSRSTNSARRSGSKRDRETA----TSTDSGRTKSHEG 76
Query: 61 EVYYTKKKRKAQLSHNETRSNKKEK-KYVHNDGHDDENYDYIIKHGEKF---LDRYEIDT 116
+ + KK+K Y + +E + Y++ GE R++I +
Sbjct: 77 AATTKQATTTPTTNVEVAPPPKKKKVTYALPNQSREEGHFYVVL-GEDIDVSTQRFKILS 135
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY-IVK 175
LLG+G+FG+VV+A+D + K A+KI++N + A+IE+Q +EK+ +AD R+ ++K
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195
Query: 176 LKGHFTWKN-HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQ---QLCCALAFLSSP 231
++ +F + H+C+V L + I HG + + AQ Q AL + +
Sbjct: 196 IQRYFQNETGHMCIVMPKYGPCLLDWIMK---HG-PFS-HRHLAQIIFQTGVALDYFHT- 249
Query: 232 ELSIIHCDLKPENILLCS--------------PKRSAIKIIDFGSSCHVGQTLYQYIQSR 277
EL ++H DLKPENIL+ + P ++I D G C + + +R
Sbjct: 250 ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTR 309
Query: 278 YYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337
+YRSPEV+LG+ + + DMWS+GCI+ EL+TG+ L+ + ++ + + + LG P
Sbjct: 310 HYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPS--- 366
Query: 338 HGASKTSKYFDRLSDNSY-VLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHS 396
A + RL NS L+ TD K L I R P
Sbjct: 367 EWAGRCGTEEARLLYNSAGQLRPCTD--------PKHLARI-----------ARARPVRE 407
Query: 397 LADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433
+ DLI +L YD +KR++ + H + LK+
Sbjct: 408 VIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444
|
Length = 467 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 108/365 (29%), Positives = 175/365 (47%), Gaps = 51/365 (13%)
Query: 76 NETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDR-YEIDTLLGKGSFGQVVKAFDHEE 134
N+ + +++E+ + +N G D++ I + ++ Y++ ++G GSFG V +A +
Sbjct: 31 NDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDT 90
Query: 135 KCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLS 194
+VAIK + + N+ + ++ L IN + Y + L +V E +
Sbjct: 91 SEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP 150
Query: 195 YNLYNLIR--NTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR 252
++ ++ N H + L L K ++ QLC ALA++ S I H DLKP+N LL P
Sbjct: 151 QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK--FICHRDLKPQN-LLIDPNT 207
Query: 253 SAIKIIDFGSSCHV--GQTLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTG 309
+K+ DFGS+ ++ GQ YI SR+YR+PE++LG Y ID+WSLGCI+ E+ G
Sbjct: 208 HTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
Query: 310 EPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLK----KSTDTRK 365
P+FSG++ VDQ+ +II+VLG P T ++ N +K K D +K
Sbjct: 268 YPIFSGQSSVDQLVRIIQVLGTP----------TEDQLKEMNPNYADIKFPDVKPKDLKK 317
Query: 366 ERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVL 425
P D I + I + L Y+P KR++P L
Sbjct: 318 V-FPKGTPDDAI---------------------------NFISQFLKYEPLKRLNPIEAL 349
Query: 426 RHEFF 430
FF
Sbjct: 350 ADPFF 354
|
Length = 440 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 95/330 (28%), Positives = 163/330 (49%), Gaps = 53/330 (16%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII---KNKKPFLNQAQIEVQLLEKINKA 166
++YE L+G+GS+G V+K E VAIK ++ K A E+++L+++
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL--- 57
Query: 167 DIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
+V L F K L LVFE + + + + + +G+ + +K+ Q+ +
Sbjct: 58 --RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIE 114
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---GQTLYQYIQSRYYRSPE 283
F S +IIH D+KPENIL+ + +K+ DFG + + G+ Y+ +R+YR+PE
Sbjct: 115 FCHSH--NIIHRDIKPENILV--SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPE 170
Query: 284 VLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342
+L+G Y A+D+W++GC++ E+ TGEPLF G +++DQ+ II+ LG
Sbjct: 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG------------ 218
Query: 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHS--LADY 400
+ + + + +K+ RLP K ++ + + P S + D
Sbjct: 219 -----NLIPRHQEIFQKNPLFAGMRLPEVKEIEPL-----------EKRFPKLSGLVLDL 262
Query: 401 MKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
K LR+ DP R S + +L HEFF
Sbjct: 263 AK---QCLRI---DPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-34
Identities = 82/229 (35%), Positives = 131/229 (57%), Gaps = 12/229 (5%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
+++E+ ++G+G++G V+K E K VAIK K+ + N+ E L E +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLK 58
Query: 170 SRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLS 229
IV+LK F + L LVFE + N+ L+ +GV + + QL A+ +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCH 117
Query: 230 SPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ----TLYQYIQSRYYRSPEVL 285
+ I+H D+KPEN+L+ +K+ DFG + ++ + +Y+ +R+YRSPE+L
Sbjct: 118 KND--IVHRDIKPENLLISH--NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173
Query: 286 LGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLG-MPP 333
LG PY A+DMWS+GCIL EL G+PLF G++E+DQ+ I +VLG +P
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-34
Identities = 99/336 (29%), Positives = 147/336 (43%), Gaps = 57/336 (16%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK---NKKPFLNQAQIEVQLLEKINKA 166
D YE +G+G++G+V KA D VA+K + +++ A E+ LL+ ++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS-- 58
Query: 167 DIHSRYIVKLKG--HFTWKN---HLCLVFELLSYNLYNLI---RNTNFHGVSLNLTKKFA 218
S YIV+L H KN L LVFE L +L + + K F
Sbjct: 59 --ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 219 QQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY---IQ 275
QL +A ++H DLKP+N+L+ ++ +KI D G + Y I
Sbjct: 117 YQLLKGVAHCHK--HGVMHRDLKPQNLLV-DKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 276 SRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPG 334
+ +YR+PEVLLG Y +D+WS+GCI E+ +PLF G +E+ Q+ I ++LG P
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233
Query: 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPG 394
+ G SK + + P K D V + P G
Sbjct: 234 QVWPGVSKLRDWHE-------------------FPQWKPQDLSRAVPDLSPEG------- 267
Query: 395 HSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
DL+ +ML YDP KRIS L H +F
Sbjct: 268 ---------LDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 102/337 (30%), Positives = 157/337 (46%), Gaps = 73/337 (21%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-----EVQLLEK-- 162
+RY +G G+FG V A D VAIK K KPF E++LL+
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 163 ----INKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFA 218
I+ +DI +I L+ + V ELL +L+ L+ S L K+F
Sbjct: 68 HENIISLSDI---FISPLEDIY-------FVTELLGTDLHRLLT-------SRPLEKQFI 110
Query: 219 Q----QLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYI 274
Q Q+ L ++ S ++H DLKP NIL+ + +KI DFG + + Y+
Sbjct: 111 QYFLYQILRGLKYVHSA--GVVHRDLKPSNILI--NENCDLKICDFGLARIQDPQMTGYV 166
Query: 275 QSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
+RYYR+PE++L YD+ +D+WS GCI E+ G+PLF GK+ V+Q + I ++LG PP
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226
Query: 334 GYLLHGASKTSKYFDRL-SDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNE 392
+ + S+N+ +S ++E +P S++ N P
Sbjct: 227 ----------DDVINTICSENTLRFVQSLP-KREPVPFSEK------FKNADPSAI---- 265
Query: 393 PGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEF 429
DL+ +ML +DP+KRIS L H +
Sbjct: 266 ------------DLLEKMLVFDPQKRISAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-33
Identities = 94/335 (28%), Positives = 150/335 (44%), Gaps = 60/335 (17%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKINKAD 167
RY+ + +G+G++G V A +VAIK I + F + E+++L + +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
I + F N + +V EL+ +LY LI+ + +S + + F Q+ L +
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH---LSNDHIQYFLYQILRGLKY 121
Query: 228 LSSPELSIIHCDLKPENILL---CSPKRSAIKIIDFG-------SSCHVGQTLYQYIQSR 277
+ S +++H DLKP N+LL C +KI DFG H G L +Y+ +R
Sbjct: 122 IHSA--NVLHRDLKPSNLLLNTNCD-----LKICDFGLARIADPEHDHTGF-LTEYVATR 173
Query: 278 YYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336
+YR+PE++L Y AID+WS+GCIL E+ + PLF GK+ + Q+ I+ VLG P
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP---- 229
Query: 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRK--ERLPGSKRLDTILGVDNGGPGGRRRNEPG 394
S S R + LP ++ N P
Sbjct: 230 --------------SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKAL------ 269
Query: 395 HSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEF 429
DL+ +MLT++P KRI+ L H +
Sbjct: 270 ----------DLLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 97/360 (26%), Positives = 152/360 (42%), Gaps = 84/360 (23%)
Query: 111 RYEIDTLLGKGSFGQVVKAF--DHEEKCQVAIKIIKNKKPF---LNQAQI-EVQLLEKIN 164
+YEI+ +G+G++G+V KA + ++ + AIK K K ++Q+ E+ LL
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLR--- 57
Query: 165 KADIHSRYIVKLKGHFTWKNHLC--LVFELLSYNLYNLI---RNTNFHGVSLNLTKKFAQ 219
++ +V L F L+F+ ++L+ +I R + ++ K
Sbjct: 58 --ELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILLCS--PKRSAIKIIDFGSSCHVGQTLYQYIQSR 277
Q+ + +L S ++H DLKP NIL+ P+R +KI D G + L
Sbjct: 116 QILNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 278 ------YYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNE---------VDQ 321
+YR+PE+LLG Y AID+W++GCI EL T EP+F G+ DQ
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233
Query: 322 MTKIIEVLGMP-----------PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPG 370
+ +I EVLG P P Y K F + S L K + K+ P
Sbjct: 234 LERIFEVLGTPTEKDWPDIKKMPEY-----DTLMKDFKTKTYPSNSLAKWMEKHKK--PD 286
Query: 371 SKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
S+ DL+ ++L YDP KRI+ L H +F
Sbjct: 287 SQGF------------------------------DLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 4e-33
Identities = 96/334 (28%), Positives = 150/334 (44%), Gaps = 59/334 (17%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQ--------AQIEVQLL 160
+D+YE +G+G++G V KA D +A+K I+ L Q A E+ LL
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIR-----LEQEDEGVPSTAIREISLL 55
Query: 161 EKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQ 220
+ ++ IV+L+ + L LVFE L +L + ++ + L K + Q
Sbjct: 56 K-----EMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ 110
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG---QTLYQYIQSR 277
+ +A+ S ++H DLKP+N LL + +A+K+ DFG + G +T + +
Sbjct: 111 ILRGIAYCHSHR--VLHRDLKPQN-LLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL 167
Query: 278 YYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336
+YR+PE+LLG Y +D+WS+GCI E+ +PLF G +E+D++ KI +LG P
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEET 227
Query: 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHS 396
G + Y K P D V P G
Sbjct: 228 WPGVTSLPDY------------------KSAFPKWPPKDLATVVPTLEPAG--------- 260
Query: 397 LADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
DL+ +ML DP KRI+ L HE+F
Sbjct: 261 -------VDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 8e-33
Identities = 94/349 (26%), Positives = 149/349 (42%), Gaps = 70/349 (20%)
Query: 111 RYE-IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---------PFLNQAQIEVQLL 160
RY LG+G++G+V KA+D VAIK +K + + I L
Sbjct: 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTL 68
Query: 161 EKIN-KADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQ 219
++ +I I+ L + + + LV ++++ +L ++ ++ + K
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR--LTESQVKCILL 126
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLY-------Q 272
Q+ L L +H DL P NI + + KI DFG + G Y +
Sbjct: 127 QILNGLNVLHK--WYFMHRDLSPANIFI--NSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 273 YIQSR----------YYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ 321
+Q R +YR+PE+L+G Y A+DMWS+GCI EL TG+PLF G+NE+DQ
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242
Query: 322 MTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVD 381
+ +I E+LG P A K Y + + +K D L TI
Sbjct: 243 LGRIFELLGTPNEDNWPQAKKLPLYTE------FTPRKPKD-----------LKTIFPNA 285
Query: 382 NGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
+ D + DL+ +L +P +RIS L+HE+F
Sbjct: 286 S---------------DDAI---DLLQSLLKLNPLERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 9e-33
Identities = 79/242 (32%), Positives = 112/242 (46%), Gaps = 31/242 (12%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLLEKINKAD 167
Y I LG+GSFG+V A D + VA+K++ +K + + E+Q+L +N
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLN--- 55
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGV-SLNLTKKFAQQLCCAL 225
H IVKL F + L LV E + +L +L++ G S + Q+ AL
Sbjct: 56 -HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC---------HVGQTLYQYIQS 276
+L IIH D+KPENILL +K+IDFG + + + +
Sbjct: 115 EYLH--SKGIIHRDIKPENILL-DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 277 RYYRSPEVLLGI---PYDLAIDMWSLGCILVELHTGEPLFSGKNE---VDQMTKIIEVLG 330
Y +PEVLLG+ + D+WSLG L EL TG P F G+ Q KII L
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231
Query: 331 MP 332
P
Sbjct: 232 TP 233
|
Length = 384 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-32
Identities = 105/329 (31%), Positives = 152/329 (46%), Gaps = 39/329 (11%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
L RY+ +G G+ G V AFD VA+K K +PF NQ + E + +
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVK--KLSRPFQNQTHAKRAYRELVLLKCV 77
Query: 169 HSRYIVKLKGHFTWKNHL------CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLC 222
+ + I+ L FT + L LV EL+ NL +I H Q+
Sbjct: 78 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDH----ERMSYLLYQML 133
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG--SSCHVGQTLYQYIQSRYYR 280
C + L S IIH DLKP NI++ S +KI+DFG + + Y+ +RYYR
Sbjct: 134 CGIKHLHSA--GIIHRDLKPSNIVVKSD--CTLKILDFGLARTACTNFMMTPYVVTRYYR 189
Query: 281 SPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340
+PEV+LG+ Y +D+WS+GCI+ EL G +F G + +DQ K+IE LG P ++
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249
Query: 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADY 400
T + +YV + + PG L D P R++ S A
Sbjct: 250 QPTVR--------NYVENRP------QYPGISF--EELFPDWIFPSESERDKLKTSQA-- 291
Query: 401 MKFKDLILRMLTYDPKKRISPTNVLRHEF 429
+DL+ +ML DP KRIS LRH +
Sbjct: 292 ---RDLLSKMLVIDPDKRISVDEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 98/340 (28%), Positives = 163/340 (47%), Gaps = 67/340 (19%)
Query: 112 YEIDTL------LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-----EVQLL 160
+E+DT +G+G++G V A + E +VAIK I N F N+ E++LL
Sbjct: 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANA--FDNRIDAKRTLREIKLL 58
Query: 161 EKINKADIHS-RYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQ 219
++ ++ + + I+ + + + +V+EL+ +L+ +IR++ +S + + F
Sbjct: 59 RHLDHENVIAIKDIMPPPHREAFND-VYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLY 115
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILL---CSPKRSAIKIIDFG---SSCHVGQTLYQY 273
QL L ++ S +++H DLKP N+LL C +KI DFG ++ G + +Y
Sbjct: 116 QLLRGLKYIHSA--NVLHRDLKPSNLLLNANCD-----LKICDFGLARTTSEKGDFMTEY 168
Query: 274 IQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332
+ +R+YR+PE+LL Y AID+WS+GCI EL +PLF GK+ V Q+ I E+LG P
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228
Query: 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRK--ERLPGSKRLDTILGVDNGGPGGRRR 390
S+ ++ R+ LP + R R
Sbjct: 229 ------------------SEEDLGFIRNEKARRYIRSLPYTPRQSF-----------ARL 259
Query: 391 NEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
+ LA DL+ +ML +DP KRI+ L H +
Sbjct: 260 FPHANPLA-----IDLLEKMLVFDPSKRITVEEALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 93/320 (29%), Positives = 146/320 (45%), Gaps = 50/320 (15%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKINKADIHSRYIVK 175
LG+G++ V K + VA+K I ++ + A E+ L++++ +I V+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI-----VR 62
Query: 176 LKGHFTWKNHLCLVFELLSYNLYNLIR-NTNFHGVSLNLTKKFAQQLCCALAFLSSPELS 234
L +N L LVFE + +L + + + N K F QL +AF E
Sbjct: 63 LHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH--ENR 120
Query: 235 IIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG---QTLYQYIQSRYYRSPEVLLGI-PY 290
++H DLKP+N+L+ KR +K+ DFG + G T + + +YR+P+VLLG Y
Sbjct: 121 VLHRDLKPQNLLI--NKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY 178
Query: 291 DLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRL 350
+ID+WS+GCI+ E+ TG PLF G N DQ+ KI ++G P G S+ +Y
Sbjct: 179 STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY---- 234
Query: 351 SDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRM 410
K P D + P G DL+ R+
Sbjct: 235 --------------KPTFPRYPPQDLQQLFPHADPLG----------------IDLLHRL 264
Query: 411 LTYDPKKRISPTNVLRHEFF 430
L +P+ RIS + L+H +F
Sbjct: 265 LQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 18/224 (8%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIK-IIKNKKP--FLNQAQIEVQLLEKINKAD 167
Y++ L+G+G+FG V K + E VAIK I K L E+ LL+ +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK--- 57
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFEL-LSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
H IVK G + L ++ E + +L +I+ F +L + Q+ LA
Sbjct: 58 -HP-NIVKYIGSIETSDSLYIILEYAENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLA 113
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---GQTLYQYIQSRYYRSPE 283
+L E +IH D+K NIL K +K+ DFG + + + + + Y+ +PE
Sbjct: 114 YLH--EQGVIHRDIKAANILT--TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE 169
Query: 284 VLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
V+ A D+WSLGC ++EL TG P + N + + +I++
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ 213
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 100/339 (29%), Positives = 159/339 (46%), Gaps = 65/339 (19%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQA-QI--EVQLLEKINKAD 167
RY+I ++GKGS+G V A D +VAIK I + ++ A +I E++LL + D
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 168 I-HSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKK----FAQQLC 222
I ++I+ +K+ + +VFEL+ +L+ +I+ + +LT + F QL
Sbjct: 61 IVEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKAND------DLTPEHHQFFLYQLL 113
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG-SSCHVGQTLYQ-----YIQS 276
AL ++ + ++ H DLKP+NIL + +KI DFG + T Y+ +
Sbjct: 114 RALKYIHTA--NVFHRDLKPKNILANA--DCKLKICDFGLARVAFNDTPTAIFWTDYVAT 169
Query: 277 RYYRSPEVLLG---IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
R+YR+PE L G Y AID+WS+GCI E+ TG+PLF GKN V Q+ I ++LG P
Sbjct: 170 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228
Query: 334 GYLLHGA--SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRN 391
+ K +Y + KK ++ P
Sbjct: 229 PETISRVRNEKARRYLSSMR------KKQPVPFSQKFPN--------------------- 261
Query: 392 EPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
AD + + L+ R+L +DPK R + L +F
Sbjct: 262 ------ADPLALR-LLERLLAFDPKDRPTAEEALADPYF 293
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-30
Identities = 95/322 (29%), Positives = 140/322 (43%), Gaps = 74/322 (22%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK-NKKPFLNQAQIEVQLLEKINKADIHS 170
+EI +GKG FG+V KA +VAIK+IK K + E+Q+L+K H
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK----HP 57
Query: 171 RYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLS 229
IVK G + K+ L +V E S +L +L+++TN ++ + ++L L +L
Sbjct: 58 -NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH 115
Query: 230 SPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRYYRSPEVLLG 287
S IIH D+K NILL S +K+IDFG S + + + + Y+ +PEV+ G
Sbjct: 116 S--NGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING 171
Query: 288 IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347
PYD D+WSLG +EL G PP Y
Sbjct: 172 KPYDYKADIWSLGITAIEL---------------------AEGKPP------------YS 198
Query: 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLI 407
+ LP K L I NG PG R + S +FKD +
Sbjct: 199 E-------------------LPPMKALFKI--ATNGPPGLRNPEK--WSD----EFKDFL 231
Query: 408 LRMLTYDPKKRISPTNVLRHEF 429
+ L +P+KR + +L+H F
Sbjct: 232 KKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-29
Identities = 103/330 (31%), Positives = 154/330 (46%), Gaps = 41/330 (12%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
L RY+ +G G+ G V A+D VAIK K +PF NQ + E + +
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 169 HSRYIVKLKGHFTWKNHL------CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLC 222
+ + I+ L FT + L LV EL+ NL +I+ H Q+
Sbjct: 74 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDH----ERMSYLLYQML 129
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT--LYQYIQSRYYR 280
C + L S IIH DLKP NI++ S +KI+DFG + G + + Y+ +RYYR
Sbjct: 130 CGIKHLHSA--GIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 281 SPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP-PGYLLHG 339
+PEV+LG+ Y +D+WS+GCI+ E+ + LF G++ +DQ K+IE LG P P ++
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLAD 399
Y + K + T + P D+ P N+ S A
Sbjct: 246 QPTVRNYVENRP------KYAGLTFPKLFP-----------DSLFPADSEHNKLKASQA- 287
Query: 400 YMKFKDLILRMLTYDPKKRISPTNVLRHEF 429
+DL+ +ML DP KRIS L+H +
Sbjct: 288 ----RDLLSKMLVIDPAKRISVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-29
Identities = 106/348 (30%), Positives = 159/348 (45%), Gaps = 47/348 (13%)
Query: 95 DENYDYIIKHGEK---FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLN 151
D N+ Y ++ G+ L RY+ +G G+ G V A+D + VAIK K +PF N
Sbjct: 7 DNNF-YSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQN 63
Query: 152 QAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL------CLVFELLSYNLYNLIRNTN 205
Q + E + ++ + I+ L FT + L +V EL+ NL +I+
Sbjct: 64 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 123
Query: 206 FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265
H Q+ C + L S IIH DLKP NI++ S +KI+DFG +
Sbjct: 124 DH----ERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSD--CTLKILDFGLART 175
Query: 266 VGQTLYQ--YIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323
G + Y+ +RYYR+PEV+LG+ Y +D+WS+GCI+ E+ G LF G + +DQ
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 235
Query: 324 KIIEVLGMPPGYLLHGASKTSKYF--DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVD 381
K+IE LG P + T + + +R Y +K L D
Sbjct: 236 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK------------------LFPD 277
Query: 382 NGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEF 429
P N+ S A +DL+ +ML D KRIS L+H +
Sbjct: 278 VLFPADSEHNKLKASQA-----RDLLSKMLVIDASKRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 97/326 (29%), Positives = 146/326 (44%), Gaps = 60/326 (18%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQI-EVQLLEKINKADIHSRYIV 174
+G+G++G V +A D VA+K ++ N++ + + + E+ LL + IV
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-----RHPNIV 69
Query: 175 KLKGHFTWKNHL---CLVFELLSYNLYNLIRN--TNFHGVSLNLTKKFAQQLCCALAFLS 229
+LK HL LV E +L +L+ N T F S + K QL L +L
Sbjct: 70 ELK-EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPF---SESQVKCLMLQLLRGLQYLH 125
Query: 230 SPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY---IQSRYYRSPEVLL 286
E IIH DLK N+LL + +KI DFG + G + + +YR+PE+LL
Sbjct: 126 --ENFIIHRDLKVSNLLLTD--KGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181
Query: 287 GIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSK 345
G Y AIDMW++GCIL EL +PL GK+E++Q+ II++LG P + G S
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241
Query: 346 YFDRLSDNSYVLKKST-DTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFK 404
+ L K + K + P +E G L ++
Sbjct: 242 V------GKFTLPKQPYNNLKHKFPWL-------------------SEAGLRLLNF---- 272
Query: 405 DLILRMLTYDPKKRISPTNVLRHEFF 430
+L YDPKKR + L +F
Sbjct: 273 -----LLMYDPKKRATAEEALESSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 80/229 (34%), Positives = 128/229 (55%), Gaps = 19/229 (8%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIK--IIKNKKPFLNQ-AQIEVQLLEKINKA 166
++YE + +G+GS+G V K + E VAIK + P + + A E+++L+++
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 167 DIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYN-LIRNTNFHGVSLNLTKKFAQQLCCAL 225
++ V L F K L LVFE + + N L +N GV +L KK Q A+
Sbjct: 61 NL-----VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAV 113
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---GQTLYQYIQSRYYRSP 282
F + + IH D+KPENIL+ K+ IK+ DFG + + G Y+ +R+YR+P
Sbjct: 114 NF--CHKHNCIHRDVKPENILIT--KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAP 169
Query: 283 EVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLG 330
E+L+G Y +D+W++GC+ EL TG+PL+ GK++VDQ+ I + LG
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 92/324 (28%), Positives = 149/324 (45%), Gaps = 57/324 (17%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIK---NKKPFLNQAQIEVQLLEKINKADIHSRYIV 174
+G+G++G V K + + VA+K I+ ++ + A E+ LL+ ++ IV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLK-----ELQHPNIV 62
Query: 175 KLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHG-VSLNLTKKFAQQLCCALAFLSSPEL 233
L+ ++ L L+FE LS +L + + + L K + Q+ + F S
Sbjct: 63 CLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR- 121
Query: 234 SIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY---IQSRYYRSPEVLLGIP- 289
++H DLKP+N+L+ + IK+ DFG + G + Y + + +YR+PEVLLG P
Sbjct: 122 -VLHRDLKPQNLLI--DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 290 YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKY--- 346
Y +D+WS+G I E+ T +PLF G +E+DQ+ +I +LG P + G + Y
Sbjct: 179 YSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238
Query: 347 FDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406
F + S K LD ++G DL
Sbjct: 239 FPKWKKGSLRSA------------VKNLD-----EDG--------------------LDL 261
Query: 407 ILRMLTYDPKKRISPTNVLRHEFF 430
+ +ML YDP KRIS L H +F
Sbjct: 262 LEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 95/328 (28%), Positives = 148/328 (45%), Gaps = 52/328 (15%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK---NKKPFLNQAQIEVQLLEKINKAD 167
+YE +G+G++G V KA + E VA+K ++ + + + A E+ LL+ +
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK-----E 55
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
+ + IV+L L LVFE +L + N + + K F QL LAF
Sbjct: 56 LKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGD-IDPEIVKSFMFQLLKGLAF 114
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY---IQSRYYRSPEV 284
S +++H DLKP+N+L+ K +K+ DFG + G + Y + + +YR P+V
Sbjct: 115 CHSH--NVLHRDLKPQNLLI--NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV 170
Query: 285 LLGIP-YDLAIDMWSLGCILVEL-HTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342
L G Y +IDMWS GCI EL + G PLF G + DQ+ +I +LG P G SK
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230
Query: 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMK 402
Y Y + +T + +P + N G
Sbjct: 231 LPDYKP------YPMYPATTSLVNVVP-------------------KLNSTGR------- 258
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEFF 430
DL+ +L +P +RIS L+H +F
Sbjct: 259 --DLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 93/339 (27%), Positives = 156/339 (46%), Gaps = 64/339 (18%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
+RY+ + +G G++G V AFD + +VA+K K +PF Q+ I + + + H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPF--QSIIHAKRTYRELRLLKH 72
Query: 170 SRY--IVKLKGHFTWK------NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQ-- 219
++ ++ L FT N + LV L+ +L N+++ LT Q
Sbjct: 73 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-------CQKLTDDHVQFL 125
Query: 220 --QLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR 277
Q+ L ++ S + IIH DLKP N L + +KI+DFG + H + Y+ +R
Sbjct: 126 IYQILRGLKYIHSAD--IIHRDLKPSN--LAVNEDCELKILDFGLARHTDDEMTGYVATR 181
Query: 278 YYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336
+YR+PE++L + Y+ +D+WS+GCI+ EL TG LF G + +DQ+ I+ ++G P L
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 241
Query: 337 LHGASKTS--KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPG 394
L S S Y L+ ++P + +G +
Sbjct: 242 LKKISSESARNYIQSLT---------------QMPKMNFANVFIGANP------------ 274
Query: 395 HSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433
DL+ +ML D KRI+ L H +F ++
Sbjct: 275 -------LAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 93/332 (28%), Positives = 154/332 (46%), Gaps = 59/332 (17%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-------EVQLLEKI 163
RY +G G++G V A D +VAIK K +PF Q++I E+ LL+ +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIK--KLSRPF--QSEIFAKRAYRELTLLKHM 71
Query: 164 NKADI---HSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQ 220
++ + + G +L + + + ++ H +S + + Q
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPY------MQTDLQKIMGHPLSEDKVQYLVYQ 125
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYR 280
+ C L ++ S IIH DLKP N L + +KI+DFG + H + Y+ +R+YR
Sbjct: 126 MLCGLKYIHSA--GIIHRDLKPGN--LAVNEDCELKILDFGLARHADAEMTGYVVTRWYR 181
Query: 281 SPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP-PGYLLH 338
+PEV+L + Y+ +D+WS+GCI+ E+ TG+ LF GK+ +DQ+T+I++V G+P P ++
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK 241
Query: 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398
K +K SY+ + LP R D P
Sbjct: 242 LEDKAAK--------SYI---------KSLPKYPRKDFSTLFPKASPQA----------- 273
Query: 399 DYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
DL+ +ML D KR++ T L H +F
Sbjct: 274 -----VDLLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 101/332 (30%), Positives = 148/332 (44%), Gaps = 54/332 (16%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKIN 164
L+ Y+ LG+GS+ V K VA+K I+ + PF A E LL+ +
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLK 61
Query: 165 KADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCA 224
A+I V L K L LVFE L +L + + G+S++ + F QL
Sbjct: 62 HANI-----VTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRG 115
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRS 281
LA+ ++H DLKP+N+L+ +R +K+ DFG + +T + + +YR
Sbjct: 116 LAYCHQRR--VLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRP 171
Query: 282 PEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSG-KNEVDQMTKIIEVLGMPPGYLLHG 339
P+VLLG Y ++DMW +GCI E+ TG PLF G + DQ+ KI VLG P G
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231
Query: 340 ASKTSKYFDRLSDNSYVLKK-STDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398
S ++ Y P RLD I P G
Sbjct: 232 VSSNPEF------KPYSFPFYPPRPLINHAP---RLDRI-------PHG----------- 264
Query: 399 DYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
++L L+ L Y+PKKRIS ++H +F
Sbjct: 265 -----EELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 87/349 (24%), Positives = 153/349 (43%), Gaps = 71/349 (20%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIK--IIKNKKP-FLNQAQIEVQLLEKINK 165
L YEI LG+G+FG+V KA + VA+K ++ N+K F A E+++L+K+
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKH 66
Query: 166 ADI---------HSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKK 216
++ + +G +V + ++L L+ N + ++ + K
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVY------MVTPYMDHDLSGLLENPSVK-LTESQIKC 119
Query: 217 FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---------- 266
+ QL + +L I+H D+K NIL+ + +KI DFG +
Sbjct: 120 YMLQLLEGINYLHENH--ILHRDIKAANILI--DNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 267 -GQTLYQY---IQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ 321
G +Y + +R+YR PE+LLG Y A+D+W +GC+ E+ T P+ GK+++DQ
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235
Query: 322 MTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVD 381
+ I ++ G P G S +Y ++ + R +L
Sbjct: 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNY--PRTLEERFGKL------------- 280
Query: 382 NGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
GP G DL+ ++L+ DP KR++ ++ L H +F
Sbjct: 281 --GPEG----------------LDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 92/355 (25%), Positives = 158/355 (44%), Gaps = 76/355 (21%)
Query: 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF-LNQAQIEVQLLEKI 163
G +++D LG GS G V A D + +VA+K I P + A E++++ ++
Sbjct: 4 GSRYMDLRP----LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL 59
Query: 164 NKADIHSRYIV---------KLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHG-VSLNL 213
+ +I Y V + G T N + +V E + +L N++ G +S
Sbjct: 60 DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE----QGPLSEEH 115
Query: 214 TKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS-------CHV 266
+ F QL L ++ S +++H DLKP N+ + + + +KI DFG + H
Sbjct: 116 ARLFMYQLLRGLKYIHSA--NVLHRDLKPANVFI-NTEDLVLKIGDFGLARIVDPHYSHK 172
Query: 267 GQTLYQYIQSRYYRSPEVLLGIP--YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTK 324
G L + + +++YRSP +LL P Y AIDMW+ GCI E+ TG+PLF+G +E++QM
Sbjct: 173 GY-LSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230
Query: 325 IIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGG 384
I+E + + R+E + ++GG
Sbjct: 231 ILESVPV-------------------------------VREEDRNELLNVIPSFVRNDGG 259
Query: 385 PGGRRRNEPGHSLADYM-----KFKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434
EP L D + + D + ++LT++P R++ L H + +S
Sbjct: 260 -------EPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 98/342 (28%), Positives = 162/342 (47%), Gaps = 70/342 (20%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-------EVQLLEK 162
+RY+ T +G G++G V A+D + +VA+K K +PF Q+ I E++LL+
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVK--KLSRPF--QSLIHARRTYRELRLLKH 70
Query: 163 INKADIHSRYIVKLKGHFTWK------NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKK 216
+ ++ + L FT N + LV L+ +L N+++ +S +
Sbjct: 71 MKHENV-----IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK---CQKLSDEHVQF 122
Query: 217 FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQS 276
QL L ++ S IIH DLKP N+ + + ++I+DFG + + Y+ +
Sbjct: 123 LIYQLLRGLKYIHSA--GIIHRDLKPSNVAV--NEDCELRILDFGLARQADDEMTGYVAT 178
Query: 277 RYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335
R+YR+PE++L + Y+ +D+WS+GCI+ EL G+ LF G + +DQ+ +I+EV+G P
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP--- 235
Query: 336 LLHGASKTSKYFDRLSDNSYVLKK--STDTRK--ERLPGSKRLDTILGVDNGGPGGRRRN 391
+ VLKK S RK + LP + D P
Sbjct: 236 -----------------SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANP------ 272
Query: 392 EPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433
LA DL+ +ML D KRIS + L H +F ++
Sbjct: 273 -----LA-----IDLLEKMLVLDSDKRISASEALAHPYFSQY 304
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK 177
+ KG++G+V A AIK+I K + + Q++ L E+ + S Y+VKL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVI-KKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 178 GHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLN--LTKKFAQQLCCALAFLSSPELS 234
F K +L LV E L +L +L+ N SL+ + + + ++ AL +L S
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVG----SLDEDVARIYIAEIVLALEYLHS--NG 113
Query: 235 IIHCDLKPENILLCSPKRSAIKIIDFGSSCH--VGQTLYQYIQSR---------YYRSPE 283
IIH DLKP+NIL+ +K+ DFG S V + + + Y +PE
Sbjct: 114 IIHRDLKPDNILI--DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 284 VLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNE 318
V+LG + +D WSLGCIL E G P F G+
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 97/352 (27%), Positives = 156/352 (44%), Gaps = 59/352 (16%)
Query: 96 ENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII---KNKKPFLNQ 152
+ Y++ + +YE +G+G+FG+V KA + K VA+K + K+ F
Sbjct: 1 DQYEFPFCDE---VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPIT 57
Query: 153 AQIEVQLLEKINKADIHSRYIV---KLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGV 209
A E+++L+ + ++ + + K + +K LVFE ++L L+ N N
Sbjct: 58 ALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK-F 116
Query: 210 SLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG----SSCH 265
+L+ KK + L L ++ + I+H D+K NIL+ K +K+ DFG S
Sbjct: 117 TLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT--KDGILKLADFGLARAFSLS 172
Query: 266 VGQTLYQY---IQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ 321
+Y + + +YR PE+LLG Y IDMW GCI+ E+ T P+ G E Q
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ 232
Query: 322 MTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVD 381
+T I ++ G S T E PG +L+ ++
Sbjct: 233 LTLISQLCG----------SIT---------------------PEVWPGVDKLELFKKME 261
Query: 382 NGGPGGRRRNEPGHSLADYMKFK---DLILRMLTYDPKKRISPTNVLRHEFF 430
P G++R L Y+K DLI ++L DP KRI L H+FF
Sbjct: 262 L--PQGQKRKVK-ERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 91/335 (27%), Positives = 157/335 (46%), Gaps = 62/335 (18%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQ-----AQIEVQLLEKIN 164
DRY +G G++G V A D +VAIK K +PF ++ A E++LL+ +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMK 72
Query: 165 KADIHSRYIVKLKGHFTWKNHL------CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFA 218
++ + L FT L LV + +L L+++ +S + +
Sbjct: 73 HENV-----IGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK---LSEDRIQFLV 124
Query: 219 QQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRY 278
Q+ L ++ + IIH DLKP N L + +KI+DFG + + Y+ +R+
Sbjct: 125 YQMLKGLKYIHAA--GIIHRDLKPGN--LAVNEDCELKILDFGLARQTDSEMTGYVVTRW 180
Query: 279 YRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337
YR+PEV+L + Y +D+WS+GCI+ E+ TG+PLF G + +DQ+ +I++V G P
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS---- 236
Query: 338 HGASKTSKYFDRLSDNSYVLKKSTDTRK--ERLPGSKRLDTILGVDNGGPGGRRRNEPGH 395
++ +L +S D + ++LP ++ D + N P
Sbjct: 237 ------KEFVQKL--------QSEDAKNYVKKLPRFRKKDFRSLLPNANP---------- 272
Query: 396 SLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
LA +++ +ML D + RI+ L H +F
Sbjct: 273 -LA-----VNVLEKMLVLDAESRITAAEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 89/331 (26%), Positives = 147/331 (44%), Gaps = 57/331 (17%)
Query: 113 EIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-----EVQLLEKINKAD 167
E D +G G+FG V D + +VA+K K F N E+++L +
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALK--KMPNVFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
+ S + H + +V EL+ +L+ +I + +S + K F Q+ L +
Sbjct: 61 VLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKY 118
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG--------SSCHVGQTLYQYIQSRYY 279
L S I+H D+KP N+L+ S +KI DFG S H + Q + ++YY
Sbjct: 119 LHSA--GILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDESKH----MTQEVVTQYY 170
Query: 280 RSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338
R+PE+L+G Y A+D+WS+GCI EL LF ++ + Q+ I ++LG P +
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230
Query: 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398
A + ++ +++L+ + P L T+ +E H
Sbjct: 231 SACEGAR--------AHILR-----GPHKPPSLPVLYTLSSQAT--------HEAVH--- 266
Query: 399 DYMKFKDLILRMLTYDPKKRISPTNVLRHEF 429
L+ RML +DP KRIS + L H +
Sbjct: 267 -------LLCRMLVFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 76/265 (28%), Positives = 110/265 (41%), Gaps = 53/265 (20%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
D +E+ ++G+G+FG+V D + A+K+++ K + + QI E+ AD
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLR-KSDMIKRNQIAHVRAERDILADAD 59
Query: 170 SRYIVKLKGHFTWKNHLCLVFE------LLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCC 223
S +IVKL F + HL LV E L++ LIR + + +L
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNL----LIR---KDVFPEETARFYIAELVL 112
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC--HVGQTLYQYIQSRY--- 278
AL + L IH D+KP+NIL+ IK+ DFG + + Y+ +
Sbjct: 113 ALDSVHK--LGFIHRDIKPDNILI--DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 279 ---------------------------YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEP 311
Y +PEVL G PY L D WSLG IL E+ G P
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
Query: 312 LFSGKNEVDQMTKII---EVLGMPP 333
F + KII E L PP
Sbjct: 229 PFYSDTLQETYNKIINWKESLRFPP 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 7e-25
Identities = 72/232 (31%), Positives = 108/232 (46%), Gaps = 38/232 (16%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAI--KIIKNKKPFLNQAQIEVQ------LLEKINKADIH 169
LGKG FG+V CQV K+ KK L++ +++ + L EK +
Sbjct: 1 LGKGGFGEVCA-------CQVKATGKMYACKK--LDKKRLKKRKGEQMALNEKKILEKVS 51
Query: 170 SRYIVKLKGHFTWKNHLCLVFEL-----LSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCA 224
SR+IV L F K+ LCLV L L Y++YN+ G +A Q+ C
Sbjct: 52 SRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNV----GEPGFPEARAIFYAAQIICG 107
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRYYRSP 282
L L + I++ DLKPEN+LL ++I D G + + G+ + + Y +P
Sbjct: 108 LEHLH--QRRIVYRDLKPENVLL--DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAP 163
Query: 283 EVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG------KNEVDQMTKIIEV 328
EVL G YD ++D ++LGC L E+ G F K E+ + T + V
Sbjct: 164 EVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 103/352 (29%), Positives = 155/352 (44%), Gaps = 79/352 (22%)
Query: 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK---NKKPFLNQAQIEVQLLE 161
G++ +D+++I +G+G++GQV KA D + VA+K ++ K+ F A E+++L
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILR 61
Query: 162 KINKADIHSRYIVKLKGHFTWKNH----------LCLVFELLSYNLYNLIRNTNFHGVSL 211
++N R IV LK T K LVFE + ++L L+ + H S
Sbjct: 62 QLNH-----RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH-FSE 115
Query: 212 NLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLY 271
+ K F +QL L + + +H D+K NILL + + IK+ DFG + LY
Sbjct: 116 DHIKSFMKQLLEGLNYCHKK--NFLHRDIKCSNILLNN--KGQIKLADFGLA-----RLY 166
Query: 272 QYIQSR---------YYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ 321
+SR +YR PE+LLG Y AID+WS GCIL EL T +P+F E+ Q
Sbjct: 167 NSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ 226
Query: 322 MTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVD 381
+ I + G P + K + N+ KK + RL
Sbjct: 227 LELISRLCGSPCPAVWPDVIKLPYF------NTMKPKK---QYRRRL------------- 264
Query: 382 NGGPGGRRRNE----PGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEF 429
R E P +L DL+ MLT DP KR + L +
Sbjct: 265 --------REEFSFIPTPAL-------DLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 12/225 (5%)
Query: 113 EIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY 172
E +LG+GS G V K A+K I + Q+ +L K ++ Y
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLREL--KTLRSCES-PY 60
Query: 173 IVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP 231
+VK G F + + +V E + +L +L++ + + A+Q+ L +L +
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHT- 117
Query: 232 ELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRSPEVLLGI 288
+ IIH D+KP N+L+ S + +KI DFG S + TL Q ++ + Y SPE + G
Sbjct: 118 KRHIIHRDIKPSNLLINS--KGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE 175
Query: 289 PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
Y A D+WSLG L+E G+ F + + + PP
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP 220
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 74/231 (32%), Positives = 120/231 (51%), Gaps = 13/231 (5%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQ-VAIKIIKNKK-----PFLNQAQIEV-QLLEKI 163
+YE +G+G++G+V KA D + + VA+K ++ + P ++ V + LE
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCC 223
++ + V + L LVFE + +L + GV K QL
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 121
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG-SSCHVGQTLYQ-YIQSRYYRS 281
L FL S ++H DLKP+NIL+ S + IK+ DFG + + Q + + +YR+
Sbjct: 122 GLDFLHSHR--VVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMALTSVVVTLWYRA 177
Query: 282 PEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332
PEVLL Y +D+WS+GCI E+ +PLF G ++VDQ+ KI++V+G+P
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 24/229 (10%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR 171
++I LG+GS+G V KA E VAIK++ ++ E+ +L++ + S
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE-IIKEISILKQCD-----SP 58
Query: 172 YIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHGVSLNLTKKFA---QQLCCALAF 227
YIVK G + L +V E + ++++ TN +L ++ A Q L +
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN---KTLT-EEEIAAILYQTLKGLEY 114
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRSPEV 284
L S IH D+K NILL + K+ DFG S + T+ + I + ++ +PEV
Sbjct: 115 LHS--NKKIHRDIKAGNILL--NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV 170
Query: 285 LLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
+ I Y+ D+WSLG +E+ G+P +S ++ M I + PP
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPPYS---DIHPMRAIFMIPNKPP 216
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 3e-23
Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 10/220 (4%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHS 170
+++ LGKGS+G V K + A+K + ++Q + E + E A ++
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGS--MSQKEREDAVNEIRILASVNH 58
Query: 171 RYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSL--NLTKKFAQQLCCALAF 227
I+ K F N LC+V E + +L I + + QL L
Sbjct: 59 PNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL-YQYIQSRYYRSPEVLL 286
L E I+H DLK NILL + +KI D G S + + + I + +Y +PEV
Sbjct: 119 LH--EQKILHRDLKSANILLVAN--DLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWK 174
Query: 287 GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
G PY D+WSLGC+L E+ T P F ++ D K+
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ 214
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 7e-23
Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 21/227 (9%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK 177
LG G FG+V + A+K +K + Q + EK + + +IVKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLY 59
Query: 178 GHFTWKNHLCLVFEL-LSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCA---LAFLSSPEL 233
F K ++ ++ E L L+ ++R L ++ + A LAF
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILR-------DRGLFDEYTARFYIACVVLAFEYLHNR 112
Query: 234 SIIHCDLKPENILLCSPKRSAIKIIDFGSS--CHVGQTLYQYIQSRYYRSPEVLLGIPYD 291
II+ DLKPEN+LL +K++DFG + GQ + + + Y +PE++L YD
Sbjct: 113 GIIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD 170
Query: 292 LAIDMWSLGCILVELHTGEPLFSGKNEVDQMT-----KIIEVLGMPP 333
++D WSLG +L EL TG P F +E K L P
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN 217
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 8e-23
Identities = 95/324 (29%), Positives = 138/324 (42%), Gaps = 56/324 (17%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYI 173
LG+GS+ V K VA+K+I K PF A E LL+ + A+I
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPF--TAIREASLLKGLKHANI----- 65
Query: 174 VKLKGHFTWKNHLCLVFELLSYNL--YNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP 231
V L K L VFE + +L Y + H ++ L F QL LA++
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL---FMFQLLRGLAYIHGQ 122
Query: 232 ELSIIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVLLG- 287
I+H DLKP+N+L+ +K+ DFG + QT + + +YR P+VLLG
Sbjct: 123 H--ILHRDLKPQNLLISY--LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA 178
Query: 288 IPYDLAIDMWSLGCILVELHTGEPLFSGKNEV-DQMTKIIEVLGMPPGYLLHGASKTSKY 346
Y A+D+W GCI +E+ G+P F G ++V +Q+ KI VLG+P G SK Y
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238
Query: 347 FDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406
++L + L+ K +DL
Sbjct: 239 ---------------KPEWFLPCKPQQLRVVW----------------KRLSRPPKAEDL 267
Query: 407 ILRMLTYDPKKRISPTNVLRHEFF 430
+ML PK RIS + L H +F
Sbjct: 268 ASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 85/273 (31%), Positives = 128/273 (46%), Gaps = 26/273 (9%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
+ +EI LG G+FG+V KA + E A K+I+ K ++ ++E ++E A +
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCN 67
Query: 170 SRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLS 229
YIVKL G F W L ++ E + I G++ + +Q+ AL +L
Sbjct: 68 HPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH 127
Query: 230 SPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRSPEVLL 286
S + IIH DLK N+LL IK+ DFG S +TL + +I + Y+ +PEV++
Sbjct: 128 S--MKIIHRDLKAGNVLLT--LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 287 -----GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341
PYD D+WSLG L+E+ EP N + + KI + PP L S
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--SEPPT--LSQPS 239
Query: 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRL 374
K S F LK + D E P + +L
Sbjct: 240 KWSMEFRDF------LKTALDKHPETRPSAAQL 266
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 70/226 (30%), Positives = 102/226 (45%), Gaps = 30/226 (13%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKA----- 166
++I T +G+G +GQV A + VA+K +K LL K+N+
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKK------------SLLFKLNEVRHVLT 50
Query: 167 --DI----HSRYIVKLKGHFTWKNHLCLVFELL-SYNLYNLIRNTNFHGVSLNLTKKFAQ 219
DI S ++VKL F +L L E + + L+ N +S + + +
Sbjct: 51 ERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV--LSEDHARFYMA 108
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYY 279
++ A+ L EL IH DLKPEN L+ IK+ DFG S + + S Y
Sbjct: 109 EMFEAVDALH--ELGYIHRDLKPENFLI--DASGHIKLTDFGLSKGIVTYANSVVGSPDY 164
Query: 280 RSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKI 325
+PEVL G YD +D WSLGC+L E G P FSG + +
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL 210
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 1e-21
Identities = 76/227 (33%), Positives = 113/227 (49%), Gaps = 24/227 (10%)
Query: 110 DRYEIDTLLGKGSFGQV--VKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK-INKA 166
D +E LG GSFG+V V+ + A+KI+ K + Q+E L EK I ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYY--ALKILS-KAKIVKLKQVEHVLNEKRILQS 57
Query: 167 DIHSRYIVKLKGHFTWKNHLCLVF------ELLSYNLYNLIRNTNFHGVSLNLTKKFAQQ 220
I ++V L G F ++L LV EL S+ L ++ F + + +A Q
Sbjct: 58 -IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSH----LRKSGRF---PEPVARFYAAQ 109
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYR 280
+ AL +L S L I++ DLKPEN+LL S IKI DFG + V Y + Y
Sbjct: 110 VVLALEYLHS--LDIVYRDLKPENLLLDS--DGYIKITDFGFAKRVKGRTYTLCGTPEYL 165
Query: 281 SPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
+PE++L Y A+D W+LG ++ E+ G P F N + KI+E
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE 212
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 4e-21
Identities = 92/320 (28%), Positives = 145/320 (45%), Gaps = 51/320 (15%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKINKADIHSRYIVK 175
LG+G++ V K + VA+K I+ +++ A EV LL+ + A+I V
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI-----VT 67
Query: 176 LKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSI 235
L + L LVFE L +L + N + +S++ K F QL L++ + I
Sbjct: 68 LHDIIHTERCLTLVFEYLDSDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCH--KRKI 124
Query: 236 IHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVLLG-IPYD 291
+H DLKP+N+L+ ++ +K+ DFG + +T + + +YR P+VLLG Y
Sbjct: 125 LHRDLKPQNLLI--NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 292 LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLS 351
IDMW +GCIL E+ TG P+F G +++ I +LG P G + ++
Sbjct: 183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF----- 237
Query: 352 DNSYVLKK-STDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRM 410
SY+ + P RLDT G+ DL+ +
Sbjct: 238 -RSYLFPQYRAQPLINHAP---RLDTD-GI------------------------DLLSSL 268
Query: 411 LTYDPKKRISPTNVLRHEFF 430
L Y+ K RIS LRH +F
Sbjct: 269 LLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 8e-21
Identities = 68/249 (27%), Positives = 120/249 (48%), Gaps = 30/249 (12%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKII------KNKKPFLNQAQIEVQLLEKINKADIHS 170
LLG+G+FG+V +D + ++A+K + K +N + E+QLL+ + H
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ----HE 64
Query: 171 RYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHG-VSLNLTKKFAQQLCCALAFL 228
R IV+ G L + E + ++ + ++ +G ++ +T+K+ +Q+ + +L
Sbjct: 65 R-IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYL 120
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS------CHVGQTLYQYIQSRYYRSP 282
S I+H D+K NIL S +K+ DFG+S C G + + Y+ SP
Sbjct: 121 HSNM--IVHRDIKGANILRDS--AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 283 EVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL-HGAS 341
EV+ G Y D+WS+GC +VE+ T +P + E + M I ++ P L S
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPQLPSHVS 233
Query: 342 KTSKYFDRL 350
++ F R
Sbjct: 234 PDARNFLRR 242
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 21/228 (9%)
Query: 118 LGKGSFGQVVKAF----DHEEKCQVAIKIIKNKKPFLNQAQI--EVQLLEKINKADIHSR 171
LG+G+FG+V K ++ +VA+K +K + E +++ K++ H
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLD----H-P 61
Query: 172 YIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSS 230
IVKL G T + L +V E + +L + +R +SL+ FA Q+ + +L S
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 231 PELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRY--YR--SPEVLL 286
+ IH DL N L+ +KI DFG S + Y ++ R +PE L
Sbjct: 122 --KNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 287 GIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPP 333
+ D+WS G +L E+ T GE + G + + + + + +P
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPK 225
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 67/230 (29%), Positives = 101/230 (43%), Gaps = 25/230 (10%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII-----KNKKPFLNQAQIEVQLLEKINKA 166
YE+ +GKGSFG V K + + K I K+ Q EV +L ++
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK--QQLVSEVNILRELK-- 57
Query: 167 DIHSRYIVKLKGHF--TWKNHLCLVFELLSY-NLYNLIRNT--NFHGVSLNLTKKFAQQL 221
H IV+ L +V E +L LI+ + + QL
Sbjct: 58 --H-PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114
Query: 222 CCALA---FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQ 275
AL S P +++H DLKP NI L + + +K+ DFG + +G Y+
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDA--NNNVKLGDFGLAKILGHDSSFAKTYVG 172
Query: 276 SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKI 325
+ YY SPE L + YD D+WSLGC++ EL P F+ +N++ +KI
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 8e-20
Identities = 73/228 (32%), Positives = 113/228 (49%), Gaps = 30/228 (13%)
Query: 117 LLGKGSFGQV----VKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY 172
+LGKG FG+V V+A C+ K K+ + A E Q+LEK+N SR+
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-----SRF 61
Query: 173 IVKLKGHFTWKNHLCLVFEL-----LSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
+V L + K+ LCLV L L +++Y++ G +A ++CC L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM----GEAGFEEGRAVFYAAEICCGLED 117
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRYYRSPEVL 285
L I++ DLKPENILL I+I D G + HV GQT+ + + Y +PEV+
Sbjct: 118 LHQER--IVYRDLKPENILL--DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 173
Query: 286 LGIPYDLAIDMWSLGCILVELHTGEPLFS------GKNEVDQMTKIIE 327
Y + D W+LGC+L E+ G+ F + EV+++ K ++
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 9e-20
Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 32/233 (13%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIK---NKKPFLNQAQIEVQLLEKINKADIHSRYIV 174
+G G+FG+V A + + +A+K I+ N + + E+++LE + ++ Y V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 175 KLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSL--NLTKKFAQQLCCALAFLSSP 231
++ H + + + E S L L+ HG L ++ + + QL LA+L S
Sbjct: 68 EV--H---REKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 232 ELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV-------GQTLYQYIQSRYYRSPEV 284
I+H D+KP NI L IK+ DFG + + G+ + + Y +PEV
Sbjct: 119 --GIVHRDIKPANIFL--DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 285 LLGIPYD---LAIDMWSLGCILVELHTGEPLFSG-KNEVDQMTKIIEVLGMPP 333
+ G A D+WSLGC+++E+ TG+ +S NE M + G P
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV--GAGHKP 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (219), Expect = 9e-20
Identities = 62/244 (25%), Positives = 104/244 (42%), Gaps = 43/244 (17%)
Query: 113 EIDTLLGKGSFGQVVKAF----DHEEKCQVAIKIIKNKKPFLNQAQI--EVQLLEKINKA 166
E+ LG+G+FG+V K + +VA+K +K + + E +++K++
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS-- 59
Query: 167 DIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTK--KFAQQLCC 223
H IV+L G T L +V E + +L + +R HG L L + A Q+
Sbjct: 60 --H-PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK---HGEKLTLKDLLQMALQIAK 113
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR-YYR-- 280
+ +L S + +H DL N L+ +KI DFG L + I YYR
Sbjct: 114 GMEYLES--KNFVHRDLAARNCLVTENLV--VKISDFG--------LSRDIYEDDYYRKR 161
Query: 281 ----------SPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVL 329
+PE L + D+WS G +L E+ T GE + G + + + + +
Sbjct: 162 GGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGY 221
Query: 330 GMPP 333
+P
Sbjct: 222 RLPR 225
|
Length = 258 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 88/319 (27%), Positives = 144/319 (45%), Gaps = 49/319 (15%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKINKADIHSRYIVK 175
LG+G++ V K + VA+K I+ +++ A EV LL+ + A+I V
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-----VT 68
Query: 176 LKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSI 235
L L LVFE L +L + + + +S++ K F Q+ LA+ + +
Sbjct: 69 LHDIVHTDKSLTLVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK--V 125
Query: 236 IHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVLLGIP-YD 291
+H DLKP+N+L+ +R +K+ DFG + +T + + +YR P+VLLG Y
Sbjct: 126 LHRDLKPQNLLI--NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 292 LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLS 351
IDMW +GCI E+ +G PLF G D++ I +LG P G S ++
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF----- 238
Query: 352 DNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411
+Y K + + + RLDT + +L+ + L
Sbjct: 239 -KNYNFPKYKP--QPLINHAPRLDT-------------------------EGIELLTKFL 270
Query: 412 TYDPKKRISPTNVLRHEFF 430
Y+ KKRIS ++H +F
Sbjct: 271 QYESKKRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 67/220 (30%), Positives = 104/220 (47%), Gaps = 38/220 (17%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQV-------AIKIIKNKKPFLNQAQI----EVQLLEKINK 165
+LGKG FG+V CQV A K ++ K+ + + E Q+LEK+N
Sbjct: 7 VLGKGGFGEVCA-------CQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN- 58
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFEL-----LSYNLYNLIRNTNFHGVSLNLTKKFAQQ 220
SR++V L + K+ LCLV L L +++YN+ G +A +
Sbjct: 59 ----SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP----GFDEERAVFYAAE 110
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRY 278
+ C L L I++ DLKPENILL I+I D G + + G+T+ + +
Sbjct: 111 ITCGLEDLHRER--IVYRDLKPENILL--DDYGHIRISDLGLAVEIPEGETIRGRVGTVG 166
Query: 279 YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNE 318
Y +PEV+ Y + D W LGC++ E+ G+ F + E
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 74/272 (27%), Positives = 125/272 (45%), Gaps = 31/272 (11%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
+E+ ++G+G++G+V KA + VAIKI+ + + + E +L K + +
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS----N 61
Query: 170 SRYIVKLKGHFTWKNHLC------LVFELLSY-NLYNLIRNTNFHGVSL--NLTKKFAQQ 220
I G F KN LV EL ++ +L++ G L ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSR 277
LA+L E +IH D+K +NILL K + +K++DFG S + TL + +I +
Sbjct: 122 TLRGLAYLH--ENKVIHRDIKGQNILLT--KNAEVKLVDFGVSAQLDSTLGRRNTFIGTP 177
Query: 278 YYRSPEVL-----LGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332
Y+ +PEV+ YD D+WSLG +EL G+P + + + KI P
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NP 234
Query: 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTR 364
P L + + K+ D +S+ L K+ + R
Sbjct: 235 PPTLKSPENWSKKFNDFISE---CLIKNYEQR 263
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 89/325 (27%), Positives = 145/325 (44%), Gaps = 59/325 (18%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKINKADIHSRYIVK 175
LG+G++ V K VA+K I+ +++ A EV LL+ + A+I V
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-----VT 68
Query: 176 LKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSI 235
L + L LVFE L +L + + + ++++ K F QL L + + +
Sbjct: 69 LHDIIHTEKSLTLVFEYLDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRK--V 125
Query: 236 IHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVLLG-IPYD 291
+H DLKP+N+L+ +R +K+ DFG + +T + + +YR P++LLG Y
Sbjct: 126 LHRDLKPQNLLI--NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 292 LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP-----PGYLLHGASKTSKY 346
IDMW +GCI E+ TG PLF G +Q+ I +LG P PG L + K+ Y
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243
Query: 347 FDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406
K D P RLD+ +G +L
Sbjct: 244 ----------PKYRADCLHNHAP---RLDS-----DGA--------------------EL 265
Query: 407 ILRMLTYDPKKRISPTNVLRHEFFL 431
+ ++L ++ +KRIS ++H +F
Sbjct: 266 LSKLLQFEGRKRISAEEAMKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 3e-19
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 11/210 (5%)
Query: 120 KGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK-INKADIHSRYIVKLKG 178
KG+FG V A AIK++K K + + Q+ E+ I S Y+ KL
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLK-KSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64
Query: 179 HFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIH 237
F K++L LV E L+ + +LI+ G+ + K++ ++ + L + IIH
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLH--QRGIIH 120
Query: 238 CDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMW 297
D+KPEN+L+ + +K+ DFG S G +++ + Y +PE +LG+ D D W
Sbjct: 121 RDIKPENLLI--DQTGHLKLTDFGLS-RNGLENKKFVGTPDYLAPETILGVGDDKMSDWW 177
Query: 298 SLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
SLGC++ E G P F D + I
Sbjct: 178 SLGCVIFEFLFGYPPFHA-ETPDAVFDNIL 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 3e-19
Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 24/229 (10%)
Query: 118 LGKGSFGQVVKAF----DHEEKCQVAIKIIKNKKPFLNQAQI--EVQLLEKINKADIHSR 171
LG+G+FG+V K ++K +VA+K +K + E +++ K++ H
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD----H-P 61
Query: 172 YIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSS 230
+VKL G T + L +V E + +L + +R +SL+ FA Q+ + +L S
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR-PKLSLSDLLSFALQIARGMEYLES 120
Query: 231 PELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQS-----RYYRSPEVL 285
+ IH DL N L+ +KI DFG S + Y + R+ +PE L
Sbjct: 121 --KNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APESL 175
Query: 286 LGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPP 333
+ D+WS G +L E+ T GE + G + + + + +P
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQ 224
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 4e-19
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 29/216 (13%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINK 165
+ E +G+G+ G+V KA D +VAIK ++ +K E+ +++
Sbjct: 18 RELYKNLEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMK---- 70
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHGVSLNLTK--KFAQQLC 222
D IV + + L +V E + L ++I + V +N + +++
Sbjct: 71 -DCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT---QNFVRMNEPQIAYVCREVL 126
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR----- 277
L +L S ++IH D+K +NILL K ++K+ DFG Q L + R
Sbjct: 127 QGLEYLHS--QNVIHRDIKSDNILL--SKDGSVKLADFG---FAAQ-LTKEKSKRNSVVG 178
Query: 278 --YYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEP 311
Y+ +PEV+ Y +D+WSLG + +E+ GEP
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 72/225 (32%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 117 LLGKGSFGQV----VKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY 172
+LGKG FG+V V+A C+ K K+ A E ++LEK+N SR+
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-----SRF 61
Query: 173 IVKLKGHFTWKNHLCLVFEL-----LSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
+V L + K+ LCLV + L +++YN+ N F +A +LCC L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFDEQRAIF---YAAELCCGLED 117
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRYYRSPEVL 285
L I++ DLKPENILL R I+I D G + + G+T+ + + Y +PEV+
Sbjct: 118 LQRER--IVYRDLKPENILL--DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI 173
Query: 286 LGIPYDLAIDMWSLGCILVELHTGEPLFS------GKNEVDQMTK 324
Y + D W LGC++ E+ G+ F + EVD+ K
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK 218
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 7e-19
Identities = 61/227 (26%), Positives = 110/227 (48%), Gaps = 21/227 (9%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKII------KNKKPFLNQAQIEVQLLEKINKADIHS 170
LLG GSFG V + + ++ A+K + + + + Q + E+ LL K+ +I
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI-- 64
Query: 171 RYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLS 229
V+ G +++L + EL+ +L L++ + + + + +Q+ L +L
Sbjct: 65 ---VQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLH 119
Query: 230 SPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ--TLYQYIQSRYYRSPEVLLG 287
+ +H D+K NIL+ +K+ DFG + V + + S Y+ +PEV+
Sbjct: 120 DR--NTVHRDIKGANILV--DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 288 I-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
Y LA D+WSLGC ++E+ TG+P +S V + KI +PP
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPP 222
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 8e-19
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 118 LGKGSFGQV----VKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYI 173
LGKG FG+V VK C+ K KK A +E ++LEK+N S +I
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-----SPFI 55
Query: 174 VKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
V L F K HLCLV L++ +L I N G+ + ++ Q+ C + L S
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS-- 113
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRYYRSPEVLLGIPY 290
+ I++ D+KPEN+LL + ++ D G + + G+T+ Q + Y +PE+L PY
Sbjct: 114 MDIVYRDMKPENVLL--DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPY 171
Query: 291 DLAIDMWSLGCILVELHTGE-PLFSGKNEVDQ 321
+D +++GC + E+ G P K +V +
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 3e-18
Identities = 90/330 (27%), Positives = 139/330 (42%), Gaps = 52/330 (15%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINK 165
D YE LG+GS+ V K VA+K+I+ ++ PF A E LL+ +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLKH 62
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCAL 225
A+I V L K L LVFE + +L + + + G+ K F QL L
Sbjct: 63 ANI-----VLLHDIIHTKETLTLVFEYVHTDLCQYM-DKHPGGLHPENVKLFLFQLLRGL 116
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSP 282
+++ + I+H DLKP+N+L+ +K+ DFG + T + + +YR P
Sbjct: 117 SYIH--QRYILHRDLKPQNLLISDT--GELKLADFGLARAKSVPSHTYSNEVVTLWYRPP 172
Query: 283 EVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEV-DQMTKIIEVLGMPPGYLLHGA 340
+VLLG Y +DMW +GCI VE+ G F G ++ DQ+ +I VLG P G
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232
Query: 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADY 400
+ + L + R + + L+
Sbjct: 233 HSLPHF----KPERFTLYSPKNLR---------------------------QAWNKLSYV 261
Query: 401 MKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
+DL ++L PK R+S L HE+F
Sbjct: 262 NHAEDLASKLLQCFPKNRLSAQAALSHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-18
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 18/225 (8%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKAD 167
Y +LGKG+FG+ E+ V K + + A E+ +L + +
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
I + Y HF N L + E + LY+ I + + Q+ A++
Sbjct: 61 IIAYY-----NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS 115
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQS----RYYRSP 282
++ + I+H D+K NI L K IK+ DFG S +G + Y ++ YY SP
Sbjct: 116 YIH--KAGILHRDIKTLNIFLT--KAGLIKLGDFGISKILG-SEYSMAETVVGTPYYMSP 170
Query: 283 EVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
E+ G+ Y+ D+W+LGC+L EL T + F N ++ + KI++
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 67/213 (31%), Positives = 106/213 (49%), Gaps = 24/213 (11%)
Query: 117 LLGKGSFGQV----VKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY 172
+LGKG FG+V V+A C+ K K+ + A E Q+LEK+N S++
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-----SQF 61
Query: 173 IVKLKGHFTWKNHLCLVFEL-----LSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
+V L + K+ LCLV + L +++YN+ N F +A ++ C L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFEEERALF---YAAEILCGLED 117
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRYYRSPEVL 285
L + ++ DLKPENILL I+I D G + + G+++ + + Y +PEVL
Sbjct: 118 LHRE--NTVYRDLKPENILL--DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL 173
Query: 286 LGIPYDLAIDMWSLGCILVELHTGEPLFSGKNE 318
Y L+ D W LGC++ E+ G+ F G+ E
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-18
Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 16/222 (7%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR 171
+EI +GKGSFG V K +K A+K I K +N+ + E + E A + S
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK--MNRREREEAIDEARVLAKLDSS 59
Query: 172 YIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSS 230
YI++ F K L +V E +L+ L++ + + +F Q+ LA L S
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 231 PELSIIHCDLKPENILLCSPKRSAIKIIDFG------SSCHVGQTLYQYIQSRYYRSPEV 284
+ I+H D+K N+ L +KI D G + + T+ + + YY SPE+
Sbjct: 120 KK--ILHRDIKSLNLFL--DAYDNVKIGDLGVAKLLSDNTNFANTI---VGTPYYLSPEL 172
Query: 285 LLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
PY+ D+W+LG +L E TG+ F N+ + KII
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII 214
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 6e-18
Identities = 71/225 (31%), Positives = 116/225 (51%), Gaps = 16/225 (7%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK 177
+GKGSFG+V++ + + A+K I+ K ++++++ L E+ A ++ +IV LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIR-KAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59
Query: 178 GHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSI 235
F L LV ++ ++L R F L+ + + +L CAL L + ++
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRF---DLSRARFYTAELLCALENLH--KFNV 114
Query: 236 IHCDLKPENILLCSPKRSAIKIIDFGSSCHVG----QTLYQYIQSRYYRSPEVLLGIPYD 291
I+ DLKPENILL + I + DFG C + + + Y +PE+LLG Y
Sbjct: 115 IYRDLKPENILL--DYQGHIALCDFGL-CKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 292 LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII-EVLGMPPGY 335
A+D W+LG +L E+ TG P F +N + KI+ E L P G+
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGF 216
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 8e-18
Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 49/283 (17%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI--EVQLLEKINKADI 168
R E L+G+G++G V + VA+KII P + + I EV LL ++ ++
Sbjct: 5 RLE---LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSL-NLTK--KFAQQLCC-- 223
+ I K G + L ++ E G S+ L K A++
Sbjct: 62 PN--ITKYYGSYLKGPRLWIIMEY-------------AEGGSVRTLMKAGPIAEKYISVI 106
Query: 224 ------ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YI 274
AL ++ + +IH D+K NIL+ + +K+ DFG + + Q + ++
Sbjct: 107 IREVLVALKYIHK--VGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSSKRSTFV 162
Query: 275 QSRYYRSPEVLL-GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
+ Y+ +PEV+ G YD D+WSLG + E+ TG P +S + M I + PP
Sbjct: 163 GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK--SKPP 220
Query: 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDT 376
+G SK + F + L + KERL + L +
Sbjct: 221 RLEDNGYSKLLREF-----VAACLDEEP---KERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 75/263 (28%), Positives = 126/263 (47%), Gaps = 22/263 (8%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
+ +EI LG G+FG+V KA + E A K+I K ++ ++E ++E A
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCD 60
Query: 170 SRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLS 229
IVKL F ++N+L ++ E + + + ++ + +Q AL +L
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 230 SPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRSPEVLL 286
E IIH DLK NIL IK+ DFG S +T+ + +I + Y+ +PEV++
Sbjct: 121 --ENKIIHRDLKAGNILFTLD--GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 287 -----GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341
PYD D+WSLG L+E+ EP +E++ M ++++ P L +
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEP---PHHELNPMRVLLKIAKSEPPTLAQPSR 233
Query: 342 KTSKYFDRLSDNSYVLKKSTDTR 364
+S++ D L L+K+ D R
Sbjct: 234 WSSEFKDFLKK---CLEKNVDAR 253
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 78/263 (29%), Positives = 124/263 (47%), Gaps = 22/263 (8%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
D +EI LG G+FG+V KA E A KII+ + ++ ++E ++E ++
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECK 60
Query: 170 SRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLS 229
IV L + ++N L ++ E + I G++ + +Q+ AL FL
Sbjct: 61 HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH 120
Query: 230 SPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRSPEVLL 286
S + +IH DLK NILL +K+ DFG S TL + +I + Y+ +PEV+
Sbjct: 121 SHK--VIHRDLKAGNILLTL--DGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVA 176
Query: 287 -----GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341
PYD D+WSLG L+EL EP +E++ M ++++L P L +
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEP---PHHELNPMRVLLKILKSEPPTLDQPSK 233
Query: 342 KTSKYFDRLSDNSYVLKKSTDTR 364
+S + D L L K D R
Sbjct: 234 WSSSFNDFLKS---CLVKDPDDR 253
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 71/232 (30%), Positives = 105/232 (45%), Gaps = 28/232 (12%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKN------KKPFLNQAQIEVQLLEKIN 164
RY + LGKGSFG V D + + +K++K QA E QLL K++
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 165 KADIHSRYIVKLKGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHG--VSLNLTKKFAQQL 221
I VK F ++ C++ E +L + G +S N ++ QL
Sbjct: 61 HPAI-----VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 222 CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG------SSCHVGQTLYQYIQ 275
+ ++ + I+H DLK +NI L K + +KI DFG SC + T
Sbjct: 116 LLGVHYMH--QRRILHRDLKAKNIFL---KNNLLKIGDFGVSRLLMGSCDLATTF---TG 167
Query: 276 SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
+ YY SPE L YD D+WSLGCIL E+ F G+N + + +I+E
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 67/244 (27%), Positives = 114/244 (46%), Gaps = 20/244 (8%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK-IN-KAD 167
+ + + +GKGSFG+V KA D VAIK+I L +A+ E++ +++ I +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-----LEEAEDEIEDIQQEIQFLSQ 55
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
S YI K G F + L ++ E + +L++ + +++ L
Sbjct: 56 CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF---ILREVLLGLE 112
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRSPE 283
+L IH D+K NILL + +K+ DFG S + T+ + ++ + ++ +PE
Sbjct: 113 YLHEEGK--IHRDIKAANILLS--EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPE 168
Query: 284 VLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343
V+ YD D+WSLG +EL GEP S + + + I + PP + SK
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK--NNPPSLEGNKFSKP 226
Query: 344 SKYF 347
K F
Sbjct: 227 FKDF 230
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 3e-17
Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 29/208 (13%)
Query: 118 LGKGSFGQVVKAF---DHEEKCQVAIKIIKNKKPFLNQAQI--EVQLLEKINKADIHSRY 172
LG+G+FG+V K + +VA+K +K + E ++++K+ H
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG----H-PN 57
Query: 173 IVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTK-------KFAQQLCCA 224
+V+L G T + L LV E + +L + +R + S + FA Q+
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQS------RY 278
+ +L+S +H DL N L+ +KI DFG S V Y ++ R+
Sbjct: 118 MEYLAS--KKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 279 YRSPEVLLGIPYDLAIDMWSLGCILVEL 306
+PE L + D+WS G +L E+
Sbjct: 174 M-APESLKDGIFTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 4e-17
Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 10/220 (4%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
D E +G G+FG+V D + A+K++ + Q + EK ++
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVM-AIPEVIRLKQEQHVHNEKRVLKEVS 59
Query: 170 SRYIVKLKGHFTWKNHLCLVFELL-SYNLYNLIRNTNFHGVSLNLTKKF-AQQLCCALAF 227
+I++L + L ++ E + L++ +RN+ G N T F A ++ CAL +
Sbjct: 60 HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEY 116
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLG 287
L S I++ DLKPENILL K IK+ DFG + + + + Y +PEV+
Sbjct: 117 LHS--KEIVYRDLKPENILL--DKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQS 172
Query: 288 IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
++ A+D W+LG ++ E+ G P F N KI+
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA 212
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 68/229 (29%), Positives = 116/229 (50%), Gaps = 21/229 (9%)
Query: 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK-INKADIHSRYIV 174
++GKGSFG+V+ A + A+K++ KK L + + + + E+ + ++ ++V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVL-QKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 175 KLKGHFTWKNHLCLVFELLSYN----LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSS 230
L H++++ L F L N ++L R +F + +A ++ AL +L S
Sbjct: 60 GL--HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPR---ARFYAAEIASALGYLHS 114
Query: 231 PELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG----QTLYQYIQSRYYRSPEVLL 286
L+II+ DLKPENILL S + + + DFG C G +T + + Y +PEVL
Sbjct: 115 --LNIIYRDLKPENILLDS--QGHVVLTDFGL-CKEGIEHSKTTSTFCGTPEYLAPEVLR 169
Query: 287 GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII-EVLGMPPG 334
PYD +D W LG +L E+ G P F ++ + I+ + L + P
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN 218
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 16/218 (7%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK--INKADIHSRYIV 174
+LGKGSFG+V+ A A+K++K K L +E + EK + A H ++
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLK-KDVILQDDDVECTMTEKRVLALAGKHP-FLT 59
Query: 175 KLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
+L F K+ L V E ++ ++++ R+ F + +A ++ L FL E
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRF---DEPRARFYAAEIVLGLQFLH--E 114
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH---VGQTLYQYIQSRYYRSPEVLLGIP 289
II+ DLK +N+LL IKI DFG G T + + Y +PE+L P
Sbjct: 115 RGIIYRDLKLDNVLL--DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP 172
Query: 290 YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
Y A+D W+LG +L E+ G+ F G +E + I+E
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 72/237 (30%), Positives = 114/237 (48%), Gaps = 25/237 (10%)
Query: 117 LLGKGSFGQV--VKAFDHEEKCQV-AIKIIKNKKPFLNQ-----AQIEVQLLEKINKADI 168
+LGKG +G+V V+ + ++ A+K++K NQ + E +LE +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK---- 58
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKF-AQQLCCALAF 227
+IV L F L L+ E LS L + G+ + T F ++ AL
Sbjct: 59 -HPFIVDLIYAFQTGGKLYLILEYLSGG--ELFMHLEREGIFMEDTACFYLSEISLALEH 115
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEV 284
L II+ DLKPENILL + +K+ DFG S H G + + + Y +PE+
Sbjct: 116 LHQ--QGIIYRDLKPENILL--DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171
Query: 285 LLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV-LGMPPGYLLHGA 340
L+ + A+D WSLG ++ ++ TG P F+ +N + KI++ L +PP YL A
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP-YLTPEA 227
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 89/343 (25%), Positives = 155/343 (45%), Gaps = 64/343 (18%)
Query: 118 LGKGSFGQVVKAF--DHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVK 175
+G+G++G V KA D ++ A+K I+ ++ + E+ LL ++ ++ S V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQKVF 67
Query: 176 LKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVS----------LNLTKKFAQQLCCAL 225
L H K + L+F+ ++L+++I+ FH S + K Q+ +
Sbjct: 68 LS-HADRK--VWLLFDYAEHDLWHIIK---FHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 226 AFLSSPELSIIHCDLKPENILLCS--PKRSAIKIID------FGSSCHVGQTLYQYIQSR 277
+L + ++H DLKP NIL+ P+R +KI D F S L + +
Sbjct: 122 HYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 278 YYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNE---------VDQMTKIIE 327
+YR+PE+LLG Y AID+W++GCI EL T EP+F + E DQ+ +I
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239
Query: 328 VLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGG 387
V+G P A K + ++ ++S ++K D R+ + +
Sbjct: 240 VMGFP-------ADKDWEDIKKMPEHSTLMK---DFRRNTYTNCSLIKYM---------- 279
Query: 388 RRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
H + K L+ ++LT DP KRI+ ++ +F
Sbjct: 280 -----EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 67/237 (28%), Positives = 104/237 (43%), Gaps = 19/237 (8%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIK-NKKPFLNQAQIEVQLLEKINKADIHSRYIVKL 176
LG G+ G V K +A+K I+ + Q QI +L I +S YIV
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI-QKQILREL--DILH-KCNSPYIVGF 64
Query: 177 KGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSII 236
G F + + E + + I + + K A + L +L + II
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE-KHKII 123
Query: 237 HCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ-YIQSRYYRSPEVLLGIPYDLAID 295
H D+KP NIL+ S R IK+ DFG S + +L + ++ + Y +PE + G Y + D
Sbjct: 124 HRDVKPSNILVNS--RGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSD 181
Query: 296 MWSLGCILVELHTGEPLFSGKNE-----VDQMTKIIEVLGMPPGYLLHGASKTSKYF 347
+WSLG L+EL TG + +N+ + + I+ PP L + K S F
Sbjct: 182 IWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPPPRL--PSGKFSPDF 233
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 94/352 (26%), Positives = 153/352 (43%), Gaps = 82/352 (23%)
Query: 118 LGKGSFGQVVKAF--DHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVK 175
+G+G++G V KA D +++ + A+K I+ ++ + E+ LL ++ ++ + V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-EIALLRELKHPNVIALQKVF 67
Query: 176 LKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVS----------LNLTKKFAQQLCCAL 225
L H K + L+F+ ++L+++I+ FH S ++ K Q+ +
Sbjct: 68 LS-HSDRK--VWLLFDYAEHDLWHIIK---FHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 226 AFLSSPELSIIHCDLKPENILLCS--PKRSAIKIID------FGSSCHVGQTLYQYIQSR 277
+L + ++H DLKP NIL+ P+R +KI D F S L + +
Sbjct: 122 HYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 278 YYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNE---------VDQMTKIIE 327
+YR+PE+LLG Y AID+W++GCI EL T EP+F + E DQ+ +I
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239
Query: 328 VLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGG 387
V+G P K D RK +P L
Sbjct: 240 VMGFPAD-----------------------KDWEDIRK--MPEYPTLQKDF--------- 265
Query: 388 RRRNEPGHSLADYM---------KFKDLILRMLTYDPKKRISPTNVLRHEFF 430
RR SL YM K L+ ++LT DP KRI+ L+ +F
Sbjct: 266 RRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-----EVQLLEKINKA 166
+E+ ++GKG+FG+V + K A+K + NK+ + + + E ++L+++N
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYM-NKQKCVEKGSVRNVLNERRILQELN-- 58
Query: 167 DIHSRYIVKLKGHFTWKNHLCLVFELL-SYNL-YNLIRNTNFHGVSLNLTKKFAQQLCCA 224
H ++V L F + ++ LV +LL +L Y+L + F S K + ++ A
Sbjct: 59 --HP-FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKF---SEEQVKFWICEIVLA 112
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRYYRSP 282
L +L S IIH D+KP+NILL ++ + I DF + V + Y +P
Sbjct: 113 LEYLHSK--GIIHRDIKPDNILL--DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAP 168
Query: 283 EVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGK 316
EVL Y +A+D WSLG E G+ + G
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH 202
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 18/218 (8%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKL 176
++GKGSFG+V+ A E+ A+K+++ K + + + + ++ ++V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 177 KGHFTWKNHLCLVFELLSYN----LYNLIRNTNFHGVSLNLTKKF-AQQLCCALAFLSSP 231
HF+++ L F L N Y+L R F L +F A ++ AL +L S
Sbjct: 62 --HFSFQTADKLYFVLDYINGGELFYHLQRERCF----LEPRARFYAAEIASALGYLHS- 114
Query: 232 ELSIIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVLLGI 288
L+I++ DLKPENILL S + I + DFG + T + + Y +PEVL
Sbjct: 115 -LNIVYRDLKPENILLDS--QGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQ 171
Query: 289 PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
PYD +D W LG +L E+ G P F +N + I+
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 8e-16
Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK 177
LGKG FG+V A K + NKK + E ++EK A +HSR+IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKL-NKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 178 GHFTWKNHLCLVFEL-----LSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
F K LCLV + L Y++YN+ + G + Q+ L L +
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNV--DEENPGFPEPRACFYTAQIISGLEHLH--Q 115
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQ-YIQSRYYRSPEVLLGIP 289
II+ DLKPEN+LL ++I D G + + GQ+ + Y + + +PE+L G
Sbjct: 116 RRIIYRDLKPENVLL--DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 290 YDLAIDMWSLGCILVELHTGEPLFSGKNE 318
YD ++D ++LG L E+ F + E
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRARGE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 76/263 (28%), Positives = 118/263 (44%), Gaps = 23/263 (8%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQ---AQIEVQLLEKINKAD 167
RYEI +G+GSFG++ A + IK I K + + ++ EV LL K+ +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNF-HGVSLNLTKKFAQQLCCALA 226
I V F L +V E +L++ N GV + + + + +L
Sbjct: 61 I-----VTFFASFQENGRLFIVMEYCDGG--DLMKRINRQRGVLFSEDQILSWFVQISLG 113
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL---YQYIQSRYYRSPE 283
+ I+H D+K +NI L A K+ DFG + + ++ Y + + YY SPE
Sbjct: 114 LKHIHDRKILHRDIKSQNIFLSKNGMVA-KLGDFGIARQLNDSMELAYTCVGTPYYLSPE 172
Query: 284 VLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP--PGYLLHGAS 341
+ PY+ D+WSLGC+L EL T + F G N + KI + P P + S
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRS 232
Query: 342 KTSKYF-----DRLSDNSYVLKK 359
S+ F DR S S +LK+
Sbjct: 233 LISQLFKVSPRDRPSITS-ILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 73/230 (31%), Positives = 118/230 (51%), Gaps = 28/230 (12%)
Query: 117 LLGKGSFGQV--VKAFDHEEKCQV-AIKIIKNKKPFLNQAQIEVQ-----LLEKINKADI 168
+LG+GSFG+V V+ + Q+ A+K++K +A ++V+ +E+ A++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLK-------KATLKVRDRVRTKMERDILAEV 55
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELL-SYNLYN-LIRNTNFHGVSLNLTKKFAQQLCCALA 226
+ +IVKL F + L L+ + L +L+ L + F + K + +L AL
Sbjct: 56 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF---TEEDVKFYLAELALALD 112
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPE 283
L S L II+ DLKPENILL + IK+ DFG S + Y + + Y +PE
Sbjct: 113 HLHS--LGIIYRDLKPENILL--DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168
Query: 284 VLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV-LGMP 332
V+ + + D WS G ++ E+ TG F GK+ + MT I++ LGMP
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 69/228 (30%), Positives = 113/228 (49%), Gaps = 21/228 (9%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKL 176
++GKGSFG+V+ A + A+K+++ K + Q + + ++ ++V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 177 KGHFTWKNHLCLVFELLSYN----LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
H++++ L F L N ++L R F + +A ++ A+ +L S
Sbjct: 62 --HYSFQTAEKLYFVLDYVNGGELFFHLQRERCF---LEPRARFYAAEVASAIGYLHS-- 114
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG----QTLYQYIQSRYYRSPEVLLGI 288
L+II+ DLKPENILL S + + + DFG C G +T + + Y +PEVL
Sbjct: 115 LNIIYRDLKPENILLDS--QGHVVLTDFGL-CKEGVEPEETTSTFCGTPEYLAPEVLRKE 171
Query: 289 PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII--EVLGMPPG 334
PYD +D W LG +L E+ G P F + +V QM I + L +P G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILHKPLQLPGG 218
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 61/221 (27%), Positives = 109/221 (49%), Gaps = 18/221 (8%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
LD + +G+GS G V A D QVA+K + +K Q + E+ E + D
Sbjct: 21 LDNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDY 73
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
IV++ + + L +V E L L +++ +T + + + AL+F
Sbjct: 74 QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI---ATVCLAVLKALSF 130
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRSPEV 284
L + +IH D+K ++ILL S R +K+ DFG V + + + + + Y+ +PEV
Sbjct: 131 LHAQ--GVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEV 186
Query: 285 LLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKI 325
+ +PY +D+WSLG +++E+ GEP + + + M +I
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 20/228 (8%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI--EVQLLEKINKADIHSRYIV 174
+G+G+FG V K +A+K I++ Q ++ ++ ++ + + YIV
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP----YIV 66
Query: 175 KLKGHFTWKNHLCLVFELLSY---NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP 231
K G + + EL+ Y + + + K A AL +L
Sbjct: 67 KFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE- 125
Query: 232 ELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQS--RYYRSPEVLL--- 286
EL IIH D+KP NILL + IK+ DFG S + ++ + + R Y +PE +
Sbjct: 126 ELKIIHRDVKPSNILL--DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA 183
Query: 287 GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEV-DQMTKIIEVLGMPP 333
YD+ D+WSLG L E+ TG+ + N V DQ+T++ V G PP
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV--VKGDPP 229
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 71/222 (31%), Positives = 111/222 (50%), Gaps = 11/222 (4%)
Query: 118 LGKGSFGQVVKA-FDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKL 176
LG GSFG+V+ A + +E+ VAIK + K + Q Q++ E+ I+ + V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSK-IIKQKQVDHVFSERKILNYINHPFCVNL 96
Query: 177 KGHFTWKNHLCLVFELLSYNLYN--LIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELS 234
G F +++L LV E + + L RN F ++ +A Q+ +L S L+
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN---DVGCFYAAQIVLIFEYLQS--LN 151
Query: 235 IIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAI 294
I++ DLKPEN+LL K IK+ DFG + V Y + Y +PE+LL + + A
Sbjct: 152 IVYRDLKPENLLL--DKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAA 209
Query: 295 DMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336
D W+LG + E+ G P F + KI+E + P +L
Sbjct: 210 DWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFL 251
|
Length = 340 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 66/256 (25%), Positives = 127/256 (49%), Gaps = 31/256 (12%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK------NKKPFLNQAQIEVQLLEKINK 165
+ + LLG+G+FG+V +D + ++A+K ++ +N + E+QLL+ +
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-- 61
Query: 166 ADIHSRYIVKLKGHF--TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLC 222
+H R IV+ G + L + E + ++ + +++ + ++ N+T+K+ +Q+
Sbjct: 62 --LHER-IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQIL 116
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS------CHVGQTLYQYIQS 276
+++L S I+H D+K NIL S +K+ DFG+S C G + +
Sbjct: 117 EGVSYLHSN--MIVHRDIKGANILRDSV--GNVKLGDFGASKRLQTICLSGTGMKSVTGT 172
Query: 277 RYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP--PG 334
Y+ SPEV+ G Y D+WS+GC +VE+ T +P ++ E + M I ++ P P
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPV 229
Query: 335 YLLHGASKTSKYFDRL 350
H + + R+
Sbjct: 230 LPPHVSDHCRDFLKRI 245
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 67/238 (28%), Positives = 116/238 (48%), Gaps = 25/238 (10%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK----INKADIHSRYI 173
+GKGSFG+V K D+ + VAIKII L +A+ E++ +++ +++ D S Y+
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD--SPYV 64
Query: 174 VKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
K G + L ++ E L + +L+R F + K ++ L +L S +
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEK 121
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRSPEVLLGIP 289
IH D+K N+LL ++ +K+ DFG + + T + ++ + ++ +PEV+
Sbjct: 122 K--IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 290 YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347
YD D+WSLG +EL GEP +++ M + + P L SK K F
Sbjct: 178 YDSKADIWSLGITAIELAKGEP---PNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEF 232
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 7e-15
Identities = 52/232 (22%), Positives = 109/232 (46%), Gaps = 22/232 (9%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINK-----ADIHSR 171
LG G+F +A D + +A+K + + N + + +++E + K A ++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVR---NTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 172 YIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP 231
+I+++ G +H L E ++ + + + + + + +QL L++L
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKEAVIINYTEQLLRGLSYLH-- 120
Query: 232 ELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLY-------QYIQSRYYRSPEV 284
E IIH D+K N+L+ S + ++I DFG++ + Q + + + +PEV
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQR-LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 285 LLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT---KIIEVLGMPP 333
L G Y + D+WS+GC+++E+ T +P ++ + + + KI P
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 8e-15
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKI--IKNKKPFLNQAQIEVQLLEKINKADIHSRYIVK 175
LG G+ G V K +A K+ I K Q E+Q++ + S YIV
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMH-----ECRSPYIVS 67
Query: 176 LKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSI 235
G F +N++C+ E + + I + + + K A + L +L + I
Sbjct: 68 FYGAFLNENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYN-VHRI 125
Query: 236 IHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ-YIQSRYYRSPEVLLGIPYDLAI 294
+H D+KP NIL+ S R IK+ DFG S + ++ ++ + Y SPE + G Y +
Sbjct: 126 MHRDIKPSNILVNS--RGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKS 183
Query: 295 DMWSLGCILVELHTGEPLFSGKNEVD 320
D+WSLG ++EL G+ F+ N D
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDD 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 9e-15
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKAD 167
D YE+ ++G G+ V A +VAIK I +K +++ + EVQ + + N +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGV-SLNLTKKFAQQLCCAL 225
+ VK F + L LV LS +L ++++++ G + +++ L
Sbjct: 61 V-----VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGL 115
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS-------CHVGQTLYQYIQSRY 278
+L S IH D+K NILL ++KI DFG S + ++ +
Sbjct: 116 EYLHSNGQ--IHRDIKAGNILLGEDG--SVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171
Query: 279 YRSPEVL-LGIPYDLAIDMWSLGCILVELHTGEPLFS 314
+ +PEV+ YD D+WS G +EL TG +S
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 13/224 (5%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKL 176
++GKGSFG+V+ A + A+K+++ K + Q + + ++ ++V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 177 KGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELS 234
F L V + ++ ++L R +F + +A ++ AL +L S ++
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR---ARFYAAEIASALGYLHS--IN 116
Query: 235 IIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVLLGIPYD 291
I++ DLKPENILL S + + + DFG T + + Y +PEV+ PYD
Sbjct: 117 IVYRDLKPENILLDS--QGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 292 LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII-EVLGMPPG 334
+D W LG +L E+ G P F ++ + I+ + L + PG
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPG 218
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK--INKADIHSRYIV 174
+LGKGSFG+V+ A AIK +K K L +E ++E+ + A H ++
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALK-KDVVLEDDDVECTMVERRVLALAWEHP-FLT 59
Query: 175 KLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPEL 233
L F K HL V E L+ +L I+++ + +A ++ C L FL
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKK-- 115
Query: 234 SIIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVLLGIPY 290
II+ DLK +N+LL K IKI DFG + + + + Y +PE+L G Y
Sbjct: 116 GIIYRDLKLDNVLL--DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY 173
Query: 291 DLAIDMWSLGCILVELHTGEPLFSGKNE 318
+ ++D WS G +L E+ G+ F G++E
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 65/222 (29%), Positives = 108/222 (48%), Gaps = 22/222 (9%)
Query: 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR--YI 173
+LGKGSFG+V+ A AIKI+K K + +E ++EK A + + ++
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILK-KDVIIQDDDVECTMVEKRVLA-LPGKPPFL 63
Query: 174 VKLKGHFTWKNHLCLVFEL-----LSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228
+L F + L V E L Y++ + + H V +A ++ L FL
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVF------YAAEIAIGLFFL 117
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVL 285
S II+ DLK +N++L + IKI DFG + G+T + + Y +PE++
Sbjct: 118 HSK--GIIYRDLKLDNVMLDA--EGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII 173
Query: 286 LGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
PY ++D W+ G +L E+ G+P F G++E + I+E
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 16/209 (7%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKL 176
LLGKG+FG+V+ + A+KI+K K+ + + ++ L E + ++ L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILK-KEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 177 KGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELS 234
K F K+ LC V E ++ ++L R F S + T+ + ++ AL +L S +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVF---SEDRTRFYGAEIVSALDYLHSGK-- 115
Query: 235 IIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG----QTLYQYIQSRYYRSPEVLLGIPY 290
I++ DLK EN++L K IKI DFG C G T+ + + Y +PEVL Y
Sbjct: 116 IVYRDLKLENLML--DKDGHIKITDFGL-CKEGITDAATMKTFCGTPEYLAPEVLEDNDY 172
Query: 291 DLAIDMWSLGCILVELHTGE-PLFSGKNE 318
A+D W LG ++ E+ G P ++ +E
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 63/225 (28%), Positives = 113/225 (50%), Gaps = 27/225 (12%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK 177
+G+GS G V A + QVA+K + +K Q + E+ E + D H +V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 178 GHFTWKNHLCLVFELLSYN-LYNLIRNTNFH-----GVSLNLTKKFAQQLCCALAFLSSP 231
+ + L +V E L L +++ +T + V L++ + AL++L +
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLR--------ALSYLHNQ 137
Query: 232 ELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRSPEVLLGI 288
+IH D+K ++ILL S R IK+ DFG V + + + + + Y+ +PEV+ +
Sbjct: 138 --GVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRL 193
Query: 289 PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
PY +D+WSLG +++E+ GEP + + + M +I + L PP
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL--PP 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 69/208 (33%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK--INKADIHSRYIV 174
+LGKGSFG+V A AIK +K K L +E ++EK ++ A H ++
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLAWEHP-FLT 59
Query: 175 KLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPEL 233
L F K +L V E L+ +L I++ H L +A ++ C L FL S
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK-- 115
Query: 234 SIIHCDLKPENILLCSPKRSAIKIIDFG--SSCHVGQT-LYQYIQSRYYRSPEVLLGIPY 290
I++ DLK +NILL IKI DFG +G + + Y +PE+LLG Y
Sbjct: 116 GIVYRDLKLDNILL--DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY 173
Query: 291 DLAIDMWSLGCILVELHTGEPLFSGKNE 318
+ ++D WS G +L E+ G+ F G +E
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 16/217 (7%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK--INKADIHSRYIV 174
+LGKGSFG+V+ A AIK++K K L ++ + EK + A H ++
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLK-KDVILQDDDVDCTMTEKRILALAAKHP-FLT 59
Query: 175 KLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
L F K+ L V E ++ ++ + R+ F ++ +A ++ AL FL
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDE---PRSRFYAAEVTLALMFLHRH- 115
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVLLGIP 289
+I+ DLK +NILL + K+ DFG G T + + Y +PE+L +
Sbjct: 116 -GVIYRDLKLDNILLDA--EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE 172
Query: 290 YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
Y ++D W+LG ++ E+ G+P F NE D I+
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 14/223 (6%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
L +E+ LG GSFG+V A AIK +K K+ L Q++ EK ++
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLK-KREILKMKQVQHVAQEKSILMEL 75
Query: 169 HSRYIVKLKGHFTWKNHLCLVFE-LLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCA--- 224
+IV + F +N + + E ++ L+ +R G N KF A
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA---GRFPNDVAKFY----HAELV 128
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEV 284
LAF II+ DLKPEN+LL + +K+ DFG + V + + Y +PEV
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLL--DNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEV 186
Query: 285 LLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
+ + A+D W++G +L E G P F KI+
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA 229
|
Length = 329 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 5e-14
Identities = 59/215 (27%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR 171
+E+ L+G G++GQV K + AIK++ + + E+ +L+K + H R
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS----HHR 63
Query: 172 YIVKLKGHFTWKN------HLCLVFELL-SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCA 224
I G F KN L LV E + ++ +LI+NT + + +++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRS 281
L+ L + +IH D+K +N+LL + + +K++DFG S + +T+ + +I + Y+ +
Sbjct: 124 LSHLH--QHKVIHRDIKGQNVLLT--ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 179
Query: 282 PEVLL-----GIPYDLAIDMWSLGCILVELHTGEP 311
PEV+ YD D+WSLG +E+ G P
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 82/339 (24%), Positives = 141/339 (41%), Gaps = 58/339 (17%)
Query: 111 RYEIDTLLGKGSFGQV---VKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKAD 167
+Y I + L GS G+V K D + K + + K P E+ +L+ I+
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTP-----GREIDILKTISH-- 145
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
R I+ L + WK+ +C+V +L+ + + + L ++L ALA+
Sbjct: 146 ---RAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRRLLEALAY 200
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSP 282
L IIH D+K ENI L P+ + + DFG++C + Y + + SP
Sbjct: 201 LH--GRGIIHRDVKTENIFLDEPENAVLG--DFGAACKLDAHPDTPQCYGWSGTLETNSP 256
Query: 283 EVLLGIPYDLAIDMWSLGCILVELHTGE-PLFSGKNEVD--QMTKIIEVLGMPPG-YLLH 338
E+L PY D+WS G +L E+ LF + + Q+ II + + P + +
Sbjct: 257 ELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316
Query: 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398
G++ K+F + Y + R P + P R+
Sbjct: 317 GSTNLCKHFKQ-----YAIVL-------RPPYTI------------PPVIRKYGM----- 347
Query: 399 DYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHSVDN 437
+M + LI +MLT+D + R S ++L F K ++
Sbjct: 348 -HMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL 385
|
Length = 392 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK-NKKPFLNQAQIEVQLLEKINKAD 167
+ YE+ +G G++G V KA D VAIK+IK Q E+ +L++ +
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSY-------NLYNLIRNTNFHGVSLNLTKKFAQQ 220
IV G + ++ L +V E Y ++Y + R L++
Sbjct: 62 -----IVAYFGSYLRRDKLWIVME---YCGGGSLQDIYQVTRGP--------LSELQIAY 105
Query: 221 LCC----ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---Y 273
+C LA+L E IH D+K NILL +K+ DFG S + T+ + +
Sbjct: 106 VCRETLKGLAYLH--ETGKIHRDIKGANILLTE--DGDVKLADFGVSAQLTATIAKRKSF 161
Query: 274 IQSRYYRSPEVL---LGIPYDLAIDMWSLGCILVELHTGEP 311
I + Y+ +PEV YD D+W+LG +EL +P
Sbjct: 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-14
Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 40/214 (18%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK----INKADIHSRYI 173
+GKGSFG+V K D+ K VAIKII L +A+ E++ +++ +++ D S YI
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD--SPYI 64
Query: 174 VKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTK----------KFAQQLCC 223
+ G + L ++ E L G +L+L K +++
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLG------------GGSALDLLKPGPLEETYIATILREILK 112
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYR 280
L +L S IH D+K N+LL ++ +K+ DFG + + T + ++ + ++
Sbjct: 113 GLDYLHSERK--IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168
Query: 281 SPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFS 314
+PEV+ YD D+WSLG +EL GEP S
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 21/211 (9%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK-----INKADIHSRY 172
LG+G FG+V+ A + AIK +K K + + ++E + EK N H +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALK-KGDIIARDEVESLMCEKRIFETANSER-HP-F 63
Query: 173 IVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP 231
+V L F ++H+C V E + +L I F S +A + L +L
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF---SEPRAVFYAACVVLGLQYLH-- 118
Query: 232 ELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH----VGQTLYQYIQSRYYRSPEVLLG 287
E I++ DLK +N+LL + +KI DFG C G + + + +PEVL
Sbjct: 119 ENKIVYRDLKLDNLLLDT--EGFVKIADFGL-CKEGMGFGDRTSTFCGTPEFLAPEVLTE 175
Query: 288 IPYDLAIDMWSLGCILVELHTGEPLFSGKNE 318
Y A+D W LG ++ E+ GE F G +E
Sbjct: 176 TSYTRAVDWWGLGVLIYEMLVGESPFPGDDE 206
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 9e-14
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 14/213 (6%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK---KPFLNQAQIEVQLLEKINKAD 167
+YE ++G+G+FG V ++ V IK I + K AQ E Q+L+ ++ +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELL-SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
I Y +F L +V E L I+ + + F Q+ AL
Sbjct: 61 IIEYY-----ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG--QTLYQYIQSRYYRSPEV 284
+ + I+H DLK +NILL + +KI DFG S + Y + + Y SPE+
Sbjct: 116 HVHTKL--ILHRDLKTQNILL-DKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPEL 172
Query: 285 LLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN 317
G PY+ D+W+LGC+L EL + + F N
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 9e-14
Identities = 67/219 (30%), Positives = 107/219 (48%), Gaps = 17/219 (7%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK-INKADIHSRYIVK 175
+LGKGSFG+V+ A + A+K +K K L +E ++EK + + ++
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALK-KDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 176 LKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPEL 233
L F K HL V E L+ ++++ F L +A ++ C L FL S
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF---DLYRATFYAAEIVCGLQFLHSK-- 115
Query: 234 SIIHCDLKPENILLCSPKRSAIKIIDFGSSCH---VGQT-LYQYIQSRYYRSPEVLLGIP 289
II+ DLK +N++L + IKI DFG C G + + Y +PE+L G+
Sbjct: 116 GIIYRDLKLDNVML--DRDGHIKIADFGM-CKENVFGDNRASTFCGTPDYIAPEILQGLK 172
Query: 290 YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV 328
Y ++D WS G +L E+ G+ F G +E D++ + I V
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 29/213 (13%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK-----NKKPFLNQAQIEVQLLEKI 163
L ++I+ +GKG F V KA + VA+K ++ + K + + E+ LL+++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTK--KFAQQ 220
+ ++ +K F N L +V EL +L +I++ + K+ Q
Sbjct: 60 DHPNV-----IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG-----SSCHVGQTL--YQY 273
LC AL + S I+H D+KP N+ + + +K+ D G SS +T +
Sbjct: 115 LCSALEHMHSKR--IMHRDIKPANVFITA--TGVVKLGDLGLGRFFSS----KTTAAHSL 166
Query: 274 IQSRYYRSPEVLLGIPYDLAIDMWSLGCILVEL 306
+ + YY SPE + Y+ D+WSLGC+L E+
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 18/235 (7%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQ-VAIKIIKNKKPFLNQAQ------IEVQLLE-KI 163
Y + LG G+FG V K +A+K I P + + I + E I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLS----YNLYNLIRNTNFHGVSLNLTKKFAQ 219
K + IV+ F + L +V +L+ +N ++ + F
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV- 120
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT--LYQYIQSR 277
Q+ AL +L E I+H DL P NI+L + + I DFG + L + +
Sbjct: 121 QMVLALRYLHK-EKRIVHRDLTPNNIMLGEDDK--VTITDFGLAKQKQPESKLTSVVGTI 177
Query: 278 YYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332
Y PE++ PY D+W+ GCIL ++ T +P F N + TKI+E + P
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP 232
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 32/231 (13%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKII----------KNKKPFLNQAQIEVQLLEKINKA 166
L+G GSFG V + +A+K + K+ L+ E+ LL+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK----- 61
Query: 167 DIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
++ IV+ G +HL + E + + N N+ L + F +Q+ L
Sbjct: 62 ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVRQILKGLN 120
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLY---------QYIQSR 277
+L + IIH D+K NIL+ + IKI DFG S + S
Sbjct: 121 YLHNRG--IIHRDIKGANILV--DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 278 YYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV 328
++ +PEV+ Y D+WSLGC++VE+ TG+ F + Q+ I ++
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKI 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 17/197 (8%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK 177
LG+G+ G V K A+K I Q QI +L +INK S YIVK
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILREL--EINK-SCKSPYIVKYY 65
Query: 178 GHFTWKNHLCLVFELLSY-------NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSS 230
G F + + Y ++Y ++ + + K A+ + L++L S
Sbjct: 66 GAFL-DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAESVLKGLSYLHS 123
Query: 231 PELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLY-QYIQSRYYRSPEVLLGIP 289
+ IIH D+KP NILL ++ +K+ DFG S + +L + + +Y +PE + G P
Sbjct: 124 RK--IIHRDIKPSNILLT--RKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKP 179
Query: 290 YDLAIDMWSLGCILVEL 306
Y + D+WSLG L+E+
Sbjct: 180 YSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 63/238 (26%), Positives = 118/238 (49%), Gaps = 33/238 (13%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----------LNQAQIEVQLLE 161
+ + LLG+G+FG+V +D + ++A+K + PF +N + E+QLL
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQV----PFDPDSQETSKEVNALECEIQLL- 58
Query: 162 KINKADIHSRYIVKLKGHFTWKNHLCLVFELL-SYNLYNLIRNTNFHGVSLNLTKKFAQQ 220
K + D +Y L+ K L + E + ++ + ++ + ++ N+T+++ +Q
Sbjct: 59 KNLRHDRIVQYYGCLRDPEEKK--LSIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQ 114
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS------CHVGQTLYQYI 274
+ +++L S I+H D+K NIL S +K+ DFG+S C G +
Sbjct: 115 ILQGVSYLHSN--MIVHRDIKGANILRDSA--GNVKLGDFGASKRIQTICMSGTGIKSVT 170
Query: 275 QSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332
+ Y+ SPEV+ G Y D+WS+ C +VE+ T +P ++ E + M I ++ P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA---EYEAMAAIFKIATQP 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 62/230 (26%), Positives = 113/230 (49%), Gaps = 27/230 (11%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIK------NKKPFLNQAQIEVQLLEKINKADIHS 170
LLG+G+FG+V +D + ++A K ++ ++ + E+QLL+ + H
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ----HE 64
Query: 171 RYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRN--TNFHGVSLNLTKKFAQQLCCALAFL 228
R IV+ G + L + Y +++ + ++ ++T+K+ +Q+ +++L
Sbjct: 65 R-IVQYYGCLRDRAEKTLTI-FMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 122
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS------CHVGQTLYQYIQSRYYRSP 282
S I+H D+K NIL S +K+ DFG+S C G + + Y+ SP
Sbjct: 123 HSN--MIVHRDIKGANILRDSA--GNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 283 EVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332
EV+ G Y D+WSLGC +VE+ T +P ++ E + M I ++ P
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWA---EYEAMAAIFKIATQP 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 66/274 (24%), Positives = 108/274 (39%), Gaps = 55/274 (20%)
Query: 173 IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
I++LKG FT+ CL+ +LY + ++ + A + A E
Sbjct: 145 IIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHE 200
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYY--------RSPEV 284
IIH D+K ENI + P + + DFG++C ++YY +PE+
Sbjct: 201 NRIIHRDIKAENIFINHP--GDVCLGDFGAACFP----VDINANKYYGWAGTIATNAPEL 254
Query: 285 LLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVD-------QMTKIIEVLGMPPG-YL 336
L PY A+D+WS G +L E+ T K+ +D Q+ II G P +
Sbjct: 255 LARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314
Query: 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHS 396
+ + + + L+ + R PGS+ L T L +
Sbjct: 315 IDAQANLDEIYIGLAK-----------KSSRKPGSRPLWTNL----------------YE 347
Query: 397 LADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
L +++ LI +ML +D R S +L F
Sbjct: 348 LPIDLEY--LICKMLAFDAHHRPSAEALLDFAAF 379
|
Length = 391 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 57/215 (26%), Positives = 110/215 (51%), Gaps = 23/215 (10%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR 171
+E+ ++G G++GQV K + AIK++ + + ++E+ +L+K + H R
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS----HHR 73
Query: 172 YIVKLKGHFTWK------NHLCLVFELL-SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCA 224
I G F K + L LV E + ++ +L++NT + + + +++
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRS 281
LA L + + +IH D+K +N+LL + + +K++DFG S + +T+ + +I + Y+ +
Sbjct: 134 LAHLHAHK--VIHRDIKGQNVLLT--ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 189
Query: 282 PEVLL-----GIPYDLAIDMWSLGCILVELHTGEP 311
PEV+ YD D+WSLG +E+ G P
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 67/223 (30%), Positives = 112/223 (50%), Gaps = 22/223 (9%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR--YIV 174
LLGKG+FG+V+ + A+KI+K K+ + + ++ L E N+ +SR ++
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILK-KEVIVAKDEVAHTLTE--NRVLQNSRHPFLT 58
Query: 175 KLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
LK F + LC V E + ++L R F S + + + ++ AL +L S E
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF---SEDRARFYGAEIVSALDYLHS-E 114
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVLLGIP 289
++++ DLK EN++L K IKI DFG G T+ + + Y +PEVL
Sbjct: 115 KNVVYRDLKLENLML--DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 172
Query: 290 YDLAIDMWSLGCILVELHTGE-PLFSGKNEVDQMTKIIEVLGM 331
Y A+D W LG ++ E+ G P ++ +E K+ E++ M
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILM 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-13
Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 22/226 (9%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIK---IIKNKKPFLNQAQIEVQLLEKINKAD 167
+Y +G+GSFG+ + E+ Q IK I K +++ EV +L + +
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
I V+ + F +L +V + +LY I + + Q+C AL
Sbjct: 61 I-----VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG------SSCHVGQTLYQYIQSRYYR 280
+ + I+H D+K +NI L K IK+ DFG S+ + +T I + YY
Sbjct: 116 HVH--DRKILHRDIKSQNIFLT--KDGTIKLGDFGIARVLNSTVELARTC---IGTPYYL 168
Query: 281 SPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
SPE+ PY+ D+W+LGC+L E+ T + F N + + KII
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 14/218 (6%)
Query: 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR-YIV 174
+LGKGSFG+V+ A AIKI+K K + +E ++EK A ++
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILK-KDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 175 KLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
+L F + L V E ++ +Y++ + F +A ++ L FL
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF---YAAEISVGLFFLH--R 119
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVLLGIP 289
II+ DLK +N++L S IKI DFG G T + + Y +PE++ P
Sbjct: 120 RGIIYRDLKLDNVMLDS--EGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 290 YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
Y ++D W+ G +L E+ G+P F G++E + I+E
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 66/218 (30%), Positives = 93/218 (42%), Gaps = 42/218 (19%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKINKAD 167
D +E LG G+ G V K +A K+I K NQ E+++L + N
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECN--- 57
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQL------ 221
S YIV G F + + E + G SL+ K A ++
Sbjct: 58 --SPYIVGFYGAFYSDGEISICME-------------HMDGGSLDQVLKKAGRIPENILG 102
Query: 222 ------CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL----Y 271
L +L + I+H D+KP NIL+ S R IK+ DFG S GQ +
Sbjct: 103 KISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNS--RGEIKLCDFGVS---GQLIDSMAN 156
Query: 272 QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTG 309
++ +R Y SPE L G Y + D+WSLG LVE+ G
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 20/220 (9%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK-INKADIHSRYIVK 175
+LGKGSFG+V+ A AIKI+K K + +E ++EK + ++ +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILK-KDVVIQDDDVECTMVEKRVLALSGKPPFLTQ 65
Query: 176 LKGHFTWKNHLCLVFEL-----LSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSS 230
L F + L V E L Y + + R H V +A ++ L FL S
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVF------YAAEIAIGLFFLHS 119
Query: 231 PELSIIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVLLG 287
II+ DLK +N++L S IKI DFG + G T + + Y +PE++
Sbjct: 120 K--GIIYRDLKLDNVMLDS--EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY 175
Query: 288 IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
PY ++D W+ G +L E+ G+ F G++E + I+E
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 19/196 (9%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK 177
LG G+ G V KA+ + +A+K+I Q QI + LE + K D S YI+
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQI-MSELEILYKCD--SPYIIGFY 65
Query: 178 GHFTWKNHLCLVFELL---SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELS 234
G F +N + + E + S ++Y I +++ + K L +L S L
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVK--------GLTYLWS--LK 115
Query: 235 IIHCDLKPENILLCSPKRSAIKIIDFGSSCH-VGQTLYQYIQSRYYRSPEVLLGIPYDLA 293
I+H D+KP N+L+ + R +K+ DFG S V Y+ + Y +PE + G Y +
Sbjct: 116 ILHRDVKPSNMLVNT--RGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 294 IDMWSLGCILVELHTG 309
D+WSLG +EL G
Sbjct: 174 SDVWSLGISFMELALG 189
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 1e-12
Identities = 79/267 (29%), Positives = 119/267 (44%), Gaps = 34/267 (12%)
Query: 105 GEKFLDRYEIDTLLGKGSFGQV--VKAFDHEEK-CQVAIKIIKNKKPFLNQAQIEVQLLE 161
GE L+ YE+ +G G FG+V VK +E C AI K+ +Q IEV ++
Sbjct: 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMR 67
Query: 162 KINKADIHSRYIVKLKGHFTWKNHLCLVF---ELLSYNL---YNLIRNTNFHGVSLNLTK 215
++ +I RYI + K ++ + F LS N+ Y + H + +++T+
Sbjct: 68 ELKHKNI-VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI-VDITR 125
Query: 216 KFAQQLCCALAFLSSPE-LSIIHCDLKPENILLCS---------------PKRSAIKIID 259
+ L P ++H DLKP+NI L + R KI D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 260 FGSSCHVG--QTLYQYIQSRYYRSPEVLL--GIPYDLAIDMWSLGCILVELHTGEPLFSG 315
FG S ++G + + + YY SPE+LL YD DMW+LGCI+ EL +G+ F
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 316 KNEVDQMTKIIEVLGMPPGYLLHGASK 342
N Q+ I L P + G SK
Sbjct: 246 ANNFSQL---ISELKRGPDLPIKGKSK 269
|
Length = 1021 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLN--QAQIEVQLLEKINKADI 168
+Y + ++G+GSFG+ + + A+K I+ K ++ E LL K+ +I
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
V K F HL +V E +L I+ + ++ Q+C +
Sbjct: 61 -----VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS---CHVGQTLYQYIQSRYYRSPEV 284
+ E ++H D+K +NI L + +K+ DFGS+ G Y+ + YY PE+
Sbjct: 116 IH--EKRVLHRDIKSKNIFLT--QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171
Query: 285 LLGIPYDLAIDMWSLGCILVELHT 308
+PY+ D+WSLGCIL EL T
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 40/211 (18%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK----INKADIHSRYI 173
+GKGSFG+V K D+ + VAIKII L +A+ E++ +++ +++ D S Y+
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD--SPYV 64
Query: 174 VKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTK----------KFAQQLCC 223
K G + L ++ E L G +L+L + +++
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLG------------GGSALDLLEPGPLDETQIATILREILK 112
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYR 280
L +L S + IH D+K N+LL + +K+ DFG + + T + ++ + ++
Sbjct: 113 GLDYLHSEKK--IHRDIKAANVLL--SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168
Query: 281 SPEVLLGIPYDLAIDMWSLGCILVELHTGEP 311
+PEV+ YD D+WSLG +EL GEP
Sbjct: 169 APEVIKQSAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 66/238 (27%), Positives = 111/238 (46%), Gaps = 16/238 (6%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK--INKADIHSRYIV 174
+LGKGSFG+V+ A E A+K++K K L +E + EK ++ A H ++
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLK-KDVILQDDDVECTMTEKRILSLARNHP-FLT 59
Query: 175 KLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
+L F + L V E ++ ++++ ++ F +A ++ AL FL
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF---YAAEITSALMFLHDK- 115
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVLLGIP 289
II+ DLK +N+LL K+ DFG G+T + + Y +PE+L +
Sbjct: 116 -GIIYRDLKLDNVLL--DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 290 YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347
Y ++D W++G +L E+ G F +NE D I+ + P +L A K F
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAF 230
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-12
Identities = 62/233 (26%), Positives = 111/233 (47%), Gaps = 29/233 (12%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQ---AQIEVQLLEKINKADIHSRYIV 174
+GKGS+G+V + Q IK + + + A+ E QLL ++ +I
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI------ 61
Query: 175 KLKGHFTWKNHLCLVFELLSY----NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSS 230
+ +W+ L++ ++ + +LY+ ++ + N ++ Q+ AL +L
Sbjct: 62 -VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH- 119
Query: 231 PELSIIHCDLKPENILLCSPKRSAIKIIDFG------SSCHVGQTLYQYIQSRYYRSPEV 284
E I+H DLK +N+ L + + IK+ D G + C + TL I + YY SPE+
Sbjct: 120 -EKHILHRDLKTQNVFLT--RTNIIKVGDLGIARVLENQCDMASTL---IGTPYYMSPEL 173
Query: 285 LLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE--VLGMPPGY 335
PY+ D+W+LGC + E+ T + F+ K+ + +IIE + MP Y
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDY 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKL 176
LLGKG+FG+V+ + A+KI+K K+ + + ++ L E + ++ L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILK-KEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 177 KGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELS 234
K F + LC V E + ++L R F S + + + ++ AL +L S +
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVF---SEDRARFYGAEIVSALGYLHSCD-- 115
Query: 235 IIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVLLGIPYD 291
+++ DLK EN++L K IKI DFG G T+ + + Y +PEVL Y
Sbjct: 116 VVYRDLKLENLML--DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 292 LAIDMWSLGCILVELHTGE-PLFSGKNEV 319
A+D W LG ++ E+ G P ++ +E
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEK 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 61/231 (26%), Positives = 111/231 (48%), Gaps = 19/231 (8%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK 177
+G+GS G V A + QVA+K++ +K Q + E+ E + D + +V++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 178 GHFTWKNHLCLVFELLSYN-LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSII 236
+ L ++ E L L +++ T + + + Q AL +L S +I
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQ---ALCYLHSQ--GVI 139
Query: 237 HCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRSPEVLLGIPYDLA 293
H D+K ++ILL R +K+ DFG + + + + + + Y+ +PEV+ PY
Sbjct: 140 HRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 294 IDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344
+D+WSLG +++E+ GEP + + V M ++ + PP L A K S
Sbjct: 198 VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD--SPPPK--LKNAHKIS 244
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 65/241 (26%), Positives = 104/241 (43%), Gaps = 42/241 (17%)
Query: 118 LGKGSFGQVVKA----FDHEEKCQVAIKIIKNKKPFLNQA--QIEVQLLEKINKADIHSR 171
LG+G FG+V QVA+K + + +++ + E+++L +
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-----DHE 66
Query: 172 YIVKLKG--HFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTK--KFAQQLCCALA 226
IVK KG L L+ E L +L + ++ H +NL + F+ Q+C +
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ---RHRDQINLKRLLLFSSQICKGMD 123
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL-YQYIQS------RYY 279
+L S IH DL NIL+ S +KI DFG + + + Y Y++ +Y
Sbjct: 124 YLGSQRY--IHRDLAARNILVESEDL--VKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179
Query: 280 RSPEVLLGIPYDLAIDMWSLGCILVELHT---------GEPLFSGKNEVDQM--TKIIEV 328
+PE L + A D+WS G L EL T E L QM T+++E+
Sbjct: 180 -APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238
Query: 329 L 329
L
Sbjct: 239 L 239
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 56/233 (24%), Positives = 101/233 (43%), Gaps = 50/233 (21%)
Query: 114 IDTLLGKGSFGQVVKAFDHEEK-----CQVAIKIIKNKKPFLNQAQI-----EVQLLEKI 163
+ LG+G FG+VVKA K VA+K++K + +++ E LL+++
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQV 60
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIR-------------------- 202
N +++KL G + L L+ E Y +L + +R
Sbjct: 61 NHP-----HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 203 --NTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260
N + +++ FA Q+ + +L+ E+ ++H DL N+L+ ++ +KI DF
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLA--EMKLVHRDLAARNVLVAEGRK--MKISDF 171
Query: 261 GSSCHVGQTLYQYIQSR-----YYRSPEVLLGIPYDLAIDMWSLGCILVELHT 308
G S V + +S+ + + E L Y D+WS G +L E+ T
Sbjct: 172 GLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-12
Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 34/229 (14%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI- 168
+ +E L+ G++G V E + + A+K I NK+ + + QI+ +E+ DI
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKI-NKQNLILRNQIQQVFVER----DIL 55
Query: 169 ---HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCA 224
+ ++V + F K HLC+V E + + L++N + +++ + + + A
Sbjct: 56 TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLA 113
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS-------------CHVGQTLY 271
L +L + I+H DLKP+N+L+ S IK+ DFG S H+ +
Sbjct: 114 LEYLHN--YGIVHRDLKPDNLLITS--MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 272 QYIQSRY-----YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG 315
+++ + Y +PEV+L Y +D W++G IL E G F G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 7e-12
Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 18/226 (7%)
Query: 118 LGKGSFGQVVKAFDHEEKCQV-AIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKL 176
LG+G++G VV H + A+K I+ Q ++ + L I+ + Y V
Sbjct: 9 LGRGAYG-VVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDL--DISMRSVDCPYTVTF 65
Query: 177 KGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSL--NLTKKFAQQLCCALAFLSSPELS 234
G + + + E++ +L + G+++ ++ K A + AL +L S +LS
Sbjct: 66 YGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLS 124
Query: 235 IIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ--SRYYRSPEVLLG----I 288
+IH D+KP N+L+ + +K+ DFG S ++ ++ + I + Y +PE +
Sbjct: 125 VIHRDVKPSNVLI--NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 182
Query: 289 PYDLAIDMWSLGCILVELHTGE-PLFSGKNEVDQMTKIIEVLGMPP 333
YD+ D+WSLG ++EL TG P S K Q+ +++E P
Sbjct: 183 GYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--EPSP 226
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 14/208 (6%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKL 176
LLGKG+FG+V+ + A+KI++ K+ + + ++ + E + ++ L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 177 KGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELS 234
K F + LC V E + ++L R F + + + ++ AL +L S +
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARFYGAEIVSALEYLHSRD-- 115
Query: 235 IIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVLLGIPYD 291
+++ D+K EN++L K IKI DFG G T+ + + Y +PEVL Y
Sbjct: 116 VVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 292 LAIDMWSLGCILVELHTGE-PLFSGKNE 318
A+D W LG ++ E+ G P ++ +E
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII--KNKKPFLNQAQIEVQLLEKINKAD 167
D +E + LG G+ G V K +A K+I + K NQ E+Q+L + N
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN--- 61
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
S YIV G F + + E + +L +++ + + K + + LA
Sbjct: 62 --SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLA 117
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ-YIQSRYYRSPEVL 285
+L I+H D+KP NIL+ S R IK+ DFG S + ++ ++ +R Y SPE L
Sbjct: 118 YLREKH-QIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 174
Query: 286 LGIPYDLAIDMWSLGCILVELHTG 309
G Y + D+WS+G LVEL G
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 53/231 (22%), Positives = 98/231 (42%), Gaps = 52/231 (22%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKI------IKNKKPFLNQAQIEVQ 158
++ + LG+GSFG V + E + +VAIK ++ + FLN+A + +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 159 LLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIR-------NTNFHGV- 209
+ ++V+L G + +V EL++ +L + +R N G
Sbjct: 66 ---------FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP 116
Query: 210 SLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT 269
+L + A ++ +A+L+ +H DL N ++ +KI DFG + +
Sbjct: 117 TLQKFIQMAAEIADGMAYLA--AKKFVHRDLAARNCMVAE--DLTVKIGDFG----MTRD 168
Query: 270 LYQYIQSRYYR------------SPEVLLGIPYDLAIDMWSLGCILVELHT 308
+Y+ + YYR +PE L + D+WS G +L E+ T
Sbjct: 169 IYE---TDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 67/233 (28%), Positives = 112/233 (48%), Gaps = 27/233 (11%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQV-AIKIIKNKKPFLNQAQI--EVQLLEKINK 165
L+ E +G G+ GQV K ++ V A+K ++ +I ++ ++ K +
Sbjct: 14 LNDLENLGEIGSGTCGQVYKM-RFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHD 72
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCAL 225
YIVK G+F + + + EL+S L L++ + ++ K + AL
Sbjct: 73 ----CPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQ-GPIPEDILGKMTVAIVKAL 127
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRY-----YR 280
+L + +IH D+KP NILL +K+ DFG S G+ + ++R Y
Sbjct: 128 HYLKE-KHGVIHRDVKPSNILL--DASGNVKLCDFGIS---GRLVDSKAKTRSAGCAAYM 181
Query: 281 SPEVLLGIP-----YDLAIDMWSLGCILVELHTGE-PLFSGKNEVDQMTKIIE 327
+PE + P YD+ D+WSLG LVEL TG+ P + K E + +TKI++
Sbjct: 182 APE-RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ 233
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 60/239 (25%), Positives = 110/239 (46%), Gaps = 26/239 (10%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQ----IEVQLLEKIN 164
L ++I+ +G+G F +V +A ++ VA+K ++ + +A+ E+ LL+++N
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 165 KADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIR--NTNFHGVSLNLTKKFAQQL 221
++ +K F N L +V EL +L +I+ + K+ QL
Sbjct: 61 HPNV-----IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115
Query: 222 CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG------SSCHVGQTLYQYIQ 275
C A+ + S ++H D+KP N+ + + +K+ D G S +L +
Sbjct: 116 CSAVEHMHSRR--VMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSL---VG 168
Query: 276 SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPP 333
+ YY SPE + Y+ D+WSLGC+L E+ P + K + + + IE PP
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 62/239 (25%), Positives = 110/239 (46%), Gaps = 26/239 (10%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI----EVQLLEKIN 164
L + I+ +G+G F +V +A + VA+K ++ +A+ E+ LL+++N
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 165 KADIHSRYIVKLKGHFTWKNHLCLVFELL-SYNLYNLIRNTNFHG--VSLNLTKKFAQQL 221
++ +K F N L +V EL + +L +I++ + K+ QL
Sbjct: 61 HPNV-----IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL 115
Query: 222 CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG------SSCHVGQTLYQYIQ 275
C AL + S ++H D+KP N+ + + +K+ D G S +L +
Sbjct: 116 CSALEHMHSRR--VMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSL---VG 168
Query: 276 SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGE-PLFSGKNEVDQMTKIIEVLGMPP 333
+ YY SPE + Y+ D+WSLGC+L E+ + P + K + + K IE PP
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII--KNKKPFLNQAQIEVQLLEKINKAD 167
D +E + LG G+ G V K +A K+I + K NQ E+Q+L + N
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN--- 61
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
S YIV G F + + E + +L +++ + + K + + L
Sbjct: 62 --SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLT 117
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ-YIQSRYYRSPEVL 285
+L I+H D+KP NIL+ S R IK+ DFG S + ++ ++ +R Y SPE L
Sbjct: 118 YLREKH-KIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL 174
Query: 286 LGIPYDLAIDMWSLGCILVELHTG 309
G Y + D+WS+G LVE+ G
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 71/280 (25%), Positives = 112/280 (40%), Gaps = 56/280 (20%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
D +E ++G+G+FG+V + A+K ++ K L + Q+ E+ A+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEAD 59
Query: 170 SRYIVKLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
+ ++VKL F +N+L L+ E L + L++ F + T+ + + LA
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTF---TEEETRFYIAE--TILAI 114
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG-----SSCHVGQTLYQ-YIQSR---- 277
S +L IH D+KP+N+LL + IK+ DFG H Y+ +
Sbjct: 115 DSIHKLGYIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLKKSHR-TEFYRILSHALPSNF 171
Query: 278 -------------------------Y-------YRSPEVLLGIPYDLAIDMWSLGCILVE 305
Y Y +PEV L Y+ D WSLG I+ E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231
Query: 306 LHTGEPLFSGKNEVDQMTKII---EVLGMPPGYLLHGASK 342
+ G P F N + KII E L P L +K
Sbjct: 232 MLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAK 271
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 65/240 (27%), Positives = 109/240 (45%), Gaps = 30/240 (12%)
Query: 113 EIDTL--LGKGSFGQVVKAFDHEEKCQVAIKIIKNK--KPFLNQAQIEVQLLEKINKADI 168
EI+ L LGKG++G V K +A+K I+ + + NQ +E+ +L K
Sbjct: 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAV---- 57
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSY----NLYNLIRNTNFHGVSLNLTKKFAQQLCCA 224
S YIV G F + + + E + LY G+ ++ ++ +
Sbjct: 58 -SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYA--GGVATEGIPEDVLRRITYAVVKG 114
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY-IQSRYYRSPE 283
L FL E +IIH D+KP N+L+ +K+ DFG S ++ +L + I + Y +PE
Sbjct: 115 LKFLKE-EHNIIHRDVKPTNVLVNG--NGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPE 171
Query: 284 VLLG------IPYDLAIDMWSLGCILVELHTGE---PLFSGKNEVDQMTKIIEVLGMPPG 334
+ Y + D+WSLG ++E+ G P + N Q++ I++ G PP
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT 229
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 23/222 (10%)
Query: 117 LLGKGSFGQVVKAFDHE---EKCQVAIKIIKNKKPFLNQAQI--EVQLLEKINKADIHSR 171
LG GSFG V + + VA+K +K+ K E ++ ++ ++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 172 YIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSS 230
Y V L + L +V EL +L + +R ++ +A Q+ + +L S
Sbjct: 62 YGVVLT------HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES 115
Query: 231 PELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYR------SPEV 284
IH DL NILL S + +KI DFG + Q Y+ + + +PE
Sbjct: 116 KRF--IHRDLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 285 LLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKI 325
L + A D+W G L E+ T GE ++G + + KI
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 68/244 (27%), Positives = 111/244 (45%), Gaps = 25/244 (10%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
D +EI +GKG++G+V K + ++ A+KI+ + + E +L+ + H
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPN---H 78
Query: 170 SRYIVKLKGHFTWKNH-----LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCC 223
+VK G F + L LV EL + ++ L++ G L+ + L
Sbjct: 79 PN-VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD-EAMISYILYG 136
Query: 224 ALAFLSSPELS-IIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY---IQSRYY 279
AL L + IIH D+K NILL + +K++DFG S + T + + + ++
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTT--EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 194
Query: 280 RSPEVL-----LGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPG 334
+PEV+ YD D+WSLG +EL G+P + V + KI PP
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NPPP 251
Query: 335 YLLH 338
LLH
Sbjct: 252 TLLH 255
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 60/230 (26%), Positives = 104/230 (45%), Gaps = 21/230 (9%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
+++ +L+G+G FG+V + A+K++K K L Q + E+ + +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMK-KSVLLAQETVSFFEEERDILSISN 59
Query: 170 SRYIVKLKGHFTWKNHLCLVFELL-SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228
S +I +L+ F K++L LV E +L +L+ N ++ + + +L LA
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL-NRYEDQFDEDMAQFYLAEL--VLAIH 116
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC------HVGQTLYQYIQSRYYRSP 282
S ++ +H D+KPEN+L+ + IK+ DFGS+ V L + + Y +P
Sbjct: 117 SVHQMGYVHRDIKPENVLI--DRTGHIKLADFGSAARLTANKMVNSKLP--VGTPDYIAP 172
Query: 283 EVLLGI------PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
EVL + Y + D WSLG I E+ G F I+
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM 222
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 7e-11
Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 111 RYEIDT-------LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKI 163
YE + +LGKG++G V A D + ++AIK I + Q E L
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS- 60
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELL-SYNLYNLIRNT----NFHGVSLNLTKKFA 218
+ R IV+ G + + E + +L L+R+ + ++ +
Sbjct: 61 ---YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF---YT 114
Query: 219 QQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG------QTLYQ 272
+Q+ L +L + I+H D+K +N+L+ + +KI DFG+S + +T
Sbjct: 115 KQILEGLKYLH--DNQIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAGINPCTETFTG 171
Query: 273 YIQSRYYRSPEVLLGIP--YDLAIDMWSLGCILVELHTGEPLF 313
+Q Y +PEV+ P Y D+WSLGC +VE+ TG+P F
Sbjct: 172 TLQ---YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 67/238 (28%), Positives = 94/238 (39%), Gaps = 39/238 (16%)
Query: 118 LGKGSFGQVVKAFDHEEKCQ---VAIKIIK------NKKPFLNQAQIEVQLLEKINKADI 168
LG G+FG VVK + + VA+K +K KK FL +A + QL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL--------- 53
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSYNLYN--LIRNTNFHGVSLNLTKKFAQQLCCALA 226
IV+L G L LV EL L + L K+ A Q+ +A
Sbjct: 54 DHPCIVRLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMA 109
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS--CHVGQTLYQYIQS-----RYY 279
+L S +H DL N+LL + R KI DFG S G Y+ + ++Y
Sbjct: 110 YLESKHF--VHRDLAARNVLLVN--RHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY 165
Query: 280 RSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGK--NEVDQMTKIIEVLGMPPG 334
+PE + + D+WS G L E + G + EV M + E L P
Sbjct: 166 -APECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEE 222
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 9e-11
Identities = 61/224 (27%), Positives = 109/224 (48%), Gaps = 20/224 (8%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI----EVQLLEKINKADIHSRY 172
++G+G FG+V + A+K + K+ + Q + E +L ++ D +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD--CPF 58
Query: 173 IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGV-SLNLTKKFAQQLCCALAFLSSP 231
IV + F + LC + +L+ N +L + + HGV S + +A ++ L + +
Sbjct: 59 IVCMTYAFHTPDKLCFILDLM--NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116
Query: 232 ELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL-YQYIQSRYYRSPEVLL-GIP 289
+++ DLKP NILL + ++I D G +C + + + + Y +PEVL G
Sbjct: 117 --FVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTA 172
Query: 290 YDLAIDMWSLGCILVELHTGEPLF-----SGKNEVDQMTKIIEV 328
YD + D +SLGC+L +L G F K+E+D+MT + V
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 61/250 (24%), Positives = 107/250 (42%), Gaps = 60/250 (24%)
Query: 111 RYEIDTLLGKGSFGQVVKA-----FDHEEKCQVAIKIIKNKKPFLNQA--QIEVQLLEKI 163
Y D +G+G+FG+V +A +E VA+K++K + QA Q E L+ +
Sbjct: 8 EYVRD--IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 65
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRN---TNFHGVSLNLTK---- 215
+ +I VKL G +CL+FE ++Y +L +R+ +S + +
Sbjct: 66 DHPNI-----VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 216 -------------KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262
A+Q+ +A+LS E +H DL N L+ + +KI DFG
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLS--ERKFVHRDLATRNCLV--GENMVVKIADFGL 176
Query: 263 SCHVGQTLYQYIQSRYYRS------------PEVLLGIPYDLAIDMWSLGCILVELHTG- 309
S + +Y + YY++ PE + Y D+W+ G +L E+ +
Sbjct: 177 S----RNIYS---ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 229
Query: 310 -EPLFSGKNE 318
+P + +E
Sbjct: 230 MQPYYGMAHE 239
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 61/243 (25%), Positives = 111/243 (45%), Gaps = 27/243 (11%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
D +EI +GKG++G+V K + + + A+KI+ + + E +L+ ++ H
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSD---H 74
Query: 170 SRYIVKLKGHFTWKN-----HLCLVFELLSY-NLYNLIRNTNFHGVSLN--LTKKFAQQL 221
+VK G + K+ L LV EL + ++ +L++ G + + +
Sbjct: 75 PN-VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 222 CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRY 278
L L IH D+K NILL + +K++DFG S + T + + + +
Sbjct: 134 LMGLQHLH--VNKTIHRDVKGNNILLTT--EGGVKLVDFGVSAQLTSTRLRRNTSVGTPF 189
Query: 279 YRSPEVL-----LGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
+ +PEV+ L YD D+WSLG +EL G+P + ++ M + ++ PP
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA---DLHPMRALFKIPRNPP 246
Query: 334 GYL 336
L
Sbjct: 247 PTL 249
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 67/254 (26%), Positives = 120/254 (47%), Gaps = 32/254 (12%)
Query: 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKAD 167
+LD + +G+GS G V A VA+K + +K Q + E+ E + D
Sbjct: 21 YLDNF---IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRD 73
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFH-----GVSLNLTKKFAQQL 221
+V++ + + L +V E L L +++ +T + V L + K
Sbjct: 74 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLK------ 127
Query: 222 CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRY 278
AL+ L + +IH D+K ++ILL R +K+ DFG V + + + + + Y
Sbjct: 128 --ALSVLHAQ--GVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPY 181
Query: 279 YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL-L 337
+ +PE++ +PY +D+WSLG +++E+ GEP + + + M I + +PP L
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD--NLPPKLKNL 239
Query: 338 HGASKTSK-YFDRL 350
H S + K + DRL
Sbjct: 240 HKVSPSLKGFLDRL 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 56/191 (29%), Positives = 82/191 (42%), Gaps = 33/191 (17%)
Query: 141 KIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY----N 196
KIIK K N + V L K N +KL T L+ + Y +
Sbjct: 47 KIIKAKN--FNAIEPMVHQLMKDNP------NFIKLYYSVTTLKGHVLI---MDYIKDGD 95
Query: 197 LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIK 256
L++L++ +S KK +QL AL L IIH D+K EN+L + I
Sbjct: 96 LFDLLKKEGK--LSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVL-YDRAKDRIY 150
Query: 257 IIDFGSSCHVGQTLYQYIQSRY-----YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEP 311
+ D+G +G S Y Y SPE + G YD++ D W++G + EL TG+
Sbjct: 151 LCDYGLCKIIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKH 204
Query: 312 LFSGKNEVDQM 322
F K + D+
Sbjct: 205 PF--KEDEDEE 213
|
Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 69/271 (25%), Positives = 114/271 (42%), Gaps = 63/271 (23%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK 177
LG G+FG+V A + K A+K ++ KK L + Q+ E+ A+ + ++V+L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLR-KKDVLLRNQVAHVKAERDILAEADNEWVVRLY 67
Query: 178 GHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSI 235
F K++L V + + + LIR F +L + + +L CA+ S ++
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPE---DLARFYIAELTCAVE--SVHKMGF 122
Query: 236 IHCDLKPENILLCSPKRSAIKIIDFG---------------------------------- 261
IH D+KP+NIL+ + IK+ DFG
Sbjct: 123 IHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 262 SSCHVGQTL----------------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVE 305
++C G L + + + Y +PEVLL Y D WS+G IL E
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240
Query: 306 LHTGEPLFSGKNEVDQMTKIIE---VLGMPP 333
+ G+P F + ++ K+I L +PP
Sbjct: 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPP 271
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 69/242 (28%), Positives = 108/242 (44%), Gaps = 46/242 (19%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK---KPFLNQAQIEVQLLEKINKAD 167
+Y I +LG G+ G V+ A + A+K++ + + N+AQ EV L D
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLN---CD 89
Query: 168 IHSRYIVKLKGHFTWKN-----HLCLVFELLSY----NLYNLIRNTNFHGVSLNLTKKFA 218
S IVK F K+ ++ ++ +L Y +L I++ + F
Sbjct: 90 FFS--IVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRA------KTNRTFR 141
Query: 219 Q--------QLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH----- 265
+ Q+ A+ + S + IH D+K NILLCS +K+ DFG S
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHM--IHRDIKSANILLCS--NGLVKLGDFGFSKMYAATV 197
Query: 266 ---VGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQM 322
VG+T + + YY +PE+ PY DM+SLG +L EL T + F G+N + M
Sbjct: 198 SDDVGRT---FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM 254
Query: 323 TK 324
K
Sbjct: 255 HK 256
|
Length = 496 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 69/248 (27%), Positives = 104/248 (41%), Gaps = 46/248 (18%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHE---EKCQVAIKIIKN------KKPFLNQAQIEVQLL 160
+ + +G+G FG V + EK VA+K KN ++ FL +A I Q
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF- 64
Query: 161 EKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQ 220
H +IVKL G T +N + +V EL N + + L ++ Q
Sbjct: 65 -------DHP-HIVKLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQ 115
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ-SRYY 279
L ALA+L S +H D+ N+L+ SP +K+ DFG L +Y++ YY
Sbjct: 116 LSTALAYLES--KRFVHRDIAARNVLVSSPD--CVKLGDFG--------LSRYLEDESYY 163
Query: 280 RSPEVLLGIP-----------YDLAIDMWSLG-CILVELHTGEPLFSGKNEVDQMTKII- 326
++ + L I + A D+W G C+ L G F G D + +I
Sbjct: 164 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN 223
Query: 327 -EVLGMPP 333
E L MPP
Sbjct: 224 GERLPMPP 231
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 60/247 (24%), Positives = 97/247 (39%), Gaps = 64/247 (25%)
Query: 117 LLGKGSFGQV-------------VKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKI 163
LLGKG G+V +K D +E +IK K + + E ++L +
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKE-------MIKRNK--VKRVLTEQEILATL 58
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLC 222
+ H ++ L F + +LCLV + L+ L++ +S + + +A ++
Sbjct: 59 D----HP-FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVL 113
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG----QTLYQYIQSRY 278
AL +L L I++ DLKPENILL + I + DF S +
Sbjct: 114 LALEYLHL--LGIVYRDLKPENILL--HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169
Query: 279 ----------------------------YRSPEVLLGIPYDLAIDMWSLGCILVELHTGE 310
Y +PEV+ G + A+D W+LG +L E+ G
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
Query: 311 PLFSGKN 317
F G N
Sbjct: 230 TPFKGSN 236
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 67/243 (27%), Positives = 104/243 (42%), Gaps = 24/243 (9%)
Query: 94 DDENYDYIIKHG--EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLN 151
D E D K E F+ +EI G GSFG V A + VA+K + N
Sbjct: 7 DPEIADLFYKDDPEEIFVGLHEI----GHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN 62
Query: 152 QAQ----IEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFH 207
+ EV+ L+++ + LK H W L + + L S + +
Sbjct: 63 EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW---LVMEYCLGSASDLLEVHKKPLQ 119
Query: 208 GVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267
V + A Q LA+L S + IH D+K NILL P + +K+ DFGS+
Sbjct: 120 EVEIAAITHGALQ---GLAYLHSHNM--IHRDIKAGNILLTEPGQ--VKLADFGSAS-KS 171
Query: 268 QTLYQYIQSRYYRSPEVLLGI---PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTK 324
++ + Y+ +PEV+L + YD +D+WSLG +EL +P N + +
Sbjct: 172 SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 231
Query: 325 IIE 327
I +
Sbjct: 232 IAQ 234
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 36/212 (16%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQ-----------VAIKIIKNKKP-FLNQAQIEVQLLEKIN 164
LGKG+FG V E C+ VA+K +++ L + E+++L+ +
Sbjct: 11 QLGKGNFGSV-------ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL- 62
Query: 165 KADIHSRYIVKLKG--HFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLC 222
IVK KG + + +L LV E L Y + + +A Q+C
Sbjct: 63 ----QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQIC 118
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYI-----QSR 277
+ +L S +H DL NIL+ S R +KI DFG + + Q Y +S
Sbjct: 119 KGMEYLGS--KRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQDKEYYKVREPGESP 174
Query: 278 -YYRSPEVLLGIPYDLAIDMWSLGCILVELHT 308
++ +PE L + +A D+WS G +L EL T
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 69/282 (24%), Positives = 125/282 (44%), Gaps = 50/282 (17%)
Query: 102 IKHGEKFLDRYEIDTLLGKGSFGQV----VKAFDHEE--------------KCQVAI-KI 142
+KH ++FL + + L G+FG++ ++A E KC+ I K
Sbjct: 140 LKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKR 199
Query: 143 IKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIR 202
+K Q + E+ L ++N +I +K++ + + ++ + ++LY+ +
Sbjct: 200 VKAGSRAAIQLENEILALGRLNHENI-----LKIEEILRSEANTYMITQKYDFDLYSFMY 254
Query: 203 NTNFHGVS---LNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILL-CSPKRSAIKII 258
+ F L T+ +QL CA+ ++ +L IH D+K ENI L C K I +
Sbjct: 255 DEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKL--IHRDIKLENIFLNCDGK---IVLG 309
Query: 259 DFGSSCHVGQTL----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGE--PL 312
DFG++ + Y ++ + SPE+L G Y D+WS G IL+++ + + P+
Sbjct: 310 DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369
Query: 313 F-SGKNEVDQMTKIIEVLGM-------PPGYL---LHGASKT 343
G Q+ KII+ L + PP L + A
Sbjct: 370 GDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEID 411
|
Length = 501 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 62/242 (25%), Positives = 114/242 (47%), Gaps = 20/242 (8%)
Query: 98 YDYIIKHGEKF---LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQ 154
Y+ I++ K + Y++ ++G+G+FG+V + H+ +V + +K + ++
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSD 86
Query: 155 IEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELL-SYNLYNLIRNTNFHGVSLNL 213
E+ A +S ++V+L F +L +V E + +L NL+ N + V
Sbjct: 87 SAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKW 143
Query: 214 TKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY 273
K + ++ AL + S + +IH D+KP+N+LL K +K+ DFG+ + +T
Sbjct: 144 AKFYTAEVVLALDAIHS--MGLIHRDVKPDNMLL--DKHGHLKLADFGTCMKMDETGMVR 199
Query: 274 IQSRY----YRSPEVLLGIP----YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKI 325
+ Y SPEVL Y D WS+G L E+ G+ F + V +KI
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
Query: 326 IE 327
++
Sbjct: 260 MD 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 24/233 (10%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIK-NKKPFLNQAQIEVQLLEKINK-----ADIHS 170
L+GKG++G+V A + +A+K ++ + +++ + D+
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 171 RYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHG-VSLNLTKKFAQQLCCALAFL 228
IV+ G T + +L + E + ++ + +R +G L + F +Q+ LA+L
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYL 124
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ------SRYYRSP 282
S I+H DLK +N+L+ KI DFG S +Y Q S ++ +P
Sbjct: 125 HSK--GILHRDLKADNLLV--DADGICKISDFGISKK-SDDIYDNDQNMSMQGSVFWMAP 179
Query: 283 EV--LLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
EV Y +D+WSLGC+++E+ G +S + + M K+ PP
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 61/241 (25%), Positives = 98/241 (40%), Gaps = 45/241 (18%)
Query: 118 LGKGSFGQVVKA-----FDHEEKCQVAIKIIKNKKPFLNQA----QIEVQLLEKINKADI 168
LG+G+FG+V +K VA+K +K N A + E +LL +
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELL-----TNF 65
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLN--------LTK---- 215
IVK G T + +VFE + + +L +R+ L LT
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 216 KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ 275
+ A Q+ + +L+S +H DL N L+ +KI DFG S V T Y +
Sbjct: 126 QIAVQIASGMVYLAS--QHFVHRDLATRNCLVGY--DLVVKIGDFGMSRDVYTTDYYRVG 181
Query: 276 SRY-----YRSPEVLLGIPYDLAIDMWSLGCILVELHT--GEPLFSGKNEVDQMTKIIEV 328
+ PE ++ + D+WS G +L E+ T +P + NE ++IE
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-----EVIEC 236
Query: 329 L 329
+
Sbjct: 237 I 237
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 60/223 (26%), Positives = 111/223 (49%), Gaps = 18/223 (8%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR---YI 173
++G+G FG+V + A+K + K+ + Q + + L E+I + + + +I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET-LALNERIMLSLVSTGDCPFI 59
Query: 174 VKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGV-SLNLTKKFAQQLCCALAFLSSPE 232
V + F + L + +L+ N +L + + HGV S + +A ++ L + +
Sbjct: 60 VCMSYAFHTPDKLSFILDLM--NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR- 116
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL-YQYIQSRYYRSPEVLL-GIPY 290
+++ DLKP NILL + ++I D G +C + + + + Y +PEVL G+ Y
Sbjct: 117 -FVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAY 173
Query: 291 DLAIDMWSLGCILVELHTGEPLFSG-----KNEVDQMTKIIEV 328
D + D +SLGC+L +L G F K+E+D+MT + V
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 9e-10
Identities = 69/226 (30%), Positives = 98/226 (43%), Gaps = 41/226 (18%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII----KNKKPFLNQAQIEVQLLE 161
+ F D EI G GSFG V A D VAIK + K EV+ L+
Sbjct: 15 KLFTDLREI----GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 162 KINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQL 221
++ + L+ H W LV E Y L ++ L + KK Q++
Sbjct: 71 QLRHPNTIEYKGCYLREHTAW-----LVME------YCLGSASDI----LEVHKKPLQEV 115
Query: 222 CCA---------LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ 272
A LA+L S IH D+K NILL P +K+ DFGS+ V
Sbjct: 116 EIAAICHGALQGLAYLHS--HERIHRDIKAGNILLTEP--GTVKLADFGSASLVSPA-NS 170
Query: 273 YIQSRYYRSPEVLLGI---PYDLAIDMWSLGCILVEL-HTGEPLFS 314
++ + Y+ +PEV+L + YD +D+WSLG +EL PLF+
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 18/217 (8%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKII----KNKKPFLNQAQIEVQLLEKINKADIHSRYI 173
+G GSFG V A D VAIK + K EV+ L++I +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 174 VKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPEL 233
L+ H W L + + L S + + V + A Q LA+L S +
Sbjct: 93 CYLREHTAW---LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ---GLAYLHSHNM 146
Query: 234 SIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGI---PY 290
IH D+K NILL P + +K+ DFGS+ ++ + Y+ +PEV+L + Y
Sbjct: 147 --IHRDIKAGNILLTEPGQ--VKLADFGSASIASPA-NSFVGTPYWMAPEVILAMDEGQY 201
Query: 291 DLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
D +D+WSLG +EL +P N + + I +
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 238
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 21/229 (9%)
Query: 118 LGKGSFGQVVKAFDHEEKCQ--VAIKIIKNKKPFLNQAQIEVQLLEKIN-KADIHSRYIV 174
LG G+FG V K +K + VA+KI+KN N ++ +LL + N + + YIV
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN---NDPALKDELLREANVMQQLDNPYIV 59
Query: 175 KLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELS 234
++ G ++ LV EL N N H N+T + Q+ + +L E +
Sbjct: 60 RMIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNIT-ELVHQVSMGMKYLE--ETN 115
Query: 235 IIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRY------YRSPEVLLGI 288
+H DL N+LL + + KI DFG S +G Y + + +PE +
Sbjct: 116 FVHRDLAARNVLLVTQHYA--KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 289 PYDLAIDMWSLGCILVELHT-GEPLFSGK--NEVDQMTKIIEVLGMPPG 334
+ D+WS G ++ E + G+ + G NEV QM + E + P
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQR 222
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 69/239 (28%), Positives = 105/239 (43%), Gaps = 40/239 (16%)
Query: 110 DRYEIDTLLGKGSFGQV-VKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
D +EI ++G+G+FG+V V H E+ A+KI+ NK L +A+ E+ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERI-YAMKIL-NKWEMLKRAETACFREERNVLVNG 58
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLC------ 222
++I L F +N+L LV + G L L KF +L
Sbjct: 59 DCQWITTLHYAFQDENYLYLVMDYY------------VGGDLLTLLSKFEDRLPEDMARF 106
Query: 223 ----CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRY 278
LA S +L +H D+KP+N+LL I++ DFGS + Q +QS
Sbjct: 107 YIAEMVLAIHSIHQLHYVHRDIKPDNVLL--DMNGHIRLADFGSCLKMNQD--GTVQSSV 162
Query: 279 ------YRSPEVLLGI-----PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
Y SPE+L + Y D WSLG + E+ GE F ++ V+ KI+
Sbjct: 163 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 28/203 (13%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLLEKINKADIHSRYI 173
LG G FG VV K VAIK+I+ ++ F+ +A++ ++L H +
Sbjct: 12 LGSGQFG-VVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLS--------HPN-L 61
Query: 174 VKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
V+L G T + + +V E ++ L N +R + +C A+ +L S
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLESN- 119
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYR------SPEVLL 286
IH DL N L+ + +K+ DFG + +V QY S+ + PEV
Sbjct: 120 -GFIHRDLAARNCLVGE--DNVVKVSDFGLARYVLDD--QYTSSQGTKFPVKWAPPEVFD 174
Query: 287 GIPYDLAIDMWSLGCILVELHTG 309
+ D+WS G ++ E+ +
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 62/231 (26%), Positives = 110/231 (47%), Gaps = 19/231 (8%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINK 165
+K RYE +G+G+ G V A D +VAIK I +K Q + E+ + E +
Sbjct: 18 KKKYTRYE---KIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVM 70
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCA 224
++ + IV F + L +V E L+ +L +++ T + + Q A
Sbjct: 71 KELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQ---A 127
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRS 281
L FL + + +IH D+K +N+LL ++K+ DFG + + + + Y+ +
Sbjct: 128 LEFLHANQ--VIHRDIKSDNVLL--GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183
Query: 282 PEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332
PEV+ Y +D+WSLG + +E+ GEP + +N + + +I G P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 74/271 (27%), Positives = 112/271 (41%), Gaps = 63/271 (23%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK 177
LG G+FG+V A + A+K ++ KK LN+ Q+ E+ A+ + ++VKL
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLR-KKDVLNRNQVAHVKAERDILAEADNEWVVKLY 67
Query: 178 GHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSI 235
F K++L V + + + LIR F V L + + +L LA S ++
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEV---LARFYIAEL--TLAIESVHKMGF 122
Query: 236 IHCDLKPENILLCSPKRSAIKIIDFG---------------------------------- 261
IH D+KP+NIL+ IK+ DFG
Sbjct: 123 IHRDIKPDNILI--DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 262 SSCHVG---QTLYQYIQSRYYR-------------SPEVLLGIPYDLAIDMWSLGCILVE 305
S+C G +TL Q ++ R +PEVLL Y D WS+G IL E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240
Query: 306 LHTGEPLFSGKNEVDQMTKII---EVLGMPP 333
+ G+P F + K+I L +PP
Sbjct: 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPP 271
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 60/230 (26%), Positives = 106/230 (46%), Gaps = 27/230 (11%)
Query: 112 YEIDTLLGKGSFGQVV---KAFDHEEKCQVAIKIIK-----NKKPFLNQAQIEVQLLEKI 163
+E+ +LG G++G+V K H+ A+K++K K + E Q+LE +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQL 221
+ ++V L F L L+ + ++ +L + +F + + + + ++
Sbjct: 62 RRCP----FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHF---TESEVRVYIAEI 114
Query: 222 CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS----CHVGQTLYQYIQSR 277
AL L +L II+ D+K ENILL + + DFG S + Y + +
Sbjct: 115 VLALDHLH--QLGIIYRDIKLENILL--DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTI 170
Query: 278 YYRSPEVLLGIP--YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKI 325
Y +PEV+ G +D A+D WSLG + EL TG F+ E + ++I
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 51/202 (25%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKL 176
++G+GS+ +V+ + A+K++K + ++ VQ + + + + ++V L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 177 KGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELS 234
F + L LV E ++ ++++ R + + +A ++C AL FL E
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK---LPEEHARFYAAEICIALNFLH--ERG 116
Query: 235 IIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVLLGIPYD 291
II+ DLK +N+LL IK+ D+G G T + + Y +PE+L G Y
Sbjct: 117 IIYRDLKLDNVLL--DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 292 LAIDMWSLGCILVELHTGEPLF 313
++D W+LG ++ E+ G F
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 31/217 (14%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKIIK------NKKPFLNQAQIEVQ 158
+ LG G+FG+VV+A + + +VA+K++K ++ +++ +I
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 159 LLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKF 217
L N IV L G T + ++ E Y +L N +R ++L F
Sbjct: 95 LGNHEN--------IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSF 146
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR 277
+ Q+ +AFL+S + IH DL N+LL K +KI DFG + + Y+
Sbjct: 147 SYQVAKGMAFLASK--NCIHRDLAARNVLLTHGK--IVKICDFGLARDIMND-SNYVVKG 201
Query: 278 YYR------SPEVLLGIPYDLAIDMWSLGCILVELHT 308
R +PE + Y D+WS G +L E+ +
Sbjct: 202 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 20/219 (9%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK---INKADIHSRYIV 174
+GKG+FGQV + + + A+K++ +KK + + ++ + E+ + S +IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL-SKKEIVAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 175 KLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
LK F + L LV + +S ++L + F S + K + +L AL L +
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRF---SEDRAKFYIAELVLALEHLH--K 114
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSS---CHVGQTLYQYIQSRYYRSPEVLLGIP 289
I++ DLKPENILL I + DFG S +T + + Y +PEVLL
Sbjct: 115 YDIVYRDLKPENILL--DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 290 -YDLAIDMWSLGCILVELHTG-EPLFSGKNEVDQMTKII 326
Y +D WSLG ++ E+ G P ++ + QM + I
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYA--EDTQQMYRNI 209
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 50/195 (25%), Positives = 84/195 (43%), Gaps = 20/195 (10%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKN----KKPFLNQAQIEVQLLEKINKADIHSRY 172
+GKG FG V+ +K VA+K +K+ + FL +A + L
Sbjct: 13 TIGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAAQAFLAEASVMTTLRHP---------N 61
Query: 173 IVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP 231
+V+L G N L +V E ++ +L + +R+ ++L FA +C + +L
Sbjct: 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 232 ELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYD 291
+H DL N+L+ S A K+ DFG + Q + +PE L +
Sbjct: 122 N--FVHRDLAARNVLV-SEDLVA-KVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFS 177
Query: 292 LAIDMWSLGCILVEL 306
D+WS G +L E+
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 53/208 (25%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 116 TLLGKGSFGQVVKAFDHEEKCQV-AIKIIKNKKPFLNQAQIE-VQLLEKINKADIHSRYI 173
++G+GS+ +V+ + ++ ++ A+K+IK K+ + I+ VQ + + + + ++
Sbjct: 1 RVIGRGSYAKVLLV-ELKKTRRIYAMKVIK-KELVNDDEDIDWVQTEKHVFETASNHPFL 58
Query: 174 VKLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNF---HGVSLNLTKKFAQQLCCALAFL 228
V L F ++ L V E +S ++++ R H + ++ ++ AL FL
Sbjct: 59 VGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHA------RFYSAEISLALNFL 112
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVL 285
E II+ DLK +N+LL + IK+ D+G G T + + Y +PE+L
Sbjct: 113 H--ERGIIYRDLKLDNVLLDA--EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 286 LGIPYDLAIDMWSLGCILVELHTGEPLF 313
G Y ++D W+LG ++ E+ G F
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 72/250 (28%), Positives = 108/250 (43%), Gaps = 45/250 (18%)
Query: 110 DRYEIDTLLGKGSFGQV--VKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKAD 167
D +EI ++G+G+FG+V VK + + A+KI+ NK L +A+ E+ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQV--YAMKIL-NKWEMLKRAETACFREERDVLVN 57
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLC----- 222
R+I L F +N+L LV + G L L KF +L
Sbjct: 58 GDRRWITNLHYAFQDENNLYLVMDYYV------------GGDLLTLLSKFEDRLPEDMAR 105
Query: 223 -----CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR 277
LA S +L +H D+KP+N+LL K I++ DFGS + +QS
Sbjct: 106 FYLAEMVLAIDSVHQLGYVHRDIKPDNVLL--DKNGHIRLADFGSCLRLLAD--GTVQSN 161
Query: 278 Y------YRSPEVLLGIP-----YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
Y SPE+L + Y D WSLG + E+ GE F ++ V+ KI+
Sbjct: 162 VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
Query: 327 ---EVLGMPP 333
E PP
Sbjct: 222 NHKEHFQFPP 231
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 70/260 (26%), Positives = 114/260 (43%), Gaps = 52/260 (20%)
Query: 103 KHGEKFLDRYE-----IDTL------------LGKGSFGQVVKAFDHEEKCQV-AIKIIK 144
K+ + FL RYE I L +G+G+FG+V + H+ QV A+K++
Sbjct: 19 KNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEV-QLVRHKSSKQVYAMKLL- 76
Query: 145 NKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELL-SYNLYNLIRN 203
+K + ++ E+ A +S +IV+L F +L +V E + +L NL+ N
Sbjct: 77 SKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN 136
Query: 204 TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG-- 261
+ + + + ++ AL + S + IH D+KP+N+LL K +K+ DFG
Sbjct: 137 ---YDIPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLL--DKSGHLKLADFGTC 189
Query: 262 ----------SSCHVGQTLYQYIQSRYYRSPEVLLGIP----YDLAIDMWSLGCILVELH 307
VG YI SPEVL Y D WS+G L E+
Sbjct: 190 MKMDANGMVRCDTAVGTP--DYI------SPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
Query: 308 TGEPLFSGKNEVDQMTKIIE 327
G+ F + V +KI++
Sbjct: 242 VGDTPFYADSLVGTYSKIMD 261
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 68/236 (28%), Positives = 101/236 (42%), Gaps = 40/236 (16%)
Query: 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQ----IEVQLLEKI 163
F D EI G GSFG V A D VAIK + N+ EV+ L+K+
Sbjct: 17 FSDLREI----GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 72
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCC 223
+ L+ H W LV E + +L L + KK Q++
Sbjct: 73 RHPNTIQYRGCYLREHTAW-----LVMEYCLGSASDL----------LEVHKKPLQEVEI 117
Query: 224 A---------LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYI 274
A LA+L S + IH D+K NILL P +K+ DFGS+ + ++
Sbjct: 118 AAVTHGALQGLAYLHSHNM--IHRDVKAGNILLSEP--GLVKLGDFGSASIMAPA-NXFV 172
Query: 275 QSRYYRSPEVLLGI---PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
+ Y+ +PEV+L + YD +D+WSLG +EL +P N + + I +
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 56/237 (23%), Positives = 92/237 (38%), Gaps = 33/237 (13%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR 171
Y + L GS G+V A + V +KI +K IE LL+ +N +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI--GQKG---TTLIEAMLLQNVNHPSV--- 119
Query: 172 YIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP 231
+++K C+V S +LY + + ++ +Q+ L +L +
Sbjct: 120 --IRMKDTLVSGAITCMVLPHYSSDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHA- 175
Query: 232 ELSIIHCDLKPENILLCSPKRSAIKIIDFGSS-CHVGQ-TLYQYIQSRYYRSPEVLLGIP 289
IIH D+K ENI + + I D G++ V + +PEVL
Sbjct: 176 -QRIIHRDVKTENIFIND--VDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDK 232
Query: 290 YDLAIDMWSLGCILVEL----HT---------GEPLFSGKNEVDQMTKIIEVLGMPP 333
Y+ D+WS G +L E+ T E + S + + KII L + P
Sbjct: 233 YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS---HLLKIISTLKVHP 286
|
Length = 357 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 8e-09
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 109 LDRYEIDTL--LGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLLEK 162
+D ++ L LG G FG VVK + VAIK+IK ++ F+ +A++ ++L
Sbjct: 1 IDPKDLTFLKELGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKL--- 56
Query: 163 INKADIHSRYIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHGVSLNLTKKFAQQL 221
+V+L G T + + +V E +S L N +R + + + +
Sbjct: 57 ------SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDV 109
Query: 222 CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLY-QYIQSRY-- 278
C +A+L S + IH DL N L+ + +K+ DFG S +V Y + S++
Sbjct: 110 CEGMAYLESKQF--IHRDLAARNCLVDD--QGCVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 279 -YRSPEVLLGIPYDLAIDMWSLGCILVELHT 308
+ PEVLL + D+W+ G ++ E+++
Sbjct: 166 RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 9e-09
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 26/201 (12%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLLEKINKADIHSRYI 173
+G G FG V + EK +VAIK I+ +++ F+ +AQ+ ++L H + +
Sbjct: 12 IGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEEDFIEEAQVMMKL--------SHPK-L 61
Query: 174 VKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPEL 233
V+L G T ++ +CLVFE + + + S +C +A+L S
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS-- 119
Query: 234 SIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR------YYRSPEVLLG 287
++IH DL N L+ + +K+ DFG + V QY S + SPEV
Sbjct: 120 NVIHRDLAARNCLV--GENQVVKVSDFGMTRFVLDD--QYTSSTGTKFPVKWSSPEVFSF 175
Query: 288 IPYDLAIDMWSLGCILVELHT 308
Y D+WS G ++ E+ +
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 63/241 (26%), Positives = 110/241 (45%), Gaps = 28/241 (11%)
Query: 112 YEIDTLLGKGSFGQVV---KAFDHEEKCQVAIKIIK-----NKKPFLNQAQIEVQLLEKI 163
+E+ +LG G++G+V K H+ A+K++K K + E Q+LE I
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQL 221
+ S ++V L F L L+ + ++ +L + F + ++ ++
Sbjct: 62 RQ----SPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF---KEQEVQIYSGEI 114
Query: 222 CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS----CHVGQTLYQYIQSR 277
AL L +L II+ D+K ENILL S + + DFG S + Y + +
Sbjct: 115 VLALEHLH--KLGIIYRDIKLENILLDS--NGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 278 YYRSPEVLLG--IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE-VLGMPPG 334
Y +P+++ G +D A+D WS+G ++ EL TG F+ E + +I +L P
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 230
Query: 335 Y 335
Y
Sbjct: 231 Y 231
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 156 EVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTK 215
E +LL +++ + + V++ G T CLV +LY + + L
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLT-----CLVLPKYRSDLYTYL-GARLRPLGLAQVT 263
Query: 216 KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ 275
A+QL A+ ++ IIH D+K EN+L+ P+ I + DFG++C + +
Sbjct: 264 AVARQLLSAIDYIHGE--GIIHRDIKTENVLVNGPED--ICLGDFGAACFARGS---WST 316
Query: 276 SRYY--------RSPEVLLGIPYDLAIDMWSLGCILVE--LHTGEPLFSGKNEVD----- 320
+Y +PEVL G PY ++D+WS G ++ E +HT LFS +
Sbjct: 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTAS-LFSASRGDERRPYD 375
Query: 321 -QMTKIIEVLGMPPG-YLLHGASK-TSKYFDRLSDN 353
Q+ +II + + H S+ S+Y R + N
Sbjct: 376 AQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARN 411
|
Length = 461 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 3e-08
Identities = 64/245 (26%), Positives = 108/245 (44%), Gaps = 39/245 (15%)
Query: 118 LGKGSFGQVVKA----FDHEEKCQ-VAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHS 170
LG+G+FG+V K + VAIK +K + + E +L+ +D+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELM-----SDLQH 67
Query: 171 RYIVKLKGHFTWKNHLCLVFELLSY-NLYN-LIRNTNFHGVSLNLTKK------------ 216
IV L G T + C++FE L++ +L+ L+RN+ V +
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 217 -FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ 275
A Q+ + +LSS +H DL N L+ + +KI DFG S + Y +Q
Sbjct: 128 HIAIQIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLT-VKISDFGLSRDIYSADYYRVQ 183
Query: 276 SR-----YYRSPEVLLGIPYDLAIDMWSLGCILVELHT--GEPLFSGKN-EVDQMTKIIE 327
S+ + PE +L + D+WS G +L E+ + +P + N EV +M + +
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ 243
Query: 328 VLGMP 332
+L P
Sbjct: 244 LLPCP 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 69/240 (28%), Positives = 107/240 (44%), Gaps = 53/240 (22%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAF-----DHEEKCQVAIKIIK---NKKPFLNQAQIEVQLL 160
DR + LG+G+FGQVVKA + E VA+K++K +K + E++++
Sbjct: 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS-EMEMM 69
Query: 161 EKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRN----------TNFHGV 209
+ I K H I+ L G T + L +V E ++ NL + +R +
Sbjct: 70 KMIGK---HKN-IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 210 SLNLTKK----FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265
LT+K FA Q+ + FL+S + IH DL N+L+ + +KI DFG +
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVT--EDHVMKIADFGLARD 181
Query: 266 VGQTLYQYIQSRYYR------------SPEVLLGIPYDLAIDMWSLGCILVELHT--GEP 311
+ +I YYR +PE L Y D+WS G +L E+ T G P
Sbjct: 182 I-----HHID--YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 5e-08
Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 16/219 (7%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK 177
+G+G+ G V A D +VAIK + ++ + I L+ + NK + IV
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENK----NPNIVNYL 82
Query: 178 GHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSII 236
+ + L +V E L+ +L +++ T + + Q AL FL S + +I
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ---ALDFLHSNQ--VI 137
Query: 237 HCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRSPEVLLGIPYDLA 293
H D+K +NILL ++K+ DFG + + + + Y+ +PEV+ Y
Sbjct: 138 HRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 294 IDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332
+D+WSLG + +E+ GEP + +N + + +I G P
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 5e-08
Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 16/219 (7%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK 177
+G+G+ G V A D +VAI+ + ++ + I L+ + NK + IV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK----NPNIVNYL 83
Query: 178 GHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSII 236
+ + L +V E L+ +L +++ T + + Q AL FL S + +I
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ---ALEFLHSNQ--VI 138
Query: 237 HCDLKPENILLCSPKRSAIKIIDFGSSCHVG---QTLYQYIQSRYYRSPEVLLGIPYDLA 293
H D+K +NILL ++K+ DFG + + + Y+ +PEV+ Y
Sbjct: 139 HRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 294 IDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332
+D+WSLG + +E+ GEP + +N + + +I G P
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTP 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 61/240 (25%), Positives = 115/240 (47%), Gaps = 27/240 (11%)
Query: 112 YEIDTLLGKGSFGQVV---KAFDHEEKCQVAIKIIK-----NKKPFLNQAQIEVQLLEKI 163
+E+ +LG G++G+V K H+ A+K+++ K + + E +LE +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQL 221
+ S ++V L F + L L+ + +S +L + NF S + + ++ ++
Sbjct: 62 RQ----SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNF---SEDEVRFYSGEI 114
Query: 222 CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV----GQTLYQYIQSR 277
AL L +L I++ D+K ENILL S + + DFG S + Y + +
Sbjct: 115 ILALEHLH--KLGIVYRDIKLENILLDS--EGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170
Query: 278 YYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE-VLGMPPGY 335
Y +PE++ G + A+D WSLG ++ EL TG F+ + E + +++ +L P +
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 62/266 (23%), Positives = 110/266 (41%), Gaps = 49/266 (18%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
D +E ++G+G+FG+V + A+KI++ K L + Q+ E+ +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-KADMLEKEQVAHIRAERDILVEAD 59
Query: 170 SRYIVKLKGHFTWKNHLCLVFELL-SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228
++VK+ F K +L L+ E L ++ L+ + +S T+ + + LA
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAE--TVLAID 115
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG--------------------- 267
+ +L IH D+KP+N+LL + + +K+ DFG +
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDA--KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 268 -----------------QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGE 310
Q Y + + Y +PEV + Y+ D WSLG I+ E+ G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 311 PLFSGKNEVDQMTKII---EVLGMPP 333
P F + + K++ E L PP
Sbjct: 234 PPFCSETPQETYRKVMNWKETLVFPP 259
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 117 LLGKGSFGQVV----KAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY 172
++G+GS+ +V+ K + +V K + N ++ Q E + E+ A H +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ---ASNHP-F 57
Query: 173 IVKLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSS 230
+V L F ++ L V E ++ ++++ R + + ++ ++ AL +L
Sbjct: 58 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLH- 113
Query: 231 PELSIIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVLLG 287
E II+ DLK +N+LL S IK+ D+G G T + + Y +PE+L G
Sbjct: 114 -ERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 288 IPYDLAIDMWSLGCILVELHTGEPLF 313
Y ++D W+LG ++ E+ G F
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 65/266 (24%), Positives = 111/266 (41%), Gaps = 53/266 (19%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR 171
+E ++G+G+FG+V + A+KI++ K L + Q+ E+ + S
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-KADMLEKEQVGHIRAERDILVEADSL 61
Query: 172 YIVKLKGHFTWKNHLCLVFELL-SYNLYNLIRNTNFHGVSLNLTKKFAQQLCC--ALAFL 228
++VK+ F K +L L+ E L ++ L+ + LT++ Q LA
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAID 115
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT-----------------LY 271
S +L IH D+KP+N+LL S + +K+ DFG + + +
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDS--KGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 272 QYIQSRY---------------------YRSPEVLLGIPYDLAIDMWSLGCILVELHTGE 310
Q + S+ Y +PEV + Y+ D WSLG I+ E+ G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 311 PLFSGKNEVDQMTKII---EVLGMPP 333
P F + + K++ E L PP
Sbjct: 234 PPFCSETPQETYKKVMNWKETLIFPP 259
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 62/236 (26%), Positives = 100/236 (42%), Gaps = 38/236 (16%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR 171
+EI ++G+G+FG+V +K+ K F + + ++L++ A
Sbjct: 3 FEILKVIGRGAFGEVA-----------VVKLKNADKVFAMKILNKWEMLKRAETACFREE 51
Query: 172 YIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLC--------- 222
V + G W L F+ NLY L+ + G L L KF +L
Sbjct: 52 RDVLVNGDNQWITTLHYAFQD-ENNLY-LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA 109
Query: 223 -CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRY--- 278
+A S +L +H D+KP+NIL+ I++ DFGS + + +QS
Sbjct: 110 EMVIAIDSVHQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMED--GTVQSSVAVG 165
Query: 279 ---YRSPEVLLGIP-----YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
Y SPE+L + Y D WSLG + E+ GE F ++ V+ KI+
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 26/238 (10%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEE----KCQVAIKIIKNKKPFLNQAQIEVQLLEKINKA 166
E +LG G+FG V K E K VAIK+++ + +A E+ L E A
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEI-LDEAYVMA 64
Query: 167 DIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLN--LTKKFAQQLCC 223
+ ++V+L G + + L+ +L+ L + +RN H ++ + Q+
Sbjct: 65 SVDHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAK 120
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS--CHVGQTLYQYIQSRY--- 278
+++L E ++H DL N+L+ +P +KI DFG + V + Y +
Sbjct: 121 GMSYLE--EKRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176
Query: 279 YRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKN--EVDQMTKIIEVLGMPP 333
+ + E +L Y D+WS G + EL T G + G E+ + + E L PP
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 57/224 (25%), Positives = 104/224 (46%), Gaps = 17/224 (7%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR 171
YE+ ++G+G+FG+V + H+ +V + +K + ++ E+ A +S
Sbjct: 45 YEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 172 YIVKLKGHFTWKNHLCLVFELL-SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSS 230
++V+L F +L +V E + +L NL+ N + + + ++ AL + S
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWARFYTAEVVLALDAIHS 160
Query: 231 PELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT----LYQYIQSRYYRSPEVLL 286
+ IH D+KP+N+LL K +K+ DFG+ + + + + Y SPEVL
Sbjct: 161 --MGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 216
Query: 287 GIP----YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
Y D WS+G L E+ G+ F + V +KI+
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 37/128 (28%), Positives = 61/128 (47%), Gaps = 14/128 (10%)
Query: 216 KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS---CHVG----- 267
K+ +Q+ +A+L ++H D+K N++L IK+IDFG + VG
Sbjct: 106 KYTKQILDGVAYLH--NNCVVHRDIKGNNVMLMP--NGIIKLIDFGCARRLAWVGLHGTH 161
Query: 268 -QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
L + Y+ +PEV+ Y D+WS+GC + E+ TG+P + + + M I
Sbjct: 162 SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG 221
Query: 327 EVLG-MPP 333
G MP
Sbjct: 222 AHRGLMPR 229
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 38/218 (17%)
Query: 118 LGKGSFGQVVKAFDH-----EEKCQVAIKIIKNKKPFLNQA-QIEVQLLEKINKADIHSR 171
LG+G+FG+V A H ++K VA+K +K Q Q E +LL + +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-----QHQ 67
Query: 172 YIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHG----------------VSLNLTK 215
+IV+ G T L +VFE + + +L R HG ++L
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHG--DLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 216 KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ 275
A Q+ + +L+S L +H DL N L+ + +KI DFG S + T Y +
Sbjct: 126 AIASQIASGMVYLAS--LHFVHRDLATRNCLV--GQGLVVKIGDFGMSRDIYSTDYYRVG 181
Query: 276 SRY-----YRSPEVLLGIPYDLAIDMWSLGCILVELHT 308
R + PE +L + D+WS G +L E+ T
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 118 LGKGSFGQV-VKAFDHEEKCQ---VAIKIIKNKKPFLNQAQIEVQLLEKIN-KADIHSRY 172
LG+G FG+V + +D VA+K +K + Q ++IN ++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE----CGQQNTSGWKKEINILKTLYHEN 67
Query: 173 IVKLKGHFTWKNH--LCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSS 230
IVK KG + + L L+ E + L +L H ++L FAQQ+C +A+L S
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 231 PELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSR----YYRSPEV 284
IH DL N+LL +KI DFG + V G Y+ + ++ + E
Sbjct: 126 QHY--IHRDLAARNVLL--DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181
Query: 285 LLGIPYDLAIDMWSLGCILVELHT 308
L + A D+WS G L EL T
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 109 LDRYEI--DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----KPFLNQAQIEVQLLEK 162
++R +I LG G +G+V + + VA+K +K + FL +A +
Sbjct: 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV------- 55
Query: 163 INKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQL 221
+I +V+L G T + ++ E ++Y NL + +R N V+ + A Q+
Sbjct: 56 --MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI 113
Query: 222 CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG-SSCHVGQTLYQYIQSRY-- 278
A+ +L + IH DL N L+ + +K+ DFG S G T + +++
Sbjct: 114 SSAMEYLEKK--NFIHRDLAARNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 169
Query: 279 -YRSPEVLLGIPYDLAIDMWSLGCILVELHT 308
+ +PE L + + D+W+ G +L E+ T
Sbjct: 170 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 31/209 (14%)
Query: 118 LGKGSFGQV-VKAFDHEEKC---QVAIKIIK--NKKPFLNQAQIEVQLLEKINKADIHSR 171
LG+G FG+V + +D E QVA+K +K + + + E+++L +++
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR-----NLYHE 66
Query: 172 YIVKLKGHFT--WKNHLCLVFELL---SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
IVK KG T N + L+ E L S Y L RN N ++L K+A Q+C +
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEY-LPRNKN--KINLKQQLKYAVQICKGMD 123
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR-------YY 279
+L S + +H DL N+L+ S + +KI DFG + + +T +Y + ++
Sbjct: 124 YLGSRQY--VHRDLAARNVLVESEHQ--VKIGDFGLTKAI-ETDKEYYTVKDDLDSPVFW 178
Query: 280 RSPEVLLGIPYDLAIDMWSLGCILVELHT 308
+PE L+ + +A D+WS G L EL T
Sbjct: 179 YAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 28/92 (30%), Positives = 45/92 (48%), Gaps = 11/92 (11%)
Query: 235 IIHCDLKPENILLC-SPKRSAIKIIDFGSSC-------HVGQTL---YQYIQSRYYRSPE 283
I+H DLKP+NI++ + R K++DFG TL + + + Y +PE
Sbjct: 100 IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
Query: 284 VLLGIPYDLAIDMWSLGCILVELHTGEPLFSG 315
L G P D+++ G I +E TG+ + G
Sbjct: 160 QLRGEPVTPNSDLYAWGLIFLECLTGQRVVQG 191
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK 177
+G+G+ G V A D +VAIK + ++ + I L+ + NK H IV
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK---HPN-IVNYL 82
Query: 178 GHFTWKNHLCLVFELLSY-NLYNLIRNTNF-HGVSLNLTKKFAQQLCCALAFLSSPELSI 235
+ + L +V E L+ +L +++ T G + ++ Q AL FL S + +
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ----ALEFLHSNQ--V 136
Query: 236 IHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRSPEVLLGIPYDL 292
IH D+K +NILL ++K+ DFG + + + + Y+ +PEV+ Y
Sbjct: 137 IHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 293 AIDMWSLGCILVELHTGEPLFSGKN 317
+D+WSLG + +E+ GEP + +N
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLLEKINKADIHSRYI 173
LG G FG VV + +VAIK I +++ F+ +A++ ++L H + +
Sbjct: 12 LGSGQFG-VVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKL--------SHPK-L 61
Query: 174 VKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
V+L G T + L +V E + L N +R +S ++ Q +C + +L
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLERN- 119
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR------YYRSPEVLL 286
S IH DL N L+ S +K+ DFG + +V +Y S + PEV
Sbjct: 120 -SFIHRDLAARNCLVSS--TGVVKVSDFGMTRYVLDD--EYTSSSGAKFPVKWSPPEVFN 174
Query: 287 GIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKI 325
Y D+WS G ++ E+ T G+ F K+ + + I
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 7e-07
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 37/215 (17%)
Query: 117 LLGKGSFGQVVKAFDHEE--KCQVAIKIIKNKKPFLNQAQI--EVQLLEKINKADIHSRY 172
++G+G+FGQV+KA ++ + AIK +K + E+++L K+ H
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG----HHPN 57
Query: 173 IVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNF----------HGVSLNLTK----KF 217
I+ L G + +L L E + NL + +R + + + L+ F
Sbjct: 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR 277
A + + +LS + IH DL NIL+ + KI DFG S GQ + Y++
Sbjct: 118 AADVARGMDYLS--QKQFIHRDLAARNILV--GENYVAKIADFGLS--RGQEV--YVKKT 169
Query: 278 YYRSPEVLLGIP------YDLAIDMWSLGCILVEL 306
R P + I Y D+WS G +L E+
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 204
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 8e-07
Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 27/205 (13%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKN------KKPFLNQAQIEVQLLEKINKADIHS 170
+GKG+FG V K + +VA+K ++ K+ FL +A+I L++ + +I
Sbjct: 2 KIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEI----LKQYDHPNI-- 54
Query: 171 RYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLS 229
VKL G K + +V EL+ +L +R + +++ + + + +L
Sbjct: 55 ---VKLIGVCVQKQPIYIVMELVPGGSLLTFLR-KKKNRLTVKKLLQMSLDAAAGMEYLE 110
Query: 230 SPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR-----YYRSPEV 284
S + IH DL N L+ + + +KI DFG S +Y + +PE
Sbjct: 111 SK--NCIHRDLAARNCLV--GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEA 166
Query: 285 LLGIPYDLAIDMWSLGCILVELHTG 309
L Y D+WS G +L E +
Sbjct: 167 LNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 57/197 (28%), Positives = 88/197 (44%), Gaps = 20/197 (10%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY---- 172
LLGKG+FG+V K ++K VA+K K P +++++ L +A I +Y
Sbjct: 2 LLGKGNFGEVFKG-TLKDKTPVAVKTCKEDLP----QELKIKFLS---EARILKQYDHPN 53
Query: 173 IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
IVKL G T + + +V EL+ + + KFA +A+L S
Sbjct: 54 IVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK- 112
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRY----YRSPEVLLGI 288
+ IH DL N L+ + + +KI DFG S +Y + + +PE L
Sbjct: 113 -NCIHRDLAARNCLV--GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYG 169
Query: 289 PYDLAIDMWSLGCILVE 305
Y D+WS G +L E
Sbjct: 170 RYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 63/251 (25%), Positives = 111/251 (44%), Gaps = 51/251 (20%)
Query: 118 LGKGSFGQVVKA------FDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKINKADIH 169
LG+ +FG++ K DH + VAIK +K N + Q E L+ A++H
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQ--LVAIKTLKDINNPQQWGEFQQEASLM-----AELH 65
Query: 170 SRYIVKLKGHFTWKNHLCLVFELLSY-NLYNL-------------------IRNTNFHGV 209
IV L G T + +C++FE L+ +L+ ++++ HG
Sbjct: 66 HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 210 SLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT 269
L++ A Q+ + +LSS +H DL NIL+ ++ +KI D G S +
Sbjct: 126 FLHI----AIQIAAGMEYLSSH--FFVHKDLAARNILI--GEQLHVKISDLGLSREIYSA 177
Query: 270 LYQYIQSRY-----YRSPEVLLGIPYDLAIDMWSLGCILVELHTG--EPLFSGKN-EVDQ 321
Y +Q + + PE ++ + D+WS G +L E+ + +P + N EV +
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237
Query: 322 MTKIIEVLGMP 332
M + ++L
Sbjct: 238 MVRKRQLLPCS 248
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK---NKKPFLNQAQIEVQLLEKINK 165
L + + ++G+G FG V++ +K VA+K IK + FL + + +L
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQGEYTGQK--VAVKNIKCDVTAQAFLEETAVMTKL------ 56
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCA 224
H + +V+L G N L +V EL+S NL N +R VS+ +F+ +
Sbjct: 57 ---HHKNLVRLLG-VILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEG 112
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEV 284
+ +L S +L +H DL NIL+ + K+ DFG + + + +PE
Sbjct: 113 MEYLESKKL--VHRDLAARNILV--SEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEA 168
Query: 285 LLGIPYDLAIDMWSLGCILVEL 306
L + D+WS G +L E+
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 37/217 (17%)
Query: 115 DTLLGKGSFGQVVKAFDHEE--KCQVAIKIIKNKKPFLNQAQI--EVQLLEKINKADIHS 170
+ ++G+G+FGQV++A ++ K AIK++K + E+++L K+ H
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG----HH 62
Query: 171 RYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNF----------HGVSLNLTK---- 215
I+ L G + +L + E Y NL + +R + HG + LT
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 216 KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ 275
+FA + + +LS E IH DL N+L+ + A KI DFG S G+ + Y++
Sbjct: 123 QFASDVATGMQYLS--EKQFIHRDLAARNVLV--GENLASKIADFGLS--RGEEV--YVK 174
Query: 276 SRYYRSPEVLLGIP------YDLAIDMWSLGCILVEL 306
R P + I Y D+WS G +L E+
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 63/261 (24%), Positives = 104/261 (39%), Gaps = 64/261 (24%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK 177
+G G+FG+V + A+K ++ K L + Q E+ A+ + ++VKL
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLR-KADVLMRNQAAHVKAERDILAEADNEWVVKLY 67
Query: 178 GHFTWKNHLCLVFE------LLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP 231
F K++L V + ++S LIR F +L + + +L CA+ S
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSL----LIRLGIFEE---DLARFYIAELTCAIE--SVH 118
Query: 232 ELSIIHCDLKPENILLCSPKRSAIKIIDFG---------------SSCH----------- 265
++ IH D+KP+NIL+ + IK+ DFG H
Sbjct: 119 KMGFIHRDIKPDNILI--DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 266 ---VGQTLYQYIQSRYYR-----------------SPEVLLGIPYDLAIDMWSLGCILVE 305
+ + + ++ R R +PEVLL Y D WS+G IL E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 306 LHTGEPLFSGKNEVDQMTKII 326
+ G+P F + K+I
Sbjct: 237 MLVGQPPFLADTPAETQLKVI 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 18/195 (9%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNK---KPFLNQAQIEVQLLEKINKADIHSRYIV 174
+GKG FG V+ D+ +VA+K IKN + FL +A + QL HS +
Sbjct: 14 IGKGEFGDVMLG-DYRGN-KVAVKCIKNDATAQAFLAEASVMTQLR--------HSNLVQ 63
Query: 175 KLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPEL 233
L K L +V E ++ +L + +R+ + + KF+ +C A+ +L +
Sbjct: 64 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN-- 121
Query: 234 SIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLA 293
+ +H DL N+L+ + + K+ DFG + T + +PE L +
Sbjct: 122 NFVHRDLAARNVLV--SEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 294 IDMWSLGCILVELHT 308
D+WS G +L E+++
Sbjct: 180 SDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 65/245 (26%), Positives = 105/245 (42%), Gaps = 43/245 (17%)
Query: 118 LGKGSFGQVVKA-----FDHEEKCQVAIKIIKN-----KKPFLNQAQIEVQLLEKINKAD 167
LG+G+FG+V A ++K VA+K +K+ +K F +A++ L
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-------- 64
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSL-------NLTKK--- 216
+IVK G + L +VFE + + +L +R V + LT+
Sbjct: 65 -QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123
Query: 217 -FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ 275
AQQ+ + +L+S +H DL N L+ + +KI DFG S V T Y +
Sbjct: 124 HIAQQIAAGMVYLASQHF--VHRDLATRNCLV--GENLLVKIGDFGMSRDVYSTDYYRVG 179
Query: 276 SRY-----YRSPEVLLGIPYDLAIDMWSLGCILVELHT--GEPLFS-GKNEVDQMTKIIE 327
+ PE ++ + D+WSLG +L E+ T +P + NEV +
Sbjct: 180 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239
Query: 328 VLGMP 332
VL P
Sbjct: 240 VLQRP 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 68/247 (27%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKC--QVAIKIIKN--------KKPFLNQAQIEVQ 158
+ RY+I L+GKG G+V A+D C +VA+K I+ KK FL +A+I
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYD--PVCSRRVALKKIREDLSENPLLKKRFLREAKIAAD 58
Query: 159 LLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY----NLYNLIRNTNFHGVSLNLT 214
L IH IV + ++ + V+ + Y L +L+++ L+
Sbjct: 59 L--------IHPG-IVPV---YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKES---LS 103
Query: 215 KKFAQQ------------LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262
K+ A++ +C + ++ S ++H DLKP+NILL + I+D+G+
Sbjct: 104 KELAEKTSVGAFLSIFHKICATIEYVHSK--GVLHRDLKPDNILL--GLFGEVVILDWGA 159
Query: 263 --------------------SCHVGQTLY-QYIQSRYYRSPEVLLGIPYDLAIDMWSLGC 301
C+ T+ + + + Y +PE LLG+P + D+++LG
Sbjct: 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGV 219
Query: 302 ILVELHT 308
IL ++ T
Sbjct: 220 ILYQMLT 226
|
Length = 932 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 20/223 (8%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNK-KPFLNQAQIEVQLLEKINKADIHSRYIVKL 176
LG G FG+V + + + +VAIKI+K+ Q EVQ L+++ + S + V
Sbjct: 14 LGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 177 KGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTK--KFAQQLCCALAFLSSPEL 233
G + ++ EL+ +L +R+ G L + A Q+ +A+L E
Sbjct: 73 VGEPVY-----IITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLE--EQ 123
Query: 234 SIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRY---YRSPEVLLGIPY 290
+ IH DL NIL+ + K+ DFG + + + +Y + + +PE +
Sbjct: 124 NSIHRDLAARNILV--GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 291 DLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMP 332
D+WS G +L E+ T G+ + G N + +I MP
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP 224
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 38/111 (34%), Positives = 56/111 (50%), Gaps = 19/111 (17%)
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL---YQYI 274
A+Q+ +A+L I+H D+KP N+L+ S K +KI DFG S + QT+ +
Sbjct: 174 ARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPCNSSV 229
Query: 275 QSRYYRSPEVLLGIPYDL--------AIDMWSLGCILVELHTGE-PLFSGK 316
+ Y SPE I DL A D+WSLG ++E + G P G+
Sbjct: 230 GTIAYMSPE---RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 39/233 (16%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDH-------EEKCQVAIKIIKNKKPFLNQAQI--EVQLL 160
DR + LG+G FGQVV+A + ++ VA+K++K+ + A + E++L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 161 EKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHG--VSLNLTKKF 217
+ I K + I+ L G T + L ++ E + NL +R G + ++TK
Sbjct: 72 KLIGK----HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127
Query: 218 AQQLC------CA------LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265
+QL CA + +L S IH DL N+L+ + + +KI DFG +
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVT--EDNVMKIADFGLARG 183
Query: 266 VGQTLYQYIQSR-----YYRSPEVLLGIPYDLAIDMWSLGCILVELHT--GEP 311
V Y S + +PE L Y D+WS G ++ E+ T G P
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 24/204 (11%)
Query: 114 IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLLEKINKADIH 169
++ LG+G FG+V +VAIK +K + + FL +AQ+ ++K+ +
Sbjct: 10 LEVKLGQGCFGEVWMG-TWNGTTRVAIKTLKPGTMSPEAFLQEAQV----MKKLRHEKLV 64
Query: 170 SRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228
Y V + + +V E +S +L + ++ + L A Q+ +A++
Sbjct: 65 QLYAV------VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 118
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYY----RSPEV 284
++ +H DL+ NIL+ + K+ DFG + + Y Q + +PE
Sbjct: 119 E--RMNYVHRDLRAANILV--GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 174
Query: 285 LLGIPYDLAIDMWSLGCILVELHT 308
L + + D+WS G +L EL T
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 109 LDRYEIDTL--LGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLLEK 162
+DR I L LG G FG+V + VA+K +K + K FL +AQI ++K
Sbjct: 3 IDRTSIQLLRKLGAGQFGEVWEGL-WNNTTPVAVKTLKPGTMDPKDFLAEAQI----MKK 57
Query: 163 INKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQL 221
+ + Y V T + + +V EL+ Y +L ++ + L A Q+
Sbjct: 58 LRHPKLIQLYAV-----CTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 222 CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRY--- 278
+A+L + + IH DL N+L+ + + K+ DFG + + + +Y+ +R
Sbjct: 113 ASGMAYLEA--QNYIHRDLAARNVLV--GENNICKVADFGLARVIKEDIYE---AREGAK 165
Query: 279 ----YRSPEVLLGIPYDLAIDMWSLGCILVELHT 308
+ +PE L + + D+WS G +L E+ T
Sbjct: 166 FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 13/28 (46%), Positives = 19/28 (67%)
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEFF 430
KDLI ++L DP+KR++ L+H FF
Sbjct: 227 AKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 42/224 (18%)
Query: 118 LGKGSFGQV------------VKAFDHEEKCQ----VAIKIIKN--KKPFLNQAQIEVQL 159
LG+G FG+V K F + VA+K+++ K N E+++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 160 LEKINKADIHSRYIVKLKGHFTWKNHLCLVFE----------LLSYNLYNLIRNTNFHGV 209
+ ++ +I ++L + LC++ E L + + +
Sbjct: 73 MSRLKDPNI-----IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 210 SLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT 269
S + A Q+ + +LSS L+ +H DL N L+ K IKI DFG S ++
Sbjct: 128 SYSTLIFMATQIASGMKYLSS--LNFVHRDLATRNCLV--GKNYTIKIADFGMSRNLYSG 183
Query: 270 LYQYIQSR-----YYRSPEVLLGIPYDLAIDMWSLGCILVELHT 308
Y IQ R + S E +L + A D+W+ G L E+ T
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 64/231 (27%), Positives = 107/231 (46%), Gaps = 24/231 (10%)
Query: 117 LLGKGSFGQVVKAF---DHEE-KCQVAIKIIK-NKKPFLNQAQIEVQLLEKINKADIHSR 171
+LG G+FG V K D E K VAIK+++ N P N+ ++ E A + S
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD----EAYVMAGVGSP 69
Query: 172 YIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSS 230
Y+ +L G + + LV +L+ Y L + +R S +L + Q+ +++L
Sbjct: 70 YVCRLLG-ICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLN-WCVQIAKGMSYLE- 126
Query: 231 PELSIIHCDLKPENILLCSPKRSAIKIIDFGSS--CHVGQTLYQYIQSRY---YRSPEVL 285
E+ ++H DL N+L+ SP +KI DFG + + +T Y + + + E +
Sbjct: 127 -EVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 286 LGIPYDLAIDMWSLGCILVELHT-GEPLFSG--KNEVDQMTKIIEVLGMPP 333
L + D+WS G + EL T G + G E+ + + E L PP
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 61/238 (25%), Positives = 91/238 (38%), Gaps = 52/238 (21%)
Query: 117 LLGKGSFGQVVKA------FDHEEKCQVAIK------IIKNKKPFLNQAQIEVQLLEKIN 164
LG G+FG+V + +VA+K + KK FL +A L+ N
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAH----LMSNFN 57
Query: 165 KADIHSRYIVKLKGHFTWKNHLCLVFE------LLSYNLYNLIRNTNFHGVSLNLTKKFA 218
+I VKL G ++ E LLSY R F L L +
Sbjct: 58 HPNI-----VKLLGVCLLNEPQYIIMELMEGGDLLSY--LRDARVERFGPPLLTLKELLD 110
Query: 219 QQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA---IKIIDFGSSCHVGQTLYQYIQ 275
L A + ++ IH DL N L+ A +KI DFG + + +Y+
Sbjct: 111 ICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG----LARDIYK--- 163
Query: 276 SRYYR------------SPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVD 320
S YYR +PE LL + D+WS G ++ E+ T G+ + N +
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 24/173 (13%)
Query: 117 LLGKGSFGQV--VKAFDHEEKCQVAIKIIKN---KKPFLNQAQIEVQLLEKINKADIHSR 171
++GKG+FG+V V+ D K ++K+ KK L + E +L A+ S
Sbjct: 8 VIGKGAFGEVRLVQKKD-TGKIYAMKTLLKSEMFKKDQLAHVKAERDVL-----AESDSP 61
Query: 172 YIVKLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLS 229
++V L F +L L+ E L + LI+ F S ++T+ + + C LA +
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTF---SEDVTRFYMAE--CVLAIEA 116
Query: 230 SPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSP 282
+L IH D+KP+NIL+ + IK+ DFG S ++ S YY+
Sbjct: 117 VHKLGFIHRDIKPDNILI--DRGGHIKLSDFGLS----TGFHKQHDSAYYQKL 163
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 33/97 (34%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 235 IIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR-----YYRSPEVLLGIP 289
++H DLK NI L IK+ DFG S ++ + S YY +PE+
Sbjct: 190 MMHRDLKSANIFLMPT--GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKR 247
Query: 290 YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
Y DMWSLG IL EL T F G ++ + M +++
Sbjct: 248 YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL 284
|
Length = 478 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 6e-05
Identities = 29/110 (26%), Positives = 45/110 (40%), Gaps = 7/110 (6%)
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPE 283
A+ L +H K NILL + GS Q Y+ +PE
Sbjct: 21 AVCLQCLGALRELHRQAKSGNILLTWDGLLKL----DGSVAFKTPE--QSRPDPYFMAPE 74
Query: 284 VLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
V+ G Y D++SLG L E E ++ + E+ + +I+ + GMP
Sbjct: 75 VIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEIL-LNGMPA 123
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 60/233 (25%), Positives = 103/233 (44%), Gaps = 39/233 (16%)
Query: 110 DRYEIDTLLGKGSFGQVVKA----FDHE---EKCQVAIKIIKNKKPFLNQAQI--EVQLL 160
D+ + LG+G FGQVV A D + E VA+K++K+ + + + E++++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 161 EKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGV--SLNLTK-- 215
+ I K + I+ L G T L ++ E S NL +R G+ S ++ +
Sbjct: 75 KMIGK----HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 216 ----KFAQQLCC------ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265
F + C + +L+S + IH DL N+L+ + + +KI DFG +
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVT--ENNVMKIADFGLARD 186
Query: 266 VGQTLYQYIQSR-----YYRSPEVLLGIPYDLAIDMWSLGCILVELHT--GEP 311
V Y + + +PE L Y D+WS G ++ E+ T G P
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 114 IDTLLGKGSFGQV-VKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLLEKINKADI 168
+D LG+G FG+V + ++ K VAIK +K + FL +AQI ++K+ +
Sbjct: 10 LDVKLGQGCFGEVWMGTWNGTTK--VAIKTLKPGTMMPEAFLQEAQI----MKKLRHDKL 63
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
Y V + + +V E + +L + ++ + + L A Q+ +A+
Sbjct: 64 VPLYAV------VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY 117
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYY----RSPE 283
+ ++ IH DL+ NIL+ KI DFG + + Y Q + +PE
Sbjct: 118 IE--RMNYIHRDLRAANILVG--DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 284 VLLGIPYDLAIDMWSLGCILVELHT 308
L + + D+WS G +L EL T
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 8e-05
Identities = 34/100 (34%), Positives = 44/100 (44%), Gaps = 4/100 (4%)
Query: 213 LTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ 272
K++A ++ AL L I+ DL P NILL R I++ F V +
Sbjct: 86 CVKRWAAEMVVALDALH--REGIVCRDLNPNNILL--DDRGHIQLTYFSRWSEVEDSCDG 141
Query: 273 YIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPL 312
Y +PEV A D WSLG IL EL TG+ L
Sbjct: 142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 25/225 (11%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLLEKINKADIHSRYI 173
LG G FG+V +VA+K +K + + FL +AQI ++K+ + Y
Sbjct: 14 LGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQI----MKKLRHDKLVQLYA 68
Query: 174 VKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
V + + +V E +S +L + +++ + L A Q+ +A++
Sbjct: 69 V------VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE--R 120
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYY----RSPEVLLGI 288
++ IH DL+ NIL+ KI DFG + + Y Q + +PE L
Sbjct: 121 MNYIHRDLRSANILVGD--GLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 289 PYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMP 332
+ + D+WS G +L EL T G + G N + + ++ MP
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMP 223
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 46/218 (21%)
Query: 118 LGKGSFGQV----VKAFDHEE-KCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY 172
LG G+FG+V + D + + QVA+K + P Q E L +A I S++
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTL----PESCSEQDESDFL---MEALIMSKF 66
Query: 173 ----IVKLKGHFTWKNHLCLVFELLS-YNLYNLIR-NTNFHGVSLNLTKKFAQQLCCALA 226
IV+L G + ++ EL++ +L + +R N +LT K +A
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 227 ----FLSSPELSIIHCDLKPENILLCS--PKRSAIKIIDFGSSCHVGQTLYQYIQSRYYR 280
+L E IH D+ N LL P R A KI DFG + + +Y ++ YYR
Sbjct: 127 KGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVA-KIADFGMA----RDIY---RASYYR 176
Query: 281 S------------PEVLLGIPYDLAIDMWSLGCILVEL 306
PE L + D+WS G +L E+
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 54/224 (24%), Positives = 102/224 (45%), Gaps = 22/224 (9%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQ-LLEKIN--KADIHSRYIV 174
LG G FG+V + + +VA+K +K + VQ LE+ N K H + +V
Sbjct: 14 LGAGQFGEVWMGYYNNST-KVAVKTLK-------PGTMSVQAFLEEANLMKTLQHDK-LV 64
Query: 175 KLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPEL 233
+L T + + ++ E ++ +L + +++ V L F+ Q+ +A++
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK-- 122
Query: 234 SIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYY----RSPEVLLGIP 289
+ IH DL+ N+L+ + KI DFG + + Y + + +PE +
Sbjct: 123 NYIHRDLRAANVLV--SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 290 YDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMP 332
+ + D+WS G +L E+ T G+ + G + D M+ + MP
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP 224
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 50/201 (24%), Positives = 87/201 (43%), Gaps = 28/201 (13%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP------FLNQAQIEVQLLEKINKADIHSR 171
+G+G+FG+V + VA+K + P FL +A+I L++ + +
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARI----LKQYSHPN---- 54
Query: 172 YIVKLKGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSS 230
IV+L G T K + +V EL+ + +R + + + + + +L S
Sbjct: 55 -IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLES 112
Query: 231 PELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLY------QYIQSRYYRSPEV 284
IH DL N L+ +++ +KI DFG S +Y + I + + +PE
Sbjct: 113 K--HCIHRDLAARNCLVT--EKNVLKISDFGMSREEEDGVYASTGGMKQIPVK-WTAPEA 167
Query: 285 LLGIPYDLAIDMWSLGCILVE 305
L Y D+WS G +L E
Sbjct: 168 LNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 45/225 (20%)
Query: 118 LGKGSFGQV---------------VKAFDHEEKCQVAIKIIKN--KKPFLNQAQIEVQLL 160
LG+G FG+V FD + VA+K+++ K N E++++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQ-PVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 161 EKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNL------IRNT-----NFHGV 209
++ +I ++L G + LC++ E + N I +T N V
Sbjct: 72 SRLKNPNI-----IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 210 SLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT 269
S+ A Q+ + +L+S L+ +H DL N L+ IKI DFG S ++
Sbjct: 127 SIANLLYMAVQIASGMKYLAS--LNFVHRDLATRNCLV--GNHYTIKIADFGMSRNLYSG 182
Query: 270 LYQYIQS------RYYRSPEVLLGIPYDLAIDMWSLGCILVELHT 308
Y IQ R+ +LLG + A D+W+ G L E+ T
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 65/234 (27%), Positives = 105/234 (44%), Gaps = 41/234 (17%)
Query: 110 DRYEIDTLLGKGSFGQVVKA----FDHEEK---CQVAIKIIKN--KKPFLNQAQIEVQLL 160
DR + LG+G FGQVV A D E+ +VA+K++K+ + L+ E++++
Sbjct: 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 77
Query: 161 EKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSL-------- 211
+ I K + I+ L G T L ++ E S NL +R G+
Sbjct: 78 KMIGK----HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 212 --NLTKK----FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265
L+ K A Q+ + +L+S + IH DL N+L+ + + +KI DFG +
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT--EDNVMKIADFGLARD 189
Query: 266 VGQTLYQYIQSRYYR------SPEVLLGIPYDLAIDMWSLGCILVELHT--GEP 311
+ Y Y ++ R +PE L Y D+WS G +L E+ T G P
Sbjct: 190 IHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 38/216 (17%)
Query: 118 LGKGSFGQVVKAF-----DHEEKCQVAIKII------KNKKPFLNQAQIEVQLLEKINKA 166
LG+GSFG V + E + +VAIK + + + FLN+A +
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV---------MK 64
Query: 167 DIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRN-----TNFHGVSLNLTKKFAQ- 219
+ + ++V+L G + ++ EL++ +L + +R+ N + KK Q
Sbjct: 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124
Query: 220 --QLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR 277
++ +A+L++ + +H DL N ++ + +KI DFG + + +T Y +
Sbjct: 125 AGEIADGMAYLNANKF--VHRDLAARNCMVA--EDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 278 -----YYRSPEVLLGIPYDLAIDMWSLGCILVELHT 308
+ SPE L + D+WS G +L E+ T
Sbjct: 181 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 22/199 (11%)
Query: 118 LGKGSFGQVVKAFDHEEKCQ--VAIKIIK--NKKPFLNQAQIEVQLLEKINKADIHSRYI 173
LG G+FG V K K Q VAIK++K N+K ++ E +++ +++ YI
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP-----YI 57
Query: 174 VKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPEL 233
V++ G + L LV E+ S N + ++++ + Q+ + +L
Sbjct: 58 VRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE--GK 114
Query: 234 SIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRY-------YRSPEVLL 286
+ +H DL N+LL + + KI DFG S +G Y ++R + +PE +
Sbjct: 115 NFVHRDLAARNVLLVN--QHYAKISDFGLSKALGAD-DSYYKARSAGKWPLKWYAPECIN 171
Query: 287 GIPYDLAIDMWSLGCILVE 305
+ D+WS G + E
Sbjct: 172 FRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 43/210 (20%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLLEKINKADIHSRYI 173
LG G FG+V +VA+K +K + + FL +AQI +L H + +
Sbjct: 14 LGAGQFGEVWMGT-WNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLR--------HDK-L 63
Query: 174 VKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTK--KFAQQLCCALAFLSS 230
V+L + + + +V E +S +L + +++ G L L + A Q+ +A+L S
Sbjct: 64 VQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLES 121
Query: 231 PELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYY----------- 279
IH DL NIL+ + KI DFG L + I+ Y
Sbjct: 122 RNY--IHRDLAARNILV--GENLVCKIADFG--------LARLIEDDEYTAREGAKFPIK 169
Query: 280 -RSPEVLLGIPYDLAIDMWSLGCILVELHT 308
+PE + + D+WS G +L E+ T
Sbjct: 170 WTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 66/251 (26%), Positives = 105/251 (41%), Gaps = 52/251 (20%)
Query: 118 LGKGSFGQVVKAFDH-----EEKCQVAIKIIKN-----KKPFLNQAQIEVQLLEKINKAD 167
LG+G+FG+V A + ++K VA+K +K+ +K F Q E +LL +
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF----QREAELL-----TN 63
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHG-----------------V 209
+ +IVK G + L +VFE + + +L +R HG +
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRA---HGPDAMILVDGQPRQAKGEL 120
Query: 210 SLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT 269
L+ A Q+ + +L+S +H DL N L+ + +KI DFG S V T
Sbjct: 121 GLSQMLHIASQIASGMVYLASQHF--VHRDLATRNCLVGA--NLLVKIGDFGMSRDVYST 176
Query: 270 LYQYIQSRY-----YRSPEVLLGIPYDLAIDMWSLGCILVELHT--GEPLFS-GKNEVDQ 321
Y + + PE ++ + D+WS G IL E+ T +P F EV +
Sbjct: 177 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236
Query: 322 MTKIIEVLGMP 332
VL P
Sbjct: 237 CITQGRVLERP 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 39/221 (17%)
Query: 118 LGKGSFGQVVKA----FDHEEKCQ---VAIKIIKNKKPFLNQAQI--EVQLLEKINKADI 168
LG+G FGQVV A D ++ + VA+K++K+ + + + E+++++ I K
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK--- 76
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGV--SLNLTKKFAQQLCC-- 223
+ I+ L G T L ++ E S NL +R G+ S + K +QL
Sbjct: 77 -HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 224 ----------ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY 273
+ +L+S + IH DL N+L+ + + +KI DFG + V Y Y
Sbjct: 136 LVSCAYQVARGMEYLASQK--CIHRDLAARNVLVT--EDNVMKIADFGLARDVHNIDY-Y 190
Query: 274 IQSRYYR------SPEVLLGIPYDLAIDMWSLGCILVELHT 308
++ R +PE L Y D+WS G +L E+ T
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 30/221 (13%)
Query: 117 LLGKGSFGQVVKAF---DHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYI 173
+LGKG FG V +A + +VA+K++K + + IE L E + +
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD--IFSSSDIEEFLREAACMKEFDHPNV 63
Query: 174 VKLKG---HFTWKNHL-----CLVF----ELLSYNLYNLIRNTNFHGVSLNLTKKFAQQL 221
+KL G K L L F +L ++ L + I F + L +F +
Sbjct: 64 IKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT-LPLQTLVRFMIDI 122
Query: 222 CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRS 281
+ +LSS + IH DL N +L + + + DFG S + Y Y Q +
Sbjct: 123 ASGMEYLSSK--NFIHRDLAARNCML--NENMTVCVADFGLSKKIYSGDY-YRQGCASKL 177
Query: 282 P------EVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSG 315
P E L Y D+W+ G + E+ T G+ ++G
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 8e-04
Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLLEKINKADIHSRYI 173
LG G FG+V + + +VAIK +K + + FL +A + QL H R +
Sbjct: 14 LGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQ--------HPR-L 63
Query: 174 VKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
V+L T + + ++ E + +L + ++ +++N A Q+ +AF+
Sbjct: 64 VRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE--R 120
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYY----RSPEVLLGI 288
+ IH DL+ NIL+ + KI DFG + + Y + + +PE +
Sbjct: 121 KNYIHRDLRAANILV--SETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 178
Query: 289 PYDLAIDMWSLGCILVELHT 308
+ + D+WS G +L E+ T
Sbjct: 179 TFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 17/207 (8%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR 171
+E+ +G G++G V KA + AIK+IK + V E I D
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHS 66
Query: 172 YIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSS 230
IV G + ++ L + E +L ++ T +S + +++ L +L S
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS 124
Query: 231 PELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRSPEVLL- 286
+H D+K NILL +K+ DFG S + T+ + +I + Y+ +PEV
Sbjct: 125 K--GKMHRDIKGANILLTD--NGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 287 --GIPYDLAIDMWSLGCILVELHTGEP 311
Y+ D+W++G +EL +P
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 113 EIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLLEKINKADI 168
+++ LG G FG+V A + + +VA+K +K + + FL +A + K
Sbjct: 9 KLEKKLGAGQFGEVWMA-TYNKHTKVAVKTMKPGSMSVEAFLAEANVM--------KTLQ 59
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
H + +VKL T K + ++ E ++ +L + +++ L F+ Q+ +AF
Sbjct: 60 HDK-LVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYY----RSPE 283
+ + + IH DL+ NIL+ KI DFG + + Y + + +PE
Sbjct: 118 IE--QRNYIHRDLRAANILV--SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
Query: 284 VLLGIPYDLAIDMWSLGCILVELHT 308
+ + + D+WS G +L+E+ T
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 117 LLGKGSFGQVVKAFDHEE--KCQVAIKIIKNKKPFLNQAQI--EVQLLEKINKADIHSRY 172
++G+G+FGQV+KA ++ + AIK +K + E+++L K+ H
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG----HHPN 69
Query: 173 IVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNF----------HGVSLNLTKK----F 217
I+ L G + +L L E + NL + +R + + + L+ + F
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR 277
A + + +LS + IH DL NIL+ + KI DFG S GQ + Y++
Sbjct: 130 AADVARGMDYLSQKQF--IHRDLAARNILV--GENYVAKIADFGLS--RGQEV--YVKKT 181
Query: 278 YYRSPEVLLGIP------YDLAIDMWSLGCILVEL 306
R P + I Y D+WS G +L E+
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 18/35 (51%), Positives = 23/35 (65%)
Query: 279 YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLF 313
Y +PE+LLG P+ A+D W+LG L E TG P F
Sbjct: 546 YLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPF 580
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 9/94 (9%)
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR 277
A Q+ + +LSS L+ +H DL N L+ + IKI DFG S ++ Y IQ R
Sbjct: 144 ALQIASGMKYLSS--LNFVHRDLATRNCLV--GENLTIKIADFGMSRNLYAGDYYRIQGR 199
Query: 278 -----YYRSPEVLLGIPYDLAIDMWSLGCILVEL 306
+ + E +L + A D+W+ G L E+
Sbjct: 200 AVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 40/145 (27%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 120 KGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179
+G+FG+V A+K++K K +N+ + E+ A S +IV L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVK-KADMINKNMVHQVQAERDALALSKSPFIVHLYYS 72
Query: 180 FTWKNHLCLVFE-LLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHC 238
N++ LV E L+ ++ +L+ + + + K+ ++ AL +L IIH
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV--KYISEVALALDYLH--RHGIIHR 128
Query: 239 DLKPENILLCSPKRSAIKIIDFGSS 263
DLKP+N+L+ + IK+ DFG S
Sbjct: 129 DLKPDNMLISN--EGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 59/237 (24%), Positives = 106/237 (44%), Gaps = 26/237 (10%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEE----KCQVAIKIIKN-KKPFLNQAQIEVQLLEKINKA 166
++ +LG G+FG V K E K VAIK ++ P N+ ++ E A
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMA 64
Query: 167 DIHSRYIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHGVSLNLTKKFAQQLCCAL 225
+ + ++ +L G + + L+ +L+ + L + +R + S L + Q+ +
Sbjct: 65 SVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIAKGM 122
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSP--- 282
+L E ++H DL N+L+ +P+ +KI DFG + +G +Y + + P
Sbjct: 123 NYLE--ERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGADEKEY-HAEGGKVPIKW 177
Query: 283 ---EVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSG--KNEVDQMTKIIEVLGMPP 333
E +L Y D+WS G + EL T G + G +E+ + + E L PP
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 437 | |||
| KOG0667|consensus | 586 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0671|consensus | 415 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG1290|consensus | 590 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0670|consensus | 752 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0591|consensus | 375 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| KOG0596|consensus | 677 | 100.0 | ||
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| KOG0577|consensus | 948 | 100.0 | ||
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0665|consensus | 369 | 100.0 | ||
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0668|consensus | 338 | 100.0 | ||
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| KOG1026|consensus | 774 | 100.0 | ||
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| KOG0194|consensus | 474 | 100.0 | ||
| KOG0664|consensus | 449 | 100.0 | ||
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1027|consensus | 903 | 100.0 | ||
| KOG1167|consensus | 418 | 100.0 | ||
| KOG0196|consensus | 996 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| KOG1152|consensus | 772 | 100.0 | ||
| KOG3653|consensus | 534 | 99.98 | ||
| KOG0200|consensus | 609 | 99.97 | ||
| KOG0576|consensus | 829 | 99.97 | ||
| KOG2052|consensus | 513 | 99.97 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1345|consensus | 378 | 99.97 | ||
| KOG1025|consensus | 1177 | 99.97 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1024|consensus | 563 | 99.95 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1163|consensus | 341 | 99.94 | ||
| KOG1164|consensus | 322 | 99.94 | ||
| KOG0590|consensus | 601 | 99.93 | ||
| KOG1165|consensus | 449 | 99.93 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0603|consensus | 612 | 99.92 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0606|consensus | 1205 | 99.89 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| KOG1240|consensus | 1431 | 99.86 | ||
| KOG4158|consensus | 598 | 99.85 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG1166|consensus | 974 | 99.84 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG1033|consensus | 516 | 99.79 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| KOG0195|consensus | 448 | 99.76 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| KOG0590|consensus | 601 | 99.71 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| KOG1023|consensus | 484 | 99.68 | ||
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| KOG0601|consensus | 524 | 99.58 | ||
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0606|consensus | 1205 | 99.56 | ||
| KOG1266|consensus | 458 | 99.53 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| KOG0601|consensus | 524 | 99.31 | ||
| KOG1243|consensus | 690 | 99.3 | ||
| KOG3087|consensus | 229 | 99.26 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.17 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.15 | |
| KOG2137|consensus | 700 | 99.05 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.98 | |
| KOG3741|consensus | 655 | 98.92 | ||
| PRK09902 | 216 | hypothetical protein; Provisional | 98.77 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.69 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.66 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.63 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.58 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.54 | |
| KOG0576|consensus | 829 | 98.43 | ||
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.43 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.39 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.36 | |
| KOG1235|consensus | 538 | 98.28 | ||
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.24 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.08 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.04 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.03 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.95 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.88 | |
| KOG2270|consensus | 520 | 97.78 | ||
| PRK05231 | 319 | homoserine kinase; Provisional | 97.74 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.72 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.69 | |
| KOG1035|consensus | 1351 | 97.59 | ||
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.59 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.59 | |
| KOG1093|consensus | 725 | 97.55 | ||
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.52 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.47 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.43 | |
| KOG2268|consensus | 465 | 97.19 | ||
| PLN02236 | 344 | choline kinase | 97.12 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.07 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.87 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.85 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.77 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.74 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.61 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.39 | |
| KOG1826|consensus | 2724 | 96.23 | ||
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.22 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.98 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.97 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.89 | |
| KOG1236|consensus | 565 | 95.87 | ||
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.84 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.76 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.54 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.35 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.11 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.05 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.8 |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-73 Score=569.26 Aligned_cols=393 Identities=50% Similarity=0.779 Sum_probs=337.5
Q ss_pred CCcccCCCCCChhhHhhHHHHHHhchhcHHHHHhhhhhhhhcccccccccccccccCCCCCCCCCCcceeecCceeccCe
Q psy11727 33 IPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRY 112 (437)
Q Consensus 33 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 112 (437)
....+|.....|+...+.++..+|+.++..++.....+.+........ .....+.++++.+|.+..++.+..+|
T Consensus 115 ~~~~~~~~~~~~~~~~~~s~~e~~ei~~~~~~~~~~~~~~~~~t~~~~------~~~~~~~~~~~~dY~~v~~d~i~~rY 188 (586)
T KOG0667|consen 115 ENSGLRPSQASPLYKHSLSLIETYEIINYPEVYFVGLNAKKVLTFPSE------GINTKNFDDEDGDYQLVVNDHIAYRY 188 (586)
T ss_pred cccCcCchhhhhhhccccchhhhhhccChHHhhhhccccccccCCCcc------cccCCCCCCCCCceeEEecceeEEEE
Confidence 344677888889999999999999998876654433332211111111 12223377888899999999999999
Q ss_pred eeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCC-cEEEecceeeECCEEEEEEE
Q psy11727 113 EIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR-YIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 113 ~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~-~iv~l~~~~~~~~~~~lV~E 191 (437)
+|.+.||+|+||+|.+|.+..|++.||||++++++.+..+...|+.+++.++..+..+. |+|+++++|...+|+|||+|
T Consensus 189 ~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfE 268 (586)
T KOG0667|consen 189 EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFE 268 (586)
T ss_pred EEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeeh
Confidence 99999999999999999999999999999999999999999999999999995544444 99999999999999999999
Q ss_pred eccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCccc
Q psy11727 192 LLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLY 271 (437)
Q Consensus 192 ~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~~ 271 (437)
+++.+|+++++.+++.++++..++.|+.||+.||.+|| ++||||||||||||||++..+..|||+|||+||..++..+
T Consensus 269 LL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~--~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy 346 (586)
T KOG0667|consen 269 LLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH--ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY 346 (586)
T ss_pred hhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCChhheeeccCCcCceeEEecccccccCCcce
Confidence 99999999999999999999999999999999999999 5699999999999999988889999999999999999999
Q ss_pred cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccC
Q psy11727 272 QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLS 351 (437)
Q Consensus 272 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~ 351 (437)
++++|++|+|||++.|.+|+.++||||||||++||++|.|+|.|.++.+++..|++.+|+||.+|++.+.++.+||+..
T Consensus 347 tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~- 425 (586)
T KOG0667|consen 347 TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSL- 425 (586)
T ss_pred eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhcc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999999985
Q ss_pred CCcceeccc-cccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCc
Q psy11727 352 DNSYVLKKS-TDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430 (437)
Q Consensus 352 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~ 430 (437)
.+.+..... ........+..+..-.....+.++|.+.+.....+...++..|.|||.+||++||.+||||.|||+||||
T Consensus 426 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl 505 (586)
T KOG0667|consen 426 KGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFL 505 (586)
T ss_pred CCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccc
Confidence 222221111 1122224444555555566677788777888888888899999999999999999999999999999999
Q ss_pred CcCC
Q psy11727 431 LKHS 434 (437)
Q Consensus 431 ~~~~ 434 (437)
++..
T Consensus 506 ~~~~ 509 (586)
T KOG0667|consen 506 TGTS 509 (586)
T ss_pred cccc
Confidence 9654
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-56 Score=431.67 Aligned_cols=265 Identities=31% Similarity=0.507 Sum_probs=220.0
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
..-.++|+++++||+|+||.||+|+.+.||..+|+|++++ +.....-+.+....|+-.....++++||+|+..|++.++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkK-S~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKK-SEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccH-HHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 4447899999999999999999999999999999999974 444444444555555544455689999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+||||||++| ++..+|.... .++++.++.++.+++.|+..|| ++|+|||||||+|+|| |..|+|||+|||+|.
T Consensus 216 LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH--~~gyIHRDIKPdNlLi--D~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIH--QLGYIHRDIKPDNLLI--DAKGHIKLSDFGLST 289 (550)
T ss_pred eEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHH--HcCcccccCChhheee--cCCCCEeeccccccc
Confidence 9999999976 6777777664 5999999999999999999999 5699999999999999 899999999999973
Q ss_pred ecCC--------------------------------------------------ccccccccccccChhhhcCCCCCCcc
Q psy11727 265 HVGQ--------------------------------------------------TLYQYIQSRYYRSPEVLLGIPYDLAI 294 (437)
Q Consensus 265 ~~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 294 (437)
-... -.++.+|||.|+|||++.+.+|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 2200 02345899999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCch
Q psy11727 295 DMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRL 374 (437)
Q Consensus 295 DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (437)
|+||||||+||||.|.|||.+.+..++..+|+..... -.|.... .+
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~------------l~fP~~~----------------------~~ 415 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET------------LKFPEEV----------------------DL 415 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh------------ccCCCcC----------------------cc
Confidence 9999999999999999999999999999999763110 0000000 00
Q ss_pred hhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC---HHHHhcCCCcCcCCCCC
Q psy11727 375 DTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS---PTNVLRHEFFLKHSVDN 437 (437)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t---~~e~l~Hp~~~~~~~~~ 437 (437)
..+..|||.+||. ||+.|.- ++|+-+||||+.+.+|+
T Consensus 416 -------------------------s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 416 -------------------------SDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred -------------------------cHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcch
Confidence 0256899999999 9999995 99999999999999874
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-56 Score=421.43 Aligned_cols=261 Identities=32% Similarity=0.469 Sum_probs=215.0
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc--------chHHHHHHHHHHHhhhcCCCCCcEEEec
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF--------LNQAQIEVQLLEKINKADIHSRYIVKLK 177 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~--------~~~~~~e~~~~~~l~~~~~~h~~iv~l~ 177 (437)
+.+.+.|.+.+.||+|+||.|-+|+.+.||+.||||++.+.... .....+|+.+|+++ .||+||+++
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-----~HP~IV~~~ 242 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-----SHPNIVRIK 242 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-----CCCCEEEEe
Confidence 34677899999999999999999999999999999999754321 22356899999988 789999999
Q ss_pred ceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC-CCCCE
Q psy11727 178 GHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP-KRSAI 255 (437)
Q Consensus 178 ~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~-~~~~i 255 (437)
++|...++.||||||++| .|++.+..+. .+.+...+-+++||+.|+.|||+ .||+||||||+|||+.++ ++..+
T Consensus 243 d~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~--~GI~HRDiKPeNILl~~~~e~~ll 318 (475)
T KOG0615|consen 243 DFFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHS--QGIIHRDIKPENILLSNDAEDCLL 318 (475)
T ss_pred eeeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHH--cCcccccCCcceEEeccCCcceEE
Confidence 999999999999999955 8999887764 47889999999999999999995 599999999999999766 55779
Q ss_pred EEEeCCCceecC--CccccccccccccChhhhcCCCCC---CcchHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Q psy11727 256 KIIDFGSSCHVG--QTLYQYIQSRYYRSPEVLLGIPYD---LAIDMWSLGCILVELHTGEPLFSGKNEVD-QMTKIIEVL 329 (437)
Q Consensus 256 kL~DFG~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlG~il~elltg~~pf~~~~~~~-~~~~i~~~~ 329 (437)
||+|||+|+..+ .-+.+.|||+.|.|||++.++.+. .++|+|||||+||.+++|.|||++..... ..++|..+
T Consensus 319 KItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G- 397 (475)
T KOG0615|consen 319 KITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG- 397 (475)
T ss_pred EecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC-
Confidence 999999999884 456689999999999999877533 47899999999999999999999876555 45555432
Q ss_pred CCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHH
Q psy11727 330 GMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILR 409 (437)
Q Consensus 330 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 409 (437)
.|.+.. -.|-...++.+|||.+
T Consensus 398 ------------------------~y~f~p----------------------------------~~w~~Iseea~dlI~~ 419 (475)
T KOG0615|consen 398 ------------------------RYAFGP----------------------------------LQWDRISEEALDLINW 419 (475)
T ss_pred ------------------------cccccC----------------------------------hhhhhhhHHHHHHHHH
Confidence 111100 0111112256899999
Q ss_pred ccccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 410 MLTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 410 ~L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
||..||+.|||+.|||+||||+...
T Consensus 420 mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 420 MLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhEeCcccCcCHHHHhcChhhhccc
Confidence 9999999999999999999998543
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-56 Score=425.46 Aligned_cols=286 Identities=35% Similarity=0.533 Sum_probs=235.5
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHH--HHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQA--QIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~--~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.+.++|.+++.||.|+||.||+|+.+.++..||||.++++-...++. .+|+..+++++ .|||||++.+++.+.+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln----~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN----PHPNIIKLKEVIRDND 82 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcC----CCCcchhhHHHhhccC
Confidence 35789999999999999999999999999999999998665444443 35777777774 4899999999999988
Q ss_pred -EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 -HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 -~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+++|||||..+|+++++.. ...|++..++.|++||++||+|+|.+ |+.||||||||||+ ..+..|||+|||+|
T Consensus 83 ~~L~fVfE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~--GfFHRDlKPENiLi--~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 83 RILYFVFEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH--GFFHRDLKPENILI--SGNDVIKIADFGLA 157 (538)
T ss_pred ceEeeeHHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc--CcccccCChhheEe--cccceeEecccccc
Confidence 99999999999999999988 47799999999999999999999965 89999999999999 44677999999999
Q ss_pred eecC--CccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 264 CHVG--QTLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 264 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
+... .+.+.++.|++|+|||++.. .-|+.+.|||++|||++|+.+-+|+|.|.++.+++.+|.+.+|.|....+..+
T Consensus 158 Rev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 158 REVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred cccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 8773 44567899999999999875 56899999999999999999999999999999999999999999987766554
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
.....- -.|.+... ....+.+.+.. ...++.+||.+||.|||.+|||
T Consensus 238 ~~La~~------mnf~~P~~---------~~~~l~~L~p~------------------~s~~~~~li~~ll~WDP~kRpT 284 (538)
T KOG0661|consen 238 YNLASA------MNFRFPQV---------KPSPLKDLLPN------------------ASSEAASLIERLLAWDPDKRPT 284 (538)
T ss_pred HHHHHH------hccCCCcC---------CCCChHHhCcc------------------cCHHHHHHHHHHhcCCCccCcc
Confidence 221110 01111100 00112222111 1236789999999999999999
Q ss_pred HHHHhcCCCcCcCC
Q psy11727 421 PTNVLRHEFFLKHS 434 (437)
Q Consensus 421 ~~e~l~Hp~~~~~~ 434 (437)
|+|+|+||||+...
T Consensus 285 A~~al~~pffq~~~ 298 (538)
T KOG0661|consen 285 ASQALQHPFFQVGR 298 (538)
T ss_pred HHHHhcCccccccc
Confidence 99999999998754
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-54 Score=427.66 Aligned_cols=249 Identities=30% Similarity=0.439 Sum_probs=218.2
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecC----CcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKN----KKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~----~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
.+|...+.||+|||+.||.+++..+|+.||+|++.+ +.........|+.|.+.+ .|||||+++++|++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-----~HpnIV~f~~~FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-----KHPNIVQFYHFFEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-----CCCcEEeeeeEeecCCc
Confidence 579999999999999999999999999999999975 333345566677776665 89999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+|||.|+|.. +|..+++. .+.+++..++.|++||+.||.|||++ +|||||||..|+|| +++.+|||+|||+|+
T Consensus 93 VYivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~--~IiHRDLKLGNlfL--~~~~~VKIgDFGLAt 166 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSL--GIIHRDLKLGNLFL--NENMNVKIGDFGLAT 166 (592)
T ss_pred eEEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhc--Cceecccchhheee--cCcCcEEecccceee
Confidence 9999999976 66666663 36799999999999999999999965 79999999999999 788899999999998
Q ss_pred ecC---CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 265 HVG---QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 265 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
... +...+.|||+.|+|||++....++..+||||+||+||.||+|+|||..++-.+++.+|...--..|....
T Consensus 167 ~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls---- 242 (592)
T KOG0575|consen 167 QLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLS---- 242 (592)
T ss_pred eecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccC----
Confidence 875 6678899999999999999999999999999999999999999999999999999999774332222111
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
...+|||.+||+.||.+|||+
T Consensus 243 -----------------------------------------------------------~~A~dLI~~lL~~~P~~Rpsl 263 (592)
T KOG0575|consen 243 -----------------------------------------------------------AEAKDLIRKLLRPNPSERPSL 263 (592)
T ss_pred -----------------------------------------------------------HHHHHHHHHHhcCCcccCCCH
Confidence 145899999999999999999
Q ss_pred HHHhcCCCcCc
Q psy11727 422 TNVLRHEFFLK 432 (437)
Q Consensus 422 ~e~l~Hp~~~~ 432 (437)
+++|.|+||+.
T Consensus 264 ~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 264 DEVLDHPFFKS 274 (592)
T ss_pred HHHhcCHhhhC
Confidence 99999999954
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-55 Score=410.30 Aligned_cols=322 Identities=36% Similarity=0.659 Sum_probs=269.8
Q ss_pred CCCCCcceeecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCC-c
Q psy11727 94 DDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR-Y 172 (437)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~-~ 172 (437)
++....+++..++.+.++|.+.+.+|+|.||.|..|.+..++..||||++++-.........|+.++++++..+.... .
T Consensus 73 dD~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~r 152 (415)
T KOG0671|consen 73 DDKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFR 152 (415)
T ss_pred CCCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceE
Confidence 667778999999999999999999999999999999999999999999999888888889999999999988765544 6
Q ss_pred EEEecceeeECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC--
Q psy11727 173 IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP-- 250 (437)
Q Consensus 173 iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~-- 250 (437)
+|++.++|...++.|||+|.++-++++++..+++.+++...++.|++|++.++++|| +++++|-||||+|||+++.
T Consensus 153 cv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh--~~kl~HTDLKPENILfvss~~ 230 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH--DLKLTHTDLKPENILFVSSEY 230 (415)
T ss_pred EEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH--hcceeecCCChheEEEeccce
Confidence 999999999999999999999999999999999999999999999999999999999 4689999999999999643
Q ss_pred ----------------CCCCEEEEeCCCceecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy11727 251 ----------------KRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFS 314 (437)
Q Consensus 251 ----------------~~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~ 314 (437)
++..|+|+|||+|+...+..++.+.|+.|+|||++.+.+++.++||||+||||+|+.||..+|.
T Consensus 231 ~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 231 FKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred EEEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 2346999999999999888888999999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCC
Q psy11727 315 GKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPG 394 (437)
Q Consensus 315 ~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (437)
+.++.+.++.+...+|++|..|+.... ..+||.+- .=.|.........++-...-..+..+. .
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~-~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~---------------~ 373 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTR-KEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYM---------------L 373 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhh-hHhhhhcc-cccCccccccccchhhhcCCccHHHHh---------------c
Confidence 999999998888889999999997765 34565542 111211111110011111111122211 1
Q ss_pred CChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 395 HSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 395 ~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
+...+...|.|||++||.+||.+|+|+.|||.||||+...
T Consensus 374 ~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 374 QDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred cCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 2223334689999999999999999999999999998754
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-54 Score=392.05 Aligned_cols=281 Identities=32% Similarity=0.558 Sum_probs=228.4
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
++|+...++|+|+||.||+|+++.||+.||||++..... ..+-+.+|+.+++.+ .|+|+|.++++|.....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-----kH~NLVnLiEVFrrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-----KHENLVNLIEVFRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-----ccchHHHHHHHHHhccee
Confidence 578999999999999999999999999999999974432 234456788888777 789999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||+|||..++++.+.... ++++...++++++|++.|+.|+|++ ++|||||||+|||+ ..+|.+||||||+|+..
T Consensus 77 hLVFE~~dhTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~--n~IHRDIKPENILi--t~~gvvKLCDFGFAR~L 151 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKN--NCIHRDIKPENILI--TQNGVVKLCDFGFARTL 151 (396)
T ss_pred EEEeeecchHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhc--CeecccCChhheEE--ecCCcEEeccchhhHhh
Confidence 9999999999888888765 6799999999999999999999986 59999999999999 67999999999999876
Q ss_pred C---CccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 267 G---QTLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 267 ~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
. +..+.++.|++|+|||.+.| ..|+.++|||++||++.||++|.|.|.|.++.+++-.|+..+|..++.-..-. .
T Consensus 152 ~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF-~ 230 (396)
T KOG0593|consen 152 SAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF-S 230 (396)
T ss_pred cCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh-c
Confidence 4 34456889999999999998 68999999999999999999999999999999999999999996554333211 1
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
...||..+ .+|.....+.. +..-++.+ ..+.||+.+||..||++|+|.+
T Consensus 231 ~N~~F~Gv----------------~lP~~~~~epL-----------e~k~p~~s----~~~ld~~k~cL~~dP~~R~sc~ 279 (396)
T KOG0593|consen 231 SNPFFHGV----------------RLPEPEHPEPL-----------ERKYPKIS----NVLLDLLKKCLKMDPDDRLSCE 279 (396)
T ss_pred cCCceeee----------------ecCCCCCccch-----------hhhcccch----HHHHHHHHHHhcCCccccccHH
Confidence 22333321 11111111000 00011111 1568999999999999999999
Q ss_pred HHhcCCCcCc
Q psy11727 423 NVLRHEFFLK 432 (437)
Q Consensus 423 e~l~Hp~~~~ 432 (437)
|+|.||||.+
T Consensus 280 qll~H~yFd~ 289 (396)
T KOG0593|consen 280 QLLHHPYFDG 289 (396)
T ss_pred HHhcChHHHH
Confidence 9999999954
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-54 Score=401.37 Aligned_cols=254 Identities=35% Similarity=0.578 Sum_probs=220.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc----chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~----~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.++||+|+||+|+.++.+.|++.+|+|+++++... ......|..+++.+ +||.||+++..|++.+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-----~hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-----KHPFIVKLIYSFQTEE 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-----CCCcEeeeEEecccCC
Confidence 57899999999999999999999999999999999754322 33455677777764 8999999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+|+|+||+.| .|+.+|.+.. .++++.++.++.+|+.||.|||+ .|||||||||+|||| |..|+|+|+|||++
T Consensus 99 kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~--~gIiyRDlKPENILL--d~~GHi~LtDFgL~ 172 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHS--KGIIYRDLKPENILL--DEQGHIKLTDFGLC 172 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHeee--cCCCcEEEeccccc
Confidence 99999999965 7998888764 49999999999999999999995 489999999999999 88999999999999
Q ss_pred eec---CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCChhhhcc
Q psy11727 264 CHV---GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVL-GMPPGYLLHG 339 (437)
Q Consensus 264 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~p~~~~~~~ 339 (437)
+.. +....+.|||+.|||||++.+.+|+.++|+||||+++|||++|.+||.+.+...+.++|...- ..+|..+.
T Consensus 173 k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls-- 250 (357)
T KOG0598|consen 173 KEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLS-- 250 (357)
T ss_pred hhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCC--
Confidence 743 445567899999999999999999999999999999999999999999999989988887643 11111110
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
...+|||.++|..||++|.
T Consensus 251 -------------------------------------------------------------~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 251 -------------------------------------------------------------EEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -------------------------------------------------------------HHHHHHHHHHhccCHHHhc
Confidence 1468999999999999996
Q ss_pred ----CHHHHhcCCCcCcCCCC
Q psy11727 420 ----SPTNVLRHEFFLKHSVD 436 (437)
Q Consensus 420 ----t~~e~l~Hp~~~~~~~~ 436 (437)
.+.++-.||||...+++
T Consensus 270 g~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 270 GGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred CCCCChHHhhcCcccccCCHH
Confidence 68889999999998875
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-53 Score=380.21 Aligned_cols=278 Identities=35% Similarity=0.562 Sum_probs=235.7
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc---chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF---LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+|...+.||+|.||.||+|++..||+.||||.|+..... .....+|+..++.+ +|+||+.++++|.+.+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-----~h~nIi~LiD~F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-----KHPNIIELIDVFPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-----cCcchhhhhhhccCCCce
Confidence 5789999999999999999999999999999999854332 56778899999988 789999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
.||+|||+.+|...++... ..++...++.++.+++.||+|||.+ .|+||||||.|+|+ ..+|.+||+|||+|+..
T Consensus 77 ~lVfEfm~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~--~IlHRDlKPnNLLi--s~~g~lKiADFGLAr~f 151 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSK--WILHRDLKPNNLLI--SSDGQLKIADFGLARFF 151 (318)
T ss_pred EEEEEeccccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhh--hhhcccCCccceEE--cCCCcEEeecccchhcc
Confidence 9999999999999998765 5699999999999999999999965 79999999999999 67899999999999988
Q ss_pred CCccc---cccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 267 GQTLY---QYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 267 ~~~~~---~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
+.... ..+-|+.|+|||.+.|. .|+..+||||.|||+.||+.|.|.|.|.++.+++..|...+|.|....|+++..
T Consensus 152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 65432 23679999999999875 699999999999999999999999999999999999999999999988887766
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
...|-+-. . .| ..|....+ ........||+.+||.+||.+|+|++
T Consensus 232 lpdY~~~~--------------~--~P-------------~~~~~~lf------~aas~d~ldLl~~m~~ynP~~Rita~ 276 (318)
T KOG0659|consen 232 LPDYVKIQ--------------Q--FP-------------KPPLNNLF------PAASSDALDLLSKMLTYNPKKRITAS 276 (318)
T ss_pred cccHHHHh--------------c--CC-------------CCcccccc------ccccHHHHHHHHhhhccCchhcccHH
Confidence 54442210 0 00 00000000 11112458999999999999999999
Q ss_pred HHhcCCCcCc
Q psy11727 423 NVLRHEFFLK 432 (437)
Q Consensus 423 e~l~Hp~~~~ 432 (437)
|+|+||||+.
T Consensus 277 qaL~~~yf~~ 286 (318)
T KOG0659|consen 277 QALKHPYFKS 286 (318)
T ss_pred HHhcchhhhc
Confidence 9999999985
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-53 Score=397.74 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=217.3
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEec--CCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC-
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN- 184 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~--~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~- 184 (437)
..++.+..+.||+|..|+||+|+++.|++.+|+|++. ......++..+|+.+++.. .|||||.+++.|..+.
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-----~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-----QSPYIVGFYGAFYSNGE 151 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-----CCCCeeeEeEEEEeCCc
Confidence 3456778899999999999999999999999999994 3445567888899888876 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
..+|+||||++ +|.++++.. +.+++....+++.+|++||.|||.. .+||||||||+|||+ +.+|+|||||||.|
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLv--NskGeVKicDFGVS 226 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEE-RKIIHRDIKPSNLLV--NSKGEVKICDFGVS 226 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhc-cCeeeccCCHHHeee--ccCCCEEecccccc
Confidence 59999999965 788777765 4699999999999999999999963 579999999999999 78999999999999
Q ss_pred eecCCc-cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHhCCCChhhh
Q psy11727 264 CHVGQT-LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGK-----NEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 264 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~-----~~~~~~~~i~~~~~~p~~~~~ 337 (437)
....+. ..+++||..|||||.+.+..|+.++||||||+.++||.+|+.||... +..+.+..|+. +.||..
T Consensus 227 ~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~--~ppP~l-- 302 (364)
T KOG0581|consen 227 GILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD--EPPPRL-- 302 (364)
T ss_pred HHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc--CCCCCC--
Confidence 876444 47899999999999999999999999999999999999999999874 45555555543 223210
Q ss_pred ccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCC
Q psy11727 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKK 417 (437)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 417 (437)
+.+ .-..+|++||..||+.||.+
T Consensus 303 -------------P~~--------------------------------------------~fS~ef~~FV~~CL~Kdp~~ 325 (364)
T KOG0581|consen 303 -------------PEG--------------------------------------------EFSPEFRSFVSCCLRKDPSE 325 (364)
T ss_pred -------------Ccc--------------------------------------------cCCHHHHHHHHHHhcCCccc
Confidence 000 01126899999999999999
Q ss_pred CCCHHHHhcCCCcCcCCC
Q psy11727 418 RISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 418 R~t~~e~l~Hp~~~~~~~ 435 (437)
|||++|+++|||+++...
T Consensus 326 R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 326 RPSAKQLLQHPFIKKFED 343 (364)
T ss_pred CCCHHHHhcCHHHhhccc
Confidence 999999999999997654
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-53 Score=409.31 Aligned_cols=257 Identities=31% Similarity=0.462 Sum_probs=226.6
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC----cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~----~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
-..+|...+.||.|+|++|++|+++.+++.||||++.++ ....+-+.+|...|.+|. .||.|++|+..|++.
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~----~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS----GHPGIVKLYFTFQDE 146 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh----CCCCeEEEEEEeecc
Confidence 356899999999999999999999999999999998642 233456677888888887 789999999999999
Q ss_pred CEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
..+|+|+||++ |+|+++|++.+ .|++..++.++.||+.||+|||+ .|||||||||||||| |+++++||+|||.
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~--~GIIHRDlKPENILL--d~dmhikITDFGs 220 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHS--NGIIHRDLKPENILL--DKDGHIKITDFGS 220 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeE--cCCCcEEEeeccc
Confidence 99999999995 58999998864 59999999999999999999995 599999999999999 8999999999999
Q ss_pred ceecCCc----------------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy11727 263 SCHVGQT----------------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326 (437)
Q Consensus 263 s~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~ 326 (437)
|..+... ..+++||..|.+||++.....+..+|+|+||||||.|+.|.|||.+.++..++++|+
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~ 300 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ 300 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH
Confidence 9765321 145899999999999999999999999999999999999999999999999999999
Q ss_pred HHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHH
Q psy11727 327 EVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406 (437)
Q Consensus 327 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 406 (437)
+..-..|+.+- +...||
T Consensus 301 ~l~y~fp~~fp---------------------------------------------------------------~~a~dL 317 (604)
T KOG0592|consen 301 ALDYEFPEGFP---------------------------------------------------------------EDARDL 317 (604)
T ss_pred HhcccCCCCCC---------------------------------------------------------------HHHHHH
Confidence 86433322110 156899
Q ss_pred HHHccccCCCCCCCHHHHhcCCCcCcCCCCC
Q psy11727 407 ILRMLTYDPKKRISPTNVLRHEFFLKHSVDN 437 (437)
Q Consensus 407 i~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~~ 437 (437)
|+++|..||.+|+|++|+-+||||..++++|
T Consensus 318 v~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 318 IKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred HHHHHccCccccccHHHHhhCcccccCChhh
Confidence 9999999999999999999999999999886
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-52 Score=402.79 Aligned_cols=280 Identities=32% Similarity=0.523 Sum_probs=231.3
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecC---CcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC-
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKN---KKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK- 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~---~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~- 183 (437)
..+.|+.+++||+|.||+||+|++..||+.||+|.++. +..+.....+|+.|++++ +||||++|.+...+.
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-----~HpNIikL~eivt~~~ 189 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-----DHPNIIKLEEIVTSKL 189 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-----CCCcccceeeEEEecC
Confidence 35679999999999999999999999999999999974 345567788999999998 789999999998876
Q ss_pred -CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 -NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 -~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
..+|||+|||+.+|..++.... -.|++.+++.|+.||+.||+|||+ .||+|||||..|||| |.+|.+||+|||+
T Consensus 190 ~~siYlVFeYMdhDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~--~gvlHRDIK~SNiLi--dn~G~LKiaDFGL 264 (560)
T KOG0600|consen 190 SGSIYLVFEYMDHDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHS--RGVLHRDIKGSNILI--DNNGVLKIADFGL 264 (560)
T ss_pred CceEEEEEecccchhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhh--cCeeeccccccceEE--cCCCCEEeccccc
Confidence 6999999999999999988754 359999999999999999999996 489999999999999 8899999999999
Q ss_pred ceecCC----ccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 263 SCHVGQ----TLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 263 s~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
|+.... ..+..+-|.+|+|||.++|. .|+.++|+||.||||.||++|+|+|.|.++.+++..|.+..|.|.+..|
T Consensus 265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 986532 34456779999999999986 6999999999999999999999999999999999999999999998876
Q ss_pred ccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCC
Q psy11727 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKK 417 (437)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 417 (437)
+ ..+.. ++... +. ..+--+.+.+.. .... ....+|+..||..||.+
T Consensus 345 ~-~~kLP-~~~~~-------kp-------~~~y~r~l~E~~----------------~~~~--~~~l~Ll~~lL~ldP~k 390 (560)
T KOG0600|consen 345 P-VSKLP-HATIF-------KP-------QQPYKRRLRETF----------------KDFP--ASALDLLEKLLSLDPDK 390 (560)
T ss_pred c-cccCC-ccccc-------CC-------CCcccchHHHHh----------------ccCC--HHHHHHHHHHhccCccc
Confidence 5 11111 11000 00 000011222221 1111 14589999999999999
Q ss_pred CCCHHHHhcCCCcC
Q psy11727 418 RISPTNVLRHEFFL 431 (437)
Q Consensus 418 R~t~~e~l~Hp~~~ 431 (437)
|.||.+||+|+||+
T Consensus 391 R~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 391 RGTASSALQSEYFT 404 (560)
T ss_pred cccHHHHhcCcccc
Confidence 99999999999994
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-52 Score=383.07 Aligned_cols=286 Identities=32% Similarity=0.511 Sum_probs=234.1
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC-
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK- 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~- 183 (437)
-.+.|+.++.|++|+||.||+|+++.|++.||+|.++..+ .+.-...+|+.++... +|||||.+..+....
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-----~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-----RHPNIVEVKEVVVGSN 148 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-----CCCCeeeeEEEEeccc
Confidence 3578999999999999999999999999999999997443 3445567889888776 789999999988754
Q ss_pred -CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 -NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 -~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+.+|||||||..+|..++..-. ++|+..+++.++.|++.|++|||. ..|+||||||+|+|+ ...|.+||+|||+
T Consensus 149 ~d~iy~VMe~~EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~--~wilHRDLK~SNLLm--~~~G~lKiaDFGL 223 (419)
T KOG0663|consen 149 MDKIYIVMEYVEHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHD--NWILHRDLKTSNLLL--SHKGILKIADFGL 223 (419)
T ss_pred cceeeeeHHHHHhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhh--ceeEecccchhheee--ccCCcEEecccch
Confidence 5799999999999999998765 679999999999999999999995 489999999999999 6789999999999
Q ss_pred ceecCCc---cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 263 SCHVGQT---LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 263 s~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
|+.++.+ .+..+-|..|+|||.+.|. .|++++||||+|||+.||++++|.|.|.++.+++.+|...+|.|.+..|+
T Consensus 224 AR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 224 AREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred hhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence 9998876 4556779999999999986 59999999999999999999999999999999999999999999999887
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
+....... . .+.+.+. | +..+.... +..+ ..+.-.+|+.++|.+||.+|
T Consensus 304 g~~~lp~~-k-----~~~f~~~--------p-yn~lr~kF--------------~~~~--lse~g~~Lln~llt~dP~kR 352 (419)
T KOG0663|consen 304 GYSELPAV-K-----KMTFSEH--------P-YNNLRKKF--------------GALS--LSEQGFDLLNKLLTYDPGKR 352 (419)
T ss_pred Cccccchh-h-----ccccCCC--------C-chhhhhhc--------------cccc--cchhHHHHHHHHhccCcccc
Confidence 66543210 0 0000000 0 00000000 0000 11134799999999999999
Q ss_pred CCHHHHhcCCCcCcCC
Q psy11727 419 ISPTNVLRHEFFLKHS 434 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~~~ 434 (437)
.||+|+|+|+||.+..
T Consensus 353 ~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 353 ITAEDGLKHEYFRETP 368 (419)
T ss_pred ccHHHhhcccccccCC
Confidence 9999999999999843
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-52 Score=376.05 Aligned_cols=254 Identities=30% Similarity=0.491 Sum_probs=222.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|+..+.||.|+||.|.+++.+.+|..+|+|++.+... .......|..+++.+ .||+++++++.|.+.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-----~~PFlv~l~~t~~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-----SHPFLVKLYGTFKDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-----cCceeEEEEEeeccCC
Confidence 5689999999999999999999999999999999974321 122233455555554 7999999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
++||||||++| .|+.++++.. .+++..++.++.||+.||+|||+ ++|++|||||||||+ |.+|.+||+|||+|
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~--~~iiYRDLKPENiLl--D~~G~iKitDFGFA 191 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHS--LDIIYRDLKPENLLL--DQNGHIKITDFGFA 191 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHh--cCeeeccCChHHeee--ccCCcEEEEeccce
Confidence 99999999966 7999998864 59999999999999999999995 479999999999999 89999999999999
Q ss_pred eecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 264 CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
+.......+.|||+.|+|||++..++|..++|+|||||++|||+.|.+||.+.+...++++|.+..-..|..+.+
T Consensus 192 K~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~----- 266 (355)
T KOG0616|consen 192 KRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSS----- 266 (355)
T ss_pred EEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCH-----
Confidence 999998999999999999999999999999999999999999999999999999999999998863333322211
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC----
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI---- 419 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~---- 419 (437)
.++|||.++|+.|-.+|.
T Consensus 267 ----------------------------------------------------------~~kdLl~~LL~vD~t~R~gnlk 288 (355)
T KOG0616|consen 267 ----------------------------------------------------------DAKDLLKKLLQVDLTKRFGNLK 288 (355)
T ss_pred ----------------------------------------------------------HHHHHHHHHHhhhhHhhhcCcC
Confidence 578999999999999994
Q ss_pred -CHHHHhcCCCcCcCCCC
Q psy11727 420 -SPTNVLRHEFFLKHSVD 436 (437)
Q Consensus 420 -t~~e~l~Hp~~~~~~~~ 436 (437)
...++-.||||+.+.++
T Consensus 289 nG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 289 NGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred CCccccccCcccccccHH
Confidence 47789999999988764
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-52 Score=388.31 Aligned_cols=281 Identities=36% Similarity=0.578 Sum_probs=229.8
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC----
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN---- 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~---- 184 (437)
.-.|.-.+++|.|+||.||+|+...+++.||||.+-..... ..+|..++..+ .|||||++.-+|....
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l-----~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKL-----DHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhc-----CCcCeeeEEEEEEecCCCch
Confidence 34688899999999999999999999999999998765543 33588888855 8999999999987432
Q ss_pred -EEEEEEEeccCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 185 -HLCLVFELLSYNLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 185 -~~~lV~E~~~~~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
++.+||||++.+|++.++.. ....++.-.++-++.||++||+|||+ .||+||||||.|+|++ .+.|.+||||||
T Consensus 95 ~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~--~~IcHRDIKPqNlLvD-~~tg~LKicDFG 171 (364)
T KOG0658|consen 95 VYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS--HGICHRDIKPQNLLVD-PDTGVLKICDFG 171 (364)
T ss_pred hHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh--cCcccCCCChheEEEc-CCCCeEEeccCC
Confidence 67899999999999999842 23568999999999999999999996 4899999999999995 466899999999
Q ss_pred Cceec--CCccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 262 SSCHV--GQTLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 262 ~s~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
+|+.. +++..+++.|++|+|||.+.|. .|+.++||||.||++.||+.|+|.|.|++..+++..|++.+|.|...-+.
T Consensus 172 SAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 172 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred cceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 99876 5566789999999999999985 69999999999999999999999999999999999999999999998887
Q ss_pred cCCccch--hhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 339 GASKTSK--YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 339 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
.+..... -|.++... ++.+ +. ......+..||+.++|.++|.
T Consensus 252 ~mn~~y~~~~~p~ik~~---------------~~~~----~~-----------------~~~~~~d~~dll~~~L~Y~P~ 295 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAH---------------PWHK----VF-----------------FKRLPPDALDLLSKLLQYSPS 295 (364)
T ss_pred hcCcccccccCcccccc---------------ccee----ec-----------------ccCCCHHHHHHHHHHhccChh
Confidence 6654311 01111110 0000 00 000111568999999999999
Q ss_pred CCCCHHHHhcCCCcCcCCCC
Q psy11727 417 KRISPTNVLRHEFFLKHSVD 436 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~~~~~~~ 436 (437)
+|.||.|||.||||....+.
T Consensus 296 ~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 296 KRLSALEALAHPFFDELRDP 315 (364)
T ss_pred hcCCHHHHhcchhhHHhhCc
Confidence 99999999999999876543
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=384.50 Aligned_cols=284 Identities=34% Similarity=0.561 Sum_probs=233.6
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecC---CcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE-
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKN---KKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW- 182 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~---~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~- 182 (437)
.+..+|...+.||+|+||.|..|.++.+|+.||||.+.+ .....++..+|+.+++.+ .|+||+.+.+.+..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-----~HeNIi~l~di~~p~ 93 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-----RHENIIGLLDIFRPP 93 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-----cCCCcceEEeecccc
Confidence 345667778999999999999999999999999999862 334456777899999888 68899999998875
Q ss_pred ----CCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 183 ----KNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 183 ----~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
-+.+|+|+|+|+.+|.+.++.+. .++...+..+++||++||.|+|+. +|+||||||.|+|+ +.+..+||+
T Consensus 94 ~~~~f~DvYiV~elMetDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSA--nViHRDLKPsNll~--n~~c~lKI~ 167 (359)
T KOG0660|consen 94 SRDKFNDVYLVFELMETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSA--NVIHRDLKPSNLLL--NADCDLKIC 167 (359)
T ss_pred cccccceeEEehhHHhhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcc--cccccccchhheee--ccCCCEEec
Confidence 35799999999999999998864 489999999999999999999965 79999999999999 677789999
Q ss_pred eCCCceecC-----CccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy11727 259 DFGSSCHVG-----QTLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332 (437)
Q Consensus 259 DFG~s~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p 332 (437)
|||+|+... ...+.++.|+.|+|||++.. ..|+.++||||+|||+.||++|++.|.|.+..++++.|++.+|.|
T Consensus 168 DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 168 DFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred cccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence 999998883 44577899999999999875 579999999999999999999999999999999999999999999
Q ss_pred ChhhhccCC--ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHc
Q psy11727 333 PGYLLHGAS--KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRM 410 (437)
Q Consensus 333 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~ 410 (437)
++..+..-. +.+.|...++.- | ...+..++. + .....+||+++|
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~~---------------p-~~~f~~~fp--------------~----a~p~AidLlekm 293 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQI---------------P-KQPFSSIFP--------------N----ANPLAIDLLEKM 293 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCCC---------------C-CCCHHHHcC--------------C----CCHHHHHHHHHH
Confidence 988776443 222333322210 0 011111111 1 112568999999
Q ss_pred cccCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 411 LTYDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 411 L~~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
|.+||.+|+|++|||+||||.+..+
T Consensus 294 L~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 294 LVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred hccCccccCCHHHHhcChhhhhhcC
Confidence 9999999999999999999988654
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-50 Score=384.81 Aligned_cols=313 Identities=35% Similarity=0.613 Sum_probs=268.2
Q ss_pred ceeecCceec-cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCC---cEEE
Q psy11727 100 YIIKHGEKFL-DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR---YIVK 175 (437)
Q Consensus 100 ~~~~~~~~~~-~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~---~iv~ 175 (437)
..++.|+.|. ++|.++++||.|-|++||+|.+..+.+.||+|+.+....+......|+.++..++..+..|+ +||+
T Consensus 67 HpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 67 HPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred ceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 4577899998 89999999999999999999999999999999998766677778889999999998775554 7999
Q ss_pred ecceeeEC----CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC-
Q psy11727 176 LKGHFTWK----NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP- 250 (437)
Q Consensus 176 l~~~~~~~----~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~- 250 (437)
|+++|... .|+|||+|+++.+|+.+|+..++++++...++.|++||+.||.|||. ++||||-||||+|||++.+
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~-ecgIIHTDlKPENvLl~~~e 225 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR-ECGIIHTDLKPENVLLCSTE 225 (590)
T ss_pred eeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH-hcCccccCCCcceeeeeccc
Confidence 99999864 59999999999999999999999999999999999999999999998 4899999999999999533
Q ss_pred --------------------------------------------------------------------------------
Q psy11727 251 -------------------------------------------------------------------------------- 250 (437)
Q Consensus 251 -------------------------------------------------------------------------------- 250 (437)
T Consensus 226 ~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~ 305 (590)
T KOG1290|consen 226 IDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNN 305 (590)
T ss_pred cchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccc
Confidence
Q ss_pred -------------------------------CC-----------------------------------------------
Q psy11727 251 -------------------------------KR----------------------------------------------- 252 (437)
Q Consensus 251 -------------------------------~~----------------------------------------------- 252 (437)
+.
T Consensus 306 ~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~ 385 (590)
T KOG1290|consen 306 EPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIP 385 (590)
T ss_pred ccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCC
Confidence 00
Q ss_pred -----CCEEEEeCCCceecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC------CHHHH
Q psy11727 253 -----SAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGK------NEVDQ 321 (437)
Q Consensus 253 -----~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~------~~~~~ 321 (437)
-.|||+|||-||+.....+..++|+.|+||||+.|.+|++.+||||++|+++||.||..+|... .+++.
T Consensus 386 ~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 386 LPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred CCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 1279999999999999888999999999999999999999999999999999999999999543 35688
Q ss_pred HHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhh
Q psy11727 322 MTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYM 401 (437)
Q Consensus 322 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (437)
++.|++.+|..|..+...+..++.||++-.+-.-. .+-.++|....|.+. -+-+.++..
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI------~~LK~WpL~~VL~eK---------------Y~~s~e~A~ 524 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHI------RRLKPWPLYEVLIEK---------------YEWSEEDAQ 524 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecc------cccCCCcHHHHHHHH---------------hCCCHHHHH
Confidence 99999999999999999999999999886542110 011122222222211 234567788
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 402 KFKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 402 ~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
+|.|||.-||+++|++||||.++|+||||...+
T Consensus 525 ~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~ 557 (590)
T KOG1290|consen 525 QFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVA 557 (590)
T ss_pred HHHHHHHHHHhcCccccccHHHHhcCccccCCC
Confidence 999999999999999999999999999998654
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=374.92 Aligned_cols=284 Identities=36% Similarity=0.577 Sum_probs=234.9
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCc-EEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~-iv~l~~~~~~~~ 184 (437)
...|..+++||+|+||+||+|+.+.+|+.||+|.++.... ......+|+.+++.+.+ +| ||.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~-----~~~iv~L~dv~~~~~ 84 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSH-----ANHIVRLHDVIHTSN 84 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCC-----CcceEEEEeeeeecc
Confidence 5568888999999999999999999999999999985543 45677899999999954 44 999999999877
Q ss_pred ------EEEEEEEeccCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEE
Q psy11727 185 ------HLCLVFELLSYNLYNLIRNTNF--HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIK 256 (437)
Q Consensus 185 ------~~~lV~E~~~~~L~~~l~~~~~--~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ik 256 (437)
.+++||||+..+|..++..... .+++...++.+++||+.||+|||++ ||+||||||.|||+ ++.|.+|
T Consensus 85 ~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~--~IlHRDLKPQNlLi--~~~G~lK 160 (323)
T KOG0594|consen 85 NHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH--GILHRDLKPQNLLI--SSSGVLK 160 (323)
T ss_pred cccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC--CeecccCCcceEEE--CCCCcEe
Confidence 8999999999999999988664 4688899999999999999999976 79999999999999 6799999
Q ss_pred EEeCCCceecCCc---cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy11727 257 IIDFGSSCHVGQT---LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332 (437)
Q Consensus 257 L~DFG~s~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p 332 (437)
|+|||+|+..+-+ ....++|..|+|||++.+. .|+...||||+|||++||+++++.|.|.++.+++.+|.+.+|.|
T Consensus 161 laDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred eeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 9999999866433 3345789999999999987 79999999999999999999999999999999999999999999
Q ss_pred ChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc
Q psy11727 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412 (437)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 412 (437)
....|+.......|-... ..+++.+.+..++.. .+ ....||+.+||+
T Consensus 241 ~e~~Wp~v~~~~~~k~~f---------------~~~~~~~~l~~~~~~--------------~~----~~~~dll~~~L~ 287 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPF---------------PKWPGPKDLSSILPK--------------LD----PDGIELLSKLLQ 287 (323)
T ss_pred CccCCCCccccccccccC---------------cCCCCccchHHhccc--------------cC----ccHHHHHHHHhc
Confidence 988777655432221100 001111122222111 00 245899999999
Q ss_pred cCCCCCCCHHHHhcCCCcCcCC
Q psy11727 413 YDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 413 ~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
++|.+|.|++.+|.||||....
T Consensus 288 y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 288 YDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred cCcccCcCHHHHhcChhhcccc
Confidence 9999999999999999998753
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=392.30 Aligned_cols=254 Identities=35% Similarity=0.499 Sum_probs=218.7
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC----c--ccchHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----K--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~----~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
...++|.+.+.||+|+||+|++|.+..+++.||+|++..+ . .......+|+.+++.+. .||||+++++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~----~HpnI~~l~ev~ 89 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLR----SHPNIIRLLEVF 89 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhc----cCCCEeEEEEEE
Confidence 4567999999999999999999999999999999987653 1 23456668998888884 489999999999
Q ss_pred eECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCC-CCEEEE
Q psy11727 181 TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR-SAIKII 258 (437)
Q Consensus 181 ~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~-~~ikL~ 258 (437)
.....+++||||+.| .|++++... +.+++..++++++||+.|++|||++ ||+||||||+|||+ +.+ +.+||+
T Consensus 90 ~t~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~--gi~HRDLK~ENill--d~~~~~~Kl~ 163 (370)
T KOG0583|consen 90 ATPTKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSR--GIVHRDLKPENILL--DGNEGNLKLS 163 (370)
T ss_pred ecCCeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhC--CEeeCCCCHHHEEe--cCCCCCEEEe
Confidence 999999999999965 899999883 4699999999999999999999964 89999999999999 566 899999
Q ss_pred eCCCceec---CCccccccccccccChhhhcCCC-CC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy11727 259 DFGSSCHV---GQTLYQYIQSRYYRSPEVLLGIP-YD-LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333 (437)
Q Consensus 259 DFG~s~~~---~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~ 333 (437)
|||++... +....+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...++..|....-..|
T Consensus 164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p 243 (370)
T KOG0583|consen 164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP 243 (370)
T ss_pred ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC
Confidence 99999876 35567899999999999999988 87 789999999999999999999999888888877655322222
Q ss_pred hhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
.+.. ...+++||++||..
T Consensus 244 ~~~~--------------------------------------------------------------S~~~~~Li~~mL~~ 261 (370)
T KOG0583|consen 244 SYLL--------------------------------------------------------------SPEARSLIEKMLVP 261 (370)
T ss_pred CCcC--------------------------------------------------------------CHHHHHHHHHHcCC
Confidence 1110 01578999999999
Q ss_pred CCCCCCCHHHHhcCCCcCc
Q psy11727 414 DPKKRISPTNVLRHEFFLK 432 (437)
Q Consensus 414 dP~~R~t~~e~l~Hp~~~~ 432 (437)
||.+|+|+.+++.||||+.
T Consensus 262 ~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 262 DPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CcccCCCHHHHhhChhhcc
Confidence 9999999999999999997
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=394.97 Aligned_cols=253 Identities=30% Similarity=0.453 Sum_probs=220.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.+-|++.+.||.|+-|.|-+|++..||+.+|||++.+.. .....+.+|+.+|+.+ .|||+++++++|+.+.
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-----~HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-----EHPNVLRLYDVWENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-----cCCCeeeeeeeeccCc
Confidence 567999999999999999999999999999999997552 3345677899999887 7899999999999999
Q ss_pred EEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
++|+|.||++ |.|++++...+ ++++..+.+++.||+.|+.|+|. .+|+||||||+|+|| |.++.|||+|||+|
T Consensus 86 ~lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~--~~icHRDLKpENlLL--d~~~nIKIADFGMA 159 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHA--FNICHRDLKPENLLL--DVKNNIKIADFGMA 159 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhh--hcceeccCCchhhhh--hcccCEeeecccee
Confidence 9999999995 58999988764 69999999999999999999995 579999999999999 77777999999999
Q ss_pred eec--CCccccccccccccChhhhcCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 264 CHV--GQTLYQYIQSRYYRSPEVLLGIPYD-LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 264 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
... +.-..+.||++.|.|||++.|.+|+ .++||||.|||||.||||+.||.+++....+.++..+....|..+.
T Consensus 160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is--- 236 (786)
T KOG0588|consen 160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNIS--- 236 (786)
T ss_pred ecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCC---
Confidence 755 3445678999999999999999987 7899999999999999999999999988888888665322221110
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
.+++|||.+||++||.+|+|
T Consensus 237 ------------------------------------------------------------~eaQdLLr~ml~VDp~~RiT 256 (786)
T KOG0588|consen 237 ------------------------------------------------------------SEAQDLLRRMLDVDPSTRIT 256 (786)
T ss_pred ------------------------------------------------------------HHHHHHHHHHhccCcccccc
Confidence 15689999999999999999
Q ss_pred HHHHhcCCCcCcCCC
Q psy11727 421 PTNVLRHEFFLKHSV 435 (437)
Q Consensus 421 ~~e~l~Hp~~~~~~~ 435 (437)
.+|+++|||+.+...
T Consensus 257 ~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 257 TEEILKHPFLSGYTS 271 (786)
T ss_pred HHHHhhCchhhcCCC
Confidence 999999999988654
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=373.38 Aligned_cols=258 Identities=31% Similarity=0.497 Sum_probs=216.4
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
..++|.+.+.||+|+||+||+|+.+.++..||||.+..+.. ..+-...|+.+++.+ .|||||.+++++..++
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-----~H~nIV~l~d~~~~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-----KHPNIVRLLDCIEDDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-----CCcceeeEEEEEecCC
Confidence 35789999999999999999999999999999999975532 233456788888887 6899999999999999
Q ss_pred EEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC-CC---CCEEEEe
Q psy11727 185 HLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP-KR---SAIKIID 259 (437)
Q Consensus 185 ~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~-~~---~~ikL~D 259 (437)
++|||||||. |+|.+++.... .+++..++.|+.||+.||++||++ +||||||||+||||+.+ .+ ..+||+|
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~--~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD 158 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHEN--NIIHRDLKPQNILLSTTARNDTSPVLKIAD 158 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCCcceEEeccCCCCCCCceEEecc
Confidence 9999999995 68999998874 699999999999999999999965 79999999999999764 33 5699999
Q ss_pred CCCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 260 FGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 260 FG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
||+|+..... ..+.|||+.|||||++..+.|+.|+|+||+|+|+|+|++|++||...+..+.+..+.......|.
T Consensus 159 FGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~--- 235 (429)
T KOG0595|consen 159 FGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV--- 235 (429)
T ss_pred cchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc---
Confidence 9999887543 45789999999999999999999999999999999999999999999988887766543222111
Q ss_pred ccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCC
Q psy11727 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKK 417 (437)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 417 (437)
++.++. ..+.+|+...|..||..
T Consensus 236 ------------------------------------~~~~~s---------------------~~~~~Ll~~ll~~~~~~ 258 (429)
T KOG0595|consen 236 ------------------------------------LPAELS---------------------NPLRELLISLLQRNPKD 258 (429)
T ss_pred ------------------------------------hhhhcc---------------------CchhhhhhHHHhcCccc
Confidence 000000 02468999999999999
Q ss_pred CCCHHHHhcCCCcCcCC
Q psy11727 418 RISPTNVLRHEFFLKHS 434 (437)
Q Consensus 418 R~t~~e~l~Hp~~~~~~ 434 (437)
|.+..+-+.|+|+....
T Consensus 259 ~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 259 RISFEDFFDHPFLAANP 275 (429)
T ss_pred cCchHHhhhhhhcccCc
Confidence 99999999999987643
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=398.85 Aligned_cols=300 Identities=30% Similarity=0.529 Sum_probs=234.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCC-CCCcEEEecceeeEC-CEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI-HSRYIVKLKGHFTWK-NHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~-~h~~iv~l~~~~~~~-~~~ 186 (437)
.++|++.+.||+|+||+||+|.+..+++.||||+++...........|+.+++.+.+.+. .|.++++++++|... .++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 578999999999999999999999999999999997544445567789999999887654 456799999998764 589
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCC--------------
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR-------------- 252 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~-------------- 252 (437)
|+|||+++++|.+++... ..+++..++.++.||+.||.|||++ .|||||||||+|||+..+..
T Consensus 208 ~iv~~~~g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~-~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 208 CIVMPKYGPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTE-LHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred EEEEeccCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 999999999999988765 3589999999999999999999963 58999999999999953321
Q ss_pred CCEEEEeCCCceecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy11727 253 SAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332 (437)
Q Consensus 253 ~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p 332 (437)
..+||+|||.++.........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+.+.+|.+
T Consensus 285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~ 364 (467)
T PTZ00284 285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364 (467)
T ss_pred ceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence 25999999998766655667789999999999999999999999999999999999999999999999999999999988
Q ss_pred ChhhhccCCc--cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHc
Q psy11727 333 PGYLLHGASK--TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRM 410 (437)
Q Consensus 333 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~ 410 (437)
|..+...... ...+++....-. ..... ..+..+... ...........+.|||.+|
T Consensus 365 p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~--------~~~~~~~~~-----------~~~~~~~~~~~~~dli~~m 421 (467)
T PTZ00284 365 PSEWAGRCGTEEARLLYNSAGQLR----PCTDP--------KHLARIARA-----------RPVREVIRDDLLCDLIYGL 421 (467)
T ss_pred CHHHHhhccchhHHHHhhhccccc----ccCCH--------HHHHhhhcc-----------cchhhhhchHHHHHHHHHh
Confidence 8877654321 122332211100 00000 000000000 0000011123688999999
Q ss_pred cccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 411 LTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 411 L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
|++||.+|||++|+|+||||++..
T Consensus 422 L~~dP~~R~ta~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 422 LHYDRQKRLNARQMTTHPYVLKYY 445 (467)
T ss_pred CCcChhhCCCHHHHhcCccccccC
Confidence 999999999999999999998853
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=396.13 Aligned_cols=258 Identities=28% Similarity=0.419 Sum_probs=221.7
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
..-.++|.+.++||+|+||+|+++..+.+++.+|||++++.. ........|..+++..+ .||.+++++.+|+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~----~HPFL~~L~~~fQ 439 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN----RHPFLVNLFSCFQ 439 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc----cCCeEeecccccc
Confidence 334678999999999999999999999999999999998653 23455667888888775 8999999999999
Q ss_pred ECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 182 WKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 182 ~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
..+++|.||||+.|+....+.. ...+++..++.|+..|+.||.|||++ |||+||||.+|||| |.+|++||+|||
T Consensus 440 T~~~l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~--~IIYRDlKLdNiLL--D~eGh~kiADFG 513 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHEN--GIIYRDLKLDNLLL--DTEGHVKIADFG 513 (694)
T ss_pred cCCeEEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhc--CceeeecchhheEE--cccCcEEecccc
Confidence 9999999999997754222222 24599999999999999999999965 89999999999999 889999999999
Q ss_pred Cceec---CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 262 SSCHV---GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 262 ~s~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
+++.. +...+++|||+.|+|||++.+..|+.++|+|||||+||||++|++||.|+++++.+..|+..--.-|.++.
T Consensus 514 lcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls- 592 (694)
T KOG0694|consen 514 LCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS- 592 (694)
T ss_pred cccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCccc-
Confidence 99753 66778999999999999999999999999999999999999999999999999999999763222221111
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
.++.++++++|..||++|
T Consensus 593 --------------------------------------------------------------~ea~~il~~ll~k~p~kR 610 (694)
T KOG0694|consen 593 --------------------------------------------------------------KEAIAIMRRLLRKNPEKR 610 (694)
T ss_pred --------------------------------------------------------------HHHHHHHHHHhccCcccc
Confidence 156899999999999999
Q ss_pred CC-----HHHHhcCCCcCcCCCC
Q psy11727 419 IS-----PTNVLRHEFFLKHSVD 436 (437)
Q Consensus 419 ~t-----~~e~l~Hp~~~~~~~~ 436 (437)
.- ++++..||||+..+++
T Consensus 611 LG~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 611 LGSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred cCCCCCCchhhhhCCccccCCHH
Confidence 96 5789999999998875
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=387.63 Aligned_cols=328 Identities=35% Similarity=0.617 Sum_probs=272.3
Q ss_pred CCCCCCcceeecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCC-
Q psy11727 93 HDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR- 171 (437)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~- 171 (437)
-++....|.+..++.+-.+|.+....|+|-|++|.+|.+...|..||||+|++.....+....|+.+|++|+.++....
T Consensus 415 WdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~ 494 (752)
T KOG0670|consen 415 WDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKF 494 (752)
T ss_pred cccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhh
Confidence 4556678999999999999999999999999999999999999999999999998888999999999999998876555
Q ss_pred cEEEecceeeECCEEEEEEEeccCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC
Q psy11727 172 YIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTN-FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP 250 (437)
Q Consensus 172 ~iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~-~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~ 250 (437)
|+++++.+|...+|+|||+|-+..+|.+++++.+ .-++.+..++.+++|++.||..|- ++||+|+||||+|||+. .
T Consensus 495 Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK--~c~vlHaDIKPDNiLVN-E 571 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK--KCGVLHADIKPDNILVN-E 571 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH--hcCeeecccCccceEec-c
Confidence 8999999999999999999999999999998643 457999999999999999999998 67999999999999995 3
Q ss_pred CCCCEEEEeCCCceecCCc-cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q psy11727 251 KRSAIKIIDFGSSCHVGQT-LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVL 329 (437)
Q Consensus 251 ~~~~ikL~DFG~s~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 329 (437)
....+||||||+|...+.. .+.|.-+++|+|||++.|.+|+...|+||.||+||||.||+..|.|.+...++...++.-
T Consensus 572 ~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred CcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 5567999999999887654 456778999999999999999999999999999999999999999999999999999999
Q ss_pred CCCChhhhccCCccchhhcccCCCcceec-ccc-ccccccC----CCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHH
Q psy11727 330 GMPPGYLLHGASKTSKYFDRLSDNSYVLK-KST-DTRKERL----PGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKF 403 (437)
Q Consensus 330 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (437)
|..|..|+..+......|+..-.--|.-- +.. ..+...+ |.-....+++++. .-+..++..-.+|
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q---------~~~deq~~~~~~~ 722 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQ---------RLPDEQPKIVQQL 722 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccC---------CCCchhHHHHHHH
Confidence 99999999888776666665332222111 111 1111111 1112223333221 1233344445578
Q ss_pred HHHHHHccccCCCCCCCHHHHhcCCCcCc
Q psy11727 404 KDLILRMLTYDPKKRISPTNVLRHEFFLK 432 (437)
Q Consensus 404 ~dli~~~L~~dP~~R~t~~e~l~Hp~~~~ 432 (437)
.|||.+||..||++|+|+.|||.||||+.
T Consensus 723 rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 723 RDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 99999999999999999999999999985
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=372.55 Aligned_cols=279 Identities=31% Similarity=0.500 Sum_probs=224.5
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.++|++.+.||.|+||.||+|.+..++..||+|+++... ........|+.++..+ .|+||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-----KHANIVTLHDIIHTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-----CCCCEeeEEEEEcCCCeE
Confidence 467999999999999999999999999999999986432 2233556788887766 789999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
++||||++++|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++...
T Consensus 79 ~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~dlkp~Nil~--~~~~~~kl~DfG~~~~~ 153 (288)
T cd07871 79 TLVFEYLDSDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR--KILHRDLKPQNLLI--NEKGELKLADFGLARAK 153 (288)
T ss_pred EEEEeCCCcCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEE--CCCCCEEECcCcceeec
Confidence 9999999999999887643 3578999999999999999999964 89999999999999 67888999999998765
Q ss_pred CCc---cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
... .....++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.|+...++....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 322 234567899999999876 5689999999999999999999999999999999999999999999888766544
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
...|..... |..+.... . .........++|||.+||++||.+|||++
T Consensus 234 ~~~~~~~~~-----------------~~~~~~~~-~---------------~~~~~~~~~~~dll~~mL~~dp~~R~t~~ 280 (288)
T cd07871 234 NEEFRSYLF-----------------PQYRAQPL-I---------------NHAPRLDTDGIDLLSSLLLYETKSRISAE 280 (288)
T ss_pred chhhhcccc-----------------CccCCCch-H---------------HhCCCCCHHHHHHHHHhcCcCcccCCCHH
Confidence 333322110 00000000 0 00000112578999999999999999999
Q ss_pred HHhcCCCc
Q psy11727 423 NVLRHEFF 430 (437)
Q Consensus 423 e~l~Hp~~ 430 (437)
|+|+||||
T Consensus 281 ~~l~hp~f 288 (288)
T cd07871 281 AALRHSYF 288 (288)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=357.14 Aligned_cols=258 Identities=33% Similarity=0.474 Sum_probs=219.4
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
..|.+.|++.+.||+|.|+.|+++.+..||+.+|+|++..++ .......+|+.|.+.+ .|||||++.+....
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-----qHP~IvrL~~ti~~ 81 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-----QHPNIVRLHDSIQE 81 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-----CCCcEeehhhhhcc
Confidence 356788999999999999999999999999999999986432 2345677788888877 78999999999999
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC-CEEEEeC
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS-AIKIIDF 260 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~-~ikL~DF 260 (437)
..+.|||+|+|.| .|..-|...- -+|+..+..+++||+.||.|+|.+ ||||||+||+|+|+.+.+++ -+||+||
T Consensus 82 ~~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n--~IvHRDvkP~nllLASK~~~A~vKL~~F 157 (355)
T KOG0033|consen 82 ESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSN--GIVHRDLKPENLLLASKAKGAAVKLADF 157 (355)
T ss_pred cceeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhc--CceeccCChhheeeeeccCCCceeeccc
Confidence 9999999999966 6877665542 379999999999999999999965 79999999999999765554 4999999
Q ss_pred CCceecCC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCCCChhhh
Q psy11727 261 GSSCHVGQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV-LGMPPGYLL 337 (437)
Q Consensus 261 G~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~p~~~~~ 337 (437)
|+|...+. ......||+.|||||++...+|+..+|||+.|||||-|+.|.+||.+.+....+++|+.. ...|+..|
T Consensus 158 GvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w- 236 (355)
T KOG0033|consen 158 GLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW- 236 (355)
T ss_pred ceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc-
Confidence 99988753 234678999999999999999999999999999999999999999999999999999875 22232221
Q ss_pred ccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCC
Q psy11727 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKK 417 (437)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 417 (437)
+ ...+..++||++||..||.+
T Consensus 237 ----------~-------------------------------------------------~is~~Ak~LvrrML~~dP~k 257 (355)
T KOG0033|consen 237 ----------D-------------------------------------------------TVTPEAKSLIRRMLTVNPKK 257 (355)
T ss_pred ----------C-------------------------------------------------cCCHHHHHHHHHHhccChhh
Confidence 1 11125689999999999999
Q ss_pred CCCHHHHhcCCCcCc
Q psy11727 418 RISPTNVLRHEFFLK 432 (437)
Q Consensus 418 R~t~~e~l~Hp~~~~ 432 (437)
|+|+.|||+|||+.+
T Consensus 258 RIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 258 RITADEALKHPWICN 272 (355)
T ss_pred hccHHHHhCCchhcc
Confidence 999999999999976
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=377.09 Aligned_cols=261 Identities=32% Similarity=0.477 Sum_probs=224.8
Q ss_pred CceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc----chHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----LNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 105 ~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~----~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
...+...|++.+.||+|.||.||+|+.+.||+.+|+|++.+.... .....+|+.+++.+. .|||||.++++|
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~----~hpniv~l~~~~ 105 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLS----GHPNIVQLKDAF 105 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhcc----CCCCEEEEEEEE
Confidence 345577899999999999999999999999999999999765432 247888999999985 389999999999
Q ss_pred eECCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCC--CCEEE
Q psy11727 181 TWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR--SAIKI 257 (437)
Q Consensus 181 ~~~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~--~~ikL 257 (437)
++.+.+++|||++. |.|++.+... . +++..+..++.|++.|+.|||+ .||+||||||+|+|+.+... +.+|+
T Consensus 106 e~~~~~~lvmEL~~GGeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH~--~gvvHrDlKpEN~L~~~~~~~~~~ik~ 180 (382)
T KOG0032|consen 106 EDPDSVYLVMELCEGGELFDRIVKK--H-YSERDAAGIIRQILEAVKYLHS--LGVVHRDLKPENLLLASKDEGSGRIKL 180 (382)
T ss_pred EcCCeEEEEEEecCCchHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHHh--CCceeccCCHHHeeeccccCCCCcEEE
Confidence 99999999999995 5899988876 2 8999999999999999999995 58999999999999976644 57999
Q ss_pred EeCCCceecCC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 258 IDFGSSCHVGQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 258 ~DFG~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
+|||+|..... .....+||+.|+|||++...+|+..+||||+||++|.|++|.+||.+.+.......|...-...+
T Consensus 181 ~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~-- 258 (382)
T KOG0032|consen 181 IDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFT-- 258 (382)
T ss_pred eeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCC--
Confidence 99999988765 56678999999999999999999999999999999999999999999998888887755321111
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
..+ |...+..+.|||++||..||
T Consensus 259 --------~~~-------------------------------------------------w~~is~~akd~i~~ll~~dp 281 (382)
T KOG0032|consen 259 --------SEP-------------------------------------------------WDDISESAKDFIRKLLEFDP 281 (382)
T ss_pred --------CCC-------------------------------------------------ccccCHHHHHHHHHhcccCc
Confidence 111 11122367999999999999
Q ss_pred CCCCCHHHHhcCCCcCcC
Q psy11727 416 KKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~~ 433 (437)
.+|+|+.++|+|||++..
T Consensus 282 ~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 282 RKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ccCCCHHHHhcCccccCC
Confidence 999999999999999875
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-49 Score=382.17 Aligned_cols=249 Identities=31% Similarity=0.511 Sum_probs=218.6
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc---chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF---LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
++|.+.+.||+|+||.||+|+.+.|.+.||+|.+.+.... .+...+|+.|++.+ .|||||.++++|+...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-----kHpniv~m~esfEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-----KHPNIVEMLESFETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-----CCcchhhHHHhhcccceE
Confidence 6899999999999999999999999999999999754322 33467789898887 789999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
++|+||+.|+|+.++.... .++++.++.++.++..||.|||+. +|+|||+||.|||+ ++.|.+|++|||+|+..
T Consensus 77 ~vVte~a~g~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~--rilhrd~kPqniLl--~~~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSN--RILHRDMKPQNILL--EKGGTLKLCDFGLARAM 150 (808)
T ss_pred EEEehhhhhhHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhc--CcccccCCcceeee--cCCCceeechhhhhhhc
Confidence 9999999999999998764 599999999999999999999965 79999999999999 88999999999999877
Q ss_pred CCcc---ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQTL---YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
+... +...||+.|||||++.+.+|+..+|+||||||+|||++|+|||...+.......|...--.||..+
T Consensus 151 ~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~------- 223 (808)
T KOG0597|consen 151 STNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTA------- 223 (808)
T ss_pred ccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccc-------
Confidence 5542 356899999999999999999999999999999999999999999887777777765433333211
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
...|..||+++|..||.+|+|-.+
T Consensus 224 --------------------------------------------------------S~~f~nfl~gLL~kdP~~RltW~~ 247 (808)
T KOG0597|consen 224 --------------------------------------------------------SSSFVNFLQGLLIKDPAQRLTWTD 247 (808)
T ss_pred --------------------------------------------------------cHHHHHHHHHHhhcChhhcccHHH
Confidence 116899999999999999999999
Q ss_pred HhcCCCcCc
Q psy11727 424 VLRHEFFLK 432 (437)
Q Consensus 424 ~l~Hp~~~~ 432 (437)
++.|||.++
T Consensus 248 Ll~HpF~k~ 256 (808)
T KOG0597|consen 248 LLGHPFWKG 256 (808)
T ss_pred HhcChHHhh
Confidence 999999875
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=367.17 Aligned_cols=285 Identities=31% Similarity=0.472 Sum_probs=218.3
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.++|++.+.||+|+||+||+|.+..+++.||+|++..... ......+|+.++..+ .|+||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-----KHANIVLLHDIIHTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-----CCCCcCeEEEEEecCCeE
Confidence 4689999999999999999999999999999999874322 223456687777766 789999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
++||||++++|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++...
T Consensus 79 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 79 TLVFEYVHTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR--YILHRDLKPQNLLI--SDTGELKLADFGLARAK 153 (303)
T ss_pred EEEEECCCcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEE--CCCCCEEECCCCcceec
Confidence 9999999999998887643 4589999999999999999999964 89999999999999 67888999999998754
Q ss_pred CC---ccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChhhhccCC
Q psy11727 267 GQ---TLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKN-EVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 267 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
.. ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.. ..+.+..+....+.|....++...
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 32 22345678999999998764 58899999999999999999999998754 345667777777777655444332
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
....+. ...+.... ...+...... ......+.|||.+||++||.+|||+
T Consensus 234 ~~~~~~----~~~~~~~~-----------~~~~~~~~~~----------------~~~~~~~~dli~~mL~~dp~~R~s~ 282 (303)
T cd07869 234 SLPHFK----PERFTLYS-----------PKNLRQAWNK----------------LSYVNHAEDLASKLLQCFPKNRLSA 282 (303)
T ss_pred hccccc----cccccccC-----------CccHHHHhhc----------------cCCChHHHHHHHHHhccCchhccCH
Confidence 111100 00000000 0000000000 0001257899999999999999999
Q ss_pred HHHhcCCCcCcCC
Q psy11727 422 TNVLRHEFFLKHS 434 (437)
Q Consensus 422 ~e~l~Hp~~~~~~ 434 (437)
+|||+||||++..
T Consensus 283 ~~~l~h~~f~~~~ 295 (303)
T cd07869 283 QAALSHEYFSDLP 295 (303)
T ss_pred HHHhcCcccccCC
Confidence 9999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=363.46 Aligned_cols=280 Identities=33% Similarity=0.566 Sum_probs=217.6
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
++|++.+.||+|+||+||+|++..+++.||+|++.... ........|+.++..+ .|+||+++++++...+.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-----KQENIVELKEAFRRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-----CCccccchhhhEecCCEE
Confidence 47999999999999999999999999999999987432 2234456677777766 688999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
++||||+++++.+.+.... ..+++..++.++.||+.||.|||+ .||+||||||+||++ +.++.+||+|||++...
T Consensus 76 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dlkp~Nill--~~~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHK--NDIVHRDIKPENLLI--SHNDVLKLCDFGFARNL 150 (287)
T ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEE--cCCCcEEEeeccCcccc
Confidence 9999999988777665543 468999999999999999999995 489999999999999 67888999999999765
Q ss_pred CCc----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 267 GQT----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 267 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
... .....|+..|+|||++.+..++.++|+|||||++|||++|++||.+.+..+....+....+..|...+.....
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 151 SEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred cccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 322 2245789999999999998999999999999999999999999999988888888888777766554432111
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
...+- ....|....... ............+.|||++||++||.+|||++
T Consensus 231 ~~~~~-----------------~~~~~~~~~~~~--------------~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~ 279 (287)
T cd07848 231 NPRFH-----------------GLRFPAVNHPQS--------------LERRYLGILSGVLLDLMKNLLKLNPTDRYLTE 279 (287)
T ss_pred cchhc-----------------ccccCcccCccc--------------HHHhhhcccCHHHHHHHHHHccCCcccCCCHH
Confidence 10000 000000000000 00000001122689999999999999999999
Q ss_pred HHhcCCCc
Q psy11727 423 NVLRHEFF 430 (437)
Q Consensus 423 e~l~Hp~~ 430 (437)
|+|+||||
T Consensus 280 ~~l~hp~f 287 (287)
T cd07848 280 QCLNHPAF 287 (287)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=344.91 Aligned_cols=256 Identities=28% Similarity=0.436 Sum_probs=220.3
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
...++|++.+.||+|-||.||+|+.++++-.||+|++.++. ....+..+|+.+. .++.||||++++++|.+
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIq-----s~L~hpnilrlY~~fhd 93 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQ-----SHLRHPNILRLYGYFHD 93 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEee-----cccCCccHHhhhhheec
Confidence 34678999999999999999999999999999999997433 1223344444444 44589999999999999
Q ss_pred CCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
....||++||.+ |.++..+.......+++..+..++.|++.||.|+|.+ +||||||||+|+|+ +..+.+||+|||
T Consensus 94 ~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k--~VIhRdiKpenlLl--g~~~~lkiAdfG 169 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK--RVIHRDIKPENLLL--GSAGELKIADFG 169 (281)
T ss_pred cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC--CcccCCCCHHHhcc--CCCCCeeccCCC
Confidence 999999999995 5899999977777899999999999999999999965 69999999999999 668889999999
Q ss_pred Cceec-CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 262 SSCHV-GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 262 ~s~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
.|... .....+.|||..|.|||+..+..++..+|+|++|++.||++.|.+||...+..+++++|.+.--..|..+.
T Consensus 170 wsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is--- 246 (281)
T KOG0580|consen 170 WSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTIS--- 246 (281)
T ss_pred ceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccC---
Confidence 99877 44556789999999999999999999999999999999999999999999999999999875332221110
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
....|||.+||..+|.+|.+
T Consensus 247 ------------------------------------------------------------~~a~dlI~~ll~~~p~~r~~ 266 (281)
T KOG0580|consen 247 ------------------------------------------------------------GGAADLISRLLVKNPIERLA 266 (281)
T ss_pred ------------------------------------------------------------hhHHHHHHHHhccCcccccc
Confidence 14689999999999999999
Q ss_pred HHHHhcCCCcCcCC
Q psy11727 421 PTNVLRHEFFLKHS 434 (437)
Q Consensus 421 ~~e~l~Hp~~~~~~ 434 (437)
..|++.|||+....
T Consensus 267 l~~v~~hpwI~a~~ 280 (281)
T KOG0580|consen 267 LTEVMDHPWIVANG 280 (281)
T ss_pred HHHHhhhHHHHhcC
Confidence 99999999997653
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=362.06 Aligned_cols=261 Identities=27% Similarity=0.394 Sum_probs=222.7
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC----cccchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~----~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
..-.++|++++.||+|.-|+||+|....++..+|+|++.+. .....+++.|..||..+ +||.++.|+..|+
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-----DHPFlPTLYa~fe 147 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-----DHPFLPTLYASFE 147 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-----CCCccchhhheee
Confidence 33467899999999999999999999999999999999743 23356777888888887 8999999999999
Q ss_pred ECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 182 WKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 182 ~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
.+++.|+|||||+| +|..+++.+..+.++++.++.++.+++.||+||| -+|||.|||||||||| -++|+|.|+||
T Consensus 148 t~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH--mlGivYRDLKPENILv--redGHIMLsDF 223 (459)
T KOG0610|consen 148 TDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH--MLGIVYRDLKPENILV--REDGHIMLSDF 223 (459)
T ss_pred ccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH--hhceeeccCCcceeEE--ecCCcEEeeec
Confidence 99999999999965 8999999888888999999999999999999999 5799999999999999 78999999999
Q ss_pred CCceecC------------------------------------C-----------------------ccccccccccccC
Q psy11727 261 GSSCHVG------------------------------------Q-----------------------TLYQYIQSRYYRS 281 (437)
Q Consensus 261 G~s~~~~------------------------------------~-----------------------~~~~~~gt~~y~a 281 (437)
.+|.... . ...+++||-.|+|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 9863210 0 0123578889999
Q ss_pred hhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceecccc
Q psy11727 282 PEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKST 361 (437)
Q Consensus 282 PE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (437)
||++.|.+.+.++|+|+||+++|||+.|..||.|.+..+++..|+...-..|..
T Consensus 304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~-------------------------- 357 (459)
T KOG0610|consen 304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE-------------------------- 357 (459)
T ss_pred ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC--------------------------
Confidence 999999999999999999999999999999999999999988886421111100
Q ss_pred ccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC----HHHHhcCCCcCcCCCC
Q psy11727 362 DTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS----PTNVLRHEFFLKHSVD 436 (437)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t----~~e~l~Hp~~~~~~~~ 436 (437)
++....++|||+++|..||.+|.. |.|+-+||||++++|.
T Consensus 358 -----------------------------------~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 358 -----------------------------------PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred -----------------------------------CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 011126799999999999999999 9999999999998874
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=360.52 Aligned_cols=279 Identities=32% Similarity=0.516 Sum_probs=217.8
Q ss_pred cCeeeeceecccCceEEEEEEEcC-CCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE---
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHE-EKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--- 182 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~-~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--- 182 (437)
++|++.+.||+|+||+||+|.+.. ++..||+|.++.... ......+|+.+++.+. .+.||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE--TFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhc--ccCCCCcceEEEEEecccC
Confidence 379999999999999999999854 578899999864321 2234556777766654 3479999999998852
Q ss_pred --CCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 183 --KNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 183 --~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
...+++|||+++++|.+++.......+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~iiH~dlkp~Nil~--~~~~~~kl~Df 154 (290)
T cd07862 79 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILV--TSSGQIKLADF 154 (290)
T ss_pred CCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEE--cCCCCEEEccc
Confidence 457999999999999999887655668999999999999999999996 489999999999999 67888999999
Q ss_pred CCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 261 GSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 261 G~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
|++...... .....||..|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..+.+..+.|....++
T Consensus 155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 999765432 234568999999999999899999999999999999999999999999999999999988877654433
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
..... +...+.... ...+..+. ......+.+||.+||+.||++|
T Consensus 235 ~~~~~-------~~~~~~~~~-----------~~~~~~~~------------------~~~~~~~~~li~~~l~~~P~~R 278 (290)
T cd07862 235 RDVAL-------PRQAFHSKS-----------AQPIEKFV------------------TDIDELGKDLLLKCLTFNPAKR 278 (290)
T ss_pred hhhcc-------cchhccCCC-----------CCCHHHHc------------------cCCCHHHHHHHHHHhccCchhc
Confidence 22110 000000000 00011110 0112257899999999999999
Q ss_pred CCHHHHhcCCCc
Q psy11727 419 ISPTNVLRHEFF 430 (437)
Q Consensus 419 ~t~~e~l~Hp~~ 430 (437)
||+.|+|+||||
T Consensus 279 ~s~~~~l~hp~f 290 (290)
T cd07862 279 ISAYSALSHPYF 290 (290)
T ss_pred CCHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=356.01 Aligned_cols=217 Identities=30% Similarity=0.446 Sum_probs=183.9
Q ss_pred CceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC---cccchHHHHHHHHHHHhhhcCCCCCcEEEecc-ee
Q psy11727 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK---KPFLNQAQIEVQLLEKINKADIHSRYIVKLKG-HF 180 (437)
Q Consensus 105 ~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~-~~ 180 (437)
+..-..+|+|.++||+|+||+||++.+..+|..+|.|.+.-. .........|+.+++.+ .|||||++++ .|
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-----~HpNIVqYy~~~f 88 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-----NHPNIVQYYAHSF 88 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-----CCchHHHHHHHhh
Confidence 344467899999999999999999999999999999998632 22234556688888887 7899999999 45
Q ss_pred eECCE-EEEEEEecc-CcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhcC--CCCCeeeCCCCCCcEEEecCCCCC
Q psy11727 181 TWKNH-LCLVFELLS-YNLYNLIRN--TNFHGVSLNLTKKFAQQLCCALAFLSS--PELSIIHCDLKPENILLCSPKRSA 254 (437)
Q Consensus 181 ~~~~~-~~lV~E~~~-~~L~~~l~~--~~~~~ls~~~~~~i~~qi~~aL~~LH~--~~~giiHrDiKp~NIll~~~~~~~ 254 (437)
..++. ++||||+|+ |+|.+.++. ...+.+++..+|+++.|++.||..+|+ .+--|+||||||.||+| +.+|.
T Consensus 89 ~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl--~~~gv 166 (375)
T KOG0591|consen 89 IEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL--TANGV 166 (375)
T ss_pred hccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE--cCCCc
Confidence 55554 999999995 588888753 233569999999999999999999998 33238999999999999 78999
Q ss_pred EEEEeCCCceecCCcc---ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q psy11727 255 IKIIDFGSSCHVGQTL---YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV 328 (437)
Q Consensus 255 ikL~DFG~s~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 328 (437)
+||+|||+++.++... .+++|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.|++-.+.-.+|..+
T Consensus 167 vKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg 243 (375)
T KOG0591|consen 167 VKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG 243 (375)
T ss_pred eeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC
Confidence 9999999998886543 4689999999999999999999999999999999999999999999877777777654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=366.33 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=211.3
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+..|+.++..+ .||||+++++++.+.++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-----SHPFIIRLFWTEHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-----CCCcHhhhHhhhccCCe
Confidence 47999999999999999999999999999999986422 1223455677777665 78999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+++||||+++ +|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~NIli--~~~~~~kl~Dfg~~~ 149 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSK--EIVYRDLKPENILL--DKEGHIKLTDFGFAK 149 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHeEE--CCCCCEEEEecCcch
Confidence 9999999965 8988887653 589999999999999999999964 89999999999999 678899999999998
Q ss_pred ecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc
Q psy11727 265 HVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344 (437)
Q Consensus 265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 344 (437)
.........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....-..|.
T Consensus 150 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~---------- 219 (291)
T cd05612 150 KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR---------- 219 (291)
T ss_pred hccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc----------
Confidence 7766556678999999999999999999999999999999999999999998877776666432100000
Q ss_pred hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC----
Q psy11727 345 KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS---- 420 (437)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t---- 420 (437)
.....+.+||++||+.||.+|++
T Consensus 220 -----------------------------------------------------~~~~~~~~li~~~l~~dp~~R~~~~~~ 246 (291)
T cd05612 220 -----------------------------------------------------HLDLYAKDLIKKLLVVDRTRRLGNMKN 246 (291)
T ss_pred -----------------------------------------------------cCCHHHHHHHHHHcCCCHHHccCCccC
Confidence 00115789999999999999995
Q ss_pred -HHHHhcCCCcCcCCC
Q psy11727 421 -PTNVLRHEFFLKHSV 435 (437)
Q Consensus 421 -~~e~l~Hp~~~~~~~ 435 (437)
++++++||||+....
T Consensus 247 ~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 247 GADDVKNHRWFKSVDW 262 (291)
T ss_pred CHHHHhcCccccCCCH
Confidence 999999999987543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=364.16 Aligned_cols=253 Identities=28% Similarity=0.475 Sum_probs=202.7
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC--EE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN--HL 186 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~--~~ 186 (437)
.++...+.||+|+||+||++.+..+|+..|||.+.... ...+....|+.++..+ .|||||+++|...... .+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-----~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-----NHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-----CCCCEEeeCCccccccCeee
Confidence 45888999999999999999999999999999986432 1145578899999888 5899999999855544 79
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC-CCCEEEEeCCCce
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK-RSAIKIIDFGSSC 264 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~-~~~ikL~DFG~s~ 264 (437)
++.|||+++ +|.+++..... .++++.++.+++||+.||+|||++ |||||||||+|||+ +. ++.+||+|||++.
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~--g~vH~DiK~~NiLl--~~~~~~~KlaDFG~a~ 166 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK--GIVHCDIKPANILL--DPSNGDVKLADFGLAK 166 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC--CEeccCcccceEEE--eCCCCeEEeccCcccc
Confidence 999999965 89999988765 799999999999999999999965 89999999999999 55 6889999999987
Q ss_pred ecCC------ccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCChhh
Q psy11727 265 HVGQ------TLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGK-NEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 265 ~~~~------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~p~~~~ 336 (437)
.... ......||+.|||||++..+ ....++|||||||++.||+||.+||... ...+.+-.+......|
T Consensus 167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P---- 242 (313)
T KOG0198|consen 167 KLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP---- 242 (313)
T ss_pred ccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC----
Confidence 6542 23357899999999999953 3345999999999999999999999874 3222222222111011
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
.+|.+ -....++||.+||..||.
T Consensus 243 ------------------------------~ip~~---------------------------ls~~a~~Fl~~C~~~~p~ 265 (313)
T KOG0198|consen 243 ------------------------------EIPDS---------------------------LSDEAKDFLRKCFKRDPE 265 (313)
T ss_pred ------------------------------CCCcc---------------------------cCHHHHHHHHHHhhcCcc
Confidence 00000 111568999999999999
Q ss_pred CCCCHHHHhcCCCcCcC
Q psy11727 417 KRISPTNVLRHEFFLKH 433 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~~~~ 433 (437)
+||||.++|+|||+++.
T Consensus 266 ~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 266 KRPTAEELLEHPFLKQN 282 (313)
T ss_pred cCcCHHHHhhChhhhcc
Confidence 99999999999999764
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=372.20 Aligned_cols=253 Identities=27% Similarity=0.415 Sum_probs=213.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ .||||+++++++.+.+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-----SHPFIVNMMCSFQDEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-----CCCCCCcEEEEEEcCC
Confidence 578999999999999999999999999999999996432 1223456677777665 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+|+||||+.+ +|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~dlkp~NIll--~~~~~~kl~Dfg~~ 165 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSK--DIIYRDLKPENLLL--DNKGHVKVTDFGFA 165 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHEEE--CCCCCEEEeeccCc
Confidence 99999999965 8888887653 589999999999999999999964 89999999999999 77889999999999
Q ss_pred eecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 264 CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
..........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+....-..|
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p---------- 235 (329)
T PTZ00263 166 KKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP---------- 235 (329)
T ss_pred eEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC----------
Confidence 8877666677899999999999999999999999999999999999999998887766666543110000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC---
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS--- 420 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t--- 420 (437)
.+ ....+.+||.+||+.||.+|++
T Consensus 236 --------------------------~~---------------------------~~~~~~~li~~~L~~dP~~R~~~~~ 262 (329)
T PTZ00263 236 --------------------------NW---------------------------FDGRARDLVKGLLQTDHTKRLGTLK 262 (329)
T ss_pred --------------------------CC---------------------------CCHHHHHHHHHHhhcCHHHcCCCCC
Confidence 00 0015689999999999999997
Q ss_pred --HHHHhcCCCcCcCCC
Q psy11727 421 --PTNVLRHEFFLKHSV 435 (437)
Q Consensus 421 --~~e~l~Hp~~~~~~~ 435 (437)
+++++.||||.+..+
T Consensus 263 ~~~~~ll~hp~f~~~~~ 279 (329)
T PTZ00263 263 GGVADVKNHPYFHGANW 279 (329)
T ss_pred CCHHHHhcCCccCCCCH
Confidence 799999999987543
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=380.47 Aligned_cols=279 Identities=34% Similarity=0.607 Sum_probs=217.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC-----
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK----- 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~----- 183 (437)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.+ .|+|||+++++|...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l-----~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNL-----NHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhc-----CCCCCcceeeeEeecccccC
Confidence 468999999999999999999999999999999886432 2345688888776 789999998887532
Q ss_pred ---CEEEEEEEeccCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 184 ---NHLCLVFELLSYNLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 184 ---~~~~lV~E~~~~~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
.++++||||++++|.+++... ....+++..++.++.||+.||+|||++ ||+||||||+|||++. ..+.+||+
T Consensus 137 ~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~--~IiHrDLKp~NILl~~-~~~~vkL~ 213 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK--FICHRDLKPQNLLIDP-NTHTLKLC 213 (440)
T ss_pred CCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCcCHHHEEEcC-CCCceeee
Confidence 367899999999998877542 234689999999999999999999964 8999999999999932 33469999
Q ss_pred eCCCceecC--CccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 259 DFGSSCHVG--QTLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 259 DFG~s~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
|||+|.... ......+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+.+++..++.|+..
T Consensus 214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 999997653 333456889999999998764 68999999999999999999999999999999999999999988776
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCC--CCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPG--SKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
.+...... | ..+ ..|. ...+...+ +. .....+++||.+||++
T Consensus 294 ~~~~~~~~--~-~~~----------------~~~~~~~~~l~~~~--------------p~---~~~~~~~~li~~~L~~ 337 (440)
T PTZ00036 294 QLKEMNPN--Y-ADI----------------KFPDVKPKDLKKVF--------------PK---GTPDDAINFISQFLKY 337 (440)
T ss_pred HHHHhchh--h-hcc----------------cCCccCchhHHHHh--------------cc---CCCHHHHHHHHHHCCC
Confidence 55432210 0 000 0000 00011000 00 0112578999999999
Q ss_pred CCCCCCCHHHHhcCCCcCcCC
Q psy11727 414 DPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 414 dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
||.+|||+.|+|+||||+...
T Consensus 338 dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 338 EPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred ChhHCcCHHHHhCChhHHhhh
Confidence 999999999999999997643
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=369.69 Aligned_cols=292 Identities=33% Similarity=0.548 Sum_probs=221.3
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+.++|++.+.||+|+||.||+|.+..++..||+|++.... .......+|+.++..+ .|+||++++++|...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~ 92 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-----NHKNIISLLNVFTPQ 92 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-----CCCCEeeeeeeeccC
Confidence 45689999999999999999999999999999999986431 2233455677766655 789999999998754
Q ss_pred C------EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 184 N------HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 184 ~------~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
+ .+|+||||++++|.+.+.. .+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||
T Consensus 93 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~--~ivHrDlkp~NIl~--~~~~~~kl 164 (359)
T cd07876 93 KSLEEFQDVYLVMELMDANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVV--KSDCTLKI 164 (359)
T ss_pred CCccccceeEEEEeCCCcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEE--CCCCCEEE
Confidence 3 5799999999998887643 378899999999999999999964 89999999999999 67889999
Q ss_pred EeCCCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 258 IDFGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 258 ~DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+.+.++.|+..
T Consensus 165 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 244 (359)
T cd07876 165 LDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 244 (359)
T ss_pred ecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence 999999754322 234578999999999999999999999999999999999999999999888999999999888876
Q ss_pred hhccCCccc-hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 336 LLHGASKTS-KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 336 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
++....... .+....+. +.-.. .....+.+ + .| .....+......+++||.+||++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~------~-----~~-----~~~~~~~~~~~~~~~li~~mL~~d 302 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQ--YPGIS----FEELFPDW------I-----FP-----SESERDKLKTSQARDLLSKMLVID 302 (359)
T ss_pred HHHHHHHHHHHHHhhCCC--CCCcc----hhhhcccc------c-----cc-----cccccccccchhHHHHHHHHhccC
Confidence 654433221 11111000 00000 00000000 0 00 000001111235789999999999
Q ss_pred CCCCCCHHHHhcCCCcCcC
Q psy11727 415 PKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~~~~ 433 (437)
|.+|||+.|+|+||||+.+
T Consensus 303 P~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 303 PDKRISVDEALRHPYITVW 321 (359)
T ss_pred cccCCCHHHHhcCchhhhh
Confidence 9999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=349.20 Aligned_cols=260 Identities=30% Similarity=0.518 Sum_probs=218.0
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---------ccchHHHHHHHHHHHhhhcCCCCCcEEEe
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---------PFLNQAQIEVQLLEKINKADIHSRYIVKL 176 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---------~~~~~~~~e~~~~~~l~~~~~~h~~iv~l 176 (437)
+.+.++|.-.+.||+|..+.|.+|..+.+|..+|+|++.... .....-..|+.+++.+. .||+|+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~----GHP~II~l 88 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVM----GHPYIIDL 88 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhc----CCCcEEEe
Confidence 445678999999999999999999999999999999986221 11223345888888875 89999999
Q ss_pred cceeeECCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCE
Q psy11727 177 KGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAI 255 (437)
Q Consensus 177 ~~~~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~i 255 (437)
.++|+.+..+++|+|+|+ |.|+|++...- .+|+..+++|++|++.++.|||.. .||||||||+|||+ +++.+|
T Consensus 89 ~D~yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~--~IVHRDLKpENILl--ddn~~i 162 (411)
T KOG0599|consen 89 QDVYESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHAR--NIVHRDLKPENILL--DDNMNI 162 (411)
T ss_pred eeeccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHh--hhhhcccChhheee--ccccce
Confidence 999999999999999995 58999998763 599999999999999999999965 69999999999999 788899
Q ss_pred EEEeCCCceec--CCccccccccccccChhhhcC------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q psy11727 256 KIIDFGSSCHV--GQTLYQYIQSRYYRSPEVLLG------IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327 (437)
Q Consensus 256 kL~DFG~s~~~--~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 327 (437)
||+|||+|+.+ +......|||++|+|||.+.. .+|+..+|+|++|||||.|+.|.|||......-++..|++
T Consensus 163 ~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime 242 (411)
T KOG0599|consen 163 KISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME 242 (411)
T ss_pred EEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh
Confidence 99999999987 566778999999999999963 3688999999999999999999999998888788888876
Q ss_pred HhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHH
Q psy11727 328 VLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLI 407 (437)
Q Consensus 328 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 407 (437)
+. |.+.++... .. ....+|||
T Consensus 243 Gk-------------------------yqF~speWa---------di-------------------------s~~~KdLI 263 (411)
T KOG0599|consen 243 GK-------------------------YQFRSPEWA---------DI-------------------------SATVKDLI 263 (411)
T ss_pred cc-------------------------cccCCcchh---------hc-------------------------cccHHHHH
Confidence 42 222221111 00 01458999
Q ss_pred HHccccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 408 LRMLTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 408 ~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
.+||+.||.+|+|++|+|.||||.+.+
T Consensus 264 srlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 264 SRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred HHHHeeCchhcccHHHHhcChHHHHHH
Confidence 999999999999999999999996643
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=366.32 Aligned_cols=280 Identities=31% Similarity=0.524 Sum_probs=219.4
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC----
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK---- 183 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~---- 183 (437)
+|++.+.||+|+||.||+|++..++..||||++.... ....++..|+.++..+ .||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-----RHPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-----CCCCEeeecceEeccCCCC
Confidence 5899999999999999999999999999999986321 1223456687777766 789999999988643
Q ss_pred -CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 -NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 -~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
..+|+||||++++|.+++.... .+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||+
T Consensus 76 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIll--~~~~~~kL~Dfg~ 149 (338)
T cd07859 76 FKDIYVVFELMESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTA--NVFHRDLKPKNILA--NADCKLKICDFGL 149 (338)
T ss_pred CceEEEEEecCCCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEE--CCCCcEEEccCcc
Confidence 3589999999999999887653 589999999999999999999964 89999999999999 7788999999999
Q ss_pred ceecCCc------cccccccccccChhhhcC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 263 SCHVGQT------LYQYIQSRYYRSPEVLLG--IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 263 s~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
+...... .....||..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+.+..+.|+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 229 (338)
T cd07859 150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229 (338)
T ss_pred ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 8754221 124578999999999876 57899999999999999999999999999988888889888998887
Q ss_pred hhhccCCcc--chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc
Q psy11727 335 YLLHGASKT--SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412 (437)
Q Consensus 335 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 412 (437)
......... ..++..+... .+ ..+... .+ .....+.+||.+||+
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~--------------~~--~~~~~~--------------~~----~~~~~~~~li~~~l~ 275 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKK--------------QP--VPFSQK--------------FP----NADPLALRLLERLLA 275 (338)
T ss_pred HHHHHhhhhhHHHHHHhhccc--------------CC--CchHHh--------------cC----CCChHHHHHHHHHcC
Confidence 765433211 1111111000 00 000000 00 011257899999999
Q ss_pred cCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 413 YDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 413 ~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
.||++|||++|+++||||++...
T Consensus 276 ~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 276 FDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred cCcccCCCHHHHhcCchhhhcCc
Confidence 99999999999999999987543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=374.11 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=210.9
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccch-HHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLN-QAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~-~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
...|.....||+|+.|.||.|....+++.||||.+....+..+ -...|+.+++. .+|+|||.+++.|...+.++
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~-----~~H~NiVnfl~Sylv~deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRD-----LHHPNIVNFLDSYLVGDELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHh-----ccchHHHHHHHHhcccceeE
Confidence 4579999999999999999999999999999999975433322 33445555554 48999999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+|||||.| +|.+.+.... +++.++..|+++++.||+|||.+ ||||||||.+|||+ ..+|.+||+|||++..+
T Consensus 347 VVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~--gIiHrDIKSDnILL--~~~g~vKltDFGFcaqi 419 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHAR--GIIHRDIKSDNILL--TMDGSVKLTDFGFCAQI 419 (550)
T ss_pred EEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhc--ceeeeccccceeEe--ccCCcEEEeeeeeeecc
Confidence 99999955 7888877764 89999999999999999999964 89999999999999 66788999999999776
Q ss_pred CC---ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQ---TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.. ...+.+||++|||||++....|+++.||||||+++.||+-|+|||-..+....+..|.. .|.|.-.
T Consensus 420 ~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk-------- 490 (550)
T KOG0578|consen 420 SEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLK-------- 490 (550)
T ss_pred ccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcC--------
Confidence 43 34578999999999999999999999999999999999999999998888777766643 2222100
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
+.......|+|||.+||+.||.+|+||.|
T Consensus 491 ---------------------------------------------------~~~klS~~~kdFL~~cL~~dv~~RasA~e 519 (550)
T KOG0578|consen 491 ---------------------------------------------------NPEKLSPELKDFLDRCLVVDVEQRASAKE 519 (550)
T ss_pred ---------------------------------------------------CccccCHHHHHHHHHHhhcchhcCCCHHH
Confidence 00001126899999999999999999999
Q ss_pred HhcCCCcCcC
Q psy11727 424 VLRHEFFLKH 433 (437)
Q Consensus 424 ~l~Hp~~~~~ 433 (437)
+|+||||+..
T Consensus 520 LL~HpFl~~a 529 (550)
T KOG0578|consen 520 LLEHPFLKMA 529 (550)
T ss_pred HhcChhhhhc
Confidence 9999999643
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=358.65 Aligned_cols=256 Identities=29% Similarity=0.427 Sum_probs=205.0
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
|++.+.||+|+||+||+|.+..+++.||+|.+..... ....+..|+.++..+ .|++|+++++++.+.++++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~~~~iv~~~~~~~~~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-----NSRFVVSLAYAYETKDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-----CCCcEEEEEEEEccCCeEE
Confidence 7889999999999999999999999999999864321 112345677777665 6889999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|.+++.......+++..+..++.||+.||+|||+ .||+||||||+|||+ ++++.++|+|||++...
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nill--~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPENILL--DDRGHIRISDLGLAVQI 152 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEE--CCCCCEEEeeCCCcEEc
Confidence 99999965 78777765444568999999999999999999995 489999999999999 67888999999999765
Q ss_pred CC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc
Q psy11727 267 GQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344 (437)
Q Consensus 267 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 344 (437)
.. ......||..|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+......+...
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------- 223 (285)
T cd05631 153 PEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEE--------- 223 (285)
T ss_pred CCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccccc---------
Confidence 32 2334678999999999999999999999999999999999999998876543333332211110000
Q ss_pred hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC----
Q psy11727 345 KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS---- 420 (437)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t---- 420 (437)
+. ......+.+||++||+.||.+|||
T Consensus 224 -~~-------------------------------------------------~~~s~~~~~li~~~l~~~P~~R~~~~~~ 253 (285)
T cd05631 224 -YS-------------------------------------------------EKFSEDAKSICRMLLTKNPKERLGCRGN 253 (285)
T ss_pred -CC-------------------------------------------------ccCCHHHHHHHHHHhhcCHHHhcCCCCC
Confidence 00 000125789999999999999997
Q ss_pred -HHHHhcCCCcCcCCC
Q psy11727 421 -PTNVLRHEFFLKHSV 435 (437)
Q Consensus 421 -~~e~l~Hp~~~~~~~ 435 (437)
++++++||||++.+.
T Consensus 254 ~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 254 GAAGVKQHPIFKNINF 269 (285)
T ss_pred CHHHHhcCHhhcCCCH
Confidence 899999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=359.85 Aligned_cols=282 Identities=30% Similarity=0.492 Sum_probs=224.3
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.++|.+.+.||+|+||+||+|.+..+++.||+|.++.... .......|+.++..+ .|+||+++++++..++..
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 79 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-----KHANIVTLHDIVHTDKSL 79 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-----CCCCcceEEEEEeeCCeE
Confidence 4679999999999999999999999999999999874322 223455677777766 689999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
++||||++++|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++...
T Consensus 80 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~--~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~ 154 (309)
T cd07872 80 TLVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR--KVLHRDLKPQNLLI--NERGELKLADFGLARAK 154 (309)
T ss_pred EEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEE--CCCCCEEECccccceec
Confidence 9999999999998887653 3589999999999999999999964 89999999999999 67888999999998765
Q ss_pred CCc---cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
... .....++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.|+...++....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 155 SVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred CCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 322 223467889999999875 4688999999999999999999999999999999999999999988877765443
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
...+.+. . .+.... .............+.|||.+||++||.+|||+.
T Consensus 235 ~~~~~~~-~----------------~~~~~~----------------~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 281 (309)
T cd07872 235 NDEFKNY-N----------------FPKYKP----------------QPLINHAPRLDTEGIELLTKFLQYESKKRISAE 281 (309)
T ss_pred hhhhhhh-h----------------cCccCC----------------CchhhhccCCCHHHHHHHHHhccCChhhCCCHH
Confidence 3222110 0 000000 000000001112578999999999999999999
Q ss_pred HHhcCCCcCcC
Q psy11727 423 NVLRHEFFLKH 433 (437)
Q Consensus 423 e~l~Hp~~~~~ 433 (437)
|+++||||+..
T Consensus 282 e~l~h~~~~~~ 292 (309)
T cd07872 282 EAMKHAYFRSL 292 (309)
T ss_pred HHhcChhhhhc
Confidence 99999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=362.97 Aligned_cols=261 Identities=29% Similarity=0.413 Sum_probs=215.1
Q ss_pred cCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---------------cchHHHHHHHHHHHhhhcCC
Q psy11727 104 HGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---------------FLNQAQIEVQLLEKINKADI 168 (437)
Q Consensus 104 ~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---------------~~~~~~~e~~~~~~l~~~~~ 168 (437)
.+.+..+.|++.+.||+|.||.|.+|++..+++.||||++.++.. ..+...+|+.+++++
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl----- 165 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL----- 165 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-----
Confidence 345667899999999999999999999999999999999964321 124677899998887
Q ss_pred CCCcEEEecceeeEC--CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q psy11727 169 HSRYIVKLKGHFTWK--NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENIL 246 (437)
Q Consensus 169 ~h~~iv~l~~~~~~~--~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIl 246 (437)
+|+|||+|+++..+. +.+|||+|||..+-..+..... ..+++.++++|++.++.||+|||.+ |||||||||+|+|
T Consensus 166 ~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~-~els~~~Ar~ylrDvv~GLEYLH~Q--giiHRDIKPsNLL 242 (576)
T KOG0585|consen 166 HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK-PELSEQQARKYLRDVVLGLEYLHYQ--GIIHRDIKPSNLL 242 (576)
T ss_pred CCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCc-ccccHHHHHHHHHHHHHHHHHHHhc--CeeccccchhheE
Confidence 789999999998764 5899999999876555544332 1289999999999999999999986 7999999999999
Q ss_pred EecCCCCCEEEEeCCCceecCC--------ccccccccccccChhhhcCCC----CCCcchHHHHHHHHHHHHhCCCCCC
Q psy11727 247 LCSPKRSAIKIIDFGSSCHVGQ--------TLYQYIQSRYYRSPEVLLGIP----YDLAIDMWSLGCILVELHTGEPLFS 314 (437)
Q Consensus 247 l~~~~~~~ikL~DFG~s~~~~~--------~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~elltg~~pf~ 314 (437)
| +++|.|||+|||.+..... ......||+.|+|||...+.. -+.+.||||+||+||.|+.|+.||-
T Consensus 243 l--~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 243 L--SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred E--cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 9 6679999999999986521 223478999999999998732 3478999999999999999999999
Q ss_pred CCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCC
Q psy11727 315 GKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPG 394 (437)
Q Consensus 315 ~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (437)
++...+.+.+|+..--..| .
T Consensus 321 ~~~~~~l~~KIvn~pL~fP----------------------------------------------------~-------- 340 (576)
T KOG0585|consen 321 DDFELELFDKIVNDPLEFP----------------------------------------------------E-------- 340 (576)
T ss_pred cchHHHHHHHHhcCcccCC----------------------------------------------------C--------
Confidence 9999999999976311111 0
Q ss_pred CChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 395 HSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 395 ~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
.++.++.++|||.+||+.||.+|+|..++..|||.++.-+
T Consensus 341 -~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 341 -NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred -cccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 0123447899999999999999999999999999987643
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=354.61 Aligned_cols=278 Identities=32% Similarity=0.532 Sum_probs=218.9
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE-----
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW----- 182 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~----- 182 (437)
+|++.+.||+|+||+||+|.+..+++.||+|.++... ........|+.+++.+.. +.|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEA--FDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhh--cCCCCeeeeeeeeccccCCC
Confidence 5899999999999999999999999999999987432 122345667777777643 479999999998864
Q ss_pred CCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 183 KNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 183 ~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
...+++|||+++++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dikp~Nili--~~~~~~kl~dfg~ 154 (288)
T cd07863 79 ETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN--CIVHRDLKPENILV--TSGGQVKLADFGL 154 (288)
T ss_pred CceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEE--CCCCCEEECccCc
Confidence 3468999999999999988776555699999999999999999999964 89999999999999 6788899999999
Q ss_pred ceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 263 SCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 263 s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
+...... .....++..|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+.++....+.+....++..
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 155 ARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 9765432 23456789999999999989999999999999999999999999999988889999888887765444321
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
.... ...+... ....+..+ .......+.|||.+||++||.+|||
T Consensus 235 ~~~~-------~~~~~~~-----------~~~~~~~~------------------~~~~~~~~~~li~~~L~~dP~~R~t 278 (288)
T cd07863 235 VTLP-------RGAFSPR-----------GPRPVQSV------------------VPEIEESGAQLLLEMLTFNPHKRIS 278 (288)
T ss_pred cccc-------ccccCCC-----------CCCchHHh------------------CcCcCHHHHHHHHHHhccCcccCCC
Confidence 1100 0000000 00000000 0011225789999999999999999
Q ss_pred HHHHhcCCCc
Q psy11727 421 PTNVLRHEFF 430 (437)
Q Consensus 421 ~~e~l~Hp~~ 430 (437)
+.|++.||||
T Consensus 279 ~~~~l~hp~f 288 (288)
T cd07863 279 AFRALQHPFF 288 (288)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=368.40 Aligned_cols=253 Identities=30% Similarity=0.443 Sum_probs=211.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCC-eEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEK-CQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~-~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.++|.+.+.||+|+||.||+|.+..++ ..||+|++.... .....+..|+.++..+ .||||+++++++.+.
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-----NHPFCVNLYGSFKDE 103 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-----CCCCCcceEEEEEeC
Confidence 568999999999999999999876654 689999986321 2233455677777665 789999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+++|+||||+++ +|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl--~~~~~ikL~DFG~ 177 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQS--LNIVYRDLKPENLLL--DKDGFIKMTDFGF 177 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEE--CCCCCEEEecCCC
Confidence 999999999955 7888887653 58999999999999999999995 489999999999999 6788999999999
Q ss_pred ceecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 263 SCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 263 s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
+........+.+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+.+.......+.......|..
T Consensus 178 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~------- 250 (340)
T PTZ00426 178 AKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKF------- 250 (340)
T ss_pred CeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCC-------
Confidence 9887666667789999999999999899999999999999999999999999988776666664321111100
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC---
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI--- 419 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~--- 419 (437)
....+.+||++||+.||.+|+
T Consensus 251 --------------------------------------------------------~~~~~~~li~~~l~~dp~~R~~~~ 274 (340)
T PTZ00426 251 --------------------------------------------------------LDNNCKHLMKKLLSHDLTKRYGNL 274 (340)
T ss_pred --------------------------------------------------------CCHHHHHHHHHHcccCHHHcCCCC
Confidence 001568999999999999996
Q ss_pred --CHHHHhcCCCcCcCCC
Q psy11727 420 --SPTNVLRHEFFLKHSV 435 (437)
Q Consensus 420 --t~~e~l~Hp~~~~~~~ 435 (437)
|++++++||||++..+
T Consensus 275 ~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 275 KKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred CCCHHHHHcCCCcCCCCH
Confidence 8999999999987653
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=367.39 Aligned_cols=290 Identities=31% Similarity=0.532 Sum_probs=222.9
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC-
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK- 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~- 183 (437)
+.++|.+.+.||+|+||.||+|++..+++.||||++.... .......+|+.+++.+ .|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKNIIGLLNVFTPQK 96 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-----CCCCccccceeecccc
Confidence 4689999999999999999999999999999999986432 2223455677666655 789999999887643
Q ss_pred -----CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 184 -----NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 184 -----~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
..+|+||||++++|.+.+.. .+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dlkp~NIll--~~~~~~kL~ 168 (364)
T cd07875 97 SLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVV--KSDCTLKIL 168 (364)
T ss_pred cccccCeEEEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC--CeecCCCCHHHEEE--CCCCcEEEE
Confidence 36899999999999888754 378899999999999999999964 89999999999999 678889999
Q ss_pred eCCCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 259 DFGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 259 DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
|||++...... .....+|..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.+..+.|...+
T Consensus 169 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred eCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99999766443 2345789999999999999999999999999999999999999999999999999999999888776
Q ss_pred hccCCccc-hhhcccCCC-cceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 337 LHGASKTS-KYFDRLSDN-SYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 337 ~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
+....... .+....+.- .+. ...+ .+..........+......++|||.+||++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~------~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 305 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYS-----------------FEKL------FPDVLFPADSEHNKLKASQARDLLSKMLVID 305 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCC-----------------hHhh------CccccccccccccccccHHHHHHHHHhcCcC
Confidence 65443321 111111000 000 0000 0000000001111112236789999999999
Q ss_pred CCCCCCHHHHhcCCCcCcC
Q psy11727 415 PKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~~~~ 433 (437)
|.+|||+.|+|+||||..+
T Consensus 306 P~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 306 ASKRISVDEALQHPYINVW 324 (364)
T ss_pred cccCCCHHHHhcCcccccc
Confidence 9999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=355.20 Aligned_cols=263 Identities=29% Similarity=0.432 Sum_probs=214.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+.|++.+.||.|..++||+|+...+++.||||++...+ ...+....|+..+..+ +||||++++..|..++.+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-----~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-----DHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-----CCCCcceEEEEEEeccee
Confidence 468999999999999999999999999999999997432 2345667777777766 899999999999999999
Q ss_pred EEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++||.||. |+++++++..-..++++..+..|.+++++||.|||. .|.||||||+.|||| +.+|.|||+|||.+-.
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~--~G~IHRdvKAgnILi--~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ--NGHIHRDVKAGNILI--DSDGTVKLADFGVSAS 175 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh--cCceecccccccEEE--cCCCcEEEcCceeeee
Confidence 99999995 589999988766789999999999999999999995 489999999999999 8899999999998754
Q ss_pred cC---Cc----cccccccccccChhhhcC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 266 VG---QT----LYQYIQSRYYRSPEVLLG--IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 266 ~~---~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
+- .. ..+.+||+.|||||++.. .+|+.|+||||||++..||.+|..||.......++- +...+.||...
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl--~tLqn~pp~~~ 253 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL--LTLQNDPPTLL 253 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH--HHhcCCCCCcc
Confidence 31 11 145689999999999653 479999999999999999999999999877655443 33445555322
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
....+... + ++ -...|+++|..||+.||.
T Consensus 254 t~~~~~d~-------~-----------k~---------------------------------~~ksf~e~i~~CL~kDP~ 282 (516)
T KOG0582|consen 254 TSGLDKDE-------D-----------KK---------------------------------FSKSFREMIALCLVKDPS 282 (516)
T ss_pred cccCChHH-------h-----------hh---------------------------------hcHHHHHHHHHHhhcCcc
Confidence 11100000 0 00 001689999999999999
Q ss_pred CCCCHHHHhcCCCcCcC
Q psy11727 417 KRISPTNVLRHEFFLKH 433 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~~~~ 433 (437)
+|||+.++|+|+||++.
T Consensus 283 kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 283 KRPTASKLLKHAFFKKA 299 (516)
T ss_pred cCCCHHHHhccHHHhhc
Confidence 99999999999999875
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=365.13 Aligned_cols=291 Identities=32% Similarity=0.523 Sum_probs=223.4
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC-
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK- 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~- 183 (437)
+.++|++.+.||+|+||.||+|.+..+++.||||.+.... .......+|+.+++.+ .|+||++++++|...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~ 89 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKNIISLLNVFTPQK 89 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-----CCCchhceeeeeeccc
Confidence 4689999999999999999999999999999999986432 1223455677776665 789999999988654
Q ss_pred -----CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 184 -----NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 184 -----~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
..+|+||||+++++.+.+.. .+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~--givHrDikp~Nill--~~~~~~kl~ 161 (355)
T cd07874 90 SLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVV--KSDCTLKIL 161 (355)
T ss_pred cccccceeEEEhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChHHEEE--CCCCCEEEe
Confidence 35799999999998887754 378899999999999999999964 89999999999999 678889999
Q ss_pred eCCCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 259 DFGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 259 DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.+.++.|...+
T Consensus 162 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred eCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99999765443 2346789999999999999999999999999999999999999999998899999999988887766
Q ss_pred hccCCccc-hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 337 LHGASKTS-KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 337 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
+....... .+....+... ....+ . ..+.................+++||.+||.+||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~----------~~~~~------~------~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP 299 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYA----------GLTFP------K------LFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299 (355)
T ss_pred HHhhcHHHHHHHhcCCccc----------cccch------h------hccccccccccccccccchHHHHHHHHHhcCCc
Confidence 65444321 2221111000 00000 0 000000000111111223367899999999999
Q ss_pred CCCCCHHHHhcCCCcCcC
Q psy11727 416 KKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~~ 433 (437)
.+|||+.|+|+||||..+
T Consensus 300 ~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 300 AKRISVDEALQHPYINVW 317 (355)
T ss_pred hhcCCHHHHhcCcchhcc
Confidence 999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=370.86 Aligned_cols=280 Identities=25% Similarity=0.400 Sum_probs=216.8
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.++|++.+.||+|+||.||+|.+..+++.||+|.... ....+|+.++..+ .|||||+++++|...+..++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAI-----NHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhC-----CCCCCCCEeEEEEECCeeEE
Confidence 4679999999999999999999999999999997642 3456788888877 68999999999999999999
Q ss_pred EEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC-
Q psy11727 189 VFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG- 267 (437)
Q Consensus 189 V~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~- 267 (437)
|||++.++|..++... ..+++..++.++.||+.||+|||++ |||||||||+|||+ +.++.+||+|||+|....
T Consensus 161 v~e~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~--~IvHrDiKP~NIll--~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 161 ILPRYKTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN--RIIHRDIKAENIFI--NHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChHhEEE--cCCCCEEEEeCCccccccc
Confidence 9999999999888765 3589999999999999999999964 89999999999999 677889999999986532
Q ss_pred ---CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHHHhCCCChhhh
Q psy11727 268 ---QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGK-------NEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 268 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~-------~~~~~~~~i~~~~~~p~~~~~ 337 (437)
......+||+.|+|||++.+..++.++|||||||++|||++|..||... ....++..+....|.+|..+.
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 2233467999999999999999999999999999999999999776543 234677788888887765443
Q ss_pred ccCCc-cchhhcccCCCcceeccccccccccCCCCCc-hhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 338 HGASK-TSKYFDRLSDNSYVLKKSTDTRKERLPGSKR-LDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 338 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
..... ....+...... ....|..+. .... ......+.+||.+||++||
T Consensus 315 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~-------------------~~~~~~l~~Li~~mL~~dP 364 (391)
T PHA03212 315 IDAQANLDEIYIGLAKK-----------SSRKPGSRPLWTNL-------------------YELPIDLEYLICKMLAFDA 364 (391)
T ss_pred cchhHHHHHHHHHHHhc-----------cCCCCCCCCCHHHH-------------------hhhhhhHHHHHHHHhcCCh
Confidence 21111 01111000000 000000000 0000 0112257899999999999
Q ss_pred CCCCCHHHHhcCCCcCcCC
Q psy11727 416 KKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~~~ 434 (437)
.+|||++|+|+||||+...
T Consensus 365 ~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 365 HHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hhCCCHHHHhcChhhccCC
Confidence 9999999999999998754
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=364.74 Aligned_cols=246 Identities=28% Similarity=0.440 Sum_probs=200.5
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
+.||+|+||.||+|.+..+|+.||+|+++... ........|+.++..+ .||||++++++|...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~i~~~~~~~~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-----RHPFLTALKYSFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-----CCCCCCCEEEEEEcCCEEEEEEe
Confidence 46899999999999999999999999997432 1122344566666554 78999999999999999999999
Q ss_pred eccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec---C
Q psy11727 192 LLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---G 267 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~---~ 267 (437)
|+++ +|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++... .
T Consensus 76 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~--~~ivHrDlkp~NIll--~~~~~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 76 YANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHS--CDVVYRDLKLENLML--DKDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEE--CCCCCEEEeeCCCCcccccCC
Confidence 9965 788887764 358999999999999999999996 489999999999999 67888999999998653 2
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhh
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 347 (437)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+.......+.......|.
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~------------- 216 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR------------- 216 (323)
T ss_pred CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC-------------
Confidence 2334567999999999999999999999999999999999999999987766655554321000000
Q ss_pred cccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC-----CHH
Q psy11727 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI-----SPT 422 (437)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~-----t~~ 422 (437)
.....+.+||.+||+.||++|| ++.
T Consensus 217 --------------------------------------------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 246 (323)
T cd05571 217 --------------------------------------------------TLSPEAKSLLAGLLKKDPKQRLGGGPEDAK 246 (323)
T ss_pred --------------------------------------------------CCCHHHHHHHHHHccCCHHHcCCCCCCCHH
Confidence 0012578999999999999999 899
Q ss_pred HHhcCCCcCcCCC
Q psy11727 423 NVLRHEFFLKHSV 435 (437)
Q Consensus 423 e~l~Hp~~~~~~~ 435 (437)
++++||||+...+
T Consensus 247 ~ll~h~~f~~~~~ 259 (323)
T cd05571 247 EIMEHRFFASINW 259 (323)
T ss_pred HHHcCCCcCCCCH
Confidence 9999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=361.78 Aligned_cols=256 Identities=32% Similarity=0.505 Sum_probs=224.3
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
++.+-|.+.+.||+|-|+.|-+|+.--||+.||||++.+.+ ........|+.-++.. .|||||++|++....
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-----QHpNiVRLYEViDTQ 89 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-----QHPNIVRLYEVIDTQ 89 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-----cCcCeeeeeehhccc
Confidence 45677999999999999999999999999999999997543 2234455677777766 789999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
..+|||+|+-.+ +|+++|.+.. .++.++.+++++.||+.|+.|+| ++.+|||||||+||.+- .+-|-|||+|||+
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCH--qLHVVHRDLKPENVVFF-EKlGlVKLTDFGF 165 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCH--QLHVVHRDLKPENVVFF-EKLGLVKLTDFGF 165 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHh--hhhhhcccCCcceeEEe-eecCceEeeeccc
Confidence 999999999955 8999998876 67999999999999999999999 67899999999999885 4678899999999
Q ss_pred ceec--CCccccccccccccChhhhcCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhcc
Q psy11727 263 SCHV--GQTLYQYIQSRYYRSPEVLLGIPYD-LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 263 s~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 339 (437)
+..+ +....+.||+..|.|||++.|..|+ +++||||||||||.|++|++||...++.+.+..|++.-..-|.+..
T Consensus 166 SNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS-- 243 (864)
T KOG4717|consen 166 SNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVS-- 243 (864)
T ss_pred cccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhh--
Confidence 9655 6778899999999999999999998 6799999999999999999999999999999999875333332221
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
.+++|||..||..||.+|.
T Consensus 244 -------------------------------------------------------------~eCrdLI~sMLvRdPkkRA 262 (864)
T KOG4717|consen 244 -------------------------------------------------------------KECRDLIQSMLVRDPKKRA 262 (864)
T ss_pred -------------------------------------------------------------HHHHHHHHHHHhcCchhhc
Confidence 2689999999999999999
Q ss_pred CHHHHhcCCCcCcCC
Q psy11727 420 SPTNVLRHEFFLKHS 434 (437)
Q Consensus 420 t~~e~l~Hp~~~~~~ 434 (437)
|.+++..|+|++..+
T Consensus 263 slEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 263 SLEEIVSTSWLQAGD 277 (864)
T ss_pred cHHHHhccccccCCC
Confidence 999999999999765
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=365.72 Aligned_cols=255 Identities=24% Similarity=0.396 Sum_probs=204.3
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|++.+.||+|+||+||+|.+..+++.||||++.... .....+..|+.++..+ .|+||+++++.+.+.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-----~~~~iv~~~~~~~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-----DSLWVVKMFYSFQDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-----CCCCcceEEEEEecCCe
Confidence 47999999999999999999999999999999997432 1223445566666554 78999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+|+||||++| +|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++.
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~--~givHrDlKp~NILi--~~~~~vkL~DFGla~ 149 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQ--LGFIHRDIKPDNLLL--DSKGHVKLSDFGLCT 149 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEE--CCCCCEEEeeccCcc
Confidence 9999999965 788888764 358999999999999999999995 489999999999999 678899999999986
Q ss_pred ecCCc--------------------------------------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHH
Q psy11727 265 HVGQT--------------------------------------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVEL 306 (437)
Q Consensus 265 ~~~~~--------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el 306 (437)
..... ....+||+.|+|||++.+..++.++|||||||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 229 (363)
T cd05628 150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (363)
T ss_pred cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHH
Confidence 43211 1235799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCC
Q psy11727 307 HTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPG 386 (437)
Q Consensus 307 ltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (437)
++|.+||.+.+..+...++........ .|...
T Consensus 230 l~G~~Pf~~~~~~~~~~~i~~~~~~~~----------------------------------~p~~~-------------- 261 (363)
T cd05628 230 LIGYPPFCSETPQETYKKVMNWKETLI----------------------------------FPPEV-------------- 261 (363)
T ss_pred HhCCCCCCCCCHHHHHHHHHcCcCccc----------------------------------CCCcC--------------
Confidence 999999999888777776654211000 00000
Q ss_pred CCCCCCCCCChhhhhHHHHHHHHccccCCC---CCCCHHHHhcCCCcCcCCC
Q psy11727 387 GRRRNEPGHSLADYMKFKDLILRMLTYDPK---KRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~dli~~~L~~dP~---~R~t~~e~l~Hp~~~~~~~ 435 (437)
.....+.+||.+|+. +|. .||+++|+++||||++..+
T Consensus 262 -----------~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~ 301 (363)
T cd05628 262 -----------PISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDW 301 (363)
T ss_pred -----------CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCH
Confidence 001156899999875 454 4589999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=314.50 Aligned_cols=281 Identities=31% Similarity=0.554 Sum_probs=236.4
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC---cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK---KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+|.-.++||+|.||+||+|++..+++.||+|.++.. ........+|+-+++.+ .|.|||++++....+..+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-----khknivrl~dvlhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-----KHKNIVRLHDVLHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-----hhcceeehhhhhccCceeE
Confidence 566778999999999999999999999999999743 34457788999999998 6788999999999999999
Q ss_pred EEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 188 LVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 188 lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
+|+|||..+|..++...+ +.+..+.++.++.|++.+|.++|++ .+.||||||.|.|+ +.+|++||+|||+++-++
T Consensus 78 lvfe~cdqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchsh--nvlhrdlkpqnlli--n~ngelkladfglarafg 152 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSH--NVLHRDLKPQNLLI--NRNGELKLADFGLARAFG 152 (292)
T ss_pred EeHHHhhHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhh--hhhhccCCcceEEe--ccCCcEEecccchhhhcC
Confidence 999999999999998876 5689999999999999999999987 59999999999999 889999999999998887
Q ss_pred Cccccc---cccccccChhhhcCC-CCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 268 QTLYQY---IQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 268 ~~~~~~---~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
-+...+ +-|..|++|.++.|. -|++.+|+||-|||+.|+.. |+|.|.|.+..+++.+|...+|+|.+..|+...+
T Consensus 153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 765443 558999999999886 58999999999999999987 8999999999999999999999999988877655
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
...|-.. -..|...++..|...-+ . .=+||++++|.-+|..|++++
T Consensus 233 lpdyk~y----------------p~ypattswsqivp~ln--s----------------~grdllqkll~cnp~qrisae 278 (292)
T KOG0662|consen 233 LPDYKPY----------------PIYPATTSWSQIVPKLN--S----------------TGRDLLQKLLKCNPAQRISAE 278 (292)
T ss_pred CCCCccc----------------CCccccchHHHHhhhhc--c----------------hhHHHHHHHhccCcccccCHH
Confidence 4333110 01122333333322111 0 127999999999999999999
Q ss_pred HHhcCCCcCcCCC
Q psy11727 423 NVLRHEFFLKHSV 435 (437)
Q Consensus 423 e~l~Hp~~~~~~~ 435 (437)
++|+||||.+...
T Consensus 279 aalqhpyf~d~s~ 291 (292)
T KOG0662|consen 279 AALQHPYFSDFSP 291 (292)
T ss_pred HHhcCccccccCC
Confidence 9999999998653
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=362.55 Aligned_cols=260 Identities=28% Similarity=0.397 Sum_probs=211.5
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|++.+.||+|+||.||+|.+..+++.||||++.... .....+..|+.++..+ .|+||+++++++...++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~iv~~~~~~~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-----KSEWLVKLLYAFQDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-----CCCCCccEEEEEEcCCE
Confidence 46999999999999999999999999999999997432 1123344566666554 68999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
.|+||||+++ +|.+++.... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~--~~~~~~kL~Dfg~a~ 149 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHE--LGYIHRDLKPENFLI--DASGHIKLTDFGLSK 149 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEE--CCCCCEEEEeCcCCc
Confidence 9999999965 8988887643 58999999999999999999995 489999999999999 678899999999998
Q ss_pred ecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc
Q psy11727 265 HVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344 (437)
Q Consensus 265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 344 (437)
..........||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+....+.........
T Consensus 150 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~---------- 219 (333)
T cd05600 150 GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR---------- 219 (333)
T ss_pred ccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC----------
Confidence 7766556678999999999999999999999999999999999999999998877766665432110000
Q ss_pred hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHH
Q psy11727 345 KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNV 424 (437)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~ 424 (437)
|... .+. ......+.+||.+||..+|.+|||++++
T Consensus 220 ------------------------~~~~-------------------~~~--~~~s~~~~~li~~~l~~~~~rr~s~~~l 254 (333)
T cd05600 220 ------------------------PVYD-------------------DPR--FNLSDEAWDLITKLINDPSRRFGSLEDI 254 (333)
T ss_pred ------------------------CCCC-------------------ccc--cccCHHHHHHHHHHhhChhhhcCCHHHH
Confidence 0000 000 0011257899999999999999999999
Q ss_pred hcCCCcCcCCC
Q psy11727 425 LRHEFFLKHSV 435 (437)
Q Consensus 425 l~Hp~~~~~~~ 435 (437)
++||||++..+
T Consensus 255 l~h~~~~~~~~ 265 (333)
T cd05600 255 KNHPFFKEVDW 265 (333)
T ss_pred HhCcccCCCCH
Confidence 99999998643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=361.91 Aligned_cols=281 Identities=31% Similarity=0.574 Sum_probs=222.0
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC-
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK- 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~- 183 (437)
+.++|.+.+.||+|+||+||+|.+..+++.||||++..... .......|+.+++.+ .|+||++++++|...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-----KHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-----CCCchhhhhhhhcccc
Confidence 45789999999999999999999999999999999864321 123445677777765 789999999988643
Q ss_pred -----CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 184 -----NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 184 -----~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
...|+++|+++++|.+++... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+
T Consensus 88 ~~~~~~~~~~~~~~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrdikp~Nil~--~~~~~~kl~ 160 (343)
T cd07878 88 SIENFNEVYLVTNLMGADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHS--AGIIHRDLKPSNVAV--NEDCELRIL 160 (343)
T ss_pred cccccCcEEEEeecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecccCChhhEEE--CCCCCEEEc
Confidence 467999999988998877643 48999999999999999999995 489999999999999 678889999
Q ss_pred eCCCceecCCccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 259 DFGSSCHVGQTLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 259 DFG~s~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
|||++...........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.++....
T Consensus 161 Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 161 DFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred CCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99999887776667789999999999987 56899999999999999999999999999888889999888888776655
Q ss_pred ccCCcc--chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 338 HGASKT--SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 338 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
...... ..+...++. .+. ..+..+. ......+.+||.+||.+||
T Consensus 241 ~~~~~~~~~~~~~~~~~---------------~~~-~~~~~~~------------------~~~~~~~~~li~~mL~~dp 286 (343)
T cd07878 241 KKISSEHARKYIQSLPH---------------MPQ-QDLKKIF------------------RGANPLAIDLLEKMLVLDS 286 (343)
T ss_pred HhcchhhHHHHhhcccc---------------ccc-hhHHHhc------------------cCCCHHHHHHHHHHcCCCh
Confidence 432211 111111000 000 0000000 0011246899999999999
Q ss_pred CCCCCHHHHhcCCCcCcCC
Q psy11727 416 KKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~~~ 434 (437)
.+|||+.|+|+||||.+..
T Consensus 287 ~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 287 DKRISASEALAHPYFSQYH 305 (343)
T ss_pred hhCCCHHHHhcCcchhccC
Confidence 9999999999999998754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=357.81 Aligned_cols=252 Identities=27% Similarity=0.419 Sum_probs=204.8
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
+|++.+.||+|+||.||+|.+..+++.||||++.... ........|..++..+. +|++|+++++++.+.+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~----~~~~i~~~~~~~~~~~~~ 76 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG----KPPFLTQLHSCFQTMDRL 76 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcC----CCCceeeeEEEEEcCCEE
Confidence 4889999999999999999999999999999997432 12233445555555443 456799999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
|+||||+++ +|.+++.... .+++..+..++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++..
T Consensus 77 ~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill--~~~~~~kL~Dfg~~~~ 150 (324)
T cd05587 77 YFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVML--DAEGHIKIADFGMCKE 150 (324)
T ss_pred EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEE--cCCCCEEEeecCccee
Confidence 999999965 7888876543 48999999999999999999996 489999999999999 6788899999999864
Q ss_pred c---CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 266 V---GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 266 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+.......|.
T Consensus 151 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~-------- 222 (324)
T cd05587 151 NIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK-------- 222 (324)
T ss_pred cCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--------
Confidence 3 22233467899999999999999999999999999999999999999998887777666432110000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH-
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP- 421 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~- 421 (437)
.....+.+||.+||..||.+|++.
T Consensus 223 -------------------------------------------------------~~~~~~~~li~~~l~~~P~~R~~~~ 247 (324)
T cd05587 223 -------------------------------------------------------SLSKEAVSICKGLLTKHPAKRLGCG 247 (324)
T ss_pred -------------------------------------------------------CCCHHHHHHHHHHhhcCHHHcCCCC
Confidence 000156899999999999999986
Q ss_pred ----HHHhcCCCcCcCCC
Q psy11727 422 ----TNVLRHEFFLKHSV 435 (437)
Q Consensus 422 ----~e~l~Hp~~~~~~~ 435 (437)
+++++||||+..++
T Consensus 248 ~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 248 PTGERDIREHAFFRRIDW 265 (324)
T ss_pred CCCHHHHhcCCCcCCCCH
Confidence 89999999987653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=354.87 Aligned_cols=283 Identities=28% Similarity=0.505 Sum_probs=207.9
Q ss_pred eceecccCceEEEEEEEc--CCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE--CCEEEEEE
Q psy11727 115 DTLLGKGSFGQVVKAFDH--EEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--KNHLCLVF 190 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--~~~~~lV~ 190 (437)
.++||+|+||+||+|.+. .+++.||+|.+... .......+|+.+++.+ .||||++++++|.. ...+|+||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-GISMSACREIALLREL-----KHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC-CCcHHHHHHHHHHHhc-----CCCCCcceeeeEecCCCcEEEEEE
Confidence 457999999999999865 46789999999743 3345567788888877 68999999999864 46789999
Q ss_pred EeccCcHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec--CCCCCEEEEeCC
Q psy11727 191 ELLSYNLYNLIRNTN-------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS--PKRSAIKIIDFG 261 (437)
Q Consensus 191 E~~~~~L~~~l~~~~-------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~--~~~~~ikL~DFG 261 (437)
||++++|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+|||+.. +..+.+||+|||
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 80 DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC--CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 999999988875432 12489999999999999999999964 8999999999999953 345789999999
Q ss_pred CceecCCc------cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHH
Q psy11727 262 SSCHVGQT------LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNE---------VDQMTKI 325 (437)
Q Consensus 262 ~s~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~---------~~~~~~i 325 (437)
++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|++||.+... .+++..+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 99765432 2345789999999999874 589999999999999999999999976543 3567788
Q ss_pred HHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHH
Q psy11727 326 IEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKD 405 (437)
Q Consensus 326 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 405 (437)
...++.|+...+..............+ + ....... ..+...+.. ........+.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--------~~~~~~~-~~~~~~~~~--------------~~~~~~~~~~d 292 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKD--F--------RRNTYTN-CSLIKYMEK--------------HKVKPDSKAFH 292 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhh--h--------hccccCc-ccccchHHh--------------cCCCCChHHHH
Confidence 888888877665543221110000000 0 0000000 000000000 00001125789
Q ss_pred HHHHccccCCCCCCCHHHHhcCCCc
Q psy11727 406 LILRMLTYDPKKRISPTNVLRHEFF 430 (437)
Q Consensus 406 li~~~L~~dP~~R~t~~e~l~Hp~~ 430 (437)
||.+||++||.+|||++|+|+||||
T Consensus 293 li~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 293 LLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=365.52 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=206.1
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|++.+.||+|+||+||+|++..+++.||||++.... .....+..|+.++..+ .|+||++++++|.+.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~h~~iv~~~~~~~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-----DNPWVVKLYYSFQDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCCcceEEEEEcCCe
Confidence 47999999999999999999999999999999997421 1223445677777765 68999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+|+||||+++ +|.+++.... .+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.++|+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~--~~ivH~Dlkp~NIl~--~~~~~~kl~Dfg~~~ 149 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHK--LGYIHRDIKPDNLLL--DAKGHIKLSDFGLCT 149 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEE--CCCCCEEEeecccce
Confidence 9999999965 7888887643 58999999999999999999995 489999999999999 778899999999986
Q ss_pred ecCCc-----------------------------------------cccccccccccChhhhcCCCCCCcchHHHHHHHH
Q psy11727 265 HVGQT-----------------------------------------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCIL 303 (437)
Q Consensus 265 ~~~~~-----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il 303 (437)
..... ....+||+.|+|||++.+..++.++|||||||++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 229 (364)
T cd05599 150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229 (364)
T ss_pred eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence 43211 1134689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCC
Q psy11727 304 VELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNG 383 (437)
Q Consensus 304 ~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (437)
|||++|.+||.+.+..+....+....... ..|...
T Consensus 230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~~~----------------------------------~~~~~~----------- 264 (364)
T cd05599 230 YEMLVGYPPFCSDNPQETYRKIINWKETL----------------------------------QFPDEV----------- 264 (364)
T ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCCcc----------------------------------CCCCCC-----------
Confidence 99999999999888766665554310000 000000
Q ss_pred CCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC---HHHHhcCCCcCcCCC
Q psy11727 384 GPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS---PTNVLRHEFFLKHSV 435 (437)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t---~~e~l~Hp~~~~~~~ 435 (437)
.....+.+||++||. +|.+|++ +.|+++||||++..+
T Consensus 265 --------------~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 265 --------------PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred --------------CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 001156899999997 9999998 999999999987643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=363.52 Aligned_cols=255 Identities=31% Similarity=0.477 Sum_probs=209.0
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|.+.+.||+|+||+||+|.+..+++.||||++.... .....+..|+.++..+ .|+||+++++++.+.++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-----DSPWIVKLYYSFQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-----CCCCccchhhheecCCe
Confidence 47999999999999999999999999999999997432 2223455566666655 68999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+|+||||+++ +|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~giiH~Dlkp~NIll--~~~~~~kL~Dfg~~~ 149 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK--LGFIHRDIKPDNILI--DADGHIKLADFGLCK 149 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEE--CCCCCEEeecCCCCc
Confidence 9999999965 898888765 468999999999999999999996 589999999999999 778899999999987
Q ss_pred ecCCcc--------------------------------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCC
Q psy11727 265 HVGQTL--------------------------------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPL 312 (437)
Q Consensus 265 ~~~~~~--------------------------------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p 312 (437)
...... ....||+.|+|||++.+..++.++|||||||++|||++|++|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCC
Confidence 654322 345689999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCC
Q psy11727 313 FSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNE 392 (437)
Q Consensus 313 f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (437)
|.+.+......++....... ..|....
T Consensus 230 f~~~~~~~~~~~i~~~~~~~----------------------------------~~p~~~~------------------- 256 (350)
T cd05573 230 FYSDTLQETYNKIINWKESL----------------------------------RFPPDPP------------------- 256 (350)
T ss_pred CCCCCHHHHHHHHhccCCcc----------------------------------cCCCCCC-------------------
Confidence 99988766666654311000 0000000
Q ss_pred CCCChhhhhHHHHHHHHccccCCCCCCC-HHHHhcCCCcCcCCC
Q psy11727 393 PGHSLADYMKFKDLILRMLTYDPKKRIS-PTNVLRHEFFLKHSV 435 (437)
Q Consensus 393 ~~~~~~~~~~~~dli~~~L~~dP~~R~t-~~e~l~Hp~~~~~~~ 435 (437)
....+.+||.+||. ||.+|++ ++++++||||++..+
T Consensus 257 ------~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~ 293 (350)
T cd05573 257 ------VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW 293 (350)
T ss_pred ------CCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence 01257899999998 9999999 999999999988654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=357.75 Aligned_cols=247 Identities=27% Similarity=0.421 Sum_probs=201.0
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
+.||+|+||+||+|.++.+++.||+|++.... ........|..++..+ ..||||+++++++.+.+.+|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~h~~iv~~~~~~~~~~~~~iv~E 76 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLA----RNHPFLTQLYCCFQTPDRLFFVME 76 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc----cCCCchhceeeEEEcCCEEEEEEc
Confidence 46899999999999999999999999986421 1122334455555443 268999999999999999999999
Q ss_pred eccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec---C
Q psy11727 192 LLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---G 267 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~---~ 267 (437)
|+++ +|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++... .
T Consensus 77 y~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~--~~ivH~dlkp~NIli--~~~~~~kL~DfG~~~~~~~~~ 150 (320)
T cd05590 77 FVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHD--KGIIYRDLKLDNVLL--DHEGHCKLADFGMCKEGIFNG 150 (320)
T ss_pred CCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEE--CCCCcEEEeeCCCCeecCcCC
Confidence 9965 788877654 358999999999999999999995 489999999999999 67888999999998653 2
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhh
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 347 (437)
.......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+.......|.+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------ 218 (320)
T cd05590 151 KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW------------ 218 (320)
T ss_pred CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCC------------
Confidence 22344678999999999999999999999999999999999999999988877766664321111000
Q ss_pred cccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH------
Q psy11727 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP------ 421 (437)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~------ 421 (437)
....+.+||++||+.||.+|||+
T Consensus 219 ---------------------------------------------------~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 247 (320)
T cd05590 219 ---------------------------------------------------LSQDAVDILKAFMTKNPTMRLGSLTLGGE 247 (320)
T ss_pred ---------------------------------------------------CCHHHHHHHHHHcccCHHHCCCCCCCCCH
Confidence 00157899999999999999998
Q ss_pred HHHhcCCCcCcCCC
Q psy11727 422 TNVLRHEFFLKHSV 435 (437)
Q Consensus 422 ~e~l~Hp~~~~~~~ 435 (437)
+++++||||+...+
T Consensus 248 ~~~~~h~~f~~~~~ 261 (320)
T cd05590 248 EAILRHPFFKELDW 261 (320)
T ss_pred HHHHcCCCcCCCCH
Confidence 99999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=357.06 Aligned_cols=251 Identities=26% Similarity=0.412 Sum_probs=204.9
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
|.+.+.||+|+||.||+|.+..+++.||||+++... ........|+.+++.+. .+.||||+++++++.+.+++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~--~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN--SERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc--ccCCCChhceeeEEEcCCEEE
Confidence 678999999999999999999999999999997432 12234455666555443 357999999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|...+.. ..+++..+..++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++...
T Consensus 79 lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrdlkp~Nill--~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHE--NKIVYRDLKLDNLLL--DTEGFVKIADFGLCKEG 151 (324)
T ss_pred EEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEE--CCCCcEEeCcccCCccC
Confidence 99999966 67766654 358999999999999999999995 489999999999999 67889999999998643
Q ss_pred ---CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 ---GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.......+|++.|+|||++.+..++.++|+|||||++|+|++|++||.+.+..+....+.......|..
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~-------- 223 (324)
T cd05589 152 MGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF-------- 223 (324)
T ss_pred CCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC--------
Confidence 222345678999999999999999999999999999999999999999988777666654321111000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC----
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI---- 419 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~---- 419 (437)
....+.+||.+||+.||.+||
T Consensus 224 -------------------------------------------------------~~~~~~~li~~~L~~dP~~R~~~~~ 248 (324)
T cd05589 224 -------------------------------------------------------LSREAISIMRRLLRRNPERRLGSGE 248 (324)
T ss_pred -------------------------------------------------------CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 001568999999999999999
Q ss_pred -CHHHHhcCCCcCcCC
Q psy11727 420 -SPTNVLRHEFFLKHS 434 (437)
Q Consensus 420 -t~~e~l~Hp~~~~~~ 434 (437)
+++++++||||++..
T Consensus 249 ~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 249 KDAEDVKKQPFFRDIN 264 (324)
T ss_pred CCHHHHhhCCCcCCCC
Confidence 799999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=365.79 Aligned_cols=254 Identities=27% Similarity=0.422 Sum_probs=203.1
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|.+.+.||+|+||+||+|.+..+++.||||++.... .....+..|+.++..+ .||||++++++|.+.++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~iv~~~~~~~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-----DSPWVVSLYYSFQDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-----CCCCcceEEEEEEcCCe
Confidence 47999999999999999999999999999999986422 1223455577666654 78999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+|+||||+++ +|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~--~givHrDlkp~NIll--~~~~~~kl~DfGla~ 149 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHK--LGFIHRDIKPDNILI--DRGGHIKLSDFGLST 149 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEE--CCCCCEEEeeccccc
Confidence 9999999954 888888754 458999999999999999999995 489999999999999 678899999999985
Q ss_pred ecCCc--------------------------------------------------cccccccccccChhhhcCCCCCCcc
Q psy11727 265 HVGQT--------------------------------------------------LYQYIQSRYYRSPEVLLGIPYDLAI 294 (437)
Q Consensus 265 ~~~~~--------------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~ 294 (437)
..... ....+||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 229 (377)
T cd05629 150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence 32110 0124689999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCch
Q psy11727 295 DMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRL 374 (437)
Q Consensus 295 DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (437)
|||||||++|||++|.+||.+.+..+.+..+....... ..|....
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------------------------~~p~~~~- 274 (377)
T cd05629 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETL----------------------------------YFPDDIH- 274 (377)
T ss_pred eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc----------------------------------CCCCCCC-
Confidence 99999999999999999999888777666654311000 0000000
Q ss_pred hhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC---CCHHHHhcCCCcCcCC
Q psy11727 375 DTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR---ISPTNVLRHEFFLKHS 434 (437)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R---~t~~e~l~Hp~~~~~~ 434 (437)
....+.+||.+||. +|.+| +|+.|+++||||+...
T Consensus 275 ------------------------~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 275 ------------------------LSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred ------------------------CCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 00157899999998 77775 5999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=355.66 Aligned_cols=252 Identities=26% Similarity=0.383 Sum_probs=205.0
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc----chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~----~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
+|.+.+.||+|+||+||+|.+..+++.||+|++...... ......|..++..+ .+|++|+++++++...+.+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~~~~i~~~~~~~~~~~~~ 76 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS----GKPPFLTQLHSCFQTMDRL 76 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhc----cCCCeEeeEEEEEecCCEE
Confidence 488999999999999999999999999999999743211 12233344444433 2678999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++||||+++ +|.+.+... ..+++..+..++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++..
T Consensus 77 ~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill--~~~~~~kL~DfG~~~~ 150 (323)
T cd05616 77 YFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVML--DSEGHIKIADFGMCKE 150 (323)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEEecCCCHHHeEE--CCCCcEEEccCCCcee
Confidence 999999965 788887654 358999999999999999999995 489999999999999 7788999999999875
Q ss_pred cC---CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 266 VG---QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 266 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+.......+.......|..
T Consensus 151 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~------- 223 (323)
T cd05616 151 NMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS------- 223 (323)
T ss_pred cCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc-------
Confidence 42 22335678999999999999999999999999999999999999999988877777765421111100
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC--
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS-- 420 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t-- 420 (437)
....+.+||.+||+.||.+|++
T Consensus 224 --------------------------------------------------------~s~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05616 224 --------------------------------------------------------MSKEAVAICKGLMTKHPGKRLGCG 247 (323)
T ss_pred --------------------------------------------------------CCHHHHHHHHHHcccCHHhcCCCC
Confidence 0115789999999999999998
Q ss_pred ---HHHHhcCCCcCcCCC
Q psy11727 421 ---PTNVLRHEFFLKHSV 435 (437)
Q Consensus 421 ---~~e~l~Hp~~~~~~~ 435 (437)
..++++||||+...+
T Consensus 248 ~~~~~~i~~h~~~~~~~~ 265 (323)
T cd05616 248 PEGERDIKEHAFFRYIDW 265 (323)
T ss_pred CCCHHHHhcCCCcCCCCH
Confidence 489999999987653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=349.04 Aligned_cols=282 Identities=28% Similarity=0.469 Sum_probs=220.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.++|.+.+.||+|+||.||+|.+..++..||+|.++... ........|+.++..+ .|+||+++++++...+.+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nI~~~~~~~~~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-----KHANIVTLHDIIHTEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-----CCCCcceEEEEEecCCeE
Confidence 468999999999999999999999999999999986432 2223455677777766 789999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
++||||++++|.+++.... ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.++|+|||++...
T Consensus 80 ~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~--~~i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~~ 154 (301)
T cd07873 80 TLVFEYLDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHR--RKVLHRDLKPQNLLI--NERGELKLADFGLARAK 154 (301)
T ss_pred EEEEeccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCHHHEEE--CCCCcEEECcCcchhcc
Confidence 9999999999998887653 458999999999999999999996 489999999999999 67788999999998654
Q ss_pred CCc---cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
... .....++..|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+...++.|+...++....
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 322 2234568899999998764 578899999999999999999999999998888888888888887665543322
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
...+.. ...|.... .............+.+||.+||++||.+|||++
T Consensus 235 ~~~~~~-----------------~~~~~~~~----------------~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ 281 (301)
T cd07873 235 NEEFKS-----------------YNYPKYRA----------------DCLHNHAPRLDSDGAELLSKLLQFEGRKRISAE 281 (301)
T ss_pred cccccc-----------------cccCcccc----------------ccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence 111100 00000000 000000001112578999999999999999999
Q ss_pred HHhcCCCcCcC
Q psy11727 423 NVLRHEFFLKH 433 (437)
Q Consensus 423 e~l~Hp~~~~~ 433 (437)
|+++||||+..
T Consensus 282 eil~h~~f~~~ 292 (301)
T cd07873 282 EAMKHPYFHCL 292 (301)
T ss_pred HHhcCcccccc
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=362.21 Aligned_cols=280 Identities=29% Similarity=0.444 Sum_probs=218.7
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC---
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN--- 184 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~--- 184 (437)
+|++.+.||+|+||+||+|.+..+++.||||.+.... ....++.+|+.++..+ .|+||+++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-----KHDNVLSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-----CCCCcCCHhheecCCCccc
Confidence 4788999999999999999999999999999986431 1224556677777665 6899999999998876
Q ss_pred --EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 185 --HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 185 --~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+.|+||||+.++|.+.+... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||+
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~--~ivH~dlkp~Nili--~~~~~~kL~Dfg~ 149 (372)
T cd07853 76 FEEIYVVTELMQSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSA--GILHRDIKPGNLLV--NSNCVLKICDFGL 149 (372)
T ss_pred cceEEEEeeccccCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChHHEEE--CCCCCEEeccccc
Confidence 89999999999998888654 3589999999999999999999964 89999999999999 6788999999999
Q ss_pred ceecCCc----cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 263 SCHVGQT----LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 263 s~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
+...... .....+++.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+++..+.+.+|.|+...+
T Consensus 150 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 150 ARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229 (372)
T ss_pred eeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 9765322 2234678899999999874 4789999999999999999999999999999999999999998876554
Q ss_pred ccCCcc-chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 338 HGASKT-SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 338 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
...... ..++.... ...+ ...... .........+.+||.+||++||.
T Consensus 230 ~~~~~~~~~~~~~~~--------------~~~~---~~~~~~---------------~~~~~~~~~~~~li~~mL~~dP~ 277 (372)
T cd07853 230 RSACEGARAHILRGP--------------HKPP---SLPVLY---------------TLSSQATHEAVHLLCRMLVFDPD 277 (372)
T ss_pred HHhhHHHHHHHHhCC--------------CCCC---chHHhc---------------ccCCCCCHHHHHHHHHhCCCChh
Confidence 332211 11110000 0000 000000 00011123678999999999999
Q ss_pred CCCCHHHHhcCCCcCcC
Q psy11727 417 KRISPTNVLRHEFFLKH 433 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~~~~ 433 (437)
+|||+.|+|+||||++.
T Consensus 278 ~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 278 KRISAADALAHPYLDEG 294 (372)
T ss_pred hCcCHHHHhcCHhhCCC
Confidence 99999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=363.32 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=202.4
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.|++++.||+|+||+||+|++..+++.||||++.... .....+..|+.+++.+ .|+||+++++++.+.+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-----~h~~iv~l~~~~~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-----DNEWVVKLYYSFQDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-----CCCCeeeeEEEEecCCEE
Confidence 5899999999999999999999999999999997432 1223455677777665 789999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
|+||||+++ +|.+++.... .+++..++.++.||+.||.|||. .||+||||||+|||+ +.++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~--~givHrDlKp~Nili--~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHK--MGFIHRDIKPDNILI--DLDGHIKLTDFGLCTG 150 (381)
T ss_pred EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCcHHHEEE--CCCCCEEEeeCcCCcc
Confidence 999999965 7888887643 58999999999999999999995 589999999999999 6788999999998743
Q ss_pred cCC--------------------------------------------------ccccccccccccChhhhcCCCCCCcch
Q psy11727 266 VGQ--------------------------------------------------TLYQYIQSRYYRSPEVLLGIPYDLAID 295 (437)
Q Consensus 266 ~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 295 (437)
... ...+.+||+.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCD 230 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccc
Confidence 210 012357999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchh
Q psy11727 296 MWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLD 375 (437)
Q Consensus 296 vwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (437)
||||||++|||++|.+||.+.+..+....+......+. .|...
T Consensus 231 iwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~----------------------------------~~~~~--- 273 (381)
T cd05626 231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLH----------------------------------IPPQV--- 273 (381)
T ss_pred eeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccC----------------------------------CCCCC---
Confidence 99999999999999999998877665555532110000 00000
Q ss_pred hhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc--cCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 376 TILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT--YDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~--~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
.....+.+||.+||. .+|..|+|+.+++.||||++..+
T Consensus 274 ----------------------~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 274 ----------------------KLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred ----------------------CCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 001157899999664 45556999999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=353.82 Aligned_cols=243 Identities=30% Similarity=0.487 Sum_probs=198.2
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEec
Q psy11727 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELL 193 (437)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~ 193 (437)
||+|+||+||+|.+..+++.||+|++.... ........|+.++..+ .||||+++++++...+..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-----NCPFIVPLKFSFQSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCcEeceeeEEecCCeEEEEEcCC
Confidence 699999999999999999999999986421 1223344566666554 7899999999999999999999999
Q ss_pred cC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC---Cc
Q psy11727 194 SY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG---QT 269 (437)
Q Consensus 194 ~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~---~~ 269 (437)
++ +|.+++... ..+++..+..++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.... ..
T Consensus 76 ~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~HrDlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~~~ 149 (312)
T cd05585 76 NGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHK--FNVIYRDLKPENILL--DYQGHIALCDFGLCKLNMKDDDK 149 (312)
T ss_pred CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHeEE--CCCCcEEEEECcccccCccCCCc
Confidence 65 788888764 358999999999999999999995 489999999999999 778899999999987532 22
Q ss_pred cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcc
Q psy11727 270 LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDR 349 (437)
Q Consensus 270 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~ 349 (437)
....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+....-..|
T Consensus 150 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~---------------- 213 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP---------------- 213 (312)
T ss_pred cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----------------
Confidence 2346789999999999999999999999999999999999999998877666555432100000
Q ss_pred cCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC---CHHHHhc
Q psy11727 350 LSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI---SPTNVLR 426 (437)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~---t~~e~l~ 426 (437)
......+.+||.+||+.||.+|| ++.+++.
T Consensus 214 -----------------------------------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 214 -----------------------------------------------DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred -----------------------------------------------CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 00011578999999999999997 5899999
Q ss_pred CCCcCcCC
Q psy11727 427 HEFFLKHS 434 (437)
Q Consensus 427 Hp~~~~~~ 434 (437)
||||.+..
T Consensus 247 hp~~~~~~ 254 (312)
T cd05585 247 HPFFSQLS 254 (312)
T ss_pred CCCcCCCC
Confidence 99998753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=354.36 Aligned_cols=246 Identities=29% Similarity=0.461 Sum_probs=198.3
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
+.||+|+||.||+|.+..+++.||+|+++.... .......|..++... ..|++|++++++|.+.+++|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~~~~i~~~~~~~~~~~~~~lv~E 76 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA----WENPFLTHLYCTFQTKEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc----cCCCCccCeeEEEEeCCEEEEEEC
Confidence 468999999999999999999999999974321 122333444444332 378999999999999999999999
Q ss_pred eccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec---C
Q psy11727 192 LLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---G 267 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~---~ 267 (437)
|+.+ +|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+|||+ +.++.++|+|||++... .
T Consensus 77 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~ 150 (316)
T cd05620 77 FLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHS--KGIIYRDLKLDNVML--DRDGHIKIADFGMCKENVFGD 150 (316)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEE--CCCCCEEeCccCCCeecccCC
Confidence 9965 788887664 358999999999999999999995 489999999999999 67888999999998643 2
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhh
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 347 (437)
......+||..|+|||++.+..++.++|||||||++|||++|..||.+.+.......+.......|.+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~------------ 218 (316)
T cd05620 151 NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRW------------ 218 (316)
T ss_pred CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC------------
Confidence 23345678999999999999999999999999999999999999999888766655553211000000
Q ss_pred cccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH-HHHhc
Q psy11727 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP-TNVLR 426 (437)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~-~e~l~ 426 (437)
....+.+||++||+.||.+|+|+ +++++
T Consensus 219 ---------------------------------------------------~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 219 ---------------------------------------------------ITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred ---------------------------------------------------CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 00157899999999999999997 58889
Q ss_pred CCCcCcCC
Q psy11727 427 HEFFLKHS 434 (437)
Q Consensus 427 Hp~~~~~~ 434 (437)
||||+...
T Consensus 248 h~~f~~~~ 255 (316)
T cd05620 248 HPFFKTIN 255 (316)
T ss_pred CCCcCCCC
Confidence 99998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=363.74 Aligned_cols=253 Identities=26% Similarity=0.439 Sum_probs=202.7
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
+|++++.||+|+||+||+|++..+++.||+|++.... .....+..|+.++..+ .|+|||++++.|.+.+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-----~h~~iv~~~~~~~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-----DNEWVVRLYYSFQDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-----CCCcCCeEEEEEEeCCEE
Confidence 6899999999999999999999999999999996432 1223455677777665 789999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
|+||||+++ +|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~--~~ivHrDlKp~NILl--~~~g~~kL~DFGla~~ 150 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHK--MGFIHRDIKPDNILI--DRDGHIKLTDFGLCTG 150 (382)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE--CCCCCEEEeECCCCcc
Confidence 999999965 788888664 358999999999999999999995 489999999999999 7788999999999742
Q ss_pred cCC--------------------------------------------------ccccccccccccChhhhcCCCCCCcch
Q psy11727 266 VGQ--------------------------------------------------TLYQYIQSRYYRSPEVLLGIPYDLAID 295 (437)
Q Consensus 266 ~~~--------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 295 (437)
... ...+.+||+.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~D 230 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 230 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeee
Confidence 210 012346899999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchh
Q psy11727 296 MWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLD 375 (437)
Q Consensus 296 vwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (437)
||||||++|||++|++||.+.+..+....+.......+ .|...
T Consensus 231 iwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~----------------------------------~p~~~--- 273 (382)
T cd05625 231 WWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLH----------------------------------IPPQA--- 273 (382)
T ss_pred EEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC----------------------------------CCCcc---
Confidence 99999999999999999998887666555543110000 00000
Q ss_pred hhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC---HHHHhcCCCcCcCC
Q psy11727 376 TILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS---PTNVLRHEFFLKHS 434 (437)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t---~~e~l~Hp~~~~~~ 434 (437)
.....+.+||.+|+ .||.+|++ ++++++||||+..+
T Consensus 274 ----------------------~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 274 ----------------------KLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred ----------------------cCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 00115689999986 59999998 99999999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=354.96 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=201.5
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
++||+|+||+||+|++..+++.||+|+++... ........|..++..+ ..||||++++++|.+.+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~----~~hp~i~~~~~~~~~~~~~~lv~E 76 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA----AKHPFLTALHCCFQTKDRLFFVME 76 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhc----cCCCCccceeeEEEcCCeEEEEEe
Confidence 46899999999999999999999999997432 1122334455555543 278999999999999999999999
Q ss_pred eccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC---
Q psy11727 192 LLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG--- 267 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~--- 267 (437)
|+++ +|...+... ..+++..+..++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDikp~Nill--~~~~~~kL~Dfg~~~~~~~~~ 150 (321)
T cd05591 77 YVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRH--GVIYRDLKLDNILL--DAEGHCKLADFGMCKEGILNG 150 (321)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHeEE--CCCCCEEEeecccceecccCC
Confidence 9965 788777654 3589999999999999999999964 89999999999999 678899999999987532
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhh
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 347 (437)
.......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+.......|.+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~------------ 218 (321)
T cd05591 151 VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVW------------ 218 (321)
T ss_pred ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC------------
Confidence 22334678999999999999999999999999999999999999999998877777664421111100
Q ss_pred cccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC-------C
Q psy11727 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI-------S 420 (437)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~-------t 420 (437)
....+.+||.+||+.||.+|+ +
T Consensus 219 ---------------------------------------------------~~~~~~~ll~~~L~~dp~~R~~~~~~~~~ 247 (321)
T cd05591 219 ---------------------------------------------------LSKEAVSILKAFMTKNPNKRLGCVASQGG 247 (321)
T ss_pred ---------------------------------------------------CCHHHHHHHHHHhccCHHHcCCCCCCCCC
Confidence 001578999999999999999 9
Q ss_pred HHHHhcCCCcCcCCC
Q psy11727 421 PTNVLRHEFFLKHSV 435 (437)
Q Consensus 421 ~~e~l~Hp~~~~~~~ 435 (437)
++++++||||....+
T Consensus 248 ~~~~~~hp~~~~~~~ 262 (321)
T cd05591 248 EDAIKQHPFFKEIDW 262 (321)
T ss_pred HHHHhcCCccCCCCH
Confidence 999999999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=356.09 Aligned_cols=245 Identities=29% Similarity=0.441 Sum_probs=198.3
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
+.||+|+||+||+|.+..+++.||+|++.... ........|+.++..+ .||||+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-----RHPFLTSLKYSFQTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCCcceEEEEEcCCEEEEEEe
Confidence 46899999999999999999999999997432 1123344566665544 78999999999999999999999
Q ss_pred eccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC---
Q psy11727 192 LLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG--- 267 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~--- 267 (437)
|+++ +|.+.+... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 y~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDikp~NIll--~~~~~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 76 YVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSG--KIVYRDLKLENLML--DKDGHIKITDFGLCKEGITDA 149 (328)
T ss_pred CCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CeEecccCHHHeEE--CCCCcEEEecCcCCccCCCcc
Confidence 9965 787777654 3589999999999999999999964 89999999999999 678899999999986532
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhh
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 347 (437)
......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+.......|
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p-------------- 215 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP-------------- 215 (328)
T ss_pred cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC--------------
Confidence 222346789999999999999999999999999999999999999988776655544421100000
Q ss_pred cccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC-----CHH
Q psy11727 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI-----SPT 422 (437)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~-----t~~ 422 (437)
. .....+.+||++||+.||.+|+ |+.
T Consensus 216 ----------------------~---------------------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 246 (328)
T cd05593 216 ----------------------R---------------------------TLSADAKSLLSGLLIKDPNKRLGGGPDDAK 246 (328)
T ss_pred ----------------------C---------------------------CCCHHHHHHHHHHcCCCHHHcCCCCCCCHH
Confidence 0 0011578999999999999997 899
Q ss_pred HHhcCCCcCcCC
Q psy11727 423 NVLRHEFFLKHS 434 (437)
Q Consensus 423 e~l~Hp~~~~~~ 434 (437)
++++||||+...
T Consensus 247 ~il~h~~~~~~~ 258 (328)
T cd05593 247 EIMRHSFFTGVN 258 (328)
T ss_pred HHhcCCCcCCCC
Confidence 999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=353.13 Aligned_cols=246 Identities=29% Similarity=0.428 Sum_probs=197.0
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
+.||+|+||.||+|.+..+++.||+|+++.... .......|..++.. ...||||+++++++...+++|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~----~~~hp~i~~~~~~~~~~~~~~lv~e 76 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLAL----AWEHPFLTHLFCTFQTKEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHh----ccCCCCccceeeEEEcCCEEEEEEc
Confidence 468999999999999999999999999974321 11222334433332 2379999999999999999999999
Q ss_pred eccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC---
Q psy11727 192 LLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG--- 267 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~--- 267 (437)
|++| +|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dlkp~Nill--~~~~~~kL~Dfg~a~~~~~~~ 150 (316)
T cd05592 77 YLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLL--DKDGHIKIADFGMCKENMNGE 150 (316)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHeEE--CCCCCEEEccCcCCeECCCCC
Confidence 9965 788887664 358999999999999999999996 489999999999999 678889999999997542
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhh
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 347 (437)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.......|.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~------------- 217 (316)
T cd05592 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR------------- 217 (316)
T ss_pred CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC-------------
Confidence 2233467899999999999999999999999999999999999999998877666655321100000
Q ss_pred cccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH-HHHhc
Q psy11727 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP-TNVLR 426 (437)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~-~e~l~ 426 (437)
.....+.+||.+||+.||.+|||+ +++++
T Consensus 218 --------------------------------------------------~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 --------------------------------------------------WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred --------------------------------------------------CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 000156899999999999999986 58889
Q ss_pred CCCcCcCC
Q psy11727 427 HEFFLKHS 434 (437)
Q Consensus 427 Hp~~~~~~ 434 (437)
||||....
T Consensus 248 h~~~~~~~ 255 (316)
T cd05592 248 HPFFRGID 255 (316)
T ss_pred CcccCCCC
Confidence 99998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=354.51 Aligned_cols=245 Identities=27% Similarity=0.431 Sum_probs=199.0
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
+.||+|+||.||++.+..+|..||+|+++... ........|+.++..+ .||||++++++|...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~i~~~~~~~~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-----RHPFLTALKYAFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-----CCCCCcceeeEEecCCEEEEEEe
Confidence 46899999999999999999999999997432 1122334566666554 78999999999999999999999
Q ss_pred eccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC---
Q psy11727 192 LLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG--- 267 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~--- 267 (437)
|+++ +|..++.... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dlkp~NIll--~~~~~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 76 YANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR--DVVYRDIKLENLML--DKDGHIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHEEE--cCCCCEEecccHHhccccCCC
Confidence 9965 7877776543 589999999999999999999954 89999999999999 678889999999986532
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhh
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 347 (437)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.......|.
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~------------- 216 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR------------- 216 (323)
T ss_pred CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC-------------
Confidence 1223467899999999999999999999999999999999999999888776665555321100000
Q ss_pred cccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC-----CHH
Q psy11727 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI-----SPT 422 (437)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~-----t~~ 422 (437)
.....+.+||.+||+.||.+|+ ++.
T Consensus 217 --------------------------------------------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 246 (323)
T cd05595 217 --------------------------------------------------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAK 246 (323)
T ss_pred --------------------------------------------------CCCHHHHHHHHHHccCCHHHhCCCCCCCHH
Confidence 0011578999999999999998 899
Q ss_pred HHhcCCCcCcCC
Q psy11727 423 NVLRHEFFLKHS 434 (437)
Q Consensus 423 e~l~Hp~~~~~~ 434 (437)
++++||||.+..
T Consensus 247 ~~l~h~~~~~~~ 258 (323)
T cd05595 247 EVMEHRFFLSIN 258 (323)
T ss_pred HHHcCCCcCCCC
Confidence 999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=357.94 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=205.9
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|.+.+.||+|+||+||+|.+..+++.||+|+++.... ....+..|+.++..+ .|+||+++++++.+.++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-----~~~~i~~~~~~~~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-----NSPWIPQLQYAFQDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCCcceeeEEecCCe
Confidence 469999999999999999999999999999999974322 223445566665543 78999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~--~~i~H~Dlkp~NIll--~~~~~~kL~Dfg~a~ 150 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQ--MGYVHRDIKPENVLI--DRTGHIKLADFGSAA 150 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeEcccCchHheEE--CCCCCEEeccCCCCe
Confidence 9999999955 8888887653 468999999999999999999995 489999999999999 778899999999997
Q ss_pred ecCCcc----ccccccccccChhhhc------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 265 HVGQTL----YQYIQSRYYRSPEVLL------GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 265 ~~~~~~----~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
...... ....||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+....+..+........
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~- 229 (330)
T cd05601 151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK- 229 (330)
T ss_pred ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC-
Confidence 654321 2346899999999997 45678999999999999999999999998887766666543210000
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
.|.. ......+.+||++||. |
T Consensus 230 ---------------------------------~~~~-------------------------~~~~~~~~~li~~ll~-~ 250 (330)
T cd05601 230 ---------------------------------FPED-------------------------PKVSSDFLDLIQSLLC-G 250 (330)
T ss_pred ---------------------------------CCCC-------------------------CCCCHHHHHHHHHHcc-C
Confidence 0000 0001257899999998 9
Q ss_pred CCCCCCHHHHhcCCCcCcCCC
Q psy11727 415 PKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~~~~~~ 435 (437)
|.+|||++++++||||+...+
T Consensus 251 p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 251 QKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred hhhCCCHHHHhCCCCcCCCCH
Confidence 999999999999999987653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=359.03 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=203.8
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ .||||+++++++.+++
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-----~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-----NSPWVVQLFCAFQDDK 116 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcCC
Confidence 468999999999999999999999999999999986321 1122344566666554 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
++|+||||+++ +|.+++... .+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~--~~IvHrDLKp~NILl--~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHS--MGLIHRDVKPDNMLL--DKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEE--CCCCCEEEEecccc
Confidence 99999999965 888888654 47999999999999999999995 489999999999999 67889999999999
Q ss_pred eecCCc----cccccccccccChhhhcCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 264 CHVGQT----LYQYIQSRYYRSPEVLLGIP----YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 264 ~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
...... ..+.+||+.|+|||++.+.. ++.++|+|||||++|+|++|.+||.+.+....+..++.....+.
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-- 267 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN-- 267 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC--
Confidence 765432 23567999999999997643 78899999999999999999999999887777776654211100
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
.|.. ......+++||.+||..+|
T Consensus 268 --------------------------------~p~~-------------------------~~~s~~~~~li~~~L~~~~ 290 (370)
T cd05621 268 --------------------------------FPED-------------------------VEISKHAKNLICAFLTDRE 290 (370)
T ss_pred --------------------------------CCCc-------------------------ccCCHHHHHHHHHHccCch
Confidence 0000 0001156899999998655
Q ss_pred CC--CCCHHHHhcCCCcCcC
Q psy11727 416 KK--RISPTNVLRHEFFLKH 433 (437)
Q Consensus 416 ~~--R~t~~e~l~Hp~~~~~ 433 (437)
.+ |+|+.|+++||||+..
T Consensus 291 ~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 291 VRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred hccCCCCHHHHhcCcccCCC
Confidence 43 8999999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=349.92 Aligned_cols=299 Identities=25% Similarity=0.363 Sum_probs=212.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.++|++.+.||+|+||.||++++..++..||+|++.... .....+..|+.++..+ .|+||+++++++...+.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-----NSPYIVGFYGAFYSDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-----CCCCCCeEEEEEEECCEE
Confidence 468999999999999999999999999999999987432 2234566787777766 789999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++||||+++ +|.+++.... .+++..+..++.|++.||.|||+. .+|+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~ 153 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILV--NSRGEIKLCDFGVSGQ 153 (331)
T ss_pred EEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEE--cCCCcEEEccCccccc
Confidence 999999965 8888887653 589999999999999999999964 369999999999999 6788899999999876
Q ss_pred cCCc-cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc
Q psy11727 266 VGQT-LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344 (437)
Q Consensus 266 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 344 (437)
.... .....|+..|+|||++.+..++.++|+|||||++|||++|+.||...+..+.... ++.+...........
T Consensus 154 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~- 228 (331)
T cd06649 154 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI----FGRPVVDGEEGEPHS- 228 (331)
T ss_pred ccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----hcccccccccCCccc-
Confidence 5332 2345789999999999999999999999999999999999999987765443222 222211100000000
Q ss_pred hhhcccCCCcceeccccc-cccccCCCCC--chhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 345 KYFDRLSDNSYVLKKSTD-TRKERLPGSK--RLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
............. ......+... .+.+.+.... + ...+ .......+++||.+||++||++|||+
T Consensus 229 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~----~~~~--~~~~~~~l~~li~~~L~~~P~~Rpt~ 295 (331)
T cd06649 229 -----ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEP--P----PKLP--NGVFTPDFQEFVNKCLIKNPAERADL 295 (331)
T ss_pred -----cCcccccccccccccccccccchhHHHHHHHHHhCC--C----cCCC--CccccHHHHHHHHHHccCCcccCCCH
Confidence 0000000000000 0000000000 0001000000 0 0000 00112368999999999999999999
Q ss_pred HHHhcCCCcCcCCC
Q psy11727 422 TNVLRHEFFLKHSV 435 (437)
Q Consensus 422 ~e~l~Hp~~~~~~~ 435 (437)
.++++||||+....
T Consensus 296 ~ell~h~~~~~~~~ 309 (331)
T cd06649 296 KMLMNHTFIKRSEV 309 (331)
T ss_pred HHHhcChHHhhccc
Confidence 99999999987643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=358.90 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=205.8
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+..|+.++..+ .||||+++++++.+.+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-----~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-----NSEWIVQLHYAFQDDK 116 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-----CCCCcceEEEEEecCC
Confidence 568999999999999999999999999999999996321 1122344566666654 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
++|+||||+++ +|.+++... .+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDLkp~NILl--~~~~~~kL~DfG~~ 189 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM--GFIHRDVKPDNMLL--DKSGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEE--cCCCCEEEEeccce
Confidence 99999999965 788887654 478999999999999999999964 89999999999999 77889999999999
Q ss_pred eecCCc----cccccccccccChhhhcCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 264 CHVGQT----LYQYIQSRYYRSPEVLLGI----PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 264 ~~~~~~----~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
...... ....+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+....+..+........
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~-- 267 (370)
T cd05596 190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT-- 267 (370)
T ss_pred eeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC--
Confidence 765432 2346789999999999754 478999999999999999999999999887777666643211000
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
.|... .....+.+||++||+.+|
T Consensus 268 --------------------------------~~~~~-------------------------~~s~~~~~li~~~L~~~p 290 (370)
T cd05596 268 --------------------------------FPDDI-------------------------EISKQAKDLICAFLTDRE 290 (370)
T ss_pred --------------------------------CCCcC-------------------------CCCHHHHHHHHHHccChh
Confidence 00000 001257899999999999
Q ss_pred CC--CCCHHHHhcCCCcCcCC
Q psy11727 416 KK--RISPTNVLRHEFFLKHS 434 (437)
Q Consensus 416 ~~--R~t~~e~l~Hp~~~~~~ 434 (437)
.+ |+|++++++||||++..
T Consensus 291 ~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 291 VRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred hccCCCCHHHHhcCcccCCCC
Confidence 98 99999999999998743
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=350.42 Aligned_cols=247 Identities=29% Similarity=0.457 Sum_probs=198.7
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
+.||+|+||+||+|.+..+++.||||+++... ........|..++... ..||||+++++++.+.+.+++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~hp~iv~~~~~~~~~~~~~lv~e 76 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA----WEHPFLTHLYCTFQTKENLFFVME 76 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc----cCCCcCcceEEEEEeCCEEEEEEe
Confidence 46899999999999999999999999997432 1122333444444332 489999999999999999999999
Q ss_pred eccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC---
Q psy11727 192 LLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG--- 267 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~--- 267 (437)
|+++ +|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 y~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~--~~ivHrdikp~Nil~--~~~~~~kl~Dfg~~~~~~~~~ 150 (316)
T cd05619 77 YLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHS--KGIVYRDLKLDNILL--DTDGHIKIADFGMCKENMLGD 150 (316)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHEEE--CCCCCEEEccCCcceECCCCC
Confidence 9965 888888764 358999999999999999999996 489999999999999 678889999999987532
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhh
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 347 (437)
.......||..|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+.......|.+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~------------ 218 (316)
T cd05619 151 AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRW------------ 218 (316)
T ss_pred CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc------------
Confidence 22335678999999999999999999999999999999999999999887766655543210000000
Q ss_pred cccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH-HHhc
Q psy11727 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT-NVLR 426 (437)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~-e~l~ 426 (437)
....+.+||.+||+.||.+||++. ++++
T Consensus 219 ---------------------------------------------------~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 ---------------------------------------------------LTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ---------------------------------------------------CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 001568999999999999999996 8999
Q ss_pred CCCcCcCCC
Q psy11727 427 HEFFLKHSV 435 (437)
Q Consensus 427 Hp~~~~~~~ 435 (437)
||||+...+
T Consensus 248 h~~~~~~~~ 256 (316)
T cd05619 248 HPFFREIDW 256 (316)
T ss_pred CcccCCCCH
Confidence 999988653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=361.55 Aligned_cols=254 Identities=25% Similarity=0.420 Sum_probs=203.4
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|++.+.||+|+||+||+|++..+++.||||++.... .....+..|+.++..+ .|+||+++++.|.++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~h~~iv~~~~~~~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-----DNEWVVKLYYSFQDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-----CCCCcceEEEEEEcCCE
Confidence 36999999999999999999999999999999986321 1234456677777766 78999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+|+||||+++ +|.+++.... .+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill--~~~~~ikL~DFG~a~ 149 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHK--MGFIHRDIKPDNILI--DRDGHIKLTDFGLCT 149 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHEEE--CCCCCEEEEeCCCCc
Confidence 9999999965 8888887653 58999999999999999999995 489999999999999 678899999999974
Q ss_pred ecCC----------------------------------------------ccccccccccccChhhhcCCCCCCcchHHH
Q psy11727 265 HVGQ----------------------------------------------TLYQYIQSRYYRSPEVLLGIPYDLAIDMWS 298 (437)
Q Consensus 265 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS 298 (437)
.... .....+||+.|+|||++.+..++.++||||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 229 (376)
T cd05598 150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229 (376)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeee
Confidence 2210 011347899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhh
Q psy11727 299 LGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTIL 378 (437)
Q Consensus 299 lG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 378 (437)
|||++|||++|++||.+.+..+....+....... ..|...
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~----------------------------------~~~~~~------ 269 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQLKVINWETTL----------------------------------HIPSQA------ 269 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHHHHhccCccc----------------------------------cCCCCC------
Confidence 9999999999999999888766555443210000 000000
Q ss_pred ccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC---CHHHHhcCCCcCcCC
Q psy11727 379 GVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI---SPTNVLRHEFFLKHS 434 (437)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~---t~~e~l~Hp~~~~~~ 434 (437)
.....+.+||.+|+ .+|.+|+ |+.++++||||++..
T Consensus 270 -------------------~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 270 -------------------KLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred -------------------CCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 00114689999977 5999999 999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=355.89 Aligned_cols=278 Identities=22% Similarity=0.314 Sum_probs=207.9
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
.+|++.+.||+|+||.||+|.+..+++.||+|+.... ....|+.++..+ .|+||+++++++...+..++|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNV-----NHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhC-----CCCCCcChhheEEeCCeeEEE
Confidence 4699999999999999999999999999999986432 234577777665 789999999999999999999
Q ss_pred EEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC--
Q psy11727 190 FELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG-- 267 (437)
Q Consensus 190 ~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~-- 267 (437)
||++.++|.+++.... ..+++..++.++.||+.||.|||++ |||||||||+|||+ +..+.+||+|||++....
T Consensus 136 ~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~Nill--~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 136 LPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ--RIIHRDVKTENIFI--NDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EEccCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEE--CCCCCEEEecCccccccccC
Confidence 9999999999887654 4689999999999999999999964 89999999999999 678889999999987542
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCC---------HHHHHHHHHHHhCCCChhhh
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTG-EPLFSGKN---------EVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg-~~pf~~~~---------~~~~~~~i~~~~~~p~~~~~ 337 (437)
.......||..|+|||++.+..++.++|||||||++|||+++ .++|.... ....+..++..++..|..+.
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 223356789999999999999999999999999999999985 45555422 12344555555665554433
Q ss_pred ccCC--ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 338 HGAS--KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 338 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
.... ....++..... ..........+. .......+.+||.+||++||
T Consensus 291 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~--------------------~~~~~~~~~~li~~mL~~dP 339 (357)
T PHA03209 291 RDPGSRLVRGFIEYASL-----------ERQPYTRYPCFQ--------------------RVNLPIDGEFLVHKMLTFDA 339 (357)
T ss_pred CCCccHHHHHHHhhccc-----------CCCcccccHHHh--------------------ccCCCchHHHHHHHHHcCCc
Confidence 2111 11111110000 000000000000 00011245789999999999
Q ss_pred CCCCCHHHHhcCCCcCcC
Q psy11727 416 KKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~~ 433 (437)
.+|||+.|+|+||||++.
T Consensus 340 ~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 340 AMRPSAEEILNYPMFAQL 357 (357)
T ss_pred ccCcCHHHHhcCchhccC
Confidence 999999999999999874
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=355.39 Aligned_cols=246 Identities=27% Similarity=0.418 Sum_probs=197.9
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
+.||+|+||+||+|.+..+++.||+|++..... .......|+.++.. +.|+||++++++|...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~-----~~hp~i~~~~~~~~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-----SRHPFLTALKYSFQTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHh-----CCCCCCCceEEEEEcCCEEEEEEe
Confidence 468999999999999999999999999974321 11233345444444 478999999999999999999999
Q ss_pred eccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC---
Q psy11727 192 LLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG--- 267 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~--- 267 (437)
|+++ +|.+++... ..+++..++.++.||+.||+|||+. .||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~-~~ivHrDikp~NIll--~~~~~~kL~Dfg~~~~~~~~~ 150 (325)
T cd05594 76 YANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLML--DKDGHIKITDFGLCKEGIKDG 150 (325)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCCCCeEEE--CCCCCEEEecCCCCeecCCCC
Confidence 9965 787777654 3589999999999999999999962 489999999999999 778899999999986532
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhh
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 347 (437)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.......|
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p-------------- 216 (325)
T cd05594 151 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP-------------- 216 (325)
T ss_pred cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC--------------
Confidence 223346799999999999999999999999999999999999999998877655555432100000
Q ss_pred cccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC-----CHH
Q psy11727 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI-----SPT 422 (437)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~-----t~~ 422 (437)
. .....+.+||.+||+.||.+|+ |+.
T Consensus 217 ----------------------~---------------------------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 247 (325)
T cd05594 217 ----------------------R---------------------------TLSPEAKSLLSGLLKKDPKQRLGGGPDDAK 247 (325)
T ss_pred ----------------------C---------------------------CCCHHHHHHHHHHhhcCHHHhCCCCCCCHH
Confidence 0 0011578999999999999997 999
Q ss_pred HHhcCCCcCcCC
Q psy11727 423 NVLRHEFFLKHS 434 (437)
Q Consensus 423 e~l~Hp~~~~~~ 434 (437)
++++||||++..
T Consensus 248 ~il~h~~~~~~~ 259 (325)
T cd05594 248 EIMQHKFFAGIV 259 (325)
T ss_pred HHhcCCCcCCCC
Confidence 999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=358.53 Aligned_cols=255 Identities=27% Similarity=0.446 Sum_probs=204.5
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|++.+.||+|+||+||+|.+..+++.||+|+++... .....+..|+.++..+ .|++|+++++.|.+.++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~iv~~~~~~~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-----DGAWVVKMFYSFQDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcCCE
Confidence 46899999999999999999999999999999996321 1223445566666554 78999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+|+||||++| +|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.++|+|||++.
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~--~givHrDLkp~NIli--~~~~~vkL~DfG~~~ 149 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQ--LGFIHRDIKPDNLLL--DAKGHVKLSDFGLCT 149 (360)
T ss_pred EEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEE--CCCCCEEEeeccCCc
Confidence 9999999965 788888764 358999999999999999999995 489999999999999 678899999999986
Q ss_pred ecCCc--------------------------------------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHH
Q psy11727 265 HVGQT--------------------------------------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVEL 306 (437)
Q Consensus 265 ~~~~~--------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el 306 (437)
..... ....+||+.|+|||++.+..++.++|||||||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel 229 (360)
T cd05627 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (360)
T ss_pred ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeec
Confidence 43210 1235789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCC
Q psy11727 307 HTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPG 386 (437)
Q Consensus 307 ltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (437)
++|++||.+.+.......+....... ..|..
T Consensus 230 ~tG~~Pf~~~~~~~~~~~i~~~~~~~----------------------------------~~p~~--------------- 260 (360)
T cd05627 230 LIGYPPFCSETPQETYRKVMNWKETL----------------------------------VFPPE--------------- 260 (360)
T ss_pred ccCCCCCCCCCHHHHHHHHHcCCCce----------------------------------ecCCC---------------
Confidence 99999999988777666654310000 00000
Q ss_pred CCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC---HHHHhcCCCcCcCCC
Q psy11727 387 GRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS---PTNVLRHEFFLKHSV 435 (437)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t---~~e~l~Hp~~~~~~~ 435 (437)
. .....+.+||.+|+. ||.+|++ ++++++||||++.++
T Consensus 261 --------~--~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 261 --------V--PISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred --------C--CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCH
Confidence 0 001256899999874 9999994 899999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=350.12 Aligned_cols=247 Identities=29% Similarity=0.417 Sum_probs=200.7
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
+.||+|+||+||+|.+..++..||||+++... ........|..++..+. .|+||+++++++...+++|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~----~h~~i~~~~~~~~~~~~~~lv~e 76 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG----KHPFLTQLHSCFQTKDRLFFVME 76 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhcc----CCCCccceeeEEEcCCEEEEEEc
Confidence 46899999999999999999999999997432 12233445666655543 78999999999999999999999
Q ss_pred eccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec---C
Q psy11727 192 LLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---G 267 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~---~ 267 (437)
|+++ +|.+.+... ..+++..+..++.||+.||+|||+ .||+||||||+|||+ ++++.+||+|||++... .
T Consensus 77 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~ 150 (318)
T cd05570 77 YVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHE--RGIIYRDLKLDNVLL--DSEGHIKIADFGMCKEGILGG 150 (318)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEccCCCHHHeEE--CCCCcEEecccCCCeecCcCC
Confidence 9965 787777654 358999999999999999999995 489999999999999 67889999999998653 2
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhh
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 347 (437)
......+|+..|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.......+.......|
T Consensus 151 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~-------------- 216 (318)
T cd05570 151 VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP-------------- 216 (318)
T ss_pred CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC--------------
Confidence 223345789999999999999999999999999999999999999998887666555532100000
Q ss_pred cccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH-----H
Q psy11727 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP-----T 422 (437)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~-----~ 422 (437)
. .....+.+||++||+.||.+|||+ .
T Consensus 217 ----------------------~---------------------------~~~~~~~~li~~~l~~dP~~R~s~~~~~~~ 247 (318)
T cd05570 217 ----------------------R---------------------------WLSKEAKSILKSFLTKNPEKRLGCLPTGEQ 247 (318)
T ss_pred ----------------------C---------------------------cCCHHHHHHHHHHccCCHHHcCCCCCCCHH
Confidence 0 001157899999999999999999 9
Q ss_pred HHhcCCCcCcCCC
Q psy11727 423 NVLRHEFFLKHSV 435 (437)
Q Consensus 423 e~l~Hp~~~~~~~ 435 (437)
+++.||||....+
T Consensus 248 ~ll~~~~~~~~~~ 260 (318)
T cd05570 248 DIKGHPFFREIDW 260 (318)
T ss_pred HHhcCCCcCCCCH
Confidence 9999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=345.23 Aligned_cols=283 Identities=29% Similarity=0.521 Sum_probs=205.7
Q ss_pred eceecccCceEEEEEEEcC--CCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE--CCEEEEEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHE--EKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--KNHLCLVF 190 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~--~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--~~~~~lV~ 190 (437)
..+||+|+||+||+|.... ++..||+|.+... .......+|+.++..+ .|+||+++++++.. +..+++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-GISMSACREIALLREL-----KHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC-CCcHHHHHHHHHHHhC-----CCCCeeeEEEEEeccCCCeEEEEE
Confidence 3579999999999998654 6688999998643 2334567788888876 68999999998854 56889999
Q ss_pred EeccCcHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec--CCCCCEEEEeCC
Q psy11727 191 ELLSYNLYNLIRNTN-------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS--PKRSAIKIIDFG 261 (437)
Q Consensus 191 E~~~~~L~~~l~~~~-------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~--~~~~~ikL~DFG 261 (437)
||++++|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+|||+.. +.++.+||+|||
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 80 DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC--CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 999999988875321 22478999999999999999999964 8999999999999943 245689999999
Q ss_pred CceecCCc------cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHH
Q psy11727 262 SSCHVGQT------LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNE---------VDQMTKI 325 (437)
Q Consensus 262 ~s~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~---------~~~~~~i 325 (437)
++...... .....+|..|+|||++.+. .++.++|||||||++|||+||.+||....+ ..++..+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 99765432 2235678999999999774 588999999999999999999999976543 2456677
Q ss_pred HHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHH
Q psy11727 326 IEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKD 405 (437)
Q Consensus 326 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 405 (437)
...++.+....+........+.....+ + ........ .+...+ ..........+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--------~~~~~~~~-~~~~~~--------------~~~~~~~~~~~~~ 292 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKD--F--------RRTTYANS-SLIKYM--------------EKHKVKPDSKVFL 292 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhh--h--------cccccCCc-hhhhhh--------------hcccCCCChHHHH
Confidence 777777766655443322222111000 0 00000000 000000 0000111225789
Q ss_pred HHHHccccCCCCCCCHHHHhcCCCc
Q psy11727 406 LILRMLTYDPKKRISPTNVLRHEFF 430 (437)
Q Consensus 406 li~~~L~~dP~~R~t~~e~l~Hp~~ 430 (437)
||.+||+.||.+|||+.|+|+||||
T Consensus 293 ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 293 LLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHHHHhccCcccccCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=351.99 Aligned_cols=246 Identities=27% Similarity=0.434 Sum_probs=196.4
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCcccc----hHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFL----NQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~----~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
+.||+|+||+||+|.+..+++.||+|++....... .....|... ....+.||||+++++.+...+.+|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~----~~~~l~hp~iv~~~~~~~~~~~~~lv~e 76 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV----LLKNVKHPFLVGLHYSFQTADKLYFVLD 76 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHH----HHhhCCCCCCCCeeEEEEeCCEEEEEEc
Confidence 46899999999999999999999999996432111 111222221 1234589999999999999999999999
Q ss_pred eccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC---
Q psy11727 192 LLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG--- 267 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~--- 267 (437)
|+.+ +|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~givH~dikp~NIll--~~~~~~kl~Dfg~~~~~~~~~ 150 (323)
T cd05575 77 YVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS--LNIIYRDLKPENILL--DSQGHVVLTDFGLCKEGIEHS 150 (323)
T ss_pred CCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEE--CCCCcEEEeccCCCcccccCC
Confidence 9965 788887654 358999999999999999999995 489999999999999 678899999999986432
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhh
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 347 (437)
......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+....-..+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-------------- 216 (323)
T cd05575 151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK-------------- 216 (323)
T ss_pred CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC--------------
Confidence 223345789999999999999999999999999999999999999998877666665543100000
Q ss_pred cccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH----HH
Q psy11727 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP----TN 423 (437)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~----~e 423 (437)
+. ....+.+||.+||+.||.+||++ .+
T Consensus 217 ---------------------------------------------~~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (323)
T cd05575 217 ---------------------------------------------PN----ISVSARHLLEGLLQKDRTKRLGAKDDFLE 247 (323)
T ss_pred ---------------------------------------------CC----CCHHHHHHHHHHhhcCHHhCCCCCCCHHH
Confidence 00 01157899999999999999998 59
Q ss_pred HhcCCCcCcCC
Q psy11727 424 VLRHEFFLKHS 434 (437)
Q Consensus 424 ~l~Hp~~~~~~ 434 (437)
+++||||....
T Consensus 248 il~~~~~~~~~ 258 (323)
T cd05575 248 IKNHVFFSSIN 258 (323)
T ss_pred HHcCCCcCCCC
Confidence 99999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=337.70 Aligned_cols=277 Identities=31% Similarity=0.523 Sum_probs=216.7
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+|++.+.||+|++|+||+|.+..++..||+|.++... ........|+.+++.+ .|+||+++++++.+++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-----QHPNIVCLQDVLMQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-----CCCCEeeeEEEEeeCCeEE
Confidence 4889999999999999999999999999999986432 2234566788887776 6899999999999999999
Q ss_pred EEEEeccCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSYNLYNLIRNTNF-HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~~L~~~l~~~~~-~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||++++|.+++..... ..+++..++.++.||+.||+|||+ .|++||||||+||++ +.++.++|+|||++...
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~ 151 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS--RRVLHRDLKPQNLLI--DNKGVIKLADFGLARAF 151 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEE--cCCCcEEECcccceeec
Confidence 9999999999888865432 458999999999999999999995 489999999999999 67888999999998765
Q ss_pred CCcc---ccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 267 GQTL---YQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 267 ~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.... ....++..|+|||++.+. .++.++|+|||||++|+|+||++||.+.+..+....+....+.+....++....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 152 GIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred CCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 4322 223567889999998764 578999999999999999999999999988888888877777766655544332
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
...+....+... ...+... .......+.+||++||+.||.+|||+.
T Consensus 232 ~~~~~~~~~~~~----------------~~~~~~~------------------~~~~~~~~~~li~~~l~~dP~~Rpt~~ 277 (285)
T cd07861 232 LPDYKNTFPKWK----------------KGSLRSA------------------VKNLDEDGLDLLEKMLIYDPAKRISAK 277 (285)
T ss_pred hHHHHhhccccC----------------cchhHHh------------------cCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence 222211111000 0000000 000112568999999999999999999
Q ss_pred HHhcCCCc
Q psy11727 423 NVLRHEFF 430 (437)
Q Consensus 423 e~l~Hp~~ 430 (437)
+++.||||
T Consensus 278 ~ll~~~~~ 285 (285)
T cd07861 278 KALNHPYF 285 (285)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=352.28 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=198.0
Q ss_pred CeeeeceecccCceEEEEEEEc---CCCeEEEEEEecCCc-----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDH---EEKCQVAIKIIKNKK-----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~---~~~~~vaiK~i~~~~-----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
+|++.+.||+|+||+||+|++. .+++.||+|++.... ........|+.+++.+. +|++|+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR----QSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhcc----CCCCcccEEEEEec
Confidence 4889999999999999999764 478999999986321 12234556777777664 58899999999999
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
.+.+++||||+++ +|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||
T Consensus 77 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nili--~~~~~~kl~DfG 150 (332)
T cd05614 77 EAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHK--LGIVYRDIKLENILL--DSEGHVVLTDFG 150 (332)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHeEE--CCCCCEEEeeCc
Confidence 9999999999965 888888664 358999999999999999999995 489999999999999 678899999999
Q ss_pred CceecCC----ccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCCCChh
Q psy11727 262 SSCHVGQ----TLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV-LGMPPGY 335 (437)
Q Consensus 262 ~s~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~p~~~ 335 (437)
++..... .....+||..|+|||++.+. .++.++|||||||++|||++|..||...........+... ....+.
T Consensus 151 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~- 229 (332)
T cd05614 151 LSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP- 229 (332)
T ss_pred CCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC-
Confidence 9875422 22346789999999999875 4789999999999999999999999754322111111111 000000
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
.| ......+.+||.+||+.||
T Consensus 230 --------------------------------~~---------------------------~~~~~~~~~li~~~l~~dp 250 (332)
T cd05614 230 --------------------------------FP---------------------------SFIGPEAQDLLHKLLRKDP 250 (332)
T ss_pred --------------------------------CC---------------------------CCCCHHHHHHHHHHcCCCH
Confidence 00 0001257899999999999
Q ss_pred CCCC-----CHHHHhcCCCcCcCC
Q psy11727 416 KKRI-----SPTNVLRHEFFLKHS 434 (437)
Q Consensus 416 ~~R~-----t~~e~l~Hp~~~~~~ 434 (437)
.+|| +++++++||||++..
T Consensus 251 ~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 251 KKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred HHcCCCCCCCHHHHHcCCCcCCCC
Confidence 9999 889999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=351.72 Aligned_cols=190 Identities=26% Similarity=0.461 Sum_probs=162.3
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
++||+|+||.||+|.+..+++.||+|+++... ........|..+++.+. .||||++++++|.+.+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~----~hp~Iv~~~~~~~~~~~~~lv~e 76 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS----NHPFLVGLHSCFQTESRLFFVIE 76 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc----CCCCCCceEEEEEcCCEEEEEEe
Confidence 46899999999999999999999999997432 12233456666666553 68999999999999999999999
Q ss_pred eccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec---C
Q psy11727 192 LLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---G 267 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~---~ 267 (437)
|+++ +|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++... .
T Consensus 77 ~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nili--~~~~~~kL~Dfg~~~~~~~~~ 150 (329)
T cd05588 77 FVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHE--RGIIYRDLKLDNVLL--DAEGHIKLTDYGMCKEGIRPG 150 (329)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEE--CCCCCEEECcCccccccccCC
Confidence 9965 788777654 358999999999999999999995 489999999999999 67888999999998642 2
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG 315 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~ 315 (437)
......+||+.|+|||++.+..++.++|+|||||++|+|++|++||..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 333456899999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=343.03 Aligned_cols=250 Identities=31% Similarity=0.509 Sum_probs=215.7
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc----chHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~----~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
.+..+|++.+.||+|.||.|-+|+....|+.||||.|++.+.. .-.+.+|+.|+..+ .||||+.++++|+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-----NHPhII~IyEVFEN 124 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-----NHPHIIQIYEVFEN 124 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-----CCCceeehhhhhcC
Confidence 3456899999999999999999999999999999999865433 23456788888877 78999999999999
Q ss_pred CCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
.+...|||||.+ |.|++++.... .+++..++.|++||..|+.|+|.+ +++|||||.+|||+ |.++++||+|||
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHkn--rVvHRDLKLENILL--D~N~NiKIADFG 198 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKN--RVVHRDLKLENILL--DQNNNIKIADFG 198 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhc--cceecccchhheee--cCCCCeeeeccc
Confidence 999999999995 58999998764 599999999999999999999965 79999999999999 889999999999
Q ss_pred CceecC--CccccccccccccChhhhcCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 262 SSCHVG--QTLYQYIQSRYYRSPEVLLGIPYD-LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 262 ~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
++..+. .-..++||++-|.+||++.|.+|. +.+|.|||||+||.|+.|..||.|.+...++.+|..+...-
T Consensus 199 LSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE------ 272 (668)
T KOG0611|consen 199 LSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE------ 272 (668)
T ss_pred hhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC------
Confidence 998764 345689999999999999999986 78999999999999999999999999888888885531111
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
|. .|. ...-||++||-.||++|
T Consensus 273 ------------------------------P~-------------~PS---------------dA~gLIRwmLmVNP~RR 294 (668)
T KOG0611|consen 273 ------------------------------PE-------------TPS---------------DASGLIRWMLMVNPERR 294 (668)
T ss_pred ------------------------------CC-------------CCc---------------hHHHHHHHHHhcCcccc
Confidence 10 000 34679999999999999
Q ss_pred CCHHHHhcCCCcC
Q psy11727 419 ISPTNVLRHEFFL 431 (437)
Q Consensus 419 ~t~~e~l~Hp~~~ 431 (437)
.|++++..|=|+.
T Consensus 295 ATieDiAsHWWvN 307 (668)
T KOG0611|consen 295 ATIEDIASHWWVN 307 (668)
T ss_pred hhHHHHhhhheee
Confidence 9999999998874
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=340.78 Aligned_cols=256 Identities=29% Similarity=0.410 Sum_probs=205.2
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.|++.+.||+|+||+||++.+..+++.||+|++..... ....+..|+.+++.+ .|+||+++++.+.+++++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-----NSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-----CCCCEeeeeeeecCCCeE
Confidence 48899999999999999999999999999999864321 112345577777666 689999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
|+||||+.+ +|.+++.......+++..+..++.|++.||.|||+. ||+||||||+||++ ++++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~--~~~~~~~l~Dfg~~~~ 151 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE--RIVYRDLKPENILL--DDYGHIRISDLGLAVE 151 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC--CcEecCCCHHHEEE--CCCCCEEEeeCCCcee
Confidence 999999965 787777655445689999999999999999999964 89999999999999 6788899999999976
Q ss_pred cCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 266 VGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 266 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.... ....+|+..|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.......+.......+..
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------- 223 (285)
T cd05605 152 IPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEE-------- 223 (285)
T ss_pred cCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccc--------
Confidence 5322 234578999999999999899999999999999999999999999876654443333221100000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC----
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI---- 419 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~---- 419 (437)
+ .......+.+||.+||..||.+||
T Consensus 224 --~-------------------------------------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05605 224 --Y-------------------------------------------------SEKFSEAARSICRQLLTKDPGFRLGCRG 252 (285)
T ss_pred --c-------------------------------------------------CcccCHHHHHHHHHHccCCHHHhcCCCC
Confidence 0 000112578999999999999999
Q ss_pred -CHHHHhcCCCcCcCC
Q psy11727 420 -SPTNVLRHEFFLKHS 434 (437)
Q Consensus 420 -t~~e~l~Hp~~~~~~ 434 (437)
|++++++||||.+..
T Consensus 253 ~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 253 EGAEEVKAHPFFRTAN 268 (285)
T ss_pred CCHHHHhcCcCccCCC
Confidence 999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=347.31 Aligned_cols=251 Identities=26% Similarity=0.401 Sum_probs=203.7
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
+|...+.||+|+||+||+|.+..+++.||+|++..... .......|..++..+. +|++|+++++++.+.+.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~----~~~~i~~~~~~~~~~~~~ 76 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD----KPPFLTQLHSCFQTVDRL 76 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcc----CCCchhheeeEEecCCEE
Confidence 37788999999999999999999999999999974321 1223444555554442 567899999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
|+||||+++ +|.+++... ..+++..+..++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++..
T Consensus 77 ~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~--~~ivHrDikp~Nill--~~~~~ikL~Dfg~~~~ 150 (323)
T cd05615 77 YFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHR--RGIIYRDLKLDNVML--DSEGHIKIADFGMCKE 150 (323)
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEE--CCCCCEEEeccccccc
Confidence 999999965 788887654 358999999999999999999995 489999999999999 6788999999999875
Q ss_pred cCC---ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 266 VGQ---TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 266 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
... ......||+.|+|||++.+..++.++|+|||||++|+|++|++||.+.+.......+.......|..
T Consensus 151 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~------- 223 (323)
T cd05615 151 HMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKS------- 223 (323)
T ss_pred cCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc-------
Confidence 422 2234568999999999999999999999999999999999999999988777776665421110000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC--
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS-- 420 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t-- 420 (437)
....+.+|+.+||+.||.+|++
T Consensus 224 --------------------------------------------------------~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 224 --------------------------------------------------------LSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred --------------------------------------------------------CCHHHHHHHHHHcccCHhhCCCCC
Confidence 0015689999999999999998
Q ss_pred ---HHHHhcCCCcCcCC
Q psy11727 421 ---PTNVLRHEFFLKHS 434 (437)
Q Consensus 421 ---~~e~l~Hp~~~~~~ 434 (437)
.+++++||||+...
T Consensus 248 ~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 248 PEGERDIREHAFFRRID 264 (323)
T ss_pred CCCHHHHhcCcccCCCC
Confidence 57899999999765
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=348.78 Aligned_cols=293 Identities=32% Similarity=0.535 Sum_probs=223.6
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC-
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK- 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~- 183 (437)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ........|+.+++.+ .|+||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-----NHKNIIGLLNVFTPQK 88 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-----CCCCCcceeeeeccCC
Confidence 4678999999999999999999999999999999986321 1223445677777665 789999999988643
Q ss_pred -----CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 184 -----NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 184 -----~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
.+.|+||||++++|.+.+... +++..+..++.||+.||+|||++ ||+||||||+||++ +.++.+||+
T Consensus 89 ~~~~~~~~~lv~e~~~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~--gi~H~dlkp~Nil~--~~~~~~kL~ 160 (353)
T cd07850 89 SLEEFQDVYLVMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVV--KSDCTLKIL 160 (353)
T ss_pred CccccCcEEEEEeccCCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEE--CCCCCEEEc
Confidence 367999999999998887643 78999999999999999999964 89999999999999 678899999
Q ss_pred eCCCceecCCcc--ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 259 DFGSSCHVGQTL--YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 259 DFG~s~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
|||++....... ....++..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...++.|+..+
T Consensus 161 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 161 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 999997764432 235678899999999999999999999999999999999999999998899999999999998877
Q ss_pred hccCCccch-hhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 337 LHGASKTSK-YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 337 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
+........ +....+... ...+.++.... ..|.. ....+......+++||.+||++||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~li~~~L~~dP 299 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYA----------------GYSFEELFPDV-LFPPD----SESHNKLKASQARDLLSKMLVIDP 299 (353)
T ss_pred HHHhhhhhhHHhhcCCCCC----------------CcchhhhCccc-ccCcc----cccccccchhHHHHHHHHHcCCCh
Confidence 665443221 111111000 00000000000 00000 000011122357899999999999
Q ss_pred CCCCCHHHHhcCCCcCcCC
Q psy11727 416 KKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~~~ 434 (437)
.+|||+.|+|+||||.++.
T Consensus 300 ~~R~t~~eiL~~~~~~~~~ 318 (353)
T cd07850 300 EKRISVDDALQHPYINVWY 318 (353)
T ss_pred hhCcCHHHHhcChhHhhcc
Confidence 9999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=352.99 Aligned_cols=251 Identities=29% Similarity=0.437 Sum_probs=206.5
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
..|...+.||+|+||.||+|.+..+++.||+|++.... ......+.|+.++..+ .++||.++++.|..+..++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-----~~~~it~yygsyl~g~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-----DSPNITEYYGSYLKGTKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-----CcchHHhhhhheeecccHH
Confidence 35777899999999999999999999999999997443 3345667788888776 6689999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
++||||.| ++.++++..+ .+.+..+..++++++.||.|||.+ +.+|||||+.|||+. ..|.+||+|||.+...
T Consensus 88 iiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~--~kiHrDIKaanil~s--~~g~vkl~DfgVa~ql 161 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSE--KKIHRDIKAANILLS--ESGDVKLADFGVAGQL 161 (467)
T ss_pred HHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhc--ceecccccccceeEe--ccCcEEEEecceeeee
Confidence 99999965 7888887654 248888999999999999999976 699999999999994 5689999999999776
Q ss_pred CCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
... ..+++||++|||||++.+..|+.++||||||++.+||++|.||+....+...+..|-+ ..||.
T Consensus 162 ~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk--~~PP~--------- 230 (467)
T KOG0201|consen 162 TNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK--SAPPR--------- 230 (467)
T ss_pred echhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC--CCCCc---------
Confidence 433 2578999999999999988999999999999999999999999998776322222211 00110
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
.+-.-...|+|||..||+.||+.||||.+
T Consensus 231 ---------------------------------------------------L~~~~S~~~kEFV~~CL~k~P~~RpsA~~ 259 (467)
T KOG0201|consen 231 ---------------------------------------------------LDGDFSPPFKEFVEACLDKNPEFRPSAKE 259 (467)
T ss_pred ---------------------------------------------------cccccCHHHHHHHHHHhhcCcccCcCHHH
Confidence 00000115899999999999999999999
Q ss_pred HhcCCCcCcC
Q psy11727 424 VLRHEFFLKH 433 (437)
Q Consensus 424 ~l~Hp~~~~~ 433 (437)
+|+|+|++..
T Consensus 260 LLKh~FIk~a 269 (467)
T KOG0201|consen 260 LLKHKFIKRA 269 (467)
T ss_pred HhhhHHHHhc
Confidence 9999999873
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=352.92 Aligned_cols=286 Identities=27% Similarity=0.435 Sum_probs=215.9
Q ss_pred CceeccCeeeeceecccCceEEEEEEEc--CCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDH--EEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 105 ~~~~~~~y~i~~~lG~G~fg~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
...+..+|.+.+.||+|+||.||+|... .++..||+|.+... ....+|+.+++.+ .|+|||+++++|..
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l-----~h~~iv~~~~~~~~ 157 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTI-----SHRAIINLIHAYRW 157 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhc-----CCCCccceeeeEee
Confidence 3344568999999999999999999754 35678999988643 3445788888876 68999999999999
Q ss_pred CCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 183 KNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 183 ~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
.+.+|+|||++.++|.+++... ..+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.++|+|||+
T Consensus 158 ~~~~~lv~e~~~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~--~givHrDlkp~Nill--~~~~~~~l~DfG~ 231 (392)
T PHA03207 158 KSTVCMVMPKYKCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFL--DEPENAVLGDFGA 231 (392)
T ss_pred CCEEEEEehhcCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEE--cCCCCEEEccCcc
Confidence 9999999999999999988443 458999999999999999999995 489999999999999 6788899999999
Q ss_pred ceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCh
Q psy11727 263 SCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN---EVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 263 s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~p~~ 334 (437)
++..... .....||..|+|||++.+..|+.++|||||||++|||++|+.||.+.. ....+..+.+.++..+.
T Consensus 232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~ 311 (392)
T PHA03207 232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPL 311 (392)
T ss_pred ccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcc
Confidence 9765432 224578999999999999999999999999999999999999997653 34566777777665554
Q ss_pred hhhccCCc-cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 335 YLLHGASK-TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 335 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
.+...... ....|.... . ...+... ....+. .......+.+||++||.+
T Consensus 312 ~~~~~~~~~~~~~~~~~~---~----------~~~~~~~-~~~~~~----------------~~~~~~~~~~li~~ml~~ 361 (392)
T PHA03207 312 EFPQNGSTNLCKHFKQYA---I----------VLRPPYT-IPPVIR----------------KYGMHMDVEYLIAKMLTF 361 (392)
T ss_pred ccCCccchhHHHHHHhhc---c----------cccCCcc-ccchhh----------------ccCcchhHHHHHHHHhcc
Confidence 32211110 001111000 0 0000000 000000 000112578999999999
Q ss_pred CCCCCCCHHHHhcCCCcCcCCC
Q psy11727 414 DPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 414 dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
||++|||+.|+|.||||++...
T Consensus 362 dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 362 DQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred ChhhCCCHHHHhhCchhhccch
Confidence 9999999999999999987544
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=381.54 Aligned_cols=255 Identities=28% Similarity=0.423 Sum_probs=216.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecC----CcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKN----KKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~----~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|+++++||+|+||.|.+++.+.|++.||+|++.+ +......+..|..++-.- +.+|||+++..|++.+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-----ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-----NSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-----CcHHHHHHHHHhcCcc
Confidence 5689999999999999999999999999999999974 234445566677666432 5789999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
++|+||||++| +|..++.+.. .++++++++|+..|..||.-|| ++|+|||||||+|||| |..|+|||+|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH--~mgyVHRDiKPDNvLl--d~~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH--SMGYVHRDIKPDNVLL--DKSGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH--hccceeccCCcceeEe--cccCcEeeccchhH
Confidence 99999999965 7888887654 6999999999999999999999 6899999999999999 89999999999998
Q ss_pred eecCCc----cccccccccccChhhhcC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH---hCC
Q psy11727 264 CHVGQT----LYQYIQSRYYRSPEVLLG-----IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV---LGM 331 (437)
Q Consensus 264 ~~~~~~----~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~---~~~ 331 (437)
..+... ....+|||.|+|||++.. +.|+..+|+||+||++|||+.|..||+.++-.+++.+|+.- ++.
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~F 302 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSF 302 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCC
Confidence 766422 345789999999999963 46899999999999999999999999999999999999874 222
Q ss_pred CChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 332 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
|.. ....+..+|||+++|
T Consensus 303 P~~--------------------------------------------------------------~~VSeeakdLI~~ll 320 (1317)
T KOG0612|consen 303 PDE--------------------------------------------------------------TDVSEEAKDLIEALL 320 (1317)
T ss_pred Ccc--------------------------------------------------------------cccCHHHHHHHHHHh
Confidence 210 001125689999988
Q ss_pred ccCCCCCCC---HHHHhcCCCcCcCCCCC
Q psy11727 412 TYDPKKRIS---PTNVLRHEFFLKHSVDN 437 (437)
Q Consensus 412 ~~dP~~R~t---~~e~l~Hp~~~~~~~~~ 437 (437)
. +|..|.. ++++-.||||.+..|+|
T Consensus 321 ~-~~e~RLgrngiedik~HpFF~g~~W~~ 348 (1317)
T KOG0612|consen 321 C-DREVRLGRNGIEDIKNHPFFEGIDWDN 348 (1317)
T ss_pred c-ChhhhcccccHHHHHhCccccCCChhh
Confidence 5 7899998 99999999999998865
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=350.80 Aligned_cols=250 Identities=25% Similarity=0.434 Sum_probs=196.2
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccC
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY 195 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~ 195 (437)
+.||+|+||+||+|.+..+|+.||+|++............+...........+.||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999999999999999996432111111111111111123345899999999999999999999999965
Q ss_pred -cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec---CCccc
Q psy11727 196 -NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---GQTLY 271 (437)
Q Consensus 196 -~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~---~~~~~ 271 (437)
+|...+... ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++... .....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~--~givH~Dlkp~NIll--~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS--INIVYRDLKPENILL--DSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEE--CCCCCEEEeecCCcccCCCCCCCcc
Confidence 787777654 358999999999999999999995 489999999999999 77889999999998643 22234
Q ss_pred cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccC
Q psy11727 272 QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLS 351 (437)
Q Consensus 272 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~ 351 (437)
..+||..|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+....-..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~------------------ 216 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR------------------ 216 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC------------------
Confidence 56789999999999999999999999999999999999999998887666655543100000
Q ss_pred CCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH----HHHhcC
Q psy11727 352 DNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP----TNVLRH 427 (437)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~----~e~l~H 427 (437)
++ ....+.++|++||+.||.+||++ .++++|
T Consensus 217 -----------------------------------------~~----~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 217 -----------------------------------------PG----ASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred -----------------------------------------CC----CCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 00 01156899999999999999987 589999
Q ss_pred CCcCcCC
Q psy11727 428 EFFLKHS 434 (437)
Q Consensus 428 p~~~~~~ 434 (437)
|||....
T Consensus 252 ~~f~~~~ 258 (325)
T cd05604 252 PFFESLS 258 (325)
T ss_pred CCcCCCC
Confidence 9998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=330.99 Aligned_cols=292 Identities=32% Similarity=0.506 Sum_probs=228.5
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCe----EEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKC----QVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~----~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
...|+++..||+|.||.||+|..+.++. .+|||.++..+ .....+.+|+.+++.+ .|+|++.+..+|.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-----~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-----KHPNVISLVKVFL 97 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-----cCCcchhHHHHHh
Confidence 4579999999999999999997665543 68999997542 3456788899999988 7899999999998
Q ss_pred E-CCEEEEEEEeccCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC--CCCCE
Q psy11727 182 W-KNHLCLVFELLSYNLYNLIRNTN---FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP--KRSAI 255 (437)
Q Consensus 182 ~-~~~~~lV~E~~~~~L~~~l~~~~---~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~--~~~~i 255 (437)
. +..+++++||.+.+|+..|+..+ .+.++...++.|+.||+.+++|||++ -|+||||||.|||+..+ ++|.|
T Consensus 98 ~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N--WvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN--WVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred ccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh--heeeccCCcceEEEeccCCccCee
Confidence 7 77999999999999999886532 24589999999999999999999975 69999999999999533 45899
Q ss_pred EEEeCCCceecCCccc------cccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC---------HH
Q psy11727 256 KIIDFGSSCHVGQTLY------QYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKN---------EV 319 (437)
Q Consensus 256 kL~DFG~s~~~~~~~~------~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~---------~~ 319 (437)
||+|||+++.+..... ..+-|..|+|||.+.|. -|+.++|||++|||+.||+|-+|.|.+.. ..
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 9999999988765433 24568899999999986 59999999999999999999999998753 34
Q ss_pred HHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhh
Q psy11727 320 DQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLAD 399 (437)
Q Consensus 320 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (437)
+++.+|.+.+|.|...-|+...+...+-+.+++ |. .. +. ....|..+.......+ +
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~--f~------~~-~~--~n~sL~~~~~~~k~k~-----------~-- 311 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSD--FR------RH-YY--DNVSLHKYYHKHKVKD-----------P-- 311 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHH--hH------Hh-hc--CcchHHHHHHHhcCCC-----------c--
Confidence 689999999999999888877665444222221 00 00 00 0011222222111000 0
Q ss_pred hhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 400 YMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 400 ~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
...+|+.+||.+||.+|+|++|||+|+||+.-
T Consensus 312 --~a~~LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 312 --SALDLLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred --hHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence 24799999999999999999999999999864
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=348.37 Aligned_cols=189 Identities=25% Similarity=0.460 Sum_probs=160.2
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
+.||+|+||+||+|.+..+++.||+|+++... ........|+.++..+ ..||||+++++++...+.+++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~----~~hp~iv~~~~~~~~~~~~~lv~E 76 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----SNHPFLVGLHSCFQTESRLFFVIE 76 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhc----CCCCcCCceeeEEEeCCEEEEEEe
Confidence 46899999999999999999999999997432 1223344565555544 278999999999999999999999
Q ss_pred eccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec---C
Q psy11727 192 LLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---G 267 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~---~ 267 (437)
|+++ +|..++... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++... .
T Consensus 77 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dikp~Nili--~~~~~~kL~DfG~~~~~~~~~ 150 (329)
T cd05618 77 YVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER--GIIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPG 150 (329)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEE--CCCCCEEEeeCCccccccCCC
Confidence 9965 787777654 3589999999999999999999964 89999999999999 67889999999998653 2
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFS 314 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~ 314 (437)
.......||..|+|||++.+..++.++|||||||++|+|++|++||.
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 22345678999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=349.30 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=197.1
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccC
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY 195 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~ 195 (437)
+.||+|+||+||+|++..+++.||+|++............++...+......+.|+||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46899999999999999999999999997432111111111111111112345899999999999999999999999966
Q ss_pred -cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC---Cccc
Q psy11727 196 -NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG---QTLY 271 (437)
Q Consensus 196 -~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~---~~~~ 271 (437)
+|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.... ....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~--~giiHrDlkp~Nili--~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILL--DSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEE--CCCCCEEEccCCCCcccccCCCCcc
Confidence 788877654 358899999999999999999995 489999999999999 678889999999986532 2234
Q ss_pred cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccC
Q psy11727 272 QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLS 351 (437)
Q Consensus 272 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~ 351 (437)
..+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~------------------ 216 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK------------------ 216 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC------------------
Confidence 56799999999999999999999999999999999999999999887776666543100000
Q ss_pred CCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH----HHhcC
Q psy11727 352 DNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT----NVLRH 427 (437)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~----e~l~H 427 (437)
+ .....+.+||.+||+.||.+|+++. ++++|
T Consensus 217 -----------------~----------------------------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~ 251 (325)
T cd05602 217 -----------------P----------------------------NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNH 251 (325)
T ss_pred -----------------C----------------------------CCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcC
Confidence 0 0001578999999999999999976 89999
Q ss_pred CCcCcCCC
Q psy11727 428 EFFLKHSV 435 (437)
Q Consensus 428 p~~~~~~~ 435 (437)
+||....+
T Consensus 252 ~~~~~~~~ 259 (325)
T cd05602 252 IFFSPINW 259 (325)
T ss_pred cccCCCCH
Confidence 99976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=338.52 Aligned_cols=250 Identities=28% Similarity=0.383 Sum_probs=195.1
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEec
Q psy11727 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELL 193 (437)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~ 193 (437)
||+|+||+||+|.+..+++.||+|.+..... ....+..|+.++..+ +|+||+++.++|...+++|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-----HSRFIVSLAYAFQTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-----CCCcEeeeeEEEcCCCeEEEEEeCC
Confidence 6999999999999999999999999864321 123344566666655 7899999999999999999999999
Q ss_pred cC-cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc-
Q psy11727 194 SY-NLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT- 269 (437)
Q Consensus 194 ~~-~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~- 269 (437)
++ +|.+.+... ....+++..+..++.||+.||+|||++ ||+||||||+||++ +.++.++|+|||++......
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nili--~~~~~~~l~dfg~~~~~~~~~ 151 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--RIIYRDLKPENVLL--DNDGNVRISDLGLAVELKDGQ 151 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEE--CCCCCEEEeeCccceecCCCC
Confidence 65 777666432 224589999999999999999999964 89999999999999 67888999999999765332
Q ss_pred --cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhh
Q psy11727 270 --LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347 (437)
Q Consensus 270 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 347 (437)
.....||+.|+|||++.+..++.++|+|||||++|+|++|+.||...........+.......+.. +
T Consensus 152 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------~- 220 (280)
T cd05608 152 SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT----------Y- 220 (280)
T ss_pred ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCC----------C-
Confidence 224578999999999999999999999999999999999999998765432222221111000000 0
Q ss_pred cccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC-----CHH
Q psy11727 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI-----SPT 422 (437)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~-----t~~ 422 (437)
+......+.+|+.+||+.||.+|| |++
T Consensus 221 ------------------------------------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~ 252 (280)
T cd05608 221 ------------------------------------------------PDKFSPASKSFCEALLAKDPEKRLGFRDGNCD 252 (280)
T ss_pred ------------------------------------------------cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHH
Confidence 000012578999999999999999 899
Q ss_pred HHhcCCCcCcCCC
Q psy11727 423 NVLRHEFFLKHSV 435 (437)
Q Consensus 423 e~l~Hp~~~~~~~ 435 (437)
++++||||++..+
T Consensus 253 ~~l~h~~~~~~~~ 265 (280)
T cd05608 253 GLRTHPLFRDLNW 265 (280)
T ss_pred HHhcChhhhcCCH
Confidence 9999999988644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=347.49 Aligned_cols=246 Identities=27% Similarity=0.410 Sum_probs=199.4
Q ss_pred eceecccCceEEEEEEEc---CCCeEEEEEEecCCc-----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 115 DTLLGKGSFGQVVKAFDH---EEKCQVAIKIIKNKK-----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~---~~~~~vaiK~i~~~~-----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
++.||+|+||.||+|.+. .+++.||+|+++... ........|+.+++.+ .||||++++++|..++.+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~iv~~~~~~~~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-----KHPFIVDLIYAFQTGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-----CCCchhceeeEEecCCeE
Confidence 367999999999999864 478899999986422 1123345677777765 789999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
|+||||+++ +|.+.+.... .+++..+..++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQ--QGIIYRDLKPENILL--DAQGHVKLTDFGLCKE 149 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEE--CCCCCEEEeeCcCCee
Confidence 999999966 7888887653 57899999999999999999995 489999999999999 6788999999999864
Q ss_pred cC---CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 266 VG---QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 266 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.. .......||+.|+|||++.+..++.++|||||||++|||++|++||.+.+....+..+.......|.
T Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~-------- 221 (323)
T cd05584 150 SIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP-------- 221 (323)
T ss_pred cccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--------
Confidence 32 2223457899999999999989999999999999999999999999988876666555431100000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC---
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI--- 419 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~--- 419 (437)
.....+.+||.+||+.||.+||
T Consensus 222 -------------------------------------------------------~~~~~~~~li~~~l~~~p~~R~~~~ 246 (323)
T cd05584 222 -------------------------------------------------------YLTPEARDLLKKLLKRNPSSRLGAG 246 (323)
T ss_pred -------------------------------------------------------CCCHHHHHHHHHHcccCHhHcCCCC
Confidence 0011578999999999999999
Q ss_pred --CHHHHhcCCCcCcCC
Q psy11727 420 --SPTNVLRHEFFLKHS 434 (437)
Q Consensus 420 --t~~e~l~Hp~~~~~~ 434 (437)
+++++++||||....
T Consensus 247 ~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 247 PGDAAEVQSHPFFRHVN 263 (323)
T ss_pred CCCHHHHhcCCCcCCCC
Confidence 899999999998754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=351.95 Aligned_cols=255 Identities=26% Similarity=0.395 Sum_probs=202.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ .||||+++++++.+.+
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-----~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-----NSPWVVQLFYAFQDDR 116 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEcCC
Confidence 578999999999999999999999999999999986321 1112334566665554 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
++|+||||+++ +|.+++... .+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NIll--~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLL--DKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHEEE--CCCCCEEEEeCCce
Confidence 99999999965 788887654 38999999999999999999995 489999999999999 67889999999999
Q ss_pred eecCCc----cccccccccccChhhhcCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 264 CHVGQT----LYQYIQSRYYRSPEVLLGIP----YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 264 ~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
...... ....+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+.......++......+
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-- 267 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT-- 267 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc--
Confidence 765432 23467999999999997643 78999999999999999999999999888777766654211100
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
.|... .....+.+||.+||..+|
T Consensus 268 --------------------------------~~~~~-------------------------~~s~~~~~li~~~L~~~~ 290 (371)
T cd05622 268 --------------------------------FPDDN-------------------------DISKEAKNLICAFLTDRE 290 (371)
T ss_pred --------------------------------CCCcC-------------------------CCCHHHHHHHHHHcCChh
Confidence 00000 001257899999998444
Q ss_pred CC--CCCHHHHhcCCCcCcCC
Q psy11727 416 KK--RISPTNVLRHEFFLKHS 434 (437)
Q Consensus 416 ~~--R~t~~e~l~Hp~~~~~~ 434 (437)
.+ |++++++++||||++..
T Consensus 291 ~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 291 VRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred hhcCCCCHHHHhcCcccCCCC
Confidence 33 78999999999998743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=344.44 Aligned_cols=297 Identities=25% Similarity=0.337 Sum_probs=210.6
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.++|++.+.||+|+||.||+|.+..++..+|+|++.... .....+..|+.++..+ .|+||++++++|.+.+++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-----NSPYIVGFYGAFYSDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-----CCCcccceeEEEEECCEE
Confidence 468999999999999999999999999999999987432 2234566788887776 789999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++||||+.+ +|.+++.... .+++..+..++.|++.||.|||+. .+|+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili--~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILV--NSRGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChhhEEE--cCCCCEEEeeCCcchh
Confidence 999999965 8998887643 488999999999999999999963 379999999999999 6778899999999875
Q ss_pred cCCc-cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCCCChhhhccCCcc
Q psy11727 266 VGQT-LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV-LGMPPGYLLHGASKT 343 (437)
Q Consensus 266 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~p~~~~~~~~~~~ 343 (437)
.... .....|+..|+|||++.+..++.++|+|||||++|+|++|+.||......+....+... .+.+..........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 232 (333)
T cd06650 154 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR- 232 (333)
T ss_pred hhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC-
Confidence 5332 23457899999999999989999999999999999999999999876653332221111 11111100000000
Q ss_pred chhhcccCCCcceeccccccccccCCCCC--chhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSK--RLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
..... +.. ......|... .+.+.+... .+... + .......+.+||.+||++||.+|||+
T Consensus 233 -----~~~~~---~~~---~~~~~~~~~~~~~~~~~~~~~--~~~~~----~--~~~~~~~~~~li~~~L~~~P~~Rpt~ 293 (333)
T cd06650 233 -----PPGRP---LSS---YGPDSRPPMAIFELLDYIVNE--PPPKL----P--SGVFGAEFQDFVNKCLIKNPAERADL 293 (333)
T ss_pred -----Cccch---hhh---hcccccccccHHHHHHHHhcC--CCccC----C--CCCcCHHHHHHHHHhccCCcccCcCH
Confidence 00000 000 0000000000 000100000 00000 0 00112358999999999999999999
Q ss_pred HHHhcCCCcCcCCC
Q psy11727 422 TNVLRHEFFLKHSV 435 (437)
Q Consensus 422 ~e~l~Hp~~~~~~~ 435 (437)
.|+++||||+....
T Consensus 294 ~ell~h~~~~~~~~ 307 (333)
T cd06650 294 KQLMVHAFIKRSEA 307 (333)
T ss_pred HHHhhCHHHhcCcc
Confidence 99999999987643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=337.67 Aligned_cols=256 Identities=29% Similarity=0.435 Sum_probs=201.4
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc----chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~----~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.|++.+.||+|+||+||+|.+..+++.||+|.+...... ......|+.++..+ .|++|+.+++.+.+.+++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~~~~i~~~~~~~~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-----NSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-----CCCCeeeeeEEEecCCEE
Confidence 377889999999999999999999999999998643211 12344577776665 688999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
|+||||+.+ +|.+++.......+++..+..++.|++.||.|||+ .||+||||||+||++ ++++.++|+|||++..
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nil~--~~~~~~~l~Dfg~~~~ 151 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ--ERIVYRDLKPENILL--DDHGHIRISDLGLAVH 151 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEE--CCCCCEEEeeccceee
Confidence 999999965 78888865554568999999999999999999995 489999999999999 6788899999999876
Q ss_pred cCC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 266 VGQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 266 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
... ......|+..|+|||++.+..++.++|+|||||++|+|++|++||.+.................+..
T Consensus 152 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-------- 223 (285)
T cd05630 152 VPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE-------- 223 (285)
T ss_pred cCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhh--------
Confidence 532 2234578999999999999999999999999999999999999998754321111111100000000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC---
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS--- 420 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t--- 420 (437)
+. ......+.+||.+||+.||.+|||
T Consensus 224 --~~-------------------------------------------------~~~~~~~~~li~~~l~~~p~~R~s~~~ 252 (285)
T cd05630 224 --YS-------------------------------------------------EKFSPDARSLCKMLLCKDPKERLGCQG 252 (285)
T ss_pred --cC-------------------------------------------------ccCCHHHHHHHHHHhhcCHHHccCCCC
Confidence 00 000114789999999999999999
Q ss_pred --HHHHhcCCCcCcCC
Q psy11727 421 --PTNVLRHEFFLKHS 434 (437)
Q Consensus 421 --~~e~l~Hp~~~~~~ 434 (437)
++|+++||||++..
T Consensus 253 ~~~~~~~~h~~~~~~~ 268 (285)
T cd05630 253 GGAREVKEHPLFKQIN 268 (285)
T ss_pred CchHHHHcChhhhccC
Confidence 99999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=335.46 Aligned_cols=276 Identities=32% Similarity=0.529 Sum_probs=213.3
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+|++.+.||+|+||.||+|.+..+|+.||+|.++... ........|+.+++.+ .|+||+++++++.+.+.++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-----KHKNIVRLYDVLHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-----CCCCeeeHHHHhccCCceE
Confidence 5889999999999999999999999999999986432 2224456688887776 6899999999999999999
Q ss_pred EEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 188 LVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 188 lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
+|+||++++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+||++ +.++.++|+|||++....
T Consensus 76 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dl~~~nil~--~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHS--HNVLHRDLKPQNLLI--NKNGELKLADFGLARAFG 150 (284)
T ss_pred EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEE--cCCCcEEECccchhhccC
Confidence 999999999998887643 458999999999999999999995 489999999999999 667889999999987654
Q ss_pred Ccc---ccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 268 QTL---YQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPL-FSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 268 ~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
... ....++..|+|||++.+. .++.++|+|||||++|+|++|..| |.+.+..+.+..+....+.++...++....
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 322 234568899999998775 478999999999999999998765 677777788888888877776554432221
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
...+ .... ..+....+... .......+.+||.+||+.||.+|||++
T Consensus 231 ~~~~-~~~~---------------~~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~P~~R~t~~ 276 (284)
T cd07839 231 LPDY-KPYP---------------MYPATTSLVNV------------------VPKLNSTGRDLLQNLLVCNPVQRISAE 276 (284)
T ss_pred cccc-cccC---------------CCCCcchhhhh------------------cccCCHHHHHHHHHHhcCChhhcCCHH
Confidence 1110 0000 00000000000 000112578999999999999999999
Q ss_pred HHhcCCCc
Q psy11727 423 NVLRHEFF 430 (437)
Q Consensus 423 e~l~Hp~~ 430 (437)
++++||||
T Consensus 277 ~il~h~~f 284 (284)
T cd07839 277 EALQHPYF 284 (284)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=346.31 Aligned_cols=247 Identities=28% Similarity=0.451 Sum_probs=194.8
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCcccc----hHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFL----NQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~----~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
++||+|+||+||+|++..+++.||+|++....... .....|... ....+.|+||++++++|.+.+..|+|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~----~l~~~~h~~iv~~~~~~~~~~~~~lv~e 76 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV----LLKNLKHPFLVGLHYSFQTAEKLYFVLD 76 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHH----HHHhCCCCCccceeeEEEcCCEEEEEEc
Confidence 46899999999999999999999999996432111 111222221 1234589999999999999999999999
Q ss_pred eccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC---
Q psy11727 192 LLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG--- 267 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~--- 267 (437)
|+++ +|...+... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~--~~ivH~Dlkp~NIll--~~~~~~kl~Dfg~~~~~~~~~ 150 (321)
T cd05603 77 YVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHS--LNIIYRDLKPENILL--DSQGHVVLTDFGLCKEGVEPE 150 (321)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEE--CCCCCEEEccCCCCccCCCCC
Confidence 9966 787777654 358999999999999999999995 489999999999999 778899999999986532
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhh
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 347 (437)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+.......+... +..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~~~------------- 214 (321)
T cd05603 151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---PLQ------------- 214 (321)
T ss_pred CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---CCC-------------
Confidence 2223457899999999999989999999999999999999999999988766655554321 000
Q ss_pred cccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH----HH
Q psy11727 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP----TN 423 (437)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~----~e 423 (437)
.| ......+.++|.+||+.||.+|+++ .+
T Consensus 215 --------------------~~---------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (321)
T cd05603 215 --------------------LP---------------------------GGKTVAACDLLVGLLHKDQRRRLGAKADFLE 247 (321)
T ss_pred --------------------CC---------------------------CCCCHHHHHHHHHHccCCHhhcCCCCCCHHH
Confidence 00 0001156899999999999999976 49
Q ss_pred HhcCCCcCcCCC
Q psy11727 424 VLRHEFFLKHSV 435 (437)
Q Consensus 424 ~l~Hp~~~~~~~ 435 (437)
+++||||....+
T Consensus 248 ~~~~~~~~~~~~ 259 (321)
T cd05603 248 IKNHVFFSPINW 259 (321)
T ss_pred HhCCCCcCCCCH
Confidence 999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=332.14 Aligned_cols=252 Identities=35% Similarity=0.525 Sum_probs=205.9
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHH---HHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQA---QIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~---~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
|++.+.||+|+||+||+|.+..+++.||+|++.......... ..|+.+++.+ .|+||+++++++.+.+..++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-----RHPNIVQILDVFQDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-----TBTTBCHEEEEEEESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-----cccccccccccccccccccc
Confidence 889999999999999999999999999999998654333332 3377777777 58899999999999999999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec-
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV- 266 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~- 266 (437)
|||++.+ +|.+++... ..+++..+..++.||+.||++||++ ||+|+||||+||++ +.++.++|+|||.+...
T Consensus 76 v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~--~i~H~dikp~NIl~--~~~~~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSK--GIVHRDIKPENILL--DENGEVKLIDFGSSVKLS 149 (260)
T ss_dssp EEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHT--TEEESSBSGGGEEE--STTSEEEESSGTTTEEST
T ss_pred ccccccccccccccccc--ccccccccccccccccccccccccc--cccccccccccccc--cccccccccccccccccc
Confidence 9999987 899998843 3489999999999999999999964 89999999999999 67888999999999753
Q ss_pred --CCccccccccccccChhhhc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 --GQTLYQYIQSRYYRSPEVLL-GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 --~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
........++..|+|||++. +..++.++|+||||+++++|++|..||...+..+....+..............
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 225 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ---- 225 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc----
Confidence 33344567899999999998 78899999999999999999999999998755555444443322111110000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
+......+.+||.+||+.||.+|||+.+
T Consensus 226 ----------------------------------------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~ 253 (260)
T PF00069_consen 226 ----------------------------------------------------SREKSEELRDLIKKMLSKDPEQRPSAEE 253 (260)
T ss_dssp ----------------------------------------------------HTTSHHHHHHHHHHHSSSSGGGSTTHHH
T ss_pred ----------------------------------------------------cchhHHHHHHHHHHHccCChhHCcCHHH
Confidence 0000126899999999999999999999
Q ss_pred HhcCCCc
Q psy11727 424 VLRHEFF 430 (437)
Q Consensus 424 ~l~Hp~~ 430 (437)
+++||||
T Consensus 254 l~~~~~~ 260 (260)
T PF00069_consen 254 LLKHPWF 260 (260)
T ss_dssp HHTSGGG
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=328.41 Aligned_cols=260 Identities=27% Similarity=0.404 Sum_probs=212.6
Q ss_pred ceeccCeeee-ceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE--
Q psy11727 106 EKFLDRYEID-TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW-- 182 (437)
Q Consensus 106 ~~~~~~y~i~-~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~-- 182 (437)
..++++|.+. ++||-|-.|.|..|..+.||+.+|+|++... ..+.+|+.+.=..+ .|+|||.++++|+.
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s----~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMAS----GHPHIVSIIDVYENSY 128 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhc----CCCceEEeehhhhhhc
Confidence 3457888885 5799999999999999999999999999743 45666777654443 78999999999864
Q ss_pred --CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC-CCCCEEEE
Q psy11727 183 --KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP-KRSAIKII 258 (437)
Q Consensus 183 --~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~-~~~~ikL~ 258 (437)
...+.+|||.|.| .|+..+...+...+++..+..|++||+.|+.|||+ ++|.||||||+|+|.++. .+..+||+
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~--~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS--MNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh--cchhhccCChhheeeecCCCCcceEec
Confidence 4689999999955 79999999888889999999999999999999996 469999999999999643 34569999
Q ss_pred eCCCceecC--CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCC
Q psy11727 259 DFGSSCHVG--QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEV----DQMTKIIEVLGMP 332 (437)
Q Consensus 259 DFG~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~----~~~~~i~~~~~~p 332 (437)
|||+|+... ....+.|-|++|.|||++....|+..+|+||+|||+|-|++|.|||.+.... .+..+|..+
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g---- 282 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG---- 282 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc----
Confidence 999998765 4556788999999999999999999999999999999999999999876542 122233221
Q ss_pred ChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc
Q psy11727 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412 (437)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 412 (437)
.|.+.. ..|....+..+|+|+++|.
T Consensus 283 ---------------------qy~FP~----------------------------------pEWs~VSe~aKdlIR~LLk 307 (400)
T KOG0604|consen 283 ---------------------QYEFPE----------------------------------PEWSCVSEAAKDLIRKLLK 307 (400)
T ss_pred ---------------------CccCCC----------------------------------hhHhHHHHHHHHHHHHHhc
Confidence 111111 1122333467999999999
Q ss_pred cCCCCCCCHHHHhcCCCcCcCC
Q psy11727 413 YDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 413 ~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
.+|.+|.|+++++.|||+.+..
T Consensus 308 t~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 308 TEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred CCchhheeHHHhhcCchhcccc
Confidence 9999999999999999998754
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=343.52 Aligned_cols=257 Identities=26% Similarity=0.366 Sum_probs=200.8
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|++.+.||+|+||+||++.+..+++.||+|++.... .....+..|+.++..+ .|+||++++++|.+.++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-----DRRWITNLHYAFQDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-----CCCCCCceEEEEecCCe
Confidence 47999999999999999999999999999999986321 1122344566555543 78999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+|+||||+.+ +|.+++.... ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++.
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~ 150 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQ--LGYVHRDIKPDNVLL--DKNGHIRLADFGSCL 150 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--CCeEECCCCHHHEEE--CCCCCEEEEECCcee
Confidence 9999999955 8988886533 458999999999999999999995 489999999999999 678899999999987
Q ss_pred ecCCcc----ccccccccccChhhhcC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 265 HVGQTL----YQYIQSRYYRSPEVLLG-----IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 265 ~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.......+
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-- 228 (331)
T cd05597 151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ-- 228 (331)
T ss_pred ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc--
Confidence 653321 22468999999999973 4578899999999999999999999998877666665543111000
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
.|. ........+++||++||..++
T Consensus 229 --------------------------------~~~------------------------~~~~~~~~~~~li~~ll~~~~ 252 (331)
T cd05597 229 --------------------------------FPP------------------------DVTDVSEEAKDLIRRLICSPE 252 (331)
T ss_pred --------------------------------CCC------------------------ccCCCCHHHHHHHHHHccCcc
Confidence 000 000011257899999997654
Q ss_pred CC--CCCHHHHhcCCCcCcCC
Q psy11727 416 KK--RISPTNVLRHEFFLKHS 434 (437)
Q Consensus 416 ~~--R~t~~e~l~Hp~~~~~~ 434 (437)
.+ |++++++++||||.+..
T Consensus 253 ~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 253 TRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred cccCCCCHHHHhcCCCCCCCC
Confidence 44 88999999999998754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=337.51 Aligned_cols=283 Identities=32% Similarity=0.470 Sum_probs=219.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC--
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK-- 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~-- 183 (437)
.++|++.+.||+|+||.||+|.+..+|+.||+|.++.... .......|+.++..+ .|+||+++++++...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-----RHPNIVELKEVVVGKHL 80 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-----CCCCCcceEEEEecCCC
Confidence 5689999999999999999999999999999999864321 122345688887776 788999999998765
Q ss_pred CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 184 NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 184 ~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
+.+++||||++++|.+++.... ..+++..++.++.||+.||+|||+ .|++||||||+||++ +.++.+||+|||++
T Consensus 81 ~~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~--~~~~~~kL~dfg~~ 155 (309)
T cd07845 81 DSIFLVMEYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHE--NFIIHRDLKVSNLLL--TDKGCLKIADFGLA 155 (309)
T ss_pred CeEEEEEecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE--CCCCCEEECcccee
Confidence 5789999999999988887643 468999999999999999999996 489999999999999 67888999999999
Q ss_pred eecCCc---cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhcc
Q psy11727 264 CHVGQT---LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 264 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 339 (437)
...... .....++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.++..+++.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 156 RTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred eecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence 776432 223345778999999876 4688999999999999999999999999999999999999888887665543
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
...... ...+.+... .. ..+... .......+.+||.+||++||.+||
T Consensus 236 ~~~~~~------~~~~~~~~~------~~---~~~~~~------------------~~~~~~~~~~li~~ml~~dp~~R~ 282 (309)
T cd07845 236 FSDLPL------VGKFTLPKQ------PY---NNLKHK------------------FPWLSEAGLRLLNFLLMYDPKKRA 282 (309)
T ss_pred hhcccc------cccccccCC------CC---CchHHh------------------ccccCHHHHHHHHHHhcCChhhCc
Confidence 211100 000000000 00 000000 000122578999999999999999
Q ss_pred CHHHHhcCCCcCcCC
Q psy11727 420 SPTNVLRHEFFLKHS 434 (437)
Q Consensus 420 t~~e~l~Hp~~~~~~ 434 (437)
|+++++.||||++.+
T Consensus 283 t~~~il~h~~f~~~~ 297 (309)
T cd07845 283 TAEEALESSYFKEKP 297 (309)
T ss_pred CHHHHhcChhhccCC
Confidence 999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=342.40 Aligned_cols=245 Identities=29% Similarity=0.383 Sum_probs=198.5
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc---chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC-E
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF---LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN-H 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~-~ 185 (437)
....+.+.||+|+||+||+|.+..+. .||||++...... ...+..|+.++.++ +|||||+++|++.... .
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l-----~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRL-----RHPNIVQFYGACTSPPGS 114 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEcCCCCc
Confidence 34556667999999999999875442 3999999754322 34788899999886 8999999999999887 7
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCC-eeeCCCCCCcEEEecCCCC-CEEEEeCCC
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELS-IIHCDLKPENILLCSPKRS-AIKIIDFGS 262 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~g-iiHrDiKp~NIll~~~~~~-~ikL~DFG~ 262 (437)
++|||||+++ +|.+++.......+++..+..|+.||+.|+.|||++ + ||||||||+|||+ +.++ ++||+|||+
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~--~~iIHrDLK~~NiLv--~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE--GPIIHRDLKSDNILV--DLKGKTLKIADFGL 190 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC--CCeeecccChhhEEE--cCCCCEEEECCCcc
Confidence 9999999965 788888774446799999999999999999999975 6 9999999999999 6776 999999999
Q ss_pred ceecCC---ccccccccccccChhhhc--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 263 SCHVGQ---TLYQYIQSRYYRSPEVLL--GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 263 s~~~~~---~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
++.... ..+...||..|||||++. ...|+.++||||||+++|||+||+.||.+.........++.....|+-.
T Consensus 191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p-- 268 (362)
T KOG0192|consen 191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP-- 268 (362)
T ss_pred ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC--
Confidence 987653 344478999999999999 5689999999999999999999999999988844444443221111100
Q ss_pred ccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCC
Q psy11727 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKK 417 (437)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 417 (437)
. .-...+..|+.+||..||..
T Consensus 269 --------------------------------~---------------------------~~~~~l~~l~~~CW~~dp~~ 289 (362)
T KOG0192|consen 269 --------------------------------K---------------------------ECPPHLSSLMERCWLVDPSR 289 (362)
T ss_pred --------------------------------c---------------------------cCCHHHHHHHHHhCCCCCCc
Confidence 0 01125789999999999999
Q ss_pred CCCHHHHh
Q psy11727 418 RISPTNVL 425 (437)
Q Consensus 418 R~t~~e~l 425 (437)
||+..+++
T Consensus 290 RP~f~ei~ 297 (362)
T KOG0192|consen 290 RPSFLEIV 297 (362)
T ss_pred CCCHHHHH
Confidence 99998876
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=333.97 Aligned_cols=277 Identities=34% Similarity=0.570 Sum_probs=218.9
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+|++.+.||.|++|.||+|++..++..||||.+..... ....+..|+.+++.+ .|+||+++++++.+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHPNIVKLLDVIHTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-----CCCCCcchhhhcccCCcEE
Confidence 48899999999999999999999999999999864321 224566788888776 6899999999999999999
Q ss_pred EEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 188 LVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 188 lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
+||||+.++|.+++.......+++..++.++.||+.||+|||+ .|++|+||+|+||++ +.++.+||+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~--~~i~H~~l~p~nill--~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLI--NTEGAIKLADFGLARAFG 151 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEE--CCCCCEEEeeccchhhcc
Confidence 9999998899988876555668999999999999999999995 489999999999999 678889999999987553
Q ss_pred Cc---cccccccccccChhhhcCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 268 QT---LYQYIQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 268 ~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.. .....++..|+|||++.+.. ++.++|+|||||++|+|+||+.||.+.++.+...++.+..+.|+..+++.....
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 32 22345678899999987654 688999999999999999999999999998888999998888877665432221
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
..+-...+.. ....+..++ ......+.+||.+||+.||.+|||+++
T Consensus 232 ~~~~~~~~~~----------------~~~~~~~~~------------------~~~~~~~~~li~~~l~~~P~~Rpt~~~ 277 (284)
T cd07860 232 PDYKPSFPKW----------------ARQDFSKVV------------------PPLDEDGRDLLSQMLHYDPNKRISAKA 277 (284)
T ss_pred HHHHhhcccc----------------cccCHHHHc------------------ccCCHHHHHHHHHhcCCCcccCCCHHH
Confidence 1111100000 000011110 001125689999999999999999999
Q ss_pred HhcCCCc
Q psy11727 424 VLRHEFF 430 (437)
Q Consensus 424 ~l~Hp~~ 430 (437)
+++||||
T Consensus 278 ~l~~~~f 284 (284)
T cd07860 278 ALAHPFF 284 (284)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=342.95 Aligned_cols=190 Identities=27% Similarity=0.480 Sum_probs=162.2
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
+.||+|+||+||+|.+..+++.||+|+++... .....+..|..++..+. .|++|+.+++++.+.+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~----~~~~i~~~~~~~~~~~~~~lv~e 76 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS----SNPFLVGLHSCFQTTSRLFLVIE 76 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhc----CCCCEeeEEEEEEeCCEEEEEEe
Confidence 46899999999999999999999999997432 12233456666666553 68999999999999999999999
Q ss_pred eccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec---C
Q psy11727 192 LLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---G 267 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~---~ 267 (437)
|+++ +|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++... .
T Consensus 77 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~Nili--~~~~~~kl~Dfg~~~~~~~~~ 150 (327)
T cd05617 77 YVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHER--GIIYRDLKLDNVLL--DADGHIKLTDYGMCKEGLGPG 150 (327)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEE--eCCCCEEEeccccceeccCCC
Confidence 9965 788777654 3589999999999999999999964 89999999999999 67888999999998753 2
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG 315 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~ 315 (437)
......+||+.|+|||++.+..++.++|||||||++|+|++|.+||..
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 151 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 333456799999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=331.65 Aligned_cols=281 Identities=31% Similarity=0.470 Sum_probs=215.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.++|.+.+.||+|+||.||+|.+..++..||+|++..... .......|+.+++.+ .|+||+++++++...+..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~~~ 78 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-----KHANIVLLHDIIHTKETL 78 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-----CCCCEeEEEEEEecCCeE
Confidence 4679999999999999999999999999999999864422 123456677777766 789999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
|+||||+++++.+.+.... ..+++..++.++.||+.||+|||++ ||+|+||||+|||+ +.++.++|+|||++...
T Consensus 79 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~dlkp~Nil~--~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ--HILHRDLKPQNLLI--SYLGELKLADFGLARAK 153 (291)
T ss_pred EEEEecccCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChHHEEE--cCCCcEEEecccccccc
Confidence 9999999989888776543 4578899999999999999999964 89999999999999 67888999999998654
Q ss_pred CCc---cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChhhhccCC
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKN-EVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
... .....++..|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+ ..+.+..+....+.|+..+.+...
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 322 2234568899999998764 57889999999999999999999997654 346677777778877776655443
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
....+......... ...+..+. ........+.+||.+||..||.+|||+
T Consensus 234 ~~~~~~~~~~~~~~---------------~~~~~~~~----------------~~~~~~~~~~~ll~~~l~~dp~~R~t~ 282 (291)
T cd07870 234 KLPNYKPEWFLPCK---------------PQQLRVVW----------------KRLSRPPKAEDLASQMLMMFPKDRISA 282 (291)
T ss_pred hcccccchhccccC---------------Ccchhhhc----------------cccCCChHHHHHHHHHhCcCcccCcCH
Confidence 32222211100000 00000000 000012357899999999999999999
Q ss_pred HHHhcCCCc
Q psy11727 422 TNVLRHEFF 430 (437)
Q Consensus 422 ~e~l~Hp~~ 430 (437)
+|++.||||
T Consensus 283 ~~~l~h~~~ 291 (291)
T cd07870 283 QDALLHPYF 291 (291)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=332.29 Aligned_cols=278 Identities=32% Similarity=0.583 Sum_probs=219.3
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+|++.+.||+|+||.||+|.+..++..||+|++.... .....+..|+.+++.+ .|+||+++++++...+.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-----QHPYVVKLLDVFPHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-----CCCCCcceeeEEecCCeeE
Confidence 5899999999999999999999999999999987432 1234566677777666 5899999999999999999
Q ss_pred EEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 188 LVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 188 lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
+||||++++|.+++.... ..+++..++.++.||+.||+|||++ |++|+||||+||++ +.++.++|+|||++....
T Consensus 76 ~v~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~ni~~--~~~~~~~l~dfg~~~~~~ 150 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN--GIMHRDLKPANLLI--SADGVLKIADFGLARLFS 150 (286)
T ss_pred EEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCcCHHHEEE--cCCCcEEEeeeeeccccc
Confidence 999999779999887654 5689999999999999999999964 89999999999999 668889999999987664
Q ss_pred Cc----cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 268 QT----LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 268 ~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.. .....++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+....+..+...++.|....++....
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 32 2345688899999998754 468999999999999999999999999998888999988888887665544322
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
...+ ..+. +. ......+..+ .......+.+||++||..||.+|||++
T Consensus 231 ~~~~-~~~~---~~-----------~~~~~~~~~~------------------~~~~~~~~~~li~~~l~~~p~~R~~~~ 277 (286)
T cd07832 231 LPDY-NKIT---FP-----------ESKPIPLEEI------------------FPDASPEALDLLKGLLVYDPSKRLSAA 277 (286)
T ss_pred cchh-hccc---CC-----------CCCcchHHHh------------------CCCccHHHHHHHHHHhccChhhCCCHH
Confidence 1111 0000 00 0000000000 001123679999999999999999999
Q ss_pred HHhcCCCcC
Q psy11727 423 NVLRHEFFL 431 (437)
Q Consensus 423 e~l~Hp~~~ 431 (437)
++|+||||.
T Consensus 278 ~~l~h~~~~ 286 (286)
T cd07832 278 EALRHPYFT 286 (286)
T ss_pred HHhhCcCcC
Confidence 999999995
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=332.06 Aligned_cols=281 Identities=33% Similarity=0.527 Sum_probs=216.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.++|++.+.||+|++|.||+|.+..+++.||+|.+..... .......|+.++..+ .|+||+++++++.+.++.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-----KHANIVTLHDIIHTKKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-----CCcceeeEEEEEecCCeE
Confidence 4689999999999999999999999999999999864322 123455688888776 688999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
++||||++++|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+||++ +.++.+||+|||++...
T Consensus 79 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~--~~i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 79 TLVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQ--RRVLHRDLKPQNLLI--SERGELKLADFGLARAK 153 (291)
T ss_pred EEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccCCHHHEEE--cCCCCEEECcccccccc
Confidence 9999999999999887654 368999999999999999999995 489999999999999 67888999999998654
Q ss_pred CCc---cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChhhhccCC
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKN-EVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
... .....++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.. ..+.+..+.+.++.|....++...
T Consensus 154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 322 122346788999999876 458899999999999999999999998766 556777777778877766655444
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
....+...... ......+.... + .......+.+||.+||++||.+|||+
T Consensus 234 ~~~~~~~~~~~---------------~~~~~~~~~~~--------------~--~~~~~~~~~~li~~~L~~~p~~Rps~ 282 (291)
T cd07844 234 SNPEFKPYSFP---------------FYPPRPLINHA--------------P--RLDRIPHGEELALKFLQYEPKKRISA 282 (291)
T ss_pred hcccccccccc---------------ccCChhHHHhC--------------c--CCCCchhHHHHHHHHhccCcccccCH
Confidence 32222111000 00000000000 0 00001256899999999999999999
Q ss_pred HHHhcCCCc
Q psy11727 422 TNVLRHEFF 430 (437)
Q Consensus 422 ~e~l~Hp~~ 430 (437)
.++++||||
T Consensus 283 ~e~l~~~~f 291 (291)
T cd07844 283 AEAMKHPYF 291 (291)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=333.19 Aligned_cols=279 Identities=33% Similarity=0.521 Sum_probs=215.3
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE-
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH- 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~- 185 (437)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......|+.++..+. +|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~----~~~~i~~~~~~~~~~~~~ 76 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS----ESIYIVRLLDVEHVEEKN 76 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHcc----CCCCccceeeeEeecCCC
Confidence 469999999999999999999999999999999864322 2345667888887774 56899999999987665
Q ss_pred ----EEEEEEeccCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC-CCCEEE
Q psy11727 186 ----LCLVFELLSYNLYNLIRNTN---FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK-RSAIKI 257 (437)
Q Consensus 186 ----~~lV~E~~~~~L~~~l~~~~---~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~-~~~ikL 257 (437)
.|+||||++++|.+++.... ...+++..++.++.||+.||.|||+ .||+||||||+||++ +. ++.+||
T Consensus 77 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~~~nil~--~~~~~~~kl 152 (295)
T cd07837 77 GKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLV--DKQKGLLKI 152 (295)
T ss_pred CCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEE--ecCCCeEEE
Confidence 89999999999998886542 2358999999999999999999995 489999999999999 44 778999
Q ss_pred EeCCCceecCCcc---ccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy11727 258 IDFGSSCHVGQTL---YQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333 (437)
Q Consensus 258 ~DFG~s~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~ 333 (437)
+|||.+....... ....+++.|+|||++.+ ..++.++|+||||+++|+|++|.+||.+.+....+..+....+.|+
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 232 (295)
T cd07837 153 ADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232 (295)
T ss_pred eecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999987553221 22356788999999865 4578999999999999999999999999988888888888777776
Q ss_pred hhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
...++.......+... +.. .+ ..+... .......+.+||.+||.+
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~--------------~~--~~~~~~------------------~~~~~~~~~~~i~~~l~~ 277 (295)
T cd07837 233 EQVWPGVSKLRDWHEF-PQW--------------KP--QDLSRA------------------VPDLSPEGLDLLQKMLRY 277 (295)
T ss_pred hhhCcchhhccchhhc-Ccc--------------cc--hhHHHh------------------ccccCHHHHHHHHHHccC
Confidence 6554433222111100 000 00 000000 001122578999999999
Q ss_pred CCCCCCCHHHHhcCCCcC
Q psy11727 414 DPKKRISPTNVLRHEFFL 431 (437)
Q Consensus 414 dP~~R~t~~e~l~Hp~~~ 431 (437)
||.+|||+.|++.||||+
T Consensus 278 ~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 278 DPAKRISAKAALTHPYFD 295 (295)
T ss_pred ChhhcCCHHHHhcCCCcC
Confidence 999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=333.40 Aligned_cols=280 Identities=33% Similarity=0.530 Sum_probs=218.2
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc------chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF------LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~------~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
+|.+.+.||+|+||.||+|.+..+++.||||.++..... ......|+.++..+ .|+||+++++++.+.+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-----KHPNIIGLLDVFGHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-----CCCCChhhhheeecCC
Confidence 588899999999999999999999999999999754322 22344566666555 6899999999999999
Q ss_pred EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 185 HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 185 ~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
..++||||+.++|.+++.... ..+++..+..++.||+.||+|||++ ||+|+||||+||++ +.++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~--~i~H~dl~p~nill--~~~~~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN--WILHRDLKPNNLLI--ASDGVLKLADFGLAR 150 (298)
T ss_pred EEEEEEcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC--CeeecCCChhhEEE--cCCCCEEEccceeee
Confidence 999999999778999887654 3589999999999999999999964 89999999999999 678889999999997
Q ss_pred ecCCc---cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 265 HVGQT---LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 265 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+..+.+.++....+.|....++..
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence 66432 223456788999999865 46789999999999999999999999998888888888887777766555433
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
.....+....... ......+ .......+.+||.+||.+||.+|||
T Consensus 231 ~~~~~~~~~~~~~-----------------~~~~~~~------------------~~~~~~~~~~li~~~l~~~P~~R~s 275 (298)
T cd07841 231 TSLPDYVEFKPFP-----------------PTPLKQI------------------FPAASDDALDLLQRLLTLNPNKRIT 275 (298)
T ss_pred ccccccccccccC-----------------Ccchhhh------------------cccccHHHHHHHHHHhcCCcccCcC
Confidence 2221111100000 0000000 0111236789999999999999999
Q ss_pred HHHHhcCCCcCcCCC
Q psy11727 421 PTNVLRHEFFLKHSV 435 (437)
Q Consensus 421 ~~e~l~Hp~~~~~~~ 435 (437)
+.|++.||||++.+.
T Consensus 276 ~~e~l~~~~~~~~~~ 290 (298)
T cd07841 276 ARQALEHPYFSNDPA 290 (298)
T ss_pred HHHHhhCccccCCCC
Confidence 999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=332.75 Aligned_cols=284 Identities=31% Similarity=0.507 Sum_probs=222.3
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
++|++.+.||+|++|+||+|.+..+++.||+|.+.... .....+..|+.+++.+ .|+||+++++++.+.+++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-----QHGNIVRLQDVVHSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-----cCCCEeeEEEEEecCCeE
Confidence 57999999999999999999999999999999986432 2224566777777766 689999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
++||||++++|.+.+.......+++..++.++.||+.||+|||++ |++||||+|+||+++. .++.+||+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~i~H~dl~p~nill~~-~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH--RVLHRDLKPQNLLIDR-RTNALKLADFGLARAF 153 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCCcceEEEEC-CCCEEEEccccccccc
Confidence 999999998999888765544578899999999999999999964 8999999999999942 3456999999999755
Q ss_pred CCc---cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
... .....++..|+|||++.+. .++.++|+|||||++|+|+||.+||.+.+..+.+.++....+.|...++.....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 332 2234568899999998764 578999999999999999999999999888888888888888888777654433
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
...+....+ .+.... ...........+.+||.+||+.||.+|||+.
T Consensus 234 ~~~~~~~~~------------------~~~~~~----------------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ 279 (294)
T PLN00009 234 LPDYKSAFP------------------KWPPKD----------------LATVVPTLEPAGVDLLSKMLRLDPSKRITAR 279 (294)
T ss_pred chhhhhhcc------------------cCCCCC----------------HHHhCcCCChHHHHHHHHHccCChhhCcCHH
Confidence 322211110 000000 0000001112578999999999999999999
Q ss_pred HHhcCCCcCcCCC
Q psy11727 423 NVLRHEFFLKHSV 435 (437)
Q Consensus 423 e~l~Hp~~~~~~~ 435 (437)
++++||||.+...
T Consensus 280 ~~l~~~~~~~~~~ 292 (294)
T PLN00009 280 AALEHEYFKDLGD 292 (294)
T ss_pred HHhcCchHhHHhc
Confidence 9999999987653
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=330.54 Aligned_cols=261 Identities=28% Similarity=0.445 Sum_probs=216.1
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
..-.++|..+++||+|.||.|.+|+.+.+++.+|+|++++.- ..........+.+.-...+..||.+..+...|+..++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKev-iiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEV-IIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhh-eeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 345678999999999999999999999999999999997532 2222222222333222334589999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+|+||||..| .|+-.+... ..++++.++.+...|..||.|||++ +||.||||.+|+|+ |++|+|||+|||+++
T Consensus 243 lCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~--~ivYRDlKLENLlL--DkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSR--NIVYRDLKLENLLL--DKDGHIKITDFGLCK 316 (516)
T ss_pred EEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhC--Ceeeeechhhhhee--ccCCceEeeecccch
Confidence 9999999954 787766654 4599999999999999999999975 79999999999999 899999999999986
Q ss_pred e---cCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 265 H---VGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 265 ~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
. .+....++|||+.|+|||++....|+.++|+|.+||++|||++|+.||...+....+..|.-.--..|..+.
T Consensus 317 E~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls---- 392 (516)
T KOG0690|consen 317 EEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLS---- 392 (516)
T ss_pred hcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCC----
Confidence 4 367778899999999999999999999999999999999999999999999988888877543222211110
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC-
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS- 420 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t- 420 (437)
.+.+.|+.++|..||.+|..
T Consensus 393 -----------------------------------------------------------~eAktLLsGLL~kdP~kRLGg 413 (516)
T KOG0690|consen 393 -----------------------------------------------------------PEAKTLLSGLLKKDPKKRLGG 413 (516)
T ss_pred -----------------------------------------------------------HHHHHHHHHHhhcChHhhcCC
Confidence 14589999999999999985
Q ss_pred ----HHHHhcCCCcCcCCCC
Q psy11727 421 ----PTNVLRHEFFLKHSVD 436 (437)
Q Consensus 421 ----~~e~l~Hp~~~~~~~~ 436 (437)
+.|+.+|+||..++++
T Consensus 414 GpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 414 GPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred CchhHHHHHhhhhhccCCHH
Confidence 8899999999988764
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=352.23 Aligned_cols=279 Identities=25% Similarity=0.338 Sum_probs=205.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
...|.+.+.||+|+||.||+|.+..+++.||||... ......|+.+++.+ .|+|||++++++...+..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L-----~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRL-----SHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHC-----CCCCCCcEEEEEEECCEEEE
Confidence 347999999999999999999999999999999643 23456788888877 78999999999999999999
Q ss_pred EEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 189 VFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 189 V~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
|||++.++|.+++.... ..+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||+++....
T Consensus 238 v~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDLKP~NILl--~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 238 VLPKYRSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLV--NGPEDICLGDFGAACFARG 312 (461)
T ss_pred EEEccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEEECcCCHHHEEE--CCCCCEEEcccCCceeccc
Confidence 99999999999887643 368999999999999999999995 489999999999999 6778899999999976532
Q ss_pred c-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCC------HHHHHHHHHHHhCCCChhh
Q psy11727 269 T-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPL-FSGKN------EVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 269 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p-f~~~~------~~~~~~~i~~~~~~p~~~~ 336 (437)
. .....||..|+|||++.+..++.++|||||||++|||++|..| |.... ...++.+++...+.....+
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 2 1235689999999999999999999999999999999998754 43321 1234445554433322111
Q ss_pred hccCCc--cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 337 LHGASK--TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 337 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
...... ...+....... .......+.|.. .. .....+.+||.+||++|
T Consensus 393 ~~~~~~~l~~~~~~~~~~~--------~~~~~~~~~~~~---~~-------------------~~~~~~~dli~~mL~~D 442 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARN--------RRPAYTRPAWTR---YY-------------------KLDLDVEYLVCRALTFD 442 (461)
T ss_pred CCCcchHHHHHHHhhhhcc--------cCCccCCcchhh---hc-------------------cccchHHHHHHHHcccC
Confidence 100000 00000000000 000000000000 00 00125789999999999
Q ss_pred CCCCCCHHHHhcCCCcCc
Q psy11727 415 PKKRISPTNVLRHEFFLK 432 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~~~ 432 (437)
|.+|||+.|||+||||+.
T Consensus 443 P~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 443 GARRPSAAELLRLPLFQS 460 (461)
T ss_pred hhhCcCHHHHhhCcccCC
Confidence 999999999999999975
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=330.65 Aligned_cols=250 Identities=28% Similarity=0.441 Sum_probs=194.9
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEec
Q psy11727 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELL 193 (437)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~ 193 (437)
||+|+||+||++.+..+|+.||+|.+..... .......|+.+++.+ .||||+++++++....++|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-----NSPFIVNLAYAFESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-----CCCcEEEEEEEEecCCeEEEEEecC
Confidence 6999999999999999999999999863221 112334467776665 7899999999999999999999999
Q ss_pred cC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc--c
Q psy11727 194 SY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT--L 270 (437)
Q Consensus 194 ~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~--~ 270 (437)
+| +|.+++......++++..+..++.||+.||+|||+ .||+||||||+||++ +.++.++|+|||++...... .
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili--~~~~~~~l~Dfg~~~~~~~~~~~ 151 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS--MDIVYRDMKPENVLL--DDQGNCRLSDLGLAVELKDGKTI 151 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH--CCEEEccCChHhEEE--cCCCCEEEeeceeeeecCCCcee
Confidence 65 78888766555568999999999999999999995 489999999999999 67888999999998765432 2
Q ss_pred ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhccc
Q psy11727 271 YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRL 350 (437)
Q Consensus 271 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~ 350 (437)
....|+..|+|||++.+..++.++|+|||||++|+|++|.+||.+.........+....-.. ...
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~-------- 216 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED-------EVK-------- 216 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc-------ccc--------
Confidence 33568899999999999899999999999999999999999997654322222221110000 000
Q ss_pred CCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH----HHHhc
Q psy11727 351 SDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP----TNVLR 426 (437)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~----~e~l~ 426 (437)
.+ .. .....+.+||.+||+.||.+|||+ ++++.
T Consensus 217 -----------------~~----------------------~~----~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 217 -----------------FE----------------------HQ----NFTEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred -----------------cc----------------------cc----cCCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 00 00 001157899999999999999999 77889
Q ss_pred CCCcCcCC
Q psy11727 427 HEFFLKHS 434 (437)
Q Consensus 427 Hp~~~~~~ 434 (437)
||||+..+
T Consensus 254 h~~f~~~~ 261 (277)
T cd05607 254 HEFFKTIN 261 (277)
T ss_pred ChhhcCCC
Confidence 99998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=347.07 Aligned_cols=247 Identities=28% Similarity=0.376 Sum_probs=193.8
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCccc----chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEec
Q psy11727 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELL 193 (437)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~----~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~ 193 (437)
||+|+||+||+|++..+++.||+|++...... ......|..++..... ..||+|+++++.|...+++|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~--~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLL--DESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhcc--CCCCcCcceEEEEecCCeEEEEEcCC
Confidence 69999999999999999999999998632211 1122233344333221 26899999999999999999999999
Q ss_pred cC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC---Cc
Q psy11727 194 SY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG---QT 269 (437)
Q Consensus 194 ~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~---~~ 269 (437)
++ +|.+.+... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++.... ..
T Consensus 79 ~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~--~ivHrDlkp~Nili--~~~~~~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 79 SGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKY--DIVYRDLKPENILL--DATGHIALCDFGLSKANLTDNKT 152 (330)
T ss_pred CCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeEE--CCCCCEEEecCCcCcCCCCCCCC
Confidence 65 788887654 3589999999999999999999964 89999999999999 678889999999986532 22
Q ss_pred cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhc
Q psy11727 270 LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFD 348 (437)
Q Consensus 270 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~ 348 (437)
....+||..|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.......+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-------------- 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK-------------- 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC--------------
Confidence 3356799999999999765 4899999999999999999999999988776665555321100000
Q ss_pred ccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC----CHHHH
Q psy11727 349 RLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI----SPTNV 424 (437)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~----t~~e~ 424 (437)
. .....+.+||++||+.||.+|| ++.++
T Consensus 219 ----------------------~--------------------------~~~~~~~~li~~~L~~~P~~R~~~~~~~~~l 250 (330)
T cd05586 219 ----------------------N--------------------------VLSDEGRQFVKGLLNRNPQHRLGAHRDAVEL 250 (330)
T ss_pred ----------------------c--------------------------cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHH
Confidence 0 0001568999999999999998 79999
Q ss_pred hcCCCcCcCC
Q psy11727 425 LRHEFFLKHS 434 (437)
Q Consensus 425 l~Hp~~~~~~ 434 (437)
++||||....
T Consensus 251 l~h~~~~~~~ 260 (330)
T cd05586 251 KEHPFFADID 260 (330)
T ss_pred hcCccccCCC
Confidence 9999998654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=344.30 Aligned_cols=245 Identities=29% Similarity=0.429 Sum_probs=198.8
Q ss_pred ceecccCceEEEEEEE---cCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFD---HEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~---~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
+.||+|+||.||++.+ ..+|+.||+|++..... .......|+.++..+ .|+||+++++++.+.+.+|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-----NHPFIVKLHYAFQTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-----CCCCcccEEEEEEcCCEEEEE
Confidence 5799999999999976 35789999999974321 122344566666655 789999999999999999999
Q ss_pred EEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 190 FELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 190 ~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
|||+. ++|.+.+... ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nil~--~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 77 LDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILL--DEEGHIKLTDFGLSKESID 150 (318)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHeEE--CCCCcEEEeeccCCcccCC
Confidence 99996 4888888654 358999999999999999999995 489999999999999 6788899999999876532
Q ss_pred c---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccch
Q psy11727 269 T---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSK 345 (437)
Q Consensus 269 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 345 (437)
. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.......|.
T Consensus 151 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~----------- 219 (318)
T cd05582 151 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ----------- 219 (318)
T ss_pred CCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC-----------
Confidence 2 34567899999999999989999999999999999999999999988876666655331100000
Q ss_pred hhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC-----
Q psy11727 346 YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS----- 420 (437)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t----- 420 (437)
.....+.+||++||+.||.+|||
T Consensus 220 ----------------------------------------------------~~~~~~~~li~~~l~~~P~~R~~a~~~~ 247 (318)
T cd05582 220 ----------------------------------------------------FLSPEAQSLLRALFKRNPANRLGAGPDG 247 (318)
T ss_pred ----------------------------------------------------CCCHHHHHHHHHHhhcCHhHcCCCCCCC
Confidence 00115689999999999999999
Q ss_pred HHHHhcCCCcCcCC
Q psy11727 421 PTNVLRHEFFLKHS 434 (437)
Q Consensus 421 ~~e~l~Hp~~~~~~ 434 (437)
+++++.||||+...
T Consensus 248 ~~~~~~~~~~~~~~ 261 (318)
T cd05582 248 VEEIKRHPFFSTID 261 (318)
T ss_pred HHHHhCCCCcCCCC
Confidence 77899999998754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=340.74 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=200.8
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|++.+.||+|+||+||++....+++.||+|++..... ....+..|+.++.. ..|++|+++++++.+.++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~-----~~~~~i~~~~~~~~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-----GDNQWITTLHYAFQDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhh-----CCCCCEeeEEEEEecCCE
Confidence 479999999999999999999999999999999863211 11223344444433 488999999999999999
Q ss_pred EEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+|+||||+. |+|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||++.
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~--~~iiHrDlkp~Nili--~~~~~~kL~DfG~a~ 150 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILM--DMNGHIRLADFGSCL 150 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEE--CCCCCEEEeecchhe
Confidence 999999995 58999887643 358999999999999999999995 589999999999999 678899999999986
Q ss_pred ecCCc----cccccccccccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 265 HVGQT----LYQYIQSRYYRSPEVLL-----GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 265 ~~~~~----~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
..... ....+||+.|+|||++. ...++.++|||||||++|||++|++||.+.+..+.+..+.......+
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-- 228 (332)
T cd05623 151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ-- 228 (332)
T ss_pred ecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc--
Confidence 54221 12357899999999986 34688999999999999999999999998887777666643110000
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
.|.. .......+.+||++||..+|
T Consensus 229 --------------------------------~p~~------------------------~~~~s~~~~~li~~ll~~~~ 252 (332)
T cd05623 229 --------------------------------FPAQ------------------------VTDVSEDAKDLIRRLICSRE 252 (332)
T ss_pred --------------------------------CCCc------------------------cccCCHHHHHHHHHHccChh
Confidence 0000 00001257899999997655
Q ss_pred CC--CCCHHHHhcCCCcCcCCC
Q psy11727 416 KK--RISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 416 ~~--R~t~~e~l~Hp~~~~~~~ 435 (437)
.. |+|++++++||||++..+
T Consensus 253 ~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 253 HRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred hhcCCCCHHHHhCCCCcCCCCH
Confidence 44 789999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=340.76 Aligned_cols=258 Identities=25% Similarity=0.367 Sum_probs=201.7
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|++.+.||+|+||+||++.+..+++.||+|++..... ....+..|+.++.. ..|++|+++++++.+.++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~-----~~~~~i~~l~~~~~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-----GDCQWITTLHYAFQDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHh-----CCCCCEeeEEEEEEcCCE
Confidence 479999999999999999999999999999999863211 11223344444443 378999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
.|+||||+.| +|.+++.... ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++.
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~--~~iiHrDlkp~Nill--~~~~~~kl~DfG~a~ 150 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQ--LHYVHRDIKPDNVLL--DMNGHIRLADFGSCL 150 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCchHHEEE--cCCCCEEEEecccee
Confidence 9999999955 8888887643 358999999999999999999995 489999999999999 678889999999987
Q ss_pred ecCCcc----ccccccccccChhhhcC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 265 HVGQTL----YQYIQSRYYRSPEVLLG-----IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 265 ~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
...... ....||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+....+......++
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~-- 228 (331)
T cd05624 151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ-- 228 (331)
T ss_pred eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc--
Confidence 654321 23568999999999976 4678999999999999999999999998887666665543110000
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
.|. ........+.+||.+||..++
T Consensus 229 --------------------------------~p~------------------------~~~~~~~~~~~li~~ll~~~~ 252 (331)
T cd05624 229 --------------------------------FPS------------------------HITDVSEEAKDLIQRLICSRE 252 (331)
T ss_pred --------------------------------CCC------------------------ccccCCHHHHHHHHHHccCch
Confidence 000 000001257899999999766
Q ss_pred CC--CCCHHHHhcCCCcCcCCC
Q psy11727 416 KK--RISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 416 ~~--R~t~~e~l~Hp~~~~~~~ 435 (437)
.+ |++++++++||||+...+
T Consensus 253 ~~~~~~~~~~~~~h~~f~~~~~ 274 (331)
T cd05624 253 RRLGQNGIEDFKKHAFFEGIDW 274 (331)
T ss_pred hhcCCCCHHHHhcCCCcCCCCH
Confidence 55 579999999999987654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=345.58 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=194.3
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.++|+..+.||+|+||+||+|.+..+++.||||++.... .....+..|+.++..+ .|+||+++++++...+.+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-----NHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-----CCCCcceeeeEeccCCeE
Confidence 467888999999999999999999999999999986432 2234566777777765 789999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++||||+.+ +|.+. ...++..+..++.||+.||+|||+ .||+||||||+|||+ ++++.+||+|||++..
T Consensus 148 ~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll--~~~~~~kL~DfG~~~~ 217 (353)
T PLN00034 148 QVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHR--RHIVHRDIKPSNLLI--NSAKNVKIADFGVSRI 217 (353)
T ss_pred EEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEE--cCCCCEEEccccccee
Confidence 999999976 55331 235678888999999999999995 489999999999999 6788899999999976
Q ss_pred cCCc---cccccccccccChhhhcC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCCCChhh
Q psy11727 266 VGQT---LYQYIQSRYYRSPEVLLG-----IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV-LGMPPGYL 336 (437)
Q Consensus 266 ~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~p~~~~ 336 (437)
.... .....||..|+|||++.. ...+.++|||||||++|||++|+.||......+....+... ...++.
T Consensus 218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 295 (353)
T PLN00034 218 LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE-- 295 (353)
T ss_pred cccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCC--
Confidence 5432 234578999999999843 23456899999999999999999999744332222211111 000000
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
........+.+||.+||+.||+
T Consensus 296 ----------------------------------------------------------~~~~~~~~l~~li~~~l~~~P~ 317 (353)
T PLN00034 296 ----------------------------------------------------------APATASREFRHFISCCLQREPA 317 (353)
T ss_pred ----------------------------------------------------------CCCccCHHHHHHHHHHccCChh
Confidence 0000112579999999999999
Q ss_pred CCCCHHHHhcCCCcCcC
Q psy11727 417 KRISPTNVLRHEFFLKH 433 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~~~~ 433 (437)
+|||+.|+++||||.+.
T Consensus 318 ~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 318 KRWSAMQLLQHPFILRA 334 (353)
T ss_pred hCcCHHHHhcCcccccC
Confidence 99999999999999875
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=329.82 Aligned_cols=256 Identities=29% Similarity=0.423 Sum_probs=205.2
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.|+..+.||+|+||+||+|.+..+++.||+|.+..... .......|+.++..+ .|++|+.+.+.+..++..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~~~~i~~~~~~~~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-----NSQFVVNLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-----CCcCceeEEEEEecCCEE
Confidence 37788899999999999999999999999999864321 122345677777766 678999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
|+||||+.+ +|.+++.......+++..+..++.|++.||.|||+ .||+||||||+||++ ++++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~--~~iiH~dikp~Nili--~~~~~~kl~Dfg~~~~ 151 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPENILL--DDYGHIRISDLGLAVK 151 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEE--CCCCCEEEecCCccee
Confidence 999999965 78777765544569999999999999999999995 489999999999999 6678899999999866
Q ss_pred cCC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 266 VGQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 266 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
... ......|+..|+|||++.+..++.++|+|||||++|+|++|.+||.+.........+...........
T Consensus 152 ~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~------- 224 (285)
T cd05632 152 IPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY------- 224 (285)
T ss_pred cCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccccc-------
Confidence 532 22345789999999999998999999999999999999999999988766554444433211110000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC---
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS--- 420 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t--- 420 (437)
+......+.+|+.+||+.||.+|||
T Consensus 225 ----------------------------------------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~ 252 (285)
T cd05632 225 ----------------------------------------------------SAKFSEEAKSICKMLLTKDPKQRLGCQE 252 (285)
T ss_pred ----------------------------------------------------CccCCHHHHHHHHHHccCCHhHcCCCcc
Confidence 0000115689999999999999999
Q ss_pred --HHHHhcCCCcCcCC
Q psy11727 421 --PTNVLRHEFFLKHS 434 (437)
Q Consensus 421 --~~e~l~Hp~~~~~~ 434 (437)
+.+++.||||...+
T Consensus 253 ~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 253 EGAGEVKRHPFFRNMN 268 (285)
T ss_pred cChHHHHcChhhhcCC
Confidence 88999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=335.52 Aligned_cols=285 Identities=32% Similarity=0.532 Sum_probs=213.3
Q ss_pred CeeeeceecccCceEEEEEEEcC--CCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC-
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHE--EKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK- 183 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~--~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~- 183 (437)
+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ........|+.++..+ .||||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-----KHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-----CCCCccceEEEEeCCC
Confidence 58899999999999999999988 89999999997532 2335566787777766 689999999999988
Q ss_pred -CEEEEEEEeccCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC----CCCE
Q psy11727 184 -NHLCLVFELLSYNLYNLIRNTNF---HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK----RSAI 255 (437)
Q Consensus 184 -~~~~lV~E~~~~~L~~~l~~~~~---~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~----~~~i 255 (437)
+.+++||||++++|.+++..... ..+++..++.++.||+.||+|||+ .||+||||||+||++ +. ++.+
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~i~h~dlkp~Nil~--~~~~~~~~~~ 151 (316)
T cd07842 76 DKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS--NWVLHRDLKPANILV--MGEGPERGVV 151 (316)
T ss_pred CceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh--CCEeeCCCCHHHEEE--cCCCCccceE
Confidence 89999999999988887754321 258999999999999999999995 489999999999999 55 7889
Q ss_pred EEEeCCCceecCCcc------ccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---------
Q psy11727 256 KIIDFGSSCHVGQTL------YQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEV--------- 319 (437)
Q Consensus 256 kL~DFG~s~~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~--------- 319 (437)
||+|||++....... ....++..|+|||++.+. .++.++|||||||++|+|++|++||.+....
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 231 (316)
T cd07842 152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231 (316)
T ss_pred EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence 999999987653322 234678889999998764 5889999999999999999999999876543
Q ss_pred HHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhh
Q psy11727 320 DQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLAD 399 (437)
Q Consensus 320 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (437)
..+..+.+.++.+.............+..... .......+. ..+...... ....
T Consensus 232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~-~~~~~~~~~---------------~~~~ 285 (316)
T cd07842 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMK----------DFKTKTYPS-NSLAKWMEK---------------HKKP 285 (316)
T ss_pred HHHHHHHHHhCCCchhHHHHHhhcccchhhhh----------hccCCCCCC-ccHHHHHHh---------------ccCC
Confidence 35667777777776655543322222111000 000000010 011111100 0012
Q ss_pred hhHHHHHHHHccccCCCCCCCHHHHhcCCCc
Q psy11727 400 YMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430 (437)
Q Consensus 400 ~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~ 430 (437)
...+.++|.+||++||.+|||+.|+++||||
T Consensus 286 ~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 286 DSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 2367899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=343.65 Aligned_cols=253 Identities=30% Similarity=0.446 Sum_probs=218.6
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc---chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF---LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
.++|..++++|+|+||.+++++.+.++..+++|.+...... ...+..|+.++.++ .|||||.+.+.|..++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-----~hP~iv~y~ds~~~~~~ 77 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-----LHPNIVEYKDSFEEDGQ 77 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-----cCCCeeeeccchhcCCc
Confidence 46799999999999999999999999999999999754332 22456677777765 89999999999999887
Q ss_pred -EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 186 -LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 186 -~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
+||||+||.| +|.+.++..+..-++++.+..++.||+.|+.|||+ ..|+|||||+.|||+ .+++.|||+|||+|
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~--~~iLHRDlK~~Nifl--tk~~~VkLgDfGla 153 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE--NRVLHRDLKCANIFL--TKDKKVKLGDFGLA 153 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh--hhhhcccchhhhhhc--cccCceeecchhhh
Confidence 9999999955 89999988776679999999999999999999995 479999999999999 56777999999999
Q ss_pred eecCCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 264 CHVGQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 264 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
+..... ..+.+||+.|++||++.+.+|..++|+|||||++|||++-+++|.+.+-.....+|......|-..+.
T Consensus 154 K~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~y--- 230 (426)
T KOG0589|consen 154 KILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMY--- 230 (426)
T ss_pred hhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccc---
Confidence 887654 45789999999999999999999999999999999999999999999998888888876533322111
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
...++.||..||..+|..|||
T Consensus 231 -----------------------------------------------------------s~el~~lv~~~l~~~P~~RPs 251 (426)
T KOG0589|consen 231 -----------------------------------------------------------SSELRSLVKSMLRKNPEHRPS 251 (426)
T ss_pred -----------------------------------------------------------cHHHHHHHHHHhhcCCccCCC
Confidence 015789999999999999999
Q ss_pred HHHHhcCCCcCc
Q psy11727 421 PTNVLRHEFFLK 432 (437)
Q Consensus 421 ~~e~l~Hp~~~~ 432 (437)
+.++|.+|.++.
T Consensus 252 a~~LL~~P~l~~ 263 (426)
T KOG0589|consen 252 ALELLRRPHLLR 263 (426)
T ss_pred HHHHhhChhhhh
Confidence 999999998864
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=327.33 Aligned_cols=275 Identities=34% Similarity=0.563 Sum_probs=211.6
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccc--hHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC--CEEE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFL--NQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK--NHLC 187 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~--~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~--~~~~ 187 (437)
|++.+.||+|+||.||+|.+..++..||+|.++...... .....|+.++..+. .|+|++++++++.+. +.++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS----PHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcC----CCCCccceEEEEecCCCCcEE
Confidence 678899999999999999999999999999987532211 12234555555542 589999999999988 8999
Q ss_pred EEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 188 LVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 188 lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
+||||++++|.+.+.... ..+++..++.++.||+.||+|||+ .|++||||+|+||++ +. +.+||+|||++....
T Consensus 77 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~p~ni~l--~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 77 LVFELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHR--NGIFHRDIKPENILI--KD-DILKLADFGSCRGIY 150 (282)
T ss_pred EEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEE--cC-CCeEEEecccccccc
Confidence 999999999999887643 458999999999999999999995 489999999999999 45 889999999997653
Q ss_pred Cc--cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc
Q psy11727 268 QT--LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344 (437)
Q Consensus 268 ~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 344 (437)
.. .....++..|+|||++.+ ..++.++|+|||||++|||++|.+||.+.+..+....+.+.++.++..+........
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 151 SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred cCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 22 233567889999998754 457889999999999999999999999999989999998888888876632211110
Q ss_pred hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHH
Q psy11727 345 KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNV 424 (437)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~ 424 (437)
...+...... ...+..+. ......+.+||.+||++||.+|||++++
T Consensus 231 -------~~~~~~~~~~---------~~~~~~~~------------------~~~~~~~~~li~~~l~~~P~~R~~~~~~ 276 (282)
T cd07831 231 -------HMNYNFPSKK---------GTGLRKLL------------------PNASAEGLDLLKKLLAYDPDERITAKQA 276 (282)
T ss_pred -------cccccCcccc---------cccHHHHc------------------ccccHHHHHHHHHHhccCcccccCHHHH
Confidence 0000000000 00000000 0112368999999999999999999999
Q ss_pred hcCCCc
Q psy11727 425 LRHEFF 430 (437)
Q Consensus 425 l~Hp~~ 430 (437)
++||||
T Consensus 277 l~~~~~ 282 (282)
T cd07831 277 LRHPYF 282 (282)
T ss_pred hhCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=324.20 Aligned_cols=279 Identities=32% Similarity=0.508 Sum_probs=208.4
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ .|+|++++++++...+.+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-----KHPNLVNLIEVFRRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-----CCCCEeeeeeEEeeCCEE
Confidence 47999999999999999999999999999999986432 1224456788887776 689999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
++||||+++++.+.+.... ..+++..++.++.||+.+|+|||+ .|++||||||+||++ +.++.++|+|||++...
T Consensus 76 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~--~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~ 150 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHK--HNCIHRDVKPENILI--TKQGQIKLCDFGFARIL 150 (286)
T ss_pred EEEEeccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCChhhEEE--cCCCcEEECccccceec
Confidence 9999999886665544332 358999999999999999999995 589999999999999 67788999999999766
Q ss_pred CCcc---ccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 267 GQTL---YQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 267 ~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.... ....++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+....+....+...........
T Consensus 151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 229 (286)
T cd07847 151 TGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS- 229 (286)
T ss_pred CCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc-
Confidence 4322 23467889999999876 457899999999999999999999999988777776666554432221111000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
...++... ..|.......+... .......+.+||.+||+.||++|||+.
T Consensus 230 ~~~~~~~~----------------~~~~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rp~~~ 278 (286)
T cd07847 230 TNQFFKGL----------------SIPEPETREPLESK---------------FPNISSPALSFLKGCLQMDPTERLSCE 278 (286)
T ss_pred cccccccc----------------cCCCcccccCHHHH---------------hccCCHHHHHHHHHHhcCCccccCCHH
Confidence 00011100 00000000000000 000123678999999999999999999
Q ss_pred HHhcCCCc
Q psy11727 423 NVLRHEFF 430 (437)
Q Consensus 423 e~l~Hp~~ 430 (437)
|++.||||
T Consensus 279 eil~~~~f 286 (286)
T cd07847 279 ELLEHPYF 286 (286)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=352.84 Aligned_cols=253 Identities=26% Similarity=0.292 Sum_probs=205.6
Q ss_pred ccCeeeeceecccCceEEEEEEEcCC-CeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEE-KCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~-~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+..... ....+..|+.++..+ .|||||+++++|...+++
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-----~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-----DHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCCCEeEEEEEEEECCEE
Confidence 34599999999999999999998877 78899997753322 123445577666655 899999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 187 CLVFELLSY-NLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
||||||+++ +|.+++... ....+++..+..++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--~ivHrDlkp~NIll--~~~~~~kL~DFgla 216 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR--KMMHRDLKSANIFL--MPTGIIKLGDFGFS 216 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC--CEEECCcCHHhEEE--CCCCcEEEEeCcCc
Confidence 999999955 888877542 234589999999999999999999964 89999999999999 67888999999999
Q ss_pred eecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 264 CHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 264 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
...... ....+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+......|...
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~--- 293 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPC--- 293 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc---
Confidence 876432 234578999999999999999999999999999999999999999888776666654321110000
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
.....+.+||.+||..||.+|
T Consensus 294 -----------------------------------------------------------~~s~~~~~li~~~L~~dP~~R 314 (478)
T PTZ00267 294 -----------------------------------------------------------PVSSGMKALLDPLLSKNPALR 314 (478)
T ss_pred -----------------------------------------------------------cCCHHHHHHHHHHhccChhhC
Confidence 000157899999999999999
Q ss_pred CCHHHHhcCCCcCc
Q psy11727 419 ISPTNVLRHEFFLK 432 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~ 432 (437)
||+.+++.|||++.
T Consensus 315 ps~~~~l~~~~~~~ 328 (478)
T PTZ00267 315 PTTQQLLHTEFLKY 328 (478)
T ss_pred cCHHHHHhCHHHHH
Confidence 99999999999864
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=359.52 Aligned_cols=293 Identities=22% Similarity=0.343 Sum_probs=206.8
Q ss_pred ecCceeccCeeeeceecccCceEEEEEEEcCCC-eEEEEE------------------EecCCcccchHHHHHHHHHHHh
Q psy11727 103 KHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEK-CQVAIK------------------IIKNKKPFLNQAQIEVQLLEKI 163 (437)
Q Consensus 103 ~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~-~~vaiK------------------~i~~~~~~~~~~~~e~~~~~~l 163 (437)
..+..+.++|++.+.||+|+||+||+|..+... ..+++| .+.........+..|+.++..+
T Consensus 141 ~~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l 220 (501)
T PHA03210 141 KHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL 220 (501)
T ss_pred ccchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC
Confidence 445567789999999999999999998754322 222222 2222222234456777777776
Q ss_pred hhcCCCCCcEEEecceeeECCEEEEEEEeccCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC
Q psy11727 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNF---HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDL 240 (437)
Q Consensus 164 ~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~---~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDi 240 (437)
.|+|||++++++...+..|+|+|++.++|++++..... .......++.++.||+.||.|||++ |||||||
T Consensus 221 -----~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~--gIiHrDL 293 (501)
T PHA03210 221 -----NHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK--KLIHRDI 293 (501)
T ss_pred -----CCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC--CeecCCC
Confidence 78999999999999999999999999999887754321 2245677889999999999999964 8999999
Q ss_pred CCCcEEEecCCCCCEEEEeCCCceecCCc----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCC-CCCC
Q psy11727 241 KPENILLCSPKRSAIKIIDFGSSCHVGQT----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEP-LFSG 315 (437)
Q Consensus 241 Kp~NIll~~~~~~~ikL~DFG~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~-pf~~ 315 (437)
||+|||+ +.++.+||+|||++...... ....+||..|+|||++.+..++.++|||||||++|||++|.. ||..
T Consensus 294 KP~NILl--~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 294 KLENIFL--NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred CHHHEEE--CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence 9999999 67888999999999766432 224579999999999999999999999999999999999875 4432
Q ss_pred --CCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCC
Q psy11727 316 --KNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEP 393 (437)
Q Consensus 316 --~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (437)
.+....+.+++..++.+...+.... .+.|+.+....+... ...+...+.. .
T Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~p~~~---~~~~~~i~~~~~~~~------------~~~~~~~~~~-~----------- 424 (501)
T PHA03210 372 GGGKPGKQLLKIIDSLSVCDEEFPDPP---CKLFDYIDSAEIDHA------------GHSVPPLIRN-L----------- 424 (501)
T ss_pred CCCCHHHHHHHHHHhcccChhhcCCcH---HHHHHHhhhhhcccC------------ccchhhHHHh-c-----------
Confidence 3445566666666554443322111 112221111000000 0001111100 0
Q ss_pred CCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 394 GHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 394 ~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
.....+.++|.+||.+||.+|||+.|+|.||||.....
T Consensus 425 ----~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~ 462 (501)
T PHA03210 425 ----GLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEE 462 (501)
T ss_pred ----CCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCc
Confidence 00125789999999999999999999999999987543
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=326.49 Aligned_cols=254 Identities=26% Similarity=0.444 Sum_probs=202.2
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC----
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK---- 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~---- 183 (437)
..+.|++.+.||+|+||+||+|.+..+++.||+|++............|+.++..+. .|+||++++++|...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~----~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS----HHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhc----CCCCeeeEeeEEeecCCCC
Confidence 356799999999999999999999999999999999765444456677887777663 589999999998753
Q ss_pred --CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 184 --NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 184 --~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
..+++||||+++ +|.+++.......+++..+..++.|++.||+|||++ ||+|+||||+||++ +.++.++|+||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~--~ivh~dl~~~nili--~~~~~~~l~Df 155 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH--KVIHRDIKGQNVLL--TENAEVKLVDF 155 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCCHHHEEE--CCCCCEEEccC
Confidence 578999999965 888888765545689999999999999999999964 89999999999999 67888999999
Q ss_pred CCceecCCc---cccccccccccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy11727 261 GSSCHVGQT---LYQYIQSRYYRSPEVLL-----GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332 (437)
Q Consensus 261 G~s~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p 332 (437)
|++...... .....|+..|+|||++. +..++.++|+|||||++|||++|.+||...........+... +
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~ 232 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P 232 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C
Confidence 998765322 23457889999999986 346888999999999999999999999765543332222110 0
Q ss_pred ChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc
Q psy11727 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412 (437)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 412 (437)
... ..... -...+.+||.+||.
T Consensus 233 ~~~------------------------------------------------------~~~~~----~~~~~~~li~~~l~ 254 (272)
T cd06637 233 APR------------------------------------------------------LKSKK----WSKKFQSFIESCLV 254 (272)
T ss_pred CCC------------------------------------------------------CCCCC----cCHHHHHHHHHHcC
Confidence 000 00000 00157899999999
Q ss_pred cCCCCCCCHHHHhcCCCc
Q psy11727 413 YDPKKRISPTNVLRHEFF 430 (437)
Q Consensus 413 ~dP~~R~t~~e~l~Hp~~ 430 (437)
.||.+|||+.+++.||||
T Consensus 255 ~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 255 KNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CChhhCCCHHHHhhCCCC
Confidence 999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=329.37 Aligned_cols=281 Identities=31% Similarity=0.500 Sum_probs=213.9
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC-
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN- 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~- 184 (437)
.++|++.+.||+|+||.||+|.+..+++.||||.+..... .......|+.+++.+ .||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-----KHENVVNLIEICRTKAT 85 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-----CCCCccceEEEEecccc
Confidence 5689999999999999999999999999999999864321 122345677777766 7889999999887643
Q ss_pred -------EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 185 -------HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 185 -------~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
..++||||++++|.+.+.... ..+++..++.++.||+.||+|||++ |++|+||||+||++ +.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~--~i~H~dl~p~nil~--~~~~~~kl 160 (310)
T cd07865 86 PYNRYKGSFYLVFEFCEHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN--KILHRDMKAANILI--TKDGILKL 160 (310)
T ss_pred cccCCCceEEEEEcCCCcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEE--CCCCcEEE
Confidence 469999999999988887654 3589999999999999999999964 89999999999999 67889999
Q ss_pred EeCCCceecCCcc-------ccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q psy11727 258 IDFGSSCHVGQTL-------YQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVL 329 (437)
Q Consensus 258 ~DFG~s~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 329 (437)
+|||++....... ....++..|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+.......+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC 240 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999987553221 234567889999998764 47889999999999999999999999988888888887777
Q ss_pred CCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHH
Q psy11727 330 GMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILR 409 (437)
Q Consensus 330 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 409 (437)
+.++..+.+...... .++.... ... . .......+ ........+.+||.+
T Consensus 241 ~~~~~~~~~~~~~~~-~~~~~~~-----~~~--~-------~~~~~~~l----------------~~~~~~~~~~dli~~ 289 (310)
T cd07865 241 GSITPEVWPGVDKLE-LFKKMEL-----PQG--Q-------KRKVKERL----------------KPYVKDPHALDLIDK 289 (310)
T ss_pred CCCChhhcccccchh-hhhhccC-----CCc--c-------chhhHHhc----------------ccccCCHHHHHHHHH
Confidence 777766655442211 1111000 000 0 00000000 000011256899999
Q ss_pred ccccCCCCCCCHHHHhcCCCc
Q psy11727 410 MLTYDPKKRISPTNVLRHEFF 430 (437)
Q Consensus 410 ~L~~dP~~R~t~~e~l~Hp~~ 430 (437)
||..||.+|||+.++|+||||
T Consensus 290 ~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 290 LLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HhcCChhhccCHHHHhcCCCC
Confidence 999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=335.85 Aligned_cols=282 Identities=31% Similarity=0.524 Sum_probs=216.5
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC--cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC--
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK--KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK-- 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~-- 183 (437)
+.++|++.+.||+|+||.||+|.+..+++.||+|.+... .........|+.++..+ .|+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~ 77 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-----KHENIIGILDIIRPPSF 77 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-----CCCCcCchhheeecccc
Confidence 357899999999999999999999999999999998632 22334455677777766 588999999887644
Q ss_pred ---CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 184 ---NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 184 ---~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
.+.++|+|+++++|.+.+... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+||
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~--~ivH~dlkp~Nill--~~~~~~kl~df 150 (336)
T cd07849 78 ESFNDVYIVQELMETDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSA--NVLHRDLKPSNLLL--NTNCDLKICDF 150 (336)
T ss_pred cccceEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHEEE--CCCCCEEECcc
Confidence 368999999999998887653 489999999999999999999964 89999999999999 67888999999
Q ss_pred CCceecCCc------cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy11727 261 GSSCHVGQT------LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333 (437)
Q Consensus 261 G~s~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~ 333 (437)
|++...... .....|+..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+.+.++.|+
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~ 230 (336)
T cd07849 151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230 (336)
T ss_pred cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 998765322 123467889999998765 4689999999999999999999999999888888888888888776
Q ss_pred hhhhccCCcc--chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 334 GYLLHGASKT--SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 334 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
...+...... ..++...+.. ....+.... ......+.+||.+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~------------------~~~~~~~~~li~~~l 276 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFK----------------PKVPWNKLF------------------PNADPKALDLLDKML 276 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcC----------------CcccHHHHh------------------cccCcHHHHHHHHHc
Confidence 5544322110 1111000000 000000000 011235789999999
Q ss_pred ccCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 412 TYDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 412 ~~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
+.||.+|||+.|+++||||.+.-+
T Consensus 277 ~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 277 TFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred CCChhhCcCHHHHhcCccccccCC
Confidence 999999999999999999987643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=335.37 Aligned_cols=295 Identities=20% Similarity=0.262 Sum_probs=200.2
Q ss_pred eeceeccc--CceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 114 IDTLLGKG--SFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 114 i~~~lG~G--~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
+.++||+| +||+||++.+..+|+.||+|++.... ........|+.+++.+ .||||++++++|..++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~hpniv~~~~~~~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-----NHPNIVPYRATFIADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEEECCEEEE
Confidence 56789999 78999999999999999999997432 2223455566666655 78999999999999999999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
||||+++ +|.+++......++++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.++++||+.+....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~iiH~dlkp~Nil~--~~~~~~~l~~~~~~~~~~ 152 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH--MGYVHRSVKASHILI--SVDGKVYLSGLRSNLSMI 152 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCChhhEEE--ecCCcEEEcccchhhccc
Confidence 9999965 78888876544568999999999999999999995 489999999999999 667789999998654321
Q ss_pred C----------ccccccccccccChhhhcC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 268 Q----------TLYQYIQSRYYRSPEVLLG--IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 268 ~----------~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
. ......++..|+|||++.+ ..++.++|||||||++|||++|.+||.............. +..+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~ 230 (327)
T cd08227 153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCL 230 (327)
T ss_pred cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCcccc
Confidence 1 0112345677999999976 4689999999999999999999999987655443332221 211111
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
+ ..... +...+..+................. ...+.................+.+||.+||++||
T Consensus 231 ~-~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 295 (327)
T cd08227 231 L-DTTTI--------PAEELTMKPSRSGANSGLGESTTVS------TPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNP 295 (327)
T ss_pred c-cccch--------hhhhcccCCcccCCcCCCCcccccC------CcCccccCCcccccccccCHHHHHHHHHHHhhCc
Confidence 0 00000 0000000000000000000000000 0000000000000111223468999999999999
Q ss_pred CCCCCHHHHhcCCCcCcCC
Q psy11727 416 KKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~~~ 434 (437)
.+|||++|+++||||++..
T Consensus 296 ~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 296 DARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hhcCCHHHHhcChhhhhcc
Confidence 9999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=340.69 Aligned_cols=244 Identities=25% Similarity=0.332 Sum_probs=212.6
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
+.+.+++.||+|-||.||.|....+ ..||+|.++...-....+.+|+.+|..+ .|++||++++++..++.+|||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L-----~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKL-----RHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhC-----cccCeEEEEEEEecCCceEEE
Confidence 3466789999999999999987544 4799999987666667888999999998 788999999999998899999
Q ss_pred EEec-cCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 190 FELL-SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 190 ~E~~-~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
|||| .|+|.++|+......+.......|+.|||.|++||.++ ++|||||...|||| +++..+||+|||+|+...+
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~--~~IHRDLAARNiLV--~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK--NYIHRDLAARNILV--DEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC--Cccchhhhhhheee--ccCceEEEcccccccccCC
Confidence 9999 56899999986667799999999999999999999975 69999999999999 7788999999999997666
Q ss_pred cccccc-c---cccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 269 TLYQYI-Q---SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 269 ~~~~~~-g---t~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
..++.. | ...|.|||.+....++.+||||||||+|+||+| |+.||.+.+..+.++.+.++..+|.+..++
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP----- 430 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCP----- 430 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCC-----
Confidence 555432 2 245999999999999999999999999999999 999999999999999998887777654332
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
..+.+++..|+..+|++|||.+.
T Consensus 431 ---------------------------------------------------------~~vY~lM~~CW~~~P~~RPtF~~ 453 (468)
T KOG0197|consen 431 ---------------------------------------------------------DEVYELMKSCWHEDPEDRPTFET 453 (468)
T ss_pred ---------------------------------------------------------HHHHHHHHHHhhCCcccCCCHHH
Confidence 14678999999999999999886
Q ss_pred Hh
Q psy11727 424 VL 425 (437)
Q Consensus 424 ~l 425 (437)
+.
T Consensus 454 L~ 455 (468)
T KOG0197|consen 454 LR 455 (468)
T ss_pred HH
Confidence 54
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.27 Aligned_cols=252 Identities=31% Similarity=0.468 Sum_probs=209.8
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|++.+.||+|+||.||++.+..+++.||+|++.... ........|+.++..+ .|+||+++++++.+.+.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-----RHPFLVNLYGSFQDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCccceeeEEEcCCe
Confidence 47999999999999999999999999999999986422 1234455677777665 68999999999999999
Q ss_pred EEEEEEec-cCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELL-SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~-~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+++||||+ +++|.+++... ..+++..+..++.||+.||.|||+ .|++|+||+|+|||+ +.++.+||+|||++.
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~--~~i~H~dl~p~nili--~~~~~~kl~dfg~~~ 149 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLL--DSDGYIKITDFGFAK 149 (290)
T ss_pred EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEE--CCCCCEEEeeCCCcc
Confidence 99999999 55899888765 358999999999999999999995 489999999999999 678889999999998
Q ss_pred ecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc
Q psy11727 265 HVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344 (437)
Q Consensus 265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 344 (437)
..........++..|+|||.+.+..++.++|+||||+++|+|++|.+||...+.....+.+.......|.
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 219 (290)
T cd05580 150 RVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS---------- 219 (290)
T ss_pred ccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc----------
Confidence 7766556667899999999999888999999999999999999999999887765555554321000000
Q ss_pred hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC-----
Q psy11727 345 KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI----- 419 (437)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~----- 419 (437)
.....+.++|++||+.||.+|+
T Consensus 220 -----------------------------------------------------~~~~~l~~li~~~l~~~p~~R~~~~~~ 246 (290)
T cd05580 220 -----------------------------------------------------FFSPDAKDLIRNLLQVDLTKRLGNLKN 246 (290)
T ss_pred -----------------------------------------------------cCCHHHHHHHHHHccCCHHHccCcccC
Confidence 0012578999999999999999
Q ss_pred CHHHHhcCCCcCcCCC
Q psy11727 420 SPTNVLRHEFFLKHSV 435 (437)
Q Consensus 420 t~~e~l~Hp~~~~~~~ 435 (437)
+++++++||||+...+
T Consensus 247 ~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 247 GVNDIKNHPWFAGIDW 262 (290)
T ss_pred CHHHHHcCcccccCCH
Confidence 9999999999987653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=365.95 Aligned_cols=264 Identities=29% Similarity=0.438 Sum_probs=207.1
Q ss_pred ecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 103 KHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 103 ~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
..++.+.++|++.+.||+|+||+||+|.+..++..||+|++.... .....+..|+.++..+ .|||||+++++
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-----~HPNIVrl~d~ 80 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-----KHKNIVRYIDR 80 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-----CCCCcCeEEEE
Confidence 456677889999999999999999999999999999999986432 2234566688877776 78999999999
Q ss_pred eeE--CCEEEEEEEeccC-cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCC-----CCeeeCCCCCCcEEEec
Q psy11727 180 FTW--KNHLCLVFELLSY-NLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPE-----LSIIHCDLKPENILLCS 249 (437)
Q Consensus 180 ~~~--~~~~~lV~E~~~~-~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~-----~giiHrDiKp~NIll~~ 249 (437)
|.+ ...+||||||+++ +|.++|... ....+++..++.|+.||+.||+|||+.. .+||||||||+||||+.
T Consensus 81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 865 4579999999965 898888652 2345899999999999999999999632 35999999999999953
Q ss_pred C---------------CCCCEEEEeCCCceecCCc--cccccccccccChhhhcC--CCCCCcchHHHHHHHHHHHHhCC
Q psy11727 250 P---------------KRSAIKIIDFGSSCHVGQT--LYQYIQSRYYRSPEVLLG--IPYDLAIDMWSLGCILVELHTGE 310 (437)
Q Consensus 250 ~---------------~~~~ikL~DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~ 310 (437)
+ ..+.+||+|||++...... .....||+.|+|||++.+ ..++.++||||||||||+|++|.
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 2 2345999999999765432 234578999999999965 45889999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCC
Q psy11727 311 PLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRR 390 (437)
Q Consensus 311 ~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (437)
+||...+....+...+... |. ...
T Consensus 241 ~PF~~~~~~~qli~~lk~~--p~-lpi----------------------------------------------------- 264 (1021)
T PTZ00266 241 TPFHKANNFSQLISELKRG--PD-LPI----------------------------------------------------- 264 (1021)
T ss_pred CCCCcCCcHHHHHHHHhcC--CC-CCc-----------------------------------------------------
Confidence 9998766544433322210 00 000
Q ss_pred CCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 391 NEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 391 ~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
.+ ....+.+||.+||..+|.+|||+.|+|.||||+..
T Consensus 265 --~~----~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 265 --KG----KSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred --CC----CCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 00 01257899999999999999999999999999754
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=326.07 Aligned_cols=276 Identities=33% Similarity=0.556 Sum_probs=217.7
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
|++.+.||.|++|+||+|.+..+|..||+|++..... ....+..|+.+++.+ .|+|++++++++.+.+..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-----~~~~iv~~~~~~~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-----NHPNIVRLLDVVHSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-----CCCCccCHhheeccCCeEEE
Confidence 6788999999999999999999999999999874321 224456688777766 68999999999999999999
Q ss_pred EEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 189 VFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 189 V~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
||||++++|.+++.......+++..+..++.|++.||+|||++ +++||||+|+||++ +.++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~--~~~H~dl~p~nil~--~~~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH--RVLHRDLKPQNLLI--DREGALKLADFGLARAFGV 151 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCHHHEEE--cCCCcEEEeecccccccCC
Confidence 9999988999988776545689999999999999999999964 89999999999999 5688899999999875532
Q ss_pred cc---ccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc
Q psy11727 269 TL---YQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344 (437)
Q Consensus 269 ~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 344 (437)
.. ....++..|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+....+..+.+..+.|....++......
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 21 233567889999988764 57899999999999999999999999998888888888888888776654433222
Q ss_pred hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHH
Q psy11727 345 KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNV 424 (437)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~ 424 (437)
.+......... + .... ........+.+||.+||+.||.+|||++|+
T Consensus 232 ~~~~~~~~~~~-------------~---~~~~------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i 277 (283)
T cd07835 232 DYKPTFPKWAR-------------Q---DLSK------------------VVPNLDEDGLDLLSKMLVYDPAKRISAKAA 277 (283)
T ss_pred hhhhhcccccc-------------c---chhh------------------hcCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 22111111000 0 0000 000011257899999999999999999999
Q ss_pred hcCCCc
Q psy11727 425 LRHEFF 430 (437)
Q Consensus 425 l~Hp~~ 430 (437)
+.||||
T Consensus 278 l~~~~~ 283 (283)
T cd07835 278 LQHPYF 283 (283)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=350.26 Aligned_cols=257 Identities=32% Similarity=0.496 Sum_probs=211.6
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
+.|.|+..||.|+||.||+|.++.++...|.|+|..+. .....+..|+.|+... +||+||+|++.|...+.++|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-----dHP~ivkLl~ayy~enkLwi 106 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-----DHPVIVKLLSAYYFENKLWI 106 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-----CChHHHHHHHHHhccCceEE
Confidence 45788999999999999999999999989999997543 3345566677777655 79999999999999999999
Q ss_pred EEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec--
Q psy11727 189 VFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV-- 266 (437)
Q Consensus 189 V~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~-- 266 (437)
+.|||+|+--+.+.-.-..+++++++..+++|++.||.|||++ .|||||||..|||+ .-+|.|+|+|||.|...
T Consensus 107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~--~iIHRDLKAGNiL~--TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ--NIIHRDLKAGNILL--TLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc--chhhhhccccceEE--EecCcEeeecccccccchh
Confidence 9999988766655443346799999999999999999999986 59999999999999 45778999999998543
Q ss_pred -CCccccccccccccChhhhcC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 267 -GQTLYQYIQSRYYRSPEVLLG-----IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 267 -~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
.....+++||++|||||+... .+|+.++||||||++|.||.-+.||-...+....+.+|.+ .-||...
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK--SePPTLl---- 256 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--SEPPTLL---- 256 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh--cCCCccc----
Confidence 233456899999999999864 5899999999999999999999999998888777666644 1222111
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
.|.||.. .|.||+.+||..||..||+
T Consensus 257 ---------------------------------------------------qPS~Ws~---~F~DfLk~cL~Knp~~Rp~ 282 (1187)
T KOG0579|consen 257 ---------------------------------------------------QPSHWSR---SFSDFLKRCLVKNPRNRPP 282 (1187)
T ss_pred ---------------------------------------------------Ccchhhh---HHHHHHHHHHhcCCccCCC
Confidence 1112211 5899999999999999999
Q ss_pred HHHHhcCCCcCcCCC
Q psy11727 421 PTNVLRHEFFLKHSV 435 (437)
Q Consensus 421 ~~e~l~Hp~~~~~~~ 435 (437)
+.++|+|||++....
T Consensus 283 aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 283 AAQLLKHPFVQNAPS 297 (1187)
T ss_pred HHHHhhCcccccCCc
Confidence 999999999997654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=337.27 Aligned_cols=283 Identities=31% Similarity=0.560 Sum_probs=223.9
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+.++|++.+.||+|+||.||+|++..++..||+|++.... ........|+.++..+ .|+||+++.+++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~ 86 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-----DHENVIGLLDVFTPA 86 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-----cCCCHHHHHHHhhcc
Confidence 34678999999999999999999999999999999986321 1223445677776665 789999999988766
Q ss_pred CE------EEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 184 NH------LCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 184 ~~------~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
+. .++|+|+++++|.+++... .+++..++.++.||+.||+|||+ .||+||||||+||++ +.++.++|
T Consensus 87 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nill--~~~~~~kL 159 (343)
T cd07851 87 SSLEDFQDVYLVTHLMGADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAV--NEDCELKI 159 (343)
T ss_pred ccccccccEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEE--CCCCCEEE
Confidence 54 9999999988999988763 48999999999999999999995 589999999999999 66788999
Q ss_pred EeCCCceecCCccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 258 IDFGSSCHVGQTLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 258 ~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
+|||++...........++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+.+..+.|++.+
T Consensus 160 ~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 160 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 999999877666666778899999999865 3678999999999999999999999999988888999999888888776
Q ss_pred hccCCccc--hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 337 LHGASKTS--KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 337 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
+....... .|...+... . ...+..+ .......+.+||.+||+.|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-------------~---~~~~~~~------------------~~~~s~~l~dli~~~l~~~ 285 (343)
T cd07851 240 LQKISSESARNYIQSLPQM-------------P---KKDFKEV------------------FSGANPLAIDLLEKMLVLD 285 (343)
T ss_pred HhhccchhHHHHHHhcccc-------------C---CCCHHHH------------------hccCCHHHHHHHHHhCCCC
Confidence 65443210 111100000 0 0000000 0001226899999999999
Q ss_pred CCCCCCHHHHhcCCCcCcCCC
Q psy11727 415 PKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~~~~~~ 435 (437)
|.+|||+.++++||||++...
T Consensus 286 P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 286 PDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred hhhCCCHHHHhcCCCccccCC
Confidence 999999999999999988654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=352.36 Aligned_cols=254 Identities=28% Similarity=0.336 Sum_probs=202.4
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
..++|.+.+.||+|+||+||+|.+..+++.||||++..... .......|+.++.. +.|++|+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~-----~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLN-----CDFFSIVKCHEDFAKKD 104 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhc-----CCCCcEEEeecceeccc
Confidence 35699999999999999999999999999999999864322 12233445554443 47899999988776432
Q ss_pred --------EEEEEEEeccC-cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC
Q psy11727 185 --------HLCLVFELLSY-NLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS 253 (437)
Q Consensus 185 --------~~~lV~E~~~~-~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~ 253 (437)
.+++||||+.+ +|.+++... ....+++..+..++.|++.||+|||++ ||+||||||+|||+ +.++
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~--~IiHrDLKP~NILl--~~~~ 180 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK--HMIHRDIKSANILL--CSNG 180 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEE--eCCC
Confidence 47899999965 898888653 234589999999999999999999964 89999999999999 6688
Q ss_pred CEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q psy11727 254 AIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV 328 (437)
Q Consensus 254 ~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 328 (437)
.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~ 260 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 8999999998765322 23467899999999999999999999999999999999999999988776666555331
Q ss_pred hCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHH
Q psy11727 329 LGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLIL 408 (437)
Q Consensus 329 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 408 (437)
...+. | ......+.+||.
T Consensus 261 ~~~~~-----------------------------------~---------------------------~~~~~~l~~li~ 278 (496)
T PTZ00283 261 RYDPL-----------------------------------P---------------------------PSISPEMQEIVT 278 (496)
T ss_pred CCCCC-----------------------------------C---------------------------CCCCHHHHHHHH
Confidence 11000 0 000125789999
Q ss_pred HccccCCCCCCCHHHHhcCCCcCc
Q psy11727 409 RMLTYDPKKRISPTNVLRHEFFLK 432 (437)
Q Consensus 409 ~~L~~dP~~R~t~~e~l~Hp~~~~ 432 (437)
+||+.||.+|||+.++++|||++.
T Consensus 279 ~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 279 ALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HHcccChhhCcCHHHHHhCHHHHH
Confidence 999999999999999999999864
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=326.95 Aligned_cols=281 Identities=35% Similarity=0.525 Sum_probs=218.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC--
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK-- 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~-- 183 (437)
.++|++.+.||+|+||.||+|.+..+++.+|+|.++.... .......|+.++..+ .|+||+++++++...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-----QHPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-----CCCCEEEEEEEEEecCC
Confidence 3579999999999999999999999999999999974322 122345677777666 689999999999887
Q ss_pred CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 184 NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 184 ~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
+.+|+||||++++|.+++.... ..+++..++.++.||+.||+|||++ |++|+||||+||++ +.++.++|+|||++
T Consensus 79 ~~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~--~i~H~dl~p~nili--~~~~~~~l~d~g~~ 153 (293)
T cd07843 79 DKIYMVMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN--WILHRDLKTSNLLL--NNRGILKICDFGLA 153 (293)
T ss_pred CcEEEEehhcCcCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCCHHHEEE--CCCCcEEEeecCce
Confidence 8999999999999998887654 3589999999999999999999964 89999999999999 67889999999998
Q ss_pred eecCCc---cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhcc
Q psy11727 264 CHVGQT---LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 264 ~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 339 (437)
...... .....++..|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+..+.+.++....+.|+...++.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 154 REYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred eeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Confidence 766443 2234568889999998764 468999999999999999999999999998888999988888887766543
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
.......-. ..+ ..+....+... .........+.+||++||+.||++||
T Consensus 234 ~~~~~~~~~----~~~-----------~~~~~~~~~~~----------------~~~~~~~~~~~~li~~~l~~~p~~R~ 282 (293)
T cd07843 234 FSELPGAKK----KTF-----------TKYPYNQLRKK----------------FPALSLSDNGFDLLNRLLTYDPAKRI 282 (293)
T ss_pred hhccchhcc----ccc-----------ccccchhhhcc----------------ccccCCChHHHHHHHHHhccCccccC
Confidence 322110000 000 00000000000 00000123578999999999999999
Q ss_pred CHHHHhcCCCc
Q psy11727 420 SPTNVLRHEFF 430 (437)
Q Consensus 420 t~~e~l~Hp~~ 430 (437)
|+.|+|.||||
T Consensus 283 t~~ell~~~~f 293 (293)
T cd07843 283 SAEDALKHPYF 293 (293)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=324.29 Aligned_cols=277 Identities=31% Similarity=0.531 Sum_probs=217.3
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
+|++.+.||.|++|+||+|.+..++..||||.++.... .......|+.+++.+ .|+||+++++.+.+.+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-----KHENIVRLHDVIHTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-----cCCCEeeeeeeEeeCCcEEE
Confidence 58899999999999999999999999999999874322 234555677777766 68999999999999999999
Q ss_pred EEEeccCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSYNLYNLIRNTN-FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~~L~~~l~~~~-~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
||||++++|.+++.... ...+++..+..++.||+.||.|||+ .|++||||||+||++ ++++.++|+|||++....
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~h~dl~p~ni~~--~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 76 VFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE--NRVLHRDLKPQNLLI--NKRGELKLADFGLARAFG 151 (284)
T ss_pred EEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEE--CCCCcEEEeecchhhhhc
Confidence 99999999998886543 2458999999999999999999995 489999999999999 678889999999986553
Q ss_pred Cc---cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 268 QT---LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 268 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.. .....++..|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+....+.+..+.|....+......
T Consensus 152 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 152 IPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred CCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC
Confidence 32 1234568889999998764 5789999999999999999999999999988888888888777766555433322
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
..+....+... ......+. ......+.++|.+||+.||.+|||+.+
T Consensus 232 ~~~~~~~~~~~----------------~~~~~~~~------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~ 277 (284)
T cd07836 232 PEYKPTFPRYP----------------PQDLQQLF------------------PHADPLGIDLLHRLLQLNPELRISAHD 277 (284)
T ss_pred chhcccccCCC----------------hHHHHHHh------------------hhcCcHHHHHHHHHhcCCcccCCCHHH
Confidence 11111000000 00000000 001225789999999999999999999
Q ss_pred HhcCCCc
Q psy11727 424 VLRHEFF 430 (437)
Q Consensus 424 ~l~Hp~~ 430 (437)
+++||||
T Consensus 278 ~l~~~~f 284 (284)
T cd07836 278 ALQHPWF 284 (284)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=324.02 Aligned_cols=280 Identities=32% Similarity=0.554 Sum_probs=216.7
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC---cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK---KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
++|++.+.||+|+||.||+|.+..+++.||+|.++.. ......+..|+.+++.+ .|+||+++++++...+..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-----RHENIVNLKEAFRRKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-----CCCCeeehhheEEECCEE
Confidence 4799999999999999999999999999999998643 22345677788888877 588999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
++||||+++++.+.+.... ..+++..+..++.||+.||+|||.+ |++||||+|+||++ ++++.+||+|||++...
T Consensus 76 ~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dl~~~ni~~--~~~~~~kl~d~g~~~~~ 150 (288)
T cd07833 76 YLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSH--NIIHRDIKPENILV--SESGVLKLCDFGFARAL 150 (288)
T ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEE--CCCCCEEEEeeeccccc
Confidence 9999999887776655443 4589999999999999999999964 89999999999999 67889999999998765
Q ss_pred CCc----cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 267 GQT----LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 267 ~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
... .....++..|+|||++.+. .++.++|+||||+++|+|++|++||.+.+..+.+..+....+..+..+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred CCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 432 2345678899999999888 88999999999999999999999999988888888777776655554433222
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
....+- . ...+.......+. ..........+.+||++||..||++|||+
T Consensus 231 ~~~~~~-~----------------~~~~~~~~~~~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 279 (288)
T cd07833 231 SNPRFA-G----------------VAFPEPSQPESLE--------------RRYPGKVSSPALDFLKACLRMDPKERLTC 279 (288)
T ss_pred cCcccc-c----------------cccCCCCCcHHHH--------------HhcCCccchHHHHHHHHHhccCchhcccH
Confidence 111100 0 0000000000000 00000012367999999999999999999
Q ss_pred HHHhcCCCc
Q psy11727 422 TNVLRHEFF 430 (437)
Q Consensus 422 ~e~l~Hp~~ 430 (437)
+++++||||
T Consensus 280 ~~il~~~~f 288 (288)
T cd07833 280 DELLQHPYF 288 (288)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=335.77 Aligned_cols=282 Identities=30% Similarity=0.518 Sum_probs=221.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE---
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--- 182 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--- 182 (437)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ........|+.+++.+ .|+||++++++|..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-----KHDNIIAIRDILRPPGA 78 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-----CCCCccCHHHhccccCC
Confidence 468999999999999999999999999999999987432 2234555677777776 68999999998863
Q ss_pred -CCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 -KNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 -~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
...+++||||++++|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+||++ +.++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~Nil~--~~~~~~kl~dfg 152 (334)
T cd07855 79 DFKDVYVVMDLMESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLV--NEDCELRIGDFG 152 (334)
T ss_pred CCceEEEEEehhhhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEE--cCCCcEEecccc
Confidence 3578999999998998888654 348999999999999999999995 489999999999999 678899999999
Q ss_pred CceecCCc-------cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy11727 262 SSCHVGQT-------LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333 (437)
Q Consensus 262 ~s~~~~~~-------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~ 333 (437)
++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+...++..+...+|.|+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~ 232 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS 232 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence 98665321 123467889999999866 4688999999999999999999999999998889999999999998
Q ss_pred hhhhccCCcc--chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 334 GYLLHGASKT--SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 334 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
...+...... ..++...+. .....+.++. ......+.+||++||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~------------------~~~~~~~~~li~~~l 278 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPR----------------KQPVPWSKIF------------------PKASPEALDLLSQML 278 (334)
T ss_pred hHhhhhhchhhHHHHHhhccc----------------CCCCCHHHHc------------------ccCCHHHHHHHHHHc
Confidence 8776533211 011111000 0000000000 011236899999999
Q ss_pred ccCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 412 TYDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 412 ~~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
+.||.+|||+.+++.||||.+...
T Consensus 279 ~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 279 QFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred cCChhhCcCHHHHHhChhhhhccC
Confidence 999999999999999999977543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=334.89 Aligned_cols=283 Identities=32% Similarity=0.517 Sum_probs=218.0
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC---cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC-
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK---KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK- 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~- 183 (437)
+.++|.+.+.||+|+||+||+|.+..+++.||||.+... .........|+.+++.+ .|+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~ni~~~~~~~~~~~ 77 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-----DHENVIAIKDIMPPPH 77 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-----CCCCccchHHheeccc
Confidence 356899999999999999999999999999999998642 11223455677777665 689999999988654
Q ss_pred ----CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 184 ----NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 184 ----~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
.++|+||||++++|.+++... ..+++..+..++.||+.||.|||++ |++||||||+||++ +.++.+||+|
T Consensus 78 ~~~~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~--~i~H~dlkp~Nil~--~~~~~~kL~D 151 (337)
T cd07858 78 REAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA--NVLHRDLKPSNLLL--NANCDLKICD 151 (337)
T ss_pred ccccCcEEEEEeCCCCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEE--cCCCCEEECc
Confidence 358999999999999888764 3589999999999999999999964 89999999999999 6678899999
Q ss_pred CCCceecCCc---cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 260 FGSSCHVGQT---LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 260 FG~s~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
||++...... .....++..|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+.......+.+..+.++..
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 152 FGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231 (337)
T ss_pred CccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 9999765332 234567889999999875 468899999999999999999999999998888888888888877665
Q ss_pred hhccCC--ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 336 LLHGAS--KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 336 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
.+.... ....+....+.. +. .............+.+||++||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~-------------------------------~~---~~~~~~~~~~~~~~~~li~~~l~~ 277 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYT-------------------------------PR---QSFARLFPHANPLAIDLLEKMLVF 277 (337)
T ss_pred HhhhcCchhhhHHHHhcCcc-------------------------------cc---cCHHHHcccCCHHHHHHHHHHhcC
Confidence 442111 111111110000 00 000000001123578999999999
Q ss_pred CCCCCCCHHHHhcCCCcCcCCC
Q psy11727 414 DPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 414 dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
||.+|||++++++||||....+
T Consensus 278 ~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 278 DPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred ChhhccCHHHHHcCcchhhhcC
Confidence 9999999999999999987543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=325.81 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=197.9
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
++|++.+.||+|+||.||+|.+..++..||+|++.... .....+..|+.++..+ .||||+++++.+...+..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-----DSPYIIGFYGAFFVENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEEECCEEE
Confidence 36888999999999999999999999999999986432 1223455677776655 7899999999999999999
Q ss_pred EEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 188 LVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 188 lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
+||||++++..+.. ..+++..+..++.|++.||.|||+ .||+|+||||+|||+ +.++.++|+|||++....
T Consensus 76 lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nill--~~~~~~~l~dfg~~~~~~ 146 (279)
T cd06619 76 ICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWS--LKILHRDVKPSNMLV--NTRGQVKLCDFGVSTQLV 146 (279)
T ss_pred EEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCCHHHEEE--CCCCCEEEeeCCcceecc
Confidence 99999977543322 236889999999999999999995 489999999999999 678899999999997654
Q ss_pred Cc-cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChhhhccCCcc
Q psy11727 268 QT-LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ---MTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 268 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~---~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.. .....|+..|+|||++.+..++.++|+|||||++|+|++|..||........ ..........+.
T Consensus 147 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------- 216 (279)
T cd06619 147 NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED---------- 216 (279)
T ss_pred cccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC----------
Confidence 33 3346789999999999999999999999999999999999999975322110 000000000000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
.+ .. + .......+.+||.+||+.||.+|||+++
T Consensus 217 ------------------------~~-------------------~~--~--~~~~~~~~~~li~~~l~~~P~~Rp~~~e 249 (279)
T cd06619 217 ------------------------PP-------------------VL--P--VGQFSEKFVHFITQCMRKQPKERPAPEN 249 (279)
T ss_pred ------------------------CC-------------------CC--C--CCcCCHHHHHHHHHHhhCChhhCCCHHH
Confidence 00 00 0 0001125789999999999999999999
Q ss_pred HhcCCCcCcCCCC
Q psy11727 424 VLRHEFFLKHSVD 436 (437)
Q Consensus 424 ~l~Hp~~~~~~~~ 436 (437)
+++||||+.....
T Consensus 250 il~~~~~~~~~~~ 262 (279)
T cd06619 250 LMDHPFIVQYNDG 262 (279)
T ss_pred HhcCcccccccCc
Confidence 9999999877543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=317.85 Aligned_cols=249 Identities=30% Similarity=0.391 Sum_probs=203.4
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+|.+.+.||+|++|.||+|.+..+++.|++|.+.... .....+..|+.++..+ .|+||+++++++...+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-----DSSYIIRYYESFLDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-----CCCCeehheeeeccCCEEE
Confidence 4788999999999999999999999999999986432 2233444566655554 7899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|.+++.......+++..+..++.|++.||.|||+ .|++|+||||+||++ +.++.++|+|||++...
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~--~~i~h~dl~~~nili--~~~~~~~l~df~~~~~~ 151 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS--KKILHRDIKSLNLFL--DAYDNVKIGDLGVAKLL 151 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEE--eCCCCEEEcccccceec
Confidence 99999965 89998877644568999999999999999999995 589999999999999 56788999999998765
Q ss_pred CCcc---ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQTL---YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.... ....++..|+|||++.+..++.++|+|||||++++|++|+.||...+.......+......+...
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 223 (256)
T cd08529 152 SDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQ-------- 223 (256)
T ss_pred cCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc--------
Confidence 4322 23467889999999999999999999999999999999999999888665555543311100000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
.....+.++|++||+.+|++||++.+
T Consensus 224 ------------------------------------------------------~~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (256)
T cd08529 224 ------------------------------------------------------MYSQQLAQLIDQCLTKDYRQRPDTFQ 249 (256)
T ss_pred ------------------------------------------------------ccCHHHHHHHHHHccCCcccCcCHHH
Confidence 00125789999999999999999999
Q ss_pred HhcCCCc
Q psy11727 424 VLRHEFF 430 (437)
Q Consensus 424 ~l~Hp~~ 430 (437)
+++|||+
T Consensus 250 ll~~~~~ 256 (256)
T cd08529 250 LLRNPSL 256 (256)
T ss_pred HhhCCCC
Confidence 9999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=333.17 Aligned_cols=280 Identities=31% Similarity=0.516 Sum_probs=218.4
Q ss_pred eccCeee-eceecccCceEEEEEEEcCCCeEEEEEEecCCcccc---------------hHHHHHHHHHHHhhhcCCCCC
Q psy11727 108 FLDRYEI-DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFL---------------NQAQIEVQLLEKINKADIHSR 171 (437)
Q Consensus 108 ~~~~y~i-~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~---------------~~~~~e~~~~~~l~~~~~~h~ 171 (437)
+.++|.. .+.||+|+||+||+|.+..+++.||||+++...... ..+..|+.++..+ .|+
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~ 80 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-----KHE 80 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-----CCc
Confidence 4567875 577999999999999999999999999986432211 1345677777666 689
Q ss_pred cEEEecceeeECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC
Q psy11727 172 YIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK 251 (437)
Q Consensus 172 ~iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~ 251 (437)
||+++++++...++.++|||+++++|.+++... ..+++..+..++.||+.||+|||+ .|++|+||+|+||++ +.
T Consensus 81 ~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~--~~i~H~dl~~~nill--~~ 154 (335)
T PTZ00024 81 NIMGLVDVYVEGDFINLVMDIMASDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHK--WYFMHRDLSPANIFI--NS 154 (335)
T ss_pred ceeeeeEEEecCCcEEEEEeccccCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHeEE--CC
Confidence 999999999999999999999999999988764 348999999999999999999995 489999999999999 67
Q ss_pred CCCEEEEeCCCceecCC-----------------ccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCC
Q psy11727 252 RSAIKIIDFGSSCHVGQ-----------------TLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLF 313 (437)
Q Consensus 252 ~~~ikL~DFG~s~~~~~-----------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf 313 (437)
++.++|+|||++..... ......++..|+|||++.+. .++.++|+|||||++|+|++|.+||
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~ 234 (335)
T PTZ00024 155 KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234 (335)
T ss_pred CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 88899999999876541 11123457789999999764 4789999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCC
Q psy11727 314 SGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEP 393 (437)
Q Consensus 314 ~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (437)
.+.+..+.+..+.+..+.|+...++.......+...... .......+.
T Consensus 235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~--------------- 282 (335)
T PTZ00024 235 PGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPR-----------------KPKDLKTIF--------------- 282 (335)
T ss_pred CCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcC-----------------CcccHHHhC---------------
Confidence 999999999999998888877655443322111100000 000000000
Q ss_pred CCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 394 GHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 394 ~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
......+.+||.+||+.||.+|||++|+|.||||+..
T Consensus 283 ---~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 283 ---PNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred ---cCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 0011257899999999999999999999999999865
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=317.43 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=200.7
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE-CCEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW-KNHL 186 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~-~~~~ 186 (437)
+|++.+.||+|++|.||++.+..+++.||+|.+..... .......|+.+++.+ .|+|++++.+.+.. ...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-----KHPNIVAYRESWEGEDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-----CCCCeeeeeeeecCCCCEE
Confidence 48999999999999999999999999999999864322 223445566666555 68899999998764 4478
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++||||+++ +|.+++.......+++..+..++.|++.||++||+ .|++|+||||+||++ +.++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~--~~i~H~di~p~nil~--~~~~~~~l~df~~~~~ 151 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE--KHILHRDLKTQNVFL--TRTNIIKVGDLGIARV 151 (257)
T ss_pred EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCchhEEE--ecCCcEEEecccceEE
Confidence 999999965 78888876554568999999999999999999995 489999999999999 6688899999999876
Q ss_pred cCCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 266 VGQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 266 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.... .....++..|+|||++.+..++.++|+|||||++++|++|+.||.+.+.......+......+..
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-------- 223 (257)
T cd08223 152 LENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMP-------- 223 (257)
T ss_pred ecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc--------
Confidence 5322 23456788999999999999999999999999999999999999887765555444331100000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
......+.+||.+||+.||.+|||+.
T Consensus 224 ------------------------------------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 249 (257)
T cd08223 224 ------------------------------------------------------KDYSPELGELIATMLSKRPEKRPSVK 249 (257)
T ss_pred ------------------------------------------------------cccCHHHHHHHHHHhccCcccCCCHH
Confidence 00012578999999999999999999
Q ss_pred HHhcCCCc
Q psy11727 423 NVLRHEFF 430 (437)
Q Consensus 423 e~l~Hp~~ 430 (437)
+++.||||
T Consensus 250 ~~l~~~~~ 257 (257)
T cd08223 250 SILRQPYI 257 (257)
T ss_pred HHhcCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=329.65 Aligned_cols=291 Identities=26% Similarity=0.383 Sum_probs=208.5
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
++|++.+.||+|+||.||++.+..++..+|+|.+.... ....++..|+.++..+ .|+||++++++|.++++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-----NSPYIVGFYGAFYSDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEeeCCEEE
Confidence 36999999999999999999999999999999986432 2234456677777765 7899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|.+++... ..+++..+..++.|++.||.|||+. .+++||||||+|||+ +.++.++|+|||++...
T Consensus 76 lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~ 150 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREK-HKIMHRDVKPSNILV--NSRGEIKLCDFGVSGQL 150 (308)
T ss_pred EEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh-CCEEECCCChHHEEE--ecCCcEEEccCCCcccc
Confidence 99999965 888888765 4589999999999999999999963 479999999999999 66788999999998654
Q ss_pred CCc-cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccch
Q psy11727 267 GQT-LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSK 345 (437)
Q Consensus 267 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 345 (437)
... .....++..|+|||++.+..++.++|+|||||++|+|++|+.||...+.... ..+. ...+............
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~---~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 151 IDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMF---GRPVSEGEAKESHRPV 226 (308)
T ss_pred cccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhh---cCccccccccCCcccc
Confidence 322 2345788999999999888899999999999999999999999987653322 2221 1111111000000000
Q ss_pred hhcccCCCcceeccccccccccCCCCCchhhhhccC-CCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHH
Q psy11727 346 YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVD-NGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNV 424 (437)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~ 424 (437)
.......+......++.... ...+. ..+. ......+.+||.+||..||++|||+.++
T Consensus 227 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~l 284 (308)
T cd06615 227 ----------------SGHPPDSPRPMAIFELLDYIVNEPPP----KLPS--GAFSDEFQDFVDKCLKKNPKERADLKEL 284 (308)
T ss_pred ----------------cCCCCCccchhhHHHHHHHHhcCCCc----cCcC--cccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 00000000000000000000 00000 0000 0122358999999999999999999999
Q ss_pred hcCCCcCcCCCC
Q psy11727 425 LRHEFFLKHSVD 436 (437)
Q Consensus 425 l~Hp~~~~~~~~ 436 (437)
++||||.+.+.+
T Consensus 285 l~~~~~~~~~~~ 296 (308)
T cd06615 285 TKHPFIKRAELE 296 (308)
T ss_pred hcChhhhhcccc
Confidence 999999886543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=334.46 Aligned_cols=281 Identities=31% Similarity=0.579 Sum_probs=218.4
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC-
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK- 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~- 183 (437)
+.++|.+.+.||+|+||.||+|.+..+++.||+|.+.... ........|+.+++.+ .|+||++++++|...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~ 87 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-----QHENVIGLLDVFTSAV 87 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-----CCCCccchhheecccc
Confidence 3578999999999999999999999999999999986421 1223456677777665 789999999998754
Q ss_pred -----CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 184 -----NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 184 -----~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
..+++|+|++..+|..+.. ..+++..+..++.|++.||+|||++ |++||||||+||++ +.++.++|+
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~--~i~H~dlkp~NIll--~~~~~~kL~ 159 (342)
T cd07879 88 SGDEFQDFYLVMPYMQTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA--GIIHRDLKPGNLAV--NEDCELKIL 159 (342)
T ss_pred cCCCCceEEEEecccccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEE--CCCCCEEEe
Confidence 3579999999877766542 2489999999999999999999964 89999999999999 678899999
Q ss_pred eCCCceecCCccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 259 DFGSSCHVGQTLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 259 DFG~s~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
|||++...........++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+....+.++..+.
T Consensus 160 dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 160 DFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred eCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99999776555555678889999999876 46889999999999999999999999999888888899888888877665
Q ss_pred ccCCccc--hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 338 HGASKTS--KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 338 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
....... .+....+ ..+ ...+... .......+.+||++||+.||
T Consensus 240 ~~~~~~~~~~~~~~~~---------------~~~-~~~~~~~------------------~~~~~~~~~~li~~~l~~dP 285 (342)
T cd07879 240 QKLEDKAAKSYIKSLP---------------KYP-RKDFSTL------------------FPKASPQAVDLLEKMLELDV 285 (342)
T ss_pred HHhcccchHHHHhhcC---------------Ccc-cchHHHH------------------hcCCCHHHHHHHHHHcCCCh
Confidence 4332211 0000000 000 0000000 00012257899999999999
Q ss_pred CCCCCHHHHhcCCCcCcCCC
Q psy11727 416 KKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~~~~ 435 (437)
.+|||+++++.||||....+
T Consensus 286 ~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 286 DKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hhCcCHHHHhcCcchhhccc
Confidence 99999999999999987643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=329.77 Aligned_cols=255 Identities=28% Similarity=0.439 Sum_probs=206.7
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|++.+.||+|+||+||+|.+..+++.||+|.+..... ....+..|+.++..+ .|+||+++++.+...+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-----DHPFLPTLYASFQTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-----CCCCchhheeeeecCCE
Confidence 379999999999999999999999999999999975432 223455566666655 68999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
.|+||||+.+ +|.+++.......+++..++.++.|++.||+|||+ .|++|+||||+||++ +.++.++|+|||++.
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili--~~~~~~~l~dfg~~~ 151 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL--LGIVYRDLKPENILL--HESGHIMLSDFDLSK 151 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChHHeEE--cCCCCEEEeecchhh
Confidence 9999999965 89998876555668999999999999999999995 589999999999999 667889999999975
Q ss_pred ecCCc--------------------------------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCC
Q psy11727 265 HVGQT--------------------------------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPL 312 (437)
Q Consensus 265 ~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p 312 (437)
..... .....|+..|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCC
Confidence 43211 1123678889999999998999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCC
Q psy11727 313 FSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNE 392 (437)
Q Consensus 313 f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (437)
|.+.+....+..+.......+ ..
T Consensus 232 f~~~~~~~~~~~~~~~~~~~~------------------------------------~~--------------------- 254 (316)
T cd05574 232 FKGSNRDETFSNILKKEVTFP------------------------------------GS--------------------- 254 (316)
T ss_pred CCCCchHHHHHHHhcCCccCC------------------------------------Cc---------------------
Confidence 998877666555432100000 00
Q ss_pred CCCChhhhhHHHHHHHHccccCCCCCCC----HHHHhcCCCcCcCC
Q psy11727 393 PGHSLADYMKFKDLILRMLTYDPKKRIS----PTNVLRHEFFLKHS 434 (437)
Q Consensus 393 ~~~~~~~~~~~~dli~~~L~~dP~~R~t----~~e~l~Hp~~~~~~ 434 (437)
......+.+||.+||+.||++||| ++++|+||||++..
T Consensus 255 ----~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 255 ----PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred ----cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 001125799999999999999999 99999999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=319.38 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=199.7
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc------cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP------FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~------~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
+.|.+.+.||+|++|.||+|.+..+++.||+|.+..... ....+.+|+.++..+ .|+||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-----QHERIVQYYGCLRDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-----CCCCeeeeEEEEccC
Confidence 468999999999999999999999999999999864321 123445566666555 789999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+.+++|||++++ +|.+++.... .+++..++.++.|++.||+|||+ .||+||||+|+||++ +.++.++|+|||+
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nilv--~~~~~~~l~dfg~ 150 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHS--NMIVHRDIKGANILR--DSAGNVKLGDFGA 150 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE--cCCCCEEEeeccc
Confidence 999999999965 7888887653 48999999999999999999995 589999999999999 6678899999999
Q ss_pred ceecCCcc------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 263 SCHVGQTL------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 263 s~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
+....... ....++..|+|||++.+..++.++||||||+++|+|++|++||...+.......+......+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 227 (263)
T cd06625 151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQ--- 227 (263)
T ss_pred ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCC---
Confidence 86543211 234577889999999998999999999999999999999999987655444333321100000
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
.| ......+.+||.+||..||.
T Consensus 228 -------------------------------~~---------------------------~~~~~~~~~li~~~l~~~p~ 249 (263)
T cd06625 228 -------------------------------LP---------------------------SHVSPDARNFLRRTFVENAK 249 (263)
T ss_pred -------------------------------CC---------------------------ccCCHHHHHHHHHHhhcCcc
Confidence 00 00112578999999999999
Q ss_pred CCCCHHHHhcCCCc
Q psy11727 417 KRISPTNVLRHEFF 430 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~ 430 (437)
+|||+.++++||||
T Consensus 250 ~Rpt~~~ll~~~~~ 263 (263)
T cd06625 250 KRPSAEELLRHFFV 263 (263)
T ss_pred cCCCHHHHhhCCCC
Confidence 99999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=323.79 Aligned_cols=254 Identities=28% Similarity=0.458 Sum_probs=201.6
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE-----
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW----- 182 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~----- 182 (437)
..+.|++.+.||+|+||+||+|.+..+++.+|+|++............|+.++..+. .|+||++++++|..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~----~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS----HHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhc----CCCcEEEEeeehhcccccC
Confidence 356899999999999999999999999999999998755444455667777777763 68999999999853
Q ss_pred -CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 183 -KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 183 -~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
.+++|+||||+++ +|.+++.......+++..+..++.||+.||+|||++ ||+|+||||+||++ +.++.++|+||
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--~ivH~dl~~~nili--~~~~~~~l~df 165 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH--KVIHRDIKGQNVLL--TENAEVKLVDF 165 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEE--CCCCCEEEeeC
Confidence 4689999999966 788888765555688999999999999999999964 89999999999999 67788999999
Q ss_pred CCceecCCc---cccccccccccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy11727 261 GSSCHVGQT---LYQYIQSRYYRSPEVLL-----GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332 (437)
Q Consensus 261 G~s~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p 332 (437)
|++...... .....|+..|+|||++. +..++.++|+|||||++|+|++|.+||...........+.. .+
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---~~ 242 (282)
T cd06636 166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NP 242 (282)
T ss_pred cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh---CC
Confidence 998755322 23456889999999986 34688899999999999999999999976554333222111 00
Q ss_pred ChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc
Q psy11727 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412 (437)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 412 (437)
+.... .. .....+.+||.+||+
T Consensus 243 ~~~~~------------------------------------------------------~~----~~~~~~~~li~~cl~ 264 (282)
T cd06636 243 PPKLK------------------------------------------------------SK----KWSKKFIDFIEGCLV 264 (282)
T ss_pred CCCCc------------------------------------------------------cc----ccCHHHHHHHHHHhC
Confidence 00000 00 001257999999999
Q ss_pred cCCCCCCCHHHHhcCCCc
Q psy11727 413 YDPKKRISPTNVLRHEFF 430 (437)
Q Consensus 413 ~dP~~R~t~~e~l~Hp~~ 430 (437)
.||.+|||+.|+++||||
T Consensus 265 ~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 265 KNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=332.28 Aligned_cols=282 Identities=28% Similarity=0.527 Sum_probs=219.2
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
+.++|++.+.||+|+||.||+|.+..++..||||++..... ....+..|+.+++.+ .|+||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-----KHENVIGLLDVFTPDL 87 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-----CCCCccceeeeecCCc
Confidence 46789999999999999999999999999999999853221 223455677777766 6899999999987653
Q ss_pred ------EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 185 ------HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 185 ------~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
.+++|||+++++|.+++... .+++..++.++.||+.||+|||. .||+||||||+||++ +.++.++|+
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~--~gi~H~dlkp~Nill--~~~~~~kl~ 160 (343)
T cd07880 88 SLDRFHDFYLVMPFMGTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHA--AGIIHRDLKPGNLAV--NEDCELKIL 160 (343)
T ss_pred cccccceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE--cCCCCEEEe
Confidence 46999999988888887653 48999999999999999999995 589999999999999 668889999
Q ss_pred eCCCceecCCccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 259 DFGSSCHVGQTLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 259 DFG~s~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
|||++...........++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+.......+....+.++..+.
T Consensus 161 dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 161 DFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred ecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99999877665555678899999999876 35889999999999999999999999998888888888887776665554
Q ss_pred ccCCcc--chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 338 HGASKT--SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 338 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
...... ..+...++.. ....+..+ .......+.++|.+||+.||
T Consensus 241 ~~~~~~~~~~~~~~~~~~----------------~~~~~~~~------------------~~~~~~~~~~li~~~l~~dP 286 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRF----------------RKKDFRSL------------------LPNANPLAVNVLEKMLVLDA 286 (343)
T ss_pred HhhcchhHHHHHHhcccc----------------CcchHHHh------------------ccCCChHHHHHHHHHcCCCh
Confidence 332211 0111100000 00000000 00111257899999999999
Q ss_pred CCCCCHHHHhcCCCcCcCCC
Q psy11727 416 KKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~~~~ 435 (437)
.+|||+.+++.||||+....
T Consensus 287 ~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 287 ESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hhCCCHHHHhcCccHhhhcC
Confidence 99999999999999987654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=331.15 Aligned_cols=281 Identities=30% Similarity=0.575 Sum_probs=220.6
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++..... .......|+.+++.+ .|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-----~h~~iv~~~~~~~~~ 88 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-----KHENVIGLLDVFTPA 88 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-----CCCcccceeeeeeec
Confidence 346789999999999999999999999999999999864321 123445566666665 789999999988643
Q ss_pred ------CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 184 ------NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 184 ------~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
...|+++++++++|.+++... .+++..++.++.||+.||+|||+ .||+||||||+||++ +.++.+||
T Consensus 89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~NIll--~~~~~~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAV--NEDCELKI 161 (345)
T ss_pred ccccccccEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEE--cCCCCEEE
Confidence 457899999988998877653 48999999999999999999995 489999999999999 67888999
Q ss_pred EeCCCceecCCccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 258 IDFGSSCHVGQTLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 258 ~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
+|||++...........++..|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+....+..+....+.++..+
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T cd07877 162 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 241 (345)
T ss_pred ecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999999877665556778999999999876 5688999999999999999999999999888888888988888888877
Q ss_pred hccCCccc--hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 337 LHGASKTS--KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 337 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
........ .++..++. .|... ..+. .......+.+||.+||+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~---------------~~~~~-~~~~------------------~~~~~~~~~~li~~~L~~d 287 (345)
T cd07877 242 LKKISSESARNYIQSLTQ---------------MPKMN-FANV------------------FIGANPLAVDLLEKMLVLD 287 (345)
T ss_pred HhhcccHhHHHHHHHhcc---------------cCCcc-hhhh------------------cCCCCHHHHHHHHHHcCCC
Confidence 65443211 11110000 00000 0000 0001225789999999999
Q ss_pred CCCCCCHHHHhcCCCcCcC
Q psy11727 415 PKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~~~~ 433 (437)
|.+|||+.+++.||||++.
T Consensus 288 p~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 288 SDKRITAAQALAHAYFAQY 306 (345)
T ss_pred hhhcCCHHHHhcChhhhhc
Confidence 9999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=332.72 Aligned_cols=280 Identities=34% Similarity=0.555 Sum_probs=222.6
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC---
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN--- 184 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~--- 184 (437)
+|++.+.||+|+||.||+|++..++..||||.+.... .....+..|+.++..+ .|+||+++.+++...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-----RHENIIGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-----CCcchhhhhhhhcccCccc
Confidence 5899999999999999999999999999999987432 2234566677777766 5899999999998775
Q ss_pred --EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 185 --HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 185 --~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
.+|+||||++++|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.++|+|||+
T Consensus 76 ~~~~~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~--gi~H~dlkp~nili--~~~~~~~L~dfg~ 149 (330)
T cd07834 76 FNDVYIVTELMETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA--NVIHRDLKPSNILV--NSNCDLKICDFGL 149 (330)
T ss_pred ccceEEEecchhhhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEE--cCCCCEEEcccCc
Confidence 899999999988988887653 689999999999999999999964 89999999999999 6678999999999
Q ss_pred ceecCCc------cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 263 SCHVGQT------LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 263 s~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
+...... .....++..|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.|+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229 (330)
T ss_pred eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence 9776443 2345678899999999888 79999999999999999999999999999999999999998888766
Q ss_pred hhccCC--ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 336 LLHGAS--KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 336 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
.+.... ....+....... ....+... .......+.+||++||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~------------------~~~~~~~~~~li~~~l~~ 275 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKK----------------PKKPLSKL------------------FPGASPEAIDLLEKMLVF 275 (330)
T ss_pred HhhhccccchhhHHhhcccC----------------CcchhHHh------------------cccCCHHHHHHHHHHccC
Confidence 554211 111111110000 00000000 000123678999999999
Q ss_pred CCCCCCCHHHHhcCCCcCcCCC
Q psy11727 414 DPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 414 dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
||.+|||++++++||||++...
T Consensus 276 ~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 276 DPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ChhhCCCHHHHHhCccHHhhcc
Confidence 9999999999999999987654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=332.04 Aligned_cols=259 Identities=31% Similarity=0.425 Sum_probs=209.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.+.|..-++||+||||.|+-|+.+.||+.+|.|.+.++. ....-...|..+++++ ..+.||.+-.+|+..+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-----~s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-----SSPFIVSLAYAFETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-----ccCcEEEEeeeecCCC
Confidence 345888899999999999999999999999999886432 2233345677777776 5679999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+|+||..|.| +|.-+|-+.+..++++..++.++.+|++||.+||. .+||.|||||+|||| |+.|+|+|+|.|+|
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~--~~iVYRDLKPeNILL--Dd~GhvRISDLGLA 334 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR--RRIVYRDLKPENILL--DDHGHVRISDLGLA 334 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh--cceeeccCChhheee--ccCCCeEeeccceE
Confidence 99999999955 67666666666789999999999999999999995 589999999999999 89999999999999
Q ss_pred eec--CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 264 CHV--GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 264 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
+.+ ++.....+||.+|||||++.+..|+...|+|||||++|||+.|+.||....+-..-+.+-...-.-+..
T Consensus 335 vei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~e------ 408 (591)
T KOG0986|consen 335 VEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEE------ 408 (591)
T ss_pred EecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhh------
Confidence 987 445566799999999999999999999999999999999999999997654432222222111101100
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC-
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS- 420 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t- 420 (437)
.+..-.+++++|.+.+|..||.+|..
T Consensus 409 -----------------------------------------------------y~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 409 -----------------------------------------------------YSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred -----------------------------------------------------cccccCHHHHHHHHHHHccCHHHhccC
Confidence 00111125789999999999999985
Q ss_pred ----HHHHhcCCCcCcCCC
Q psy11727 421 ----PTNVLRHEFFLKHSV 435 (437)
Q Consensus 421 ----~~e~l~Hp~~~~~~~ 435 (437)
++++-+||||+..++
T Consensus 436 rg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 436 RGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred CCcCcchhhhCcccccCCH
Confidence 679999999998764
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=335.70 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=198.1
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecC---CcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKN---KKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~---~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.|+++++||.||.+.||++.... ...||+|.+.. ......-+..|+.+|.++. .|.+||+|+++-..++++|
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLk----g~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLK----GHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhc----CCceEEEEeeeeccCceEE
Confidence 59999999999999999998644 45677776642 2344566788999999997 5578999999999999999
Q ss_pred EEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 188 LVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 188 lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
||||+-..+|..+|..... .++.-.++.+..||+.|+.++|.+ ||||.||||.|+|+. +|.+||+|||.|..+.
T Consensus 437 mvmE~Gd~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~--gIVHSDLKPANFLlV---kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 437 MVMECGDIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQH--GIVHSDLKPANFLLV---KGRLKLIDFGIANAIQ 510 (677)
T ss_pred EEeecccccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHh--ceeecCCCcccEEEE---eeeEEeeeechhcccC
Confidence 9999988899999987653 244348899999999999999975 899999999999995 6789999999998775
Q ss_pred Cccc-----cccccccccChhhhcCCC-----------CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy11727 268 QTLY-----QYIQSRYYRSPEVLLGIP-----------YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331 (437)
Q Consensus 268 ~~~~-----~~~gt~~y~aPE~~~~~~-----------~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 331 (437)
...+ +.+||+.|||||.+.... .+.++||||||||||+|+.|++||..-. ...+++.....
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~- 587 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITD- 587 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcC-
Confidence 4433 468999999999996432 5578999999999999999999997532 12233222111
Q ss_pred CChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 332 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
|-. -+ -|. ....+..++++++.||
T Consensus 588 P~~-~I--------efp-----------------------------------------------~~~~~~~li~~mK~CL 611 (677)
T KOG0596|consen 588 PNH-EI--------EFP-----------------------------------------------DIPENDELIDVMKCCL 611 (677)
T ss_pred CCc-cc--------ccc-----------------------------------------------CCCCchHHHHHHHHHH
Confidence 100 00 000 0011114799999999
Q ss_pred ccCCCCCCCHHHHhcCCCcCcC
Q psy11727 412 TYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 412 ~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
.+||.+|||+.++|+|||++..
T Consensus 612 ~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 612 ARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred hcCcccCCCcHHHhcCcccccc
Confidence 9999999999999999999873
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=321.11 Aligned_cols=254 Identities=30% Similarity=0.484 Sum_probs=206.6
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
++|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ .|+||+++.+++.+...++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-----RSPYITKYYGSFLKGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-----CCCCeeeeeEEEEECCeEE
Confidence 47889999999999999999999999999999986432 1223455677776665 6899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+|+||+++ +|.+++... .+++..++.++.|++.||.|||++ |++||||+|+||++ ++++.++|+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~--~i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~ 148 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE--GKIHRDIKAANILL--SEEGDVKLADFGVSGQL 148 (274)
T ss_pred EEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEE--CCCCCEEEcccccceee
Confidence 99999966 788888764 589999999999999999999964 79999999999999 67888999999999776
Q ss_pred CCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
... .....++..|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+... .++..
T Consensus 149 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~--~~~~~-------- 218 (274)
T cd06609 149 TSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN--NPPSL-------- 218 (274)
T ss_pred cccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc--CCCCC--------
Confidence 543 23456788899999999988999999999999999999999999876654443333221 00000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
+ .. .....+.++|.+||..||++|||+++
T Consensus 219 -------------------------~------------------------~~--~~~~~~~~~l~~~l~~~p~~Rpt~~~ 247 (274)
T cd06609 219 -------------------------E------------------------GN--KFSKPFKDFVSLCLNKDPKERPSAKE 247 (274)
T ss_pred -------------------------c------------------------cc--ccCHHHHHHHHHHhhCChhhCcCHHH
Confidence 0 00 00125789999999999999999999
Q ss_pred HhcCCCcCcCCCC
Q psy11727 424 VLRHEFFLKHSVD 436 (437)
Q Consensus 424 ~l~Hp~~~~~~~~ 436 (437)
+++||||++....
T Consensus 248 il~~~~~~~~~~~ 260 (274)
T cd06609 248 LLKHKFIKKAKKT 260 (274)
T ss_pred HhhChhhcCCCcc
Confidence 9999999886544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=317.22 Aligned_cols=255 Identities=29% Similarity=0.406 Sum_probs=196.7
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccC
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY 195 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~ 195 (437)
+.||+|+||.||+|.+..+++.||+|++...................+......|+|++++++++...+.+++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999999999999999986432111111111111112222334789999999999999999999999965
Q ss_pred -cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCcccccc
Q psy11727 196 -NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYI 274 (437)
Q Consensus 196 -~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~~~~~ 274 (437)
+|.+++... ..+++..+..++.||+.||.|||+. |++||||+|+||++ +.++.++|+|||++..... .....
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~--~i~H~dl~p~nil~--~~~~~~~l~dfg~~~~~~~-~~~~~ 154 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQR--GIIHRDIKPENLLI--DQTGHLKLTDFGLSRNGLE-NKKFV 154 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEE--CCCCcEEEeecccceeccc-cccCC
Confidence 788888764 3589999999999999999999964 89999999999999 6678899999999876543 23456
Q ss_pred ccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCc
Q psy11727 275 QSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNS 354 (437)
Q Consensus 275 gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 354 (437)
++..|+|||.+.+..++.++|+||||+++|+|++|.+||...+.......+.......+...
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------ 216 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEV------------------ 216 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcc------------------
Confidence 88899999999988899999999999999999999999988776655554432110000000
Q ss_pred ceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH---HHHhcCCCcC
Q psy11727 355 YVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP---TNVLRHEFFL 431 (437)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~---~e~l~Hp~~~ 431 (437)
.......+.++|.+||+.||++|||+ +|++.||||+
T Consensus 217 -----------------------------------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~ 255 (260)
T cd05611 217 -----------------------------------------KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255 (260)
T ss_pred -----------------------------------------cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhh
Confidence 00001257899999999999999955 7999999999
Q ss_pred cCCCC
Q psy11727 432 KHSVD 436 (437)
Q Consensus 432 ~~~~~ 436 (437)
+..+|
T Consensus 256 ~~~~~ 260 (260)
T cd05611 256 SINWD 260 (260)
T ss_pred cCCCC
Confidence 87665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=327.47 Aligned_cols=282 Identities=31% Similarity=0.546 Sum_probs=222.7
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE-
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW- 182 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~- 182 (437)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ........|+.++..+ .||||+++.++|..
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~ 81 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-----RHENIISLSDIFISP 81 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-----CCCCeeeEeeeEecC
Confidence 35678999999999999999999999999999999885321 2234556677777766 68999999999876
Q ss_pred CCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 183 KNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 183 ~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
.+..++||||++++|.+++... .+++..+..++.||+.||+|||+ .||+||||+|+||++ ++++.++|+|||.
T Consensus 82 ~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~--~~iiH~dl~p~Nili--~~~~~~~l~dfg~ 154 (328)
T cd07856 82 LEDIYFVTELLGTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHS--AGVVHRDLKPSNILI--NENCDLKICDFGL 154 (328)
T ss_pred CCcEEEEeehhccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEeE--CCCCCEEeCcccc
Confidence 5688999999988888887653 47889999999999999999995 489999999999999 6788999999999
Q ss_pred ceecCCccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 263 SCHVGQTLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 263 s~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
+...........++..|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+.......+.+.++.|+..+.....
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 155 ARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred ccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 9876555555678889999999866 568999999999999999999999999998888888888889988877765432
Q ss_pred cc--chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 342 KT--SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 342 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
.. ..++....... ..| ..+. .......+.++|++||+.||.+||
T Consensus 235 ~~~~~~~~~~~~~~~------------~~~----~~~~------------------~~~~~~~~~~li~~~l~~~P~~R~ 280 (328)
T cd07856 235 SENTLRFVQSLPKRE------------PVP----FSEK------------------FKNADPSAIDLLEKMLVFDPQKRI 280 (328)
T ss_pred chhhHHHHhhccccC------------CCc----HHHH------------------cCCCCHHHHHHHHHHcCCChhhCC
Confidence 21 11111110000 000 0000 000113678999999999999999
Q ss_pred CHHHHhcCCCcCcCC
Q psy11727 420 SPTNVLRHEFFLKHS 434 (437)
Q Consensus 420 t~~e~l~Hp~~~~~~ 434 (437)
|+++++.||||.+..
T Consensus 281 t~~ell~~~~~~~~~ 295 (328)
T cd07856 281 SAAEALAHPYLAPYH 295 (328)
T ss_pred CHHHHhcCCcccccc
Confidence 999999999997643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=323.12 Aligned_cols=257 Identities=32% Similarity=0.519 Sum_probs=201.6
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.+.|++.+.||+|+||.||+|.+..++..||+|.+..... ....+..|+.++..+ .|+||+++++.+..++.++
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-----NHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCCcEeeeEEEEEeCCeEE
Confidence 4679999999999999999999999999999999874432 233455566666654 7899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|..++.... ..+++..+..++.|++.+|.|||+ .|++||||||+||++ +.++.++|+|||++...
T Consensus 86 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nili--~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHS--MKIIHRDLKAGNVLL--TLDGDIKLADFGVSAKN 160 (292)
T ss_pred EEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc--CCeeecCCCcceEEE--cCCCCEEEccCccceec
Confidence 99999977 5655655433 468999999999999999999995 489999999999999 66888999999998654
Q ss_pred CCc---cccccccccccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLL-----GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
... .....++..|+|||++. ...++.++|+|||||++|+|++|.+||...+......++... .++. ...
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~-~~~ 237 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPPT-LSQ 237 (292)
T ss_pred cccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--CCcc-CCC
Confidence 322 22356788999999985 345788999999999999999999999877654444333211 0000 000
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
.......+.+||.+||..||++|
T Consensus 238 ---------------------------------------------------------~~~~~~~~~~li~~~l~~~p~~R 260 (292)
T cd06644 238 ---------------------------------------------------------PSKWSMEFRDFLKTALDKHPETR 260 (292)
T ss_pred ---------------------------------------------------------CcccCHHHHHHHHHHhcCCcccC
Confidence 00001157899999999999999
Q ss_pred CCHHHHhcCCCcCcCCC
Q psy11727 419 ISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~~~~ 435 (437)
||+.++++||||.....
T Consensus 261 p~~~~il~~~~~~~~~~ 277 (292)
T cd06644 261 PSAAQLLEHPFVSSVTS 277 (292)
T ss_pred cCHHHHhcCcccccccc
Confidence 99999999999987554
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=318.00 Aligned_cols=276 Identities=33% Similarity=0.495 Sum_probs=214.5
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE---
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH--- 185 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~--- 185 (437)
|++.+.||+|+||.||+|.+..++..||+|.++.... .......|+.++..+. .+.|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLE--SFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhh--ccCCCCcceEEEEEeeccCCCC
Confidence 6788999999999999999988899999999974322 1223445766666663 3469999999999998776
Q ss_pred --EEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 186 --LCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 186 --~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
++++||+++++|.+++.......+++..++.++.|++.||.|||++ |++|+||+|+||++ +.++.++|+|||++
T Consensus 79 ~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~--~i~h~~l~~~nili--~~~~~~~l~dfg~~ 154 (287)
T cd07838 79 LKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH--RIVHRDLKPQNILV--TSDGQVKIADFGLA 154 (287)
T ss_pred ceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCChhhEEE--ccCCCEEEeccCcc
Confidence 9999999998999888765444689999999999999999999964 89999999999999 66789999999998
Q ss_pred eecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 264 CHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 264 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
...... .....++..|+|||++.+..++.++|+|||||++|+|++|.+||.+.+..+.+.++.+..+.+...-+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 155 RIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred eeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 766432 223457888999999999999999999999999999999999999999988888888776655432221111
Q ss_pred cc-chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 342 KT-SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 342 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
.. ...+. .................+.+||.+||+.||.+|||
T Consensus 235 ~~~~~~~~-------------------------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~ 277 (287)
T cd07838 235 SLPRSSFP-------------------------------------SYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS 277 (287)
T ss_pred ccchhhcc-------------------------------------cccccchhhhhhhhhHHHHHHHHHHhccCCccCCC
Confidence 00 00000 00000000111122346789999999999999999
Q ss_pred HHHHhcCCCc
Q psy11727 421 PTNVLRHEFF 430 (437)
Q Consensus 421 ~~e~l~Hp~~ 430 (437)
+++++.||||
T Consensus 278 ~~~il~~~~~ 287 (287)
T cd07838 278 AFEALQHPYF 287 (287)
T ss_pred HHHHhcCcCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=323.93 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=203.0
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
++|++.+.||+|+||.||+|.+..++..||+|.++... .....+..|+.++..+ .|+||+++++.+...+.++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-----VSPYIVDFYGAFFIEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-----CCCcHHhhhhheecCCeEE
Confidence 46899999999999999999999999999999886432 1224556677777665 6899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 188 LVFELLSY-NLYNLIRNTN-FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~-~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
+||||+++ +|.+++.... ...+++..+..++.||+.||.|||+. .||+|+||||+||++ +.++.++|+|||++..
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~--~~~~~~~l~dfg~~~~ 152 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE-HNIIHRDVKPTNVLV--NGNGQVKLCDFGVSGN 152 (286)
T ss_pred EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCEeeCCCCHHHEEE--CCCCCEEEeecCCccc
Confidence 99999976 7777776531 23589999999999999999999963 489999999999999 5688899999999876
Q ss_pred cCCc-cccccccccccChhhhcCC------CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 266 VGQT-LYQYIQSRYYRSPEVLLGI------PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 266 ~~~~-~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
.... .....++..|+|||++.+. .++.++|+|||||++|+|++|..||...........+......++....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 231 (286)
T cd06622 153 LVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLP- 231 (286)
T ss_pred ccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCC-
Confidence 5332 2345678899999998654 3578999999999999999999999765544443333222111110000
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
......+.+||.+||+.||.+|
T Consensus 232 ----------------------------------------------------------~~~~~~~~~li~~~l~~~p~~R 253 (286)
T cd06622 232 ----------------------------------------------------------SGYSDDAQDFVAKCLNKIPNRR 253 (286)
T ss_pred ----------------------------------------------------------cccCHHHHHHHHHHcccCcccC
Confidence 0011257899999999999999
Q ss_pred CCHHHHhcCCCcCcCCC
Q psy11727 419 ISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~~~~ 435 (437)
||+++++.||||.....
T Consensus 254 p~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 254 PTYAQLLEHPWLVKYKN 270 (286)
T ss_pred CCHHHHhcChhhhhccC
Confidence 99999999999977643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=324.63 Aligned_cols=280 Identities=29% Similarity=0.440 Sum_probs=215.1
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC-
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK- 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~- 183 (437)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+|+.+++.+ .|+||+++++.+...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 80 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-----KHPNVVPLIDMAVERP 80 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-----CCCCccchhhheeccc
Confidence 36899999999999999999999999999999999864321 223456788887766 688999999987543
Q ss_pred -------CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEE
Q psy11727 184 -------NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIK 256 (437)
Q Consensus 184 -------~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ik 256 (437)
..+++||||+.+++.+.+.... ..+++..++.++.||+.||+|||+ .||+|+||||+||++ ++++.++
T Consensus 81 ~~~~~~~~~~~lv~~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~--~~i~H~dl~p~nil~--~~~~~~~ 155 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMDHDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHE--NHILHRDIKAANILI--DNQGILK 155 (311)
T ss_pred ccccccCceEEEEEecCCcCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE--CCCCCEE
Confidence 3579999999998888776543 459999999999999999999995 489999999999999 7788999
Q ss_pred EEeCCCceecCCcc--------------ccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy11727 257 IIDFGSSCHVGQTL--------------YQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ 321 (437)
Q Consensus 257 L~DFG~s~~~~~~~--------------~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~ 321 (437)
|+|||++....... ....+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+....
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~ 235 (311)
T cd07866 156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235 (311)
T ss_pred ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999986543211 123457789999988654 588999999999999999999999999999888
Q ss_pred HHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhh
Q psy11727 322 MTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYM 401 (437)
Q Consensus 322 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (437)
...+....+.++...++.+......-..... ......+... ......
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~------------------~~~~~~ 282 (311)
T cd07866 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSF---------------TNYPRTLEER------------------FGKLGP 282 (311)
T ss_pred HHHHHHHhCCCChhhchhhhhcccccccccC---------------CCCCccHHHH------------------cccCCh
Confidence 8888888887776655433221111000000 0000000000 000113
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcCCCc
Q psy11727 402 KFKDLILRMLTYDPKKRISPTNVLRHEFF 430 (437)
Q Consensus 402 ~~~dli~~~L~~dP~~R~t~~e~l~Hp~~ 430 (437)
.+.+||.+||..||.+|||+.+++.||||
T Consensus 283 ~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 283 EGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred hHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 57899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=323.14 Aligned_cols=283 Identities=32% Similarity=0.479 Sum_probs=217.3
Q ss_pred CceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 105 ~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
++...++|++.+.||+|+||+||+|.++.+++.||+|.++... ........|+.++..+ .||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-----~h~~i~~~~~~~~ 76 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-----NHRNIVNLKEIVT 76 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-----CCCCeeeeeheec
Confidence 3455788999999999999999999999999999999996432 2223445677777665 7899999999987
Q ss_pred ECC----------EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC
Q psy11727 182 WKN----------HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK 251 (437)
Q Consensus 182 ~~~----------~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~ 251 (437)
+.. ++++|+||+++++.+.+.... ..+++..++.++.||+.||+|||+ .||+|+||||+||++ ++
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~--~~i~H~dl~p~nili--~~ 151 (302)
T cd07864 77 DKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHK--KNFLHRDIKCSNILL--NN 151 (302)
T ss_pred CcchhhhccccCCcEEEEEcccCccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE--CC
Confidence 654 899999999998888877642 468999999999999999999995 489999999999999 67
Q ss_pred CCCEEEEeCCCceecCCcc----ccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy11727 252 RSAIKIIDFGSSCHVGQTL----YQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326 (437)
Q Consensus 252 ~~~ikL~DFG~s~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~ 326 (437)
++.+||+|||++....... ....++..|+|||++.+. .++.++|||||||++++|++|++||...+..+.+..+.
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~ 231 (302)
T cd07864 152 KGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231 (302)
T ss_pred CCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 8899999999987653322 123457789999988754 57899999999999999999999999988888888888
Q ss_pred HHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHH
Q psy11727 327 EVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406 (437)
Q Consensus 327 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 406 (437)
+..+.++...++.......+.+....... .+...... . .....+.+|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~--------------~----~~~~~~~~l 278 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQY---------------RRRLREEF--------------S----FIPTPALDL 278 (302)
T ss_pred HHhCCCChhhccccccccccccccccccc---------------ccchhhhc--------------C----CCCHHHHHH
Confidence 88877776655433322211110000000 00000000 0 001257999
Q ss_pred HHHccccCCCCCCCHHHHhcCCCc
Q psy11727 407 ILRMLTYDPKKRISPTNVLRHEFF 430 (437)
Q Consensus 407 i~~~L~~dP~~R~t~~e~l~Hp~~ 430 (437)
|.+||..||.+|||+.+++.||||
T Consensus 279 i~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 279 LDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HHHHccCChhhCCCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=325.59 Aligned_cols=253 Identities=27% Similarity=0.446 Sum_probs=209.6
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
+-|.++.+||+|+||.||+|..+.+|..+|||.+.- .....+...|+.++... .++++|++++.+.....++||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC-----~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQC-----KSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHc-----CCchhhhhhhhhccCCceEee
Confidence 358899999999999999999999999999999863 44456777888888876 778999999999999999999
Q ss_pred EEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 190 FELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 190 ~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
||||+ |+..+.++..+ ++++++.+..+++..+.+|+||| .+.-||||||..|||+ +.+|+.||+|||.|-.+.+
T Consensus 107 MEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH--~~~KIHRDIKAGNILL--NT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLH--DLKKIHRDIKAGNILL--NTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred hhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHH--HHHHHHhhcccccEEE--cccchhhhhhccccchhhh
Confidence 99996 57777776654 78999999999999999999999 4568999999999999 7789999999999977654
Q ss_pred c---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccch
Q psy11727 269 T---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSK 345 (437)
Q Consensus 269 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 345 (437)
. ..+.+||++|||||++....|+.++||||||++..||..|+|||..-.+... |.-.-..||+.
T Consensus 182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFMIPT~PPPT---------- 248 (502)
T KOG0574|consen 182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IFMIPTKPPPT---------- 248 (502)
T ss_pred hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---eEeccCCCCCC----------
Confidence 3 3467999999999999999999999999999999999999999987655322 21111111111
Q ss_pred hhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHh
Q psy11727 346 YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVL 425 (437)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l 425 (437)
.+.-+ .|. ..|.|||++||..+|++|-|+-+++
T Consensus 249 -------------------------F~KPE-------------------~WS---~~F~DFi~~CLiK~PE~R~TA~~L~ 281 (502)
T KOG0574|consen 249 -------------------------FKKPE-------------------EWS---SEFNDFIRSCLIKKPEERKTALRLC 281 (502)
T ss_pred -------------------------CCChH-------------------hhh---hHHHHHHHHHhcCCHHHHHHHHHHh
Confidence 01111 111 2689999999999999999999999
Q ss_pred cCCCcCcC
Q psy11727 426 RHEFFLKH 433 (437)
Q Consensus 426 ~Hp~~~~~ 433 (437)
+|||++..
T Consensus 282 ~H~FiknA 289 (502)
T KOG0574|consen 282 EHTFIKNA 289 (502)
T ss_pred hhhhhcCC
Confidence 99999864
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=319.65 Aligned_cols=257 Identities=25% Similarity=0.403 Sum_probs=198.4
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
++|++.+.||+|+||.||+|.+..+|+.||+|+++.... ...+...|..+..+ ..+|+||+++++++..++..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~----~~~~~~iv~~~~~~~~~~~~~ 76 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMR----SVDCPYTVTFYGALFREGDVW 76 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHH----HcCCCCeeeeeEEEecCCcEE
Confidence 468999999999999999999999999999999874321 11223334333222 248899999999999999999
Q ss_pred EEEEeccCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 188 LVFELLSYNLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 188 lV~E~~~~~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
+||||++++|.+++... ....+++..++.++.||+.||+|||++ .+++||||||+||++ +.++.+||+|||++..
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~i~h~dlkp~nil~--~~~~~~kl~dfg~~~~ 153 (283)
T cd06617 77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK-LSVIHRDVKPSNVLI--NRNGQVKLCDFGISGY 153 (283)
T ss_pred EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCeecCCCCHHHEEE--CCCCCEEEeecccccc
Confidence 99999999988887642 224589999999999999999999963 479999999999999 6788899999999876
Q ss_pred cCCcc--ccccccccccChhhhcC----CCCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCChhhhc
Q psy11727 266 VGQTL--YQYIQSRYYRSPEVLLG----IPYDLAIDMWSLGCILVELHTGEPLFSGK-NEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 266 ~~~~~--~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
..... ....++..|+|||++.+ ..++.++|+|||||++|+|++|+.||... ...+.+..+... .++..
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~--- 228 (283)
T cd06617 154 LVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE--PSPQL--- 228 (283)
T ss_pred cccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--CCCCC---
Confidence 54322 22467888999999865 45789999999999999999999999642 222333332211 00000
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
|. ......+.+||.+||..||.+|
T Consensus 229 ------------------------------~~--------------------------~~~~~~l~~li~~~l~~~p~~R 252 (283)
T cd06617 229 ------------------------------PA--------------------------EKFSPEFQDFVNKCLKKNYKER 252 (283)
T ss_pred ------------------------------Cc--------------------------cccCHHHHHHHHHHccCChhhC
Confidence 00 0001257899999999999999
Q ss_pred CCHHHHhcCCCcCcCC
Q psy11727 419 ISPTNVLRHEFFLKHS 434 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~~~ 434 (437)
||++++++||||.+..
T Consensus 253 p~~~~il~~~~~~~~~ 268 (283)
T cd06617 253 PNYPELLQHPFFELHL 268 (283)
T ss_pred cCHHHHhcCchhhhcc
Confidence 9999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=318.80 Aligned_cols=258 Identities=28% Similarity=0.419 Sum_probs=202.5
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC--
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK-- 183 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~-- 183 (437)
....++|++.+.||+|+||.||+|.+..+++.+|+|++............|+.++..+. .|+|++++++++...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~----~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP----NHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhc----CCCCeEEEEEEEEeccc
Confidence 34578899999999999999999999999999999999754444455667777777663 689999999998754
Q ss_pred ---CEEEEEEEeccC-cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 184 ---NHLCLVFELLSY-NLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 184 ---~~~~lV~E~~~~-~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
+.+++||||+++ +|.+++... ....+++..++.++.|++.||+|||+ .|++||||||+||++ +.++.+||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~nili--~~~~~~kl 169 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN--NRIIHRDVKGNNILL--TTEGGVKL 169 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEE--cCCCCEEE
Confidence 368999999965 788877532 22458999999999999999999995 489999999999999 66778999
Q ss_pred EeCCCceecCCc---cccccccccccChhhhcCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q psy11727 258 IDFGSSCHVGQT---LYQYIQSRYYRSPEVLLGI-----PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVL 329 (437)
Q Consensus 258 ~DFG~s~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 329 (437)
+|||++...... .....|+..|+|||++... .++.++|+|||||++|+|++|++||...+....+..+...
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~- 248 (291)
T cd06639 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN- 248 (291)
T ss_pred eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC-
Confidence 999998754322 2235678899999998643 3689999999999999999999999877655444433211
Q ss_pred CCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHH
Q psy11727 330 GMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILR 409 (437)
Q Consensus 330 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 409 (437)
.++. +.. .......+.+||.+
T Consensus 249 -~~~~-~~~---------------------------------------------------------~~~~~~~l~~li~~ 269 (291)
T cd06639 249 -PPPT-LLH---------------------------------------------------------PEKWCRSFNHFISQ 269 (291)
T ss_pred -CCCC-CCc---------------------------------------------------------ccccCHHHHHHHHH
Confidence 0100 000 00001157899999
Q ss_pred ccccCCCCCCCHHHHhcCCCcC
Q psy11727 410 MLTYDPKKRISPTNVLRHEFFL 431 (437)
Q Consensus 410 ~L~~dP~~R~t~~e~l~Hp~~~ 431 (437)
||+.||++|||+.++++||||+
T Consensus 270 ~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 270 CLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HhhcChhhCcCHHHHhcCcccC
Confidence 9999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=320.39 Aligned_cols=279 Identities=33% Similarity=0.542 Sum_probs=206.8
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+..|+.++..+ .|+||+++++++...+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-----RHENLVNLIEVFRRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-----CCcchhhHHHhcccCCeE
Confidence 479999999999999999999998999999998864322 223455677776665 789999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
++||||+.+++.+.+.... ..+++..+..++.||+.||+|||+ .|++|+||+|+||++ ++++.++|+|||++...
T Consensus 76 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~i~h~~l~p~ni~~--~~~~~~~l~dfg~~~~~ 150 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHS--HNIIHRDIKPENILV--SQSGVVKLCDFGFARTL 150 (286)
T ss_pred EEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEE--CCCCcEEEEeeeeeeec
Confidence 9999999875544443322 348999999999999999999995 489999999999999 67888999999998765
Q ss_pred CCc---cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
... .....++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+....+............
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 151 AAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred cCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence 322 2235678899999998763 478899999999999999999999998888777777776655433221110000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
. ..+.. ...|........... .......+.+||.+||+.||.+|||+.
T Consensus 231 ~-~~~~~----------------~~~~~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~P~~Rp~~~ 278 (286)
T cd07846 231 N-PLFAG----------------MRLPEVKEIEPLEKR---------------FPKLSGLVLDLAKQCLRIDPDDRPSSS 278 (286)
T ss_pred c-hHhhc----------------cccccccCcchHHHh---------------CCCcCHHHHHHHHHHhcCCcccchhHH
Confidence 0 00000 000000000000000 001123689999999999999999999
Q ss_pred HHhcCCCc
Q psy11727 423 NVLRHEFF 430 (437)
Q Consensus 423 e~l~Hp~~ 430 (437)
++++||||
T Consensus 279 ~il~~~~~ 286 (286)
T cd07846 279 QLLHHEFF 286 (286)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=314.95 Aligned_cols=250 Identities=30% Similarity=0.476 Sum_probs=203.4
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
++|++.+.||+|+||.||+|....++..+|+|.+..... ...+..|+.++..+ .|+||+++++.+.+..++|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQC-----DSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhC-----CCCcEeeeeeeeecCCcEEEE
Confidence 579999999999999999999998899999999975433 56677788887776 789999999999999999999
Q ss_pred EEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 190 FELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 190 ~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
+|++++ +|.+++.... ..+++..++.++.|++.||.|||+ .|++|+||+|+||++ +.++.++|+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~ni~~--~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 77 MEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHS--NKKIHRDIKAGNILL--NEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred EecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEE--CCCCcEEEcccccchhccc
Confidence 999976 7888876543 468999999999999999999995 489999999999999 6678899999999876543
Q ss_pred cc---ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccch
Q psy11727 269 TL---YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSK 345 (437)
Q Consensus 269 ~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 345 (437)
.. ....++..|+|||++.+..++.++||||||+++|+|++|++||...........+.. .++..
T Consensus 152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~---------- 218 (256)
T cd06612 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPPPT---------- 218 (256)
T ss_pred CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CCCCC----------
Confidence 32 234578899999999999999999999999999999999999987655432222110 00000
Q ss_pred hhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHh
Q psy11727 346 YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVL 425 (437)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l 425 (437)
+ ..+......+.+||.+||+.||.+|||+.|+|
T Consensus 219 -~----------------------------------------------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il 251 (256)
T cd06612 219 -L----------------------------------------------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLL 251 (256)
T ss_pred -C----------------------------------------------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHh
Confidence 0 00000112578999999999999999999999
Q ss_pred cCCCc
Q psy11727 426 RHEFF 430 (437)
Q Consensus 426 ~Hp~~ 430 (437)
+||||
T Consensus 252 ~~~~~ 256 (256)
T cd06612 252 QHPFI 256 (256)
T ss_pred cCCCC
Confidence 99997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=319.06 Aligned_cols=276 Identities=37% Similarity=0.617 Sum_probs=217.7
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
|.+.+.||+|++|.||+|.+..+++.+|+|.+..... .......|+.+++.+ .|++|+++++++.+.+..++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-----NHPNIIKLLDVFRHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-----cCCCcchHHHhhccCCCEEE
Confidence 6678899999999999999999999999999864432 234556677777766 58999999999999999999
Q ss_pred EEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 189 VFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 189 V~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
||||++++|.+.+.... ..+++..+..++.||+.||.|||++ ||+|+||||+||++ +.++.++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dl~p~nili--~~~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH--GILHRDLKPENLLI--NTEGVLKLADFGLARSFGS 150 (283)
T ss_pred EEeccCCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC--CeeecCcCHHHEEE--CCCCcEEEeeeeeeEecCC
Confidence 99999999988887754 4689999999999999999999964 79999999999999 6778899999999976654
Q ss_pred cc---ccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc
Q psy11727 269 TL---YQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344 (437)
Q Consensus 269 ~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 344 (437)
.. ....++..|+|||.+.+. .++.++|+||||+++|+|++|++||.+.+..+.+..+.+.++.+....+.......
T Consensus 151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 32 234577889999999877 78999999999999999999999999999988888888888777665544332211
Q ss_pred hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHH
Q psy11727 345 KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNV 424 (437)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~ 424 (437)
.+.. +.. |.................+.+||.+||.+||.+|||+.++
T Consensus 231 ~~~~------~~~---------------------------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~l 277 (283)
T cd05118 231 RNYK------FSF---------------------------PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA 277 (283)
T ss_pred hhhh------hhh---------------------------ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHH
Confidence 1000 000 0000000000011123468999999999999999999999
Q ss_pred hcCCCc
Q psy11727 425 LRHEFF 430 (437)
Q Consensus 425 l~Hp~~ 430 (437)
+.||||
T Consensus 278 l~~~~~ 283 (283)
T cd05118 278 LAHPYF 283 (283)
T ss_pred hhCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=313.28 Aligned_cols=249 Identities=28% Similarity=0.430 Sum_probs=204.2
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+|++.+.||+|+||+||++.+..+++.||+|.+.... .....+..|+.+++.+ .|+||+++.+++...++.+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-----KHPNIVQYQESFEENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-----CCCCeeeeEeeecCCCeEE
Confidence 5899999999999999999999999999999986321 2223556677776665 7899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+.+ +|.+.+.......+++..+..++.|++.||.|||+ .|++|+||+|+||++ +.++.++|+|||++...
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~l~~~nil~--~~~~~~~l~d~~~~~~~ 151 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFL--TKDGTIKLGDFGIARVL 151 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEE--cCCCCEEEeeccceeec
Confidence 99999965 89888876544568999999999999999999995 489999999999999 66788999999999766
Q ss_pred CCcc---ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQTL---YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.... ....|+..|+|||++.+..++.++|+|||||++++|++|..||...+..+....+......+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---------- 221 (256)
T cd08218 152 NSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---------- 221 (256)
T ss_pred CcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC----------
Confidence 4432 234578889999999998999999999999999999999999987776666555532110000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
.......+.++|.+||+.+|.+|||+.+
T Consensus 222 ----------------------------------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08218 222 ----------------------------------------------------SSHYSYDLRNLVSQLFKRNPRDRPSVNS 249 (256)
T ss_pred ----------------------------------------------------cccCCHHHHHHHHHHhhCChhhCcCHHH
Confidence 0000115789999999999999999999
Q ss_pred HhcCCCc
Q psy11727 424 VLRHEFF 430 (437)
Q Consensus 424 ~l~Hp~~ 430 (437)
+++||||
T Consensus 250 vl~~~~~ 256 (256)
T cd08218 250 ILEKNFI 256 (256)
T ss_pred HhhCcCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.86 Aligned_cols=254 Identities=29% Similarity=0.439 Sum_probs=202.5
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC----
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN---- 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~---- 184 (437)
.++|++.+.||+|+||.||+|.+..+++.+|+|++.........+..|+.++..+. .|+||++++++|....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~----~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS----NHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhc----CCCChheEEEEEEecCCCCc
Confidence 57899999999999999999999989999999999765554566778888888763 5899999999997644
Q ss_pred --EEEEEEEeccC-cHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 185 --HLCLVFELLSY-NLYNLIRNTN--FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 185 --~~~lV~E~~~~-~L~~~l~~~~--~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
.+++||||+++ +|.+++.... ...+++..++.++.|++.||.|||++ |++|+||+|+||++ +.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~--~i~H~~l~p~ni~~--~~~~~~~l~d 156 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN--KVIHRDIKGQNILL--TKNAEVKLVD 156 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC--CcccCCCCHHHEEE--ccCCeEEECC
Confidence 59999999976 7888776432 34689999999999999999999964 89999999999999 6678899999
Q ss_pred CCCceecCCc---cccccccccccChhhhcC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy11727 260 FGSSCHVGQT---LYQYIQSRYYRSPEVLLG-----IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331 (437)
Q Consensus 260 FG~s~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 331 (437)
||++...... .....++..|+|||++.. ..++.++|||||||++|+|++|.+||...........+... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~ 234 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN--P 234 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc--C
Confidence 9998665332 234567889999999864 34678999999999999999999999876554444433221 0
Q ss_pred CChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 332 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
++ .+. ........+.+||++||
T Consensus 235 ~~-~~~---------------------------------------------------------~~~~~~~~~~~li~~~l 256 (275)
T cd06608 235 PP-TLK---------------------------------------------------------SPENWSKKFNDFISECL 256 (275)
T ss_pred CC-CCC---------------------------------------------------------chhhcCHHHHHHHHHHh
Confidence 00 000 00001125789999999
Q ss_pred ccCCCCCCCHHHHhcCCCc
Q psy11727 412 TYDPKKRISPTNVLRHEFF 430 (437)
Q Consensus 412 ~~dP~~R~t~~e~l~Hp~~ 430 (437)
..||.+|||++++++|||+
T Consensus 257 ~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 257 IKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hcChhhCcCHHHHhcCCCC
Confidence 9999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=318.61 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=202.0
Q ss_pred ecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceee-
Q psy11727 103 KHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT- 181 (437)
Q Consensus 103 ~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~- 181 (437)
.......++|++.+.||+|+||.||+|.+..+++.+|+|++.........+..|..++..+. .|+||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~~~~~~ 86 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS----DHPNVVKFYGMYYK 86 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHh----cCCCeeeeeeeeee
Confidence 34445678999999999999999999999999999999998654333456677888877764 5899999999874
Q ss_pred ----ECCEEEEEEEeccC-cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCC
Q psy11727 182 ----WKNHLCLVFELLSY-NLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA 254 (437)
Q Consensus 182 ----~~~~~~lV~E~~~~-~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ 254 (437)
..+.+++||||+++ +|.+++... ....+++..++.++.|++.||.|||++ +|+||||||+||++ +.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~nili--~~~~~ 162 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN--KTIHRDVKGNNILL--TTEGG 162 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC--CccccCCCHHhEEE--CCCCC
Confidence 44689999999965 788877532 224588999999999999999999964 89999999999999 66788
Q ss_pred EEEEeCCCceecCCc---cccccccccccChhhhcC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy11727 255 IKIIDFGSSCHVGQT---LYQYIQSRYYRSPEVLLG-----IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326 (437)
Q Consensus 255 ikL~DFG~s~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~ 326 (437)
++|+|||++...... .....|+..|+|||++.. ..++.++|+|||||++|+|++|++||...+....+..+.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 242 (286)
T cd06638 163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242 (286)
T ss_pred EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence 999999998765332 233568899999999853 457899999999999999999999998765433322211
Q ss_pred HHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHH
Q psy11727 327 EVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406 (437)
Q Consensus 327 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 406 (437)
. +.++... .+. .....+.+|
T Consensus 243 ~--~~~~~~~-------------------------------------------------------~~~---~~~~~~~~l 262 (286)
T cd06638 243 R--NPPPTLH-------------------------------------------------------QPE---LWSNEFNDF 262 (286)
T ss_pred c--cCCCccc-------------------------------------------------------CCC---CcCHHHHHH
Confidence 1 0000000 000 001157899
Q ss_pred HHHccccCCCCCCCHHHHhcCCCc
Q psy11727 407 ILRMLTYDPKKRISPTNVLRHEFF 430 (437)
Q Consensus 407 i~~~L~~dP~~R~t~~e~l~Hp~~ 430 (437)
|.+||+.||.+|||+.|+++||||
T Consensus 263 i~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 263 IRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HHHHccCCcccCCCHHHHhhcccC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=317.32 Aligned_cols=249 Identities=26% Similarity=0.368 Sum_probs=194.2
Q ss_pred ccCeeeecee--cccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLL--GKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~l--G~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.++|.+.+.+ |+|+||.||++.++.++..+|+|.+..... .. .|....+.+. .|+||+++++.|...+.+
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~--~e~~~~~~~~----~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF--NA--IEPMVHQLMK----DNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc--ch--hhHHHHHHhh----cCCCEEEEEEEEecCCee
Confidence 4567777666 999999999999999999999999864321 11 1333322222 689999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC-CEEEEeCCCce
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS-AIKIIDFGSSC 264 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~-~ikL~DFG~s~ 264 (437)
|+||||+++ +|.+++.... .+++..+..++.||+.||.|||+ .|++||||||+||++. .++ .++|+|||++.
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~~--~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHK--HNIIHNDIKLENVLYD--RAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEEe--CCCCeEEEecCccce
Confidence 999999964 8999887653 68999999999999999999995 4899999999999994 455 89999999987
Q ss_pred ecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhhccCCcc
Q psy11727 265 HVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ-MTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
..... ....++..|+|||++.+..++.++|+|||||++|+|++|..||........ ...+......+. ...
T Consensus 159 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~------ 230 (267)
T PHA03390 159 IIGTP-SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL-PFI------ 230 (267)
T ss_pred ecCCC-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccC-Ccc------
Confidence 76543 335688999999999998999999999999999999999999986544321 111111100000 000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC-HH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS-PT 422 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t-~~ 422 (437)
......+.+||.+||+.||.+||+ .+
T Consensus 231 -----------------------------------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~ 257 (267)
T PHA03390 231 -----------------------------------------------------KNVSKNANDFVQSMLKYNINYRLTNYN 257 (267)
T ss_pred -----------------------------------------------------cccCHHHHHHHHHHhccChhhCCchHH
Confidence 001125799999999999999996 59
Q ss_pred HHhcCCCcCc
Q psy11727 423 NVLRHEFFLK 432 (437)
Q Consensus 423 e~l~Hp~~~~ 432 (437)
++|+||||..
T Consensus 258 ~~l~h~~~~~ 267 (267)
T PHA03390 258 EIIKHPFLKI 267 (267)
T ss_pred HHhcCCcccC
Confidence 9999999963
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=317.94 Aligned_cols=277 Identities=36% Similarity=0.573 Sum_probs=215.6
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC--CEE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK--NHL 186 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~--~~~ 186 (437)
|++.+.||.|+||.||+|.+..+++.+|+|.+.... .....+..|+.++..+ .|+|++++++++... +..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~ 75 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-----RHPNIVRLKEIVTSKGKGSI 75 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-----cCCCeeeheeeEecCCCCcE
Confidence 678899999999999999999999999999997542 2234466677777776 689999999999988 899
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
++||||++++|.+++.... ..+++..++.++.||+.||+|||+ .|++|+||+|+||++ ++++.++|+|||++...
T Consensus 76 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~--~~~~h~dl~p~nil~--~~~~~~~l~d~g~~~~~ 150 (287)
T cd07840 76 YMVFEYMDHDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILI--NNDGVLKLADFGLARPY 150 (287)
T ss_pred EEEeccccccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEE--cCCCCEEEccccceeec
Confidence 9999999999998887653 468999999999999999999995 489999999999999 67889999999999766
Q ss_pred CCcc----ccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 267 GQTL----YQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 267 ~~~~----~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
.... ....++..|+|||.+.+ ..++.++||||||+++|+|++|++||...+....+..+.+..+.|....++...
T Consensus 151 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 151 TKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred cCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence 4432 23456788999998765 457899999999999999999999999999888888888877776655443322
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
... ++.... ...+....+.+++.. .....+.++|++||..||.+|||+
T Consensus 231 ~~~-~~~~~~--------------~~~~~~~~~~~~~~~-----------------~~~~~~~~~i~~~l~~~P~~Rp~~ 278 (287)
T cd07840 231 KLP-WFENLK--------------PKKPYKRRLREFFKH-----------------LIDPSALDLLDKLLTLDPKKRISA 278 (287)
T ss_pred cch-hhhhcc--------------ccccchhHHHHHhcc-----------------cCCHHHHHHHHHHcCCChhhCcCH
Confidence 210 000000 000000011111100 012367999999999999999999
Q ss_pred HHHhcCCCc
Q psy11727 422 TNVLRHEFF 430 (437)
Q Consensus 422 ~e~l~Hp~~ 430 (437)
.++++||||
T Consensus 279 ~~~l~~~~~ 287 (287)
T cd07840 279 DQALQHEYF 287 (287)
T ss_pred HHHhhCcCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=317.61 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=197.8
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.++|.+.+.||+|+||.||+|.+..+++.||+|.++.... .......|+.+++.+ .|+||+++++.+...+.++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-----~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-----KHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-----CCCCeeeEEEEEEeCCEEE
Confidence 4579999999999999999999999999999999874422 122345566665554 7899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|.+++... ..+++..++.++.|++.||.|||+ .|++|+||||+||++ +.++.++|+|||++...
T Consensus 83 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nili--~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHS--KGKMHRDIKGANILL--TDNGHVKLADFGVSAQI 156 (267)
T ss_pred EEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEE--CCCCCEEECcceeeeEc
Confidence 99999976 788887654 358999999999999999999995 489999999999999 67888999999998765
Q ss_pred CCcc---ccccccccccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 267 GQTL---YQYIQSRYYRSPEVLL---GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 267 ~~~~---~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
.... ....|+..|+|||++. ...++.++|+|||||++|+|++|.+||...........+......++.. .
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~--- 232 (267)
T cd06645 157 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKL-K--- 232 (267)
T ss_pred cCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcc-c---
Confidence 4322 2357889999999985 4568899999999999999999999997655433322221110000000 0
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
+ .......+.+||.+||..||++|||
T Consensus 233 -----------------------------------~-------------------~~~~~~~~~~li~~~l~~~P~~R~~ 258 (267)
T cd06645 233 -----------------------------------D-------------------KMKWSNSFHHFVKMALTKNPKKRPT 258 (267)
T ss_pred -----------------------------------c-------------------cCCCCHHHHHHHHHHccCCchhCcC
Confidence 0 0000115789999999999999999
Q ss_pred HHHHhcCCC
Q psy11727 421 PTNVLRHEF 429 (437)
Q Consensus 421 ~~e~l~Hp~ 429 (437)
++++++|||
T Consensus 259 ~~~ll~~~~ 267 (267)
T cd06645 259 AEKLLQHPF 267 (267)
T ss_pred HHHHhcCCC
Confidence 999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=314.64 Aligned_cols=255 Identities=28% Similarity=0.431 Sum_probs=201.9
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
++|++.+.||.|+||+||+|....++..+|+|++.... .....+..|+.++..+ .|+||+++++.+...+..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-----NHPNVVKYYTSFVVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-----CCCCEEEEEEEEeeCCEEE
Confidence 47999999999999999999998899999999986432 2334566677766655 7899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 188 LVFELLSY-NLYNLIRNTNF-HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~-~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
+|||++++ +|.+++..... ..+++..+..++.|++.||+|||+ .|++|+||+|+||++ ++++.++|+|||++..
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~--~~i~h~~l~p~ni~~--~~~~~~~l~df~~~~~ 151 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS--NGQIHRDIKAGNILL--GEDGSVKIADFGVSAS 151 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEE--cCCCCEEEcccchHHH
Confidence 99999965 78888876432 458999999999999999999995 489999999999999 6678899999999865
Q ss_pred cCCcc-------ccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 266 VGQTL-------YQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 266 ~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
..... ....|+..|+|||++... .++.++|+|||||++++|++|+.||...+....+..+... .++. ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~-~~ 228 (267)
T cd06610 152 LADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DPPS-LE 228 (267)
T ss_pred hccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC--CCCC-cC
Confidence 53321 234678899999999877 7899999999999999999999999876655444433221 0000 00
Q ss_pred ccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCC
Q psy11727 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKK 417 (437)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 417 (437)
. . .. .......+.+||.+||..||++
T Consensus 229 ~--------------------------------~--------------------~~--~~~~~~~~~~li~~~l~~~p~~ 254 (267)
T cd06610 229 T--------------------------------G--------------------AD--YKKYSKSFRKMISLCLQKDPSK 254 (267)
T ss_pred C--------------------------------c--------------------cc--cccccHHHHHHHHHHcCCChhh
Confidence 0 0 00 0000125789999999999999
Q ss_pred CCCHHHHhcCCCc
Q psy11727 418 RISPTNVLRHEFF 430 (437)
Q Consensus 418 R~t~~e~l~Hp~~ 430 (437)
|||+.++++||||
T Consensus 255 Rp~~~~ll~~p~~ 267 (267)
T cd06610 255 RPTAEELLKHKFF 267 (267)
T ss_pred CcCHHHHhhCCCC
Confidence 9999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=313.30 Aligned_cols=273 Identities=29% Similarity=0.431 Sum_probs=210.8
Q ss_pred eccCeee-eceecccCceEEEEEEEcCCCeEEEEEEecCCccc-chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 108 FLDRYEI-DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF-LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 108 ~~~~y~i-~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
|.+-|++ .+.||+|+|+.|--|++..+|..||||+|.+.... ..++.+|+.++...+ .|+||++++++|+++..
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cq----gh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQ----GHKNILQLIEFFEDDTR 150 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhc----CCccHHHHHHHhcccce
Confidence 3444665 46899999999999999999999999999755332 356778888887765 89999999999999999
Q ss_pred EEEEEEec-cCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCC-CCEEEEeCCCc
Q psy11727 186 LCLVFELL-SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR-SAIKIIDFGSS 263 (437)
Q Consensus 186 ~~lV~E~~-~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~-~~ikL~DFG~s 263 (437)
+|||||-| +|.|+..|.+... +++..+.++++.|+.||.|||. .||.||||||+|||-...+. .-|||+||.++
T Consensus 151 FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~--kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHT--KGIAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred EEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhh--cCcccccCCccceeecCCCCcCceeeeccccc
Confidence 99999999 5589998887653 8999999999999999999995 48999999999999854333 34999999876
Q ss_pred eec----------CCccccccccccccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q psy11727 264 CHV----------GQTLYQYIQSRYYRSPEVLL-----GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV 328 (437)
Q Consensus 264 ~~~----------~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 328 (437)
.-. .....+.+|+..|||||+.. ...|+.++|.||||||+|-|++|.+||.|....+-
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC------- 299 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC------- 299 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC-------
Confidence 432 12234678999999999874 23689999999999999999999999988654221
Q ss_pred hCCCChhhhccCCcc----chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHH
Q psy11727 329 LGMPPGYLLHGASKT----SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFK 404 (437)
Q Consensus 329 ~~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (437)
-|+.+... .+.|..+.+|.|.+...... ......+
T Consensus 300 -------GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWa----------------------------------hIS~eak 338 (463)
T KOG0607|consen 300 -------GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWA----------------------------------HISSEAK 338 (463)
T ss_pred -------CccCCCccHHHHHHHHHHHhccCCcCChhhhH----------------------------------HhhHHHH
Confidence 00000000 13445555555443322111 1112568
Q ss_pred HHHHHccccCCCCCCCHHHHhcCCCcCcCCCC
Q psy11727 405 DLILRMLTYDPKKRISPTNVLRHEFFLKHSVD 436 (437)
Q Consensus 405 dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~ 436 (437)
|||+.+|..||..|.++.++++|||++..+.+
T Consensus 339 dlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 339 DLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 99999999999999999999999999987654
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=318.83 Aligned_cols=253 Identities=31% Similarity=0.457 Sum_probs=200.6
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVF 190 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~ 190 (437)
|++.+.||+|+||.||+|.+..++..+|+|.+.... .....+..|+.++..+ .|+||+++++.+...+..++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~ii~~~~~~~~~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-----DHPNIVKLLDAFYYENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-----CCCCeeeEEEEEeeCCEEEEEE
Confidence 788899999999999999999999999999986433 2233455566666655 7899999999999999999999
Q ss_pred EeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc
Q psy11727 191 ELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT 269 (437)
Q Consensus 191 E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~ 269 (437)
||+++ +|..++.... ..+++..+..++.|++.||.|||+ .|++||||||+||++ +.++.++|+|||++......
T Consensus 82 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~--~~i~H~dlkp~nili--~~~~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 82 EFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHE--NKIIHRDLKAGNILF--TLDGDIKLADFGVSAKNTRT 156 (282)
T ss_pred EecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEE--ccCCCEEEcccccccccccc
Confidence 99976 5656555432 468999999999999999999996 489999999999999 67788999999998654322
Q ss_pred ---cccccccccccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 270 ---LYQYIQSRYYRSPEVLL-----GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 270 ---~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
.....++..|+|||++. +..++.++|+|||||++|+|++|.+||...+..+....+..... +. +.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~-~~---- 229 (282)
T cd06643 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP--PT-LA---- 229 (282)
T ss_pred ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC--CC-CC----
Confidence 23356788999999984 45678899999999999999999999988776655555433111 00 00
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
.| ......+.+||.+||+.||.+|||+
T Consensus 230 --------------------------~~---------------------------~~~~~~~~~li~~~l~~~p~~Rp~~ 256 (282)
T cd06643 230 --------------------------QP---------------------------SRWSSEFKDFLKKCLEKNVDARWTT 256 (282)
T ss_pred --------------------------Cc---------------------------cccCHHHHHHHHHHccCChhhCcCH
Confidence 00 0001257899999999999999999
Q ss_pred HHHhcCCCcCcCC
Q psy11727 422 TNVLRHEFFLKHS 434 (437)
Q Consensus 422 ~e~l~Hp~~~~~~ 434 (437)
.++++||||+...
T Consensus 257 ~~il~~~~~~~~~ 269 (282)
T cd06643 257 TQLLQHPFVTVNS 269 (282)
T ss_pred HHHhcCCCEeccC
Confidence 9999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=330.59 Aligned_cols=203 Identities=28% Similarity=0.422 Sum_probs=163.7
Q ss_pred ccCeeeeceecccCceEEEEEEE-----cCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFD-----HEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~-----~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|++.+.||+|+||.||+|.+ ..+++.||+|+++.... ....+..|+.++..+. .||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~~~~~~~ 81 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIG----NHLNVVNLLGACT 81 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhc----cCcceeeEEeEec
Confidence 36899999999999999999974 24457899999974321 2234667887777764 6899999999887
Q ss_pred EC-CEEEEEEEeccC-cHHHHHHhcC------------------------------------------------------
Q psy11727 182 WK-NHLCLVFELLSY-NLYNLIRNTN------------------------------------------------------ 205 (437)
Q Consensus 182 ~~-~~~~lV~E~~~~-~L~~~l~~~~------------------------------------------------------ 205 (437)
.. +.+++||||+++ +|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 64 468999999965 8888886431
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCcc-----cccc
Q psy11727 206 ------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL-----YQYI 274 (437)
Q Consensus 206 ------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~-----~~~~ 274 (437)
...+++..+..++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++....... ....
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDiKp~Nil~--~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 237 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS--RKCIHRDLAARNILL--SENNVVKICDFGLARDIYKDPDYVRKGSAR 237 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCccceEEE--cCCCcEEEeecccccccccCcchhcccCCC
Confidence 1247888899999999999999996 489999999999999 668889999999997643211 1233
Q ss_pred ccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy11727 275 QSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEV 319 (437)
Q Consensus 275 gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~ 319 (437)
++..|+|||++.+..++.++|||||||++|||++ |.+||.+....
T Consensus 238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~ 283 (338)
T cd05102 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN 283 (338)
T ss_pred CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc
Confidence 4578999999999999999999999999999997 99999876543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=319.59 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=202.6
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
..+|.+.+.||+|+||.||+|++..++..||+|.+..... ....+..|+.++..+ .|+||+++++.|...++.|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-----~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-----CCCCEeeEEEEEEeCCEEE
Confidence 4689999999999999999999999999999999874332 234455677766654 7899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|.+++... .+++..+..++.|++.||+|||+ .||+||||||+|||+ +.++.++|+|||++...
T Consensus 94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~--~gi~H~dLkp~Nill--~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILL--GMDGSVKLTDFGFCAQI 166 (296)
T ss_pred EeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE--cCCCCEEECccccchhc
Confidence 99999965 788887653 37899999999999999999995 489999999999999 67788999999998654
Q ss_pred CCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
... .....++..|+|||.+.+..++.++|+|||||++|+|++|++||...+.......+.. .+.++.
T Consensus 167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~--------- 236 (296)
T cd06654 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPEL--------- 236 (296)
T ss_pred cccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCCCC---------
Confidence 322 2234678899999999988899999999999999999999999987765433222211 011000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
+ ........+.+||.+||..||.+|||+.+
T Consensus 237 -------------------------~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~e 266 (296)
T cd06654 237 -------------------------Q-------------------------NPEKLSAIFRDFLNRCLDMDVEKRGSAKE 266 (296)
T ss_pred -------------------------C-------------------------CccccCHHHHHHHHHHCcCCcccCcCHHH
Confidence 0 00001125789999999999999999999
Q ss_pred HhcCCCcCcC
Q psy11727 424 VLRHEFFLKH 433 (437)
Q Consensus 424 ~l~Hp~~~~~ 433 (437)
+++||||...
T Consensus 267 il~~~~~~~~ 276 (296)
T cd06654 267 LLQHQFLKIA 276 (296)
T ss_pred HhhChhhhcc
Confidence 9999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=317.33 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=196.8
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ........|+.++..+ .|+||+++++.+...+.++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-----~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-----KHCNIVAYFGSYLSREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-----CCCCeeeeeEEEEeCCEEE
Confidence 457999999999999999999999999999999987432 2223455677766655 7899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|.+++... ..+++..+..++.|++.||.|||+ .||+||||||+||++ +.++.++|+|||++...
T Consensus 83 iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nill--~~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHS--KGKMHRDIKGANILL--TDNGDVKLADFGVAAKI 156 (267)
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEE--CCCCCEEECcCccceee
Confidence 99999975 788887654 358999999999999999999995 489999999999999 67888999999999765
Q ss_pred CCcc---ccccccccccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 267 GQTL---YQYIQSRYYRSPEVLL---GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 267 ~~~~---~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
.... ....++..|+|||.+. ...++.++|+|||||++|||++|.+||......+....+......++.
T Consensus 157 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 230 (267)
T cd06646 157 TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPK------ 230 (267)
T ss_pred cccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCC------
Confidence 4322 2356788999999985 345788999999999999999999999755433222111110000000
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
... .......+.+||++||+.||++|||
T Consensus 231 ------------------------------~~~----------------------~~~~~~~~~~li~~~l~~~P~~Rp~ 258 (267)
T cd06646 231 ------------------------------LKD----------------------KTKWSSTFHNFVKISLTKNPKKRPT 258 (267)
T ss_pred ------------------------------Ccc----------------------ccccCHHHHHHHHHHhhCChhhCcC
Confidence 000 0001125789999999999999999
Q ss_pred HHHHhcCCC
Q psy11727 421 PTNVLRHEF 429 (437)
Q Consensus 421 ~~e~l~Hp~ 429 (437)
++++++|+|
T Consensus 259 ~~~il~~l~ 267 (267)
T cd06646 259 AERLLTHLF 267 (267)
T ss_pred HHHHhcCCC
Confidence 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=311.70 Aligned_cols=249 Identities=27% Similarity=0.406 Sum_probs=206.6
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+|++.+.||+|+||.||.+.+..++..+++|.+.... .....+..|+.+++.+ .|+||+++++++.+.+.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-----QHPNIIAYYNHFMDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-----CCCCeeEEEeEEecCCeEE
Confidence 5899999999999999999999999999999886432 2234566788777766 6899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|.+++.......+++..+..++.|++.+|+|||+ .|++|+||+|+||++ +.++.+||+|||++...
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~ni~~--~~~~~~kl~d~~~~~~~ 151 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK--AGILHRDIKTLNIFL--TKAGLIKLGDFGISKIL 151 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCChHhEEE--eCCCCEEECcCcceEEc
Confidence 99999965 89998877544568999999999999999999995 489999999999999 66788999999998765
Q ss_pred CCcc---ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQTL---YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.... ....++..|+|||++.+..++.++|+||||+++++|++|..||...+..+....+......+..
T Consensus 152 ~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~--------- 222 (256)
T cd08221 152 GSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVV--------- 222 (256)
T ss_pred ccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---------
Confidence 4332 3456889999999999888999999999999999999999999987776666655321100000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
......+.++|.+||..||.+|||+.+
T Consensus 223 -----------------------------------------------------~~~~~~~~~~i~~~l~~~p~~R~s~~~ 249 (256)
T cd08221 223 -----------------------------------------------------SVYSSELISLVHSLLQQDPEKRPTADE 249 (256)
T ss_pred -----------------------------------------------------cccCHHHHHHHHHHcccCcccCCCHHH
Confidence 000125789999999999999999999
Q ss_pred HhcCCCc
Q psy11727 424 VLRHEFF 430 (437)
Q Consensus 424 ~l~Hp~~ 430 (437)
+++||||
T Consensus 250 ll~~~~l 256 (256)
T cd08221 250 VLDQPLL 256 (256)
T ss_pred HhhCcCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=325.63 Aligned_cols=280 Identities=34% Similarity=0.562 Sum_probs=216.9
Q ss_pred CeeeeceecccCceEEEEEEEcCC--CeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC--
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEE--KCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK-- 183 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~--~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~-- 183 (437)
+|.+.+.||+|+||.||++.+..+ +..||+|.+.... ........|+.++..+. .|+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~~~~~~~ 76 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFR----GHKNITCLYDMDIVFPG 76 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhc----CCCChheeeeeeeeccc
Confidence 588999999999999999999888 8899999986421 12345566877777763 589999999875432
Q ss_pred --CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 184 --NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 184 --~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
..+++++|+++++|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.++|+|||
T Consensus 77 ~~~~~~~~~e~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~givH~dlkp~Nili--~~~~~~kl~Dfg 150 (332)
T cd07857 77 NFNELYLYEELMEADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHS--ANVLHRDLKPGNLLV--NADCELKICDFG 150 (332)
T ss_pred cCCcEEEEEecccCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHeEE--cCCCCEEeCcCC
Confidence 568999999999999988654 358999999999999999999995 489999999999999 678889999999
Q ss_pred CceecCCc-------cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy11727 262 SSCHVGQT-------LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333 (437)
Q Consensus 262 ~s~~~~~~-------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~ 333 (437)
++...... .....|+..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+....+..++..++.|+
T Consensus 151 ~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (332)
T cd07857 151 LARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD 230 (332)
T ss_pred CceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCC
Confidence 99765321 123468899999998866 4689999999999999999999999999999999999999999888
Q ss_pred hhhhccCCccc--hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 334 GYLLHGASKTS--KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 334 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
..++....... .+...... .+ ...+..+ .......+.+||.+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~---------------~~-~~~~~~~------------------~~~~~~~~~~li~~~l 276 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPN---------------IP-KKPFESI------------------FPNANPLALDLLEKLL 276 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccc---------------cC-CcchHhh------------------CCCCCHHHHHHHHHHc
Confidence 76654332111 00000000 00 0000000 0011236789999999
Q ss_pred ccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 412 TYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 412 ~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
++||.+|||+.+++.||||+++.
T Consensus 277 ~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 277 AFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred cCCcccCCCHHHHhcChhhhhhc
Confidence 99999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=314.93 Aligned_cols=247 Identities=28% Similarity=0.440 Sum_probs=198.6
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc----------chHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----------LNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~----------~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
+|.+.+.||+|+||.||+|.+..++..||+|.+...... ...+..|+.++..+ .|+||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~ 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-----QHENIVQYLGSS 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-----CCCCeeeEEEEE
Confidence 477889999999999999999989999999988643221 12345566666665 789999999999
Q ss_pred eECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 181 TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 181 ~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
...++.++||||+++ +|.+++... ..+++..+..++.|++.||+|||+ .|++||||+|+||++ ++++.++|+|
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~--~~ivH~di~p~nil~--~~~~~~~l~d 149 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHN--RGIIHRDIKGANILV--DNKGGIKISD 149 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHh--cCcccccCCHHHEEE--cCCCCEEecc
Confidence 999999999999966 788888764 358999999999999999999995 489999999999999 6788899999
Q ss_pred CCCceecCCc---------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q psy11727 260 FGSSCHVGQT---------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLG 330 (437)
Q Consensus 260 FG~s~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 330 (437)
||++...... .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+.......+....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~- 228 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA- 228 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC-
Confidence 9998655421 112457888999999998889999999999999999999999998766544333322210
Q ss_pred CCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHc
Q psy11727 331 MPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRM 410 (437)
Q Consensus 331 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~ 410 (437)
.+. . .......+.+||++|
T Consensus 229 -~~~---------------------------------~---------------------------~~~~~~~~~~li~~~ 247 (267)
T cd06628 229 -SPE---------------------------------I---------------------------PSNISSEAIDFLEKT 247 (267)
T ss_pred -CCc---------------------------------C---------------------------CcccCHHHHHHHHHH
Confidence 000 0 000112578999999
Q ss_pred cccCCCCCCCHHHHhcCCCc
Q psy11727 411 LTYDPKKRISPTNVLRHEFF 430 (437)
Q Consensus 411 L~~dP~~R~t~~e~l~Hp~~ 430 (437)
|+.||.+|||+.++++||||
T Consensus 248 l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 248 FEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ccCCchhCcCHHHHhhCCCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=321.98 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=201.5
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
..+|.+.+.||+|+||.||+|.+..+++.||+|.+..... ....+..|+.++..+ .|+||++++++|...++.+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-----CCCCEeeEEEEEecCCEEE
Confidence 4789999999999999999999999999999999864322 223344566665554 8899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|.+++... .+++..+..++.|++.||.|||+ .|++||||||+|||+ +.++.++|+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~--~~i~H~dL~p~Nili--~~~~~~~l~Dfg~~~~~ 165 (297)
T cd06656 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHS--NQVIHRDIKSDNILL--GMDGSVKLTDFGFCAQI 165 (297)
T ss_pred EeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE--CCCCCEEECcCccceEc
Confidence 99999965 788887653 37899999999999999999995 489999999999999 67888999999998765
Q ss_pred CCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
... .....++..|+|||.+.+..++.++|+|||||++|+|++|.+||.+.+.......+.. .+.|+.
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~~--------- 235 (297)
T cd06656 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL--------- 235 (297)
T ss_pred cCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCCC---------
Confidence 332 1234678899999999998899999999999999999999999987654322211110 000000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
.........+.+||.+||..||.+|||+.+
T Consensus 236 --------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 265 (297)
T cd06656 236 --------------------------------------------------QNPERLSAVFRDFLNRCLEMDVDRRGSAKE 265 (297)
T ss_pred --------------------------------------------------CCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 000001124689999999999999999999
Q ss_pred HhcCCCcCcCC
Q psy11727 424 VLRHEFFLKHS 434 (437)
Q Consensus 424 ~l~Hp~~~~~~ 434 (437)
+++||||+...
T Consensus 266 il~~~~~~~~~ 276 (297)
T cd06656 266 LLQHPFLKLAK 276 (297)
T ss_pred HhcCchhcccc
Confidence 99999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=333.70 Aligned_cols=256 Identities=29% Similarity=0.432 Sum_probs=214.8
Q ss_pred ccCeee--eceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 109 LDRYEI--DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 109 ~~~y~i--~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
..-|+| .++||.|.||+||-|+.+++|+.||||+|.+.+ ....+...|+.|++.+ +||.||.+...|+..
T Consensus 561 stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-----~HPGiV~le~M~ET~ 635 (888)
T KOG4236|consen 561 STVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-----HHPGIVNLECMFETP 635 (888)
T ss_pred HHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-----CCCCeeEEEEeecCC
Confidence 334666 589999999999999999999999999997432 2236677899999887 889999999999999
Q ss_pred CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC-CCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK-RSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~-~~~ikL~DFG~ 262 (437)
+..++|||-+.|++++.|.....+.+++...+.++.||+.||.|||.+ +|+||||||+|||+.+.+ -..+||||||+
T Consensus 636 ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k--nIvHCDLKPENVLLas~~~FPQvKlCDFGf 713 (888)
T KOG4236|consen 636 ERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK--NIVHCDLKPENVLLASASPFPQVKLCDFGF 713 (888)
T ss_pred ceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc--ceeeccCCchheeeccCCCCCceeeccccc
Confidence 999999999999999999887778899999999999999999999964 799999999999996543 35799999999
Q ss_pred ceecCCcc--ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCChhhhcc
Q psy11727 263 SCHVGQTL--YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLG-MPPGYLLHG 339 (437)
Q Consensus 263 s~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~-~p~~~~~~~ 339 (437)
|+.+++.. .+.+||+.|+|||++..+.|....||||.|||+|.-++|..||..+.+ +-.+|....- .||.
T Consensus 714 ARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyPp~----- 786 (888)
T KOG4236|consen 714 ARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYPPN----- 786 (888)
T ss_pred eeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccCCC-----
Confidence 99998765 357899999999999999999999999999999999999999975432 3333332211 1221
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
.|.+.....+|||..+|+..-++|.
T Consensus 787 -------------------------------------------------------PW~eis~~AidlIn~LLqVkm~kRy 811 (888)
T KOG4236|consen 787 -------------------------------------------------------PWSEISPEAIDLINNLLQVKMRKRY 811 (888)
T ss_pred -------------------------------------------------------chhhcCHHHHHHHHHHHHHHHHHhc
Confidence 1122222568999999999999999
Q ss_pred CHHHHhcCCCcCcC
Q psy11727 420 SPTNVLRHEFFLKH 433 (437)
Q Consensus 420 t~~e~l~Hp~~~~~ 433 (437)
|.+..|.|||+++.
T Consensus 812 svdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 812 SVDKSLSHPWLQDY 825 (888)
T ss_pred chHhhccchhhhcc
Confidence 99999999999873
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=318.42 Aligned_cols=275 Identities=36% Similarity=0.565 Sum_probs=214.3
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccch--HHHHHHHHHHHhhhcCCC-CCcEEEecceeeECCEEEE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLN--QAQIEVQLLEKINKADIH-SRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~--~~~~e~~~~~~l~~~~~~-h~~iv~l~~~~~~~~~~~l 188 (437)
|++.+.||+|+||+||+|.+..+++.||||.+........ ....|+..+..+ . |+||+++++.+.+++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-----~~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKL-----NEHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhc-----cCCCCchhHHHHhhcCCcEEE
Confidence 6788999999999999999999999999999864432222 223355555444 5 8999999999999999999
Q ss_pred EEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 189 VFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 189 V~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
||||++++|.+.+.......+++..+..++.|++.+|.|||++ |++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~--~i~H~dl~~~ni~i--~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH--GFFHRDLKPENLLV--SGPEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChhhEEE--cCCCCEEEeecccceeccC
Confidence 9999988999988776545689999999999999999999964 89999999999999 6788999999999976643
Q ss_pred c--cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccch
Q psy11727 269 T--LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSK 345 (437)
Q Consensus 269 ~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 345 (437)
. .....++..|+|||++.+ ..++.++|+||||+++++|++|++||.+.+..+.+..+...++.|+...+........
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 2 234567889999998854 4578999999999999999999999999999899999888888877654433221110
Q ss_pred hhcccCCCcceeccccccccccCCCC--CchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 346 YFDRLSDNSYVLKKSTDTRKERLPGS--KRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
.+. + ..+.. ..+.+. .......+.+||++||..||.+|||++|
T Consensus 232 ~~~------~-----------~~~~~~~~~~~~~------------------~~~~~~~~~~li~~cl~~~p~~Rpt~~e 276 (283)
T cd07830 232 KLG------F-----------RFPQFAPTSLHQL------------------IPNASPEAIDLIKDMLRWDPKKRPTASQ 276 (283)
T ss_pred ccc------c-----------cccccccccHHHH------------------cccCCHHHHHHHHHhcccCcccCCCHHH
Confidence 000 0 00000 000000 0011236899999999999999999999
Q ss_pred HhcCCCc
Q psy11727 424 VLRHEFF 430 (437)
Q Consensus 424 ~l~Hp~~ 430 (437)
++.||||
T Consensus 277 i~~~~~~ 283 (283)
T cd07830 277 ALQHPYF 283 (283)
T ss_pred HhhCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=326.90 Aligned_cols=281 Identities=29% Similarity=0.446 Sum_probs=207.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC----
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK---- 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~---- 183 (437)
..+|.+.+.||.|+||.||+|.+..++..||+|.+..... .......|+.+++.+ .|+||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-----~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-----DHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-----CCCcchhhHhhhccccccc
Confidence 5789999999999999999999999999999999865432 234566677777766 688999999876654
Q ss_pred ----------CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC
Q psy11727 184 ----------NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS 253 (437)
Q Consensus 184 ----------~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~ 253 (437)
...|+||||++++|.+++... .+++..++.++.||+.||.|||+ .||+||||||+||+++. .++
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~--~givH~dikp~Nili~~-~~~ 152 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYMETDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANVFINT-EDL 152 (342)
T ss_pred ccccccccccceEEEEeecccccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcC-CCc
Confidence 468999999998888877643 48999999999999999999995 48999999999999942 455
Q ss_pred CEEEEeCCCceecCCc------cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy11727 254 AIKIIDFGSSCHVGQT------LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326 (437)
Q Consensus 254 ~ikL~DFG~s~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~ 326 (437)
.++|+|||++...... .....++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+....+.
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 7899999998765321 112356888999998754 568899999999999999999999999988877777766
Q ss_pred HHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHH
Q psy11727 327 EVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406 (437)
Q Consensus 327 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 406 (437)
.....+....... +....+.. ......+....+..++ ......+.+|
T Consensus 233 ~~~~~~~~~~~~~------~~~~~~~~---------~~~~~~~~~~~~~~~~------------------~~~~~~~~~l 279 (342)
T cd07854 233 ESVPVVREEDRNE------LLNVIPSF---------VRNDGGEPRRPLRDLL------------------PGVNPEALDF 279 (342)
T ss_pred HhcCCCChHHhhh------hhhhhhhh---------hhhcccccCCCHHHHc------------------cCCCHHHHHH
Confidence 6543333221110 11100000 0000000000011110 0111257899
Q ss_pred HHHccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 407 ILRMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 407 i~~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
|++||+.||.+|||+.+++.||||+..
T Consensus 280 i~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 280 LEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHHHhCCCchhccCHHHHhCCCccccc
Confidence 999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=318.17 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=203.3
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.+|++.+.||.|+||.||+|.+..+++.||+|.+..... ....+..|+.++..+ .|+||+++++++...+.+++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-----KNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-----CCCceeeeeeeEecCceEEE
Confidence 579999999999999999999999999999999864322 233455566666654 78999999999999999999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
|+||+.+ +|.+++... .+++..+..++.|++.||+|||++ |++||||||+||++ +.++.++|+|||++....
T Consensus 94 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~--~i~H~dL~p~Nili--~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 94 VMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN--QVIHRDIKSDNVLL--GMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEE--CCCCCEEEccCccchhcc
Confidence 9999966 777777543 489999999999999999999964 89999999999999 668889999999986543
Q ss_pred Cc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc
Q psy11727 268 QT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344 (437)
Q Consensus 268 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 344 (437)
.. .....++..|+|||.+.+..++.++|+|||||++|+|++|.+||.+.+.......+... +.++..
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~--------- 236 (296)
T cd06655 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPELQ--------- 236 (296)
T ss_pred cccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcccC---------
Confidence 22 12346788999999999888999999999999999999999999988765554433221 100000
Q ss_pred hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHH
Q psy11727 345 KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNV 424 (437)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~ 424 (437)
.+......+.+||++||..||.+|||+.++
T Consensus 237 --------------------------------------------------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~i 266 (296)
T cd06655 237 --------------------------------------------------NPEKLSPIFRDFLNRCLEMDVEKRGSAKEL 266 (296)
T ss_pred --------------------------------------------------CcccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence 000001157899999999999999999999
Q ss_pred hcCCCcCcCC
Q psy11727 425 LRHEFFLKHS 434 (437)
Q Consensus 425 l~Hp~~~~~~ 434 (437)
++||||....
T Consensus 267 l~~~~~~~~~ 276 (296)
T cd06655 267 LQHPFLKLAK 276 (296)
T ss_pred hhChHhhhcc
Confidence 9999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=318.56 Aligned_cols=256 Identities=32% Similarity=0.475 Sum_probs=203.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.++|++.+.||.|+||+||+|.+..++..||+|.+..... ....+..|+.++..+ .|+||+++++.+..++.++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-----KHPNIVGLYEAYFYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-----CCCceeEEEEEEecCCeEE
Confidence 3579999999999999999999988999999999874422 233455677777665 6899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|.+++.... ..+++..++.++.|++.||.|||+ .||+|+||||+||++ +.++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~nili--~~~~~~~l~d~g~~~~~ 153 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHS--HKVIHRDLKAGNILL--TLDGDVKLADFGVSAKN 153 (280)
T ss_pred EEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEE--CCCCCEEEccCccchhh
Confidence 99999976 7777776543 468999999999999999999995 489999999999999 67888999999998654
Q ss_pred CCc---cccccccccccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLL-----GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
... .....++..|+|||++. +..++.++|+|||||++|+|++|.+||.+.+....+..+.. +.++..-.
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~- 230 (280)
T cd06611 154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK--SEPPTLDQ- 230 (280)
T ss_pred cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc--CCCCCcCC-
Confidence 322 23356888999999985 34577899999999999999999999988766554443321 11100000
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
| ..-...+.+||.+||..||.+|
T Consensus 231 ------------------------------~---------------------------~~~~~~~~~li~~~l~~~p~~R 253 (280)
T cd06611 231 ------------------------------P---------------------------SKWSSSFNDFLKSCLVKDPDDR 253 (280)
T ss_pred ------------------------------c---------------------------ccCCHHHHHHHHHHhccChhhC
Confidence 0 0000157899999999999999
Q ss_pred CCHHHHhcCCCcCcCC
Q psy11727 419 ISPTNVLRHEFFLKHS 434 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~~~ 434 (437)
||+.++++||||.+..
T Consensus 254 ps~~~il~~~~~~~~~ 269 (280)
T cd06611 254 PTAAELLKHPFVSDQS 269 (280)
T ss_pred cCHHHHhcChhhcccc
Confidence 9999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=312.91 Aligned_cols=248 Identities=25% Similarity=0.419 Sum_probs=196.9
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc-------chHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF-------LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~-------~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
+|.+.+.||+|+||+||+|.+ .+++.+|+|.+...... ...+..|+.+++.+ .|+||+++.+++.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-----KHVNIVQYLGTCLDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-----CCCCEeeEeeEeecC
Confidence 478899999999999999986 47889999998643211 13345566666655 688999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+.+++||||+++ +|.+++... ..+++..+..++.|++.||+|||+ .||+|+||+|+||++ ++++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nil~--~~~~~~~l~dfg~ 148 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHN--NCVVHRDIKGNNVML--MPNGIIKLIDFGC 148 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHhEEE--CCCCeEEeccchh
Confidence 999999999965 888888764 358999999999999999999995 489999999999999 6788899999999
Q ss_pred ceecCC---------ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy11727 263 SCHVGQ---------TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333 (437)
Q Consensus 263 s~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~ 333 (437)
+..... ......++..|+|||++.+..++.++|+|||||++|+|++|.+||...+.......+....+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 228 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP 228 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC
Confidence 865421 12234678899999999998999999999999999999999999987665444333322111111
Q ss_pred hhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
.. .......+.+||++||..
T Consensus 229 ~~------------------------------------------------------------~~~~~~~~~~~i~~~l~~ 248 (265)
T cd06631 229 RL------------------------------------------------------------PDSFSAAAIDFVTSCLTR 248 (265)
T ss_pred CC------------------------------------------------------------CCCCCHHHHHHHHHHhcC
Confidence 00 000112578999999999
Q ss_pred CCCCCCCHHHHhcCCCc
Q psy11727 414 DPKKRISPTNVLRHEFF 430 (437)
Q Consensus 414 dP~~R~t~~e~l~Hp~~ 430 (437)
||.+|||+.++++||||
T Consensus 249 ~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 249 DQHERPSALQLLRHDFL 265 (265)
T ss_pred CcccCCCHHHHhcCCCC
Confidence 99999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=319.20 Aligned_cols=262 Identities=26% Similarity=0.362 Sum_probs=199.9
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
++|+..+.||+|+||.||++.+..+++.||+|.+.... .....+..|+.++.++. .|+||+++++++...+..+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~----~~~~iv~~~~~~~~~~~~~ 79 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS----DCPYIVKFYGALFREGDCW 79 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhc----CCCCEeeeeeEEecCCcEE
Confidence 35677889999999999999999999999999986432 12234555666665552 4899999999999999999
Q ss_pred EEEEeccCcHHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 188 LVFELLSYNLYNLIR---NTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 188 lV~E~~~~~L~~~l~---~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
++||++++++.++.. ......+++..+..++.|++.||+|||+. .|++||||||+||++ +.++.++|+|||++.
T Consensus 80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~--~~~~~~kl~dfg~~~ 156 (288)
T cd06616 80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE-LKIIHRDVKPSNILL--DRNGNIKLCDFGISG 156 (288)
T ss_pred EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc-CCeeccCCCHHHEEE--ccCCcEEEeecchhH
Confidence 999999876655432 22235689999999999999999999963 489999999999999 667889999999986
Q ss_pred ecCCc--cccccccccccChhhhcCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCChhhhc
Q psy11727 265 HVGQT--LYQYIQSRYYRSPEVLLGI---PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLG-MPPGYLLH 338 (437)
Q Consensus 265 ~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~-~p~~~~~~ 338 (437)
..... .....|+..|+|||++.+. .++.++|+|||||++|+|++|++||...+. ....+.+... .++. ...
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~-~~~ 233 (288)
T cd06616 157 QLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPI-LSN 233 (288)
T ss_pred HhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCc-CCC
Confidence 55332 2334678899999999876 689999999999999999999999976542 2222222111 1110 000
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
..+......+.+||.+||+.||.+|
T Consensus 234 -------------------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~R 258 (288)
T cd06616 234 -------------------------------------------------------SEEREFSPSFVNFINLCLIKDESKR 258 (288)
T ss_pred -------------------------------------------------------cCCCccCHHHHHHHHHHccCChhhC
Confidence 0000011257899999999999999
Q ss_pred CCHHHHhcCCCcCcCCCC
Q psy11727 419 ISPTNVLRHEFFLKHSVD 436 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~~~~~ 436 (437)
||+++++.||||++....
T Consensus 259 pt~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 259 PKYKELLEHPFIKDYEER 276 (288)
T ss_pred cCHHHHhcChhhhchhhc
Confidence 999999999999875543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=310.13 Aligned_cols=250 Identities=30% Similarity=0.394 Sum_probs=203.5
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+|++.+.||+|+||.||+|.+..++..+|+|.+.... .....+..|+.+++.+ .|+||+++++.+...+.++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-----SHPNIIEYYENFLEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-----CCCchhheeeeEecCCEEE
Confidence 5899999999999999999999999999999986432 1233556677777766 6899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|.+++.......+++..+..++.|++.+|+|||++ |++|+||+|+||+++ ++++.++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~--~i~h~dl~~~nil~~-~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK--LILHRDLKTQNILLD-KHKMVVKIGDFGISKIL 152 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEc-CCCCEEEEccCCCceec
Confidence 99999965 899998775545689999999999999999999964 899999999999994 23456899999999876
Q ss_pred CCcc--ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc
Q psy11727 267 GQTL--YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344 (437)
Q Consensus 267 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 344 (437)
.... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+......+.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 221 (256)
T cd08220 153 SSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI----------- 221 (256)
T ss_pred CCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCC-----------
Confidence 5432 235678899999999988899999999999999999999999988776555444432110000
Q ss_pred hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHH
Q psy11727 345 KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNV 424 (437)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~ 424 (437)
++ .....+.++|.+||..||.+|||+.|+
T Consensus 222 ------~~---------------------------------------------~~~~~l~~li~~~l~~~p~~Rpt~~~l 250 (256)
T cd08220 222 ------SD---------------------------------------------RYSPDLRQLILSMLNLDPSKRPQLSQI 250 (256)
T ss_pred ------CC---------------------------------------------CcCHHHHHHHHHHccCChhhCCCHHHH
Confidence 00 001157899999999999999999999
Q ss_pred hcCCCc
Q psy11727 425 LRHEFF 430 (437)
Q Consensus 425 l~Hp~~ 430 (437)
++||||
T Consensus 251 l~~p~~ 256 (256)
T cd08220 251 MAQPIC 256 (256)
T ss_pred hhCCCC
Confidence 999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=315.69 Aligned_cols=275 Identities=36% Similarity=0.584 Sum_probs=219.8
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCC---cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK---KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
|++.+.||+|+||.||+|....+++.||+|++... .........|+.+++.+ .|+|++++++++.+.+..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-----KHPNIVKLLDVIHTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-----CCCCHHHHHhhhhcCCceEE
Confidence 66788999999999999999999999999999754 22334556677777766 58999999999999999999
Q ss_pred EEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 189 VFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 189 V~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
|||+++++|.+++.... ..+++..+..++.|++.||+|||++ ||+||||+|+||++ ++++.++|+|||++.....
T Consensus 76 v~e~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~~l~~~ni~~--~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 76 VFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH--RILHRDLKPQNILI--NRDGVLKLADFGLARAFGI 150 (282)
T ss_pred EecCcCcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChheEEE--cCCCCEEEecCCcccccCC
Confidence 99999999999988753 3589999999999999999999964 89999999999999 6688999999999876543
Q ss_pred cc---ccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc
Q psy11727 269 TL---YQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344 (437)
Q Consensus 269 ~~---~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 344 (437)
.. ....++..|+|||++.+. .++.++|+|||||+++||++|.+||.+.+..+.+.++...++.+....+.......
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 32 233456789999999876 78999999999999999999999999999999999999988888877765544332
Q ss_pred hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHH
Q psy11727 345 KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNV 424 (437)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~ 424 (437)
+++..... + + .....+. .......+.++|.+||+.||.+|||+.++
T Consensus 231 -~~~~~~~~-~-------------~-~~~~~~~------------------~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~ 276 (282)
T cd07829 231 -DYKPTFPK-F-------------P-PKDLEKV------------------LPRLDPEGIDLLSKMLQYNPAKRISAKEA 276 (282)
T ss_pred -cccccccc-c-------------C-ccchHHh------------------cccccHHHHHHHHHhhccCcccCCCHHHH
Confidence 11110000 0 0 0000000 00112368999999999999999999999
Q ss_pred hcCCCc
Q psy11727 425 LRHEFF 430 (437)
Q Consensus 425 l~Hp~~ 430 (437)
+.||||
T Consensus 277 l~~p~~ 282 (282)
T cd07829 277 LKHPYF 282 (282)
T ss_pred hhCcCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=327.64 Aligned_cols=212 Identities=25% Similarity=0.290 Sum_probs=181.1
Q ss_pred CCcceeecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc-chHHHHHHHHHHHhhhcCCCCCcEEE
Q psy11727 97 NYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF-LNQAQIEVQLLEKINKADIHSRYIVK 175 (437)
Q Consensus 97 ~~~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~e~~~~~~l~~~~~~h~~iv~ 175 (437)
...|.+.+....+++|.-.+.||+|+||.||+|.... +..||||.+...... ..++..|+.++..+ +|||+|+
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-----~H~Nlv~ 135 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRL-----RHPNLVK 135 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcC-----CCcCccc
Confidence 3445666667778899999999999999999998654 489999988755443 56689999999887 7899999
Q ss_pred ecceeeECC-EEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCC-CCCeeeCCCCCCcEEEecCCC
Q psy11727 176 LKGHFTWKN-HLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP-ELSIIHCDLKPENILLCSPKR 252 (437)
Q Consensus 176 l~~~~~~~~-~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~-~~giiHrDiKp~NIll~~~~~ 252 (437)
|+|+|.+.+ +.+||+|||+ |+|.+++.......++|..+.+|+.++|+||+|||.. ...||||||||.|||| |++
T Consensus 136 LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL--D~~ 213 (361)
T KOG1187|consen 136 LLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL--DED 213 (361)
T ss_pred EEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE--CCC
Confidence 999999988 5999999996 5899988775432789999999999999999999985 2259999999999999 889
Q ss_pred CCEEEEeCCCceecCC-ccc--cc-cccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy11727 253 SAIKIIDFGSSCHVGQ-TLY--QY-IQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGK 316 (437)
Q Consensus 253 ~~ikL~DFG~s~~~~~-~~~--~~-~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~ 316 (437)
..+||+|||+|..... ... +. .||.+|+|||++..+..+.++|||||||+|.|++||+.+....
T Consensus 214 ~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred CCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 9999999999966653 222 22 7999999999999989999999999999999999999888754
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=314.05 Aligned_cols=254 Identities=30% Similarity=0.455 Sum_probs=201.3
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
++|++.+.||+|+||.||+|.+..+++.+|+|.+.... ....++..|+.+++.+ .|+||+++++.+...+.++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-----NSPYIVGFYGAFYNNGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-----CCCchhhhheeeecCCEEE
Confidence 36888999999999999999999999999999987542 2223455566666654 6899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+|+|++++ +|.+++.... ..+++..+..++.|++.||+|||+. .|++|+||||+||++ +.++.++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~-~~i~H~dl~~~ni~~--~~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK-HKIIHRDVKPSNILV--NSRGQIKLCDFGVSGQL 151 (265)
T ss_pred EEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCC-CCeecCCCCHHHEEE--CCCCCEEEeecccchhh
Confidence 99999974 8888887653 5689999999999999999999961 589999999999999 66888999999998655
Q ss_pred CCcc-ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCChhhhccC
Q psy11727 267 GQTL-YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN-----EVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 267 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~-----~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
.... ....++..|+|||++.+..++.++|+|||||++|+|++|..||...+ ..+.++.+.. .++...
T Consensus 152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~---- 224 (265)
T cd06605 152 VNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPPPRL---- 224 (265)
T ss_pred HHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCCCCC----
Confidence 3221 12667889999999999999999999999999999999999997642 1122222211 100000
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
+ . ......+.+||.+||..||.+|||
T Consensus 225 ----------------------------~------------------------~--~~~~~~~~~li~~~l~~~p~~Rpt 250 (265)
T cd06605 225 ----------------------------P------------------------S--GKFSPDFQDFVNLCLIKDPRERPS 250 (265)
T ss_pred ----------------------------C------------------------h--hhcCHHHHHHHHHHcCCCchhCcC
Confidence 0 0 001125789999999999999999
Q ss_pred HHHHhcCCCcCcC
Q psy11727 421 PTNVLRHEFFLKH 433 (437)
Q Consensus 421 ~~e~l~Hp~~~~~ 433 (437)
+.+++.||||++.
T Consensus 251 ~~~ll~~~~~~~~ 263 (265)
T cd06605 251 YKELLEHPFIKKY 263 (265)
T ss_pred HHHHhhCchhhcc
Confidence 9999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=310.54 Aligned_cols=252 Identities=30% Similarity=0.417 Sum_probs=202.2
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... ....+..|+.++..+ .|+||+++++.+.+.+.+|+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-----RHPNIVAYFGSYLRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-----CCCChhceEEEEEeCCEEEE
Confidence 579999999999999999999999999999999874322 234566677776665 78999999999999999999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
+|||+++ +|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||+|+||++ +.++.++|+|||++....
T Consensus 78 ~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHE--TGKIHRDIKGANILL--TEDGDVKLADFGVSAQLT 152 (262)
T ss_pred EEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh--CCceecCCChhhEEE--CCCCCEEECccccchhhh
Confidence 9999976 7777776542 458999999999999999999995 489999999999999 678889999999987654
Q ss_pred Cc---cccccccccccChhhhcCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 268 QT---LYQYIQSRYYRSPEVLLGI---PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 268 ~~---~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
.. .....++..|+|||.+.+. .++.++|+|||||++|+|++|.+||.+.+.......+... ..++..+.
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~---- 227 (262)
T cd06613 153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS-NFPPPKLK---- 227 (262)
T ss_pred hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCCcccc----
Confidence 32 2335678889999999877 8899999999999999999999999887655444333221 00000000
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
........+.+||++||..||..|||+
T Consensus 228 -----------------------------------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~ 254 (262)
T cd06613 228 -----------------------------------------------------DKEKWSPVFHDFIKKCLTKDPKKRPTA 254 (262)
T ss_pred -----------------------------------------------------chhhhhHHHHHHHHHHcCCChhhCCCH
Confidence 000011257899999999999999999
Q ss_pred HHHhcCCC
Q psy11727 422 TNVLRHEF 429 (437)
Q Consensus 422 ~e~l~Hp~ 429 (437)
++++.|||
T Consensus 255 ~~il~~~~ 262 (262)
T cd06613 255 TKLLQHPF 262 (262)
T ss_pred HHHhcCCC
Confidence 99999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=315.95 Aligned_cols=249 Identities=31% Similarity=0.424 Sum_probs=195.9
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEec
Q psy11727 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELL 193 (437)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~ 193 (437)
||+|+||+||+|.+..+|+.||+|++..... ....+..|+.++..+ .|+||+++++.+...+.+|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-----SSRFIVSLAYAFETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-----CCCCEeeeeeEEecCCeEEEEEecC
Confidence 6999999999999999999999999864321 122334566666665 6899999999999999999999999
Q ss_pred cC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC--cc
Q psy11727 194 SY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ--TL 270 (437)
Q Consensus 194 ~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~--~~ 270 (437)
++ +|.+++.......+++..+..++.|++.||.|||+ .|++||||+|+||++ ++++.++|+|||.+..... ..
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~Nil~--~~~~~~~l~dfg~~~~~~~~~~~ 151 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ--RRIVYRDLKPENVLL--DDHGNVRISDLGLAVELKGGKKI 151 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEE--CCCCCEEEccCcchhhhccCCcc
Confidence 75 88888876554568999999999999999999995 489999999999999 6788899999999865532 22
Q ss_pred ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCChhhhccCCccchhhcc
Q psy11727 271 YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLG-MPPGYLLHGASKTSKYFDR 349 (437)
Q Consensus 271 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~-~p~~~~~~~~~~~~~~~~~ 349 (437)
....++..|+|||++.+..++.++|+|||||++|+|++|+.||...........+..... .+..
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------- 216 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVE--------------- 216 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccccccc---------------
Confidence 234567889999999988899999999999999999999999987654222222211100 0000
Q ss_pred cCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC-----CHHHH
Q psy11727 350 LSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI-----SPTNV 424 (437)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~-----t~~e~ 424 (437)
. +......+.+||.+||+.||.+|| |+.++
T Consensus 217 ------------------~---------------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l 251 (277)
T cd05577 217 ------------------Y---------------------------PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEV 251 (277)
T ss_pred ------------------C---------------------------CccCCHHHHHHHHHHccCChhHccCCCcccHHHH
Confidence 0 000012578999999999999999 99999
Q ss_pred hcCCCcCcCCC
Q psy11727 425 LRHEFFLKHSV 435 (437)
Q Consensus 425 l~Hp~~~~~~~ 435 (437)
++||||.+.++
T Consensus 252 l~h~~~~~~~~ 262 (277)
T cd05577 252 REHPLFKDLNW 262 (277)
T ss_pred HhChhhhcCCh
Confidence 99999987664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=312.38 Aligned_cols=252 Identities=23% Similarity=0.435 Sum_probs=198.7
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-------cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-------FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-------~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
+|+..+.||+|+||.||+|.+..+++.||+|++..... ....+..|+.+++.+ .|+||+++++++.+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-----NHPHIIRMLGATCED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-----CCCceehhhceeccC
Confidence 47888999999999999999999999999999864321 234556677777766 789999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC-CEEEEeCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS-AIKIIDFG 261 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~-~ikL~DFG 261 (437)
+++++||||+.+ +|.+++... ..+++..+..++.||+.||+|||++ |++|+||+|+||++ +.++ .++|+|||
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~--~i~H~~i~~~nil~--~~~~~~~~l~dfg 149 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN--QIIHRDVKGANLLI--DSTGQRLRIADFG 149 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEE--cCCCCEEEEcccc
Confidence 999999999965 788888754 3589999999999999999999964 89999999999999 4444 59999999
Q ss_pred CceecCCcc-------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 262 SSCHVGQTL-------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 262 ~s~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
++....... ....++..|+|||++.+..++.++|+|||||++++|++|.+||...........+.+......
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 228 (268)
T cd06630 150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT- 228 (268)
T ss_pred cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC-
Confidence 987654321 224578899999999988999999999999999999999999976543333332222100000
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
.+.........+.++|.+||..|
T Consensus 229 ---------------------------------------------------------~~~~~~~~~~~~~~~i~~~l~~~ 251 (268)
T cd06630 229 ---------------------------------------------------------APSIPEHLSPGLRDVTLRCLELQ 251 (268)
T ss_pred ---------------------------------------------------------CCCCchhhCHHHHHHHHHHcCCC
Confidence 00000011125789999999999
Q ss_pred CCCCCCHHHHhcCCCcC
Q psy11727 415 PKKRISPTNVLRHEFFL 431 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~~ 431 (437)
|.+|||+.++++||||+
T Consensus 252 p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 252 PEDRPPSRELLKHPVFR 268 (268)
T ss_pred cccCcCHHHHhcCcccC
Confidence 99999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=343.54 Aligned_cols=248 Identities=26% Similarity=0.362 Sum_probs=199.8
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEec-CCcccchHHHHHHHHHHHhhhcCCCCCcEEEeccee-eE----
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK-NKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHF-TW---- 182 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~-~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~-~~---- 182 (437)
.-+++|.+.|.+|||+.||+|.+...|..||+|++- ......+...+|+.+++.|. .|+|||.+++.. ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~----gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLS----GHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhc----CCCceeeEeccccccccCC
Confidence 346889999999999999999999888899999764 34555678889999999996 799999999933 21
Q ss_pred --CCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 183 --KNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 183 --~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
.-.++|+||||. |+|.|++......+|++.++++|+.|+++|+++||.....|||||||-||||| ..++++||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl--s~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL--SADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE--cCCCCEEeCc
Confidence 136899999997 59999998765567999999999999999999999887779999999999999 6688899999
Q ss_pred CCCceecCCcc------------ccccccccccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy11727 260 FGSSCHVGQTL------------YQYIQSRYYRSPEVLL---GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTK 324 (437)
Q Consensus 260 FG~s~~~~~~~------------~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~ 324 (437)
||+++..-... .....|+.|+|||++. +.+.+.|+|||+|||+||-|+....||.......
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la---- 265 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA---- 265 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----
Confidence 99997543221 1123588999999984 7789999999999999999999999998764321
Q ss_pred HHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHH
Q psy11727 325 IIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFK 404 (437)
Q Consensus 325 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (437)
|+. + +|.+|... .....|+
T Consensus 266 Iln-------------------------g-----------~Y~~P~~p-------------------------~ys~~l~ 284 (738)
T KOG1989|consen 266 ILN-------------------------G-----------NYSFPPFP-------------------------NYSDRLK 284 (738)
T ss_pred EEe-------------------------c-----------cccCCCCc-------------------------cHHHHHH
Confidence 111 1 11122111 1122689
Q ss_pred HHHHHccccCCCCCCCHHHHhcC
Q psy11727 405 DLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 405 dli~~~L~~dP~~R~t~~e~l~H 427 (437)
+||..||+.||.+||++-|++.+
T Consensus 285 ~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 285 DLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred HHHHHHhccCcccCCCHHHHHHH
Confidence 99999999999999999998853
|
|
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=334.38 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=210.0
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC----cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~----~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.|.-++.||.|+||.||.|++..+.+.||||.+.-. ......+..|+.++..+ .|||+|.+.++|......
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-----~HPntieYkgCyLre~Ta 101 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-----RHPNTIEYKGCYLREHTA 101 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-----cCCCcccccceeeccchH
Confidence 466778899999999999999999999999998632 12234566788888887 789999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||||-|+-.|++.-.. +++-+..+..|+.+.+.||+|||++ +.||||||..|||+ .+.|.|||+|||+|...
T Consensus 102 WLVMEYClGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~--~~IHRDiKAGNILL--se~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 102 WLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH--NRIHRDIKAGNILL--SEPGLVKLADFGSASIM 176 (948)
T ss_pred HHHHHHHhccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHh--hHHhhhccccceEe--cCCCeeeeccccchhhc
Confidence 9999999887777765544 5689999999999999999999976 69999999999999 77999999999998655
Q ss_pred CCccccccccccccChhhhcC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQTLYQYIQSRYYRSPEVLLG---IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.. ..+++||++|||||+|.. +.|+-++||||||+++.||...+||.-..+....+--|...- +|..
T Consensus 177 ~P-AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe--sPtL-------- 245 (948)
T KOG0577|consen 177 AP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--SPTL-------- 245 (948)
T ss_pred Cc-hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC--CCCC--------
Confidence 43 567899999999999974 579999999999999999999999998888777766664421 1100
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
..++|. +.|+.||..||+.-|.+|||.++
T Consensus 246 ------------------------------------------------qs~eWS---~~F~~Fvd~CLqKipqeRptse~ 274 (948)
T KOG0577|consen 246 ------------------------------------------------QSNEWS---DYFRNFVDSCLQKIPQERPTSEE 274 (948)
T ss_pred ------------------------------------------------CCchhH---HHHHHHHHHHHhhCcccCCcHHH
Confidence 011111 25899999999999999999999
Q ss_pred HhcCCCcCcCC
Q psy11727 424 VLRHEFFLKHS 434 (437)
Q Consensus 424 ~l~Hp~~~~~~ 434 (437)
+|.|+|+..-.
T Consensus 275 ll~H~fv~R~R 285 (948)
T KOG0577|consen 275 LLKHRFVLRER 285 (948)
T ss_pred HhhcchhccCC
Confidence 99999997643
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=315.75 Aligned_cols=238 Identities=21% Similarity=0.235 Sum_probs=193.5
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCccc----chHHHHHHHHHHHhhhcCCCCCcEEEecceeeE----CCEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW----KNHLC 187 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~----~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~----~~~~~ 187 (437)
..||+|++|.||+|.. +|+.||||.++..... ...+.+|+.++..+ .|||||++++++.+ ...++
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~~~g~~~~~~~~~~~~~ 98 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-----DSNNILKIYGFIIDIVDDLPRLS 98 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-----CCCCEEEEeeeEEecccCCCceE
Confidence 4689999999999976 6889999999754322 24455788888776 78899999999877 45789
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+.+ +|.+++... ..+++.....++.|++.||.|||.. .+++||||||+|||+ ++++.+||+|||++...
T Consensus 99 lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~Hrdlkp~nill--~~~~~~kl~dfg~~~~~ 173 (283)
T PHA02988 99 LILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKY-TNKPYKNLTSVSFLV--TENYKLKIICHGLEKIL 173 (283)
T ss_pred EEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhc-CCCCCCcCChhhEEE--CCCCcEEEcccchHhhh
Confidence 99999965 788888764 3589999999999999999999963 478999999999999 67889999999999876
Q ss_pred CCccccccccccccChhhhcC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc
Q psy11727 267 GQTLYQYIQSRYYRSPEVLLG--IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344 (437)
Q Consensus 267 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 344 (437)
........|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+......++.
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~---------- 243 (283)
T PHA02988 174 SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL---------- 243 (283)
T ss_pred ccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC----------
Confidence 655556678999999999976 68999999999999999999999999988776666555432111100
Q ss_pred hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHH
Q psy11727 345 KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNV 424 (437)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~ 424 (437)
| ......+.+||.+||+.||.+|||++++
T Consensus 244 ------------------------~---------------------------~~~~~~l~~li~~cl~~dp~~Rps~~el 272 (283)
T PHA02988 244 ------------------------P---------------------------LDCPLEIKCIVEACTSHDSIKRPNIKEI 272 (283)
T ss_pred ------------------------C---------------------------CcCcHHHHHHHHHHhcCCcccCcCHHHH
Confidence 0 0001257899999999999999999999
Q ss_pred hc
Q psy11727 425 LR 426 (437)
Q Consensus 425 l~ 426 (437)
++
T Consensus 273 l~ 274 (283)
T PHA02988 273 LY 274 (283)
T ss_pred HH
Confidence 85
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=313.14 Aligned_cols=249 Identities=27% Similarity=0.397 Sum_probs=200.4
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
+|++.+.||+|+||.||+|.+..++..||+|++.... ...+....|+.+++.+ .||||+++++.+...+.+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-----NHPFLVNLWYSFQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-----CCCChHHHHHhhcCCCeE
Confidence 4899999999999999999999999999999997432 2234556677766655 789999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++|+||+.+ +|.+.+... ..+++..+..++.||+.||.|||+ .|++|+||+|+||++ ++++.++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~--~~~~~~~l~d~~~~~~ 149 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS--KGIIHRDIKPDNILL--DEQGHVHITDFNIATK 149 (258)
T ss_pred EEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEE--cCCCCEEEeecccccc
Confidence 999999965 788888765 468999999999999999999995 489999999999999 6788999999999876
Q ss_pred cCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 266 VGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 266 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.... .....|+..|+|||++.+..++.++|+||||+++|+|++|..||...+... ...+..........
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~-------- 220 (258)
T cd05578 150 VTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-RDQIRAKQETADVL-------- 220 (258)
T ss_pred cCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-HHHHHHHhcccccc--------
Confidence 5433 234567888999999998889999999999999999999999998776421 11111110000000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH--
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP-- 421 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~-- 421 (437)
. +......+.++|++||..||.+|||.
T Consensus 221 ------------------------~---------------------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 249 (258)
T cd05578 221 ------------------------Y---------------------------PATWSTEAIDAINKLLERDPQKRLGDNL 249 (258)
T ss_pred ------------------------C---------------------------cccCcHHHHHHHHHHccCChhHcCCccH
Confidence 0 00011267899999999999999999
Q ss_pred HHHhcCCCc
Q psy11727 422 TNVLRHEFF 430 (437)
Q Consensus 422 ~e~l~Hp~~ 430 (437)
+|+++||||
T Consensus 250 ~~l~~~~~~ 258 (258)
T cd05578 250 KDLKNHPYF 258 (258)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=303.20 Aligned_cols=256 Identities=29% Similarity=0.401 Sum_probs=203.0
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
++.+.+..||.|+.|+||+++.+.+|...|||.+.... ...+++...+.++-.- .++|+||+.+|+|..+..++
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s----~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKS----HDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhc----cCCCeeeeeeeEEeeCchHH
Confidence 34556788999999999999999999999999997432 2223333344333222 26799999999999999999
Q ss_pred EEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 188 LVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 188 lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
+.||.|+.-...+++.- .+++++..+-++...+..||.||..+ -||||||+||+|||+ |+.|+|||||||.|-.+-
T Consensus 168 IcMelMs~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeK-H~viHRDvKPSNILl--De~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILL--DERGNIKLCDFGISGRLV 243 (391)
T ss_pred HHHHHHHHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHh-cceeecccCccceEE--ccCCCEEeecccccceee
Confidence 99999986555555543 36699999999999999999999775 489999999999999 899999999999996653
Q ss_pred C--ccccccccccccChhhhcC---CCCCCcchHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 268 Q--TLYQYIQSRYYRSPEVLLG---IPYDLAIDMWSLGCILVELHTGEPLFSG-KNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 268 ~--~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
+ ..+...|.+.|||||.+.- -.|+..+||||||+.++||.||+.||.+ +.+.+++.++.+ ..||- ++...
T Consensus 244 dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln--~ePP~--L~~~~ 319 (391)
T KOG0983|consen 244 DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN--EEPPL--LPGHM 319 (391)
T ss_pred cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh--cCCCC--CCccc
Confidence 3 3345678899999999964 3689999999999999999999999988 456677777765 22221 10000
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
.+ ...|++|+..||..|+.+||.-
T Consensus 320 -----------------------------------------------gF---------Sp~F~~fv~~CL~kd~r~RP~Y 343 (391)
T KOG0983|consen 320 -----------------------------------------------GF---------SPDFQSFVKDCLTKDHRKRPKY 343 (391)
T ss_pred -----------------------------------------------Cc---------CHHHHHHHHHHhhcCcccCcch
Confidence 00 0168999999999999999999
Q ss_pred HHHhcCCCcCcC
Q psy11727 422 TNVLRHEFFLKH 433 (437)
Q Consensus 422 ~e~l~Hp~~~~~ 433 (437)
.++|+|||+...
T Consensus 344 ~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 344 NKLLEHPFIKRY 355 (391)
T ss_pred HHHhcCcceeec
Confidence 999999999764
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=314.14 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=190.1
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCccc----chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEe
Q psy11727 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFEL 192 (437)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~----~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~ 192 (437)
.||+|+||.||++.+..+++.+|+|.+...... ......|..+++.+.. ..|++|+.+++++...+..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhh--CCCCcEeEEEEEEecCCeEEEEEec
Confidence 479999999999999999999999998643221 1122334433333322 3689999999999999999999999
Q ss_pred ccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc-c
Q psy11727 193 LSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT-L 270 (437)
Q Consensus 193 ~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~-~ 270 (437)
+++ +|.+++.... .+++..+..++.|++.||+|||++ ||+||||||+|||+ ++++.++|+|||++...... .
T Consensus 79 ~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~--~ivH~dikp~Nil~--~~~~~~~l~dfg~~~~~~~~~~ 152 (279)
T cd05633 79 MNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNR--FVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKP 152 (279)
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CcCCCCCCHHHEEE--CCCCCEEEccCCcceeccccCc
Confidence 965 7877776543 589999999999999999999964 89999999999999 67888999999998755332 2
Q ss_pred ccccccccccChhhhc-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChhhhccCCccchhh
Q psy11727 271 YQYIQSRYYRSPEVLL-GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVD--QMTKIIEVLGMPPGYLLHGASKTSKYF 347 (437)
Q Consensus 271 ~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~--~~~~i~~~~~~p~~~~~~~~~~~~~~~ 347 (437)
....|+..|+|||++. +..++.++|+|||||++|+|++|..||.+..... ....... ..++.
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~------------- 217 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TVNVE------------- 217 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh--cCCcC-------------
Confidence 2356899999999986 4568999999999999999999999997643221 1111100 00000
Q ss_pred cccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC-----CHH
Q psy11727 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI-----SPT 422 (437)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~-----t~~ 422 (437)
. +......+.+||.+||..||.+|| |++
T Consensus 218 --------------------~---------------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 250 (279)
T cd05633 218 --------------------L---------------------------PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQ 250 (279)
T ss_pred --------------------C---------------------------ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHH
Confidence 0 000112578999999999999999 699
Q ss_pred HHhcCCCcCcCC
Q psy11727 423 NVLRHEFFLKHS 434 (437)
Q Consensus 423 e~l~Hp~~~~~~ 434 (437)
++++||||++..
T Consensus 251 ~~~~h~~~~~~~ 262 (279)
T cd05633 251 EVKEHVFFKGID 262 (279)
T ss_pred HHHhCccccCCC
Confidence 999999998854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=324.01 Aligned_cols=283 Identities=34% Similarity=0.563 Sum_probs=216.9
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC---cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK---KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|.+... .........|+.++..+. .|+||++++++|...
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~ni~~~~~~~~~~ 79 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG----DHPNIVKLLNVIKAE 79 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhc----CCCCccceeeeeccC
Confidence 4567899999999999999999999989999999988532 112234455777776652 689999999988653
Q ss_pred --CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 184 --NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 184 --~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
..+++||||++++|.+++... .+++..++.++.||+.||+|||+ .||+||||||+||++ +.++.+||+|||
T Consensus 80 ~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~--~~i~H~dl~p~nill--~~~~~~kl~d~g 152 (337)
T cd07852 80 NDKDIYLVFEYMETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS--GNVIHRDLKPSNILL--NSDCRVKLADFG 152 (337)
T ss_pred CCceEEEEecccccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEE--cCCCcEEEeecc
Confidence 478999999999998888764 47889999999999999999995 489999999999999 778899999999
Q ss_pred CceecCC--------ccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy11727 262 SSCHVGQ--------TLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332 (437)
Q Consensus 262 ~s~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p 332 (437)
.+..... ....+.|+..|+|||++.+ ..++.++|+|||||++|+|++|++||.+....+...++....+.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232 (337)
T ss_pred chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9865432 1223568889999998865 457899999999999999999999999998888888888888777
Q ss_pred ChhhhccCCcc--chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHc
Q psy11727 333 PGYLLHGASKT--SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRM 410 (437)
Q Consensus 333 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~ 410 (437)
+...+...... ..+++.+... ........ .......+.+||.+|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~------------------~~~~~~~l~~li~~~ 278 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSR----------------PRKPLDEL------------------LPKASDDALDLLKKL 278 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccc----------------cccchhhh------------------ccCCCHHHHHHHHHh
Confidence 65443322110 0111100000 00000000 001123679999999
Q ss_pred cccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 411 LTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 411 L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
|+.||.+|||+.++++||||++..
T Consensus 279 l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 279 LVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred ccCCcccccCHHHHhhChhhhhhc
Confidence 999999999999999999998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=312.69 Aligned_cols=252 Identities=29% Similarity=0.459 Sum_probs=201.9
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
..|+..+.||.|+||.||+|.+..++..||+|++.... .....+..|+.++..+ .|+||+++++++.+.++++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVTKYYGSYLKGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEECCEEE
Confidence 45888899999999999999999999999999987432 2233455566666655 7899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|.+++... .+++..+..++.|++.||+|||+ .+++|+||+|+||++ +.++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~--~~ivH~dl~p~Nil~--~~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 79 IIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHS--EKKIHRDIKAANVLL--SEQGDVKLADFGVAGQL 151 (277)
T ss_pred EEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh--CCccCcCCChhhEEE--cCCCCEEEcccccceec
Confidence 99999966 788887653 48899999999999999999995 489999999999999 66788999999999665
Q ss_pred CCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
... .....++..|+|||++.+..++.++|+|||||++|||++|.+||...+.......+.. +.++.
T Consensus 152 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~--------- 220 (277)
T cd06640 152 TDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NNPPT--------- 220 (277)
T ss_pred cCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--CCCCC---------
Confidence 432 2234578889999999988899999999999999999999999987665433322210 00000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
........+.+||.+||+.||.+|||+.+
T Consensus 221 ---------------------------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (277)
T cd06640 221 ---------------------------------------------------LTGEFSKPFKEFIDACLNKDPSFRPTAKE 249 (277)
T ss_pred ---------------------------------------------------CchhhhHHHHHHHHHHcccCcccCcCHHH
Confidence 00011125789999999999999999999
Q ss_pred HhcCCCcCcCCC
Q psy11727 424 VLRHEFFLKHSV 435 (437)
Q Consensus 424 ~l~Hp~~~~~~~ 435 (437)
+++||||.+...
T Consensus 250 il~~~~~~~~~~ 261 (277)
T cd06640 250 LLKHKFIVKNAK 261 (277)
T ss_pred HHhChHhhhcch
Confidence 999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=310.67 Aligned_cols=248 Identities=27% Similarity=0.453 Sum_probs=200.2
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEec
Q psy11727 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELL 193 (437)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~ 193 (437)
||.|+||.||+|.+..+++.||+|++..... ....+..|+.++..+ .|+||+++++.+.+++.+++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-----NHPFIVKLYRTFKDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-----CCCCEeeeeeeEEcCCccEEEEecC
Confidence 6999999999999999999999999864321 223455666666555 7899999999999999999999999
Q ss_pred cC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc--c
Q psy11727 194 SY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT--L 270 (437)
Q Consensus 194 ~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~--~ 270 (437)
++ +|.+++.... .+++..+..++.||+.||+|||+ .|++|+||+|+||++ +.++.++|+|||++...... .
T Consensus 76 ~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~--~~~~h~dl~~~nilv--~~~~~~~l~df~~~~~~~~~~~~ 149 (262)
T cd05572 76 LGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHN--RGIIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQKT 149 (262)
T ss_pred CCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEE--cCCCCEEEeeCCcccccCccccc
Confidence 65 8998887653 48999999999999999999996 489999999999999 66788999999999776543 3
Q ss_pred ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCChhhhccCCccchhhc
Q psy11727 271 YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN--EVDQMTKIIEVLGMPPGYLLHGASKTSKYFD 348 (437)
Q Consensus 271 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~--~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~ 348 (437)
....++..|+|||++.+..++.++|+||||+++|+|++|.+||.... ..+....+......+.
T Consensus 150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------- 214 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE--------------- 214 (262)
T ss_pred ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC---------------
Confidence 34567889999999988889999999999999999999999998776 4344443321100000
Q ss_pred ccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC-----HHH
Q psy11727 349 RLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS-----PTN 423 (437)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t-----~~e 423 (437)
.| ......+.+||.+||+.||.+||| ++|
T Consensus 215 -------------------~~---------------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~ 248 (262)
T cd05572 215 -------------------FP---------------------------NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKD 248 (262)
T ss_pred -------------------CC---------------------------cccCHHHHHHHHHHccCChhhCcCCcccCHHH
Confidence 00 000125799999999999999999 999
Q ss_pred HhcCCCcCcCCCCC
Q psy11727 424 VLRHEFFLKHSVDN 437 (437)
Q Consensus 424 ~l~Hp~~~~~~~~~ 437 (437)
+++||||+...++.
T Consensus 249 l~~~~~~~~~~~~~ 262 (262)
T cd05572 249 IKKHKWFNGFDWEG 262 (262)
T ss_pred HhcChhhhCCCCCC
Confidence 99999999887663
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=316.40 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=201.9
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|++.+.||+|+||.||++.+..+++.||+|.+..... ....+..|+.++..+ .|+||+++++.+..+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-----ENPFVVSMFCSFETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-----CCCCeeeeEEEEecCCE
Confidence 368999999999999999999999999999999864321 122344566666544 78999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+++||||++| +|.+++... ..+++..+..++.|++.||+|||+ .|++||||||+||++ +.++.++|+|||++.
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~NIll--~~~~~~~l~dfg~~~ 149 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHN--YGIVHRDLKPDNLLI--TSMGHIKLTDFGLSK 149 (305)
T ss_pred EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCchHHEEE--CCCCCEEEeeCCCcc
Confidence 9999999966 788888665 358999999999999999999995 489999999999999 678889999999875
Q ss_pred ecCCc------------------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy11727 265 HVGQT------------------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326 (437)
Q Consensus 265 ~~~~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~ 326 (437)
..... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+....+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 31100 012356778999999998899999999999999999999999999877666555554
Q ss_pred HHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHH
Q psy11727 327 EVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406 (437)
Q Consensus 327 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 406 (437)
......|.. . ......+.+|
T Consensus 230 ~~~~~~~~~--------------------------------------------------------~----~~~~~~~~~l 249 (305)
T cd05609 230 SDDIEWPEG--------------------------------------------------------D----EALPADAQDL 249 (305)
T ss_pred hcccCCCCc--------------------------------------------------------c----ccCCHHHHHH
Confidence 321100000 0 0001157899
Q ss_pred HHHccccCCCCCCC---HHHHhcCCCcCcCC
Q psy11727 407 ILRMLTYDPKKRIS---PTNVLRHEFFLKHS 434 (437)
Q Consensus 407 i~~~L~~dP~~R~t---~~e~l~Hp~~~~~~ 434 (437)
|.+||+.||.+||| +.++|+||||....
T Consensus 250 i~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 250 ISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred HHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 99999999999998 89999999997654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=318.03 Aligned_cols=254 Identities=26% Similarity=0.363 Sum_probs=202.9
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc----chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~----~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
..+|.+.+.||+|+||+||+|.+..+++.||+|.+...... ...+..|+.++..+ .|+||+++.+++.+.+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-----~h~niv~~~~~~~~~~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-----RHPNTIEYKGCYLREH 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEEeCC
Confidence 46799999999999999999999999999999998633211 23345566666654 7899999999999999
Q ss_pred EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 185 HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 185 ~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
..++||||+.+++.+++.... ..+++..+..++.||+.||.|||+ .||+||||+|+||++ ++++.++|+|||++.
T Consensus 89 ~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~--~~i~H~dl~p~nIl~--~~~~~~kL~dfg~~~ 163 (307)
T cd06607 89 TAWLVMEYCLGSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHS--HERIHRDIKAGNILL--TEPGTVKLADFGSAS 163 (307)
T ss_pred eEEEEHHhhCCCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcccEEE--CCCCCEEEeecCcce
Confidence 999999999999888876543 458999999999999999999995 489999999999999 678889999999986
Q ss_pred ecCCccccccccccccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 265 HVGQTLYQYIQSRYYRSPEVLL---GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 265 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
..... ....++..|+|||++. ...++.++||||||+++|||++|.+||.+.+.......+... .++...
T Consensus 164 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~----- 235 (307)
T cd06607 164 LVSPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPTLS----- 235 (307)
T ss_pred ecCCC-CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCCCCC-----
Confidence 55433 3456788999999985 356889999999999999999999999877655443332110 000000
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
...-...+.+||.+||+.||.+|||+
T Consensus 236 ------------------------------------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~ 261 (307)
T cd06607 236 ------------------------------------------------------SNDWSDYFRNFVDSCLQKIPQDRPSS 261 (307)
T ss_pred ------------------------------------------------------chhhCHHHHHHHHHHhcCChhhCcCH
Confidence 00001257899999999999999999
Q ss_pred HHHhcCCCcCcCC
Q psy11727 422 TNVLRHEFFLKHS 434 (437)
Q Consensus 422 ~e~l~Hp~~~~~~ 434 (437)
.+++.||||.+..
T Consensus 262 ~~il~~~~~~~~~ 274 (307)
T cd06607 262 EELLKHRFVLRER 274 (307)
T ss_pred HHHhcChhhcccC
Confidence 9999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=312.65 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=192.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCcccc----hHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEe
Q psy11727 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFL----NQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFEL 192 (437)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~----~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~ 192 (437)
.||+|+||.||+|.+..+++.||+|++....... .....|..+++.+.. ..|++|+.+.+.+...+.+++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHh--CCCCcEeeeeeeeecCCEEEEEEec
Confidence 4799999999999999999999999987432211 123334444444433 3789999999999999999999999
Q ss_pred ccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC-cc
Q psy11727 193 LSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ-TL 270 (437)
Q Consensus 193 ~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~-~~ 270 (437)
+.| +|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||++ ++++.++|+|||++..... ..
T Consensus 79 ~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~nili--~~~~~~kl~dfg~~~~~~~~~~ 152 (278)
T cd05606 79 MNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHN--RFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKP 152 (278)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEEcCCCCHHHEEE--CCCCCEEEccCcCccccCccCC
Confidence 965 787777654 358999999999999999999995 489999999999999 6778899999999875532 22
Q ss_pred ccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcc
Q psy11727 271 YQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDR 349 (437)
Q Consensus 271 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~ 349 (437)
....|+..|+|||++.+. .++.++|+||+||++|+|++|..||.+................++.
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------- 217 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--------------- 217 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC---------------
Confidence 345789999999999754 6899999999999999999999999875322111111000000000
Q ss_pred cCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC-----CHHHH
Q psy11727 350 LSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI-----SPTNV 424 (437)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~-----t~~e~ 424 (437)
.|. .....+.++|.+||..||.+|| |+.++
T Consensus 218 ------------------~~~---------------------------~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~l 252 (278)
T cd05606 218 ------------------LPD---------------------------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 252 (278)
T ss_pred ------------------CCC---------------------------cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHH
Confidence 000 0012578999999999999999 99999
Q ss_pred hcCCCcCcCCC
Q psy11727 425 LRHEFFLKHSV 435 (437)
Q Consensus 425 l~Hp~~~~~~~ 435 (437)
++||||.+...
T Consensus 253 l~~~~~~~~~~ 263 (278)
T cd05606 253 KEHPFFRSLDW 263 (278)
T ss_pred HhCccccCCCc
Confidence 99999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=307.98 Aligned_cols=246 Identities=27% Similarity=0.449 Sum_probs=200.1
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
+|++.+.||+|+||.||++.+..++..+|+|.++... ........|+.+++.+ .|+||+++++.+.+.+++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-----KHPNIVAFKESFEADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-----CCCCcceEEEEEEECCEEEE
Confidence 5889999999999999999999999999999986332 2234555676666655 78999999999999999999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
||||+++ +|.+++.......+++..+..++.||+.||.|||+ .||+|+||||+||++ ++++.++|+|||++....
T Consensus 76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dl~p~nili--~~~~~~~l~dfg~~~~~~ 151 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE--KRVLHRDIKSKNIFL--TQNGKVKLGDFGSARLLT 151 (255)
T ss_pred EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEE--CCCCcEEEcccCcceeec
Confidence 9999965 78888876554568999999999999999999995 489999999999999 678889999999987654
Q ss_pred Cc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc
Q psy11727 268 QT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344 (437)
Q Consensus 268 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 344 (437)
.. .....|+..|+|||++.+..++.++|+||||+++|+|++|.+||...+.......+......+.
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 220 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL----------- 220 (255)
T ss_pred ccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC-----------
Confidence 32 2245688899999999998999999999999999999999999988776555444432110000
Q ss_pred hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHH
Q psy11727 345 KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNV 424 (437)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~ 424 (437)
| ......+.+||.+||+.||.+|||+.++
T Consensus 221 ------------------------~---------------------------~~~~~~~~~li~~~l~~~P~~Rp~~~~i 249 (255)
T cd08219 221 ------------------------P---------------------------SHYSYELRSLIKQMFKRNPRSRPSATTI 249 (255)
T ss_pred ------------------------C---------------------------cccCHHHHHHHHHHHhCCcccCCCHHHH
Confidence 0 0001157899999999999999999999
Q ss_pred hcC
Q psy11727 425 LRH 427 (437)
Q Consensus 425 l~H 427 (437)
+.-
T Consensus 250 l~~ 252 (255)
T cd08219 250 LSR 252 (255)
T ss_pred hhc
Confidence 864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=309.32 Aligned_cols=291 Identities=33% Similarity=0.514 Sum_probs=234.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC---cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC-
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK---KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN- 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~- 184 (437)
..+|.-...+|.|+- .|..|.+.-+++.||+|.+... ....+++.+|..++..+ .|+||++++.+|....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-----~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-----NHKNIISLLNVFTPQKT 89 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-----cccceeeeeeccCcccc
Confidence 457888999999998 8889999999999999987532 23346677788887776 7789999999997653
Q ss_pred -----EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 185 -----HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 185 -----~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
..|+|||+|..+|.+.+... +.-..+..++.|+++|+.+||+ .||+||||||+||++ +.+..+||.|
T Consensus 90 l~~~~e~y~v~e~m~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs--~~IihRdLkPsnivv--~~~~~lKi~d 161 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDANLCQVILME----LDHETISYILYQMLCGIKHLHS--AGIIHRDLKPSNIVV--NSDCTLKILD 161 (369)
T ss_pred HHHHHhHHHHHHhhhhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHh--cceeecccCccccee--cchhheeecc
Confidence 68999999999999988843 6778899999999999999995 589999999999999 7788899999
Q ss_pred CCCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 260 FGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 260 FG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
||+|...... .+.++.|+.|+|||++.+..|...+||||+|||+.||++|...|.|.+..++..++.+.+|.|...+.
T Consensus 162 fg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 162 FGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred chhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 9999876544 45688999999999999999999999999999999999999999999999999999999999999988
Q ss_pred ccCCccch-hhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 338 HGASKTSK-YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 338 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
.+...... |..-.+ .|.. +..+.-.|+..-......+..+.-.++||+.+||..||+
T Consensus 242 ~qL~~~~r~yv~~~~--~y~~--------------------~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe 299 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRP--QYQA--------------------ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPE 299 (369)
T ss_pred HHhhHHHHHHhhcCh--Hhhc--------------------cchhhhCCcccccccccCCccchHHHHHHHHHhhccChh
Confidence 87776533 332111 1110 011111222222233333334444678999999999999
Q ss_pred CCCCHHHHhcCCCcCcCCC
Q psy11727 417 KRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~~~~~~ 435 (437)
+|.|+++||+||||+=+.+
T Consensus 300 ~Risv~daL~HPY~~vw~~ 318 (369)
T KOG0665|consen 300 KRISVDDALRHPYIKVWYD 318 (369)
T ss_pred hcccHHHHhcCCeeeeecc
Confidence 9999999999999984443
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.34 Aligned_cols=253 Identities=32% Similarity=0.445 Sum_probs=204.7
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
++|++.+.||+|++|.||+|.+..+++.||+|++..... ....+..|+..+..+ .|+||+++++++...+.++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-----ESPYVVKCYGAFYKEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEccCCeEE
Confidence 368899999999999999999999999999999875432 234566677776665 5899999999999999999
Q ss_pred EEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||++ ++|.+++... ..+++..+..++.||+.||+|||+. .|++||||+|+||++ +.++.++|+|||++...
T Consensus 76 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~-~~~~H~~l~~~ni~~--~~~~~~~l~df~~~~~~ 150 (264)
T cd06623 76 IVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTK-RHIIHRDIKPSNLLI--NSKGEVKIADFGISKVL 150 (264)
T ss_pred EEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcc-CCCccCCCCHHHEEE--CCCCCEEEccCccceec
Confidence 9999997 5899888765 4589999999999999999999951 589999999999999 67889999999998766
Q ss_pred CCccc---cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCChhhhccC
Q psy11727 267 GQTLY---QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN---EVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 267 ~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
..... ...++..|+|||.+.+..++.++|+||||+++|+|++|.+||.... ..+....+.. ......
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~---- 223 (264)
T cd06623 151 ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPPPSL---- 223 (264)
T ss_pred ccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCCCCC----
Confidence 43222 3467889999999999899999999999999999999999998764 2222222221 000000
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChh-hhhHHHHHHHHccccCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA-DYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~dli~~~L~~dP~~R~ 419 (437)
+.. ....+.++|++||..+|.+||
T Consensus 224 -------------------------------------------------------~~~~~~~~l~~li~~~l~~~p~~R~ 248 (264)
T cd06623 224 -------------------------------------------------------PAEEFSPEFRDFISACLQKDPKKRP 248 (264)
T ss_pred -------------------------------------------------------CcccCCHHHHHHHHHHccCChhhCC
Confidence 000 112578999999999999999
Q ss_pred CHHHHhcCCCcCcCC
Q psy11727 420 SPTNVLRHEFFLKHS 434 (437)
Q Consensus 420 t~~e~l~Hp~~~~~~ 434 (437)
|+.++++||||+..+
T Consensus 249 ~~~~ll~~~~~~~~~ 263 (264)
T cd06623 249 SAAELLQHPFIKKAD 263 (264)
T ss_pred CHHHHHhCHHHHhcc
Confidence 999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=310.40 Aligned_cols=252 Identities=26% Similarity=0.437 Sum_probs=195.2
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc-----------chHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF-----------LNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~-----------~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
+|.+.+.||+|+||.||+|.+..+++.||+|.++..... .+.+..|+.++..+ .|+|+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~ 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-----DHLNIVQYLGF 76 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-----CCCCcceEEEE
Confidence 588999999999999999999999999999988632111 12334455555554 78999999999
Q ss_pred eeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 180 FTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 180 ~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
+...+..++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++ |++|+||+|+||++ +.++.++|+
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~~~nil~--~~~~~~~l~ 150 (272)
T cd06629 77 ETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK--GILHRDLKADNLLV--DADGICKIS 150 (272)
T ss_pred eccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC--CeeecCCChhhEEE--cCCCeEEEe
Confidence 9999999999999965 788888765 3589999999999999999999964 89999999999999 678899999
Q ss_pred eCCCceecCCc-----cccccccccccChhhhcCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy11727 259 DFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIP--YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331 (437)
Q Consensus 259 DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 331 (437)
|||++...... .....++..|+|||++.+.. ++.++|+||||++++++++|..||...........+......
T Consensus 151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 230 (272)
T cd06629 151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA 230 (272)
T ss_pred eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC
Confidence 99998754322 22345788999999998754 889999999999999999999999765443322221110000
Q ss_pred CChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 332 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
++ .+. .........+.+||.+||
T Consensus 231 ~~----------------------------------~~~-----------------------~~~~~~~~~~~~li~~~l 253 (272)
T cd06629 231 PP----------------------------------IPP-----------------------DVSMNLSPVALDFLNACF 253 (272)
T ss_pred Cc----------------------------------CCc-----------------------cccccCCHHHHHHHHHHh
Confidence 00 000 000001126799999999
Q ss_pred ccCCCCCCCHHHHhcCCCc
Q psy11727 412 TYDPKKRISPTNVLRHEFF 430 (437)
Q Consensus 412 ~~dP~~R~t~~e~l~Hp~~ 430 (437)
..||.+|||+.++|+|||+
T Consensus 254 ~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 254 TINPDNRPTARELLQHPFI 272 (272)
T ss_pred cCChhhCCCHHHHhhCCCC
Confidence 9999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=309.52 Aligned_cols=249 Identities=26% Similarity=0.442 Sum_probs=194.3
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc------cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE-
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP------FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW- 182 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~------~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~- 182 (437)
.+|++.+.||+|+||.||+|.+..++..||+|.+..... ....+..|+.++..+ .|+||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~ 76 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-----QHERIVQYYGCLRDR 76 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-----CCCCeeeEEEEEEcC
Confidence 368899999999999999999999999999999864321 123455577666665 78999999998875
Q ss_pred -CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 183 -KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 183 -~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
.+.++++|||+++ +|.+++.... .+++..++.++.||+.||+|||+ .||+||||||+||++ +.++.++|+||
T Consensus 77 ~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~--~~i~H~~l~p~nil~--~~~~~~~l~df 150 (266)
T cd06651 77 AEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHS--NMIVHRDIKGANILR--DSAGNVKLGDF 150 (266)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEE--CCCCCEEEccC
Confidence 3688999999965 7988887653 48999999999999999999995 489999999999999 67888999999
Q ss_pred CCceecCCc------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 261 GSSCHVGQT------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 261 G~s~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
|++...... .....++..|+|||++.+..++.++|+|||||++|+|++|++||...........+.. .+..
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~~ 227 (266)
T cd06651 151 GASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTN 227 (266)
T ss_pred CCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCCC
Confidence 998654321 1224578889999999998899999999999999999999999987654333322211 0000
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
+.........+.+|| +||..|
T Consensus 228 ----------------------------------------------------------~~~~~~~~~~~~~li-~~~~~~ 248 (266)
T cd06651 228 ----------------------------------------------------------PQLPSHISEHARDFL-GCIFVE 248 (266)
T ss_pred ----------------------------------------------------------CCCchhcCHHHHHHH-HHhcCC
Confidence 000000112467888 677789
Q ss_pred CCCCCCHHHHhcCCCcC
Q psy11727 415 PKKRISPTNVLRHEFFL 431 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~~ 431 (437)
|++|||++|+++||||+
T Consensus 249 p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 249 ARHRPSAEELLRHPFAQ 265 (266)
T ss_pred hhhCcCHHHHhcCcccc
Confidence 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=316.44 Aligned_cols=258 Identities=28% Similarity=0.434 Sum_probs=212.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhc-CCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKA-DIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~-~~~h~~iv~l~~~~~~~~~~~ 187 (437)
..+|..+.+||+|+||.|.+|..+.+.+.+|||++++.-. ......|..+.++-..+ .-..|.+++++.+|+.-+.+|
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDVi-iQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVI-IQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhcccee-eecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 4578889999999999999999999999999999975422 22222233333322211 125679999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+.| +|.-.+... +.+.+..+..++.+|+-||-+||++ |||.||||.+|||| +.+|+|||+|||+++.-
T Consensus 427 FVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~k--gIiYRDLKLDNvmL--d~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSK--GIIYRDLKLDNVML--DSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcC--CeeeeeccccceEe--ccCCceEeeeccccccc
Confidence 99999955 666666654 3588999999999999999999964 89999999999999 88999999999998643
Q ss_pred ---CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 ---GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
+....++|||+.|+|||++..++|+.++|+||+||+||||+.|++||.|.++.+.++.|++..-.-|..+.
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslS------ 574 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLS------ 574 (683)
T ss_pred ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccccc------
Confidence 55667899999999999999999999999999999999999999999999999999999885332222111
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC---
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS--- 420 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t--- 420 (437)
.+..++...+|...|.+|..
T Consensus 575 ---------------------------------------------------------kEAv~ickg~ltK~P~kRLGcg~ 597 (683)
T KOG0696|consen 575 ---------------------------------------------------------KEAVAICKGLLTKHPGKRLGCGP 597 (683)
T ss_pred ---------------------------------------------------------HHHHHHHHHHhhcCCccccCCCC
Confidence 14578999999999999986
Q ss_pred --HHHHhcCCCcCcCCCC
Q psy11727 421 --PTNVLRHEFFLKHSVD 436 (437)
Q Consensus 421 --~~e~l~Hp~~~~~~~~ 436 (437)
-+++-.||||+..+++
T Consensus 598 ~ge~di~~H~FFR~iDWe 615 (683)
T KOG0696|consen 598 EGERDIREHPFFRRIDWE 615 (683)
T ss_pred ccccchhhCcchhhccHH
Confidence 3678899999998775
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=314.06 Aligned_cols=262 Identities=27% Similarity=0.414 Sum_probs=202.3
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.++|++.+.||+|+||+||++.+..++..||+|++.... .....+..|+.++..+ .|+||+++++++...+.+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-----RSPYIVSFYGAFLNENNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-----CCCCcceEeeeEecCCEE
Confidence 357999999999999999999999999999999886432 2234566777777665 789999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++||||+++ +|.+++... ..+++..+..++.|++.||.|||+. .|++||||||+||++ ++++.++|+|||++..
T Consensus 79 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~--~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNV-HRIMHRDIKPSNILV--NSRGQIKLCDFGVSGE 153 (284)
T ss_pred EEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHh-cCeeccCCCHHHEEE--CCCCcEEEccCCcccc
Confidence 999999976 777777654 3589999999999999999999963 379999999999999 6788899999999865
Q ss_pred cCCc-cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChhhhccC
Q psy11727 266 VGQT-LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ----MTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 266 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~----~~~i~~~~~~p~~~~~~~~ 340 (437)
.... .....|+..|+|||++.+..++.++|+|||||++|+|++|.+||........ ...+.+.. ..++...
T Consensus 154 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 229 (284)
T cd06620 154 LINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL----QQIVQEP 229 (284)
T ss_pred hhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH----HHHhhcc
Confidence 4222 2345788999999999888999999999999999999999999987554211 00010000 0000000
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
.. ..+ .......+.+||.+||+.||.+|||
T Consensus 230 ~~------------------------~~~--------------------------~~~~~~~~~~li~~~l~~dp~~Rpt 259 (284)
T cd06620 230 PP------------------------RLP--------------------------SSDFPEDLRDFVDACLLKDPTERPT 259 (284)
T ss_pred CC------------------------CCC--------------------------chhcCHHHHHHHHHHhcCCcccCcC
Confidence 00 000 0001125789999999999999999
Q ss_pred HHHHhcCCCcCcCC
Q psy11727 421 PTNVLRHEFFLKHS 434 (437)
Q Consensus 421 ~~e~l~Hp~~~~~~ 434 (437)
+.|+++||||.+..
T Consensus 260 ~~e~~~~~~~~~~~ 273 (284)
T cd06620 260 PQQLCAMPPFIQAL 273 (284)
T ss_pred HHHHhcCccccccc
Confidence 99999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=307.55 Aligned_cols=251 Identities=29% Similarity=0.411 Sum_probs=199.3
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE--CCE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--KNH 185 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--~~~ 185 (437)
+|++.+.||.|+||.||+|.+..++..||+|++..... ...++..|+.+++.+ .|+||+++++++.. ...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-----KHPNIVRYYDRIIDRSNQT 75 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-----CCCccceeeeeeecCCCCE
Confidence 58899999999999999999999999999999864321 223444566666655 78999999998764 457
Q ss_pred EEEEEEeccC-cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCC---CCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 186 LCLVFELLSY-NLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSP---ELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~---~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
++++|||+++ +|.+++... ....+++..++.++.||+.||+|||.. ..+++|+||||+||++ +.++.+||+|
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili--~~~~~~kl~d 153 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL--DANNNVKLGD 153 (265)
T ss_pred EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE--ecCCCEEEec
Confidence 8999999965 888888653 234689999999999999999999932 3479999999999999 5678899999
Q ss_pred CCCceecCCcc---ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 260 FGSSCHVGQTL---YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 260 FG~s~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
||++....... ....++..|+|||++.+..++.++|+||||+++++|++|..||...+.......+.... .+.
T Consensus 154 ~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~-- 229 (265)
T cd08217 154 FGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK--FRR-- 229 (265)
T ss_pred ccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC--CCC--
Confidence 99997764332 24568899999999999889999999999999999999999999877554444332210 000
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
++ ......+.+|+.+||+.+|.
T Consensus 230 -------------~~---------------------------------------------~~~~~~~~~l~~~~l~~~p~ 251 (265)
T cd08217 230 -------------IP---------------------------------------------YRYSSELNEVIKSMLNVDPD 251 (265)
T ss_pred -------------Cc---------------------------------------------cccCHHHHHHHHHHccCCcc
Confidence 00 00012578999999999999
Q ss_pred CCCCHHHHhcCCCc
Q psy11727 417 KRISPTNVLRHEFF 430 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~ 430 (437)
+|||+.++++|||+
T Consensus 252 ~Rp~~~~il~~~~~ 265 (265)
T cd08217 252 KRPSTEELLQLPLI 265 (265)
T ss_pred cCCCHHHHhhCCCC
Confidence 99999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=310.82 Aligned_cols=259 Identities=27% Similarity=0.439 Sum_probs=198.3
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC--CE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK--NH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~--~~ 185 (437)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... ...++.+|+.++..+ .|+||++++++|.+. +.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 75 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-----KSPYIVKYYGAFLDESSSS 75 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-----CCCCeeeeeeEEEccCCCe
Confidence 468999999999999999999999999999999874322 334566677776665 789999999988653 47
Q ss_pred EEEEEEeccC-cHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 186 LCLVFELLSY-NLYNLIRN--TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~--~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+++||||+++ +|.+++.. .....+++..+..++.||+.||+|||+ .|++|+||+|+||++ +.++.++|+|||+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~--~~i~H~dl~~~nil~--~~~~~~~l~dfg~ 151 (287)
T cd06621 76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS--RKIIHRDIKPSNILL--TRKGQVKLCDFGV 151 (287)
T ss_pred EEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE--ecCCeEEEeeccc
Confidence 9999999965 78777643 223458999999999999999999995 489999999999999 5677899999999
Q ss_pred ceecCCcc-ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCChhh
Q psy11727 263 SCHVGQTL-YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNE-----VDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 263 s~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~-----~~~~~~i~~~~~~p~~~~ 336 (437)
+....... ....++..|+|||.+.+..++.++|+|||||++|+|++|..||..... .+....+. ..+...+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~ 228 (287)
T cd06621 152 SGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV---NMPNPEL 228 (287)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh---cCCchhh
Confidence 86553322 234578889999999999999999999999999999999999986532 11111111 1000000
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
... .. ....-...+.+||.+||..||.
T Consensus 229 -~~~---------------------------------------------------~~-~~~~~~~~~~~li~~~l~~~p~ 255 (287)
T cd06621 229 -KDE---------------------------------------------------PG-NGIKWSEEFKDFIKQCLEKDPT 255 (287)
T ss_pred -ccC---------------------------------------------------CC-CCCchHHHHHHHHHHHcCCCcc
Confidence 000 00 0000112578999999999999
Q ss_pred CCCCHHHHhcCCCcCcC
Q psy11727 417 KRISPTNVLRHEFFLKH 433 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~~~~ 433 (437)
+|||+.|++.||||++.
T Consensus 256 ~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 256 RRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred cCCCHHHHHhCcccccc
Confidence 99999999999999764
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=312.03 Aligned_cols=246 Identities=19% Similarity=0.265 Sum_probs=192.9
Q ss_pred ccCeeeeceecccCceEEEEEEEc---CCCeEEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDH---EEKCQVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~---~~~~~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.++|++.+.||+|+||.||+|... ..+..||+|.++..... ...+..|+.++..+ .||||+++++++...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-----DHSNIVRLEGVITRG 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-----CCCCcCeEEEEEecC
Confidence 357999999999999999999765 45678999998754221 22344566555544 789999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
++.++||||+++ +|.+++.... ..+++..++.++.||+.||+|||+ .|++||||||+|||+ +.++.++++|||.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~--~~iiH~dikp~nili--~~~~~~~l~dfg~ 153 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSE--MGYVHKGLAAHKVLV--NSDLVCKISGFRR 153 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEeeccccHhhEEE--cCCCcEEECCCcc
Confidence 999999999976 6777776543 468999999999999999999995 489999999999999 6788899999998
Q ss_pred ceecCCcc----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 263 SCHVGQTL----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 263 s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
+....... ....++..|+|||++.+..++.++|||||||++||+++ |.+||.+.+..+....+.+....|...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 231 (266)
T cd05064 154 LQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPR-- 231 (266)
T ss_pred cccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCC--
Confidence 76542221 11234568999999999999999999999999999775 999999888776666553321111100
Q ss_pred ccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCC
Q psy11727 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKK 417 (437)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 417 (437)
.-...+.+++.+||+.+|.+
T Consensus 232 ------------------------------------------------------------~~~~~~~~li~~c~~~~p~~ 251 (266)
T cd05064 232 ------------------------------------------------------------NCPNLLHQLMLDCWQKERGE 251 (266)
T ss_pred ------------------------------------------------------------CCCHHHHHHHHHHcCCCchh
Confidence 00015789999999999999
Q ss_pred CCCHHHHhc
Q psy11727 418 RISPTNVLR 426 (437)
Q Consensus 418 R~t~~e~l~ 426 (437)
|||++++++
T Consensus 252 RP~~~~i~~ 260 (266)
T cd05064 252 RPRFSQIHS 260 (266)
T ss_pred CCCHHHHHH
Confidence 999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=311.77 Aligned_cols=255 Identities=25% Similarity=0.448 Sum_probs=203.1
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+.+++.+.. ..|+|++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~--~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ--SQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhcc--CCCCCeeeEeeeeeeCCEEEE
Confidence 4788899999999999999999999999999986432 223456778888888754 368999999999999999999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
||||+.+ +|.+++... .+++..+..++.|++.||.|||+ .||+|+||+|+||++ +.++.++|+|||++....
T Consensus 80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHK--VGVIHRDIKAANILV--TNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHHEEE--cCCCCEEEccCCceeecC
Confidence 9999966 788877553 58999999999999999999995 589999999999999 668889999999987664
Q ss_pred Cc---cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 268 QT---LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 268 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.. .....|+..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.........+.. ..++. +
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~--~~~~~-~------- 222 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK--SKPPR-L------- 222 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc--CCCCC-C-------
Confidence 32 223468889999999875 4578999999999999999999999987654322211100 00000 0
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
+. ......+.+|+.+||+.||.+|||+.+
T Consensus 223 -------------------------~~--------------------------~~~~~~~~~~i~~~l~~~p~~R~~~~~ 251 (277)
T cd06917 223 -------------------------ED--------------------------NGYSKLLREFVAACLDEEPKERLSAEE 251 (277)
T ss_pred -------------------------Cc--------------------------ccCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 00 000125789999999999999999999
Q ss_pred HhcCCCcCcCCC
Q psy11727 424 VLRHEFFLKHSV 435 (437)
Q Consensus 424 ~l~Hp~~~~~~~ 435 (437)
++.||||++.+.
T Consensus 252 il~~~~~~~~~~ 263 (277)
T cd06917 252 LLKSKWIKAHSK 263 (277)
T ss_pred HhhChHhhcccc
Confidence 999999988664
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=318.42 Aligned_cols=254 Identities=25% Similarity=0.403 Sum_probs=201.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.+.|.....||+|+||.||++.+..++..||||.+..... ....+..|+.++..+ .|+||+++++.+...++.+
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-----HHENVVDMYNSYLVGDELW 95 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-----CCCcHHHHHHheecCCeEE
Confidence 3456666789999999999999999999999999864321 223455566666554 7899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|.+++... .+++..+..++.||+.||+|||++ ||+||||||+||++ +.++.++|+|||++...
T Consensus 96 lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~Nill--~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 96 VVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQ--GVIHRDIKSDSILL--TSDGRIKLSDFGFCAQV 168 (292)
T ss_pred EEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEE--cCCCCEEEccCcchhhc
Confidence 99999976 677776543 489999999999999999999964 89999999999999 66788999999998654
Q ss_pred CCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
... .....++..|+|||++.+..++.++|+||||+++|||++|..||.+.+....+..+..........
T Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 240 (292)
T cd06658 169 SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKD-------- 240 (292)
T ss_pred ccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcccc--------
Confidence 322 223568889999999998899999999999999999999999998877655544443211100000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
. ......+.+||.+||..||.+|||+++
T Consensus 241 ---------------------------~-------------------------~~~~~~~~~li~~~l~~~P~~Rpt~~~ 268 (292)
T cd06658 241 ---------------------------S-------------------------HKVSSVLRGFLDLMLVREPSQRATAQE 268 (292)
T ss_pred ---------------------------c-------------------------cccCHHHHHHHHHHccCChhHCcCHHH
Confidence 0 000115789999999999999999999
Q ss_pred HhcCCCcCcCC
Q psy11727 424 VLRHEFFLKHS 434 (437)
Q Consensus 424 ~l~Hp~~~~~~ 434 (437)
+++||||....
T Consensus 269 il~~~~~~~~~ 279 (292)
T cd06658 269 LLQHPFLKLAG 279 (292)
T ss_pred HhhChhhhccC
Confidence 99999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=309.39 Aligned_cols=246 Identities=23% Similarity=0.349 Sum_probs=200.3
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
.+|.+.+.||+|+||.||+|.+..+++.||+|++.........+..|+.+++.+ .|+||+++++++...+.+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-----CCCChhheEEEEcCCCCcEEE
Confidence 468999999999999999999999999999999875544445667788887776 689999999999999999999
Q ss_pred EEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 190 FELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 190 ~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
|||+++ +|.+++.......+++..++.++.|++.||+|||+ .|++||||||+||++ ++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~nil~--~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLV--GENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEE--cCCCcEEeCCCcccccccc
Confidence 999965 89988876555568999999999999999999995 489999999999999 6788899999999876644
Q ss_pred cccc----ccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 269 TLYQ----YIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 269 ~~~~----~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.... ..++..|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+......+.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 226 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMER---------- 226 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC----------
Confidence 3221 123457999999999999999999999999999998 9999998776555444422110000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
| ......+.+||.+||+.||.+|||+.+
T Consensus 227 -------------------------~---------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~ 254 (263)
T cd05052 227 -------------------------P---------------------------EGCPPKVYELMRACWQWNPSDRPSFAE 254 (263)
T ss_pred -------------------------C---------------------------CCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 0 000125789999999999999999999
Q ss_pred Hhc
Q psy11727 424 VLR 426 (437)
Q Consensus 424 ~l~ 426 (437)
+++
T Consensus 255 l~~ 257 (263)
T cd05052 255 IHQ 257 (263)
T ss_pred HHH
Confidence 975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=305.09 Aligned_cols=284 Identities=29% Similarity=0.471 Sum_probs=227.3
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecC---CcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE--
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKN---KKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW-- 182 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~---~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~-- 182 (437)
..+.|+-..+||+|.||.||+|+.+.+++.||+|++-. +..+.....+|+.+++.+ .|+|++.+++.|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-----kHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-----KHENVVNLIEICRTKA 89 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-----cchhHHHHHHHHhhcc
Confidence 35678888999999999999999999999999987643 455667788899999988 67788888877753
Q ss_pred ------CCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEE
Q psy11727 183 ------KNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIK 256 (437)
Q Consensus 183 ------~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ik 256 (437)
...+|+||.+|..+|..++.+.. ..++...+.+++.++..+|.|+|.. .|+|||+||+|+|| +++|.+|
T Consensus 90 Tp~~r~r~t~ylVf~~cehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~--kilHRDmKaaNvLI--t~dgilk 164 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRN--KILHRDMKAANVLI--TKDGILK 164 (376)
T ss_pred CCcccccceeeeeHHHhhhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHh--hHHhhcccHhhEEE--cCCceEE
Confidence 24699999999999999887654 5699999999999999999999954 69999999999999 7899999
Q ss_pred EEeCCCceecCCc-------cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q psy11727 257 IIDFGSSCHVGQT-------LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV 328 (437)
Q Consensus 257 L~DFG~s~~~~~~-------~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 328 (437)
|+|||+++.++.. .+..+-|..|++||.+.|. .|+++.|+|.-|||+.||.||.|.|.+.++..++..|...
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 9999999655322 1223558999999999985 6999999999999999999999999999999999999999
Q ss_pred hCCCChhhhccCCccchhhc----ccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHH
Q psy11727 329 LGMPPGYLLHGASKTSKYFD----RLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFK 404 (437)
Q Consensus 329 ~~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (437)
.|...++.|++......+-. .++.+.+ +.+.+++. |. +. .....
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~----------------rkv~n~~k-----p~-------~k----d~~a~ 292 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQK----------------RKVKNRLK-----PY-------VK----DDEAL 292 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchh----------------hhhhhhcc-----cc-------cC----ChhHH
Confidence 99888888877655432211 0111111 11111111 00 00 11457
Q ss_pred HHHHHccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 405 DLILRMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 405 dli~~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
||+.+||.+||.+|+++++||+|.||.+-
T Consensus 293 dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 293 DLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred HHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 99999999999999999999999999753
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=306.18 Aligned_cols=249 Identities=27% Similarity=0.459 Sum_probs=196.6
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc------cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP------FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~------~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+|++.+.||+|+||.||+|.+..+++.||||.+..... ....+..|+.+++.+ .|+||+++++++.+.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~ 76 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-----LHERIVQYYGCLRDP 76 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-----CCCCeeeEEeEeccC
Confidence 468999999999999999999999999999998853211 123455677777766 789999999998763
Q ss_pred --CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 184 --NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 184 --~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
..+++||||+++ +|.+++.... .+++..+..++.|++.||+|||++ |++|+||||+||++ +.++.++|+||
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~--~i~H~dl~p~nil~--~~~~~~~l~Df 150 (265)
T cd06652 77 MERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSN--MIVHRDIKGANILR--DSVGNVKLGDF 150 (265)
T ss_pred CCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEe--cCCCCEEECcC
Confidence 578999999965 7888887543 478999999999999999999954 89999999999999 67888999999
Q ss_pred CCceecCC------ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 261 GSSCHVGQ------TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 261 G~s~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
|++..... ......++..|+|||++.+..++.++|+|||||++|+|++|++||...........+. ..+..
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~ 227 (265)
T cd06652 151 GASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPTN 227 (265)
T ss_pred ccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCCC
Confidence 99875432 1223467889999999998889999999999999999999999998765443333221 11110
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
.. ........+.++|++|+ .+
T Consensus 228 ~~----------------------------------------------------------~~~~~~~~~~~~i~~~l-~~ 248 (265)
T cd06652 228 PV----------------------------------------------------------LPPHVSDHCRDFLKRIF-VE 248 (265)
T ss_pred CC----------------------------------------------------------CchhhCHHHHHHHHHHh-cC
Confidence 00 00011125789999999 49
Q ss_pred CCCCCCHHHHhcCCCcC
Q psy11727 415 PKKRISPTNVLRHEFFL 431 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~~ 431 (437)
|.+|||++++++|||+.
T Consensus 249 p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 249 AKLRPSADELLRHTFVH 265 (265)
T ss_pred hhhCCCHHHHhcCcccC
Confidence 99999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=316.58 Aligned_cols=251 Identities=26% Similarity=0.462 Sum_probs=199.0
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVF 190 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~ 190 (437)
|.....||+|+||.||+|.+..++..||+|.+..... ....+..|+.++..+ .||||+++++.+...+..++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-----QHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-----CCCchhhhhhheeeCCeEEEEE
Confidence 4455678999999999999999999999999864322 223444566555544 7899999999999999999999
Q ss_pred EeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc
Q psy11727 191 ELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT 269 (437)
Q Consensus 191 E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~ 269 (437)
||+++ +|.+++... .+++..++.++.|++.||+|||+ .|++||||||+||++ +.++.++|+|||++......
T Consensus 98 e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dl~p~Nill--~~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 98 EFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHS--QGVIHRDIKSDSILL--TLDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred ecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHeEE--ccCCcEEEeechhHhhcccc
Confidence 99976 677766543 48999999999999999999995 489999999999999 67889999999998654322
Q ss_pred ---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchh
Q psy11727 270 ---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKY 346 (437)
Q Consensus 270 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~ 346 (437)
.....++..|+|||++.+..++.++|+|||||++|||++|++||...+..+.+..+... ++.... .
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~-~------- 239 (297)
T cd06659 171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPPKLK-N------- 239 (297)
T ss_pred cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCCCcc-c-------
Confidence 23456889999999999989999999999999999999999999887766555443210 100000 0
Q ss_pred hcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhc
Q psy11727 347 FDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
.......+.+||.+||+.||.+|||+.++++
T Consensus 240 -------------------------------------------------~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 240 -------------------------------------------------AHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred -------------------------------------------------cCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000115789999999999999999999999
Q ss_pred CCCcCcCC
Q psy11727 427 HEFFLKHS 434 (437)
Q Consensus 427 Hp~~~~~~ 434 (437)
||||.+..
T Consensus 271 ~~~~~~~~ 278 (297)
T cd06659 271 HPFLLQTG 278 (297)
T ss_pred ChhhccCC
Confidence 99998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=305.94 Aligned_cols=248 Identities=29% Similarity=0.476 Sum_probs=199.3
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc------ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK------PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~------~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
+|+..+.||+|+||+||+|.+..++..||+|.+.... .....+..|+.+++.+ .|+||+++++++...+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-----QHPNIVQYLGTEREED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-----CCCCchheeeeEecCC
Confidence 4778899999999999999999899999999986432 1234455677666655 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+++||||+++ +|.+++... ..+++..+..++.||+.||+|||+ .|++|+||+|+||++ +.++.+||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~~~ni~~--~~~~~~kl~d~~~~ 149 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHD--RNTVHRDIKGANILV--DTNGVVKLADFGMA 149 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE--CCCCCEEEccCccc
Confidence 99999999976 888888764 358899999999999999999995 489999999999999 67888999999998
Q ss_pred eecCCc--cccccccccccChhhhcCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 264 CHVGQT--LYQYIQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 264 ~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
...... .....++..|+|||.+.... ++.++|+|||||++|+|++|++||...........+......+.
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 222 (258)
T cd06632 150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPP------- 222 (258)
T ss_pred eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCC-------
Confidence 765432 23456788999999998776 89999999999999999999999987664443333321110000
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
.+......+.+||++||+.||.+|||
T Consensus 223 ------------------------------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~ 248 (258)
T cd06632 223 ------------------------------------------------------IPDHLSDEAKDFILKCLQRDPSLRPT 248 (258)
T ss_pred ------------------------------------------------------cCCCcCHHHHHHHHHHhhcCcccCcC
Confidence 00001125789999999999999999
Q ss_pred HHHHhcCCCc
Q psy11727 421 PTNVLRHEFF 430 (437)
Q Consensus 421 ~~e~l~Hp~~ 430 (437)
+.+++.|||+
T Consensus 249 ~~~~l~~~~~ 258 (258)
T cd06632 249 AAELLEHPFV 258 (258)
T ss_pred HHHHhcCCCC
Confidence 9999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=316.00 Aligned_cols=251 Identities=28% Similarity=0.465 Sum_probs=199.8
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+.|+..+.||+|+||.||+|.+..++..||+|.+.... .....+..|+.++..+ .|+||+++++++...+.++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 78 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYITRYYGSYLKGTKLW 78 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-----CCCccHhhhcccccCCceE
Confidence 45778899999999999999999999999999986332 2223455666666654 7899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|.+++.. ..+++..++.++.||+.||.|||+ .|++|+||+|+||++ ++++.++|+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~ivH~dl~p~ni~i--~~~~~~~l~dfg~~~~~ 151 (277)
T cd06642 79 IIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHS--ERKIHRDIKAANVLL--SEQGDVKLADFGVAGQL 151 (277)
T ss_pred EEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc--CCeeccCCChheEEE--eCCCCEEEccccccccc
Confidence 99999976 78777754 348999999999999999999995 489999999999999 56788999999998765
Q ss_pred CCcc---ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQTL---YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.... ....++..|+|||++.+..++.++|+|||||++|||++|.+||...........+... .++.
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~--------- 220 (277)
T cd06642 152 TDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--SPPT--------- 220 (277)
T ss_pred cCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--CCCC---------
Confidence 4322 2345788899999999989999999999999999999999999866544333221110 0000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
........+.+||.+||..+|.+|||+.+
T Consensus 221 ---------------------------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (277)
T cd06642 221 ---------------------------------------------------LEGQYSKPFKEFVEACLNKDPRFRPTAKE 249 (277)
T ss_pred ---------------------------------------------------CCcccCHHHHHHHHHHccCCcccCcCHHH
Confidence 00001125789999999999999999999
Q ss_pred HhcCCCcCcCC
Q psy11727 424 VLRHEFFLKHS 434 (437)
Q Consensus 424 ~l~Hp~~~~~~ 434 (437)
+++||||....
T Consensus 250 il~~~~~~~~~ 260 (277)
T cd06642 250 LLKHKFITRYT 260 (277)
T ss_pred HHHhHHHHHHh
Confidence 99999997643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=306.83 Aligned_cols=249 Identities=30% Similarity=0.445 Sum_probs=200.8
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+|++.+.||+|+||.||+|.+..++..||+|.+.... ........|+.+++.+ .|+||+++++.+...+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-----~h~~i~~~~~~~~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-----KHPNIVTFFASFQENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-----CCCChhhhhheeccCCeEE
Confidence 5889999999999999999999999999999986431 2234555677777665 6899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCC-CCEEEEeCCCcee
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR-SAIKIIDFGSSCH 265 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~-~~ikL~DFG~s~~ 265 (437)
+|+||+++ +|.+++.......+++..+..++.|++.||+|||+ .+++|+||||+||+++ ++ ..++|+|||.+..
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~ 151 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD--RKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQ 151 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccccCCHHHEEEc--CCCCeEEecccccchh
Confidence 99999965 89888876554568999999999999999999995 4899999999999994 44 3579999999876
Q ss_pred cCCcc---ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 266 VGQTL---YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 266 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
..... ....|+..|+|||++.+..++.++|+||||+++++|++|..||...+..+....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 218 (257)
T cd08225 152 LNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY------------- 218 (257)
T ss_pred ccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------
Confidence 54322 23457889999999988889999999999999999999999998776554443332110
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
+.... ......+.++|.+||..+|++|||+.
T Consensus 219 ----~~~~~---------------------------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~ 249 (257)
T cd08225 219 ----FAPIS---------------------------------------------PNFSRDLRSLISQLFKVSPRDRPSIT 249 (257)
T ss_pred ----CCCCC---------------------------------------------CCCCHHHHHHHHHHhccChhhCcCHH
Confidence 00000 00012578999999999999999999
Q ss_pred HHhcCCCc
Q psy11727 423 NVLRHEFF 430 (437)
Q Consensus 423 e~l~Hp~~ 430 (437)
++++||||
T Consensus 250 ~ll~~~~~ 257 (257)
T cd08225 250 SILKRPFL 257 (257)
T ss_pred HHhhCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=314.17 Aligned_cols=209 Identities=23% Similarity=0.326 Sum_probs=167.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcC----------------CCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHE----------------EKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHS 170 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~----------------~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h 170 (437)
.++|.+.+.||+|+||.||+|.+.. ++..||+|++..... ....+..|+.++..+ .|
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h 78 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-----KD 78 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-----CC
Confidence 4689999999999999999997532 345799999875321 223466777777765 78
Q ss_pred CcEEEecceeeECCEEEEEEEeccC-cHHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHhcCCC
Q psy11727 171 RYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNF-----------------HGVSLNLTKKFAQQLCCALAFLSSPE 232 (437)
Q Consensus 171 ~~iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~-----------------~~ls~~~~~~i~~qi~~aL~~LH~~~ 232 (437)
+||+++++++.+.+..++||||+++ +|.+++..... ..+++..+..++.||+.||.|||++
T Consensus 79 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~- 157 (304)
T cd05096 79 PNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL- 157 (304)
T ss_pred CCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence 9999999999999999999999965 88888754321 2367888999999999999999964
Q ss_pred CCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHH
Q psy11727 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELH 307 (437)
Q Consensus 233 ~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ell 307 (437)
||+||||||+|||+ +.++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|||+
T Consensus 158 -~ivH~dlkp~Nill--~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 158 -NFVHRDLATRNCLV--GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred -CccccCcchhheEE--cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence 89999999999999 677889999999997653321 1233467899999999889999999999999999998
Q ss_pred h--CCCCCCCCCHHHHHHHHH
Q psy11727 308 T--GEPLFSGKNEVDQMTKII 326 (437)
Q Consensus 308 t--g~~pf~~~~~~~~~~~i~ 326 (437)
+ +..||.+.+..+....+.
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~ 255 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAG 255 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHH
Confidence 7 568888776655555443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=330.92 Aligned_cols=255 Identities=24% Similarity=0.403 Sum_probs=201.5
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc----chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~----~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
.-|..++.||-|+||+|.++....|...||+|.+++.... ...+..|..||... ++++||+|+..|++++.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-----Dn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-----DNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-----CCcceEEEEEEeccCCc
Confidence 4588899999999999999999999999999999854322 22334466666544 78899999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+|+||+|.+| ++..+|...+ -|.++.++.++.++.+|+++.| ++|+|||||||+|||| |.+|+|||+|||+++
T Consensus 704 LYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVH--kmGFIHRDiKPDNILI--DrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILI--DRDGHIKLTDFGLCT 777 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHH--hccceecccCccceEE--ccCCceeeeeccccc
Confidence 9999999965 7888776653 3899999999999999999999 7899999999999999 889999999999975
Q ss_pred ecCCc---------------------------------------------cccccccccccChhhhcCCCCCCcchHHHH
Q psy11727 265 HVGQT---------------------------------------------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSL 299 (437)
Q Consensus 265 ~~~~~---------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 299 (437)
-+... ....+||+.|+|||++...+|+..+|+||.
T Consensus 778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~ 857 (1034)
T KOG0608|consen 778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV 857 (1034)
T ss_pred cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence 33210 123478999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhc
Q psy11727 300 GCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILG 379 (437)
Q Consensus 300 G~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (437)
|||||||+.|++||......++..+++. |+..-+|.-
T Consensus 858 gvil~em~~g~~pf~~~tp~~tq~kv~n-------------------------------------------w~~~l~~~~ 894 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTPGETQYKVIN-------------------------------------------WRNFLHIPY 894 (1034)
T ss_pred hHHHHHHhhCCCCccCCCCCcceeeeee-------------------------------------------hhhcccccc
Confidence 9999999999999998877655444432 111111100
Q ss_pred cCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC---HHHHhcCCCcCcCCC
Q psy11727 380 VDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS---PTNVLRHEFFLKHSV 435 (437)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t---~~e~l~Hp~~~~~~~ 435 (437)
+. ....++.+||.++ ..+++.|.. ++|+-.||||+..+.
T Consensus 895 ~~----------------~ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 895 QG----------------NLSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred cc----------------ccCHHHHHHHHHH-hcChhhhhcccchhhhhcCccccccch
Confidence 00 0012568888885 457888885 788999999998754
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=310.99 Aligned_cols=248 Identities=34% Similarity=0.529 Sum_probs=202.9
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|.+.+.||+|+||.||+|.+..++..||+|++..... .......|..++..+. .|+||+++++++.+.+.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~----~~~~i~~~~~~~~~~~~ 76 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN----GHPGIIKLYYTFQDEEN 76 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcc----cCCCchhHHHHhcCCce
Confidence 479999999999999999999999999999999864221 1234455666665552 48999999999999999
Q ss_pred EEEEEEec-cCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELL-SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~-~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
.++|||++ +++|.+++.... .+++..++.++.|++.||.+||+ .|++|+||+|+||++ +.++.++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~--~~~~H~dl~~~ni~i--~~~~~~~l~df~~~~ 150 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHS--KGIIHRDLKPENILL--DKDMHIKITDFGTAK 150 (280)
T ss_pred EEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEE--CCCCCEEecCCcccc
Confidence 99999999 558999887653 58999999999999999999995 489999999999999 667889999999987
Q ss_pred ecCCcc-----------------------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy11727 265 HVGQTL-----------------------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ 321 (437)
Q Consensus 265 ~~~~~~-----------------------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~ 321 (437)
...... ....++..|+|||++.+..++.++|+||||++++++++|++||...+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 230 (280)
T cd05581 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230 (280)
T ss_pred ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 653322 123567889999999988899999999999999999999999998876655
Q ss_pred HHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhh
Q psy11727 322 MTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYM 401 (437)
Q Consensus 322 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (437)
++.+.......|.. ...
T Consensus 231 ~~~~~~~~~~~~~~---------------------------------------------------------------~~~ 247 (280)
T cd05581 231 FQKILKLEYSFPPN---------------------------------------------------------------FPP 247 (280)
T ss_pred HHHHHhcCCCCCCc---------------------------------------------------------------cCH
Confidence 55554321111100 012
Q ss_pred HHHHHHHHccccCCCCCCCH----HHHhcCCCc
Q psy11727 402 KFKDLILRMLTYDPKKRISP----TNVLRHEFF 430 (437)
Q Consensus 402 ~~~dli~~~L~~dP~~R~t~----~e~l~Hp~~ 430 (437)
.+.+||++||+.||.+|||+ +++++||||
T Consensus 248 ~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 248 DAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 57899999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=329.88 Aligned_cols=253 Identities=26% Similarity=0.429 Sum_probs=208.4
Q ss_pred cCee-eeceecccCceEEEEEEEcCCCeEEEEEEec-----CCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 110 DRYE-IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK-----NKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 110 ~~y~-i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~-----~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
++|. ...+||+|+|-+||+|.|..+|..||.-.++ +......++..|+.+|+.| .|+|||+++++|.+.
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-----~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-----KHPNIIRFYDSWVDT 113 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-----CCCceeeeeeheecC
Confidence 3443 3568999999999999999999999875543 2233346777788888776 789999999999876
Q ss_pred C--EEEEEEEec-cCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 184 N--HLCLVFELL-SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 184 ~--~~~lV~E~~-~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
. ...+|+|++ +|+|..++++.+ .++...++.|++||+.||.|||+++..|||||||-+||||+ ...|.|||+|+
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin-G~~G~VKIGDL 190 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN-GNLGEVKIGDL 190 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc-CCcCceeecch
Confidence 5 588999999 679999998864 48999999999999999999999999999999999999995 56789999999
Q ss_pred CCceecCCcc-ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCCCChhhhc
Q psy11727 261 GSSCHVGQTL-YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG-KNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 261 G~s~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
|+|+...... ...+|||.|||||++. ..|+..+||||||++|.||+|+..||+. .+...++.++.. |..|..+.
T Consensus 191 GLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--GiKP~sl~- 266 (632)
T KOG0584|consen 191 GLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--GIKPAALS- 266 (632)
T ss_pred hHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--CCCHHHhh-
Confidence 9998876544 3469999999999998 5899999999999999999999999964 556666666654 22332211
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
++. +.+.++||.+||.. ..+|
T Consensus 267 ----------kV~------------------------------------------------dPevr~fIekCl~~-~~~R 287 (632)
T KOG0584|consen 267 ----------KVK------------------------------------------------DPEVREFIEKCLAT-KSER 287 (632)
T ss_pred ----------ccC------------------------------------------------CHHHHHHHHHHhcC-chhc
Confidence 110 12679999999999 9999
Q ss_pred CCHHHHhcCCCcCcC
Q psy11727 419 ISPTNVLRHEFFLKH 433 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~~ 433 (437)
+|+.|+|+||||+.-
T Consensus 288 ~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 288 LSAKELLKDPFFDED 302 (632)
T ss_pred cCHHHHhhChhhccc
Confidence 999999999999874
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=299.74 Aligned_cols=249 Identities=35% Similarity=0.538 Sum_probs=203.6
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
+|.+.+.||+|++|.||++.+..++..+++|++..... ....+..|+.++..+ .|++++++.+++...+..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-----KHPNIVKYYGSYLKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-----CCCCEeEEEEEEecCCeEEEE
Confidence 48889999999999999999998999999999975433 345666777777766 589999999999999999999
Q ss_pred EEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 190 FELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 190 ~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
+||+++ +|.+++.... ..+++..+..++.|++.||++||. .|++||||+|+||++ +.++.++|+|||.+.....
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~--~~i~h~dl~p~ni~i--~~~~~~~l~d~~~~~~~~~ 150 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS--NGIIHRDIKAANILL--TSDGEVKLIDFGLSAQLSD 150 (253)
T ss_pred EecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc--CCEecCCCCHHHEEE--ccCCeEEEeeccccccccc
Confidence 999985 8888877653 468999999999999999999996 589999999999999 6678899999999977655
Q ss_pred cc--ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchh
Q psy11727 269 TL--YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKY 346 (437)
Q Consensus 269 ~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~ 346 (437)
.. ....++..|+|||++.+..++.++|+||||+++|+|++|++||...+.......+.. ...+..
T Consensus 151 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~----------- 217 (253)
T cd05122 151 TKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NGPPGL----------- 217 (253)
T ss_pred cccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--cCCCCc-----------
Confidence 43 456788899999999988899999999999999999999999987755444333321 000000
Q ss_pred hcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhc
Q psy11727 347 FDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
+. .......+.++|.+||+.||.+|||+.++++
T Consensus 218 ----------------------~~-------------------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 218 ----------------------RN-------------------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ----------------------Cc-------------------------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0000125789999999999999999999999
Q ss_pred CCC
Q psy11727 427 HEF 429 (437)
Q Consensus 427 Hp~ 429 (437)
|||
T Consensus 251 ~~~ 253 (253)
T cd05122 251 HPF 253 (253)
T ss_pred CCC
Confidence 999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=304.83 Aligned_cols=250 Identities=29% Similarity=0.457 Sum_probs=198.1
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+|.+.+.||+|+||.||+|.+..+++.||+|.++.... ....+..|+.++..+ .|+||+++++.+...+.++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-----KHPNLVKYYGVEVHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-----CCCChhheeeeEecCCEEE
Confidence 58999999999999999999998999999999975433 344566677776665 7889999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+|+||+++ +|.+++.... .+++..+..++.|++.||.|||+ .||+|+||+|+||++ +.++.+||+|||++...
T Consensus 76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~~~nil~--~~~~~~kl~d~g~~~~~ 149 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHS--HGIVHRDIKPANIFL--DHNGVIKLGDFGCAVKL 149 (264)
T ss_pred EEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEE--CCCCCEEEccccccccc
Confidence 99999965 7888887643 47899999999999999999995 489999999999999 66888999999998765
Q ss_pred CCccc-------cccccccccChhhhcCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 267 GQTLY-------QYIQSRYYRSPEVLLGIP---YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 267 ~~~~~-------~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
..... ...++..|+|||++.+.. ++.++||||||++++++++|+.||............... +.++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~-- 226 (264)
T cd06626 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPP-- 226 (264)
T ss_pred CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCC--
Confidence 43221 245678899999998766 889999999999999999999999765322221111110 11100
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
.|.. ......+.+||.+||+.||.
T Consensus 227 -------------------------------~~~~-------------------------~~~~~~~~~li~~~l~~~p~ 250 (264)
T cd06626 227 -------------------------------IPDS-------------------------LQLSPEGKDFLDRCLESDPK 250 (264)
T ss_pred -------------------------------CCcc-------------------------cccCHHHHHHHHHHccCCcc
Confidence 0000 00012568999999999999
Q ss_pred CCCCHHHHhcCCCc
Q psy11727 417 KRISPTNVLRHEFF 430 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~ 430 (437)
+|||+.+++.|||+
T Consensus 251 ~R~~~~~i~~~~~~ 264 (264)
T cd06626 251 KRPTASELLQHPFV 264 (264)
T ss_pred cCCCHHHHhcCCCC
Confidence 99999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=306.67 Aligned_cols=246 Identities=21% Similarity=0.314 Sum_probs=199.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.++|++.+.||+|+||.||+|... ++..||+|.+.........+..|+.++..+ .|+||+++++.+...+..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTL-----QHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhC-----CCCCeeeEEEEEcCCCCcEE
Confidence 467999999999999999999865 456799999875444445667788887766 68999999999999999999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
||||+++ +|.+++.......+++..+..++.|++.||+|||+ .|++||||||+||++ +.++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nili--~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER--KNYIHRDLRAANVLV--SESLMCKIADFGLARVIE 154 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEe--cCCCcEEECCCccceecC
Confidence 9999964 89998876555568999999999999999999995 489999999999999 678889999999997764
Q ss_pred Cccc----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 268 QTLY----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 268 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.... ...++..|+|||++.+..++.++|+|||||++|+|++ |..||.+.........+......|..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-------- 226 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRM-------- 226 (261)
T ss_pred CCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCC--------
Confidence 3221 2234567999999998889999999999999999998 99999887766655554321111000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
......+.+||.+||..||++|||++
T Consensus 227 ------------------------------------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ 252 (261)
T cd05072 227 ------------------------------------------------------ENCPDELYDIMKTCWKEKAEERPTFD 252 (261)
T ss_pred ------------------------------------------------------CCCCHHHHHHHHHHccCCcccCcCHH
Confidence 00012578999999999999999999
Q ss_pred HHhc
Q psy11727 423 NVLR 426 (437)
Q Consensus 423 e~l~ 426 (437)
++++
T Consensus 253 ~i~~ 256 (261)
T cd05072 253 YLQS 256 (261)
T ss_pred HHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=327.56 Aligned_cols=251 Identities=29% Similarity=0.425 Sum_probs=210.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc---chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF---LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
.+.|.+.+.||+|.|+.|.+|+...++..||||++.+.... .....+|+.++..+ .|||||+++.+.+....
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-----~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-----NHPNIVKLFSVIETEAT 129 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-----CCcceeeeeeeeeecce
Confidence 56799999999999999999999999999999999754322 22356788888776 78999999999999999
Q ss_pred EEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+|+||||+. |.+++++.+.. .+.+..++.++.|+..|++|||++ +|||||||++|||| +.+.++||+|||+|.
T Consensus 130 lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k--~ivHrdLk~eNilL--~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSK--NIVHRDLKAENILL--DENMNIKIADFGFST 203 (596)
T ss_pred eEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhc--ceeccccchhhccc--ccccceeeeccccce
Confidence 999999995 58999998875 377799999999999999999976 69999999999999 788889999999998
Q ss_pred ecC--CccccccccccccChhhhcCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 265 HVG--QTLYQYIQSRYYRSPEVLLGIPYD-LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 265 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
.+. ....++||++.|.|||++.+..|+ +++|+||+|+++|.|+.|..||.|.+-.+.-.+.+.
T Consensus 204 ~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~-------------- 269 (596)
T KOG0586|consen 204 FFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR-------------- 269 (596)
T ss_pred eecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee--------------
Confidence 774 445689999999999999998876 789999999999999999999998765333222211
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
.++++|.... ..+.+||+++|..+|.+|+++
T Consensus 270 ----------------------gk~rIp~~ms---------------------------~dce~lLrk~lvl~Pskr~~~ 300 (596)
T KOG0586|consen 270 ----------------------GKYRIPFYMS---------------------------CDCEDLLRKFLVLNPSKRGPC 300 (596)
T ss_pred ----------------------eeecccceee---------------------------chhHHHHHHhhccCccccCCH
Confidence 1122221111 157899999999999999999
Q ss_pred HHHhcCCCcCcC
Q psy11727 422 TNVLRHEFFLKH 433 (437)
Q Consensus 422 ~e~l~Hp~~~~~ 433 (437)
++++.|.|....
T Consensus 301 dqim~~~W~n~~ 312 (596)
T KOG0586|consen 301 DQIMKDRWRNDL 312 (596)
T ss_pred HHhhhhcccchh
Confidence 999999998654
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=307.29 Aligned_cols=250 Identities=27% Similarity=0.459 Sum_probs=200.0
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
-|++.+.||.|+||.||+|.+..+++.||+|++..... ....+..|+.++..+ .|+||+++++++..++++++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVTKYYGSYLKDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-----CCCCEeEEEEEEEeCCeEEE
Confidence 47788899999999999999998999999999863321 223455566666655 78999999999999999999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
||||+++ +|.+++... .+++..+..++.|++.++.+||+ .|++|+||+|+||++ +.++.++|+|||++....
T Consensus 80 v~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~Ni~i--~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06641 80 IMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLL--SEHGEVKLADFGVAGQLT 152 (277)
T ss_pred EEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHcc--CCeecCCCCHHhEEE--CCCCCEEEeecccceecc
Confidence 9999976 777777643 48999999999999999999995 489999999999999 677889999999986653
Q ss_pred Cc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc
Q psy11727 268 QT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344 (437)
Q Consensus 268 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 344 (437)
.. .....++..|+|||.+.+..++.++|+|||||++|+|++|.+||...+.......+... .++. .
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~-~-------- 221 (277)
T cd06641 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--NPPT-L-------- 221 (277)
T ss_pred cchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--CCCC-C--------
Confidence 32 12346788899999999888999999999999999999999999876654444333110 0000 0
Q ss_pred hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHH
Q psy11727 345 KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNV 424 (437)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~ 424 (437)
.......+.++|.+||..||.+||++.++
T Consensus 222 ---------------------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 250 (277)
T cd06641 222 ---------------------------------------------------EGNYSKPLKEFVEACLNKEPSFRPTAKEL 250 (277)
T ss_pred ---------------------------------------------------CcccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 00001257899999999999999999999
Q ss_pred hcCCCcCcCC
Q psy11727 425 LRHEFFLKHS 434 (437)
Q Consensus 425 l~Hp~~~~~~ 434 (437)
++||||.+..
T Consensus 251 l~~~~~~~~~ 260 (277)
T cd06641 251 LKHKFIVRFA 260 (277)
T ss_pred HhCHHHhhhh
Confidence 9999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=309.38 Aligned_cols=253 Identities=26% Similarity=0.448 Sum_probs=202.2
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
.|...+.||+|++|.||++.+..+++.+|+|.+..... ....+.+|+.+++.+ .|+||+++++++...++.++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-----~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-----QHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-----CCCChheEEEEEEcCCeEEEE
Confidence 35556799999999999999999999999998864322 123455666666655 789999999999999999999
Q ss_pred EEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 190 FELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 190 ~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
+||+.+ +|.+++.. ..+++..+..++.|++.||+|||++ |++||||+|+||++ +.++.++|+|||.+.....
T Consensus 95 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~--~i~H~dl~p~Nil~--~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 95 MEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ--GVIHRDIKSDSILL--TSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred EeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCChhhEEE--cCCCcEEEcccccchhhcc
Confidence 999965 88888776 3489999999999999999999964 89999999999999 6788899999998765432
Q ss_pred c---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccch
Q psy11727 269 T---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSK 345 (437)
Q Consensus 269 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 345 (437)
. .....|+..|+|||++.+..++.++|+|||||++|+|++|.+||...+.......+... .++. ...
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~--~~~~-~~~------- 237 (285)
T cd06648 168 EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--LPPK-LKN------- 237 (285)
T ss_pred CCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc--CCCC-Ccc-------
Confidence 2 12346888999999999888999999999999999999999999887766555544321 1100 000
Q ss_pred hhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHh
Q psy11727 346 YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVL 425 (437)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l 425 (437)
.......+.+||++||+.||.+|||+.+++
T Consensus 238 --------------------------------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 267 (285)
T cd06648 238 --------------------------------------------------LHKVSPRLRSFLDRMLVRDPAQRATAAELL 267 (285)
T ss_pred --------------------------------------------------cccCCHHHHHHHHHHcccChhhCcCHHHHc
Confidence 000012578999999999999999999999
Q ss_pred cCCCcCcCCC
Q psy11727 426 RHEFFLKHSV 435 (437)
Q Consensus 426 ~Hp~~~~~~~ 435 (437)
+||||++...
T Consensus 268 ~~~~~~~~~~ 277 (285)
T cd06648 268 NHPFLAKAGP 277 (285)
T ss_pred cCcccccCCC
Confidence 9999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=325.31 Aligned_cols=204 Identities=26% Similarity=0.416 Sum_probs=165.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCC-----CeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEE-----KCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~-----~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|++.+.||+|+||.||+|++..+ +..||+|+++.... ....+..|+.+++.+. .|+|||+++++|.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~----~h~nIv~~~~~~~ 112 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG----QHKNIVNLLGACT 112 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhc----cCCceeeEeeEec
Confidence 35799999999999999999986443 35799999974321 2234566888777663 6899999999999
Q ss_pred ECCEEEEEEEeccC-cHHHHHHhcC-------------------------------------------------------
Q psy11727 182 WKNHLCLVFELLSY-NLYNLIRNTN------------------------------------------------------- 205 (437)
Q Consensus 182 ~~~~~~lV~E~~~~-~L~~~l~~~~------------------------------------------------------- 205 (437)
..+.+++||||+++ +|.+++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 99999999999965 8888875421
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCccc-
Q psy11727 206 -------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLY- 271 (437)
Q Consensus 206 -------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~~- 271 (437)
...+++..++.++.||+.||+|||++ ||+||||||+|||+ ++++.+||+|||++........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--giiHrDLkp~Nil~--~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK--NCIHRDVAARNVLL--TDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC--CEEeccCchheEEE--eCCCeEEEeeceeeeeccCCcce
Confidence 12478889999999999999999964 89999999999999 5678899999999876533211
Q ss_pred ----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy11727 272 ----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVD 320 (437)
Q Consensus 272 ----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~ 320 (437)
...++..|+|||++.+..++.++|||||||++|+|++ |++||.......
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~ 322 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS 322 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH
Confidence 1223567999999999899999999999999999997 999998765443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=328.47 Aligned_cols=247 Identities=29% Similarity=0.401 Sum_probs=205.4
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+.+.|.+...+|.|+|+.|-.|.+..+++..++|++.... .....|+.++.... .|+||+++.+.+.+..+.
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~----~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVR----DHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhc----CCCcceeecceecCCcee
Confidence 46788999999999999999999999999999999997542 33445665655553 789999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++|||.+.| .+.+.+.... .....+..|+.+|+.|+.|||.+ |+|||||||+|||+. +..++++|+|||.++.
T Consensus 392 ~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~--gvvhRDLkp~NIL~~-~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQ--GVVHRDLKPGNILLD-GSAGHLRLTYFGFWSE 465 (612)
T ss_pred eeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhc--CeeecCCChhheeec-CCCCcEEEEEechhhh
Confidence 999999966 5666666554 22377788999999999999974 899999999999995 4678899999999988
Q ss_pred cCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccch
Q psy11727 266 VGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSK 345 (437)
Q Consensus 266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 345 (437)
......+.+-|..|.|||++...+|+.++|+||||++||+|++|+.||...... ..|....+.|+..
T Consensus 466 ~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s---------- 532 (612)
T KOG0603|consen 466 LERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS---------- 532 (612)
T ss_pred CchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc----------
Confidence 877766677889999999999999999999999999999999999999876655 3333333333211
Q ss_pred hhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHh
Q psy11727 346 YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVL 425 (437)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l 425 (437)
......++|||++||++||.+|+|+.+++
T Consensus 533 ---------------------------------------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 533 ---------------------------------------------------ECVSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred ---------------------------------------------------cccCHHHHHHHHHhccCChhhCcChhhhc
Confidence 00111579999999999999999999999
Q ss_pred cCCCc
Q psy11727 426 RHEFF 430 (437)
Q Consensus 426 ~Hp~~ 430 (437)
.||||
T Consensus 562 ~h~w~ 566 (612)
T KOG0603|consen 562 AHPWF 566 (612)
T ss_pred cCcch
Confidence 99999
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=311.90 Aligned_cols=254 Identities=26% Similarity=0.408 Sum_probs=200.8
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.++|.+.+.||+|+||.||++.+..++..||+|.+.... .....+..|+.++.. +.||||+++++.+...+..+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~-----l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE-----NKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhh-----cCCCCeeehhheeeeCCcEE
Confidence 478999999999999999999998899999999986332 222344556655554 47899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+|+||+++ +|.+++... .+++..+..++.|++.||+|||+ .|++|+||||+||++ +.++.++|+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~--~gi~H~dL~p~Nili--~~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILL--GMDGSVKLTDFGFCAQI 165 (293)
T ss_pred EEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh--CCEeeccCCHHHEEE--cCCCCEEEccCcceecc
Confidence 99999965 888887654 37899999999999999999995 489999999999999 66788999999988655
Q ss_pred CCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
... .....++..|+|||++.+..++.++|+|||||++|++++|++||...+....+..+.. .+.+.
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~---------- 234 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE---------- 234 (293)
T ss_pred cccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC----------
Confidence 322 2234678889999999988899999999999999999999999987655333222110 00000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
+ + .+......+.+||++||..||.+|||+.+
T Consensus 235 ---~---------------------~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 265 (293)
T cd06647 235 ---L---------------------Q-------------------------NPEKLSAIFRDFLNRCLEMDVEKRGSAKE 265 (293)
T ss_pred ---C---------------------C-------------------------CccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 0 0 00001125789999999999999999999
Q ss_pred HhcCCCcCcCC
Q psy11727 424 VLRHEFFLKHS 434 (437)
Q Consensus 424 ~l~Hp~~~~~~ 434 (437)
++.||||+...
T Consensus 266 il~h~~~~~~~ 276 (293)
T cd06647 266 LLQHPFLKIAK 276 (293)
T ss_pred HhcCHHHhcCc
Confidence 99999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=323.59 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=192.7
Q ss_pred ccCeeeeceecccCceEEEEEEE-----cCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFD-----HEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~-----~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|++.+.||+|+||+||+|.. ..++..||||+++.... ....+..|+.++..+. .||||++++++|.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~----~HpnIv~l~~~~~ 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG----NHINIVNLLGACT 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhc----CCcceeeeeeeec
Confidence 34799999999999999999964 35677899999864321 2234567888877763 6899999999999
Q ss_pred ECCEEEEEEEeccC-cHHHHHHhcC-------------------------------------------------------
Q psy11727 182 WKNHLCLVFELLSY-NLYNLIRNTN------------------------------------------------------- 205 (437)
Q Consensus 182 ~~~~~~lV~E~~~~-~L~~~l~~~~------------------------------------------------------- 205 (437)
..+..++||||+++ +|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 99999999999965 8888886432
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 206 ------------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 206 ------------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
...+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~Nill--~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK--NCIHRDLAARNILL--THGRITKICDFGLARDIR 265 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCchhhEEE--ECCCcEEEecCccceecc
Confidence 12478888999999999999999964 89999999999999 567789999999997654
Q ss_pred Cccc-----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 268 QTLY-----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 268 ~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
.... ...++..|+|||++.+..++.++|||||||++|||++ |.+||.+........+.+.....+.
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 337 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML-------- 337 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--------
Confidence 3221 1223567999999999999999999999999999998 8999987654433333222100000
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
.| . .....+.+||.+||+.||.+|||+
T Consensus 338 --------------------------~~------------------------~---~~~~~l~~li~~cl~~dP~~RPs~ 364 (375)
T cd05104 338 --------------------------SP------------------------E---CAPSEMYDIMKSCWDADPLKRPTF 364 (375)
T ss_pred --------------------------CC------------------------C---CCCHHHHHHHHHHccCChhHCcCH
Confidence 00 0 001257899999999999999999
Q ss_pred HHHhcC
Q psy11727 422 TNVLRH 427 (437)
Q Consensus 422 ~e~l~H 427 (437)
.|+++.
T Consensus 365 ~eil~~ 370 (375)
T cd05104 365 KQIVQL 370 (375)
T ss_pred HHHHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=310.40 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=197.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCC-----eEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEK-----CQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~-----~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|++.+.||+|+||.||+|.....+ ..||+|.++.... ....+..|+.++..+ .|+||+++++++.
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~i~~~~~~~~ 78 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-----QHPNIVCLLGVCT 78 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-----CCcccceEEEEEc
Confidence 357899999999999999999876555 6899999864321 223456677777665 7899999999999
Q ss_pred ECCEEEEEEEeccC-cHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q psy11727 182 WKNHLCLVFELLSY-NLYNLIRNTNF--------------HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENIL 246 (437)
Q Consensus 182 ~~~~~~lV~E~~~~-~L~~~l~~~~~--------------~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIl 246 (437)
..+..+++|||+++ +|.+++..... ..+++..+..++.||+.||+|||++ |++||||||+||+
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~--~i~H~dlkp~Nil 156 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH--HFVHRDLAARNCL 156 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccccccceEE
Confidence 99999999999965 89988875421 4578899999999999999999964 8999999999999
Q ss_pred EecCCCCCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy11727 247 LCSPKRSAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVD 320 (437)
Q Consensus 247 l~~~~~~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~ 320 (437)
+ ++++.++|+|||++...... .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+
T Consensus 157 ~--~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05048 157 V--GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234 (283)
T ss_pred E--cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9 66788999999998765322 123345778999999998899999999999999999998 999999887766
Q ss_pred HHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhh
Q psy11727 321 QMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADY 400 (437)
Q Consensus 321 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (437)
....+......+. | ....
T Consensus 235 ~~~~i~~~~~~~~-----------------------------------~---------------------------~~~~ 252 (283)
T cd05048 235 VIEMIRSRQLLPC-----------------------------------P---------------------------EDCP 252 (283)
T ss_pred HHHHHHcCCcCCC-----------------------------------c---------------------------ccCC
Confidence 6555433111000 0 0001
Q ss_pred hHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 401 MKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 401 ~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
..+.+|+.+||+.||.+|||++++++|
T Consensus 253 ~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 253 ARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 257899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=304.64 Aligned_cols=244 Identities=25% Similarity=0.336 Sum_probs=197.2
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
++|++.+.||+|+||.||++.... +..+|+|.+.........+..|+.+++.+ .||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKL-----SHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHC-----CCCCceeEEEEEccCCCEEEE
Confidence 468899999999999999998754 55799999875544445677788888876 689999999999999999999
Q ss_pred EEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 190 FELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 190 ~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
|||+++ +|.+++.... ..+++..+..++.|++.||+|||+ .||+||||||+||++ ++++.+||+|||.+.....
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i--~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLER--NSFIHRDLAARNCLV--SSTGVVKVSDFGMTRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcceEEE--cCCCeEEECCCCCccccCC
Confidence 999964 7888887543 358999999999999999999995 489999999999999 6788899999999876532
Q ss_pred ccc----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 269 TLY----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 269 ~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
... ...++..|+|||++.+..++.++|+||||+++|+|++ |++||...+..+....+......+.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~---------- 222 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---------- 222 (256)
T ss_pred CceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC----------
Confidence 221 1233457999999998899999999999999999999 9999998887766666543211000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
|. .....+.+||.+||+.||.+|||+++
T Consensus 223 -------------------------~~---------------------------~~~~~~~~li~~c~~~~p~~Rps~~~ 250 (256)
T cd05114 223 -------------------------PK---------------------------LASMTVYEVMYSCWHEKPEGRPTFAE 250 (256)
T ss_pred -------------------------CC---------------------------CCCHHHHHHHHHHccCCcccCcCHHH
Confidence 00 00125789999999999999999999
Q ss_pred Hhc
Q psy11727 424 VLR 426 (437)
Q Consensus 424 ~l~ 426 (437)
+++
T Consensus 251 l~~ 253 (256)
T cd05114 251 LLR 253 (256)
T ss_pred HHH
Confidence 985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=327.07 Aligned_cols=249 Identities=26% Similarity=0.319 Sum_probs=195.6
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
+...+...+...||+|+||+||+|.+..+ ||||++.... .....+..|+..+++- +|.||+-+.|++..
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-----RH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKT-----RHENILLFMGACMN 459 (678)
T ss_pred ccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhc-----chhhheeeehhhcC
Confidence 44456678899999999999999998664 9999997543 3345566777777766 78899999999998
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
+.+ .||+.+|+| +|+.++.-.. ..|.+..++.|++||++|+.|||.+ +|||||||..|||+ .+++.|||+|||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK--~IIHrDLKSnNIFl--~~~~kVkIgDFG 533 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK--NIIHRDLKSNNIFL--HEDLKVKIGDFG 533 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh--hhhhhhccccceEE--ccCCcEEEeccc
Confidence 877 999999988 8999887654 4589999999999999999999976 69999999999999 667899999999
Q ss_pred CceecC-----CccccccccccccChhhhcCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy11727 262 SSCHVG-----QTLYQYIQSRYYRSPEVLLGI---PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333 (437)
Q Consensus 262 ~s~~~~-----~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~ 333 (437)
++.... .......|+..|||||+++.+ +|++.+||||||+++|||+||..||...+.+.++-.+-.++.+|.
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd 613 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD 613 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc
Confidence 986542 233345678889999999854 699999999999999999999999995554433333222222221
Q ss_pred hhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
..-. ...+ ..++++|+..|+.+
T Consensus 614 ~s~~-------------------------------------------~s~~---------------pk~mk~Ll~~C~~~ 635 (678)
T KOG0193|consen 614 LSKI-------------------------------------------RSNC---------------PKAMKRLLSDCWKF 635 (678)
T ss_pred chhh-------------------------------------------hccC---------------HHHHHHHHHHHHhc
Confidence 1000 0000 12679999999999
Q ss_pred CCCCCCCHHHHhc
Q psy11727 414 DPKKRISPTNVLR 426 (437)
Q Consensus 414 dP~~R~t~~e~l~ 426 (437)
+|++||+..++|.
T Consensus 636 ~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 636 DREERPLFPQLLS 648 (678)
T ss_pred CcccCccHHHHHH
Confidence 9999999988875
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=304.07 Aligned_cols=246 Identities=22% Similarity=0.337 Sum_probs=199.3
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.++|++.+.||+|+||.||+|.+.. +..||+|.++........+..|+.++..+ .|+||+++++++...+..++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKL-----RHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHC-----CCCCccceeEEEecCCCeee
Confidence 4679999999999999999998754 56899999975544445677788888776 68899999999999999999
Q ss_pred EEEec-cCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELL-SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~-~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
|||++ +++|.+++.......+++..+..++.|++.||.+||+ .||+||||||+||++ ++++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~--~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA--QNYIHRDLAARNVLV--GENNICKVADFGLARVIK 154 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCcceEEE--cCCCCEEECCcceEEEcc
Confidence 99999 5689999877554568999999999999999999995 489999999999999 678889999999997765
Q ss_pred Cccc-cccc---cccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 268 QTLY-QYIQ---SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 268 ~~~~-~~~g---t~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.... ...+ +..|+|||++.+..++.++|+||||+++|+|++ |++||.+.+.......+......+..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-------- 226 (261)
T cd05068 155 EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCP-------- 226 (261)
T ss_pred CCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--------
Confidence 3322 1222 346999999999899999999999999999999 99999988766655554322111100
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
......+.+++.+||+.||.+|||++
T Consensus 227 ------------------------------------------------------~~~~~~~~~li~~~l~~~P~~Rp~~~ 252 (261)
T cd05068 227 ------------------------------------------------------PGCPKELYDIMLDCWKEDPDDRPTFE 252 (261)
T ss_pred ------------------------------------------------------CcCCHHHHHHHHHHhhcCcccCCCHH
Confidence 00012578999999999999999999
Q ss_pred HHhc
Q psy11727 423 NVLR 426 (437)
Q Consensus 423 e~l~ 426 (437)
++++
T Consensus 253 ~l~~ 256 (261)
T cd05068 253 TLQW 256 (261)
T ss_pred HHHH
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=309.34 Aligned_cols=257 Identities=21% Similarity=0.320 Sum_probs=197.5
Q ss_pred eccCeeeeceecccCceEEEEEEEcC-----CCeEEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHE-----EKCQVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
..++|++.+.||+|+||.||+|..+. .+..||+|.+...... ...+..|+.+++.+ .|+||+++++++
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~ 78 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-----TCHHVVRLLGVV 78 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEE
Confidence 35789999999999999999997542 3558999988643221 12234455555544 789999999999
Q ss_pred eECCEEEEEEEecc-CcHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC
Q psy11727 181 TWKNHLCLVFELLS-YNLYNLIRNTN--------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK 251 (437)
Q Consensus 181 ~~~~~~~lV~E~~~-~~L~~~l~~~~--------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~ 251 (437)
...+..|+||||++ |+|.+++.... ....+...+..++.||+.||.|||++ ||+||||||+||++ ++
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~i~H~dikp~nili--~~ 154 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK--KFVHRDLAARNCMV--AH 154 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCcCCCCChheEEE--cC
Confidence 99999999999996 48999886532 12346778899999999999999964 89999999999999 66
Q ss_pred CCCEEEEeCCCceecCCccc-----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy11727 252 RSAIKIIDFGSSCHVGQTLY-----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKI 325 (437)
Q Consensus 252 ~~~ikL~DFG~s~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i 325 (437)
++.++|+|||++........ ...++..|+|||.+.+..++.++|+|||||++|||++ |.+||.+.+..+....+
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 88899999999875432211 1234567999999998899999999999999999999 78999887766555444
Q ss_pred HHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHH
Q psy11727 326 IEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKD 405 (437)
Q Consensus 326 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 405 (437)
..... ++ .+ ......+.+
T Consensus 235 ~~~~~-~~----------------------------------~~---------------------------~~~~~~~~~ 252 (288)
T cd05061 235 MDGGY-LD----------------------------------QP---------------------------DNCPERVTD 252 (288)
T ss_pred HcCCC-CC----------------------------------CC---------------------------CCCCHHHHH
Confidence 32100 00 00 000125799
Q ss_pred HHHHccccCCCCCCCHHHHhc------CCCcCcCCC
Q psy11727 406 LILRMLTYDPKKRISPTNVLR------HEFFLKHSV 435 (437)
Q Consensus 406 li~~~L~~dP~~R~t~~e~l~------Hp~~~~~~~ 435 (437)
+|.+||+.||.+|||+.++++ ||||...++
T Consensus 253 li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 253 LMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 999999999999999999987 999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=311.16 Aligned_cols=257 Identities=28% Similarity=0.392 Sum_probs=198.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.++|++.+.||+|+||+||+|.+..+++.||||.++.... .......|+.++... ..|+||+++++++.+...+
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~----~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS----HDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhc----cCCCchHhhheeeecCCeE
Confidence 4679999999999999999999998899999999974321 112233344433332 2689999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
|+||||+++.+.+++.... ..+++..+..++.||+.||+|||+. .||+||||+|+||++ ++++.+||+|||++...
T Consensus 90 ~~v~e~~~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~-~~i~H~dl~p~nill--~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 90 FICMELMSTCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEK-HGVIHRDVKPSNILL--DASGNVKLCDFGISGRL 165 (296)
T ss_pred EEEeeccCcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh-CCEecCCCcHHHEEE--cCCCCEEECccccchhc
Confidence 9999999888877776543 3689999999999999999999963 389999999999999 67889999999998765
Q ss_pred CCc--cccccccccccChhhhcCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChhhhcc
Q psy11727 267 GQT--LYQYIQSRYYRSPEVLLGIP----YDLAIDMWSLGCILVELHTGEPLFSGKNE-VDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 267 ~~~--~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~p~~~~~~~ 339 (437)
... .....++..|+|||++.+.. ++.++|+||||+++|+|++|+.||..... .+.+..+.... .+.
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~----- 238 (296)
T cd06618 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE--PPS----- 238 (296)
T ss_pred cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC--CCC-----
Confidence 332 12334678899999997654 78999999999999999999999976432 22333322110 000
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
.+.. ......+.+||.+||..||.+||
T Consensus 239 ----------------------------~~~~-------------------------~~~~~~l~~li~~~l~~~p~~Rp 265 (296)
T cd06618 239 ----------------------------LPPN-------------------------EGFSPDFCSFVDLCLTKDHRKRP 265 (296)
T ss_pred ----------------------------CCCC-------------------------CCCCHHHHHHHHHHccCChhhCC
Confidence 0000 00012579999999999999999
Q ss_pred CHHHHhcCCCcCcC
Q psy11727 420 SPTNVLRHEFFLKH 433 (437)
Q Consensus 420 t~~e~l~Hp~~~~~ 433 (437)
|++++++||||+..
T Consensus 266 ~~~~il~~~~~~~~ 279 (296)
T cd06618 266 KYRELLQHPFIRRY 279 (296)
T ss_pred CHHHHhcChhhhcc
Confidence 99999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=305.27 Aligned_cols=246 Identities=32% Similarity=0.466 Sum_probs=198.0
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEec
Q psy11727 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELL 193 (437)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~ 193 (437)
||.|+||.||+|.+..+++.+|+|.+..... .......|+.++..+ .|+||+++++.+...+..|+|||++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-----QSPYVVKLYYSFQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-----CCcchhHHHHheecCcEEEEEEecC
Confidence 6899999999999999999999999864332 233445555655554 6899999999999999999999999
Q ss_pred cC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc---
Q psy11727 194 SY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT--- 269 (437)
Q Consensus 194 ~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~--- 269 (437)
.+ +|.+++.... .+++..+..++.||+.||+|||. .|++|+||+|+||++ +.++.++|+|||++......
T Consensus 76 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~di~~~nil~--~~~~~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 76 PGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHS--NGIIHRDLKPDNILI--DSNGHLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--cCeecCCCCHHHeEE--cCCCCEEEEecccchhcccCccc
Confidence 65 8888887654 58999999999999999999995 489999999999999 67888999999998654222
Q ss_pred --------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 270 --------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 270 --------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
.....++..|+|||+..+..++.++|+||||+++|++++|..||...........+......++..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 223 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED------ 223 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc------
Confidence 123457788999999998889999999999999999999999998887766655543311000000
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
......+.+||.+||+.+|.+|||+
T Consensus 224 -------------------------------------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~ 248 (265)
T cd05579 224 -------------------------------------------------------VEVSDEAIDLISKLLVPDPEKRLGA 248 (265)
T ss_pred -------------------------------------------------------ccCCHHHHHHHHHHhcCCHhhcCCC
Confidence 0001257899999999999999999
Q ss_pred ---HHHhcCCCcCcCCC
Q psy11727 422 ---TNVLRHEFFLKHSV 435 (437)
Q Consensus 422 ---~e~l~Hp~~~~~~~ 435 (437)
.++|+||||++.++
T Consensus 249 ~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 249 KSIEEIKNHPFFKGIDW 265 (265)
T ss_pred ccHHHHhcCccccCCCC
Confidence 99999999987653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=301.39 Aligned_cols=249 Identities=32% Similarity=0.485 Sum_probs=203.7
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+|.+.+.||.|+||.||++.+..++..||+|++.... ........|+.++..+ .|+|++++.+.+...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~~~~~~~~~~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-----NHPNIIKYYESFEEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-----CCCChhheEEEEecCCEEE
Confidence 5889999999999999999999999999999987432 2234455677666665 6899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 188 LVFELLSY-NLYNLIRNTN--FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~--~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+|+|++++ +|.+.+.... ...+++..+..++.|++.||+|||++ |++|+||+|+||++ +.++.++|+|||.+.
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~~H~dl~~~nil~--~~~~~~~l~d~~~~~ 151 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--KILHRDIKPQNIFL--TSNGLVKLGDFGISK 151 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC--CEecccCChHHeEE--cCCCcEEECCcccee
Confidence 99999976 8988887643 35689999999999999999999964 89999999999999 667889999999987
Q ss_pred ecCCcc---ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 265 HVGQTL---YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 265 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
...... ....|+..|+|||.+.+..++.++|+||+|+++++|++|..||...+.......+......+.
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 223 (258)
T cd08215 152 VLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI-------- 223 (258)
T ss_pred ecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCC--------
Confidence 664432 235678899999999998999999999999999999999999988775554444322110000
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
+. .....+.++|.+||..||.+|||+
T Consensus 224 ---------~~---------------------------------------------~~~~~~~~~i~~~l~~~p~~Rp~~ 249 (258)
T cd08215 224 ---------PS---------------------------------------------QYSSELRNLVSSLLQKDPEERPSI 249 (258)
T ss_pred ---------CC---------------------------------------------CCCHHHHHHHHHHcCCChhhCcCH
Confidence 00 001257899999999999999999
Q ss_pred HHHhcCCCc
Q psy11727 422 TNVLRHEFF 430 (437)
Q Consensus 422 ~e~l~Hp~~ 430 (437)
.++|+||||
T Consensus 250 ~~ll~~~~~ 258 (258)
T cd08215 250 AQILQSPFI 258 (258)
T ss_pred HHHhcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=317.40 Aligned_cols=293 Identities=20% Similarity=0.215 Sum_probs=194.9
Q ss_pred ceeccc--CceEEEEEEEcCCCeEEEEEEecCCccc---chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEE
Q psy11727 116 TLLGKG--SFGQVVKAFDHEEKCQVAIKIIKNKKPF---LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVF 190 (437)
Q Consensus 116 ~~lG~G--~fg~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~ 190 (437)
..||+| +||+||+|.+..+++.||+|++...... .+.+..|+.+++.+ .|+||++++++|...+..++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-----~h~niv~~~~~~~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-----RHPNIMTSWTVFTTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCcceEeeeEecCCceEEEE
Confidence 456666 9999999999999999999998643221 23445555555444 7899999999999999999999
Q ss_pred EeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC-
Q psy11727 191 ELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ- 268 (437)
Q Consensus 191 E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~- 268 (437)
||+.+ ++.+++.......+++..+..++.||+.||+|||+ .||+||||||+|||+ +.++.++++||+.+.....
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivHrDlkp~Nill--~~~~~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILI--SGDGLVSLSGLSHLYSLVRN 154 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEE--eCCCcEEEechHHHhhhhcc
Confidence 99965 88888876544568999999999999999999995 489999999999999 5678899999985432211
Q ss_pred --c-------cccccccccccChhhhcCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 269 --T-------LYQYIQSRYYRSPEVLLGI--PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 269 --~-------~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
. .....++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.........+.......|....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 0 0112245669999999763 4789999999999999999999999887665544443332111111000
Q ss_pred ccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCC
Q psy11727 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKK 417 (437)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 417 (437)
........+.. ............ ...+.. .... .... .....+......+.+||++||++||.+
T Consensus 235 ~~~~~~~~~~~----~~~~~~~~~~~~-~~~~~~--~~~~--------~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~ 298 (328)
T cd08226 235 TFPCEESRMKN----SQSGVDSGIGES-VVAAGM--TQTM--------TSER-LRTPSSKTFSPAFQNLVELCLQQDPEK 298 (328)
T ss_pred ccchhhhhhcc----chhhhhcccccc-hhcccc--cccc--------cccc-ccchhhhhhhHHHHHHHHHHccCCccc
Confidence 00000000000 000000000000 000000 0000 0000 000111223347899999999999999
Q ss_pred CCCHHHHhcCCCcCcC
Q psy11727 418 RISPTNVLRHEFFLKH 433 (437)
Q Consensus 418 R~t~~e~l~Hp~~~~~ 433 (437)
|||+.|+|+||||.+.
T Consensus 299 Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 299 RPSASSLLSHAFFKQV 314 (328)
T ss_pred CCCHHHHhhCHHHHHH
Confidence 9999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=328.63 Aligned_cols=248 Identities=26% Similarity=0.432 Sum_probs=199.7
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCC-cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccC
Q psy11727 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNK-KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY 195 (437)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~ 195 (437)
+||+|.||+||-|++..|...+|||.+..+ +........|+.+...+ .|.|||+++|.+..++++-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-----rHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-----RHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-----hhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 689999999999999999999999999754 34455677888888887 678899999999999999999999976
Q ss_pred -cHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC---Cc
Q psy11727 196 -NLYNLIRNTNFHGV--SLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG---QT 269 (437)
Q Consensus 196 -~L~~~l~~~~~~~l--s~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~---~~ 269 (437)
+|.+++... -+++ .++.+-.+.+||+.||.|||.. .|||||||-+|||+. .-.|.+||+|||.++... .-
T Consensus 657 GSLSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen--~IVHRDIKGDNVLvN-TySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 657 GSLSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHEN--KIVHRDIKGDNVLVN-TYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CcHHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhc--ceeeccccCCcEEEe-eccceEEecccccchhhccCCcc
Confidence 677777653 3456 8899999999999999999965 699999999999996 477899999999998763 23
Q ss_pred cccccccccccChhhhcCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhh
Q psy11727 270 LYQYIQSRYYRSPEVLLGI--PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347 (437)
Q Consensus 270 ~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 347 (437)
..++.||..|||||++..+ +|+.++|||||||++.||.||+|||...... ...|.. ..+|
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-------------qAAMFk-----VGmy 794 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-------------QAAMFK-----VGMY 794 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-------------hHhhhh-----hcce
Confidence 3468899999999999765 5999999999999999999999999753321 111110 0011
Q ss_pred cccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
... |.-+.+...+.+.||.+|+.+||.+||+|+++|+.
T Consensus 795 KvH------------------------------------------P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 795 KVH------------------------------------------PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred ecC------------------------------------------CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 110 01112223367899999999999999999999999
Q ss_pred CCcCcC
Q psy11727 428 EFFLKH 433 (437)
Q Consensus 428 p~~~~~ 433 (437)
||++..
T Consensus 833 pFlq~~ 838 (1226)
T KOG4279|consen 833 PFLQHN 838 (1226)
T ss_pred cccccC
Confidence 999864
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=309.12 Aligned_cols=247 Identities=25% Similarity=0.341 Sum_probs=196.8
Q ss_pred ccCeeeeceecccCceEEEEEEEcC-----CCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHE-----EKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.++.... ....+..|+.+++.+ .|+||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~ 78 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-----QHENIVKFYGVCT 78 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-----CCCCchheeeEEe
Confidence 3568899999999999999998743 467899999874432 234667788887776 6889999999999
Q ss_pred ECCEEEEEEEeccC-cHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEe
Q psy11727 182 WKNHLCLVFELLSY-NLYNLIRNTN------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLC 248 (437)
Q Consensus 182 ~~~~~~lV~E~~~~-~L~~~l~~~~------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~ 248 (437)
..+..++||||+++ +|.+++.... ...+++..+..++.||+.||.|||++ |++||||||+||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~--~i~h~dlkp~nili- 155 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ--HFVHRDLATRNCLV- 155 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC--CeeccccccceEEE-
Confidence 99999999999965 8988886542 23478899999999999999999954 89999999999999
Q ss_pred cCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy11727 249 SPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQM 322 (437)
Q Consensus 249 ~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~ 322 (437)
+.++.++|+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+..
T Consensus 156 -~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~ 234 (280)
T cd05049 156 -GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234 (280)
T ss_pred -cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 677899999999987543221 12334678999999999999999999999999999998 99999887776655
Q ss_pred HHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhH
Q psy11727 323 TKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMK 402 (437)
Q Consensus 323 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (437)
..+......++.. .....
T Consensus 235 ~~~~~~~~~~~~~--------------------------------------------------------------~~~~~ 252 (280)
T cd05049 235 ECITQGRLLQRPR--------------------------------------------------------------TCPSE 252 (280)
T ss_pred HHHHcCCcCCCCC--------------------------------------------------------------CCCHH
Confidence 5543211000000 00015
Q ss_pred HHHHHHHccccCCCCCCCHHHHhc
Q psy11727 403 FKDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 403 ~~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
+.+||++||+.||.+|||+.|+++
T Consensus 253 ~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 253 VYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHH
Confidence 789999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=290.68 Aligned_cols=199 Identities=26% Similarity=0.329 Sum_probs=163.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC----
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK---- 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~---- 183 (437)
.+||.+.+.||+|||+.||+++...+++.+|+|++.-.. ...+...+|+...+++ .|||+++++++...+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-----~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-----NSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-----CCcchHHHHHHHHHhhccC
Confidence 468999999999999999999999999999999986433 3334455566665555 789999999987543
Q ss_pred -CEEEEEEEec-cCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 184 -NHLCLVFELL-SYNLYNLIRNTNF--HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 184 -~~~~lV~E~~-~~~L~~~l~~~~~--~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
...||+++|. .|+|.+.+..... ..+++..+..|+.+|++||.+||.....+.||||||.|||+ .+.+.++|.|
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl--s~~~~~vl~D 172 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL--SDSGLPVLMD 172 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe--cCCCceEEEe
Confidence 3599999999 5679998865433 34899999999999999999999875569999999999999 5578899999
Q ss_pred CCCceecCCccc------------cccccccccChhhhcCC---CCCCcchHHHHHHHHHHHHhCCCCCC
Q psy11727 260 FGSSCHVGQTLY------------QYIQSRYYRSPEVLLGI---PYDLAIDMWSLGCILVELHTGEPLFS 314 (437)
Q Consensus 260 FG~s~~~~~~~~------------~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltg~~pf~ 314 (437)
||+++...-... .-..|..|+|||.+.-+ ..+.++|||||||+||+|+.|..||.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe 242 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE 242 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence 999976543221 22457889999998644 56789999999999999999999996
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=306.72 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=208.4
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
..+.|++.+.||+|+||.||+|.+..++..||+|++.........+..|+.++..+ .|+|++++++.+...+..+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-----KHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-----CCCCeeEEEEEEEECCEEE
Confidence 45679999999999999999999998899999999975443344566677777665 6889999999999999999
Q ss_pred EEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+|+||++ ++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||+|+||++ +.++.++|+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~--~gi~H~dl~p~ni~i--~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS--QNVIHRDIKSDNILL--SKDGSVKLADFGFAAQL 166 (286)
T ss_pred EEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCChhhEEE--cCCCCEEECccchhhhh
Confidence 9999997 58999988754 368999999999999999999995 589999999999999 67888999999988654
Q ss_pred CCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
... .....++..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+... +.++...
T Consensus 167 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~------- 238 (286)
T cd06614 167 TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPPLKN------- 238 (286)
T ss_pred ccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCCcc-------
Confidence 322 12345678899999999989999999999999999999999999887765544443221 0000000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
...-...+.+||++||+.+|.+|||+.+
T Consensus 239 ----------------------------------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 266 (286)
T cd06614 239 ----------------------------------------------------PEKWSPEFKDFLNKCLVKDPEKRPSAEE 266 (286)
T ss_pred ----------------------------------------------------hhhCCHHHHHHHHHHhccChhhCcCHHH
Confidence 0000125789999999999999999999
Q ss_pred HhcCCCcCcCC
Q psy11727 424 VLRHEFFLKHS 434 (437)
Q Consensus 424 ~l~Hp~~~~~~ 434 (437)
+++||||++..
T Consensus 267 il~~~~~~~~~ 277 (286)
T cd06614 267 LLQHPFLKKAC 277 (286)
T ss_pred HhhChHhhccC
Confidence 99999998843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=302.88 Aligned_cols=246 Identities=21% Similarity=0.316 Sum_probs=197.3
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
..++|++.++||+|+||.||+|... +++.||+|.+.........+..|+.++..+ .|+||+++++++. .+..+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQL-----QHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhc-----CCcCeeeEEEEEc-cCCcE
Confidence 4568999999999999999999864 567899999976554456677788887776 6889999998764 56789
Q ss_pred EEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+|||++. ++|.+++.......+++..+..++.|++.||+|||+ .|++||||||+||++ +.++.++|+|||++...
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~--~~i~H~dl~p~ni~i--~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER--KNYIHRDLRAANILV--SETLCCKIADFGLARLI 152 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHHhEEE--cCCCCEEEccCcceeec
Confidence 9999995 489998876555568999999999999999999995 589999999999999 67888999999999765
Q ss_pred CCccc----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 267 GQTLY----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 267 ~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
..... ...++..|+|||++.+..++.++|+||||+++|||++ |++||.+.+..+....+......+...
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 226 (260)
T cd05067 153 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD------ 226 (260)
T ss_pred CCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC------
Confidence 42211 2234567999999998889999999999999999999 999999877665555443211111000
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
.....+.+||.+||+.||++|||+
T Consensus 227 --------------------------------------------------------~~~~~~~~li~~~l~~~p~~Rp~~ 250 (260)
T cd05067 227 --------------------------------------------------------NCPEELYELMRLCWKEKPEERPTF 250 (260)
T ss_pred --------------------------------------------------------CCCHHHHHHHHHHccCChhhCCCH
Confidence 001157999999999999999999
Q ss_pred HHHhc
Q psy11727 422 TNVLR 426 (437)
Q Consensus 422 ~e~l~ 426 (437)
++++.
T Consensus 251 ~~l~~ 255 (260)
T cd05067 251 EYLRS 255 (260)
T ss_pred HHHHH
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=310.26 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=201.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc----chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~----~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.+.|...+.||+|+||+||+|++..++..||+|++...... ...+..|+.+++.+ .|+|++++++++.+.+
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~ 94 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-----KHPNTIEYKGCYLKEH 94 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-----CCCCCccEEEEEEeCC
Confidence 34477788899999999999999999999999998643221 12344566666554 7899999999999999
Q ss_pred EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 185 HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 185 ~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
..++||||+.+++.+++.... ..+++..+..++.||+.||.|||+ .|++|+||+|+||++ +.++.+||+|||++.
T Consensus 95 ~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dl~p~nili--~~~~~~kL~dfg~~~ 169 (313)
T cd06633 95 TAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILL--TEPGQVKLADFGSAS 169 (313)
T ss_pred EEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChhhEEE--CCCCCEEEeecCCCc
Confidence 999999999999888876644 458999999999999999999995 489999999999999 667889999999986
Q ss_pred ecCCccccccccccccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 265 HVGQTLYQYIQSRYYRSPEVLL---GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 265 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
.... .....|+..|+|||++. +..++.++|+|||||++|+|++|.+||...+.......+... .++....
T Consensus 170 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~---- 242 (313)
T cd06633 170 KSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPTLQS---- 242 (313)
T ss_pred ccCC-CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCCCCCc----
Confidence 5432 23457888999999984 356889999999999999999999999887665555444221 0100000
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
......+.+||.+||+.+|.+|||+
T Consensus 243 -------------------------------------------------------~~~~~~l~~li~~~l~~~P~~Rp~~ 267 (313)
T cd06633 243 -------------------------------------------------------NEWTDSFRGFVDYCLQKIPQERPAS 267 (313)
T ss_pred -------------------------------------------------------cccCHHHHHHHHHHccCChhhCcCH
Confidence 0000147899999999999999999
Q ss_pred HHHhcCCCcCcCC
Q psy11727 422 TNVLRHEFFLKHS 434 (437)
Q Consensus 422 ~e~l~Hp~~~~~~ 434 (437)
.+++.||||+...
T Consensus 268 ~~~l~~~~~~~~~ 280 (313)
T cd06633 268 AELLRHDFVRRDR 280 (313)
T ss_pred HHHhcCcccCCCc
Confidence 9999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.03 Aligned_cols=248 Identities=27% Similarity=0.437 Sum_probs=190.2
Q ss_pred eeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEe
Q psy11727 114 IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFEL 192 (437)
Q Consensus 114 i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~ 192 (437)
....||+|+||.||+|.+..++..||+|.+..... ....+..|+.+++.+ .|+||+++++++...+..++||||
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-----KHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-----CCCCeeeeeeeeccCCEEEEEEec
Confidence 34579999999999999999999999999864432 234566777777665 789999999999999999999999
Q ss_pred ccC-cHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc
Q psy11727 193 LSY-NLYNLIRNTNFHGV--SLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT 269 (437)
Q Consensus 193 ~~~-~L~~~l~~~~~~~l--s~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~ 269 (437)
+++ +|.+++.... ..+ ++..+..++.||+.||+|||+ .||+||||||+||+++. ..+.++|+|||++......
T Consensus 87 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~h~dl~p~nil~~~-~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 87 VPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHD--NQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred CCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcC-CCCeEEEecchhheecccC
Confidence 965 8888887542 234 788899999999999999995 48999999999999942 3568999999998765321
Q ss_pred ---cccccccccccChhhhcCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc
Q psy11727 270 ---LYQYIQSRYYRSPEVLLGIP--YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344 (437)
Q Consensus 270 ---~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 344 (437)
.....++..|+|||++.+.. ++.++|+||||+++|+|++|.+||...................+
T Consensus 163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 231 (268)
T cd06624 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP----------- 231 (268)
T ss_pred CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCC-----------
Confidence 22345788999999987643 78999999999999999999999975432111110000000000
Q ss_pred hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHH
Q psy11727 345 KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNV 424 (437)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~ 424 (437)
..+......+.+|+++||+.+|.+|||+.|+
T Consensus 232 -------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 262 (268)
T cd06624 232 -------------------------------------------------EIPESLSAEAKNFILRCFEPDPDKRASAHDL 262 (268)
T ss_pred -------------------------------------------------CCCcccCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 0000011257899999999999999999999
Q ss_pred hcCCCc
Q psy11727 425 LRHEFF 430 (437)
Q Consensus 425 l~Hp~~ 430 (437)
+.||||
T Consensus 263 l~~~~~ 268 (268)
T cd06624 263 LQDPFL 268 (268)
T ss_pred HhCCCC
Confidence 999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=302.88 Aligned_cols=245 Identities=23% Similarity=0.312 Sum_probs=196.1
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
++|.+.+.||+|+||+||+|.+.. +..+|+|.+.........+..|+.+++.+ .||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKL-----SHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcC-----CCCCeeeEEEEEccCCCcEEE
Confidence 468999999999999999997654 45699999875544345667777777665 789999999999999999999
Q ss_pred EEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 190 FELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 190 ~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
|||+.+ +|.+++.... ..+++..++.++.||+.||+|||+ .|++|+||||+||++ +.++.+||+|||++.....
T Consensus 78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~nili--~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLES--KQFIHRDLAARNCLV--DDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEE--cCCCCEEECCCccceecCC
Confidence 999965 7888887643 358999999999999999999995 489999999999999 6678899999999875533
Q ss_pred ccc----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 269 TLY----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 269 ~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
... ...++..|+|||++.+..++.++|+|||||++|+|++ |..||...+..+....+......+...
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 224 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPH-------- 224 (256)
T ss_pred CceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCC--------
Confidence 221 1234467999999998889999999999999999999 999998877665555553321110000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
.....+.+++.+||+.||.+|||+.+
T Consensus 225 ------------------------------------------------------~~~~~~~~li~~cl~~~p~~Rp~~~~ 250 (256)
T cd05113 225 ------------------------------------------------------LASEKVYAIMYSCWHEKAEERPTFQQ 250 (256)
T ss_pred ------------------------------------------------------CCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 00125789999999999999999999
Q ss_pred HhcC
Q psy11727 424 VLRH 427 (437)
Q Consensus 424 ~l~H 427 (437)
++.+
T Consensus 251 ll~~ 254 (256)
T cd05113 251 LLSS 254 (256)
T ss_pred HHHh
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=298.57 Aligned_cols=249 Identities=29% Similarity=0.483 Sum_probs=201.1
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC--CE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK--NH 185 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~--~~ 185 (437)
+|.+.+.||+|++|.||+|.+..++..|++|++.... .....+..|+.+++.+ .|+||+++++.+... +.
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-----QHPNIVRYYGSERDEEKNT 75 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-----CCCCEeeEEEEEecCCCCe
Confidence 4788899999999999999999899999999987544 2345566777777776 589999999999988 89
Q ss_pred EEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+++|+|+++ ++|.+++.... .+++..+..++.|++.||+|||+ .|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~--~~~~h~dl~p~ni~i--~~~~~~~l~d~~~~~ 149 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS--NGIVHRDIKGANILV--DSDGVVKLADFGCAK 149 (260)
T ss_pred EEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEE--cCCCCEEEcccccEE
Confidence 999999995 58988887654 68999999999999999999996 589999999999999 567889999999998
Q ss_pred ecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhcc
Q psy11727 265 HVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 265 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 339 (437)
...... ....++..|+|||.+.+..++.++|+||||+++++|++|..||...+. ....+........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~------ 221 (260)
T cd06606 150 RLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGSSGE------ 221 (260)
T ss_pred ecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccccCC------
Confidence 765442 345678899999999988899999999999999999999999987662 1111111100000
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
.. ..| ......+.+||.+||+.||.+||
T Consensus 222 -------~~------------------~~~---------------------------~~~~~~l~~~i~~~l~~~p~~Rp 249 (260)
T cd06606 222 -------PP------------------EIP---------------------------EHLSEEAKDFLRKCLRRDPKKRP 249 (260)
T ss_pred -------Cc------------------CCC---------------------------cccCHHHHHHHHHhCcCChhhCC
Confidence 00 000 00012679999999999999999
Q ss_pred CHHHHhcCCCc
Q psy11727 420 SPTNVLRHEFF 430 (437)
Q Consensus 420 t~~e~l~Hp~~ 430 (437)
|+.++++||||
T Consensus 250 ~~~~ll~~~~~ 260 (260)
T cd06606 250 TADELLQHPFL 260 (260)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=308.87 Aligned_cols=255 Identities=29% Similarity=0.468 Sum_probs=200.3
Q ss_pred CeeeeceecccCceEEEEEEEc---CCCeEEEEEEecCCc-----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDH---EEKCQVAIKIIKNKK-----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~---~~~~~vaiK~i~~~~-----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
.|++.+.||+|+||.||+|.+. .+|..||+|+++... ........|+.+++.+. +|++|+.++++|..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR----QSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcc----cCCChhceeeEeec
Confidence 4889999999999999999874 478999999986422 12345566888887764 57899999999999
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
+..+|+||||+++ +|.+++.... .+++..+..++.|++.||.|||+ .|++||||+|+|||+ +.++.+||+|||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nil~--~~~~~~kl~dfg 150 (290)
T cd05613 77 DTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHK--LGIIYRDIKLENILL--DSNGHVVLTDFG 150 (290)
T ss_pred CCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEE--CCCCCEEEeeCc
Confidence 9999999999975 8988887653 58899999999999999999995 589999999999999 667889999999
Q ss_pred CceecCCc----cccccccccccChhhhcCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC--CCC
Q psy11727 262 SSCHVGQT----LYQYIQSRYYRSPEVLLGI--PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLG--MPP 333 (437)
Q Consensus 262 ~s~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~--~p~ 333 (437)
++...... .....|+..|+|||++.+. .++.++|+||||+++|+|++|..||...........+.+... .++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (290)
T cd05613 151 LSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 230 (290)
T ss_pred cceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC
Confidence 98765332 2235688899999998753 477899999999999999999999975433222222222110 000
Q ss_pred hhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
.| ......+.+|+++||+.
T Consensus 231 ----------------------------------~~---------------------------~~~~~~~~~ll~~~l~~ 249 (290)
T cd05613 231 ----------------------------------YP---------------------------QEMSALAKDIIQRLLMK 249 (290)
T ss_pred ----------------------------------CC---------------------------ccCCHHHHHHHHHHhcC
Confidence 00 00012578999999999
Q ss_pred CCCCCC-----CHHHHhcCCCcCcCCCC
Q psy11727 414 DPKKRI-----SPTNVLRHEFFLKHSVD 436 (437)
Q Consensus 414 dP~~R~-----t~~e~l~Hp~~~~~~~~ 436 (437)
||.+|| ++++++.||||++..++
T Consensus 250 ~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 277 (290)
T cd05613 250 DPKKRLGCGPSDADEIKKHPFFQKINWD 277 (290)
T ss_pred CHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence 999997 89999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=310.68 Aligned_cols=275 Identities=22% Similarity=0.266 Sum_probs=191.7
Q ss_pred CceEEEEEEEcCCCeEEEEEEecCC---cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccC-cH
Q psy11727 122 SFGQVVKAFDHEEKCQVAIKIIKNK---KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NL 197 (437)
Q Consensus 122 ~fg~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~-~L 197 (437)
++|.||.++...+++.||||++... ......+..|+.++..+ .|+||++++++|...+..+++|||+++ +|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-----~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-----QHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-----CCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4566666666779999999998743 22334666777777766 689999999999999999999999975 78
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc--------
Q psy11727 198 YNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT-------- 269 (437)
Q Consensus 198 ~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~-------- 269 (437)
.+++.......+++..+..++.|++.||+|||++ ||+||||||+||++ +.++.+||+|||.+......
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~--~ivH~dlk~~Nili--~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK--GFIHRSVKASHILL--SGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCcceEEE--ecCCceEEecCccceeeccccccccccc
Confidence 8888765445689999999999999999999964 89999999999999 56788999999988654211
Q ss_pred --cccccccccccChhhhcC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccch
Q psy11727 270 --LYQYIQSRYYRSPEVLLG--IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSK 345 (437)
Q Consensus 270 --~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 345 (437)
.....++..|+|||++.+ ..++.++|+|||||++|+|++|.+||............ ..+..+..+.. ... ..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~-~~~-~~ 238 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK--VRGTVPCLLDK-STY-PL 238 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhccCcccccc-Cch-hh
Confidence 122346778999999976 35889999999999999999999999876654332221 12222111110 000 00
Q ss_pred hhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHh
Q psy11727 346 YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVL 425 (437)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l 425 (437)
....... .. ..... +.................+.+||.+||.+||++|||++++|
T Consensus 239 ~~~~~~~-------~~--~~~~~----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 293 (314)
T cd08216 239 YEDSMSQ-------SR--SSNEH----------------PNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293 (314)
T ss_pred hcCCcCc-------cc--ccccc----------------cchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHh
Confidence 0000000 00 00000 00000000011112223688999999999999999999999
Q ss_pred cCCCcCcCC
Q psy11727 426 RHEFFLKHS 434 (437)
Q Consensus 426 ~Hp~~~~~~ 434 (437)
+||||++..
T Consensus 294 ~~p~~~~~~ 302 (314)
T cd08216 294 NHSFFKQCK 302 (314)
T ss_pred cCchHhhhc
Confidence 999998864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=310.09 Aligned_cols=252 Identities=26% Similarity=0.359 Sum_probs=201.8
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc----chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~----~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
..|...+.||+|+||.||++++..++..||+|.+...... ...+..|+.+++.+ .|+|++++++++.+.+.
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~ 99 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-----KHPNSIEYKGCYLREHT 99 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEeeCCe
Confidence 4588899999999999999999999999999998643221 22344566666554 78999999999999999
Q ss_pred EEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 186 LCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 186 ~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
.++||||++|+|.+.+.... ..+++..+..++.||+.||.|||+ .||+||||+|+||++ +.++.++|+|||++..
T Consensus 100 ~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~--~~i~H~dL~p~Nil~--~~~~~~kl~dfg~~~~ 174 (317)
T cd06635 100 AWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILL--TEPGQVKLADFGSASI 174 (317)
T ss_pred EEEEEeCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcccEEE--CCCCCEEEecCCCccc
Confidence 99999999999888776543 458999999999999999999995 489999999999999 6678899999999865
Q ss_pred cCCccccccccccccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 266 VGQTLYQYIQSRYYRSPEVLL---GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 266 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.... ....++..|+|||++. +..++.++|||||||++|+|++|.+||...+.......+......+..
T Consensus 175 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------- 245 (317)
T cd06635 175 ASPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ-------- 245 (317)
T ss_pred cCCc-ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCC--------
Confidence 5432 3456888999999984 456889999999999999999999999887665555544332110000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
.......+.+||.+||+.+|.+|||+.
T Consensus 246 -----------------------------------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~ 272 (317)
T cd06635 246 -----------------------------------------------------SNEWSDYFRNFVDSCLQKIPQDRPTSE 272 (317)
T ss_pred -----------------------------------------------------CccccHHHHHHHHHHccCCcccCcCHH
Confidence 000011478999999999999999999
Q ss_pred HHhcCCCcCcC
Q psy11727 423 NVLRHEFFLKH 433 (437)
Q Consensus 423 e~l~Hp~~~~~ 433 (437)
++++|||+...
T Consensus 273 ~il~~~~~~~~ 283 (317)
T cd06635 273 ELLKHMFVLRE 283 (317)
T ss_pred HHHhChhhhcc
Confidence 99999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=309.62 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=194.3
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCe--EEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKC--QVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~--~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|++.+.||+|+||.||+|.+..++. .+++|.++... .....+..|+.++.++. +||||+++++++...+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~~~~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG----HHPNIINLLGACENRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhc----CCCchhheEEEEccCCc
Confidence 579999999999999999999877764 47888876321 22345666777777663 58999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC
Q psy11727 186 LCLVFELLSY-NLYNLIRNTN--------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP 250 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~--------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~ 250 (437)
+++||||+++ +|.+++.... ...+++..++.++.||+.||+|||+ .||+||||||+|||+ +
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nill--~ 153 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARNVLV--G 153 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCcCCcceEEE--C
Confidence 9999999964 8998886532 1248899999999999999999995 489999999999999 6
Q ss_pred CCCCEEEEeCCCceecCCccccc--cccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q psy11727 251 KRSAIKIIDFGSSCHVGQTLYQY--IQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIE 327 (437)
Q Consensus 251 ~~~~ikL~DFG~s~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~ 327 (437)
.++.+||+|||++.......... ..+..|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+..
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~ 233 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233 (297)
T ss_pred CCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 67889999999986443222222 22456999999999899999999999999999998 9999998877666555432
Q ss_pred HhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHH
Q psy11727 328 VLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLI 407 (437)
Q Consensus 328 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 407 (437)
....+.. ......+.+||
T Consensus 234 ~~~~~~~--------------------------------------------------------------~~~~~~~~~li 251 (297)
T cd05089 234 GYRMEKP--------------------------------------------------------------RNCDDEVYELM 251 (297)
T ss_pred CCCCCCC--------------------------------------------------------------CCCCHHHHHHH
Confidence 1110000 00012578999
Q ss_pred HHccccCCCCCCCHHHHhcC
Q psy11727 408 LRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 408 ~~~L~~dP~~R~t~~e~l~H 427 (437)
.+||+.||.+|||++++++.
T Consensus 252 ~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 252 RQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=308.24 Aligned_cols=251 Identities=25% Similarity=0.430 Sum_probs=199.0
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVF 190 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~ 190 (437)
|.-...||+|+||.||++....+++.||+|.+..... ....+..|+.++..+ .|+||+++++.|...++.++||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-----QHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-----CCcchhheeeEEEeCCEEEEEE
Confidence 3344678999999999999999999999999864322 223455566666655 6899999999999999999999
Q ss_pred EeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc
Q psy11727 191 ELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT 269 (437)
Q Consensus 191 E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~ 269 (437)
||+++ +|.+++... .+++..++.++.|++.||+|||+. |++|+||+|+||++ ++++.++|+|||++......
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~--givH~dl~p~Nilv--~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 97 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ--GVIHRDIKSDSILL--THDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred ecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEE--CCCCCEEEcccccceecccc
Confidence 99976 677766443 479999999999999999999964 89999999999999 67788999999998655332
Q ss_pred ---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchh
Q psy11727 270 ---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKY 346 (437)
Q Consensus 270 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~ 346 (437)
.....++..|+|||++.+..++.++|+||||+++|+|++|.+||.+.........+.... ++..
T Consensus 170 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~----------- 236 (292)
T cd06657 170 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL--PPKL----------- 236 (292)
T ss_pred cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC--Cccc-----------
Confidence 223567889999999988889999999999999999999999999877665554443211 1000
Q ss_pred hcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhc
Q psy11727 347 FDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
..+ ......+.++|.+||+.||.+|||+.++++
T Consensus 237 -~~~----------------------------------------------~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 237 -KNL----------------------------------------------HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred -CCc----------------------------------------------ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 000 000114689999999999999999999999
Q ss_pred CCCcCcCC
Q psy11727 427 HEFFLKHS 434 (437)
Q Consensus 427 Hp~~~~~~ 434 (437)
||||.+.-
T Consensus 270 ~~~~~~~~ 277 (292)
T cd06657 270 HPFLAKAG 277 (292)
T ss_pred ChHHhccC
Confidence 99998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=301.61 Aligned_cols=245 Identities=23% Similarity=0.352 Sum_probs=196.1
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
..++|++.+.||+|+||+||+|.+. ++..+|+|.+.........+..|+.+++.+ .|++++++++++. .+..+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-----~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL-----RHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc-----CCCceEEEEeEEC-CCCcE
Confidence 3568999999999999999999865 456799999976544445677888888776 6789999999875 45688
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|.+++.......+++..++.++.|++.||+|||+ .|++||||||+||++ ++++.++|+|||++...
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~Nili--~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER--MNYIHRDLRSANILV--GDGLVCKIADFGLARLI 152 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCccceEEE--eCCceEEeCCceeeeec
Confidence 99999965 89998876554568999999999999999999995 489999999999999 56788999999999765
Q ss_pred CCccc----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 267 GQTLY----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 267 ~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
..... ...++..|+|||++.+..++.++|+||||+++|+|++ |.+||.+.+..+....+......+.
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 224 (260)
T cd05070 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC-------- 224 (260)
T ss_pred cCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence 43221 1234557999999998899999999999999999999 8999988776666555432111000
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
+......+.+||.+||..||.+|||+
T Consensus 225 ------------------------------------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~ 250 (260)
T cd05070 225 ------------------------------------------------------PQDCPISLHELMLQCWKKDPEERPTF 250 (260)
T ss_pred ------------------------------------------------------CCcCCHHHHHHHHHHcccCcccCcCH
Confidence 00001257899999999999999999
Q ss_pred HHHh
Q psy11727 422 TNVL 425 (437)
Q Consensus 422 ~e~l 425 (437)
.+++
T Consensus 251 ~~l~ 254 (260)
T cd05070 251 EYLQ 254 (260)
T ss_pred HHHH
Confidence 9886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=311.44 Aligned_cols=249 Identities=25% Similarity=0.313 Sum_probs=193.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeE--EEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQ--VAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~--vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||+||+|.+..++.. +|+|.++... .....+..|+.++..+. .|+||+++++++...+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~----~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG----HHPNIINLLGACEHRG 81 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhc----CCCCcceEEEEECCCC
Confidence 35799999999999999999998877754 5777765321 22335566877777763 6899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTN--------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS 249 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~--------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~ 249 (437)
.+++||||+++ +|.+++.... ...+++..++.++.||+.||+|||+ .|++||||||+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dlkp~Nili-- 157 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILV-- 157 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEe--
Confidence 99999999964 8999886542 1247899999999999999999995 489999999999999
Q ss_pred CCCCCEEEEeCCCceecCCcccc--ccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy11727 250 PKRSAIKIIDFGSSCHVGQTLYQ--YIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKII 326 (437)
Q Consensus 250 ~~~~~ikL~DFG~s~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~ 326 (437)
+.++.+||+|||++......... ..++..|+|||++.+..++.++|||||||++|||+| |.+||.+.+..+....+.
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred cCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 67788999999998643222122 223567999999988889999999999999999998 999998877655544331
Q ss_pred HHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHH
Q psy11727 327 EVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406 (437)
Q Consensus 327 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 406 (437)
... .+. .+ ......+.+|
T Consensus 238 ~~~--~~~---------------------------------~~---------------------------~~~~~~~~~l 255 (303)
T cd05088 238 QGY--RLE---------------------------------KP---------------------------LNCDDEVYDL 255 (303)
T ss_pred cCC--cCC---------------------------------CC---------------------------CCCCHHHHHH
Confidence 100 000 00 0001157899
Q ss_pred HHHccccCCCCCCCHHHHhcC
Q psy11727 407 ILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 407 i~~~L~~dP~~R~t~~e~l~H 427 (437)
|.+||+.||++|||+++++++
T Consensus 256 i~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 256 MRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=301.91 Aligned_cols=245 Identities=21% Similarity=0.300 Sum_probs=195.6
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
.+|++.+.||+|+||.||+|.+. ++..+|+|++.........+..|+.+++.+ .|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-----SHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-----CCCCEEEEEEEEcCCCceEEE
Confidence 35889999999999999999875 466899999875444345666788877765 689999999999999999999
Q ss_pred EEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 190 FELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 190 ~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
|||+++ +|.+++.... ..+++..+..++.||+.||+|||+ .|++||||||+||++ +.++.+||+|||++.....
T Consensus 78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~i~H~dl~p~ni~i--~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 78 TEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLES--NGFIHRDLAARNCLV--GEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred EecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHhhEEE--CCCCcEEECCcccceeccc
Confidence 999965 7999887644 358999999999999999999995 489999999999999 6788899999999876543
Q ss_pred ccc-ccc---ccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 269 TLY-QYI---QSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 269 ~~~-~~~---gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
... ... ++..|+|||++.+..++.++|+||||+++|+|++ |.+||.+.+..+....+......+.
T Consensus 153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 222 (256)
T cd05059 153 DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR---------- 222 (256)
T ss_pred ccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCC----------
Confidence 221 112 2346999999999899999999999999999999 8999988776655544432111000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
| ......+.+++.+||..+|++|||+.+
T Consensus 223 -------------------------~---------------------------~~~~~~~~~li~~cl~~~p~~Rpt~~~ 250 (256)
T cd05059 223 -------------------------P---------------------------KLAPTEVYTIMYSCWHEKPEDRPAFKK 250 (256)
T ss_pred -------------------------C---------------------------CCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 0 000125789999999999999999999
Q ss_pred HhcC
Q psy11727 424 VLRH 427 (437)
Q Consensus 424 ~l~H 427 (437)
+++.
T Consensus 251 ~l~~ 254 (256)
T cd05059 251 LLSQ 254 (256)
T ss_pred HHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=301.71 Aligned_cols=245 Identities=22% Similarity=0.335 Sum_probs=195.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.++|++.+.||+|+||+||+|.+..++ .||+|+++........+..|+.+++.+ .|+||+++++.+. .+..++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l-----~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhC-----CCCCcceEEEEEC-CCCcEE
Confidence 467999999999999999999886654 599999975444445677788888776 6889999998775 456899
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
||||+++ +|.+++.......+++..+..++.|++.||+|||+ .|++||||||+||++ +.++.++|+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~Nill--~~~~~~~L~dfg~~~~~~ 153 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILV--GENLVCKVADFGLARLIE 153 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcccEEE--cCCCcEEeccCCceeecc
Confidence 9999965 89888876544458999999999999999999995 489999999999999 667889999999997654
Q ss_pred Cccc----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 268 QTLY----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 268 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.... ...++..|+|||++.+..++.++|+|||||++|+|++ |.+||.+.........+......+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 224 (262)
T cd05071 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC--------- 224 (262)
T ss_pred ccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC---------
Confidence 3322 2334567999999998899999999999999999999 8999988776555544422110000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
+......+.+||.+||+.||.+|||+.
T Consensus 225 -----------------------------------------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~ 251 (262)
T cd05071 225 -----------------------------------------------------PPECPESLHDLMCQCWRKEPEERPTFE 251 (262)
T ss_pred -----------------------------------------------------ccccCHHHHHHHHHHccCCcccCCCHH
Confidence 000112578999999999999999999
Q ss_pred HHhc
Q psy11727 423 NVLR 426 (437)
Q Consensus 423 e~l~ 426 (437)
++++
T Consensus 252 ~~~~ 255 (262)
T cd05071 252 YLQA 255 (262)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=300.44 Aligned_cols=199 Identities=26% Similarity=0.452 Sum_probs=167.0
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|++.+.||+|+||.||+|.+..+++.||||.+..... ....+..|+.+++.+ .||||+++++++.+.+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-----NHPNVIKYLDSFIEDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-----CCcceeeeeeeEEECCe
Confidence 579999999999999999999999999999998753221 122345577766665 78999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 186 LCLVFELLSY-NLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
.++||||+++ +|.+++... ....+++..+..++.||+.||+|||+ .|++|+||||+||++ +.++.++|+|||+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~nil~--~~~~~~~l~d~g~ 152 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS--RRVMHRDIKPANVFI--TATGVVKLGDLGL 152 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCCHHHEEE--cCCCCEEECcccc
Confidence 9999999975 788777532 22347899999999999999999995 489999999999999 6678899999999
Q ss_pred ceecCCcc---ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy11727 263 SCHVGQTL---YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN 317 (437)
Q Consensus 263 s~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~ 317 (437)
+....... ....++..|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 153 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence 87664322 23467889999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=301.07 Aligned_cols=198 Identities=23% Similarity=0.374 Sum_probs=162.6
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEec
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELL 193 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~ 193 (437)
+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+.+++.+ .|+||+++++++...+..++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-----SHPNIVRLIGVCTQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEcCCCCeEEEEeec
Confidence 46899999999999999999999999886332 2234566777777665 7899999999999999999999999
Q ss_pred cC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCcccc
Q psy11727 194 SY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ 272 (437)
Q Consensus 194 ~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~~~ 272 (437)
++ +|.+++.... ..+++..++.++.|++.||+|||+ .|++||||||+|||+ +.++.+||+|||++.........
T Consensus 76 ~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~--~~~~~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 76 QGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLES--KHCIHRDLAARNCLV--TEKNVLKISDFGMSREEEDGVYA 150 (252)
T ss_pred cCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEE--cCCCcEEECccccCccccccccc
Confidence 65 7888886543 358999999999999999999995 489999999999999 66788999999998754432211
Q ss_pred c-----cccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy11727 273 Y-----IQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMT 323 (437)
Q Consensus 273 ~-----~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~ 323 (437)
. ..+..|+|||.+.+..++.++|+|||||++|+|++ |.+||..........
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~ 207 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE 207 (252)
T ss_pred ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH
Confidence 1 12346999999998899999999999999999998 899998766544433
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=300.03 Aligned_cols=245 Identities=23% Similarity=0.341 Sum_probs=195.9
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.++|.+.+.||+|+||+||+|.+..++ .+|+|.+.........+..|+.+++.+ .|++++++++++. .+..++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKL-----RHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhC-----CCCCeeeEEEEEc-CCCcEE
Confidence 467999999999999999999876654 699999875544445677788888776 6889999998875 466899
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
||||+++ +|.+++.......+++..+..++.|++.||+|||+ .|++|+||||+||++ ++++.++|+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dl~~~Nill--~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER--MNYIHRDLRAANILV--GDNLVCKIADFGLARLIE 153 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEE--cCCCeEEECCCccceEcc
Confidence 9999965 89999876544458999999999999999999995 489999999999999 678889999999997654
Q ss_pred Cccc----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 268 QTLY----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 268 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.... ...++..|+|||++.+..++.++|+|||||++|+|++ |.+||.+....+....+......+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 224 (260)
T cd05069 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC--------- 224 (260)
T ss_pred CCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---------
Confidence 3221 2234567999999998899999999999999999999 9999998776665555432111000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
+......+.+|+++||..||.+|||++
T Consensus 225 -----------------------------------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~ 251 (260)
T cd05069 225 -----------------------------------------------------PQGCPESLHELMKLCWKKDPDERPTFE 251 (260)
T ss_pred -----------------------------------------------------CcccCHHHHHHHHHHccCCcccCcCHH
Confidence 000012578999999999999999999
Q ss_pred HHhc
Q psy11727 423 NVLR 426 (437)
Q Consensus 423 e~l~ 426 (437)
++++
T Consensus 252 ~i~~ 255 (260)
T cd05069 252 YIQS 255 (260)
T ss_pred HHHH
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=306.38 Aligned_cols=246 Identities=25% Similarity=0.345 Sum_probs=195.0
Q ss_pred cCeeeeceecccCceEEEEEEE-----cCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFD-----HEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~-----~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+|.+.+.||+|+||+||++.+ ..++..+|+|.+.... .....+..|+.++..+ .|+||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-----QHEHIVKFYGVCVEG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEecC
Confidence 4689999999999999999975 3356679999987433 2234566777777765 789999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTN-----------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK 251 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~-----------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~ 251 (437)
+.+++||||+++ +|.+++.... ...+++..+..++.||+.||+|||+ .|++||||||+|||+ ++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~--~~i~H~dlkp~Nili--~~ 155 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLV--GE 155 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEE--cc
Confidence 999999999965 8888886542 1248999999999999999999995 489999999999999 67
Q ss_pred CCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy11727 252 RSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKI 325 (437)
Q Consensus 252 ~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i 325 (437)
++.++|+|||++....... ....++..|+|||++.+..++.++|+|||||++|+|++ |.+||.+.+..+....+
T Consensus 156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i 235 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235 (288)
T ss_pred CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 8889999999987553221 12334668999999999899999999999999999998 99999888776665555
Q ss_pred HHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHH
Q psy11727 326 IEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKD 405 (437)
Q Consensus 326 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 405 (437)
......+. + . .....+.+
T Consensus 236 ~~~~~~~~-----------------------------------~------------------------~---~~~~~l~~ 253 (288)
T cd05093 236 TQGRVLQR-----------------------------------P------------------------R---TCPKEVYD 253 (288)
T ss_pred HcCCcCCC-----------------------------------C------------------------C---CCCHHHHH
Confidence 33110000 0 0 00015799
Q ss_pred HHHHccccCCCCCCCHHHHhc
Q psy11727 406 LILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 406 li~~~L~~dP~~R~t~~e~l~ 426 (437)
|+.+||+.||.+|||+++++.
T Consensus 254 li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 254 LMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHHccCChhhCCCHHHHHH
Confidence 999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=296.31 Aligned_cols=247 Identities=29% Similarity=0.491 Sum_probs=201.6
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+|++.+.||+|++|.||++.+..+++.||+|.+..... ....+..|+.++..+ .|+|++++++++.+.+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-----KHPNIVKYIGSIETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-----CCCCccEEEEEEEeCCEEE
Confidence 58899999999999999999999999999999975542 334556677766665 6889999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+|||++++ +|.+++... ..+++..+..++.|++.||.+||+ .||+||||+|+||++ +.++.++|+|||.+...
T Consensus 76 ~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i--~~~~~~~l~d~~~~~~~ 149 (254)
T cd06627 76 IILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE--QGVIHRDIKAANILT--TKDGVVKLADFGVATKL 149 (254)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEE--CCCCCEEEeccccceec
Confidence 99999976 888888765 458999999999999999999995 489999999999999 56788999999999776
Q ss_pred CCcc---ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQTL---YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.... ....++..|+|||...+..++.++|+||||+++|+|++|.+||...+.......+.... .++
T Consensus 150 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~---------- 218 (254)
T cd06627 150 NDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPP---------- 218 (254)
T ss_pred CCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC-CCC----------
Confidence 4433 23567889999999988888999999999999999999999998766544433332100 000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
. +......+.++|.+||..+|++|||+.+
T Consensus 219 ------------------------~---------------------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 247 (254)
T cd06627 219 ------------------------L---------------------------PEGISPELKDFLMQCFQKDPNLRPTAKQ 247 (254)
T ss_pred ------------------------C---------------------------CCCCCHHHHHHHHHHHhCChhhCcCHHH
Confidence 0 0000125789999999999999999999
Q ss_pred HhcCCCc
Q psy11727 424 VLRHEFF 430 (437)
Q Consensus 424 ~l~Hp~~ 430 (437)
++.||||
T Consensus 248 ~l~~~~~ 254 (254)
T cd06627 248 LLKHPWI 254 (254)
T ss_pred HhcCCCC
Confidence 9999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=309.37 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=201.5
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
...|...+.||+|+||+||+|++..++..+|+|.+..... ....+..|+.+++.+ .|+|++++.+++...+
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 88 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-----RHPNTIQYRGCYLREH 88 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-----CCCCcccEEEEEEcCC
Confidence 3458888999999999999999999999999999863211 122344566666655 7899999999999999
Q ss_pred EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 185 HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 185 ~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
..++||||+.+++.+.+.... ..+++..+..++.|++.||.|||+ .|++||||+|+||++ +.++.++|+|||++.
T Consensus 89 ~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nil~--~~~~~~kl~dfg~~~ 163 (308)
T cd06634 89 TAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILL--SEPGLVKLGDFGSAS 163 (308)
T ss_pred eeEEEEEccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHhEEE--CCCCcEEECCcccce
Confidence 999999999988888776543 458999999999999999999995 489999999999999 667889999999987
Q ss_pred ecCCccccccccccccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 265 HVGQTLYQYIQSRYYRSPEVLL---GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 265 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
..... ....++..|+|||++. ...++.++|||||||++|+|++|..||...+..+....+..... |. ..
T Consensus 164 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~-~~----- 235 (308)
T cd06634 164 IMAPA-NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PA-LQ----- 235 (308)
T ss_pred eecCc-ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-CC-cC-----
Confidence 65433 3456888999999985 34678899999999999999999999987665544443322100 00 00
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
.......+.+||.+||+.+|.+|||+
T Consensus 236 ------------------------------------------------------~~~~~~~~~~li~~cl~~~P~~Rp~~ 261 (308)
T cd06634 236 ------------------------------------------------------SGHWSEYFRNFVDSCLQKIPQDRPTS 261 (308)
T ss_pred ------------------------------------------------------cccccHHHHHHHHHHhhCCcccCCCH
Confidence 00001257899999999999999999
Q ss_pred HHHhcCCCcCcCC
Q psy11727 422 TNVLRHEFFLKHS 434 (437)
Q Consensus 422 ~e~l~Hp~~~~~~ 434 (437)
++++.|||+....
T Consensus 262 ~~ll~~~~~~~~~ 274 (308)
T cd06634 262 EVLLKHRFVLRER 274 (308)
T ss_pred HHHhhCccccccC
Confidence 9999999997754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=304.77 Aligned_cols=249 Identities=23% Similarity=0.332 Sum_probs=192.9
Q ss_pred eccCeeeeceecccCceEEEEEEEc-----CCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
..++|++.+.||+|+||+||+|.+. .++..||+|.+..... ....+..|+.++..+ .|+||+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~iv~~~~~~ 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-----NCHHVVRLLGVV 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEE
Confidence 3578999999999999999999764 2456799999863321 122345566666554 789999999999
Q ss_pred eECCEEEEEEEeccC-cHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC
Q psy11727 181 TWKNHLCLVFELLSY-NLYNLIRNTN--------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK 251 (437)
Q Consensus 181 ~~~~~~~lV~E~~~~-~L~~~l~~~~--------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~ 251 (437)
......++||||+++ +|.+++.... ...+++..+..++.|++.||+|||+ .|++||||||+||++ ++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~vH~dlkp~Nil~--~~ 154 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMV--AE 154 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCcchheEEE--cC
Confidence 999999999999965 8888886532 1235778889999999999999995 489999999999999 67
Q ss_pred CCCEEEEeCCCceecCCccc-----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy11727 252 RSAIKIIDFGSSCHVGQTLY-----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKI 325 (437)
Q Consensus 252 ~~~ikL~DFG~s~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i 325 (437)
++.++|+|||++........ ...++..|+|||++.+..++.++|+|||||++|||++ |.+||.+.+.......+
T Consensus 155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 88899999999865432211 1234677999999999899999999999999999999 78999887776555544
Q ss_pred HHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHH
Q psy11727 326 IEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKD 405 (437)
Q Consensus 326 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 405 (437)
.+.. .++. + ......+.+
T Consensus 235 ~~~~-~~~~----------------------------------~---------------------------~~~~~~~~~ 252 (277)
T cd05062 235 MEGG-LLDK----------------------------------P---------------------------DNCPDMLFE 252 (277)
T ss_pred HcCC-cCCC----------------------------------C---------------------------CCCCHHHHH
Confidence 3210 0000 0 000115789
Q ss_pred HHHHccccCCCCCCCHHHHhcC
Q psy11727 406 LILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 406 li~~~L~~dP~~R~t~~e~l~H 427 (437)
||.+||+.||.+|||+.|++++
T Consensus 253 li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 253 LMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=304.34 Aligned_cols=250 Identities=21% Similarity=0.307 Sum_probs=193.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcC-----CCeEEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHE-----EKCQVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ...+..|+.++..+ .|+||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~ 79 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-----NHQNIVRLIGVSF 79 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEc
Confidence 4679999999999999999999877 7789999988633211 22345566666554 7899999999999
Q ss_pred ECCEEEEEEEecc-CcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC-CCC
Q psy11727 182 WKNHLCLVFELLS-YNLYNLIRNTNF-----HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK-RSA 254 (437)
Q Consensus 182 ~~~~~~lV~E~~~-~~L~~~l~~~~~-----~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~-~~~ 254 (437)
+.+..++||||+. ++|.+++..... ..+++..+..++.||+.||+|||++ |++||||||+||+++... ...
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN--HFIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccchheEEEeccCCCcc
Confidence 9999999999995 489988866431 2489999999999999999999964 799999999999995322 236
Q ss_pred EEEEeCCCceecCCccc-----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q psy11727 255 IKIIDFGSSCHVGQTLY-----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEV 328 (437)
Q Consensus 255 ikL~DFG~s~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 328 (437)
+||+|||++........ ....+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999976532221 1223457999999998899999999999999999997 99999987765554433221
Q ss_pred hCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHH
Q psy11727 329 LGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLIL 408 (437)
Q Consensus 329 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 408 (437)
..... | ......+.+++.
T Consensus 238 ~~~~~-----------------------------------~---------------------------~~~~~~~~~~i~ 255 (277)
T cd05036 238 GRLDP-----------------------------------P---------------------------KGCPGPVYRIMT 255 (277)
T ss_pred CcCCC-----------------------------------C---------------------------CCCCHHHHHHHH
Confidence 00000 0 000115789999
Q ss_pred HccccCCCCCCCHHHHhcC
Q psy11727 409 RMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 409 ~~L~~dP~~R~t~~e~l~H 427 (437)
+||+.||++|||+.++++|
T Consensus 256 ~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 256 DCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHcCCCcccCcCHHHHHHH
Confidence 9999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=289.00 Aligned_cols=285 Identities=27% Similarity=0.490 Sum_probs=219.6
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC--CEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK--NHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~--~~~ 186 (437)
.++|++.+++|+|.|++||.|.+..+++.++||+++.-+ .+.+.+|+.+++.+. .||||+++++...+. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~----gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLR----GGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhcc----CCCCeeehhhhhcCccccCc
Confidence 578999999999999999999999999999999997433 477889999999886 689999999998865 478
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
.||+|++.+.-+..+- ..++.-.++.++.+++.||.|+|+ +||+|||+||.|++++. ..-.++|+|+|+|...
T Consensus 111 aLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS--~GImHRDVKPhNvmIdh-~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHS--MGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHh--cCcccccCCcceeeech-hhceeeeeecchHhhc
Confidence 8999999875444332 347888999999999999999995 59999999999999963 4456999999999765
Q ss_pred C--CccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 267 G--QTLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGE-PLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 267 ~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~-~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
. ....-.+.|+.|--||.+... .|+.+.|+|||||++..|+..+ |-|.|.+..+++-+|.+.+|.-. +.
T Consensus 184 Hp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e--l~----- 256 (338)
T KOG0668|consen 184 HPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE--LY----- 256 (338)
T ss_pred CCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH--HH-----
Confidence 3 333335678999999999764 5899999999999999999976 55689999999999999888431 11
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
.|. .++.+...+.+.+|++.....|-.+.-...+.. -...+..|||.++|.+|..+|+||+
T Consensus 257 --~Yl----------------~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~h-l~~peaiDlldklLrYDHqeRlTak 317 (338)
T KOG0668|consen 257 --AYL----------------NKYQIDLDPQFEDILGRHSRKPWSRFINSENQH-LVSPEAIDLLDKLLRYDHQERLTAK 317 (338)
T ss_pred --HHH----------------HHHccCCChhHhhHhhccccccHHHhCCccccc-cCChHHHHHHHHHHhhccccccchH
Confidence 111 112222233344455444433332222111111 1123568999999999999999999
Q ss_pred HHhcCCCcCc
Q psy11727 423 NVLRHEFFLK 432 (437)
Q Consensus 423 e~l~Hp~~~~ 432 (437)
||+.||||..
T Consensus 318 Eam~HpyF~~ 327 (338)
T KOG0668|consen 318 EAMAHPYFAP 327 (338)
T ss_pred HHhcCchHHH
Confidence 9999999975
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=303.22 Aligned_cols=246 Identities=23% Similarity=0.357 Sum_probs=200.3
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
..+|++.+.||.|+||.||+|.+.. +..+|+|++..... ....+..|+.++..+ .|+||+++++++.+.+..+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 78 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-----RHKHLISLFAVCSVGEPVY 78 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-----CCcchhheeeeEecCCCeE
Confidence 4579999999999999999999877 88999999875433 244566677766655 6899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|.+++.......+++..+..++.||+.||.|||+ .||+|+||||+||++ +.++.+||+|||.+...
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~h~dl~~~nilv--~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE--QNSIHRDLAARNILV--GEDLVCKVADFGLARLI 154 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccCcceEEE--cCCceEEEccccchhhc
Confidence 99999965 89999987655568999999999999999999995 489999999999999 66788999999999765
Q ss_pred CCccc---cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 267 GQTLY---QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 267 ~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
..... ...++..|+|||++.+..++.++|+||||+++|+|++ |++||.+.+..+.+..+......+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------- 226 (261)
T cd05148 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCP-------- 226 (261)
T ss_pred CCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCC--------
Confidence 43322 2234567999999998899999999999999999998 89999988876666665432111100
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
......+.++|.+||+.||.+|||+.
T Consensus 227 ------------------------------------------------------~~~~~~~~~~i~~~l~~~p~~Rpt~~ 252 (261)
T cd05148 227 ------------------------------------------------------AKCPQEIYKIMLECWAAEPEDRPSFK 252 (261)
T ss_pred ------------------------------------------------------CCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 00012578999999999999999999
Q ss_pred HHhc
Q psy11727 423 NVLR 426 (437)
Q Consensus 423 e~l~ 426 (437)
++++
T Consensus 253 ~l~~ 256 (261)
T cd05148 253 ALRE 256 (261)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=298.37 Aligned_cols=246 Identities=24% Similarity=0.338 Sum_probs=200.9
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.++|.+.+.||+|+||.||+|.+. ++..||||.+.........+..|+.+++.+ .|+||+++++++......++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-----RHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhC-----CCCCEeeeeeeeecCCceEE
Confidence 568999999999999999999875 457799999986555556777888888776 68999999999998899999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
|||++.+ +|.+++.......+++..+..++.||+.||.|||. .|++|+||||+||++ +.++.++|+|||++....
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~--~~i~h~di~p~nili--~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES--RNYIHRDLAARNILV--GENLVCKIADFGLARLIE 154 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcchheEEE--cCCCCEEECccccceecc
Confidence 9999965 89998877654568999999999999999999995 489999999999999 667889999999987664
Q ss_pred Cccc----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 268 QTLY----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 268 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.... ...++..|+|||.+.+..++.++|+|||||++|+|++ |++||.+.+....+..+......+..
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~-------- 226 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRP-------- 226 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC--------
Confidence 3221 1223467999999998889999999999999999999 99999988776666665432111100
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
.. ....+.+++.+||+.||.+|||++
T Consensus 227 --------------------------------------------------~~----~~~~~~~~i~~~l~~~p~~Rp~~~ 252 (261)
T cd05034 227 --------------------------------------------------PN----CPEELYDLMLQCWDKDPEERPTFE 252 (261)
T ss_pred --------------------------------------------------CC----CCHHHHHHHHHHcccCcccCCCHH
Confidence 00 012578999999999999999999
Q ss_pred HHhc
Q psy11727 423 NVLR 426 (437)
Q Consensus 423 e~l~ 426 (437)
++++
T Consensus 253 ~l~~ 256 (261)
T cd05034 253 YLQS 256 (261)
T ss_pred HHHH
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=316.04 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=189.6
Q ss_pred cCeeeeceecccCceEEEEEEEc-----CCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
++|++.+.||+|+||.||+|... .+++.||+|+++.... .......|+.++..+. .|+||+++++++..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~----~h~niv~~~~~~~~ 82 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG----HHLNVVNLLGACTK 82 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhc----cCcchhheeeeEec
Confidence 58999999999999999999743 3457899999864321 1234556777776663 68999999998865
Q ss_pred -CCEEEEEEEeccC-cHHHHHHhcC-------------------------------------------------------
Q psy11727 183 -KNHLCLVFELLSY-NLYNLIRNTN------------------------------------------------------- 205 (437)
Q Consensus 183 -~~~~~lV~E~~~~-~L~~~l~~~~------------------------------------------------------- 205 (437)
...++++|||+++ +|.+++....
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 4578999999965 8888875422
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCcc-----cccccc
Q psy11727 206 ----FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL-----YQYIQS 276 (437)
Q Consensus 206 ----~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt 276 (437)
...+++..+..++.||+.||+|||+ .||+||||||+|||+ +.++.++|+|||++....... ....++
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivHrDikp~Nill--~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILL--SENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEE--eCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 1257899999999999999999995 489999999999999 567889999999997653211 123446
Q ss_pred ccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcc
Q psy11727 277 RYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSY 355 (437)
Q Consensus 277 ~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 355 (437)
..|+|||++.+..++.++|||||||++|||++ |.+||.+....+.+.........+.
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------- 296 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR---------------------- 296 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC----------------------
Confidence 67999999999999999999999999999998 9999987554333322221100000
Q ss_pred eeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 356 VLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
.| ......+.+++.+||+.+|++|||+.|+++|
T Consensus 297 ------------~~---------------------------~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 297 ------------AP---------------------------EYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ------------CC---------------------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 0001257899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=304.38 Aligned_cols=247 Identities=22% Similarity=0.310 Sum_probs=193.5
Q ss_pred cCeeeeceecccCceEEEEEEE----cCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFD----HEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~----~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
++|++.+.||+|+||+||+|.+ ..++..||+|.+..... ....+..|+.+++.+ .|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-----HHPNIVCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-----CCCCeeeEEEEEecC
Confidence 5789999999999999999985 34567899999874322 223456677777765 789999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTN---------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILL 247 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~---------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll 247 (437)
+..|+||||+++ +|.+++.... ...+++..+..++.||+.||+|||+ .|++||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~nili 157 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNILI 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--cCeehhccccceEEE
Confidence 999999999965 8888875321 1247888999999999999999995 489999999999999
Q ss_pred ecCCCCCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy11727 248 CSPKRSAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQ 321 (437)
Q Consensus 248 ~~~~~~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~ 321 (437)
+.++.+||+|||++...... .....++..|+|||++.+..++.++|+|||||++|||++ |.+||.+.+..+.
T Consensus 158 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 158 --GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred --cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 66778999999999765322 122344667999999998889999999999999999998 9999988776555
Q ss_pred HHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhh
Q psy11727 322 MTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYM 401 (437)
Q Consensus 322 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (437)
...+......+. +.....
T Consensus 236 ~~~~~~~~~~~~--------------------------------------------------------------~~~~~~ 253 (283)
T cd05090 236 IEMVRKRQLLPC--------------------------------------------------------------SEDCPP 253 (283)
T ss_pred HHHHHcCCcCCC--------------------------------------------------------------CCCCCH
Confidence 444432110000 000012
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 402 KFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 402 ~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
.+.+++.+||+.||.+||++.+++++
T Consensus 254 ~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 254 RMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHHH
Confidence 57899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=298.78 Aligned_cols=245 Identities=20% Similarity=0.293 Sum_probs=198.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.++|++.+.||+|+||.||+|.. .|+.||+|.+........++..|+.++..+ .|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTL-----RHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhc-----CCcceeeeEEEEcCCCCeEE
Confidence 35789999999999999999976 478899999975544345666777777766 68899999999999999999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
||||+++ +|.+++.......+++..+..++.|++.||.|||++ |++|+||||+||++ +.++.++|+|||.+....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~--~i~H~di~p~Nili--~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK--NFVHRDLAARNVLV--SEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccchhcccceEEE--eCCCCEEEcccccccccc
Confidence 9999975 899998776545689999999999999999999954 89999999999999 678889999999997765
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchh
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKY 346 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~ 346 (437)
........+..|+|||++.+..++.++|+||||+++|+|++ |..||...+..+....+..... +.
T Consensus 154 ~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--~~------------ 219 (256)
T cd05039 154 QGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR--ME------------ 219 (256)
T ss_pred cccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--CC------------
Confidence 44333444667999999998889999999999999999997 9999988766554443322100 00
Q ss_pred hcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhc
Q psy11727 347 FDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
.+ ......+.+||.+||..+|.+|||+.++++
T Consensus 220 ---~~---------------------------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 220 ---AP---------------------------------------------EGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ---Cc---------------------------------------------cCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00 000125789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=298.72 Aligned_cols=243 Identities=21% Similarity=0.294 Sum_probs=194.4
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceee-ECCEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT-WKNHLCL 188 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~-~~~~~~l 188 (437)
.+|++.+.||+|+||.||++.. .+..||+|.++.. .....+..|+.++..+ .|++++++++++. ..+..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~-~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-ATAQAFLAEASVMTQL-----RHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC-chHHHHHHHHHHHHhC-----CCCCeeeEEEEEEcCCCceEE
Confidence 5789999999999999999975 4678999998643 2344566787777766 6889999998754 5568999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
||||+++ +|.+++.......+++..+..++.||+.||+|||++ |++||||||+||++ ++++.+||+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~nil~--~~~~~~kl~dfg~~~~~~ 153 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN--NFVHRDLAARNVLV--SEDNVAKVSDFGLTKEAS 153 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CEeccccchheEEE--cCCCcEEecCCccceecc
Confidence 9999965 899998776545589999999999999999999964 89999999999999 678889999999987665
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchh
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKY 346 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~ 346 (437)
.......++..|+|||++.+..++.++|||||||++|+|++ |++||...+..+....+.... ++.
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--~~~------------ 219 (256)
T cd05082 154 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--KMD------------ 219 (256)
T ss_pred ccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--CCC------------
Confidence 44444455678999999999899999999999999999998 999998776655444432210 000
Q ss_pred hcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhc
Q psy11727 347 FDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
.. ......+.++|.+||+.||.+|||+.++++
T Consensus 220 ---~~---------------------------------------------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 220 ---AP---------------------------------------------DGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ---CC---------------------------------------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 000125789999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=296.53 Aligned_cols=249 Identities=28% Similarity=0.368 Sum_probs=199.2
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+|++.+.||+|+||.||++.+..+++.+|+|.+..... .......|+.+++.+ .|+||+++.+++.+....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-----NHPNIISYKEAFLDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-----CCCCchhhhhhhccCCEEE
Confidence 58899999999999999999999999999999864321 122334455555544 6899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 188 LVFELLSY-NLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+||||+++ +|.+++... ....+++..+..++.|++.||+|||+ .|++|+||+|+||++ +.++.+||+|||++.
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~--~~i~h~~l~~~ni~~--~~~~~~kl~d~g~~~ 151 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE--QKILHRDLKSANILL--VANDLVKIGDLGISK 151 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEE--ecCCcEEEeeccchh
Confidence 99999966 788887652 22458999999999999999999995 489999999999999 457789999999987
Q ss_pred ecCCcc-ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 265 HVGQTL-YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 265 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
...... ....++..|+|||.+.+..++.++|+||||+++++|++|+.||...+..+....+......+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 221 (256)
T cd08530 152 VLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI---------- 221 (256)
T ss_pred hhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----------
Confidence 654432 234578899999999998999999999999999999999999998776554443322100000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
+......+.++|.+||..+|.+|||+.+
T Consensus 222 ----------------------------------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08530 222 ----------------------------------------------------PPIYSQDLQNFIRSMLQVKPKLRPNCDK 249 (256)
T ss_pred ----------------------------------------------------chhhCHHHHHHHHHHcCCCcccCCCHHH
Confidence 0011125799999999999999999999
Q ss_pred HhcCCCc
Q psy11727 424 VLRHEFF 430 (437)
Q Consensus 424 ~l~Hp~~ 430 (437)
+++||++
T Consensus 250 ~l~~p~~ 256 (256)
T cd08530 250 ILASPAV 256 (256)
T ss_pred HhcCCCC
Confidence 9999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=337.10 Aligned_cols=200 Identities=25% Similarity=0.386 Sum_probs=168.0
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|++.++||+|+||.||+|++..+++.||+|+++.... ...++.+|+.++..+ .||||+++++++.+.+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-----~HPNIVkl~~v~~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-----IHPGIVPVYSICSDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-----CCcCcCeEEEEEeeCCE
Confidence 689999999999999999999999999999999974321 233456677777665 78999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCE
Q psy11727 186 LCLVFELLSY-NLYNLIRNTN---------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAI 255 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~---------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~i 255 (437)
.++||||++| +|.+++.... ...+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~--GIIHRDLKPeNILL--d~dg~v 152 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK--GVLHRDLKPDNILL--GLFGEV 152 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC--CccccCCchheEEE--cCCCCE
Confidence 9999999965 8888876421 12356778889999999999999964 89999999999999 678889
Q ss_pred EEEeCCCceecCCc---------------------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy11727 256 KIIDFGSSCHVGQT---------------------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFS 314 (437)
Q Consensus 256 kL~DFG~s~~~~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~ 314 (437)
+|+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||+||++||.
T Consensus 153 KLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~ 232 (932)
T PRK13184 153 VILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232 (932)
T ss_pred EEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence 99999999755110 112468999999999999999999999999999999999999998
Q ss_pred CCCH
Q psy11727 315 GKNE 318 (437)
Q Consensus 315 ~~~~ 318 (437)
+...
T Consensus 233 ~~~~ 236 (932)
T PRK13184 233 RKKG 236 (932)
T ss_pred Ccch
Confidence 7544
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=310.87 Aligned_cols=245 Identities=21% Similarity=0.307 Sum_probs=189.7
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeE----EEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQ----VAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~----vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+|++.+.||+|+||+||+|.+..++.. ||+|+++... ....++..|+.++..+ .|+||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~g~~~~~ 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-----DNPHVCRLLGICLTS 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEcCC
Confidence 5799999999999999999988766654 8999986432 2234455666666655 789999999988764
Q ss_pred CEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
..++|+|++. |+|.+++.... ..+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~--~iiH~dlkp~Nill--~~~~~~kl~DfG~ 155 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER--RLVHRDLAARNVLV--KTPQHVKITDFGL 155 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc--CeeccccchhheEe--cCCCcEEEccccc
Confidence 5679999995 48999887654 3588999999999999999999964 89999999999999 6678899999999
Q ss_pred ceecCCccc-----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 263 SCHVGQTLY-----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 263 s~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
+........ ...++..|+|||++.+..++.++|||||||++|||++ |.+||.+....+... +......++.
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~-- 232 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQ-- 232 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCCCCC--
Confidence 976543221 1223567999999999999999999999999999998 999998876554332 2221100000
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
+ + .....+.+++.+||..||.
T Consensus 233 --------------------------------~-----------------------~----~~~~~~~~li~~cl~~~p~ 253 (316)
T cd05108 233 --------------------------------P-----------------------P----ICTIDVYMIMVKCWMIDAD 253 (316)
T ss_pred --------------------------------C-----------------------C----CCCHHHHHHHHHHccCChh
Confidence 0 0 0001578999999999999
Q ss_pred CCCCHHHHhcC
Q psy11727 417 KRISPTNVLRH 427 (437)
Q Consensus 417 ~R~t~~e~l~H 427 (437)
+|||+.+++.+
T Consensus 254 ~Rps~~~l~~~ 264 (316)
T cd05108 254 SRPKFRELIIE 264 (316)
T ss_pred hCcCHHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=296.71 Aligned_cols=241 Identities=25% Similarity=0.361 Sum_probs=195.5
Q ss_pred ceecccCceEEEEEEEcCC---CeEEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEE---KCQVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVF 190 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~---~~~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~ 190 (437)
+.||+|+||.||+|.+... +..||+|++...... ...+..|+.++..+ .|+||+++++++.....+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-----GHPNVVRLLGVCTEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-----CCCChheeeeeecCCCceEEEE
Confidence 4689999999999998866 889999999754332 34566677777665 5899999999999999999999
Q ss_pred Eec-cCcHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 191 ELL-SYNLYNLIRNTN-------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 191 E~~-~~~L~~~l~~~~-------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
||+ +++|.+++.... ...+++..++.++.|++.||+|||+ .|++||||||+||++ +.++.++|+|||.
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~nili--~~~~~~~l~dfg~ 151 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS--KKFVHRDLAARNCLV--GEDLVVKISDFGL 151 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc--CCcccCccCcceEEE--CCCCcEEEccccc
Confidence 999 568999887652 2568999999999999999999996 489999999999999 6778999999999
Q ss_pred ceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 263 SCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 263 s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
+...... .....++..|+|||.+.+..++.++|+|||||++|+|++ |.+||.+....+....+......+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 228 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPK--- 228 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence 9766443 233456788999999998889999999999999999999 6999998877666555543100000
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
| ......+.++|.+||..||.
T Consensus 229 --------------------------------~---------------------------~~~~~~~~~li~~~l~~~p~ 249 (262)
T cd00192 229 --------------------------------P---------------------------EYCPDELYELMLSCWQLDPE 249 (262)
T ss_pred --------------------------------C---------------------------ccCChHHHHHHHHHccCCcc
Confidence 0 00012678999999999999
Q ss_pred CCCCHHHHhcC
Q psy11727 417 KRISPTNVLRH 427 (437)
Q Consensus 417 ~R~t~~e~l~H 427 (437)
+|||+.|+++|
T Consensus 250 ~Rps~~~l~~~ 260 (262)
T cd00192 250 DRPTFSELVER 260 (262)
T ss_pred cCcCHHHHHHh
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=296.54 Aligned_cols=248 Identities=25% Similarity=0.456 Sum_probs=196.6
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc------ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK------PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~------~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... .....+..|+.+++.+ .|+||+++++++.+.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~i~~~~~~~~~~ 76 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-----RHDRIVQYYGCLRDP 76 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-----CCCCcceEEEEEEcC
Confidence 47999999999999999999999999999999875321 1223455677777766 688999999998764
Q ss_pred --CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 184 --NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 184 --~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
..+++||||+++ +|.+++.... .+++..+..++.||+.||.|||++ |++|+||||+||++ +.++.++|+||
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~--~i~H~dl~p~ni~i--~~~~~~~l~df 150 (264)
T cd06653 77 EEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN--MIVHRDIKGANILR--DSAGNVKLGDF 150 (264)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEE--cCCCCEEECcc
Confidence 578999999965 7888887643 488999999999999999999954 89999999999999 66788999999
Q ss_pred CCceecCC------ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 261 GSSCHVGQ------TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 261 G~s~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
|++..... ......++..|+|||++.+..++.++|+|||||++|+|++|++||..........++ ...+..
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~ 227 (264)
T cd06653 151 GASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQPTK 227 (264)
T ss_pred ccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCCCC
Confidence 99875432 112356788999999999988999999999999999999999999876554433332 222211
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
...+ ......+.++|++||. +
T Consensus 228 ~~~p----------------------------------------------------------~~~~~~~~~~i~~~l~-~ 248 (264)
T cd06653 228 PMLP----------------------------------------------------------DGVSDACRDFLKQIFV-E 248 (264)
T ss_pred CCCC----------------------------------------------------------cccCHHHHHHHHHHhc-C
Confidence 1110 0011257899999999 5
Q ss_pred CCCCCCHHHHhcCCCc
Q psy11727 415 PKKRISPTNVLRHEFF 430 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~ 430 (437)
|..|||+.+++.|||.
T Consensus 249 ~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 249 EKRRPTAEFLLRHPFV 264 (264)
T ss_pred cccCccHHHHhcCCCC
Confidence 7999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=320.43 Aligned_cols=235 Identities=27% Similarity=0.438 Sum_probs=191.1
Q ss_pred eeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEec
Q psy11727 114 IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELL 193 (437)
Q Consensus 114 i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~ 193 (437)
-++.||.|+-|.||+|+. .++.||||.++ ..-..++.-|++| .|+||+.+.|+|...-.+|||||||
T Consensus 128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~------elkETdIKHLRkL-----kH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVR------ELKETDIKHLRKL-----KHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred hhhhhccCcccceeeeec--cCceehhHHHh------hhhhhhHHHHHhc-----cCcceeeEeeeecCCceeEEeeecc
Confidence 467899999999999975 46789999886 3334566667766 8899999999999999999999999
Q ss_pred c-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc--c
Q psy11727 194 S-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT--L 270 (437)
Q Consensus 194 ~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~--~ 270 (437)
. |-|+..|+..+ .++......|..+|+.++.|||.|+ |||||||.-||||+ .+..|||+|||.+....+. .
T Consensus 195 a~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs--~~d~VKIsDFGTS~e~~~~STk 268 (904)
T KOG4721|consen 195 AQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILIS--YDDVVKISDFGTSKELSDKSTK 268 (904)
T ss_pred ccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEee--ccceEEeccccchHhhhhhhhh
Confidence 5 57999998764 5889999999999999999999884 99999999999995 4557999999999876544 3
Q ss_pred ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhccc
Q psy11727 271 YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRL 350 (437)
Q Consensus 271 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~ 350 (437)
..++||..|||||+|...+.+.|+|||||||+|||||||..||...+...+ +.+.|
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----IwGVG-------------------- 324 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IWGVG-------------------- 324 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EEecc--------------------
Confidence 468999999999999999999999999999999999999999987653211 11111
Q ss_pred CCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCC
Q psy11727 351 SDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHE 428 (437)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp 428 (437)
.+. |. |.+....|+ -|+=||++||+-.|..|||..++|.|=
T Consensus 325 -sNs-------------------L~--LpvPstcP~---------------GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 325 -SNS-------------------LH--LPVPSTCPD---------------GFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred -CCc-------------------cc--ccCcccCch---------------HHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 000 00 111112233 478899999999999999999999983
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=335.51 Aligned_cols=145 Identities=28% Similarity=0.431 Sum_probs=124.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|.+.+.||+|+||+||+|.+..+++.||||+++.... ....+..|+.++..+ .|+||+++++++...+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~Iv~~~~~~~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-----KSPFIVHLYYSLQSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-----CCCCcCeEEEEEEECC
Confidence 4689999999999999999999999999999999974322 123455566666554 7899999999999999
Q ss_pred EEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
++||||||+. ++|.+++.... .+++..++.++.||+.||.|||.+ |||||||||+|||+ +.++.+||+|||++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~--gIiHrDLKP~NILl--~~~g~vkL~DFGls 151 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH--GIIHRDLKPDNMLI--SNEGHIKLTDFGLS 151 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CEEeCCccHHHEEE--cCCCCEEEEeCCCC
Confidence 9999999995 48988887643 488999999999999999999964 89999999999999 66788999999986
Q ss_pred e
Q psy11727 264 C 264 (437)
Q Consensus 264 ~ 264 (437)
.
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=299.53 Aligned_cols=248 Identities=31% Similarity=0.464 Sum_probs=193.8
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc------ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK------PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~------~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
+|.+.+.||+|+||+||++.+..++..+++|+++... ....+...|..++..+ .||||+++++++.+.+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-----DHPAIVKFHASFLERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-----CCCcHHHHHHHHhcCC
Confidence 6899999999999999999998887777777765321 1112344455555544 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 185 HLCLVFELLSY-NLYNLIRN--TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~--~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
..++||||+++ +|.+++.. .....+++..++.++.|++.||.|||+ .|++|+||+|+||+++ ++.++|+|||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~~l~~~nili~---~~~~~l~d~g 150 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ--RRILHRDLKAKNIFLK---NNLLKIGDFG 150 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH--cCccccCCChhheEee---cCCEeecccC
Confidence 99999999976 78777754 223458999999999999999999995 5899999999999994 3459999999
Q ss_pred CceecCCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 262 SSCHVGQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 262 ~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
++...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+.. +.++..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~--- 225 (260)
T cd08222 151 VSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GPTPSL--- 225 (260)
T ss_pred ceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCCCCC---
Confidence 98665322 2234578899999999888899999999999999999999999987665544444322 111100
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
+......+.++|.+||..||++|
T Consensus 226 ---------------------------------------------------------~~~~~~~~~~li~~~l~~~p~~R 248 (260)
T cd08222 226 ---------------------------------------------------------PETYSRQLNSIMQSMLNKDPSLR 248 (260)
T ss_pred ---------------------------------------------------------cchhcHHHHHHHHHHhcCChhhC
Confidence 00001257899999999999999
Q ss_pred CCHHHHhcCCCc
Q psy11727 419 ISPTNVLRHEFF 430 (437)
Q Consensus 419 ~t~~e~l~Hp~~ 430 (437)
||+.++++||||
T Consensus 249 p~~~~il~~~~~ 260 (260)
T cd08222 249 PSAAEILRNPFI 260 (260)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=299.69 Aligned_cols=199 Identities=26% Similarity=0.454 Sum_probs=167.4
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|.+.+.||+|+||.||+|.+..++..+|||.+..... ....+..|+.++..+ .|+||+++++++...+.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-----NHPNVIKYYASFIEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-----cCCchhhhhheeEeCCe
Confidence 578999999999999999999999999999998864221 123455566666655 78999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 186 LCLVFELLSY-NLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
.++||||+.+ +|.+++... ....+++..++.++.||+.||+|||+ .|++|+||||+||++ +.++.++|+|||+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili--~~~~~~~l~dfg~ 152 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFI--TATGVVKLGDLGL 152 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEE--cCCCCEEECcchh
Confidence 9999999965 888887642 22458999999999999999999995 489999999999999 6788899999999
Q ss_pred ceecCCcc---ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy11727 263 SCHVGQTL---YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN 317 (437)
Q Consensus 263 s~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~ 317 (437)
+....... ....++..|+|||++.+..++.++|+||||+++|+|++|..||.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 153 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred hhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 87654322 23468889999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=298.80 Aligned_cols=246 Identities=20% Similarity=0.321 Sum_probs=194.3
Q ss_pred cCeeeeceecccCceEEEEEEEcCC---CeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEE---KCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~---~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
++|++.+.||+|+||.||+|.+..+ ...||+|.++.... ....+..|+.++..+ .|+||+++++.+...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-----DHPNIIRLEGVVTKSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-----CCCCcceEeEEEecCC
Confidence 5799999999999999999988644 45799999864322 123445566666655 6899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+ .||+||||||+|||+ ++++.++|+|||++
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~di~p~nili--~~~~~~~l~dfg~~ 153 (266)
T cd05033 79 PVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSE--MNYVHRDLAARNILV--NSNLVCKVSDFGLS 153 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEE--cCCCCEEECccchh
Confidence 99999999965 8888887644 358999999999999999999995 589999999999999 67888999999999
Q ss_pred eecCCccc-----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 264 CHVGQTLY-----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 264 ~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
........ ...++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+......|...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 231 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPM-- 231 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCC--
Confidence 77642111 1223567999999998899999999999999999998 999998776655555443211111000
Q ss_pred ccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCC
Q psy11727 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKK 417 (437)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 417 (437)
.....+.+|+.+||+.||++
T Consensus 232 ------------------------------------------------------------~~~~~l~~li~~cl~~~p~~ 251 (266)
T cd05033 232 ------------------------------------------------------------DCPSALYQLMLDCWQKDRNE 251 (266)
T ss_pred ------------------------------------------------------------CCCHHHHHHHHHHcCCCccc
Confidence 00125789999999999999
Q ss_pred CCCHHHHhcC
Q psy11727 418 RISPTNVLRH 427 (437)
Q Consensus 418 R~t~~e~l~H 427 (437)
|||+.+++++
T Consensus 252 Rp~~~ei~~~ 261 (266)
T cd05033 252 RPTFSQIVST 261 (266)
T ss_pred CcCHHHHHHH
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=300.71 Aligned_cols=247 Identities=23% Similarity=0.353 Sum_probs=193.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCC-----CeEEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEE-----KCQVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~-----~~~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|.+.+.||+|+||.||+|.+... +..||+|.+...... ...+..|+.++..+ .|+||+++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~ 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-----NCHHVVRLLGVVS 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-----CCCceeEEEEEEc
Confidence 46899999999999999999987643 478999998643211 12344565555544 7899999999999
Q ss_pred ECCEEEEEEEecc-CcHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCC
Q psy11727 182 WKNHLCLVFELLS-YNLYNLIRNTN--------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR 252 (437)
Q Consensus 182 ~~~~~~lV~E~~~-~~L~~~l~~~~--------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~ 252 (437)
.....++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+ .||+||||||+|||+ +.+
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~di~p~nill--~~~ 155 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMV--AED 155 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccChheEEE--cCC
Confidence 9999999999996 58988886532 1236888999999999999999995 489999999999999 678
Q ss_pred CCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy11727 253 SAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKII 326 (437)
Q Consensus 253 ~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~ 326 (437)
+.+||+|||++...... .....++..|+|||.+.+..++.++|||||||++||+++ |.+||.+.+..+....+.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 89999999998755322 122345678999999998889999999999999999998 999998877666555443
Q ss_pred HHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHH
Q psy11727 327 EVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406 (437)
Q Consensus 327 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 406 (437)
.. +.++ .|.. ....+.+|
T Consensus 236 ~~-~~~~----------------------------------~~~~---------------------------~~~~~~~l 253 (277)
T cd05032 236 DG-GHLD----------------------------------LPEN---------------------------CPDKLLEL 253 (277)
T ss_pred cC-CCCC----------------------------------CCCC---------------------------CCHHHHHH
Confidence 11 0000 0000 01257899
Q ss_pred HHHccccCCCCCCCHHHHhc
Q psy11727 407 ILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 407 i~~~L~~dP~~R~t~~e~l~ 426 (437)
|.+||+.+|.+|||+.++++
T Consensus 254 i~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 254 MRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=304.24 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=195.1
Q ss_pred ccCeeeeceecccCceEEEEEEE-----cCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFD-----HEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~-----~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|.+.+.||+|+||.||+|.+ ..++..||+|+++.... ....+..|+.++..+. .|+||+++++++.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~~~ 109 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG----NHENIVNLLGACT 109 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhcc----CCCCcceEEEEEe
Confidence 46899999999999999999975 33456899999874321 1234566777777663 5899999999999
Q ss_pred ECCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 182 WKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 182 ~~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
..+..++||||++ ++|.+++.......+++..+..++.||+.||.|||++ ||+|+||||+|||+ +.++.++|+||
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~ivH~dlkp~Nil~--~~~~~~~l~df 185 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNVLL--THGKIVKICDF 185 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeehhhhccceEEE--cCCCeEEECCC
Confidence 9999999999996 5899988765444589999999999999999999964 79999999999999 66778999999
Q ss_pred CCceecCCccc-----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 261 GSSCHVGQTLY-----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 261 G~s~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
|++........ ...++..|+|||++.+..++.++|||||||++|+|++ |.+||.+....+........ +.++.
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~ 264 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE-GYRMA 264 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc-CCcCC
Confidence 99876533211 2234677999999999899999999999999999998 99999877654444333221 00000
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
.+. .....+.+|+.+||+.+
T Consensus 265 ---------------------------------------------------------~~~---~~~~~~~~li~~cl~~~ 284 (302)
T cd05055 265 ---------------------------------------------------------QPE---HAPAEIYDIMKTCWDAD 284 (302)
T ss_pred ---------------------------------------------------------CCC---CCCHHHHHHHHHHcCCC
Confidence 000 00125789999999999
Q ss_pred CCCCCCHHHHhc
Q psy11727 415 PKKRISPTNVLR 426 (437)
Q Consensus 415 P~~R~t~~e~l~ 426 (437)
|++|||+.|+++
T Consensus 285 p~~Rpt~~ell~ 296 (302)
T cd05055 285 PLKRPTFKQIVQ 296 (302)
T ss_pred chhCcCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=302.69 Aligned_cols=207 Identities=27% Similarity=0.366 Sum_probs=169.4
Q ss_pred cCeeeeceecccCceEEEEEEEc-----CCCeEEEEEEecCCccc-chHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKIIKNKKPF-LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~i~~~~~~-~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+...... ...+.+|+.++..+ .|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-----QHEHIVKFYGVCGDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-----CCCCcceEEEEEccC
Confidence 46899999999999999999753 34567999998644322 23466677776665 789999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEe
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTN--------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLC 248 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~--------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~ 248 (437)
+..++||||+++ +|.+++.... ...+++..++.++.||+.||+|||+ .||+||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nil~- 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS--QHFVHRDLATRNCLV- 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEE-
Confidence 999999999965 8998886542 1347899999999999999999995 489999999999999
Q ss_pred cCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy11727 249 SPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQM 322 (437)
Q Consensus 249 ~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~ 322 (437)
+.++.++|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|+| |.+||...+..+..
T Consensus 157 -~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 235 (291)
T cd05094 157 -GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 235 (291)
T ss_pred -ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 678889999999997553321 22345778999999999999999999999999999999 99999887776655
Q ss_pred HHH
Q psy11727 323 TKI 325 (437)
Q Consensus 323 ~~i 325 (437)
..+
T Consensus 236 ~~~ 238 (291)
T cd05094 236 ECI 238 (291)
T ss_pred HHH
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=294.94 Aligned_cols=239 Identities=35% Similarity=0.533 Sum_probs=196.7
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEec
Q psy11727 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELL 193 (437)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~ 193 (437)
||+|+||.||++.+..+++.+|+|++..... ....+..|+.+++.+ .|+||+++++.+..++..|+|||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-----NHPFIVKLHYAFQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-----CCCcHHHHHHHeecCCeeEEEEecC
Confidence 6999999999999988899999999875432 233566677777766 5899999999999999999999999
Q ss_pred -cCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc---
Q psy11727 194 -SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT--- 269 (437)
Q Consensus 194 -~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~--- 269 (437)
+++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||++ +.++.++|+|||++......
T Consensus 76 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~--~~~~H~~l~p~ni~~--~~~~~~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 76 PGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHS--LGIIYRDLKPENILL--DADGHIKLTDFGLAKELSSEGSR 149 (250)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcceEEE--cCCCcEEEeecCcceecccCCCc
Confidence 558999887653 48999999999999999999995 589999999999999 66788999999999776442
Q ss_pred cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcc
Q psy11727 270 LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDR 349 (437)
Q Consensus 270 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~ 349 (437)
.....++..|+|||.+.+..++.++|+||||+++|++++|..||...+.......+... .++
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~---------------- 211 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD--PLR---------------- 211 (250)
T ss_pred ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--CCC----------------
Confidence 34456788999999999888899999999999999999999999887765444444320 000
Q ss_pred cCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH---HHHhc
Q psy11727 350 LSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP---TNVLR 426 (437)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~---~e~l~ 426 (437)
.|. .....+.+||++||..||++|||+ +++++
T Consensus 212 ------------------~~~---------------------------~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 212 ------------------FPE---------------------------FLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred ------------------CCC---------------------------CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 000 001257899999999999999999 99999
Q ss_pred CCCc
Q psy11727 427 HEFF 430 (437)
Q Consensus 427 Hp~~ 430 (437)
||||
T Consensus 247 ~~~f 250 (250)
T cd05123 247 HPFF 250 (250)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=293.97 Aligned_cols=199 Identities=28% Similarity=0.457 Sum_probs=168.7
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|++.+.||+|+||.||+|.+..+++.||+|.++... .....+..|+.+++.+ .|++++++++.+...+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-----~~~~i~~~~~~~~~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-----DHPNVIKYLASFIENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-----CCCCeeeeeeeeecCCe
Confidence 57999999999999999999999899999999886321 1134556677777665 68899999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 186 LCLVFELLSY-NLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
.++||||+++ +|.+++... ....+++..+..++.|++.||+|||+ .||+||||+|+||++ +.++.++|+|||+
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~nil~--~~~~~~~l~d~~~ 152 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS--KRIMHRDIKPANVFI--TATGVVKLGDLGL 152 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecCCcChhhEEE--CCCCcEEEeccce
Confidence 9999999965 888888642 22458999999999999999999995 489999999999999 6788899999999
Q ss_pred ceecCCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy11727 263 SCHVGQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN 317 (437)
Q Consensus 263 s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~ 317 (437)
+...... .....++..|+|||++.+..++.++|+|||||++|+|++|..||....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 153 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred eeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 8765432 233567889999999999899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=294.53 Aligned_cols=244 Identities=26% Similarity=0.371 Sum_probs=196.4
Q ss_pred eeeeceecccCceEEEEEEEcCCC----eEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEK----CQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~----~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
+.+.+.||+|+||.||+|.+..++ ..||+|.+..... ....+..|+.++..+ .|+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-----DHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-----CCCchheEEEEEcCCCe
Confidence 356789999999999999998766 8999999975432 244666677777665 68899999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
.++|||++++ +|.+++.......+++..+..++.||+.||++||+ .|++|+||||+||++ +.++.++|+|||++.
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~--~~~~h~dl~~~nil~--~~~~~~~l~dfg~~~ 151 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES--KNFIHRDLAARNCLV--GENLVVKISDFGLSR 151 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc--CCeeecccccceEEE--ccCCeEEEcccCCce
Confidence 9999999965 88888876543338999999999999999999995 489999999999999 667789999999997
Q ss_pred ecCCcccc----ccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhcc
Q psy11727 265 HVGQTLYQ----YIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 265 ~~~~~~~~----~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 339 (437)
........ ..++..|+|||.+.+..++.++|+||||+++++|++ |.+||.+.+.....+.+......+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 226 (258)
T smart00219 152 DLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP----- 226 (258)
T ss_pred ecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC-----
Confidence 66443211 225678999999988889999999999999999998 89999887776666655331110000
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
......+.+++.+||..||.+||
T Consensus 227 ---------------------------------------------------------~~~~~~~~~~i~~~l~~~p~~Rp 249 (258)
T smart00219 227 ---------------------------------------------------------ENCPPEIYKLMLQCWAEDPEDRP 249 (258)
T ss_pred ---------------------------------------------------------CcCCHHHHHHHHHHCcCChhhCc
Confidence 00112578999999999999999
Q ss_pred CHHHHhc
Q psy11727 420 SPTNVLR 426 (437)
Q Consensus 420 t~~e~l~ 426 (437)
|+.|+++
T Consensus 250 t~~~ll~ 256 (258)
T smart00219 250 TFSELVE 256 (258)
T ss_pred CHHHHHh
Confidence 9999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=304.21 Aligned_cols=247 Identities=22% Similarity=0.275 Sum_probs=192.1
Q ss_pred cCeeeeceecccCceEEEEEEEcC-----CCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHE-----EKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
.+|++.+.||+|+||.||+|.+.. ++..||+|+++.... ....+..|+.++..+ .|+||+++++++..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-----~h~~iv~~~~~~~~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-----QHPNIVCLLGVVTK 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-----CCCCcCeEEEEEcC
Confidence 468899999999999999998754 357899999974332 123344555555544 78999999999999
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTN--------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILL 247 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~--------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll 247 (437)
.+..++++||+.+ +|.+++.... ...+++..+..++.|++.||.|||+ .||+||||||+||++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~--~gi~H~dlkp~Nil~ 157 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS--HHVVHKDLATRNVLV 157 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--cCccccccchhheEe
Confidence 9999999999965 7888875321 1347888899999999999999995 489999999999999
Q ss_pred ecCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy11727 248 CSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQ 321 (437)
Q Consensus 248 ~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~ 321 (437)
++++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+.
T Consensus 158 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 158 --FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred --cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 567789999999987553221 12344678999999998889999999999999999998 8899998877666
Q ss_pred HHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhh
Q psy11727 322 MTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYM 401 (437)
Q Consensus 322 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (437)
...+......+.. .....
T Consensus 236 ~~~i~~~~~~~~~--------------------------------------------------------------~~~~~ 253 (283)
T cd05091 236 IEMIRNRQVLPCP--------------------------------------------------------------DDCPA 253 (283)
T ss_pred HHHHHcCCcCCCC--------------------------------------------------------------CCCCH
Confidence 6655432111000 00011
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 402 KFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 402 ~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
.+.+|+.+||+.||.+|||+.+++..
T Consensus 254 ~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 254 WVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 46899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=302.80 Aligned_cols=249 Identities=26% Similarity=0.354 Sum_probs=194.9
Q ss_pred ccCeeeeceecccCceEEEEEEEcCC-----CeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEE-----KCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~-----~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|++.+.||+|+||.||++..... ...+|+|.+..... ....+..|+.+++.+. .|+||+++++++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~i~~~~~~~~ 86 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG----KHKNIINLLGVCT 86 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhc----CCCCeeeEEEEEc
Confidence 46799999999999999999987643 37899999874321 1234556777776653 6899999999999
Q ss_pred ECCEEEEEEEeccC-cHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q psy11727 182 WKNHLCLVFELLSY-NLYNLIRNT--------------NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENIL 246 (437)
Q Consensus 182 ~~~~~~lV~E~~~~-~L~~~l~~~--------------~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIl 246 (437)
..+.+++||||+++ +|.+++... ....+++..+..++.||+.||+|||+ .||+||||||+|||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~Nil 164 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVL 164 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCccccccceeeEE
Confidence 99999999999955 888888642 23458999999999999999999995 48999999999999
Q ss_pred EecCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy11727 247 LCSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVD 320 (437)
Q Consensus 247 l~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~ 320 (437)
+ +.++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+....+
T Consensus 165 ~--~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 165 V--TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred E--cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 9 668889999999997654321 11223567999999998899999999999999999998 999998877665
Q ss_pred HHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhh
Q psy11727 321 QMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADY 400 (437)
Q Consensus 321 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (437)
....+......+. +....
T Consensus 243 ~~~~~~~~~~~~~--------------------------------------------------------------~~~~~ 260 (293)
T cd05053 243 LFKLLKEGYRMEK--------------------------------------------------------------PQNCT 260 (293)
T ss_pred HHHHHHcCCcCCC--------------------------------------------------------------CCCCC
Confidence 5554432110000 00001
Q ss_pred hHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 401 MKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 401 ~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
..+.+|+.+||..||.+|||+++++++
T Consensus 261 ~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 261 QELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 257899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=294.91 Aligned_cols=245 Identities=25% Similarity=0.361 Sum_probs=196.9
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
.+|++.+.||+|+||.||+|.+. .+..+|+|.+.........+..|+.+++.+ .|++++++++++......++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKL-----SHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhC-----CCCCeeeEEEEEccCCceEEE
Confidence 47889999999999999999875 467899999875544445677888888876 688999999999999999999
Q ss_pred EEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 190 FELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 190 ~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
|||+.+ +|.+++.... ..+++..++.++.|++.+|+|||+ .|++||||||+||++ +.++.++|+|||.+.....
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~dl~p~ni~i--~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLES--SNVIHRDLAARNCLV--GENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH--CCccccccccceEEE--cCCCeEEECCCcceeeccc
Confidence 999965 7887776543 357899999999999999999995 489999999999999 6678899999999876543
Q ss_pred ccc----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 269 TLY----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 269 ~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
... ...++..|+|||++.+..++.++|+||||+++|||++ |.+||...........+.+......
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 222 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK---------- 222 (256)
T ss_pred CcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC----------
Confidence 322 1234567999999998899999999999999999998 9999988776665555422110000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
| .. ....+.+|+.+||+.+|.+|||+++
T Consensus 223 -------------------------~-----------------------~~----~~~~~~~l~~~~l~~~p~~Rp~~~~ 250 (256)
T cd05112 223 -------------------------P-----------------------RL----ASQSVYELMQHCWKERPEDRPSFSL 250 (256)
T ss_pred -------------------------C-----------------------CC----CCHHHHHHHHHHcccChhhCCCHHH
Confidence 0 00 0025789999999999999999999
Q ss_pred HhcC
Q psy11727 424 VLRH 427 (437)
Q Consensus 424 ~l~H 427 (437)
++++
T Consensus 251 ~l~~ 254 (256)
T cd05112 251 LLHQ 254 (256)
T ss_pred HHHh
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=304.98 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=193.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcC-------CCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHE-------EKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~-------~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
.++|.+.+.||+|+||.||+|.+.. +...+|+|.+.... .....+..|+.++..+. .|+||++++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~~~ 92 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG----KHKNIINLLGA 92 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhc----CCCCEeeEEEE
Confidence 4789999999999999999997643 23579999987432 12234556777776653 58999999999
Q ss_pred eeECCEEEEEEEeccC-cHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q psy11727 180 FTWKNHLCLVFELLSY-NLYNLIRNTNF--------------HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPEN 244 (437)
Q Consensus 180 ~~~~~~~~lV~E~~~~-~L~~~l~~~~~--------------~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~N 244 (437)
+...+..++||||+++ +|.+++..... ..+++..+..++.||+.||+|||+ .|++||||||+|
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~N 170 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS--KKCIHRDLAARN 170 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHHh
Confidence 9999999999999965 89999876421 247889999999999999999995 489999999999
Q ss_pred EEEecCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy11727 245 ILLCSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNE 318 (437)
Q Consensus 245 Ill~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~ 318 (437)
|++ +.++.+||+|||++....... ....++..|+|||++.+..++.++|+|||||++|+|++ |.+||.+...
T Consensus 171 ill--~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 171 VLV--TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred eEE--cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 999 677889999999987553211 11223467999999999899999999999999999998 8899988766
Q ss_pred HHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChh
Q psy11727 319 VDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398 (437)
Q Consensus 319 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (437)
.+....+......+. +..
T Consensus 249 ~~~~~~~~~~~~~~~--------------------------------------------------------------~~~ 266 (307)
T cd05098 249 EELFKLLKEGHRMDK--------------------------------------------------------------PSN 266 (307)
T ss_pred HHHHHHHHcCCCCCC--------------------------------------------------------------CCc
Confidence 554444322100000 000
Q ss_pred hhhHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 399 DYMKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 399 ~~~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
....+.+||.+||..+|.+|||+.+++++
T Consensus 267 ~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 267 CTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 01257899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=347.87 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=206.8
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC---cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK---KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
.-+++-...||.|.||.||-|.+..||+..|+|.++.. ........+|..+++.+ .|||+|+.+|+-.+.+.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-----nHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-----NHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-----cCccccccCceeecHHH
Confidence 44677788999999999999999999999999988632 34456778899999988 78999999999999999
Q ss_pred EEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
++|.||||. |+|.+++.... -.++...+.+..|++.|++|||.+ |||||||||+|||| +.+|.||++|||+|.
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~--gIVHRDIK~aNI~L--d~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEH--GIVHRDIKPANILL--DFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhc--CceecCCCccceee--ecCCcEEeeccccee
Confidence 999999995 57888877653 368889999999999999999965 89999999999999 778899999999998
Q ss_pred ecCCcc-------ccccccccccChhhhcCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCC
Q psy11727 265 HVGQTL-------YQYIQSRYYRSPEVLLGI---PYDLAIDMWSLGCILVELHTGEPLFSGKNE-VDQMTKIIEVLGMPP 333 (437)
Q Consensus 265 ~~~~~~-------~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~p~ 333 (437)
.+.... ..+.||+.|||||++.+. +...+.|||||||++.||+||+.||...+. ..++-..-.+. .|+
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh-~Pq 1461 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGH-KPQ 1461 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccC-CCC
Confidence 775443 357899999999999863 466899999999999999999999986443 33333321111 111
Q ss_pred hhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
+|.. + ...-+|||..||+.
T Consensus 1462 ----------------------------------~P~~--l-------------------------s~~g~dFle~Cl~~ 1480 (1509)
T KOG4645|consen 1462 ----------------------------------IPER--L-------------------------SSEGRDFLEHCLEQ 1480 (1509)
T ss_pred ----------------------------------Cchh--h-------------------------hHhHHHHHHHHHhc
Confidence 0000 0 00237999999999
Q ss_pred CCCCCCCHHHHhcCCCcCcCCCC
Q psy11727 414 DPKKRISPTNVLRHEFFLKHSVD 436 (437)
Q Consensus 414 dP~~R~t~~e~l~Hp~~~~~~~~ 436 (437)
||..||++.|+|+|.|=+-..++
T Consensus 1481 dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1481 DPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred CchhhhHHHHHHHhhcccccccc
Confidence 99999999999999998776654
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=298.41 Aligned_cols=245 Identities=20% Similarity=0.292 Sum_probs=188.4
Q ss_pred eeeeceecccCceEEEEEEEcCC---CeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEE---KCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~---~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
|.+.+.||+|+||.||+|....+ +..||+|.++.... ....+..|+.+++.+ .|+||+++++.+...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~ 75 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-----DHPNVMKLIGVCFEASS 75 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEeeeccCCc
Confidence 56789999999999999987653 47899999874322 123455676666655 78999999998765443
Q ss_pred ------EEEEEEeccC-cHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCC
Q psy11727 186 ------LCLVFELLSY-NLYNLIRNTN----FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA 254 (437)
Q Consensus 186 ------~~lV~E~~~~-~L~~~l~~~~----~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ 254 (437)
.++||||+.+ +|..++.... ...+++..+..++.|++.||.|||+ .|++||||||+||++ ++++.
T Consensus 76 ~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~--~~i~H~dlkp~Nil~--~~~~~ 151 (273)
T cd05035 76 LQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN--RNFIHRDLAARNCML--REDMT 151 (273)
T ss_pred cccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchheEEE--CCCCe
Confidence 8999999965 7887774432 2358999999999999999999995 489999999999999 67788
Q ss_pred EEEEeCCCceecCCccc-----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q psy11727 255 IKIIDFGSSCHVGQTLY-----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEV 328 (437)
Q Consensus 255 ikL~DFG~s~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 328 (437)
+||+|||++........ ...++..|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+.+..+...
T Consensus 152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 231 (273)
T cd05035 152 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG 231 (273)
T ss_pred EEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999976533221 1234567999999988899999999999999999999 89999887765554444321
Q ss_pred hCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHH
Q psy11727 329 LGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLIL 408 (437)
Q Consensus 329 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 408 (437)
...+ .| ......+.++|.
T Consensus 232 ~~~~-----------------------------------~~---------------------------~~~~~~~~~li~ 249 (273)
T cd05035 232 NRLK-----------------------------------QP---------------------------EDCLDELYDLMY 249 (273)
T ss_pred CCCC-----------------------------------CC---------------------------cCCCHHHHHHHH
Confidence 0000 00 001125789999
Q ss_pred HccccCCCCCCCHHHHhcC
Q psy11727 409 RMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 409 ~~L~~dP~~R~t~~e~l~H 427 (437)
+||+.||.+|||+.+++.+
T Consensus 250 ~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 250 SCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=297.21 Aligned_cols=246 Identities=20% Similarity=0.284 Sum_probs=193.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCe---EEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKC---QVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~---~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.++|+..+.||+|+||.||+|.+..++. .+|+|.+..... ....+..|+.++..+ .|+||+++.+++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~ 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-----SHHNIIRLEGVVTKF 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-----CCCCeeEEEEEEccC
Confidence 3578899999999999999999876554 799999864321 123345566555544 789999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+ .|++||||||+||++ +.++.+||+|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nili--~~~~~~kl~dfg~ 153 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSD--MNYVHRDLAARNILV--NSNLECKVSDFGL 153 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEE--cCCCcEEECCCcc
Confidence 999999999976 7888876543 458999999999999999999995 489999999999999 6688899999999
Q ss_pred ceecCCcccc------ccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 263 SCHVGQTLYQ------YIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 263 s~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
+......... ...+..|+|||++.+..++.++|+|||||++|||++ |..||...+..+....+......|...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 233 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPM 233 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCC
Confidence 8765332111 112346999999998889999999999999999998 999998877766666654321111100
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
.....+.+|+.+||..||
T Consensus 234 --------------------------------------------------------------~~~~~~~~li~~c~~~~p 251 (268)
T cd05063 234 --------------------------------------------------------------DCPSAVYQLMLQCWQQDR 251 (268)
T ss_pred --------------------------------------------------------------CCCHHHHHHHHHHcCCCc
Confidence 001257899999999999
Q ss_pred CCCCCHHHHhc
Q psy11727 416 KKRISPTNVLR 426 (437)
Q Consensus 416 ~~R~t~~e~l~ 426 (437)
.+||+++++++
T Consensus 252 ~~Rp~~~~i~~ 262 (268)
T cd05063 252 ARRPRFVDIVN 262 (268)
T ss_pred ccCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=295.68 Aligned_cols=242 Identities=24% Similarity=0.329 Sum_probs=192.9
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
++|.+.+.||+|+||.||++. .+++.||+|.++.. .....+..|+.++..+ .|+|++++++++... ..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD-VTAQAFLEETAVMTKL-----HHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc-chHHHHHHHHHHHHhC-----CCCCcCeEEEEEcCC-CcEEE
Confidence 579999999999999999985 47788999998643 2334566777777665 789999999988754 57999
Q ss_pred EEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 190 FELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 190 ~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
|||+++ +|.+++.......+++..+..++.|++.||.|||+ .|++||||||+||++ +.++.++|+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~~~H~dl~p~nili--~~~~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES--KKLVHRDLAARNILV--SEDGVAKVSDFGLARVGSM 152 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEE--cCCCcEEECCCccceeccc
Confidence 999965 89999877655568999999999999999999995 589999999999999 6678899999999876544
Q ss_pred ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhh
Q psy11727 269 TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347 (437)
Q Consensus 269 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 347 (437)
.......+..|+|||++.+..++.++|+|||||++|+|++ |++||...+..+....+......++.
T Consensus 153 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------- 219 (254)
T cd05083 153 GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPP------------- 219 (254)
T ss_pred cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCC-------------
Confidence 3333444667999999998899999999999999999998 99999887765544433221100000
Q ss_pred cccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhc
Q psy11727 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
......+.+||.+||+.+|.+|||+++++.
T Consensus 220 -------------------------------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 220 -------------------------------------------------EGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred -------------------------------------------------CcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000125789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=336.06 Aligned_cols=254 Identities=30% Similarity=0.453 Sum_probs=193.8
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC--cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC-
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK--KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK- 183 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~- 183 (437)
....+|+..+.||+||||.||+++++-+|+.||||+|... ........+|+.++.++ +|||||+++..|...
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-----nHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-----NHPNVVRYYSAWVEST 550 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-----CCcceeeeehhhhccC
Confidence 4567789999999999999999999999999999999765 34455677899999888 789999988755210
Q ss_pred --------------------------------------------------------------------------------
Q psy11727 184 -------------------------------------------------------------------------------- 183 (437)
Q Consensus 184 -------------------------------------------------------------------------------- 183 (437)
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence
Q ss_pred --------------------------------------CEEEEEEEeccCcHHHHH-HhcCCCCCCHHHHHHHHHHHHHH
Q psy11727 184 --------------------------------------NHLCLVFELLSYNLYNLI-RNTNFHGVSLNLTKKFAQQLCCA 224 (437)
Q Consensus 184 --------------------------------------~~~~lV~E~~~~~L~~~l-~~~~~~~ls~~~~~~i~~qi~~a 224 (437)
-.+||-||||..++.+.+ ..+.+ .-.....+++++||+.|
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~-~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF-NSQRDEAWRLFREILEG 709 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc-chhhHHHHHHHHHHHHH
Confidence 127999999988655554 44432 11468889999999999
Q ss_pred HHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC---------------------CccccccccccccChh
Q psy11727 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG---------------------QTLYQYIQSRYYRSPE 283 (437)
Q Consensus 225 L~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~---------------------~~~~~~~gt~~y~aPE 283 (437)
|+|+|+ .|||||||||.|||+ +++..|||+|||+|+... ...++.+||..|+|||
T Consensus 710 LaYIH~--~giIHRDLKP~NIFL--d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 710 LAYIHD--QGIIHRDLKPRNIFL--DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHHHHh--CceeeccCCcceeEE--cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence 999995 589999999999999 678889999999997621 1234578999999999
Q ss_pred hhcCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChhhhccCCccchhhcccCCCcceecc
Q psy11727 284 VLLGIP---YDLAIDMWSLGCILVELHTGEPLFSGKNEVD-QMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKK 359 (437)
Q Consensus 284 ~~~~~~---~~~~~DvwSlG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (437)
++.+.. |+.|+||||||+|++||+ .||...-+.. .+..+. -|..|.. ..||+
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR--~g~iP~~--------~~f~~----------- 841 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLR--KGSIPEP--------ADFFD----------- 841 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcc--cCCCCCC--------ccccc-----------
Confidence 998765 999999999999999999 4687543332 222221 1111110 01110
Q ss_pred ccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCc
Q psy11727 360 STDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432 (437)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~ 432 (437)
.....-..+|++||+.||.+||||.|+|+|.||-.
T Consensus 842 --------------------------------------~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 842 --------------------------------------PEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred --------------------------------------ccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 01112368999999999999999999999999974
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=295.08 Aligned_cols=207 Identities=23% Similarity=0.377 Sum_probs=171.4
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
..++|++.+.||+|+||.||++.+. .+..+|+|.+.........+..|+.+++.+ .|+||+++++.+.. ...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-----QHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhc-----CCCCcceEEEEEcC-CCeE
Confidence 4578999999999999999999865 455699999875544445667788887765 68899999999887 7889
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
++|||+++ +|.+++.......+++..+..++.||+.||.|||+ .|++|+||||+||++ +.++.+||+|||.+...
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~ni~i--~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILV--SASLVCKIADFGLARVI 152 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEE--cCCCcEEECCCcceeec
Confidence 99999964 89999877554568889999999999999999995 489999999999999 67889999999998765
Q ss_pred CCccc----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy11727 267 GQTLY----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKI 325 (437)
Q Consensus 267 ~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i 325 (437)
..... ...++..|+|||++.+..++.++|+|||||++|++++ |.+||.+.+.......+
T Consensus 153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05073 153 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216 (260)
T ss_pred cCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 43211 1234567999999998889999999999999999999 99999987766555544
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=293.95 Aligned_cols=237 Identities=25% Similarity=0.369 Sum_probs=185.0
Q ss_pred ceecccCceEEEEEEEcCCC---eEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEK---CQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVF 190 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~---~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~ 190 (437)
+.||+|+||.||+|....++ ..+|+|.+..... ....+..|+.+++.+ .|+||+++++++. .+.+++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~-~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-----DHPCIVRLIGVCK-GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEc-CCceEEEE
Confidence 46899999999999876555 7899999875443 234556677776655 7899999999876 45689999
Q ss_pred EeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc
Q psy11727 191 ELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT 269 (437)
Q Consensus 191 E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~ 269 (437)
||+.+ +|.+++.... .+++..+..++.|++.||+|||. .|++|+||||+|||+ +.++.+||+|||++......
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~nili--~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 75 ELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLES--KHFVHRDLAARNVLL--VNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred EeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhh--cCeeccCcccceEEE--cCCCcEEeccccccceeecC
Confidence 99964 8999887654 58999999999999999999995 489999999999999 67888999999999766433
Q ss_pred cccc------cccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 270 LYQY------IQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 270 ~~~~------~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.... .++..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+..+....+......+.
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 219 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPR--------- 219 (257)
T ss_pred CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCC---------
Confidence 2211 12357999999998899999999999999999998 9999988766554444322100000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
|. .....+.++|.+||..||.+|||+.
T Consensus 220 --------------------------~~---------------------------~~~~~l~~li~~cl~~~p~~Rp~~~ 246 (257)
T cd05060 220 --------------------------PE---------------------------ECPQEIYSIMLSCWKYRPEDRPTFS 246 (257)
T ss_pred --------------------------CC---------------------------CCCHHHHHHHHHHhcCChhhCcCHH
Confidence 00 0001578999999999999999999
Q ss_pred HHhc
Q psy11727 423 NVLR 426 (437)
Q Consensus 423 e~l~ 426 (437)
++++
T Consensus 247 ~l~~ 250 (257)
T cd05060 247 ELES 250 (257)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=298.29 Aligned_cols=245 Identities=19% Similarity=0.274 Sum_probs=186.6
Q ss_pred eeeeceecccCceEEEEEEEcCCCe--EEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC---
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKC--QVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK--- 183 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~--~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~--- 183 (437)
|.+.+.||+|+||.||+|.+..++. .||+|.++... .....+..|..++..+ .|+||+++++.+...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-----DHPNVMRLIGVCLQTVES 75 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEccCCcc
Confidence 3567899999999999999877765 69999886432 2233445566666555 789999999876432
Q ss_pred ---CEEEEEEEecc-CcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCE
Q psy11727 184 ---NHLCLVFELLS-YNLYNLIRNTN----FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAI 255 (437)
Q Consensus 184 ---~~~~lV~E~~~-~~L~~~l~~~~----~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~i 255 (437)
...++||||+. ++|.+++.... ...+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~--~~~~~~ 151 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK--SFIHRDLAARNCML--NENMNV 151 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC--CeeccccchhheEE--cCCCCE
Confidence 35789999996 47888764322 23489999999999999999999964 89999999999999 678889
Q ss_pred EEEeCCCceecCCccc-----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHh
Q psy11727 256 KIIDFGSSCHVGQTLY-----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVL 329 (437)
Q Consensus 256 kL~DFG~s~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 329 (437)
||+|||++........ ...++..|+|||++.+..++.++|+|||||++|+|++ |++||.+.........+....
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 231 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999976543221 2234667999999999899999999999999999999 899998876655544443210
Q ss_pred CCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHH
Q psy11727 330 GMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILR 409 (437)
Q Consensus 330 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 409 (437)
..+. .......+.++|.+
T Consensus 232 ~~~~--------------------------------------------------------------~~~~~~~~~~li~~ 249 (272)
T cd05075 232 RLKQ--------------------------------------------------------------PPDCLDGLYSLMSS 249 (272)
T ss_pred CCCC--------------------------------------------------------------CCCCCHHHHHHHHH
Confidence 0000 00001157899999
Q ss_pred ccccCCCCCCCHHHHhcC
Q psy11727 410 MLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 410 ~L~~dP~~R~t~~e~l~H 427 (437)
||+.||++|||+.+++++
T Consensus 250 ~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 250 CWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HcCCCcccCcCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=300.42 Aligned_cols=202 Identities=22% Similarity=0.239 Sum_probs=158.0
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCC---CeEEEEEEecCCcccchHHHHHHHH----------HHHhhhcCCCCCcE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEE---KCQVAIKIIKNKKPFLNQAQIEVQL----------LEKINKADIHSRYI 173 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~~~e~~~----------~~~l~~~~~~h~~i 173 (437)
...++|++.++||+|+||+||+|.+..+ +..+|+|+...... ....|... ........+.|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~---~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENE---TIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCC---chhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 3456899999999999999999998877 66778886542221 11111111 11122345689999
Q ss_pred EEecceeeECC----EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec
Q psy11727 174 VKLKGHFTWKN----HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS 249 (437)
Q Consensus 174 v~l~~~~~~~~----~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~ 249 (437)
+++++++.... +.++++|++..++.+.+.... ..++..++.++.|++.||+|||++ ||+||||||+|||+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~--~iiHrDiKp~Nill-- 159 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEH--GISHGDIKPENIMV-- 159 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEE--
Confidence 99998766543 568899998888877766542 357888999999999999999964 89999999999999
Q ss_pred CCCCCEEEEeCCCceecCC----------ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy11727 250 PKRSAIKIIDFGSSCHVGQ----------TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN 317 (437)
Q Consensus 250 ~~~~~ikL~DFG~s~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~ 317 (437)
+.++.++|+|||+|..... ......||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 6678899999999976521 1123468999999999999999999999999999999999999998774
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=295.20 Aligned_cols=180 Identities=25% Similarity=0.293 Sum_probs=152.1
Q ss_pred cCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccC-cHHH
Q psy11727 121 GSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYN 199 (437)
Q Consensus 121 G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~-~L~~ 199 (437)
|.||.||++++..+++.||+|.+.... ....|...+. ...||||+++++++...+..++||||+++ +|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~-----~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTII-----PHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHH-----hcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 899999999999999999999997542 1222322221 12589999999999999999999999965 8988
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCccccccccccc
Q psy11727 200 LIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYY 279 (437)
Q Consensus 200 ~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~~~~~gt~~y 279 (437)
++.... .+++..+..++.|++.||+|||. .||+||||||+||++ +.++.++|+|||.+...........++..|
T Consensus 75 ~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nil~--~~~~~~~l~df~~~~~~~~~~~~~~~~~~y 148 (237)
T cd05576 75 HISKFL--NIPEECVKRWAAEMVVALDALHR--EGIVCRDLNPNNILL--DDRGHIQLTYFSRWSEVEDSCDGEAVENMY 148 (237)
T ss_pred HHHHhc--CCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEE--cCCCCEEEecccchhccccccccCCcCccc
Confidence 887653 48999999999999999999995 589999999999999 677889999999887665555555667889
Q ss_pred cChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy11727 280 RSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG 315 (437)
Q Consensus 280 ~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~ 315 (437)
+|||.+.+..++.++|+||+||++|+|++|..||..
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 999999888899999999999999999999988753
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=302.76 Aligned_cols=248 Identities=25% Similarity=0.349 Sum_probs=193.1
Q ss_pred ccCeeeeceecccCceEEEEEEEc-------CCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDH-------EEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~-------~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
.++|.+.+.||+|+||.||+|... .....+|+|.++.... ....+..|+.++..+. .|+||++++++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~ 86 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG----KHKNIINLLGV 86 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhcc----CCCCeeeEEEE
Confidence 468999999999999999999753 2345799999874322 2234556777766652 58999999999
Q ss_pred eeECCEEEEEEEeccC-cHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q psy11727 180 FTWKNHLCLVFELLSY-NLYNLIRNTN--------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPEN 244 (437)
Q Consensus 180 ~~~~~~~~lV~E~~~~-~L~~~l~~~~--------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~N 244 (437)
+.+.+.+++||||+++ +|.+++.... ...+++..+..++.||+.||.|||+ .|++||||||+|
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~N 164 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES--RRCIHRDLAARN 164 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeecccccee
Confidence 9999999999999965 8998886532 1348899999999999999999995 489999999999
Q ss_pred EEEecCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy11727 245 ILLCSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNE 318 (437)
Q Consensus 245 Ill~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~ 318 (437)
||+ +.++.+||+|||++....... ....++..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+.
T Consensus 165 ill--~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 165 VLV--TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEE--cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 999 667889999999997654321 11223457999999999899999999999999999999 8999988776
Q ss_pred HHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChh
Q psy11727 319 VDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398 (437)
Q Consensus 319 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (437)
.+....+........ + ..
T Consensus 243 ~~~~~~~~~~~~~~~-----------------------------------~---------------------------~~ 260 (314)
T cd05099 243 EELFKLLREGHRMDK-----------------------------------P---------------------------SN 260 (314)
T ss_pred HHHHHHHHcCCCCCC-----------------------------------C---------------------------CC
Confidence 665555432100000 0 00
Q ss_pred hhhHHHHHHHHccccCCCCCCCHHHHhc
Q psy11727 399 DYMKFKDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 399 ~~~~~~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
....+.+||.+||..||.+|||+.++++
T Consensus 261 ~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 261 CTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0115789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=299.43 Aligned_cols=257 Identities=27% Similarity=0.440 Sum_probs=196.3
Q ss_pred CeeeeceecccCceEEEEEEEc---CCCeEEEEEEecCCc-----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDH---EEKCQVAIKIIKNKK-----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~---~~~~~vaiK~i~~~~-----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
+|++.+.||+|+||.||++.+. .+++.||||+++... ........|+.++..+. +|++|+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~----~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVR----RCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhcc----CCcchhhhheeeec
Confidence 4889999999999999999864 467889999986422 12234556777777664 58999999999999
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
.+.+++||||+++ +|.+.+... ..+++..++.++.|++.+|.|||+ .|++||||||+||++ +.++.++|+|||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~--~~~~H~dl~p~nil~--~~~~~~~l~dfg 150 (288)
T cd05583 77 DTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQ--LGIIYRDIKLENILL--DSEGHVVLTDFG 150 (288)
T ss_pred CCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEE--CCCCCEEEEECc
Confidence 9999999999965 788887654 348999999999999999999995 489999999999999 667889999999
Q ss_pred CceecCCcc----ccccccccccChhhhcCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 262 SSCHVGQTL----YQYIQSRYYRSPEVLLGIP--YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 262 ~s~~~~~~~----~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
++....... ....|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||...........+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~------ 224 (288)
T cd05583 151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI------ 224 (288)
T ss_pred cccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH------
Confidence 986543221 2345788999999987765 7889999999999999999999997543222222221110
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
..... ..| ......+.+||.+||+.||
T Consensus 225 -~~~~~-------------------------~~~---------------------------~~~~~~l~~li~~~l~~~p 251 (288)
T cd05583 225 -LKSKP-------------------------PFP---------------------------KTMSAEARDFIQKLLEKDP 251 (288)
T ss_pred -HccCC-------------------------CCC---------------------------cccCHHHHHHHHHHhcCCH
Confidence 00000 000 0001156899999999999
Q ss_pred CCCCC---HHHHhcCCCcCcCCCC
Q psy11727 416 KKRIS---PTNVLRHEFFLKHSVD 436 (437)
Q Consensus 416 ~~R~t---~~e~l~Hp~~~~~~~~ 436 (437)
++||| +.++|+||||+...++
T Consensus 252 ~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 252 KKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred hhccCcchHHHHhcCcccccCCHH
Confidence 99999 5677999999987653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=297.82 Aligned_cols=201 Identities=24% Similarity=0.324 Sum_probs=159.5
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCe----EEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKC----QVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~----~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
++|++.+.||+|+||+||+|.+..+++ .+++|.+..... ....+..|+..+ ..+.|+||+++++++. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l-----~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM-----GSLDHAYIVRLLGICP-G 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHH-----hcCCCCCcceEEEEEC-C
Confidence 578899999999999999999877776 477777753221 112222333333 3458999999999875 4
Q ss_pred CEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
...++|+|+++ |+|.+++.... ..+++..+..++.||+.||+|||+ .|++||||||+|||+ +.++.+||+|||+
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~nili--~~~~~~kl~Dfg~ 155 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEE--HRMVHRNLAARNILL--KSDSIVQIADFGV 155 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEE--cCCCcEEEcCCcc
Confidence 56788999996 58999887643 458999999999999999999995 479999999999999 6788899999999
Q ss_pred ceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy11727 263 SCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQ 321 (437)
Q Consensus 263 s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~ 321 (437)
+....... ....++..|+|||++.+..++.++|||||||++|||++ |.+||.+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~ 220 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV 220 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 97653221 22345678999999998899999999999999999998 9999988765443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.66 Aligned_cols=272 Identities=20% Similarity=0.272 Sum_probs=181.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCC----CeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecce-----
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEE----KCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGH----- 179 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~----~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~----- 179 (437)
.++|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ..|..+.+.+.+. .+.+++.+...
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e~l~~~--~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNERVRRA--CPNSCADFVYGFLEPV 202 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHHHHHhh--chhhHHHHHHhhhccc
Confidence 57899999999999999999999988 8999999886322 1233333333221 11112222211
Q ss_pred -eeECCEEEEEEEeccC-cHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCC
Q psy11727 180 -FTWKNHLCLVFELLSY-NLYNLIRNTNFH------------------GVSLNLTKKFAQQLCCALAFLSSPELSIIHCD 239 (437)
Q Consensus 180 -~~~~~~~~lV~E~~~~-~L~~~l~~~~~~------------------~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrD 239 (437)
......+++||||+++ +|.+++...... ......+..++.||+.||+|||++ ||+|||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~--gIiHRD 280 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST--GIVHRD 280 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC--CEEeCc
Confidence 2456689999999966 788887654311 112345678999999999999964 899999
Q ss_pred CCCCcEEEecCCCCCEEEEeCCCceecCC----ccccccccccccChhhhcCC----------------------CCCCc
Q psy11727 240 LKPENILLCSPKRSAIKIIDFGSSCHVGQ----TLYQYIQSRYYRSPEVLLGI----------------------PYDLA 293 (437)
Q Consensus 240 iKp~NIll~~~~~~~ikL~DFG~s~~~~~----~~~~~~gt~~y~aPE~~~~~----------------------~~~~~ 293 (437)
|||+|||++ +.++.+||+|||+|..... .....++++.|+|||.+... .++.+
T Consensus 281 LKP~NILl~-~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 281 VKPQNIIFS-EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CCHHHEEEe-CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 999999994 2457899999999975432 22356789999999976432 23456
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCc
Q psy11727 294 IDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKR 373 (437)
Q Consensus 294 ~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (437)
+|||||||++|||+++..++ .+....+..+....+.....|....... + .+....
T Consensus 360 ~DVwSlGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~--~---------------------~~~~~~ 414 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRKLVEPR--A---------------------SPDLRR 414 (566)
T ss_pred cccHHHHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHHhhccc--c---------------------chhhhh
Confidence 79999999999999966553 4444555555554443332221110000 0 000000
Q ss_pred hhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 374 LDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
.-+++ ..+.....|||.+||++||.+|||+.|+|+||||++..
T Consensus 415 ~~~~~------------------d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 415 GFEVL------------------DLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred hhhhc------------------cccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCC
Confidence 00000 00112457999999999999999999999999998754
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=296.87 Aligned_cols=241 Identities=26% Similarity=0.325 Sum_probs=187.4
Q ss_pred ceecccCceEEEEEEEcCCCe--EEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKC--QVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~--~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
+.||+|+||.||+|.+..++. .+|+|.++... .....+..|+.++.++. .||||+++++++...+.+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~~~~~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG----HHPNIINLLGACEHRGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhc----cCCCeeeEEEEEecCCCceEEEE
Confidence 468999999999999988775 46888876322 22345667888777764 68999999999999999999999
Q ss_pred ecc-CcHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEE
Q psy11727 192 LLS-YNLYNLIRNTN--------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIK 256 (437)
Q Consensus 192 ~~~-~~L~~~l~~~~--------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ik 256 (437)
|++ ++|.+++.... ...+++..+..++.|++.||+|||+ .|++||||||+|||+ ++++.+|
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nili--~~~~~~k 152 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILV--GENYVAK 152 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccccceEEE--cCCCeEE
Confidence 996 48999886532 1247899999999999999999995 489999999999999 6788899
Q ss_pred EEeCCCceecCCcccc--ccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Q psy11727 257 IIDFGSSCHVGQTLYQ--YIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPP 333 (437)
Q Consensus 257 L~DFG~s~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~ 333 (437)
|+|||++......... ...+..|+|||++.+..++.++|+|||||++|||++ |..||.+.+..+....+......+.
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 232 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 232 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCC
Confidence 9999998533221111 223557999999998899999999999999999997 9999988776555544321100000
Q ss_pred hhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
+ ......+.+|+.+||..
T Consensus 233 -----------------------------------~---------------------------~~~~~~~~~li~~~l~~ 250 (270)
T cd05047 233 -----------------------------------P---------------------------LNCDDEVYDLMRQCWRE 250 (270)
T ss_pred -----------------------------------C---------------------------CcCCHHHHHHHHHHccc
Confidence 0 00011578999999999
Q ss_pred CCCCCCCHHHHhc
Q psy11727 414 DPKKRISPTNVLR 426 (437)
Q Consensus 414 dP~~R~t~~e~l~ 426 (437)
||.+|||+.+++.
T Consensus 251 ~p~~Rps~~~il~ 263 (270)
T cd05047 251 KPYERPSFAQILV 263 (270)
T ss_pred ChhhCCCHHHHHH
Confidence 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=312.84 Aligned_cols=203 Identities=25% Similarity=0.377 Sum_probs=164.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcC-----CCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHE-----EKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|.+.+.||+|+||.||+|.+.. ++..||||+++.... ....+..|+.++..+. .|||||++++++.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~----~HpnIv~l~~~~~ 111 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG----PHLNIVNLLGACT 111 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC----CCCCeeeEEEEEc
Confidence 4578899999999999999998643 335799999964322 2234667888777763 4899999999999
Q ss_pred ECCEEEEEEEeccC-cHHHHHHhcC-------------------------------------------------------
Q psy11727 182 WKNHLCLVFELLSY-NLYNLIRNTN------------------------------------------------------- 205 (437)
Q Consensus 182 ~~~~~~lV~E~~~~-~L~~~l~~~~------------------------------------------------------- 205 (437)
..+..||||||+++ +|.+++....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 99999999999965 8888775421
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q psy11727 206 ---------------------------------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENIL 246 (437)
Q Consensus 206 ---------------------------------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIl 246 (437)
...+++..+..++.||+.||+|||+ .||+||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dikp~Nil 269 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHhEE
Confidence 1247888899999999999999996 48999999999999
Q ss_pred EecCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy11727 247 LCSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEV 319 (437)
Q Consensus 247 l~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~ 319 (437)
+ +.++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 270 l--~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 270 L--AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred E--eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9 567789999999997653221 12345678999999999899999999999999999997 99999875443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=316.16 Aligned_cols=260 Identities=27% Similarity=0.453 Sum_probs=217.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
..+.+++..||-||||.|=++........+|+|++++. ...+.-+.|....++-.+...++++||+++..|.+..++|+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~-hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKK-HIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHh-hccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 45677788999999999999987766667999999743 33344444444444433334478999999999999999999
Q ss_pred EEEec-cCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELL-SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~-~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
+||-| +|.+...+.... .+....++.++.-++.|++|||.+ |||.|||||+|.++ +.+|-+||.|||+|+.++
T Consensus 498 LmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k--~iIYRDLKPENllL--d~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRK--GIIYRDLKPENLLL--DNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhc--CceeccCChhheee--ccCCceEEeehhhHHHhc
Confidence 99999 778999888764 589999999999999999999965 89999999999999 889999999999998874
Q ss_pred --CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccch
Q psy11727 268 --QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSK 345 (437)
Q Consensus 268 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 345 (437)
....++|||+.|.|||++.++..+.++|.||||+++|||++|.|||++.++..+++.|.++..+..
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~------------ 639 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE------------ 639 (732)
T ss_pred cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh------------
Confidence 455689999999999999999999999999999999999999999999999999999988653211
Q ss_pred hhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC-----
Q psy11727 346 YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS----- 420 (437)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t----- 420 (437)
+|.. . .....+||+++...+|.+|..
T Consensus 640 ----------------------~Pr~--I-------------------------~k~a~~Lik~LCr~~P~ERLG~~~~g 670 (732)
T KOG0614|consen 640 ----------------------FPRR--I-------------------------TKTATDLIKKLCRDNPTERLGYQKGG 670 (732)
T ss_pred ----------------------cccc--c-------------------------chhHHHHHHHHHhcCcHhhhccccCC
Confidence 0000 0 003579999999999999997
Q ss_pred HHHHhcCCCcCcCCCC
Q psy11727 421 PTNVLRHEFFLKHSVD 436 (437)
Q Consensus 421 ~~e~l~Hp~~~~~~~~ 436 (437)
+.++-+|.||..-+++
T Consensus 671 I~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 671 INDIKKHRWFEGFDWE 686 (732)
T ss_pred hHHHHhhhhhhcCChh
Confidence 8899999999988776
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=298.44 Aligned_cols=243 Identities=30% Similarity=0.377 Sum_probs=189.1
Q ss_pred eeeceecccCceEEEEEEEc----CCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 113 EIDTLLGKGSFGQVVKAFDH----EEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 113 ~i~~~lG~G~fg~V~~~~~~----~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+.+.||.|+||.||+|... ..+..|+||.++.... ....+..|+..+..+ .||||+++++++...+..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~g~~~~~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-----RHPNIVKLYGFCIENEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-----SBTTBE-EEEEEESSSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-----cccccccccccccccccc
Confidence 46789999999999999887 4567899999964322 245666677777666 789999999999988889
Q ss_pred EEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++||||++ |+|.+++.......+++..+..|+.||+.||+|||++ +++|+||+++|||+ ++++.+||+|||++..
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~--~iiH~~l~~~nill--~~~~~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN--NIIHGNLSPSNILL--DSNGQVKLSDFGLSRP 152 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT--TEEEST-SGGGEEE--ETTTEEEEESTTTGEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc--cccccccccccccccc
Confidence 99999997 5899999887456699999999999999999999964 79999999999999 6688999999999977
Q ss_pred cCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhcc
Q psy11727 266 VGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 266 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 339 (437)
..... ........|+|||.+.+..++.++||||||+++||+++ |+.||...+..+....+.+....+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---- 228 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPD---- 228 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBT----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceecc----
Confidence 63211 12345678999999998889999999999999999999 789999888877776663321111100
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
.....+.++|.+||+.||.+||
T Consensus 229 ----------------------------------------------------------~~~~~~~~li~~C~~~~p~~RP 250 (259)
T PF07714_consen 229 ----------------------------------------------------------NCPKDIYSLIQQCWSHDPEKRP 250 (259)
T ss_dssp ----------------------------------------------------------TSBHHHHHHHHHHT-SSGGGS-
T ss_pred ----------------------------------------------------------chhHHHHHHHHHHcCCChhhCc
Confidence 0011578999999999999999
Q ss_pred CHHHHhc
Q psy11727 420 SPTNVLR 426 (437)
Q Consensus 420 t~~e~l~ 426 (437)
|++++++
T Consensus 251 s~~~i~~ 257 (259)
T PF07714_consen 251 SFQEILQ 257 (259)
T ss_dssp -HHHHHH
T ss_pred CHHHHHh
Confidence 9999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=299.21 Aligned_cols=209 Identities=23% Similarity=0.323 Sum_probs=170.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCC----------------eEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEK----------------CQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHS 170 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~----------------~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h 170 (437)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+.... .....+..|+.++..+ .|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-----~~ 78 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-----SD 78 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-----CC
Confidence 457999999999999999999876543 568999987432 2234566688877776 68
Q ss_pred CcEEEecceeeECCEEEEEEEeccC-cHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC
Q psy11727 171 RYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTN---------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDL 240 (437)
Q Consensus 171 ~~iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~---------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDi 240 (437)
+||+++++++..++..++|||++.+ +|.+++.... ...+++..++.++.|++.||+|||+ .||+||||
T Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~--~~i~H~dl 156 (296)
T cd05051 79 PNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES--LNFVHRDL 156 (296)
T ss_pred CCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH--cCcccccc
Confidence 9999999999999999999999965 8888886543 1258999999999999999999995 48999999
Q ss_pred CCCcEEEecCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh--CCCCC
Q psy11727 241 KPENILLCSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT--GEPLF 313 (437)
Q Consensus 241 Kp~NIll~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--g~~pf 313 (437)
||+||++ +.++.++|+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 157 kp~Nili--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 157 ATRNCLV--GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred chhceee--cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 9999999 667889999999987543221 22345678999999998889999999999999999998 77899
Q ss_pred CCCCHHHHHHHHH
Q psy11727 314 SGKNEVDQMTKII 326 (437)
Q Consensus 314 ~~~~~~~~~~~i~ 326 (437)
...+....+..+.
T Consensus 235 ~~~~~~~~~~~~~ 247 (296)
T cd05051 235 EHLTDQQVIENAG 247 (296)
T ss_pred CCcChHHHHHHHH
Confidence 8776655555443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=297.04 Aligned_cols=245 Identities=19% Similarity=0.262 Sum_probs=187.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCe----EEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKC----QVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~----~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
.++|++.+.||+|+||+||+|.+..++. .||+|+++.... ....+..|..++.. +.|+||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~-----~~~~~i~~~~~~~~~ 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAG-----VGSPYVCRLLGICLT 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHh-----cCCCCCceEEEEEcC
Confidence 3579999999999999999999877765 489999864321 12334445555444 478999999998875
Q ss_pred CCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
...+++||+++ |+|.+++.... ..+++..+..++.||+.||+|||++ ||+||||||+|||+ ++++.+||+|||
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~--~iiH~dlkp~Nil~--~~~~~~kL~dfG 154 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV--RLVHRDLAARNVLV--KSPNHVKITDFG 154 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC--CeeccccccceEEE--cCCCcEEECCCC
Confidence 45789999995 58988887643 3589999999999999999999964 89999999999999 567789999999
Q ss_pred CceecCCccc-----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 262 SSCHVGQTLY-----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 262 ~s~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
++........ ...++..|+|||.+.+..++.++|||||||++|||++ |.+||...........+......+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~- 233 (279)
T cd05109 155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQP- 233 (279)
T ss_pred ceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCC-
Confidence 9976643221 1223567999999999899999999999999999998 99999876655443333211100000
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
......+.++|.+||..||
T Consensus 234 -------------------------------------------------------------~~~~~~~~~li~~~l~~dp 252 (279)
T cd05109 234 -------------------------------------------------------------PICTIDVYMIMVKCWMIDS 252 (279)
T ss_pred -------------------------------------------------------------ccCCHHHHHHHHHHcCCCh
Confidence 0001257899999999999
Q ss_pred CCCCCHHHHhc
Q psy11727 416 KKRISPTNVLR 426 (437)
Q Consensus 416 ~~R~t~~e~l~ 426 (437)
+.|||+.+++.
T Consensus 253 ~~Rp~~~~l~~ 263 (279)
T cd05109 253 ECRPRFRELVD 263 (279)
T ss_pred hhCcCHHHHHH
Confidence 99999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=298.97 Aligned_cols=245 Identities=24% Similarity=0.365 Sum_probs=190.5
Q ss_pred CeeeeceecccCceEEEEEEEcC-----CCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHE-----EKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... ....+..|+.++..+ .||||+++++.+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-----NHPHVIKLYGACSQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-----CCCCEeeEEEEEecC
Confidence 47889999999999999998753 335799998864332 123456677777665 789999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTN----------------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDL 240 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~----------------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDi 240 (437)
+..++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||+ .||+||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~ivH~di 153 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE--MKLVHRDL 153 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH--CCeehhhh
Confidence 999999999964 8888875421 1247889999999999999999995 48999999
Q ss_pred CCCcEEEecCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q psy11727 241 KPENILLCSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFS 314 (437)
Q Consensus 241 Kp~NIll~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~ 314 (437)
||+|||+ ++++.+||+|||++....... ....++..|+|||++.+..++.++||||||+++|||++ |.+||.
T Consensus 154 kp~nill--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 154 AARNVLV--AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hhheEEE--cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 9999999 667889999999987542211 12234668999999998899999999999999999998 999998
Q ss_pred CCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCC
Q psy11727 315 GKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPG 394 (437)
Q Consensus 315 ~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (437)
+.......+.+......+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~------------------------------------------------------------ 251 (290)
T cd05045 232 GIAPERLFNLLKTGYRMERP------------------------------------------------------------ 251 (290)
T ss_pred CCCHHHHHHHHhCCCCCCCC------------------------------------------------------------
Confidence 87765544433221100000
Q ss_pred CChhhhhHHHHHHHHccccCCCCCCCHHHHhc
Q psy11727 395 HSLADYMKFKDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 395 ~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
......+.+||.+||+.||.+|||+.++++
T Consensus 252 --~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 252 --ENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred --CCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 000125789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=295.42 Aligned_cols=245 Identities=21% Similarity=0.296 Sum_probs=192.4
Q ss_pred cCeeeeceecccCceEEEEEEEcCCC---eEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEK---CQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~---~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
++|++.+.||+|+||.||+|.+..++ ..+|+|.++... .....+..|+.++..+ .||||+++++++...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-----DHPNIIHLEGVVTKSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEecCC
Confidence 57899999999999999999876444 379999886432 1123455566666554 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+ .|++||||||+|||+ +.++.++|+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~--~~i~h~dlkp~nili--~~~~~~~l~dfg~~ 153 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILV--NSNLVCKVSDFGLS 153 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEeehhhchhcEEE--CCCCeEEeCCCCcc
Confidence 99999999965 7888887643 458999999999999999999995 489999999999999 67888999999998
Q ss_pred eecCCccc---c---ccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 264 CHVGQTLY---Q---YIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 264 ~~~~~~~~---~---~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
........ . ..++..|+|||++.+..++.++|+|||||++|++++ |..||...+..+....+.+....|..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 231 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAP-- 231 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCC--
Confidence 76533211 1 122457999999998899999999999999999887 99999887766655555332111100
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
......+.+|+.+||+.+|.
T Consensus 232 ------------------------------------------------------------~~~~~~~~~li~~~l~~~p~ 251 (267)
T cd05066 232 ------------------------------------------------------------MDCPAALHQLMLDCWQKDRN 251 (267)
T ss_pred ------------------------------------------------------------CCCCHHHHHHHHHHcccCch
Confidence 00011578999999999999
Q ss_pred CCCCHHHHhc
Q psy11727 417 KRISPTNVLR 426 (437)
Q Consensus 417 ~R~t~~e~l~ 426 (437)
+|||+.++++
T Consensus 252 ~Rp~~~~i~~ 261 (267)
T cd05066 252 ERPKFEQIVS 261 (267)
T ss_pred hCCCHHHHHH
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=293.35 Aligned_cols=236 Identities=24% Similarity=0.348 Sum_probs=184.0
Q ss_pred eecccCceEEEEEEE--cCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 117 LLGKGSFGQVVKAFD--HEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 117 ~lG~G~fg~V~~~~~--~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
.||+|+||.||+|.. ..++..+|+|+++.... ....+..|+.++..+ .|+||+++++++. .+..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~-~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-----DNPYIVRMIGICE-AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEc-CCCcEEEEe
Confidence 589999999999964 46778999999864322 223455666666655 7899999999875 457799999
Q ss_pred eccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCcc
Q psy11727 192 LLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL 270 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~ 270 (437)
|+++ +|.+++.... .+++..+..++.|++.||+|||+ .||+||||||.||++ +.++.+||+|||++.......
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~nill--~~~~~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 76 LAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEE--TNFVHRDLAARNVLL--VTQHYAKISDFGLSKALGADE 149 (257)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchhhEEE--cCCCeEEECCCccccccCCCC
Confidence 9975 7888886543 58999999999999999999995 489999999999999 667889999999987654322
Q ss_pred c------cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 271 Y------QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 271 ~------~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
. ...++..|+|||.+.+..++.++|+|||||++|||++ |.+||.+.+..+....+......+.
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~---------- 219 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC---------- 219 (257)
T ss_pred CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC----------
Confidence 1 1223568999999988889999999999999999998 9999998777666555432111000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
| ......+.+||++||+.||++|||+.+
T Consensus 220 -------------------------~---------------------------~~~~~~l~~li~~~~~~~p~~Rp~~~~ 247 (257)
T cd05116 220 -------------------------P---------------------------QRCPPEMYDLMKLCWTYGVDERPGFAV 247 (257)
T ss_pred -------------------------C---------------------------CCCCHHHHHHHHHHhccCchhCcCHHH
Confidence 0 000125789999999999999999998
Q ss_pred Hhc
Q psy11727 424 VLR 426 (437)
Q Consensus 424 ~l~ 426 (437)
+.+
T Consensus 248 i~~ 250 (257)
T cd05116 248 VEL 250 (257)
T ss_pred HHH
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=296.97 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=192.4
Q ss_pred cCeeeeceecccCceEEEEEEEc-----CCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+|.+.+.||+|+||.||++... .++..+|+|.+.... .....+..|+.++..+ .|+||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-----QHQHIVRFYGVCTEG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-----CCCCCceEEEEEecC
Confidence 46888999999999999999643 356789999886432 2234566677777665 789999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNF-------------HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS 249 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~-------------~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~ 249 (437)
+..++||||+++ +|.+++..... ..+++..+..++.||+.||+|||+ .|++||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~nil~-- 155 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS--LHFVHRDLATRNCLV-- 155 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH--CCeecccccHhhEEE--
Confidence 999999999965 88888865421 247899999999999999999995 489999999999999
Q ss_pred CCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy11727 250 PKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMT 323 (437)
Q Consensus 250 ~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~ 323 (437)
++++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |.+||......+...
T Consensus 156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05092 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235 (280)
T ss_pred cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH
Confidence 567889999999987553221 12234678999999999999999999999999999998 999998777665555
Q ss_pred HHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHH
Q psy11727 324 KIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKF 403 (437)
Q Consensus 324 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (437)
.+........ + ......+
T Consensus 236 ~~~~~~~~~~-----------------------------------~---------------------------~~~~~~~ 253 (280)
T cd05092 236 CITQGRELER-----------------------------------P---------------------------RTCPPEV 253 (280)
T ss_pred HHHcCccCCC-----------------------------------C---------------------------CCCCHHH
Confidence 4432110000 0 0000146
Q ss_pred HHHHHHccccCCCCCCCHHHHhc
Q psy11727 404 KDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 404 ~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
.+||.+||+.||.+|||+.+++.
T Consensus 254 ~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 254 YAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHHHccCChhhCCCHHHHHH
Confidence 89999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=300.20 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=195.3
Q ss_pred ccCeeeeceecccCceEEEEEEEc-------CCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDH-------EEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~-------~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
.++|.+.+.||+|+||.||+|+.. .++..||+|.+.... .....+..|+.++..+. .|+||++++++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~i~~~~~~ 89 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG----KHKNIINLLGA 89 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhc----cCCCchheeEE
Confidence 568999999999999999999742 245679999986432 22345667888777663 68999999999
Q ss_pred eeECCEEEEEEEeccC-cHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q psy11727 180 FTWKNHLCLVFELLSY-NLYNLIRNTN--------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPEN 244 (437)
Q Consensus 180 ~~~~~~~~lV~E~~~~-~L~~~l~~~~--------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~N 244 (437)
+...+..++||||+++ +|.+++.... ...+++..+..++.||+.||.|||++ |++||||||+|
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--givH~dlkp~N 167 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ--KCIHRDLAARN 167 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC--Ceeecccccce
Confidence 9999999999999965 8888887532 13478888999999999999999964 89999999999
Q ss_pred EEEecCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy11727 245 ILLCSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNE 318 (437)
Q Consensus 245 Ill~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~ 318 (437)
|++ +.++.+||+|||++....... ....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus 168 ili--~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 168 VLV--TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred EEE--cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999 667889999999997654321 12234567999999999889999999999999999998 8899988776
Q ss_pred HHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChh
Q psy11727 319 VDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398 (437)
Q Consensus 319 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (437)
.+....+........ + ..
T Consensus 246 ~~~~~~~~~~~~~~~-----------------------------------~---------------------------~~ 263 (304)
T cd05101 246 EELFKLLKEGHRMDK-----------------------------------P---------------------------AN 263 (304)
T ss_pred HHHHHHHHcCCcCCC-----------------------------------C---------------------------CC
Confidence 665554432110000 0 00
Q ss_pred hhhHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 399 DYMKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 399 ~~~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
....+.+||.+||..+|.+|||+.++++.
T Consensus 264 ~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 264 CTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 01257899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=291.26 Aligned_cols=240 Identities=25% Similarity=0.316 Sum_probs=190.0
Q ss_pred ceecccCceEEEEEEEcC-CC--eEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHE-EK--CQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVF 190 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~-~~--~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~ 190 (437)
+.||+|++|.||+|.+.. ++ ..||||.+..... ....+..|+.++..+ .|+||+++++.+.. ..+++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-----DHENLIRLYGVVLT-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-----CCCCccceeEEEcC-CeEEEEE
Confidence 468999999999998765 33 3699999975433 234566677777665 78999999999988 8999999
Q ss_pred Eecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc
Q psy11727 191 ELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT 269 (437)
Q Consensus 191 E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~ 269 (437)
|++. ++|.+++.......+++..++.++.|++.||+|||+ .|++|+||||+||++ +.++.+||+|||++......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~di~p~nil~--~~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES--KRFIHRDLAARNILL--ASDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh--CCccccccCcccEEE--ecCCEEEecccccccccccc
Confidence 9995 589998877543468999999999999999999995 489999999999999 56788999999998766432
Q ss_pred c------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 270 L------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 270 ~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
. ....++..|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+......++
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 221 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--------- 221 (257)
T ss_pred ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC---------
Confidence 1 12345678999999999899999999999999999999 9999988777766555532100000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
.+ ......+.+++.+||+.+|.+|||+.
T Consensus 222 -------------------------~~---------------------------~~~~~~~~~li~~~l~~~p~~Rps~~ 249 (257)
T cd05040 222 -------------------------RP---------------------------EACPQDIYNVMLQCWAHNPADRPTFA 249 (257)
T ss_pred -------------------------CC---------------------------ccCCHHHHHHHHHHCCCCcccCCCHH
Confidence 00 00012578999999999999999999
Q ss_pred HHhc
Q psy11727 423 NVLR 426 (437)
Q Consensus 423 e~l~ 426 (437)
++++
T Consensus 250 ~~~~ 253 (257)
T cd05040 250 ALRE 253 (257)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=297.99 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=193.6
Q ss_pred ccCeeeeceecccCceEEEEEEEcC-----CCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHE-----EKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|++.+.||+|+||.||+|.+.. ++..||+|++..... ....+..|+.++..+ .|+||+++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~iv~~~~~~~ 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-----DHPNIVKLLGVCA 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-----CCCchheEEEEEc
Confidence 4579999999999999999998743 678899999864321 234466677777766 7899999999999
Q ss_pred ECCEEEEEEEeccC-cHHHHHHhcC--------------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC
Q psy11727 182 WKNHLCLVFELLSY-NLYNLIRNTN--------------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDL 240 (437)
Q Consensus 182 ~~~~~~lV~E~~~~-~L~~~l~~~~--------------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDi 240 (437)
+.+.+++||||+++ +|.+++.... ...+++..+..++.||+.||+|||. .|++||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~--~~i~H~dl 156 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--RKFVHRDL 156 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCeecccc
Confidence 99999999999965 8988886431 1246788899999999999999995 48999999
Q ss_pred CCCcEEEecCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q psy11727 241 KPENILLCSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFS 314 (437)
Q Consensus 241 Kp~NIll~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~ 314 (437)
||+||++ +.++.++|+|||++....... .....+..|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 157 ~p~nil~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 157 ATRNCLV--GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred cHhheEe--cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999 678889999999986543221 12234567999999998899999999999999999998 889998
Q ss_pred CCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCC
Q psy11727 315 GKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPG 394 (437)
Q Consensus 315 ~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (437)
+.+..+....+......+. |
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-----------------------------------~------------------------- 254 (288)
T cd05050 235 GMAHEEVIYYVRDGNVLSC-----------------------------------P------------------------- 254 (288)
T ss_pred CCCHHHHHHHHhcCCCCCC-----------------------------------C-------------------------
Confidence 8776655544422100000 0
Q ss_pred CChhhhhHHHHHHHHccccCCCCCCCHHHHhc
Q psy11727 395 HSLADYMKFKDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 395 ~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
......+.+||.+||+.||.+|||+.|+++
T Consensus 255 --~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 255 --DNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred --CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 000125789999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=294.98 Aligned_cols=245 Identities=21% Similarity=0.328 Sum_probs=193.0
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCe---EEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKC---QVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~---~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
+.|++.+.||+|+||.||+|....+++ .||||.+.... .....+..|+.++..+ .||||+++++++...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-----DHPNIIHLEGVVTKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-----CCcCcceEEEEECCCC
Confidence 468999999999999999999877664 69999986432 1233555677666655 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+++||||+++ +|.+++.... ..+++..++.++.|++.||+|||+ .|++|+||||+||++ +.++.++|+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~--~g~~H~dl~p~nili--~~~~~~kl~dfg~~ 153 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSE--MNYVHRDLAARNILV--NSNLVCKVSDFGLS 153 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccChheEEE--cCCCcEEECCCccc
Confidence 99999999966 7877776543 458999999999999999999995 489999999999999 67888999999998
Q ss_pred eecCCccc--cc---c---ccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 264 CHVGQTLY--QY---I---QSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 264 ~~~~~~~~--~~---~---gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
........ .. . .+..|+|||++.+..++.++|||||||++|||++ |.+||...+..+....+......|..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 233 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPP 233 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCc
Confidence 65432211 11 1 1346999999999899999999999999999887 99999887776665555321111110
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
. .....+.+++.+||..+
T Consensus 234 ~--------------------------------------------------------------~~~~~~~~li~~~l~~~ 251 (269)
T cd05065 234 M--------------------------------------------------------------DCPTALHQLMLDCWQKD 251 (269)
T ss_pred c--------------------------------------------------------------cCCHHHHHHHHHHcCCC
Confidence 0 00115789999999999
Q ss_pred CCCCCCHHHHhc
Q psy11727 415 PKKRISPTNVLR 426 (437)
Q Consensus 415 P~~R~t~~e~l~ 426 (437)
|.+|||+.+++.
T Consensus 252 p~~Rp~~~~i~~ 263 (269)
T cd05065 252 RNARPKFGQIVS 263 (269)
T ss_pred hhhCcCHHHHHH
Confidence 999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=291.96 Aligned_cols=249 Identities=26% Similarity=0.378 Sum_probs=194.0
Q ss_pred CeeeeceecccCceEEEEEEEcC-CCeEEEEEEecCCcc-----------cchHHHHHHHHHHHhhhcCCCCCcEEEecc
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHE-EKCQVAIKIIKNKKP-----------FLNQAQIEVQLLEKINKADIHSRYIVKLKG 178 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~-~~~~vaiK~i~~~~~-----------~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~ 178 (437)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... .......|+.++.. .+.|+||+++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~----~~~h~~i~~~~~ 76 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE----QLRHPNIVRYYK 76 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhh----cCCCCCeeeEEe
Confidence 47889999999999999999887 688999998863211 11122334443332 247999999999
Q ss_pred eeeECCEEEEEEEeccC-cHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCE
Q psy11727 179 HFTWKNHLCLVFELLSY-NLYNLIRN--TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAI 255 (437)
Q Consensus 179 ~~~~~~~~~lV~E~~~~-~L~~~l~~--~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~i 255 (437)
++...++.++||||+++ +|.+++.. .....+++..++.++.|++.+|.|||+. .|++|+||+|+||++ +.++.+
T Consensus 77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~i~H~dl~~~nil~--~~~~~~ 153 (269)
T cd08528 77 TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE-KRIVHRDLTPNNIML--GEDDKV 153 (269)
T ss_pred eEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC-CceeecCCCHHHEEE--CCCCcE
Confidence 99999999999999965 78887743 2234589999999999999999999963 479999999999999 678889
Q ss_pred EEEeCCCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy11727 256 KIIDFGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333 (437)
Q Consensus 256 kL~DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~ 333 (437)
+|+|||.+...... .....|+..|+|||++.+..++.++|+||||+++|+|++|.+||...+.......+.+....|.
T Consensus 154 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd08528 154 TITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL 233 (269)
T ss_pred EEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC
Confidence 99999999765433 2345678899999999998899999999999999999999999987766555544433211110
Q ss_pred hhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
.. ......+.+||.+||+.
T Consensus 234 ~~-------------------------------------------------------------~~~~~~l~~li~~cl~~ 252 (269)
T cd08528 234 PE-------------------------------------------------------------GMYSEDVTDVITSCLTP 252 (269)
T ss_pred Cc-------------------------------------------------------------ccCCHHHHHHHHHHCCC
Confidence 00 00001578999999999
Q ss_pred CCCCCCCHHHHhcC
Q psy11727 414 DPKKRISPTNVLRH 427 (437)
Q Consensus 414 dP~~R~t~~e~l~H 427 (437)
||++|||+.|+..+
T Consensus 253 ~p~~Rp~~~e~~~~ 266 (269)
T cd08528 253 DAEARPDIIQVSAM 266 (269)
T ss_pred CCccCCCHHHHHHH
Confidence 99999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=306.06 Aligned_cols=202 Identities=28% Similarity=0.431 Sum_probs=162.0
Q ss_pred ccCeeeeceecccCceEEEEEEE-----cCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFD-----HEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~-----~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++.... ....+..|+.++..+. +|+||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~~~~~~~ 81 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG----HHLNVVNLLGACT 81 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhcc----CCccHhhhcceee
Confidence 36899999999999999999984 34678999999974321 2334567888877764 5789999999876
Q ss_pred EC-CEEEEEEEeccC-cHHHHHHhcC------------------------------------------------------
Q psy11727 182 WK-NHLCLVFELLSY-NLYNLIRNTN------------------------------------------------------ 205 (437)
Q Consensus 182 ~~-~~~~lV~E~~~~-~L~~~l~~~~------------------------------------------------------ 205 (437)
.. ..+++||||+++ +|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 578999999965 8888876431
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCcc----
Q psy11727 206 -----------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL---- 270 (437)
Q Consensus 206 -----------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~---- 270 (437)
...+++..+..++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~Nil~--~~~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS--RKCIHRDLAARNILL--SENNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCccCeEEE--cCCCcEEEEecccccccccCcchhh
Confidence 0236788889999999999999996 489999999999999 678889999999987642211
Q ss_pred -ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy11727 271 -YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNE 318 (437)
Q Consensus 271 -~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~ 318 (437)
....++..|+|||++.+..++.++|+|||||++|+|++ |..||.+...
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 287 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 287 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc
Confidence 12234567999999999899999999999999999997 9999977543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=298.19 Aligned_cols=207 Identities=23% Similarity=0.361 Sum_probs=166.3
Q ss_pred cCeeeeceecccCceEEEEEEEcCC--------------CeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEE--------------KCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYI 173 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~--------------~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~i 173 (437)
++|++.+.||+|+||.||+|.+..+ ...||+|.++.... ....+..|+.++..+ .|+|+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~i 79 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-----KNPNI 79 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-----CCCCc
Confidence 5899999999999999999987543 23589999874321 223466687877766 78999
Q ss_pred EEecceeeECCEEEEEEEeccC-cHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCC
Q psy11727 174 VKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNF----------HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKP 242 (437)
Q Consensus 174 v~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~----------~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp 242 (437)
+++++++...+..++||||+++ +|.+++..... ..+++..+..++.|++.||+|||+ .|++||||||
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp 157 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS--LNFVHRDLAT 157 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh--cCeeccccCh
Confidence 9999999999999999999965 88888754321 136888999999999999999995 4899999999
Q ss_pred CcEEEecCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh--CCCCCCC
Q psy11727 243 ENILLCSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT--GEPLFSG 315 (437)
Q Consensus 243 ~NIll~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--g~~pf~~ 315 (437)
+||++ +.++.+||+|||++....... ....++..|+|||++.+..++.++|+|||||++|+|++ |..||..
T Consensus 158 ~Nill--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 158 RNCLV--GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hhEEE--cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999 567789999999986543221 11233568999999998899999999999999999998 6789988
Q ss_pred CCHHHHHHHH
Q psy11727 316 KNEVDQMTKI 325 (437)
Q Consensus 316 ~~~~~~~~~i 325 (437)
.+..+....+
T Consensus 236 ~~~~~~~~~~ 245 (295)
T cd05097 236 LSDEQVIENT 245 (295)
T ss_pred cChHHHHHHH
Confidence 7766655544
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=294.77 Aligned_cols=197 Identities=28% Similarity=0.373 Sum_probs=160.4
Q ss_pred ccCe-eeeceecccCceEEEEEE----EcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRY-EIDTLLGKGSFGQVVKAF----DHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y-~i~~~lG~G~fg~V~~~~----~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++| .+.+.||+|+||+||++. ...++..||+|.++.... ....+..|+.++..+ .|+||+++++++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~ 76 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-----YHENIVKYKGCCS 76 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEe
Confidence 3566 899999999999998864 345778999999974322 234456677777766 7899999999877
Q ss_pred EC--CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 182 WK--NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 182 ~~--~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
.. ..+++||||+++ +|.+++... .+++..++.++.|++.||.|||++ ||+||||||+|||+ +.++.++|+
T Consensus 77 ~~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~--~i~H~dlkp~Nili--~~~~~~~l~ 149 (283)
T cd05080 77 EQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ--HYIHRDLAARNVLL--DNDRLVKIG 149 (283)
T ss_pred cCCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC--CeeccccChheEEE--cCCCcEEEe
Confidence 53 478999999965 788888654 389999999999999999999964 89999999999999 667889999
Q ss_pred eCCCceecCCccc------cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy11727 259 DFGSSCHVGQTLY------QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN 317 (437)
Q Consensus 259 DFG~s~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~ 317 (437)
|||++........ ...++..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred ecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence 9999876543221 1234567999999998889999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=292.53 Aligned_cols=194 Identities=22% Similarity=0.289 Sum_probs=149.4
Q ss_pred ceecccCceEEEEEEEcC------------CCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 116 TLLGKGSFGQVVKAFDHE------------EKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~------------~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
+.||+|+||+||+|.... ....||+|.+..... ....+..|..++..+ .||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-----~hp~iv~~~~~~~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-----SHKHIVLLYGVCVR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-----CCCCEeeEEEEEec
Confidence 468999999999997532 233588998764322 122334455555544 78999999999999
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCC-----CCEE
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR-----SAIK 256 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~-----~~ik 256 (437)
+...++||||+++ +|..++... ...+++..+..++.||+.||+|||++ ||+||||||+|||+..+.. ..++
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDK--DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhC--CeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999976 555555443 24589999999999999999999964 8999999999999953221 1389
Q ss_pred EEeCCCceecCCccccccccccccChhhhc-CCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCH
Q psy11727 257 IIDFGSSCHVGQTLYQYIQSRYYRSPEVLL-GIPYDLAIDMWSLGCILVELH-TGEPLFSGKNE 318 (437)
Q Consensus 257 L~DFG~s~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~ell-tg~~pf~~~~~ 318 (437)
++|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|.+||.....
T Consensus 153 l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 153 LSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred eCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence 9999998655332 2346788899999987 467899999999999999997 58899887543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=302.66 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=194.5
Q ss_pred ccCeeeeceecccCceEEEEEEEcC-------CCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHE-------EKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~-------~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
..+|.+.+.||+|+||.||+|.+.. ++..||+|.++... .....+..|+.+++.+. .|+||++++++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~ 86 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG----KHKNIINLLGA 86 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhc----CCCCeeeeeEE
Confidence 3579999999999999999997643 23479999886432 22345667888777663 58899999999
Q ss_pred eeECCEEEEEEEeccC-cHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q psy11727 180 FTWKNHLCLVFELLSY-NLYNLIRNTN--------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPEN 244 (437)
Q Consensus 180 ~~~~~~~~lV~E~~~~-~L~~~l~~~~--------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~N 244 (437)
+...+..++||||+++ +|.+++.... ...+++..+..++.||+.||+|||. .|++||||||+|
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~N 164 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS--QKCIHRDLAARN 164 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccce
Confidence 9999999999999965 8998886532 1247888899999999999999995 489999999999
Q ss_pred EEEecCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy11727 245 ILLCSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNE 318 (437)
Q Consensus 245 Ill~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~ 318 (437)
||+ +.++.+||+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |.+||.+.+.
T Consensus 165 ill--~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 165 VLV--TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEE--cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999 667889999999987654321 11223457999999999999999999999999999998 8999988776
Q ss_pred HHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChh
Q psy11727 319 VDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398 (437)
Q Consensus 319 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (437)
.+....+......+. + ..
T Consensus 243 ~~~~~~~~~~~~~~~-----------------------------------~---------------------------~~ 260 (334)
T cd05100 243 EELFKLLKEGHRMDK-----------------------------------P---------------------------AN 260 (334)
T ss_pred HHHHHHHHcCCCCCC-----------------------------------C---------------------------CC
Confidence 665555432110000 0 00
Q ss_pred hhhHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 399 DYMKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 399 ~~~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
....+.+||.+||+.+|.+|||+.+++.+
T Consensus 261 ~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 261 CTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 01157899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=295.34 Aligned_cols=196 Identities=21% Similarity=0.337 Sum_probs=154.7
Q ss_pred ceecccCceEEEEEEEcCCCeE-------EEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQ-------VAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~-------vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+.||+|+||+||+|.+..++.. ||+|.+.... .....+..|..+++.+ .|+||+++++++...+..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-----~h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-----SHKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-----CCCChhheeeEEEeCCCcE
Confidence 4689999999999988665443 8888875432 1223445566665554 7899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCC------CCEEEEeC
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR------SAIKIIDF 260 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~------~~ikL~DF 260 (437)
+||||+++ +|.+++.... ..+++..+..++.||+.||+|||+ .||+||||||+||+++.+.. +.++++||
T Consensus 76 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999966 7888877654 358999999999999999999995 48999999999999964322 13799999
Q ss_pred CCceecCCccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhC-CCCCCCCCHHH
Q psy11727 261 GSSCHVGQTLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTG-EPLFSGKNEVD 320 (437)
Q Consensus 261 G~s~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg-~~pf~~~~~~~ 320 (437)
|.+...... ....++..|+|||++.+. .++.++|+|||||++|+|++| .+||...+...
T Consensus 153 g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~ 213 (258)
T cd05078 153 GISITVLPK-EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213 (258)
T ss_pred ccccccCCc-hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH
Confidence 998665432 335678899999999864 589999999999999999998 57776655443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=287.50 Aligned_cols=238 Identities=26% Similarity=0.396 Sum_probs=188.0
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEec
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELL 193 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~ 193 (437)
++||+|+||.||+|.+.. ++.||+|.+..... ....+..|+.+++.+ .|+||+++++++...+..++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-----DHPNIVKLIGVCVQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCeEEEEEEEecCCCeEEEEEcC
Confidence 468999999999999877 89999999874332 223455677776665 7899999999999999999999999
Q ss_pred cC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCcccc
Q psy11727 194 SY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ 272 (437)
Q Consensus 194 ~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~~~ 272 (437)
.+ +|.+++.... ..+++..+..++.|++.||+|||++ |++||||||+|||+ +.++.++|+|||++.........
T Consensus 75 ~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~--~i~h~di~p~nili--~~~~~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 75 PGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESK--NCIHRDLAARNCLV--GENNVLKISDFGMSREEEGGIYT 149 (251)
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC--CEehhhcCcceEEE--cCCCcEEEeeccccccccCCcce
Confidence 65 7888886643 3588999999999999999999954 89999999999999 67888999999998765422111
Q ss_pred -----ccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchh
Q psy11727 273 -----YIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKY 346 (437)
Q Consensus 273 -----~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~ 346 (437)
...+..|+|||++.+..++.++|+|||||++|+|++ |..||.+.........+......+..
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~------------ 217 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAP------------ 217 (251)
T ss_pred eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCC------------
Confidence 122456999999998899999999999999999999 88999887765544443221110000
Q ss_pred hcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhc
Q psy11727 347 FDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
......+.+|+.+||+.+|.+|||++|+++
T Consensus 218 --------------------------------------------------~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 218 --------------------------------------------------QLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred --------------------------------------------------ccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 000115789999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=287.32 Aligned_cols=238 Identities=26% Similarity=0.374 Sum_probs=186.6
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEec
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELL 193 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~ 193 (437)
++||+|+||.||+|... ++..+|+|.+...... ...+..|+.++..+ .|+||+++++++...+..++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQY-----DHPNIVKLIGVCTQRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-----CCCCcCeEEEEEecCCccEEEEECC
Confidence 46899999999999854 6788999998643211 22355677666655 7899999999999999999999999
Q ss_pred cC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCcccc
Q psy11727 194 SY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ 272 (437)
Q Consensus 194 ~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~~~ 272 (437)
++ +|.+++.... ..+++..+..++.|++.||.|||+ .|++||||||+||++ +.++.+||+|||++.........
T Consensus 75 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~~~H~dl~p~nili--~~~~~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 75 PGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLES--KNCIHRDLAARNCLV--GENNVLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccChheEEE--cCCCeEEECCCccceeccccccc
Confidence 65 7888776543 457899999999999999999995 489999999999999 67888999999998765433221
Q ss_pred ----ccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhh
Q psy11727 273 ----YIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347 (437)
Q Consensus 273 ----~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 347 (437)
..++..|+|||++.+..++.++|+||||+++|++++ |..||.+.........+........
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 215 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC-------------- 215 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCC--------------
Confidence 233457999999998889999999999999999998 9999988776655444422110000
Q ss_pred cccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhc
Q psy11727 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
+......+.+|+.+||+.+|++|||+.++++
T Consensus 216 ------------------------------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 216 ------------------------------------------------PQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred ------------------------------------------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0000126789999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=294.86 Aligned_cols=206 Identities=24% Similarity=0.344 Sum_probs=165.8
Q ss_pred ccCeeeeceecccCceEEEEEEEcC----------------CCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHE----------------EKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHS 170 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~----------------~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h 170 (437)
.++|++.+.||+|+||+||++.+.. ++..||+|.+.... .....+..|+.+++.+ .|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-----~~ 78 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-----KD 78 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CC
Confidence 3579999999999999999985432 34579999987432 1234566788887766 68
Q ss_pred CcEEEecceeeECCEEEEEEEeccC-cHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC
Q psy11727 171 RYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNF---------HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDL 240 (437)
Q Consensus 171 ~~iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~---------~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDi 240 (437)
+||+++++++...+..++||||+++ +|.+++..... ..+++..+..++.||+.||+|||++ |++||||
T Consensus 79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~--~i~H~dl 156 (296)
T cd05095 79 PNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL--NFVHRDL 156 (296)
T ss_pred CCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC--CeecccC
Confidence 9999999999999999999999964 89888865321 2367889999999999999999954 8999999
Q ss_pred CCCcEEEecCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh--CCCCC
Q psy11727 241 KPENILLCSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT--GEPLF 313 (437)
Q Consensus 241 Kp~NIll~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--g~~pf 313 (437)
||+|||+ +.++.++|+|||++....... ....++..|+|||+..+..++.++|+|||||++|||++ |..||
T Consensus 157 kp~Nili--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 157 ATRNCLV--GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred ChheEEE--cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 9999999 668889999999987653221 11233567999999988899999999999999999998 77999
Q ss_pred CCCCHHHHHH
Q psy11727 314 SGKNEVDQMT 323 (437)
Q Consensus 314 ~~~~~~~~~~ 323 (437)
...+..+...
T Consensus 235 ~~~~~~~~~~ 244 (296)
T cd05095 235 SQLSDEQVIE 244 (296)
T ss_pred cccChHHHHH
Confidence 8766655443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=288.37 Aligned_cols=237 Identities=22% Similarity=0.319 Sum_probs=183.3
Q ss_pred eecccCceEEEEEEEc--CCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEe
Q psy11727 117 LLGKGSFGQVVKAFDH--EEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFEL 192 (437)
Q Consensus 117 ~lG~G~fg~V~~~~~~--~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~ 192 (437)
.||+|+||.||+|.+. .++..||+|++..... ....+..|+.+++.+ .|+||+++++++. .+..++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~ii~~~~~~~-~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-----DNPYIVRMIGVCE-AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-----CCCCeEEEEEEEc-CCCeEEEEEe
Confidence 3799999999999765 4556799999875422 123466777777776 7899999999876 4578999999
Q ss_pred ccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCccc
Q psy11727 193 LSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLY 271 (437)
Q Consensus 193 ~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~~ 271 (437)
+++ +|.+++.... ..+++..+..++.||+.||+|||++ |++||||||+|||+ +.++.+||+|||++........
T Consensus 76 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~nil~--~~~~~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 76 ASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK--NFVHRDLAARNVLL--VNQHYAKISDFGLSKALGADDS 150 (257)
T ss_pred CCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc--CeeecccchheEEE--cCCCcEEeccCCccccccCCcc
Confidence 965 7888876533 4689999999999999999999964 89999999999999 6678899999999875432211
Q ss_pred ------cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc
Q psy11727 272 ------QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344 (437)
Q Consensus 272 ------~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 344 (437)
...++..|+|||++.+..++.++|+|||||++|++++ |.+||.+....+....+......+.
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 219 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC----------- 219 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC-----------
Confidence 1122467999999998889999999999999999996 9999988776655444322110000
Q ss_pred hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHH
Q psy11727 345 KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNV 424 (437)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~ 424 (437)
+......+.++|.+||..||++|||..++
T Consensus 220 ---------------------------------------------------~~~~~~~l~~li~~c~~~~~~~Rp~~~~i 248 (257)
T cd05115 220 ---------------------------------------------------PAECPPEMYALMKDCWIYKWEDRPNFAKV 248 (257)
T ss_pred ---------------------------------------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 00011267899999999999999999998
Q ss_pred hc
Q psy11727 425 LR 426 (437)
Q Consensus 425 l~ 426 (437)
.+
T Consensus 249 ~~ 250 (257)
T cd05115 249 EE 250 (257)
T ss_pred HH
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=289.65 Aligned_cols=191 Identities=24% Similarity=0.343 Sum_probs=155.7
Q ss_pred ceecccCceEEEEEEEcCCC----------eEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEK----------CQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~----------~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
+.||+|+||.||+|.+..++ ..+++|.+.........+.+|+.+++.+ .|+||+++++++.. +.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-----SHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-----CCcchhheeeEEec-CC
Confidence 46899999999999998776 4588888764433245566677666654 78999999999888 77
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC-------CEEE
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS-------AIKI 257 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~-------~ikL 257 (437)
.++||||+++ +|.+++.... ..+++..+..++.||+.||+|||+ .||+||||||+|||++ .++ .+||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dlkp~Nill~--~~~~~~~~~~~~kl 149 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLED--KKLVHGNVCGKNILVA--RYGLNEGYVPFIKL 149 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh--CCeecccCccceEEEe--cCccccCCceeEEe
Confidence 8999999965 7888877654 258999999999999999999995 4899999999999995 344 6999
Q ss_pred EeCCCceecCCccccccccccccChhhhcCC--CCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy11727 258 IDFGSSCHVGQTLYQYIQSRYYRSPEVLLGI--PYDLAIDMWSLGCILVELHT-GEPLFSGKNE 318 (437)
Q Consensus 258 ~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt-g~~pf~~~~~ 318 (437)
+|||++..... .....++..|+|||++.+. .++.++|+|||||++|+|++ |.+||...+.
T Consensus 150 ~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~ 212 (259)
T cd05037 150 SDPGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212 (259)
T ss_pred CCCCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence 99999976644 2234567789999999876 78999999999999999999 5788877643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=291.42 Aligned_cols=245 Identities=26% Similarity=0.361 Sum_probs=190.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCC---CeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEE---KCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~---~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.++|.+.+.||+|+||.||+|.+... ...||||...... .....+..|+.++..+ .|+||+++++++.+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~- 78 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-----DHPHIVKLIGVITE- 78 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-----CCCchhceeEEEcC-
Confidence 35688999999999999999987544 4569999886443 1233556677776665 78999999998875
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+..++||||+++ +|.+++.... ..+++..+..++.||+.||+|||+ .|++||||||+||++ +.++.++|+|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~~H~dl~p~nili--~~~~~~~l~d~g~ 153 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLES--KRFVHRDIAARNVLV--SSPDCVKLGDFGL 153 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccChheEEE--ecCCCeEEccCce
Confidence 567899999965 8998887643 358999999999999999999995 489999999999999 5678899999999
Q ss_pred ceecCCccc----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 263 SCHVGQTLY----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 263 s~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
+........ ...++..|+|||.+.+..++.++|||||||++|+|++ |.+||.+.+..+....+......+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 229 (270)
T cd05056 154 SRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM---- 229 (270)
T ss_pred eeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCC----
Confidence 876533211 1223457999999988889999999999999999996 9999988876655544422110000
Q ss_pred ccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCC
Q psy11727 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKK 417 (437)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 417 (437)
+ . .....+.++|.+||.++|.+
T Consensus 230 -------------------------------~-----------------------~----~~~~~~~~li~~~l~~~P~~ 251 (270)
T cd05056 230 -------------------------------P-----------------------P----NCPPTLYSLMTKCWAYDPSK 251 (270)
T ss_pred -------------------------------C-----------------------C----CCCHHHHHHHHHHcCCChhh
Confidence 0 0 00115789999999999999
Q ss_pred CCCHHHHhc
Q psy11727 418 RISPTNVLR 426 (437)
Q Consensus 418 R~t~~e~l~ 426 (437)
|||+.+++.
T Consensus 252 Rpt~~~~~~ 260 (270)
T cd05056 252 RPRFTELKA 260 (270)
T ss_pred CcCHHHHHH
Confidence 999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=307.26 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=192.6
Q ss_pred ccCeeeeceecccCceEEEEEEEc-----CCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|.+.+.||+|+||.||+|.+. .++..||+|+++.... ....+..|+.++..+. .|+|||++++++.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~----~H~niv~~~~~~~ 111 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLG----PHLNIVNLLGACT 111 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcC----CCCCeEEEEEEEc
Confidence 456889999999999999999854 3557899999974321 1234566888877763 3899999999999
Q ss_pred ECCEEEEEEEeccC-cHHHHHHhcC-------------------------------------------------------
Q psy11727 182 WKNHLCLVFELLSY-NLYNLIRNTN------------------------------------------------------- 205 (437)
Q Consensus 182 ~~~~~~lV~E~~~~-~L~~~l~~~~------------------------------------------------------- 205 (437)
..+..++||||+++ +|.+++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999965 8998886432
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q psy11727 206 -----------------------------------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPEN 244 (437)
Q Consensus 206 -----------------------------------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~N 244 (437)
...+++..+..++.||+.||+|||+ .|++||||||+|
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrdlkp~N 269 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS--KNCVHRDLAARN 269 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCcCcccCCcce
Confidence 1236778889999999999999995 489999999999
Q ss_pred EEEecCCCCCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy11727 245 ILLCSPKRSAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNE 318 (437)
Q Consensus 245 Ill~~~~~~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~ 318 (437)
||+ ++.+.+||+|||++...... .....++..|+|||++.+..++.++|+|||||++|||++ |..||.....
T Consensus 270 iLl--~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 270 VLI--CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EEE--eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999 56778999999999754221 122346778999999999899999999999999999998 8999987654
Q ss_pred HHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChh
Q psy11727 319 VDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398 (437)
Q Consensus 319 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (437)
.+.....+.. +..+. .| ..
T Consensus 348 ~~~~~~~~~~-~~~~~---------------------------------~p---------------------------~~ 366 (401)
T cd05107 348 NEQFYNAIKR-GYRMA---------------------------------KP---------------------------AH 366 (401)
T ss_pred hHHHHHHHHc-CCCCC---------------------------------CC---------------------------CC
Confidence 4443332221 00000 00 00
Q ss_pred hhhHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 399 DYMKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 399 ~~~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
....+.+||.+||..||.+|||+.++++.
T Consensus 367 ~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 367 ASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 01257899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=292.56 Aligned_cols=247 Identities=19% Similarity=0.287 Sum_probs=191.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcC----CCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHE----EKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~----~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ....+..|+.+++.+ .|+||+++++++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~ 79 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-----SHQNILPILHVCIE 79 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEec
Confidence 4689999999999999999999876 357899998864321 123344566665554 88999999998765
Q ss_pred -CCEEEEEEEecc-CcHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCC
Q psy11727 183 -KNHLCLVFELLS-YNLYNLIRNTNF------HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA 254 (437)
Q Consensus 183 -~~~~~lV~E~~~-~~L~~~l~~~~~------~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ 254 (437)
....++++|+++ ++|.+++..... ..+++..+..++.||+.||+|||+ .+++||||||+||++ ++++.
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~i~H~di~p~nil~--~~~~~ 155 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK--RGVIHKDIAARNCVI--DEELQ 155 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCHhhEEE--cCCCc
Confidence 578899999996 488888865422 358999999999999999999995 489999999999999 66788
Q ss_pred EEEEeCCCceecCCccc-----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q psy11727 255 IKIIDFGSSCHVGQTLY-----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEV 328 (437)
Q Consensus 255 ikL~DFG~s~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 328 (437)
+||+|||++........ ...++..|+|||++.+..++.++|||||||++||+++ |++||...+..+....+...
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 235 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG 235 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC
Confidence 99999999975532211 2234667999999998899999999999999999999 99999887765544433221
Q ss_pred hCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHH
Q psy11727 329 LGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLIL 408 (437)
Q Consensus 329 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 408 (437)
...+ .. ......+.+++.
T Consensus 236 ~~~~-------------------------------------~~-------------------------~~~~~~~~~li~ 253 (280)
T cd05043 236 YRLA-------------------------------------QP-------------------------INCPDELFAVMA 253 (280)
T ss_pred CCCC-------------------------------------CC-------------------------CcCCHHHHHHHH
Confidence 1000 00 000015789999
Q ss_pred HccccCCCCCCCHHHHhc
Q psy11727 409 RMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 409 ~~L~~dP~~R~t~~e~l~ 426 (437)
+||..||++|||+.++++
T Consensus 254 ~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 254 CCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHcCCChhhCCCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=291.66 Aligned_cols=203 Identities=22% Similarity=0.362 Sum_probs=161.2
Q ss_pred ceecccCceEEEEEEEcCCC------eEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEK------CQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~------~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+.||+|+||.||+|...... ..+|+|.+.... .....+..|+.++..+ .|+||+++++++...+..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-----NHPNIVKLLGVCLLNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-----CCCCeeeEeeeecCCCCeE
Confidence 36899999999999876543 789999886432 2234556677776655 7899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC---CCCEEEE
Q psy11727 188 LVFELLSY-NLYNLIRNTN-----FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK---RSAIKII 258 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~-----~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~---~~~ikL~ 258 (437)
+||||+++ +|.+++.... ...+++..+..++.||+.||+|||+ .+++|+||||+||+++.+. ...++|+
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~~~~~l~ 153 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDADRVVKIG 153 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh--CCcccCCCChheEEEecCCCCCCcceEEC
Confidence 99999965 8988886532 2347889999999999999999995 4899999999999995322 1279999
Q ss_pred eCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy11727 259 DFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKI 325 (437)
Q Consensus 259 DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i 325 (437)
|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~ 226 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH
Confidence 999986553221 12234678999999999899999999999999999998 99999887765554443
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=290.70 Aligned_cols=206 Identities=23% Similarity=0.333 Sum_probs=167.5
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCe----EEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKC----QVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~----~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
..+|++.+.||+|+||+||+|.+..++. .+|+|.+..... ....+..|+.++..+ .|+||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~ 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-----DHPHVVRLLGICLS 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEec
Confidence 3579999999999999999999876664 589998864432 223455666666665 78999999999887
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
...++||||+++ +|.+++.... ..+++..+..++.||+.||+|||+ .|++||||||+||++ +.++.+||+|||
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~di~p~nil~--~~~~~~kL~dfg 154 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEE--KRLVHRDLAARNVLV--KTPQHVKITDFG 154 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCEEecccCcceEEE--cCCCeEEECCCc
Confidence 789999999964 8988887653 348999999999999999999996 489999999999999 667789999999
Q ss_pred CceecCCccc--c---ccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy11727 262 SSCHVGQTLY--Q---YIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKI 325 (437)
Q Consensus 262 ~s~~~~~~~~--~---~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i 325 (437)
++........ . ..++..|+|||.+....++.++|+|||||++||+++ |.+||.+....+....+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 224 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9976543221 1 122467999999988899999999999999999999 99999987766655544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=292.34 Aligned_cols=195 Identities=21% Similarity=0.264 Sum_probs=149.1
Q ss_pred eecccCceEEEEEEEcC------------------------CCeEEEEEEecCCccc-chHHHHHHHHHHHhhhcCCCCC
Q psy11727 117 LLGKGSFGQVVKAFDHE------------------------EKCQVAIKIIKNKKPF-LNQAQIEVQLLEKINKADIHSR 171 (437)
Q Consensus 117 ~lG~G~fg~V~~~~~~~------------------------~~~~vaiK~i~~~~~~-~~~~~~e~~~~~~l~~~~~~h~ 171 (437)
.||+|+||.||+|.... ....||+|++...... ...+..|..++.. +.|+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~-----l~h~ 76 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQ-----VSHI 76 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhc-----CCCC
Confidence 58999999999997432 1245889988643211 1233344444443 4799
Q ss_pred cEEEecceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC
Q psy11727 172 YIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP 250 (437)
Q Consensus 172 ~iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~ 250 (437)
||+++++++.+....++||||+++ +|..++... ...+++..+..++.||+.||+|||+ .||+||||||+|||++..
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLED--KNLVHGNVCAKNILLARL 153 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHc--CCccCCCCCcccEEEecc
Confidence 999999999999999999999976 566666543 2458999999999999999999995 489999999999999532
Q ss_pred C-----CCCEEEEeCCCceecCCccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHH-hCCCCCCCCCHHH
Q psy11727 251 K-----RSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELH-TGEPLFSGKNEVD 320 (437)
Q Consensus 251 ~-----~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~ell-tg~~pf~~~~~~~ 320 (437)
. .+.+|++|||++...... ....++..|+|||.+.+ ..++.++|+|||||++|||+ +|.+||.+....+
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred CcccCccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 1 234899999988544222 23457788999999875 56899999999999999985 6999998765543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=290.26 Aligned_cols=248 Identities=21% Similarity=0.306 Sum_probs=194.4
Q ss_pred cCeeeeceecccCceEEEEEEEcC-----CCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHE-----EKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
++|++.+.||+|+||+||+|+.+. +.+.||+|.+..... ....+..|+.+++.+ .|+||+++++++.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-----SHKNVVRLLGLCRE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-----CCcceeeeEEEECC
Confidence 578999999999999999998654 356799998864332 235677788888776 68899999999999
Q ss_pred CCEEEEEEEecc-CcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCC
Q psy11727 183 KNHLCLVFELLS-YNLYNLIRNTNF-------HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA 254 (437)
Q Consensus 183 ~~~~~lV~E~~~-~~L~~~l~~~~~-------~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ 254 (437)
.+..++||||++ ++|.+++..... ..+++..+..++.||+.||+|||+. ||+||||||+||++ +.++.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~--~i~H~dlkp~Nili--~~~~~ 155 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA--RFVHRDLAARNCLV--SSQRE 155 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc--CcccCcCccceEEE--eCCCc
Confidence 999999999996 489888876541 1589999999999999999999954 79999999999999 66788
Q ss_pred EEEEeCCCceecCCc----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHh
Q psy11727 255 IKIIDFGSSCHVGQT----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVL 329 (437)
Q Consensus 255 ikL~DFG~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 329 (437)
++|+|||++...... .....++..|+|||.+.+..++.++||||||+++|+|++ |.+||.+.........+....
T Consensus 156 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~ 235 (275)
T cd05046 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK 235 (275)
T ss_pred EEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC
Confidence 999999998644221 112345677999999988889999999999999999999 889998766554444432110
Q ss_pred CCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHH
Q psy11727 330 GMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILR 409 (437)
Q Consensus 330 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 409 (437)
... +. .......+.++|.+
T Consensus 236 ~~~------------------------------------~~-------------------------~~~~~~~l~~~i~~ 254 (275)
T cd05046 236 LEL------------------------------------PV-------------------------PEGCPSRLYKLMTR 254 (275)
T ss_pred cCC------------------------------------CC-------------------------CCCCCHHHHHHHHH
Confidence 000 00 00001257899999
Q ss_pred ccccCCCCCCCHHHHhcC
Q psy11727 410 MLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 410 ~L~~dP~~R~t~~e~l~H 427 (437)
||+.||.+|||+.|++.+
T Consensus 255 ~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 255 CWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HcCCCcccCCCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=314.85 Aligned_cols=257 Identities=28% Similarity=0.455 Sum_probs=214.6
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE-----C
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW-----K 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~-----~ 183 (437)
.+.|++.+.||.|.+|.||+++...+++.+|+|+.........+.+.|..+++.+. +|||++.++++|.. +
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~----~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYS----HHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhcc----CCCCcceEEEEEEEecCCCC
Confidence 46799999999999999999999999999999999877666677777888887765 89999999999874 4
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+.++||||||+| +..|++++.....+.|..+.-|++.++.||.+||.+ .++|||||-.|||+ ..++.|||+|||.
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n--kviHRDikG~NiLL--T~e~~VKLvDFGv 169 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN--KVIHRDIKGQNVLL--TENAEVKLVDFGV 169 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc--ceeeecccCceEEE--eccCcEEEeeeee
Confidence 689999999955 889999887777899999999999999999999965 59999999999999 6788999999999
Q ss_pred ceecCC---ccccccccccccChhhhcCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 263 SCHVGQ---TLYQYIQSRYYRSPEVLLGI-----PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 263 s~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
|..... ...+.+||++|||||++... .|+..+|+||||++..||.-|.||+........+-.|- .-||.
T Consensus 170 SaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip---RNPPP 246 (953)
T KOG0587|consen 170 SAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---RNPPP 246 (953)
T ss_pred eeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC---CCCCc
Confidence 976643 33568999999999999753 47788999999999999999999999887755544442 22222
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
.+.. ..+ =..+|.|||+.||..|
T Consensus 247 kLkr-p~k--------------------------------------------------------Ws~~FndFIs~cL~Kd 269 (953)
T KOG0587|consen 247 KLKR-PKK--------------------------------------------------------WSKKFNDFISTCLVKD 269 (953)
T ss_pred cccc-hhh--------------------------------------------------------HHHHHHHHHHHHHhhc
Confidence 1110 000 0126899999999999
Q ss_pred CCCCCCHHHHhcCCCcCcC
Q psy11727 415 PKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~~~~ 433 (437)
-..||+..++|+|||++..
T Consensus 270 ~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 270 YEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred cccCcchhhhccCCccccc
Confidence 9999999999999999853
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.35 Aligned_cols=211 Identities=27% Similarity=0.401 Sum_probs=178.5
Q ss_pred ccCeeeeceecccCceEEEEEEEc-----CCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
..+-...+.||+|+||+||+|+-. .+...||||.++.... ...++++|+.++..+ +|||||+++|.|.
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-----~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-----QHPNIVRLLGVCR 559 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-----cCCCeEEEEEEEc
Confidence 345667889999999999999753 2446799999985543 356788999999887 7899999999999
Q ss_pred ECCEEEEEEEec-cCcHHHHHHhcC--------CC----CCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEe
Q psy11727 182 WKNHLCLVFELL-SYNLYNLIRNTN--------FH----GVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLC 248 (437)
Q Consensus 182 ~~~~~~lV~E~~-~~~L~~~l~~~~--------~~----~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~ 248 (437)
.++-+|+|+||| .|+|.++|.... .. +++..+...|+.|||.|+.||.++ .+|||||-..|+||
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~--~FVHRDLATRNCLV- 636 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH--HFVHRDLATRNCLV- 636 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--cccccchhhhhcee-
Confidence 999999999999 569999986532 11 278899999999999999999865 59999999999999
Q ss_pred cCCCCCEEEEeCCCceecCCccccccc-----cccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy11727 249 SPKRSAIKIIDFGSSCHVGQTLYQYIQ-----SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQM 322 (437)
Q Consensus 249 ~~~~~~ikL~DFG~s~~~~~~~~~~~g-----t~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~ 322 (437)
.++..|||+|||+++..-...+...+ ...|||||.|...+||++|||||+||+|||+++ |..||.+-++.+.+
T Consensus 637 -ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 637 -GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred -ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 67889999999999876443333233 356999999999999999999999999999999 99999999999998
Q ss_pred HHHHHH
Q psy11727 323 TKIIEV 328 (437)
Q Consensus 323 ~~i~~~ 328 (437)
+.|.++
T Consensus 716 e~i~~g 721 (774)
T KOG1026|consen 716 ECIRAG 721 (774)
T ss_pred HHHHcC
Confidence 888653
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=292.54 Aligned_cols=195 Identities=28% Similarity=0.397 Sum_probs=160.2
Q ss_pred CeeeeceecccCceEEEEEEE----cCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC-
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFD----HEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK- 183 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~----~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~- 183 (437)
-|++.+.||+|+||.||+|.. ..++..||+|.++... .....+..|+.+++.+ .|+||+++.+++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 79 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-----YHENIVKYKGICTEDG 79 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-----CCCCeeeeeeEEecCC
Confidence 368899999999999999974 4578899999986432 2234566788777766 789999999998875
Q ss_pred -CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 184 -NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 184 -~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
...++||||++| +|.+++.... ..+++..+..++.||+.||+|||+ .|++||||||+||++ +.++.++|+|||
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~--~gi~H~dlkp~Nil~--~~~~~~~l~dfg 154 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLV--ESEHQVKIGDFG 154 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccchheEEE--cCCCCEEECCCc
Confidence 678999999965 7888886543 358999999999999999999995 489999999999999 567889999999
Q ss_pred CceecCCcc------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy11727 262 SSCHVGQTL------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG 315 (437)
Q Consensus 262 ~s~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~ 315 (437)
++....... ....++..|+|||++.+..++.++|||||||++|+|+++..|+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~ 214 (284)
T cd05079 155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESS 214 (284)
T ss_pred cccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCcc
Confidence 987653321 123456679999999988999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=285.54 Aligned_cols=255 Identities=26% Similarity=0.473 Sum_probs=209.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC----cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~----~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|.+.++||+|+|++|.+++.++|.+.+|+|++++. ....+..+.|..+.+... .||.+|-++.+|+...
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~as----n~pflvglhscfqtes 324 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS----NNPFLVGLHSCFQTES 324 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhcc----CCCeEEehhhhhcccc
Confidence 46899999999999999999999999999999999743 344566778888887764 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+++|.||++| +|.-.+..+ ..++++.++.+...|+.||.|||+ .|||.||||.+|||+ |..|+|||+|+|++
T Consensus 325 rlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~--rgiiyrdlkldnvll--daeghikltdygmc 398 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHE--RGIIYRDLKLDNVLL--DAEGHIKLTDYGMC 398 (593)
T ss_pred eEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhh--cCeeeeeccccceEE--ccCCceeecccchh
Confidence 99999999976 554444444 359999999999999999999995 599999999999999 88999999999998
Q ss_pred eec---CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC-------CCHHHH-HHHHHHHhCCC
Q psy11727 264 CHV---GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG-------KNEVDQ-MTKIIEVLGMP 332 (437)
Q Consensus 264 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~-------~~~~~~-~~~i~~~~~~p 332 (437)
+.- +...+++|||+.|+|||++.+..|...+|+|+|||+++||+.|+.||.- .+.++. ++-|.+.
T Consensus 399 ke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek---- 474 (593)
T KOG0695|consen 399 KEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK---- 474 (593)
T ss_pred hcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh----
Confidence 653 5667889999999999999999999999999999999999999999953 122222 3333332
Q ss_pred ChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc
Q psy11727 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412 (437)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 412 (437)
+.++|+..+. .....++..|+
T Consensus 475 --------------------------------qiriprslsv---------------------------kas~vlkgfln 495 (593)
T KOG0695|consen 475 --------------------------------QIRIPRSLSV---------------------------KASHVLKGFLN 495 (593)
T ss_pred --------------------------------cccccceeeh---------------------------hhHHHHHHhhc
Confidence 1222222111 34578899999
Q ss_pred cCCCCCCC------HHHHhcCCCcCcCCCC
Q psy11727 413 YDPKKRIS------PTNVLRHEFFLKHSVD 436 (437)
Q Consensus 413 ~dP~~R~t------~~e~l~Hp~~~~~~~~ 436 (437)
.||.+|.. ..++-.||||+..++|
T Consensus 496 kdp~erlgc~~~~g~~dik~h~ffr~idwd 525 (593)
T KOG0695|consen 496 KDPKERLGCRPQTGFSDIKSHAFFRSIDWD 525 (593)
T ss_pred CCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence 99999976 5788999999977664
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=286.97 Aligned_cols=239 Identities=21% Similarity=0.295 Sum_probs=178.7
Q ss_pred ceecccCceEEEEEEEcC---CCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceee-ECCEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHE---EKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT-WKNHLCLV 189 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~---~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~-~~~~~~lV 189 (437)
+.||+|+||+||+|.+.. ++..||+|.+.... .....+..|+.+++. +.||||+++++++. .++..++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~-----l~h~~iv~~~~~~~~~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKD-----FSHPNVLSLLGICLPSEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHcc-----CCCCCcceEEEEeecCCCCcEEE
Confidence 468999999999998653 34679999885322 112344445555444 48999999999765 45578999
Q ss_pred EEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 190 FELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 190 ~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
|||+.+ +|.+++.... ...++..+..++.||+.||+|||+ .|++||||||+|||+ +.++.+||+|||++.....
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlk~~nili--~~~~~~kl~dfg~~~~~~~ 150 (262)
T cd05058 76 LPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLAS--KKFVHRDLAARNCML--DESFTVKVADFGLARDIYD 150 (262)
T ss_pred EecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEE--cCCCcEEECCccccccccC
Confidence 999964 8888886543 346778888999999999999995 489999999999999 6678899999999875432
Q ss_pred cc-------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 269 TL-------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 269 ~~-------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
.. ....++..|+|||++.+..++.++|||||||++|||++ |.+||...+..+....+......+.
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 223 (262)
T cd05058 151 KEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ------- 223 (262)
T ss_pred CcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC-------
Confidence 11 12344668999999998899999999999999999999 5788887665554433321100000
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
+ . .....+.+++.+||..+|++|||
T Consensus 224 ----------------------------~------------------------~---~~~~~~~~li~~cl~~~p~~Rp~ 248 (262)
T cd05058 224 ----------------------------P------------------------E---YCPDPLYEVMLSCWHPKPEMRPT 248 (262)
T ss_pred ----------------------------C------------------------C---cCCHHHHHHHHHHcCCChhhCCC
Confidence 0 0 00015789999999999999999
Q ss_pred HHHHhc
Q psy11727 421 PTNVLR 426 (437)
Q Consensus 421 ~~e~l~ 426 (437)
+.++++
T Consensus 249 ~~~il~ 254 (262)
T cd05058 249 FSELVS 254 (262)
T ss_pred HHHHHH
Confidence 999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=287.02 Aligned_cols=202 Identities=20% Similarity=0.276 Sum_probs=155.8
Q ss_pred ceecccCceEEEEEEEcC--CCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHE--EKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~--~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
+.||+|+||+||+|.... ....+|+|.+..... ....+..|+.+++.+ .|+||+++++.+...+.+++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-----~h~nii~~~~~~~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-----NHPNVLQCLGQCIESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-----CCCCcceEEEEECCCCceEEEEE
Confidence 358999999999996433 445788888753321 122344566665544 78999999999999999999999
Q ss_pred eccC-cHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 192 LLSY-NLYNLIRNTNF---HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~~---~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
|+++ +|.+++..... ...++..+..++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill--~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--ADFIHSDLALRNCQL--TADLSVKIGDYGLALEQY 151 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh--cCEecccccHhheEe--cCCCcEEEeccccccccc
Confidence 9965 89888866432 234678889999999999999995 489999999999999 678889999999986532
Q ss_pred Cc-----cccccccccccChhhhcC-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy11727 268 QT-----LYQYIQSRYYRSPEVLLG-------IPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKII 326 (437)
Q Consensus 268 ~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~ 326 (437)
.. .....++..|+|||++.. ..++.++|||||||++|||++ |.+||......+.+..+.
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 223 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV 223 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh
Confidence 21 112234567999999753 356789999999999999999 789998877666555543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=285.38 Aligned_cols=198 Identities=21% Similarity=0.274 Sum_probs=155.6
Q ss_pred ceecccCceEEEEEEEc--CCCeEEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDH--EEKCQVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~--~~~~~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
+.||+|+||.||+|... .++..+|+|.++..... ...+..|+.++..+ .|+||+++++++.+....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-----QHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEcCCCCcEEEEE
Confidence 36899999999999754 35567999988744321 22455566666655 78999999999999999999999
Q ss_pred eccC-cHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 192 LLSY-NLYNLIRNTN---FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~---~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
|+++ +|.+++.... ....++..+..++.|++.||+|||+ .|++||||||+||++ +.++.++|+|||++....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dlkp~nil~--~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--NNFIHSDLALRNCLL--TADLTVKIGDYGLSHNKY 151 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEE--cCCCcEEECCcccccccc
Confidence 9964 8888886532 1235677888999999999999995 489999999999999 667889999999986543
Q ss_pred Ccc-----ccccccccccChhhhcCC-------CCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy11727 268 QTL-----YQYIQSRYYRSPEVLLGI-------PYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQM 322 (437)
Q Consensus 268 ~~~-----~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~ 322 (437)
... ....++..|+|||++.+. .++.++|+|||||++|||++ |.+||......+..
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 219 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL 219 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH
Confidence 221 123457789999998642 35789999999999999996 99999876655443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=323.03 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=202.5
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCC-----eEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEK-----CQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
...-++.+.||+|+||.||.|...... ..||||.++... +....+..+.|.+.+.++.|||||+++|.+.+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~---~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS---SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 345778899999999999999765432 248999887432 344445556666666777999999999999999
Q ss_pred CEEEEEEEecc-CcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 184 NHLCLVFELLS-YNLYNLIRNTN-----FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 184 ~~~~lV~E~~~-~~L~~~l~~~~-----~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
...+|++|||. |+|..+|++.+ ...++......|+.|||+|+.||+++ ++|||||...|+|| +.+..+||
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~--~fvHRDLAaRNCLL--~~~r~VKI 843 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK--HFVHRDLAARNCLL--DERRVVKI 843 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC--CCcCcchhhhheee--cccCcEEE
Confidence 99999999995 58999998762 23589999999999999999999964 79999999999999 67789999
Q ss_pred EeCCCceecCCccccccc-----cccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Q psy11727 258 IDFGSSCHVGQTLYQYIQ-----SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGM 331 (437)
Q Consensus 258 ~DFG~s~~~~~~~~~~~g-----t~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 331 (437)
+|||+|+.+....+...+ ...|||||.+..+.++.++|||||||+|||++| |..||.+.+..+.+.-.++.-.+
T Consensus 844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL 923 (1025)
T KOG1095|consen 844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL 923 (1025)
T ss_pred cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence 999999855433332222 246999999999999999999999999999999 99999999999888877665444
Q ss_pred CChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 332 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
+++..++ ..+.+++..||
T Consensus 924 ~~P~~CP--------------------------------------------------------------~~ly~lM~~CW 941 (1025)
T KOG1095|consen 924 DPPSYCP--------------------------------------------------------------EKLYQLMLQCW 941 (1025)
T ss_pred CCCCCCC--------------------------------------------------------------hHHHHHHHHHc
Confidence 4433322 14679999999
Q ss_pred ccCCCCCCCHHHHhc
Q psy11727 412 TYDPKKRISPTNVLR 426 (437)
Q Consensus 412 ~~dP~~R~t~~e~l~ 426 (437)
..+|++||+...+++
T Consensus 942 ~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 942 KHDPEDRPSFRTIVE 956 (1025)
T ss_pred cCChhhCccHHHHHh
Confidence 999999999998886
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=288.10 Aligned_cols=196 Identities=27% Similarity=0.397 Sum_probs=159.7
Q ss_pred cCeeeeceecccCceEEEEEE----EcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE--
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAF----DHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW-- 182 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~----~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~-- 182 (437)
.+|++.+.||+|+||+||+|. +..++..||+|.+..... ....+..|+.++..+ .|+||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-----QHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCCCeeEEEEEEccCC
Confidence 478999999999999999997 445788999999864432 234566788877765 78999999997653
Q ss_pred CCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
...+++||||++ ++|.+++.... ..+++..+..++.||+.||+|||+ .||+||||||+||++ ++++.+||+|||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~--~~i~H~dlkp~nili--~~~~~~~l~dfg 153 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGS--KRYVHRDLATRNILV--ESENRVKIGDFG 153 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHhhEEE--CCCCeEEECCCc
Confidence 357899999996 48998886543 358999999999999999999995 489999999999999 677889999999
Q ss_pred CceecCCccc------cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy11727 262 SSCHVGQTLY------QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG 315 (437)
Q Consensus 262 ~s~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~ 315 (437)
++........ ...++..|+|||++.+..++.++|+|||||++|||++|..|+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred ccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 9976533211 11234469999999988999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=298.61 Aligned_cols=273 Identities=28% Similarity=0.376 Sum_probs=203.5
Q ss_pred ecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHH---HHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 103 KHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQ---IEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 103 ~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~---~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
.....+.++|-++.+||+|||+.||+|.+...++.||+|+-...+.+.++-. .....-+.-.|..++||.||+++++
T Consensus 456 kDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy 535 (775)
T KOG1151|consen 456 KDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY 535 (775)
T ss_pred ccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence 4455678899999999999999999999999999999999764433322211 1222233333555699999999999
Q ss_pred ee-ECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC-CCCCEEE
Q psy11727 180 FT-WKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP-KRSAIKI 257 (437)
Q Consensus 180 ~~-~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~-~~~~ikL 257 (437)
|. +.+.+|-|+|||+|+-+++..+.. ..+++..++.|+.||+.||.||......|||-||||.||||.+. ..|.|||
T Consensus 536 fslDtdsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 536 FSLDTDSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeeccccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence 97 567899999999986555444433 45999999999999999999999877889999999999999643 2478999
Q ss_pred EeCCCceecCCcc----------ccccccccccChhhhcCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy11727 258 IDFGSSCHVGQTL----------YQYIQSRYYRSPEVLLGI----PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323 (437)
Q Consensus 258 ~DFG~s~~~~~~~----------~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~ 323 (437)
+|||+++.+.... ....||.+|++||.+.-. ..+.++||||+|||+|.++.|+-||..+-. .+
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs---QQ 691 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS---QQ 691 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh---HH
Confidence 9999998764432 235789999999998643 467899999999999999999999975422 22
Q ss_pred HHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHH
Q psy11727 324 KIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKF 403 (437)
Q Consensus 324 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (437)
.|.+...... ..... +|. .|..+. +.
T Consensus 692 dILqeNTIlk-----------------------------AtEVq----------------FP~-----KPvVss----eA 717 (775)
T KOG1151|consen 692 DILQENTILK-----------------------------ATEVQ----------------FPP-----KPVVSS----EA 717 (775)
T ss_pred HHHhhhchhc-----------------------------ceecc----------------CCC-----CCccCH----HH
Confidence 2322111000 00000 000 011111 45
Q ss_pred HHHHHHccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 404 ~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
++||++||++--++|+...++..||+|..+
T Consensus 718 kaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 718 KAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred HHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 899999999999999999999999999754
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=306.03 Aligned_cols=245 Identities=23% Similarity=0.361 Sum_probs=196.5
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCe---E-EEEEEecCC----cccchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKC---Q-VAIKIIKNK----KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~---~-vaiK~i~~~----~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
++-.+.++||+|+||.||+|..+..+. . ||+|..+.+ .....++..|.++++.+ .|||||+++|+..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-----~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-----NHPNVVRFYGVAV 231 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEc
Confidence 345567999999999999998765422 3 899998742 22344556677777765 8999999999999
Q ss_pred ECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 182 WKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 182 ~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
....++||||+|.| +|.++|++.. ..++..+...++.+.+.||+|||++ ++|||||-..|+|+ ..++.+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k--~~IHRDIAARNcL~--~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSK--NCIHRDIAARNCLY--SKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHC--CCcchhHhHHHhee--cCCCeEEeCcc
Confidence 99999999999955 8999998875 3699999999999999999999975 69999999999999 55667899999
Q ss_pred CCceecCCccccc---cccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH-HhCCCChh
Q psy11727 261 GSSCHVGQTLYQY---IQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIE-VLGMPPGY 335 (437)
Q Consensus 261 G~s~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~-~~~~p~~~ 335 (437)
|+|+......... .-...|+|||.+....|+.++|||||||++||+++ |..||.+....+..++|.. ...+++..
T Consensus 307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~ 386 (474)
T KOG0194|consen 307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS 386 (474)
T ss_pred ccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC
Confidence 9987654221111 12367999999999999999999999999999999 8899999999988888843 33333211
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
.....+..++.+|+..||
T Consensus 387 --------------------------------------------------------------~~p~~~~~~~~~c~~~~p 404 (474)
T KOG0194|consen 387 --------------------------------------------------------------KTPKELAKVMKQCWKKDP 404 (474)
T ss_pred --------------------------------------------------------------CCHHHHHHHHHHhccCCh
Confidence 011146788999999999
Q ss_pred CCCCCHHHHhc
Q psy11727 416 KKRISPTNVLR 426 (437)
Q Consensus 416 ~~R~t~~e~l~ 426 (437)
+.|||+.++.+
T Consensus 405 ~~R~tm~~i~~ 415 (474)
T KOG0194|consen 405 EDRPTMSTIKK 415 (474)
T ss_pred hhccCHHHHHH
Confidence 99999988763
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=285.21 Aligned_cols=281 Identities=29% Similarity=0.499 Sum_probs=216.3
Q ss_pred eeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC-----
Q psy11727 113 EIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN----- 184 (437)
Q Consensus 113 ~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~----- 184 (437)
+-.+.||-|+||.||.+.+..+|+.||+|.+.+-. ...+++.+|..++.-. .|.|++..++..+...
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-----kHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-----RHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-----ccccHHHHHHhcCCCCchHHH
Confidence 34568899999999999999999999999886432 2245666788777766 6677888777766442
Q ss_pred EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 185 HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 185 ~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
.+|+|+|+|..+|...+... +.++.+.++.|.+||+++|.|||+. +|.||||||.|.|+ +.+..+||+|||+++
T Consensus 131 EiYV~TELmQSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA--~ILHRDIKPGNLLV--NSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 131 ELYVLTELMQSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTA--NILHRDIKPGNLLV--NSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHHHhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhc--chhhccCCCccEEe--ccCceEEeccccccc
Confidence 57889999988888877664 4699999999999999999999964 79999999999999 778899999999998
Q ss_pred ecCC----ccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhcc
Q psy11727 265 HVGQ----TLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 265 ~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 339 (437)
.... .++..+-|.+|+|||+++|. .|+.++||||.|||+.|++-.+.+|...+..++++.|.+.+|.|..+-+..
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 6643 33445668899999999986 599999999999999999999999999999999999999999999877754
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
+-...+- ++ ++ ..-..|....|-.+- ++. ...-+..+++.+||.+||++|+
T Consensus 285 ACEGAk~--H~------LR-----~~~k~Ps~~vLYtls------------S~~----~~~heav~~~~~~l~~d~dkri 335 (449)
T KOG0664|consen 285 ACEGAKN--HV------LR-----AGLRAPDTQRLYKIA------------SPD----DKNHEAVDLLQKLLHFDPDKRI 335 (449)
T ss_pred HhhhhHH--Hh------hc-----cCCCCCCccceeeec------------CCc----ccchHHHHHHHHHhCCCCcccc
Confidence 4332110 00 00 000111111111110 000 0111457899999999999999
Q ss_pred CHHHHhcCCCcCcC
Q psy11727 420 SPTNVLRHEFFLKH 433 (437)
Q Consensus 420 t~~e~l~Hp~~~~~ 433 (437)
+..+++.|+++.+.
T Consensus 336 s~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 336 SVEEALQHRYLEEG 349 (449)
T ss_pred cHhhhccccccccc
Confidence 99999999998764
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=291.71 Aligned_cols=201 Identities=22% Similarity=0.294 Sum_probs=160.7
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCe----EEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKC----QVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~----~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
++|++.+.||+|+||.||+|.+..++. .||+|.+...... ...+..|+.++..+ .|+||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-----~h~niv~~~~~~~~~ 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-----DHPHLVRLLGVCLSP 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCcccEEEEEcCC
Confidence 568899999999999999999877775 4788888643211 12344566655554 789999999988754
Q ss_pred CEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
..++++||++ |+|.+++.... ..+++..+..++.||+.||+|||++ ||+||||||+||++ +.++.+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~--~ivH~dikp~Nill--~~~~~~kL~Dfg~ 155 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER--RLVHRDLAARNVLV--KSPNHVKITDFGL 155 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhc--Ceeccccccceeee--cCCCceEEccccc
Confidence 5679999996 47888877643 3588999999999999999999964 89999999999999 5677899999999
Q ss_pred ceecCCccc-----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy11727 263 SCHVGQTLY-----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQ 321 (437)
Q Consensus 263 s~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~ 321 (437)
+........ ...++..|+|||++.+..++.++|||||||++|||++ |..||.+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~ 220 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 976532211 2234668999999999899999999999999999998 9999987664443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=286.14 Aligned_cols=197 Identities=26% Similarity=0.368 Sum_probs=163.4
Q ss_pred cCeeeeceecccCceEEEEEEEc----CCCeEEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEecceeeE-
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDH----EEKCQVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW- 182 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~----~~~~~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~- 182 (437)
..|.+.+.||+|+||.||+|... .++..||+|.+...... ...+..|+.+++.+ .|+||+++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-----~~~~i~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-----DHENIVKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-----CCCChheEEeeeecC
Confidence 46788899999999999999854 34789999999755432 45667777777765 68899999999887
Q ss_pred -CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 183 -KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 183 -~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
..+.++||||+++ +|.+++.... ..+++..+..++.||+.||+|||+ .|++|+||||+||++ +.++.++|+||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~nil~--~~~~~~~l~df 153 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS--QRYIHRDLAARNILV--ESEDLVKISDF 153 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEE--cCCCCEEEccc
Confidence 5689999999965 8988887654 358999999999999999999995 489999999999999 66788999999
Q ss_pred CCceecCCccc------cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy11727 261 GSSCHVGQTLY------QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGK 316 (437)
Q Consensus 261 G~s~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~ 316 (437)
|.+........ ...++..|+|||.+.+..++.++|+|||||+++||++|..||...
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 154 GLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred ccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 99976652211 123345699999999889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=283.20 Aligned_cols=245 Identities=20% Similarity=0.281 Sum_probs=186.2
Q ss_pred eeeeceecccCceEEEEEEEc---CCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC-
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDH---EEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN- 184 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~---~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~- 184 (437)
|.+.+.||+|+||.||+|... .++..||||++.... ....++..|+.+++.+ .||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~ 75 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-----DHPNVIKLIGVSLRSRA 75 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-----CCCCcceEEEEEccCCC
Confidence 567889999999999999864 357899999986432 1233455677766665 7899999999886532
Q ss_pred -----EEEEEEEecc-CcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCC
Q psy11727 185 -----HLCLVFELLS-YNLYNLIRNTN----FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA 254 (437)
Q Consensus 185 -----~~~lV~E~~~-~~L~~~l~~~~----~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ 254 (437)
..++++||+. ++|.+++.... ...+++..+..++.||+.||+|||+ .||+||||||+||++ +.++.
T Consensus 76 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~nili--~~~~~ 151 (273)
T cd05074 76 KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS--KNFIHRDLAARNCML--NENMT 151 (273)
T ss_pred CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccchhhEEE--cCCCC
Confidence 3578899995 47777764322 1247889999999999999999995 489999999999999 66788
Q ss_pred EEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q psy11727 255 IKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEV 328 (437)
Q Consensus 255 ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 328 (437)
+||+|||++....... ....++..|++||.+.+..++.++|||||||++|+|++ |++||.+.+..+....+...
T Consensus 152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 231 (273)
T cd05074 152 VCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG 231 (273)
T ss_pred EEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999987653221 12234567999999998899999999999999999999 89999887765554444321
Q ss_pred hCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHH
Q psy11727 329 LGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLIL 408 (437)
Q Consensus 329 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 408 (437)
...+. .......+.+++.
T Consensus 232 ~~~~~--------------------------------------------------------------~~~~~~~~~~l~~ 249 (273)
T cd05074 232 NRLKQ--------------------------------------------------------------PPDCLEDVYELMC 249 (273)
T ss_pred CcCCC--------------------------------------------------------------CCCCCHHHHHHHH
Confidence 00000 0000125789999
Q ss_pred HccccCCCCCCCHHHHhcC
Q psy11727 409 RMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 409 ~~L~~dP~~R~t~~e~l~H 427 (437)
+||+.+|.+|||+.+++++
T Consensus 250 ~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 250 QCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=281.16 Aligned_cols=201 Identities=19% Similarity=0.258 Sum_probs=154.3
Q ss_pred eecccCceEEEEEEEcCC--CeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEe
Q psy11727 117 LLGKGSFGQVVKAFDHEE--KCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFEL 192 (437)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~--~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~ 192 (437)
.||+|+||.||+|....+ ...+++|.+..... ....+..|+.++.. +.||||+++++.+.+....|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~-----l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRI-----LQHPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhc-----cCCcchhheEEEecCCCccEEEEec
Confidence 589999999999975433 33566777653321 12344555555544 4799999999999999999999999
Q ss_pred ccC-cHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC-
Q psy11727 193 LSY-NLYNLIRNTN--FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ- 268 (437)
Q Consensus 193 ~~~-~L~~~l~~~~--~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~- 268 (437)
+++ +|.+++.... ....++..++.++.||+.||+|||+ .+++||||||+|||+ +.++.++|+|||++.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nil~--~~~~~~~l~Dfg~~~~~~~~ 152 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK--HNFLHSDLALRNCFL--TSDLTVKVGDYGIGPSRYKE 152 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCeeccCCccceEEE--cCCccEEecccccccccCcc
Confidence 975 8988887542 2346777888999999999999995 489999999999999 6788899999999854321
Q ss_pred ----ccccccccccccChhhhcC-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy11727 269 ----TLYQYIQSRYYRSPEVLLG-------IPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKII 326 (437)
Q Consensus 269 ----~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~ 326 (437)
......++..|+|||++.. ..++.++|||||||++|||++ |.+||...+..+.+..+.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 222 (268)
T cd05086 153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI 222 (268)
T ss_pred hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 1123467889999999853 346789999999999999997 578998777666555543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=306.14 Aligned_cols=200 Identities=30% Similarity=0.404 Sum_probs=169.6
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC----
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK---- 183 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~---- 183 (437)
.-+...+.||+||||.||+++++.+|+.||||.+++.. ...+...+|+.+++++ .|+|||++++.-++.
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-----nh~NIVk~f~iee~~~~~~ 87 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-----NHPNIVKLFDIEETKFLGL 87 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-----CchhhhhhcccCCccccCc
Confidence 34677889999999999999999999999999997533 2234556799999988 578999999976543
Q ss_pred --CEEEEEEEecc-CcHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC--CCCEEE
Q psy11727 184 --NHLCLVFELLS-YNLYNLIRN-TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK--RSAIKI 257 (437)
Q Consensus 184 --~~~~lV~E~~~-~~L~~~l~~-~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~--~~~ikL 257 (437)
+...+|||||. |+|+..+.. .+..|+++...+.+...++.||.|||.+ |||||||||.||++-..+ ....||
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn--~IvHRDlKP~NIvl~~Gedgq~IyKL 165 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN--GIVHRDLKPGNIVLQIGEDGQSIYKL 165 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc--CceeccCCCCcEEEeecCCCceEEee
Confidence 46789999995 589988865 4557899999999999999999999954 899999999999985433 345899
Q ss_pred EeCCCceecCCc--cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy11727 258 IDFGSSCHVGQT--LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGK 316 (437)
Q Consensus 258 ~DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~ 316 (437)
+|||.|+...+. ..+.+||+.|.+||++.. +.|+..+|.|||||++|++.||..||...
T Consensus 166 tDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 166 TDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 999999987544 457899999999999995 78999999999999999999999999543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=298.70 Aligned_cols=204 Identities=24% Similarity=0.366 Sum_probs=152.0
Q ss_pred ccCeeeeceecccCceEEEEEEEc----------------CCCeEEEEEEecCCccc---------------chHHHHHH
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDH----------------EEKCQVAIKIIKNKKPF---------------LNQAQIEV 157 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~----------------~~~~~vaiK~i~~~~~~---------------~~~~~~e~ 157 (437)
.++|.+.++||+|+||+||+|... ..++.||||.+...... .+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999752 24567999998643211 12233466
Q ss_pred HHHHHhhhcCCCCCcEEEecceeeE--------CCEEEEEEEeccC-cHHHHHHhcC----------------------C
Q psy11727 158 QLLEKINKADIHSRYIVKLKGHFTW--------KNHLCLVFELLSY-NLYNLIRNTN----------------------F 206 (437)
Q Consensus 158 ~~~~~l~~~~~~h~~iv~l~~~~~~--------~~~~~lV~E~~~~-~L~~~l~~~~----------------------~ 206 (437)
.++.++.+.++.+.++++++++|.. .+..+|||||+++ +|.+++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 6666776666666677888887753 3578999999965 7888775421 0
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCcc--cc--ccccccccCh
Q psy11727 207 HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL--YQ--YIQSRYYRSP 282 (437)
Q Consensus 207 ~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~--~~--~~gt~~y~aP 282 (437)
..+++..++.++.|++.+|.|||+ .+|+||||||+|||+ +.++.+||+|||++....... .. ..+++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~--~~ivHrDLKp~NILl--~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHR--IGIVHRDIKPENLLV--TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCchHhEEE--CCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 124677889999999999999995 489999999999999 667889999999986543221 11 2347899999
Q ss_pred hhhcCCC--------------------CC--CcchHHHHHHHHHHHHhCCC-CCCCC
Q psy11727 283 EVLLGIP--------------------YD--LAIDMWSLGCILVELHTGEP-LFSGK 316 (437)
Q Consensus 283 E~~~~~~--------------------~~--~~~DvwSlG~il~elltg~~-pf~~~ 316 (437)
|++.... |+ .+.|+||+||++|+|++|.. ||.+.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~ 436 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANI 436 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccch
Confidence 9986432 11 24799999999999999985 77653
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=277.45 Aligned_cols=260 Identities=25% Similarity=0.361 Sum_probs=197.6
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
.+-...||.|+||+|++-..+.+|+..|||.|+.... ...++..|+....+ .-..||||+++|....++.-+|-
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mk----s~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMK----SSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHh----hcCCcHHHHHhhhhhcCCceeee
Confidence 3345678999999999999999999999999974332 12333334433332 23778999999999888999999
Q ss_pred EEeccCcHHHHH---HhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 190 FELLSYNLYNLI---RNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 190 ~E~~~~~L~~~l---~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
||+|.-++..+. -......++++.+-.|......||.||.. ++.|||||+||+|||+ +..|.|||||||.+-.+
T Consensus 142 MELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-~lkiIHRDvKPSNILl--dr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 142 MELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-ELKIIHRDVKPSNILL--DRHGDVKLCDFGICGQL 218 (361)
T ss_pred HHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-HhhhhhccCChhheEE--ecCCCEeeecccchHhH
Confidence 999987654433 22222458999999999999999999976 4789999999999999 88999999999998766
Q ss_pred CCcc--ccccccccccChhhhcC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChhhhccCC
Q psy11727 267 GQTL--YQYIQSRYYRSPEVLLG--IPYDLAIDMWSLGCILVELHTGEPLFSGKN-EVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 267 ~~~~--~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
-... +...|.+.|||||.+.. .+|+.+|||||||++|||+.||..|+.+-+ ..+++.+++ .|-||....+.
T Consensus 219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~l~~~~-- 294 (361)
T KOG1006|consen 219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPILLFDK-- 294 (361)
T ss_pred HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCeecCcc--
Confidence 4332 33578889999999964 469999999999999999999999998643 334444443 34444221110
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
+.......+..||.-||..|-..||+-
T Consensus 295 -----------------------------------------------------~~~~~s~~~~~fintCl~Kd~~~Rpky 321 (361)
T KOG1006|consen 295 -----------------------------------------------------ECVHYSFSMVRFINTCLIKDRSDRPKY 321 (361)
T ss_pred -----------------------------------------------------cccccCHHHHHHHHHHhhcccccCcch
Confidence 001111267899999999999999999
Q ss_pred HHHhcCCCcCcCCC
Q psy11727 422 TNVLRHEFFLKHSV 435 (437)
Q Consensus 422 ~e~l~Hp~~~~~~~ 435 (437)
.+++++||+...+.
T Consensus 322 ~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 322 DDLKKFPFYRMYAV 335 (361)
T ss_pred hhhhcCchhhhhhh
Confidence 99999999976543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=266.15 Aligned_cols=238 Identities=37% Similarity=0.559 Sum_probs=192.1
Q ss_pred CceEEEEEEEcCCCeEEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccC-cHH
Q psy11727 122 SFGQVVKAFDHEEKCQVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLY 198 (437)
Q Consensus 122 ~fg~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~-~L~ 198 (437)
+||.||+|....+++.+|+|++...... ...+..|+..+..+ .|++|+++.+++......+++||++++ +|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-----KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-----CCCcHHHHHhheeeCCEEEEEEeCCCCCCHH
Confidence 6899999999988999999999754322 35667777777766 788999999999999999999999977 899
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC--cccccccc
Q psy11727 199 NLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ--TLYQYIQS 276 (437)
Q Consensus 199 ~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~--~~~~~~gt 276 (437)
+++.... .+++..+..++.+++.++.+||.. |++|+||+|.||++ +.++.++|+|||.+..... ......++
T Consensus 76 ~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~~i~~~ni~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 149 (244)
T smart00220 76 DLLKKRG--RLSEDEARFYARQILSALEYLHSN--GIIHRDLKPENILL--DEDGHVKLADFGLARQLDPGGLLTTFVGT 149 (244)
T ss_pred HHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHc--CeecCCcCHHHeEE--CCCCcEEEccccceeeeccccccccccCC
Confidence 8887654 289999999999999999999964 89999999999999 5678899999999987655 33456778
Q ss_pred ccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcc
Q psy11727 277 RYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG-KNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSY 355 (437)
Q Consensus 277 ~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 355 (437)
..|+|||.+.+..++.++|+||||++++++++|..||.. .+.......+......+...
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------- 209 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP-------------------- 209 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccc--------------------
Confidence 899999999988899999999999999999999999987 43333333222110000000
Q ss_pred eeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCc
Q psy11727 356 VLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430 (437)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~ 430 (437)
.......+.+++.+||..||++|||+.++++||||
T Consensus 210 ----------------------------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 210 ----------------------------------------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ----------------------------------------cccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 00001257899999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=320.45 Aligned_cols=189 Identities=22% Similarity=0.296 Sum_probs=155.0
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
..|...+.||+|+||.||+|.+..++..||+|.+..... ....|+..+..+ +|||||++++++.+.+..++|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l-----~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKL-----QHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhC-----CCCCcceEEEEEEcCCCCEEE
Confidence 456777899999999999999989999999999864332 223345555444 899999999999999999999
Q ss_pred EEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCC-CCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 190 FELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP-ELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 190 ~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~-~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
|||+++ +|.+++.. +++..+..++.||+.||+|||.+ ..+|+||||||+||++ +.++..++. ||.+....
T Consensus 762 ~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~--~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 762 HEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII--DGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE--CCCCceEEE-eccccccc
Confidence 999965 88888853 78999999999999999999964 4589999999999999 555556654 55543322
Q ss_pred CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy11727 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG 315 (437)
Q Consensus 268 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~ 315 (437)
. .....+|..|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 834 ~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 834 T-DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred c-CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 1 1234678999999999999999999999999999999999999953
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=305.70 Aligned_cols=248 Identities=32% Similarity=0.431 Sum_probs=193.1
Q ss_pred eeeeceecccCceE-EEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEE
Q psy11727 112 YEIDTLLGKGSFGQ-VVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVF 190 (437)
Q Consensus 112 y~i~~~lG~G~fg~-V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~ 190 (437)
|.-.+++|.|+.|+ ||+|.. +|+.||||.+- ......+.+|+..+..-. .|||||++++.-.++.+.||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll--~e~~~~A~rEi~lL~eSD----~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLL--EEFFDFAQREIQLLQESD----EHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHh--hHhHHHHHHHHHHHHhcc----CCCceEEEEeeccCCceEEEEe
Confidence 34457889999987 688965 67899999885 345577889999887654 8999999999999999999999
Q ss_pred EeccCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec---CCCCCEEEEeCCCcee
Q psy11727 191 ELLSYNLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS---PKRSAIKIIDFGSSCH 265 (437)
Q Consensus 191 E~~~~~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~---~~~~~ikL~DFG~s~~ 265 (437)
|+|..+|.+++... ..........+....|++.||++||+ ++||||||||.||||+. +....++|+|||+++.
T Consensus 583 ELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs--l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 583 ELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS--LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred hHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh--cccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 99999999999873 22112224557889999999999995 78999999999999975 3556799999999987
Q ss_pred cCCc------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 266 VGQT------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTG-EPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 266 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
.... ..+..||-+|+|||++....-+.++||+||||++|+.++| ..||...-+. -..|+.
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~----------- 727 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILT----------- 727 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhc-----------
Confidence 6432 3346789999999999998888899999999999999995 8999764332 122221
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
+.+.+.... .+ .+. ...|||.+||++||..|
T Consensus 728 --------------~~~~L~~L~-----------~~-----------------------~d~-eA~dLI~~ml~~dP~~R 758 (903)
T KOG1027|consen 728 --------------GNYTLVHLE-----------PL-----------------------PDC-EAKDLISRMLNPDPQLR 758 (903)
T ss_pred --------------Cccceeeec-----------cC-----------------------chH-HHHHHHHHhcCCCcccC
Confidence 111111000 00 000 45899999999999999
Q ss_pred CCHHHHhcCCCcC
Q psy11727 419 ISPTNVLRHEFFL 431 (437)
Q Consensus 419 ~t~~e~l~Hp~~~ 431 (437)
|||.++|.||||=
T Consensus 759 Psa~~VL~HPlFW 771 (903)
T KOG1027|consen 759 PSATDVLNHPLFW 771 (903)
T ss_pred CCHHHHhCCCccC
Confidence 9999999999994
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=280.33 Aligned_cols=302 Identities=25% Similarity=0.378 Sum_probs=210.2
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcC---CCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHE---EKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
..+.+.|.++++||.|.|++||++.+.. ..+.||+|.+. ......+...|+.++..+. .+.||+++.+++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~-~ts~p~ri~~El~~L~~~g----G~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIY-RTSSPSRILNELEMLYRLG----GSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecc-cccCchHHHHHHHHHHHhc----cchhhhcchhhhcc
Confidence 3446679999999999999999998887 78899999986 3445678999999999986 55689999999999
Q ss_pred CCEEEEEEEeccCc-HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLSYN-LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~~~-L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
++..++||||++.. -.++... ++...++.+++.++.||+++|. .|||||||||.|+|.. ...+.-.|+|||
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~--~GIvHRDiKpsNFL~n-~~t~rg~LvDFg 178 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHK--NGIVHRDIKPSNFLYN-RRTQRGVLVDFG 178 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhc--cCccccCCCccccccc-cccCCceEEech
Confidence 99999999999874 4444433 6789999999999999999995 4899999999999995 355667899999
Q ss_pred CceecC-----------------C------------------------------ccccccccccccChhhhcCC-CCCCc
Q psy11727 262 SSCHVG-----------------Q------------------------------TLYQYIQSRYYRSPEVLLGI-PYDLA 293 (437)
Q Consensus 262 ~s~~~~-----------------~------------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~ 293 (437)
+|.... . ......||++|+|||++... .-+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 986210 0 01123689999999999865 46789
Q ss_pred chHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCC
Q psy11727 294 IDMWSLGCILVELHTGEPLF-SGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSK 372 (437)
Q Consensus 294 ~DvwSlG~il~elltg~~pf-~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (437)
+||||.|||+..+++++.|| ...++.+.+..|+..+|.-.-.-+.-......++.+ . .........-.+.
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~k---s------n~~~~~e~~~~f~ 329 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQK---S------NIPTIPELRVNFE 329 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeecc---c------cccccHHHHhchh
Confidence 99999999999999999886 555666777777766663221111111100001111 0 0000000000011
Q ss_pred chhhhhccCCCCCCCCCCCCCCCChhhh-hHHHHHHHHccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 373 RLDTILGVDNGGPGGRRRNEPGHSLADY-MKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
++. +..+.. .. ...-....+.+.+ ..+.||+.+||+.||.+|+|+++||+||||...
T Consensus 330 s~~-~~~~~~-~~--q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 330 TLH-IESIYK-SR--QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred ccC-hhhccc-cc--ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 110 000000 00 0000111122222 257899999999999999999999999999854
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.73 Aligned_cols=246 Identities=21% Similarity=0.330 Sum_probs=208.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCC---eEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEK---CQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~---~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.....|.++||.|.||.|++|+.+..| ..||||.++.... ....+..|..||-.+ +||||++|.|+....
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-----dHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-----DHPNIIRLEGVVTKS 702 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-----CCCcEEEEEEEEecC
Confidence 445778999999999999999987766 4699999985432 233455677776655 899999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
.-++||+|||.+ .|..+|+.+. +.|+.-+..-+.+.|+.|+.||. ++++|||||...|||+ +.+..+|++|||+
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLs--dm~YVHRDLAARNILV--NsnLvCKVsDFGL 777 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLS--DMNYVHRDLAARNILV--NSNLVCKVSDFGL 777 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHh--hcCchhhhhhhhheee--ccceEEEeccccc
Confidence 999999999965 6777887766 45999999999999999999999 6789999999999999 7899999999999
Q ss_pred ceecCCcc---ccccc---cccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 263 SCHVGQTL---YQYIQ---SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 263 s~~~~~~~---~~~~g---t~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
|+...+.. ++..| ...|.|||.|....++.++||||+|++|||.++ |+.||...++.+.+..|.+.+++||+.
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPm 857 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPM 857 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCC
Confidence 98774433 22222 357999999999999999999999999999888 999999999999999999999998864
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
-++ ..+.+|+..|++.|=
T Consensus 858 DCP--------------------------------------------------------------~aL~qLMldCWqkdR 875 (996)
T KOG0196|consen 858 DCP--------------------------------------------------------------AALYQLMLDCWQKDR 875 (996)
T ss_pred CCc--------------------------------------------------------------HHHHHHHHHHHHHHh
Confidence 332 157899999999999
Q ss_pred CCCCCHHHHhc
Q psy11727 416 KKRISPTNVLR 426 (437)
Q Consensus 416 ~~R~t~~e~l~ 426 (437)
.+||+..|++.
T Consensus 876 ~~RP~F~qiV~ 886 (996)
T KOG0196|consen 876 NRRPKFAQIVS 886 (996)
T ss_pred hcCCCHHHHHH
Confidence 99999999875
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=283.70 Aligned_cols=209 Identities=23% Similarity=0.356 Sum_probs=181.3
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVF 190 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~ 190 (437)
+..+..+||-|.||.||.|+++.-...||||.++...-...++..|..+++.+ .|||+|+|+++|...--+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-----kHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-----cCccHHHHhhhhccCCCeEEEE
Confidence 35567889999999999999999999999999986655566777777777766 8999999999999999999999
Q ss_pred Eec-cCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc
Q psy11727 191 ELL-SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT 269 (437)
Q Consensus 191 E~~-~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~ 269 (437)
||| .|+|+++|+..+...++.-....++.||..|+.||..+ .+|||||-..|.|+ .++..||++|||+++.+...
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk--nFIHRDLAARNCLV--gEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLV--GENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh--hhhhhhhhhhhccc--cccceEEeeccchhhhhcCC
Confidence 999 56999999998877788888899999999999999854 69999999999999 67888999999999887655
Q ss_pred ccc-cccc---ccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q psy11727 270 LYQ-YIQS---RYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEV 328 (437)
Q Consensus 270 ~~~-~~gt---~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 328 (437)
.++ ..|. ..|.|||-+.-..++.++|||+|||+|||+.| |..||.|.+-...+..+.+.
T Consensus 419 TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg 482 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG 482 (1157)
T ss_pred ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc
Confidence 544 3443 45999999998899999999999999999999 89999998877666666543
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=285.93 Aligned_cols=243 Identities=26% Similarity=0.382 Sum_probs=191.1
Q ss_pred eeeeceecccCceEEEEEEEcC----CCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHE----EKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~----~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
..+.++||.|-||.||+|.... ..-.||||..++.. .....|..+.+...+.+++|||||+++|.+.+ ...+
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 4456789999999999997643 23358999987543 22235666666666777799999999999885 6789
Q ss_pred EEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
||||+++ |.|..++..+. ..++......++.||+.||+|||+. .+|||||...|||+++ .--|||+|||+|+..
T Consensus 467 ivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSk--rfVHRDIAaRNiLVsS--p~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESK--RFVHRDIAARNILVSS--PQCVKLADFGLSRYL 541 (974)
T ss_pred EEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhh--chhhhhhhhhheeecC--cceeeecccchhhhc
Confidence 9999996 47888887765 5689999999999999999999986 5999999999999954 456999999999988
Q ss_pred CCccccc--cc--cccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 267 GQTLYQY--IQ--SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 267 ~~~~~~~--~g--t~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
....+.. .| ..-|||||.+.-..++.++|||.|||++||++. |.-||.|..+.+.+-.|..+-..|-+..+
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nC---- 617 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNC---- 617 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCC----
Confidence 7654422 22 245999999999999999999999999999888 99999998776665555443333221111
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
| ..+..|+.+||++||.+||+.
T Consensus 618 -------------------------------------------P---------------p~LYslmskcWayeP~kRPrf 639 (974)
T KOG4257|consen 618 -------------------------------------------P---------------PALYSLMSKCWAYEPSKRPRF 639 (974)
T ss_pred -------------------------------------------C---------------hHHHHHHHHHhccCcccCCcH
Confidence 1 146789999999999999998
Q ss_pred HHHh
Q psy11727 422 TNVL 425 (437)
Q Consensus 422 ~e~l 425 (437)
.++.
T Consensus 640 tei~ 643 (974)
T KOG4257|consen 640 TEIK 643 (974)
T ss_pred HHHH
Confidence 8764
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=288.64 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=202.2
Q ss_pred cCeeeeceecccCceEEEEEEEcCC---CeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEE---KCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~---~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
++..+.++||+|+||.|++|.+... ...||||+++.... ..+.+.+|+.++..+ .|+|+++|||...+ .
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-----~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-----QHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-----cCcceeEEeeeecc-c
Confidence 3456778999999999999988653 24689999985432 456788888888777 78999999999887 7
Q ss_pred EEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
-..||||+++ |+|++.|.+.....|.......|+.||+.|+.||-++ ++|||||-..|+|| ...-.|||+|||+.
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk--rlvHRDLAARNlll--asprtVKI~DFGLm 259 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK--RLVHRDLAARNLLL--ASPRTVKICDFGLM 259 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh--hhhhhhhhhhhhee--cccceeeeecccce
Confidence 7889999996 4899988875555688999999999999999999975 69999999999999 45667999999999
Q ss_pred eecCCcccccc--c----cccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 264 CHVGQTLYQYI--Q----SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 264 ~~~~~~~~~~~--g----t~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
+.++.....|+ + ...|+|||.+....++.++|||++||++|||+| |+.||.|.....++++|-++..+|....
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~ 339 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKY 339 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCC
Confidence 88765433322 2 245999999999999999999999999999999 8899999999999888854332222111
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
.. +.+.+++..||..+|.
T Consensus 340 -----------------------------------------------------------cs---edIY~imk~cWah~pa 357 (1039)
T KOG0199|consen 340 -----------------------------------------------------------CS---EDIYQIMKNCWAHNPA 357 (1039)
T ss_pred -----------------------------------------------------------Ch---HHHHHHHHHhccCCcc
Confidence 11 1467999999999999
Q ss_pred CCCCHHHHhcCCCc
Q psy11727 417 KRISPTNVLRHEFF 430 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~ 430 (437)
+|||...+...-++
T Consensus 358 DRptFsair~~~~l 371 (1039)
T KOG0199|consen 358 DRPTFSAIREDLVL 371 (1039)
T ss_pred ccccHHHHHHhHHH
Confidence 99999887654443
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=275.65 Aligned_cols=209 Identities=24% Similarity=0.357 Sum_probs=172.8
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
++..+.++||+|-||.|.+|.- ..+..||+|+++..... .+.+..|+++|.++ .|||||.++++|..++.+|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-----khPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRL-----KHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhcc-----CCCCeeEEEeeeecCCchH
Confidence 3566789999999999999975 34689999999854322 35677899998887 7899999999999999999
Q ss_pred EEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+|+||+. |+|.+++..+....+......+|+.||+.|++||.+ +.+|||||.+.|+|+ ++++++||+|||+|+.+
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes--~nfVHrd~a~rNcLv--~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES--LNFVHRDLATRNCLV--DGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh--hchhhccccccceee--cCcccEEecCccccccc
Confidence 9999995 589999988754445566677899999999999995 579999999999999 89999999999999855
Q ss_pred CCcc-ccccc----cccccChhhhcCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHHHH
Q psy11727 267 GQTL-YQYIQ----SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT--GEPLFSGKNEVDQMTKIIEV 328 (437)
Q Consensus 267 ~~~~-~~~~g----t~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--g~~pf~~~~~~~~~~~i~~~ 328 (437)
-... +...| ...|||||.+.-+++++++|+|+||+++||+++ .+.||.....+...+..-..
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~ 756 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEF 756 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhh
Confidence 3322 22222 467999999999999999999999999999766 78999988777666655443
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=243.68 Aligned_cols=212 Identities=24% Similarity=0.370 Sum_probs=172.5
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+.......||+|++|.|-+.+...+|...|+|.++..-. ..++..+|+.+. .....+|++|.++|........
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~----~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDII----MRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhh----ccCCCCCeEEEeehhhhccccE
Confidence 3445567789999999999999999999999999974322 122222333332 2345889999999999999999
Q ss_pred EEEEEeccCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 187 CLVFELLSYNLYNLIRN--TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~--~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+|.||.|..+|..+.+. .....+++..+-+|+..+..||.|||++ +.+||||+||.|||+ +..|.+|+||||.|-
T Consensus 121 wIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLI--n~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILI--NYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEE--ccCCcEEEcccccce
Confidence 99999998877665433 1235689999999999999999999995 889999999999999 889999999999998
Q ss_pred ecCCcccc--ccccccccChhhhcC----CCCCCcchHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHH
Q psy11727 265 HVGQTLYQ--YIQSRYYRSPEVLLG----IPYDLAIDMWSLGCILVELHTGEPLFS-GKNEVDQMTKIIE 327 (437)
Q Consensus 265 ~~~~~~~~--~~gt~~y~aPE~~~~----~~~~~~~DvwSlG~il~elltg~~pf~-~~~~~~~~~~i~~ 327 (437)
.+.++... ..|...|||||.+.. ..|+.++||||||+++.||.+++.||. +.++.+++.++++
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 77555432 467788999999864 379999999999999999999999995 5778888888876
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=274.48 Aligned_cols=198 Identities=27% Similarity=0.425 Sum_probs=174.4
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---------cchHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---------FLNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---------~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
.+|...+.+|.|+||+|++|.++.+...|+||.|.+.+. .......|++||..++.+ .|+||++++++|
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~--sH~NIlKlLdfF 638 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKH--SHENILKLLDFF 638 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhc--Cccchhhhhhee
Confidence 459999999999999999999999999999999976542 233455799999999865 689999999999
Q ss_pred eECCEEEEEEEecc-C-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 181 TWKNHLCLVFELLS-Y-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 181 ~~~~~~~lV~E~~~-~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
++++++||+||--+ | +|+++|.... .+++..++-|++|++.|+++||++ ||||||||-+||.+ +.+|-+||+
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~--~ivhrdikdenviv--d~~g~~kli 712 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQ--GIVHRDIKDENVIV--DSNGFVKLI 712 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhcccccccc--CceecccccccEEE--ecCCeEEEe
Confidence 99999999999984 4 7999998764 499999999999999999999965 89999999999999 889999999
Q ss_pred eCCCceecC-CccccccccccccChhhhcCCCCC-CcchHHHHHHHHHHHHhCCCCCCC
Q psy11727 259 DFGSSCHVG-QTLYQYIQSRYYRSPEVLLGIPYD-LAIDMWSLGCILVELHTGEPLFSG 315 (437)
Q Consensus 259 DFG~s~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~pf~~ 315 (437)
|||+|.... .+...++||..|.|||++.|.+|- ..-|||+||++||.++..+.||..
T Consensus 713 dfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 713 DFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999997663 344568999999999999998875 679999999999999999888863
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=262.15 Aligned_cols=192 Identities=26% Similarity=0.335 Sum_probs=158.7
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC----E
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN----H 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~----~ 185 (437)
....+.++||+|.||.||+|.. +++.||||++.. .....+..|..|.+... ..|+||+++++.-.... .
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~--~~kqs~~~Ek~Iy~lp~---m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE--QEKQSFQNEKNIYSLPG---MKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCH--HHHHHHHhHHHHHhccC---ccchhHHHhhchhccCCccccc
Confidence 3466788999999999999965 568999999963 33467788888887664 48999999999876555 8
Q ss_pred EEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCC-------CCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 186 LCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP-------ELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 186 ~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~-------~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
++||++|.+ |+|.++|+.+. ++|....+++.-|++||+|||+. +.+|+|||||..|||| ..++...|
T Consensus 283 ywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv--K~DlTccI 357 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV--KNDLTCCI 357 (534)
T ss_pred eeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE--ccCCcEEe
Confidence 999999995 69999999864 89999999999999999999973 3569999999999999 56888999
Q ss_pred EeCCCceecCCc-----cccccccccccChhhhcCCC-CC-----CcchHHHHHHHHHHHHhCCCCC
Q psy11727 258 IDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIP-YD-----LAIDMWSLGCILVELHTGEPLF 313 (437)
Q Consensus 258 ~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwSlG~il~elltg~~pf 313 (437)
+|||+|..+... ....+||..|||||++.+.- +. ...||||+|.+||||++.-.-+
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 999999766321 22368999999999998742 22 4699999999999999975444
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=273.88 Aligned_cols=246 Identities=26% Similarity=0.403 Sum_probs=191.4
Q ss_pred CeeeeceecccCceEEEEEEEc----C---CCeEEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDH----E---EKCQVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~----~---~~~~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
+..+.+.||.|+||+|++|.-. . ....||||.++..... ...+..|+.++..+. .|+||+.+.+++.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g----~H~niv~llG~~t 372 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELG----KHPNIVNLLGACT 372 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhc----CCcchhhheeeec
Confidence 3456679999999999999632 1 2567999998744322 355667888888775 7999999999999
Q ss_pred ECCEEEEEEEecc-CcHHHHHHhcC------C--------CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q psy11727 182 WKNHLCLVFELLS-YNLYNLIRNTN------F--------HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENIL 246 (437)
Q Consensus 182 ~~~~~~lV~E~~~-~~L~~~l~~~~------~--------~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIl 246 (437)
.++.+++|+||+. |+|.++++... . ..++......++.||+.|++||++. ++|||||-..|||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~--~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV--PCVHRDLAARNVL 450 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC--CccchhhhhhhEE
Confidence 9999999999995 68999987654 1 1288999999999999999999964 6999999999999
Q ss_pred EecCCCCCEEEEeCCCceecCC-cccccccc-----ccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC-H
Q psy11727 247 LCSPKRSAIKIIDFGSSCHVGQ-TLYQYIQS-----RYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKN-E 318 (437)
Q Consensus 247 l~~~~~~~ikL~DFG~s~~~~~-~~~~~~gt-----~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~-~ 318 (437)
+ .++..+||+|||+|+.... ..+...++ ..|||||.+....|+.++||||+|++|||++| |..||.+.. .
T Consensus 451 i--~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 451 I--TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred e--cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 9 5677899999999986533 22222222 34999999999999999999999999999999 889999854 4
Q ss_pred HHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChh
Q psy11727 319 VDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398 (437)
Q Consensus 319 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (437)
.+.++.+.++. +...|.+-.
T Consensus 529 ~~l~~~l~~G~-----------------------------------------------------------r~~~P~~c~- 548 (609)
T KOG0200|consen 529 EELLEFLKEGN-----------------------------------------------------------RMEQPEHCS- 548 (609)
T ss_pred HHHHHHHhcCC-----------------------------------------------------------CCCCCCCCC-
Confidence 44444443322 222222221
Q ss_pred hhhHHHHHHHHccccCCCCCCCHHHHhc
Q psy11727 399 DYMKFKDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 399 ~~~~~~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
.++.++++.|++.+|++|||..++.+
T Consensus 549 --~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 549 --DEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred --HHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 14569999999999999999888753
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=271.23 Aligned_cols=256 Identities=26% Similarity=0.381 Sum_probs=205.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.++|++...+|.|+||.||+++++.+++..|+|+++.... ...-.+.|+.+++.. +|+|||.+++.+...+.++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-----~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-----RHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-----CCcChHHHHhhhhhhcCcE
Confidence 4689999999999999999999999999999999985432 223344565555444 8999999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+.||||+| +|.+...-+ ..+++.++...++..+++|+|||+ .|=+|||||-.|||+ .+.|.+|++|||.+-.+
T Consensus 89 icMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs--~gk~hRdiKGanill--td~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHS--QGKIHRDIKGANILL--TDEGDVKLADFGVSAQI 162 (829)
T ss_pred EEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhc--CCcccccccccceee--cccCceeecccCchhhh
Confidence 99999976 666654443 469999999999999999999995 478999999999999 67889999999998776
Q ss_pred CCcc---ccccccccccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 267 GQTL---YQYIQSRYYRSPEVLL---GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 267 ~~~~---~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
+... ..++||+.|||||+.. .+.|...+|+|++|+...|+-.-++|--.......+..+.+-...||..
T Consensus 163 tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l----- 237 (829)
T KOG0576|consen 163 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL----- 237 (829)
T ss_pred hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc-----
Confidence 5433 4689999999999874 4579999999999999999999888866655554444443333333310
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
.++..| +..|.+|++.+|..+|++|||
T Consensus 238 --------------------------------------------------kDk~kw---s~~fh~fvK~altknpKkRpt 264 (829)
T KOG0576|consen 238 --------------------------------------------------KDKTKW---SEFFHNFVKGALTKNPKKRPT 264 (829)
T ss_pred --------------------------------------------------cCCccc---hHHHHHHHHHHhcCCCccCCC
Confidence 001111 125899999999999999999
Q ss_pred HHHHhcCCCcCcC
Q psy11727 421 PTNVLRHEFFLKH 433 (437)
Q Consensus 421 ~~e~l~Hp~~~~~ 433 (437)
++.+|+|||.+++
T Consensus 265 aeklL~h~fvs~~ 277 (829)
T KOG0576|consen 265 AEKLLQHPFVSQT 277 (829)
T ss_pred hhhheeceeeccc
Confidence 9999999999875
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=246.55 Aligned_cols=190 Identities=24% Similarity=0.316 Sum_probs=155.1
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC---
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN--- 184 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~--- 184 (437)
+.....+.+.||+|.||+||+|.+. |+.||||++..... ....+|.+|.+.... +|+||+.+++.=..++
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE--~SWfrEtEIYqTvmL---RHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE--RSWFRETEIYQTVML---RHENILGFIAADNKDNGSW 281 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEecccch--hhhhhHHHHHHHHHh---ccchhhhhhhccccCCCce
Confidence 3556889999999999999999875 66899999975443 556667777776543 8999999988755433
Q ss_pred -EEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCC------CCCeeeCCCCCCcEEEecCCCCCEE
Q psy11727 185 -HLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP------ELSIIHCDLKPENILLCSPKRSAIK 256 (437)
Q Consensus 185 -~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~------~~giiHrDiKp~NIll~~~~~~~ik 256 (437)
.++||++|.+ |+|+|+|... .++.....+++.-++.||++||.. +..|.|||||+.|||+ .+++.+-
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV--Kkn~~C~ 356 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCC 356 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE--ccCCcEE
Confidence 7999999995 6999999885 489999999999999999999974 3459999999999999 7799999
Q ss_pred EEeCCCceecCCc-------cccccccccccChhhhcCCC------CCCcchHHHHHHHHHHHHhC
Q psy11727 257 IIDFGSSCHVGQT-------LYQYIQSRYYRSPEVLLGIP------YDLAIDMWSLGCILVELHTG 309 (437)
Q Consensus 257 L~DFG~s~~~~~~-------~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlG~il~elltg 309 (437)
|+|+|+|...... ....+||..|||||++...- --..+||||||+++||+...
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR 422 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 9999999766433 33468999999999997532 11458999999999998753
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=286.55 Aligned_cols=195 Identities=22% Similarity=0.272 Sum_probs=145.8
Q ss_pred cEEEeccee-------eECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q psy11727 172 YIVKLKGHF-------TWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPEN 244 (437)
Q Consensus 172 ~iv~l~~~~-------~~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~N 244 (437)
||++++++| ...+.++++||+++++|.+++.... ..+++..++.+++||+.||+|||+ .|||||||||+|
T Consensus 34 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~--~gIvHrDlKP~N 110 (793)
T PLN00181 34 YVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHS--QGIVVHNVRPSC 110 (793)
T ss_pred HHHHhhcccCCccccccccchhhhhhccCCccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHh--CCeeeccCCchh
Confidence 566667766 3345788899999999999997543 459999999999999999999995 489999999999
Q ss_pred EEEec-----------------CCCCCEEEEeCCCceecCC-------------------ccccccccccccChhhhcCC
Q psy11727 245 ILLCS-----------------PKRSAIKIIDFGSSCHVGQ-------------------TLYQYIQSRYYRSPEVLLGI 288 (437)
Q Consensus 245 Ill~~-----------------~~~~~ikL~DFG~s~~~~~-------------------~~~~~~gt~~y~aPE~~~~~ 288 (437)
|||+. +.++.+||+|||++..... .....+||+.|+|||++.+.
T Consensus 111 iLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~ 190 (793)
T PLN00181 111 FVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGS 190 (793)
T ss_pred EEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccC
Confidence 99942 2345677888887754211 00124578889999999999
Q ss_pred CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccC
Q psy11727 289 PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERL 368 (437)
Q Consensus 289 ~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (437)
.|+.++|||||||+||||++|.+|+.... ..+..+... ..|+.. ..
T Consensus 191 ~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~-~~~~~~-~~------------------------------ 236 (793)
T PLN00181 191 SSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR-VLPPQI-LL------------------------------ 236 (793)
T ss_pred CCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh-hcChhh-hh------------------------------
Confidence 99999999999999999999999876422 122222111 111110 00
Q ss_pred CCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 369 PGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
......+++.+||..||.+|||+.|+|+||||++.
T Consensus 237 ------------------------------~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 237 ------------------------------NWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred ------------------------------cCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 00134689999999999999999999999999763
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=239.93 Aligned_cols=201 Identities=25% Similarity=0.369 Sum_probs=168.3
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecce-eeECCE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGH-FTWKNH 185 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~-~~~~~~ 185 (437)
.+.+.|.|.+.||+|.||.+-+|..+.++..+++|.+.........+.+|...--.+. .|.||+.-++. |+..+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls----~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLS----PHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeec----cchhhhHHHHHHhhcCce
Confidence 3567899999999999999999999999999999999866666677777766554443 56788887665 888999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+++++||++. +|..-+.. .++.+...++++.|++.|+.|||++ .+||||||.+||||-..+.-.|||||||.+.
T Consensus 97 YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsk--nlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSK--NLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred EEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhcc--chhhcccccceEEEecCCccEEEeeeccccc
Confidence 9999999975 66655444 4689999999999999999999987 5999999999999987677789999999998
Q ss_pred ecCCccccccccccccChhhhcCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy11727 265 HVGQTLYQYIQSRYYRSPEVLLGI-----PYDLAIDMWSLGCILVELHTGEPLFSGK 316 (437)
Q Consensus 265 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~elltg~~pf~~~ 316 (437)
..+.......-+..|.+||+.... ...+.+|+|.||+|+|.++||.+||...
T Consensus 172 k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 172 KVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred ccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 887766555567789999988643 2467899999999999999999999743
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=262.54 Aligned_cols=205 Identities=23% Similarity=0.320 Sum_probs=164.8
Q ss_pred eeeceecccCceEEEEEEEcCCCe----EEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 113 EIDTLLGKGSFGQVVKAFDHEEKC----QVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 113 ~i~~~lG~G~fg~V~~~~~~~~~~----~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
...++||+|+||+||+|.+-..|+ +||||++...... ..++.. +.+.+..++|+|+++|++++.... +
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~Ld-----eAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLD-----EALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHH-----HHHHHhcCCCchHHHHhhhcccch-H
Confidence 346789999999999998876665 5888988643321 223333 344555669999999999999765 8
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
.||++|+++ .|.++++..+ ..+.......|..||++|+.|||.+ .+|||||-..|||+ .+-.++||+|||++..
T Consensus 773 qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~q--rlVHrdLaaRNVLV--ksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQ--RLVHRDLAARNVLV--KSPNHVKITDFGLAKL 847 (1177)
T ss_pred HHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhc--chhhhhhhhhheee--cCCCeEEEEecchhhc
Confidence 999999965 8999998865 5688999999999999999999965 69999999999999 4566799999999987
Q ss_pred cCCccccc---cc--cccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Q psy11727 266 VGQTLYQY---IQ--SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEV 328 (437)
Q Consensus 266 ~~~~~~~~---~g--t~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 328 (437)
.......+ .| ...|||-|.+....|+.++|||||||++||++| |.-|+.+....++-..+...
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g 916 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG 916 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc
Confidence 64432222 22 345999999999999999999999999999999 99999999887776655443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-29 Score=224.12 Aligned_cols=179 Identities=41% Similarity=0.579 Sum_probs=154.0
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEecc-
Q psy11727 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLS- 194 (437)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~- 194 (437)
||+|++|+||++....+++.+++|++...... ...+..|+..++.+ .|++++++++++......+++||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-----NHPNIVKLYGVFEDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-----CCCCeeeEeeeeecCCeEEEEEecCCC
Confidence 68999999999999888999999999754431 35677788888877 45899999999999999999999998
Q ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC-CCCEEEEeCCCceecCCc---c
Q psy11727 195 YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK-RSAIKIIDFGSSCHVGQT---L 270 (437)
Q Consensus 195 ~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~-~~~ikL~DFG~s~~~~~~---~ 270 (437)
++|.+++.... ..++...+..++.+++.+|.+||+. |++|+||+|.||++ +. .+.++|+|||.+...... .
T Consensus 76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~--~~~H~dl~~~ni~~--~~~~~~~~l~d~~~~~~~~~~~~~~ 150 (215)
T cd00180 76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSN--GIIHRDLKPENILL--DSDNGKVKLADFGLSKLLTSDKSLL 150 (215)
T ss_pred CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHhhEEE--eCCCCcEEEecCCceEEccCCcchh
Confidence 58898887653 3589999999999999999999964 89999999999999 44 678999999999877554 3
Q ss_pred ccccccccccChhhhcCC-CCCCcchHHHHHHHHHHH
Q psy11727 271 YQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVEL 306 (437)
Q Consensus 271 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~el 306 (437)
....+...|++||.+... .++.+.|+||||++++++
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 445678889999999887 788999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-29 Score=229.18 Aligned_cols=207 Identities=35% Similarity=0.486 Sum_probs=172.9
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
|.+.+.||.|++|+||++....+++.+|+|.+..... ....+..|+..+..+ .|++++++++++...+..+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-----~~~~i~~~~~~~~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-----KHPNIVKLYGVFEDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-----CCCChhhheeeeecCCceEEE
Confidence 5678899999999999999998899999999975433 245566677777666 678999999999999999999
Q ss_pred EEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 190 FELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 190 ~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
+|++++ +|.+++..... .+++..+..++.+++.++.+||.+ |++|+||+|.||++ +.++.++|+|||.+.....
T Consensus 76 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~di~~~ni~v--~~~~~~~l~d~g~~~~~~~ 150 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL--GIVHRDLKPENILL--GMDGLVKLADFGLARFIHR 150 (225)
T ss_pred EeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEE--cCCCCEEEeeCceeeEecC
Confidence 999977 89998876542 278999999999999999999964 89999999999999 5668899999999987755
Q ss_pred cc----ccccccccccChhhh-cCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CC-HHHHHHHHHHH
Q psy11727 269 TL----YQYIQSRYYRSPEVL-LGIPYDLAIDMWSLGCILVELHTGEPLFSG-KN-EVDQMTKIIEV 328 (437)
Q Consensus 269 ~~----~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~il~elltg~~pf~~-~~-~~~~~~~i~~~ 328 (437)
.. ....++..|++||.+ ....++.++|+||||+++++|++|++||.. .+ ...+.+.|...
T Consensus 151 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 151 DLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred cccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 43 456778889999999 666788899999999999999999999977 33 33555555443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=231.03 Aligned_cols=254 Identities=20% Similarity=0.250 Sum_probs=200.9
Q ss_pred cCceeccCeeeeceecccCceEEEEEEEcCCC-----eEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecc
Q psy11727 104 HGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEK-----CQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKG 178 (437)
Q Consensus 104 ~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~ 178 (437)
+......|+++..++-+|.||.||.|.+.+++ +.|.+|.+++.. .+.+....+.+.+...++.|||+..+.+
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A---S~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA---SQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc---cHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 33444567888999999999999999776543 346667665432 4555556666667777889999999999
Q ss_pred eeeE-CCEEEEEEEecc-CcHHHHHH-----h-cCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC
Q psy11727 179 HFTW-KNHLCLVFELLS-YNLYNLIR-----N-TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP 250 (437)
Q Consensus 179 ~~~~-~~~~~lV~E~~~-~~L~~~l~-----~-~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~ 250 (437)
.+.. .+..+.++.+++ |+|..++. . ...+.++..+...++.|++.|++|||.+ ||||.||...|.+| |
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~--~ViHkDiAaRNCvI--d 430 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH--GVIHKDIAARNCVI--D 430 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc--Ccccchhhhhccee--h
Confidence 8765 457788888885 58988886 2 2334578888899999999999999965 79999999999999 7
Q ss_pred CCCCEEEEeCCCceecCCccccccc-----cccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy11727 251 KRSAIKIIDFGSSCHVGQTLYQYIQ-----SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTK 324 (437)
Q Consensus 251 ~~~~ikL~DFG~s~~~~~~~~~~~g-----t~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~ 324 (437)
+...+||+|=.+|+..-...+...| ...|||||.+.+..|+.++|+|||||+||||+| |+.|+..-++.++..-
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y 510 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY 510 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence 8899999999999877554454444 346999999999999999999999999999999 9999999999998887
Q ss_pred HHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHH
Q psy11727 325 IIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFK 404 (437)
Q Consensus 325 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (437)
+.++.....+..+ | .++.
T Consensus 511 lkdGyRlaQP~NC-----------------------------------------------P---------------DeLf 528 (563)
T KOG1024|consen 511 LKDGYRLAQPFNC-----------------------------------------------P---------------DELF 528 (563)
T ss_pred HhccceecCCCCC-----------------------------------------------c---------------HHHH
Confidence 7664332211110 1 1578
Q ss_pred HHHHHccccCCCCCCCHHHHhc
Q psy11727 405 DLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 405 dli~~~L~~dP~~R~t~~e~l~ 426 (437)
..+.-||..+|++|||.+|+..
T Consensus 529 ~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 529 TVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHHHHhcCcccCCCHHHHHH
Confidence 8999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=214.46 Aligned_cols=169 Identities=21% Similarity=0.231 Sum_probs=127.0
Q ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCcccccc
Q psy11727 195 YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYI 274 (437)
Q Consensus 195 ~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~~~~~ 274 (437)
|+|.+++.... ..+++..++.++.||+.||.|||++ + ||+|||+ +.++.+|+ ||++....... ..
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~--~------kp~Nil~--~~~~~~~~--fG~~~~~~~~~--~~ 65 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQ--A------KSGNILL--TWDGLLKL--DGSVAFKTPEQ--SR 65 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc--C------CcccEeE--cCccceee--ccceEeecccc--CC
Confidence 57888887643 4699999999999999999999965 4 9999999 67888898 99987665432 36
Q ss_pred ccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhhhccCCccchhhcccCCC
Q psy11727 275 QSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEV-DQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDN 353 (437)
Q Consensus 275 gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 353 (437)
||+.|+|||++.+..++.++|||||||++|||++|++||...... ..+..+........ ..
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~----------- 127 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD-------PR----------- 127 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC-------cc-----------
Confidence 899999999999999999999999999999999999999765432 22222222110000 00
Q ss_pred cceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCc
Q psy11727 354 SYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432 (437)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~ 432 (437)
.+ ...........+.+||.+||..||.+|||+.|+++|+|+..
T Consensus 128 ---------------------------------~~---~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 128 ---------------------------------DR---SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred ---------------------------------cc---ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 00 00000001125799999999999999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=205.51 Aligned_cols=226 Identities=23% Similarity=0.302 Sum_probs=186.5
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
..++|.+++.||.|+||.+|.|.....|+.||||+-. +.....+...|..+.+.++. ...|..+..++.+.++-.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es-~~a~hpqL~yEskvY~iL~~----g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLES-SKAKHPQLLYESKVYRILQG----GVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeec-ccCCCcchhHHHHHHHHhcc----CCCCchhhhhccccccce
Confidence 4678999999999999999999999999999999876 34455677889999999874 345777777888889999
Q ss_pred EEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC-CCCEEEEeCCCceec
Q psy11727 188 LVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK-RSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~-~~~ikL~DFG~s~~~ 266 (437)
+||++++.+|.+++.-.. ..++...+..++-|++.-++|+|.+ ++|||||||+|+|.+-+. ...+.|+|||+|+..
T Consensus 88 lVMdLLGPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r--~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 88 LVMDLLGPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLR--NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeeccCccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhh--ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 999999999999887654 4589999999999999999999965 799999999999995433 235899999999765
Q ss_pred CCc----------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHH-hCCC
Q psy11727 267 GQT----------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ---MTKIIEV-LGMP 332 (437)
Q Consensus 267 ~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~---~~~i~~~-~~~p 332 (437)
.+. .....||..|.+-....+..-+...|+-|+|.+|.++.-|..||.|-..... +++|.+. ...|
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 332 2245789999999999998999999999999999999999999998765544 4455554 5667
Q ss_pred ChhhhccCC
Q psy11727 333 PGYLLHGAS 341 (437)
Q Consensus 333 ~~~~~~~~~ 341 (437)
++.++...+
T Consensus 245 ie~LC~G~P 253 (341)
T KOG1163|consen 245 IEVLCKGFP 253 (341)
T ss_pred HHHHhCCCc
Confidence 777666555
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=219.50 Aligned_cols=205 Identities=28% Similarity=0.301 Sum_probs=170.6
Q ss_pred CeeeeceecccCceEEEEEEEcCCC-eEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEeccee-eECCEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEK-CQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHF-TWKNHLC 187 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~-~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~-~~~~~~~ 187 (437)
+|.+.+.||+|+||+||+|.+..++ ..+|+|+...... .......|..++..+.. .....++..+++.. ....+-+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~-~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEK-KNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhh-hcCCCCCCEEEEeccCCCceeE
Confidence 8999999999999999999988774 6799998764322 22378889999999875 22234688888888 5778999
Q ss_pred EEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC-C--CCEEEEeCCCce
Q psy11727 188 LVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK-R--SAIKIIDFGSSC 264 (437)
Q Consensus 188 lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~-~--~~ikL~DFG~s~ 264 (437)
+||++++.+|.++......+.++...+..++.|++.+|.+||+ .|++||||||+|++++... . ..+.|.|||+++
T Consensus 98 iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~--~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 98 IVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS--KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh--cCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999999999998876666779999999999999999999994 5999999999999996433 1 469999999998
Q ss_pred --ecC-C---------c-cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy11727 265 --HVG-Q---------T-LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNE 318 (437)
Q Consensus 265 --~~~-~---------~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~ 318 (437)
... . . .....||..|+++.+..+.+.+.+.|+||++.++.+++.|..||.+...
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 321 0 1 1235599999999999999999999999999999999999999977654
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-27 Score=245.23 Aligned_cols=267 Identities=24% Similarity=0.319 Sum_probs=192.8
Q ss_pred eccCe-eeeceecccCceEEEEEEEcCCCeEEEEEEecCC--cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 108 FLDRY-EIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK--KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 108 ~~~~y-~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
+.+.| ....++|.|++|.|+.+......+.++.|..+.. .....+........+.+....+.|+|++.....+.+..
T Consensus 315 ~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~ 394 (601)
T KOG0590|consen 315 FSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID 394 (601)
T ss_pred cccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc
Confidence 34556 3567899999998888887777776777655421 11111111222333445566779999988888877766
Q ss_pred EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 185 HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 185 ~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
...-+||||+++|+.++.... .++...+..++.|++.|+.|||+ +||.||||||+|+++ ..+|.+||+|||.+.
T Consensus 395 ~~~~~mE~~~~Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~--~GiahrdlK~enll~--~~~g~lki~Dfg~~~ 468 (601)
T KOG0590|consen 395 GILQSMEYCPYDLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHS--MGLAHRDLKLENLLV--TENGILKIIDFGAAS 468 (601)
T ss_pred cchhhhhcccHHHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHh--cCceeccCccccEEE--ecCCceEEeecCcce
Confidence 665569999889998888763 37889999999999999999995 599999999999999 678899999999986
Q ss_pred ecCC-------ccccccccccccChhhhcCCCCCC-cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 265 HVGQ-------TLYQYIQSRYYRSPEVLLGIPYDL-AIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 265 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
.... .....+|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||......+...
T Consensus 469 vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------------- 535 (601)
T KOG0590|consen 469 VFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------------- 535 (601)
T ss_pred eeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------------
Confidence 5522 234578999999999999999986 6999999999999999999997544332211
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
+.+... ..++....-.+.+. ......+.+|.+||++||.
T Consensus 536 ---------~~~~~~----------~~~~~~~~~~~~~~----------------------~lp~~~~~~~~~~l~~~P~ 574 (601)
T KOG0590|consen 536 ---------KTNNYS----------DQRNIFEGPNRLLS----------------------LLPRETRIIIYRMLQLDPT 574 (601)
T ss_pred ---------hhhccc----------cccccccChHHHHH----------------------hchhhHHHHHHHHccCChh
Confidence 000000 00000000001111 1112568999999999999
Q ss_pred CCCCHHHHhcCCCcCcCC
Q psy11727 417 KRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~~~~~ 434 (437)
+|+|+++|++.+||+.+.
T Consensus 575 ~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 575 KRITIEQILNDEWIRSIE 592 (601)
T ss_pred heecHHHHhhChHhhhcc
Confidence 999999999999999865
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=207.10 Aligned_cols=225 Identities=23% Similarity=0.261 Sum_probs=184.9
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.-.|.+.++||+|+||..+.|.+.-+++.||||.-. .+....+...|-...+.|. ..+.|..++.+-+...+-.|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rkS~APQLrdEYr~YKlL~----g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RKSEAPQLRDEYRTYKLLG----GTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecc-ccCCcchHHHHHHHHHHHc----CCCCCCceeeeccccchhhh
Confidence 347999999999999999999999999999999865 3334567778888888886 44678888888888889999
Q ss_pred EEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC---CCCEEEEeCCCcee
Q psy11727 189 VFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK---RSAIKIIDFGSSCH 265 (437)
Q Consensus 189 V~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~---~~~ikL~DFG~s~~ 265 (437)
|+|+++.+|.|++.-.. ..||...+..++.||+.-++|+|++ .+|.|||||+|+||+... ...|.|+|||+|+.
T Consensus 102 VidLLGPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k--~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 102 VIDLLGPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEK--DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhCcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhc--ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 99999999999887765 4699999999999999999999987 599999999999996433 24589999999987
Q ss_pred cCCcc----------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHH-hCC
Q psy11727 266 VGQTL----------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNE---VDQMTKIIEV-LGM 331 (437)
Q Consensus 266 ~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~---~~~~~~i~~~-~~~ 331 (437)
..++. .+..||..||+-....|.+-+...|+-|||-++++.|-|..||.|-.. -+.+++|-+. ...
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 75432 245789999999999999999999999999999999999999988543 3445555544 334
Q ss_pred CChhhhccCC
Q psy11727 332 PPGYLLHGAS 341 (437)
Q Consensus 332 p~~~~~~~~~ 341 (437)
|...++...+
T Consensus 259 ~i~~Lc~g~P 268 (449)
T KOG1165|consen 259 PIEVLCEGFP 268 (449)
T ss_pred CHHHHHhcCH
Confidence 5555555443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-23 Score=200.53 Aligned_cols=256 Identities=36% Similarity=0.484 Sum_probs=194.1
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCC-cEEEecceeeECCEE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSR-YIVKLKGHFTWKNHL 186 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~-~iv~l~~~~~~~~~~ 186 (437)
|.+.+.||.|+||.||++.+. ..+++|.+..... ....+.+|..++..+. |+ +++++.+.+......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-----~~~~i~~~~~~~~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLN-----HPPNIVKLYDFFQDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-----CCcceeeEEEEEecCCEE
Confidence 788899999999999999887 6899999875432 2445667777777664 44 799999999888889
Q ss_pred EEEEEeccC-cHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC-CEEEEeCCCc
Q psy11727 187 CLVFELLSY-NLYNLIRNTNF-HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS-AIKIIDFGSS 263 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~-~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~-~ikL~DFG~s 263 (437)
+++++++.+ .+.+++..... ..++......++.|++.++.|+|. .|++|||+||+||++ +..+ .++++|||.+
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~--~~~~hrd~kp~nil~--~~~~~~~~l~dfg~~ 149 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS--KGIIHRDIKPENILL--DRDGRVVKLIDFGLA 149 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeee--cCCCCeEEEeccCcc
Confidence 999999976 67655555421 258999999999999999999995 479999999999999 5565 6999999998
Q ss_pred eecCCc---------cccccccccccChhhhcC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHH
Q psy11727 264 CHVGQT---------LYQYIQSRYYRSPEVLLG---IPYDLAIDMWSLGCILVELHTGEPLFSGKNE---VDQMTKIIEV 328 (437)
Q Consensus 264 ~~~~~~---------~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~pf~~~~~---~~~~~~i~~~ 328 (437)
...... .....||..|+|||.+.+ ..++...|+||+|++++++++|..||..... ..........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 229 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh
Confidence 755332 356788999999999988 5788999999999999999999999887764 2333333332
Q ss_pred hCCC-ChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHH
Q psy11727 329 LGMP-PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLI 407 (437)
Q Consensus 329 ~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 407 (437)
...+ ...... +.. . ......+.+++
T Consensus 230 ~~~~~~~~~~~------------------------------~~~---------------------~---~~~~~~~~~~~ 255 (384)
T COG0515 230 LPTPSLASPLS------------------------------PSN---------------------P---ELISKAASDLL 255 (384)
T ss_pred cCCcccccccC------------------------------ccc---------------------c---chhhHHHHHHH
Confidence 2211 000000 000 0 11112568999
Q ss_pred HHccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 408 LRMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 408 ~~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
.+++..+|..|.+..+...++|....
T Consensus 256 ~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 256 KKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred HHHHhcCchhcCCHHHHhhchHhhCc
Confidence 99999999999999999988776553
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-26 Score=228.22 Aligned_cols=239 Identities=28% Similarity=0.422 Sum_probs=191.3
Q ss_pred eecccCceEEEEEEE---cCCCeEEEEEEecCCcccch---HHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEE
Q psy11727 117 LLGKGSFGQVVKAFD---HEEKCQVAIKIIKNKKPFLN---QAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVF 190 (437)
Q Consensus 117 ~lG~G~fg~V~~~~~---~~~~~~vaiK~i~~~~~~~~---~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~ 190 (437)
++|+|+||.|+++.. ...+..+|+|+.++...... ....|..+++..+ .|+.+|++...|+.+..+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~----~~~f~v~lhyafqt~~kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVH----NTPFLVKLHYAFQTDGKLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhcc----CCCceeeeeeeeccccchhHhh
Confidence 379999999998743 34677899998875432211 2333555655553 4789999999999999999999
Q ss_pred EeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc
Q psy11727 191 ELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT 269 (437)
Q Consensus 191 E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~ 269 (437)
++..| .|...+.... .+.+...+.+...++-+++.+| ++||+|||+|++||++ +.+|+|++.|||+++..-..
T Consensus 77 d~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh--~l~iiyrd~k~enill--d~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLH--KLGIAYRDYKLENVLL--LLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred hhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcc--hhHHHHhcccccceee--cccCccccCCchhhhHhHhh
Confidence 99955 6776665543 4788888999999999999999 6799999999999999 88999999999999876443
Q ss_pred cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hCCCChhhhccCCccchhhc
Q psy11727 270 LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV-LGMPPGYLLHGASKTSKYFD 348 (437)
Q Consensus 270 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~p~~~~~~~~~~~~~~~~ 348 (437)
... |||..|||||++. +.+.+.|+||||++++||+||..||.+ +.+.+|... +++|. .++.
T Consensus 151 ~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~-~l~~---------- 212 (612)
T KOG0603|consen 151 KIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR-ELSA---------- 212 (612)
T ss_pred hhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch-hhhH----------
Confidence 333 9999999999998 568999999999999999999999998 666777663 33332 2221
Q ss_pred ccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC-----HHH
Q psy11727 349 RLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS-----PTN 423 (437)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t-----~~e 423 (437)
...+++..|+..+|..|.- +.|
T Consensus 213 -----------------------------------------------------~a~~~~~~l~~r~p~nrLg~~~~~~~e 239 (612)
T KOG0603|consen 213 -----------------------------------------------------EARSLFRQLFKRNPENRLGAGPDGVDE 239 (612)
T ss_pred -----------------------------------------------------HHHHHHHHHHhhCHHHHhccCcchhHH
Confidence 4589999999999999986 478
Q ss_pred HhcCCCcCcCCCC
Q psy11727 424 VLRHEFFLKHSVD 436 (437)
Q Consensus 424 ~l~Hp~~~~~~~~ 436 (437)
+.+|+||+.+.++
T Consensus 240 ik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 240 IKQHEFFQSIDWN 252 (612)
T ss_pred HhccchheeeeHh
Confidence 9999999988764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=206.40 Aligned_cols=161 Identities=20% Similarity=0.202 Sum_probs=121.3
Q ss_pred CceeccCeeeeceecccCceEEEEEEEcC-CCeEEEEEEecCC------cccchHHHHHHHHHHHhhhcCCCCCcEE-Ee
Q psy11727 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHE-EKCQVAIKIIKNK------KPFLNQAQIEVQLLEKINKADIHSRYIV-KL 176 (437)
Q Consensus 105 ~~~~~~~y~i~~~lG~G~fg~V~~~~~~~-~~~~vaiK~i~~~------~~~~~~~~~e~~~~~~l~~~~~~h~~iv-~l 176 (437)
...+.++|.+.+.||+|+||+||+|++.. +++.||||++... ......+.+|+.+++.+ .|++++ .+
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-----~h~~iv~~l 87 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-----RGIGVVPQL 87 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-----cCCCCCcEE
Confidence 34567889999999999999999998876 6788899987532 11234577899999888 456666 44
Q ss_pred cceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC-CCCcEEEecCCCCC
Q psy11727 177 KGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDL-KPENILLCSPKRSA 254 (437)
Q Consensus 177 ~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDi-Kp~NIll~~~~~~~ 254 (437)
++ .+..|+||||++| +|. .+.. .. ...++.|++.+|.|||+ .||+|||| ||+|||+ +.++.
T Consensus 88 ~~----~~~~~LVmE~~~G~~L~-~~~~-----~~---~~~~~~~i~~aL~~lH~--~gIiHrDL~KP~NILv--~~~~~ 150 (365)
T PRK09188 88 LA----TGKDGLVRGWTEGVPLH-LARP-----HG---DPAWFRSAHRALRDLHR--AGITHNDLAKPQNWLM--GPDGE 150 (365)
T ss_pred EE----cCCcEEEEEccCCCCHH-HhCc-----cc---hHHHHHHHHHHHHHHHH--CCCeeCCCCCcceEEE--cCCCC
Confidence 43 2467999999977 554 2211 11 14688999999999996 48999999 9999999 56778
Q ss_pred EEEEeCCCceecCCc-----------cccccccccccChhhhcC
Q psy11727 255 IKIIDFGSSCHVGQT-----------LYQYIQSRYYRSPEVLLG 287 (437)
Q Consensus 255 ikL~DFG~s~~~~~~-----------~~~~~gt~~y~aPE~~~~ 287 (437)
+||+|||+|...... .....+++.|+|||++..
T Consensus 151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999999999865332 123456788999999864
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-23 Score=217.98 Aligned_cols=221 Identities=27% Similarity=0.374 Sum_probs=164.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHH-HhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLE-KINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~-~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
..+|..++.|..|+||.||.++++.+.+.+|+|+=+ .. .+++ .+.. ...|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~----------lilRnilt~--a~npfvv------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN----------LILRNILTF--AGNPFVV------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc----------hhhhccccc--cCCccee-------------
Confidence 457999999999999999999999999999995432 11 1111 1111 1223333
Q ss_pred EEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 188 LVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 188 lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
|+=..+++.-. .++.+. +.+++|||+ .||+|||+||+|.+| ..-|++|++|||+++...
T Consensus 136 -------gDc~tllk~~g--~lPvdm--------vla~Eylh~--ygivhrdlkpdnllI--T~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 -------GDCATLLKNIG--PLPVDM--------VLAVEYLHS--YGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred -------chhhhhcccCC--CCcchh--------hHHhHhhcc--CCeecCCCCCCccee--eecccccccchhhhhhhh
Confidence 33333444332 344333 789999995 589999999999999 568999999999985432
Q ss_pred Cc------------------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q psy11727 268 QT------------------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVL 329 (437)
Q Consensus 268 ~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 329 (437)
.. ....+||+.|+|||++..+.|+..+|+|++|+|+||.+.|..||.|+..++.+.+.+...
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~ 274 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 274 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence 11 224589999999999999999999999999999999999999999999999888876643
Q ss_pred CCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHH
Q psy11727 330 GMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILR 409 (437)
Q Consensus 330 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 409 (437)
..-|+... +-..+.+|+|.+
T Consensus 275 i~wpE~de------------------------------------------------------------a~p~Ea~dli~~ 294 (1205)
T KOG0606|consen 275 IEWPEEDE------------------------------------------------------------ALPPEAQDLIEQ 294 (1205)
T ss_pred ccccccCc------------------------------------------------------------CCCHHHHHHHHH
Confidence 32222100 011156899999
Q ss_pred ccccCCCCCCC---HHHHhcCCCcCcCCCC
Q psy11727 410 MLTYDPKKRIS---PTNVLRHEFFLKHSVD 436 (437)
Q Consensus 410 ~L~~dP~~R~t---~~e~l~Hp~~~~~~~~ 436 (437)
+|+.+|..|.- +-++-+|+||+..++.
T Consensus 295 LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 295 LLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred HHHhChHhhcccchhhhhhhccceeecccc
Confidence 99999999974 6678899999987763
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-22 Score=187.27 Aligned_cols=203 Identities=22% Similarity=0.305 Sum_probs=130.8
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc----chHHHHHHHHHHHhhh-c---------CCCCC-cEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----LNQAQIEVQLLEKINK-A---------DIHSR-YIVK 175 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~----~~~~~~e~~~~~~l~~-~---------~~~h~-~iv~ 175 (437)
.....+.||.|+++.||.+.+..|++.+|+|+....... .+...+|......+.. . .+.-| -+++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 456678999999999999999999999999998633211 1222222222111100 0 00001 1333
Q ss_pred ecc---eeeEC---C-----EEEEEEEeccCcHHHHHH---hcCCC--CCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCC
Q psy11727 176 LKG---HFTWK---N-----HLCLVFELLSYNLYNLIR---NTNFH--GVSLNLTKKFAQQLCCALAFLSSPELSIIHCD 239 (437)
Q Consensus 176 l~~---~~~~~---~-----~~~lV~E~~~~~L~~~l~---~~~~~--~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrD 239 (437)
+-+ ++... . ..+++|+-+.++|.+++. ..... ++.......+..|+++.+++||. .|+||+|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~--~GlVHgd 170 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS--YGLVHGD 170 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH--TTEEEST
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh--cceEecc
Confidence 321 11111 1 247889999888887653 22211 13334445667999999999995 4899999
Q ss_pred CCCCcEEEecCCCCCEEEEeCCCceecCCccccccccccccChhhhcC--------CCCCCcchHHHHHHHHHHHHhCCC
Q psy11727 240 LKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLG--------IPYDLAIDMWSLGCILVELHTGEP 311 (437)
Q Consensus 240 iKp~NIll~~~~~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlG~il~elltg~~ 311 (437)
|+|+|+|+ +.+|.+.|+||+.....+........+..|.|||.... ..++.+.|.|+||+++|.|.+|..
T Consensus 171 i~~~nfll--~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 171 IKPENFLL--DQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp -SGGGEEE---TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred cceeeEEE--cCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999 77899999999998888776654455678999998754 247889999999999999999999
Q ss_pred CCCCCC
Q psy11727 312 LFSGKN 317 (437)
Q Consensus 312 pf~~~~ 317 (437)
||....
T Consensus 249 Pf~~~~ 254 (288)
T PF14531_consen 249 PFGLSS 254 (288)
T ss_dssp STCCCG
T ss_pred CCCCCC
Confidence 998654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=176.86 Aligned_cols=139 Identities=22% Similarity=0.233 Sum_probs=105.8
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCcccc---------------------------hHHHHHHHHHHHhhhcC
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFL---------------------------NQAQIEVQLLEKINKAD 167 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~---------------------------~~~~~e~~~~~~l~~~~ 167 (437)
...||+|+||+||+|.+. +|+.||||+++...... .....|..++..+.+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 89999999997532110 11234888999988776
Q ss_pred CCCCcEEEecceeeECCEEEEEEEeccCc-HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHh-cCCCCCeeeCCCCCCcE
Q psy11727 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL-SSPELSIIHCDLKPENI 245 (437)
Q Consensus 168 ~~h~~iv~l~~~~~~~~~~~lV~E~~~~~-L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~L-H~~~~giiHrDiKp~NI 245 (437)
+.+|+++.. .+ .+|||||++|+ +....... .++++..+..++.|++.+|.+| |+ .||+||||||+||
T Consensus 81 v~~p~~~~~------~~-~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~--~giiHrDlkP~NI 149 (190)
T cd05147 81 IPCPEPILL------KS-HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQD--CRLVHADLSEYNL 149 (190)
T ss_pred CCCCcEEEe------cC-CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHE
Confidence 666665421 12 27999999874 43332222 3589999999999999999999 64 4899999999999
Q ss_pred EEecCCCCCEEEEeCCCceecCC
Q psy11727 246 LLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 246 ll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
|++ ++.++|+|||+|.....
T Consensus 150 li~---~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 150 LYH---DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred EEE---CCcEEEEEccccccCCC
Confidence 994 36799999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.8e-22 Score=180.05 Aligned_cols=176 Identities=11% Similarity=0.138 Sum_probs=123.4
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchH----------HHHHHHHHHHhhhcCCCCCcEE-
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQ----------AQIEVQLLEKINKADIHSRYIV- 174 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~----------~~~e~~~~~~l~~~~~~h~~iv- 174 (437)
+.+.++|.+.++||.|+||.||++.. ++..+|||+++........ +.+|+..+.++.+.++..+...
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 34578999999999999999999754 4668999999743322222 4677778888866554443221
Q ss_pred --EecceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC
Q psy11727 175 --KLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK 251 (437)
Q Consensus 175 --~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~ 251 (437)
.....+......+|||||++| +|.++.. +++ ....+++.+|..||. .|++|||+||.||++ +.
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~--~gi~H~Dikp~Nili--~~ 170 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQ--HGMVSGDPHKGNFIV--SK 170 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHH--cCCccCCCChHHEEE--eC
Confidence 222222223568999999988 7766521 233 345699999999995 489999999999999 45
Q ss_pred CCCEEEEeCCCceecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHH
Q psy11727 252 RSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELH 307 (437)
Q Consensus 252 ~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ell 307 (437)
++ ++|+|||.+......... ..+.....|+.++|+||||+++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~---------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK---------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH---------HHHHHHhHhcccccccceeEeehHHH
Confidence 56 999999987654222111 11444556778999999999987654
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.7e-23 Score=213.30 Aligned_cols=193 Identities=27% Similarity=0.386 Sum_probs=147.0
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.|...+.||.+.|=+|.+|++.+ | .|+||++-+.... ...+.+.+.-.+ ..-..+||++.+.-+-..+...||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik---~~l~~~pn~lPfqk~~~t~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK---FALMKAPNCLPFQKVLVTDKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH---HHhhcCCcccchHHHHHhhHHHHH
Confidence 68889999999999999997643 4 4999998655422 233333222222 222378899998888778888999
Q ss_pred EEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee--c
Q psy11727 189 VFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH--V 266 (437)
Q Consensus 189 V~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~--~ 266 (437)
|-+|+..+|+|.+....+ +.+-+.+.|+.||+.||.-+| +.||+|||||.+|||+++ -.=+.|+||..=+. +
T Consensus 99 vRqyvkhnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH--~~gVcHGDIKsENILiTS--WNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCH--KLGVCHGDIKSENILITS--WNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHHHhhhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHH--HcCccccccccceEEEee--echhhhhcccccCCccC
Confidence 999999999999988765 788889999999999999999 679999999999999964 33478999986432 2
Q ss_pred CCc---cc-----cccccccccChhhhcCC----------C-CCCcchHHHHHHHHHHHHh-CCCCCC
Q psy11727 267 GQT---LY-----QYIQSRYYRSPEVLLGI----------P-YDLAIDMWSLGCILVELHT-GEPLFS 314 (437)
Q Consensus 267 ~~~---~~-----~~~gt~~y~aPE~~~~~----------~-~~~~~DvwSlG~il~ellt-g~~pf~ 314 (437)
... .+ +......|+|||.+... + .+++-||||+||+++||++ |+|||.
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 111 11 11223469999988642 1 5678999999999999999 899995
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-21 Score=183.22 Aligned_cols=145 Identities=21% Similarity=0.285 Sum_probs=116.7
Q ss_pred CCCCcEEEecceeeEC---------------------------CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHH
Q psy11727 168 IHSRYIVKLKGHFTWK---------------------------NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQ 220 (437)
Q Consensus 168 ~~h~~iv~l~~~~~~~---------------------------~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~q 220 (437)
..|||||++.++|.+. ..+|+||.....+|.+++..+. .+......++.|
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC---CchHHHHHHHHH
Confidence 4799999999998652 4699999999999999998765 577888899999
Q ss_pred HHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC--CEEEEeCCCceecCC---------ccccccccccccChhhhcCCC
Q psy11727 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRS--AIKIIDFGSSCHVGQ---------TLYQYIQSRYYRSPEVLLGIP 289 (437)
Q Consensus 221 i~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~--~ikL~DFG~s~~~~~---------~~~~~~gt~~y~aPE~~~~~~ 289 (437)
++.|+.|||.| ||.|||+|++|||+.-|+++ .+.|+|||++--... .....-|.-.-||||+....+
T Consensus 350 lLEav~hL~~h--gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 350 LLEAVTHLHKH--GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHc--cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999966 89999999999999655554 478899998632111 112234567789999987543
Q ss_pred ------CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy11727 290 ------YDLAIDMWSLGCILVELHTGEPLFSGKN 317 (437)
Q Consensus 290 ------~~~~~DvwSlG~il~elltg~~pf~~~~ 317 (437)
--.+.|.|+.|.+.||+++...||.+..
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG 461 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG 461 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccc
Confidence 1257999999999999999999998844
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=167.61 Aligned_cols=139 Identities=19% Similarity=0.209 Sum_probs=104.5
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCccc---------------------------chHHHHHHHHHHHhhhcC
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF---------------------------LNQAQIEVQLLEKINKAD 167 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~---------------------------~~~~~~e~~~~~~l~~~~ 167 (437)
...||+|+||+||+|.+. +|+.||||+++..... ......|...+.++.+.+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 8999999999754211 011245777788887665
Q ss_pred CCCCcEEEecceeeECCEEEEEEEeccCc-HHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcE
Q psy11727 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYN-LYN-LIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENI 245 (437)
Q Consensus 168 ~~h~~iv~l~~~~~~~~~~~lV~E~~~~~-L~~-~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NI 245 (437)
+..|.++.. . ..+|||||++|. +.. .+.. ..++...+..++.|++.++.+||+. .||+||||||+||
T Consensus 81 i~~p~~~~~-----~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~-~givHrDlkP~NI 149 (190)
T cd05145 81 VPVPEPILL-----K--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQE-AGLVHGDLSEYNI 149 (190)
T ss_pred CCCceEEEe-----c--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHh-CCEecCCCChhhE
Confidence 544443321 1 248999999874 333 3332 3478889999999999999999961 4899999999999
Q ss_pred EEecCCCCCEEEEeCCCceecCC
Q psy11727 246 LLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 246 ll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
|++ ++.++|+|||++.....
T Consensus 150 ll~---~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 150 LYH---DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EEE---CCCEEEEEcccceecCC
Confidence 994 57899999999976654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.6e-21 Score=202.94 Aligned_cols=195 Identities=25% Similarity=0.360 Sum_probs=156.7
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.-.+.|.|.+.||+|+||+||+|.... |+.||||+-+... ..++..=.+++++|. .. .-+.|..+..++...+.-
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~--~WEfYI~~q~~~RLk-~~-~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN--PWEFYICLQVMERLK-PQ-MLPSIMHISSAHVFQNAS 769 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCC--ceeeeehHHHHHhhc-hh-hhcchHHHHHHHccCCcc
Confidence 335679999999999999999998766 9999999975433 344444455556654 11 113477777777888888
Q ss_pred EEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec-----CCCCCEEEEeC
Q psy11727 187 CLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS-----PKRSAIKIIDF 260 (437)
Q Consensus 187 ~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~-----~~~~~ikL~DF 260 (437)
+||+||.+ |+|++++... +.+++..+..|+.||+..+..||. .+|||+||||+|+||.. .+...++|+||
T Consensus 770 ~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~--~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHA--MGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHh--cceecccCCcceeEeecccCCCCcccceEEEec
Confidence 99999996 5899998843 569999999999999999999995 58999999999999942 12345999999
Q ss_pred CCceec-----CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCC
Q psy11727 261 GSSCHV-----GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGE 310 (437)
Q Consensus 261 G~s~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~ 310 (437)
|.|..+ +.......+|-.+-++|+..|.+++..+|.|.|+.+++.||.|+
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 999654 22334456788899999999999999999999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.6e-20 Score=164.31 Aligned_cols=183 Identities=15% Similarity=0.121 Sum_probs=134.0
Q ss_pred eeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccch-----HHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 113 EIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLN-----QAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 113 ~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~-----~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.+...|++|+||+|+.+.. .+..++.+.+........ .+.+|+.+++.+.+ ++++++++++ +..+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~----~~~vP~ll~~----~~~~ 74 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDG----LPRTPRLLHW----DGRH 74 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCC----CCCCCEEEEE----cCEE
Confidence 4567899999999998854 677888887765444333 47789999999853 3556666664 4469
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCC-CCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDL-KPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDi-Kp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++|||+.| +|.+.+.. . ...++.|++.+|.++|. .||+|||| ||+|||+ +.++.++|+|||+|..
T Consensus 75 lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~--~GIvHrDL~kp~NILv--~~~g~i~LIDFG~A~~ 141 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHR--CGVAHNDLAKEANWLV--QEDGSPAVIDFQLAVR 141 (218)
T ss_pred EEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHH--CcCccCCCCCcceEEE--cCCCCEEEEECCCcee
Confidence 99999977 56543211 1 13578899999999995 48999999 7999999 5677899999999985
Q ss_pred cCCccc----------------cccccccccChhhhcCC-CCC-CcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy11727 266 VGQTLY----------------QYIQSRYYRSPEVLLGI-PYD-LAIDMWSLGCILVELHTGEPLFSGKNE 318 (437)
Q Consensus 266 ~~~~~~----------------~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlG~il~elltg~~pf~~~~~ 318 (437)
...... ....++.|++|+...-. ..+ ...++++.|+-+|.++|+..|+.++++
T Consensus 142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 543221 01236677777755432 233 567888999999999999998877654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=164.74 Aligned_cols=139 Identities=17% Similarity=0.170 Sum_probs=108.2
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCC-cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC---E-EEEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK-KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN---H-LCLV 189 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~---~-~~lV 189 (437)
.+.||+|+||.||. ++.++.. +||++... ........+|+.++..+.+.+..||||++++++++++. . +.+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 56899999999995 5666655 69988643 22345788999999999888889999999999999874 4 3488
Q ss_pred EEecc---CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHhcCCCCCeeeCCCCCCcEEEecC--CCCCEEEEeCCCc
Q psy11727 190 FELLS---YNLYNLIRNTNFHGVSLNLTKKFAQQLCCAL-AFLSSPELSIIHCDLKPENILLCSP--KRSAIKIIDFGSS 263 (437)
Q Consensus 190 ~E~~~---~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL-~~LH~~~~giiHrDiKp~NIll~~~--~~~~ikL~DFG~s 263 (437)
|||++ ++|.+++... .+++. ..++.|++.++ +|||++ +||||||||+|||+... .++.++|+||+.+
T Consensus 84 ~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~--~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN--RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 99954 5899999664 25555 35677888777 999965 79999999999999532 3447999995443
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.7e-20 Score=180.84 Aligned_cols=118 Identities=31% Similarity=0.440 Sum_probs=101.4
Q ss_pred CEEEEEEEecc-CcHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 184 NHLCLVFELLS-YNLYNLIRN-TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 184 ~~~~lV~E~~~-~~L~~~l~~-~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
.++||.|++|. .+|.+|+.. ......++.....++.|++.|+.| + |.+|+|+||.||++ ..+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k--~~ihrdlkp~nif~--~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K--GLIHRDLKPSNIFF--SDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c--cchhhhcccccccc--ccchhhhhhhhh
Confidence 47999999995 589999973 334557889999999999999999 2 79999999999999 445579999999
Q ss_pred CceecCCc---------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh
Q psy11727 262 SSCHVGQT---------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT 308 (437)
Q Consensus 262 ~s~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt 308 (437)
+.+..... .+...||..||+||.+.+..|+.++||||||+||+|++.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 98765432 345688999999999999999999999999999999997
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=162.63 Aligned_cols=145 Identities=19% Similarity=0.154 Sum_probs=107.6
Q ss_pred CeeeeceecccCceEEEEEE-EcCCCeEEEEEEecCCccc-------------------------chHHHHHHHHHHHhh
Q psy11727 111 RYEIDTLLGKGSFGQVVKAF-DHEEKCQVAIKIIKNKKPF-------------------------LNQAQIEVQLLEKIN 164 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~-~~~~~~~vaiK~i~~~~~~-------------------------~~~~~~e~~~~~~l~ 164 (437)
-|.+.+.||+|+||+||+|. +..+|+.||+|+++..... ......|..++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 38889999999999999998 6778999999999743210 012457888888886
Q ss_pred hcCCCCCcEEEecceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCC-eeeCCCCC
Q psy11727 165 KADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELS-IIHCDLKP 242 (437)
Q Consensus 165 ~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~g-iiHrDiKp 242 (437)
...+.-| ++++. . ..++||||++| +|....... ..+....+..++.||+.+|++||++ | |+||||||
T Consensus 109 ~~~i~~p---~~~~~---~-~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~--g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVP---KPIAW---R-RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKE--GELVHGDLSE 177 (237)
T ss_pred hcCCCCC---eeeEe---c-CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhc--CCEEeCCCCh
Confidence 5332222 33221 2 34799999988 454433222 2356667789999999999999964 7 99999999
Q ss_pred CcEEEecCCCCCEEEEeCCCceecCCc
Q psy11727 243 ENILLCSPKRSAIKIIDFGSSCHVGQT 269 (437)
Q Consensus 243 ~NIll~~~~~~~ikL~DFG~s~~~~~~ 269 (437)
+||++. ++.++|+|||.+...+.+
T Consensus 178 ~NIli~---~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 178 YNILVH---DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred hhEEEE---CCCEEEEEChhhhccCCc
Confidence 999994 677999999998765543
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.2e-19 Score=160.26 Aligned_cols=200 Identities=22% Similarity=0.276 Sum_probs=150.0
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
...+..+|...-.|+.|+|++..+ .+++|++.-.. .....+..|.-.++. +.||||..+++.|....++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lri-----fshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRI-----FSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred hhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceee-----ecCCchhhhhhhccCCCCce
Confidence 344567788899999999988655 46667764221 122334444434433 38999999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEE--EEeCCCce
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIK--IIDFGSSC 264 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ik--L~DFG~s~ 264 (437)
+|..||+. +|+.++.....--+...++.+|+..|+.+++|||+-+.-|.---|....|++ |++...+ .+|--+|.
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi--dedltarismad~kfsf 341 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI--DEDLTARISMADTKFSF 341 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe--cchhhhheecccceeee
Confidence 99999975 8999998876556788999999999999999999875445556788999999 5555544 44544443
Q ss_pred ecCCccccccccccccChhhhcCCCCC---CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy11727 265 HVGQTLYQYIQSRYYRSPEVLLGIPYD---LAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323 (437)
Q Consensus 265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlG~il~elltg~~pf~~~~~~~~~~ 323 (437)
.... ..-++.|++||.+..++-+ .++|+|||++++||+.|.+.||..-++.+.--
T Consensus 342 qe~g----r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm 399 (448)
T KOG0195|consen 342 QEVG----RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM 399 (448)
T ss_pred eccc----cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh
Confidence 2222 2347889999999887654 57999999999999999999999877765533
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.3e-17 Score=150.26 Aligned_cols=133 Identities=21% Similarity=0.271 Sum_probs=101.5
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCccc---------chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF---------LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~---------~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
+.||+|++|.||+|.. +|..|++|+....... ......|..++..+.+.++..| ..++.+.+..
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p-----~~~~~~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVP-----AVYFVDPENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCC-----eEEEEeCCCC
Confidence 5789999999999976 6778999986532211 1245568888888765444333 3334566778
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++||||++| +|.+++.... . ....++.+++.+|.+||+ .|++|||++|.|||+. .+.++|+|||++..
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~--~~i~H~Dl~p~Nil~~---~~~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHS--AGIIHGDLTTSNMILS---GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHh--CCcccCCCCcccEEEE---CCCEEEEECCcccC
Confidence 999999976 7888775432 2 778999999999999995 4899999999999994 66799999999865
Q ss_pred c
Q psy11727 266 V 266 (437)
Q Consensus 266 ~ 266 (437)
.
T Consensus 144 ~ 144 (211)
T PRK14879 144 S 144 (211)
T ss_pred C
Confidence 3
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-16 Score=145.74 Aligned_cols=137 Identities=23% Similarity=0.238 Sum_probs=101.0
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc-----------------------chHHHHHHHHHHHhhhcCC
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF-----------------------LNQAQIEVQLLEKINKADI 168 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~-----------------------~~~~~~e~~~~~~l~~~~~ 168 (437)
|.+.+.||+|+||.||++... +|+.||||+++..... ......|..++..+.+.++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 778899999999999999864 7999999987643210 1124567777777755432
Q ss_pred CCCcEEEecceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q psy11727 169 HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILL 247 (437)
Q Consensus 169 ~h~~iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll 247 (437)
.+...++ ....++||||++| +|..... ......++.+++.++.++|. .||+||||||+||++
T Consensus 96 ---~v~~~~~----~~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~--~gi~H~Dl~p~Nill 158 (198)
T cd05144 96 ---PVPKPID----WNRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYK--HGIIHGDLSEFNILV 158 (198)
T ss_pred ---CCCceee----cCCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHH--CCCCcCCCCcccEEE
Confidence 2333332 2445899999987 5544321 13456788999999999995 589999999999999
Q ss_pred ecCCCCCEEEEeCCCceecCC
Q psy11727 248 CSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 248 ~~~~~~~ikL~DFG~s~~~~~ 268 (437)
++++.++|+|||.+.....
T Consensus 159 --~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 --DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred --cCCCcEEEEECCccccCCC
Confidence 6688899999999865544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-18 Score=182.41 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=187.7
Q ss_pred cCeeeeceecccCceEEEEEEEcC-CCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHE-EKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~-~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
..|.+.+.||+|+|+.|-.+.+.. +...+|+|.+.... ........|..+...+. .|.|++.+++.....+.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s----~h~n~~~~~~~~~~~~~ 95 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLS----KHSNTVHMIEPSSSPRS 95 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCcccccccccc----ccccccccCCccCCCcc
Confidence 468888889999999999987643 34457777765432 11222233555544443 38899999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC-CEEEEeCCCc
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS-AIKIIDFGSS 263 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~-~ikL~DFG~s 263 (437)
.++++++..| .+++.+......+.+...+..++.|+..++.|+|. +.++.|+||||+|.++ +..+ .++++|||+|
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~-~~~~~h~~ikP~n~~l--~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP-ENGVTHRDIKPSNSLL--DESGSALKIADFGLA 172 (601)
T ss_pred cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc-ccccccCCCCCccchh--ccCCCcccCCCchhh
Confidence 9999999855 67777633333367888999999999999999995 2489999999999999 6677 8999999999
Q ss_pred eecCC-c-----cccccc-cccccChhhhcCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 264 CHVGQ-T-----LYQYIQ-SRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 264 ~~~~~-~-----~~~~~g-t~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
..... . ....+| ++.|+|||...+.. .....|+||.|+++.-+++|..|+......+.
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-------------- 238 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-------------- 238 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc--------------
Confidence 87654 1 234678 99999999998854 45789999999999999999999876443220
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
.|+..... . .. ..+..+..+ .....+++.++|..+|
T Consensus 239 ---------~~~~~~~~--------~-~~-~~~~~~~~~-------------------------~~~~~~~l~k~l~~~~ 274 (601)
T KOG0590|consen 239 ---------RYSSWKSN--------K-GR-FTQLPWNSI-------------------------SDQAHDLLHKILKENP 274 (601)
T ss_pred ---------cceeeccc--------c-cc-cccCccccC-------------------------ChhhhhcccccccCCc
Confidence 00000000 0 00 000000000 0134789999999999
Q ss_pred CCCCCHHHHhcCCCcCc
Q psy11727 416 KKRISPTNVLRHEFFLK 432 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~ 432 (437)
..|.+.+++-.+||+..
T Consensus 275 ~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 275 SNRLSIEELKLDNWLSS 291 (601)
T ss_pred hhccccccccccccccc
Confidence 99999999999999987
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-16 Score=143.68 Aligned_cols=129 Identities=21% Similarity=0.230 Sum_probs=97.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCcc---------cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---------FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---------~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.||+|+||.||+|. .++..|++|....... ...+...|..++..+.+.++..|.+. +...+..+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~-----~~~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVY-----DVDPDNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEE-----EEECCCCE
Confidence 37999999999997 3567899998653221 12345578888888876554444332 33556678
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||++| +|.+++.... . .++.|++.+|.+||+ .|++|+|++|.||++. ++.++++|||++...
T Consensus 74 lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~--~gi~H~Dl~~~Nil~~---~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHK--AGIVHGDLTTSNIIVR---DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHH--CCeecCCCCcceEEEE---CCcEEEEECCCCcCC
Confidence 99999976 7777664421 1 889999999999995 5899999999999994 677999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=159.68 Aligned_cols=146 Identities=21% Similarity=0.325 Sum_probs=120.8
Q ss_pred CCCCCcEEEecceeeECCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcE
Q psy11727 167 DIHSRYIVKLKGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENI 245 (437)
Q Consensus 167 ~~~h~~iv~l~~~~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NI 245 (437)
.+.|.|+.++++.+.+....++|.+||+ |+|.|.+.... ..+++-....++++|+.+|+|||+...+ .|+.+++.|.
T Consensus 3 ~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~-~hg~l~s~nC 80 (484)
T KOG1023|consen 3 QLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIG-YHGALKSSNC 80 (484)
T ss_pred ccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcce-eeeeeccccc
Confidence 4578999999999999999999999995 58999888754 4588888999999999999999986544 9999999999
Q ss_pred EEecCCCCCEEEEeCCCceecCC-----ccccccccccccChhhhcCCC-------CCCcchHHHHHHHHHHHHhCCCCC
Q psy11727 246 LLCSPKRSAIKIIDFGSSCHVGQ-----TLYQYIQSRYYRSPEVLLGIP-------YDLAIDMWSLGCILVELHTGEPLF 313 (437)
Q Consensus 246 ll~~~~~~~ikL~DFG~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwSlG~il~elltg~~pf 313 (437)
++ +.+..+||+|||+...... ......-..-|.|||.+.+.. .+.+.|+||||++++|+++...||
T Consensus 81 lv--d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 81 LV--DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred ee--eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 99 7899999999999765532 111112244599999998742 356799999999999999999999
Q ss_pred CCC
Q psy11727 314 SGK 316 (437)
Q Consensus 314 ~~~ 316 (437)
...
T Consensus 159 ~~~ 161 (484)
T KOG1023|consen 159 DLR 161 (484)
T ss_pred ccc
Confidence 763
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.8e-16 Score=138.76 Aligned_cols=138 Identities=20% Similarity=0.280 Sum_probs=94.1
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHH-------------------------HHHHHHHHHhhhcCCC
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQA-------------------------QIEVQLLEKINKADIH 169 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~-------------------------~~e~~~~~~l~~~~~~ 169 (437)
.+.||+|+||+||+|.+. +++.||||+++......... ..|...+..+....+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~- 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV- 79 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC-
Confidence 467999999999999876 78999999987432211111 234444444443221
Q ss_pred CCcEEEecceeeECCEEEEEEEeccC-cHH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q psy11727 170 SRYIVKLKGHFTWKNHLCLVFELLSY-NLY-NLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILL 247 (437)
Q Consensus 170 h~~iv~l~~~~~~~~~~~lV~E~~~~-~L~-~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll 247 (437)
.+.+.+++ ...++||||+++ .+. ..+.... .. ..++.++.+++.++.++|.. .||+|+||||+||++
T Consensus 80 --~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~-~~ivH~Dl~p~Nili 148 (187)
T cd05119 80 --PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYRE-AGLVHGDLSEYNILV 148 (187)
T ss_pred --CCCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhc-cCcCcCCCChhhEEE
Confidence 12222222 245899999987 221 2222211 11 67789999999999999962 589999999999999
Q ss_pred ecCCCCCEEEEeCCCceecCC
Q psy11727 248 CSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 248 ~~~~~~~ikL~DFG~s~~~~~ 268 (437)
+ ++.++|+|||++.....
T Consensus 149 ~---~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D---DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E---CCcEEEEECcccccccC
Confidence 4 67899999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.5e-16 Score=160.43 Aligned_cols=136 Identities=20% Similarity=0.195 Sum_probs=99.8
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---------ccchHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---------PFLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---------~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
...|...+.||+|+||+||++..... .+++|+...+. ....+...|..++..+. |++++....+
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~~~i~~p~~~ 404 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-----RAGVPTPVIY 404 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-----ccCCCeeEEE
Confidence 44567789999999999999976544 34444322111 11234567888888874 4455555555
Q ss_pred eeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 180 FTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 180 ~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
+.+.+..++||||++| +|.+++. ....++.|++.+|.+||+ .|++||||||+|||+ +++.++|+
T Consensus 405 ~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~--~giiHrDlkp~NILl---~~~~~~li 469 (535)
T PRK09605 405 DVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK--AGIVHGDLTTSNFIV---RDDRLYLI 469 (535)
T ss_pred EEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh--CCCccCCCChHHEEE---ECCcEEEE
Confidence 5666678899999976 7877765 346789999999999995 489999999999999 24579999
Q ss_pred eCCCceec
Q psy11727 259 DFGSSCHV 266 (437)
Q Consensus 259 DFG~s~~~ 266 (437)
|||++...
T Consensus 470 DFGla~~~ 477 (535)
T PRK09605 470 DFGLGKYS 477 (535)
T ss_pred eCcccccC
Confidence 99998653
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=1e-15 Score=131.50 Aligned_cols=135 Identities=23% Similarity=0.206 Sum_probs=107.1
Q ss_pred eeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEec
Q psy11727 114 IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELL 193 (437)
Q Consensus 114 i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~ 193 (437)
+.+.||+|.++.||++.... ..+++|....... ...+..|..+++.+.+. ..++++++.++...+..+++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~---~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARK---GLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHc---CCCCCeEEEEcCCCCccEEEEEec
Confidence 45789999999999998744 6799999865433 45678899999999764 245667777777778899999999
Q ss_pred cCc-HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCC-CCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 194 SYN-LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE-LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 194 ~~~-L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~-~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++. +..+ +......++.+++.+|++||... .+++|+|++|+||++. +.+.++++|||.+..
T Consensus 76 ~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~--~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD--DGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE--CCcEEEEEecccccC
Confidence 774 3322 45667788999999999999642 4799999999999994 467899999998853
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.1e-15 Score=151.42 Aligned_cols=250 Identities=24% Similarity=0.229 Sum_probs=184.9
Q ss_pred ccCeeeeceecc--cCceEEEEEEE--cCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGK--GSFGQVVKAFD--HEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~--G~fg~V~~~~~--~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
...+.+...+|. |.+|.||.+.. ..++..+|+|.-+... .....-.+|......+ -.|++.++.+..++
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i----~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKI----DSHENPVRDSPAWE 188 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhccccc----CccccccccCcccc
Confidence 446778888999 99999999988 8889999999743211 1112222233222222 26779999999999
Q ss_pred ECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHhcCCCCCeeeCCCCCCcEEEecCCC-CCEE
Q psy11727 182 WKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCC----ALAFLSSPELSIIHCDLKPENILLCSPKR-SAIK 256 (437)
Q Consensus 182 ~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~----aL~~LH~~~~giiHrDiKp~NIll~~~~~-~~ik 256 (437)
..+.+++-+|+++..|..+..... ..++...++....+... ||..+|+. +++|-|+||+||++. ++ ..++
T Consensus 189 ~~~~lfiqtE~~~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~--~~~~~~~kp~~i~~~--~~~~s~~ 263 (524)
T KOG0601|consen 189 GSGILFIQTELCGESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSN--NIVHDDLKPANIFTT--SDWTSCK 263 (524)
T ss_pred cCCcceeeeccccchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCC--cccccccchhheecc--cccceee
Confidence 999999999999998888877654 34788899999999999 99999975 699999999999994 45 7799
Q ss_pred EEeCCCceecCCcc--------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHH
Q psy11727 257 IIDFGSSCHVGQTL--------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGK--NEVDQMTKII 326 (437)
Q Consensus 257 L~DFG~s~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~--~~~~~~~~i~ 326 (437)
++|||+...++... ....|..-|++||...+ .++...|++|||.++.+..+|..++... +...++..+.
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 99999988775432 12256677999999876 6789999999999999999988666543 2222211110
Q ss_pred HHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHH
Q psy11727 327 EVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406 (437)
Q Consensus 327 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 406 (437)
.|.+++ + +++. .+...
T Consensus 343 -----ip~e~~----------~---------------------------------------------~~s~----~l~~~ 358 (524)
T KOG0601|consen 343 -----IPLEFC----------E---------------------------------------------GGSS----SLRSV 358 (524)
T ss_pred -----Cchhhh----------c---------------------------------------------Ccch----hhhhH
Confidence 111111 0 1111 23448
Q ss_pred HHHccccCCCCCCCHHHHhcCCCcCc
Q psy11727 407 ILRMLTYDPKKRISPTNVLRHEFFLK 432 (437)
Q Consensus 407 i~~~L~~dP~~R~t~~e~l~Hp~~~~ 432 (437)
+..|++.+|..|++++.++.|+++..
T Consensus 359 ~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 359 TSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred HHHhcCcchhhhhHHHHHhccccccc
Confidence 99999999999999999999999864
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=8.7e-14 Score=130.06 Aligned_cols=134 Identities=17% Similarity=0.170 Sum_probs=95.9
Q ss_pred ceec-ccCceEEEEEEEcCCCeEEEEEEecCCc--------------ccchHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 116 TLLG-KGSFGQVVKAFDHEEKCQVAIKIIKNKK--------------PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 116 ~~lG-~G~fg~V~~~~~~~~~~~vaiK~i~~~~--------------~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
..|| .||.|+||.+.. .+..++||.+.... ....+..+|..++..+.+.++.- +..+++.
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~v---P~pl~~~ 111 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPV---PRPIAAR 111 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCC---ceeEeee
Confidence 4567 888889998865 36789999875311 12245677999999997765433 3333333
Q ss_pred eE-CC---EEEEEEEeccC--cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCC
Q psy11727 181 TW-KN---HLCLVFELLSY--NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA 254 (437)
Q Consensus 181 ~~-~~---~~~lV~E~~~~--~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ 254 (437)
.. .. ..++|||+++| +|.+++... .++.. .+.||+.+|.+||. .||+||||||+|||+ +.++.
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~--~GI~HrDlkp~NILv--~~~~~ 180 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHD--AGVYHADLNAHNILL--DPDGK 180 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHH--CCCCCCCCCchhEEE--cCCCC
Confidence 22 22 23699999975 677777543 34543 36789999999995 489999999999999 55668
Q ss_pred EEEEeCCCcee
Q psy11727 255 IKIIDFGSSCH 265 (437)
Q Consensus 255 ikL~DFG~s~~ 265 (437)
++|+|||.+..
T Consensus 181 v~LIDfg~~~~ 191 (239)
T PRK01723 181 FWLIDFDRGEL 191 (239)
T ss_pred EEEEECCCccc
Confidence 99999998854
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.4e-15 Score=160.13 Aligned_cols=262 Identities=24% Similarity=0.280 Sum_probs=190.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.+.+.+.+-+-.|+++.++.+.-..+|...++|...............+.- +.-.....++|.++...-.|.-....+|
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~-~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRS-KSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCC-ccCccccCCCCceecccCCCCCCCCcch
Confidence 466888889999999999999888888777777654221111100000000 0000111245667766666667788999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
|++|+.+ +|...+.+.. ..+...++.+...+..++++||+. .++|+|++|.|+|. ...++.+++|||.....+
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~--~r~h~~~~p~~~l~--~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS--LRKHRDLKPDSLLI--AYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc--hhhcccccccchhh--cccCCcccCccccccccc
Confidence 9999965 7888777654 478888899999999999999964 48999999999999 678889999998431110
Q ss_pred ----------------------------------CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy11727 268 ----------------------------------QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLF 313 (437)
Q Consensus 268 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf 313 (437)
.......+|+.|.+||...+......+|+|++|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0012346789999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCC
Q psy11727 314 SGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEP 393 (437)
Q Consensus 314 ~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (437)
........++.|....-. + |.+
T Consensus 1036 na~tpq~~f~ni~~~~~~------------------------------------~----------------p~g------ 1057 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIP------------------------------------W----------------PEG------ 1057 (1205)
T ss_pred CCcchhhhhhccccCCCC------------------------------------C----------------CCC------
Confidence 998877666555331100 0 000
Q ss_pred CCChhhhhHHHHHHHHccccCCCCCCCHH---HHhcCCCcCcCCCCC
Q psy11727 394 GHSLADYMKFKDLILRMLTYDPKKRISPT---NVLRHEFFLKHSVDN 437 (437)
Q Consensus 394 ~~~~~~~~~~~dli~~~L~~dP~~R~t~~---e~l~Hp~~~~~~~~~ 437 (437)
........++++.++|..+|.+|..+. ++-.||||+..+++|
T Consensus 1058 --~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1058 --PEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred --ccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence 011112458999999999999999988 888999999999875
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.53 E-value=1e-15 Score=142.50 Aligned_cols=238 Identities=22% Similarity=0.277 Sum_probs=158.5
Q ss_pred EEEEEEEcCCCeEEEEEEecC---CcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC-----EEEEEEEec-cC
Q psy11727 125 QVVKAFDHEEKCQVAIKIIKN---KKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN-----HLCLVFELL-SY 195 (437)
Q Consensus 125 ~V~~~~~~~~~~~vaiK~i~~---~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~-----~~~lV~E~~-~~ 195 (437)
.||++.+...|..|..-.++. +........++...-..+. ..|-|||+++.++.+.. ...++.||| .|
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllq---lvHsnlvkfH~yw~d~K~~e~~rviFiteymssg 157 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQ---LVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSG 157 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHH---HHHHHHHHHHHhhcccccccccceEEEEecccch
Confidence 456676666666665443321 1111122223333333332 25778999999887654 588999999 56
Q ss_pred cHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce-ecC-C---
Q psy11727 196 NLYNLIRNTN--FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC-HVG-Q--- 268 (437)
Q Consensus 196 ~L~~~l~~~~--~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~-~~~-~--- 268 (437)
.+.++|+... ...+.....++|+-||+.||.|||+....|+|+++.-+-|++ ..+|-||+.--.-.. ... .
T Consensus 158 s~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifi--q~ngLIkig~~ap~s~h~s~~~~~ 235 (458)
T KOG1266|consen 158 SLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFI--QHNGLIKIGSVAPDSTHPSVNSTR 235 (458)
T ss_pred hHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheee--cCCceEEecccCccccchhhhhhh
Confidence 8888887643 245788888999999999999999998899999999999999 577777764322111 100 0
Q ss_pred --ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCChhhhccCCccch
Q psy11727 269 --TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPL-FSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSK 345 (437)
Q Consensus 269 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 345 (437)
......+-++|.|||.-..-..+.++|||+||.+..+|..|..- -.+.+..+.-..|...
T Consensus 236 ~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~----------------- 298 (458)
T KOG1266|consen 236 EAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV----------------- 298 (458)
T ss_pred HhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh-----------------
Confidence 01113456789999987776778899999999999999988733 3333332222222111
Q ss_pred hhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHh
Q psy11727 346 YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVL 425 (437)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l 425 (437)
|++.+++ .-+++|.+||+..|..||++.+++
T Consensus 299 -------------------------------i~~len~------------------lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 299 -------------------------------IIGLENG------------------LQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred -------------------------------eeeccCc------------------cccCcCcccccCCCCCCcchhhhh
Confidence 1111110 115789999999999999999999
Q ss_pred cCCCcCcC
Q psy11727 426 RHEFFLKH 433 (437)
Q Consensus 426 ~Hp~~~~~ 433 (437)
.||-+=++
T Consensus 330 fHpllfeV 337 (458)
T KOG1266|consen 330 FHPLLFEV 337 (458)
T ss_pred cCceeeec
Confidence 99986543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.5e-12 Score=132.08 Aligned_cols=144 Identities=19% Similarity=0.212 Sum_probs=92.9
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCcccchH------------------------------------------
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQ------------------------------------------ 152 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~------------------------------------------ 152 (437)
.+.||.|++|+||+|+.+ +|+.||||+.+..- ...
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i--~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~El 198 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGI--EKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRREL 198 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCc--HHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHH
Confidence 357999999999999864 78999999986431 111
Q ss_pred -HHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHhc
Q psy11727 153 -AQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCC-ALAFLS 229 (437)
Q Consensus 153 -~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~-aL~~LH 229 (437)
+..|...++++...--+++++.--.-+.......+|||||++| +|.+...... .+. ....++.+++. .+..+|
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCC---CHHHHHHHHHHHHHHHHH
Confidence 2234444444433222333322211122223457899999977 6766654321 112 23456666655 466778
Q ss_pred CCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc
Q psy11727 230 SPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT 269 (437)
Q Consensus 230 ~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~ 269 (437)
. .|++|+|++|.||++ +.++.++|+|||++...+..
T Consensus 275 ~--~g~~H~D~hPgNilv--~~~g~i~liDfG~~~~l~~~ 310 (437)
T TIGR01982 275 R--DGFFHADLHPGNIFV--LKDGKIIALDFGIVGRLSEE 310 (437)
T ss_pred h--CCceeCCCCcccEEE--CCCCcEEEEeCCCeeECCHH
Confidence 4 489999999999999 66788999999999777543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.5e-13 Score=139.60 Aligned_cols=149 Identities=16% Similarity=0.243 Sum_probs=93.2
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-----------------------------------cchH
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-----------------------------------FLNQ 152 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-----------------------------------~~~~ 152 (437)
+...|+. +.||.|++|+||+|+.+.+|+.||||+++..-. +...
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456776 789999999999999988899999999974310 0011
Q ss_pred H------HHHHHHHHHhhhcCCCCCcEEEecceee-ECCEEEEEEEeccC-cHHHH--HHhcCC--CCCCHHHHHHHHHH
Q psy11727 153 A------QIEVQLLEKINKADIHSRYIVKLKGHFT-WKNHLCLVFELLSY-NLYNL--IRNTNF--HGVSLNLTKKFAQQ 220 (437)
Q Consensus 153 ~------~~e~~~~~~l~~~~~~h~~iv~l~~~~~-~~~~~~lV~E~~~~-~L~~~--l~~~~~--~~ls~~~~~~i~~q 220 (437)
. ..|...+.++... ..+...+.+-..+. .....+|||||+.| .+.+. +...+. ..+....+..++.|
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~-f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 197 LHDELDLMREAANASQLRRN-FEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHH-ccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 1 1233333333221 11222222222222 23456799999977 66653 222211 12445555566666
Q ss_pred HHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC----CEEEEeCCCceecCCc
Q psy11727 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRS----AIKIIDFGSSCHVGQT 269 (437)
Q Consensus 221 i~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~----~ikL~DFG~s~~~~~~ 269 (437)
++. .|++|+|+||.||++. .++ .++++|||++...+..
T Consensus 276 if~---------~GffHaDpHPGNIlv~--~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 VFR---------DGFFHADMHPGNIFVS--YDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHh---------CCeeeCCCChHHeEEe--cCCCCCCeEEEEecceEEECCHH
Confidence 653 3899999999999994 444 8999999998776543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=6.1e-12 Score=113.01 Aligned_cols=140 Identities=21% Similarity=0.243 Sum_probs=101.9
Q ss_pred eceecccCceEEEEEEEcC------CCeEEEEEEecCCc--------------c---------cchH----HHHHHHHHH
Q psy11727 115 DTLLGKGSFGQVVKAFDHE------EKCQVAIKIIKNKK--------------P---------FLNQ----AQIEVQLLE 161 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~------~~~~vaiK~i~~~~--------------~---------~~~~----~~~e~~~~~ 161 (437)
...||.|.-+.||.|.... .+..+|||+.+... . .... ...|...+.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3468999999999997653 35789999875211 0 0111 236999999
Q ss_pred HhhhcCCCCCcEEEecceeeECCEEEEEEEeccCc-HHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHh-cCCCCCeeeC
Q psy11727 162 KINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYN-LYN-LIRNTNFHGVSLNLTKKFAQQLCCALAFL-SSPELSIIHC 238 (437)
Q Consensus 162 ~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~~-L~~-~l~~~~~~~ls~~~~~~i~~qi~~aL~~L-H~~~~giiHr 238 (437)
++...++.-|.++-+ ..-+|||||++++ +.. .++.. .++......+..+++.+|..| | +.||||+
T Consensus 82 rl~~~Gv~vP~pi~~-------~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H--~~glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL-------KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYK--ECNLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe-------cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHH--hCCeecC
Confidence 999888877766632 4467899999763 322 23322 255566778889999999998 7 4589999
Q ss_pred CCCCCcEEEecCCCCCEEEEeCCCceecCCc
Q psy11727 239 DLKPENILLCSPKRSAIKIIDFGSSCHVGQT 269 (437)
Q Consensus 239 DiKp~NIll~~~~~~~ikL~DFG~s~~~~~~ 269 (437)
||++.|||+. ++.+.|+|||.+.....+
T Consensus 150 DLs~~NIL~~---~~~v~iIDF~qav~~~hp 177 (197)
T cd05146 150 DLSEYNMLWH---DGKVWFIDVSQSVEPTHP 177 (197)
T ss_pred CCCHHHEEEE---CCcEEEEECCCceeCCCC
Confidence 9999999994 356999999998766543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=7.1e-12 Score=110.52 Aligned_cols=129 Identities=20% Similarity=0.135 Sum_probs=91.3
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEecc
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLS 194 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~ 194 (437)
.+.|+.|.++.||++... +..|++|+.............|..+++.+....+ .| +++.+. ....++|||+++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~-~P---~~~~~~--~~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGI-GP---KLYYFD--PETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCC-CC---ceEEEe--CCCCeEEEEecC
Confidence 457899999999999754 7789999986543223346789999998876543 23 333332 233579999998
Q ss_pred C-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCC---CCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 195 Y-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE---LSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 195 ~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~---~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
| ++.+. . .....++.+++.+|+.||... .+++|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~----~------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~---~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE----D------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD---DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc----c------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE---CCeEEEEeccccc
Confidence 8 44322 0 112346789999999999652 1369999999999994 4569999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.31 E-value=2e-12 Score=130.08 Aligned_cols=201 Identities=21% Similarity=0.186 Sum_probs=146.3
Q ss_pred CceeccCeeeeceecccCceEEEEEEEc-CCCeEEEEEEecCCcccchH---HHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDH-EEKCQVAIKIIKNKKPFLNQ---AQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 105 ~~~~~~~y~i~~~lG~G~fg~V~~~~~~-~~~~~vaiK~i~~~~~~~~~---~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
......+|..+..||.|.|+.|+.+... .++..|++|.+.+....... ...|+.+...+. .|.+++.....|
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~----~~~~~~g~~~~W 335 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILG----SHLPSVGKNSSW 335 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhh----cccccCCCCCCc
Confidence 3455678999999999999999998755 67889999988754322211 123444444443 566788877888
Q ss_pred eECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 181 TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 181 ~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
...+..++-.|||.+ ++...+ .. ...+.+...+++..|++.++.++|+ ..++|+|+||+||++.++. +..++.|
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~-~~-~~~~d~~~~~~~~~q~~~~l~~i~s--~~~~~~d~~psni~i~~~~-~~~~~~~ 410 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRS-VT-SQMLDEDPRLRLTAQILTALNVIHS--KLFVHLDVKPSNILISNDG-FFSKLGD 410 (524)
T ss_pred cccccccCchhhhcCcchhhhh-HH-HHhcCcchhhhhHHHHHhccccccc--hhhhcccccccceeeccch-hhhhccc
Confidence 877888899999965 333222 11 1337888999999999999999995 5799999999999996543 7789999
Q ss_pred CCCceecCCcccccccccccc--ChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy11727 260 FGSSCHVGQTLYQYIQSRYYR--SPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFS 314 (437)
Q Consensus 260 FG~s~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~ 314 (437)
||+.+...-......+.-.+. +++......+..+.|++|||.-+.+..+|.+.-.
T Consensus 411 ~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~ 467 (524)
T KOG0601|consen 411 FGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE 467 (524)
T ss_pred cccccccceecccccccccccccchhhccccccccccccccccccccccccCcccCc
Confidence 999876433333333333344 5555556678899999999999999999885543
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.5e-11 Score=121.67 Aligned_cols=166 Identities=17% Similarity=0.236 Sum_probs=120.9
Q ss_pred EEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccCcHHHHHHhcCC
Q psy11727 128 KAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNF 206 (437)
Q Consensus 128 ~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~ 206 (437)
.|..+.++.+|.|...+.... ......+.+.-++. ++||+|+++++.++..+++|||+|-+-. |..+++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKt-----lRHP~Il~yL~t~e~~~~~ylvTErV~P-l~~~lk~l-- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKT-----LRHPNILSYLDTTEEEGTLYLVTERVRP-LETVLKEL-- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhh-----ccCchhhhhhhhhcccCceEEEeecccc-HHHHHHHh--
Confidence 466677888999988875443 11223333333433 4899999999999999999999999842 33344443
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCcc---ccccccccccChh
Q psy11727 207 HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL---YQYIQSRYYRSPE 283 (437)
Q Consensus 207 ~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~---~~~~gt~~y~aPE 283 (437)
+......-+.||+.||.|||.. .+++|++|.-+-|++ +..|..||++|.+++...... ....--..|..|+
T Consensus 102 ---~~~~v~~Gl~qIl~AL~FL~~d-~~lvHgNv~~~SVfV--n~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 102 ---GKEEVCLGLFQILAALSFLNDD-CNLVHGNVCKDSVFV--NESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPE 175 (690)
T ss_pred ---HHHHHHHHHHHHHHHHHHHhcc-CCeeeccEeeeeEEE--cCCCcEEEeeeEEEeccccCCcccccchhhhcccChh
Confidence 3556677899999999999874 689999999999999 789999999999886553322 1111223467777
Q ss_pred hhcCCCCCCcchHHHHHHHHHHHHhC
Q psy11727 284 VLLGIPYDLAIDMWSLGCILVELHTG 309 (437)
Q Consensus 284 ~~~~~~~~~~~DvwSlG~il~elltg 309 (437)
.+.... -..|.|-|||+++|++.|
T Consensus 176 ~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 176 EIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcCccc--cchhhhhHHHHHHHHhCc
Confidence 653322 457999999999999999
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.7e-10 Score=100.27 Aligned_cols=143 Identities=22% Similarity=0.187 Sum_probs=109.1
Q ss_pred eeceecccCceEEEEEEEcCCCeEEEEEEecCCc---------ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 114 IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---------PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 114 i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---------~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
....|-||+-+.|+++.+ .|+.+.||.-..+. ....+...|..++.++....+..|-+. |.+..
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~-----~~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI-----FIDTY 83 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE-----EEecC
Confidence 567889999999999965 57778887543221 223456679999999988888777554 55667
Q ss_pred EEEEEEEeccC--cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC-CEEEEeCC
Q psy11727 185 HLCLVFELLSY--NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS-AIKIIDFG 261 (437)
Q Consensus 185 ~~~lV~E~~~~--~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~-~ikL~DFG 261 (437)
.-+|+|||++| ++.+++........+......++++|-..+.-||.. +|||+||..+||++.++.+- .+.++|||
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n--diiHGDLTTSNill~~~~~~~~~~lIdfg 161 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN--DIIHGDLTTSNILLRSDGNQITPILIDFG 161 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC--CeecccccccceEEecCCCcCceEEEeec
Confidence 77899999988 788888776544444555578999999999999964 79999999999999654332 35899999
Q ss_pred Ccee
Q psy11727 262 SSCH 265 (437)
Q Consensus 262 ~s~~ 265 (437)
++..
T Consensus 162 ls~~ 165 (229)
T KOG3087|consen 162 LSSV 165 (229)
T ss_pred chhc
Confidence 9843
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.6e-10 Score=103.93 Aligned_cols=142 Identities=13% Similarity=0.120 Sum_probs=100.2
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC---CEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK---NHLCLVF 190 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~---~~~~lV~ 190 (437)
+.||.|..+.||++.... |..+++|+...... .......|..+++.+....+..|.++ .+.... +..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~---~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVL---ALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEE---EECCCCCccCCceEEE
Confidence 568999999999997643 57899999865432 35677889999999876544444444 333332 3678999
Q ss_pred EeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q psy11727 191 ELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP-------------------------------------- 231 (437)
Q Consensus 191 E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~-------------------------------------- 231 (437)
|+++| ++.+.+.. ..++......++.+++.+|+.||+-
T Consensus 80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99987 45443321 2356667777777777777777742
Q ss_pred ----------------CCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 232 ----------------ELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 232 ----------------~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
...++|+|+.|.||+++.+..+.+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 245799999999999943214568999999874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=7.8e-10 Score=96.53 Aligned_cols=128 Identities=19% Similarity=0.193 Sum_probs=93.7
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCc---------ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---------PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---------~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
..+++|+-+.++.+... |..+++|.=..+. ....+-.+|..++.++...++..|.+. +.+.+..
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~-----dvD~~~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVY-----DVDPDNG 74 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEE-----EEcCCCC
Confidence 35789999999999653 4446666533221 112345568889998888887766443 4566778
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
.|+|||.+| .|.+.+... ...++..+-..+.-||. .||||+||.++||++. .+.+.++|||++.
T Consensus 75 ~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~--~givHGDLTtsNiIl~---~~~i~~IDfGLg~ 139 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHK--AGIVHGDLTTSNIILS---GGRIYFIDFGLGE 139 (204)
T ss_pred EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHh--cCeecCCCccceEEEe---CCcEEEEECCccc
Confidence 899999998 466676654 14577778888889994 5899999999999994 2339999999985
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.3e-11 Score=121.08 Aligned_cols=152 Identities=20% Similarity=0.316 Sum_probs=111.6
Q ss_pred HHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC------cccc------ccccccccChhhhcCC
Q psy11727 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ------TLYQ------YIQSRYYRSPEVLLGI 288 (437)
Q Consensus 221 i~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~------~~~~------~~gt~~y~aPE~~~~~ 288 (437)
++.|+.|+|.+ .++||++|.|++|.+ +..+..||+.|+++..... ..++ ......|.|||++.+.
T Consensus 108 v~dgl~flh~s-Ak~VH~ni~p~~i~~--na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 108 VADGLAFLHRS-AKVVHGNIQPEAIVV--NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred ccchhhhhccC-cceeecccchhheee--ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 34899999985 689999999999999 7889999999998754322 1111 1235679999999998
Q ss_pred CCCCcchHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceecccccccccc
Q psy11727 289 PYDLAIDMWSLGCILVELH-TGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKER 367 (437)
Q Consensus 289 ~~~~~~DvwSlG~il~ell-tg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (437)
-.+.++|++||||++|.+. .|++.+.+.+.......-....+...
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~---------------------------------- 230 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGA---------------------------------- 230 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccc----------------------------------
Confidence 8889999999999999999 67888877654333222211111000
Q ss_pred CCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 368 LPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
.+.+-+...++++=|.++|..|+.-||++.+++..|||++..
T Consensus 231 -------------------------~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 231 -------------------------FGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred -------------------------ccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 000111112678999999999999999999999999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=2e-08 Score=95.22 Aligned_cols=135 Identities=11% Similarity=0.047 Sum_probs=96.1
Q ss_pred EEEEEEcCCCeEEEEEEecCCc------------ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE--CCEEEEEEE
Q psy11727 126 VVKAFDHEEKCQVAIKIIKNKK------------PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--KNHLCLVFE 191 (437)
Q Consensus 126 V~~~~~~~~~~~vaiK~i~~~~------------~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--~~~~~lV~E 191 (437)
|+++. -.|+.|.||...... .-...+.+|...+..+...++.-|.+|-+...-.. ...-+||||
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 45543 356678888653221 00114778999999999888877766544221111 235789999
Q ss_pred eccC--cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec-----CCCCCEEEEeCCCce
Q psy11727 192 LLSY--NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS-----PKRSAIKIIDFGSSC 264 (437)
Q Consensus 192 ~~~~--~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~-----~~~~~ikL~DFG~s~ 264 (437)
++++ +|.+++........+......++.+++..+.-||. .||+|+|+++.|||+.. ++...+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~--~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA--AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH--CcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9987 68888764322345677888999999999999995 48999999999999963 235679999999874
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.9e-09 Score=93.85 Aligned_cols=128 Identities=22% Similarity=0.283 Sum_probs=79.8
Q ss_pred EEEEEEEcCCCeEEEEEEecCCc---------------------------ccchHHHHHHHHHHHhhhcCCCCCcEEEec
Q psy11727 125 QVVKAFDHEEKCQVAIKIIKNKK---------------------------PFLNQAQIEVQLLEKINKADIHSRYIVKLK 177 (437)
Q Consensus 125 ~V~~~~~~~~~~~vaiK~i~~~~---------------------------~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~ 177 (437)
.||.|.. .+|..+|||+.+... ........|...|.++...++.-|-++
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~--- 76 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPY--- 76 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EE---
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEE---
Confidence 4889976 457799999985321 011234568889988887776656444
Q ss_pred ceeeECCEEEEEEEecc--CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-hcCCCCCeeeCCCCCCcEEEecCCCCC
Q psy11727 178 GHFTWKNHLCLVFELLS--YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF-LSSPELSIIHCDLKPENILLCSPKRSA 254 (437)
Q Consensus 178 ~~~~~~~~~~lV~E~~~--~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~-LH~~~~giiHrDiKp~NIll~~~~~~~ 254 (437)
++ . .-+|||||++ |.....+.... ++......++.+++..+.. +| ..||||+||.+.|||+. ++ .
T Consensus 77 ~~--~--~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~--~~givHGDLs~~NIlv~--~~-~ 144 (188)
T PF01163_consen 77 DY--N--RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH--KAGIVHGDLSEYNILVD--DG-K 144 (188)
T ss_dssp EE--E--TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH--CTTEEESS-STTSEEEE--TT-C
T ss_pred EE--e--CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH--hcCceecCCChhhEEee--cc-e
Confidence 22 1 2369999998 74334344332 2245567788888885555 56 45999999999999994 33 7
Q ss_pred EEEEeCCCceecCC
Q psy11727 255 IKIIDFGSSCHVGQ 268 (437)
Q Consensus 255 ikL~DFG~s~~~~~ 268 (437)
+.|+|||.+.....
T Consensus 145 ~~iIDf~qav~~~~ 158 (188)
T PF01163_consen 145 VYIIDFGQAVDSSH 158 (188)
T ss_dssp EEE--GTTEEETTS
T ss_pred EEEEecCcceecCC
Confidence 99999999876654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.92 E-value=5.2e-08 Score=96.90 Aligned_cols=167 Identities=20% Similarity=0.207 Sum_probs=122.2
Q ss_pred ceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE----CCEEEEEEEeccC--
Q psy11727 123 FGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW----KNHLCLVFELLSY-- 195 (437)
Q Consensus 123 fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~----~~~~~lV~E~~~~-- 195 (437)
-.+.|+|....+|..|++|++...+ ........-+..++++ .|.|+|++.++|.. +..+++|++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-----~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-----CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-----ccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 3578999999999999999994222 1222333455666666 78899999999983 4589999999976
Q ss_pred cHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 196 NLYNLIRNTN-------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 196 ~L~~~l~~~~-------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+|+++.-... ..+.++..+|.++.|+..||.++|+. |+.-+-|.|.+||+ .++..|+|+..|.
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss--GLAck~L~~~kIlv--~G~~RIriS~C~i 439 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS--GLACKTLDLKKILV--TGKMRIRISGCGI 439 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc--CceeecccHhHeEe--eCcceEEEecccc
Confidence 7888653211 12367899999999999999999965 78889999999999 5565788877776
Q ss_pred ceecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCC
Q psy11727 263 SCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPL 312 (437)
Q Consensus 263 s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p 312 (437)
......... |-+.+ -.+-|.=.||.+++.|.||..-
T Consensus 440 ~Dvl~~d~~-----------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 440 MDVLQEDPT-----------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred eeeecCCCC-----------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 543322210 11211 2467999999999999999643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.9e-07 Score=83.18 Aligned_cols=142 Identities=12% Similarity=0.077 Sum_probs=104.7
Q ss_pred cccCceEEEEEEEcCCCeEEEEEEecCC-------cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE--CCEEEEE
Q psy11727 119 GKGSFGQVVKAFDHEEKCQVAIKIIKNK-------KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--KNHLCLV 189 (437)
Q Consensus 119 G~G~fg~V~~~~~~~~~~~vaiK~i~~~-------~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--~~~~~lV 189 (437)
|+||.+.|++... .|..+-+|.-.+. ......+.+|...++.+...++.-|-++ ..+.-.. .-.-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 7789999998754 3336778865421 1234578899999999998887666555 2221111 1257899
Q ss_pred EEeccC--cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 190 FELLSY--NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 190 ~E~~~~--~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
+|-++| +|.+++........+......+..+++.+++-||. .|+.|+|+-+.|||+..++...|+++||.-+..
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~--~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS--VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 999985 78888877554456788888999999999999995 589999999999999533333499999997743
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.5e-07 Score=90.03 Aligned_cols=189 Identities=16% Similarity=0.199 Sum_probs=125.0
Q ss_pred eeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEE--------ecceeeECCE
Q psy11727 114 IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVK--------LKGHFTWKNH 185 (437)
Q Consensus 114 i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~--------l~~~~~~~~~ 185 (437)
..+.||+|+-+.+|-.-. -.-.+.|+......-... +..+.+.. ...||-+-. ++|- .....
T Consensus 15 ~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~a-----qk~a~la~-~p~~p~~~~rvaWPqa~L~G~-~~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQA-----QKVAELAA-TPDAPLLNYRVAWPQATLHGG-RRGKV 84 (637)
T ss_pred CCccccCCccceeeecch---hhchhheeecCCCchHHH-----HHHHHhcc-CCCCcchhhhhcccHHHhhCC-Cccce
Confidence 456789999999996632 222445776533221111 11122211 124442111 1111 11223
Q ss_pred EEEEEEeccC--cHHHHHH----hcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 186 LCLVFELLSY--NLYNLIR----NTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 186 ~~lV~E~~~~--~L~~~l~----~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
.-++|..++| ...+++. .+.+.-..|+...+.++.|+.+.+-||.+ |.+-+|+.++|+|+ .+.+.+.|+|
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~--Gh~vGDVn~~~~lV--sd~~~V~LVd 160 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH--GHVVGDVNQNSFLV--SDDSKVVLVD 160 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc--CCcccccCccceee--ecCceEEEEc
Confidence 6788888866 4555442 33444578999999999999999999965 89999999999999 5677788887
Q ss_pred CCCceec--CCccccccccccccChhhhc-----CCCCCCcchHHHHHHHHHHHHhC-CCCCCCC
Q psy11727 260 FGSSCHV--GQTLYQYIQSRYYRSPEVLL-----GIPYDLAIDMWSLGCILVELHTG-EPLFSGK 316 (437)
Q Consensus 260 FG~s~~~--~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg-~~pf~~~ 316 (437)
=.+=... +......+|+..|.+||... +.+-+...|.|.||+++++++.| +.||+|.
T Consensus 161 sDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 161 SDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 5542211 22233567899999999876 34556789999999999999986 9999884
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.6e-07 Score=82.79 Aligned_cols=113 Identities=21% Similarity=0.224 Sum_probs=85.1
Q ss_pred chHHHHHHHHHHHhhhcCCCCCcEEEecceeeE-CCEEEEEEEeccC--cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Q psy11727 150 LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW-KNHLCLVFELLSY--NLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226 (437)
Q Consensus 150 ~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~-~~~~~lV~E~~~~--~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~ 226 (437)
..+..+|...+..+...++.-|-.|-+...-.. ....+||+|.+++ +|.+++..... .+......++.+++..++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 456788999999998888776655544322111 1356899999977 68888876432 567788899999999999
Q ss_pred HhcCCCCCeeeCCCCCCcEEEecCC-CCCEEEEeCCCceec
Q psy11727 227 FLSSPELSIIHCDLKPENILLCSPK-RSAIKIIDFGSSCHV 266 (437)
Q Consensus 227 ~LH~~~~giiHrDiKp~NIll~~~~-~~~ikL~DFG~s~~~ 266 (437)
-||. .||+|+|+++.|||+..++ ...+.|+||+.+...
T Consensus 133 ~lH~--~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHD--AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHH--CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9995 4899999999999995432 237999999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.9e-07 Score=86.46 Aligned_cols=138 Identities=22% Similarity=0.274 Sum_probs=91.9
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-------------------c----cchHHHHHHHHHHHhhhcCC
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-------------------P----FLNQAQIEVQLLEKINKADI 168 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-------------------~----~~~~~~~e~~~~~~l~~~~~ 168 (437)
+.+.+.||-|.-+.||.|.+. .|..+|||.-+... . ....+++|..+|..+...+.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 556789999999999999876 67899999753211 0 11235568888888764422
Q ss_pred CCCcEEEecceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q psy11727 169 HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILL 247 (437)
Q Consensus 169 ~h~~iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll 247 (437)
. +.+.++ .+..++|||+..| .|+..-. +......++..|+.-+.-.. ..||||+|+.+-||++
T Consensus 172 ~---VP~P~~----~nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~--~~GiVHGDlSefNIlV 235 (304)
T COG0478 172 K---VPKPIA----WNRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAY--RRGIVHGDLSEFNILV 235 (304)
T ss_pred C---CCCccc----cccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHH--HcCccccCCchheEEE
Confidence 2 222222 3667899999988 4443321 22333444444554444443 3589999999999999
Q ss_pred ecCCCCCEEEEeCCCceecCC
Q psy11727 248 CSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 248 ~~~~~~~ikL~DFG~s~~~~~ 268 (437)
+++|.+.++||--+...+.
T Consensus 236 --~~dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 236 --TEDGDIVVIDWPQAVPISH 254 (304)
T ss_pred --ecCCCEEEEeCcccccCCC
Confidence 6687899999987655443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=4e-07 Score=93.46 Aligned_cols=144 Identities=17% Similarity=0.234 Sum_probs=89.2
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCc-----------------------------------ccchH------HH
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-----------------------------------PFLNQ------AQ 154 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-----------------------------------~~~~~------~~ 154 (437)
+.|+.++-|+||+|+.+. |+.||||+.+..- ...+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 678999999999998754 9999999975320 00011 12
Q ss_pred HHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccC-cHHHH--HHhcCCCCCCHHHHHHHHHHHHHHHHHhcCC
Q psy11727 155 IEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNL--IRNTNFHGVSLNLTKKFAQQLCCALAFLSSP 231 (437)
Q Consensus 155 ~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~-~L~~~--l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~ 231 (437)
+|..-++++...--..+++.--.=+++....-.|+|||+.| .+.+. ++.. +++...+.....++.--.-+-|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d~k~ia~~~~~~f~~q~~~d-- 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---GIDRKELAELLVRAFLRQLLRD-- 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc---CCCHHHHHHHHHHHHHHHHHhc--
Confidence 35555555544322344333222233445667899999988 56665 3443 3443222222222111111222
Q ss_pred CCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc
Q psy11727 232 ELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT 269 (437)
Q Consensus 232 ~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~ 269 (437)
|++|+|..|-||++ +.+|.+.+.|||+....+..
T Consensus 285 --gffHaDpHpGNi~v--~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 --GFFHADPHPGNILV--RSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred --CccccCCCccceEE--ecCCcEEEEcCcceecCCHH
Confidence 79999999999999 67789999999998776543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.54 E-value=1e-06 Score=80.90 Aligned_cols=138 Identities=19% Similarity=0.215 Sum_probs=93.7
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCccc-------------------------chHHHHHHHHHHHhhhcCCCCC
Q psy11727 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF-------------------------LNQAQIEVQLLEKINKADIHSR 171 (437)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~-------------------------~~~~~~e~~~~~~l~~~~~~h~ 171 (437)
.|..|.-+.||+|.. .++..+|+|+.+..... ......|..-|.++..+++..|
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 567788889999964 56789999998643211 1122347777777777666555
Q ss_pred cEEEecceeeECCEEEEEEEeccCc--HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec
Q psy11727 172 YIVKLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS 249 (437)
Q Consensus 172 ~iv~l~~~~~~~~~~~lV~E~~~~~--L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~ 249 (437)
- -+.+ ..-.|||||++.. -.-.|+.. ++....+..+..++++.+.-|.. ..|+||+||+.-|||+
T Consensus 134 ~---Pi~~----~~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~-~a~LVHgDLSEyNiL~-- 200 (268)
T COG1718 134 E---PIAF----RNNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYK-EAGLVHGDLSEYNILV-- 200 (268)
T ss_pred C---ceee----cCCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHH-hcCcccccchhhheEE--
Confidence 2 1111 2236999999764 11122222 23444688888889998888874 3689999999999999
Q ss_pred CCCCCEEEEeCCCceecCCc
Q psy11727 250 PKRSAIKIIDFGSSCHVGQT 269 (437)
Q Consensus 250 ~~~~~ikL~DFG~s~~~~~~ 269 (437)
. ++.+.|||||-|.....+
T Consensus 201 ~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 201 H-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred E-CCeEEEEECccccccCCC
Confidence 3 667999999999766544
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.9e-08 Score=99.98 Aligned_cols=185 Identities=19% Similarity=0.155 Sum_probs=134.1
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCc-EEEecceeeECCEEEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~-iv~l~~~~~~~~~~~lV 189 (437)
.|....-+++|+++++++.+...+...+ .+.+... .....++.++.+. .||| .+..++-++.+++..++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~-----n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKV-----NNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHc-----cCCCCcccccccCCcccccchh
Confidence 3555666799999999999887776555 6766532 3444567777776 4555 77777777888899999
Q ss_pred EEeccCc--HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 190 FELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 190 ~E~~~~~--L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
|++++++ ........ ...+..-....+.+.-+.++++||+- -=+|+| ||+.+ ++..+..||+....+.
T Consensus 313 ~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~--~~~~~d----~~l~s---~~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSS--YKVHRD----NILGS---EEEVKLLDFAVPPQLT 382 (829)
T ss_pred hhhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccc--cccCcc----ccccc---ccccccccccCCcccC
Confidence 9999764 22111111 01133334445666677889999953 238888 88874 3568999999987775
Q ss_pred Cc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy11727 268 QT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG 315 (437)
Q Consensus 268 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~ 315 (437)
.. ..+..+++.++|||+.....+....|+||+|+-..+|--|-+|-..
T Consensus 383 ~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 383 RTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 55 5567899999999999999999999999999877788778887765
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.43 E-value=5.1e-06 Score=76.64 Aligned_cols=82 Identities=12% Similarity=0.153 Sum_probs=57.0
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEecc
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLS 194 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~ 194 (437)
++.|+.|..+.||++.... ..+++|..... ........|..+++.+....+.-|-++............+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4678999999999997654 48999998643 34567778999999998776633444432222234456899999998
Q ss_pred C-cHHH
Q psy11727 195 Y-NLYN 199 (437)
Q Consensus 195 ~-~L~~ 199 (437)
| .+..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 7 4444
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.1e-05 Score=72.89 Aligned_cols=133 Identities=17% Similarity=0.300 Sum_probs=97.6
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCc-----------------ccchHHHHHHHHHHHhh-hcCCCCCcEEEe
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-----------------PFLNQAQIEVQLLEKIN-KADIHSRYIVKL 176 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-----------------~~~~~~~~e~~~~~~l~-~~~~~h~~iv~l 176 (437)
...||+|+.-.||.- ..+...+||+..... ...++..+|+.....+. ..+..+.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356899999988865 445568899987544 23567778888888888 778888899999
Q ss_pred cceeeECCEEEEEEEecc---C----cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec
Q psy11727 177 KGHFTWKNHLCLVFELLS---Y----NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS 249 (437)
Q Consensus 177 ~~~~~~~~~~~lV~E~~~---~----~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~ 249 (437)
+|+.+++.-+-+|+|... | +|.+++.... ++. .....+.++. .||-. .+|+.+||+|.||++..
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~~f~---~~l~~--~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALDEFK---RYLLD--HHIVIRDLNPHNIVVQR 153 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHHHHH---HHHHH--cCCeecCCCcccEEEEe
Confidence 999999999999999872 2 5777775543 555 4444444444 44443 25999999999999976
Q ss_pred CCCCC--EEEEe
Q psy11727 250 PKRSA--IKIID 259 (437)
Q Consensus 250 ~~~~~--ikL~D 259 (437)
..++. +.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 65554 67777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.8e-06 Score=75.67 Aligned_cols=140 Identities=17% Similarity=0.229 Sum_probs=90.5
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccc----------hHHHHHHHHHHHhhhcCCCC---CcEE
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFL----------NQAQIEVQLLEKINKADIHS---RYIV 174 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~----------~~~~~e~~~~~~l~~~~~~h---~~iv 174 (437)
+.++|.+.+++-......|.+.. -+|+.+++|..+...... ....+.+..+..+...++.. +.++
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 35678888888887777777764 467789999886532211 12223444444444333332 2444
Q ss_pred EecceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC
Q psy11727 175 KLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS 253 (437)
Q Consensus 175 ~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~ 253 (437)
-..-.+......+|||||++| .|.+... +++ .+...|..++.-||. .|+.|+|..|.|+++. + +
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~--~G~~HGD~hpgNFlv~--~-~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHK--HGFYHGDPHPGNFLVS--N-N 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHH--cCCccCCCCcCcEEEE--C-C
Confidence 444444444667899999988 5554421 222 244567778899995 5999999999999994 3 3
Q ss_pred CEEEEeCCCce
Q psy11727 254 AIKIIDFGSSC 264 (437)
Q Consensus 254 ~ikL~DFG~s~ 264 (437)
.++++||+...
T Consensus 172 ~i~iID~~~k~ 182 (229)
T PF06176_consen 172 GIRIIDTQGKR 182 (229)
T ss_pred cEEEEECcccc
Confidence 49999998754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.2e-05 Score=82.54 Aligned_cols=145 Identities=17% Similarity=0.176 Sum_probs=88.3
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCc--------------------------------ccchH------HHHH
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--------------------------------PFLNQ------AQIE 156 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--------------------------------~~~~~------~~~e 156 (437)
.+.||.-+.|+|++|+.+. |+.||||+-+..- ...+. +..|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 3578999999999998765 9999999864210 00111 1123
Q ss_pred HHHHHHhhhcCCCCCc------EEEecceeeECCEEEEEEEeccC---cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q psy11727 157 VQLLEKINKADIHSRY------IVKLKGHFTWKNHLCLVFELLSY---NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227 (437)
Q Consensus 157 ~~~~~~l~~~~~~h~~------iv~l~~~~~~~~~~~lV~E~~~~---~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~ 227 (437)
.+-.++... +..|.. |.+++-. ......|+||||+| +-.+.+.+.+ ++...+..-+.+...-+-+
T Consensus 245 A~Nae~~~~-~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~~~qIf 318 (538)
T KOG1235|consen 245 AKNAERFRE-NFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAYLEQIF 318 (538)
T ss_pred HHhHHHHHH-HHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHHHHHHH
Confidence 333333221 112222 3344322 23467899999987 3335555543 5665444444443332333
Q ss_pred hcCCCCCeeeCCCCCCcEEEecC--CCCCEEEEeCCCceecCCcc
Q psy11727 228 LSSPELSIIHCDLKPENILLCSP--KRSAIKIIDFGSSCHVGQTL 270 (437)
Q Consensus 228 LH~~~~giiHrDiKp~NIll~~~--~~~~ikL~DFG~s~~~~~~~ 270 (437)
.| |++|+|-.|-||++..+ .++.+.+-|||+........
T Consensus 319 ~~----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~~ 359 (538)
T KOG1235|consen 319 KT----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHKT 359 (538)
T ss_pred hc----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHHH
Confidence 33 79999999999999643 46779999999987776543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.24 E-value=3.5e-05 Score=71.38 Aligned_cols=72 Identities=17% Similarity=0.103 Sum_probs=52.6
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccC
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY 195 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~ 195 (437)
..||+|..+.||+. .+..+++|..... .......+|..++..+...++..|-+ +.+..+.+...+|||+++|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~---~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHP---FDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCce---EEEEecCCeeeeeeeecCC
Confidence 56899999999984 2446788987642 23456788999999988766655544 4445566778899999987
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.08 E-value=5.8e-05 Score=70.66 Aligned_cols=70 Identities=10% Similarity=0.032 Sum_probs=48.4
Q ss_pred ecccCc-eEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccC
Q psy11727 118 LGKGSF-GQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY 195 (437)
Q Consensus 118 lG~G~f-g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~ 195 (437)
|-.|.. ..||++.. .+..+.+|+..... ......|..++..+... +. +.+++++....+..++|||+++|
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~-~~---vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP--TYELEREAERLRWLAGK-LP---VPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCc--ccchHHHHHHHHHHHhc-CC---CCeEEEEEecCCccEEEEEeeCC
Confidence 445555 78899854 34678888875432 34577899999888754 33 44555666666678999999987
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.04 E-value=4.4e-05 Score=71.13 Aligned_cols=74 Identities=8% Similarity=0.025 Sum_probs=45.0
Q ss_pred ceecccCce-EEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhc-CCCCCcEEEecceeeECCEEEEEEEec
Q psy11727 116 TLLGKGSFG-QVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKA-DIHSRYIVKLKGHFTWKNHLCLVFELL 193 (437)
Q Consensus 116 ~~lG~G~fg-~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~-~~~h~~iv~l~~~~~~~~~~~lV~E~~ 193 (437)
+.|+.|+.. .||+. +..+++|+... .........|..++..+... .+..|-++..-..-......++||+++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 456777776 48876 12477787653 22345788899999988753 445554433211111112458899998
Q ss_pred cC
Q psy11727 194 SY 195 (437)
Q Consensus 194 ~~ 195 (437)
+|
T Consensus 77 ~G 78 (235)
T cd05155 77 EG 78 (235)
T ss_pred cC
Confidence 77
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.03 E-value=0.00011 Score=66.19 Aligned_cols=129 Identities=24% Similarity=0.342 Sum_probs=91.9
Q ss_pred cCeeeeceecccCc-eEEEEEEEcCCCeEEEEEEecC---C------------c-------ccchHHHHHHHHHHHhhhc
Q psy11727 110 DRYEIDTLLGKGSF-GQVVKAFDHEEKCQVAIKIIKN---K------------K-------PFLNQAQIEVQLLEKINKA 166 (437)
Q Consensus 110 ~~y~i~~~lG~G~f-g~V~~~~~~~~~~~vaiK~i~~---~------------~-------~~~~~~~~e~~~~~~l~~~ 166 (437)
.+++.++.||.|+- |.||++.- +|..+|+|+++. . . .....+..|.....++...
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67889999999999 99999964 677999999431 0 0 2234556788888888766
Q ss_pred CCCCCcEEEecceeeEC------------------CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHh
Q psy11727 167 DIHSRYIVKLKGHFTWK------------------NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228 (437)
Q Consensus 167 ~~~h~~iv~l~~~~~~~------------------~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~L 228 (437)
+-.+-.-|+++|+..-. -...||.||++..- .++. .=+.+|..-+..+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHH
Confidence 54343459999987422 13567888776532 1233 3345666777888
Q ss_pred cCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 229 H~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
| ..||+-+|+++.|.. +| +|+|||.+
T Consensus 181 ~--k~gI~~~Dv~~~ny~-----~G--~lvDfs~~ 206 (207)
T PF13095_consen 181 H--KLGIVPRDVKPRNYR-----GG--KLVDFSSS 206 (207)
T ss_pred H--HCCeeeccCcccccc-----CC--EEEecccC
Confidence 9 579999999999987 22 89999975
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00015 Score=79.86 Aligned_cols=79 Identities=14% Similarity=0.066 Sum_probs=52.5
Q ss_pred eceecccCceEEEEEEEcCCC--eEEEEEEecCCc--ccchHHHHHHHHHHHhh-hcCCCCCcEEEecceeeEC---CEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEK--CQVAIKIIKNKK--PFLNQAQIEVQLLEKIN-KADIHSRYIVKLKGHFTWK---NHL 186 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~--~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~-~~~~~h~~iv~l~~~~~~~---~~~ 186 (437)
.+.++.|.+..+|+......+ ..+++|+..... .......+|..+++.+. +.++.. .+++.++.+. +..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpV---P~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPV---PKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCC---CcEEEEecCCCcCCCc
Confidence 567799999999998764432 357777754322 12246778999999986 344433 4445555543 467
Q ss_pred EEEEEeccCc
Q psy11727 187 CLVFELLSYN 196 (437)
Q Consensus 187 ~lV~E~~~~~ 196 (437)
|+|||+++|.
T Consensus 120 flVME~v~G~ 129 (822)
T PLN02876 120 FYIMEYLEGR 129 (822)
T ss_pred eEEEEecCCc
Confidence 8999999773
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00034 Score=64.99 Aligned_cols=73 Identities=18% Similarity=0.307 Sum_probs=48.0
Q ss_pred eceecccCceEEEEEEEcC-CCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEec
Q psy11727 115 DTLLGKGSFGQVVKAFDHE-EKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELL 193 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~-~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~ 193 (437)
++.|..|-...+|++.... .+..|++|+........-....|..++..+...++ .|-+ +..+. + .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl-~P~v---~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGL-APKL---YATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCC-CCeE---EEEeC--C--cEEEEee
Confidence 3567778888999996543 35678899876443333344578999998877665 3433 33322 2 3799999
Q ss_pred cC
Q psy11727 194 SY 195 (437)
Q Consensus 194 ~~ 195 (437)
+|
T Consensus 75 ~G 76 (235)
T cd05157 75 PG 76 (235)
T ss_pred CC
Confidence 76
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00021 Score=69.21 Aligned_cols=141 Identities=25% Similarity=0.315 Sum_probs=103.8
Q ss_pred eeceecccCceEEEEEEEcCCCeEEEEEEecCCc---------------------------ccchHHHHHHHHHHHhhhc
Q psy11727 114 IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---------------------------PFLNQAQIEVQLLEKINKA 166 (437)
Q Consensus 114 i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---------------------------~~~~~~~~e~~~~~~l~~~ 166 (437)
+..+|..|.-+.||.|.. .+|..+|||+.+..- -..-.+..|+.-+.+++.+
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 456788899999999974 567789999985320 0012344588888889888
Q ss_pred CCCCCcEEEecceeeECCEEEEEEEeccCc--HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q psy11727 167 DIHSRYIVKLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPEN 244 (437)
Q Consensus 167 ~~~h~~iv~l~~~~~~~~~~~lV~E~~~~~--L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~N 244 (437)
++.+|--+-|. .-.|||+|++.+ -.-.|+.. .++...+..+-.|++.-+.-|.. .+++||.||.=-|
T Consensus 227 GIP~PePIlLk-------~hVLVM~FlGrdgw~aPkLKd~---~ls~~ka~~~Y~~~v~~MR~lY~-~c~LVHADLSEfN 295 (520)
T KOG2270|consen 227 GIPCPEPILLK-------NHVLVMEFLGRDGWAAPKLKDA---SLSTSKARELYQQCVRIMRRLYQ-KCRLVHADLSEFN 295 (520)
T ss_pred CCCCCCceeee-------cceEeeeeccCCCCcCcccccc---cCChHHHHHHHHHHHHHHHHHHH-Hhceeccchhhhh
Confidence 88887443332 236899999763 22234433 37888899999999999988875 4689999999999
Q ss_pred EEEecCCCCCEEEEeCCCceecCCc
Q psy11727 245 ILLCSPKRSAIKIIDFGSSCHVGQT 269 (437)
Q Consensus 245 Ill~~~~~~~ikL~DFG~s~~~~~~ 269 (437)
+|+ .+|.+.|+|.+-|.....+
T Consensus 296 ~Ly---hdG~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 296 LLY---HDGKLYIIDVSQSVEHDHP 317 (520)
T ss_pred heE---ECCEEEEEEccccccCCCh
Confidence 999 5678999999988766443
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.0009 Score=65.27 Aligned_cols=77 Identities=5% Similarity=0.013 Sum_probs=51.0
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecc---eeeECCEEEEEEEe
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKG---HFTWKNHLCLVFEL 192 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~---~~~~~~~~~lV~E~ 192 (437)
+.|+.|...++|+.... +| .+++|+.. .........|..+++.+...++..|.++.-.+ +....+..++++++
T Consensus 28 ~~l~~G~~n~~y~v~t~-~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTT-QG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeC-CC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 45667777899998643 33 68899875 22234556678888888877766665554221 12345678999999
Q ss_pred ccCc
Q psy11727 193 LSYN 196 (437)
Q Consensus 193 ~~~~ 196 (437)
++|.
T Consensus 104 l~G~ 107 (319)
T PRK05231 104 LEGK 107 (319)
T ss_pred cCCC
Confidence 9773
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00025 Score=61.98 Aligned_cols=131 Identities=19% Similarity=0.186 Sum_probs=82.9
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE 191 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E 191 (437)
-.+.+.||+|.+|.||+|.+ .|..+|+|+-+ .......+..|..+++.+....+.. +++.+ +.-++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr-~ds~r~~l~kEakiLeil~g~~~~p----~vy~y----g~~~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRR-RDSPRRNLEKEAKILEILAGEGVTP----EVYFY----GEDFIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEec-CCcchhhHHHHHHHHHHhhhcCCCc----eEEEe----chhhhhhh
Confidence 34567899999999999975 45689999876 3444567788999999987665432 33332 22345599
Q ss_pred eccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCC-CCcEEEecCCCCCEEEEeCCCceec
Q psy11727 192 LLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLK-PENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 192 ~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiK-p~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
|+.| .|.++.... .-..+ ..++.+ +|.=+ .+||-|..|. |..+++. ++..+.|+||..|+..
T Consensus 93 ~i~G~~L~~~~~~~-----~rk~l----~~vlE~-a~~LD-~~GI~H~El~~~~k~vlv--~~~~~~iIDFd~At~k 156 (201)
T COG2112 93 YIDGRPLGKLEIGG-----DRKHL----LRVLEK-AYKLD-RLGIEHGELSRPWKNVLV--NDRDVYIIDFDSATFK 156 (201)
T ss_pred hhcCcchhhhhhcc-----cHHHH----HHHHHH-HHHHH-HhccchhhhcCCceeEEe--cCCcEEEEEccchhhc
Confidence 9988 776654321 11222 223333 22222 4578787775 4444443 2336999999999743
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00089 Score=64.74 Aligned_cols=79 Identities=11% Similarity=0.061 Sum_probs=52.3
Q ss_pred eeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcC-CCCCcEEEecceeeECCEEEEEEEe
Q psy11727 114 IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKAD-IHSRYIVKLKGHFTWKNHLCLVFEL 192 (437)
Q Consensus 114 i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~-~~h~~iv~l~~~~~~~~~~~lV~E~ 192 (437)
-.+.||.|..+.||...... + .+.+|..+. ......+..|...++.+.... +..|-++.+.......+..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQ-G-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCC-C-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 35678999999999985432 3 467777542 123457888999999997643 4444444332222334678999999
Q ss_pred ccC
Q psy11727 193 LSY 195 (437)
Q Consensus 193 ~~~ 195 (437)
+.|
T Consensus 95 i~G 97 (297)
T PRK10593 95 LRG 97 (297)
T ss_pred cCC
Confidence 976
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.59 E-value=9.5e-05 Score=80.63 Aligned_cols=189 Identities=21% Similarity=0.237 Sum_probs=122.0
Q ss_pred CCCCCcEEEecceeeECCEEE----EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCC
Q psy11727 167 DIHSRYIVKLKGHFTWKNHLC----LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLK 241 (437)
Q Consensus 167 ~~~h~~iv~l~~~~~~~~~~~----lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiK 241 (437)
.+.|+|++.++.+-......- +..+++++ .+...+.... .++....+.+..++..+|+|+|+..++ |.-+.
T Consensus 238 k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~~l~--~v~L~ 313 (1351)
T KOG1035|consen 238 KIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSLSLE--HVVLS 313 (1351)
T ss_pred hhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHhccc--eeEEe
Confidence 347788888777655443332 33456655 6666666553 478899999999999999999975322 22111
Q ss_pred CC---cEEEecCCCCCEEEE--eCCCceecCCcccc--ccccccccChhhhcCCCCCCc--chHHHHHHHHHHHHhCCCC
Q psy11727 242 PE---NILLCSPKRSAIKII--DFGSSCHVGQTLYQ--YIQSRYYRSPEVLLGIPYDLA--IDMWSLGCILVELHTGEPL 312 (437)
Q Consensus 242 p~---NIll~~~~~~~ikL~--DFG~s~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~--~DvwSlG~il~elltg~~p 312 (437)
.. +.-. +..+.+.++ ||+.+......... ...+..+.++|......++.+ .|+|.+|..+.-+..|..+
T Consensus 314 ~s~~~~~~~--~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i 391 (1351)
T KOG1035|consen 314 ASSSKESTV--DGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDI 391 (1351)
T ss_pred ccccccccc--CccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcc
Confidence 11 1111 344556666 88888776554332 334566888888877665544 7999999999999887644
Q ss_pred CCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCC
Q psy11727 313 FSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNE 392 (437)
Q Consensus 313 f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (437)
-.-.. .....+. .. .
T Consensus 392 ~~~~~---~~~~~l~-----------~~----------~----------------------------------------- 406 (1351)
T KOG1035|consen 392 SEKSA---VPVSLLD-----------VL----------S----------------------------------------- 406 (1351)
T ss_pred ccccc---chhhhhc-----------cc----------c-----------------------------------------
Confidence 32110 0111100 00 0
Q ss_pred CCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 393 PGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 393 ~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
. ....+++.+|+.-++++|+++.+++.|||+.-.
T Consensus 407 ----~---~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 407 ----T---SELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred ----c---hhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 0 024689999999999999999999999998653
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00082 Score=65.27 Aligned_cols=145 Identities=17% Similarity=0.210 Sum_probs=83.0
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecc---eeeECCEEEEEEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKG---HFTWKNHLCLVFE 191 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~---~~~~~~~~~lV~E 191 (437)
.+.++.|....+|++.. .++ .+++|+.... ........|..+++.+...++..|-++...+ .....+..++|++
T Consensus 27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEe-CCC-cEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45667777789998853 334 5778987532 1234566788888888776665554444322 1123567899999
Q ss_pred eccCc-H-----H------HH---HHh--cCCCC-----CCHHH-----HH----------HHHHHHHHHHHHhcC----
Q psy11727 192 LLSYN-L-----Y------NL---IRN--TNFHG-----VSLNL-----TK----------KFAQQLCCALAFLSS---- 230 (437)
Q Consensus 192 ~~~~~-L-----~------~~---l~~--~~~~~-----ls~~~-----~~----------~i~~qi~~aL~~LH~---- 230 (437)
+++|. + . .. +.. ..+.. ..... .. .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 98762 1 0 11 111 11100 00000 00 011122334444421
Q ss_pred -CCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 231 -PELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 231 -~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
...++||+|+.+.||++. +++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~--~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFD--GDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEE--CCceEEEeeccccc
Confidence 236899999999999994 45556899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00072 Score=65.18 Aligned_cols=145 Identities=16% Similarity=0.176 Sum_probs=83.6
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEec-c--eeeECCEEEEEEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK-G--HFTWKNHLCLVFE 191 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~-~--~~~~~~~~~lV~E 191 (437)
.+.|..|....+|++.. ++..+++|+... ........|..+++.+...++.-|-++... + +....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 45677788889999854 334688998764 233566778999999877665444333321 1 1234567789999
Q ss_pred eccC-cHH-----------HHH---Hh--cCCCC-----CCHHHHHH------------HHHHHHHHHHHhcC-----CC
Q psy11727 192 LLSY-NLY-----------NLI---RN--TNFHG-----VSLNLTKK------------FAQQLCCALAFLSS-----PE 232 (437)
Q Consensus 192 ~~~~-~L~-----------~~l---~~--~~~~~-----ls~~~~~~------------i~~qi~~aL~~LH~-----~~ 232 (437)
+++| .+. ..+ .. ..+.. ........ ....+..++.++.. ..
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9976 221 111 11 01100 00000000 11112233444332 13
Q ss_pred CCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 233 ~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
.++||+|+.|.||++ ++++.+.|+||+.++.
T Consensus 175 ~~l~HgD~~~~Nil~--~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLF--DGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEE--eCCceEEEeehhhhcC
Confidence 479999999999999 4555568999998743
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00015 Score=73.04 Aligned_cols=161 Identities=20% Similarity=0.250 Sum_probs=100.6
Q ss_pred CCCCcEEEecceeeE-CCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q psy11727 168 IHSRYIVKLKGHFTW-KNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENIL 246 (437)
Q Consensus 168 ~~h~~iv~l~~~~~~-~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIl 246 (437)
+.|++....+++-.. .....+|||++..+|++.+........+.- -| |+.| -||+
T Consensus 39 l~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~l~~~s~~---------------~~----~~~~-----~~~~ 94 (725)
T KOG1093|consen 39 LQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGNLKDESLL---------------AH----GVLH-----LNII 94 (725)
T ss_pred hcCccceeeEeeecCccceEEEEehhhccchHHHHHhcccchhhhc---------------cc----ccce-----ehhh
Confidence 367777777766543 346899999999999998876542111110 11 2222 2222
Q ss_pred EecCCCCCEEEEeCCCceecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy11727 247 LCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326 (437)
Q Consensus 247 l~~~~~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~ 326 (437)
+.+| .++... .+.+ .+++||||+|.++.++..|...+....+.+....+.
T Consensus 95 ---------~~td-~~~t~~----~~~~----------------~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~ 144 (725)
T KOG1093|consen 95 ---------YITD-HFLTKY----PSPI----------------GPKSDVWSLGFIILELYLGISLEAELTESEYLEILL 144 (725)
T ss_pred ---------hccc-cccccC----CCCC----------------CcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHH
Confidence 3333 111000 1111 149999999999999999999998888877777776
Q ss_pred HHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHH
Q psy11727 327 EVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406 (437)
Q Consensus 327 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 406 (437)
+....+.....-.... ++ ..+....+.++
T Consensus 145 k~~~~d~~~~~~a~e~----------------------------------~~-----------------~~~~d~~~~~~ 173 (725)
T KOG1093|consen 145 KYYTDDQELLSTAMEH----------------------------------LI-----------------QLLADKKRLPL 173 (725)
T ss_pred HhccCchhHHHHHHHH----------------------------------HH-----------------HHhhhHhHHHH
Confidence 6443332211110000 00 01122367899
Q ss_pred HHHccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 407 ILRMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 407 i~~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
+.+|+-..|..||.+.++.+|+-|++.
T Consensus 174 ~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 174 LKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred hccCCccccccccchhHHhcCccHHHH
Confidence 999999999999999999999998764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00089 Score=63.17 Aligned_cols=134 Identities=16% Similarity=0.150 Sum_probs=75.1
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCcccc-hHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccC-
Q psy11727 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFL-NQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY- 195 (437)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~- 195 (437)
+..|-.+.+|+.. .++..+++|+........ -....|..+++.+...++ .|.++.. . . -++||||++|
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~-~P~~i~~---~--~--~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGL-APKPILV---N--E--HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCC-CCceEEE---e--C--CEEEEEeccCc
Confidence 4567778899886 456678888765332221 235779999999887654 3544432 1 2 2689999977
Q ss_pred cHH--------------HHHH---hcCC--CCCCH-HHHHHHHHHH---------HHHHHHhcC------CCCCeeeCCC
Q psy11727 196 NLY--------------NLIR---NTNF--HGVSL-NLTKKFAQQL---------CCALAFLSS------PELSIIHCDL 240 (437)
Q Consensus 196 ~L~--------------~~l~---~~~~--~~ls~-~~~~~i~~qi---------~~aL~~LH~------~~~giiHrDi 240 (437)
.+. +.+. .... ..++. ..+..+..++ ...+..+-. ....++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 321 1111 1111 11111 1111221111 111211111 1235899999
Q ss_pred CCCcEEEecCCCCCEEEEeCCCce
Q psy11727 241 KPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 241 Kp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
.|.||+++ +++ +.|+||+.|.
T Consensus 154 ~~~Nil~~--~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 154 HAYNLVVT--PQG-LKLIDWEYAS 174 (256)
T ss_pred CcCcEEEe--CCC-CEEEeccccC
Confidence 99999994 444 7899999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0032 Score=63.11 Aligned_cols=77 Identities=23% Similarity=0.170 Sum_probs=52.9
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCC--------cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK--------KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~--------~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+.||.|.+..||++.+...++.++||.-... .....+...|...+..+... ...++.+++.+ +.+..
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~--~p~~VPkV~~~--D~~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKY--VPDLVPKVYHY--DEELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhh--CCCCCCeEEEE--CCCCC
Confidence 35689999999999988654468999974311 12345677788888876542 22346666654 44667
Q ss_pred EEEEEeccC
Q psy11727 187 CLVFELLSY 195 (437)
Q Consensus 187 ~lV~E~~~~ 195 (437)
++|||++++
T Consensus 107 ~lVME~L~~ 115 (401)
T PRK09550 107 VTVMEDLSD 115 (401)
T ss_pred EEEEecCCC
Confidence 899999965
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0022 Score=62.07 Aligned_cols=72 Identities=14% Similarity=0.209 Sum_probs=46.8
Q ss_pred ceecccCceEEEEEEEcC------CCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHE------EKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~------~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
+.|..|-...||++.... +++.+++|+.............|..++..+...++ .|.+ +..+.. .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~-~P~~---~~~~~~----~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNL-GPKL---YGIFPN----GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCC-CCce---EEEeCC----Cch
Confidence 445666667888886433 25789999986544444566789999999887664 3433 333332 258
Q ss_pred EEeccC
Q psy11727 190 FELLSY 195 (437)
Q Consensus 190 ~E~~~~ 195 (437)
+||++|
T Consensus 76 ~e~i~G 81 (302)
T cd05156 76 EEFIPS 81 (302)
T ss_pred hheeCC
Confidence 898866
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.00045 Score=65.99 Aligned_cols=136 Identities=19% Similarity=0.252 Sum_probs=91.7
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC----------c---------cc--c--hHHHHHHHHHHHhhhcC
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----------K---------PF--L--NQAQIEVQLLEKINKAD 167 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~----------~---------~~--~--~~~~~e~~~~~~l~~~~ 167 (437)
-+.+.+.||-|.-+.||.+-+. .|...++|+-+.. . .+ . -.+..|...++.+...+
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3778999999999999999764 5778888864211 1 01 1 12446888888887655
Q ss_pred CCCCcEEEecceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q psy11727 168 IHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENIL 246 (437)
Q Consensus 168 ~~h~~iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIl 246 (437)
..-| +.+ +.+..|+|||++.| .|.+.-.-. .+..+...+..-+.-|.. .|+||||..-=||+
T Consensus 172 fpVP---kpi----D~~RH~Vvmelv~g~Pl~~v~~v~--------d~~~ly~~lm~~Iv~la~--~GlIHgDFNEFNim 234 (465)
T KOG2268|consen 172 FPVP---KPI----DHNRHCVVMELVDGYPLRQVRHVE--------DPPTLYDDLMGLIVRLAN--HGLIHGDFNEFNIM 234 (465)
T ss_pred CCCC---Ccc----cccceeeHHHhhcccceeeeeecC--------ChHHHHHHHHHHHHHHHH--cCceecccchheeE
Confidence 4433 322 34667899999977 666543221 223444555555555653 48999999999999
Q ss_pred EecCCCCCEEEEeCCCceec
Q psy11727 247 LCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 247 l~~~~~~~ikL~DFG~s~~~ 266 (437)
+ ++++.+++|||--....
T Consensus 235 v--~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 235 V--KDDDKIVVIDFPQMVST 252 (465)
T ss_pred E--ecCCCEEEeechHhhcc
Confidence 9 56777999999754433
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0072 Score=59.71 Aligned_cols=139 Identities=17% Similarity=0.191 Sum_probs=77.5
Q ss_pred eecccCceEEEEEEEcC----CCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEe
Q psy11727 117 LLGKGSFGQVVKAFDHE----EKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFEL 192 (437)
Q Consensus 117 ~lG~G~fg~V~~~~~~~----~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~ 192 (437)
.|-.|-.-.+|++.... +++.|++|+........-....|..+++.+...++. |.++ +.+... .|.+|
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~-P~~~---~~~~~g----~v~ef 114 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQG-PRLL---GRFPNG----RVEEF 114 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCC-CceE---EEECCc----eEEEe
Confidence 44446667788875422 346789998865433333347799999999887763 3333 444322 57888
Q ss_pred ccC-cHHH--------------HH---HhcCC--C--CCCHHHHHHHHHHHH-----------------HHHH----Hhc
Q psy11727 193 LSY-NLYN--------------LI---RNTNF--H--GVSLNLTKKFAQQLC-----------------CALA----FLS 229 (437)
Q Consensus 193 ~~~-~L~~--------------~l---~~~~~--~--~ls~~~~~~i~~qi~-----------------~aL~----~LH 229 (437)
+++ ++.. .+ ..... . ...+..+..+..++. ..+. .+.
T Consensus 115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~ 194 (344)
T PLN02236 115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS 194 (344)
T ss_pred eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence 865 3321 01 11110 0 111223333332211 1111 122
Q ss_pred C--CCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 230 S--PELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 230 ~--~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
. ....++|+|+++.|||+. ++++.+.|+||..+.
T Consensus 195 ~~~~~~~~cH~Dl~~~Nil~~-~~~~~~~lID~Eya~ 230 (344)
T PLN02236 195 GDDQEIGFCHNDLQYGNIMID-EETRAITIIDYEYAS 230 (344)
T ss_pred ccCCCceEEeCCCCcCcEEEe-CCCCcEEEEeehhcc
Confidence 1 134689999999999995 234679999999874
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0019 Score=57.97 Aligned_cols=102 Identities=25% Similarity=0.309 Sum_probs=74.3
Q ss_pred HHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccC-cHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHhcCCC
Q psy11727 155 IEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRN-TNFHGVSLNLTKKFAQQLCCALAFLSSPE 232 (437)
Q Consensus 155 ~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~-~~~~~ls~~~~~~i~~qi~~aL~~LH~~~ 232 (437)
.|..++..+... +++.+++|+|-. ++|.|+.+. .++..... ...-.-+|..+.+++.+++..+.+|+...
T Consensus 8 ~E~lll~~l~~~----~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 8 NEPLLLQLLQGS----EPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred cHHHHHHHcCCC----CCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 377777777643 379999998843 579999974 44321000 01123589999999999999999997642
Q ss_pred C-CeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 233 L-SIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 233 ~-giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
. .+.-+|++|+|+-+ ++++.+|++|.......
T Consensus 80 ~~~~~lcDv~~~nfgv--~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGV--NDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCcEEEeecchHHeEE--eCCCcEEEEechhcchh
Confidence 2 38889999999999 56778999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.016 Score=56.95 Aligned_cols=72 Identities=17% Similarity=0.300 Sum_probs=43.6
Q ss_pred ceecccCceEEEEEEEcCC---CeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEe
Q psy11727 116 TLLGKGSFGQVVKAFDHEE---KCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFEL 192 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~---~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~ 192 (437)
+.|..|=-..+|++..... +..|++|+........-....|..+++.+...++. | ++++++. .. +|.+|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~-P---~~l~~~~-~G---~i~~f 91 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFG-A---KLLGVFG-NG---MIQSF 91 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCC-C---ceeEEeC-Cc---Eeehh
Confidence 3344466667888754332 33788998765443333456799999999877754 3 2334342 22 47888
Q ss_pred ccC
Q psy11727 193 LSY 195 (437)
Q Consensus 193 ~~~ 195 (437)
+.|
T Consensus 92 i~g 94 (330)
T PLN02421 92 INA 94 (330)
T ss_pred hcC
Confidence 765
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.012 Score=57.22 Aligned_cols=69 Identities=13% Similarity=0.178 Sum_probs=42.9
Q ss_pred CceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCC--cEEEecc--eeeECCEEEEEEEeccC
Q psy11727 122 SFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR--YIVKLKG--HFTWKNHLCLVFELLSY 195 (437)
Q Consensus 122 ~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~--~iv~l~~--~~~~~~~~~lV~E~~~~ 195 (437)
.-|.||++.. .+| .+++|.+... .........+++.+...++.++ .+..--| +...++..+++|++++|
T Consensus 18 ~~~~v~~v~T-~~G-~~~Lk~~~~~---~~~l~~~~~~~~~L~~~G~~~~~~~~~t~~G~~~~~~~~~~~~L~~wi~G 90 (309)
T TIGR02904 18 VTGKLFKVYT-DQG-VFALKKLYAD---RNTIESFVSQIQVLSEKGFSRIVPVYPTKDGSYYLFHGHFLYYLMPWLDI 90 (309)
T ss_pred ccCcEEEEEe-CCC-CEEEEEeccc---hHhHHHHHHHHHHHHHcCCCcCCceeecCCCCeeeEECCEEEEEeCCccc
Confidence 3568999854 334 6899988632 2445567777788877665442 2222222 23345667999999866
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.025 Score=55.68 Aligned_cols=75 Identities=20% Similarity=0.180 Sum_probs=49.9
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEec----C----CcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIK----N----KKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~~~vaiK~i~----~----~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.||-|....||++.+..+++.|+||.-. . -.....+...|...+...... ....+.+++. .+.+...+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~--~P~~vP~vy~--~D~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEH--VPHLVPRIFH--FDTEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhcc--CccccCeEEE--Ecccccee
Confidence 4689999999999976444689999642 1 123356667788888765542 2224555543 45667779
Q ss_pred EEEeccC
Q psy11727 189 VFELLSY 195 (437)
Q Consensus 189 V~E~~~~ 195 (437)
|||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 9999954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.065 Score=51.87 Aligned_cols=66 Identities=17% Similarity=0.165 Sum_probs=42.5
Q ss_pred EEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecc---eeeECCEEEEEEEeccC
Q psy11727 125 QVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKG---HFTWKNHLCLVFELLSY 195 (437)
Q Consensus 125 ~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~---~~~~~~~~~lV~E~~~~ 195 (437)
.||++.. . +..+++|++... ......+..+++.+...++.-|-++...+ +...++..++|+|+++|
T Consensus 11 ~v~~v~t-~-~g~~~LK~~~~~---~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G 79 (313)
T TIGR02906 11 NVYKVET-D-SGNKCLKKINYP---PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEG 79 (313)
T ss_pred cEEEEEe-C-CCCeEEEEcCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccC
Confidence 4888863 2 336889987522 24456678888888777664444554322 12346789999999976
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.074 Score=52.10 Aligned_cols=74 Identities=15% Similarity=0.046 Sum_probs=46.3
Q ss_pred cCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecc--eeeECCEEEEEEEeccC
Q psy11727 121 GSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKG--HFTWKNHLCLVFELLSY 195 (437)
Q Consensus 121 G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~--~~~~~~~~~lV~E~~~~ 195 (437)
+.-..||+... .++..+++|+.+.......+...|+..+..+...++.-+-.+..-+ ....++..+.|+++++|
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 34457888854 4456799998764333345667899999888765543221122222 22345678889999876
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.027 Score=53.82 Aligned_cols=30 Identities=27% Similarity=0.498 Sum_probs=23.8
Q ss_pred CCeeeCCCCCCcEEEecCCCCC-EEEEeCCCce
Q psy11727 233 LSIIHCDLKPENILLCSPKRSA-IKIIDFGSSC 264 (437)
Q Consensus 233 ~giiHrDiKp~NIll~~~~~~~-ikL~DFG~s~ 264 (437)
..++|+|+.|.|||++ +++. .-|+||+.+.
T Consensus 185 ~~lvHGD~~~~Nilv~--~~~~~~gviDWe~a~ 215 (276)
T cd05152 185 TVLVHGDLHPGHILID--EDARVTGLIDWTEAK 215 (276)
T ss_pred CeeEeCCCCCCcEEEe--CCCCEEEEECcHhcc
Confidence 3589999999999994 3344 5699999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.001 Score=74.67 Aligned_cols=157 Identities=11% Similarity=-0.036 Sum_probs=105.3
Q ss_pred HHHHHHHHhhhcCCCCCcEEEecceee--ECCEEEEEEEec-cCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHhc
Q psy11727 155 IEVQLLEKINKADIHSRYIVKLKGHFT--WKNHLCLVFELL-SYNLYNLIRNTN--FHGVSLNLTKKFAQQLCCALAFLS 229 (437)
Q Consensus 155 ~e~~~~~~l~~~~~~h~~iv~l~~~~~--~~~~~~lV~E~~-~~~L~~~l~~~~--~~~ls~~~~~~i~~qi~~aL~~LH 229 (437)
.|..+.++-......|++++....-.. .....+.+++++ .|.+++.+.+.. +..+....+.....+...+..-+|
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 344444432222335666555444333 234678899999 558888876543 223444444444444455555555
Q ss_pred CC-CCC--eeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC---ccccccccccccChhhhcCCCCCCcchHHHHHHHH
Q psy11727 230 SP-ELS--IIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ---TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCIL 303 (437)
Q Consensus 230 ~~-~~g--iiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il 303 (437)
+. +.| .+|++||+.|.+| ..+-.+|+.++|+.+.... ......+++.|++|+......++.++|+|+.|+-+
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmI--Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMI--VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred hcccCCccchhhhhhhhccce--ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 43 222 6899999999999 4566799999999983222 12345667889999999998999999999999999
Q ss_pred HHHHhCCCCC
Q psy11727 304 VELHTGEPLF 313 (437)
Q Consensus 304 ~elltg~~pf 313 (437)
|+..-|.++|
T Consensus 1431 y~rs~~n~~f 1440 (2724)
T KOG1826|consen 1431 YLRSDGNAYF 1440 (2724)
T ss_pred HHHhcccHHH
Confidence 9998888887
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.13 Score=50.37 Aligned_cols=138 Identities=21% Similarity=0.306 Sum_probs=79.0
Q ss_pred CceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCC-cEEEeccee--eECC--EEEEEEEeccCc
Q psy11727 122 SFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR-YIVKLKGHF--TWKN--HLCLVFELLSYN 196 (437)
Q Consensus 122 ~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~-~iv~l~~~~--~~~~--~~~lV~E~~~~~ 196 (437)
.-..||+..... |+ +++|+.... ....+...|+..+..+....+.-+ -+..+-|-. .-.. +.+-|++|++|.
T Consensus 37 ~eN~~f~~~~~~-g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTED-GR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecC-CC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 455788886533 33 499998765 556778889999999887665432 123332221 1234 888999999873
Q ss_pred HHH------H----------HH--hcCCC--------CCCHHH----H---------HHHHHHHHHHHHHhc------CC
Q psy11727 197 LYN------L----------IR--NTNFH--------GVSLNL----T---------KKFAQQLCCALAFLS------SP 231 (437)
Q Consensus 197 L~~------~----------l~--~~~~~--------~ls~~~----~---------~~i~~qi~~aL~~LH------~~ 231 (437)
... . +. ..++. ...+.. . .....++...+..+. ..
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 222 0 00 01111 112220 0 012223333333332 22
Q ss_pred CCC--eeeCCCCCCcEEEecCCCC-CEEEEeCCCce
Q psy11727 232 ELS--IIHCDLKPENILLCSPKRS-AIKIIDFGSSC 264 (437)
Q Consensus 232 ~~g--iiHrDiKp~NIll~~~~~~-~ikL~DFG~s~ 264 (437)
..+ +||+|+.|+||++ +... .+.++||+-++
T Consensus 194 ~~~~~iIH~D~~~~NVl~--d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLF--DDDTDVSGFIDFDDAG 227 (331)
T ss_pred cccceeeecCCCccceeE--cCCCCeeeEEEccccc
Confidence 334 9999999999999 4444 48899999875
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.062 Score=53.66 Aligned_cols=83 Identities=22% Similarity=0.206 Sum_probs=55.1
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEec----CC---cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIK----NK---KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~----~~---~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.+.||-|.-.-||++.+...++.|+||.-. .. ....++...|...++...... ..++.+++. .+.+...
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~--P~~VP~vy~--~D~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELA--PGLVPKVYL--FDSVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhC--CCcCCeEEE--ECcHHhh
Confidence 567799999999999875445679988632 11 233567778888888765422 224666653 4566778
Q ss_pred EEEEeccC--cHHHHH
Q psy11727 188 LVFELLSY--NLYNLI 201 (437)
Q Consensus 188 lV~E~~~~--~L~~~l 201 (437)
+|||+++. .|.+.+
T Consensus 110 ~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 110 CVMEDLSDHTILRTAL 125 (409)
T ss_pred HHHHhCcccHHHHHHH
Confidence 99999854 344443
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.17 Score=57.24 Aligned_cols=148 Identities=16% Similarity=0.245 Sum_probs=79.6
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhc--CCCCCcEEEecc-ee----eE-CC--E
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKA--DIHSRYIVKLKG-HF----TW-KN--H 185 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~--~~~h~~iv~l~~-~~----~~-~~--~ 185 (437)
+.|+ |..-.+|+... .+|..+++|+.+.. ........|..++..+... .+.-|.++...+ -. .. .+ +
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~-~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPS-EPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCc-cchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3453 34567787753 45667999998743 2233455567778777654 455555554332 11 11 12 5
Q ss_pred EEEEEEeccC-cHHHH-----------------HHh--cCC------CCCCHH-----------------HHHHHHHHHH
Q psy11727 186 LCLVFELLSY-NLYNL-----------------IRN--TNF------HGVSLN-----------------LTKKFAQQLC 222 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~-----------------l~~--~~~------~~ls~~-----------------~~~~i~~qi~ 222 (437)
.+-+++|++| .+.+. +.. ..+ ..+.|. ..+.++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 7889999987 34330 000 001 111111 1122222332
Q ss_pred HHHH-----HhcCCCCCeeeCCCCCCcEEEecCCCCCEE-EEeCCCceec
Q psy11727 223 CALA-----FLSSPELSIIHCDLKPENILLCSPKRSAIK-IIDFGSSCHV 266 (437)
Q Consensus 223 ~aL~-----~LH~~~~giiHrDiKp~NIll~~~~~~~ik-L~DFG~s~~~ 266 (437)
..+. .+..-..++||+|+.++|||+..+..+.+. |+|||-++..
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~ 237 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVHA 237 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence 2221 222223479999999999999533322555 9999988643
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.044 Score=49.96 Aligned_cols=31 Identities=42% Similarity=0.643 Sum_probs=20.3
Q ss_pred CCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 233 ~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
..++|.|+.|.|||+. +.++.++|+||..|.
T Consensus 143 ~v~cHnDl~~~Nil~~-~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILIN-NKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEET-SSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEec-cCCCeEEEecHHHHh
Confidence 4689999999999993 356679999999874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.04 Score=54.61 Aligned_cols=59 Identities=25% Similarity=0.294 Sum_probs=40.8
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEe
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLC 248 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~ 248 (437)
..|+=+|..| ++..+++... .++...++++.-...|+--+---+ +++|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vD-NFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVD-NFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhh-cceecccCCCcEEEE
Confidence 4455566666 6777776654 466677777777777765442212 599999999999995
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.064 Score=52.44 Aligned_cols=73 Identities=22% Similarity=0.216 Sum_probs=57.5
Q ss_pred CCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 183 KNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 183 ~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
..+.|++|++-++.+.- ++. ..++++..|+.+.+..++-+.. +...-|||+.-+|||| + +|+|.|+||-+
T Consensus 298 ~~y~yl~~kdhgt~is~-ik~-----~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLI--d-~GnvtLIDfkl 367 (488)
T COG5072 298 TLYLYLHFKDHGTPISI-IKA-----DRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILI--D-EGNVTLIDFKL 367 (488)
T ss_pred ceEEEEEEecCCceeee-eec-----ccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceee--e-cCceEEEEeee
Confidence 35788899988776542 222 3567888899998888877765 4678999999999999 5 88999999999
Q ss_pred cee
Q psy11727 263 SCH 265 (437)
Q Consensus 263 s~~ 265 (437)
++.
T Consensus 368 sRl 370 (488)
T COG5072 368 SRL 370 (488)
T ss_pred eec
Confidence 973
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.091 Score=50.46 Aligned_cols=75 Identities=12% Similarity=0.117 Sum_probs=49.6
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEecc
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLS 194 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~ 194 (437)
.+.++-|....+|+.. .+++.+.||+-. ......+..|..-++.+.... .-.+.+++.+....+.-+|||||+.
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~--~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEAN--PIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTT--TSBS--EEEEEE-SSCCEEEEE---
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcC--CCCCCeEEEEEeecCCceEEEEeec
Confidence 4567889999999986 677789999876 444577888999999996532 2246677777777777799999985
Q ss_pred C
Q psy11727 195 Y 195 (437)
Q Consensus 195 ~ 195 (437)
.
T Consensus 96 ~ 96 (288)
T PF03881_consen 96 M 96 (288)
T ss_dssp -
T ss_pred C
Confidence 3
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.21 Score=50.00 Aligned_cols=73 Identities=15% Similarity=0.141 Sum_probs=43.4
Q ss_pred eceecccCceEEEEEEEcCCC------eEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEK------CQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~------~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.+.|..|=...+|++...... +.|.++.........-....|..+++.+...++. .++++.|.. .+
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glg----P~l~~~f~~----g~ 126 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFG----PKIIGRFGD----FT 126 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCC----CeEEEecCC----EE
Confidence 345555777888888643321 1255554333333333446688999998766543 344555542 58
Q ss_pred EEEeccC
Q psy11727 189 VFELLSY 195 (437)
Q Consensus 189 V~E~~~~ 195 (437)
|.||++|
T Consensus 127 l~efIeG 133 (383)
T PTZ00384 127 IQEWVEG 133 (383)
T ss_pred EEEEecc
Confidence 9999976
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.3 Score=47.48 Aligned_cols=31 Identities=16% Similarity=0.395 Sum_probs=25.4
Q ss_pred CCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 233 ~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
..++|+|+.+.||++. ...-+-|+||+++..
T Consensus 198 ~~lvHGD~~~gNlii~--~~~~~gVlDwe~~~l 228 (321)
T COG3173 198 PVLVHGDYRPGNLIID--PGRPTGVLDWELATL 228 (321)
T ss_pred ceeeeCCcccCCEEEe--CCCeeEEEecccccc
Confidence 3589999999999995 344488999999854
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.25 Score=49.60 Aligned_cols=75 Identities=12% Similarity=0.027 Sum_probs=48.3
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEec-----CCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIK-----NKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~-----~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+.||-|....||+..+. +..++||.-. ... ....+...|...++.+... ....+.+++.++. +.-
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~--~p~~VPkVy~~de--d~~ 110 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRL--CPDHVPEVYHFDR--TMA 110 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhc--CCCCCCeEEEECC--CCC
Confidence 567799999999999763 4468898754 111 1345555666666555432 2225667776655 556
Q ss_pred EEEEEeccC
Q psy11727 187 CLVFELLSY 195 (437)
Q Consensus 187 ~lV~E~~~~ 195 (437)
+++||++++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 788999965
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.17 Score=46.30 Aligned_cols=117 Identities=15% Similarity=0.122 Sum_probs=72.2
Q ss_pred ccCceEEEEEEEcCCCeEEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccCcH
Q psy11727 120 KGSFGQVVKAFDHEEKCQVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNL 197 (437)
Q Consensus 120 ~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~~L 197 (437)
-|+.++...+..+- | ...+|.++...-. ..-+..+-.++.++. .|+++..- ..-.+-+|.|.|-.-
T Consensus 72 ~~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~~~~y~nky~v~Armh-------GilrL~ND--n~~~yGvIlE~Cy~~- 139 (308)
T PF07387_consen 72 FNGNSTLLIGKTKI-G-PLFLKKIRSLPCCINDALYFNKYRVFARMH-------GILRLKND--NNYKYGVILERCYKI- 139 (308)
T ss_pred cCCceEEEEecccc-c-hhhhhhccCCCcccchhhhhhhhhHHHHhh-------heeEeecC--CCceeEEEEeeccCc-
Confidence 35555655554333 3 4556666533222 233455666666653 48888742 334677999998421
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 198 YNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 198 ~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.... ..++..=+.+|.-.|+.+-+.+|+|..|+||+- |+.|.+||.|=++-
T Consensus 140 ------------~i~~-~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~--D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 140 ------------KINF-SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMC--DKFGYLKLVDPVCL 190 (308)
T ss_pred ------------ccch-hHHHHHhHHHHHHhhccCCCeecCCCChhheee--cCCCCEEecChhhh
Confidence 0000 112222246778889766789999999999999 89999999997753
|
The function of this family is unknown. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.65 Score=47.45 Aligned_cols=74 Identities=16% Similarity=0.090 Sum_probs=46.5
Q ss_pred eeceecccCceEEEEEEEcC--------CCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 114 IDTLLGKGSFGQVVKAFDHE--------EKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 114 i~~~lG~G~fg~V~~~~~~~--------~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
-++.|..|=.-.+|++.... +++.|.+++.-......-....|..+++.+...++..+ + ++.|..
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~-l---~~~f~g--- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQ-L---LNTFSG--- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCc-e---EEEeCC---
Confidence 34556666667788876432 25679999876544333345668899998888776543 3 344431
Q ss_pred EEEEEEeccC
Q psy11727 186 LCLVFELLSY 195 (437)
Q Consensus 186 ~~lV~E~~~~ 195 (437)
..|.||++|
T Consensus 182 -g~I~efi~g 190 (442)
T PTZ00296 182 -GRIEEWLYG 190 (442)
T ss_pred -CEEEEeeCC
Confidence 357888865
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 437 | ||||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-135 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-135 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-134 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-69 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-69 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-68 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 5e-43 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-43 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 6e-43 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-42 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 5e-42 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 6e-41 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-37 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-37 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-37 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 4e-31 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 4e-31 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 6e-31 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-30 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-30 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-30 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-30 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-30 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-30 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-30 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-29 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-29 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-29 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-29 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-29 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-29 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-29 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-29 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-29 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-29 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-29 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-29 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-29 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-29 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-29 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-29 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-29 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-29 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-29 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-29 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-29 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-29 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-29 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-29 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-29 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-28 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-28 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-28 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-28 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-28 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-28 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-28 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-28 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-28 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-28 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-28 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-28 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-28 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-28 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-28 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-28 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-27 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-27 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-27 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-27 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-27 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-27 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-27 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-27 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-27 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-27 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-27 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-27 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-27 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-27 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-27 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-27 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-27 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-27 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-27 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-27 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-27 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-27 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-27 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-27 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-27 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-27 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-27 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-27 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-27 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-26 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-26 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-26 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-26 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-26 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-26 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-26 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-26 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-26 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-26 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-26 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-26 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-25 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-25 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-25 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-25 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-25 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-25 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-25 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-25 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-25 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-25 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-25 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-25 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-25 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-25 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-25 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-25 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-25 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-25 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-25 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-25 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-25 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-25 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-25 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-25 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-25 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-25 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-25 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-25 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-25 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-25 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-25 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-25 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-25 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-25 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-25 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-25 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-25 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-25 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-25 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-25 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-25 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-25 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-25 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-25 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-25 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-25 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-25 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-24 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-24 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-24 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-24 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-24 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-24 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-24 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-24 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-24 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-24 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-24 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-24 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-24 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-24 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-24 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-24 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-24 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-24 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-24 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-24 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-24 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-23 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-23 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-23 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-23 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-23 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-23 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-23 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-23 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-23 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-23 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-23 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-23 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-23 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-22 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-22 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-22 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-22 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-22 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-22 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-22 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-22 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-22 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-22 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-22 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-22 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-22 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-22 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-22 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-22 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-22 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-22 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-22 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-22 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-22 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-22 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-22 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-22 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-22 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-22 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-22 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-22 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-21 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-21 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-21 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-21 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-21 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-21 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-21 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-20 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-20 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-20 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-19 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-19 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-19 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-19 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-18 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-17 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-17 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-17 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-17 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-17 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-16 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-16 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-16 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-16 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-16 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 8e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-16 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-16 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-16 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-15 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-15 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-15 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-15 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-15 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-15 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-15 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-15 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-15 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-15 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-15 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-15 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-14 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-14 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-14 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-14 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-14 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-14 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-14 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-14 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-14 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-14 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-14 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-13 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-13 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-13 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-12 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-11 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-10 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-08 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 3e7e_A | 365 | Structure And Substrate Recruitment Of The Human Sp | 4e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-05 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-05 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-05 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-05 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-05 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-05 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-05 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-05 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-05 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-04 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-04 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-04 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-04 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-04 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-04 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-04 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-04 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-04 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-04 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-04 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-04 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-04 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 5e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-04 |
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3E7E|A Chain A, Structure And Substrate Recruitment Of The Human Spindle Checkpoint Kinase Bub Length = 365 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 437 | |||
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-177 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 1e-174 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-156 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-152 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 1e-149 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-136 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-78 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 4e-64 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-62 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-62 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-59 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 5e-59 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-58 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-56 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-56 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-56 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 3e-56 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-55 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-55 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 6e-55 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 6e-55 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-54 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-54 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-54 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 3e-54 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 4e-54 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 6e-54 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 7e-54 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 7e-54 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 9e-54 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-53 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 4e-53 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 6e-53 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-52 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-51 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-49 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-48 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 8e-48 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-47 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-46 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 4e-46 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 5e-46 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 5e-45 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-43 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-04 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-43 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 4e-43 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 8e-05 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 5e-43 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 9e-43 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 9e-43 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-42 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 4e-04 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 8e-42 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-05 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-41 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-04 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-41 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-04 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-41 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-04 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-41 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-04 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-41 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 9e-05 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 8e-41 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-05 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 8e-41 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-05 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-40 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-40 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 6e-04 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-40 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-05 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 5e-40 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 5e-40 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 7e-06 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 7e-40 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 4e-06 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 8e-40 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-04 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-39 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-04 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-39 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-04 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-39 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-04 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-39 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-05 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-39 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-39 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-05 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 7e-39 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 4e-05 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 7e-39 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 9e-39 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 6e-05 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-38 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 4e-05 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-38 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 8e-06 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-38 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-05 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-38 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-05 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-38 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 5e-06 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 7e-38 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-37 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-06 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 4e-37 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-05 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 6e-37 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-05 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 7e-37 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 7e-37 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 7e-05 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 9e-37 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-05 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-36 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-05 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 4e-36 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 5e-36 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-35 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-04 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-35 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-05 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-35 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 7e-35 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-34 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 3e-34 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-04 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-34 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 5e-34 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-33 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-33 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 8e-06 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-32 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 8e-06 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-32 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 5e-05 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-32 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-32 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 5e-05 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-32 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-32 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-05 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 5e-32 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 7e-32 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 8e-31 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-30 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-30 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-30 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-30 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 3e-30 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-30 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 5e-30 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 6e-30 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 5e-05 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 6e-30 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-29 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 6e-04 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-29 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-29 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 6e-29 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 6e-29 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 5e-04 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 7e-29 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 8e-29 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-28 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-28 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-28 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 5e-28 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-27 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-27 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-27 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-27 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-27 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 7e-27 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 8e-27 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-26 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 8e-04 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-26 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-26 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-26 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 6e-26 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 7e-26 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 8e-26 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 9e-26 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-25 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-25 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-04 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 3e-25 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 4e-25 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 6e-25 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 7e-04 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 7e-25 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 7e-25 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 8e-25 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 9e-25 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 9e-25 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 5e-24 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 6e-24 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 8e-24 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-23 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-23 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-04 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 5e-23 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 5e-23 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 5e-23 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 7e-23 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 5e-22 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 5e-22 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 8e-22 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 8e-22 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-21 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 7e-20 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-19 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-19 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-19 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 3e-19 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-18 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-18 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-18 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 7e-18 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 4e-17 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 4e-17 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 5e-17 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 6e-17 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 6e-17 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 9e-17 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-16 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-16 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-16 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-16 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 3e-16 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 3e-16 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 3e-16 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-16 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 6e-16 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-15 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-15 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-15 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-15 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-15 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-15 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-15 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-15 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 3e-15 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 4e-15 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 4e-15 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 6e-15 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 7e-15 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 7e-15 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 9e-15 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-14 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-14 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-14 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-14 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-14 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-14 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 3e-14 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 3e-14 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-14 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 4e-14 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 5e-14 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 5e-14 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 7e-14 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 7e-14 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 8e-14 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-13 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-13 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-13 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 3e-13 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 5e-13 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 5e-12 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 6e-12 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 7e-12 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-11 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 9e-11 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 3e-09 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 6e-09 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-08 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-06 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 7e-06 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 3e-06 |
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 500 bits (1288), Expect = e-177
Identities = 249/359 (69%), Positives = 307/359 (85%), Gaps = 2/359 (0%)
Query: 74 SHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHE 133
+ ++ S+ K+++ V+NDG+DD+NYDYI+K+GEK++DRYEID+L+GKGSFGQVVKA+D
Sbjct: 18 LYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRV 77
Query: 134 EKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFEL 192
E+ VAIKIIKNKK FLNQAQIEV+LLE +NK D +Y IV LK HF ++NHLCLVFE+
Sbjct: 78 EQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM 137
Query: 193 LSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR 252
LSYNLY+L+RNTNF GVSLNLT+KFAQQ+C AL FL++PELSIIHCDLKPENILLC+PKR
Sbjct: 138 LSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197
Query: 253 SAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPL 312
SAIKI+DFGSSC +GQ +YQYIQSR+YRSPEVLLG+PYDLAIDMWSLGCILVE+HTGEPL
Sbjct: 198 SAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPL 257
Query: 313 FSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKE-RLPGS 371
FSG NEVDQM KI+EVLG+PP ++L A K K+F++L D ++ LKK+ D ++E + PG+
Sbjct: 258 FSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGT 317
Query: 372 KRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
++L ILGV+ GGPGGRR E GH++ADY+KFKDLILRML YDPK RI P L+H FF
Sbjct: 318 RKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 376
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 493 bits (1270), Expect = e-174
Identities = 154/403 (38%), Positives = 214/403 (53%), Gaps = 22/403 (5%)
Query: 32 RIPMQFRDPATAPLRKLSV---DLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKEKKYV 88
PM ++KL+ I +Y I + KKR+
Sbjct: 28 ATPMTPEQAMKQYMQKLTAFEHHEIFSYPEIYFLGLNAKKRQGMTG------------GP 75
Query: 89 HNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP 148
+N G+DD+ Y+ + RYE+ ++GKGSFGQVVKA+DH+ VA+K+++N+K
Sbjct: 76 NNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR 135
Query: 149 FLNQAQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFH 207
F QA E+++LE + K D + ++ + +FT++NH+C+ FELLS NLY LI+ F
Sbjct: 136 FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQ 195
Query: 208 GVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267
G SL L +KFA + L L IIHCDLKPENILL RS IK+IDFGSSC+
Sbjct: 196 GFSLPLVRKFAHSILQCLDALHK--NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253
Query: 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
Q +Y YIQSR+YR+PEV+LG Y + IDMWSLGCIL EL TG PL G++E DQ+ +IE
Sbjct: 254 QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE 313
Query: 328 VLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGG 387
+LGMP LL + + + Y + L G + L G P
Sbjct: 314 LLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKL---RGPPES 370
Query: 388 RRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
R D F D + + L +DP R++P LRH +
Sbjct: 371 REWGNALKG-CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 445 bits (1146), Expect = e-156
Identities = 104/379 (27%), Positives = 176/379 (46%), Gaps = 44/379 (11%)
Query: 75 HNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEE 134
H+ + + DDE + K G + + + +G G+FG+V+ +
Sbjct: 2 HHHHHHSSGRENL--YFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDN 59
Query: 135 KCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLS 194
K A+K+++N K + A+IE +L+KI DI++ IVK G F + +H+CL+FE L
Sbjct: 60 KKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLG 119
Query: 195 YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP---- 250
+LY +I N++G + K + ++ AL +L ++S+ H DLKPENILL P
Sbjct: 120 PSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR--KMSLTHTDLKPENILLDDPYFEK 177
Query: 251 -------------------KRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYD 291
K + IK+IDFG + I +R YR+PEV+L + +D
Sbjct: 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWD 237
Query: 292 LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLS 351
++ DMWS GC+L EL+TG LF ++ + + ++ P +L+ A+KT+
Sbjct: 238 VSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNK 297
Query: 352 DNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411
D + + + K+ P + + + F D + +L
Sbjct: 298 DELKLAWPENASSINSIKHVKKC-----------------LPLYKIIKHELFCDFLYSIL 340
Query: 412 TYDPKKRISPTNVLRHEFF 430
DP R SP +L+H+F
Sbjct: 341 QIDPTLRPSPAELLKHKFL 359
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 434 bits (1117), Expect = e-152
Identities = 108/356 (30%), Positives = 175/356 (49%), Gaps = 40/356 (11%)
Query: 94 DDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEE-KCQVAIKIIKNKKPFLNQ 152
DD+ + + G+ +RYEI LG+G+FG+VV+ DH K QVA+KII+N +
Sbjct: 3 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA 62
Query: 153 AQIEVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSL 211
A++E+ +L+KI + D +++ V + F + H+C+ FELL N + ++ NF L
Sbjct: 63 ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPL 122
Query: 212 NLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS-----------------PKRSA 254
+ A QLC AL FL E + H DLKPENIL + K ++
Sbjct: 123 PHVRHMAYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 255 IKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFS 314
I++ DFGS+ + + +R+YR PEV+L + + D+WS+GCIL E + G LF
Sbjct: 181 IRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240
Query: 315 GKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRL 374
+ + + ++LG P +++H K KYF + + K L
Sbjct: 241 THENREHLVMMEKILGPIPSHMIHRTRKQ-KYFYKGGLVWDENSSD---GRYVKENCKPL 296
Query: 375 DTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
+ + D+ ++++ DL+ RML +DP +RI+ L H FF
Sbjct: 297 KSYMLQDS---------------LEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 427 bits (1100), Expect = e-149
Identities = 107/360 (29%), Positives = 176/360 (48%), Gaps = 42/360 (11%)
Query: 97 NYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQ-VAIKIIKNKKPFLNQAQI 155
+ I + G+ RYEI LG+G+FG+VV+ DH+ + VA+KI+KN + A+
Sbjct: 1 SMHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS 60
Query: 156 EVQLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLT 214
E+Q+LE +N D +S + V++ F H+C+VFELL + Y+ I+ F L+
Sbjct: 61 EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHI 120
Query: 215 KKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS-----------------PKRSAIKI 257
+K A Q+C ++ FL + H DLKPENIL IK+
Sbjct: 121 RKMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 258 IDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN 317
+DFGS+ + + + +R+YR+PEV+L + + D+WS+GCIL+E + G +F +
Sbjct: 179 VDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238
Query: 318 EVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTI 377
+ + + +LG P +++ K KYF + + + + K L
Sbjct: 239 SKEHLAMMERILGPLPKHMIQKTRKR-KYFH---HDRLDWDEHSSAGRYVSRACKPLKEF 294
Query: 378 LGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF--LKHSV 435
+ + ++ + DLI +ML YDP KRI+ L+H FF LK S+
Sbjct: 295 MLSQD---------------VEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI 339
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 394 bits (1015), Expect = e-136
Identities = 106/358 (29%), Positives = 161/358 (44%), Gaps = 43/358 (12%)
Query: 94 DDENYDYIIKHGEKFLD-RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQ 152
+ GE + D RY + LG G F V A D VA+KI++ K +
Sbjct: 2 YRPGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA 61
Query: 153 AQIEVQLLEKINKADIH------SRYIVKLKGHFTWKN----HLCLVFELLSYNLYNLIR 202
A+ E++LL+++N AD + +I+KL HF K H+ +VFE+L NL LI+
Sbjct: 62 AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK 121
Query: 203 NTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA----IKII 258
G+ L K+ ++QL L ++ IIH D+KPEN+L+ IKI
Sbjct: 122 KYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIA 180
Query: 259 DFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGK-- 316
D G++C + IQ+R YRSPEVLLG P+ D+WS C++ EL TG+ LF
Sbjct: 181 DLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240
Query: 317 ----NEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSK 372
+ D + +IIE+LG P YLL T +F+ + K ++ L
Sbjct: 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL---- 296
Query: 373 RLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
+ S + + D + ML DP+KR ++ H +
Sbjct: 297 -----------------TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 2e-78
Identities = 104/404 (25%), Positives = 173/404 (42%), Gaps = 86/404 (21%)
Query: 91 DGHDDENYD----YIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK 146
+ D +Y +++K G+ F RY + LG G F V ++D + K VA+K++K+
Sbjct: 14 EQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA 73
Query: 147 KPFLNQAQIEVQLLEKINKADIH---SRYIVKLKGHFTWK----NHLCLVFELLSYNLYN 199
+ + A E++LL+ + +D + +V+L F H+C+VFE+L ++L
Sbjct: 74 EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLK 133
Query: 200 LIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP--------- 250
I +N+ G+ L KK QQ+ L +L + + IIH D+KPENILL
Sbjct: 134 WIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRLAA 192
Query: 251 --------------------------------------KRSAIKIIDFGSSCHVGQTLYQ 272
++ +KI D G++C V + +
Sbjct: 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE 252
Query: 273 YIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN------EVDQMTKII 326
IQ+R YRS EVL+G Y+ D+WS C+ EL TG+ LF + + D + II
Sbjct: 253 DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII 312
Query: 327 EVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPG 386
E+LG P L+ + ++F + K +L + ++
Sbjct: 313 ELLGKVPRKLIVAGKYSKEFFTK---------KGDLKHITKLKPWGLFEVLVE------- 356
Query: 387 GRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
+ S + F D +L ML P+KR + LRH +
Sbjct: 357 -----KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 4e-64
Identities = 99/331 (29%), Positives = 156/331 (47%), Gaps = 56/331 (16%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHS 170
Y ++G GSFG V +A + VAIK + K F N+ E+Q++ K++ H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLD----H- 106
Query: 171 RYIVKLKGHFT------WKNHLCLVFELLSYNLYNLIRNTNFHG--VSLNLTKKFAQQLC 222
IV+L+ F + +L LV + + +Y + R+ + + + K + QL
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS--SCHVGQTLYQYIQSRYYR 280
+LA++ S I H D+KP+N+LL P + +K+ DFGS G+ YI SRYYR
Sbjct: 167 RSLAYIHS--FGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223
Query: 281 SPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339
+PE++ G Y +ID+WS GC+L EL G+P+F G + VDQ+ +II+VLG P
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP------- 276
Query: 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLAD 399
T + ++ N K + + P +K R P ++
Sbjct: 277 ---TREQIREMNPNYTEFKFP---QIKAHPWTKVF--------------RPRTPPEAI-- 314
Query: 400 YMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
L R+L Y P R++P H FF
Sbjct: 315 -----ALCSRLLEYTPTARLTPLEACAHSFF 340
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-62
Identities = 91/339 (26%), Positives = 145/339 (42%), Gaps = 53/339 (15%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINK 165
K +DR++++ + G+G+FG V + VAIK + F E+Q+++ +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAV 75
Query: 166 ADIHSRYIVKLKGHFTWKNH-------LCLVFELLSYNLYNLIRNTNFHG--VSLNLTKK 216
H IV+L+ +F L +V E + L+ RN L K
Sbjct: 76 LH-H-PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV 133
Query: 217 FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS--SCHVGQTLYQYI 274
F QL ++ L P +++ H D+KP N+L+ + +K+ DFGS + YI
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV-NEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 275 QSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
SRYYR+PE++ G Y A+D+WS+GCI E+ GEP+F G N Q+ +I+ VLG P
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252
Query: 334 GYLLH--GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRN 391
+L S T + +P S +
Sbjct: 253 REVLRKLNPSHTDVDLY---------------NSKGIPWSNVF-------------SDHS 284
Query: 392 EPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
A DL+ +L Y P++R+ P L H +F
Sbjct: 285 LKDAKEA-----YDLLSALLQYLPEERMKPYEALCHPYF 318
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 5e-62
Identities = 101/345 (29%), Positives = 152/345 (44%), Gaps = 69/345 (20%)
Query: 103 KHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK 162
K GE+ Y ++G GSFG V +A E +VAIK + K F N+ E+Q++
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNR---ELQIMRI 88
Query: 163 INKADIHSRYIVKLK------GHFTWKNHLCLVFELLSYNLYNLIR--NTNFHGVSLNLT 214
+ H +V LK G + L LV E + +Y R + + L
Sbjct: 89 VK----HP-NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLI 143
Query: 215 KKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS--SCHVGQTLYQ 272
K + QL +LA++ S + I H D+KP+N LL P +K+IDFGS G+
Sbjct: 144 KLYMYQLLRSLAYIHS--IGICHRDIKPQN-LLLDPPSGVLKLIDFGSAKILIAGEPNVS 200
Query: 273 YIQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331
YI SRYYR+PE++ G Y ID+WS GC++ EL G+PLF G++ +DQ+ +II+VLG
Sbjct: 201 YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260
Query: 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRN 391
P + + + + + P
Sbjct: 261 P-------------------SREQIKTMNPNYMEHKFP---------------------Q 280
Query: 392 EPGHSLADYMKFK------DLILRMLTYDPKKRISPTNVLRHEFF 430
H + + + DLI R+L Y P R++ L H FF
Sbjct: 281 IRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 3e-59
Identities = 95/370 (25%), Positives = 161/370 (43%), Gaps = 92/370 (24%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINK 165
E +Y + LG GSFG V + FD E + A+K + + N+ E+ +++ ++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR---ELDIMKVLD- 58
Query: 166 ADIHSRYIVKLKGHFTWK--------------------------------------NHLC 187
H I+KL +F +L
Sbjct: 59 ---H-VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114
Query: 188 LVFELLSYNLYNLIRNTNFHG--VSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENI 245
++ E + L+ ++++ G + +NL + QL A+ F+ S L I H D+KP+N+
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS--LGICHRDIKPQNL 172
Query: 246 LLCSPKRSAIKIIDFGS--SCHVGQTLYQYIQSRYYRSPEVLLGIP-YDLAIDMWSLGCI 302
L+ + K + +K+ DFGS + YI SR+YR+PE++LG Y +ID+WS+GC+
Sbjct: 173 LV-NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231
Query: 303 LVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTD 362
EL G+PLFSG+ +DQ+ +II+++G P + + Y +
Sbjct: 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN--PHYTEV------------- 276
Query: 363 TRKERLPGSKR--LDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420
R P K IL P ++ DL+ ++L Y+P RI+
Sbjct: 277 ----RFPTLKAKDWRKIL----------PEGTPSLAI-------DLLEQILRYEPDLRIN 315
Query: 421 PTNVLRHEFF 430
P + H FF
Sbjct: 316 PYEAMAHPFF 325
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 5e-59
Identities = 85/331 (25%), Positives = 142/331 (42%), Gaps = 53/331 (16%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK--KPFLNQAQI-EVQLLEKINK 165
+++YE +G+GS+G V K + + VAIK P + + + E+++L+++
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK- 60
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCAL 225
H +V L F K L LVFE + + + + GV +L K Q A+
Sbjct: 61 ---HP-NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAV 115
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSP 282
F + IH D+KPENIL+ K S IK+ DFG + +R+YRSP
Sbjct: 116 NFCHK--HNCIHRDVKPENILIT--KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171
Query: 283 EVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341
E+L+G Y +D+W++GC+ EL +G PL+ GK++VDQ+ I + LG S
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231
Query: 342 KTSKYFDRLSDNSYVLKKSTDTR--KERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLAD 399
+ + + D + + P + +
Sbjct: 232 TNQYF------SGVKIPDPEDMEPLELKFP---NISY-PAL------------------- 262
Query: 400 YMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
L+ L DP +R++ +L H +F
Sbjct: 263 -----GLLKGCLHMDPTERLTCEQLLHHPYF 288
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 2e-58
Identities = 86/331 (25%), Positives = 149/331 (45%), Gaps = 53/331 (16%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-----PFLNQAQIEVQLLEKI 163
+++YE L+G+GS+G V+K + + VAIK A E++LL+++
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK--IAMREIKLLKQL 81
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCC 223
H +V L K LVFE + + + + + +G+ + +K+ Q+
Sbjct: 82 R----HE-NLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIIN 135
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYR 280
+ F S +IIH D+KPENIL+ + +K+ DFG + G+ + +R+YR
Sbjct: 136 GIGFCHS--HNIIHRDIKPENILVS--QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR 191
Query: 281 SPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339
+PE+L+G + Y A+D+W++GC++ E+ GEPLF G +++DQ+ I+ LG
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251
Query: 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLAD 399
+K + + K + + R P +L
Sbjct: 252 FNKNPVF----AGVRLPEIKEREPLERRYP---KLS---------EVVI----------- 284
Query: 400 YMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
DL + L DP KR +L H+FF
Sbjct: 285 -----DLAKKCLHIDPDKRPFCAELLHHDFF 310
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 1e-56
Identities = 97/334 (29%), Positives = 147/334 (44%), Gaps = 47/334 (14%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-----EVQLLEKI 163
L RY+ +G G+ G V A+D VAIK K +PF NQ E+ L++ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCV 118
Query: 164 NKADIHS-RYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLC 222
N +I S + + + LV EL+ NL +I+ + Q+
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQML 174
Query: 223 CALAFLSSPELSIIHCDLKPENILL---CSPKRSAIKIIDFGSSCHVGQTLY--QYIQSR 277
C + L S IIH DLKP NI++ C+ +KI+DFG + G + Y+ +R
Sbjct: 175 CGIKHLHS--AGIIHRDLKPSNIVVKSDCT-----LKILDFGLARTAGTSFMMTPYVVTR 227
Query: 278 YYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337
YYR+PEV+LG+ Y +D+WS+GCI+ E+ + LF G++ +DQ K+IE LG P +
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287
Query: 338 HGA-SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHS 396
Y + K + T + P S R
Sbjct: 288 KKLQPTVRNYVENRP------KYAGLTFPKLFPDSLFPADSEHNKLKASQAR-------- 333
Query: 397 LADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
DL+ +ML DP KRIS + L+H +
Sbjct: 334 --------DLLSKMLVIDPAKRISVDDALQHPYI 359
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-56
Identities = 90/344 (26%), Positives = 139/344 (40%), Gaps = 65/344 (18%)
Query: 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK------NKKPFLNQAQIEVQ 158
G RYE +G G++G V KA D VA+K ++ EV
Sbjct: 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVA 63
Query: 159 LLEKINKADIHSRYIVKLK-----GHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNL 213
LL ++ + H +V+L + + LVFE + +L + G+
Sbjct: 64 LLRRLEAFE-H-PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAET 121
Query: 214 TKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG--SSCHVGQTLY 271
K +Q L FL + I+H DLKPENIL+ +K+ DFG L
Sbjct: 122 IKDLMRQFLRGLDFLHA--NCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQMALT 177
Query: 272 QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331
+ + +YR+PEVLL Y +DMWS+GCI E+ +PLF G +E DQ+ KI +++G+
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237
Query: 332 P-----PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPG 386
P P L ++ + + +P ++
Sbjct: 238 PPEDDWPR------------DVSLPRGAFPPRGPRPVQ-SVVP---EME---------ES 272
Query: 387 GRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
G L+L MLT++P KRIS L+H +
Sbjct: 273 GA----------------QLLLEMLTFNPHKRISAFRALQHSYL 300
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-56
Identities = 101/338 (29%), Positives = 152/338 (44%), Gaps = 55/338 (16%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-----EVQLLEKI 163
L RY+ +G G+ G V A+D + VAIK K +PF NQ E+ L++ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 164 NKADIHS-RYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQ--- 219
N +I + + + +V EL+ NL +I+ + L +
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--------MELDHERMSYLL 133
Query: 220 -QLCCALAFLSSPELSIIHCDLKPENILL---CSPKRSAIKIIDFGSSCHVGQTLY--QY 273
Q+ C + L S IIH DLKP NI++ C+ +KI+DFG + G + Y
Sbjct: 134 YQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCT-----LKILDFGLARTAGTSFMMTPY 186
Query: 274 IQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
+ +RYYR+PEV+LG+ Y +D+WS+GCI+ E+ G LF G + +DQ K+IE LG P
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246
Query: 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLD-TILGVDNGGPGGRRRNE 392
+ T + +YV E P L D P N+
Sbjct: 247 PEFMKKLQPTVR--------TYV---------ENRPKYAGYSFEKLFPDVLFPADSEHNK 289
Query: 393 PGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
S A +DL+ +ML D KRIS L+H +
Sbjct: 290 LKASQA-----RDLLSKMLVIDASKRISVDEALQHPYI 322
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 2e-55
Identities = 93/337 (27%), Positives = 148/337 (43%), Gaps = 63/337 (18%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQ-VAIKIIK---NKKPFLNQAQIEVQLLEKINK 165
+YE +G+G++G+V KA D + + VA+K ++ ++ EV +L +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 166 ADIHSRYIVKLK-----GHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQ 220
+ H +V+L + L LVFE + +L + GV K Q
Sbjct: 71 FE-H-PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG--QTLYQYIQSRY 278
L L FL S ++H DLKP+NIL+ IK+ DFG + L + + +
Sbjct: 129 LLRGLDFLHS--HRVVHRDLKPQNILV--TSSGQIKLADFGLARIYSFQMALTSVVVTLW 184
Query: 279 YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP-----P 333
YR+PEVLL Y +D+WS+GCI E+ +PLF G ++VDQ+ KI++V+G+P P
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244
Query: 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEP 393
L ++ K + K +D G+
Sbjct: 245 R------------DVALPRQAFHSKSAQPIEKFV----TDID---------ELGK----- 274
Query: 394 GHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
DL+L+ LT++P KRIS + L H +F
Sbjct: 275 -----------DLLLKCLTFNPAKRISAYSALSHPYF 300
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 3e-55
Identities = 75/347 (21%), Positives = 133/347 (38%), Gaps = 72/347 (20%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-----EVQLLEKI 163
RY LG G G V A D++ +VAIK K + + E++++ ++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK----KIVLTDPQSVKHALREIKIIRRL 65
Query: 164 NKADI---------HSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLT 214
+ +I + G T N + +V E + +L N++ L
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE-------QGPLL 118
Query: 215 KKFAQ----QLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG------SSC 264
++ A+ QL L ++ S +++H DLKP N+ + + + +KI DFG
Sbjct: 119 EEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANLFINT-EDLVLKIGDFGLARIMDPHY 175
Query: 265 HVGQTLYQYIQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323
L + + +++YRSP +LL Y AIDMW+ GCI E+ TG+ LF+G +E++QM
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ 235
Query: 324 KIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNG 383
I+E + + + R +
Sbjct: 236 LILESIPVVHEEDRQELLSVIPVYIR-----------------NDMTEPHKPLTQLLPGI 278
Query: 384 GPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
D + ++LT+ P R++ L H +
Sbjct: 279 SREAV----------------DFLEQILTFSPMDRLTAEEALSHPYM 309
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 6e-55
Identities = 90/337 (26%), Positives = 152/337 (45%), Gaps = 60/337 (17%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKINKAD 167
+++ LG G++ V K + VA+K +K +++ + A E+ L++++
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK--- 61
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFH----GVSLNLTKKFAQQLCC 223
H IV+L +N L LVFE + +L + + G+ LNL K F QL
Sbjct: 62 -HE-NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY---IQSRYYR 280
LAF E I+H DLKP+N+L+ KR +K+ DFG + G + + + + +YR
Sbjct: 120 GLAFC--HENKILHRDLKPQNLLI--NKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR 175
Query: 281 SPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP-----PG 334
+P+VL+G Y +ID+WS GCIL E+ TG+PLF G N+ +Q+ I +++G P P
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS 235
Query: 335 YLLHGASKTSKYFDRLSD-NSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEP 393
+L N + ++ ++ L + +D
Sbjct: 236 ------------VTKLPKYNPNIQQRPPRDLRQVLQPHTK----EPLDGNL--------- 270
Query: 394 GHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
D + +L +P R+S L H +F
Sbjct: 271 ----------MDFLHGLLQLNPDMRLSAKQALHHPWF 297
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 6e-55
Identities = 98/362 (27%), Positives = 151/362 (41%), Gaps = 77/362 (21%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQ--AQ---IEVQLLEKI 163
L +YE+ LGKG++G V K+ D VA+K K F N AQ E+ +L ++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTEL 65
Query: 164 NKADIHSRYIVKLKGHFTWKN--HLCLVFELLSYNLYNLIRN---TNFHGVSLNLTKKFA 218
+ H IV L N + LVF+ + +L+ +IR H +
Sbjct: 66 SG---H-ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH------KQYVV 115
Query: 219 QQLCCALAFLSSPELSIIHCDLKPENILL---CSPKRSAIKIIDFG-------------- 261
QL + +L S ++H D+KP NILL C +K+ DFG
Sbjct: 116 YQLIKVIKYLHSGG--LLHRDMKPSNILLNAECH-----VKVADFGLSRSFVNIRRVTNN 168
Query: 262 ----------SSCHVGQTLYQYIQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGE 310
+ L Y+ +R+YR+PE+LLG Y IDMWSLGCIL E+ G+
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
Query: 311 PLFSGKNEVDQMTKIIEVLGMPPGYLLH--GASKTSKYFDRLSDNSYVLKKSTDTRKERL 368
P+F G + ++Q+ +II V+ P + + + L K +
Sbjct: 229 PIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLK------------EKVEI 276
Query: 369 PGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHE 428
S + D N + A DL+ ++L ++P KRIS + L+H
Sbjct: 277 RQSNKRDIFTKWKNLLL-KINPKADCNEEA-----LDLLDKLLQFNPNKRISANDALKHP 330
Query: 429 FF 430
F
Sbjct: 331 FV 332
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 1e-54
Identities = 109/344 (31%), Positives = 151/344 (43%), Gaps = 68/344 (19%)
Query: 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-----PFLNQAQIEVQL 159
+DRY T LG+G++G+V KA D VAIK I+ + P A EV L
Sbjct: 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPG--TAIREVSL 86
Query: 160 LEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQ 219
L+++ H I++LK + L L+FE +L + VS+ + K F
Sbjct: 87 LKELQ----HR-NIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNP--DVSMRVIKSFLY 139
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILL---CSPKRSAIKIIDFGSSCHVGQTLYQY--- 273
QL + F S +H DLKP+N+LL + + +KI DFG + G + Q+
Sbjct: 140 QLINGVNFCHSR--RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE 197
Query: 274 IQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332
I + +YR PE+LLG Y ++D+WS+ CI E+ PLF G +E+DQ+ KI EVLG+P
Sbjct: 198 IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP 257
Query: 333 -----PGYLLHGASKTSKYFDRLSD-NSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPG 386
PG L D K T K L LD
Sbjct: 258 DDTTWPG------------VTALPDWKQSFPKFRGKTLKRVLG--ALLD---------DE 294
Query: 387 GRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
G DL+ ML DP KRIS N L H +F
Sbjct: 295 GL----------------DLLTAMLEMDPVKRISAKNALEHPYF 322
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-54
Identities = 84/333 (25%), Positives = 139/333 (41%), Gaps = 59/333 (17%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKINKA 166
++ Y LG+G++ V K VA+K I+ +++ A EV LL+ +
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-- 58
Query: 167 DIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
H IV L + L LVFE L +L + + + ++++ K F QL LA
Sbjct: 59 --H-ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLA 114
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY---IQSRYYRSPE 283
+ ++H DLKP+N+L+ +R +K+ DFG + Y + + +YR P+
Sbjct: 115 YCHRQ--KVLHRDLKPQNLLI--NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPD 170
Query: 284 VLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP-----PGYLL 337
+LLG Y IDMW +GCI E+ TG PLF G +Q+ I +LG P PG
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI-- 228
Query: 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSL 397
+ + + P + + G
Sbjct: 229 --------------------LSNEEFKTYNYPKYRAEALLSHAPRLDSDGA--------- 259
Query: 398 ADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
DL+ ++L ++ + RIS + ++H FF
Sbjct: 260 -------DLLTKLLQFEGRNRISAEDAMKHPFF 285
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-54
Identities = 94/337 (27%), Positives = 146/337 (43%), Gaps = 68/337 (20%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-----PFLNQAQIEVQLLEKI 163
+++Y +G+G++G V KA ++ + A+K I+ +K P E+ +L+++
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPS--TTIREISILKEL 57
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCC 223
HS IVKL K L LVFE L +L L+ G+ K F QL
Sbjct: 58 K----HS-NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLN 111
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY---IQSRYYR 280
+A+ ++H DLKP+N+L+ + +KI DFG + G + +Y I + +YR
Sbjct: 112 GIAYCHD--RRVLHRDLKPQNLLI--NREGELKIADFGLARAFGIPVRKYTHEIVTLWYR 167
Query: 281 SPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP-----PG 334
+P+VL+G Y ID+WS+GCI E+ G PLF G +E DQ+ +I +LG P P
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227
Query: 335 YLLHGASKTSKYFDRLSD-NSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEP 393
L + + L LD G
Sbjct: 228 ------------VTELPKYDPNFTVYEPLPWESFLK---GLD---------ESGI----- 258
Query: 394 GHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
DL+ +ML DP +RI+ L H +F
Sbjct: 259 -----------DLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-54
Identities = 83/336 (24%), Positives = 140/336 (41%), Gaps = 65/336 (19%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-----EVQLLEKIN 164
Y T +G G++G V A D +VAIK K +PF ++ E+ LL+ +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 165 KADIHS-RYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRN--TNFHGVSLNLTKKFAQQL 221
++ + LV + +L ++ + + Q+
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEK------IQYLVYQM 135
Query: 222 CCALAFLSSPELSIIHCDLKPENILL---CSPKRSAIKIIDFGSSCHVGQTLYQYIQSRY 278
L ++ S ++H DLKP N+ + C +KI+DFG + H + Y+ +R+
Sbjct: 136 LKGLKYIHSAG--VVHRDLKPGNLAVNEDCE-----LKILDFGLARHADAEMTGYVVTRW 188
Query: 279 YRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337
YR+PEV+L Y+ +D+WS+GCI+ E+ TG+ LF GK+ +DQ+T+I++V G+P +
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248
Query: 338 H--GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGH 395
Y L + R ++ P
Sbjct: 249 QKLNDKAAKSYIQSLP------------QTPRKDFTQLF------------------PRA 278
Query: 396 S-LADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
S A DL+ +ML D KR++ L H FF
Sbjct: 279 SPQA-----ADLLEKMLELDVDKRLTAAQALTHPFF 309
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-54
Identities = 93/336 (27%), Positives = 150/336 (44%), Gaps = 64/336 (19%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK---NKKPFLNQAQIEVQLLEKINK 165
+ +YE +G+G++G V KA + E VA+K ++ + + + A E+ LL+++
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK- 59
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCAL 225
H + IV+L L LVFE +L + N + + K F QL L
Sbjct: 60 ---H-KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGL 114
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY---IQSRYYRSP 282
F S +++H DLKP+N+L+ + +K+ +FG + G + Y + + +YR P
Sbjct: 115 GFCHS--RNVLHRDLKPQNLLI--NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 283 EVLLGIP-YDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMP-----PGY 335
+VL G Y +IDMWS GCI EL G PLF G + DQ+ +I +LG P P
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS- 229
Query: 336 LLHGASKTSKYFDRLSD-NSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPG 394
+L D Y + +T + +P +L+ GR
Sbjct: 230 -----------MTKLPDYKPYPMYPATTSLVNVVP---KLN---------ATGR------ 260
Query: 395 HSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
DL+ +L +P +RIS L+H +F
Sbjct: 261 ----------DLLQNLLKCNPVQRISAEEALQHPYF 286
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 6e-54
Identities = 88/340 (25%), Positives = 150/340 (44%), Gaps = 65/340 (19%)
Query: 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-----PFLNQAQIEVQL 159
+ +++Y+ +G+G++G V KA D + + VA+K I+ P A E+ L
Sbjct: 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPS--TAIREISL 72
Query: 160 LEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQ 219
L++++ H IV L + L LVFE + +L ++ G+ + K +
Sbjct: 73 LKELH----HP-NIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLY 126
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY---IQS 276
QL +A I+H DLKP+N+L+ A+K+ DFG + G + Y + +
Sbjct: 127 QLLRGVAHCHQ--HRILHRDLKPQNLLI--NSDGALKLADFGLARAFGIPVRSYTHEVVT 182
Query: 277 RYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP--- 332
+YR+P+VL+G Y ++D+WS+GCI E+ TG+PLF G + DQ+ KI +LG P
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242
Query: 333 --PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRR 390
P ++ ++ ++ + G
Sbjct: 243 EWPQV----------------------QELPLWKQRTFQVFEKKPWSSIIPGFCQEGI-- 278
Query: 391 NEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
DL+ ML +DP KRIS + + H +F
Sbjct: 279 --------------DLLSNMLCFDPNKRISARDAMNHPYF 304
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 7e-54
Identities = 80/337 (23%), Positives = 140/337 (41%), Gaps = 66/337 (19%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-----EVQLLEKIN 164
Y +G G++G V A D +VAIK K +PF ++ E++LL+ +
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMR 82
Query: 165 KADIHS-RYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRN---TNFHGVSLNLTKKFAQQ 220
++ + LV + +L L+++ + Q
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR------IQFLVYQ 136
Query: 221 LCCALAFLSSPELSIIHCDLKPENILL---CSPKRSAIKIIDFGSSCHVGQTLYQYIQSR 277
+ L ++ + IIH DLKP N+ + C +KI+DFG + + Y+ +R
Sbjct: 137 MLKGLRYIHAA--GIIHRDLKPGNLAVNEDCE-----LKILDFGLARQADSEMTGYVVTR 189
Query: 278 YYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336
+YR+PEV+L Y +D+WS+GCI+ E+ TG+ LF G + +DQ+ +I++V G PP
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249
Query: 337 LH--GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPG 394
+ + + Y L E+ + L
Sbjct: 250 VQRLQSDEAKNYMKGLP------------ELEKKDFASIL------------------TN 279
Query: 395 HS-LADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
S LA +L+ +ML D ++R++ L H +F
Sbjct: 280 ASPLA-----VNLLEKMLVLDAEQRVTAGEALAHPYF 311
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 7e-54
Identities = 62/308 (20%), Positives = 116/308 (37%), Gaps = 47/308 (15%)
Query: 89 HNDGHDDENYDYIIKHGEKF---LDRYEIDTLLGKGSFGQVVKA-----FDHEEKCQVAI 140
+ + + + IK +F + LLG+G+F QV +A D + K + +
Sbjct: 41 YPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVL 100
Query: 141 KIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY----N 196
K+ K + I QL+E++ + H +K ++N LV EL SY N
Sbjct: 101 KVQK--PANPWEFYIGTQLMERLKPSMQH--MFMKFYSAHLFQNGSVLVGELYSYGTLLN 156
Query: 197 LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP------ 250
NL +NT + L FA ++ + + IIH D+KP+N +L +
Sbjct: 157 AINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDD 214
Query: 251 ---KRSAIKIIDFGSSCHV-----GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCI 302
+ + +ID G S + G ++ ++ E+L P++ ID + +
Sbjct: 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAAT 274
Query: 303 LVELHTGEPL--------------FSGKNEVDQMTKIIEV-LGMPPGYLLHGASKTSKYF 347
+ + G + F +D + V L +P + L +
Sbjct: 275 VYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334
Query: 348 DRLSDNSY 355
++ Y
Sbjct: 335 KKVFQQHY 342
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 9e-54
Identities = 87/349 (24%), Positives = 143/349 (40%), Gaps = 76/349 (21%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-----EVQLLEKI 163
+++ +LLG+G++G V A VAIK I+ PF E+++L+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHF 66
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRN---TNFHGVSLNLTKKFAQQ 220
+I + + ++ F N + ++ EL+ +L+ +I ++ H + F Q
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH------IQYFIYQ 120
Query: 221 LCCALAFLSSPELSIIHCDLKPENILL---CSPKRSAIKIIDFG-------------SSC 264
A+ L +IH DLKP N+L+ C +K+ DFG
Sbjct: 121 TLRAVKVLHGSN--VIHRDLKPSNLLINSNCD-----LKVCDFGLARIIDESAADNSEPT 173
Query: 265 HVGQTLYQYIQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323
+ +++ +R+YR+PEV+L Y A+D+WS GCIL EL P+F G++ Q+
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233
Query: 324 KIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRK--ERLPGSKRLDTILGVD 381
I ++G P SDN +S R+ + LP
Sbjct: 234 LIFGIIGTPH-----------------SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFP 276
Query: 382 NGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
P G DL+ RML +DP KRI+ L H +
Sbjct: 277 RVNPKGI----------------DLLQRMLVFDPAKRITAKEALEHPYL 309
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-53
Identities = 80/353 (22%), Positives = 127/353 (35%), Gaps = 72/353 (20%)
Query: 104 HGEKF--LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI------ 155
E Y + + GS+G V D E VAIK + N I
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGI-PVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 156 ------EVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGV 209
E++LL + +I + + + L LV EL+ +L +I +
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR---- 128
Query: 210 SLNLTKKFAQ----QLCCALAFLSSPELSIIHCDLKPENILL---CSPKRSAIKIIDFG- 261
+ ++ + Q + L L ++H DL P NILL I I DF
Sbjct: 129 -IVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNND-----ITICDFNL 180
Query: 262 -SSCHVGQTLYQYIQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEV 319
Y+ R+YR+PE+++ + +DMWS GC++ E+ + LF G
Sbjct: 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240
Query: 320 DQMTKIIEVLGMPPGYLLH--GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTI 377
+Q+ KI+EV+G P + + Y + L
Sbjct: 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYL-----------------RNSLSNVPARAWT 283
Query: 378 LGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
V P DLI +ML ++P++RIS LRH +F
Sbjct: 284 AVVPTADPVAL----------------DLIAKMLEFNPQRRISTEQALRHPYF 320
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-53
Identities = 90/346 (26%), Positives = 146/346 (42%), Gaps = 83/346 (23%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI----------EVQ 158
RYE LG+G F V KA D VAIK IK ++++ E++
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK----LGHRSEAKDGINRTALREIK 64
Query: 159 LLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFA 218
LL++++ H I+ L F K+++ LVF+ + +L +I++ + ++ + K +
Sbjct: 65 LLQELS----HP-NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYM 118
Query: 219 QQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY---IQ 275
L +L I+H DLKP N+LL + +K+ DFG + G Y +
Sbjct: 119 LMTLQGLEYLHQ--HWILHRDLKPNNLLL--DENGVLKLADFGLAKSFGSPNRAYTHQVV 174
Query: 276 SRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP-- 332
+R+YR+PE+L G Y + +DMW++GCIL EL P G +++DQ+T+I E LG P
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE 234
Query: 333 ---PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRR 389
P LP
Sbjct: 235 EQWPDM------------------------------CSLPDYVTF--------------- 249
Query: 390 RNEPGHSLADYMKF-----KDLILRMLTYDPKKRISPTNVLRHEFF 430
++ PG L DLI + ++P RI+ T L+ ++F
Sbjct: 250 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 6e-53
Identities = 87/336 (25%), Positives = 153/336 (45%), Gaps = 64/336 (19%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-----EVQLLEKIN 164
+RY+ + +G G++G V AFD + +VA+K + PF + E++LL+ +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--PFQSIIHAKRTYRELRLLKHMK 86
Query: 165 KADIHS-RYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQ---- 219
++ + N + LV L+ +L N+++ LT Q
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-------CQKLTDDHVQFLIY 139
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILL---CSPKRSAIKIIDFGSSCHVGQTLYQYIQS 276
Q+ L ++ S + IIH DLKP N+ + C +KI+DFG + H + Y+ +
Sbjct: 140 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDCE-----LKILDFGLARHTADEMTGYVAT 192
Query: 277 RYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335
R+YR+PE++L Y+ +D+WS+GCI+ EL TG LF G + +DQ+ I+ ++G P
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252
Query: 336 LLHG-ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPG 394
LL +S++++ +Y+ + L +++ P
Sbjct: 253 LLKKISSESAR--------NYI---------QSLTQMPKMNFANVFIGANPLAV------ 289
Query: 395 HSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
DL+ +ML D KRI+ L H +F
Sbjct: 290 ----------DLLEKMLVLDSDKRITAAQALAHAYF 315
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-52
Identities = 91/342 (26%), Positives = 151/342 (44%), Gaps = 72/342 (21%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-----EVQLLEKIN 164
RY + +G+G++G V A+D+ K +VAIK I PF +Q E+++L +
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFR 83
Query: 165 KADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQ----Q 220
+I + + +V +L+ +LY L++ + +L+ Q
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-------TQHLSNDHICYFLYQ 136
Query: 221 LCCALAFLSSPELSIIHCDLKPENILL---CSPKRSAIKIIDFG------SSCHVGQTLY 271
+ L ++ S ++H DLKP N+LL C +KI DFG L
Sbjct: 137 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCD-----LKICDFGLARVADPDHDHTGFLT 189
Query: 272 QYIQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLG 330
+Y+ +R+YR+PE++L Y +ID+WS+GCIL E+ + P+F GK+ +DQ+ I+ +LG
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249
Query: 331 MPPGYLLH--GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGR 388
P L+ K Y L K ++P ++ P
Sbjct: 250 SPSQEDLNCIINLKARNYLLSLP------------HKNKVPWNRLF----------PN-- 285
Query: 389 RRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
S A DL+ +MLT++P KRI L H +
Sbjct: 286 -----ADSKA-----LDLLDKMLTFNPHKRIEVEQALAHPYL 317
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-51
Identities = 79/330 (23%), Positives = 144/330 (43%), Gaps = 51/330 (15%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-EVQLLEKINKADI 168
D Y++ LG+G + +V +A + +V +KI+ KP + E+++LE +
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLR---- 88
Query: 169 HSRYIVKLKG--HFTWKNHLCLVFE-LLSYNLYNLIRN-TNFHGVSLNLTKKFAQQLCCA 224
I+ L LVFE + + + L + T++ + + ++ A
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD------IRFYMYEILKA 142
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG--SSCHVGQTLYQYIQSRYYRSP 282
L + S + I+H D+KP N+++ + +++ID+G H GQ + SRY++ P
Sbjct: 143 LDYCHS--MGIMHRDVKPHNVMI-DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 199
Query: 283 EVLLGIP-YDLAIDMWSLGCILVELHTG-EPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340
E+L+ YD ++DMWSLGC+L + EP F G + DQ+ +I +VLG
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE-------- 251
Query: 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADY 400
Y+ K + R + ILG + R + L
Sbjct: 252 ----------DLYDYI-------DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS- 293
Query: 401 MKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
+ D + ++L YD + R++ + H +F
Sbjct: 294 PEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-49
Identities = 85/350 (24%), Positives = 138/350 (39%), Gaps = 78/350 (22%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-----PFLNQAQIEVQLLEKI 163
+ +YE +G+G+FG+V KA + +VA+K + + P A E+++L+ +
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI--TALREIKILQLL 73
Query: 164 NKADIHSRYIVKLKG--------HFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTK 215
H +V L + K + LVF+ ++L L+ N +L+ K
Sbjct: 74 K----H-ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIK 127
Query: 216 KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG----SSCHVGQTLY 271
+ Q L L ++ I+H D+K N+L+ + +K+ DFG S
Sbjct: 128 RVMQMLLNGLYYIHR--NKILHRDMKAANVLI--TRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 272 QYIQ---SRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
+Y + +YR PE+LLG Y ID+W GCI+ E+ T P+ G E Q+ I +
Sbjct: 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243
Query: 328 VLGMP-----PGYLLHGASKTSKYFDRLSD-NSYVLKKSTDTR-KERLPGSKRLDTILGV 380
+ G P D L K + K+RL
Sbjct: 244 LCGSITPEVWPN------------VDNYELYEKLELVKGQKRKVKDRLKA-------YVR 284
Query: 381 DNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
D DLI ++L DP +RI + L H+FF
Sbjct: 285 DPYA-------------------LDLIDKLLVLDPAQRIDSDDALNHDFF 315
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-48
Identities = 87/375 (23%), Positives = 155/375 (41%), Gaps = 76/375 (20%)
Query: 94 DDENYDYIIK---HGEKFLDRYEIDTL-LGKGSFGQVVKAFDHEEKCQ--VAIKIIKNKK 147
D +YD+ +K E+ D +E + +G+G++G V KA + K A+K I+
Sbjct: 1 DKMDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE-GT 59
Query: 148 PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK--NHLCLVFELLSYNLYNLIR--- 202
A E+ LL ++ H ++ L+ F + L+F+ ++L+++I+
Sbjct: 60 GISMSACREIALLRELK----H-PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHR 114
Query: 203 ----NTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS--PKRSAIK 256
N + + K Q+ + +L + ++H DLKP NIL+ P+R +K
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVK 172
Query: 257 IIDFGSSCHVGQTLYQYIQSRY------YRSPEVLLGIP-YDLAIDMWSLGCILVELHTG 309
I D G + L YR+PE+LLG Y AID+W++GCI EL T
Sbjct: 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232
Query: 310 EPLFSGKNEV---------DQMTKIIEVLGMP-----PGYLLHGASKTSKYFDRLSDNSY 355
EP+F + E DQ+ +I V+G P ++ ++S
Sbjct: 233 EPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWED------------IKKMPEHST 280
Query: 356 VLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415
++K K + +++ + L+ ++LT DP
Sbjct: 281 LMKDFRRNTYTNCSLIKYM--------------EKHKVKPDSKAF----HLLQKLLTMDP 322
Query: 416 KKRISPTNVLRHEFF 430
KRI+ ++ +F
Sbjct: 323 IKRITSEQAMQDPYF 337
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 8e-48
Identities = 71/376 (18%), Positives = 137/376 (36%), Gaps = 86/376 (22%)
Query: 66 KKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYD-----YIIKHGEKFLDRYEIDTLLGK 120
K++R + K + D + + + + + LD Y+I LG
Sbjct: 108 KRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGT 167
Query: 121 GSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI--EVQLLEKINKADIHSRYIVKLKG 178
G+FG V + + A K + ++ + E+Q + + H +V L
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLR----HPT-LVNLHD 221
Query: 179 HFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKK----FAQQLCCALAFLSSPEL 233
F N + +++E +S L+ + + + +++ + +Q+C L +
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHMHE--N 274
Query: 234 SIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRYYRSPEVLLGIPYD 291
+ +H DLKPENI+ + + + +K+IDFG + H+ Q++ + + +PEV G P
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 292 LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLS 351
DMWS+G + L +G F G+N+ + + V F +S
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRN---VKSCDWNM-------DDSAFSGIS 384
Query: 352 DNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411
++ KD I ++L
Sbjct: 385 EDG-------------------------------------------------KDFIRKLL 395
Query: 412 TYDPKKRISPTNVLRH 427
DP R++ L H
Sbjct: 396 LADPNTRMTIHQALEH 411
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-47
Identities = 70/329 (21%), Positives = 120/329 (36%), Gaps = 78/329 (23%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINK 165
++ ++Y I LG+G FG V + + K K +K K + E+ +L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR- 59
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLT----KKFAQQ 220
H I+ L F L ++FE +S +++ I + F L + Q
Sbjct: 60 ---HRN-ILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQ 110
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRY 278
+C AL FL S +I H D++PENI+ + + S IKII+FG + + G +
Sbjct: 111 VCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE 168
Query: 279 YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338
Y +PEV A DMWSLG ++ L +G F + + ++ +
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN---IMNAEYTF--- 222
Query: 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398
+ F +S +
Sbjct: 223 ----DEEAFKEISIEA-------------------------------------------- 234
Query: 399 DYMKFKDLILRMLTYDPKKRISPTNVLRH 427
D + R+L + K R++ + L+H
Sbjct: 235 -----MDFVDRLLVKERKSRMTASEALQH 258
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-46
Identities = 57/231 (24%), Positives = 89/231 (38%), Gaps = 11/231 (4%)
Query: 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLE-KINKA 166
F ++ + LG GS+G+V K E+ A+K PF +L E ++
Sbjct: 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRS--MSPFRGPKDRARKLAEVGSHEK 112
Query: 167 DIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
V+L+ + L L EL +L + + + ALA
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALA 171
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ--SRYYRSPEV 284
L S ++H D+KP NI L R K+ DFG +G +Q Y +PE+
Sbjct: 172 HLHS--QGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227
Query: 285 LLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335
L G Y A D++SLG ++E+ L G Q+ + G
Sbjct: 228 LQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGL 277
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-46
Identities = 98/445 (22%), Positives = 153/445 (34%), Gaps = 133/445 (29%)
Query: 67 KKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKF--LDRYEIDTLLGKGSFG 124
++ T S +++ H + + + + DRYEI L+G GS+G
Sbjct: 8 AAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYG 67
Query: 125 QVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-----EVQLLEKINKADIHSRYIVKLK-- 177
V +A+D EK VAIK I F + E+ +L ++N H ++VK+
Sbjct: 68 HVCEAYDKLEKRVVAIKKILR--VFEDLIDCKRILREIAILNRLN----H-DHVVKVLDI 120
Query: 178 ---GHFTWKNHLCLVFELLSYNLYNLIRN----TNFHGVSLNLTKKFAQQLCCALAFLSS 230
+ L +V E+ + L R T H K L + ++ S
Sbjct: 121 VIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELH------IKTLLYNLLVGVKYVHS 174
Query: 231 PELSIIHCDLKPENILL---CSPKRSAIKIIDFG-------------------------- 261
I+H DLKP N L+ CS +K+ DFG
Sbjct: 175 AG--ILHRDLKPANCLVNQDCS-----VKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 262 ----SSCHVGQTLYQYIQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHT-------- 308
+ ++ + L ++ +R+YR+PE++L Y AID+WS+GCI EL
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287
Query: 309 ---GEPLFSGKN--------------------EVDQMTKIIEVLGMPPGYLLHGASKTSK 345
PLF G + DQ+ I +LG P
Sbjct: 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPS------------ 335
Query: 346 YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKD 405
D + K+ P + D
Sbjct: 336 ----EEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAI----------------H 375
Query: 406 LILRMLTYDPKKRISPTNVLRHEFF 430
L+ RML ++P KRI+ L H FF
Sbjct: 376 LLKRMLVFNPNKRITINECLAHPFF 400
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 5e-46
Identities = 90/418 (21%), Positives = 147/418 (35%), Gaps = 131/418 (31%)
Query: 89 HNDGHDDENYDYIIKHGEKF--LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK 146
H+ H + + + D Y I L+G+GS+G V A+D + VAIK +
Sbjct: 3 HHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR- 61
Query: 147 KPFLNQAQI-----EVQLLEKINKADIHSRYIVKLK-----GHFTWKNHLCLVFELLSYN 196
F + E+ +L ++ YI++L + L +V E+ +
Sbjct: 62 -MFEDLIDCKRILREITILNRLK----S-DYIIRLYDLIIPDDLLKFDELYIVLEIADSD 115
Query: 197 LYNLIRNTNFHGVSLNLTKKFAQ----QLCCALAFLSSPELSIIHCDLKPENILL---CS 249
L L + F LT++ + L F+ IIH DLKP N LL CS
Sbjct: 116 LKKLFKTPIF------LTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCS 167
Query: 250 PKRSAIKIIDFG-------------------------SSCHVGQTLYQYIQSRYYRSPEV 284
+K+ DFG + ++ + L ++ +R+YR+PE+
Sbjct: 168 -----VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL 222
Query: 285 LLGIP-YDLAIDMWSLGCILVELHTG-----------EPLFSG----------------- 315
+L Y +ID+WS GCI EL PLF G
Sbjct: 223 ILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHE 282
Query: 316 KNEVDQMTKIIEVLGMPPGYLLH--GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKR 373
K+ DQ+ I ++G P L + KY ++ + ++
Sbjct: 283 KSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFP------------HRKPINLKQK 330
Query: 374 LDTILGVDNGGPGGRRRNEPGHS-LADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
P S +L+ ML ++P KRI+ L H +
Sbjct: 331 Y------------------PSISDDG-----INLLESMLKFNPNKRITIDQALDHPYL 365
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 5e-45
Identities = 67/332 (20%), Positives = 112/332 (33%), Gaps = 81/332 (24%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHS 170
+ +LG G+ G +V + + VA+K I + A EVQLL + D H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNR-DVAVKRIL--PECFSFADREVQLLRES---DEHP 78
Query: 171 RYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSS 230
+++ + + EL + L + +F + L QQ LA L S
Sbjct: 79 -NVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE-PITLLQQTTSGLAHLHS 136
Query: 231 PELSIIHCDLKPENILLCSPKRSA---IKIIDFGSSCHVGQ------TLYQYIQSRYYRS 281
L+I+H DLKP NIL+ P I DFG + + + +
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 282 PEVLLGIP---YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338
PE+L +D++S GC+ + + G P
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE--------------------GSHP----- 229
Query: 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398
+ L + +L + + +
Sbjct: 230 -------FGKSLQRQANILLGACSLDCLHPEKHEDVI----------------------- 259
Query: 399 DYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
++LI +M+ DP+KR S +VL+H FF
Sbjct: 260 ----ARELIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-43
Identities = 55/259 (21%), Positives = 105/259 (40%), Gaps = 31/259 (11%)
Query: 89 HNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII---KN 145
H+ G D + + Y I +G G +V + +E+K AIK + +
Sbjct: 7 HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEA 65
Query: 146 KKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTN 205
L+ + E+ L K+ + HS I++L + ++ +V E + +L + ++
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQ---HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-- 120
Query: 206 FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265
+ K + + + A+ + I+H DLKP N L+ +K+IDFG +
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQ--HGIVHSDLKPANFLI---VDGMLKLIDFGIANQ 175
Query: 266 V-----GQTLYQYIQSRYYRSPEVLLGIP-----------YDLAIDMWSLGCILVELHTG 309
+ + + Y PE + + D+WSLGCIL + G
Sbjct: 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235
Query: 310 EPLFSG-KNEVDQMTKIIE 327
+ F N++ ++ II+
Sbjct: 236 KTPFQQIINQISKLHAIID 254
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 10/33 (30%), Positives = 17/33 (51%)
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435
+D++ L DPK+RIS +L H + +
Sbjct: 269 LQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-43
Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 18/229 (7%)
Query: 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII---KNKKPFLNQAQIEVQLLEKI 163
+ +++Y +G+GSFG+ + E+ Q IK I + +++ EV +L
Sbjct: 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVL--- 77
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLC 222
A++ IV+ + F L +V + +L+ I + + Q+C
Sbjct: 78 --ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR----Y 278
AL + I+H D+K +NI L K +++ DFG + + T+ + ++ Y
Sbjct: 136 LALKHVHDR--KILHRDIKSQNIFLT--KDGTVQLGDFGIARVLNSTV-ELARACIGTPY 190
Query: 279 YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
Y SPE+ PY+ D+W+LGC+L EL T + F + + + KII
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS 239
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-43
Identities = 73/262 (27%), Positives = 123/262 (46%), Gaps = 18/262 (6%)
Query: 73 LSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDH 132
+ H+ S+ +E Y D +I + Y+ LG G++G+V+ D
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPG-MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDK 59
Query: 133 EEKCQVAIKII-KNKKPFLNQAQI--EVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189
+ AIKII K + +++ EV +L+ ++ H I+KL F K + LV
Sbjct: 60 VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD----HP-NIMKLYDFFEDKRNYYLV 114
Query: 190 FELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLC 248
E L++ I + + +Q+ + +L +I+H DLKPEN+LL
Sbjct: 115 MECYKGGELFDEIIHRMKF--NEVDAAVIIKQVLSGVTYLHK--HNIVHRDLKPENLLLE 170
Query: 249 SPK-RSAIKIIDFGSSCHV--GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVE 305
S + + IKI+DFG S + + + + + YY +PEVL YD D+WS+G IL
Sbjct: 171 SKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFI 229
Query: 306 LHTGEPLFSGKNEVDQMTKIIE 327
L G P F G+ + + + K+ +
Sbjct: 230 LLAGYPPFGGQTDQEILRKVEK 251
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 12/32 (37%), Positives = 18/32 (56%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435
KDLI +ML +D ++RIS L H + +
Sbjct: 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCS 300
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-43
Identities = 62/346 (17%), Positives = 111/346 (32%), Gaps = 67/346 (19%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI--EVQLLEKINKAD 167
+ + +LG+G+ V + + AIK+ N E ++L+K+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN--- 65
Query: 168 IHSRYIVKLKGHF--TWKNHLCLVFELLSY-NLYN-LIRNTNFHGVSLNLTKKFAQQLCC 223
H + IVKL T H L+ E +LY L +N +G+ + + +
Sbjct: 66 -H-KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPK--RSAIKIIDFGSSCHV--GQTLYQYIQSRYY 279
+ L I+H ++KP NI+ + +S K+ DFG++ + + + Y
Sbjct: 124 GMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181
Query: 280 RSPEVLLGI--------PYDLAIDMWSLGCILVELHTGEPLF----SGKNEVDQMTKIIE 327
P++ Y +D+WS+G TG F + + M KII
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 328 VLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGG 387
G P G + + D D S +
Sbjct: 242 --GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL--------------------- 278
Query: 388 RRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433
++ +L D +K + H
Sbjct: 279 ---------------LTPVLANILEADQEKCWGFDQFFAETSDILH 309
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 9e-43
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 21/235 (8%)
Query: 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLL 160
G L + I+ +G+G F +V +A + VA+K ++ E+ LL
Sbjct: 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLL 86
Query: 161 EKINKADIHSRYIVKLKGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSL--NLTKKF 217
+++N ++K F N L +V EL +L +I++ + K+
Sbjct: 87 KQLN-----HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT---LYQYI 274
QLC AL + S ++H D+KP N+ + +K+ D G + +
Sbjct: 142 FVQLCSALEHMHS--RRVMHRDIKPANVFIT--ATGVVKLGDLGLGRFFSSKTTAAHSLV 197
Query: 275 QSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGK--NEVDQMTKIIE 327
+ YY SPE + Y+ D+WSLGC+L E+ + F G N KI +
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 252
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 9e-43
Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 23/237 (9%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEK 162
+ YE+ +G GS+G+ K + + K + EV LL
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL-- 59
Query: 163 INKADIHSRYIVKLKGHFTWK--NHLCLVFELLS-YNLYNLIRNTNFHGVSL--NLTKKF 217
++ IV+ + L +V E +L ++I L +
Sbjct: 60 ---RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 116
Query: 218 AQQLCCALAFL---SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYI 274
QL AL S +++H DLKP N+ L + +K+ DFG + + +
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD--GKQNVKLGDFGLARILNHDT-SFA 173
Query: 275 QSR----YYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
++ YY SPE + + Y+ D+WSLGC+L EL P F+ ++ + KI E
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-42
Identities = 60/278 (21%), Positives = 120/278 (43%), Gaps = 35/278 (12%)
Query: 73 LSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEK-------------FLDRYEIDTLLG 119
+ + + K DG +YD + K D Y+I LG
Sbjct: 1 MRGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELG 60
Query: 120 KGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI--EVQLLEKINKADIHSRYIVKLK 177
G+FG V + + K I L++ + E+ ++ +++ H + ++ L
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFIN-TPYPLDKYTVKNEISIMNQLH----HPK-LINLH 114
Query: 178 GHFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKK----FAQQLCCALAFLSSPE 232
F K + L+ E LS L++ I ++ +++ + +Q C L +
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEGLKHMHE-- 167
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRYYRSPEVLLGIPY 290
SI+H D+KPENI+ + K S++KIIDFG + + + + + + +PE++ P
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 227
Query: 291 DLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV 328
DMW++G + L +G F+G+++++ + +
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 265
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 9/24 (37%), Positives = 15/24 (62%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRH 427
KD I +L +P+KR++ + L H
Sbjct: 282 KDFIKNLLQKEPRKRLTVHDALEH 305
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 8e-42
Identities = 68/266 (25%), Positives = 112/266 (42%), Gaps = 20/266 (7%)
Query: 76 NETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEK 135
+ + ++ ++ G Y+ K K + Y LG G++G+V+ +
Sbjct: 2 HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61
Query: 136 CQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHS----------RYIVKLKGHFTWKNH 185
+ AIK+I K F + + +I++ I+KL F K +
Sbjct: 62 SEKAIKVI-KKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 186 LCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPEN 244
LV E L+ I N + +Q+ + +L +I+H D+KPEN
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKF--DECDAANIMKQILSGICYLHK--HNIVHRDIKPEN 176
Query: 245 ILLCSPK-RSAIKIIDFGSSCHV--GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGC 301
ILL + IKI+DFG S L + + YY +PEVL Y+ D+WS G
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGV 235
Query: 302 ILVELHTGEPLFSGKNEVDQMTKIIE 327
I+ L G P F G+N+ D + K+ +
Sbjct: 236 IMYILLCGYPPFGGQNDQDIIKKVEK 261
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 12/33 (36%), Positives = 18/33 (54%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSVD 436
K+LI MLTYD KR + L + K++ +
Sbjct: 279 KELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-41
Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 31/237 (13%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII---KNKKPFLNQAQIEVQLLEKINKAD 167
Y I +G G +V + +E+K AIK + + L+ + E+ L K+ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-- 66
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
HS I++L + ++ +V E + +L + ++ + K + + + A+
Sbjct: 67 -HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHT 123
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV-----GQTLYQYIQSRYYRSP 282
+ + I+H DLKP N L+ +K+IDFG + + + + Y P
Sbjct: 124 IH--QHGIVHSDLKPANFLI---VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 283 EVLLGIP-----------YDLAIDMWSLGCILVELHTGEPLFSG-KNEVDQMTKIIE 327
E + + D+WSLGCIL + G+ F N++ ++ II+
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 10/32 (31%), Positives = 17/32 (53%)
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434
+D++ L DPK+RIS +L H + +
Sbjct: 250 LQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-41
Identities = 72/273 (26%), Positives = 117/273 (42%), Gaps = 44/273 (16%)
Query: 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKA 166
++ +E +LG+G+FGQVVKA + + AIK I++ + L+ EV LL +N
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN-- 60
Query: 167 DIHSRYIVKLKGHFTWKNH-------------LCLVFELLSYN-LYNLIRNTNFHGVSLN 212
+Y+V+ + + + L + E LY+LI + N + +
Sbjct: 61 ---HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQRD 116
Query: 213 LTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ 272
+ +Q+ AL+++ S IIH DLKP NI + + +KI DFG + +V ++L
Sbjct: 117 EYWRLFRQILEALSYIHS--QGIIHRDLKPMNIFID--ESRNVKIGDFGLAKNVHRSLDI 172
Query: 273 YIQSR-----------------YYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFS 314
Y + EVL G Y+ IDM+SLG I E+ P +
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFST 230
Query: 315 GKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347
G V+ + K+ V P K K
Sbjct: 231 GMERVNILKKLRSVSIEFPPDFDDNKMKVEKKI 263
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 7/28 (25%), Positives = 13/28 (46%)
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEFF 430
K +I ++ +DP KR +L +
Sbjct: 260 EKKIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 80/237 (33%), Positives = 123/237 (51%), Gaps = 20/237 (8%)
Query: 100 YIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI---- 155
++ F DRY+ +LGKGSFG+V+ D + A+K+I +K+ +
Sbjct: 16 FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLL 74
Query: 156 -EVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNL 213
EVQLL++++ H I+KL F K + LV E+ + L++ I + S
Sbjct: 75 REVQLLKQLD----HP-NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVD 127
Query: 214 TKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP-KRSAIKIIDFGSSCHV--GQTL 270
+ +Q+ + ++ I+H DLKPEN+LL S K + I+IIDFG S H + +
Sbjct: 128 AARIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 271 YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
I + YY +PEVL G YD D+WS G IL L +G P F+G NE D + K+ +
Sbjct: 186 KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK 241
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 15/34 (44%), Positives = 21/34 (61%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSVDN 437
KDLI +MLTY P RIS + L HE+ ++ +
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQ 292
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-41
Identities = 67/227 (29%), Positives = 98/227 (43%), Gaps = 17/227 (7%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI--EVQLLEKI 163
+ +LG G+F +V A+K IK K P + + E+ +L+KI
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKI 63
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLI-RNTNFHGVSLNLTKKFAQQL 221
H IV L+ + H LV +L+S L++ I + + QQ+
Sbjct: 64 K----H-ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVY---TEKDASLVIQQV 115
Query: 222 CCALAFLSSPELSIIHCDLKPENILLCSPKR-SAIKIIDFG-SSCHVGQTLYQYIQSRYY 279
A+ +L I+H DLKPEN+L +P+ S I I DFG S + + Y
Sbjct: 116 LSAVKYLHE--NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGY 173
Query: 280 RSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
+PEVL PY A+D WS+G I L G P F + E KI
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK 220
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 9/24 (37%), Positives = 12/24 (50%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRH 427
KD I +L DP +R + L H
Sbjct: 239 KDFICHLLEKDPNERYTCEKALSH 262
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-41
Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 18/238 (7%)
Query: 101 IIKHGEKFLDRYEI-DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI---- 155
+ E F + Y + LG+G F V + + A K +K ++ Q
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR--RGQDCRAEIL 76
Query: 156 -EVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNL 213
E+ +LE ++ L + + + L+ E + +++L VS N
Sbjct: 77 HEIAVLELAK----SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND 132
Query: 214 TKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR-SAIKIIDFGSSCHV--GQTL 270
+ +Q+ + +L +I+H DLKP+NILL S IKI+DFG S + L
Sbjct: 133 VIRLIKQILEGVYYLHQ--NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL 190
Query: 271 YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV 328
+ + + Y +PE+L P A DMW++G I L T F G++ + I +V
Sbjct: 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV 248
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 9/34 (26%), Positives = 16/34 (47%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSVDN 437
D I +L +P+KR + L H + + +N
Sbjct: 265 TDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-41
Identities = 69/230 (30%), Positives = 107/230 (46%), Gaps = 18/230 (7%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI---EVQLLEK 162
KF D Y++ LGKG+F V + + A KII KK Q E ++ K
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 163 INKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLI-RNTNFHGVSLNLTKKFAQQ 220
+ H IV+L ++ LVF+L++ L+ I + S QQ
Sbjct: 62 LQ----H-PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY---SEADASHCIQQ 113
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSP-KRSAIKIIDFGSSCHV--GQTLYQYIQSR 277
+ ++A+ S I+H +LKPEN+LL S K +A+K+ DFG + V + + + +
Sbjct: 114 ILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171
Query: 278 YYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
Y SPEVL PY +D+W+ G IL L G P F +++ +I
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 221
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 1e-05
Identities = 12/31 (38%), Positives = 16/31 (51%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434
K LI MLT +PKKRI+ L+ +
Sbjct: 239 KSLIDSMLTVNPKKRITADQALKVPWICNRE 269
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 8e-41
Identities = 69/237 (29%), Positives = 111/237 (46%), Gaps = 18/237 (7%)
Query: 99 DYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI--- 155
++++ KF D Y++ LGKG+F V + + A KII KK Q
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 156 EVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLI-RNTNFHGVSLNL 213
E ++ K+ H IV+L ++ LVF+L++ L+ I + S
Sbjct: 78 EARICRKLQ----H-PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY---SEAD 129
Query: 214 TKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP-KRSAIKIIDFGSSCHV--GQTL 270
QQ+ ++A+ S I+H +LKPEN+LL S K +A+K+ DFG + V +
Sbjct: 130 ASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187
Query: 271 YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
+ + + Y SPEVL PY +D+W+ G IL L G P F +++ +I
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 244
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 12/32 (37%), Positives = 16/32 (50%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435
K LI MLT +PKKRI+ L+ +
Sbjct: 262 KSLIDSMLTVNPKKRITADQALKVPWICNRER 293
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 56/250 (22%), Positives = 92/250 (36%), Gaps = 36/250 (14%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINK 165
++F ++ L+G G FGQV KA + IK +K +A+ EV+ L
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKAL----- 58
Query: 166 ADIHSRYIVKLKGHF----------------TWKNHLCLVFELLS-YNLYNLIRNTNFHG 208
A + IV G + + L + E L I
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 209 VSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268
+ L + +Q+ + ++ S +I+ DLKP NI L +KI DFG +
Sbjct: 119 LDKVLALELFEQITKGVDYIHSK--KLINRDLKPSNIFLV--DTKQVKIGDFGLVTSLKN 174
Query: 269 T--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVEL-HTGEPLFSGKNEVDQMTKI 325
+ + Y SPE + Y +D+++LG IL EL H + F +
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG 234
Query: 326 IEVLGMPPGY 335
I + +
Sbjct: 235 I----ISDIF 240
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 1e-40
Identities = 52/236 (22%), Positives = 99/236 (41%), Gaps = 31/236 (13%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII---KNKKPFLNQAQIEVQLLEKINKAD 167
Y I +G G +V + +E+K AIK + + L+ + E+ L K+ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-- 113
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
HS I++L + ++ +V E + +L + ++ + K + + + A+
Sbjct: 114 -HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHT 170
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV-----GQTLYQYIQSRYYRSP 282
+ + I+H DLKP N L+ +K+IDFG + + + + Y P
Sbjct: 171 IH--QHGIVHSDLKPANFLI---VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 283 EVLLGIP-----------YDLAIDMWSLGCILVELHTGEPLFSG-KNEVDQMTKII 326
E + + D+WSLGCIL + G+ F N++ ++ II
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 10/32 (31%), Positives = 17/32 (53%)
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434
+D++ L DPK+RIS +L H + +
Sbjct: 297 LQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 79/244 (32%), Positives = 117/244 (47%), Gaps = 21/244 (8%)
Query: 93 HDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQ 152
H + + F +RY I +LGKGSFG+V+K D + + A+K+I
Sbjct: 5 HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS--AKN 62
Query: 153 AQI-----EVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLS-YNLYNLIRNTNF 206
EV+LL+K++ H I+KL + +V EL + L++ I
Sbjct: 63 KDTSTILREVELLKKLD----HP-NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 207 HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK-RSAIKIIDFGSSCH 265
S + + +Q+ + ++ +I+H DLKPENILL S + IKIIDFG S
Sbjct: 118 F--SEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 266 V--GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323
+ I + YY +PEVL G YD D+WS G IL L +G P F GKNE D +
Sbjct: 174 FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK 232
Query: 324 KIIE 327
++
Sbjct: 233 RVET 236
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 15/34 (44%), Positives = 21/34 (61%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSVDN 437
KDLI +MLT+ P RI+ T L H + K+S +
Sbjct: 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET 287
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-40
Identities = 75/338 (22%), Positives = 128/338 (37%), Gaps = 59/338 (17%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI--EVQLLEKI 163
+ +E+ LG G FG V++ + QVAIK + + N+ + E+Q+++K+
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 164 NKADIHSRYIVKL------KGHFTWKNHLCLVFELLS-YNLYNLI-RNTNFHGVSLNLTK 215
N H +V + L E +L + + N G+ +
Sbjct: 70 N----H-PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124
Query: 216 KFAQQLCCALAFLSSPELSIIHCDLKPENILLCS-PKRSAIKIIDFGSSCHV--GQTLYQ 272
+ AL +L E IIH DLKPENI+L P+R KIID G + + G+ +
Sbjct: 125 TLLSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE 182
Query: 273 YIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332
++ + Y +PE+L Y + +D WS G + E TG F + Q +
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR----- 237
Query: 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNE 392
K++++ D + +K S+ LP L IL
Sbjct: 238 --------EKSNEHIVVYDDLTGAVKFSSV-----LPTPNHLSGILA------------- 271
Query: 393 PGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
K + + ML + ++R + F
Sbjct: 272 --------GKLERWLQCMLMWHQRQRGTDPQNPNVGCF 301
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-40
Identities = 81/249 (32%), Positives = 122/249 (48%), Gaps = 22/249 (8%)
Query: 88 VHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK 147
+H+ H + + G F +RY I +LGKGSFG+V+K D + + A+K+I
Sbjct: 1 MHHHHHHSSGRENLYFQGT-FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS 59
Query: 148 PFLNQAQI-----EVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLI 201
EV+LL+K++ H I+KL + +V EL + L++ I
Sbjct: 60 --AKNKDTSTILREVELLKKLD----H-PNIMKLFEILEDSSSFYIVGELYTGGELFDEI 112
Query: 202 RNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR-SAIKIIDF 260
S + + +Q+ + ++ +I+H DLKPENILL S ++ IKIIDF
Sbjct: 113 IKRKRF--SEHDAARIIKQVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 261 GSSCHV--GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNE 318
G S + I + YY +PEVL G YD D+WS G IL L +G P F GKNE
Sbjct: 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 319 VDQMTKIIE 327
D + ++
Sbjct: 228 YDILKRVET 236
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 15/31 (48%), Positives = 20/31 (64%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434
KDLI +MLT+ P RI+ T L H + K+S
Sbjct: 254 KDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-40
Identities = 64/293 (21%), Positives = 110/293 (37%), Gaps = 61/293 (20%)
Query: 89 HNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP 148
H+ EN + + +Y + +G+GS+G V A +++ + AIKI+ K
Sbjct: 5 HHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKI 64
Query: 149 FLNQAQI------EVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLS-------- 194
+ EV+L++K++ I +L + + ++CLV EL
Sbjct: 65 RQINPKDVERIKTEVRLMKKLH-----HPNIARLYEVYEDEQYICLVMELCHGGHLLDKL 119
Query: 195 ---------------------------YNLYNLIRNTNFHGVSLNLTKKFA----QQLCC 223
N + + +K +Q+
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV-------GQTLYQYIQS 276
AL +L + I H D+KPEN L + K IK++DFG S + +
Sbjct: 180 ALHYLHN--QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
Query: 277 RYYRSPEVLLGI--PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
Y+ +PEVL Y D WS G +L L G F G N+ D +++++
Sbjct: 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN 290
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 7/31 (22%), Positives = 15/31 (48%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434
+DL+ +L + +R L+H + + S
Sbjct: 308 RDLLSNLLNRNVDERFDAMRALQHPWISQFS 338
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 8e-40
Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 21/235 (8%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-------EVQ 158
+K D Y+I LG G F V K + + A K IK ++ ++ + EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 159 LLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKF 217
+L ++ H ++ L + + + L+ EL+S L++ + S F
Sbjct: 68 ILRQVL----HHN-VITLHDVYENRTDVVLILELVSGGELFDFLAQKESL--SEEEATSF 120
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR--SAIKIIDFGSSCHV--GQTLYQY 273
+Q+ + +L + I H DLKPENI+L IK+IDFG + + G
Sbjct: 121 IKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 274 IQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV 328
+ + +PE++ P L DMWS+G I L +G F G + + + I V
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 9/27 (33%), Positives = 16/27 (59%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFF 430
KD I ++L + +KR++ LRH +
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWI 276
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 65/233 (27%), Positives = 103/233 (44%), Gaps = 21/233 (9%)
Query: 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-------EVQLL 160
D YE+ LG G F V K + A K IK ++ ++ + EV +L
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 161 EKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQ 219
+I H I+ L F K + L+ EL+S L++ + + + +F +
Sbjct: 63 REIR----HPN-IITLHDIFENKTDVVLILELVSGGELFDFLAEKESL--TEDEATQFLK 115
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILLCSPKR--SAIKIIDFGSSCHV--GQTLYQYIQ 275
Q+ + +L S I H DLKPENI+L IK+IDFG + + G
Sbjct: 116 QILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG 173
Query: 276 SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV 328
+ + +PE++ P L DMWS+G I L +G F G+ + + +T I V
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 226
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 11/24 (45%), Positives = 15/24 (62%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRH 427
KD I R+L DPK+R++ L H
Sbjct: 243 KDFIRRLLVKDPKRRMTIAQSLEH 266
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 21/235 (8%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-------EVQ 158
+K D Y+I LG G F V K + + A K IK ++ ++ + EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 159 LLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKF 217
+L ++ H I+ L + + + L+ EL+S L++ + S F
Sbjct: 68 ILRQVL----H-PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL--SEEEATSF 120
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSP--KRSAIKIIDFGSSCHV--GQTLYQY 273
+Q+ + +L + I H DLKPENI+L IK+IDFG + + G
Sbjct: 121 IKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 274 IQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV 328
+ + +PE++ P L DMWS+G I L +G F G + + + I V
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 9/34 (26%), Positives = 16/34 (47%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSVDN 437
KD I ++L + +KR++ LRH +
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQ 283
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 21/235 (8%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-------EVQ 158
E D Y+ LG G F V K + Q A K IK ++ ++ + EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 159 LLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKF 217
+L++I H ++ L + K + L+ EL++ L++ + + +F
Sbjct: 67 ILKEIQ----HPN-VITLHEVYENKTDVILILELVAGGELFDFLAEKESL--TEEEATEF 119
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR--SAIKIIDFGSSCHV--GQTLYQY 273
+Q+ + +L S L I H DLKPENI+L IKIIDFG + + G
Sbjct: 120 LKQILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 274 IQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV 328
+ + +PE++ P L DMWS+G I L +G F G + + + + V
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 12/24 (50%), Positives = 17/24 (70%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRH 427
KD I R+L DPKKR++ + L+H
Sbjct: 249 KDFIRRLLVKDPKKRMTIQDSLQH 272
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-39
Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 22/226 (9%)
Query: 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-------EVQL 159
F D YE+ ++GKG F V + + E Q A+KI+ + F + + E +
Sbjct: 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIV-DVAKFTSSPGLSTEDLKREASI 79
Query: 160 LEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLI--RNTNFHGVSLNLTKK 216
+ H +IV+L ++ L +VFE + +L I R S +
Sbjct: 80 CHMLK----H-PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 217 FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA-IKIIDFGSSCHV---GQTLYQ 272
+ +Q+ AL + +IIH D+KP +LL S + SA +K+ FG + + G
Sbjct: 135 YMRQILEALRYCHD--NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
Query: 273 YIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNE 318
+ + ++ +PEV+ PY +D+W G IL L +G F G E
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE 238
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 12/27 (44%), Positives = 16/27 (59%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFF 430
KDL+ RML DP +RI+ L H +
Sbjct: 264 KDLVRRMLMLDPAERITVYEALNHPWL 290
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 4e-39
Identities = 62/346 (17%), Positives = 109/346 (31%), Gaps = 67/346 (19%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI--EVQLLEKINKAD 167
+ + +LG+G+ V + + AIK+ N E ++L+K+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN--- 65
Query: 168 IHSRYIVKLKGHF--TWKNHLCLVFELLSY-NLYN-LIRNTNFHGVSLNLTKKFAQQLCC 223
H IVKL T H L+ E +LY L +N +G+ + + +
Sbjct: 66 -HK-NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSP--KRSAIKIIDFGSSCHV--GQTLYQYIQSRYY 279
+ L I+H ++KP NI+ +S K+ DFG++ + + + Y
Sbjct: 124 GMNHLRE--NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEY 181
Query: 280 RSPEVLLGI--------PYDLAIDMWSLGCILVELHTGEPLF----SGKNEVDQMTKIIE 327
P++ Y +D+WS+G TG F + + M KII
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 328 VLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGG 387
G P G + + D D S +
Sbjct: 242 --GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL--------------------- 278
Query: 388 RRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433
++ +L D +K + H
Sbjct: 279 ---------------LTPVLANILEADQEKCWGFDQFFAETSDILH 309
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-39
Identities = 80/286 (27%), Positives = 127/286 (44%), Gaps = 31/286 (10%)
Query: 58 HINEVYYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTL 117
+N K KR+ L++N + + V D D + + D Y +
Sbjct: 86 FVNTELVGKGKRR-PLNNNSEIALSLSRNKVFV--FFDLTVDDQSVYPKALRDEYIMSKT 142
Query: 118 LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI----------EVQLLEKINKAD 167
LG G+ G+V AF+ + +VAI+II +K+ F + E+++L+K+N
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRII-SKRKFAIGSAREADPALNVETEIEILKKLN--- 198
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
H I+K+K F +V EL+ L++ + + K + Q+ A+
Sbjct: 199 -H-PCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQ 253
Query: 227 FLSSPELSIIHCDLKPENILLCSP-KRSAIKIIDFGSSCHV--GQTLYQYIQSRYYRSPE 283
+L IIH DLKPEN+LL S + IKI DFG S + + + Y +PE
Sbjct: 254 YLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 311
Query: 284 VLLGI---PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
VL+ + Y+ A+D WSLG IL +G P FS + I
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 357
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 10/34 (29%), Positives = 16/34 (47%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSVDN 437
DL+ ++L DPK R + LRH + +
Sbjct: 377 LDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-39
Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 16/230 (6%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI--EVQLLEKI 163
D + LG G+FG V + + IK I + + QI E+++L+ +
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHGVSLN--LTKKFAQQ 220
+ H I+K+ F +++ +V E L I + G +L+ + +Q
Sbjct: 78 D----H-PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKR-SAIKIIDFGSSCHV--GQTLYQYIQSR 277
+ ALA+ S ++H DLKPENIL S IKIIDFG + + +
Sbjct: 133 MMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTA 190
Query: 278 YYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
Y +PEV D+WS G ++ L TG F+G + + K
Sbjct: 191 LYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY 239
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 14/27 (51%), Positives = 19/27 (70%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFF 430
DL+ +MLT DP++R S VL HE+F
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-39
Identities = 45/244 (18%), Positives = 86/244 (35%), Gaps = 35/244 (14%)
Query: 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKI 163
++ + +G G FG V K + C AIK K A EV +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSL--NLTKKFAQQ 220
++V+ + +H+ + E + +L + I K Q
Sbjct: 68 G----QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLC-----------------SPKRSAIKIIDFGSS 263
+ L ++ S +S++H D+KP NI + + + KI D G
Sbjct: 124 VGRGLRYIHS--MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG-- 179
Query: 264 CHVGQTLYQYIQ--SRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVD 320
HV + ++ + + EVL + D+++L +V EPL ++
Sbjct: 180 -HVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238
Query: 321 QMTK 324
++ +
Sbjct: 239 EIRQ 242
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-39
Identities = 66/277 (23%), Positives = 120/277 (43%), Gaps = 23/277 (8%)
Query: 65 TKKKRKAQLSHNETRSNKKEKKYVHNDGHDDE-------NYDYIIKHGEKFLDRYEIDTL 117
+ K S+ + K + D ++ + Y +
Sbjct: 35 GHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKT 94
Query: 118 --LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI--EVQLLEKINKADIHSRYI 173
LG G FGQV K + ++A KIIK + ++ ++ E+ ++ +++ H +
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIK-TRGMKDKEEVKNEISVMNQLD----H-ANL 148
Query: 174 VKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE 232
++L F KN + LV E + L++ I + +++ ++ T F +Q+C + +
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN-LTELDTILFMKQICEGIRHMHQ-- 205
Query: 233 LSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRYYRSPEVLLGIPY 290
+ I+H DLKPENIL + IKIIDFG + + L + + +PEV+
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV 265
Query: 291 DLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
DMWS+G I L +G F G N+ + + I+
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA 302
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 9/34 (26%), Positives = 18/34 (52%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSVDN 437
K+ I ++L + RIS + L+H + H + +
Sbjct: 320 KEFISKLLIKEKSWRISASEALKHPWLSDHKLHS 353
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 61/247 (24%), Positives = 101/247 (40%), Gaps = 40/247 (16%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINK 165
+ + + +LG GS G VV + VA+K + F + A +E++LL +
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRML--IDFCDIALMEIKLLTES-- 65
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNL-----TKKFAQQ 220
D H +++ T L + EL + NL +L+ + N +L L +Q
Sbjct: 66 -DDHP-NVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSA-----------IKIIDFGSSCHVGQT 269
+ +A L S L IIH DLKP+NIL+ + R I I DFG +
Sbjct: 124 IASGVAHLHS--LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 270 LYQYIQ-------SRYYRSPEVLLGI-------PYDLAIDMWSLGCIL-VELHTGEPLFS 314
+ + +R+PE+L +ID++S+GC+ L G+ F
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 315 GKNEVDQ 321
K +
Sbjct: 242 DKYSRES 248
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 13/27 (48%), Positives = 17/27 (62%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFF 430
DLI +M+ +DP KR + VLRH F
Sbjct: 273 TDLISQMIDHDPLKRPTAMKVLRHPLF 299
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 60/232 (25%), Positives = 104/232 (44%), Gaps = 19/232 (8%)
Query: 103 KHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI--EVQLL 160
Y ++ +G+GS+G+V A + + A K I K + + E++++
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKI-PKYFVEDVDRFKQEIEIM 60
Query: 161 EKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFA 218
+ ++ H I++L F + LV EL + ++ F + +
Sbjct: 61 KSLD----H-PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVF---RESDAARIM 112
Query: 219 QQLCCALAFLSSPELSIIHCDLKPENILLCSPKR-SAIKIIDFGSSCHV--GQTLYQYIQ 275
+ + A+A+ L++ H DLKPEN L + S +K+IDFG + G+ + +
Sbjct: 113 KDVLSAVAYCHK--LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG 170
Query: 276 SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
+ YY SP+VL G Y D WS G ++ L G P FS + + M KI E
Sbjct: 171 TPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 8e-06
Identities = 14/34 (41%), Positives = 20/34 (58%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSVDN 437
+ LI R+LT PK+RI+ L HE+F K +
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-38
Identities = 67/234 (28%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 108 FLDRYEIDTL---LGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKIN 164
F Y++D LG+GSF K + A+KII + Q E+ L+
Sbjct: 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM--EANTQKEITALKLC- 62
Query: 165 KADIHSRYIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHGVSLNLTKKFA----Q 219
+ H IVKL F + H LV ELL+ L+ I+ ++ A +
Sbjct: 63 --EGH-PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH------FSETEASYIMR 113
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILLCSPKR-SAIKIIDFGSSCHV---GQTLYQYIQ 275
+L A++ + + ++H DLKPEN+L IKIIDFG + Q L
Sbjct: 114 KLVSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171
Query: 276 SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVL 329
+ +Y +PE+L YD + D+WSLG IL + +G+ F + T +E++
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM 225
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 12/32 (37%), Positives = 18/32 (56%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435
KDLI +LT DP KR+ + + +E+ S
Sbjct: 248 KDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 64/232 (27%), Positives = 104/232 (44%), Gaps = 19/232 (8%)
Query: 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI---EVQLLE 161
+F + Y++ LGKG+F V + + A II KK Q E ++
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 162 KINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLI-RNTNFHGVSLNLTKKFAQ 219
+ H IV+L + + H L+F+L++ L+ I + S Q
Sbjct: 66 LLK----H-PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYY---SEADASHCIQ 117
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILLCSP-KRSAIKIIDFGSSCHV---GQTLYQYIQ 275
Q+ A+ + ++H +LKPEN+LL S K +A+K+ DFG + V Q + +
Sbjct: 118 QILEAVLHCHQ--MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175
Query: 276 SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
+ Y SPEVL PY +D+W+ G IL L G P F +++ +I
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA 227
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 14/32 (43%), Positives = 19/32 (59%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435
KDLI +MLT +P KRI+ L+H + S
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPWISHRST 276
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-38
Identities = 37/255 (14%), Positives = 70/255 (27%), Gaps = 36/255 (14%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII----KNKKPFLNQAQIEVQLLEKINKA 166
+ ++ L G V D E A+K+ +N + L + ++
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 167 DIHSRY----------IVKLKGH-----------FTWKNHLCLVFELLSYNLYNLIRNTN 205
V ++ + L+ S +L L +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 206 FHGV-----SLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260
F V + QL A L S ++H P+N+ + + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQS--KGLVHGHFTPDNLFIM--PDGRLMLGDV 238
Query: 261 GSSCHVGQTLYQYIQSRYYRSPEVLLG--IPYDLAIDMWSLGCILVELHTGEPLFSGKNE 318
+ VG Y E L + A++ W LG + + F
Sbjct: 239 SALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 319 VDQMTKIIEVLGMPP 333
+ + L +P
Sbjct: 299 GIKGSWKRPSLRVPG 313
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 5e-06
Identities = 10/29 (34%), Positives = 16/29 (55%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLK 432
K LI R L +D ++R+ P + FL+
Sbjct: 330 KTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-38
Identities = 54/360 (15%), Positives = 120/360 (33%), Gaps = 73/360 (20%)
Query: 102 IKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLE 161
+K +K+++ Y I L +G F +++ + A+K K + +
Sbjct: 23 VKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKF--YALKKY-EKSLLEKKRDFTKSNND 79
Query: 162 KINKADIHSR--------------YIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRN--- 203
KI+ + Y + +G T + + +++E + ++
Sbjct: 80 KISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 204 ---TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260
+ + + K + + + +++ + E +I H D+KP NIL+ R +K+ DF
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGR--VKLSDF 196
Query: 261 GSSCHV-GQTLYQYIQSRYYRSPEVLLGIP--YDLAIDMWSLGCILVELHTGEPLFSGKN 317
G S ++ + + + + PE +D+WSLG L + FS K
Sbjct: 197 GESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
Query: 318 EVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTI 377
+ ++ I +T P +
Sbjct: 257 SLVELFNNI---------------RTKNI--------------------EYPLDRNHFLY 281
Query: 378 LGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHSVDN 437
+ D + L +P +RI+ + L+HE+ ++++
Sbjct: 282 PLTNKKSTCSNNFLSNE--------DIDFLKLFLRKNPAERITSEDALKHEWLADTNIED 333
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 67/245 (27%), Positives = 103/245 (42%), Gaps = 31/245 (12%)
Query: 103 KHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI------- 155
F + YE +LG+G V + + A+KII A+
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 156 ---EVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYN-LIRNTNFHGVS 210
EV +L K+ H I++LK + LVF+L+ L++ L S
Sbjct: 70 TLKEVDILRKV---SGH-PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL---S 122
Query: 211 LNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQ 268
T+K + L + L L+I+H DLKPENILL IK+ DFG SC + G+
Sbjct: 123 EKETRKIMRALLEVICALHK--LNIVHRDLKPENILLDD--DMNIKLTDFGFSCQLDPGE 178
Query: 269 TLYQYIQSRYYRSPEVLLGI------PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQM 322
L + + Y +PE++ Y +DMWS G I+ L G P F + ++ +
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 323 TKIIE 327
I+
Sbjct: 239 RMIMS 243
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 13/34 (38%), Positives = 19/34 (55%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSVDN 437
KDL+ R L P+KR + L H FF ++ V+
Sbjct: 261 KDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-37
Identities = 73/241 (30%), Positives = 115/241 (47%), Gaps = 30/241 (12%)
Query: 104 HGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-------- 155
+ + D Y + LG G+ G+V AF+ + +VAIKII +K+ F +
Sbjct: 4 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKII-SKRKFAIGSAREADPALNV 62
Query: 156 --EVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYN-LYNLI-RNTNFHGVSL 211
E+++L+K+N H I+K+K F +++ +V EL+ L++ + N
Sbjct: 63 ETEIEILKKLN----H-PCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRL---KE 113
Query: 212 NLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP-KRSAIKIIDFGSSCHV--GQ 268
K + Q+ A+ +L IIH DLKPEN+LL S + IKI DFG S +
Sbjct: 114 ATCKLYFYQMLLAVQYLHE--NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
Query: 269 TLYQYIQSRYYRSPEVLLGI---PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKI 325
+ + Y +PEVL+ + Y+ A+D WSLG IL +G P FS +
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231
Query: 326 I 326
I
Sbjct: 232 I 232
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 10/34 (29%), Positives = 16/34 (47%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSVDN 437
DL+ ++L DPK R + LRH + +
Sbjct: 252 LDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 285
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-37
Identities = 76/314 (24%), Positives = 134/314 (42%), Gaps = 37/314 (11%)
Query: 38 RDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQL-----SHNETRSNKKEKKYVHNDG 92
R A +R L + + + A L N+ + E Y + G
Sbjct: 19 RRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMG 78
Query: 93 HDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQ 152
+DE D+ ++F +Y+ ++G+G V + + A+KI++ L+
Sbjct: 79 PEDELPDW--AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSP 136
Query: 153 AQI---------EVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYN-LI 201
Q+ E +L ++ H +I+ L + + + LVF+L+ L++ L
Sbjct: 137 EQLEEVREATRRETHILRQVAG---H-PHIITLIDSYESSSFMFLVFDLMRKGELFDYLT 192
Query: 202 RNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261
S T+ + L A++FL + +I+H DLKPENILL I++ DFG
Sbjct: 193 EKVAL---SEKETRSIMRSLLEAVSFLHA--NNIVHRDLKPENILLDD--NMQIRLSDFG 245
Query: 262 SSCHV--GQTLYQYIQSRYYRSPEVLLGI------PYDLAIDMWSLGCILVELHTGEPLF 313
SCH+ G+ L + + Y +PE+L Y +D+W+ G IL L G P F
Sbjct: 246 FSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305
Query: 314 SGKNEVDQMTKIIE 327
+ ++ + I+E
Sbjct: 306 WHRRQILMLRMIME 319
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 13/29 (44%), Positives = 19/29 (65%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLK 432
KDLI R+L DP+ R++ L+H FF +
Sbjct: 337 KDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-37
Identities = 61/252 (24%), Positives = 101/252 (40%), Gaps = 42/252 (16%)
Query: 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKIN 164
++L +E LG+G FG V +A + + C AIK I+ N++ + EV+ L K+
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 165 KADIHSRYIVKLKGHF------------TWKNHLCLVFELLS-YNLYNLIRNTN-FHGVS 210
H IV+ + + K +L + +L NL + +
Sbjct: 62 ----H-PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 211 LNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT- 269
++ Q+ A+ FL S ++H DLKP NI +K+ DFG + Q
Sbjct: 117 RSVCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFT--MDDVVKVGDFGLVTAMDQDE 172
Query: 270 --------------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG 315
+ ++ Y SPE + G Y +D++SLG IL EL P +
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQ 230
Query: 316 KNEVDQMTKIIE 327
V +T +
Sbjct: 231 MERVRTLTDVRN 242
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-37
Identities = 64/272 (23%), Positives = 114/272 (41%), Gaps = 16/272 (5%)
Query: 60 NEVYYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLG 119
+ +++ + + +Y + + D +E+++ LG
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELG 62
Query: 120 KGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179
+G+ V + + A+K++K K + E+ +L +++ H I+KLK
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVRTEIGVLLRLS----H-PNIIKLKEI 116
Query: 180 FTWKNHLCLVFELLSYN-LYNLI-RNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIH 237
F + LV EL++ L++ I + S +Q+ A+A+L I+H
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYY---SERDAADAVKQILEAVAYLHE--NGIVH 171
Query: 238 CDLKPENILLCSPKR-SAIKIIDFGSSCHV--GQTLYQYIQSRYYRSPEVLLGIPYDLAI 294
DLKPEN+L +P + +KI DFG S V + + Y +PE+L G Y +
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEV 231
Query: 295 DMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
DMWS+G I L G F + M + I
Sbjct: 232 DMWSVGIITYILLCGFEPFYDERGDQFMFRRI 263
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 10/34 (29%), Positives = 20/34 (58%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSVDN 437
KDL+ +++ DPKKR++ L+H + + +
Sbjct: 283 KDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF 316
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-37
Identities = 69/244 (28%), Positives = 109/244 (44%), Gaps = 30/244 (12%)
Query: 103 KHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK 162
K + L+ +EI LGKG FG V A + + K +A+K++ + L +A +E QL +
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ--LEKAGVEHQLRRE 59
Query: 163 INKADIHSR----YIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKF 217
+ I S I++L G+F + L+ E +Y ++ T +
Sbjct: 60 VE---IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATY 114
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR 277
+L AL++ S +IH D+KPEN+LL S +KI DFG S H + R
Sbjct: 115 ITELANALSYCHS--KRVIHRDIKPENLLLGS--AGELKIADFGWSVHAPSSR------R 164
Query: 278 Y-------YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV-L 329
Y PE++ G +D +D+WSLG + E G+P F + +I V
Sbjct: 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 224
Query: 330 GMPP 333
P
Sbjct: 225 TFPD 228
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 11/31 (35%), Positives = 18/31 (58%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434
+DLI R+L ++P +R VL H + +S
Sbjct: 235 RDLISRLLKHNPSQRPMLREVLEHPWITANS 265
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 25/229 (10%)
Query: 103 KHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK 162
++ +F D YE+ +G GS+ + + A+KII K E+++L +
Sbjct: 15 RNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK---RDPTEEIEILLR 71
Query: 163 INKADIHSRYIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHGVSLNLTKKFA--- 218
+ H I+ LK + ++ +V EL+ L + I F +++ A
Sbjct: 72 YGQ---H-PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF------FSEREASAV 121
Query: 219 -QQLCCALAFLSSPELSIIHCDLKPENILLCSPKR--SAIKIIDFGSSCHV---GQTLYQ 272
+ + +L + ++H DLKP NIL +I+I DFG + + L
Sbjct: 122 LFTITKTVEYLHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 273 YIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ 321
+ + +PEVL YD A D+WSLG +L + TG F+ +
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP 228
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 12/32 (37%), Positives = 19/32 (59%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435
KDL+ +ML DP +R++ VLRH + +
Sbjct: 255 KDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-36
Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 19/229 (8%)
Query: 103 KHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-------PFLNQAQI 155
K E F Y + LLGKG FG V ++ QVAIK+I + +
Sbjct: 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 156 EVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHG-VSLN 212
EV LL K+ H +++L F + LV E L++ I G +
Sbjct: 84 EVALLWKVGAGGGH-PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEG 139
Query: 213 LTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ 272
++ F Q+ A+ S ++H D+K ENIL+ +R K+IDFGS + Y
Sbjct: 140 PSRCFFGQVVAAIQHCHS--RGVVHRDIKDENILI-DLRRGCAKLIDFGSGALLHDEPYT 196
Query: 273 YIQ-SRYYRSPEVLLGIPYD-LAIDMWSLGCILVELHTGEPLFSGKNEV 319
+R Y PE + Y L +WSLG +L ++ G+ F E+
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI 245
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-36
Identities = 52/239 (21%), Positives = 83/239 (34%), Gaps = 32/239 (13%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII-KNKKPFLNQAQIEVQLLEKINKADIH 169
Y LG+G F V + A+K I +++ +AQ E + N H
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN----H 85
Query: 170 SRYIVKLKGHF----TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTK--KFAQQLC 222
I++L + K+ L+ L+N I G L + +C
Sbjct: 86 -PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS------------CHVGQTL 270
L + + H DLKP NILL + ++D GS Q
Sbjct: 145 RGLEAIHAK--GYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 271 YQYIQSRYYRSPEVLLGIPY---DLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
+ YR+PE+ + D D+WSLGC+L + GE + + +
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-35
Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 18/233 (7%)
Query: 103 KHGEKFLDRYEID-TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLE 161
D Y++ +LG G G+V++ F + A+K++ + +A+ EV
Sbjct: 21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHW 76
Query: 162 KINKADIHSRYIVKLKGHF----TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKK 216
+ + +IV + + K L ++ E + L++ I+ + +
Sbjct: 77 QASG---G-PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAE 132
Query: 217 FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR-SAIKIIDFGSSCHV-GQTLYQYI 274
+ + A+ FL S +I H D+KPEN+L S ++ + +K+ DFG + L
Sbjct: 133 IMRDIGTAIQFLHS--HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC 190
Query: 275 QSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
+ YY +PEVL YD + DMWSLG I+ L G P F +
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR 243
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 9/24 (37%), Positives = 14/24 (58%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRH 427
K LI +L DP +R++ T + H
Sbjct: 265 KQLIRLLLKTDPTERLTITQFMNH 288
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 65/239 (27%), Positives = 107/239 (44%), Gaps = 32/239 (13%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
+D ++I LGKG FG V A + + K +A+K++ + L + +E QL +I I
Sbjct: 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQ--LEKEGVEHQLRREIE---I 67
Query: 169 HSR----YIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHG-VSLNLTKKFAQQLC 222
S I+++ +F + + L+ E LY ++ HG + F ++L
Sbjct: 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK---HGRFDEQRSATFMEELA 124
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRY---- 278
AL + +IH D+KPEN+L+ + +KI DFG S H R
Sbjct: 125 DALHYCHE--RKVIHRDIKPENLLMGY--KGELKIADFGWSVHAPSLR------RRTMCG 174
Query: 279 ---YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV-LGMPP 333
Y PE++ G +D +D+W G + E G P F + + +I+ V L PP
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP 233
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 11/31 (35%), Positives = 18/31 (58%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434
KDLI ++L Y P +R+ V+ H + +S
Sbjct: 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 21/229 (9%)
Query: 103 KHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-------PFLNQAQI 155
K E +Y++ LLG G FG V + VAIK ++ + P + +
Sbjct: 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 156 EVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHG-VSLN 212
EV LL+K++ +++L F + L+ E L++ I G +
Sbjct: 96 EVVLLKKVSSGFSG---VIRLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEE 149
Query: 213 LTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ 272
L + F Q+ A+ + ++H D+K ENIL+ R +K+IDFGS + T+Y
Sbjct: 150 LARSFFWQVLEAVRHCHN--CGVLHRDIKDENILI-DLNRGELKLIDFGSGALLKDTVYT 206
Query: 273 YIQ-SRYYRSPEVLLGIPYD-LAIDMWSLGCILVELHTGEPLFSGKNEV 319
+R Y PE + Y + +WSLG +L ++ G+ F E+
Sbjct: 207 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 255
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-35
Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 19/225 (8%)
Query: 100 YIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQL 159
++I + E E++ ++G+G+FG V KA + VAIK I+++ +E++
Sbjct: 3 HMIDYKE-----IEVEEVVGRGAFGVVCKAKWRAKD--VAIKQIESES-ERKAFIVELRQ 54
Query: 160 LEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNT-NFHGVSLNLTKKF 217
L ++ + IVKL G N +CLV E +LYN++ + +
Sbjct: 55 LSRV-----NHPNIVKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107
Query: 218 AQQLCCALAFL-SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQS 276
Q +A+L S ++IH DLKP N+LL + + +KI DFG++C + + S
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVA-GGTVLKICDFGTACDIQTHMTNNKGS 166
Query: 277 RYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ 321
+ +PEV G Y D++S G IL E+ T F
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 57/247 (23%), Positives = 110/247 (44%), Gaps = 20/247 (8%)
Query: 111 RYE-IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF---LNQAQIEVQLLEKINKA 166
R+ D +G+GSF V K D E +VA ++++K + + E ++L+ +
Sbjct: 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-- 83
Query: 167 DIHSRYIVKLKGHF----TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQL 221
H IV+ + K + LV EL++ L ++ F + + + + + +Q+
Sbjct: 84 --H-PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQI 138
Query: 222 CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL-YQYIQSRYYR 280
L FL + IIH DLK +NI + + ++KI D G + + I + +
Sbjct: 139 LKGLQFLHTRTPPIIHRDLKCDNIFI-TGPTGSVKIGDLGLATLKRASFAKAVIGTPEFM 197
Query: 281 SPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340
+PE+ YD ++D+++ G ++E+ T E +S Q+ + + G+ P A
Sbjct: 198 APEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV-TSGVKPASFDKVA 255
Query: 341 SKTSKYF 347
K
Sbjct: 256 IPEVKEI 262
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-34
Identities = 58/272 (21%), Positives = 115/272 (42%), Gaps = 19/272 (6%)
Query: 65 TKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEI-DTLLGKGSF 123
+ + + +D Y++ +LG G
Sbjct: 16 APAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGIN 75
Query: 124 GQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHF--- 180
G+V++ F+ + + A+K++++ +A+ EV+L + ++ +IV++ +
Sbjct: 76 GKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQ---C-PHIVRIVDVYENL 127
Query: 181 -TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHC 238
+ L +V E L L++ I++ + + + + A+ +L S ++I H
Sbjct: 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHR 185
Query: 239 DLKPENILLCSPKR-SAIKIIDFGSSCHV--GQTLYQYIQSRYYRSPEVLLGIPYDLAID 295
D+KPEN+L S + + +K+ DFG + +L + YY +PEVL YD + D
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 245
Query: 296 MWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
MWSLG I+ L G P F + + +
Sbjct: 246 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 8/32 (25%), Positives = 18/32 (56%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435
K LI +L +P +R++ T + H + ++ +
Sbjct: 299 KMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 50/226 (22%), Positives = 88/226 (38%), Gaps = 23/226 (10%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
+ +G+GSFG+V + D + Q A+K + E+ +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACA-----GL 107
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
S IV L G + + ELL +L LI+ + + + Q L +
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEY 165
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR--------YY 279
L + I+H D+K +N+LL S S + DFG + + +
Sbjct: 166 LHT--RRILHGDVKADNVLL-SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 280 RSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKI 325
+PEV++G P D +D+WS C+++ + G ++ KI
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-34
Identities = 55/248 (22%), Positives = 99/248 (39%), Gaps = 28/248 (11%)
Query: 95 DENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP------ 148
++ + E E + +GKG FG V K ++K VAIK +
Sbjct: 9 PKSRLPTLADNE-----IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM 63
Query: 149 --FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTN 205
+ Q EV ++ +N H IVKL G +V E + +LY+ + +
Sbjct: 64 IEKFQEFQREVFIMSNLN----H-PNIVKLYG-LMHNP-PRMVMEFVPCGDLYHRLLDKA 116
Query: 206 FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA---IKIIDFGS 262
H + ++ + + + ++ + I+H DL+ NI L S +A K+ DFG
Sbjct: 117 -HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175
Query: 263 SCHVGQTLYQYIQSRYYRSPEVLLG--IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVD 320
S ++ + + + +PE + Y D +S IL + TGE F +
Sbjct: 176 SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG- 234
Query: 321 QMTKIIEV 328
++ I +
Sbjct: 235 KIKFINMI 242
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 55/235 (23%), Positives = 91/235 (38%), Gaps = 34/235 (14%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII-KNKKPFLNQAQIEVQLLEKINKADIH 169
R + +L +G F V +A D + A+K + N++ EV ++K++
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS----G 84
Query: 170 SRYIVKLKGHFTWKNH--------LCLVFELLSYNLYNLIRNTNFHG-VSLNLTKKFAQQ 220
IV+ + L+ EL L ++ G +S + K Q
Sbjct: 85 HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR--- 277
C A+ + + IIH DLK EN+LL + IK+ DFGS+ + ++
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDFGSATTISHYPDYSWSAQRRA 202
Query: 278 ------------YYRSPEVL---LGIPYDLAIDMWSLGCILVELHTGEPLFSGKN 317
YR+PE++ P D+W+LGCIL L + F
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 71/266 (26%), Positives = 109/266 (40%), Gaps = 51/266 (19%)
Query: 104 HGEKFLDRYEI-DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI--EVQLL 160
+F D Y++ + +LG+G+ +V + + A+KII K+P ++++ EV++L
Sbjct: 6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKII-EKQPGHIRSRVFREVEML 64
Query: 161 EKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSL--------N 212
+ H R +++L F ++ LVFE + G S+ +
Sbjct: 65 YQCQG---H-RNVLELIEFFEEEDRFYLVFEKMR-------------GGSILSHIHKRRH 107
Query: 213 LTKKFA----QQLCCALAFLSSPELSIIHCDLKPENILLCSPKR-SAIKIIDFGSSCHV- 266
+ A Q + AL FL + I H DLKPENIL P + S +KI DF +
Sbjct: 108 FNELEASVVVQDVASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165
Query: 267 ---------GQTLYQYIQSRYYRSPEVLLGI-----PYDLAIDMWSLGCILVELHTGEPL 312
L S Y +PEV+ YD D+WSLG IL L +G P
Sbjct: 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
Query: 313 FSGKNEVDQMTKIIEVLGMPPGYLLH 338
F G+ D E L
Sbjct: 226 FVGRCGSDCGWDRGEACPACQNMLFE 251
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 13/34 (38%), Positives = 21/34 (61%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSVDN 437
KDLI ++L D K+R+S VL+H + + +N
Sbjct: 273 KDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPEN 306
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 19/234 (8%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
++ +++ LLGKGSF V +A +VAIK+I K + +A + ++ ++ I
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA--MYKAGMVQRVQNEV---KI 64
Query: 169 HSR----YIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHGVSLNLTKKFAQQLCC 223
H + I++L +F N++ LV E+ + ++N S N + F Q+
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIIT 123
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---GQTLYQYIQSRYYR 280
+ +L S I+H DL N+LL IKI DFG + + + Y + Y
Sbjct: 124 GMLYLHS--HGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPHEKHYTLCGTPNYI 179
Query: 281 SPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV-LGMPP 333
SPE+ + L D+WSLGC+ L G P F + + K++ MP
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS 233
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 8e-06
Identities = 13/31 (41%), Positives = 21/31 (67%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434
KDLI ++L +P R+S ++VL H F ++S
Sbjct: 240 KDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 59/246 (23%), Positives = 98/246 (39%), Gaps = 31/246 (12%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
RY LGKG F + + D + K A KI+ L + ++ +I+ I
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMSMEIS---I 94
Query: 169 HSR----YIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHG-VSLNLTKKFAQQLC 222
H ++V G F + + +V EL L L + ++ + + +Q+
Sbjct: 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIV 151
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRY---- 278
+L +IH DLK N+ L +KI DFG + T +Y R
Sbjct: 152 LGCQYLHR--NRVIHRDLKLGNLFLNE--DLEVKIGDFGLA-----TKVEYDGERKKVLC 202
Query: 279 ----YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPG 334
Y +PEVL + +D+WS+GCI+ L G+P F + +I + P
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK 262
Query: 335 YLLHGA 340
++ A
Sbjct: 263 HINPVA 268
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 11/32 (34%), Positives = 15/32 (46%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435
LI +ML DP R + +L EFF +
Sbjct: 269 ASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 68/235 (28%), Positives = 111/235 (47%), Gaps = 17/235 (7%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
+ + +LGKG FG+V A K ++ KK + + L EK +
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE-KKRIKKRKGEAMALNEKQILEKV 241
Query: 169 HSRYIVKLKGHFTWKNHLCLVFEL-----LSYNLYNLIRNTNFHGVSLNLTKKFAQQLCC 223
+SR++V L + K+ LCLV L L +++Y++ + G +A ++CC
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ----AGFPEARAVFYAAEICC 297
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRYYRS 281
L L I++ DLKPENILL I+I D G + HV GQT+ + + Y +
Sbjct: 298 GLEDLHR--ERIVYRDLKPENILL--DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 353
Query: 282 PEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE-VLGMPPGY 335
PEV+ Y + D W+LGC+L E+ G+ F + + + ++ V +P Y
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY 408
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 58/241 (24%), Positives = 98/241 (40%), Gaps = 21/241 (8%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
RY LGKG F + + D + K A KI+ L + ++ +I+ I
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMSMEIS---I 68
Query: 169 HSR----YIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHG-VSLNLTKKFAQQLC 222
H ++V G F + + +V EL L L + ++ + + +Q+
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR---RKALTEPEARYYLRQIV 125
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---GQTLYQYIQSRYY 279
+L +IH DLK N+ L +KI DFG + V G+ + Y
Sbjct: 126 LGCQYLHR--NRVIHRDLKLGNLFLNE--DLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181
Query: 280 RSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339
+PEVL + +D+WS+GCI+ L G+P F + +I + P ++
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 241
Query: 340 A 340
A
Sbjct: 242 A 242
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 5e-05
Identities = 11/30 (36%), Positives = 14/30 (46%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKH 433
LI +ML DP R + +L EFF
Sbjct: 243 ASLIQKMLQTDPTARPTINELLNDEFFTSG 272
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 66/231 (28%), Positives = 109/231 (47%), Gaps = 20/231 (8%)
Query: 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII-KNKKPFLNQAQI--EVQLLE 161
+ + Y + +GKG+F +V A +VAIKII K + + ++ EV++++
Sbjct: 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMK 69
Query: 162 KINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHG-VSLNLTKKFAQ 219
+N H IVKL + L L+ E S +++ + HG + + +
Sbjct: 70 ILN----H-PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA---HGRMKEKEARSKFR 121
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSR 277
Q+ A+ + I+H DLK EN+LL + IKI DFG S G L + +
Sbjct: 122 QIVSAVQYCHQ--KRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLDAFCGAP 177
Query: 278 YYRSPEVLLGIPYD-LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
Y +PE+ G YD +D+WSLG IL L +G F G+N + +++
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 228
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 3e-32
Identities = 45/346 (13%), Positives = 101/346 (29%), Gaps = 64/346 (18%)
Query: 31 ARIPMQFRDPATAPLRKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKEKKYVHN 90
R + F+ P + +L + I + Q + + S
Sbjct: 10 GRENLYFQGPGDVVIEEL-------FNRIPQANVRTTSEYMQSAADSLVSTS-------- 54
Query: 91 DGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFL 150
+ + + + GE+ T+LG+ ++A D E + + +
Sbjct: 55 LWNTGQPFRVESELGERPR-TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP 113
Query: 151 NQAQ-------IEVQLLEKINKADIHSRY-----------------IVKLKGHF--TWKN 184
+ A + ++LL I + +++++ W
Sbjct: 114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 173
Query: 185 HLCLVFELLSYNLYNLIRNTNFHG-----VSLNLTKKFAQQLCCALAFLSSPELSIIHCD 239
++ + NL H + + + Q+ LA L ++H
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTY 231
Query: 240 LKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLL-----------GI 288
L+P +I+L +R + + F G SR + PE+
Sbjct: 232 LRPVDIVLD--QRGGVFLTGFEHLVRDG-ARVVSSVSRGFEPPELEARRATISYHRDRRT 288
Query: 289 PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE-VLGMPP 333
+ D W+LG ++ + + + + I +P
Sbjct: 289 LMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQ 334
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 5/30 (16%), Positives = 12/30 (40%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKH 433
+ L+ L Y + R+ P + + +
Sbjct: 337 RALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-32
Identities = 79/338 (23%), Positives = 132/338 (39%), Gaps = 37/338 (10%)
Query: 103 KHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLL 160
K GE D +E + LG G+ G V K +A K+I K NQ E+Q+L
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 161 EKINKADIHSRYIVKLKGHFTWKNHLCLVFELL---SYNLYNLIRNTNFHGVSLNLTKKF 217
+ +S YIV G F + + E + S L +++ + + K
Sbjct: 86 -----HECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAG--RIPEQILGKV 136
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ-YIQS 276
+ + L +L + I+H D+KP NIL+ S R IK+ DFG S + ++ ++ +
Sbjct: 137 SIAVIKGLTYLRE-KHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQLIDSMANSFVGT 193
Query: 277 RYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336
R Y SPE L G Y + D+WS+G LVE+ G + + +
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253
Query: 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHS 396
+ ++ +S + LD I V+ P + S
Sbjct: 254 PPRPRTPGRPLNKFGMDSRPPMAIFEL----------LDYI--VNEPPP---KLPSGVFS 298
Query: 397 LADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434
L F+D + + L +P +R ++ H F +
Sbjct: 299 LE----FQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-32
Identities = 61/256 (23%), Positives = 100/256 (39%), Gaps = 22/256 (8%)
Query: 70 KAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKA 129
K H+ + D I + I +G GSFG V +A
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCD-----LNIKEKIGAGSFGTVHRA 56
Query: 130 FDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186
H VA+KI+ + +N+ EV +++++ H IV G T +L
Sbjct: 57 EWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRLR----H-PNIVLFMGAVTQPPNL 109
Query: 187 CLVFELLSY-NLYNLIRNTNFHG-VSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPEN 244
+V E LS +LY L+ + + A + + +L + I+H +LK N
Sbjct: 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPN 169
Query: 245 ILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR---YYRSPEVLLGIPYDLAIDMWSLGC 301
+L+ +K+ DFG S T + + +PEVL P + D++S G
Sbjct: 170 LLVDKKYT--VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGV 227
Query: 302 ILVELHTGEPLFSGKN 317
IL EL T + + N
Sbjct: 228 ILWELATLQQPWGNLN 243
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-31
Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 21/236 (8%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK-NKKPFLNQAQIEVQLLEKINKAD 167
D +LGKG++G V D + ++AIK I + E+ L +
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK-----H 75
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHG---VSLNLTKKFAQQLCC 223
+ + IV+ G F+ + + E + +L L+R+ G + + +Q+
Sbjct: 76 LKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS--KWGPLKDNEQTIGFYTKQILE 133
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---GQTLYQYIQSRYYR 280
L +L + I+H D+K +N+L+ + +KI DFG+S + + + Y
Sbjct: 134 GLKYLHDNQ--IVHRDIKGDNVLI-NTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM 190
Query: 281 SPEVLLGIP--YDLAIDMWSLGCILVELHTGEPLFSG-KNEVDQMTKIIEVLGMPP 333
+PE++ P Y A D+WSLGC ++E+ TG+P F M K+ P
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE 246
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 104 HGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---------PFLNQAQ 154
++ +Y + LG G+FG V A D E+ +V +K IK +K P L +
Sbjct: 18 CEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT 77
Query: 155 IEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY--NLYNLIRNTNFHG-VSL 211
+E+ +L ++ H I+K+ F + LV E +L+ I H +
Sbjct: 78 LEIAILSRVE----H-ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR---HPRLDE 129
Query: 212 NLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQT 269
L +QL A+ +L IIH D+K ENI++ IK+IDFGS+ ++ G+
Sbjct: 130 PLASYIFRQLVSAVGYLRL--KDIIHRDIKDENIVIAE--DFTIKLIDFGSAAYLERGKL 185
Query: 270 LYQYIQSRYYRSPEVLLGIPYD-LAIDMWSLGCILVELHTGEPLFSGKNEV 319
Y + + Y +PEVL+G PY ++MWSLG L L E F E
Sbjct: 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET 236
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 113 EIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-----EVQLLEKINKAD 167
++ ++G G FG+V +AF ++ VA+K ++ I E +L +
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLK--- 64
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
H I+ L+G + +LCLV E L ++ + ++ +A Q+ +
Sbjct: 65 -H-PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMN 119
Query: 227 FL-SSPELSIIHCDLKPENILL------CSPKRSAIKIIDFGSSCHVGQTLYQYIQSRY- 278
+L + IIH DLK NIL+ +KI DFG + +T Y
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYA 179
Query: 279 YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN 317
+ +PEV+ + D+WS G +L EL TGE F G +
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 58/248 (23%), Positives = 104/248 (41%), Gaps = 16/248 (6%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
D E LG+G++G V K +A+K I+ Q ++ + L I+ +
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL--DISMRTV 63
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSL--NLTKKFAQQLCCALA 226
+ V G + + + EL+ +L + G ++ ++ K A + AL
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ--YIQSRYYRSPEV 284
L S +LS+IH D+KP N+L+ + +K+ DFG S ++ + + + Y +PE
Sbjct: 124 HLHS-KLSVIHRDVKPSNVLINA--LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPER 180
Query: 285 LLG----IPYDLAIDMWSLGCILVELHTGE-PLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339
+ Y + D+WSLG ++EL P S Q+ +++E P
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE--EPSPQLPADK 238
Query: 340 ASKTSKYF 347
S F
Sbjct: 239 FSAEFVDF 246
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 20/222 (9%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKL 176
+LG+G FG+V A K + KK + + ++EK A +HSR+IV L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLN-KKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 177 KGHFTWKNHLCLVFEL-----LSYNLYNLI-RNTNFHGVSLNLTKKFAQQLCCALAFLSS 230
F K LCLV + + Y++YN+ N F + Q+ L L
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF---QEPRAIFYTAQIVSGLEHLHQ 307
Query: 231 PELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---GQTLYQYIQSRYYRSPEVLLG 287
+II+ DLKPEN+LL ++I D G + + Y + + +PE+LLG
Sbjct: 308 --RNIIYRDLKPENVLL--DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 288 IPYDLAIDMWSLGCILVELHTGEPLFSGKNE---VDQMTKII 326
YD ++D ++LG L E+ F + E ++ + +
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 66/230 (28%), Positives = 105/230 (45%), Gaps = 23/230 (10%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
+ ++ +LG+GSF VV A + + AIKI++ K+ + + ++ E+ + +
Sbjct: 29 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVTRERDVMSRL 87
Query: 169 HSRYIVKLKGHFTWKNHLCLVF------ELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLC 222
+ VKL F L ELL Y + + +F T+ + ++
Sbjct: 88 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY----IRKIGSF---DETCTRFYTAEIV 140
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRY---- 278
AL +L IIH DLKPENILL I+I DFG++ + Q + +
Sbjct: 141 SALEYLHG--KGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 279 -YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
Y SPE+L + D+W+LGCI+ +L G P F NE KII+
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 246
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-30
Identities = 44/226 (19%), Positives = 80/226 (35%), Gaps = 24/226 (10%)
Query: 113 EIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIH 169
T L + G++ K + +K++K + E L + H
Sbjct: 13 NFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFS----H 66
Query: 170 SRYIVKLKGHFT--WKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
++ + G H L+ + Y +LYN++ V + KFA + +A
Sbjct: 67 -PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT--LYQYIQSRYYRSPEV 284
FL + E I L ++++ +I +Y + +PE
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKFSFQSPGRMYAPA----WVAPEA 179
Query: 285 LLGIPYDL---AIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
L P D + DMWS +L EL T E F+ + ++ K+
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL 225
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 57/290 (19%), Positives = 95/290 (32%), Gaps = 77/290 (26%)
Query: 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKIN 164
++L +E +G+G FG V +A + + C AIK I+ N++ + EV+ L K+
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 165 KADIHSRYIVKLKGHFTWKNH--------------------------------------- 185
I + L+
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 186 -------------LCLVFELLSY-NLYNLIRNTNFHGV-SLNLTKKFAQQLCCALAFLSS 230
L + +L NL + + + Q+ A+ FL S
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 231 PELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT---------------LYQYIQ 275
++H DLKP NI +K+ DFG + Q +
Sbjct: 183 --KGLMHRDLKPSNIFFT--MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238
Query: 276 SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKI 325
++ Y SPE + G Y +D++SLG IL EL + V +T +
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDV 286
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-30
Identities = 52/232 (22%), Positives = 98/232 (42%), Gaps = 35/232 (15%)
Query: 102 IKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLE 161
IK D +LG G G+V++ F+ + + A+K++++ EV+L
Sbjct: 10 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHW 65
Query: 162 KINKADIHSRYIVKLKGHF----TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKK 216
+ ++ +IV++ + + L +V E L L++ I++ + +
Sbjct: 66 RASQ---C-PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 121
Query: 217 FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR-SAIKIIDFGSSCHVGQTLYQYIQ 275
+ + A+ +L S ++I H D+KPEN+L S + + +K+ DFG +
Sbjct: 122 IMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFA------------ 167
Query: 276 SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
E YD + DMWSLG I+ L G P F + + +
Sbjct: 168 ------KETTGE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 212
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 8/32 (25%), Positives = 18/32 (56%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435
K LI +L +P +R++ T + H + ++ +
Sbjct: 234 KMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-29
Identities = 40/264 (15%), Positives = 79/264 (29%), Gaps = 45/264 (17%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII----KNKKPFLNQAQIEVQLLEKINK- 165
T+LG+ ++A D E + + + + Q + EV L +
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 166 -----ADIHSRY-----IVKLKGHFT-----------WKNHLCLVFELLSYNLYNLIRNT 204
A +H R+ +VK W ++ + NL
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 205 NFHG-----VSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259
H + + + Q+ LA L ++H L+P +I+L +R + +
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLD--QRGGVFLTG 254
Query: 260 FGSSCHVGQTLYQYIQSRY----YRSPEVLLGIP-----YDLAIDMWSLGCILVELHTGE 310
F G + I + + +L A D W+LG + + +
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 311 PLFSGKNEVDQMTKII-EVLGMPP 333
+ + I +P
Sbjct: 315 LPNTDDAALGGSEWIFRSCKNIPQ 338
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 5/28 (17%), Positives = 11/28 (39%)
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEFF 430
+ L+ L Y + R+ P + +
Sbjct: 340 VRALLEGFLRYPKEDRLLPLQAMETPEY 367
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 69/342 (20%), Positives = 128/342 (37%), Gaps = 90/342 (26%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII-KNKKP-FLNQAQIEVQLLEKI 163
F++ +++ LG+G++G+V A + + VA+KI+ + + E+ + + +
Sbjct: 3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHGVSLNLTKKFAQQLC 222
N H +VK GH N L E S L++ I G+ ++F QL
Sbjct: 63 N----HE-NVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLM 115
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRY---- 278
+ +L + I H D+KPEN+LL +KI DFG + T+++Y
Sbjct: 116 AGVVYLHG--IGITHRDIKPENLLLDERDN--LKISDFGLA-----TVFRYNNRERLLNK 166
Query: 279 ------YRSPEVLLGIPYD-LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331
Y +PE+L + +D+WS G + L + M
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIV---------LTA----------------M 201
Query: 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRN 391
G L +D+ SD+ + + P K +D+
Sbjct: 202 LAGELP---------WDQPSDSCQEYSDWKEKKTYLNPWKK-------IDSAP------- 238
Query: 392 EPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433
L+ ++L +P RI+ ++ + ++ K
Sbjct: 239 ------------LALLHKILVENPSARITIPDIKKDRWYNKP 268
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 58/238 (24%), Positives = 101/238 (42%), Gaps = 42/238 (17%)
Query: 108 FLDRYEID-------TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI---EV 157
FL ++I L+GKG FGQV H E VAI++I ++ +Q + EV
Sbjct: 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREV 80
Query: 158 QLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKK 216
+ H +V G HL ++ L LY+++R+ + +N T++
Sbjct: 81 MAYRQTR----H-ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQ 134
Query: 217 FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQS 276
AQ++ + +L + I+H DLK +N+ + K + I DFG G +
Sbjct: 135 IAQEIVKGMGYLHAK--GILHKDLKSKNVFYDNGK---VVITDFGLFSISGVLQAGRRED 189
Query: 277 RY--------YRSPEVL---------LGIPYDLAIDMWSLGCILVELHTGEPLFSGKN 317
+ + +PE++ +P+ D+++LG I ELH E F +
Sbjct: 190 KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-29
Identities = 66/247 (26%), Positives = 104/247 (42%), Gaps = 18/247 (7%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
++ E +G G+ GQV K + +A+K ++ +I + L +
Sbjct: 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDL--DVVLKSH 81
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228
YIV+ G F + + EL+ L + + + K + AL +L
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYL 140
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ--YIQSRYYRSPEVL- 285
+ +IH D+KP NILL R IK+ DFG S + + Y +PE +
Sbjct: 141 KE-KHGVIHRDVKPSNILLDE--RGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERID 197
Query: 286 ----LGIPYDLAIDMWSLGCILVELHTGE-PLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340
YD+ D+WSLG LVEL TG+ P + K + + +TK+ + PP LL G
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV--LQEEPP--LLPGH 253
Query: 341 SKTSKYF 347
S F
Sbjct: 254 MGFSGDF 260
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 67/224 (29%), Positives = 91/224 (40%), Gaps = 15/224 (6%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
DRY+ +G G+FG D K VA+K I+ Q E+ +
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR---- 74
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHG-VSLNLTKKFAQQLCCALA 226
H IV+ K HL ++ E S LY I N G S + + F QQL ++
Sbjct: 75 H-PNIVRFKEVILTPTHLAIIMEYASGGELYERICN---AGRFSEDEARFFFQQLLSGVS 130
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS--CHVGQTLYQYIQSRYYRSPEV 284
+ S + I H DLK EN LL +KI DFG S + + + Y +PEV
Sbjct: 131 YCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188
Query: 285 LLGIPYD-LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
LL YD D+WS G L + G F E K I+
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ 232
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 12/30 (40%), Positives = 16/30 (53%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKH 433
LI R+ DP RIS + H +FLK+
Sbjct: 252 CHLISRIFVADPATRISIPEIKTHSWFLKN 281
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-29
Identities = 65/249 (26%), Positives = 101/249 (40%), Gaps = 17/249 (6%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
+ + +G+G++G V K +A+K I++ Q Q+ + L +
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL--DVVMRSS 78
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELL---SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCAL 225
YIV+ G + + EL+ Y + + + + K AL
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ--YIQSRYYRSPE 283
L L IIH D+KP NILL IK+ DFG S + ++ + R Y +PE
Sbjct: 139 NHLKE-NLKIIHRDIKPSNILLDR--SGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 195
Query: 284 VL----LGIPYDLAIDMWSLGCILVELHTGE-PLFSGKNEVDQMTKIIEVLGMPPGYLLH 338
+ YD+ D+WSLG L EL TG P + DQ+T++ V G PP
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV--VKGDPPQLSNS 253
Query: 339 GASKTSKYF 347
+ S F
Sbjct: 254 EEREFSPSF 262
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 62/339 (18%), Positives = 109/339 (32%), Gaps = 44/339 (12%)
Query: 110 DRYEIDTLLGKG--SFGQVVKAFDHEEKCQVAIKII---KNKKPFLNQAQIEVQLLEKIN 164
YE+ T++GKG V A V ++ I + Q E+ +
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVS---- 80
Query: 165 KADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCC 223
+ IV + F N L +V ++Y + +LI G++ Q +
Sbjct: 81 -KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL----------YQY 273
AL ++ + +H +K +IL+ + + S+ +
Sbjct: 140 ALDYIHH--MGYVHRSVKASHILISV--DGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 274 IQSRYYRSPEVL--LGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331
++ + SPEVL YD D++S+G EL G F + + + G
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GT 253
Query: 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRN 391
P L D S + + R + L L P
Sbjct: 254 VP---------------CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP 298
Query: 392 EPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
+ F + + L +P R S + +L H FF
Sbjct: 299 SHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 68/255 (26%), Positives = 117/255 (45%), Gaps = 19/255 (7%)
Query: 80 SNKKEKKYVHNDGHDDENYDYIIKHGEKF-LDRYEIDTLLGKGSFGQVVKAFDHEEKCQV 138
S ++ K +D + LD+++ LG GSFG+V+ E
Sbjct: 10 SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 139 AIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVF------EL 192
A+KI+ K+ + QIE L EK ++ ++VKL+ F ++L +V E+
Sbjct: 70 AMKILD-KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 193 LSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR 252
S+ L R F S + +A Q+ +L S L +I+ DLKPEN+L+ ++
Sbjct: 129 FSH----LRRIGRF---SEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLI--DQQ 177
Query: 253 SAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPL 312
I++ DFG + V + + +PE++L Y+ A+D W+LG ++ E+ G P
Sbjct: 178 GYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
Query: 313 FSGKNEVDQMTKIIE 327
F + KI+
Sbjct: 238 FFADQPIQIYEKIVS 252
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 71/264 (26%), Positives = 114/264 (43%), Gaps = 42/264 (15%)
Query: 83 KEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKI 142
K+ + H+ G D D+ I G+ + +G GSFG V K H + VA+K+
Sbjct: 2 KKGHHHHHHGSRDAADDWEIPDGQ-----ITVGQRIGSGSFGTVYKGKWHGD---VAVKM 53
Query: 143 IKNKKP-------FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY 195
+ P F N EV +L K H I+ G+ T L +V +
Sbjct: 54 LNVTAPTPQQLQAFKN----EVGVLRKTR----HVN-ILLFMGYST-APQLAIVTQWCEG 103
Query: 196 -NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA 254
+LY+ + + + A+Q + +L + SIIH DLK NI L + +
Sbjct: 104 SSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK--SIIHRDLKSNNIFLH--EDNT 158
Query: 255 IKIIDFGSSCHVGQTLYQYIQSR-----YYRSPEVLLG---IPYDLAIDMWSLGCILVEL 306
+KI DFG + + + + + +PEV+ PY D+++ G +L EL
Sbjct: 159 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYEL 218
Query: 307 HTGEPLFSGKNEVDQMTKIIEVLG 330
TG+ +S N DQ IIE++G
Sbjct: 219 MTGQLPYSNINNRDQ---IIEMVG 239
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 61/265 (23%), Positives = 116/265 (43%), Gaps = 21/265 (7%)
Query: 73 LSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDH 132
L ++ ++ K + N ++ I+ + YE+ ++G+G+FG+V
Sbjct: 32 LVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK 91
Query: 133 EEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFEL 192
+ A+K++ K + ++ E+ A +S ++V+L F +L +V E
Sbjct: 92 STRKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150
Query: 193 LS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK 251
+ +L NL+ N + + + ++ AL + S + IH D+KP+N+LL K
Sbjct: 151 MPGGDLVNLMSNYDV---PEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLD--K 203
Query: 252 RSAIKIIDFGSSCHVGQTLYQYIQSRY------YRSPEVLLG----IPYDLAIDMWSLGC 301
+K+ DFG+ + + ++ Y SPEVL Y D WS+G
Sbjct: 204 SGHLKLADFGTCMKMNKE--GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV 261
Query: 302 ILVELHTGEPLFSGKNEVDQMTKII 326
L E+ G+ F + V +KI+
Sbjct: 262 FLYEMLVGDTPFYADSLVGTYSKIM 286
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 66/269 (24%), Positives = 116/269 (43%), Gaps = 14/269 (5%)
Query: 72 QLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKF-LDRYEIDTLLGKGSFGQVVKAF 130
L ++ +E + K + ++ +E LLGKG+FG+V+
Sbjct: 109 GLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVK 168
Query: 131 DHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVF 190
+ A+KI+K K+ + + ++ L E + ++ LK F + LC V
Sbjct: 169 EKATGRYYAMKILK-KEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227
Query: 191 ELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLC 248
E + ++L R F S + + + ++ AL +L S E ++++ DLK EN++L
Sbjct: 228 EYANGGELFFHLSRERVF---SEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLD 283
Query: 249 SPKRSAIKIIDFGSS---CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVE 305
IKI DFG G T+ + + Y +PEVL Y A+D W LG ++ E
Sbjct: 284 K--DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 341
Query: 306 LHTGEPLFSGKNEVDQMTKII-EVLGMPP 333
+ G F ++ I+ E + P
Sbjct: 342 MMCGRLPFYNQDHEKLFELILMEEIRFPR 370
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 48/207 (23%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK-NKKPFLNQAQIEVQLLEKINKADI 168
+ +G+GS G V A + QVA+K++ K+ EV ++ D
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIM-----RDY 99
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
+V++ + L ++ E L L +++ + + + ALA+
Sbjct: 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRL---NEEQIATVCEAVLQALAY 156
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRSPEV 284
L + +IH D+K ++ILL +K+ DFG + + + + + + Y+ +PEV
Sbjct: 157 LHAQ--GVIHRDIKSDSILLTL--DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV 212
Query: 285 LLGIPYDLAIDMWSLGCILVELHTGEP 311
+ Y +D+WSLG +++E+ GEP
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEP 239
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 69/231 (29%), Positives = 108/231 (46%), Gaps = 30/231 (12%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
L ++I LG GSFG+V A+K++K K+ + Q+E E++ + +
Sbjct: 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLSIV 63
Query: 169 HSRYIVKLKGHFTWKNHLCLVF------ELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLC 222
+I+++ G F + ++ EL S L ++ F + K +A ++C
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL----LRKSQRF---PNPVAKFYAAEVC 116
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLY------QYIQS 276
AL +L S II+ DLKPENILL K IKI DFG + +V Y YI
Sbjct: 117 LALEYLHS--KDIIYRDLKPENILLD--KNGHIKITDFGFAKYVPDVTYTLCGTPDYI-- 170
Query: 277 RYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
+PEV+ PY+ +ID WS G ++ E+ G F N + KI+
Sbjct: 171 ----APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 217
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK-NKKPFLNQAQIEVQLLEKINKADI 168
+Y +G+G+ G V A D +VAI+ + ++P E+ ++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM-----REN 74
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
+ IV + + L +V E L+ +L +++ T ++ AL F
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEF 131
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRSPEV 284
L S +IH D+K +NILL ++K+ DFG + + + + Y+ +PEV
Sbjct: 132 LHS--NQVIHRDIKSDNILLGM--DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 285 LLGIPYDLAIDMWSLGCILVELHTGEP 311
+ Y +D+WSLG + +E+ GEP
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 22/262 (8%)
Query: 80 SNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVA 139
S + KYV + E +K D +EI ++G+G+F +V + A
Sbjct: 31 SELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYA 90
Query: 140 IKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLY 198
+KI+ K L + ++ E+ + R+I +L F +N+L LV E +L
Sbjct: 91 MKIMN-KWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL 149
Query: 199 NLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258
L+ + + + + ++ A+ + L +H D+KP+NILL + I++
Sbjct: 150 TLLSKFGER-IPAEMARFYLAEIVMAIDSVHR--LGYVHRDIKPDNILL--DRCGHIRLA 204
Query: 259 DFGSSCHVGQTLYQYIQSRY------YRSPEVLLGI-------PYDLAIDMWSLGCILVE 305
DFGS + ++S Y SPE+L + Y D W+LG E
Sbjct: 205 DFGSCLKLRA--DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262
Query: 306 LHTGEPLFSGKNEVDQMTKIIE 327
+ G+ F + + KI+
Sbjct: 263 MFYGQTPFYADSTAETYGKIVH 284
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 7e-27
Identities = 61/259 (23%), Positives = 111/259 (42%), Gaps = 20/259 (7%)
Query: 80 SNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVA 139
S + +K + + + +K + +EI ++G+G+FG+V A
Sbjct: 44 SPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFA 103
Query: 140 IKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLY 198
+KI+ K L +A+ E+ + S++I L F N+L LV + +L
Sbjct: 104 MKILN-KWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL 162
Query: 199 NLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258
L+ + + + + ++ A+ + L +H D+KP+NIL+ I++
Sbjct: 163 TLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILM--DMNGHIRLA 217
Query: 259 DFGSSCHVGQTLYQYIQSRY------YRSPEVLLGIP-----YDLAIDMWSLGCILVELH 307
DFGS + + +QS Y SPE+L + Y D WSLG + E+
Sbjct: 218 DFGSCLKLME--DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275
Query: 308 TGEPLFSGKNEVDQMTKII 326
GE F ++ V+ KI+
Sbjct: 276 YGETPFYAESLVETYGKIM 294
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 55/241 (22%), Positives = 106/241 (43%), Gaps = 29/241 (12%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-----EVQLLEKI 163
++ + + ++G+G FG+V + A+K + KK + E +L +
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD-KKRIKMKQGETLALNERIMLSLV 246
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFEL-----LSYNLYNLIRNTNFHGVSLNLTKKFA 218
+ D +IV + F + L + +L L Y+L ++ F S + +A
Sbjct: 247 STGD--CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVF---SEADMRFYA 298
Query: 219 QQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV-GQTLYQYIQSR 277
++ L + + +++ DLKP NILL + ++I D G +C + + + +
Sbjct: 299 AEIILGLEHMHN--RFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPHASVGTH 354
Query: 278 YYRSPEVLL-GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ---MTKIIEV-LGMP 332
Y +PEVL G+ YD + D +SLGC+L +L G F D+ + + + +P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 414
Query: 333 P 333
Sbjct: 415 D 415
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 59/238 (24%), Positives = 104/238 (43%), Gaps = 33/238 (13%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI--EVQLLEKI 163
F++ +++ LG+G++G+V A + + VA+KI+ K+ I E+ + + +
Sbjct: 3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHG-VSLNLTKKFAQQL 221
N H +VK GH N L E S L++ I + ++F QL
Sbjct: 63 N----HE-NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQL 114
Query: 222 CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRY--- 278
+ +L + I H D+KPEN+LL +KI DFG + T+++Y
Sbjct: 115 MAGVVYLHG--IGITHRDIKPENLLLDERDN--LKISDFGLA-----TVFRYNNRERLLN 165
Query: 279 -------YRSPEVLLGIPYD-LAIDMWSLGCILVELHTGEPLFSGKNEVDQM-TKIIE 327
Y +PE+L + +D+WS G +L + GE + ++ Q + E
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 223
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 6/30 (20%), Positives = 16/30 (53%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKH 433
L+ ++L +P RI+ ++ + ++ K
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKP 268
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 13/224 (5%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
++ ++ LLGKG+FG+V+ + A+KI++ K+ + + ++ + E +
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNT 62
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLS--YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
++ LK F + LC V E + ++L R F + + + ++ AL
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARFYGAEIVSALE 119
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS---CHVGQTLYQYIQSRYYRSPE 283
+L S +++ D+K EN++L IKI DFG G T+ + + Y +PE
Sbjct: 120 YLHS--RDVVYRDIKLENLMLDK--DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 284 VLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
VL Y A+D W LG ++ E+ G F ++ I+
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 82/340 (24%), Positives = 122/340 (35%), Gaps = 82/340 (24%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK-INK-AD 167
D YE+ ++G G+ V A+ +K +VAIK I L + Q + L K I +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN-----LEKCQTSMDELLKEIQAMSQ 69
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQ------Q 220
H IV F K+ L LV +LLS ++ ++I++ G + + +
Sbjct: 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR--- 277
+ L +L IH D+K NILL +++I DFG S +
Sbjct: 130 VLEGLEYLHK--NGQIHRDVKAGNILLGE--DGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 278 -----YYRSPEVLL-GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331
+ +PEV+ YD D+WS G +EL TG
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA--------------------- 224
Query: 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRN 391
P Y P K L L N P
Sbjct: 225 AP------------YHK-------------------YPPMKVLMLTL--QNDPPSLETGV 251
Query: 392 EPGHSLADYMK-FKDLILRMLTYDPKKRISPTNVLRHEFF 430
+ L Y K F+ +I L DP+KR + +LRH+FF
Sbjct: 252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 22/235 (9%)
Query: 102 IKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-----E 156
+ ++ + Y I LG+GSFG+V A ++ + +VA+K I +++ E
Sbjct: 1 MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFI-SRQLLKKSDMHMRVERE 59
Query: 157 VQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHG-VSLNLTK 215
+ L+ + H +I+KL T + +V E L++ I ++ + +
Sbjct: 60 ISYLKLLR----H-PHIIKLYDVITTPTDIVMVIEYAGGELFDYIVE---KKRMTEDEGR 111
Query: 216 KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS--CHVGQTLYQY 273
+F QQ+ CA+ + I+H DLKPEN+LL +KI DFG S G L
Sbjct: 112 RFFQQIICAIEYCHR--HKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFLKTS 167
Query: 274 IQSRYYRSPEVLLGIPYD-LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
S Y +PEV+ G Y +D+WS G +L + G F + + K+
Sbjct: 168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS 222
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 63/262 (24%), Positives = 113/262 (43%), Gaps = 14/262 (5%)
Query: 72 QLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFD 131
+ + + K + +D L + +LGKGSFG+V+ +
Sbjct: 303 RQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSER 362
Query: 132 HEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK-INKADIHSRYIVKLKGHFTWKNHLCLVF 190
A+KI+K K + +E ++EK + ++ +L F + L V
Sbjct: 363 KGTDELYAVKILK-KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421
Query: 191 ELLS--YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLC 248
E ++ +Y++ + F +A ++ L FL S II+ DLK +N++L
Sbjct: 422 EYVNGGDLMYHIQQVGRF---KEPHAVFYAAEIAIGLFFLQS--KGIIYRDLKLDNVMLD 476
Query: 249 SPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVE 305
S IKI DFG + G T + + Y +PE++ PY ++D W+ G +L E
Sbjct: 477 S--EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 534
Query: 306 LHTGEPLFSGKNEVDQMTKIIE 327
+ G+ F G++E + I+E
Sbjct: 535 MLAGQAPFEGEDEDELFQSIME 556
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 22/237 (9%)
Query: 109 LDRYEIDTLLGKGSFGQVV---KAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINK 165
+ +E+ +LGKG +G+V K A+K++K N E+
Sbjct: 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLS-----YNLYNLIRNTNFHGVSLNLTKKFAQQ 220
++ +IV L F L L+ E LS L R F + + +
Sbjct: 76 EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE---REGIF---MEDTACFYLAE 129
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS---CHVGQTLYQYIQSR 277
+ AL L II+ DLKPENI+L + +K+ DFG H G + + +
Sbjct: 130 ISMALGHLHQ--KGIIYRDLKPENIML--NHQGHVKLTDFGLCKESIHDGTVTHTFCGTI 185
Query: 278 YYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII-EVLGMPP 333
Y +PE+L+ ++ A+D WSLG ++ ++ TG P F+G+N + KI+ L +PP
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP 242
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 14/225 (6%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK-INKAD 167
++ + + +LGKGSFG+V A + AIK +K K L +E ++EK +
Sbjct: 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLA 74
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCCAL 225
++ + F K +L V E L+ +Y++ F L+ +A ++ L
Sbjct: 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF---DLSRATFYAAEIILGL 131
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS---CHVGQTLYQYIQSRYYRSP 282
FL S I++ DLK +NILL IKI DFG + + Y +P
Sbjct: 132 QFLHS--KGIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 187
Query: 283 EVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
E+LLG Y+ ++D WS G +L E+ G+ F G++E + I
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 67/242 (27%), Positives = 113/242 (46%), Gaps = 33/242 (13%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK-INKAD 167
+ ++GKGSFG+V+ A E+ A+K+++ KK L + + + + E+ + +
Sbjct: 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ-KKAILKKKEEKHIMSERNVLLKN 95
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLS-----YNLYNLIRNTNFHGVSLNLTKKFAQQLC 222
+ ++V L F + L V + ++ Y+L R F + +A ++
Sbjct: 96 VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ---RERCF---LEPRARFYAAEIA 149
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS---CHVGQTLY------QY 273
AL +L S L+I++ DLKPENILL S + I + DFG T +Y
Sbjct: 150 SALGYLHS--LNIVYRDLKPENILLDS--QGHIVLTDFGLCKENIEHNSTTSTFCGTPEY 205
Query: 274 IQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII-EVLGMP 332
+ +PEVL PYD +D W LG +L E+ G P F +N + I+ + L +
Sbjct: 206 L------APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK 259
Query: 333 PG 334
P
Sbjct: 260 PN 261
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 25/234 (10%)
Query: 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-----PFLNQAQIEVQLLE 161
K + +Y + LLG+GS+G+V + D E C+ A+KI+K KK + E+QLL
Sbjct: 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 162 KINKADIHSRYIVKLK---GHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFA 218
++ H + +++L + K + +V E + ++ + + +
Sbjct: 62 RLR----H-KNVIQLVDVLYNEE-KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 219 QQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS-----CHVGQTLYQY 273
QL L +L S I+H D+KP N+LL + +KI G + T
Sbjct: 116 CQLIDGLEYLHS--QGIVHKDIKPGNLLLTTGGT--LKISALGVAEALHPFAADDTCRTS 171
Query: 274 IQSRYYRSPEVLLGI-PYD-LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKI 325
S ++ PE+ G+ + +D+WS G L + TG F G N I
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 12/30 (40%), Positives = 17/30 (56%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKH 433
DL+ ML Y+P KR S + +H +F K
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK-NKKPFLNQAQIEVQLLEKINKADI 168
+ +EI LG G+FG+V KA + E A K+I+ + L +E+++L A
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEIL-----ATC 73
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
YIVKL G + L ++ E + ++ + G++ + +Q+ AL F
Sbjct: 74 DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNF 132
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRSPEV 284
L S IIH DLK N+L+ I++ DFG S +TL + +I + Y+ +PEV
Sbjct: 133 LHS--KRIIHRDLKAGNVLMTL--EGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEV 188
Query: 285 LL-----GIPYDLAIDMWSLGCILVELHTGEP 311
++ PYD D+WSLG L+E+ EP
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 72/259 (27%), Positives = 119/259 (45%), Gaps = 25/259 (9%)
Query: 88 VHNDGHDDENYDYIIKHGEKF-LDRYEIDTLLGKGSFGQVV---KAFDHEEKCQVAIKII 143
+ + ++ + EK ++E+ +LG+GSFG+V K + + A+K++
Sbjct: 1 MEGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL 60
Query: 144 KNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLS-----YNLY 198
K K + ++ +E+ +++ +IVKL F + L L+ + L L
Sbjct: 61 K-KATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS 118
Query: 199 NLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258
+ F + K + +L AL L S L II+ DLKPENILL IK+
Sbjct: 119 ---KEVMF---TEEDVKFYLAELALALDHLHS--LGIIYRDLKPENILLDE--EGHIKLT 168
Query: 259 DFGSS---CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG 315
DFG S + Y + + Y +PEV+ + + D WS G ++ E+ TG F G
Sbjct: 169 DFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228
Query: 316 KNEVDQMTKII-EVLGMPP 333
K+ + MT I+ LGMP
Sbjct: 229 KDRKETMTMILKAKLGMPQ 247
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 66/233 (28%), Positives = 102/233 (43%), Gaps = 23/233 (9%)
Query: 103 KHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI-----EV 157
G + Y + LG G+FG+V +VA+KI+ N++ + + E+
Sbjct: 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKIL-NRQKIRSLDVVGKIKREI 62
Query: 158 QLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHG-VSLNLTK 215
Q L+ H +I+KL + +V E +S L++ I HG V +
Sbjct: 63 QNLKLFR----H-PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK---HGRVEEMEAR 114
Query: 216 KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS--CHVGQTLYQY 273
+ QQ+ A+ + ++H DLKPEN+LL + KI DFG S G+ L
Sbjct: 115 RLFQQILSAVDYCHR--HMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFLRTS 170
Query: 274 IQSRYYRSPEVLLGIPYD-LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKI 325
S Y +PEV+ G Y +D+WS G IL L G F ++ KI
Sbjct: 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI 223
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 7e-04
Identities = 10/30 (33%), Positives = 17/30 (56%)
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFFLKH 433
L++ ML DP KR + ++ HE+F +
Sbjct: 239 ATLLMHMLQVDPLKRATIKDIREHEWFKQD 268
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 48/226 (21%), Positives = 89/226 (39%), Gaps = 37/226 (16%)
Query: 113 EIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKN-----KKPFLNQAQIEVQLLEKINKAD 167
+LGKG FGQ +K E + +K + ++ FL EV+++ +
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK----EVKVMRCLE--- 65
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
H ++K G L + E + L +I++ + + FA+ + +A
Sbjct: 66 -HPN-VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMA 122
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYR------ 280
+L S ++IIH DL N L+ + + + DFG + + Q R +
Sbjct: 123 YLHS--MNIIHRDLNSHNCLV--RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 281 -----------SPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG 315
+PE++ G YD +D++S G +L E+
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-25
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK-INK-AD 167
+ + +GKGSFG+V K D+ + VAIKII L +A+ E++ +++ I +
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQ 76
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
S Y+ K G + L ++ E L + +L+ + +++ L
Sbjct: 77 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT---ILREILKGLD 133
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRSPE 283
+L S IH D+K N+LL +K+ DFG + + T + ++ + ++ +PE
Sbjct: 134 YLHS--EKKIHRDIKAANVLLSE--HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 189
Query: 284 VLLGIPYDLAIDMWSLGCILVELHTGEP 311
V+ YD D+WSLG +EL GEP
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEP 217
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
+E+ L+G G++GQV K + AIK++ + + E+ +L+K + H
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS----H 79
Query: 170 SRYIVKLKGHF------TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLC 222
R I G F + L LV E ++ +LI+NT + + +++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYY 279
L+ L +IH D+K +N+LL + + +K++DFG S + +T+ + +I + Y+
Sbjct: 140 RGLSHLHQH--KVIHRDIKGQNVLLT--ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 195
Query: 280 RSPEVLL-----GIPYDLAIDMWSLGCILVELHTGEP 311
+PEV+ YD D+WSLG +E+ G P
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 64/234 (27%), Positives = 104/234 (44%), Gaps = 32/234 (13%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK-INKAD 167
+D +E +LGKGSFG+V+ A E A+K++K K L +E + EK I
Sbjct: 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK-KDVILQDDDVECTMTEKRILSLA 80
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLS-----YNLYNLIRNTNFHGVSLNLTKKFAQQLC 222
+ ++ +L F + L V E ++ +++ ++ F + +A ++
Sbjct: 81 RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRF---DEARARFYAAEII 134
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS---CHVGQTLY------QY 273
AL FL II+ DLK +N+LL K+ DFG G T Y
Sbjct: 135 SALMFLHD--KGIIYRDLKLDNVLLDH--EGHCKLADFGMCKEGICNGVTTATFCGTPDY 190
Query: 274 IQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
I +PE+L + Y A+D W++G +L E+ G F +NE D I+
Sbjct: 191 I------APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 62/232 (26%), Positives = 108/232 (46%), Gaps = 15/232 (6%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK-INKAD 167
L + +LGKGSFG+V+ + A+KI+K K + +E ++EK +
Sbjct: 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK-KDVVIQDDDVECTMVEKRVLALP 77
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLS--YNLYNLIRNTNFHGVSLNLTKKFAQQLCCAL 225
++ +L F + L V E ++ +Y++ + F +A ++ L
Sbjct: 78 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF---KEPHAVFYAAEIAIGL 134
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG---SSCHVGQTLYQYIQSRYYRSP 282
FL S II+ DLK +N++L S IKI DFG + G T + + Y +P
Sbjct: 135 FFLQS--KGIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAP 190
Query: 283 EVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV-LGMPP 333
E++ PY ++D W+ G +L E+ G+ F G++E + I+E + P
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK 242
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 21/232 (9%)
Query: 103 KHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQ 158
G + Y + LG G+FG+V +VA+KI+ +K + + + E+Q
Sbjct: 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ 68
Query: 159 LLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHG-VSLNLTKK 216
L+ H +I+KL + + + +V E +S L++ I +G + +++
Sbjct: 69 NLKLFR----H-PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK---NGRLDEKESRR 120
Query: 217 FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS--CHVGQTLYQYI 274
QQ+ + + ++H DLKPEN+LL + KI DFG S G+ L
Sbjct: 121 LFQQILSGVDYCHR--HMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFLRTSC 176
Query: 275 QSRYYRSPEVLLGIPYD-LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKI 325
S Y +PEV+ G Y +D+WS G IL L G F + KI
Sbjct: 177 GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI 228
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 65/296 (21%), Positives = 122/296 (41%), Gaps = 39/296 (13%)
Query: 63 YYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKF-LDRYEIDTLLGKG 121
++ +++ + T ++ + + + H EK ++ +E+ +LG G
Sbjct: 6 HHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTG 65
Query: 122 SFGQVV---KAFDHEEKCQVAIKIIKNKKPFLNQAQI-----EVQLLEKINKADIHSRYI 173
++G+V K H+ A+K++K E Q+LE I S ++
Sbjct: 66 AYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR----QSPFL 121
Query: 174 VKLKGHFTWKNHLCLVFELLS-----YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228
V L F + L L+ + ++ +L + F + + + + ++ AL L
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLS---QRERF---TEHEVQIYVGEIVLALEHL 175
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS----CHVGQTLYQYIQSRYYRSPEV 284
L II+ D+K ENILL S + + DFG S + Y + + Y +P++
Sbjct: 176 HK--LGIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 285 LLGIP--YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV-----LGMPP 333
+ G +D A+D WSLG ++ EL TG F+ E + +I P
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 287
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 60/240 (25%), Positives = 101/240 (42%), Gaps = 25/240 (10%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
D +EI +GKGSFG+V ++ K A+K + K+ + + ++ E +
Sbjct: 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMN-KQKCVERNEVRNVFKELQIMQGL 72
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLS-----YNLYNLIRNTNFHGVSLNLTKKFAQQLCC 223
++V L F + + +V +LL Y+L +N +F K F +L
Sbjct: 73 EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ---QNVHF---KEETVKLFICELVM 126
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRYYRS 281
AL +L + IIH D+KP+NILL + I DF + + + ++ Y +
Sbjct: 127 ALDYLQN--QRIIHRDMKPDNILLDE--HGHVHITDFNIAAMLPRETQITTMAGTKPYMA 182
Query: 282 PEVLL---GIPYDLAIDMWSLGCILVELHTGEPLF---SGKNEVDQMTKIIEV-LGMPPG 334
PE+ G Y A+D WSLG EL G + S + + + + P
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA 242
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
+ +++ LG+GS+G V KA E VAIK + + L + E+ ++
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-LQEIIKEISIM-----QQCD 82
Query: 170 SRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228
S ++VK G + L +V E ++ ++IR N ++ + Q L +L
Sbjct: 83 SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYL 141
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ---YIQSRYYRSPEVL 285
+ IH D+K NILL + K+ DFG + + T+ + I + ++ +PEV+
Sbjct: 142 HF--MRKIHRDIKAGNILLNT--EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197
Query: 286 LGIPYDLAIDMWSLGCILVELHTGEP 311
I Y+ D+WSLG +E+ G+P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKP 223
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-23
Identities = 56/253 (22%), Positives = 101/253 (39%), Gaps = 40/253 (15%)
Query: 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKIN 164
L++Y + +GKGS+G V A++ + A+K++ +KK + QA + +
Sbjct: 8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVL-SKKKLIRQAGFPRRPPPRGT 66
Query: 165 KADIHSRY--------------IVKLKGH-----------FTWKNHLCLVFELLSY-NLY 198
+ I+K H ++HL +VFEL++ +
Sbjct: 67 RPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM 126
Query: 199 NLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258
+ S + + + Q L + +L IIH D+KP N+L+ IKI
Sbjct: 127 EVPTLKPL---SEDQARFYFQDLIKGIEYLHY--QKIIHRDIKPSNLLVGEDGH--IKIA 179
Query: 259 DFGSSC---HVGQTLYQYIQSRYYRSPEVLLGI--PYD-LAIDMWSLGCILVELHTGEPL 312
DFG S L + + + +PE L + A+D+W++G L G+
Sbjct: 180 DFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
Query: 313 FSGKNEVDQMTKI 325
F + + +KI
Sbjct: 240 FMDERIMCLHSKI 252
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 11/30 (36%), Positives = 16/30 (53%)
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEFFLK 432
KDLI RML +P+ RI + H + +
Sbjct: 269 LKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-23
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 18/209 (8%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII----KNKKPFLNQAQIEVQLLEKINK 165
+ +G GSFG V A D VAIK + K EV+ L
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL----- 108
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCAL 225
+ ++ +G + ++ LV E + +L+ + L
Sbjct: 109 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGL 167
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVL 285
A+L S ++IH D+K NILL +K+ DFGS+ + ++ + Y+ +PEV+
Sbjct: 168 AYLHS--HNMIHRDVKAGNILLSE--PGLVKLGDFGSASIMAPA-NSFVGTPYWMAPEVI 222
Query: 286 LGI---PYDLAIDMWSLGCILVELHTGEP 311
L + YD +D+WSLG +EL +P
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKP 251
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 5e-23
Identities = 44/232 (18%), Positives = 82/232 (35%), Gaps = 40/232 (17%)
Query: 113 EIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKINKADIHS 170
+ +GKG FG+V + E+ VA+KI ++ + +A E+ +
Sbjct: 45 VLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFREA--EIYQTVML-----RH 95
Query: 171 RYIVKLKGHFTWKN----HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCAL 225
I+ N L LV + + +L++ + + V++ K A L
Sbjct: 96 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGL 152
Query: 226 AFL------SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRY- 278
A L + + +I H DLK +NIL+ I D G + +
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNH 210
Query: 279 ------YRSPEVLLG------IPYDLAIDMWSLGCILVELHTGEPLFSGKNE 318
Y +PEVL D++++G + E+ + +
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-23
Identities = 45/232 (19%), Positives = 82/232 (35%), Gaps = 40/232 (17%)
Query: 113 EIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKINKADIHS 170
+ +GKG +G+V + E VA+KI ++K + + E+ + H
Sbjct: 11 TLLECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFRET--ELYNTVMLR----HE 62
Query: 171 RYIVKLKGHFTWKNH----LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCAL 225
I+ H L L+ +LY+ ++ + + + L
Sbjct: 63 N-ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGL 118
Query: 226 AFL------SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQS--- 276
A L + + +I H DLK +NIL+ + I D G + Q+ Q
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 277 ----RYYRSPEVLLGIP------YDLAIDMWSLGCILVELHTGEPLFSGKNE 318
+ Y +PEVL +D+W+ G +L E+ +
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 48/238 (20%), Positives = 93/238 (39%), Gaps = 26/238 (10%)
Query: 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHE-EKCQVAIKIIKNKK--PFLNQAQIEVQLLE 161
G+ +YE+ + G G + A D V +K + + A E Q L
Sbjct: 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLA 134
Query: 162 KINKADIHSRYIVKL-----KGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTK 215
++ H IV++ +V E + +L + +
Sbjct: 135 EVV----HPS-IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAI 185
Query: 216 KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ 275
+ ++ AL++L + +++ DLKPENI+L +K+ID G+ +
Sbjct: 186 AYLLEILPALSYLH--SIGLVYNDLKPENIMLT---EEQLKLIDLGAVSRINSF-GYLYG 239
Query: 276 SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
+ +++PE++ P A D++++G L L P +G+ VD + + VL
Sbjct: 240 TPGFQAPEIVRTGPTV-ATDIYTVGRTLAALTLDLPTRNGRY-VDGLPEDDPVLKTYD 295
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-22
Identities = 55/264 (20%), Positives = 108/264 (40%), Gaps = 27/264 (10%)
Query: 74 SHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEID-----TLLGKGSFGQVVK 128
++ + + G ++E + K + ++G+GS+ +V+
Sbjct: 11 DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLL 70
Query: 129 AFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK--INKADIHSRYIVKLKGHFTWKNHL 186
+ A++++K K+ + I+ EK +A H ++V L F ++ L
Sbjct: 71 VRLKKTDRIYAMRVVK-KELVNDDEDIDWVQTEKHVFEQASNHP-FLVGLHSCFQTESRL 128
Query: 187 CLVFELLS-----YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLK 241
V E ++ +++ R + ++ ++ AL +L E II+ DLK
Sbjct: 129 FFVIEYVNGGDLMFHMQ---RQRKL---PEEHARFYSAEISLALNYLH--ERGIIYRDLK 180
Query: 242 PENILLCSPKRSAIKIIDFGSS---CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWS 298
+N+LL S IK+ D+G G T + + Y +PE+L G Y ++D W+
Sbjct: 181 LDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 238
Query: 299 LGCILVELHTGEPLFSGKNEVDQM 322
LG ++ E+ G F D
Sbjct: 239 LGVLMFEMMAGRSPFDIVGSSDNP 262
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 8e-22
Identities = 49/233 (21%), Positives = 82/233 (35%), Gaps = 42/233 (18%)
Query: 113 EIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKINKADIHS 170
++ +GKG +G+V EK VA+K+ + + + E+ +
Sbjct: 40 QMVKQIGKGRYGEVWMGKWRGEK--VAVKVFFTTEEASWFRET--EIYQTVLM-----RH 90
Query: 171 RYIVKL-----KGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCA 224
I+ KG +W L L+ + +LY+ +++ + K A
Sbjct: 91 ENILGFIAADIKGTGSWT-QLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSG 146
Query: 225 LAFL------SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC-HVGQTLYQYIQS- 276
L L + + +I H DLK +NIL+ I D G + + T I
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPN 204
Query: 277 -----RYYRSPEVLLG------IPYDLAIDMWSLGCILVELHTGEPLFSGKNE 318
+ Y PEVL + DM+S G IL E+ E
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 8e-22
Identities = 53/224 (23%), Positives = 100/224 (44%), Gaps = 22/224 (9%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEK--INKA 166
L +++ ++G+GS+ +V+ + A+K++K K+ + I+ EK +A
Sbjct: 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVK-KELVNDDEDIDWVQTEKHVFEQA 66
Query: 167 DIHSRYIVKLKGHFTWKNHLCLVFELLS-----YNLYNLIRNTNFHGVSLNLTKKFAQQL 221
H ++V L F ++ L V E ++ +++ R + ++ ++
Sbjct: 67 SNHP-FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKL---PEEHARFYSAEI 119
Query: 222 CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS---CHVGQTLYQYIQSRY 278
AL +L II+ DLK +N+LL S IK+ D+G G T + +
Sbjct: 120 SLALNYLHE--RGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTSTFCGTPN 175
Query: 279 YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQM 322
Y +PE+L G Y ++D W+LG ++ E+ G F D
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 219
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-21
Identities = 65/233 (27%), Positives = 103/233 (44%), Gaps = 38/233 (16%)
Query: 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLL 160
G+ +RY+I LG G V A D +VAIK I K+ L + + EV
Sbjct: 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVH-- 63
Query: 161 EKINKADIHSRYIVKL-------KGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHG-VSL 211
N + + + IV + ++ LV E + L I + HG +S+
Sbjct: 64 ---NSSQLSHQNIVSMIDVDEEDDCYY-------LVMEYIEGPTLSEYIES---HGPLSV 110
Query: 212 NLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG-----SSCHV 266
+ F Q+ + + ++ I+H D+KP+NIL+ +KI DFG S +
Sbjct: 111 DTAINFTNQILDGIKH--AHDMRIVHRDIKPQNILI--DSNKTLKIFDFGIAKALSETSL 166
Query: 267 GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEV 319
QT + + Y SPE G D D++S+G +L E+ GEP F+G+ V
Sbjct: 167 TQT-NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV 218
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 7e-20
Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 34/234 (14%)
Query: 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLL 160
DRYE+ +LG G +V A D + VA+K+++ F + + E Q
Sbjct: 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 161 EKINKADIHSRY------IVKLKGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHG-VSLN 212
+N I + Y + +V E + L +++ G ++
Sbjct: 67 AALNHPAIVAVYDTGEAETPAGPLPY-------IVMEYVDGVTLRDIVHT---EGPMTPK 116
Query: 213 LTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG-------SSCH 265
+ C AL F S + IIH D+KP NI++ +A+K++DFG S
Sbjct: 117 RAIEVIADACQALNF--SHQNGIIHRDVKPANIMIS--ATNAVKVMDFGIARAIADSGNS 172
Query: 266 VGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEV 319
V QT I + Y SPE G D D++SLGC+L E+ TGEP F+G + V
Sbjct: 173 VTQT-AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 57/257 (22%), Positives = 94/257 (36%), Gaps = 47/257 (18%)
Query: 109 LDRYEIDT-------LLGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQL 159
+ + + +G FG V KA E VA+KI +K+ + N+ EV
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFPIQDKQSWQNEY--EVYS 71
Query: 160 LEKINKADIHSRYIVKLKGHFTWKNH----LCLVFELLSY-NLYNLIRNTNFHGVSLNLT 214
L + I++ G L L+ +L + ++ + VS N
Sbjct: 72 LPGM-----KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNEL 123
Query: 215 KKFAQQLCCALAFL--------SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266
A+ + LA+L + +I H D+K +N+LL + I DFG +
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT--ACIADFGLALKF 181
Query: 267 GQTLYQYIQSRY-----YRSPEVL-----LGIPYDLAIDMWSLGCILVELHTGEPLFSGK 316
Y +PEVL L IDM+++G +L EL + G
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241
Query: 317 NEVDQMTKIIEVLGMPP 333
+ + M E +G P
Sbjct: 242 VD-EYMLPFEEEIGQHP 257
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 52/223 (23%), Positives = 95/223 (42%), Gaps = 45/223 (20%)
Query: 110 DRYEID-------TLLGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQ 158
D++E++ LG G +G+V + + VA+K +K + FL +A +
Sbjct: 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV--- 269
Query: 159 LLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKF 217
+++I H +V+L G T + ++ E ++Y NL + +R N VS +
Sbjct: 270 -MKEIK----HPN-LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 323
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR 277
A Q+ A+ +L + IH +L N L+ +K+ DFG L + +
Sbjct: 324 ATQISSAMEYLEK--KNFIHRNLAARNCLVGE--NHLVKVADFG--------LSRLMTGD 371
Query: 278 YYRS------------PEVLLGIPYDLAIDMWSLGCILVELHT 308
Y + PE L + + D+W+ G +L E+ T
Sbjct: 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 45/223 (20%)
Query: 110 DRYEID-------TLLGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQ 158
D++E++ LG G +G+V + + VA+K +K + FL +A +
Sbjct: 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV--- 62
Query: 159 LLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKF 217
+++I H +V+L G T + ++ E ++Y NL + +R N VS +
Sbjct: 63 -MKEIK----HPN-LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR 277
A Q+ A+ +L + IH DL N L+ +K+ DFG L + +
Sbjct: 117 ATQISSAMEYLEK--KNFIHRDLAARNCLVGENH--LVKVADFG--------LSRLMTGD 164
Query: 278 YYRS------------PEVLLGIPYDLAIDMWSLGCILVELHT 308
Y + PE L + + D+W+ G +L E+ T
Sbjct: 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 48/234 (20%), Positives = 83/234 (35%), Gaps = 47/234 (20%)
Query: 109 LDRYEIDTLLGKGSFGQVVKA-FDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKINK 165
LD ++ L+G+G +G V K D VA+K+ N++ F+N+ + + +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLDERP---VAVKVFSFANRQNFINEK--NIYRVPLM-- 64
Query: 166 ADIHSRYIVKL-----KGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQ 220
I + + + LV E +L + + H + + A
Sbjct: 65 ---EHDNIARFIVGDERVTADGRMEYLLVMEYYPNG--SLXKYLSLHTSDWVSSCRLAHS 119
Query: 221 LCCALAFL-------SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY 273
+ LA+L + +I H DL N+L+ + I DFG S +
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--CVISDFGLSMRLTGNRLVR 177
Query: 274 IQSRY-----------YRSPEVLLGI-------PYDLAIDMWSLGCILVELHTG 309
Y +PEVL G +DM++LG I E+
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 65/289 (22%), Positives = 108/289 (37%), Gaps = 62/289 (21%)
Query: 80 SNKKEKKYVHNDGHDDENYDYIIKHGEKFL--DRYEID-------TLLGKGSFGQVVKA- 129
S + D EN + G F D + + LGKG+FG V
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCR 61
Query: 130 ---FDHEEKCQVAIKIIK-----NKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKG--H 179
VA+K ++ + + F + +I L IVK KG +
Sbjct: 62 YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL---------QHDNIVKYKGVCY 112
Query: 180 FTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTK--KFAQQLCCALAFLSSPELSII 236
+ +L L+ E L Y +L + ++ H ++ K ++ Q+C + +L + I
Sbjct: 113 SAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGT--KRYI 167
Query: 237 HCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRS------------PEV 284
H DL NIL+ + R +KI DFG + + Q YY+ PE
Sbjct: 168 HRDLATRNILVENENR--VKIGDFGLTKVLPQ------DKEYYKVKEPGESPIFWYAPES 219
Query: 285 LLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
L + +A D+WS G +L EL T + + + ++G
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTY-----IEKSKSPPAEFMRMIGNDK 263
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 56/242 (23%), Positives = 97/242 (40%), Gaps = 53/242 (21%)
Query: 118 LGKGSFGQVVKA----FDHEEKCQVAIKIIK-----NKKPFLNQAQIEVQLLEKINKADI 168
LGKG+FG V VA+K ++ + + F + +I L
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL--------- 68
Query: 169 HSRYIVKLKG--HFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTK--KFAQQLCC 223
IVK KG + + +L L+ E L Y +L + ++ H ++ K ++ Q+C
Sbjct: 69 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICK 125
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRS-- 281
+ +L + IH DL NIL+ + R +KI DFG + + Q +++
Sbjct: 126 GMEYLGT--KRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQ------DKEFFKVKE 175
Query: 282 ----------PEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331
PE L + +A D+WS G +L EL T + + + ++G
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY-----IEKSKSPPAEFMRMIGN 230
Query: 332 PP 333
Sbjct: 231 DK 232
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 49/221 (22%), Positives = 88/221 (39%), Gaps = 30/221 (13%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKN--------KKPFLNQAQIEVQLL 160
Y + L+G+G G V +A D + VA+K++ + +A+ +L
Sbjct: 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ 92
Query: 161 EKINKADIHSRYIVKLKGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQ 219
E + IH G L + L++ +L ++R ++ +
Sbjct: 93 EP-HVVPIHDF------GEID--GQLYVDMRLINGVDLAAMLRR--QGPLAPPRAVAIVR 141
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG-----SSCHVGQTLYQYI 274
Q+ AL + H D+KPENIL+ + ++DFG + + Q +
Sbjct: 142 QIGSALDA--AHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTDEKLTQL-GNTV 196
Query: 275 QSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG 315
+ YY +PE D+++L C+L E TG P + G
Sbjct: 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 65/267 (24%), Positives = 100/267 (37%), Gaps = 64/267 (23%)
Query: 92 GHDDENYDYIIKHGEKFLDRYEID-------TLLGKGSFGQVVKA----FDHEEKCQVAI 140
GH ++ D + + LGKG+FG V VA+
Sbjct: 2 GHHHHHHA----QLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAV 57
Query: 141 KIIKNKKP-----FLNQAQIEVQLLEKINKADIHSRYIVKLKG--HFTWKNHLCLVFELL 193
K +++ P F + QI L HS +IVK +G + + L LV E L
Sbjct: 58 KQLQHSGPDQQRDFQREIQILKAL---------HSDFIVKYRGVSYGPGRQSLRLVMEYL 108
Query: 194 SY-NLYNLIRNTNFHGVSLNLTK--KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP 250
L + ++ H L+ ++ ++ Q+C + +L S +H DL NIL+ S
Sbjct: 109 PSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGS--RRCVHRDLAARNILVESE 163
Query: 251 KRSAIKIIDFGSSCHVGQTLYQYIQSR--YYRS------------PEVLLGIPYDLAIDM 296
+KI DFG L + + YY PE L + D+
Sbjct: 164 AH--VKIADFG--------LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDV 213
Query: 297 WSLGCILVELHT-GEPLFSGKNEVDQM 322
WS G +L EL T + S E +M
Sbjct: 214 WSFGVVLYELFTYCDKSCSPSAEFLRM 240
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 58/257 (22%), Positives = 105/257 (40%), Gaps = 39/257 (15%)
Query: 63 YYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGS 122
YY+K L H T K D + I + ++ LG+G
Sbjct: 231 YYSKHA--DGLCHRLTTVCPTSKPQTQGLAKDA----WEIPR-----ESLRLEVKLGQGC 279
Query: 123 FGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKG 178
FG+V +VAIK +K + + FL +AQ+ +L H + +V+L
Sbjct: 280 FGEVWMG-TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR--------HEK-LVQLYA 329
Query: 179 HFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIH 237
+ + + +V E +S +L + ++ + L A Q+ +A++ ++ +H
Sbjct: 330 VVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--MNYVH 386
Query: 238 CDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYR------SPEVLLGIPYD 291
DL+ NIL+ K+ DFG + + +Y + + +PE L +
Sbjct: 387 RDLRAANILVGE--NLVCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 292 LAIDMWSLGCILVELHT 308
+ D+WS G +L EL T
Sbjct: 443 IKSDVWSFGILLTELTT 459
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 49/226 (21%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKI--IKNKKPFLNQAQIEVQLLEKINKAD 167
+RY + +G GSFG + D +VAIK+ +K K P L IE ++ + +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL---HIESKIYKMMQGGV 65
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
I ++ ++ +V ELL +L +L + SL A Q+ + +
Sbjct: 66 ----GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEY 120
Query: 228 LSSPELSIIHCDLKPENILLCSPKRS-AIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLL 286
+ S + IH D+KP+N L+ K+ + IIDFG ++ YR
Sbjct: 121 IHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL-------------AKKYRDARTHQ 165
Query: 287 GIPYD-----------------LAI------DMWSLGCILVELHTG 309
IPY L I D+ SLG +L+ + G
Sbjct: 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 211
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 110 DRYEID-------TLLGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQ 158
D +EI LG+G FG+V + +VAIK +K + + FL +AQ+ +
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKK 235
Query: 159 LLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKF 217
L H + +V+L + + + +V E +S +L + ++ + L
Sbjct: 236 LR--------HEK-LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 285
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR 277
A Q+ +A++ ++ +H DL+ NIL+ K+ DFG + + +Y +
Sbjct: 286 AAQIASGMAYVER--MNYVHRDLRAANILVGE--NLVCKVADFGLARLIEDN--EYTARQ 339
Query: 278 YYR------SPEVLLGIPYDLAIDMWSLGCILVELHT 308
+ +PE L + + D+WS G +L EL T
Sbjct: 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 42/232 (18%)
Query: 96 ENYDYIIKHGEKFLDRYEI--DTLLGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPF 149
+ + R + + LG G FG+V A ++ +VA+K +K + + F
Sbjct: 172 SKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAF 230
Query: 150 LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHG 208
L +A + L H + +VKL T K + ++ E ++ +L + +++
Sbjct: 231 LAEANVMKTL--------QHDK-LVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSK 280
Query: 209 VSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268
L F+ Q+ +AF+ + IH DL+ NIL+ + KI DFG
Sbjct: 281 QPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSA--SLVCKIADFG------- 329
Query: 269 TLYQYIQSRYYRS------------PEVLLGIPYDLAIDMWSLGCILVELHT 308
L + I+ Y + PE + + + D+WS G +L+E+ T
Sbjct: 330 -LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 52/226 (23%), Positives = 91/226 (40%), Gaps = 49/226 (21%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKI--IKNKKPFLNQAQIEVQLLEKINKAD 167
+++ + +G GSFG++ + + +VAIK+ +K K P L E ++ +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL---LYESKIYRILQGGT 63
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
I ++ ++ LV +LL +L +L + +SL A Q+ + F
Sbjct: 64 ----GIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEF 118
Query: 228 LSSPELSIIHCDLKPENILL-CSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLL 286
+ S S +H D+KP+N L+ + + + IIDFG ++ YR
Sbjct: 119 VHS--KSFLHRDIKPDNFLMGLGRRANQVYIIDFGL-------------AKKYRDTSTHQ 163
Query: 287 GIPYD-----------------LAI------DMWSLGCILVELHTG 309
IPY L I D+ SLG +L+ G
Sbjct: 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 9e-17
Identities = 63/283 (22%), Positives = 113/283 (39%), Gaps = 62/283 (21%)
Query: 63 YYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGS 122
Y K+K K + R E ++ D + E + + LG G+
Sbjct: 4 YKYKQKPK-----YQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGA 58
Query: 123 FGQVVKA-----FDHEEKCQVAIKIIKN------KKPFLNQAQIEVQLLEKINKADIHSR 171
FG+VV+A + +VA+K++K+ K+ ++ E++++ + + H
Sbjct: 59 FGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS----ELKIMSHLGQ---HEN 111
Query: 172 YIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNT--------NFHGVSLNLTKK----FA 218
IV L G T + ++ E Y +L N +R F + + + F+
Sbjct: 112 -IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 219 QQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR- 277
Q+ +AFL+S + IH D+ N+LL + KI DFG L + I +
Sbjct: 171 SQVAQGMAFLAS--KNCIHRDVAARNVLLTNGH--VAKIGDFG--------LARDIMNDS 218
Query: 278 YYR------------SPEVLLGIPYDLAIDMWSLGCILVELHT 308
Y +PE + Y + D+WS G +L E+ +
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 48/227 (21%), Positives = 87/227 (38%), Gaps = 51/227 (22%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKI--IKNKKPFLNQAQIEVQLLEKINKADI 168
+ + +G G+FG++ + VAIK+ +K++ P L+ E + +++
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL---EYRFYKQLGS--- 63
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228
I ++ + +V ELL +L +L + SL A QL + ++
Sbjct: 64 -GDGIPQVYYFGPCGKYNAMVLELLGPSLEDL-FDLCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 229 SSPELSIIHCDLKPENILL---CSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVL 285
S ++I+ D+KPEN L+ + + I IIDF ++ Y PE
Sbjct: 122 HS--KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL-------------AKEYIDPETK 166
Query: 286 LGIPYD-----------------LAI------DMWSLGCILVELHTG 309
IPY L D+ +LG + + G
Sbjct: 167 KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 47/228 (20%), Positives = 84/228 (36%), Gaps = 51/228 (22%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKI--IKNKKPFLNQAQIEVQLLEKINKAD 167
Y++ +G+GSFG + + + QVAIK ++ P L E + + +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD---EYRTYKLLAGCT 66
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
I + H LV +LL +L +L+ S+ A+Q+ +
Sbjct: 67 ----GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQS 121
Query: 228 LSSPELSIIHCDLKPENILL---CSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEV 284
+ S+++ D+KP+N L+ S + I ++DFG ++YR P
Sbjct: 122 IHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM-------------VKFYRDPVT 166
Query: 285 LLGIPYD-----------------LAI------DMWSLGCILVELHTG 309
IPY L D+ +LG + + G
Sbjct: 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 54/267 (20%), Positives = 102/267 (38%), Gaps = 37/267 (13%)
Query: 88 VHNDGHDDENYDYIIKHGEKFLDRYEI--DTLLGKGSFGQVVKA---FDHEEKCQVAIKI 142
+ + H E + + ++ I + ++G G G+V + VAIK
Sbjct: 25 FYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA 84
Query: 143 IK------NKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY- 195
+K ++ FL++A I Q H I++L+G T +V E +
Sbjct: 85 LKAGYTERQRRDFLSEASIMGQF--------DHPN-IIRLEGVVTRGRLAMIVTEYMENG 135
Query: 196 NLYNLIRNTNFHGVSLNLTK--KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS 253
+L +R H + + + + + +LS L +H DL N+L+ S
Sbjct: 136 SLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSD--LGYVHRDLAARNVLVDSNL-- 188
Query: 254 AIKIIDFGSSCHVGQTLYQYIQSRYYR------SPEVLLGIPYDLAIDMWSLGCILVELH 307
K+ DFG S + + + +PE + + A D+WS G ++ E+
Sbjct: 189 VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248
Query: 308 T-GEPLFSGKNEVDQMTKIIEVLGMPP 333
GE + D ++ + E +P
Sbjct: 249 AYGERPYWNMTNRDVISSVEEGYRLPA 275
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 64/260 (24%), Positives = 100/260 (38%), Gaps = 68/260 (26%)
Query: 97 NYDYIIKHGEKFLDRYEID-------TLLGKGSFGQVVKA-----FDHEEKCQVAIKIIK 144
NY YI + ++E LG G+FG+VV+A + VA+K++K
Sbjct: 3 NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62
Query: 145 ------NKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NL 197
++ ++ E+++L + H IV L G T ++ E Y +L
Sbjct: 63 PSAHLTEREALMS----ELKVLSYLGN---HMN-IVNLLGACTIGGPTLVITEYCCYGDL 114
Query: 198 YNLIRN------------TNFHGVSLNLTKK----FAQQLCCALAFLSSPELSIIHCDLK 241
N +R L L + F+ Q+ +AFL+S + IH DL
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS--KNCIHRDLA 172
Query: 242 PENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR-YYR------------SPEVLLGI 288
NILL + KI DFG L + I++ Y +PE +
Sbjct: 173 ARNILLTHGR--ITKICDFG--------LARDIKNDSNYVVKGNARLPVKWMAPESIFNC 222
Query: 289 PYDLAIDMWSLGCILVELHT 308
Y D+WS G L EL +
Sbjct: 223 VYTFESDVWSYGIFLWELFS 242
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 64/283 (22%), Positives = 110/283 (38%), Gaps = 41/283 (14%)
Query: 75 HNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEI--DTLLGKGSFGQVVKA--- 129
N + +V D H E+ + K LD I D ++G G FG+V
Sbjct: 10 GNGHLKLPGLRTFV--DPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK 67
Query: 130 FDHEEKCQVAIKIIK------NKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183
+++ VAIK +K ++ FL +A I Q I++L+G T
Sbjct: 68 LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF---------DHPNIIRLEGVVTKS 118
Query: 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTK--KFAQQLCCALAFLSSPELSIIHCDL 240
+ +V E + +L + +R H + + + + + +LS + +H DL
Sbjct: 119 KPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDL 173
Query: 241 KPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYR------SPEVLLGIPYDLAI 294
NIL+ S K+ DFG + +R + SPE + + A
Sbjct: 174 AARNILINSNL--VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 295 DMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIE--VLGMPPG 334
D+WS G +L E+ + GE + + D + + E L P
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMD 274
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 3e-16
Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 47/223 (21%)
Query: 110 DRYEID-------TLLGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQ 158
D +E+ LG G FG+V + + +VA+K +K + FL +A + Q
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQ 64
Query: 159 LLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKF 217
L H R +V+L T + + ++ E + +L + ++ + +++N
Sbjct: 65 LQ--------HQR-LVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ-S 276
A Q+ +AF+ + IH DL+ NIL+ + KI DFG L + I+ +
Sbjct: 115 AAQIAEGMAFIEE--RNYIHRDLRAANILVSDTL--SCKIADFG--------LARLIEDN 162
Query: 277 RYYRS-----------PEVLLGIPYDLAIDMWSLGCILVELHT 308
Y PE + + + D+WS G +L E+ T
Sbjct: 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 49/217 (22%), Positives = 92/217 (42%), Gaps = 39/217 (17%)
Query: 110 DRYEID-------TLLGKGSFGQVVKAFDHEEKCQVAIKIIKN---KKPFLNQAQIEVQL 159
+ ++ +GKG FG V+ K VA+K IKN + FL +A +
Sbjct: 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASV---- 239
Query: 160 LEKINKADIHSRYIVKLKGHFTWKN-HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKF 217
+ ++ HS +V+L G + L +V E ++ +L + +R+ + + KF
Sbjct: 240 MTQLR----HSN-LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 294
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR 277
+ +C A+ +L + +H DL N+L+ + K+ DFG +
Sbjct: 295 SLDVCEAMEYLEG--NNFVHRDLAARNVLVSE--DNVAKVSDFGLTKEA------SSTQD 344
Query: 278 YYR------SPEVLLGIPYDLAIDMWSLGCILVELHT 308
+ +PE L + D+WS G +L E+++
Sbjct: 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-16
Identities = 44/231 (19%), Positives = 89/231 (38%), Gaps = 53/231 (22%)
Query: 109 LDRYEIDTL--LGKGSFGQVVKA-------FDHEEKCQVAIKIIKN-----KKPFLNQAQ 154
+ ++ LG+G+F ++ K + + +V +K++ + F A
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAAS 64
Query: 155 IEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNL 213
+ +L +++V G + LV E + + +L ++ + +N+
Sbjct: 65 MMSKL---------SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINI 112
Query: 214 TKK--FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA------IKIIDFGSSCH 265
K A+QL A+ FL ++IH ++ +NILL + IK+ D G
Sbjct: 113 LWKLEVAKQLAAAMHFLEE--NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG---- 166
Query: 266 VGQTLYQYIQSR-YYR------SPEVLL-GIPYDLAIDMWSLGCILVELHT 308
+ + + + PE + +LA D WS G L E+ +
Sbjct: 167 ----ISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 56/302 (18%), Positives = 106/302 (35%), Gaps = 57/302 (18%)
Query: 61 EVYYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEI--DTLL 118
Y+ + E Y G + + + + + ++
Sbjct: 2 SYYHHHHHHDYDIPTTENL-------YF--QGAMGSDPNQAVLKFTTEIHPSCVTRQKVI 52
Query: 119 GKGSFGQVVKAF----DHEEKCQVAIKIIK------NKKPFLNQAQIEVQLLEKINKADI 168
G G FG+V K +++ VAIK +K + FL +A I Q
Sbjct: 53 GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF--------- 103
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTK--KFAQQLCCAL 225
I++L+G + + ++ E + L +R ++ + + + +
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGM 160
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRS---- 281
+L++ ++ +H DL NIL+ S K+ DFG S + Y S
Sbjct: 161 KYLAN--MNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPEAT----YTTSGGKI 212
Query: 282 ------PEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIE--VLGMP 332
PE + + A D+WS G ++ E+ T GE + + + M I + L P
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 272
Query: 333 PG 334
Sbjct: 273 MD 274
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 62/240 (25%), Positives = 97/240 (40%), Gaps = 52/240 (21%)
Query: 118 LGKGSFGQVVKA----FDHEEKCQVAIKIIK------NKKPFLNQAQIEVQLLEKINKAD 167
LG+G FG+V + VA+K +K ++ + + I L
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-------- 90
Query: 168 IHSRYIVKLKG--HFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCA 224
+ +I+K KG L LV E + +L + + H + L FAQQ+C
Sbjct: 91 -YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEG 146
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYR---- 280
+A+L + IH DL N+LL + + +KI DFG + V + YYR
Sbjct: 147 MAYLHA--QHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEG------HEYYRVRED 196
Query: 281 --------SPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332
+PE L + A D+WS G L EL T + TK +E++G+
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH-----CDSSQSPPTKFLELIGIA 251
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 57/233 (24%), Positives = 88/233 (37%), Gaps = 56/233 (24%)
Query: 110 DRYEID-------TLLGKGSFGQVVKA----FDHEEKCQVAIKIIK------NKKPFLNQ 152
D + LG+G FG+V QVA+K +K + +
Sbjct: 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKE 73
Query: 153 AQIEVQLLEKINKADIHSRYIVKLKG--HFTWKNHLCLVFELLSY-NLYNLIRNTNFHGV 209
+I L + IVK KG N + L+ E L +L + +
Sbjct: 74 IEILRNL---------YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKN 121
Query: 210 SLNLTK--KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267
+NL + K+A Q+C + +L S +H DL N+L+ S + +KI DFG + +
Sbjct: 122 KINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAI- 176
Query: 268 QTLYQYIQSRYYRS------------PEVLLGIPYDLAIDMWSLGCILVELHT 308
YY PE L+ + +A D+WS G L EL T
Sbjct: 177 -----ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 44/220 (20%)
Query: 109 LDRYEI--DTLLGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLLEK 162
L R EI LG G FG V + + VA+K+IK ++ F +AQ ++L
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS-- 61
Query: 163 INKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTK--KFAQ 219
H + +VK G + + + +V E +S L N +R+ HG L ++ +
Sbjct: 62 ------HPK-LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCY 111
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYY 279
+C +AFL S IH DL N L+ +K+ DFG + +V + +Y
Sbjct: 112 DVCEGMAFLES--HQFIHRDLAARNCLVDRDL--CVKVSDFGMTRYV-------LDDQYV 160
Query: 280 RS-----------PEVLLGIPYDLAIDMWSLGCILVELHT 308
S PEV Y D+W+ G ++ E+ +
Sbjct: 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 66/274 (24%), Positives = 103/274 (37%), Gaps = 62/274 (22%)
Query: 75 HNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEI--DTLLGKGSFGQVVKA--- 129
+ + + E K GH EN Y + R +I LG+G+FG+V A
Sbjct: 4 GSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECH 63
Query: 130 --FDHEEKCQVAIKIIKN-----KKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182
++K VA+K +K ++ F E +LL + H IV+ G T
Sbjct: 64 NLLPEQDKMLVAVKALKEASESARQDFQR----EAELLTMLQ----HQH-IVRFFGVCTE 114
Query: 183 KNHLCLVFELLSY-NLYNLIRN---------TNFHGVSLNLTKK----FAQQLCCALAFL 228
L +VFE + + +L +R+ L A Q+ + +L
Sbjct: 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL 174
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR-YYR------- 280
+ L +H DL N L+ +KI DFG + + I S YYR
Sbjct: 175 AG--LHFVHRDLATRNCLVGQ--GLVVKIGDFG--------MSRDIYSTDYYRVGGRTML 222
Query: 281 -----SPEVLL-GIPYDLAIDMWSLGCILVELHT 308
PE +L + D+WS G +L E+ T
Sbjct: 223 PIRWMPPESILYRK-FTTESDVWSFGVVLWEIFT 255
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 48/221 (21%), Positives = 92/221 (41%), Gaps = 35/221 (15%)
Query: 107 KFLDRYEI--DTLLGKGSFGQVVKAF----DHEEKCQVAIKIIK------NKKPFLNQAQ 154
+ L E +LG G+FG V K + K VAIK ++ K L++A
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 155 IEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNL 213
+ + + ++ +L G + + L+ +L+ + L + +R + +
Sbjct: 70 VMASV---------DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVRE-HKDNIGSQY 118
Query: 214 TKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY 273
+ Q+ + +L + ++H DL N+L+ +P +KI DFG + +G +Y
Sbjct: 119 LLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEY 174
Query: 274 IQS------RYYRSPEVLLGIPYDLAIDMWSLGCILVELHT 308
++ + E +L Y D+WS G + EL T
Sbjct: 175 HAEGGKVPIKWM-ALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 63/280 (22%), Positives = 106/280 (37%), Gaps = 49/280 (17%)
Query: 71 AQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEI---DTLLGKGSFGQVV 127
A+++ + V D +K + FL R + D LG G+FG V
Sbjct: 297 ARITSPDKPRPMPMDTSVFESPFSDPEE---LKDKKLFLKRDNLLIADIELGCGNFGSVR 353
Query: 128 KAF--DHEEKCQVAIKIIK------NKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179
+ +++ VAIK++K + + + +AQI QL + YIV+L G
Sbjct: 354 QGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL---------DNPYIVRLIGV 404
Query: 180 FTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHC 238
L LV E+ L+ + N+ + Q+ + +L E + +H
Sbjct: 405 CQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA-ELLHQVSMGMKYLE--EKNFVHR 460
Query: 239 DLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRS------------PEVLL 286
+L N+LL + R KI DFG S +G YY + PE +
Sbjct: 461 NLAARNVLLVN--RHYAKISDFGLSKALGA------DDSYYTARSAGKWPLKWYAPECIN 512
Query: 287 GIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKI 325
+ D+WS G + E + G+ + + M I
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 64/259 (24%), Positives = 108/259 (41%), Gaps = 59/259 (22%)
Query: 110 DRYEID-------TLLGKGSFGQVVKAF---DHEEKCQVAIKIIK------NKKPFLNQA 153
+Y I +LG+G FG+V + EK VA+K K NK+ F+++A
Sbjct: 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEA 64
Query: 154 QIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLN 212
I L +IVKL G + ++ EL Y L + + + SL
Sbjct: 65 VIMKNL---------DHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLER---NKNSLK 111
Query: 213 LTK--KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL 270
+ ++ Q+C A+A+L S ++ +H D+ NIL+ SP +K+ DFG L
Sbjct: 112 VLTLVLYSLQICKAMAYLES--INCVHRDIAVRNILVASP--ECVKLGDFG--------L 159
Query: 271 YQYIQSR-YYRS-----------PEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKN 317
+YI+ YY++ PE + + A D+W + E+ + G+ F
Sbjct: 160 SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219
Query: 318 EVDQMTKII--EVLGMPPG 334
D + + + L P
Sbjct: 220 NKDVIGVLEKGDRLPKPDL 238
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 46/221 (20%)
Query: 109 LDRYEI--DTLLGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLLEK 162
+D E+ +G G FG V + K +VAIK I+ +++ F+ +A++ ++L
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL--- 60
Query: 163 INKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTK--KFAQ 219
H + +V+L G + +CLV E + + L + +R
Sbjct: 61 -----SHPK-LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCL 111
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYY 279
+C +A+L +IH DL N L+ IK+ DFG + +++ Y
Sbjct: 112 DVCEGMAYLEE--ACVIHRDLAARNCLVGE--NQVIKVSDFG--------MTRFVLDDQY 159
Query: 280 RS------------PEVLLGIPYDLAIDMWSLGCILVELHT 308
S PEV Y D+WS G ++ E+ +
Sbjct: 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 54/245 (22%), Positives = 89/245 (36%), Gaps = 42/245 (17%)
Query: 87 YVHN-DGHDDENYDYIIKHGEKFLDRYEID----TL---LGKGSFGQVVKAFDHEEKCQV 138
+ ++ + + K D++ ++ L +G+G+FG+V + V
Sbjct: 85 LLSTQQPLTKKSGVVLHRAVPK--DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLV 142
Query: 139 AIKIIKN------KKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFEL 192
A+K + K FL +A+I Q IV+L G T K + +V EL
Sbjct: 143 AVKSCRETLPPDLKAKFLQEARILKQY---------SHPNIVRLIGVCTQKQPIYIVMEL 193
Query: 193 LSY-NLYNLIRNTNFHGVSLNLTKK--FAQQLCCALAFLSSPELSIIHCDLKPENILLCS 249
+ + +R G L + + +L S IH DL N L+
Sbjct: 194 VQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLES--KCCIHRDLAARNCLVTE 248
Query: 250 PKRSAIKIIDFGSSCHVGQTLYQYIQSRYYR------SPEVLLGIPYDLAIDMWSLGCIL 303
+KI DFG S +Y + +PE L Y D+WS G +L
Sbjct: 249 KN--VLKISDFGMSREEADGVY-AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL 305
Query: 304 VELHT 308
E +
Sbjct: 306 WETFS 310
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 67/309 (21%), Positives = 111/309 (35%), Gaps = 77/309 (24%)
Query: 57 KHINEVYYTKKK----RKAQLSHNETRSNKKEKKYVH-----NDGHDDENYDYIIKHGEK 107
+ V+ K+ R+ +S + S V + D + ++
Sbjct: 12 QDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELP 71
Query: 108 FLDRYEID-------TLLGKGSFGQVVKA-------FDHEEKCQVAIKIIK------NKK 147
++E LG+G FGQVV A +E VA+K++K +
Sbjct: 72 EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 131
Query: 148 PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRN--- 203
++ E+++++ I K H I+ L G T L ++ E S NL +R
Sbjct: 132 DLVS----EMEMMKMIGK---HKN-IINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 183
Query: 204 -------TNFHGVSLNLTKK----FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR 252
+T K QL + +L+S IH DL N+L+
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENN- 240
Query: 253 SAIKIIDFGSSCHVGQTLYQYIQSR-YYR------------SPEVLLGIPYDLAIDMWSL 299
+KI DFG L + I + YY+ +PE L Y D+WS
Sbjct: 241 -VMKIADFG--------LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 291
Query: 300 GCILVELHT 308
G ++ E+ T
Sbjct: 292 GVLMWEIFT 300
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 50/217 (23%), Positives = 91/217 (41%), Gaps = 39/217 (17%)
Query: 110 DRYEID-------TLLGKGSFGQVVKAFDHEEKCQVAIKIIKN---KKPFLNQAQIEVQL 159
+ ++ +GKG FG V+ K VA+K IKN + FL +A +
Sbjct: 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASV---- 67
Query: 160 LEKINKADIHSRYIVKLKG-HFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKF 217
+ ++ HS +V+L G K L +V E ++ +L + +R+ + + KF
Sbjct: 68 MTQLR----HSN-LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR 277
+ +C A+ +L + +H DL N+L+ K+ DFG +
Sbjct: 123 SLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDN--VAKVSDFGLT------KEASSTQD 172
Query: 278 YYR------SPEVLLGIPYDLAIDMWSLGCILVELHT 308
+ +PE L + D+WS G +L E+++
Sbjct: 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 57/247 (23%), Positives = 93/247 (37%), Gaps = 67/247 (27%)
Query: 109 LDRYEID-------TLLGKGSFGQVVKAF-----DHEEKCQVAIKIIK------NKKPFL 150
++E LG+G+FGQV++A VA+K++K + +
Sbjct: 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 78
Query: 151 NQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN-HLCLVFELLSY-NLYNLIRN----- 203
+ E+++L I H +V L G T L ++ E + NL +R+
Sbjct: 79 S----ELKILIHIGH---HLN-VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 130
Query: 204 -----TNFHGVSLNLTKK----FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA 254
LT + ++ Q+ + FL+S IH DL NILL
Sbjct: 131 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKN--V 186
Query: 255 IKIIDFGSSCHVGQTLYQYIQSR-YYR------------SPEVLLGIPYDLAIDMWSLGC 301
+KI DFG L + I Y +PE + Y + D+WS G
Sbjct: 187 VKICDFG--------LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 238
Query: 302 ILVELHT 308
+L E+ +
Sbjct: 239 LLWEIFS 245
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 7e-15
Identities = 35/237 (14%), Positives = 76/237 (32%), Gaps = 56/237 (23%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHS 170
++ + +G G FG + AF + + A ++K + E++ +++ K D
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 171 RYIVKLKG------HFTW--------KNHLCLVFELLSYNLYNLIR-NTNFHGVSLNLTK 215
++I + + F +++ +V E L +L + N F +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTF---KKSTVL 154
Query: 216 KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ 275
+ ++ L ++ E +H D+K N+LL + + D+G
Sbjct: 155 QLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGL------------- 199
Query: 276 SRYYRSPEVLLGIPYDLAI-----------------------DMWSLGCILVELHTG 309
S Y + D+ LG ++ G
Sbjct: 200 SYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCG 256
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 7e-15
Identities = 52/225 (23%), Positives = 94/225 (41%), Gaps = 51/225 (22%)
Query: 110 DRYEID-------TLLGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQ 158
+EID LG G FG V + VAIK+IK ++ F+ +A++ +
Sbjct: 17 GSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 75
Query: 159 LLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTK-- 215
L H + +V+L G T + + ++ E ++ L N +R +
Sbjct: 76 LS--------HEK-LVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLL 123
Query: 216 KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ 275
+ + +C A+ +L S +H DL N L+ + +K+ DFG L +Y+
Sbjct: 124 EMCKDVCEAMEYLES--KQFLHRDLAARNCLVND--QGVVKVSDFG--------LSRYVL 171
Query: 276 SRYYRS------------PEVLLGIPYDLAIDMWSLGCILVELHT 308
Y S PEVL+ + D+W+ G ++ E+++
Sbjct: 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 9e-15
Identities = 54/248 (21%), Positives = 93/248 (37%), Gaps = 55/248 (22%)
Query: 110 DRYEID--------TLLGKGSFGQVVKAF--DHEEKCQVAIKIIK------NKKPFLNQA 153
+ + LG G+FG V + +++ VAIK++K + + + +A
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 154 QIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLN 212
QI QL + YIV+L G L LV E+ L+ + +
Sbjct: 62 QIMHQL---------DNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVG---KREEIP 108
Query: 213 LTK--KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL 270
++ + Q+ + +L E + +H DL N+LL + KI DFG S +G
Sbjct: 109 VSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRH--YAKISDFGLSKALGA-- 162
Query: 271 YQYIQSRYYRS------------PEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKN 317
YY + PE + + D+WS G + E + G+ +
Sbjct: 163 ----DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218
Query: 318 EVDQMTKI 325
+ M I
Sbjct: 219 GPEVMAFI 226
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 62/284 (21%), Positives = 108/284 (38%), Gaps = 71/284 (25%)
Query: 77 ETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEID-------TLLGKGSFGQVVKA 129
+ + + + V G D Y Y+ ++ ++E +LG G+FG+V+ A
Sbjct: 5 KQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNA 64
Query: 130 -----FDHEEKCQVAIKIIK------NKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKG 178
QVA+K++K ++ ++ E++++ ++ H IV L G
Sbjct: 65 TAYGISKTGVSIQVAVKMLKEKADSSEREALMS----ELKMMTQLGS---HEN-IVNLLG 116
Query: 179 HFTWKNHLCLVFELLSY-NLYNLIRN-----------------TNFHGVSLNLTKK---- 216
T + L+FE Y +L N +R+ LT +
Sbjct: 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 176
Query: 217 FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQS 276
FA Q+ + FL S +H DL N+L+ K +KI DFG + +
Sbjct: 177 FAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGK--VVKICDFGLA-------RDIMSD 225
Query: 277 RYYR------------SPEVLLGIPYDLAIDMWSLGCILVELHT 308
Y +PE L Y + D+WS G +L E+ +
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 60/261 (22%), Positives = 94/261 (36%), Gaps = 65/261 (24%)
Query: 88 VHNDGHDDENYDYIIKHGEKFLDRYEI--DTLLGKGSFGQVVKAF--DHEEKCQVAIKII 143
+ H + LD +I ++G+G+FGQV+KA + AIK +
Sbjct: 1 MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 60
Query: 144 KN------KKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-N 196
K + F E+++L K+ H I+ L G + +L L E + N
Sbjct: 61 KEYASKDDHRDFAG----ELEVLCKLGH---HPN-IINLLGACEHRGYLYLAIEYAPHGN 112
Query: 197 LYNLIRN----------TNFHGVSLNLTKK----FAQQLCCALAFLSSPELSIIHCDLKP 242
L + +R + + L+ + FA + + +LS IH DL
Sbjct: 113 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAA 170
Query: 243 ENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR---YYR------------SPEVLLG 287
NIL+ KI DFG L SR Y + E L
Sbjct: 171 RNILVGENY--VAKIADFG--------L-----SRGQEVYVKKTMGRLPVRWMAIESLNY 215
Query: 288 IPYDLAIDMWSLGCILVELHT 308
Y D+WS G +L E+ +
Sbjct: 216 SVYTTNSDVWSYGVLLWEIVS 236
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 40/239 (16%), Positives = 86/239 (35%), Gaps = 57/239 (23%)
Query: 111 RYEIDTLLGKGSFGQVVKAFD--------HEEKCQVAIKI------IKNKKPFLNQAQIE 156
++++ + + + G + +A +K + ++K+ + N++ F +A
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 157 VQLLEKINKADIHSRYIVKLKGHFTWKN-HLCLVFELLSYNLYNLIRNTNFHGVSLNLTK 215
+Q+ + I G ++ + LV L +L + + + H +S
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVL 162
Query: 216 KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS------------ 263
+ A +L AL FL E +H ++ ENI + +S + + +G +
Sbjct: 163 QVACRLLDALEFLHENEY--VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220
Query: 264 ------CHVGQTLYQYI-------QSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTG 309
H G + + SR RS D+ SLG +++ G
Sbjct: 221 VEGSRSPHEGDLEFISMDLHKGCGPSR--RS-------------DLQSLGYCMLKWLYG 264
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 68/259 (26%), Positives = 104/259 (40%), Gaps = 59/259 (22%)
Query: 110 DRYEID-------TLLGKGSFGQVVKA---FDHEEKCQVAIKIIK------NKKPFLNQA 153
YEI +G+G FG V + VAIK K ++ FL +A
Sbjct: 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 67
Query: 154 QIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLN 212
Q +IVKL G T +N + ++ EL + L + ++ SL+
Sbjct: 68 LTMRQF---------DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLD 114
Query: 213 LTK--KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL 270
L +A QL ALA+L S +H D+ N+L+ S +K+ DFG L
Sbjct: 115 LASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSND--CVKLGDFG--------L 162
Query: 271 YQYIQ-SRYYRS-----------PEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKN 317
+Y++ S YY++ PE + + A D+W G + E+ G F G
Sbjct: 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222
Query: 318 EVDQMTKIIE--VLGMPPG 334
D + +I L MPP
Sbjct: 223 NNDVIGRIENGERLPMPPN 241
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 59/259 (22%), Positives = 93/259 (35%), Gaps = 58/259 (22%)
Query: 88 VHNDGHDDENYDYIIKHGEKFLDRYEID-------TLLGKGSFGQVVKAF-----DHEEK 135
H+ H + NY + K D E+ LG G+FG+V + +
Sbjct: 2 AHHHHHHNPNYCFAGK-TSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSP 60
Query: 136 CQVAIKIIK------NKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189
QVA+K + ++ FL E ++ K N H IV+ G ++
Sbjct: 61 LQVAVKTLPEVCSEQDELDFLM----EALIISKFN----HQN-IVRCIGVSLQSLPRFIL 111
Query: 190 FELLSY-NLYNLIRN---TNFHGVSLNLTK--KFAQQLCCALAFLSSPELSIIHCDLKPE 243
EL++ +L + +R SL + A+ + C +L IH D+
Sbjct: 112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAAR 169
Query: 244 NILLCSPKRS-AIKIIDFGSSCHVGQTLYQYIQSR-YYR------------SPEVLLGIP 289
N LL P KI DFG + + I YYR PE +
Sbjct: 170 NCLLTCPGPGRVAKIGDFG--------MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI 221
Query: 290 YDLAIDMWSLGCILVELHT 308
+ D WS G +L E+ +
Sbjct: 222 FTSKTDTWSFGVLLWEIFS 240
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 60/240 (25%), Positives = 95/240 (39%), Gaps = 61/240 (25%)
Query: 110 DRYEIDTLLGKGSFGQVVKA-------FDHEEKCQVAIKIIK------NKKPFLNQAQIE 156
D+ + LG+G+FGQVV A +E VA+K++K + ++ E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS----E 90
Query: 157 VQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRN----------TN 205
+++++ I K H I+ L G T L ++ E S NL +R
Sbjct: 91 MEMMKMIGK---HKN-IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 206 FHGVSLNLTKK----FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261
+T K QL + +L+S IH DL N+L+ +KI DFG
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENN--VMKIADFG 202
Query: 262 SSCHVGQTLYQYIQSR-YYR------------SPEVLLGIPYDLAIDMWSLGCILVELHT 308
L + I + YY+ +PE L Y D+WS G ++ E+ T
Sbjct: 203 --------LARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 59/252 (23%), Positives = 104/252 (41%), Gaps = 61/252 (24%)
Query: 97 NYDYIIKHGEKFLDRYEID----TL---LGKGSFGQVVKA-----FDHEEKCQVAIKIIK 144
N +Y D +E+ T+ LG+GSFG V + E + +VAIK +
Sbjct: 5 NPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN 64
Query: 145 ------NKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NL 197
+ FLN E ++++ N ++V+L G + ++ EL++ +L
Sbjct: 65 EAASMRERIEFLN----EASVMKEFN----C-HHVVRLLGVVSQGQPTLVIMELMTRGDL 115
Query: 198 YNLIRN------TNFHGVSLNLTK--KFAQQLCCALAFLSSPELSIIHCDLKPENILLCS 249
+ +R+ N +L+K + A ++ +A+L++ +H DL N ++
Sbjct: 116 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAE 173
Query: 250 PKRSAIKIIDFGSSCHVGQTLYQYIQSR-YYR------------SPEVLLGIPYDLAIDM 296
+KI DFG + + I YYR SPE L + D+
Sbjct: 174 DF--TVKIGDFG--------MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV 223
Query: 297 WSLGCILVELHT 308
WS G +L E+ T
Sbjct: 224 WSFGVVLWEIAT 235
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 66/294 (22%), Positives = 109/294 (37%), Gaps = 56/294 (19%)
Query: 46 RKLSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHG 105
R ++ + +L++NE + + V E D +
Sbjct: 319 RLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYT 378
Query: 106 EKFLDRYEID-------TLLGKGSFGQVVKAF---DHEEKCQVAIKIIK------NKKPF 149
YEI +G+G FG V + VAIK K ++ F
Sbjct: 379 MPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF 438
Query: 150 LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHG 208
L +A Q +IVKL G T +N + ++ EL + L + ++
Sbjct: 439 LQEALTMRQF---------DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RK 485
Query: 209 VSLNLTK--KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266
SL+L +A QL ALA+L S +H D+ N+L+ S +K+ DFG
Sbjct: 486 FSLDLASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSND--CVKLGDFG----- 536
Query: 267 GQTLYQYIQ-SRYYRS-----------PEVLLGIPYDLAIDMWSLGCILVELHT 308
L +Y++ S YY++ PE + + A D+W G + E+
Sbjct: 537 ---LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 57/251 (22%), Positives = 95/251 (37%), Gaps = 43/251 (17%)
Query: 108 FLDRYEI--DTLLGKGSFGQVVKAF---DHEEKCQVAIKIIKN--------KKPFLNQAQ 154
+ ++ LG GSFG V + + VA+K +K F+ +
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73
Query: 155 IEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNL 213
L R +++L G + +V EL +L + +R H L
Sbjct: 74 AMHSL---------DHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGH-FLLGT 122
Query: 214 TKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY 273
++A Q+ + +L S IH DL N+LL + +KI DFG + Q Y
Sbjct: 123 LSRYAVQVAEGMGYLES--KRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHY 178
Query: 274 IQSRYYR------SPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKN--EVDQMTK 324
+ + + +PE L + A D W G L E+ T G+ + G N ++
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK-- 236
Query: 325 IIEVLG--MPP 333
I+ G +P
Sbjct: 237 -IDKEGERLPR 246
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 62/304 (20%), Positives = 109/304 (35%), Gaps = 69/304 (22%)
Query: 53 IKTYKHINEVYYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRY 112
+ ++ T+ + + + + + + ++ R+
Sbjct: 6 HHHHHD-YDIPTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRW 64
Query: 113 EID-------TLLGKGSFGQVVKA-------FDHEEKCQVAIKIIK------NKKPFLNQ 152
E+ LG+G+FGQVV A +VA+K++K + ++
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS- 123
Query: 153 AQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRN-------- 203
E+++++ I K H I+ L G T L ++ E S NL ++
Sbjct: 124 ---EMEMMKMIGK---HKN-IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 176
Query: 204 --TNFHGVSLNLTKK----FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKI 257
H L+ K A Q+ + +L+S IH DL N+L+ +KI
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDN--VMKI 232
Query: 258 IDFGSSCHVGQTLYQYIQSR-YYR------------SPEVLLGIPYDLAIDMWSLGCILV 304
DFG L + I YY+ +PE L Y D+WS G +L
Sbjct: 233 ADFG--------LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 284
Query: 305 ELHT 308
E+ T
Sbjct: 285 EIFT 288
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 48/221 (21%), Positives = 92/221 (41%), Gaps = 35/221 (15%)
Query: 107 KFLDRYEI--DTLLGKGSFGQVVKAF----DHEEKCQVAIKIIK------NKKPFLNQAQ 154
+ L E +LG G+FG V K + K VAIK ++ K L++A
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 155 IEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNL 213
+ + + ++ +L G + + L+ +L+ + L + +R + +
Sbjct: 70 VMASV---------DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVRE-HKDNIGSQY 118
Query: 214 TKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQY 273
+ Q+ + +L + ++H DL N+L+ +P +KI DFG + +G +Y
Sbjct: 119 LLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEY 174
Query: 274 IQS------RYYRSPEVLLGIPYDLAIDMWSLGCILVELHT 308
++ + E +L Y D+WS G + EL T
Sbjct: 175 HAEGGKVPIKWM-ALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 5e-14
Identities = 57/230 (24%), Positives = 90/230 (39%), Gaps = 61/230 (26%)
Query: 118 LGKGSFGQVVKA-----FDHEEKCQVAIKIIKN-----KKPFLNQAQIEVQLLEKINKAD 167
LG+G+FG+V A ++K VA+K +K+ +K F E +LL +
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR----EAELLTNLQ--- 75
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIR----------NTNFHGVSLNLTKK 216
H IVK G + L +VFE + + +L +R + L
Sbjct: 76 -HEH-IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 217 ----FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ 272
A Q+ + +L+S +H DL N L+ +KI DFG + +
Sbjct: 134 QMLHIASQIASGMVYLAS--QHFVHRDLATRNCLV-GANLL-VKIGDFG--------MSR 181
Query: 273 YIQSR-YYR------------SPEVLL-GIPYDLAIDMWSLGCILVELHT 308
+ S YYR PE ++ + D+WS G IL E+ T
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFT 230
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 29/197 (14%), Positives = 65/197 (32%), Gaps = 32/197 (16%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKIIKNKKP-------FLNQAQIEVQ 158
+++ +G+G FG + A + +K+ + F +A Q
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 159 LLEKINKADIHSRYIVKLKGH----FTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLT 214
+ + I + + K G K++ ++ + +L + N S
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIY-EANAKRFSRKTV 154
Query: 215 KKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYI 274
+ + ++ L ++ E +H D+K N+LL + ++D+G
Sbjct: 155 LQLSLRILDILEYIHEHEY--VHGDIKASNLLLNYKNPDQVYLVDYGL------------ 200
Query: 275 QSRYYRSPEVLLGIPYD 291
+ Y V D
Sbjct: 201 -AYRYCPEGVHKAYAAD 216
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 62/300 (20%), Positives = 101/300 (33%), Gaps = 58/300 (19%)
Query: 48 LSVDLIKTYKHINEVYYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEK 107
+S + + + + K K + D N +Y
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTS 60
Query: 108 FL-DRYEID----TL---LGKGSFGQVVKAF-----DHEEKCQVAIKIIK------NKKP 148
+ D E+ TL LG G+FG+V + + QVA+K + ++
Sbjct: 61 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 120
Query: 149 FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRN---T 204
FL E ++ K N H IV+ G ++ EL++ +L + +R
Sbjct: 121 FLM----EALIISKFN----HQN-IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR 171
Query: 205 NFHGVSLNLTK--KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS-AIKIIDFG 261
SL + A+ + C +L IH D+ N LL P KI DFG
Sbjct: 172 PSQPSSLAMLDLLHVARDIACGCQYLEE--NHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229
Query: 262 SSCHVGQTLYQYIQSR-YYR------------SPEVLLGIPYDLAIDMWSLGCILVELHT 308
+ + I YYR PE + + D WS G +L E+ +
Sbjct: 230 --------MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 8e-14
Identities = 48/224 (21%), Positives = 81/224 (36%), Gaps = 45/224 (20%)
Query: 109 LDRYEI--DTLLGKGSFGQVVKAF----DHEEKCQVAIKIIKN------KKPFLNQAQIE 156
E+ +LG G FG V K K V IK+I++ + +
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAI 69
Query: 157 VQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTK 215
L +IV+L G + L LV + L +L + +R + + L
Sbjct: 70 GSL---------DHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ-HRGALGPQLLL 118
Query: 216 KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ 275
+ Q+ + +L E ++H +L N+LL SP S +++ DFG + +
Sbjct: 119 NWGVQIAKGMYYLE--EHGMVHRNLAARNVLLKSP--SQVQVADFGVADLL------PPD 168
Query: 276 SRYYRS-----------PEVLLGIPYDLAIDMWSLGCILVELHT 308
+ E + Y D+WS G + EL T
Sbjct: 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 58/253 (22%), Positives = 94/253 (37%), Gaps = 75/253 (29%)
Query: 110 DRYEID-------TLLGKGSFGQVVKAF-----DHEEKCQVAIKIIK------NKKPFLN 151
++E LG+G FG+VVKA VA+K++K + L+
Sbjct: 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS 75
Query: 152 QAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRN------- 203
E +L+++N H ++KL G + L L+ E Y +L +R
Sbjct: 76 ----EFNVLKQVN----HPH-VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 204 -----------TNFHGVSLNLTKK----FAQQLCCALAFLSSPELSIIHCDLKPENILLC 248
+ H LT FA Q+ + +L+ + ++H DL NIL+
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE--MKLVHRDLAARNILVA 184
Query: 249 SPKRSAIKIIDFGSSCHVGQTLYQYIQSR-YYR------------SPEVLLGIPYDLAID 295
+ +KI DFG L + + Y + E L Y D
Sbjct: 185 EGR--KMKISDFG--------LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSD 234
Query: 296 MWSLGCILVELHT 308
+WS G +L E+ T
Sbjct: 235 VWSFGVLLWEIVT 247
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 47/260 (18%), Positives = 93/260 (35%), Gaps = 61/260 (23%)
Query: 89 HNDGHDDENYDYIIKHGEKFLDRYEID-------TLLGKGSFGQVVKAF---DHEEKCQV 138
H+ H + + L+ ID +LG+G FG V++ + +V
Sbjct: 6 HHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKV 65
Query: 139 AIKIIKN-------KKPFLNQAQIEVQLLEKINKADIHSRYIVKL-----KGHFTWKNHL 186
A+K +K + FL+ E ++ + H +++L +
Sbjct: 66 AVKTMKLDNSSQREIEEFLS----EAACMKDFS----HPN-VIRLLGVCIEMSSQGIPKP 116
Query: 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKK----FAQQLCCALAFLSSPELSIIHCDLK 241
++ + Y +L+ + + ++ + F + + +LS+ + +H DL
Sbjct: 117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN--RNFLHRDLA 174
Query: 242 PENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR-YYR------------SPEVLLGI 288
N +L + + DFG L + I S YYR + E L
Sbjct: 175 ARNCMLRDDM--TVCVADFG--------LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR 224
Query: 289 PYDLAIDMWSLGCILVELHT 308
Y D+W+ G + E+ T
Sbjct: 225 VYTSKSDVWAFGVTMWEIAT 244
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 57/233 (24%), Positives = 92/233 (39%), Gaps = 49/233 (21%)
Query: 102 IKHGEKFLDRYEI---DTLLGKGSFGQVVKAF--DHEEKCQVAIKIIKN-------KKPF 149
I+ E +LDR + D LG G+FG V K + + VA+KI+KN K
Sbjct: 6 IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL 65
Query: 150 LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYN-LIRNTNFH 207
L +A + QL + YIV++ G LV E+ L L +N +
Sbjct: 66 LAEANVMQQL---------DNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVK 115
Query: 208 GVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267
++ + Q+ + +L + +H DL N+LL + KI DFG S +
Sbjct: 116 DKNI---IELVHQVSMGMKYLEE--SNFVHRDLAARNVLLVTQ--HYAKISDFGLSKALR 168
Query: 268 QTLYQYIQSRYYRS------------PEVLLGIPYDLAIDMWSLGCILVELHT 308
YY++ PE + + D+WS G ++ E +
Sbjct: 169 A------DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 52/241 (21%), Positives = 90/241 (37%), Gaps = 62/241 (25%)
Query: 109 LDRYEID-------TLLGKGSFGQVVKAF---DHEEKCQVAIKIIK-------NKKPFLN 151
L+ I +LGKG FG V +A + +VA+K++K + + FL
Sbjct: 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 152 QAQIEVQLLEKINKADIHSRYIVKLKG------HFTWKNHLCLVFELLSY-NLYNLIRNT 204
E +++ + H + KL G ++ + + +L+ + +
Sbjct: 75 ----EAACMKEFD----HPH-VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS 125
Query: 205 NFHGVSLNLTKK----FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260
NL + F + C + +LSS + IH DL N +L + + DF
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAEDM--TVCVADF 181
Query: 261 GSSCHVGQTLYQYIQSR-YYR------------SPEVLLGIPYDLAIDMWSLGCILVELH 307
G L + I S YYR + E L Y + D+W+ G + E+
Sbjct: 182 G--------LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
Query: 308 T 308
T
Sbjct: 234 T 234
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 26/227 (11%), Positives = 52/227 (22%), Gaps = 38/227 (16%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQ--LLEKINKAD 167
RY + G Q +A D QVA+ + P +Q L + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVD---PQGVLPDDVLQETLSRTLRLSR 87
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELL-SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
I + ++ + +V E + +L + S + Q L A
Sbjct: 88 IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD----TSPSPVGAIRAMQSLAAAAD 143
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLL 286
+ + P + + + +
Sbjct: 144 A--AHRAGVALSIDHPSRVRVSI--DGDVVLAYPA-----------------TMPDA--- 179
Query: 287 GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
+ D+ +G L L + P
Sbjct: 180 ----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 51/269 (18%), Positives = 91/269 (33%), Gaps = 49/269 (18%)
Query: 95 DENYDYIIKHGEKFLDRYEI--DTLLGKGSFGQVVKAF---DHEEKCQVAIKIIKN---- 145
+ ++H + + ++G+G FG V + +K A+K +
Sbjct: 72 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 131
Query: 146 --KKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH-LCLVFELLSY-NLYNLI 201
FL + I D ++ L G +V + + +L N I
Sbjct: 132 GEVSQFLTEGII---------MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 182
Query: 202 RNTNFHGVSLNLTK--KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259
RN + + F Q+ + FL+S +H DL N +L +K+ D
Sbjct: 183 RN---ETHNPTVKDLIGFGLQVAKGMKFLAS--KKFVHRDLAARNCMLDEKF--TVKVAD 235
Query: 260 FGSSCHVGQTLYQYIQSRYYR-----------SPEVLLGIPYDLAIDMWSLGCILVELHT 308
FG + + + + + E L + D+WS G +L EL T
Sbjct: 236 FGLARDMYDKEFD----SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
Query: 309 -GEPLFSGKNEVDQMTKIIE--VLGMPPG 334
G P + N D +++ L P
Sbjct: 292 RGAPPYPDVNTFDITVYLLQGRRLLQPEY 320
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 6e-12
Identities = 50/239 (20%), Positives = 90/239 (37%), Gaps = 62/239 (25%)
Query: 110 DRYEIDTLLGKGSFGQVVKA-----FDHEEKCQVAIKIIKN------KKPFLNQAQIEVQ 158
LG+ FG+V K E+ VAIK +K+ ++ F + E
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH----EAM 64
Query: 159 LLEKINKADIHSRYIVKLKGHFTWKNHLCLVFE------LLSY-------NLYNLIRNTN 205
L ++ H +V L G T L ++F L + + +
Sbjct: 65 LRARLQ----HPN-VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 206 FHGVSLNLTK--KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263
+L Q+ + +LSS ++H DL N+L+ K + +KI D G
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNVLV-YDKLN-VKISDLG-- 173
Query: 264 CHVGQTLYQYIQSR-YYR------------SPEVLL-GIPYDLAIDMWSLGCILVELHT 308
L++ + + YY+ +PE ++ G + + D+WS G +L E+ +
Sbjct: 174 ------LFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFS 225
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 61/294 (20%), Positives = 105/294 (35%), Gaps = 77/294 (26%)
Query: 63 YYTKKKRKAQLSHNETRSNKKEKKYVHNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGS 122
T ++L + N ++ + E + E +G+G+
Sbjct: 7 AVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSL-------EYPRNNIEYVRDIGEGA 59
Query: 123 FGQVVKA-----FDHEEKCQVAIKIIK------NKKPFLNQAQIEVQLLEKINKADIHSR 171
FG+V +A +E VA+K++K + F E L+ + + +
Sbjct: 60 FGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR----EAALMAEFD----NPN 111
Query: 172 YIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTK--------------- 215
IVKL G +CL+FE ++Y +L +R+ + H V
Sbjct: 112 -IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 216 -------KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268
A+Q+ +A+LS +H DL N L+ +KI DFG
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSE--RKFVHRDLATRNCLVGENM--VVKIADFG------- 219
Query: 269 TLYQYIQSR-YYR------------SPEVLL-GIPYDLAIDMWSLGCILVELHT 308
L + I S YY+ PE + Y D+W+ G +L E+ +
Sbjct: 220 -LSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFS 271
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 46/244 (18%), Positives = 82/244 (33%), Gaps = 54/244 (22%)
Query: 95 DENYDYIIKHGEKFLDRYEI--DTLLGKGSFGQVVKAF---DHEEKCQVAIKIIKN---- 145
+ ++H + + ++G+G FG V + +K A+K +
Sbjct: 8 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 67
Query: 146 --KKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH-LCLVFELLSY-NLYNLI 201
FL + I ++ L G +V + + +L N I
Sbjct: 68 GEVSQFLTEGIIMKDF---------SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118
Query: 202 RNTNFHGVSLNLTK--KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259
RN + + F Q+ + +L+S +H DL N +L +K+ D
Sbjct: 119 RN---ETHNPTVKDLIGFGLQVAKGMKYLAS--KKFVHRDLAARNCMLDEKF--TVKVAD 171
Query: 260 FGSSCHVGQTLYQYIQSR-YYR--------------SPEVLLGIPYDLAIDMWSLGCILV 304
FG L + + + YY + E L + D+WS G +L
Sbjct: 172 FG--------LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 223
Query: 305 ELHT 308
EL T
Sbjct: 224 ELMT 227
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 9e-11
Identities = 48/224 (21%), Positives = 80/224 (35%), Gaps = 52/224 (23%)
Query: 113 EIDTLLGKGSFGQVVKAF---DHEEKCQVAIKIIKN------KKPFLNQAQIEVQLLEKI 163
D ++GKG FG V + + Q AIK + + FL + + + +
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLL----MRGL 79
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCL-VFELLSY-NLYNLIRNTNFHGVSLNLTK--KFAQ 219
N H ++ L G L + + + +L IR+ + + F
Sbjct: 80 N----HPN-VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGL 131
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR-Y 278
Q+ + +L+ +H DL N +L +K+ DFG L + I R Y
Sbjct: 132 QVARGMEYLAE--QKFVHRDLAARNCMLDESF--TVKVADFG--------LARDILDREY 179
Query: 279 YR--------------SPEVLLGIPYDLAIDMWSLGCILVELHT 308
Y + E L + D+WS G +L EL T
Sbjct: 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 3e-09
Identities = 44/254 (17%), Positives = 73/254 (28%), Gaps = 64/254 (25%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI- 168
++ + +G+G FG+V + VAIKII + P L + E + + I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 169 ------------HSRYIVKLKGHFTWKN-------------------------------- 184
+ + L +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 185 HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPEN 244
+ L FE +L + + SL K QL +LA + L H DL N
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLS----SLATAKSILHQLTASLAVAEA-SLRFEHRDLHWGN 192
Query: 245 ILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILV 304
+LL + G S + Q I Y L+ +
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI------------IDYTLSRLERDGIVVFC 240
Query: 305 ELHTGEPLFSGKNE 318
++ E LF+G +
Sbjct: 241 DVSMDEDLFTGDGD 254
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 6e-09
Identities = 39/159 (24%), Positives = 68/159 (42%), Gaps = 30/159 (18%)
Query: 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK-----KPFLNQAQIEVQLLEKINKADIH 169
L+G G FG+V K + +VA+K + + F E++ L
Sbjct: 44 KFLIGHGVFGKVYKGVLRDGA-KVALKRRTPESSQGIEEFET----EIETLSFC-----R 93
Query: 170 SRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCA---- 224
++V L G +N + L+++ + NL + ++ +S++ + Q+L
Sbjct: 94 HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS----WEQRLEICIGAA 149
Query: 225 --LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261
L +L + +IIH D+K NILL KI DFG
Sbjct: 150 RGLHYLHTR--AIIHRDVKSINILL-DENFVP-KITDFG 184
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 2e-08
Identities = 38/160 (23%), Positives = 64/160 (40%), Gaps = 32/160 (20%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIK------NKKPFLNQAQIEVQLLEKINKADIHS 170
+LG+G FG+V K + VA+K +K + F EV+++ +
Sbjct: 37 ILGRGGFGKVYKGRLADGT-LVAVKRLKEERTQGGELQFQT----EVEMI-----SMAVH 86
Query: 171 RYIVKLKGHFTWKNHLCLVFELLSYN-LYNLIRNTNFHGVSLNLT--KKFAQQLCCALAF 227
R +++L+G LV+ ++ + + +R L+ ++ A LA+
Sbjct: 87 RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAY 146
Query: 228 L---SSPELSIIHCDLKPENILL---CSPKRSAIKIIDFG 261
L P IIH D+K NILL DFG
Sbjct: 147 LHDHCDP--KIIHRDVKAANILLDEEFEAVVG-----DFG 179
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 42/209 (20%), Positives = 73/209 (34%), Gaps = 29/209 (13%)
Query: 110 DRYEID-------TLLGKGSFGQVVKAF-----DHEEKCQVAIKIIKNK--KPFLNQAQI 155
++E LG+G+FGQV++A VA+K++K
Sbjct: 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 74
Query: 156 EVQLLEKINKADIHSRYIVKLKGHFT-WKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNL 213
E+++L I H +V L G T L ++ E + NL +R+ V
Sbjct: 75 ELKILIHIGH---H-LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKT 130
Query: 214 TKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA-IKIIDFGSSCHVGQTLYQ 272
+Q + I DLK + S + SA ++ S V +
Sbjct: 131 KGARFRQ--------GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182
Query: 273 YIQSRYYRSPEVLLGIPYDLAIDMWSLGC 301
+ + + E L+ + +A M L
Sbjct: 183 EDLYKDFLTLEHLICYSFQVAKGMEFLAS 211
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 7e-06
Identities = 28/99 (28%), Positives = 46/99 (46%), Gaps = 11/99 (11%)
Query: 216 KFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ 275
++ Q+ + FL+S IH DL NILL +KI DFG + + + Y++
Sbjct: 197 CYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPD-YVR 251
Query: 276 SRYYR------SPEVLLGIPYDLAIDMWSLGCILVELHT 308
R +PE + Y + D+WS G +L E+ +
Sbjct: 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 3e-06
Identities = 55/214 (25%), Positives = 86/214 (40%), Gaps = 38/214 (17%)
Query: 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---------FLNQAQIEVQLLEKINK 165
+G+G FG V K + + VA+K + F E++++
Sbjct: 36 GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQ----EIKVM----- 84
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLSYN--LYNLIRNTNFHGVSLNLTKKFAQQLCC 223
A +V+L G + + LCLV+ + L L +S ++ K AQ
Sbjct: 85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN 144
Query: 224 ALAFLSSPELSIIHCDLKPENILLCS---PKRSAIKIIDFGSSCHVGQTLYQYIQSR--- 277
+ FL E IH D+K NILL K S DFG + + + SR
Sbjct: 145 GINFLH--ENHHIHRDIKSANILLDEAFTAKIS-----DFGLARASEKFAQTVMTSRIVG 197
Query: 278 -Y-YRSPEVLLGIPYDLAIDMWSLGCILVELHTG 309
Y +PE L G + D++S G +L+E+ TG
Sbjct: 198 TTAYMAPEALRGEITPKS-DIYSFGVVLLEIITG 230
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 437 | |||
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.06 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.03 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.48 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.47 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.3 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.3 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.18 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.11 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.09 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.65 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.58 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.56 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.46 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.42 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.29 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.23 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.22 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.13 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.13 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.84 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.8 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.06 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.01 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.71 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.26 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.35 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.76 |
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-60 Score=474.58 Aligned_cols=348 Identities=70% Similarity=1.195 Sum_probs=314.0
Q ss_pred CCCCCCCCCCcceeecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhh-cC
Q psy11727 89 HNDGHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINK-AD 167 (437)
Q Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~-~~ 167 (437)
.+.+.++..+++.+..++.+.++|++.+.||+|+||+||+|.+..+++.||||+++...........|+.+++.+.+ .+
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~ 112 (382)
T 2vx3_A 33 YNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDT 112 (382)
T ss_dssp BGGGTBCTTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSS
T ss_pred CcCCcCCCCCcEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhccc
Confidence 34456677788899999999999999999999999999999999999999999998666666778889999998874 45
Q ss_pred CCCCcEEEecceeeECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q psy11727 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILL 247 (437)
Q Consensus 168 ~~h~~iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll 247 (437)
+.|++|+++++++...+++|+|||+++++|.+++......++++..++.++.||+.||.|||+++.|||||||||+|||+
T Consensus 113 ~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll 192 (382)
T 2vx3_A 113 EMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL 192 (382)
T ss_dssp GGGGGBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEE
T ss_pred ccceeEEEeeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEE
Confidence 56778999999999999999999999999999998877677999999999999999999999866799999999999999
Q ss_pred ecCCCCCEEEEeCCCceecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q psy11727 248 CSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327 (437)
Q Consensus 248 ~~~~~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 327 (437)
+.+.++.+||+|||+|+.........+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..+.+
T Consensus 193 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 272 (382)
T 2vx3_A 193 CNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272 (382)
T ss_dssp SSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ecCCCCcEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 76678889999999999888777788999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCCChhhhccCCccchhhcccCCCcceeccccccc-cccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHH
Q psy11727 328 VLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTR-KERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406 (437)
Q Consensus 328 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 406 (437)
..+.|+..+++..+....+|..++++.|.+....+.. ....|..+.+..++....+.|.+++.++.++..++...+.+|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 352 (382)
T 2vx3_A 273 VLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDL 352 (382)
T ss_dssp HHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHH
T ss_pred HhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHH
Confidence 9999999999999999999999999999877665543 456677888999999999999999999999999999999999
Q ss_pred HHHccccCCCCCCCHHHHhcCCCcCcCCCC
Q psy11727 407 ILRMLTYDPKKRISPTNVLRHEFFLKHSVD 436 (437)
Q Consensus 407 i~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~ 436 (437)
|.+||++||.+|||++|||+||||++..+|
T Consensus 353 i~~mL~~dP~~Rpta~e~L~hp~f~~~~~e 382 (382)
T 2vx3_A 353 ILRMLDYDPKTRIQPYYALQHSFFKKTADE 382 (382)
T ss_dssp HHHHTCSCTTTSCCHHHHTTSGGGCC----
T ss_pred HHHhcCCChhhCCCHHHHhcCcccccCCCC
Confidence 999999999999999999999999998764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-61 Score=463.43 Aligned_cols=255 Identities=29% Similarity=0.457 Sum_probs=220.3
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC----cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~----~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||+||+|+++.+++.||||++.+. ......+.+|+.+++.+ .|||||+++++|++++
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-----DHPFFVKLYFTFQDDE 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSS
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEeCC
Confidence 46799999999999999999999999999999999642 22345677888888766 7999999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
++|||||||.| +|.+++.... .+++..++.++.||+.||+|||++ |||||||||+|||+ +.++.+||+|||+|
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~--~IiHRDlKPeNILl--~~~g~vKl~DFGla 179 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK--GIIHRDLKPENILL--NEDMHIQITDFGTA 179 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE--CTTSCEEECCCTTC
T ss_pred EEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCCHHHeEE--cCCCCEEEEEcCCc
Confidence 99999999965 8999998763 599999999999999999999964 89999999999999 77889999999999
Q ss_pred eecCC-----ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 264 CHVGQ-----TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 264 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
+.... ...+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++.+|....-..|..
T Consensus 180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~--- 256 (311)
T 4aw0_A 180 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEK--- 256 (311)
T ss_dssp EECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT---
T ss_pred eecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc---
Confidence 87632 2346799999999999999999999999999999999999999999999988888886632111100
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
. ...++|||.+||+.||.+|
T Consensus 257 --------------------------------------------------------~----s~~~~dli~~lL~~dp~~R 276 (311)
T 4aw0_A 257 --------------------------------------------------------F----FPKARDLVEKLLVLDATKR 276 (311)
T ss_dssp --------------------------------------------------------C----CHHHHHHHHHHSCSSGGGS
T ss_pred --------------------------------------------------------c----CHHHHHHHHHHccCCHhHC
Confidence 0 0157899999999999999
Q ss_pred CCHHH------HhcCCCcCcCCCCC
Q psy11727 419 ISPTN------VLRHEFFLKHSVDN 437 (437)
Q Consensus 419 ~t~~e------~l~Hp~~~~~~~~~ 437 (437)
||++| +++||||++.++++
T Consensus 277 ~t~~e~~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 277 LGCEEMEGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp TTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred cChHHHcCCHHHHCCCCcCCCCHHH
Confidence 99998 58999999988764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-60 Score=463.53 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=218.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.+.|++.+.||+|+||+||+|+++.+|+.||||++.... .....+.+|+.+++.+ .|||||+++++|++++++|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-----~HpnIV~l~~~~~~~~~~~ 147 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-----QHENVVEMYNSYLVGDELW 147 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-----CCTTBCCEEEEEEETTEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEE
Confidence 357999999999999999999999999999999996432 2345677899999887 7899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
||||||+| +|.+++... .+++..++.|+.||+.||+|||++ |||||||||+|||| +.++.+||+|||+|+..
T Consensus 148 ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl--~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ--GVIHRDIKSDSILL--THDGRVKLSDFGFCAQV 220 (346)
T ss_dssp EEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC--CcccccCCHHHEEE--CCCCCEEEecCcCceec
Confidence 99999966 788888764 489999999999999999999964 89999999999999 77889999999999876
Q ss_pred CC---ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQ---TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.. ...+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|.........
T Consensus 221 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~--------- 291 (346)
T 4fih_A 221 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLK--------- 291 (346)
T ss_dssp CSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCS---------
T ss_pred CCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCC---------
Confidence 43 345679999999999999999999999999999999999999999999998888877653211100
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
.+.. ....++|||.+||+.||.+|||++|
T Consensus 292 --~~~~-------------------------------------------------~s~~~~dli~~~L~~dP~~R~ta~e 320 (346)
T 4fih_A 292 --NLHK-------------------------------------------------VSPSLKGFLDRLLVRDPAQRATAAE 320 (346)
T ss_dssp --CGGG-------------------------------------------------SCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred --cccc-------------------------------------------------CCHHHHHHHHHHcCCChhHCcCHHH
Confidence 0000 0125799999999999999999999
Q ss_pred HhcCCCcCcCC
Q psy11727 424 VLRHEFFLKHS 434 (437)
Q Consensus 424 ~l~Hp~~~~~~ 434 (437)
+|+||||++..
T Consensus 321 ~l~Hp~~~~~~ 331 (346)
T 4fih_A 321 LLKHPFLAKAG 331 (346)
T ss_dssp HTTCGGGGGCC
T ss_pred HhcCHhhcCCC
Confidence 99999998753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=453.74 Aligned_cols=250 Identities=30% Similarity=0.437 Sum_probs=203.3
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||+||+|++..+|+.||||++.... .....+.+|+.+++.+ .|||||+++++|++++
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-----RHPHIIKLYDVIKSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-----CCCCCCeEEEEEEECC
Confidence 478999999999999999999999999999999996432 2234677899999887 6899999999999999
Q ss_pred EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 185 HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 185 ~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
.+||||||++|+|.+++... ..+++..++.++.||+.||+|||++ |||||||||+|||+ ++++.+||+|||+|+
T Consensus 87 ~~~ivmEy~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~--~IiHRDiKP~NILl--~~~~~vkl~DFGla~ 160 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRH--KIVHRDLKPENLLL--DEHLNVKIADFGLSN 160 (275)
T ss_dssp EEEEEEECCCEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCTTTEEE--CTTCCEEECCSSCC-
T ss_pred EEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCChHHeEE--CCCCCEEEeecCCCe
Confidence 99999999999999998775 3599999999999999999999964 89999999999999 778899999999997
Q ss_pred ecCC--ccccccccccccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 265 HVGQ--TLYQYIQSRYYRSPEVLLGIPY-DLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 265 ~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
.... ...+.+||+.|+|||++.+..| +.++|||||||++|+|+||++||.+.+....+..+....-..|..
T Consensus 161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~------ 234 (275)
T 3hyh_A 161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKF------ 234 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT------
T ss_pred ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCC------
Confidence 6543 3346789999999999999886 579999999999999999999999998888877776532111100
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
....+++||.+||+.||.+|||+
T Consensus 235 ---------------------------------------------------------~s~~~~~li~~~L~~dP~~R~s~ 257 (275)
T 3hyh_A 235 ---------------------------------------------------------LSPGAAGLIKRMLIVNPLNRISI 257 (275)
T ss_dssp ---------------------------------------------------------SCHHHHHHHHHHSCSSGGGSCCH
T ss_pred ---------------------------------------------------------CCHHHHHHHHHHccCChhHCcCH
Confidence 00157899999999999999999
Q ss_pred HHHhcCCCcCc
Q psy11727 422 TNVLRHEFFLK 432 (437)
Q Consensus 422 ~e~l~Hp~~~~ 432 (437)
+|+++||||+.
T Consensus 258 ~eil~hpw~k~ 268 (275)
T 3hyh_A 258 HEIMQDDWFKV 268 (275)
T ss_dssp HHHHHCHHHHT
T ss_pred HHHHcCccccc
Confidence 99999999975
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-60 Score=466.68 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=213.8
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
.++|++++.||+|+||+||+|++..+|+.||||++.... .....+.+|+.++..+ .|||||+++++|++++.
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIV~~~~~~~~~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-----KHPNIVQYRESFEENGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-----CCCCCCcEEEEEEECCE
Confidence 478999999999999999999999999999999997442 2234567888888887 78999999999999999
Q ss_pred EEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+|||||||+ |+|.+++.......+++..++.|+.||+.||+|||++ |||||||||+|||| +.++.+||+|||+|+
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl--~~~g~vKl~DFGla~ 173 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR--KILHRDIKSQNIFL--TKDGTVQLGDFGIAR 173 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--TCEETTCCGGGEEE--CTTCCEEECSTTEES
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCCHHHEEE--CCCCCEEEcccccce
Confidence 999999996 4899999876656689999999999999999999964 89999999999999 678899999999998
Q ss_pred ecCCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 265 HVGQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 265 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
..... ..+.+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+..+.+.+|......+...
T Consensus 174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~------ 247 (350)
T 4b9d_A 174 VLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSL------ 247 (350)
T ss_dssp CCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT------
T ss_pred eecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCc------
Confidence 76543 345789999999999999999999999999999999999999999999988888886632111000
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
.....+.+||.+||+.||.+|||+
T Consensus 248 --------------------------------------------------------~~s~~~~~li~~~L~~dP~~R~s~ 271 (350)
T 4b9d_A 248 --------------------------------------------------------HYSYDLRSLVSQLFKRNPRDRPSV 271 (350)
T ss_dssp --------------------------------------------------------TSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred --------------------------------------------------------cCCHHHHHHHHHHccCChhHCcCH
Confidence 000157899999999999999999
Q ss_pred HHHhcCCCcCcC
Q psy11727 422 TNVLRHEFFLKH 433 (437)
Q Consensus 422 ~e~l~Hp~~~~~ 433 (437)
+|+|+||||++.
T Consensus 272 ~e~l~hp~~~~~ 283 (350)
T 4b9d_A 272 NSILEKGFIAKR 283 (350)
T ss_dssp HHHHTSHHHHTT
T ss_pred HHHhcCHHhhcC
Confidence 999999999763
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-59 Score=465.59 Aligned_cols=254 Identities=24% Similarity=0.393 Sum_probs=218.3
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.+.|++.+.||+|+||+||+|+++.+|+.||||++.... .....+.+|+.+++.+ .|||||+++++|.+.+++|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-----~HpnIV~l~~~~~~~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-----QHENVVEMYNSYLVGDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-----CCCCCCceEEEEEECCEEE
Confidence 467999999999999999999999999999999997443 3345678899999887 7899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
||||||+| +|.+++... .+++..++.|+.||+.||+|||++ |||||||||+|||| +.+|.+||+|||+|...
T Consensus 225 iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~--~IiHRDiKp~NILl--~~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ--GVIHRDIKSDSILL--THDGRVKLSDFGFCAQV 297 (423)
T ss_dssp EEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSTTTEEE--CTTCCEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC--CeecccCCHHHEEE--cCCCCEEEecCccceEC
Confidence 99999965 788888754 489999999999999999999964 89999999999999 77889999999999876
Q ss_pred CC---ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQ---TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.. ...+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|.........
T Consensus 298 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~--------- 368 (423)
T 4fie_A 298 SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLK--------- 368 (423)
T ss_dssp CSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCS---------
T ss_pred CCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCc---------
Confidence 43 345679999999999999999999999999999999999999999999998888877552110000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
.+.. ....+++||.+||+.||.+|||++|
T Consensus 369 --~~~~-------------------------------------------------~s~~~~dli~~~L~~dP~~R~ta~e 397 (423)
T 4fie_A 369 --NLHK-------------------------------------------------VSPSLKGFLDRLLVRDPAQRATAAE 397 (423)
T ss_dssp --CTTS-------------------------------------------------SCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred --cccc-------------------------------------------------CCHHHHHHHHHHcCCChhHCcCHHH
Confidence 0000 0125799999999999999999999
Q ss_pred HhcCCCcCcCC
Q psy11727 424 VLRHEFFLKHS 434 (437)
Q Consensus 424 ~l~Hp~~~~~~ 434 (437)
+|+||||++..
T Consensus 398 ll~Hp~~~~~~ 408 (423)
T 4fie_A 398 LLKHPFLAKAG 408 (423)
T ss_dssp HTTCGGGGGCC
T ss_pred HhcCHHhcCCC
Confidence 99999998753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=451.09 Aligned_cols=252 Identities=28% Similarity=0.431 Sum_probs=208.8
Q ss_pred cCeeeeceecccCceEEEEEEEc---CCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDH---EEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~---~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
++|++.+.||+|+||+||+|++. .+++.||||+++... ....++.+|+.++.. +.|||||+++++|+++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~-----l~HpnIv~l~~~~~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE-----VNHPFIVKLHYAFQTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCC-----CCCTTEECEEEEEEET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHH-----CCCCCCCeEEEEEEEC
Confidence 57999999999999999999874 468899999997432 122345556666544 4899999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+.+|||||||+| +|.+++.... .+++..++.++.||+.||+|||++ |||||||||+|||+ +.++.+||+|||+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl--~~~g~vKl~DFGl 172 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL--GIIYRDLKPENILL--DEEGHIKLTDFGL 172 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCCGGGEEE--CTTSCEEEESSEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCCCHHHeEE--cCCCCEEeccccc
Confidence 999999999965 8999998764 599999999999999999999964 89999999999999 7788999999999
Q ss_pred ceecC---CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhcc
Q psy11727 263 SCHVG---QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 263 s~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 339 (437)
|+... ....+.+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+..+.+.+|....-..|..
T Consensus 173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~---- 248 (304)
T 3ubd_A 173 SKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF---- 248 (304)
T ss_dssp EEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT----
T ss_pred ceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCc----
Confidence 97652 23456789999999999999999999999999999999999999999999988888886532111100
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
....+.+||.+||+.||.+||
T Consensus 249 -----------------------------------------------------------~s~~~~~li~~~L~~dP~~R~ 269 (304)
T 3ubd_A 249 -----------------------------------------------------------LSPEAQSLLRMLFKRNPANRL 269 (304)
T ss_dssp -----------------------------------------------------------SCHHHHHHHHHHTCSSGGGST
T ss_pred -----------------------------------------------------------CCHHHHHHHHHHcccCHHHCC
Confidence 001578999999999999999
Q ss_pred C-----HHHHhcCCCcCcCCC
Q psy11727 420 S-----PTNVLRHEFFLKHSV 435 (437)
Q Consensus 420 t-----~~e~l~Hp~~~~~~~ 435 (437)
| ++|+++||||+..++
T Consensus 270 ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 270 GAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp TCSTTTHHHHHTSGGGTTCCH
T ss_pred CCCcCCHHHHHcCccccCCCH
Confidence 9 589999999998764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=460.47 Aligned_cols=281 Identities=32% Similarity=0.532 Sum_probs=226.5
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE---
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--- 182 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--- 182 (437)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... ....+.+|+.+++.+ .|||||++++++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~~ 127 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-----KHDNIIAIKDILRPTVP 127 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEECCCSSC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-----CCCCcceEeeeeecccc
Confidence 4689999999999999999999999999999999975432 234566789888887 68999999998764
Q ss_pred ---CCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 183 ---KNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 183 ---~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
.+++|||||||+|+|.+++... +.+++..++.|++||+.||+|||++ |||||||||+|||+ +.++.+||+|
T Consensus 128 ~~~~~~~~ivmE~~~g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~--~iiHRDlKP~NIl~--~~~~~~Ki~D 201 (398)
T 4b99_A 128 YGEFKSVYVVLDLMESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSA--QVIHRDLKPSNLLV--NENCELKIGD 201 (398)
T ss_dssp TTTCCCEEEEEECCSEEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEE--CTTCCEEECC
T ss_pred cccCCEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--cCcCCCcCcccccc--CCCCCEEEee
Confidence 3689999999999999998765 4699999999999999999999964 89999999999999 7788999999
Q ss_pred CCCceecC-------CccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy11727 260 FGSSCHVG-------QTLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331 (437)
Q Consensus 260 FG~s~~~~-------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 331 (437)
||+|+... ....+.+||+.|+|||++.+. .|+.++||||+|||+|||++|++||.+.+..+++..|....|.
T Consensus 202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~ 281 (398)
T 4b99_A 202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT 281 (398)
T ss_dssp CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred cceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99997652 223467999999999999876 5689999999999999999999999999999999999999999
Q ss_pred CChhhhccCCcc--chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHH
Q psy11727 332 PPGYLLHGASKT--SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILR 409 (437)
Q Consensus 332 p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 409 (437)
|+...+...... ..++...+.. ....+..+. + .....++|||.+
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~--------------~----~~s~~~~dLl~~ 327 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPR----------------QPVPWETVY--------------P----GADRQALSLLGR 327 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCC----------------CCCCHHHHS--------------T----TCCHHHHHHHHH
T ss_pred CChHHhhhhhhhhhhhhhhcCCCc----------------CCCCHHHhC--------------C----CCCHHHHHHHHH
Confidence 987766443221 1111111100 000011110 0 011257899999
Q ss_pred ccccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 410 MLTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 410 ~L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
||++||.+|||++|||+||||++..
T Consensus 328 mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 328 MLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp HSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred HCcCChhHCcCHHHHhcCHhhCcCC
Confidence 9999999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-58 Score=441.41 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=203.6
Q ss_pred cCe-eeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE---
Q psy11727 110 DRY-EIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--- 182 (437)
Q Consensus 110 ~~y-~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--- 182 (437)
++| ++.+.||+|+||+||+|.+..++..||+|++.... .....+.+|+.++..+ .|||||+++++|++
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIV~~~~~~~~~~~ 99 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-----QHPNIVRFYDSWESTVK 99 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEEEET
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEeeccC
Confidence 355 67888999999999999999999999999996432 2234566788888776 79999999999976
Q ss_pred -CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 183 -KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 183 -~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
++.+|||||||+| +|.+++.... .+++..++.|+.||+.||+|||+++.+||||||||+||||+ +.++.+||+||
T Consensus 100 ~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~-~~~g~vKl~DF 176 (290)
T 3fpq_A 100 GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT-GPTGSVKIGDL 176 (290)
T ss_dssp TEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES-STTSCEEECCT
T ss_pred CCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE-CCCCCEEEEeC
Confidence 3579999999965 8999998753 58999999999999999999997644599999999999993 24688999999
Q ss_pred CCceecCC-ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhcc
Q psy11727 261 GSSCHVGQ-TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 261 G~s~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 339 (437)
|+|+.... ...+.+||+.|||||++.+ .|+.++|||||||++|||+||++||.+.+....+.+.+.. +.+|..+...
T Consensus 177 Gla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~~~~~~~~~ 254 (290)
T 3fpq_A 177 GLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPASFDKV 254 (290)
T ss_dssp TGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCGGGGGC
T ss_pred cCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CCCCCCCCcc
Confidence 99976533 3456789999999999876 6999999999999999999999999876554443333221 1111110000
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
....+.+||.+||+.||.+||
T Consensus 255 -----------------------------------------------------------~~~~~~~li~~~L~~dP~~R~ 275 (290)
T 3fpq_A 255 -----------------------------------------------------------AIPEVKEIIEGCIRQNKDERY 275 (290)
T ss_dssp -----------------------------------------------------------CCHHHHHHHHHHSCSSGGGSC
T ss_pred -----------------------------------------------------------CCHHHHHHHHHHccCChhHCc
Confidence 001578999999999999999
Q ss_pred CHHHHhcCCCcCcC
Q psy11727 420 SPTNVLRHEFFLKH 433 (437)
Q Consensus 420 t~~e~l~Hp~~~~~ 433 (437)
|++|+|+||||++.
T Consensus 276 s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 276 SIKDLLNHAFFQEE 289 (290)
T ss_dssp CHHHHHTSGGGC--
T ss_pred CHHHHhcCccccCC
Confidence 99999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-57 Score=449.10 Aligned_cols=300 Identities=21% Similarity=0.325 Sum_probs=218.2
Q ss_pred eeccCeeeeceecccCceEEEEEEEc---CCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDH---EEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~---~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+.++|++.+.||+|+||+||+|+++ .+++.||||.+... ....+..+|+.++..+. .|||||+++++|.+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-~~~~~~~~E~~~l~~~~----~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-SHPIRIAAELQCLTVAG----GQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-SCHHHHHHHHHHHHHTC----SBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-cCHHHHHHHHHHHHHhc----CCCCCceEEEEEEEC
Confidence 34678999999999999999999875 46789999998643 33456778888888764 689999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+++|||||||+| +|.+++. .+++..++.+++||+.||+|||++ |||||||||+|||++. +.+.+||+|||+
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~--gIiHRDiKPeNiLl~~-~~~~~kl~DFGl 164 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF--GIVHRDVKPSNFLYNR-RLKKYALVDFGL 164 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEET-TTTEEEECCCTT
T ss_pred CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC--CeEeCcCCHHHeEEeC-CCCeEEECcCCC
Confidence 999999999965 8988873 389999999999999999999964 8999999999999952 347899999999
Q ss_pred ceecCC-------------------------------ccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCC
Q psy11727 263 SCHVGQ-------------------------------TLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGE 310 (437)
Q Consensus 263 s~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~ 310 (437)
|+.... ...+.+||+.|+|||++.+. .|+.++||||+|||+|||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 975432 12345899999999999876 4899999999999999999999
Q ss_pred CCC-CCCCHHHHHHHHHHHhCCCChhhhccCCccchhhc-ccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCC
Q psy11727 311 PLF-SGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFD-RLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGR 388 (437)
Q Consensus 311 ~pf-~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (437)
+|| .+.++.+++..|...+|.++............+.. ..+..... .....+.+.....|...
T Consensus 245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~---------------~~~~~~~~~~~~~p~~~ 309 (361)
T 4f9c_A 245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLR---------------KLCERLRGMDSSTPKLT 309 (361)
T ss_dssp SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHH---------------HHHHHHC----------
T ss_pred CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhh---------------HHHHhhccccccccccc
Confidence 988 56778899999999998766544332211110000 00000000 00000000000000000
Q ss_pred -----CCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 389 -----RRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 389 -----~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
.......+......++|||++||++||.+|||++|||+||||++.+
T Consensus 310 ~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 310 SDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp ------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred cccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 0000011112223679999999999999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-57 Score=441.56 Aligned_cols=251 Identities=22% Similarity=0.270 Sum_probs=207.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.++..+ .|||||+++++|.+++.+||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l-----~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGL-----SSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTC-----CCTTBCCEEEEEEETTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhC-----CCCCCCcEEEEEEECCEEEE
Confidence 4579999999999999999999999999999999975432 23466666554 89999999999999999999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC-CEEEEeCCCceec
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS-AIKIIDFGSSCHV 266 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~-~ikL~DFG~s~~~ 266 (437)
|||||+| +|.+++.... .+++..++.|+.||+.||+|||++ |||||||||+|||| +.+| .+||+|||+|+..
T Consensus 128 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl--~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTR--RILHGDVKADNVLL--SSDGSRAALCDFGHALCL 201 (336)
T ss_dssp EECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT--TEECSCCCGGGEEE--CTTSCCEEECCCTTCEEC
T ss_pred EEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CceecccCHHHEEE--eCCCCEEEEeeCCCCeEc
Confidence 9999965 8999998764 599999999999999999999964 89999999999999 5565 6999999999876
Q ss_pred CCc--------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 267 GQT--------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 267 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
... ....+||+.|||||++.+..|+.++|||||||++|||+||++||.+.+..+.+.+|... .++..-
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~~~-- 277 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPPIRE-- 277 (336)
T ss_dssp ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCGGGG--
T ss_pred cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCCchh--
Confidence 322 12357999999999999999999999999999999999999999988777666666542 111000
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
+.. .....+.+||.+||+.||.+|
T Consensus 278 -------~~~-------------------------------------------------~~s~~~~~li~~~L~~dP~~R 301 (336)
T 4g3f_A 278 -------IPP-------------------------------------------------SCAPLTAQAIQEGLRKEPVHR 301 (336)
T ss_dssp -------SCT-------------------------------------------------TSCHHHHHHHHHHTCSSGGGS
T ss_pred -------cCc-------------------------------------------------cCCHHHHHHHHHHccCCHhHC
Confidence 000 001257899999999999999
Q ss_pred CCHHHH-------------hcCCCcCcCC
Q psy11727 419 ISPTNV-------------LRHEFFLKHS 434 (437)
Q Consensus 419 ~t~~e~-------------l~Hp~~~~~~ 434 (437)
||+.|+ |+|||+++..
T Consensus 302 ~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 302 ASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp CCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred cCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 999997 6899998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=425.24 Aligned_cols=253 Identities=27% Similarity=0.378 Sum_probs=192.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC--
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN-- 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~-- 184 (437)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... .....+.+|+.++..+ .|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-----~HpnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-----EHPGIVRYFNAWLEKNTT 78 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEEEC--
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEecCcc
Confidence 467999999999999999999999999999999996432 2234566777777665 7999999999997654
Q ss_pred ----------EEEEEEEeccC-cHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCC
Q psy11727 185 ----------HLCLVFELLSY-NLYNLIRNTNF-HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR 252 (437)
Q Consensus 185 ----------~~~lV~E~~~~-~L~~~l~~~~~-~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~ 252 (437)
++|||||||.| +|.+++..... ...++..++.++.||+.||+|||++ |||||||||+|||+ +.+
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~--~IiHRDlKp~NILl--~~~ 154 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK--GLMHRDLKPSNIFF--TMD 154 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEE--CTT
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC--cCccccCcHHHeEE--CCC
Confidence 47999999965 89999876532 2345677899999999999999964 89999999999999 678
Q ss_pred CCEEEEeCCCceecCCc---------------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy11727 253 SAIKIIDFGSSCHVGQT---------------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN 317 (437)
Q Consensus 253 ~~ikL~DFG~s~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~ 317 (437)
+.+||+|||+|+..... ..+.+||+.|||||++.+..|+.++|||||||++|||++ ||.+..
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 89999999999765321 234589999999999999999999999999999999996 786532
Q ss_pred HHHHHHHHHHHhC-CCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCC
Q psy11727 318 EVDQMTKIIEVLG-MPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHS 396 (437)
Q Consensus 318 ~~~~~~~i~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (437)
+....+..... ..|..+.
T Consensus 232 --~~~~~~~~~~~~~~p~~~~----------------------------------------------------------- 250 (299)
T 4g31_A 232 --ERVRTLTDVRNLKFPPLFT----------------------------------------------------------- 250 (299)
T ss_dssp --HHHHHHHHHHTTCCCHHHH-----------------------------------------------------------
T ss_pred --HHHHHHHHHhcCCCCCCCc-----------------------------------------------------------
Confidence 33333322211 1111110
Q ss_pred hhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 397 LADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 397 ~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
.....+.+||++||+.||.+|||+.|+|+||||++.+.
T Consensus 251 -~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 251 -QKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp -HHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred -ccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 00114579999999999999999999999999998653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-55 Score=457.02 Aligned_cols=263 Identities=24% Similarity=0.448 Sum_probs=224.0
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
+.+.++|++.+.||+|+||+||+|.++.+|+.||+|++..... ....+.+|+.++..+ .|||||+++++|++.+
T Consensus 153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-----RHPTLVNLHDAFEDDN 227 (573)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-----CCTTBCCEEEEEECSS
T ss_pred CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-----CCCCCCeEEEEEEECC
Confidence 3456899999999999999999999999999999999975432 234567788888877 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
++|||||||.| +|++++.... ..+++..++.|++||+.||.|||++ ||+||||||+|||++.+..+.+||+|||+|
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~--~iiHRDlKp~Nill~~~~~~~vKl~DFG~a 304 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLT 304 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCSSC
T ss_pred EEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCChhhccccCCCCCCEEEeeccce
Confidence 99999999965 8999886543 4699999999999999999999964 899999999999997656689999999999
Q ss_pred eecCC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 264 CHVGQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 264 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
+.... ...+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+++..|......++......
T Consensus 305 ~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~-- 382 (573)
T 3uto_A 305 AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG-- 382 (573)
T ss_dssp EECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTT--
T ss_pred eEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccC--
Confidence 87643 34567899999999999999999999999999999999999999999999988888865432222111100
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
+ ...++|||.+||+.||.+|||+
T Consensus 383 --------~-------------------------------------------------s~~~~dli~~~L~~dp~~R~t~ 405 (573)
T 3uto_A 383 --------I-------------------------------------------------SEDGKDFIRKLLLADPNTRMTI 405 (573)
T ss_dssp --------S-------------------------------------------------CHHHHHHHHTTSCSSGGGSCCH
T ss_pred --------C-------------------------------------------------CHHHHHHHHHHccCChhHCcCH
Confidence 0 0157899999999999999999
Q ss_pred HHHhcCCCcCcCCC
Q psy11727 422 TNVLRHEFFLKHSV 435 (437)
Q Consensus 422 ~e~l~Hp~~~~~~~ 435 (437)
+|||+||||++..+
T Consensus 406 ~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 406 HQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHSTTTSCCCC
T ss_pred HHHhcCcCcCCCCC
Confidence 99999999997654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=431.95 Aligned_cols=323 Identities=43% Similarity=0.757 Sum_probs=264.2
Q ss_pred CCCCCCCcceeecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhc-CCCC
Q psy11727 92 GHDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKA-DIHS 170 (437)
Q Consensus 92 ~~~~~~~~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~-~~~h 170 (437)
+.++....+....++.+..+|++.+.||+|+||+||+|.+..+++.||||+++...........|+.+++.+.+. ...|
T Consensus 79 ~~~~~~~~~~~~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~ 158 (429)
T 3kvw_A 79 GYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158 (429)
T ss_dssp TTBCTTSCBCCCTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSC
T ss_pred CCCccCCCccccCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCC
Confidence 345555666667788889999999999999999999999999999999999987666667788899999998764 3478
Q ss_pred CcEEEecceeeECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC
Q psy11727 171 RYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP 250 (437)
Q Consensus 171 ~~iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~ 250 (437)
+||+++++++...+++|+|||+++++|.+++......++++..++.++.||+.||+|||++ |||||||||+|||++.+
T Consensus 159 ~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlKp~NILl~~~ 236 (429)
T 3kvw_A 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN--RIIHCDLKPENILLKQQ 236 (429)
T ss_dssp SCBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH--TEECSCCSGGGEEESST
T ss_pred cCEEEEEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEEccC
Confidence 8999999999999999999999999999999887777799999999999999999999964 89999999999999443
Q ss_pred CCCCEEEEeCCCceecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q psy11727 251 KRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLG 330 (437)
Q Consensus 251 ~~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 330 (437)
....+||+|||+|+.......+.+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+++..+++.++
T Consensus 237 ~~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~ 316 (429)
T 3kvw_A 237 GRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316 (429)
T ss_dssp TSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred CCcceEEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 33349999999999888877888999999999999999999999999999999999999999999999999999999999
Q ss_pred CCChhhhccCCccchhhcccCCCcceecccc-c------------cccccCCCCCchhhhhccCCCCCCCCCCCCCCCCh
Q psy11727 331 MPPGYLLHGASKTSKYFDRLSDNSYVLKKST-D------------TRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSL 397 (437)
Q Consensus 331 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (437)
.|+..++........|++......+...... + .+....+....+...+. .
T Consensus 317 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-----------------~ 379 (429)
T 3kvw_A 317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALK-----------------G 379 (429)
T ss_dssp CCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTT-----------------T
T ss_pred CCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhcc-----------------c
Confidence 9999999888877777754332211110000 0 00001111111111110 0
Q ss_pred hhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 398 ADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 398 ~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
.....|.+||++||++||.+|||++|||+||||++.
T Consensus 380 ~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp CCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred cchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence 112468999999999999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=450.07 Aligned_cols=258 Identities=22% Similarity=0.359 Sum_probs=210.3
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
-.++|++.++||+|+||+||+|+++.+|+.||||++.+.. ........|..+++.+. ...|||||+++++|++.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~--~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS--TGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHS--SSCCTTBCCEEEEEECS
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHh--hCCCCCEeEEEEEEEEC
Confidence 3678999999999999999999999999999999996432 12233445555555443 34899999999999999
Q ss_pred CEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+++|||||||. |+|.+++.... .+++..++.|+.||+.||+|||++ |||||||||+|||| +.+|+|||+|||+
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~--gIiHRDLKPeNILl--d~~G~vKL~DFGl 338 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR--FVVYRDLKPANILL--DEHGHVRISDLGL 338 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCSGGGEEE--CTTSCEEECCCTT
T ss_pred CEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCchHHeEE--eCCCCEEecccce
Confidence 99999999996 48999998753 599999999999999999999964 89999999999999 7889999999999
Q ss_pred ceecCC-ccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChhhh
Q psy11727 263 SCHVGQ-TLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEV---DQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 263 s~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~p~~~~~ 337 (437)
|+.... ...+.+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+.. .....+....-..|.
T Consensus 339 A~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~--- 415 (689)
T 3v5w_A 339 ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--- 415 (689)
T ss_dssp CEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCT---
T ss_pred eeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCc---
Confidence 987643 4457899999999999974 57999999999999999999999999864332 223333221000000
Q ss_pred ccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCC
Q psy11727 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKK 417 (437)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 417 (437)
.....+++||.+||+.||.+
T Consensus 416 ------------------------------------------------------------~~S~~a~dLI~~lL~~dP~~ 435 (689)
T 3v5w_A 416 ------------------------------------------------------------SFSPELRSLLEGLLQRDVNR 435 (689)
T ss_dssp ------------------------------------------------------------TSCHHHHHHHHHHTCSCGGG
T ss_pred ------------------------------------------------------------cCCHHHHHHHHHHccCCHhH
Confidence 00115799999999999999
Q ss_pred CCC-----HHHHhcCCCcCcCCCC
Q psy11727 418 RIS-----PTNVLRHEFFLKHSVD 436 (437)
Q Consensus 418 R~t-----~~e~l~Hp~~~~~~~~ 436 (437)
|++ ++|+++||||++.+++
T Consensus 436 Rl~~~~~ga~ei~~HpfF~~idW~ 459 (689)
T 3v5w_A 436 RLGCLGRGAQEVKESPFFRSLDWQ 459 (689)
T ss_dssp CTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred CCCCCCCCHHHHhcCccccCCCHH
Confidence 998 7999999999988764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=417.60 Aligned_cols=317 Identities=33% Similarity=0.592 Sum_probs=256.0
Q ss_pred CCCCCCcceeecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCc
Q psy11727 93 HDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRY 172 (437)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~ 172 (437)
.+++...+.+..+..+.++|.+.+.||+|+||+||+|.+..+++.||||+++...........|..+++.+.+..+.|+|
T Consensus 18 ~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 18 GDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp --CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred cCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 45667778889999999999999999999999999999999999999999986555566778899999999888888999
Q ss_pred EEEecceeeECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec---
Q psy11727 173 IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS--- 249 (437)
Q Consensus 173 iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~--- 249 (437)
|+++++++...+++|+|||+++++|.+++......++++..++.++.||+.||+|||++ ||+||||||+|||++.
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM--SLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCTTC
T ss_pred eecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCcccEEEccccc
Confidence 99999999999999999999988999999887766799999999999999999999964 8999999999999943
Q ss_pred --------------------CCCCCEEEEeCCCceecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhC
Q psy11727 250 --------------------PKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTG 309 (437)
Q Consensus 250 --------------------~~~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg 309 (437)
...+.+||+|||+|...........||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 137789999999999887777778899999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc--hhhcccCCCcceeccccccccccCCCCC-chhhhhccCCCCCC
Q psy11727 310 EPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS--KYFDRLSDNSYVLKKSTDTRKERLPGSK-RLDTILGVDNGGPG 386 (437)
Q Consensus 310 ~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 386 (437)
++||.+.+..+.+..+....+.+|..++....... .++.. ... ...+|... ....+......
T Consensus 256 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~---~~~---------~~~~p~~~~~~~~~~~~~~~--- 320 (360)
T 3llt_A 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNK---DEL---------KLAWPENASSINSIKHVKKC--- 320 (360)
T ss_dssp SCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEET---TTT---------EECTTTTCSCHHHHHHHHTC---
T ss_pred CCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCc---ccc---------eecCcccccchhhhhhhhhc---
Confidence 99999999999999999999988887765443321 11111 000 01111110 00000000000
Q ss_pred CCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcC
Q psy11727 387 GRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFL 431 (437)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~ 431 (437)
.+.........+.+||.+||++||.+|||+.|+|+||||+
T Consensus 321 -----~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 321 -----LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp -----CCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred -----ccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 0000011123678999999999999999999999999996
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=414.16 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=204.1
Q ss_pred ccCeeeeceecccCceEEEEEEEc-----CCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
.++|.+.+.||+|+||+||+|+.. .++..||||+++.... ...++.+|+.++..+ +|||||+++++|.+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-----~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-----QHEHIVKFYGVCVE 86 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-----CCCCCccEEEEEee
Confidence 357999999999999999999865 4688999999975432 234567788887765 79999999999999
Q ss_pred CCEEEEEEEecc-CcHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC
Q psy11727 183 KNHLCLVFELLS-YNLYNLIRNTN-----------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP 250 (437)
Q Consensus 183 ~~~~~lV~E~~~-~~L~~~l~~~~-----------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~ 250 (437)
.+.+|||||||+ |+|.+++.... ...+++..+..|+.||+.||+|||++ +||||||||+|||| +
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHRDlKp~NILl--~ 162 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ--HFVHRDLATRNCLV--G 162 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE--C
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCccCHhhEEE--C
Confidence 999999999995 58999997532 34699999999999999999999965 79999999999999 6
Q ss_pred CCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy11727 251 KRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTK 324 (437)
Q Consensus 251 ~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~ 324 (437)
+++.+||+|||+|+...... ....||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..+.+..
T Consensus 163 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~ 242 (299)
T 4asz_A 163 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 242 (299)
T ss_dssp GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 78899999999997654322 23468999999999999999999999999999999999 9999999998888877
Q ss_pred HHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHH
Q psy11727 325 IIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFK 404 (437)
Q Consensus 325 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (437)
+......+.+. .-...+.
T Consensus 243 i~~~~~~~~p~--------------------------------------------------------------~~~~~~~ 260 (299)
T 4asz_A 243 ITQGRVLQRPR--------------------------------------------------------------TCPQEVY 260 (299)
T ss_dssp HHHTCCCCCCT--------------------------------------------------------------TCCHHHH
T ss_pred HHcCCCCCCCc--------------------------------------------------------------cchHHHH
Confidence 76532211100 0001578
Q ss_pred HHHHHccccCCCCCCCHHHHhcCCCcCc
Q psy11727 405 DLILRMLTYDPKKRISPTNVLRHEFFLK 432 (437)
Q Consensus 405 dli~~~L~~dP~~R~t~~e~l~Hp~~~~ 432 (437)
+||.+||+.||.+|||++|+ |+||++
T Consensus 261 ~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 261 ELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp HHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 99999999999999999998 456543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=409.60 Aligned_cols=248 Identities=24% Similarity=0.308 Sum_probs=198.9
Q ss_pred ccCeeeeceecccCceEEEEEEEc-----CCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
.++|.+.+.||+|+||+||+|+.. .+++.||||+++.... ....+.+|+.++..+ +|||||+++++|.+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-----~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-----QHQHIVRFFGVCTE 114 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEE
Confidence 357889999999999999999865 4688999999975432 234567788887765 79999999999999
Q ss_pred CCEEEEEEEecc-CcHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEe
Q psy11727 183 KNHLCLVFELLS-YNLYNLIRNTN-------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLC 248 (437)
Q Consensus 183 ~~~~~lV~E~~~-~~L~~~l~~~~-------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~ 248 (437)
.+.+|||||||+ |+|.+++.... ...+++..+..|+.||+.||+|||++ +||||||||+||||
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHRDLKp~NILl- 191 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL--HFVHRDLATRNCLV- 191 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEE-
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC--CeecccccHhhEEE-
Confidence 999999999996 48999987643 23589999999999999999999964 79999999999999
Q ss_pred cCCCCCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy11727 249 SPKRSAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQM 322 (437)
Q Consensus 249 ~~~~~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~ 322 (437)
++++.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..+.+
T Consensus 192 -~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 270 (329)
T 4aoj_A 192 -GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270 (329)
T ss_dssp -ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred -CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 67889999999999765322 234678999999999999999999999999999999999 89999999988887
Q ss_pred HHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhH
Q psy11727 323 TKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMK 402 (437)
Q Consensus 323 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (437)
..+......+.+. .-...
T Consensus 271 ~~i~~g~~~~~p~--------------------------------------------------------------~~~~~ 288 (329)
T 4aoj_A 271 DCITQGRELERPR--------------------------------------------------------------ACPPE 288 (329)
T ss_dssp HHHHHTCCCCCCT--------------------------------------------------------------TCCHH
T ss_pred HHHHcCCCCCCcc--------------------------------------------------------------cccHH
Confidence 7776532211100 00025
Q ss_pred HHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 403 FKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 403 ~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
+.+||.+||+.||++|||++|++++
T Consensus 289 ~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 289 VYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCcChhHCcCHHHHHHH
Confidence 7899999999999999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-53 Score=407.57 Aligned_cols=248 Identities=23% Similarity=0.302 Sum_probs=204.5
Q ss_pred ccCeeeeceecccCceEEEEEEEc-----CCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.+.+++.+.||+|+||+||+|... .+++.||||+++... .....+.+|+.++..+ .|||||+++++|.
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-----~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-----QHPNVVCLLGVVT 99 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-----CCTTBCCEEEEEC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-----CCCCCCCcceEEE
Confidence 456888999999999999999853 467899999997432 2345688899999887 7999999999999
Q ss_pred ECCEEEEEEEecc-CcHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q psy11727 182 WKNHLCLVFELLS-YNLYNLIRNTN--------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENIL 246 (437)
Q Consensus 182 ~~~~~~lV~E~~~-~~L~~~l~~~~--------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIl 246 (437)
+++.++||||||+ |+|.++|.... ...+++..+..|+.||+.||+|||++ +||||||||+|||
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHRDLK~~NIL 177 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH--HVVHKDLATRNVL 177 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--CCCCCCccccceE
Confidence 9999999999995 58999986532 13589999999999999999999965 7999999999999
Q ss_pred EecCCCCCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy11727 247 LCSPKRSAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVD 320 (437)
Q Consensus 247 l~~~~~~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~ 320 (437)
| ++++.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.+..+
T Consensus 178 l--~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 178 V--YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp E--CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred E--CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9 77889999999999765322 234678999999999999999999999999999999999 899999999888
Q ss_pred HHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhh
Q psy11727 321 QMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADY 400 (437)
Q Consensus 321 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (437)
.+..+......|.+. .-.
T Consensus 256 ~~~~i~~~~~~~~p~--------------------------------------------------------------~~~ 273 (308)
T 4gt4_A 256 VVEMIRNRQVLPCPD--------------------------------------------------------------DCP 273 (308)
T ss_dssp HHHHHHTTCCCCCCT--------------------------------------------------------------TCC
T ss_pred HHHHHHcCCCCCCcc--------------------------------------------------------------cch
Confidence 777765432211100 000
Q ss_pred hHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 401 MKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 401 ~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
..+.+|+.+||+.||.+|||+.|++++
T Consensus 274 ~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 274 AWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 157899999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=405.06 Aligned_cols=252 Identities=27% Similarity=0.324 Sum_probs=195.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
.+++.+.+.||+|+||+||+|+... .||||+++... .....+.+|+.++..+ +|||||++++++. .+.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-----~HpNIV~l~g~~~-~~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKT-----RHVNILLFMGYMT-KDN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEC-SSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEE-CCe
Confidence 4678899999999999999997532 59999987432 2234566777777665 7999999999876 456
Q ss_pred EEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+|||||||+ |+|.+++.... ..+++..+..|+.||+.||+|||++ +||||||||+|||| ++++.+||+|||+|+
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~--~IiHRDlKp~NILl--~~~~~~Ki~DFGla~ 180 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAK--NIIHRDMKSNNIFL--HEGLTVKIGDFGLAT 180 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCCSSSEEE--ETTEEEEECCCSSCB
T ss_pred EEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHC--CccCCccCHHHEEE--CCCCcEEEeeccCce
Confidence 899999996 58999987654 4699999999999999999999964 79999999999999 678899999999997
Q ss_pred ecCC-----ccccccccccccChhhhcC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 265 HVGQ-----TLYQYIQSRYYRSPEVLLG---IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 265 ~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
.... ...+.+||+.|||||++.+ ..|+.++|||||||++|||+||++||.+.+....+..++.....+|...
T Consensus 181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 260 (307)
T 3omv_A 181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLS 260 (307)
T ss_dssp C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCST
T ss_pred ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence 6532 2345689999999999974 3589999999999999999999999998776666555544211111000
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
.........+.+||.+||+.||.
T Consensus 261 ---------------------------------------------------------~~~~~~~~~l~~li~~cl~~dP~ 283 (307)
T 3omv_A 261 ---------------------------------------------------------KLYKNCPKAMKRLVADCVKKVKE 283 (307)
T ss_dssp ---------------------------------------------------------TSCTTSCHHHHHHHHHHTCSSST
T ss_pred ---------------------------------------------------------cccccchHHHHHHHHHHcCCCHh
Confidence 00000012578999999999999
Q ss_pred CCCCHHHH------hcCCCcC
Q psy11727 417 KRISPTNV------LRHEFFL 431 (437)
Q Consensus 417 ~R~t~~e~------l~Hp~~~ 431 (437)
+|||+.|+ |+|||-+
T Consensus 284 ~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 284 ERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp TSCCHHHHHHHHHHHHTTCCC
T ss_pred HCcCHHHHHHHHHHHhccCCC
Confidence 99999976 5777643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=410.42 Aligned_cols=312 Identities=33% Similarity=0.555 Sum_probs=252.4
Q ss_pred cceeecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCC---CCcEEE
Q psy11727 99 DYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH---SRYIVK 175 (437)
Q Consensus 99 ~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~---h~~iv~ 175 (437)
.+.+..++.+.++|++.+.||+|+||+||+|++..+++.||||++.........+.+|+.+++.+.+.+.. |+||++
T Consensus 26 ~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 26 YHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred ceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 34567788889999999999999999999999999999999999986655567788899999999875433 678999
Q ss_pred ecceee----ECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC
Q psy11727 176 LKGHFT----WKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK 251 (437)
Q Consensus 176 l~~~~~----~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~ 251 (437)
++++|. ...++|+|||+++++|.+.+.......+++..++.++.||+.||+|||++ .||+||||||+|||++.+.
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~-~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK-CRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECCCCSGGGEEECCCH
T ss_pred eecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHeeEeccc
Confidence 999998 45689999999999999988877666799999999999999999999963 2799999999999994321
Q ss_pred -----------------------------------------------CCCEEEEeCCCceecCCccccccccccccChhh
Q psy11727 252 -----------------------------------------------RSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEV 284 (437)
Q Consensus 252 -----------------------------------------------~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~ 284 (437)
...+||+|||++..........+||+.|+|||+
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHH
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChh
Confidence 137999999999988777777889999999999
Q ss_pred hcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceec
Q psy11727 285 LLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN------EVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLK 358 (437)
Q Consensus 285 ~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~------~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (437)
+.+..++.++|||||||++|+|++|++||.+.+ ..+.+..+.+.++.+|..++........+|.........
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-- 342 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI-- 342 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC--
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc--
Confidence 999999999999999999999999999998765 567788899999999998887776666666543221100
Q ss_pred cccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCc
Q psy11727 359 KSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432 (437)
Q Consensus 359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~ 432 (437)
.....+. +.+++. .....+......+.+||.+||++||.+|||+.|+|+||||++
T Consensus 343 -------~~~~~~~-~~~~~~-----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 343 -------TKLKPWG-LFEVLV-----------EKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp -------CCCCCCC-HHHHHH-----------HTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred -------cccCCcc-hhHhhh-----------hhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0000000 001110 001223445567899999999999999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=393.27 Aligned_cols=289 Identities=30% Similarity=0.503 Sum_probs=227.8
Q ss_pred CceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc------ccchHHHHHHHHHHHhhhcCCCCCcEEEecc
Q psy11727 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK------PFLNQAQIEVQLLEKINKADIHSRYIVKLKG 178 (437)
Q Consensus 105 ~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~------~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~ 178 (437)
+..+.++|++.+.||+|+||+||+|++..+++.||||++.... .......+|+.+++.+... .||||+++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~h~niv~~~~ 81 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF--EHPNVVRLMD 81 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHH--CCTTBCCEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhc--CCCCeEEeee
Confidence 4556789999999999999999999999999999999986322 2234677888888887542 6899999999
Q ss_pred eeeECC-----EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC
Q psy11727 179 HFTWKN-----HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS 253 (437)
Q Consensus 179 ~~~~~~-----~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~ 253 (437)
++.... .+++|||+++++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~Nil~--~~~~ 157 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN--CIVHRDLKPENILV--TSGG 157 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCTTTEEE--CTTS
T ss_pred eeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEE--cCCC
Confidence 998765 68999999999999999887666699999999999999999999964 89999999999999 6788
Q ss_pred CEEEEeCCCceecCC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy11727 254 AIKIIDFGSSCHVGQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331 (437)
Q Consensus 254 ~ikL~DFG~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 331 (437)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+.++.+..+.
T Consensus 158 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 158 TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred CEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999999976543 234568899999999999999999999999999999999999999999999999999999998
Q ss_pred CChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 332 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
++...++...... .+.+. ....+.+..+. ......+.+||.+||
T Consensus 238 ~~~~~~~~~~~~~-------~~~~~-----------~~~~~~~~~~~------------------~~~~~~~~~li~~~L 281 (308)
T 3g33_A 238 PPEDDWPRDVSLP-------RGAFP-----------PRGPRPVQSVV------------------PEMEESGAQLLLEML 281 (308)
T ss_dssp CCTTTSCSSCSSC-------GGGSC-----------CCCCCCHHHHS------------------CSCCHHHHHHHHHHT
T ss_pred CChhhccchhhcc-------ccccC-----------CCCCCcHHHhC------------------ccccHHHHHHHHHHh
Confidence 8876554322110 00000 00001111110 011236789999999
Q ss_pred ccCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 412 TYDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 412 ~~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
++||.+|||+.|+|+||||++...
T Consensus 282 ~~dP~~R~t~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 282 TFNPHKRISAFRALQHSYLHKDEG 305 (308)
T ss_dssp CSSTTTSCCHHHHHTSTTC-----
T ss_pred cCCCccCCCHHHHhcCccccCCCC
Confidence 999999999999999999997543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=395.08 Aligned_cols=288 Identities=30% Similarity=0.501 Sum_probs=228.8
Q ss_pred cCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 104 HGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 104 ~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
.++.+.++|++.+.||+|+||+||+|.+. +++.||+|++..... ....+.+|+.+++.+ .||||+++++++
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~ 88 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-----HHPNIVSLIDVI 88 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-----CCTTBCCEEEEE
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-----CCCCEeeeeeEE
Confidence 34567889999999999999999999985 588999999974322 224566788888877 689999999999
Q ss_pred eECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 181 TWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 181 ~~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
.+.+++++||||++++|.+.+.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~Dikp~NIl~--~~~~~~kl~Df 163 (311)
T 3niz_A 89 HSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH--RILHRDLKPQNLLI--NSDGALKLADF 163 (311)
T ss_dssp CCSSCEEEEEECCSEEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEE--CTTCCEEECCC
T ss_pred ccCCEEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCchHhEEE--CCCCCEEEccC
Confidence 9999999999999999999887754 4699999999999999999999964 89999999999999 67888999999
Q ss_pred CCceecCCc---cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 261 GSSCHVGQT---LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 261 G~s~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
|++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|+...
T Consensus 164 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 243 (311)
T 3niz_A 164 GLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPRE 243 (311)
T ss_dssp TTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTT
T ss_pred cCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHH
Confidence 999876532 334578999999999986 5689999999999999999999999999999999999999998887665
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
++.......+...... ......+..+.. .....+.+||.+||++||.
T Consensus 244 ~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~------------------~~~~~~~~li~~~L~~dP~ 290 (311)
T 3niz_A 244 WPQVQELPLWKQRTFQ---------------VFEKKPWSSIIP------------------GFCQEGIDLLSNMLCFDPN 290 (311)
T ss_dssp SGGGTTSHHHHSCCCC---------------CCCCCCHHHHST------------------TCCHHHHHHHHHHSCSCTT
T ss_pred hhhhhccchhhhcccc---------------cccCCcHHHhCc------------------ccCHHHHHHHHHHcCCChh
Confidence 5443332222111000 000000111100 0112578999999999999
Q ss_pred CCCCHHHHhcCCCcCcCCC
Q psy11727 417 KRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~~~~~~ 435 (437)
+|||++|+|+||||++...
T Consensus 291 ~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 291 KRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp TSCCHHHHHTSGGGTTSCT
T ss_pred HCCCHHHHhcCcccccCCc
Confidence 9999999999999998764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=414.59 Aligned_cols=292 Identities=31% Similarity=0.538 Sum_probs=225.2
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC---cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK---KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+.++|++.+.||+|+||+||+|.+..+++.||||++... .....++.+|+.+++.+ .|||||+++++|...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~ 133 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKNIISLLNVFTPQ 133 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSC
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEccC
Confidence 4578999999999999999999999999999999999743 22234566788887776 789999999999654
Q ss_pred ------CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 184 ------NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 184 ------~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
.++|+||||++++|.+.+.. .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||
T Consensus 134 ~~~~~~~~~~lv~E~~~~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~--~iiHrDlkp~NIll--~~~~~~kl 205 (464)
T 3ttj_A 134 KTLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVV--KSDCTLKI 205 (464)
T ss_dssp CSTTTCCEEEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEE--CTTSCEEE
T ss_pred CccccCCeEEEEEeCCCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChHhEEE--eCCCCEEE
Confidence 47899999999998888754 389999999999999999999964 89999999999999 77889999
Q ss_pred EeCCCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 258 IDFGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 258 ~DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
+|||+|...... ....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++.+|++.+|.|+..
T Consensus 206 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 206 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 285 (464)
T ss_dssp CCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred EEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 999999876543 345789999999999999999999999999999999999999999999999999999999999988
Q ss_pred hhccCCccc-hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 336 LLHGASKTS-KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 336 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
++....... .++...+... ...+.... |.................++|||.+||++|
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~------~~~~~~~~~~~~~~~s~~~~dLl~~mL~~d 343 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYA----------------GLTFPKLF------PDSLFPADSEHNKLKASQARDLLSKMLVID 343 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCC----------------CCCHHHHS------CGGGSCCSSHHHHHHHHHHHHHHHHHSCSS
T ss_pred HHHHcchhhhhHhhcccccC----------------CCChHHhC------cccccccccccccccCHHHHHHHHHHcCCC
Confidence 876554321 2222111000 00000000 000000000111112346899999999999
Q ss_pred CCCCCCHHHHhcCCCcCcC
Q psy11727 415 PKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~~~~ 433 (437)
|.+|||++|||+||||+..
T Consensus 344 P~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 344 PAKRISVDDALQHPYINVW 362 (464)
T ss_dssp TTTSCCHHHHHTSTTTGGG
T ss_pred hhhCCCHHHHhcChhhhhc
Confidence 9999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=392.50 Aligned_cols=314 Identities=32% Similarity=0.555 Sum_probs=250.9
Q ss_pred ceeecCceeccCeeeeceecccCceEEEEEEE-cCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcC-CCCCcEEEec
Q psy11727 100 YIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFD-HEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKAD-IHSRYIVKLK 177 (437)
Q Consensus 100 ~~~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~-~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~-~~h~~iv~l~ 177 (437)
.....++.+.++|++.+.||+|+||+||+|.+ ..+++.||||+++...........|+.+++.+.+.+ ..|+++++++
T Consensus 4 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 4 LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp GTCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred eeeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 44567888899999999999999999999998 568899999999866555677888999999998754 4566899999
Q ss_pred ceeeECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC------
Q psy11727 178 GHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK------ 251 (437)
Q Consensus 178 ~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~------ 251 (437)
+++...+++++||||++++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++.+.
T Consensus 84 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 84 EWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN--KLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESCCCEEEEEC
T ss_pred cccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC--CCcCCCCCHHHEEEeccccccccC
Confidence 999999999999999988999999887666799999999999999999999964 899999999999995332
Q ss_pred -----------CCCEEEEeCCCceecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy11727 252 -----------RSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVD 320 (437)
Q Consensus 252 -----------~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~ 320 (437)
++.+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred CccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 667999999999888777677889999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhh
Q psy11727 321 QMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADY 400 (437)
Q Consensus 321 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (437)
....+....+.+|..++........+..... .|. ............. .+. ...........
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~--~~~-------------~~~~~~~~~~~~~-~~~---~~~~~~~~~~~ 302 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRL--DWD-------------EHSSAGRYVSRAC-KPL---KEFMLSQDVEH 302 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEE--CCC-------------TTSHHHHHHHHHC-CCG---GGGCSCCSHHH
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccc--ccc-------------ccccccchhhhcC-cch---hhhcccchhhH
Confidence 9999999999999888776554322221100 000 0000000000000 000 00001112334
Q ss_pred hHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 401 MKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 401 ~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
..+.+||.+||+.||.+|||+.|+++||||+...
T Consensus 303 ~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 303 ERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred HHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence 4789999999999999999999999999998754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=394.35 Aligned_cols=321 Identities=31% Similarity=0.562 Sum_probs=256.1
Q ss_pred CCCCCcceeecCceeccCeeeeceecccCceEEEEEEEcCCC-eEEEEEEecCCcccchHHHHHHHHHHHhhhcC-CCCC
Q psy11727 94 DDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEK-CQVAIKIIKNKKPFLNQAQIEVQLLEKINKAD-IHSR 171 (437)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~-~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~-~~h~ 171 (437)
++....+....++.+.++|++.+.||+|+||+||+|.+..++ ..||+|+++...........|+.+++.+.+.+ ..+.
T Consensus 3 ~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~ 82 (355)
T 2eu9_A 3 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKF 82 (355)
T ss_dssp BCTTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCS
T ss_pred cccCCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCce
Confidence 345556778889999999999999999999999999998776 79999999865555667788999999998754 3455
Q ss_pred cEEEecceeeECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec--
Q psy11727 172 YIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS-- 249 (437)
Q Consensus 172 ~iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~-- 249 (437)
+++.+.+++...+++|+|||+++++|.+.+.......+++..++.++.||+.||+|||++ ||+||||||+|||+..
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--~ivH~Dlkp~NIll~~~~ 160 (355)
T 2eu9_A 83 LCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN--QLTHTDLKPENILFVNSE 160 (355)
T ss_dssp CBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEESCCC
T ss_pred eEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEeccc
Confidence 799999999999999999999999999988877666799999999999999999999964 8999999999999943
Q ss_pred ---------------CCCCCEEEEeCCCceecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy11727 250 ---------------PKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFS 314 (437)
Q Consensus 250 ---------------~~~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~ 314 (437)
+.++.+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|.+||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp EEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 24678999999999887777777889999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCC
Q psy11727 315 GKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPG 394 (437)
Q Consensus 315 ~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (437)
+.+..+.+..+....+.+|..++........++..-.. ++........+.... .+. .....
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~-~~~---~~~~~ 301 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLV---------------WDENSSDGRYVKENC-KPL---KSYML 301 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEEC---------------CCTTSHHHHHHHHHC-CCG---GGGCS
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccc---------------cccccchhccccccC-Ccc---ccccc
Confidence 99999999999999999999888766544333321100 000000000000000 000 00001
Q ss_pred CChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 395 HSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 395 ~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
........+.+||.+||+.||.+|||+.|+|+||||++...
T Consensus 302 ~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTP 342 (355)
T ss_dssp CCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCH
T ss_pred ccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCCh
Confidence 11233447899999999999999999999999999998653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=406.46 Aligned_cols=297 Identities=30% Similarity=0.498 Sum_probs=219.3
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
..+.++|++.+.||+|+||+||+|.+..+++.||||++.... .......+|+.++..+. .|+||+++++++..
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~l~~~~~~ 80 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS----GHENIVNLLNVLRA 80 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTT----TCTTBCCEEEEEEC
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhcc----CCCCCCeeeeEEec
Confidence 445789999999999999999999999999999999986432 22344556777777763 58999999999986
Q ss_pred CC--EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 183 KN--HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 183 ~~--~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
.+ .+|+||||++++|.+++... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll--~~~~~~kl~DF 153 (388)
T 3oz6_A 81 DNDRDVYLVFDYMETDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG--GLLHRDMKPSNILL--NAECHVKVADF 153 (388)
T ss_dssp TTSSCEEEEEECCSEEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEE--CTTCCEEECCC
T ss_pred CCCCEEEEEecccCcCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC--CEEeCCCCHHHeEE--cCCCCEEecCC
Confidence 54 79999999999999988764 489999999999999999999964 89999999999999 77889999999
Q ss_pred CCceecCC------------------------ccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy11727 261 GSSCHVGQ------------------------TLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSG 315 (437)
Q Consensus 261 G~s~~~~~------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~ 315 (437)
|+|+.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 99976422 1234689999999999987 6799999999999999999999999999
Q ss_pred CCHHHHHHHHHHHhCCCChhhhccCCcc--chhhcccCCCcceeccccccccccCCCCCchh---hhhccCCCCCCCCCC
Q psy11727 316 KNEVDQMTKIIEVLGMPPGYLLHGASKT--SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLD---TILGVDNGGPGGRRR 390 (437)
Q Consensus 316 ~~~~~~~~~i~~~~~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 390 (437)
.+..+++..|...++.|+...+...... ..++..+.... .. ...+...... ..+....
T Consensus 234 ~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~--~~~~~~~~~~~~~~~~~~~~-------- 296 (388)
T 3oz6_A 234 SSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKV-------EI--RQSNKRDIFTKWKNLLLKIN-------- 296 (388)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHC-------C-------CCCCHHHHHHHHHHHC--------
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccc-------cc--cCCCHHHhCcchhhhccccc--------
Confidence 9999999999999999998877543321 12221111000 00 0000000000 0000000
Q ss_pred CCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 391 NEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 391 ~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
........+.+||.+||++||.+|||++|||+||||+...
T Consensus 297 ----~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 297 ----PKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp ----TTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred ----ccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhc
Confidence 0001112579999999999999999999999999998653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=405.63 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=204.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCC-----CeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEE-----KCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~-----~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|++.+.||+|+||+||+|.+..+ ++.||||++..... ....+..|+.++..+. +|||||+++++|.
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~----hhpnIV~l~g~~~ 138 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG----HHLNVVNLLGACT 138 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEEEC
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcC----CCCcEEEEEEEEE
Confidence 57899999999999999999987654 46899999975432 2345778999998885 5689999999987
Q ss_pred EC-CEEEEEEEeccC-cHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcE
Q psy11727 182 WK-NHLCLVFELLSY-NLYNLIRNTN--------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENI 245 (437)
Q Consensus 182 ~~-~~~~lV~E~~~~-~L~~~l~~~~--------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NI 245 (437)
.. +.+|||||||++ +|.++|.... ...+++..+..|+.||+.||+|||++ +||||||||+||
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~--~iiHRDLK~~NI 216 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNI 216 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGE
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC--CeecCccCccce
Confidence 64 579999999965 8999997532 23489999999999999999999965 799999999999
Q ss_pred EEecCCCCCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy11727 246 LLCSPKRSAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEV 319 (437)
Q Consensus 246 ll~~~~~~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~ 319 (437)
|+ ++++.+||+|||+|+..... ..+.+||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..
T Consensus 217 Ll--~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 217 LL--SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp EE--CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ee--CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99 67889999999999865332 234578999999999999999999999999999999998 99999987654
Q ss_pred HHHHHHHHH-hCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChh
Q psy11727 320 DQMTKIIEV-LGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398 (437)
Q Consensus 320 ~~~~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (437)
+.+.+++.. ..++.+. .
T Consensus 295 ~~~~~~i~~g~~~~~p~----------------------------------------------------------~---- 312 (353)
T 4ase_A 295 EEFCRRLKEGTRMRAPD----------------------------------------------------------Y---- 312 (353)
T ss_dssp HHHHHHHHHTCCCCCCT----------------------------------------------------------T----
T ss_pred HHHHHHHHcCCCCCCCc----------------------------------------------------------c----
Confidence 444433332 1111100 0
Q ss_pred hhhHHHHHHHHccccCCCCCCCHHHHhcC--CCcCcC
Q psy11727 399 DYMKFKDLILRMLTYDPKKRISPTNVLRH--EFFLKH 433 (437)
Q Consensus 399 ~~~~~~dli~~~L~~dP~~R~t~~e~l~H--p~~~~~ 433 (437)
....+.+||.+||+.||.+|||+.|+++| .+++..
T Consensus 313 ~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 313 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 01157899999999999999999999998 455433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=385.00 Aligned_cols=280 Identities=30% Similarity=0.505 Sum_probs=223.0
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc---chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF---LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
++|++.+.||+|+||+||+|.+..+++.||+|++...... .....+|+.+++.+ .||||+++++++.+.+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-----KHKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-----CCCCEeeEEeEEEeCCEE
Confidence 6899999999999999999999999999999999744322 24455677666655 789999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
++||||+++++.+.+.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~--~ivH~dikp~Nil~--~~~~~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSR--NVLHRDLKPQNLLI--NRNGELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEE--CTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEE--cCCCCEEEeecccceec
Confidence 9999999999988877644 4699999999999999999999964 89999999999999 67889999999999876
Q ss_pred CCc---cccccccccccChhhhcCCC-CCCcchHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGE-PLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~-~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
... .....||+.|+|||++.+.. ++.++|||||||++|+|++|. |+|.+.+..+.+..+....+.|+...++...
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 432 23457899999999998766 899999999999999999876 5578888889999999999988776554332
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
....+... ...+.... ...........+.+||.+||++||.+|||+
T Consensus 232 ~~~~~~~~----------------~~~~~~~~------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 277 (292)
T 3o0g_A 232 KLPDYKPY----------------PMYPATTS------------------LVNVVPKLNATGRDLLQNLLKCNPVQRISA 277 (292)
T ss_dssp GSTTCCCC----------------CCCCTTCC------------------CTTTSTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred cccccccc----------------ccccCCcc------------------hhhcccccChHHHHHHHHHhccChhhCCCH
Confidence 21111000 00000000 000111122367899999999999999999
Q ss_pred HHHhcCCCcCcC
Q psy11727 422 TNVLRHEFFLKH 433 (437)
Q Consensus 422 ~e~l~Hp~~~~~ 433 (437)
+|+|+||||++.
T Consensus 278 ~e~l~hp~f~~~ 289 (292)
T 3o0g_A 278 EEALQHPYFSDF 289 (292)
T ss_dssp HHHHTSGGGTTC
T ss_pred HHHhcCcccccC
Confidence 999999999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=394.51 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=222.0
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+.++|.+.+.||+|+||+||+|.+..+++.||+|++.........+.+|+.++..+ .||||+++++++.+.+.+
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~~ 76 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-----RHRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-----CCTTBCCEEEEEEETTEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-----CCCCCCeEeEEEecCCEE
Confidence 356899999999999999999999999999999999976554455677888888876 689999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++||||++| +|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+.++.+||+|||++..
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~--givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC--CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 999999965 8999886643 4589999999999999999999964 89999999999999654478999999999987
Q ss_pred cCC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 266 VGQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 266 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+......++...+...
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--- 230 (321)
T 1tki_A 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI--- 230 (321)
T ss_dssp CCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTS---
T ss_pred CCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccC---
Confidence 643 334567899999999999988999999999999999999999999999988888887765433332221110
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
...+.+||.+||..||.+|||+.|
T Consensus 231 --------------------------------------------------------s~~~~~li~~~L~~dp~~Rpt~~e 254 (321)
T 1tki_A 231 --------------------------------------------------------SIEAMDFVDRLLVKERKSRMTASE 254 (321)
T ss_dssp --------------------------------------------------------CHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred --------------------------------------------------------CHHHHHHHHHHcCCChhHCcCHHH
Confidence 015789999999999999999999
Q ss_pred HhcCCCcCcC
Q psy11727 424 VLRHEFFLKH 433 (437)
Q Consensus 424 ~l~Hp~~~~~ 433 (437)
+|+||||++.
T Consensus 255 ~l~hp~~~~~ 264 (321)
T 1tki_A 255 ALQHPWLKQK 264 (321)
T ss_dssp HHHSHHHHSC
T ss_pred HhcChhhccC
Confidence 9999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=392.22 Aligned_cols=256 Identities=27% Similarity=0.399 Sum_probs=216.1
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
....++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+++.+ .||||+++++++..
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~ 85 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-----NHPNIVKLFEVIET 85 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEC
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEE
Confidence 345689999999999999999999999999999999996432 2234566788888776 68999999999999
Q ss_pred CCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
.+.+|+||||++ ++|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~NIll--~~~~~~kl~DFG 159 (328)
T 3fe3_A 86 EKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQK--RIVHRDLKAENLLL--DADMNIKIADFG 159 (328)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEE--CTTSCEEECSTT
T ss_pred CCEEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CEeccCCCHHHEEE--cCCCCEEEeecc
Confidence 999999999995 48999887653 589999999999999999999964 89999999999999 778899999999
Q ss_pred CceecC--CccccccccccccChhhhcCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 262 SSCHVG--QTLYQYIQSRYYRSPEVLLGIPYD-LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 262 ~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
++.... ......+||+.|+|||++.+..++ .++|||||||++|+|++|++||.+.+..+....+.......|..
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~--- 236 (328)
T 3fe3_A 160 FSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY--- 236 (328)
T ss_dssp CCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT---
T ss_pred CceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC---
Confidence 997653 334567899999999999988875 78999999999999999999999998887777765421111100
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
....+.+||.+||+.||.+|
T Consensus 237 ------------------------------------------------------------~s~~~~~li~~~L~~dP~~R 256 (328)
T 3fe3_A 237 ------------------------------------------------------------MSTDCENLLKRFLVLNPIKR 256 (328)
T ss_dssp ------------------------------------------------------------SCHHHHHHHHHHCCSSTTTS
T ss_pred ------------------------------------------------------------CCHHHHHHHHHHCCCChhHC
Confidence 00157899999999999999
Q ss_pred CCHHHHhcCCCcCcCCC
Q psy11727 419 ISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~~~~ 435 (437)
||++|+++||||+....
T Consensus 257 ~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 257 GTLEQIMKDRWINAGHE 273 (328)
T ss_dssp CCHHHHTTCTTTTTTCT
T ss_pred cCHHHHhcCHhhcCCCc
Confidence 99999999999987543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-50 Score=395.23 Aligned_cols=259 Identities=27% Similarity=0.441 Sum_probs=217.8
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-------cchHHHHHHHHHHHhhhcCCCCCcEEEecc
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-------FLNQAQIEVQLLEKINKADIHSRYIVKLKG 178 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-------~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~ 178 (437)
..+.++|.+.+.||+|+||+||+|.+..+|+.||+|++..... ....+..|+.++..+ .||||+++++
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~ 82 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-----LHPNIITLHD 82 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-----CCTTBCCEEE
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-----CCcCCCcEEE
Confidence 4557889999999999999999999999999999999975432 124567788887765 6899999999
Q ss_pred eeeECCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC----
Q psy11727 179 HFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS---- 253 (437)
Q Consensus 179 ~~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~---- 253 (437)
+|.+.+.+++||||++ ++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||+. .++
T Consensus 83 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDlkp~NIll~--~~~~~~~ 156 (361)
T 2yab_A 83 VYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK--KIAHFDLKPENIMLL--DKNIPIP 156 (361)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEES--CTTSSSC
T ss_pred EEEeCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEe--CCCCCcc
Confidence 9999999999999995 5899988764 3599999999999999999999964 899999999999994 343
Q ss_pred CEEEEeCCCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy11727 254 AIKIIDFGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331 (437)
Q Consensus 254 ~ikL~DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 331 (437)
.+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 157 ~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 236 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD 236 (361)
T ss_dssp CEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred CEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Confidence 7999999999876432 34578999999999999999999999999999999999999999999988888877654322
Q ss_pred CChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 332 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
.+...+. .+ ...+.+||.+||
T Consensus 237 ~~~~~~~----------~~-------------------------------------------------s~~~~~li~~~L 257 (361)
T 2yab_A 237 FDEEFFS----------QT-------------------------------------------------SELAKDFIRKLL 257 (361)
T ss_dssp CCHHHHT----------TS-------------------------------------------------CHHHHHHHHHHS
T ss_pred CCchhcc----------CC-------------------------------------------------CHHHHHHHHHHC
Confidence 2222111 00 015789999999
Q ss_pred ccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 412 TYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 412 ~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
..||.+|||+.|+|+||||+...
T Consensus 258 ~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 258 VKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp CSSTTTSCCHHHHHTSTTTSCSS
T ss_pred CCChhHCcCHHHHhcCcCcCCCc
Confidence 99999999999999999998654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=389.42 Aligned_cols=289 Identities=31% Similarity=0.526 Sum_probs=215.9
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.++|++.+.||+|+||+||+|.+..+++.||+|+++... .....+.+|+.++..+ .||||+++++++.+.+.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-----KHENIVRLYDVIHTENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-----CBTTBCCEEEEECCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-----CCCCcceEEEEEEECCeE
Confidence 468999999999999999999999999999999997432 2335667788877766 689999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 187 CLVFELLSYNLYNLIRNTN----FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~----~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
++||||++++|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--~ivH~Dlkp~NIl~--~~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 79 TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN--KILHRDLKPQNLLI--NKRGQLKLGDFGL 154 (317)
T ss_dssp EEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEE--CTTCCEEECCCSS
T ss_pred EEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCChHHeEE--cCCCCEEECcCcc
Confidence 9999999999999886542 23589999999999999999999964 89999999999999 6788999999999
Q ss_pred ceecCCc---cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 263 SCHVGQT---LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 263 s~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.|+...++
T Consensus 155 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 155 ARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp CEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred ceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence 9876432 3346789999999999864 68999999999999999999999999999999999999999988876665
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
.......+...+... ....+...+... ........+.+||.+||+.||.+|
T Consensus 235 ~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~L~~dP~~R 285 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQR----------------PPRDLRQVLQPH-------------TKEPLDGNLMDFLHGLLQLNPDMR 285 (317)
T ss_dssp GGGGCTTCCTTCCCC----------------CCCCSHHHHGGG-------------CSSCCCHHHHHHHHHHSCSSGGGS
T ss_pred hhhhhhhcccccccc----------------cchhHHHhhccc-------------ccccCCHHHHHHHHHHCCCCcccC
Confidence 433322221110000 000111111000 000011268999999999999999
Q ss_pred CCHHHHhcCCCcCcCCC
Q psy11727 419 ISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~~~~ 435 (437)
||++|+|+||||++...
T Consensus 286 pt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 286 LSAKQALHHPWFAEYYH 302 (317)
T ss_dssp CCHHHHTTSGGGGGGCC
T ss_pred CCHHHHhCChhhhcccc
Confidence 99999999999998654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=399.71 Aligned_cols=254 Identities=27% Similarity=0.422 Sum_probs=211.5
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||+||+|++..+++.||||+++... ........|..++..+. .||||++++++|.+.+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~----~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR----NHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTT----TCTTBCCEEEEEECSS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhcc----CCCceeeEEEEEEeCC
Confidence 578999999999999999999999999999999997431 22344556777776653 6899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+|+||||+.| +|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||+|
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NILl--~~~g~ikL~DFG~a 171 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDK--GIIYRDLKLDNVLL--DHEGHCKLADFGMC 171 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEE--CTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCCHHHEEE--CCCCCEEEccccce
Confidence 99999999965 8988887653 589999999999999999999964 89999999999999 77889999999999
Q ss_pred eec---CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 264 CHV---GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 264 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
... .....+.+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|.......|.+
T Consensus 172 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~----- 246 (353)
T 3txo_A 172 KEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW----- 246 (353)
T ss_dssp BCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-----
T ss_pred eecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC-----
Confidence 753 233456789999999999999899999999999999999999999999999988888886532111110
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
....+.+||.+||+.||.+|||
T Consensus 247 ----------------------------------------------------------~~~~~~~li~~lL~~dP~~R~~ 268 (353)
T 3txo_A 247 ----------------------------------------------------------LHEDATGILKSFMTKNPTMRLG 268 (353)
T ss_dssp ----------------------------------------------------------SCHHHHHHHHHHTCSSGGGSTT
T ss_pred ----------------------------------------------------------CCHHHHHHHHHHhhhCHHHccC
Confidence 0015789999999999999999
Q ss_pred H------HHHhcCCCcCcCCC
Q psy11727 421 P------TNVLRHEFFLKHSV 435 (437)
Q Consensus 421 ~------~e~l~Hp~~~~~~~ 435 (437)
+ +|+++||||++.++
T Consensus 269 ~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 269 SLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp SGGGTCTHHHHTSGGGTTCCH
T ss_pred CcccCCHHHHhhCCcccCCCH
Confidence 8 89999999998754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=395.67 Aligned_cols=281 Identities=28% Similarity=0.525 Sum_probs=226.0
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC-
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK- 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~- 183 (437)
+.++|++.+.||+|+||+||+|.+..+|+.||||++.... ....++.+|+.++..+ .||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-----RHENVIGLLDVFTPDE 97 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-----CBTTBCCCSEEECSCS
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-----CCcCCCCceeeEecCC
Confidence 4678999999999999999999999999999999985432 2234566788888776 689999999999865
Q ss_pred -----CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 184 -----NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 184 -----~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
..+|+||||++++|.+++... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~--~ivH~Dlkp~NIll--~~~~~~kl~ 170 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA--GIIHRDLKPGNLAV--NEDCELKIL 170 (367)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEE--CTTCCEEEC
T ss_pred ccccCceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC--CccccCcCHHHEEE--cCCCCEEEE
Confidence 356999999988999988763 489999999999999999999964 89999999999999 678899999
Q ss_pred eCCCceecCCccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 259 DFGSSCHVGQTLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 259 DFG~s~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
|||++..........++|+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+++..|.+..|.|+..++
T Consensus 171 Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 171 DFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99999988777777899999999999987 67999999999999999999999999999999999999999999999887
Q ss_pred ccCCcc--chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 338 HGASKT--SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 338 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
...... ..|+..++... ...+..+. ......+.+||.+||.+||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~------------------~~~~~~~~~ll~~mL~~dP 296 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELE----------------KKDFASIL------------------TNASPLAVNLLEKMLVLDA 296 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCC----------------CCCGGGTC------------------TTCCHHHHHHHHHHSCSST
T ss_pred HHhhhHHHHHHHHhCCCCC----------------CCCHHHHC------------------CCCCHHHHHHHHHHccCCh
Confidence 655432 22222221100 00000000 0111257999999999999
Q ss_pred CCCCCHHHHhcCCCcCcCC
Q psy11727 416 KKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~~~ 434 (437)
.+|||++|||+||||++..
T Consensus 297 ~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 297 EQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp TTSCCHHHHHHSGGGTTTC
T ss_pred hHCCCHHHHhcChHHHhhc
Confidence 9999999999999998754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=381.99 Aligned_cols=279 Identities=32% Similarity=0.545 Sum_probs=218.1
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
++|++.+.||+|+||+||+|.+ .+++.||+|++..... ....+.+|+.+++.+ .||||+++++++.+.+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-----KHSNIVKLYDVIHTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-----CCTTBCCEEEEEECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-----CCCCEeeeeeEEccCCeE
Confidence 6899999999999999999998 6788999999964432 234566777777665 689999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
++|||+++++|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++...
T Consensus 76 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR--RVLHRDLKPQNLLI--NREGELKIADFGLARAF 150 (288)
T ss_dssp EEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEE--CTTSCEEECCTTHHHHH
T ss_pred EEEEEecCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEE--cCCCCEEEeECcccccc
Confidence 9999999999999887654 4689999999999999999999964 89999999999999 67889999999999765
Q ss_pred CCc---cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
... .....||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....+.++...++....
T Consensus 151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence 432 2345789999999999764 589999999999999999999999999999999999999888776544432221
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
...+-.... .. ...+ .... .......+.+||.+||+.||.+|||++
T Consensus 231 ~~~~~~~~~-----~~-------~~~~----~~~~------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~ 276 (288)
T 1ob3_A 231 LPKYDPNFT-----VY-------EPLP----WESF------------------LKGLDESGIDLLSKMLKLDPNQRITAK 276 (288)
T ss_dssp STTCCTTCC-----CC-------CCCC----GGGT------------------CCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred ccccccccc-----cc-------cCcc----HHHH------------------hhhcCHHHHHHHHHHcCCCcccCCCHH
Confidence 111100000 00 0000 0000 001123678999999999999999999
Q ss_pred HHhcCCCcCcC
Q psy11727 423 NVLRHEFFLKH 433 (437)
Q Consensus 423 e~l~Hp~~~~~ 433 (437)
|+|+||||++.
T Consensus 277 e~l~hp~f~~~ 287 (288)
T 1ob3_A 277 QALEHAYFKEN 287 (288)
T ss_dssp HHHTSGGGGC-
T ss_pred HHhcCcchhhc
Confidence 99999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=388.20 Aligned_cols=253 Identities=30% Similarity=0.482 Sum_probs=217.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||+||+|++..+|+.||+|+++... ........|..++..+ .||||++++++|.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~Iv~~~~~~~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-----THPFIIRMWGTFQDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CBTTBCCEEEEEECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-----CCCCCceEeEEEEeCC
Confidence 468999999999999999999999999999999996431 1233455566666554 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+|+||||+.| +|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll--~~~g~~kL~Dfg~a 153 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK--DIIYRDLKPENILL--DKNGHIKITDFGFA 153 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEE--CTTSCEEECCCSSC
T ss_pred EEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChheEEE--cCCCCEEEeecCcc
Confidence 99999999965 8999987653 589999999999999999999964 89999999999999 77889999999999
Q ss_pred eecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 264 CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
........+.+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+.+....+..+....-..|..
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~-------- 225 (318)
T 1fot_A 154 KYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF-------- 225 (318)
T ss_dssp EECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTT--------
T ss_pred eecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC--------
Confidence 988777778899999999999999999999999999999999999999999998888877776521111100
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC----
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI---- 419 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~---- 419 (437)
....+.+||.+||..||.+||
T Consensus 226 -------------------------------------------------------~~~~~~~li~~lL~~dp~~R~~~~~ 250 (318)
T 1fot_A 226 -------------------------------------------------------FNEDVKDLLSRLITRDLSQRLGNLQ 250 (318)
T ss_dssp -------------------------------------------------------SCHHHHHHHHHHTCSCTTTCTTSST
T ss_pred -------------------------------------------------------CCHHHHHHHHHHhccCHHHcCCCcC
Confidence 001578999999999999999
Q ss_pred -CHHHHhcCCCcCcCCC
Q psy11727 420 -SPTNVLRHEFFLKHSV 435 (437)
Q Consensus 420 -t~~e~l~Hp~~~~~~~ 435 (437)
|++++++||||++..+
T Consensus 251 ~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 251 NGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp TTTHHHHTSGGGSSCCH
T ss_pred CCHHHHhcCccccCCCH
Confidence 9999999999998654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=408.69 Aligned_cols=283 Identities=32% Similarity=0.515 Sum_probs=211.8
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC-
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK- 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~- 183 (437)
+.++|++.+.||+|+||+||+|++..+++.||||++.... ....++.+|+.++..+ .|+|||++++++...
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-----NHDHVVKVLDIVIPKD 125 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEECCCSC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-----CCCCCCceEEEEecCC
Confidence 4578999999999999999999999999999999996432 2234566788888877 689999999998543
Q ss_pred ----CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 184 ----NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 184 ----~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
+.+|+|||+++++|.+++... ..+++..++.++.||+.||+|||++ |||||||||+|||+ +.++.+||+|
T Consensus 126 ~~~~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~--~iiHrDlKp~NILl--~~~~~~kl~D 199 (458)
T 3rp9_A 126 VEKFDELYVVLEIADSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSA--GILHRDLKPANCLV--NQDCSVKVCD 199 (458)
T ss_dssp TTTCCCEEEEECCCSEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEE--CTTCCEEECC
T ss_pred cccCceEEEEEeccccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhC--CcCCCCCChhhEEE--CCCCCEeecc
Confidence 579999999999999998765 3599999999999999999999964 89999999999999 7788999999
Q ss_pred CCCceecCC------------------------------ccccccccccccChhhhc-CCCCCCcchHHHHHHHHHHHHh
Q psy11727 260 FGSSCHVGQ------------------------------TLYQYIQSRYYRSPEVLL-GIPYDLAIDMWSLGCILVELHT 308 (437)
Q Consensus 260 FG~s~~~~~------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~ellt 308 (437)
||+|+.... .....+||+.|+|||++. +..|+.++||||||||+|||++
T Consensus 200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 999976531 234567899999999874 5679999999999999999999
Q ss_pred -----------CCCCCCCCC--------------------HHHHHHHHHHHhCCCChhhhccCCccc--hhhcccCCCcc
Q psy11727 309 -----------GEPLFSGKN--------------------EVDQMTKIIEVLGMPPGYLLHGASKTS--KYFDRLSDNSY 355 (437)
Q Consensus 309 -----------g~~pf~~~~--------------------~~~~~~~i~~~~~~p~~~~~~~~~~~~--~~~~~~~~~~~ 355 (437)
|++||.+.+ ..+++..|.+.+|.|+...+....... .+....+...
T Consensus 280 g~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~- 358 (458)
T 3rp9_A 280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKRE- 358 (458)
T ss_dssp TSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCC-
T ss_pred hccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCC-
Confidence 888888765 357889999999999988876554321 1111111000
Q ss_pred eeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 356 VLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
...+.+. .......+.+||++||.+||.+|||++|||+||||++..+
T Consensus 359 ---------------~~~~~~~------------------~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 359 ---------------GTDLAER------------------FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp ---------------CCCGGGG------------------STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred ---------------CCCHHHH------------------CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 0000000 0011236789999999999999999999999999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=389.28 Aligned_cols=196 Identities=22% Similarity=0.270 Sum_probs=158.6
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC----
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN---- 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~---- 184 (437)
..+|.+.+.||+|+||+||+|+. +|+.||||++..... .....|.++ .....++|||||++++++.+++
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~--~~~~~e~Ei---~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEI---YQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHH---HTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hhHHHHHHH---HHHhcCCCCCCCcEEEEEEecCCCce
Confidence 45789999999999999999986 688999999964322 233333322 2234468999999999998754
Q ss_pred EEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCC------CCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 185 HLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP------ELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 185 ~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~------~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
.+|||||||+ |+|.+++... ++++..+..++.|++.||+|||++ +.+||||||||+|||| +.++.+||
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl--~~~~~~Ki 149 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCI 149 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE--CTTSCEEE
T ss_pred EEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE--CCCCCEEE
Confidence 6899999996 5899999764 489999999999999999999975 3489999999999999 77899999
Q ss_pred EeCCCceecCCc-------cccccccccccChhhhcCC------CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy11727 258 IDFGSSCHVGQT-------LYQYIQSRYYRSPEVLLGI------PYDLAIDMWSLGCILVELHTGEPLFSGK 316 (437)
Q Consensus 258 ~DFG~s~~~~~~-------~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~elltg~~pf~~~ 316 (437)
+|||+|+..... ....+||+.|||||++.+. .|+.++|||||||++|||+||.+||...
T Consensus 150 ~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~ 221 (303)
T 3hmm_A 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred EeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcc
Confidence 999999765322 1235799999999999764 3678999999999999999999888654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=389.47 Aligned_cols=253 Identities=27% Similarity=0.442 Sum_probs=213.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC----cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~----~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. .........|+.++..+ .||||++++++|.+.+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~l~~~~~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-----RHPFLTALKYAFQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CCTTBCCEEEEEECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-----CCCcCcceEEEEEeCC
Confidence 47899999999999999999999999999999999642 12234455677766654 7999999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+|+||||++| +|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll--~~~g~vkL~DFG~a 152 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR--DVVYRDIKLENLML--DKDGHIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEE--CTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeecCcCCHHHEEE--CCCCCEEEeeccch
Confidence 99999999965 8988887653 589999999999999999999964 89999999999999 77889999999999
Q ss_pred eec---CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 264 CHV---GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 264 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
... .......+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+.+.......+....-..|..
T Consensus 153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~----- 227 (337)
T 1o6l_A 153 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----- 227 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-----
T ss_pred hhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC-----
Confidence 753 233456789999999999999999999999999999999999999999988877777765421111000
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC-
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI- 419 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~- 419 (437)
....+.+||.+||+.||.+||
T Consensus 228 ----------------------------------------------------------~s~~~~~li~~lL~~dP~~R~g 249 (337)
T 1o6l_A 228 ----------------------------------------------------------LSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp ----------------------------------------------------------SCHHHHHHHHHHTCSSTTTSTT
T ss_pred ----------------------------------------------------------CCHHHHHHHHHHhhcCHHHhcC
Confidence 001578999999999999999
Q ss_pred ----CHHHHhcCCCcCcCCC
Q psy11727 420 ----SPTNVLRHEFFLKHSV 435 (437)
Q Consensus 420 ----t~~e~l~Hp~~~~~~~ 435 (437)
|++|+++||||+..++
T Consensus 250 ~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 250 GGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp CSTTTHHHHHTSGGGTTCCH
T ss_pred CCCCCHHHHHcCCCcCCCCH
Confidence 9999999999987654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=389.73 Aligned_cols=290 Identities=35% Similarity=0.554 Sum_probs=222.6
Q ss_pred CceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc---chHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF---LNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 105 ~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.....++|++.+.||+|+||+||+|.+..+++.||||+++..... ...+.+|+.+++.+ .||||+++++++.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~ 103 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-----QHRNIIELKSVIH 103 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-----CCTTBCCEEEEEE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-----CCCCcceEEEEEe
Confidence 445578999999999999999999999999999999999643321 23345677776665 7899999999999
Q ss_pred ECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC---CCCCEEEE
Q psy11727 182 WKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP---KRSAIKII 258 (437)
Q Consensus 182 ~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~---~~~~ikL~ 258 (437)
+.+.+++||||++++|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||+..+ ..+.+||+
T Consensus 104 ~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 104 HNHRLHLIFEYAENDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSR--RCLHRDLKPQNLLLSVSDASETPVLKIG 179 (329)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred cCCEEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CEECCCCCHHHEEEecCCCCccceEEEC
Confidence 999999999999999999988754 489999999999999999999964 89999999999999532 34559999
Q ss_pred eCCCceecCC---ccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 259 DFGSSCHVGQ---TLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 259 DFG~s~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
|||++..... .....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.|+.
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 180 DFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp CTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred cCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence 9999976543 23345789999999999875 4899999999999999999999999999999999999999998876
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
..++.......+....+. .....+...+.. .....+.+||.+||++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~-----------------~~~~~~~~li~~~L~~d 306 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPK----------------FRGKTLKRVLGA-----------------LLDDEGLDLLTAMLEMD 306 (329)
T ss_dssp TTSTTGGGSTTCCTTCCC----------------CCCCCHHHHHGG-----------------GSCHHHHHHHHHHTCSS
T ss_pred hhhhhhhhhhhhhhhhhh----------------hccccHhhhccc-----------------ccCHHHHHHHHHHccCC
Confidence 655433221111110000 000111111110 01136789999999999
Q ss_pred CCCCCCHHHHhcCCCcCcCCCC
Q psy11727 415 PKKRISPTNVLRHEFFLKHSVD 436 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~~~~~~~ 436 (437)
|.+|||++|+|+||||++.+.+
T Consensus 307 P~~R~t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 307 PVKRISAKNALEHPYFSHNDFD 328 (329)
T ss_dssp GGGSCCHHHHHTSGGGSSSCSC
T ss_pred hhhCCCHHHHhCCcccCCCCCC
Confidence 9999999999999999998765
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=391.60 Aligned_cols=282 Identities=29% Similarity=0.498 Sum_probs=220.3
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
++|.+.+.||+|+||+||+|.+..+++.||+|++...... ...+.+|+.+++.+ .||||+++++++.+.+.++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-----KHANIVTLHDIIHTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-----CCTTBCCEEEEEECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-----CCCCCCeeeeEEeeCCEEE
Confidence 6899999999999999999999999999999999643211 11233577776655 6899999999999999999
Q ss_pred EEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 188 LVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 188 lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
+||||++++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++....
T Consensus 77 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dikp~NIl~--~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQ--KVLHRDLKPQNLLI--NERGELKLADFGLARAKS 151 (324)
T ss_dssp EEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT--TEEESSCCGGGEEE--CTTCCEEECSSSEEECC-
T ss_pred EEecccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC--CccCCCcCHHHEEE--CCCCCEEEccCccccccc
Confidence 999999999999887754 4689999999999999999999954 89999999999999 678899999999997654
Q ss_pred Cc---cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 268 QT---LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 268 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|+...++.....
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 32 234578999999999987 56899999999999999999999999999999999999999999887766544332
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
..+... ..+.... ..+.. ........+.+||.+||++||.+|||++|
T Consensus 232 ~~~~~~-----------------~~~~~~~-~~~~~---------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e 278 (324)
T 3mtl_A 232 EEFKTY-----------------NYPKYRA-EALLS---------------HAPRLDSDGADLLTKLLQFEGRNRISAED 278 (324)
T ss_dssp HHHHHT-----------------CCCCCCC-CCHHH---------------HCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred hhhccc-----------------ccccccc-hhhhh---------------hcCCCCHHHHHHHHHHcCcCcccCCCHHH
Confidence 221110 0000000 00000 00011126789999999999999999999
Q ss_pred HhcCCCcCcCC
Q psy11727 424 VLRHEFFLKHS 434 (437)
Q Consensus 424 ~l~Hp~~~~~~ 434 (437)
+|+||||++..
T Consensus 279 ~l~hp~f~~~~ 289 (324)
T 3mtl_A 279 AMKHPFFLSLG 289 (324)
T ss_dssp HTTSGGGGGGC
T ss_pred HhcChhhhhcc
Confidence 99999998764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=391.86 Aligned_cols=254 Identities=28% Similarity=0.444 Sum_probs=215.6
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|.+.+.||+|+||+||+|+++.+++.||||+++... ........|..++..+. .||||++++++|.+.+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~----~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW----EHPFLTHMFCTFQTKE 91 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT----TCTTBCCEEEEEECSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcC----CCCCCCcEEEEEEeCC
Confidence 578999999999999999999999999999999997431 22345566777776652 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+|+||||++| +|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll--~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK--GIVYRDLKLDNILL--DKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEE--CTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCChhhEEE--CCCCCEEEeEChhh
Confidence 99999999955 8999887653 589999999999999999999964 89999999999999 77889999999999
Q ss_pred eec---CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 264 CHV---GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 264 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
... .......+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+.+..+.+..+.......|.+
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~----- 240 (345)
T 1xjd_A 166 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW----- 240 (345)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-----
T ss_pred hhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcc-----
Confidence 754 233456789999999999999999999999999999999999999999999888877775421111100
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
....+.+||.+||+.||.+|||
T Consensus 241 ----------------------------------------------------------~s~~~~~li~~lL~~dp~~R~~ 262 (345)
T 1xjd_A 241 ----------------------------------------------------------LEKEAKDLLVKLFVREPEKRLG 262 (345)
T ss_dssp ----------------------------------------------------------SCHHHHHHHHHHSCSSGGGSBT
T ss_pred ----------------------------------------------------------cCHHHHHHHHHHhcCCHhHcCC
Confidence 0015789999999999999999
Q ss_pred HH-HHhcCCCcCcCCC
Q psy11727 421 PT-NVLRHEFFLKHSV 435 (437)
Q Consensus 421 ~~-e~l~Hp~~~~~~~ 435 (437)
+. ++++||||+..++
T Consensus 263 ~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 263 VRGDIRQHPLFREINW 278 (345)
T ss_dssp TBSCGGGSGGGTTCCH
T ss_pred ChHHHHcCccccCCCH
Confidence 98 9999999998764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=392.72 Aligned_cols=304 Identities=34% Similarity=0.540 Sum_probs=242.6
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCC------CCCcEEEecceeeE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI------HSRYIVKLKGHFTW 182 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~------~h~~iv~l~~~~~~ 182 (437)
.++|.+.+.||+|+||+||+|.+..+++.||||++............|+.+++.+.+... .|+||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 468999999999999999999999999999999998655556677889999999876432 37899999999987
Q ss_pred CC----EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC----CCCC
Q psy11727 183 KN----HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP----KRSA 254 (437)
Q Consensus 183 ~~----~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~----~~~~ 254 (437)
.+ ++++|||+++++|.+++.......+++..++.++.||+.||+|||++ .||+||||||+|||++.+ ..+.
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~-~~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChHHeEEeccCCCcCcce
Confidence 54 89999999988999999876656799999999999999999999953 379999999999999532 3347
Q ss_pred EEEEeCCCceecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHH
Q psy11727 255 IKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN------EVDQMTKIIEV 328 (437)
Q Consensus 255 ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~------~~~~~~~i~~~ 328 (437)
+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|++||.+.+ ..+.+..+.+.
T Consensus 177 ~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (373)
T 1q8y_A 177 IKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256 (373)
T ss_dssp EEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred EEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHh
Confidence 999999999988777777789999999999999999999999999999999999999998765 56778889999
Q ss_pred hCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHH
Q psy11727 329 LGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLIL 408 (437)
Q Consensus 329 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 408 (437)
++.+|..++........+|+....... ........+..++.. ....+......+.+||.
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~li~ 315 (373)
T 1q8y_A 257 LGELPSYLLRNGKYTRTFFNSRGLLRN----------ISKLKFWPLEDVLTE-----------KYKFSKDEAKEISDFLS 315 (373)
T ss_dssp HCSCCHHHHHHCTTHHHHBCC--CBSS----------CCCCCBCCHHHHHHH-----------TTCCCHHHHHHHHHHHG
T ss_pred cCCCCHHHHhccchhhhhcCCcchhcc----------cccccccchhhhhhh-----------cccCCcchHHHHHHHHH
Confidence 999999998877766666653221000 000000011111111 01123344557899999
Q ss_pred HccccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 409 RMLTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 409 ~~L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
+||+.||.+|||+.|+|+||||++..
T Consensus 316 ~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 316 PMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp GGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HHhccCccccCCHHHHhhChhhhccc
Confidence 99999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=397.49 Aligned_cols=284 Identities=30% Similarity=0.492 Sum_probs=224.3
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+.++|++.+.||+|+||+||+|.+..+++.||||++.... ....++.+|+.+++.+ .|+||+++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-----KSDYIIRLYDLIIPD 97 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEECCCS
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-----CCCCcceEEEEEecC
Confidence 34679999999999999999999999999999999997432 2234566788888877 689999999999876
Q ss_pred -----CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 184 -----NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 184 -----~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
+.+|+|||+++++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~--givHrDlkp~NILl--~~~~~~kL~ 171 (432)
T 3n9x_A 98 DLLKFDELYIVLEIADSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHES--GIIHRDLKPANCLL--NQDCSVKVC 171 (432)
T ss_dssp CTTTCCCEEEEEECCSEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEE--CTTCCEEEC
T ss_pred CCCcCCeEEEEEecCCcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC--CCCCCCCCHHHeEE--CCCCCEEEc
Confidence 679999999999999998764 3589999999999999999999964 89999999999999 778899999
Q ss_pred eCCCceecCCc-------------------------cccccccccccChhhh-cCCCCCCcchHHHHHHHHHHHHh----
Q psy11727 259 DFGSSCHVGQT-------------------------LYQYIQSRYYRSPEVL-LGIPYDLAIDMWSLGCILVELHT---- 308 (437)
Q Consensus 259 DFG~s~~~~~~-------------------------~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~il~ellt---- 308 (437)
|||+|+..... ....+||+.|+|||++ .+..|+.++|||||||++|||++
T Consensus 172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 99999765322 3567899999999987 45579999999999999999998
Q ss_pred -------CCCCCCCCC-----------------HHHHHHHHHHHhCCCChhhhccCCccc--hhhcccCCCcceeccccc
Q psy11727 309 -------GEPLFSGKN-----------------EVDQMTKIIEVLGMPPGYLLHGASKTS--KYFDRLSDNSYVLKKSTD 362 (437)
Q Consensus 309 -------g~~pf~~~~-----------------~~~~~~~i~~~~~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 362 (437)
|.++|.+.+ ..+++..|.+.+|.|+...+....... .+....+..
T Consensus 252 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~--------- 322 (432)
T 3n9x_A 252 HINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHR--------- 322 (432)
T ss_dssp TCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCC---------
T ss_pred cccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCC---------
Confidence 667777765 468899999999999988776543321 111111100
Q ss_pred cccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 363 TRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
....+.... + .....+.+||++||++||.+|||++|||+||||++..+
T Consensus 323 -------~~~~~~~~~--------------~----~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 323 -------KPINLKQKY--------------P----SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp -------CCCCHHHHS--------------T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred -------CCCCHHHHC--------------C----CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 000000000 0 01126789999999999999999999999999998754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=394.06 Aligned_cols=254 Identities=23% Similarity=0.412 Sum_probs=209.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.++||+|+||+||+|+++.+++.||+|++++.. ........|..++..+. .|||||+++++|.+.+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~----~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS----NHPFLVGLHSCFQTES 126 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHT----TCTTBCCEEEEEECSS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcC----CCCCcCeeEEEEEECC
Confidence 578999999999999999999999999999999997432 23345677888887764 6899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+|+||||++| +|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||+|
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~--givHrDLKp~NILl--~~~g~ikL~DFGla 200 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER--GIIYRDLKLDNVLL--DSEGHIKLTDYGMC 200 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEE--CTTSCEEECCCTTC
T ss_pred EEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CEEeccCCHHHEEE--CCCCCEEEeeccee
Confidence 99999999965 8888887653 599999999999999999999964 89999999999999 77889999999999
Q ss_pred eec---CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHHHhCC
Q psy11727 264 CHV---GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNE---------VDQMTKIIEVLGM 331 (437)
Q Consensus 264 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~---------~~~~~~i~~~~~~ 331 (437)
+.. .....+.+||+.|+|||++.+..|+.++|||||||++|||++|++||.+... ....+.+....-.
T Consensus 201 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~ 280 (396)
T 4dc2_A 201 KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280 (396)
T ss_dssp BCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC
T ss_pred eecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC
Confidence 752 3445567899999999999999999999999999999999999999965321 1122222221000
Q ss_pred CChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 332 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
.|. .....+.+||++||
T Consensus 281 ------------------------------------~p~---------------------------~~s~~~~~li~~lL 297 (396)
T 4dc2_A 281 ------------------------------------IPR---------------------------SLSVKAASVLKSFL 297 (396)
T ss_dssp ------------------------------------CCT---------------------------TSCHHHHHHHHHHT
T ss_pred ------------------------------------CCC---------------------------cCCHHHHHHHHHHh
Confidence 000 00125789999999
Q ss_pred ccCCCCCCCH------HHHhcCCCcCcCCC
Q psy11727 412 TYDPKKRISP------TNVLRHEFFLKHSV 435 (437)
Q Consensus 412 ~~dP~~R~t~------~e~l~Hp~~~~~~~ 435 (437)
+.||.+|||+ +|+++||||++.++
T Consensus 298 ~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 298 NKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp CSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred cCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 9999999995 79999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=390.03 Aligned_cols=253 Identities=27% Similarity=0.450 Sum_probs=217.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||+||+|++..+++.||||++.... ........|+.++..+ .||||++++++|.+.+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFLVKLEFSFKDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEcCC
Confidence 578999999999999999999999999999999996432 1233455566666544 7899999999999999
Q ss_pred EEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+|+||||++ ++|.+++.... .+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~NIll--~~~g~~kL~DFg~a 188 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS--LDLIYRDLKPENLLI--DQQGYIQVTDFGFA 188 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTSCEEECCCTTC
T ss_pred EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccccCccceEEE--CCCCCEEEcccccc
Confidence 9999999995 58999988753 58999999999999999999995 489999999999999 77889999999999
Q ss_pred eecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 264 CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
..........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..+.......|..
T Consensus 189 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~-------- 260 (350)
T 1rdq_E 189 KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH-------- 260 (350)
T ss_dssp EECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--------
T ss_pred eeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCC--------
Confidence 988777777899999999999999999999999999999999999999999998888887776531111100
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC---
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS--- 420 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t--- 420 (437)
....+.+||.+||+.||.+||+
T Consensus 261 -------------------------------------------------------~~~~~~~li~~lL~~dp~~R~~~~~ 285 (350)
T 1rdq_E 261 -------------------------------------------------------FSSDLKDLLRNLLQVDLTKRFGNLK 285 (350)
T ss_dssp -------------------------------------------------------CCHHHHHHHHHHSCSCTTTCTTSST
T ss_pred -------------------------------------------------------CCHHHHHHHHHHhhcCHHhccCCcc
Confidence 0015789999999999999999
Q ss_pred --HHHHhcCCCcCcCCC
Q psy11727 421 --PTNVLRHEFFLKHSV 435 (437)
Q Consensus 421 --~~e~l~Hp~~~~~~~ 435 (437)
++++++||||+..++
T Consensus 286 ~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 286 NGVNDIKNHKWFATTDW 302 (350)
T ss_dssp TTTHHHHTSGGGTTCCH
T ss_pred CCHHHHHhCcCcCCCCH
Confidence 999999999987654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=387.54 Aligned_cols=291 Identities=31% Similarity=0.520 Sum_probs=219.1
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC---
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN--- 184 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~--- 184 (437)
..++|++.+.||+|+||+||+|.+..+++.||||++............++..+..+ .||||++++++|...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-----~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-----HHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-----CCTTBCCEEEEEEEECSSC
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-----CCCCcccHHHhhhcccccc
Confidence 36789999999999999999999999999999999976655555666666666665 6899999999997643
Q ss_pred ----EEEEEEEeccCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 185 ----HLCLVFELLSYNLYNLIRN--TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 185 ----~~~lV~E~~~~~L~~~l~~--~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
++++||||++++|.+.+.. .....+++..++.++.||+.||.|||.+..||+||||||+|||++ ..++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~-~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN-EADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE-TTTTEEEEC
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe-CCCCcEEEe
Confidence 3899999999998876653 233568999999999999999999995556899999999999994 237789999
Q ss_pred eCCCceecCCc--cccccccccccChhhhcCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 259 DFGSSCHVGQT--LYQYIQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 259 DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+....+..+....+.|+..
T Consensus 175 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp CCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred eCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence 99999866432 34567899999999997654 8999999999999999999999999999999999999999999988
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
++.........++.... . ...+.... +.........+.+||.+||++||
T Consensus 255 ~~~~~~~~~~~~~~~~~----------------~-~~~~~~~~--------------~~~~~~~~~~~~~li~~~L~~dP 303 (360)
T 3e3p_A 255 VLRKLNPSHTDVDLYNS----------------K-GIPWSNVF--------------SDHSLKDAKEAYDLLSALLQYLP 303 (360)
T ss_dssp HHHHHCTTCCCGGGGCC----------------C-CCCHHHHT--------------TTCCCTTHHHHHHHHHHHTCSSG
T ss_pred HHHhcccchhhcccccc----------------c-cCCccccc--------------chhhccccHHHHHHHHHHhccCc
Confidence 77544322111110000 0 00000000 01111223468999999999999
Q ss_pred CCCCCHHHHhcCCCcCcCCC
Q psy11727 416 KKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~~~~ 435 (437)
.+|||+.|+|+||||++..+
T Consensus 304 ~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 304 EERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp GGSCCHHHHTTSGGGGGGGC
T ss_pred cccCCHHHHhcCccccccCC
Confidence 99999999999999998643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=381.95 Aligned_cols=259 Identities=29% Similarity=0.461 Sum_probs=217.5
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-------cchHHHHHHHHHHHhhhcCCCCCcEEEecc
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-------FLNQAQIEVQLLEKINKADIHSRYIVKLKG 178 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-------~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~ 178 (437)
+.+.++|.+.+.||+|+||+||+|.+..+++.||+|++..... ....+.+|+.++..+ .||||+++++
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~ 81 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-----QHPNVITLHE 81 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-----CCCCCCcEEE
Confidence 3456789999999999999999999999999999999975332 235677899988887 6899999999
Q ss_pred eeeECCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC----
Q psy11727 179 HFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS---- 253 (437)
Q Consensus 179 ~~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~---- 253 (437)
+|.+.+.+++||||++ ++|.+++... ..+++..++.++.||+.||.|||+ .||+||||||+|||+. .++
T Consensus 82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~ivH~Dlkp~NIll~--~~~~~~~ 155 (326)
T 2y0a_A 82 VYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS--LQIAHFDLKPENIMLL--DRNVPKP 155 (326)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEES--CSSSSSC
T ss_pred EEEeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHH--CCeEcCCCCHHHEEEe--cCCCCCC
Confidence 9999999999999995 4899988654 458999999999999999999995 4899999999999994 444
Q ss_pred CEEEEeCCCceecC--CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy11727 254 AIKIIDFGSSCHVG--QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331 (437)
Q Consensus 254 ~ikL~DFG~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 331 (437)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 156 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~ 235 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 235 (326)
T ss_dssp CEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC
T ss_pred CEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC
Confidence 79999999998764 3334567999999999999999999999999999999999999999999888777777553322
Q ss_pred CChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 332 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
.+....... ...+.+||.+||
T Consensus 236 ~~~~~~~~~-----------------------------------------------------------~~~~~~li~~~L 256 (326)
T 2y0a_A 236 FEDEYFSNT-----------------------------------------------------------SALAKDFIRRLL 256 (326)
T ss_dssp CCHHHHTTS-----------------------------------------------------------CHHHHHHHHHHS
T ss_pred cCccccccC-----------------------------------------------------------CHHHHHHHHHHc
Confidence 222111100 015789999999
Q ss_pred ccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 412 TYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 412 ~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
+.||.+|||++|+|+||||++..
T Consensus 257 ~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 257 VKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp CSSGGGSCCHHHHHHSTTTSCCS
T ss_pred cCChhhCCCHHHHhcCCCccCCc
Confidence 99999999999999999998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=386.11 Aligned_cols=283 Identities=25% Similarity=0.359 Sum_probs=226.4
Q ss_pred CCCCCCCCCcceeecCceeccCeeee-ceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhh
Q psy11727 90 NDGHDDENYDYIIKHGEKFLDRYEID-TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINK 165 (437)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~y~i~-~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~ 165 (437)
..|.|..+.+..+...+.+.++|.+. +.||+|+||+||+|.+..+++.||+|++.... .....+..|+.++..+.
T Consensus 8 ~~~~~~~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~- 86 (327)
T 3lm5_A 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK- 86 (327)
T ss_dssp --------CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTT-
T ss_pred cccccccchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhcc-
Confidence 44667777777888889999999998 89999999999999999999999999997432 22356677888888774
Q ss_pred cCCCCCcEEEecceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q psy11727 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPEN 244 (437)
Q Consensus 166 ~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~N 244 (437)
.||||+++++++.+.+.+++||||+.+ +|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|
T Consensus 87 ---~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~--givH~Dikp~N 161 (327)
T 3lm5_A 87 ---SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN--NIVHLDLKPQN 161 (327)
T ss_dssp ---TCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGG
T ss_pred ---CCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--CeecCcCChHH
Confidence 579999999999999999999999966 888888665556799999999999999999999964 89999999999
Q ss_pred EEEecC-CCCCEEEEeCCCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy11727 245 ILLCSP-KRSAIKIIDFGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ 321 (437)
Q Consensus 245 Ill~~~-~~~~ikL~DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~ 321 (437)
||++.. ..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 162 Il~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 241 (327)
T 3lm5_A 162 ILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET 241 (327)
T ss_dssp EEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence 999421 2678999999999876443 2456799999999999999999999999999999999999999999988877
Q ss_pred HHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhh
Q psy11727 322 MTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYM 401 (437)
Q Consensus 322 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (437)
...+......++..... ....
T Consensus 242 ~~~i~~~~~~~~~~~~~-----------------------------------------------------------~~~~ 262 (327)
T 3lm5_A 242 YLNISQVNVDYSEETFS-----------------------------------------------------------SVSQ 262 (327)
T ss_dssp HHHHHHTCCCCCTTTTT-----------------------------------------------------------TSCH
T ss_pred HHHHHhcccccCchhhc-----------------------------------------------------------ccCH
Confidence 77765543222211100 0012
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcCCCcCcCCCCC
Q psy11727 402 KFKDLILRMLTYDPKKRISPTNVLRHEFFLKHSVDN 437 (437)
Q Consensus 402 ~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~~ 437 (437)
.+.+||.+||+.||.+|||++++|+||||++...++
T Consensus 263 ~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~ 298 (327)
T 3lm5_A 263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN 298 (327)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence 578999999999999999999999999999887653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=393.23 Aligned_cols=282 Identities=30% Similarity=0.568 Sum_probs=211.0
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+|+.+++.+ .||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~ 100 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-----KHENVIGLLDVFTPA 100 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSC
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEecC
Confidence 44689999999999999999999999999999999996432 2234556788888776 689999999998754
Q ss_pred ------CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 184 ------NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 184 ------~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
..+|+|||+++++|.+++.. ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||
T Consensus 101 ~~~~~~~~~~lv~e~~~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll--~~~~~~kL 173 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAV--NEDCELKI 173 (367)
T ss_dssp SSGGGCCCCEEEEECCCEECC--------CCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--CTTCCEEE
T ss_pred CccccCCeEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHhhEEE--CCCCCEEE
Confidence 57899999998899988875 358999999999999999999996 489999999999999 67889999
Q ss_pred EeCCCceecCCccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 258 IDFGSSCHVGQTLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 258 ~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
+|||++..........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+++..|.+..|.|+...
T Consensus 174 ~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 174 LDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp CC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999999887776677889999999999987 6799999999999999999999999999999999999999999999888
Q ss_pred hccCCcc--chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 337 LHGASKT--SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 337 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
+...... ..+...++.. +. ..+..+. ......+.+||.+||++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~---------------~~-~~~~~~~------------------~~~~~~~~dLl~~mL~~d 299 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQM---------------PK-MNFANVF------------------IGANPLAVDLLEKMLVLD 299 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCC---------------CC-CCHHHHT------------------TTCCHHHHHHHHHHSCSS
T ss_pred HHHhhhHHHHHHHhccCCC---------------CC-CCHHHHC------------------CCCCHHHHHHHHHhCCCC
Confidence 7655432 1222211100 00 0011110 001125799999999999
Q ss_pred CCCCCCHHHHhcCCCcCcCC
Q psy11727 415 PKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~~~~~ 434 (437)
|.+|||+.|+|+||||++..
T Consensus 300 P~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 300 SDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp GGGSCCHHHHHTSGGGTTTC
T ss_pred cccCcCHHHHhcChhhhhcc
Confidence 99999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=399.77 Aligned_cols=260 Identities=29% Similarity=0.396 Sum_probs=216.3
Q ss_pred CceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 105 ~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
...+.++|++.+.||+|+||+||+|.+..+|+.||+|++..... ....+.+|+.++..+ .||||+++++++.
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~ 80 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-----KHPNIVRLHDSIS 80 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-----CBTTBCCEEEEEE
T ss_pred cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCcCCCeEEEEEE
Confidence 34567899999999999999999999999999999999975432 223466788888776 6899999999999
Q ss_pred ECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC-CCCCEEEEe
Q psy11727 182 WKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP-KRSAIKIID 259 (437)
Q Consensus 182 ~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~-~~~~ikL~D 259 (437)
+.+..|+||||+.| +|.+.+.... .+++..+..++.||+.||.|||++ ||+||||||+|||++.+ .++.+||+|
T Consensus 81 ~~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~--givHrDlKp~NIll~~~~~~~~vkL~D 156 (444)
T 3soa_A 81 EEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQM--GVVHRNLKPENLLLASKLKGAAVKLAD 156 (444)
T ss_dssp CSSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSSTTEEESBSSTTCCEEECC
T ss_pred ECCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEEeccCCCCcEEEcc
Confidence 99999999999965 8999887754 589999999999999999999964 89999999999999543 457899999
Q ss_pred CCCceecCCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 260 FGSSCHVGQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 260 FG~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+....+.......+...
T Consensus 157 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 236 (444)
T 3soa_A 157 FGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 236 (444)
T ss_dssp CSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred CceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc
Confidence 9999766433 2356899999999999999999999999999999999999999999998888888766432222110
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
++ .....+.+||.+||+.||.
T Consensus 237 ~~-----------------------------------------------------------~~s~~~~~li~~~L~~dP~ 257 (444)
T 3soa_A 237 WD-----------------------------------------------------------TVTPEAKDLINKMLTINPS 257 (444)
T ss_dssp TT-----------------------------------------------------------TSCHHHHHHHHHHSCSSTT
T ss_pred cc-----------------------------------------------------------cCCHHHHHHHHHHcCCChh
Confidence 00 0012578999999999999
Q ss_pred CCCCHHHHhcCCCcCc
Q psy11727 417 KRISPTNVLRHEFFLK 432 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~~~ 432 (437)
+|||+.|+|+||||++
T Consensus 258 ~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 258 KRITAAEALKHPWISH 273 (444)
T ss_dssp TSCCHHHHHHSCTTHH
T ss_pred HCCCHHHHhcCccccC
Confidence 9999999999999964
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=376.20 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=212.3
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.++|++.+.||+|+||+||+|.+..+++.||||++..... ....+..|+.++..+ .||||++++++|...+.++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-----CCCCCCeEeEEEEECCEEE
Confidence 5689999999999999999999999999999999864332 234566788877775 7899999999999999999
Q ss_pred EEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+. ++|.+++... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~Dlkp~Nil~--~~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILL--GMDGSVKLTDFGFCAQI 166 (297)
T ss_dssp EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCHHHEEE--CCCCCEEEeeCCCceec
Confidence 9999995 5899988765 489999999999999999999964 89999999999999 67888999999999766
Q ss_pred CCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+..........
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------- 238 (297)
T 3fxz_A 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN-------- 238 (297)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSC--------
T ss_pred CCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC--------
Confidence 432 335679999999999999999999999999999999999999999988877666654431111000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
+......+.+||.+||+.||.+|||+.|
T Consensus 239 ----------------------------------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e 266 (297)
T 3fxz_A 239 ----------------------------------------------------PEKLSAIFRDFLNRCLEMDVEKRGSAKE 266 (297)
T ss_dssp ----------------------------------------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ----------------------------------------------------ccccCHHHHHHHHHHccCChhHCcCHHH
Confidence 0000125789999999999999999999
Q ss_pred HhcCCCcCcC
Q psy11727 424 VLRHEFFLKH 433 (437)
Q Consensus 424 ~l~Hp~~~~~ 433 (437)
+|+||||+..
T Consensus 267 ll~h~~~~~~ 276 (297)
T 3fxz_A 267 LLQHQFLKIA 276 (297)
T ss_dssp HTTCGGGGGC
T ss_pred HhhChhhccc
Confidence 9999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=390.49 Aligned_cols=293 Identities=31% Similarity=0.533 Sum_probs=219.8
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+.++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.+ .||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~ 96 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKNIIGLLNVFTPQ 96 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEECSC
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-----CCCCccceEEeeccc
Confidence 35689999999999999999999999999999999997432 2234456677777766 689999999999866
Q ss_pred C------EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 184 N------HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 184 ~------~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
+ .+|+||||++++|.+.+.. .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||
T Consensus 97 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~NIl~--~~~~~~kl 168 (371)
T 2xrw_A 97 KSLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVV--KSDCTLKI 168 (371)
T ss_dssp CSTTTCCEEEEEEECCSEEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEE--CTTSCEEE
T ss_pred cccccccceEEEEEcCCCCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC--CeecccCCHHHEEE--cCCCCEEE
Confidence 5 8999999999999988863 389999999999999999999964 89999999999999 67889999
Q ss_pred EeCCCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 258 IDFGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 258 ~DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.|+..
T Consensus 169 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 169 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 248 (371)
T ss_dssp CCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHH
T ss_pred EEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999999776443 345688999999999999999999999999999999999999999999999999999999999888
Q ss_pred hhccCCccch-hhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 336 LLHGASKTSK-YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 336 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
++........ ++...+. + .. ..+..... ..........+......+.+||.+||++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~--~-------------~~-~~~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~mL~~d 306 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPK--Y-------------AG-YSFEKLFP------DVLFPADSEHNKLKASQARDLLSKMLVID 306 (371)
T ss_dssp HHTTSCHHHHHHHHSSCC--C-------------CC-CCHHHHSC------GGGSCCSSHHHHHHHHHHHHHHHHHSCSS
T ss_pred HHHHhhhHHHHHHhhCcc--c-------------cc-cchhhhcc------cccCcccccccccccHHHHHHHHHHCcCC
Confidence 7765543321 1111000 0 00 00000000 00000000011122346899999999999
Q ss_pred CCCCCCHHHHhcCCCcCcCC
Q psy11727 415 PKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~~~~~ 434 (437)
|.+|||++|+|+||||+...
T Consensus 307 P~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 307 ASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp GGGSCCHHHHHHSHHHHTTC
T ss_pred hhhCCCHHHHhCCcchhhhc
Confidence 99999999999999998643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=396.52 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=216.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC----cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~----~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||+||+|++..+++.||+|++... ......+..|+.++..+ .|||||+++++|.+.+
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-----NSPWVVQLFYAFQDDR 142 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-----CCTTBCCEEEEEECSS
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEECC
Confidence 57899999999999999999999999999999999642 22234567788888776 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
++|+||||++| +|.+++... .+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||+|
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~--~givHrDLKp~NILl--~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLL--DKSGHLKLADFGTC 215 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeeE--CCCCCEEEecccee
Confidence 99999999955 899888764 48999999999999999999996 489999999999999 78889999999999
Q ss_pred eecCCc----cccccccccccChhhhcCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 264 CHVGQT----LYQYIQSRYYRSPEVLLGIP----YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 264 ~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
...... ..+.+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+.+|+.......
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-- 293 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT-- 293 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC--
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc--
Confidence 876543 23678999999999998765 88999999999999999999999999999888888865311000
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
.|.... ....+++||.+||..+|
T Consensus 294 --------------------------------~p~~~~-------------------------~s~~~~~li~~lL~~~~ 316 (410)
T 3v8s_A 294 --------------------------------FPDDND-------------------------ISKEAKNLICAFLTDRE 316 (410)
T ss_dssp --------------------------------CCTTCC-------------------------CCHHHHHHHHHHSSCGG
T ss_pred --------------------------------CCCccc-------------------------ccHHHHHHHHHHccChh
Confidence 000000 00157899999999999
Q ss_pred CC--CCCHHHHhcCCCcCcCCCC
Q psy11727 416 KK--RISPTNVLRHEFFLKHSVD 436 (437)
Q Consensus 416 ~~--R~t~~e~l~Hp~~~~~~~~ 436 (437)
.+ |+|++|+++||||+...++
T Consensus 317 ~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 317 VRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp GCTTSSCHHHHHTSGGGCCSSCC
T ss_pred hhCCCCCHHHHhcCccccCCCHH
Confidence 88 9999999999999987653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=388.91 Aligned_cols=254 Identities=26% Similarity=0.399 Sum_probs=213.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||+||+|++..+++.||||+++... ........|..++..+. .||+|++++++|++.+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~----~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG----KPPFLTQLHSCFQTMD 94 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTT----CCTTBCCEEEEEECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcC----CCCEEeeEEEEEEcCC
Confidence 578999999999999999999999999999999997432 12233445555554432 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+|+||||++| +|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NIll--~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK--GIIYRDLKLDNVML--DSEGHIKIADFGMC 168 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEE--CTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CEEeccCCHHHEEE--cCCCcEEEEeCCcc
Confidence 99999999965 8999887653 489999999999999999999964 89999999999999 77889999999999
Q ss_pred eec---CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 264 CHV---GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 264 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
... .......+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..|....-..|..
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~----- 243 (353)
T 2i0e_A 169 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----- 243 (353)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-----
T ss_pred cccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCC-----
Confidence 763 233456789999999999999999999999999999999999999999999888888876521111100
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
....+.+||.+||+.||.+||+
T Consensus 244 ----------------------------------------------------------~s~~~~~li~~lL~~dP~~R~~ 265 (353)
T 2i0e_A 244 ----------------------------------------------------------MSKEAVAICKGLMTKHPGKRLG 265 (353)
T ss_dssp ----------------------------------------------------------SCHHHHHHHHHHTCSCTTSCTT
T ss_pred ----------------------------------------------------------CCHHHHHHHHHHhhcCHHHcCC
Confidence 0015789999999999999994
Q ss_pred -----HHHHhcCCCcCcCCC
Q psy11727 421 -----PTNVLRHEFFLKHSV 435 (437)
Q Consensus 421 -----~~e~l~Hp~~~~~~~ 435 (437)
++++++||||+..++
T Consensus 266 ~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 266 CGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp CSTTHHHHHHTSGGGTTCCH
T ss_pred CCCCCHHHHhcCccccCCCH
Confidence 699999999997654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=388.32 Aligned_cols=281 Identities=31% Similarity=0.565 Sum_probs=220.7
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE-----
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW----- 182 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~----- 182 (437)
..++|++.+.||+|+||+||+|.+..+|+.||||++...... ..+|+.+++.+ .|+|||+++++|..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l-----~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVL-----DHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTC-----CCTTBCCEEEEEEEC----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHc-----CCCCccchhheeeecCccc
Confidence 457899999999999999999999999999999999754332 23588887666 78999999999843
Q ss_pred ---------------------------------CCEEEEEEEeccCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHH
Q psy11727 183 ---------------------------------KNHLCLVFELLSYNLYNLIRN--TNFHGVSLNLTKKFAQQLCCALAF 227 (437)
Q Consensus 183 ---------------------------------~~~~~lV~E~~~~~L~~~l~~--~~~~~ls~~~~~~i~~qi~~aL~~ 227 (437)
..++++||||++++|.+.+.. .....+++..++.++.||+.||+|
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 345999999999998887764 233569999999999999999999
Q ss_pred hcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC--CccccccccccccChhhhcCC-CCCCcchHHHHHHHHH
Q psy11727 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG--QTLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILV 304 (437)
Q Consensus 228 LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~ 304 (437)
||+ .||+||||||+|||++ ..++.+||+|||+|.... .......||+.|+|||++.+. .++.++|||||||++|
T Consensus 157 LH~--~gi~H~Dikp~Nil~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 157 IHS--LGICHRDIKPQNLLVN-SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHT--TTEECSCCCGGGEEEE-TTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHH--CcCccCccCHHHEEEc-CCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 995 4899999999999994 256789999999998653 334567889999999999875 4899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCC
Q psy11727 305 ELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGG 384 (437)
Q Consensus 305 elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (437)
+|++|++||.+.+..+++..++..+|.|+...+...... +... .+. ......+..++.
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~---~~~~---~~~-----------~~~~~~~~~~~~----- 291 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPH---YTEV---RFP-----------TLKAKDWRKILP----- 291 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT---C--C---CCC-----------CCCCCCHHHHSC-----
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcc---cccc---cCC-----------ccCcccHHhhCC-----
Confidence 999999999999999999999999999987765433211 0000 000 000000111100
Q ss_pred CCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 385 PGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
......+.+||.+||++||.+|||+.|+|+||||++.
T Consensus 292 ------------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 292 ------------EGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp ------------TTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred ------------CCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 0011257899999999999999999999999999753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=381.65 Aligned_cols=285 Identities=27% Similarity=0.453 Sum_probs=225.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE---
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--- 182 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--- 182 (437)
.++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.++..+ .|+||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-----KHENVVNLIEICRTKAS 90 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-----CCTTBCCEEEEEEEC--
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-----cCCCcccHhheeecccc
Confidence 578999999999999999999999999999999986432 2234667888888887 68999999999987
Q ss_pred -----CCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 183 -----KNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 183 -----~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
.+.+++||||++++|.+.+.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||
T Consensus 91 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIl~--~~~~~~kl 165 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRN--KILHRDMKAANVLI--TRDGVLKL 165 (351)
T ss_dssp ------CEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEE--CTTSCEEE
T ss_pred ccccCCceEEEEEeccCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCHHHEEE--cCCCCEEE
Confidence 45799999999999998887654 4599999999999999999999964 89999999999999 67889999
Q ss_pred EeCCCceecCC-------ccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q psy11727 258 IDFGSSCHVGQ-------TLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVL 329 (437)
Q Consensus 258 ~DFG~s~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 329 (437)
+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+....
T Consensus 166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 245 (351)
T 3mi9_A 166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245 (351)
T ss_dssp CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999976531 2234578999999999986 458999999999999999999999999999999999999998
Q ss_pred CCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHH
Q psy11727 330 GMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILR 409 (437)
Q Consensus 330 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 409 (437)
+.++...++....... +..... .......+.+.+.. ......+.+||.+
T Consensus 246 ~~~~~~~~~~~~~~~~-~~~~~~--------------~~~~~~~~~~~~~~----------------~~~~~~~~~li~~ 294 (351)
T 3mi9_A 246 GSITPEVWPNVDNYEL-YEKLEL--------------VKGQKRKVKDRLKA----------------YVRDPYALDLIDK 294 (351)
T ss_dssp CCCCTTTSTTGGGCGG-GTSSCC--------------CSSCCCCHHHHHHH----------------HHCCHHHHHHHHH
T ss_pred CCCChhhccccccchh-hccccc--------------ccccccCHHHHhhh----------------ccCChHHHHHHHH
Confidence 8887766554332211 111000 00000000000000 0001257899999
Q ss_pred ccccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 410 MLTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 410 ~L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
||++||.+|||++|+|+||||+...
T Consensus 295 ~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 295 LLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred HhcCChhhCCCHHHHhCCCCcCCCC
Confidence 9999999999999999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=387.29 Aligned_cols=265 Identities=30% Similarity=0.424 Sum_probs=217.4
Q ss_pred ceeecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEe
Q psy11727 100 YIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKL 176 (437)
Q Consensus 100 ~~~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l 176 (437)
+.......+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.++..+ .||||+++
T Consensus 19 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~ 93 (362)
T 2bdw_A 19 FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-----QHPNIVRL 93 (362)
T ss_dssp -----CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-----CCTTBCCE
T ss_pred EeecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCCCCCeE
Confidence 3444566778899999999999999999999999999999999975432 234566788888876 68999999
Q ss_pred cceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC-CCC
Q psy11727 177 KGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK-RSA 254 (437)
Q Consensus 177 ~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~-~~~ 254 (437)
++++.+.+..|+||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++ ||+||||||+|||++.+. .+.
T Consensus 94 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~--~ivH~Dlkp~NIll~~~~~~~~ 169 (362)
T 2bdw_A 94 HDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAA 169 (362)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEESCSSTTCC
T ss_pred EEEEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCchHHEEEecCCCCCC
Confidence 9999999999999999965 8988887653 589999999999999999999964 899999999999995432 356
Q ss_pred EEEEeCCCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy11727 255 IKIIDFGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332 (437)
Q Consensus 255 ikL~DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p 332 (437)
+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+....+.......
T Consensus 170 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 249 (362)
T 2bdw_A 170 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 249 (362)
T ss_dssp EEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred EEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 999999999776432 235689999999999999999999999999999999999999999998888777776542221
Q ss_pred ChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc
Q psy11727 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412 (437)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 412 (437)
+...+. . ....+.+||.+||+
T Consensus 250 ~~~~~~----------~-------------------------------------------------~~~~~~~li~~~L~ 270 (362)
T 2bdw_A 250 PSPEWD----------T-------------------------------------------------VTPEAKSLIDSMLT 270 (362)
T ss_dssp CTTGGG----------G-------------------------------------------------SCHHHHHHHHHHSC
T ss_pred Cccccc----------C-------------------------------------------------CCHHHHHHHHHHcC
Confidence 111000 0 01257899999999
Q ss_pred cCCCCCCCHHHHhcCCCcCc
Q psy11727 413 YDPKKRISPTNVLRHEFFLK 432 (437)
Q Consensus 413 ~dP~~R~t~~e~l~Hp~~~~ 432 (437)
.||.+|||+.|+|+||||+.
T Consensus 271 ~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 271 VNPKKRITADQALKVPWICN 290 (362)
T ss_dssp SSGGGSCCHHHHTTSHHHHT
T ss_pred CChhhCcCHHHHhcCcccCC
Confidence 99999999999999999964
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=376.85 Aligned_cols=258 Identities=25% Similarity=0.293 Sum_probs=203.2
Q ss_pred eecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccch---HHHHHHHHHHHhhhcCCCCCcEEEecc
Q psy11727 102 IKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLN---QAQIEVQLLEKINKADIHSRYIVKLKG 178 (437)
Q Consensus 102 ~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~---~~~~e~~~~~~l~~~~~~h~~iv~l~~ 178 (437)
...++.+.++|++.+.||+|+||+||+|.+..+++.||||++........ ....|+..+..+ ..|+||+++++
T Consensus 49 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~----~~h~~iv~l~~ 124 (311)
T 3p1a_A 49 SRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV----GQHPCCVRLEQ 124 (311)
T ss_dssp TSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHH----CCCTTBCCEEE
T ss_pred CCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHh----cCCCcEEEEEE
Confidence 34566677899999999999999999999999999999999864332222 222233333322 27899999999
Q ss_pred eeeECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 179 HFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 179 ~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
+|.+.+.+|+||||++++|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+
T Consensus 125 ~~~~~~~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIll--~~~~~~kl~ 199 (311)
T 3p1a_A 125 AWEEGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ--GLVHLDVKPANIFL--GPRGRCKLG 199 (311)
T ss_dssp EEEETTEEEEEEECCCCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEE--CGGGCEEEC
T ss_pred EEEeCCEEEEEEeccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHEEE--CCCCCEEEc
Confidence 999999999999999999999887764 4699999999999999999999964 89999999999999 678889999
Q ss_pred eCCCceecCCcc--ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 259 DFGSSCHVGQTL--YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 259 DFG~s~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
|||++....... ....||+.|+|||++.+ .++.++|||||||++|||++|..||.+.... ..+.. +..+..+
T Consensus 200 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~~--~~~~~~~ 273 (311)
T 3p1a_A 200 DFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW---QQLRQ--GYLPPEF 273 (311)
T ss_dssp CCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH---HHHTT--TCCCHHH
T ss_pred cceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHhc--cCCCccc
Confidence 999997764432 34568999999999987 7999999999999999999998776653322 22211 1111111
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
... ....+.+||.+||+.||.
T Consensus 274 ~~~-----------------------------------------------------------~~~~l~~li~~~L~~dP~ 294 (311)
T 3p1a_A 274 TAG-----------------------------------------------------------LSSELRSVLVMMLEPDPK 294 (311)
T ss_dssp HTT-----------------------------------------------------------SCHHHHHHHHHHSCSSTT
T ss_pred ccC-----------------------------------------------------------CCHHHHHHHHHHcCCChh
Confidence 000 012679999999999999
Q ss_pred CCCCHHHHhcCCCcCcC
Q psy11727 417 KRISPTNVLRHEFFLKH 433 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~~~~ 433 (437)
+|||+.|+|+||||++.
T Consensus 295 ~Rpt~~ell~hp~~~~p 311 (311)
T 3p1a_A 295 LRATAEALLALPVLRQP 311 (311)
T ss_dssp TSCCHHHHHTSGGGSCC
T ss_pred hCcCHHHHHhCccccCC
Confidence 99999999999999873
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=395.91 Aligned_cols=260 Identities=25% Similarity=0.371 Sum_probs=217.0
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC----cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~----~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
...++|++.++||+|+||+||+|++..+++.||+|++... ......+..|+.++..+ .||||++++++|.+
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-----~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-----DSKWITTLHYAFQD 145 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-----CTTTBCCEEEEEEC
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEee
Confidence 3467899999999999999999999999999999999642 12223466788887765 78999999999999
Q ss_pred CCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
.+.+|+||||+. |+|.+++.... ..+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILl--~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILM--DMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecccCHHHeeE--cCCCCEEEcchh
Confidence 999999999995 58999987643 459999999999999999999995 489999999999999 778899999999
Q ss_pred CceecCCc----cccccccccccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC--
Q psy11727 262 SSCHVGQT----LYQYIQSRYYRSPEVLL-----GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLG-- 330 (437)
Q Consensus 262 ~s~~~~~~----~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~-- 330 (437)
+|...... ....+||+.|+|||++. +..|+.++|||||||++|||++|++||.+.+..+.+.+|+....
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 300 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 300 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc
Confidence 99765332 23468999999999997 56789999999999999999999999999999888888864311
Q ss_pred -CCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHH
Q psy11727 331 -MPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILR 409 (437)
Q Consensus 331 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 409 (437)
.|.. . ......+++||++
T Consensus 301 ~~p~~-~------------------------------------------------------------~~~s~~~~dLi~~ 319 (437)
T 4aw2_A 301 QFPTQ-V------------------------------------------------------------TDVSENAKDLIRR 319 (437)
T ss_dssp CCCSS-C------------------------------------------------------------CCSCHHHHHHHHT
T ss_pred cCCcc-c------------------------------------------------------------ccCCHHHHHHHHH
Confidence 1100 0 0001257899999
Q ss_pred ccccCCCC--CCCHHHHhcCCCcCcCCCCC
Q psy11727 410 MLTYDPKK--RISPTNVLRHEFFLKHSVDN 437 (437)
Q Consensus 410 ~L~~dP~~--R~t~~e~l~Hp~~~~~~~~~ 437 (437)
||..+|++ |++++|+++||||++.++++
T Consensus 320 lL~~~~~r~~r~~~~eil~Hpff~~i~w~~ 349 (437)
T 4aw2_A 320 LICSREHRLGQNGIEDFKKHPFFSGIDWDN 349 (437)
T ss_dssp TSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred HhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence 99999888 99999999999999987763
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=388.03 Aligned_cols=261 Identities=25% Similarity=0.423 Sum_probs=215.5
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++..... ....+.+|+.++..+ .||||++++++|.+.+.
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-----HHPKLINLHDAFEDKYE 122 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-----CSTTBCCEEEEEECSSE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-----CCcCCCeEEEEEEeCCE
Confidence 346789999999999999999999999999999999975432 223456677776655 78999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+..+.+||+|||++.
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDlkp~NIll~~~~~~~vkL~DFG~a~ 199 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLAT 199 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC--CeeecccchHHeEEecCCCCceEEEecccce
Confidence 9999999965 8988887543 4589999999999999999999964 8999999999999965566789999999998
Q ss_pred ecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 265 HVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 265 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
..... ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.......+...
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~------ 273 (387)
T 1kob_A 200 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA------ 273 (387)
T ss_dssp ECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST------
T ss_pred ecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc------
Confidence 76433 3346799999999999999999999999999999999999999999988777777654211111000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
+. .....+.+||.+||+.||.+|||+.
T Consensus 274 ----~~-------------------------------------------------~~s~~~~~li~~~L~~dP~~Rpt~~ 300 (387)
T 1kob_A 274 ----FS-------------------------------------------------SVSPEAKDFIKNLLQKEPRKRLTVH 300 (387)
T ss_dssp ----TT-------------------------------------------------TSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred ----cc-------------------------------------------------cCCHHHHHHHHHHcCCChhHCcCHH
Confidence 00 0012578999999999999999999
Q ss_pred HHhcCCCcCcCC
Q psy11727 423 NVLRHEFFLKHS 434 (437)
Q Consensus 423 e~l~Hp~~~~~~ 434 (437)
|+|+||||+...
T Consensus 301 ell~hp~~~~~~ 312 (387)
T 1kob_A 301 DALEHPWLKGDH 312 (387)
T ss_dssp HHHTSTTTSSCC
T ss_pred HHhhCccccCCc
Confidence 999999998643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=371.08 Aligned_cols=284 Identities=31% Similarity=0.478 Sum_probs=215.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc---chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF---LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
.++|++.+.||+|+||+||+|.+..+++.||+|++...... ...+..|+.++..+ .||||+++++++...+.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-----KHPNLVNLLEVFRRKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-----CCCCccchhheeecCCe
Confidence 57899999999999999999999999999999998644322 23455677777776 68999999999999999
Q ss_pred EEEEEEeccCc-HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSYN-LYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~~-L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
.++||||++++ |.+++... ..+++..++.++.||+.||+|||++ ||+||||||+||++ +.++.+||+|||++.
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~--~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~ 150 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKH--NCIHRDVKPENILI--TKHSVIKLCDFGFAR 150 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEE--CTTSCEEECCCTTCE
T ss_pred EEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCCChhhEEE--cCCCCEEEeeCCCch
Confidence 99999999875 55554443 4589999999999999999999964 89999999999999 678899999999997
Q ss_pred ecCCc---cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 265 HVGQT---LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 265 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.+..+.++.......
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 151 LLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp ECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred hccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence 76432 234578999999999986 57899999999999999999999999999999999999888877665443221
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
... .++... ..|........... . ......+.+||.+||++||.+|||
T Consensus 231 ~~~-~~~~~~----------------~~~~~~~~~~~~~~-----------~----~~~~~~~~~li~~~L~~dP~~Rpt 278 (311)
T 4agu_A 231 STN-QYFSGV----------------KIPDPEDMEPLELK-----------F----PNISYPALGLLKGCLHMDPTERLT 278 (311)
T ss_dssp HTC-GGGTTC----------------CCCCCSSCCCHHHH-----------C----TTCCHHHHHHHHHHCCSSTTTSCC
T ss_pred ccc-cccccC----------------cCCCccccchhhhh-----------c----ccccHHHHHHHHHHccCChhhcCC
Confidence 111 111100 00000000000000 0 011125789999999999999999
Q ss_pred HHHHhcCCCcCcCCC
Q psy11727 421 PTNVLRHEFFLKHSV 435 (437)
Q Consensus 421 ~~e~l~Hp~~~~~~~ 435 (437)
++|+|+||||++...
T Consensus 279 ~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 279 CEQLLHHPYFENIRE 293 (311)
T ss_dssp HHHHHTSGGGTTCC-
T ss_pred HHHHhcChHHHhccC
Confidence 999999999998653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=381.64 Aligned_cols=254 Identities=24% Similarity=0.415 Sum_probs=207.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||+||+|+++.+++.||+|++..... .......|..++..+. .||||++++++|.+.+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~----~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS----NHPFLVGLHSCFQTES 83 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTT----TCTTBCCEEEEEECSS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcC----CCCccCeEEEEEEeCC
Confidence 5789999999999999999999999999999999974322 2234556777776653 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+|+||||+.| +|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll--~~~g~~kL~DFG~a 157 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER--GIIYRDLKLDNVLL--DSEGHIKLTDYGMC 157 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEE--CTTSCEEECCGGGC
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCHHHEEE--CCCCCEEEEecccc
Confidence 99999999965 8988887653 589999999999999999999964 89999999999999 77889999999999
Q ss_pred eec---CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHHHHhCC
Q psy11727 264 CHV---GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN---------EVDQMTKIIEVLGM 331 (437)
Q Consensus 264 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~---------~~~~~~~i~~~~~~ 331 (437)
... .......+||+.|+|||++.+..++.++|+|||||++|||++|++||.... .....+.+....-.
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~ 237 (345)
T 3a8x_A 158 KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 237 (345)
T ss_dssp BCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC
T ss_pred ccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC
Confidence 753 334456789999999999999999999999999999999999999997521 22222222221000
Q ss_pred CChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 332 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
.|. .....+.+||.+||
T Consensus 238 ------------------------------------~p~---------------------------~~s~~~~~li~~lL 254 (345)
T 3a8x_A 238 ------------------------------------IPR---------------------------SLSVKAASVLKSFL 254 (345)
T ss_dssp ------------------------------------CCT---------------------------TSCHHHHHHHHHHT
T ss_pred ------------------------------------CCC---------------------------CCCHHHHHHHHHHh
Confidence 000 00125789999999
Q ss_pred ccCCCCCCCH------HHHhcCCCcCcCCC
Q psy11727 412 TYDPKKRISP------TNVLRHEFFLKHSV 435 (437)
Q Consensus 412 ~~dP~~R~t~------~e~l~Hp~~~~~~~ 435 (437)
+.||.+|||+ +|+++||||++..+
T Consensus 255 ~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 255 NKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp CSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred cCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 9999999996 89999999988654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=387.40 Aligned_cols=285 Identities=34% Similarity=0.567 Sum_probs=222.5
Q ss_pred CceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 105 ~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
++....+|.+.+.||+|+||+||+|++..++. ||+|++....... .+|+.+++.+ .||||++++++|...+
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~---~~E~~il~~l-----~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK---NRELQIMRIV-----KHPNVVDLKAFFYSNG 105 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSC---CHHHHHHHTC-----CCTTBCCEEEEEEEES
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchH---HHHHHHHHhC-----CCCCcceEEEEEEecC
Confidence 45567789999999999999999999887766 8888776443322 3588888776 6899999999996543
Q ss_pred ------EEEEEEEeccCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEE
Q psy11727 185 ------HLCLVFELLSYNLYNLIRN--TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIK 256 (437)
Q Consensus 185 ------~~~lV~E~~~~~L~~~l~~--~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ik 256 (437)
++++||||+++++.+.+.. .....+++..++.++.||+.||+|||++ ||+||||||+|||++ ..++.+|
T Consensus 106 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~Nill~-~~~~~~k 182 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI--GICHRDIKPQNLLLD-PPSGVLK 182 (394)
T ss_dssp SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEE-TTTTEEE
T ss_pred CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--CccCCCCCHHHEEEc-CCCCcEE
Confidence 4899999999988776542 2235699999999999999999999964 899999999999994 2678899
Q ss_pred EEeCCCceec--CCccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy11727 257 IIDFGSSCHV--GQTLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333 (437)
Q Consensus 257 L~DFG~s~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~ 333 (437)
|+|||+|... +......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+++..+...+|.|+
T Consensus 183 L~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 183 LIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp ECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred EeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999999765 3334567889999999999775 589999999999999999999999999999999999999999998
Q ss_pred hhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
...+...... +... .+. ......+..... ......+.+||.+||++
T Consensus 263 ~~~~~~~~~~--~~~~----~~~-----------~~~~~~~~~~~~-----------------~~~~~~~~~li~~~L~~ 308 (394)
T 4e7w_A 263 REQIKTMNPN--YMEH----KFP-----------QIRPHPFSKVFR-----------------PRTPPDAIDLISRLLEY 308 (394)
T ss_dssp HHHHHHHCGG--GSSS----CCC-----------CCCCCCHHHHSC-----------------TTCCHHHHHHHHHHCCS
T ss_pred HHHHHhhChh--hhhh----ccc-----------cccCCcHHHhcc-----------------ccCCHHHHHHHHHHhCC
Confidence 8766533211 1000 000 000000111100 00112689999999999
Q ss_pred CCCCCCCHHHHhcCCCcCcCCC
Q psy11727 414 DPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 414 dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
||.+|||+.|+++||||++..+
T Consensus 309 dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 309 TPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp SGGGSCCHHHHHTSGGGSTTTS
T ss_pred ChhhCCCHHHHhcChhhhhhcc
Confidence 9999999999999999997654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=385.17 Aligned_cols=281 Identities=30% Similarity=0.544 Sum_probs=224.2
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+.++|.+.+.||+|+||+||+|.+..+|+.||||++..... ....+.+|+.+++.+ .||||+++++++...
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~ 113 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-----QHENVIGLLDVFTPA 113 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSC
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-----CCCCchhhhhheecc
Confidence 456899999999999999999999999999999999975322 234566777777776 689999999999877
Q ss_pred CEE------EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 184 NHL------CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 184 ~~~------~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
+.. |+||||++++|.+.+.. .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||
T Consensus 114 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIll--~~~~~~kL 185 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQTDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSA--GVVHRDLKPGNLAV--NEDCELKI 185 (371)
T ss_dssp SSSTTCCCCEEEEECCCEEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEE--CTTCCEEE
T ss_pred CCcccceeEEEEEccccccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCcCHHHeEE--CCCCCEEE
Confidence 654 99999999998877632 389999999999999999999964 89999999999999 67888999
Q ss_pred EeCCCceecCCccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 258 IDFGSSCHVGQTLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 258 ~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
+|||++..........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.|+..+
T Consensus 186 ~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 186 LDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp CSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred EecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 999999888777777889999999999987 6899999999999999999999999999999999999999999999888
Q ss_pred hccCCccc--hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 337 LHGASKTS--KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 337 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
........ .+...++.. ....+..+. ......+.+||.+||++|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~------------------~~~~~~~~~li~~~L~~d 311 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQT----------------PRKDFTQLF------------------PRASPQAADLLEKMLELD 311 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCC----------------CCCCHHHHS------------------TTSCHHHHHHHHHHSCSC
T ss_pred HHHhhhhhhhhhhhccCCC----------------cchhHHHhc------------------cccChHHHHHHHHHCCCC
Confidence 76554321 111111100 000000000 001236899999999999
Q ss_pred CCCCCCHHHHhcCCCcCcCC
Q psy11727 415 PKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~~~~~ 434 (437)
|.+|||+.|+|+||||++..
T Consensus 312 P~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 312 VDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp TTTSCCHHHHHTSGGGTTTC
T ss_pred hhhcCCHHHHhcCcccccCC
Confidence 99999999999999998753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=382.12 Aligned_cols=280 Identities=30% Similarity=0.538 Sum_probs=226.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC---
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK--- 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~--- 183 (437)
.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.++..+ .||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-----RHENIIGINDIIRAPTIE 100 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-----CCTTBCCCCEEECCSSTT
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-----CCCCCccceeEEecCCcc
Confidence 468999999999999999999999999999999997432 2235566788888877 689999999998765
Q ss_pred --CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 184 --NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 184 --~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
...|+|||+++++|.+++... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||
T Consensus 101 ~~~~~~iv~e~~~~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIl~--~~~~~~kl~Dfg 173 (364)
T 3qyz_A 101 QMKDVYIVQDLMETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA--NVLHRDLKPSNLLL--NTTCDLKICDFG 173 (364)
T ss_dssp TCCCEEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEE--CTTCCEEECCCT
T ss_pred ccceEEEEEcccCcCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCChHhEEE--CCCCCEEEEeCc
Confidence 479999999999999998764 489999999999999999999964 89999999999999 678889999999
Q ss_pred CceecCCc------cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 262 SSCHVGQT------LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 262 ~s~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|+.
T Consensus 174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253 (364)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99866433 234588999999998765 45899999999999999999999999999999999999999999998
Q ss_pred hhhccCCccc--hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc
Q psy11727 335 YLLHGASKTS--KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412 (437)
Q Consensus 335 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 412 (437)
..+....... .+....+. +....+..+. ......+.+||.+||+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~------------------~~~~~~~~~li~~~L~ 299 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPH----------------KNKVPWNRLF------------------PNADSKALDLLDKMLT 299 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCC----------------CCCCCHHHHC------------------TTSCHHHHHHHHHHTC
T ss_pred HHHHHhhhhhHHHHHHhcCC----------------ccCCCHHHhC------------------CCCCHHHHHHHHHHcC
Confidence 8776543321 11111110 0000001100 0011257899999999
Q ss_pred cCCCCCCCHHHHhcCCCcCcCC
Q psy11727 413 YDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 413 ~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
+||.+|||+.|+|+||||++..
T Consensus 300 ~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 300 FNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp SSTTTSCCHHHHHTSGGGTTTC
T ss_pred CChhhCCCHHHHhcCcchhhcc
Confidence 9999999999999999999853
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=391.69 Aligned_cols=281 Identities=31% Similarity=0.527 Sum_probs=220.3
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC-----
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK----- 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~----- 183 (437)
..+|++.+.||+|+||.||+|++..+++.||||++...... ..+|+.+++.+ .|+|||+++++|...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~E~~il~~l-----~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKL-----DHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHHTC-----CCTTBCCEEEEEEEEETTTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh---HHHHHHHHHHc-----CCCCccceeeEEeccCCCCc
Confidence 45799999999999999999999999999999999754322 33588888776 789999999998542
Q ss_pred -CEEEEEEEeccCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 184 -NHLCLVFELLSYNLYNLIRN--TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 184 -~~~~lV~E~~~~~L~~~l~~--~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
.++++||||+++++.+.+.. .....+++..++.++.||+.||+|||++ ||+||||||+|||++. +.+.+||+||
T Consensus 125 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NILl~~-~~~~~kl~DF 201 (420)
T 1j1b_A 125 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDP-DTAVLKLCDF 201 (420)
T ss_dssp EEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECSCCSGGGEEEET-TTTEEEECCC
T ss_pred ceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChhhEEEeC-CCCeEEeccc
Confidence 25789999999988877653 2335699999999999999999999964 8999999999999942 3456899999
Q ss_pred CCceecC--CccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 261 GSSCHVG--QTLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 261 G~s~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
|++.... ......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+++..+++.+|.|....+
T Consensus 202 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 202 GSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp TTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9998653 334457899999999999875 7999999999999999999999999999999999999999999987766
Q ss_pred ccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCC
Q psy11727 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKK 417 (437)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 417 (437)
...... +. .+.+... ....+..++. ......+.+||.+||++||.+
T Consensus 282 ~~~~~~---~~-----~~~~p~~---------~~~~~~~~~~-----------------~~~~~~~~~Li~~~L~~dP~~ 327 (420)
T 1j1b_A 282 REMNPN---YT-----EFKFPQI---------KAHPWTKVFR-----------------PRTPPEAIALCSRLLEYTPTA 327 (420)
T ss_dssp HHHCSC---CC-----CCCCCCC---------CCCCHHHHSC-----------------TTSCHHHHHHHHHHSCSSGGG
T ss_pred HhhChh---hh-----hhccCcc---------CCCCHHHhcC-----------------CCCCHHHHHHHHHhccCChhH
Confidence 432211 00 0000000 0000000000 001126799999999999999
Q ss_pred CCCHHHHhcCCCcCcCC
Q psy11727 418 RISPTNVLRHEFFLKHS 434 (437)
Q Consensus 418 R~t~~e~l~Hp~~~~~~ 434 (437)
|||+.|+++||||++..
T Consensus 328 R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 328 RLTPLEACAHSFFDELR 344 (420)
T ss_dssp SCCHHHHHTSGGGGGGG
T ss_pred CCCHHHHhCCHhhcccc
Confidence 99999999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=387.80 Aligned_cols=259 Identities=26% Similarity=0.401 Sum_probs=209.5
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhh-hcCCCCCcEEEecceeeECCEE
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKIN-KADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~-~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
..++|++.+.||+|+||+||+|+++.+++.||||++........ ...+....+... ...+.||||++++++|.+.+.+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~-~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh-HHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 35789999999999999999999999999999999975432111 111111222221 3456899999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
|+||||+.| +|.+++.... .+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++..
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~givHrDlkp~NIll--~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHS--LNIVYRDLKPENILL--DSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--CTTSCEEECCCCBCGG
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCHHHEEE--CCCCCEEEeeCccccc
Confidence 999999965 8988887653 58999999999999999999995 489999999999999 7788999999999975
Q ss_pred c---CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 266 V---GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 266 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
. .......+||+.|+|||++.+..|+.++|+|||||++|||++|.+||.+.+..+.+..|....-..+.
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 260 (373)
T 2r5t_A 189 NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP-------- 260 (373)
T ss_dssp GBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS--------
T ss_pred cccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC--------
Confidence 3 23345678999999999999999999999999999999999999999999988888877652100000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH-
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP- 421 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~- 421 (437)
.....+.+||.+||+.||.+||++
T Consensus 261 -------------------------------------------------------~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 261 -------------------------------------------------------NITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp -------------------------------------------------------SSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred -------------------------------------------------------CCCHHHHHHHHHHcccCHHhCCCCC
Confidence 000157899999999999999997
Q ss_pred ---HHHhcCCCcCcCCCC
Q psy11727 422 ---TNVLRHEFFLKHSVD 436 (437)
Q Consensus 422 ---~e~l~Hp~~~~~~~~ 436 (437)
.++++||||+..+++
T Consensus 286 ~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 286 DDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp TTHHHHHTSGGGTTCCHH
T ss_pred CCHHHHhCCccccCCCHH
Confidence 699999999987653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=382.87 Aligned_cols=259 Identities=27% Similarity=0.381 Sum_probs=210.2
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc------ccchHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK------PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~------~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
.+.++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.++..+ .||||+++++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~ 95 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-----KHPHIVELLETY 95 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-----CCTTBCCEEEEE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-----CCCCCCcEEEEE
Confidence 45678999999999999999999999999999999986321 1245677899888877 689999999999
Q ss_pred eECCEEEEEEEeccC-cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC-CCCEE
Q psy11727 181 TWKNHLCLVFELLSY-NLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK-RSAIK 256 (437)
Q Consensus 181 ~~~~~~~lV~E~~~~-~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~-~~~ik 256 (437)
.+.+.+|+||||+.| +|.+.+... ....+++..++.++.||+.||+|||++ ||+||||||+|||++.+. .+.+|
T Consensus 96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~ivHrDlkp~NIl~~~~~~~~~vk 173 (351)
T 3c0i_A 96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN--NIIHRDVKPHCVLLASKENSAPVK 173 (351)
T ss_dssp EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECSSSTTCCEE
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCChHHeEEecCCCCCcEE
Confidence 999999999999965 888877543 223489999999999999999999964 899999999999995432 34599
Q ss_pred EEeCCCceecCCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy11727 257 IIDFGSSCHVGQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333 (437)
Q Consensus 257 L~DFG~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~ 333 (437)
|+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.. .+....+.......+
T Consensus 174 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~ 252 (351)
T 3c0i_A 174 LGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMN 252 (351)
T ss_dssp ECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCC
T ss_pred EecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCC
Confidence 9999999876543 234679999999999999999999999999999999999999998854 344444444221111
Q ss_pred hhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
...+. . ....+.+||.+||+.
T Consensus 253 ~~~~~----------~-------------------------------------------------~s~~~~~li~~~L~~ 273 (351)
T 3c0i_A 253 PRQWS----------H-------------------------------------------------ISESAKDLVRRMLML 273 (351)
T ss_dssp HHHHT----------T-------------------------------------------------SCHHHHHHHHHHTCS
T ss_pred ccccc----------c-------------------------------------------------CCHHHHHHHHHHCCC
Confidence 11100 0 001578999999999
Q ss_pred CCCCCCCHHHHhcCCCcCc
Q psy11727 414 DPKKRISPTNVLRHEFFLK 432 (437)
Q Consensus 414 dP~~R~t~~e~l~Hp~~~~ 432 (437)
||.+|||+.|+|+||||++
T Consensus 274 dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 274 DPAERITVYEALNHPWLKE 292 (351)
T ss_dssp STTTSCCHHHHHTSHHHHT
T ss_pred ChhHCcCHHHHhcChhhcC
Confidence 9999999999999999976
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=390.39 Aligned_cols=254 Identities=29% Similarity=0.453 Sum_probs=207.5
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC----cccchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~----~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
....++|.+.+.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.+ .||||+++++++.
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~ 79 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-----RHPHIIKLYDVIT 79 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-----CCTTBCCEEEEEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-----CCCCCCeEEEEEE
Confidence 34568999999999999999999999999999999998632 12234667788877665 6899999999999
Q ss_pred ECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 182 WKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 182 ~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
+.+.+++||||++|+|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||
T Consensus 80 ~~~~~~lv~E~~~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~--givH~Dlkp~NIll--~~~~~~kl~DFG 153 (336)
T 3h4j_B 80 TPTDIVMVIEYAGGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRH--KIVHRDLKPENLLL--DDNLNVKIADFG 153 (336)
T ss_dssp CSSEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCSTTTEEE--CTTCCEEECCSS
T ss_pred eCCEEEEEEECCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCchhhEEE--cCCCCEEEEEec
Confidence 999999999999889999887653 589999999999999999999964 89999999999999 778899999999
Q ss_pred CceecCC--ccccccccccccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 262 SSCHVGQ--TLYQYIQSRYYRSPEVLLGIPY-DLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 262 ~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
++..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|++||.+......
T Consensus 154 ~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------- 216 (336)
T 3h4j_B 154 LSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------- 216 (336)
T ss_dssp CTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----------------
T ss_pred cceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----------------
Confidence 9976543 2345789999999999998876 6899999999999999999999976432111
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
+..+..+.+ ..|. .....+.+||++||+.||.+|
T Consensus 217 --------~~~i~~~~~-----------~~p~---------------------------~~s~~~~~li~~~L~~dP~~R 250 (336)
T 3h4j_B 217 --------FKKVNSCVY-----------VMPD---------------------------FLSPGAQSLIRRMIVADPMQR 250 (336)
T ss_dssp --------BCCCCSSCC-----------CCCT---------------------------TSCHHHHHHHHTTSCSSGGGS
T ss_pred --------HHHHHcCCC-----------CCcc---------------------------cCCHHHHHHHHHHcCCChhHC
Confidence 111110000 0000 011257899999999999999
Q ss_pred CCHHHHhcCCCcCcC
Q psy11727 419 ISPTNVLRHEFFLKH 433 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~~ 433 (437)
||++|+++||||+..
T Consensus 251 pt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 251 ITIQEIRRDPWFNVN 265 (336)
T ss_dssp CCHHHHTTCHHHHTT
T ss_pred cCHHHHHhChhhccC
Confidence 999999999999753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=390.56 Aligned_cols=258 Identities=25% Similarity=0.373 Sum_probs=214.9
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC----cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~----~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
..++|++.+.||+|+||+||+|+++.+++.||||++.+. ......+..|..++..+ .|+||++++++|++.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-----~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-----DRRWITQLHFAFQDE 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-----CTTTBCCEEEEEECS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEeeC
Confidence 357899999999999999999999999999999999642 12234466788877665 789999999999999
Q ss_pred CEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+++|+||||++ |+|.+++.... ..+++..++.++.||+.||+|||+ .|||||||||+|||+ +.++++||+|||+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~--~giiHrDLKp~NILl--d~~g~vkL~DFGl 208 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHR--LGYVHRDIKPDNILL--DRCGHIRLADFGS 208 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTSCEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccCHHHeee--cCCCCEEEeechh
Confidence 99999999995 58999987653 358999999999999999999995 489999999999999 7788999999999
Q ss_pred ceecCCc----cccccccccccChhhhc-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh--
Q psy11727 263 SCHVGQT----LYQYIQSRYYRSPEVLL-------GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVL-- 329 (437)
Q Consensus 263 s~~~~~~----~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~-- 329 (437)
+...... ....+||+.|+|||++. +..|+.++|||||||++|||++|++||.+.+..+.+.+|+...
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 288 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH 288 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 9876432 23468999999999997 4578999999999999999999999999999888888876421
Q ss_pred -CCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHH
Q psy11727 330 -GMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLIL 408 (437)
Q Consensus 330 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 408 (437)
..|.. . ......+++||+
T Consensus 289 ~~~p~~--~-----------------------------------------------------------~~~s~~~~dli~ 307 (412)
T 2vd5_A 289 LSLPLV--D-----------------------------------------------------------EGVPEEARDFIQ 307 (412)
T ss_dssp CCCC-----------------------------------------------------------------CCCHHHHHHHH
T ss_pred cCCCcc--c-----------------------------------------------------------cCCCHHHHHHHH
Confidence 11100 0 000015799999
Q ss_pred HccccCCCCC---CCHHHHhcCCCcCcCCCCC
Q psy11727 409 RMLTYDPKKR---ISPTNVLRHEFFLKHSVDN 437 (437)
Q Consensus 409 ~~L~~dP~~R---~t~~e~l~Hp~~~~~~~~~ 437 (437)
+||. +|.+| +|++|+++||||+..++++
T Consensus 308 ~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~ 338 (412)
T 2vd5_A 308 RLLC-PPETRLGRGGAGDFRTHPFFFGLDWDG 338 (412)
T ss_dssp TTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred HHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 9999 99998 5999999999999987763
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=381.36 Aligned_cols=282 Identities=32% Similarity=0.539 Sum_probs=222.0
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc------ccchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK------PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~------~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
..++|++.+.||+|+||+||+|.+..+|+.||||++.... .....+.+|+.++..+ .||||++++++|.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~ 82 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-----SHPNIIGLLDAFG 82 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-----CCTTBCCEEEEEC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-----CCCCCCeEEEEEe
Confidence 3578999999999999999999999999999999986422 1234567788888877 6899999999999
Q ss_pred ECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 182 WKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 182 ~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
+.+..++||||++++|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||
T Consensus 83 ~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~--~~~~~~kl~Dfg 157 (346)
T 1ua2_A 83 HKSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH--WILHRDLKPNNLLL--DENGVLKLADFG 157 (346)
T ss_dssp CTTCCEEEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEE--CTTCCEEECCCG
T ss_pred eCCceEEEEEcCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC--CEECCCCCHHHEEE--cCCCCEEEEecc
Confidence 999999999999999998887654 4689999999999999999999964 89999999999999 678899999999
Q ss_pred CceecCCc---cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 262 SSCHVGQT---LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 262 ~s~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
++...... ....+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.|+...+
T Consensus 158 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 158 LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp GGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 99765432 3346789999999999764 5899999999999999999999999999999999999999998877655
Q ss_pred ccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCC
Q psy11727 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKK 417 (437)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 417 (437)
+.......+... ...|.. .+..+. ......+.+||.+||+.||.+
T Consensus 238 ~~~~~~~~~~~~----------------~~~~~~-~~~~~~------------------~~~~~~~~~li~~~L~~dP~~ 282 (346)
T 1ua2_A 238 PDMCSLPDYVTF----------------KSFPGI-PLHHIF------------------SAAGDDLLDLIQGLFLFNPCA 282 (346)
T ss_dssp SSTTSSTTCCCC----------------CCCCCC-CHHHHC------------------TTCCHHHHHHHHHHHCSSTTT
T ss_pred hhhccCcccccc----------------cccCCC-ChHHhh------------------ccCCHHHHHHHHHHhccChhh
Confidence 443322111100 000000 000000 011136899999999999999
Q ss_pred CCCHHHHhcCCCcCcCC
Q psy11727 418 RISPTNVLRHEFFLKHS 434 (437)
Q Consensus 418 R~t~~e~l~Hp~~~~~~ 434 (437)
|||++|+|+||||++..
T Consensus 283 Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 283 RITATQALKMKYFSNRP 299 (346)
T ss_dssp SCCHHHHHTSGGGTSSS
T ss_pred CCCHHHHhcChhhhcCC
Confidence 99999999999998643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=392.20 Aligned_cols=296 Identities=28% Similarity=0.495 Sum_probs=213.0
Q ss_pred ceeccCeee-eceecccCceEEEEEEEc--CCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 106 EKFLDRYEI-DTLLGKGSFGQVVKAFDH--EEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 106 ~~~~~~y~i-~~~lG~G~fg~V~~~~~~--~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
..+.+.|++ .++||+|+||+||+|.+. .+++.||||++... .....+.+|+.+++.+ .||||++++++|..
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~ 89 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLREL-----KHPNVISLQKVFLS 89 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-SCCHHHHHHHHHHHHC-----CCTTBCCCCEEEEE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-CCCHHHHHHHHHHHhc-----CCCCeeeEeeEEec
Confidence 445667887 458999999999999966 57889999999743 3445778899999887 68999999999965
Q ss_pred --CCEEEEEEEeccCcHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec--CC
Q psy11727 183 --KNHLCLVFELLSYNLYNLIRNTN-------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS--PK 251 (437)
Q Consensus 183 --~~~~~lV~E~~~~~L~~~l~~~~-------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~--~~ 251 (437)
...+|+||||++++|.+++.... ...+++..++.++.||+.||+|||++ ||+||||||+|||+.. +.
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--~ivH~Dlkp~NIll~~~~~~ 167 (405)
T 3rgf_A 90 HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPE 167 (405)
T ss_dssp TTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECCSSTT
T ss_pred CCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--CEeCCCcCHHHeEEecCCCC
Confidence 67999999999999998876321 12489999999999999999999964 8999999999999953 35
Q ss_pred CCCEEEEeCCCceecCC------ccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCH------
Q psy11727 252 RSAIKIIDFGSSCHVGQ------TLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNE------ 318 (437)
Q Consensus 252 ~~~ikL~DFG~s~~~~~------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~------ 318 (437)
++.+||+|||+|+.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 247 (405)
T 3rgf_A 168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247 (405)
T ss_dssp TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence 67899999999976643 22346789999999999874 589999999999999999999999987665
Q ss_pred ---HHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCC
Q psy11727 319 ---VDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGH 395 (437)
Q Consensus 319 ---~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (437)
.+++..+...+|.|+...+........+.....+ .+....+... +...+....
T Consensus 248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~-~~~~~~~~~------------- 303 (405)
T 3rgf_A 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKD----------FRRNTYTNCS-LIKYMEKHK------------- 303 (405)
T ss_dssp CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHH----------CCGGGGTTCC-HHHHHHTTT-------------
T ss_pred cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhh----------ccccCCCcch-hhhhHhhcC-------------
Confidence 4788999999999987665544322211110000 0000000000 001110000
Q ss_pred ChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 396 SLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 396 ~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
......+.+||.+||++||.+|||++|||+||||++..
T Consensus 304 -~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 304 -VKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP 341 (405)
T ss_dssp -CCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred -CCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence 00112678999999999999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=383.66 Aligned_cols=259 Identities=27% Similarity=0.392 Sum_probs=208.3
Q ss_pred CceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 105 ~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
...+.++|++.+.||+|+||+||+|.++.+++.||||++..... ....|+.++..+. .||||++++++|.+.+
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~----~hp~iv~~~~~~~~~~ 89 (342)
T 2qr7_A 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYG----QHPNIITLKDVYDDGK 89 (342)
T ss_dssp --CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHT----TSTTBCCEEEEEECSS
T ss_pred ccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhc----CCCCcCeEEEEEEcCC
Confidence 34567899999999999999999999999999999999975432 3345777777663 6899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCC--CCEEEEeCC
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR--SAIKIIDFG 261 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~--~~ikL~DFG 261 (437)
.+|+||||+.| +|.+.+.... .+++..++.++.||+.||+|||++ ||+||||||+|||+..+.. +.+||+|||
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~--givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQ--GVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 99999999965 8999887653 589999999999999999999964 8999999999999853222 359999999
Q ss_pred CceecCC---ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhCCCChh
Q psy11727 262 SSCHVGQ---TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGK---NEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 262 ~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~---~~~~~~~~i~~~~~~p~~~ 335 (437)
++..... ...+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+. +..+.+..+.......+..
T Consensus 166 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 245 (342)
T 2qr7_A 166 FAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGG 245 (342)
T ss_dssp TCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCST
T ss_pred CcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcc
Confidence 9986532 234568899999999999888999999999999999999999999863 4444555543321110000
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
+ +......+.+||.+||..||
T Consensus 246 ----------~-------------------------------------------------~~~~s~~~~~li~~~L~~dP 266 (342)
T 2qr7_A 246 ----------Y-------------------------------------------------WNSVSDTAKDLVSKMLHVDP 266 (342)
T ss_dssp ----------T-------------------------------------------------TTTSCHHHHHHHHHHTCSST
T ss_pred ----------c-------------------------------------------------cccCCHHHHHHHHHHCCCCh
Confidence 0 00011257899999999999
Q ss_pred CCCCCHHHHhcCCCcCcC
Q psy11727 416 KKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~~ 433 (437)
.+|||+.++++||||.++
T Consensus 267 ~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 267 HQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TTSCCHHHHTTSHHHHTG
T ss_pred hHCcCHHHHhcCCeecCc
Confidence 999999999999999764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=380.19 Aligned_cols=262 Identities=26% Similarity=0.386 Sum_probs=200.3
Q ss_pred CceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 105 ~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.+.+.++|++.+.||+|+||+||+|.+..+++.||||++.... ....+..|+.++..+ .||||++++++|...+
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~ 121 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRL-----SHPNIIKLKEIFETPT 121 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHC-----CCTTBCCEEEEEECSS
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhC-----CCCCCcceeeeEecCC
Confidence 3456788999999999999999999999999999999997432 345566788888877 6899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec-CCCCCEEEEeCCC
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS-PKRSAIKIIDFGS 262 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~-~~~~~ikL~DFG~ 262 (437)
..++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+|||++. +.++.+||+|||+
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHEN--GIVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred eEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 99999999965 8999887653 489999999999999999999964 8999999999999953 3478899999999
Q ss_pred ceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChhhhcc
Q psy11727 263 SCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVD-QMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 263 s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~p~~~~~~~ 339 (437)
+...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... .+..+.......+..+.
T Consensus 198 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~-- 275 (349)
T 2w4o_A 198 SKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWW-- 275 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTT--
T ss_pred ccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchh--
Confidence 9765432 235678999999999999999999999999999999999999998766544 34444321111100000
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
......+.+||.+||+.||.+||
T Consensus 276 ---------------------------------------------------------~~~~~~~~~li~~~L~~dP~~Rp 298 (349)
T 2w4o_A 276 ---------------------------------------------------------DEVSLNAKDLVRKLIVLDPKKRL 298 (349)
T ss_dssp ---------------------------------------------------------TTSCHHHHHHHHTTSCSSGGGSC
T ss_pred ---------------------------------------------------------hhCCHHHHHHHHHHccCChhhCc
Confidence 00112578999999999999999
Q ss_pred CHHHHhcCCCcCcCCC
Q psy11727 420 SPTNVLRHEFFLKHSV 435 (437)
Q Consensus 420 t~~e~l~Hp~~~~~~~ 435 (437)
|+.|+|+||||++...
T Consensus 299 t~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 299 TTFQALQHPWVTGKAA 314 (349)
T ss_dssp CHHHHHHSTTTTSTTC
T ss_pred CHHHHhcCcccCCCcc
Confidence 9999999999988654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=384.07 Aligned_cols=258 Identities=30% Similarity=0.389 Sum_probs=200.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.++|++.+.||+|+||+||+|++..+++.||||++...........+|+.+++.+ .||||+++++++.+.+.+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-----RHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-----CCCCCCcEEEEEeeCCEEEE
Confidence 5789999999999999999999999999999999986666667788899888876 68999999999999999999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec-
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV- 266 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~- 266 (437)
||||+.+ +|.+++.... .+++..++.++.||+.||+|||+ .||+||||||+|||++.+..+.+||+|||++...
T Consensus 94 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~--~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 94 IMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999954 8999887653 58999999999999999999995 4899999999999995444456999999998743
Q ss_pred -CCccccccccccccChhhhcCCCCCCc-chHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCChhhhccCCcc
Q psy11727 267 -GQTLYQYIQSRYYRSPEVLLGIPYDLA-IDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVL-GMPPGYLLHGASKT 343 (437)
Q Consensus 267 -~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~p~~~~~~~~~~~ 343 (437)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|++||.+.+.......+.... ....
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------- 239 (361)
T 3uc3_A 170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY---------- 239 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC----------
T ss_pred ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC----------
Confidence 233345689999999999998888765 899999999999999999998765433333222211 0000
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
..|... .....+.+||.+||+.||.+|||+.|
T Consensus 240 -----------------------~~~~~~-------------------------~~s~~~~~li~~~L~~dP~~Rps~~e 271 (361)
T 3uc3_A 240 -----------------------SIPDDI-------------------------RISPECCHLISRIFVADPATRISIPE 271 (361)
T ss_dssp -----------------------CCCTTS-------------------------CCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred -----------------------CCCCcC-------------------------CCCHHHHHHHHHHccCChhHCcCHHH
Confidence 000000 00125789999999999999999999
Q ss_pred HhcCCCcCcC
Q psy11727 424 VLRHEFFLKH 433 (437)
Q Consensus 424 ~l~Hp~~~~~ 433 (437)
+++||||++.
T Consensus 272 ll~hp~f~~~ 281 (361)
T 3uc3_A 272 IKTHSWFLKN 281 (361)
T ss_dssp HHTSHHHHTT
T ss_pred HHhCcchhcC
Confidence 9999999654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=394.89 Aligned_cols=273 Identities=30% Similarity=0.402 Sum_probs=222.1
Q ss_pred CCCCCCcceeecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--------------ccchHHHHHHH
Q psy11727 93 HDDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--------------PFLNQAQIEVQ 158 (437)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--------------~~~~~~~~e~~ 158 (437)
..-....+.......+.++|.+.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.
T Consensus 19 ~~~~~~~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 98 (504)
T 3q5i_A 19 IAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98 (504)
T ss_dssp CCCCGGGGCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHH
T ss_pred eeechhheeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHH
Confidence 3334455666677778899999999999999999999999999999999997432 22345667888
Q ss_pred HHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeee
Q psy11727 159 LLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIH 237 (437)
Q Consensus 159 ~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiH 237 (437)
++..+ .||||++++++|.+.+++|+||||+++ +|.+.+.... .+++..++.++.||+.||+|||++ ||+|
T Consensus 99 ~l~~l-----~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~--~ivH 169 (504)
T 3q5i_A 99 LLKSL-----DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKH--NIVH 169 (504)
T ss_dssp HHHTC-----CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT--TEEC
T ss_pred HHHhC-----CCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeEe
Confidence 88776 789999999999999999999999965 8989887653 589999999999999999999964 8999
Q ss_pred CCCCCCcEEEecCCC-CCEEEEeCCCceecCC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy11727 238 CDLKPENILLCSPKR-SAIKIIDFGSSCHVGQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFS 314 (437)
Q Consensus 238 rDiKp~NIll~~~~~-~~ikL~DFG~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~ 314 (437)
|||||+|||++.+.. ..+||+|||++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.
T Consensus 170 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 248 (504)
T 3q5i_A 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFG 248 (504)
T ss_dssp SCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999953322 3699999999987643 3345689999999999875 69999999999999999999999999
Q ss_pred CCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCC
Q psy11727 315 GKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPG 394 (437)
Q Consensus 315 ~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (437)
+.+..+.+..+......++...+...
T Consensus 249 ~~~~~~~~~~i~~~~~~~~~~~~~~~------------------------------------------------------ 274 (504)
T 3q5i_A 249 GQNDQDIIKKVEKGKYYFDFNDWKNI------------------------------------------------------ 274 (504)
T ss_dssp CSSHHHHHHHHHHCCCCCCHHHHTTS------------------------------------------------------
T ss_pred CCCHHHHHHHHHcCCCCCCccccCCC------------------------------------------------------
Confidence 99988888887664322221111100
Q ss_pred CChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 395 HSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 395 ~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
...+.+||.+||++||.+|||++|+|+||||++..
T Consensus 275 -----s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 275 -----SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp -----CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred -----CHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 01579999999999999999999999999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=371.47 Aligned_cols=259 Identities=26% Similarity=0.437 Sum_probs=217.1
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-------cchHHHHHHHHHHHhhhcCCCCCcEEEecc
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-------FLNQAQIEVQLLEKINKADIHSRYIVKLKG 178 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-------~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~ 178 (437)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+..|+.++..+ .||||+++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~ 82 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-----LHHNVITLHD 82 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-----CCCCcceEEE
Confidence 4457789999999999999999999999999999999975432 234577888888877 6899999999
Q ss_pred eeeECCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC----
Q psy11727 179 HFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS---- 253 (437)
Q Consensus 179 ~~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~---- 253 (437)
++.+.+.+++||||++ ++|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~--~ivH~dikp~NIl~--~~~~~~~~ 156 (321)
T 2a2a_A 83 VYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK--KIAHFDLKPENIML--LDKNIPIP 156 (321)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEE--SCTTSSSC
T ss_pred EEecCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCChHHEEE--ecCCCCcC
Confidence 9999999999999995 4899988764 3589999999999999999999964 89999999999999 4444
Q ss_pred CEEEEeCCCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy11727 254 AIKIIDFGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331 (437)
Q Consensus 254 ~ikL~DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 331 (437)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 157 ~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 236 (321)
T 2a2a_A 157 HIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD 236 (321)
T ss_dssp CEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred CEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc
Confidence 7999999999876443 34567899999999999999999999999999999999999999998888777776543222
Q ss_pred CChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 332 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
.+....... ...+.+||.+||
T Consensus 237 ~~~~~~~~~-----------------------------------------------------------~~~~~~li~~~l 257 (321)
T 2a2a_A 237 FDEEFFSHT-----------------------------------------------------------SELAKDFIRKLL 257 (321)
T ss_dssp CCHHHHTTC-----------------------------------------------------------CHHHHHHHHTTS
T ss_pred cChhhhccc-----------------------------------------------------------CHHHHHHHHHHc
Confidence 222111000 015789999999
Q ss_pred ccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 412 TYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 412 ~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
+.||.+|||++|+++||||+...
T Consensus 258 ~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 258 VKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp CSSTTTSCCHHHHHHSTTTSCSS
T ss_pred CCChhhCcCHHHHhcCccccCCC
Confidence 99999999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=374.95 Aligned_cols=254 Identities=27% Similarity=0.418 Sum_probs=206.8
Q ss_pred eccCeeeeceecccCceEEEEEEEc---CCCeEEEEEEecCCc-----ccchHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDH---EEKCQVAIKIIKNKK-----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~---~~~~~vaiK~i~~~~-----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
..++|++.+.||+|+||+||+|++. .+++.||+|+++... ........|+.+++.+ .||||++++++
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~ 89 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-----KHPFIVDLIYA 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-----CCTTBCCEEEE
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-----CCCCccceeEE
Confidence 3578999999999999999999985 689999999997532 1233456688888776 68999999999
Q ss_pred eeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 180 FTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 180 ~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
+...+.+|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~--~ivH~Dlkp~Nill--~~~~~~kl~ 163 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQK--GIIYRDLKPENIML--NHQGHVKLT 163 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCTTTEEE--CTTSCEEEC
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC--CEEcccCCHHHeEE--CCCCcEEEE
Confidence 9999999999999965 8999887653 489999999999999999999964 89999999999999 678899999
Q ss_pred eCCCceecC---CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 259 DFGSSCHVG---QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 259 DFG~s~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
|||++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+.......|..
T Consensus 164 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~ 243 (327)
T 3a62_A 164 DFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY 243 (327)
T ss_dssp CCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT
T ss_pred eCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCC
Confidence 999987542 22345679999999999999999999999999999999999999999998888777776531111100
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
....+.+||.+||+.||
T Consensus 244 ---------------------------------------------------------------~~~~~~~li~~~L~~dp 260 (327)
T 3a62_A 244 ---------------------------------------------------------------LTQEARDLLKKLLKRNA 260 (327)
T ss_dssp ---------------------------------------------------------------SCHHHHHHHHHHSCSCG
T ss_pred ---------------------------------------------------------------CCHHHHHHHHHHHhcCH
Confidence 01157899999999999
Q ss_pred CCCC-----CHHHHhcCCCcCcCCC
Q psy11727 416 KKRI-----SPTNVLRHEFFLKHSV 435 (437)
Q Consensus 416 ~~R~-----t~~e~l~Hp~~~~~~~ 435 (437)
.+|| |+.|+++||||+...+
T Consensus 261 ~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 261 ASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp GGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred hhccCCCCCCHHHHHcCCcccCCCH
Confidence 9999 8999999999987653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=368.10 Aligned_cols=285 Identities=32% Similarity=0.493 Sum_probs=228.9
Q ss_pred eccCeeeeceecccCceEEEEEEEc-CCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceee--
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDH-EEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT-- 181 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~-~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~-- 181 (437)
..++|++.+.||+|+||+||+|.+. .+++.||+|++.... .......+|+.+++.+.. +.||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET--FEHPNVVRLFDVCTVS 86 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHH--TCCTTBCCEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhc--cCCCCeEeeeeeeeec
Confidence 3578999999999999999999995 678999999986322 223466778888887754 37899999999987
Q ss_pred ---ECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 182 ---WKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 182 ---~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
....+++|||+++++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--gi~H~dlkp~Nili--~~~~~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILV--TSSGQIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEE--CTTCCEEEC
T ss_pred ccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCHHHeEE--cCCCCEEEe
Confidence 45689999999999999999877656699999999999999999999964 89999999999999 678899999
Q ss_pred eCCCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 259 DFGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 259 DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
|||++...... .....||..|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.|+...
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 99999766432 3346789999999999999999999999999999999999999999999999999999988887655
Q ss_pred hccCCccch-hhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 337 LHGASKTSK-YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 337 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
++....... .+.... ...+..+ .......+.+||.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~-------------------~~~~~~~------------------~~~~~~~~~~li~~~L~~dP 285 (326)
T 1blx_A 243 WPRDVALPRQAFHSKS-------------------AQPIEKF------------------VTDIDELGKDLLLKCLTFNP 285 (326)
T ss_dssp SCTTCSSCGGGSCCCC-------------------CCCGGGT------------------CCSCCHHHHHHHHHHSCSST
T ss_pred CccccccchhhhcccC-------------------cchhhhc------------------cccCCHHHHHHHHHHcCCCc
Confidence 433221100 000000 0000000 00011257899999999999
Q ss_pred CCCCCHHHHhcCCCcCcCCC
Q psy11727 416 KKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~~~~ 435 (437)
.+|||+.|+++||||++...
T Consensus 286 ~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 286 AKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp TTSCCHHHHHTSGGGTTCCC
T ss_pred ccCCCHHHHhcCccccccch
Confidence 99999999999999987643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=382.46 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=209.3
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
....++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ .|||||+++++|.
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-----EHPFLVNLWYSFQ 85 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-----CCTTBCCEEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEE
Confidence 344688999999999999999999999999999999996422 2234566788877765 7899999999999
Q ss_pred ECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 182 WKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 182 ~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
+.+.+|+||||+.| +|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+||
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NIll--~~~g~vkL~DF 159 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQ--RIIHRDMKPDNILL--DEHGHVHITDF 159 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEE--CTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCcHHHeEE--CCCCCEEEecc
Confidence 99999999999965 888888764 3599999999999999999999964 89999999999999 77889999999
Q ss_pred CCceecC--CccccccccccccChhhhcC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCC
Q psy11727 261 GSSCHVG--QTLYQYIQSRYYRSPEVLLG---IPYDLAIDMWSLGCILVELHTGEPLFSGKNE---VDQMTKIIEVLGMP 332 (437)
Q Consensus 261 G~s~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~p 332 (437)
|++.... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+. ......+.......
T Consensus 160 G~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 239 (384)
T 4fr4_A 160 NIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTY 239 (384)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCC
T ss_pred ceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCC
Confidence 9998764 33456789999999999974 4589999999999999999999999975433 22223222211000
Q ss_pred ChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc
Q psy11727 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412 (437)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 412 (437)
|. .....+.+||.+||+
T Consensus 240 p~---------------------------------------------------------------~~s~~~~~li~~lL~ 256 (384)
T 4fr4_A 240 PS---------------------------------------------------------------AWSQEMVSLLKKLLE 256 (384)
T ss_dssp CT---------------------------------------------------------------TSCHHHHHHHHHHSC
T ss_pred CC---------------------------------------------------------------cCCHHHHHHHHHHhc
Confidence 00 001257899999999
Q ss_pred cCCCCCCC-HHHHhcCCCcCcCCC
Q psy11727 413 YDPKKRIS-PTNVLRHEFFLKHSV 435 (437)
Q Consensus 413 ~dP~~R~t-~~e~l~Hp~~~~~~~ 435 (437)
.||.+||| ++++++||||++.++
T Consensus 257 ~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 257 PNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp SSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred CCHhHhcccHHHHHcChhhhcCCH
Confidence 99999998 999999999998765
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=383.37 Aligned_cols=300 Identities=20% Similarity=0.238 Sum_probs=210.0
Q ss_pred ccCeeeeceeccc--CceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 109 LDRYEIDTLLGKG--SFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G--~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.++|++.+.||+| +||+||+|++..+++.||||++.... .....+.+|+.+++.+ .|||||+++++|.+.
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-----NHPNIVPYRATFIAD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEET
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-----CCCCCCcEeEEEEEC
Confidence 4689999999999 99999999999999999999997442 2234556688888776 689999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+.+|+||||+.+ +|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivHrDlkp~NIll--~~~~~~kl~dfg~ 174 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM--GYVHRSVKASHILI--SVDGKVYLSGLRS 174 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEE--CTTCCEEECCGGG
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEE--cCCCCEEEccccc
Confidence 999999999964 899998876556799999999999999999999964 89999999999999 6788999999998
Q ss_pred ceecC----------CccccccccccccChhhhcC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q psy11727 263 SCHVG----------QTLYQYIQSRYYRSPEVLLG--IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLG 330 (437)
Q Consensus 263 s~~~~----------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 330 (437)
+.... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..+....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~- 253 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT- 253 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-
Confidence 85431 11223478999999999988 679999999999999999999999999877665555443321
Q ss_pred CCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHc
Q psy11727 331 MPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRM 410 (437)
Q Consensus 331 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~ 410 (437)
.+. +..........+....... .....+.+.+......|.................+.+||.+|
T Consensus 254 -~~~-~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 317 (389)
T 3gni_B 254 -VPC-LLDTSTIPAEELTMSPSRS--------------VANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317 (389)
T ss_dssp --------------------------------------------------------------------CCHHHHHHHHHH
T ss_pred -CCc-ccccccccccccccccccc--------------ccccccccccccCccccccCCCCCCccccccCHHHHHHHHHH
Confidence 110 0000000000000000000 000000000000000000000000011122234689999999
Q ss_pred cccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 411 LTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 411 L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
|++||.+|||+.|+|+||||++..
T Consensus 318 L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 318 LQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp TCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred hhcCcccCCCHHHHhcCHHHHHHh
Confidence 999999999999999999998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=385.69 Aligned_cols=257 Identities=27% Similarity=0.435 Sum_probs=199.2
Q ss_pred eccCeeee-ceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE----
Q psy11727 108 FLDRYEID-TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW---- 182 (437)
Q Consensus 108 ~~~~y~i~-~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~---- 182 (437)
+.++|.+. +.||+|+||+||+|.+..+++.||||++... ....+|+.++.++. .|+||++++++|..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~----~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS----QCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT----TSTTBCCEEEEEEEEETT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhc----CCCCcceEeEEEeecccC
Confidence 45678886 7899999999999999999999999999643 45667777765543 78999999999876
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC-CCCEEEEeC
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK-RSAIKIIDF 260 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~-~~~ikL~DF 260 (437)
.+++||||||+.| +|.+++.......+++..++.++.||+.||.|||+ .||+||||||+|||++.+. ++.+||+||
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH--CCccccCcCcceEEEecCCCCccEEEEec
Confidence 6689999999965 89999987655569999999999999999999996 4899999999999994322 688999999
Q ss_pred CCceecCC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCCh
Q psy11727 261 GSSCHVGQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVD----QMTKIIEVLGMPPG 334 (437)
Q Consensus 261 G~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~----~~~~i~~~~~~p~~ 334 (437)
|++..... .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+... ....+.......+.
T Consensus 209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp TTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred ccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 99987643 2346788999999999999999999999999999999999999998765321 22222211000000
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
+.+ ......+.+||.+||+.|
T Consensus 289 ----------------------------------~~~-------------------------~~~s~~~~~li~~~L~~d 309 (400)
T 1nxk_A 289 ----------------------------------PEW-------------------------SEVSEEVKMLIRNLLKTE 309 (400)
T ss_dssp ----------------------------------TTT-------------------------TTSCHHHHHHHHTTSCSS
T ss_pred ----------------------------------ccc-------------------------ccCCHHHHHHHHHHCCCC
Confidence 000 001125799999999999
Q ss_pred CCCCCCHHHHhcCCCcCcC
Q psy11727 415 PKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~~~~ 433 (437)
|.+|||+.|+++||||.+.
T Consensus 310 P~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 310 PTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp GGGSCCHHHHHHSHHHHTT
T ss_pred hhHCcCHHHHhcCccccCC
Confidence 9999999999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=363.03 Aligned_cols=261 Identities=30% Similarity=0.413 Sum_probs=215.5
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+..|+.+++.+ .||||+++++++..
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~ 76 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-----QHPNIVRLHDSIQE 76 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEC
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-----CCCCcCeEEEEEEc
Confidence 3467899999999999999999999999999999999974432 224456788887776 68999999999999
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC-CCCEEEEeC
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK-RSAIKIIDF 260 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~-~~~ikL~DF 260 (437)
.+..++||||+.+ +|.+.+.... .+++..+..++.||+.||.|||+ .||+||||||+||+++.+. .+.+||+||
T Consensus 77 ~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~Nil~~~~~~~~~~kl~Df 152 (284)
T 3kk8_A 77 ESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADF 152 (284)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCCGGGEEESSSSTTCCEEECCC
T ss_pred CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--CCcCcCCCCHHHEEEecCCCCCcEEEeec
Confidence 9999999999965 8888887653 48999999999999999999996 4899999999999995332 245999999
Q ss_pred CCceecCCcc--ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 261 GSSCHVGQTL--YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 261 G~s~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
|++....... ....||+.|+|||++.+..++.++||||||+++|+|++|.+||.+.+.......+.......+.....
T Consensus 153 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T 3kk8_A 153 GLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 232 (284)
T ss_dssp TTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred eeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhc
Confidence 9997765432 34678999999999999999999999999999999999999999988887777765532221110000
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
.....+.+||.+||+.||.+|
T Consensus 233 -----------------------------------------------------------~~~~~~~~li~~~l~~dp~~R 253 (284)
T 3kk8_A 233 -----------------------------------------------------------TVTPEAKSLIDSMLTVNPKKR 253 (284)
T ss_dssp -----------------------------------------------------------TSCHHHHHHHHHHSCSSTTTS
T ss_pred -----------------------------------------------------------ccCHHHHHHHHHHcccChhhC
Confidence 001257899999999999999
Q ss_pred CCHHHHhcCCCcCcCC
Q psy11727 419 ISPTNVLRHEFFLKHS 434 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~~~ 434 (437)
||+.|+|+||||++..
T Consensus 254 ps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 254 ITADQALKVPWICNRE 269 (284)
T ss_dssp CCHHHHTTSHHHHSCC
T ss_pred CCHHHHhcCccccCCh
Confidence 9999999999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=375.17 Aligned_cols=255 Identities=25% Similarity=0.390 Sum_probs=205.3
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.+.++|++.+.||+|+||+||+|.+..+++.||||++..... ....+..|+.++..+ .||||+++++++.+.+
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-----NHENVVKFYGHRREGN 78 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-----CCTTBCCEEEEEECSS
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-----CCCCCCeEEEEEecCC
Confidence 357899999999999999999999999999999999964432 234567788888776 6899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
..|+||||+++ +|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~givH~Dlkp~NIll--~~~~~~kl~Dfg~a 152 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG--IGITHRDIKPENLLL--DERDNLKISDFGLA 152 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--CTTCCEEECCCTTC
T ss_pred eEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccccchHHEEE--eCCCCEEEEEeecc
Confidence 99999999966 888887654 358999999999999999999995 489999999999999 67889999999999
Q ss_pred eecCC-----ccccccccccccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhh
Q psy11727 264 CHVGQ-----TLYQYIQSRYYRSPEVLLGIPY-DLAIDMWSLGCILVELHTGEPLFSGKNEVDQ-MTKIIEVLGMPPGYL 336 (437)
Q Consensus 264 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~p~~~~ 336 (437)
..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|++||.+.+.... ...+......++.
T Consensus 153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 230 (323)
T 3tki_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP-- 230 (323)
T ss_dssp EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTT--
T ss_pred ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCc--
Confidence 75421 1235679999999999988775 7789999999999999999999987654322 2221111000000
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
+ ......+.+||.+||+.||.
T Consensus 231 ----------~-------------------------------------------------~~~~~~~~~li~~~L~~dP~ 251 (323)
T 3tki_A 231 ----------W-------------------------------------------------KKIDSAPLALLHKILVENPS 251 (323)
T ss_dssp ----------G-------------------------------------------------GGSCHHHHHHHHHHSCSSTT
T ss_pred ----------c-------------------------------------------------ccCCHHHHHHHHHHccCChh
Confidence 0 00012578999999999999
Q ss_pred CCCCHHHHhcCCCcCcC
Q psy11727 417 KRISPTNVLRHEFFLKH 433 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~~~~ 433 (437)
+|||++|+++||||++.
T Consensus 252 ~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 252 ARITIPDIKKDRWYNKP 268 (323)
T ss_dssp TSCCHHHHTTCTTTTCC
T ss_pred hCcCHHHHhhChhhccc
Confidence 99999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=383.33 Aligned_cols=258 Identities=27% Similarity=0.399 Sum_probs=208.4
Q ss_pred ccCeee--eceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 109 LDRYEI--DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 109 ~~~y~i--~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
.+.|.+ .+.||+|+||+||+|.+..+|+.||+|+++... .....+.+|+.++..+ .||||+++++++.+.+.
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~ 160 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-----DHANLIQLYDAFESKND 160 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSE
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-----CCCCCCeEEEEEEECCE
Confidence 445655 678999999999999999999999999997543 2234566677777665 78999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+++||||+++ +|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+..+..+.+||+|||++.
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~ 237 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM--YILHLDLKPENILCVNRDAKQIKIIDFGLAR 237 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred EEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence 9999999965 8888886543 3589999999999999999999964 8999999999999976677889999999998
Q ss_pred ecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 265 HVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 265 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+..+......++.....
T Consensus 238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~---- 313 (373)
T 2x4f_A 238 RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQ---- 313 (373)
T ss_dssp ECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGT----
T ss_pred ecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhc----
Confidence 76432 334579999999999999899999999999999999999999999999888888776542211110000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
. ....+.+||.+||+.||.+|||+.
T Consensus 314 ------~-------------------------------------------------~~~~~~~li~~~L~~dp~~Rps~~ 338 (373)
T 2x4f_A 314 ------D-------------------------------------------------ISEEAKEFISKLLIKEKSWRISAS 338 (373)
T ss_dssp ------T-------------------------------------------------SCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred ------c-------------------------------------------------CCHHHHHHHHHHcCCChhhCCCHH
Confidence 0 012579999999999999999999
Q ss_pred HHhcCCCcCcC
Q psy11727 423 NVLRHEFFLKH 433 (437)
Q Consensus 423 e~l~Hp~~~~~ 433 (437)
|+|+||||++.
T Consensus 339 e~l~hp~~~~~ 349 (373)
T 2x4f_A 339 EALKHPWLSDH 349 (373)
T ss_dssp HHHHSHHHHCH
T ss_pred HHhcCcCcCCC
Confidence 99999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=369.98 Aligned_cols=263 Identities=30% Similarity=0.404 Sum_probs=200.6
Q ss_pred eeccCeeee-ceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 107 KFLDRYEID-TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 107 ~~~~~y~i~-~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.+.++|.+. +.||+|+||+||+|.+..+++.||||++.... .....+.+|+.++..+. .||||+++++++.+.+
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~----~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ----GHRNVLELIEFFEEED 84 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTC----CCTTBCCEEEEEEETT
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhc----CCCCeeeEEEEEeeCC
Confidence 456789995 78999999999999999999999999997543 22456777888887652 7899999999999999
Q ss_pred EEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCC-CCEEEEeCCC
Q psy11727 185 HLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR-SAIKIIDFGS 262 (437)
Q Consensus 185 ~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~-~~ikL~DFG~ 262 (437)
.+++||||+. ++|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||++.+.. ..+||+|||+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNK--GIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 9999999996 58999987753 589999999999999999999964 8999999999999943221 2499999999
Q ss_pred ceecCC----------ccccccccccccChhhhcC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH--------
Q psy11727 263 SCHVGQ----------TLYQYIQSRYYRSPEVLLG-----IPYDLAIDMWSLGCILVELHTGEPLFSGKNEV-------- 319 (437)
Q Consensus 263 s~~~~~----------~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~pf~~~~~~-------- 319 (437)
+..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 865421 1224568999999999975 45889999999999999999999999876421
Q ss_pred -------HHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCC
Q psy11727 320 -------DQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNE 392 (437)
Q Consensus 320 -------~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (437)
.....+.......|...+.
T Consensus 241 ~~~~~~~~~~~~i~~~~~~~~~~~~~------------------------------------------------------ 266 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGKYEFPDKDWA------------------------------------------------------ 266 (316)
T ss_dssp CCHHHHHHHHHHHHHCCCCCCHHHHT------------------------------------------------------
T ss_pred cchhHHHHHHHHHhccCcccCchhcc------------------------------------------------------
Confidence 1222222211111100000
Q ss_pred CCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCCCC
Q psy11727 393 PGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHSVD 436 (437)
Q Consensus 393 ~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~ 436 (437)
.....+.+||.+||+.||.+|||+.|+|+||||++...+
T Consensus 267 -----~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 267 -----HISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE 305 (316)
T ss_dssp -----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----
T ss_pred -----cCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCc
Confidence 001257899999999999999999999999999986544
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=391.04 Aligned_cols=256 Identities=27% Similarity=0.400 Sum_probs=207.2
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ........|+.++ ..+.||||++++++|..
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l-----~~l~h~~iv~l~~~~~~ 219 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVL-----QNSRHPFLTALKYSFQT 219 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CC-----CCCSCTTSCCEEEEEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHH-----HhCCCCeEeeEEEEEee
Confidence 34678999999999999999999999999999999997321 1112223333333 44589999999999999
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
.+.+|+||||+++ +|.+++.... .+++..++.++.||+.||+|||+. .|||||||||+|||+ +.++.+||+|||
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~-~giiHrDlkp~NIll--~~~~~~kl~DFG 294 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLML--DKDGHIKITDFG 294 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCCCGGGEEE--CSSSCEEECCCC
T ss_pred CCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhc-CCEEECCCCHHHEEE--CCCCCEEEccCC
Confidence 9999999999965 8888887653 589999999999999999999961 489999999999999 678899999999
Q ss_pred CceecC---CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 262 SSCHVG---QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 262 ~s~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
+|.... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+.......+.......|..
T Consensus 295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~--- 371 (446)
T 4ejn_A 295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT--- 371 (446)
T ss_dssp CCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT---
T ss_pred CceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCcc---
Confidence 997532 23445789999999999999999999999999999999999999999988877777765421111100
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
....+.+||.+||+.||.+|
T Consensus 372 ------------------------------------------------------------~~~~~~~li~~~L~~dP~~R 391 (446)
T 4ejn_A 372 ------------------------------------------------------------LGPEAKSLLSGLLKKDPKQR 391 (446)
T ss_dssp ------------------------------------------------------------SCHHHHHHHHHHTCSSTTTS
T ss_pred ------------------------------------------------------------CCHHHHHHHHHHcccCHHHh
Confidence 01257899999999999999
Q ss_pred C-----CHHHHhcCCCcCcCCC
Q psy11727 419 I-----SPTNVLRHEFFLKHSV 435 (437)
Q Consensus 419 ~-----t~~e~l~Hp~~~~~~~ 435 (437)
| |++|+++||||++..+
T Consensus 392 ~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 392 LGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp TTCSTTTHHHHHTSGGGTTCCH
T ss_pred CCCCCCCHHHHHhCccccCCCH
Confidence 9 9999999999998653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=375.96 Aligned_cols=258 Identities=30% Similarity=0.413 Sum_probs=189.3
Q ss_pred eeccCeeee---ceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 107 KFLDRYEID---TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 107 ~~~~~y~i~---~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.|.++|++. +.||+|+||+||+|.+..+++.||||++... .......|+.+++.+. .||||+++++++.+.
T Consensus 5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~----~h~niv~~~~~~~~~ 78 (325)
T 3kn6_A 5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCE----GHPNIVKLHEVFHDQ 78 (325)
T ss_dssp HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTT----TCTTBCCEEEEEECS
T ss_pred cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhc----CCCCeeEEEEEEEcC
Confidence 345678885 7899999999999999999999999999643 3356677888888774 589999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC-CCCEEEEeCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK-RSAIKIIDFG 261 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~-~~~ikL~DFG 261 (437)
++.|+||||+.+ +|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ ...+||+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV--GVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred CEEEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 999999999965 899988775 3599999999999999999999964 899999999999995432 2379999999
Q ss_pred CceecCC---ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHHhCC
Q psy11727 262 SSCHVGQ---TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEV-------DQMTKIIEVLGM 331 (437)
Q Consensus 262 ~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~~ 331 (437)
++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.. +.+..+......
T Consensus 155 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~ 234 (325)
T 3kn6_A 155 FARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234 (325)
T ss_dssp TCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC
T ss_pred cceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC
Confidence 9976533 234567899999999999999999999999999999999999999875432 223322211110
Q ss_pred CChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 332 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
++...+ ......+.+||.+||
T Consensus 235 ~~~~~~-----------------------------------------------------------~~~s~~~~~li~~~L 255 (325)
T 3kn6_A 235 FEGEAW-----------------------------------------------------------KNVSQEAKDLIQGLL 255 (325)
T ss_dssp CCSHHH-----------------------------------------------------------HTSCHHHHHHHHHHH
T ss_pred CCcccc-----------------------------------------------------------cCCCHHHHHHHHHHC
Confidence 000000 001126789999999
Q ss_pred ccCCCCCCCHHHHhcCCCcCcC
Q psy11727 412 TYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 412 ~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
+.||.+|||++|+++||||++.
T Consensus 256 ~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 256 TVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CCCTTTCCCTTTSTTCGGGCTT
T ss_pred CCChhHCCCHHHHhcChhhccC
Confidence 9999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=376.61 Aligned_cols=281 Identities=29% Similarity=0.530 Sum_probs=222.4
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+.++|.+.+.||+|+||+||+|.+..+|+.||||++..... ....+.+|+.++..+ .||||+++++++...
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~ 95 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-----QHENVIGLLDVFTPA 95 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSC
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-----CCCCcccHhheEecc
Confidence 346789999999999999999999999999999999964321 234556677777766 689999999999876
Q ss_pred CE------EEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 184 NH------LCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 184 ~~------~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
+. +|+||||++++|.+++.. .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||
T Consensus 96 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~--~ivH~dlkp~NIl~--~~~~~~kl 167 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQTDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA--GVVHRDLKPGNLAV--NEDCELKI 167 (353)
T ss_dssp SSGGGCCCCEEEEECCSEEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCCGGGEEE--CTTCCEEE
T ss_pred cccccceeEEEEeccccCCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEeE--CCCCcEEE
Confidence 53 599999999888876632 489999999999999999999964 89999999999999 67889999
Q ss_pred EeCCCceecCCccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 258 IDFGSSCHVGQTLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 258 ~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
+|||++...........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.|+..+
T Consensus 168 ~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 168 LDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp CSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred eecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999999887766667789999999999987 6789999999999999999999999999999999999999999999887
Q ss_pred hccCCccc--hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 337 LHGASKTS--KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 337 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
........ .++..++.. .+.............+.+||.+||+.|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~~~~~~li~~~L~~d 293 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQT----------------------------------PRKDFTQLFPRASPQAADLLEKMLELD 293 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBC----------------------------------SSCCTTTTCTTSCHHHHHHHHHHSCSC
T ss_pred HHHHhhHHHHHHHHhCcCC----------------------------------CCccHHHhcCCcCHHHHHHHHHHcCCC
Confidence 76544321 111111100 000000000111236899999999999
Q ss_pred CCCCCCHHHHhcCCCcCcCC
Q psy11727 415 PKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~~~~~ 434 (437)
|.+|||+.|+|+||||+...
T Consensus 294 p~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 294 VDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp TTTSCCHHHHHTSGGGTTTC
T ss_pred cccCCCHHHHhcCcchhhcc
Confidence 99999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=377.82 Aligned_cols=263 Identities=26% Similarity=0.395 Sum_probs=211.3
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC------cccchHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK------KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~------~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++... ......+..|+.++..+ .||||+++++++
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~ 97 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-----HHPNIARLYEVY 97 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-----CCTTBCCEEEEE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-----CCCCcceeehhh
Confidence 4568899999999999999999999999999999998642 22335677788888887 689999999999
Q ss_pred eECCEEEEEEEeccC-cHHHHHHhcC--------------------------------------CCCCCHHHHHHHHHHH
Q psy11727 181 TWKNHLCLVFELLSY-NLYNLIRNTN--------------------------------------FHGVSLNLTKKFAQQL 221 (437)
Q Consensus 181 ~~~~~~~lV~E~~~~-~L~~~l~~~~--------------------------------------~~~ls~~~~~~i~~qi 221 (437)
.+.+..++||||+++ +|.+++.... ...+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 999999999999954 8888874210 1124678889999999
Q ss_pred HHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC-------ccccccccccccChhhhcC--CCCCC
Q psy11727 222 CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ-------TLYQYIQSRYYRSPEVLLG--IPYDL 292 (437)
Q Consensus 222 ~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~-------~~~~~~gt~~y~aPE~~~~--~~~~~ 292 (437)
+.||+|||++ ||+||||||+|||++.+..+.+||+|||++..... ......||+.|+|||++.+ ..++.
T Consensus 178 ~~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 178 FSALHYLHNQ--GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHHHT--TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHHHC--CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 9999999964 89999999999999554445899999999976532 1235678999999999975 67899
Q ss_pred cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCC
Q psy11727 293 AIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSK 372 (437)
Q Consensus 293 ~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (437)
++|||||||++|+|++|++||.+.+..+....+......++.....
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------------- 301 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYN---------------------------------- 301 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGG----------------------------------
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccc----------------------------------
Confidence 9999999999999999999999998888877776532211110000
Q ss_pred chhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 373 RLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
.....+.+||.+||+.||.+|||+.|+|+||||++..+
T Consensus 302 -------------------------~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 302 -------------------------VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp -------------------------GSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred -------------------------cCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 00125789999999999999999999999999998765
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=407.59 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=215.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||+||+|.+..+++.||||+++... ........|..++..+. .|++|++++++|++.+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~----~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG----KPPFLTQLHSCFQTMD 415 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTT----CCTTBCCEEEECBCSS
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhcc----CCCeEEEEEEEEEeCC
Confidence 578999999999999999999999999999999997421 22334455665555443 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+||||||+.| +|.+++.... .+++..++.++.||+.||+|||++ |||||||||+|||| +.++.+||+|||+|
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~--gIiHrDLKp~NILl--~~~g~ikL~DFGla 489 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK--GIIYRDLKLDNVML--DSEGHIKIADFGMC 489 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT--SEECCCCCSTTEEE--CSSSCEEECCCTTC
T ss_pred EEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CeEeccCChhhEEE--cCCCcEEEeeccee
Confidence 99999999965 8999888753 589999999999999999999964 89999999999999 77889999999999
Q ss_pred eec---CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 264 CHV---GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 264 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
... +....+.+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..++++.|.......|..
T Consensus 490 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~----- 564 (674)
T 3pfq_A 490 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----- 564 (674)
T ss_dssp EECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTT-----
T ss_pred eccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCcc-----
Confidence 763 233456789999999999999999999999999999999999999999999988888886522111100
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
....+.+||++||+.||.+||+
T Consensus 565 ----------------------------------------------------------~s~~~~~li~~lL~~dP~~R~~ 586 (674)
T 3pfq_A 565 ----------------------------------------------------------MSKEAVAICKGLMTKHPGKRLG 586 (674)
T ss_dssp ----------------------------------------------------------SCHHHHHHHHHHSCSSSTTCTT
T ss_pred ----------------------------------------------------------CCHHHHHHHHHHccCCHHHCCC
Confidence 0115789999999999999999
Q ss_pred H-----HHHhcCCCcCcCCCC
Q psy11727 421 P-----TNVLRHEFFLKHSVD 436 (437)
Q Consensus 421 ~-----~e~l~Hp~~~~~~~~ 436 (437)
+ +|+++||||+..+++
T Consensus 587 ~~~~~~~ei~~h~ff~~i~w~ 607 (674)
T 3pfq_A 587 CGPEGERDIKEHAFFRYIDWE 607 (674)
T ss_dssp CSTTHHHHHHSSGGGSSCCHH
T ss_pred CCCCcHHHHhcCccccCCCHH
Confidence 7 999999999987653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=368.85 Aligned_cols=252 Identities=28% Similarity=0.423 Sum_probs=202.0
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---------------------------cchHHHHHHHHH
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---------------------------FLNQAQIEVQLL 160 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---------------------------~~~~~~~e~~~~ 160 (437)
..++|++.+.||+|+||+||+|.+..+++.||||++..... ....+..|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 36789999999999999999999999999999999974421 124566788888
Q ss_pred HHhhhcCCCCCcEEEecceeeE--CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeee
Q psy11727 161 EKINKADIHSRYIVKLKGHFTW--KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIH 237 (437)
Q Consensus 161 ~~l~~~~~~h~~iv~l~~~~~~--~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiH 237 (437)
+.+ .||||+++++++.+ .+++++||||+++ +|.+++. ...+++..++.++.||+.||+|||++ ||+|
T Consensus 91 ~~l-----~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH 160 (298)
T 2zv2_A 91 KKL-----DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQ--KIIH 160 (298)
T ss_dssp HTC-----CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHT--TEEC
T ss_pred HhC-----CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC--Ceec
Confidence 776 68999999999987 5799999999965 6665432 24589999999999999999999964 8999
Q ss_pred CCCCCCcEEEecCCCCCEEEEeCCCceecCCc---cccccccccccChhhhcCCC---CCCcchHHHHHHHHHHHHhCCC
Q psy11727 238 CDLKPENILLCSPKRSAIKIIDFGSSCHVGQT---LYQYIQSRYYRSPEVLLGIP---YDLAIDMWSLGCILVELHTGEP 311 (437)
Q Consensus 238 rDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~---~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~elltg~~ 311 (437)
|||||+|||+ +.++.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|++
T Consensus 161 ~Dlkp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 161 RDIKPSNLLV--GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp CCCCGGGEEE--CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCHHHEEE--CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 9999999999 67889999999999876432 23567899999999998765 3778999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCC
Q psy11727 312 LFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRN 391 (437)
Q Consensus 312 pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (437)
||.+.+.......+.......+. ..
T Consensus 239 pf~~~~~~~~~~~~~~~~~~~~~------------------------------------~~------------------- 263 (298)
T 2zv2_A 239 PFMDERIMCLHSKIKSQALEFPD------------------------------------QP------------------- 263 (298)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCCS------------------------------------SS-------------------
T ss_pred CCCCccHHHHHHHHhcccCCCCC------------------------------------cc-------------------
Confidence 99988776655554331110000 00
Q ss_pred CCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCc
Q psy11727 392 EPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432 (437)
Q Consensus 392 ~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~ 432 (437)
.....+.+||.+||+.||.+|||+.|+++||||++
T Consensus 264 ------~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 264 ------DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp ------CCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred ------ccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 00125789999999999999999999999999974
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=360.55 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=216.3
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
.+.++|.+.+.||+|+||+||+|.+..++..||+|++.... .....+..|+.+++.+ .||||+++++++.+.+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-----DHPNIIRLYETFEDNTD 80 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-----CCCCEeeEEEEEecCCe
Confidence 45678999999999999999999999999999999987432 2345677788888776 68999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec-CCCCCEEEEeCCCc
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS-PKRSAIKIIDFGSS 263 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~-~~~~~ikL~DFG~s 263 (437)
.++||||+++ +|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+|||+.. +.++.+||+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 9999999965 8988887653 489999999999999999999964 8999999999999943 34678999999999
Q ss_pred eecCC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 264 CHVGQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 264 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
..... ......||+.|+|||++.+. ++.++||||||+++|+|++|.+||.+.+..+....+......++.......
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (277)
T 3f3z_A 157 ARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNV- 234 (277)
T ss_dssp EECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTS-
T ss_pred eeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcC-
Confidence 76543 33456789999999998764 899999999999999999999999999888887777664433333221110
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
...+.+||.+||+.||.+|||+
T Consensus 235 ----------------------------------------------------------~~~~~~li~~~l~~dp~~R~s~ 256 (277)
T 3f3z_A 235 ----------------------------------------------------------SPQAESLIRRLLTKSPKQRITS 256 (277)
T ss_dssp ----------------------------------------------------------CHHHHHHHHHHTCSSTTTSCCH
T ss_pred ----------------------------------------------------------CHHHHHHHHHHccCChhhCcCH
Confidence 0157899999999999999999
Q ss_pred HHHhcCCCcCcC
Q psy11727 422 TNVLRHEFFLKH 433 (437)
Q Consensus 422 ~e~l~Hp~~~~~ 433 (437)
.++|+||||++.
T Consensus 257 ~~~l~h~~~~~~ 268 (277)
T 3f3z_A 257 LQALEHEWFEKQ 268 (277)
T ss_dssp HHHTTSHHHHHH
T ss_pred HHHhcCHHHhcc
Confidence 999999999763
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=395.21 Aligned_cols=265 Identities=35% Similarity=0.483 Sum_probs=218.2
Q ss_pred eeecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEe
Q psy11727 101 IIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKL 176 (437)
Q Consensus 101 ~~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l 176 (437)
+...+..+.++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.++..+ .||||+++
T Consensus 17 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~ 91 (484)
T 3nyv_A 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-----DHPNIMKL 91 (484)
T ss_dssp --CCCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-----CCTTBCCE
T ss_pred eccCCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-----CCCCCCcE
Confidence 33445667889999999999999999999999999999999996432 2234566788877665 78999999
Q ss_pred cceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec-CCCCC
Q psy11727 177 KGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS-PKRSA 254 (437)
Q Consensus 177 ~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~-~~~~~ 254 (437)
+++|.+.+.+++||||+.+ +|.+.+.... .+++..++.++.||+.||+|||++ ||+||||||+|||+.. +.++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~ 167 (484)
T 3nyv_A 92 YEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN--KIVHRDLKPENLLLESKSKDAN 167 (484)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSTTCC
T ss_pred EEEEEeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEEecCCCCCc
Confidence 9999999999999999954 8999887653 589999999999999999999964 8999999999999953 24678
Q ss_pred EEEEeCCCceecCC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy11727 255 IKIIDFGSSCHVGQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332 (437)
Q Consensus 255 ikL~DFG~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p 332 (437)
+||+|||++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......+
T Consensus 168 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 246 (484)
T 3nyv_A 168 IRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF 246 (484)
T ss_dssp EEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred EEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999999976543 3345689999999999987 69999999999999999999999999999888888776532211
Q ss_pred ChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc
Q psy11727 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412 (437)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 412 (437)
+...+. .....+.+||.+||+
T Consensus 247 ~~~~~~-----------------------------------------------------------~~s~~~~~li~~~L~ 267 (484)
T 3nyv_A 247 ELPQWK-----------------------------------------------------------KVSESAKDLIRKMLT 267 (484)
T ss_dssp CSGGGG-----------------------------------------------------------GSCHHHHHHHHHHTC
T ss_pred CCcccc-----------------------------------------------------------cCCHHHHHHHHHHCC
Confidence 100000 001257899999999
Q ss_pred cCCCCCCCHHHHhcCCCcCcCC
Q psy11727 413 YDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 413 ~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
+||.+|||+.|+|+||||++..
T Consensus 268 ~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 268 YVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp SSGGGSCCHHHHHTSHHHHHHT
T ss_pred CChhHCcCHHHHhhChhhcccc
Confidence 9999999999999999998644
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=392.20 Aligned_cols=265 Identities=30% Similarity=0.427 Sum_probs=215.1
Q ss_pred cceeecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEE
Q psy11727 99 DYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVK 175 (437)
Q Consensus 99 ~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~ 175 (437)
.++......+.++|++.+.||+|+||+||+|.+..++..||+|++.... .....+.+|+.++..+ .|||||+
T Consensus 26 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~ 100 (494)
T 3lij_A 26 MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-----DHPNIMK 100 (494)
T ss_dssp GGCCCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-----CCTTBCC
T ss_pred heeecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-----CCCCCCe
Confidence 4455555667889999999999999999999999999999999997532 2245566788877665 7899999
Q ss_pred ecceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC-CCC
Q psy11727 176 LKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP-KRS 253 (437)
Q Consensus 176 l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~-~~~ 253 (437)
++++|.+.+.+|+||||+.+ +|.+.+.... .+++..++.++.||+.||+|||++ ||+||||||+|||++.. ..+
T Consensus 101 ~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~ 176 (494)
T 3lij_A 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKH--NIVHRDLKPENLLLESKEKDA 176 (494)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSTTC
T ss_pred EEEEEEeCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CceeccCChhhEEEeCCCCCC
Confidence 99999999999999999965 8988887653 589999999999999999999964 89999999999999542 245
Q ss_pred CEEEEeCCCceecCC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy11727 254 AIKIIDFGSSCHVGQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331 (437)
Q Consensus 254 ~ikL~DFG~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 331 (437)
.+||+|||+|..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus 177 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 255 (494)
T 3lij_A 177 LIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT 255 (494)
T ss_dssp CEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred cEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 699999999976643 3345689999999999864 6999999999999999999999999999988888877664322
Q ss_pred CChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 332 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
++...+.. ....+.+||.+||
T Consensus 256 ~~~~~~~~-----------------------------------------------------------~s~~~~~li~~~L 276 (494)
T 3lij_A 256 FDSPEWKN-----------------------------------------------------------VSEGAKDLIKQML 276 (494)
T ss_dssp CCSGGGTT-----------------------------------------------------------SCHHHHHHHHHHT
T ss_pred CCchhccc-----------------------------------------------------------CCHHHHHHHHHHC
Confidence 21111100 0015789999999
Q ss_pred ccCCCCCCCHHHHhcCCCcCc
Q psy11727 412 TYDPKKRISPTNVLRHEFFLK 432 (437)
Q Consensus 412 ~~dP~~R~t~~e~l~Hp~~~~ 432 (437)
++||.+|||+.|+|+||||++
T Consensus 277 ~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 277 QFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp CSSTTTSCCHHHHHTCHHHHH
T ss_pred CCChhhCccHHHHhcCccccc
Confidence 999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=371.30 Aligned_cols=284 Identities=28% Similarity=0.483 Sum_probs=221.1
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
..+.++|.+.+.||+|+||+||+|.+..+|+.||||++.... .....+.+|+.++..+ .||||+++++++...
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~ 81 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-----KHENIITIFNIQRPD 81 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEECCCS
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-----cCCCcCCeeeeeccc
Confidence 345789999999999999999999999999999999996432 2234456788888776 689999999987754
Q ss_pred -----CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 184 -----NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 184 -----~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
...++|||+++++|.+++... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+
T Consensus 82 ~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~--~ivH~Dlkp~Nil~--~~~~~~kl~ 154 (353)
T 2b9h_A 82 SFENFNEVYIIQELMQTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGS--NVIHRDLKPSNLLI--NSNCDLKVC 154 (353)
T ss_dssp CSTTCCCEEEEECCCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEE--CTTCCEEEC
T ss_pred ccCccceEEEEEeccCccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEE--cCCCcEEEE
Confidence 689999999999999988764 489999999999999999999964 89999999999999 678889999
Q ss_pred eCCCceecCCc-------------cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy11727 259 DFGSSCHVGQT-------------LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTK 324 (437)
Q Consensus 259 DFG~s~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~ 324 (437)
|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 234 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 99999765422 123578999999998765 6789999999999999999999999999999999999
Q ss_pred HHHHhCCCChhhhccCCcc---chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhh
Q psy11727 325 IIEVLGMPPGYLLHGASKT---SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYM 401 (437)
Q Consensus 325 i~~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (437)
+....+.|+.......... ..+...++. .+ ...+.... .....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~-~~~~~~~~------------------~~~~~ 280 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPM---------------YP-AAPLEKMF------------------PRVNP 280 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCC---------------CC-CCCHHHHS------------------TTSCH
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccC---------------CC-Ccchhhhc------------------ccCCH
Confidence 9888887763322111110 011110000 00 00000000 01112
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 402 KFKDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 402 ~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
.+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 281 KGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 6789999999999999999999999999988654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=390.36 Aligned_cols=255 Identities=28% Similarity=0.428 Sum_probs=213.7
Q ss_pred CceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 105 ~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
+....++|.+.+.||+|+||+||+|.+..+|+.||||++.... .....+.+|+.+++.+ .||||+++++++
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~l~~~~ 85 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-----RHPHIIKLYQVI 85 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-----CCTTBCCEEEEE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEE
Confidence 4455789999999999999999999999999999999996432 1234566677777655 789999999999
Q ss_pred eECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 181 TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 181 ~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
.+.+.+|+||||+++ +|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|
T Consensus 86 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDLkp~NIll--~~~~~vkL~D 159 (476)
T 2y94_A 86 STPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRH--MVVHRDLKPENVLL--DAHMNAKIAD 159 (476)
T ss_dssp ECSSEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTT--TEECSCCSGGGEEE--CTTCCEEECC
T ss_pred EECCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CCCcccccHHHEEE--ecCCCeEEEe
Confidence 999999999999955 899988754 3599999999999999999999964 89999999999999 6788999999
Q ss_pred CCCceecCC--ccccccccccccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 260 FGSSCHVGQ--TLYQYIQSRYYRSPEVLLGIPY-DLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 260 FG~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
||++..... ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+.......+.......|..
T Consensus 160 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~- 238 (476)
T 2y94_A 160 FGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY- 238 (476)
T ss_dssp CSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTT-
T ss_pred ccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCcc-
Confidence 999987643 2346789999999999998776 689999999999999999999999988777777665422111100
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
....+.+||.+||+.||.
T Consensus 239 --------------------------------------------------------------~s~~~~~Li~~~L~~dP~ 256 (476)
T 2y94_A 239 --------------------------------------------------------------LNPSVISLLKHMLQVDPM 256 (476)
T ss_dssp --------------------------------------------------------------CCHHHHHHHHHHTCSSTT
T ss_pred --------------------------------------------------------------CCHHHHHHHHHHcCCCch
Confidence 001578999999999999
Q ss_pred CCCCHHHHhcCCCcCcC
Q psy11727 417 KRISPTNVLRHEFFLKH 433 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~~~~ 433 (437)
+|||++|+++||||++.
T Consensus 257 ~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 257 KRATIKDIREHEWFKQD 273 (476)
T ss_dssp TSCCHHHHHTCHHHHTT
T ss_pred hCcCHHHHHhCHHhhhc
Confidence 99999999999999763
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=391.23 Aligned_cols=260 Identities=36% Similarity=0.492 Sum_probs=215.2
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC---cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK---KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+.++|++.+.||+|+||+||+|.+..+++.||||++... ......+.+|+.++..+ .||||+++++++.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-----DHPNIMKLFEILEDS 93 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECS
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-----CCCCcCeEEEEEEcC
Confidence 4578999999999999999999999999999999998632 22345677899888887 689999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC-CCCCEEEEeCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP-KRSAIKIIDFG 261 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~-~~~~ikL~DFG 261 (437)
+.+++||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++ ||+||||||+|||++.. .++.+||+|||
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 169 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFG 169 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCchHHEEEecCCCCCCEEEEECC
Confidence 999999999965 8988887653 589999999999999999999964 89999999999999542 35679999999
Q ss_pred CceecCC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhcc
Q psy11727 262 SSCHVGQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 262 ~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 339 (437)
++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......++...+
T Consensus 170 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-- 246 (486)
T 3mwu_A 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW-- 246 (486)
T ss_dssp CTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGG--
T ss_pred cCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccc--
Confidence 9976533 2345689999999999986 5999999999999999999999999999988888877653221111000
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
.. ....+.+||.+||+.||.+||
T Consensus 247 --------~~-------------------------------------------------~s~~~~~li~~~L~~dp~~R~ 269 (486)
T 3mwu_A 247 --------RT-------------------------------------------------ISDDAKDLIRKMLTFHPSLRI 269 (486)
T ss_dssp --------GG-------------------------------------------------SCHHHHHHHHHHTCSSTTTSC
T ss_pred --------CC-------------------------------------------------CCHHHHHHHHHHcCCChhhCc
Confidence 00 011578999999999999999
Q ss_pred CHHHHhcCCCcCcCCC
Q psy11727 420 SPTNVLRHEFFLKHSV 435 (437)
Q Consensus 420 t~~e~l~Hp~~~~~~~ 435 (437)
|+.|+|+||||++...
T Consensus 270 t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 270 TATQCLEHPWIQKYSS 285 (486)
T ss_dssp CHHHHHHCHHHHHTCC
T ss_pred CHHHHhcCHhhccCcc
Confidence 9999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=370.17 Aligned_cols=283 Identities=30% Similarity=0.492 Sum_probs=216.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc---chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF---LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ...+..|+.++..+ .||||+++++++.+.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-----RHENLVNLLEVCKKKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-----CCCCEeeEEEEeecCCE
Confidence 57899999999999999999999999999999998644321 23355677777776 68999999999999999
Q ss_pred EEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 186 LCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 186 ~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
.++||||+++++.+.+.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++..
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSH--NIIHRDIKPENILV--SQSGVVKLCDFGFART 173 (331)
T ss_dssp EEEEEECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEE--CTTSCEEECCCTTC--
T ss_pred EEEEEecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC--CEEccCcChheEEE--cCCCcEEEEeCCCcee
Confidence 99999999886555443332 4599999999999999999999964 89999999999999 6788999999999976
Q ss_pred cCC---ccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 266 VGQ---TLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 266 ~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+....+.++........
T Consensus 174 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 174 LAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred ecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence 533 23346789999999999875 78999999999999999999999999999999999998888876654432111
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
.... +.. ...|.......... ........+.+||.+||+.||.+|||+
T Consensus 254 ~~~~-~~~----------------~~~~~~~~~~~~~~---------------~~~~~~~~l~~li~~~L~~dP~~Rpt~ 301 (331)
T 4aaa_A 254 KNPV-FAG----------------VRLPEIKEREPLER---------------RYPKLSEVVIDLAKKCLHIDPDKRPFC 301 (331)
T ss_dssp HCGG-GTT----------------CCCCCCSSCCCHHH---------------HSTTSCHHHHHHHHHHTCSSGGGSCCG
T ss_pred hccc-ccc----------------ccCccccccchhhh---------------cccchhHHHHHHHHHHhccCcccCCCH
Confidence 1100 000 00000000000000 000112368999999999999999999
Q ss_pred HHHhcCCCcCcC
Q psy11727 422 TNVLRHEFFLKH 433 (437)
Q Consensus 422 ~e~l~Hp~~~~~ 433 (437)
.|+|+||||+..
T Consensus 302 ~ell~hp~f~~~ 313 (331)
T 4aaa_A 302 AELLHHDFFQMD 313 (331)
T ss_dssp GGGGGSHHHHGG
T ss_pred HHHhcCchhccC
Confidence 999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=361.82 Aligned_cols=253 Identities=29% Similarity=0.450 Sum_probs=208.8
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
..++|++.+.||+|+||+||+|.+..++..||+|++.... .....+..|+.++..+ .||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~ 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-----RHPNILRLYGYFHDA 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECS
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-----CCCCCcchhheEecC
Confidence 3678999999999999999999999999999999986321 1223455566666554 689999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+..++||||+++ +|.+++.... .+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~dlkp~Nili--~~~~~~~l~Dfg~ 155 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLL--GSAGELKIADFGW 155 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT--TTCEECCCCGGGEEE--CTTSCEEECSCCE
T ss_pred CEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHhEEE--cCCCCEEEEeccc
Confidence 999999999975 8888887653 58999999999999999999995 489999999999999 6788999999999
Q ss_pred ceecCCc-cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 263 SCHVGQT-LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 263 s~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
+...... .....|++.|+|||++.+..++.++||||||+++|+|++|.+||.+.+..+....+.......|..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 229 (279)
T 3fdn_A 156 SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF------ 229 (279)
T ss_dssp ESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTT------
T ss_pred cccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCc------
Confidence 8655332 345678999999999999999999999999999999999999999988877777665422111100
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
....+.+||.+||+.||.+|||+
T Consensus 230 ---------------------------------------------------------~~~~~~~li~~~l~~~p~~Rps~ 252 (279)
T 3fdn_A 230 ---------------------------------------------------------VTEGARDLISRLLKHNPSQRPML 252 (279)
T ss_dssp ---------------------------------------------------------SCHHHHHHHHHHCCSSGGGSCCH
T ss_pred ---------------------------------------------------------CCHHHHHHHHHHhccChhhCCCH
Confidence 01157899999999999999999
Q ss_pred HHHhcCCCcCcCC
Q psy11727 422 TNVLRHEFFLKHS 434 (437)
Q Consensus 422 ~e~l~Hp~~~~~~ 434 (437)
+|+++||||+...
T Consensus 253 ~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 253 REVLEHPWITANS 265 (279)
T ss_dssp HHHHHCHHHHHHC
T ss_pred HHHhhCccccCCc
Confidence 9999999998754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=371.90 Aligned_cols=258 Identities=28% Similarity=0.476 Sum_probs=213.6
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc---------chHHHHHHHHHHHhhhcCCCCCcEEEe
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF---------LNQAQIEVQLLEKINKADIHSRYIVKL 176 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~---------~~~~~~e~~~~~~l~~~~~~h~~iv~l 176 (437)
..+.++|.+.+.||+|+||+||+|.+..+|+.||||++...... ...+..|+.++..+. .||||+++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~ 165 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA----GHPHIITL 165 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT----TCTTBCCE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc----CCCCEeEE
Confidence 44567899999999999999999999999999999999754311 234566777777763 68999999
Q ss_pred cceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCE
Q psy11727 177 KGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAI 255 (437)
Q Consensus 177 ~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~i 255 (437)
++++...+..++||||+.| +|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~--gi~H~Dlkp~NIl~--~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN--NIVHRDLKPENILL--DDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE--CTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEE--CCCCCE
Confidence 9999999999999999966 899988765 3589999999999999999999964 89999999999999 678899
Q ss_pred EEEeCCCceecCC--ccccccccccccChhhhcC------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q psy11727 256 KIIDFGSSCHVGQ--TLYQYIQSRYYRSPEVLLG------IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327 (437)
Q Consensus 256 kL~DFG~s~~~~~--~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 327 (437)
||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+..
T Consensus 240 kl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~ 319 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319 (365)
T ss_dssp EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 9999999987643 3345689999999999863 3588999999999999999999999999888777776655
Q ss_pred HhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHH
Q psy11727 328 VLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLI 407 (437)
Q Consensus 328 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 407 (437)
....++...+.. ....+.+||
T Consensus 320 ~~~~~~~~~~~~-----------------------------------------------------------~~~~~~~li 340 (365)
T 2y7j_A 320 GQYQFSSPEWDD-----------------------------------------------------------RSSTVKDLI 340 (365)
T ss_dssp TCCCCCHHHHSS-----------------------------------------------------------SCHHHHHHH
T ss_pred CCCCCCCccccc-----------------------------------------------------------CCHHHHHHH
Confidence 322222111100 001578999
Q ss_pred HHccccCCCCCCCHHHHhcCCCcCc
Q psy11727 408 LRMLTYDPKKRISPTNVLRHEFFLK 432 (437)
Q Consensus 408 ~~~L~~dP~~R~t~~e~l~Hp~~~~ 432 (437)
.+||+.||.+|||+.|+|+||||++
T Consensus 341 ~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 341 SRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHcCCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=364.98 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=208.5
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
.|...+.||+|+||+||+|.+..+|+.||||++..... ....+..|+.++..+ .|+||+++++++...+..++|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-----QHFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-----CCCCcceEEEEEEECCEEEEE
Confidence 47788899999999999999999999999999975432 234466677776655 789999999999999999999
Q ss_pred EEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 190 FELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 190 ~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
|||+++ +|.+++... .+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++.....
T Consensus 121 ~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll--~~~~~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 121 MEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQ--GVIHRDIKSDSILL--TLDGRVKLSDFGFCAQISK 193 (321)
T ss_dssp ECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEE--CTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEE--CCCCcEEEeeeeeeeeccc
Confidence 999965 788877643 489999999999999999999964 89999999999999 6788899999999977643
Q ss_pred c---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccch
Q psy11727 269 T---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSK 345 (437)
Q Consensus 269 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 345 (437)
. .....||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+.... ++....
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~-------- 263 (321)
T 2c30_A 194 DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP--PPKLKN-------- 263 (321)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS--CCCCTT--------
T ss_pred CccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCcCc--------
Confidence 2 345679999999999999999999999999999999999999999988777666554311 110000
Q ss_pred hhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHh
Q psy11727 346 YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVL 425 (437)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l 425 (437)
.......+.+||.+||+.||.+|||++|++
T Consensus 264 --------------------------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell 293 (321)
T 2c30_A 264 --------------------------------------------------SHKVSPVLRDFLERMLVRDPQERATAQELL 293 (321)
T ss_dssp --------------------------------------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred --------------------------------------------------cccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 000012578999999999999999999999
Q ss_pred cCCCcCcCC
Q psy11727 426 RHEFFLKHS 434 (437)
Q Consensus 426 ~Hp~~~~~~ 434 (437)
+||||++..
T Consensus 294 ~hp~~~~~~ 302 (321)
T 2c30_A 294 DHPFLLQTG 302 (321)
T ss_dssp TSGGGGGCC
T ss_pred cChhhccCC
Confidence 999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=394.88 Aligned_cols=257 Identities=30% Similarity=0.454 Sum_probs=212.3
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.... .....+..|+.+++.+ .|||||+++++|.+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~~~~~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-----NSRFVVSLAYAYET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-----CCCCEeeEEEEEee
Confidence 34578999999999999999999999999999999996421 2234456788888776 68999999999999
Q ss_pred CCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
.+.+|+||||+. |+|.+++.......+++..++.++.||+.||+|||++ |||||||||+|||+ +.++.+||+|||
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~--gIvHrDLKPeNILl--d~~g~vKL~DFG 331 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE--RIVYRDLKPENILL--DDHGHIRISDLG 331 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEE--CTTSCEEECCCT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CEeccCCchheEEE--eCCCCeEEEecc
Confidence 999999999995 5899988876655699999999999999999999964 89999999999999 778899999999
Q ss_pred CceecCC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCChh
Q psy11727 262 SSCHVGQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNE----VDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 262 ~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~----~~~~~~i~~~~~~p~~~ 335 (437)
++..... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+. ......+... +..
T Consensus 332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~---~~~- 407 (576)
T 2acx_A 332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV---PEE- 407 (576)
T ss_dssp TCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC---CCC-
T ss_pred cceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc---ccc-
Confidence 9987643 33457899999999999999999999999999999999999999987642 2233332211 000
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
.| ......+.+||.+||+.||
T Consensus 408 --------------------------------~p---------------------------~~~s~~~~dLI~~lL~~dP 428 (576)
T 2acx_A 408 --------------------------------YS---------------------------ERFSPQARSLCSQLLCKDP 428 (576)
T ss_dssp --------------------------------CC---------------------------TTSCHHHHHHHHHHTCSSG
T ss_pred --------------------------------CC---------------------------ccCCHHHHHHHHHhccCCH
Confidence 00 0001257899999999999
Q ss_pred CCCC-----CHHHHhcCCCcCcCCC
Q psy11727 416 KKRI-----SPTNVLRHEFFLKHSV 435 (437)
Q Consensus 416 ~~R~-----t~~e~l~Hp~~~~~~~ 435 (437)
.+|| |++|+++||||++.++
T Consensus 429 ~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 429 AERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp GGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred HHcCCCCCCCHHHHHhChhhccCCH
Confidence 9999 8999999999998654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=358.03 Aligned_cols=262 Identities=29% Similarity=0.436 Sum_probs=214.3
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----------ccchHHHHHHHHHHHhhhcCCCCCcEEE
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----------PFLNQAQIEVQLLEKINKADIHSRYIVK 175 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----------~~~~~~~~e~~~~~~l~~~~~~h~~iv~ 175 (437)
..+.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+..|+.++..+. .||||++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~ 88 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS----GHPNIIQ 88 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT----TCTTBCC
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhc----CCCCEee
Confidence 345789999999999999999999999999999999997432 11234556888887774 5899999
Q ss_pred ecceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCC
Q psy11727 176 LKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA 254 (437)
Q Consensus 176 l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ 254 (437)
+++++...+..++||||+++ +|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+||++ +.++.
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~--~~~~~ 162 (298)
T 1phk_A 89 LKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL--NIVHRDLKPENILL--DDDMN 162 (298)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE--CTTCC
T ss_pred eeeeeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCcceEEE--cCCCc
Confidence 99999999999999999964 899998765 3589999999999999999999954 89999999999999 67888
Q ss_pred EEEEeCCCceecCC--ccccccccccccChhhhc------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy11727 255 IKIIDFGSSCHVGQ--TLYQYIQSRYYRSPEVLL------GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326 (437)
Q Consensus 255 ikL~DFG~s~~~~~--~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~ 326 (437)
+||+|||++..... ......|++.|+|||++. ...++.++||||||+++|+|++|..||.+.+.......+.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 242 (298)
T 1phk_A 163 IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242 (298)
T ss_dssp EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh
Confidence 99999999977643 334567899999999985 4568899999999999999999999999988877766665
Q ss_pred HHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHH
Q psy11727 327 EVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406 (437)
Q Consensus 327 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 406 (437)
......+.... ......+.+|
T Consensus 243 ~~~~~~~~~~~-----------------------------------------------------------~~~~~~l~~l 263 (298)
T 1phk_A 243 SGNYQFGSPEW-----------------------------------------------------------DDYSDTVKDL 263 (298)
T ss_dssp HTCCCCCTTTG-----------------------------------------------------------GGSCHHHHHH
T ss_pred cCCcccCcccc-----------------------------------------------------------cccCHHHHHH
Confidence 53211110000 0001257899
Q ss_pred HHHccccCCCCCCCHHHHhcCCCcCcCCCC
Q psy11727 407 ILRMLTYDPKKRISPTNVLRHEFFLKHSVD 436 (437)
Q Consensus 407 i~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~ 436 (437)
|.+||+.||.+|||+.|+++||||++...+
T Consensus 264 i~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (298)
T 1phk_A 264 VSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293 (298)
T ss_dssp HHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred HHHHccCCcccCCCHHHHHhChHhhhccch
Confidence 999999999999999999999999987654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=360.70 Aligned_cols=259 Identities=27% Similarity=0.360 Sum_probs=206.5
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.+.++|.+.+.||+|+||+||+|.+..++..||+|++..... ....+..|+.+++.+ .||||+++++++.+.+
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~ 93 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-----DHPNIIKIFEVFEDYH 93 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSS
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-----CCchHHhHHHheecCC
Confidence 346789999999999999999999999999999999975432 235677788888776 6899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec-CCCCCEEEEeC
Q psy11727 185 HLCLVFELLSY-NLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS-PKRSAIKIIDF 260 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~-~~~~~ikL~DF 260 (437)
..++||||+++ +|.+.+... ....+++..++.++.||+.||+|||++ ||+||||||+|||+.. +.++.+||+||
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~dikp~NIl~~~~~~~~~~kl~Df 171 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ--HVVHKDLKPENILFQDTSPHSPIKIIDF 171 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC--CEEECCCCHHHEEEecCCCCCCEEEEee
Confidence 99999999965 898887543 235699999999999999999999964 8999999999999954 23577999999
Q ss_pred CCceecCC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 261 GSSCHVGQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 261 G~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
|++..... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+.......+..
T Consensus 172 g~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~--- 247 (285)
T 3is5_A 172 GLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE--- 247 (285)
T ss_dssp CCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC----
T ss_pred ecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc---
Confidence 99976533 234567899999999986 478999999999999999999999999988766655443211000000
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
. ......+.+||.+||+.||.+|
T Consensus 248 --------------------------------~-------------------------~~~~~~~~~li~~~L~~dP~~R 270 (285)
T 3is5_A 248 --------------------------------C-------------------------RPLTPQAVDLLKQMLTKDPERR 270 (285)
T ss_dssp ----------------------------------------------------------CCCCHHHHHHHHHHTCSCTTTS
T ss_pred --------------------------------c-------------------------CcCCHHHHHHHHHHccCChhhC
Confidence 0 0001257899999999999999
Q ss_pred CCHHHHhcCCCcCcC
Q psy11727 419 ISPTNVLRHEFFLKH 433 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~~ 433 (437)
||+.|+|+||||++.
T Consensus 271 ps~~e~l~hp~f~~a 285 (285)
T 3is5_A 271 PSAAQVLHHEWFKQA 285 (285)
T ss_dssp CCHHHHHTSGGGGC-
T ss_pred cCHHHHhcCHHhhcC
Confidence 999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=372.06 Aligned_cols=287 Identities=28% Similarity=0.465 Sum_probs=218.5
Q ss_pred cCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc------------chHHHHHHHHHHHhhhcCCCCC
Q psy11727 104 HGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF------------LNQAQIEVQLLEKINKADIHSR 171 (437)
Q Consensus 104 ~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~------------~~~~~~e~~~~~~l~~~~~~h~ 171 (437)
....+.++|.+.+.||+|+||.||+|.+.. +..||||++...... ...+.+|+.++..+ .||
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~ 89 (362)
T 3pg1_A 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-----HHP 89 (362)
T ss_dssp HHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-----CCT
T ss_pred HHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-----CCc
Confidence 344567899999999999999999998755 889999998632211 25667788888877 689
Q ss_pred cEEEecceeeE-----CCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEE
Q psy11727 172 YIVKLKGHFTW-----KNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENIL 246 (437)
Q Consensus 172 ~iv~l~~~~~~-----~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIl 246 (437)
||+++++++.. ...+|+||||++++|.+.+.... ..+++..++.++.||+.||.|||++ ||+||||||+|||
T Consensus 90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 90 NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEA--GVVHRDLHPGNIL 166 (362)
T ss_dssp TBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEE
T ss_pred CccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC--cCEecCCChHHEE
Confidence 99999999854 34799999999999999888654 4689999999999999999999964 8999999999999
Q ss_pred EecCCCCCEEEEeCCCceecCC--ccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy11727 247 LCSPKRSAIKIIDFGSSCHVGQ--TLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT 323 (437)
Q Consensus 247 l~~~~~~~ikL~DFG~s~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~ 323 (437)
+ +.++.+||+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+.
T Consensus 167 ~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 167 L--ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp E--CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred E--cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9 6788899999999975432 2344678999999999987 678999999999999999999999999999999999
Q ss_pred HHHHHhCCCChhhhccCCcc--chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhh
Q psy11727 324 KIIEVLGMPPGYLLHGASKT--SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYM 401 (437)
Q Consensus 324 ~i~~~~~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (437)
.+.+..+.|+.......... ..++.... ...+.. ..... ......
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~-~~~~~------------------~~~~~~ 291 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSL--------------SNVPAR-AWTAV------------------VPTADP 291 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCC--------------CCCCCC-CHHHH------------------STTSCH
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhc--------------ccCChh-hHHhh------------------CCCCCH
Confidence 99999998876654332211 11111000 000000 00000 001123
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 402 KFKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 402 ~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
.+.+||.+||++||.+|||+.|+|+||||++..
T Consensus 292 ~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 292 VALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 578999999999999999999999999999763
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=364.76 Aligned_cols=287 Identities=25% Similarity=0.441 Sum_probs=214.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE--CCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--KNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--~~~~ 186 (437)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ...+..|+.+++.+. .|+||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~----~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLR----GGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHT----TSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcC----CCCCEEEeeeeeccCCCCce
Confidence 578999999999999999999999999999999997433 467888999999985 58999999999987 6789
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++||||+.+ +|.+++. .+++..++.++.||+.||+|||++ ||+||||||+|||++. +...+||+|||++..
T Consensus 109 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dikp~Nil~~~-~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM--GIMHRDVKPHNVMIDH-EHRKLRLIDWGLAEF 180 (330)
T ss_dssp EEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEET-TTTEEEECCCTTCEE
T ss_pred EEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEEcC-CCCEEEEEeCCCceE
Confidence 999999976 6776653 278999999999999999999964 8999999999999942 333799999999976
Q ss_pred cCC--ccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChhhh-ccC
Q psy11727 266 VGQ--TLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLF-SGKNEVDQMTKIIEVLGMPPGYLL-HGA 340 (437)
Q Consensus 266 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf-~~~~~~~~~~~i~~~~~~p~~~~~-~~~ 340 (437)
... ......||..|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+.+..+...++.+...-. ...
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 181 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred cCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 533 3345678999999999987 67999999999999999999999888 556677777777776664332111 100
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
.. ... ..+.+++.......-. ..............+.+||.+||++||.+|||
T Consensus 261 ~~-------------~~~-------------~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 313 (330)
T 3nsz_A 261 NI-------------ELD-------------PRFNDILGRHSRKRWE-RFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 313 (330)
T ss_dssp TC-------------CCC-------------THHHHHHCCCCCCCGG-GGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC
T ss_pred cc-------------ccc-------------cchhhhhhhccccchh-hhccccccccCCHHHHHHHHHHhcCCcccCCC
Confidence 00 000 0000000000000000 00000001112236899999999999999999
Q ss_pred HHHHhcCCCcCcCCCC
Q psy11727 421 PTNVLRHEFFLKHSVD 436 (437)
Q Consensus 421 ~~e~l~Hp~~~~~~~~ 436 (437)
++|+|+||||++...|
T Consensus 314 a~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 314 AREAMEHPYFYTVVKD 329 (330)
T ss_dssp HHHHHTSGGGTTCC--
T ss_pred HHHHhcCccHhhhccC
Confidence 9999999999988765
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=390.11 Aligned_cols=256 Identities=28% Similarity=0.397 Sum_probs=210.9
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
-.++|.+.+.||+|+||+||+|++..+|+.||+|++.... .....+..|+.+++.+ .||||++++++|.+.
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~~~~~~~ 257 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-----HSRFIVSLAYAFETK 257 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECS
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-----CCCCEeeEEEEEeeC
Confidence 3578999999999999999999999999999999996432 2234566788888776 789999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTN--FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~--~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
+.+|+||||+.| +|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+||
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~--gIvHrDLKP~NILl--~~~g~vkL~DF 333 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR--NIIYRDLKPENVLL--DDDGNVRISDL 333 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEE--CTTSCEEECCC
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc--CCcccCCChHHEEE--eCCCCEEEeec
Confidence 999999999965 8988887643 34699999999999999999999964 89999999999999 77889999999
Q ss_pred CCceecCCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCC
Q psy11727 261 GSSCHVGQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN----EVDQMTKIIEVLGMPP 333 (437)
Q Consensus 261 G~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~----~~~~~~~i~~~~~~p~ 333 (437)
|++...... ....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+ ..+....+.......|
T Consensus 334 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p 413 (543)
T 3c4z_A 334 GLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413 (543)
T ss_dssp TTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC
T ss_pred ceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC
Confidence 999876432 234589999999999999999999999999999999999999998763 2344444433111000
Q ss_pred hhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
. .....+.+||.+||+.
T Consensus 414 ~---------------------------------------------------------------~~s~~~~~li~~lL~~ 430 (543)
T 3c4z_A 414 D---------------------------------------------------------------KFSPASKDFCEALLQK 430 (543)
T ss_dssp T---------------------------------------------------------------TSCHHHHHHHHHHSCS
T ss_pred c---------------------------------------------------------------ccCHHHHHHHHHhccC
Confidence 0 0012578999999999
Q ss_pred CCCCCCC-----HHHHhcCCCcCcCCC
Q psy11727 414 DPKKRIS-----PTNVLRHEFFLKHSV 435 (437)
Q Consensus 414 dP~~R~t-----~~e~l~Hp~~~~~~~ 435 (437)
||.+||+ ++++++||||+..++
T Consensus 431 dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 431 DPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp SGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred CHhHCCCCcccCHHHHHcCccccCCCH
Confidence 9999996 589999999998654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=362.45 Aligned_cols=261 Identities=28% Similarity=0.361 Sum_probs=214.5
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
..+.++|.+.+.||+|+||+||+|.+..+++.||+|++..... ....+.+|+.++..+ .||||+++++++.+.+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 79 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-----KHENIVTLEDIYESTT 79 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-----CCTTBCCEEEEEECSS
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-----CCCCeeehhhhcccCC
Confidence 3456789999999999999999999999999999999975432 234567788888876 6899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec-CCCCCEEEEeCCC
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS-PKRSAIKIIDFGS 262 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~-~~~~~ikL~DFG~ 262 (437)
.+++||||+++ +|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+||++.. +.++.+||+|||+
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~ 155 (304)
T 2jam_A 80 HYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHEN--GIVHRDLKPENLLYLTPEENSKIMITDFGL 155 (304)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred EEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence 99999999965 8999887653 589999999999999999999964 8999999999999943 3567899999999
Q ss_pred ceecCCc-cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 263 SCHVGQT-LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 263 s~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
+...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+.+.....+....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~---- 231 (304)
T 2jam_A 156 SKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFW---- 231 (304)
T ss_dssp TCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTT----
T ss_pred ceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcccc----
Confidence 9765433 33457899999999999999999999999999999999999999998887777776553211110000
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
. .....+.+||.+||+.||.+|||+
T Consensus 232 ------~-------------------------------------------------~~~~~~~~li~~~l~~dp~~Rps~ 256 (304)
T 2jam_A 232 ------D-------------------------------------------------DISESAKDFICHLLEKDPNERYTC 256 (304)
T ss_dssp ------T-------------------------------------------------TSCHHHHHHHHHHHCSSTTTSCCH
T ss_pred ------c-------------------------------------------------cCCHHHHHHHHHHcCCChhHCcCH
Confidence 0 001257899999999999999999
Q ss_pred HHHhcCCCcCcCC
Q psy11727 422 TNVLRHEFFLKHS 434 (437)
Q Consensus 422 ~e~l~Hp~~~~~~ 434 (437)
+|+++||||++..
T Consensus 257 ~~~l~h~~~~~~~ 269 (304)
T 2jam_A 257 EKALSHPWIDGNT 269 (304)
T ss_dssp HHHHTSHHHHSSC
T ss_pred HHHhcCccccCCC
Confidence 9999999998643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=371.20 Aligned_cols=255 Identities=25% Similarity=0.350 Sum_probs=211.7
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
..++|.+.+.||+|+||+||+|.+..+++.||||++..... ....+..|+.++..+ .||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~ 126 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-----RHPNTIQYRGCYLRE 126 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEET
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEEC
Confidence 34679999999999999999999999999999999974322 123466788888776 689999999999999
Q ss_pred CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 184 NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 184 ~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
+..++||||+.|+|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++
T Consensus 127 ~~~~lv~e~~~g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll--~~~~~~kL~DfG~a 201 (348)
T 1u5q_A 127 HTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNILL--SEPGLVKLGDFGSA 201 (348)
T ss_dssp TEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEE--ETTTEEEECCCTTC
T ss_pred CeEEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEE--CCCCCEEEeeccCc
Confidence 9999999999999999886544 4689999999999999999999964 89999999999999 56788999999999
Q ss_pred eecCCccccccccccccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 264 CHVGQTLYQYIQSRYYRSPEVLL---GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 264 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
...... ....||+.|+|||++. +..++.++|||||||++|||++|++||.+.+....+..+......+..
T Consensus 202 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 274 (348)
T 1u5q_A 202 SIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ------ 274 (348)
T ss_dssp BSSSSB-CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCC------
T ss_pred eecCCC-CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC------
Confidence 766543 4568999999999985 467899999999999999999999999988877666655432110000
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
+. .....+.+||.+||+.||.+|||
T Consensus 275 ----------------------------------------------------~~---~~~~~l~~li~~~l~~dP~~Rps 299 (348)
T 1u5q_A 275 ----------------------------------------------------SG---HWSEYFRNFVDSCLQKIPQDRPT 299 (348)
T ss_dssp ----------------------------------------------------CT---TSCHHHHHHHHHHTCSSGGGSCC
T ss_pred ----------------------------------------------------CC---CCCHHHHHHHHHHcccChhhCcC
Confidence 00 00125789999999999999999
Q ss_pred HHHHhcCCCcCcCC
Q psy11727 421 PTNVLRHEFFLKHS 434 (437)
Q Consensus 421 ~~e~l~Hp~~~~~~ 434 (437)
++++++||||.+..
T Consensus 300 ~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 300 SEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHTTCHHHHSCC
T ss_pred HHHHhhChhhhccC
Confidence 99999999997643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=365.36 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=198.3
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.+.++|++.+.||+|+||+||+|++..+++.||||+++... .....+.+|+.++..+ .||||++++++|.+.+
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-----EHPGIVRYFNAWLETP 77 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-----CCTTBCCEEEEEEECC
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEEec
Confidence 45688999999999999999999999999999999997432 2334566777777766 7899999999986543
Q ss_pred ---------------------------------------------------------EEEEEEEeccC-cHHHHHHhcCC
Q psy11727 185 ---------------------------------------------------------HLCLVFELLSY-NLYNLIRNTNF 206 (437)
Q Consensus 185 ---------------------------------------------------------~~~lV~E~~~~-~L~~~l~~~~~ 206 (437)
++++||||+.+ +|.+++.....
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 157 (332)
T 3qd2_B 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157 (332)
T ss_dssp SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence 48999999965 89998876432
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc---------------c
Q psy11727 207 -HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT---------------L 270 (437)
Q Consensus 207 -~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~---------------~ 270 (437)
...++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++...... .
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll--~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLHSK--GLMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEE--CTTCCEEECCCTTCEECSCC--------------CC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHhC--CeeecCCCcccEEE--eCCCCEEEeecCcccccccchhhccccccccccccc
Confidence 2356677899999999999999964 89999999999999 67889999999999876443 1
Q ss_pred ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCChhhhccCCccchhhcc
Q psy11727 271 YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVL-GMPPGYLLHGASKTSKYFDR 349 (437)
Q Consensus 271 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~p~~~~~~~~~~~~~~~~~ 349 (437)
...+||+.|+|||++.+..++.++|||||||++|+|++|..|+.. ....+.... +..+...
T Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~~~~------------- 295 (332)
T 3qd2_B 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPLLF------------- 295 (332)
T ss_dssp CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCCHHH-------------
T ss_pred cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCCccc-------------
Confidence 235689999999999999999999999999999999998776532 111111111 1111100
Q ss_pred cCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCC
Q psy11727 350 LSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEF 429 (437)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~ 429 (437)
......+.+||.+||+.||.+|||+.|+|+|||
T Consensus 296 -----------------------------------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 328 (332)
T 3qd2_B 296 -----------------------------------------------TQKYPQEHMMVQDMLSPSPTERPEATDIIENAI 328 (332)
T ss_dssp -----------------------------------------------HHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTT
T ss_pred -----------------------------------------------ccCChhHHHHHHHHccCCCCcCCCHHHHhhchh
Confidence 001125689999999999999999999999999
Q ss_pred cCcC
Q psy11727 430 FLKH 433 (437)
Q Consensus 430 ~~~~ 433 (437)
|++.
T Consensus 329 f~~~ 332 (332)
T 3qd2_B 329 FENL 332 (332)
T ss_dssp CCCC
T ss_pred hhcC
Confidence 9863
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=356.19 Aligned_cols=258 Identities=29% Similarity=0.442 Sum_probs=210.6
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-------cchHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-------FLNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-------~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
+.++|++.+.||+|+||+||+|.+..+++.||+|++..... ....+..|+.++..+ .||||+++++++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~ 77 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-----RHPNIITLHDIF 77 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-----CCTTBCCEEEEE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-----CCCCeeehhhee
Confidence 35689999999999999999999999999999999874321 235677888888877 689999999999
Q ss_pred eECCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC--CCCEEE
Q psy11727 181 TWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK--RSAIKI 257 (437)
Q Consensus 181 ~~~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~--~~~ikL 257 (437)
.+.+..++|||+++ ++|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+||+++.+. .+.+||
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~~~~kl 153 (283)
T 3bhy_A 78 ENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSK--RIAHFDLKPENIMLLDKNVPNPRIKL 153 (283)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSSSSCCEEE
T ss_pred cCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCChHHEEEecCCCCCCceEE
Confidence 99999999999995 58999887653 589999999999999999999964 899999999999994322 227999
Q ss_pred EeCCCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 258 IDFGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 258 ~DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
+|||++...... .....|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.......+..
T Consensus 154 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T 3bhy_A 154 IDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEE 233 (283)
T ss_dssp CCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHH
T ss_pred EecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcch
Confidence 999999876432 234578999999999999999999999999999999999999999988877766664422211111
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
.... ....+.+||.+||+.||
T Consensus 234 ~~~~-----------------------------------------------------------~~~~~~~li~~~l~~dp 254 (283)
T 3bhy_A 234 YFSN-----------------------------------------------------------TSELAKDFIRRLLVKDP 254 (283)
T ss_dssp HHTT-----------------------------------------------------------CCHHHHHHHHTTSCSSG
T ss_pred hccc-----------------------------------------------------------CCHHHHHHHHHHccCCH
Confidence 1100 00157899999999999
Q ss_pred CCCCCHHHHhcCCCcCcC
Q psy11727 416 KKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~~ 433 (437)
.+|||+.|+++||||++.
T Consensus 255 ~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 255 KRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp GGSCCHHHHHHCHHHHHH
T ss_pred hHCcCHHHHHhCHHHHHH
Confidence 999999999999999764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=362.05 Aligned_cols=287 Identities=29% Similarity=0.428 Sum_probs=214.8
Q ss_pred cCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEeccee--
Q psy11727 104 HGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHF-- 180 (437)
Q Consensus 104 ~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~-- 180 (437)
.+..+.++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.+ .||||+++++++
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~ 79 (320)
T 2i6l_A 5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-----DHDNIVKVFEILGP 79 (320)
T ss_dssp -CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEECT
T ss_pred ccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-----CCCCeeEEEEeccc
Confidence 35567889999999999999999999999999999999987443 2234566777777766 789999999877
Q ss_pred ------------eECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEe
Q psy11727 181 ------------TWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLC 248 (437)
Q Consensus 181 ------------~~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~ 248 (437)
...+..++||||++++|.+++.. ..+++..++.++.||+.||+|||++ ||+||||||+|||++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 80 SGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANLFIN 154 (320)
T ss_dssp TSCBCCC----CCSCSEEEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEEE
T ss_pred cccccccccccccccCceeEEeeccCCCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEc
Confidence 34578999999999999998865 3589999999999999999999964 899999999999995
Q ss_pred cCCCCCEEEEeCCCceecCC------ccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy11727 249 SPKRSAIKIIDFGSSCHVGQ------TLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ 321 (437)
Q Consensus 249 ~~~~~~ikL~DFG~s~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~ 321 (437)
..++.+||+|||++..... ......++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.
T Consensus 155 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 233 (320)
T 2i6l_A 155 -TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233 (320)
T ss_dssp -TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 2456899999999976532 1234567889999999876 6789999999999999999999999999999888
Q ss_pred HHHHHHHhCCCChhhhccCCccc-hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhh
Q psy11727 322 MTKIIEVLGMPPGYLLHGASKTS-KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADY 400 (437)
Q Consensus 322 ~~~i~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (437)
+..+......+............ .+.... ...+ ...+.... ....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~-~~~~~~~~------------------~~~~ 279 (320)
T 2i6l_A 234 MQLILESIPVVHEEDRQELLSVIPVYIRND---------------MTEP-HKPLTQLL------------------PGIS 279 (320)
T ss_dssp HHHHHHHSCCCCHHHHHHHHTTSCHHHHHH---------------TTSC-CCCHHHHS------------------TTCC
T ss_pred HHHHHHhcCCCchhhhhhhhhcCccccccc---------------ccCC-CCChhHhc------------------chhh
Confidence 88888876665544332111100 000000 0000 00000000 0011
Q ss_pred hHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 401 MKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 401 ~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
..+.+||.+||+.||.+|||++|+|+||||+....
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 280 REAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred HHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 26899999999999999999999999999987654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=359.24 Aligned_cols=260 Identities=23% Similarity=0.326 Sum_probs=192.6
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
..++|++.+.||+|+||+||+|.+..+++.||+|++........ ..+....+........||||+++++++.+.+..+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE--QKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHH--HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHH--HHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 35789999999999999999999999999999999974422111 1111111122234568999999999999999999
Q ss_pred EEEEeccCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 188 LVFELLSYNLYNLIRN--TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 188 lV~E~~~~~L~~~l~~--~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
+||||++++|.+++.. .....+++..++.++.||+.||+|||++ .||+||||||+|||+ +.++.+||+|||++..
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK-LSVIHRDVKPSNVLI--NALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-SCCCCCCCSGGGCEE--CTTCCEEBCCC-----
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc-CCeecCCCCHHHEEE--CCCCCEEEeecCCccc
Confidence 9999999998887754 2335699999999999999999999963 389999999999999 6788999999999976
Q ss_pred cCCcc--ccccccccccChhhh----cCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCChhhhc
Q psy11727 266 VGQTL--YQYIQSRYYRSPEVL----LGIPYDLAIDMWSLGCILVELHTGEPLFSGK-NEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 266 ~~~~~--~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
..... ....||+.|+|||++ .+..++.++|||||||++|+|++|+.||... .....+..+........
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 234 (290)
T 3fme_A 160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL----- 234 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCC-----
T ss_pred ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCc-----
Confidence 64332 235789999999996 4567899999999999999999999999863 34344443332110000
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
+ .......+.+||.+||+.||.+|
T Consensus 235 ------------------------------~--------------------------~~~~~~~~~~li~~~l~~~p~~R 258 (290)
T 3fme_A 235 ------------------------------P--------------------------ADKFSAEFVDFTSQCLKKNSKER 258 (290)
T ss_dssp ------------------------------C--------------------------TTTSCHHHHHHHHHHTCSSGGGS
T ss_pred ------------------------------c--------------------------cccCCHHHHHHHHHHhhcChhhC
Confidence 0 00001257899999999999999
Q ss_pred CCHHHHhcCCCcCcC
Q psy11727 419 ISPTNVLRHEFFLKH 433 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~~ 433 (437)
||+.|+++||||+..
T Consensus 259 pt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 259 PTYPELMQHPFFTLH 273 (290)
T ss_dssp CCHHHHTTSHHHHHH
T ss_pred cCHHHHHhCcccccC
Confidence 999999999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=374.73 Aligned_cols=263 Identities=17% Similarity=0.147 Sum_probs=191.9
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecc------
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKG------ 178 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~------ 178 (437)
...|.+.+.||+|+||+||+|.+..+++.||||++.... .....+..|+.+++.+.. .||||++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~---~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG---ESPEEARDRRRLLLPS 137 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-------------CBCCCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc---cChhhhhhceeEEeee
Confidence 345999999999999999999999999999999998643 223445567777777754 6899887653
Q ss_pred -eeeEC-----------------CEEEEEEEeccCcHHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHhcCCCCC
Q psy11727 179 -HFTWK-----------------NHLCLVFELLSYNLYNLIRNTNFHGVSLNLT------KKFAQQLCCALAFLSSPELS 234 (437)
Q Consensus 179 -~~~~~-----------------~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~------~~i~~qi~~aL~~LH~~~~g 234 (437)
++... ..+|+||||++++|.+++.... ..+++..+ ..++.||+.||+|||++ |
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--~ 214 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSK--G 214 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT--T
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHC--C
Confidence 33322 4489999999999999998643 23455555 67789999999999964 8
Q ss_pred eeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCccccccccccccChhhhcC--CCCCCcchHHHHHHHHHHHHhCCCC
Q psy11727 235 IIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLG--IPYDLAIDMWSLGCILVELHTGEPL 312 (437)
Q Consensus 235 iiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p 312 (437)
|+||||||+|||+ +.++.+||+|||+|...+.......+|+.|+|||++.+ ..++.++|||||||++|||++|++|
T Consensus 215 ivHrDikp~NIll--~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 215 LVHGHFTPDNLFI--MPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp EEETTCSGGGEEE--CTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CccCcCCHHHEEE--CCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999 67889999999999988776656677899999999987 6799999999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCC
Q psy11727 313 FSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNE 392 (437)
Q Consensus 313 f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (437)
|.+...... . .+..... ..........+..
T Consensus 293 f~~~~~~~~----------------~-------~~~~~~~------~~~~~~~~~~~~~--------------------- 322 (371)
T 3q60_A 293 FGLVTPGIK----------------G-------SWKRPSL------RVPGTDSLAFGSC--------------------- 322 (371)
T ss_dssp TTBCCTTCT----------------T-------CCCBCCT------TSCCCCSCCCTTS---------------------
T ss_pred CCCcCcccc----------------c-------chhhhhh------hhccccccchhhc---------------------
Confidence 987643100 0 0000000 0000000000000
Q ss_pred CCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 393 PGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 393 ~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
......+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 323 ----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 323 ----TPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp ----SCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred ----cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 0111267999999999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=355.50 Aligned_cols=251 Identities=26% Similarity=0.444 Sum_probs=211.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ .|+||+++++++.+.+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-----RHPNILRMYNYFHDRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-----CCCCEeeEEEEEEcCC
Confidence 578999999999999999999999999999999986321 2234566777777766 6899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
..++||||+++ +|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+||++ +.++.+||+|||++
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~--~~~~~~kl~Dfg~~ 161 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHER--KVIHRDIKPENLLM--GYKGELKIADFGWS 161 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCSGGGEEE--CTTCCEEECCCTTC
T ss_pred EEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCHHHEEE--cCCCCEEEeccccc
Confidence 99999999965 8999887753 489999999999999999999964 89999999999999 67888999999999
Q ss_pred eecCC-ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 264 CHVGQ-TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 264 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
..... ......|++.|+|||++.+..++.++||||||+++|+|++|.+||.+.+..+....+.......|.
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------- 233 (284)
T 2vgo_A 162 VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP-------- 233 (284)
T ss_dssp EECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--------
T ss_pred ccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCC--------
Confidence 76543 234567899999999999999999999999999999999999999988877666655431100000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
.....+.+||.+||+.||.+|||++
T Consensus 234 -------------------------------------------------------~~~~~~~~li~~~l~~~p~~Rps~~ 258 (284)
T 2vgo_A 234 -------------------------------------------------------FLSDGSKDLISKLLRYHPPQRLPLK 258 (284)
T ss_dssp -------------------------------------------------------TSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred -------------------------------------------------------cCCHHHHHHHHHHhhcCHhhCCCHH
Confidence 0012578999999999999999999
Q ss_pred HHhcCCCcCcC
Q psy11727 423 NVLRHEFFLKH 433 (437)
Q Consensus 423 e~l~Hp~~~~~ 433 (437)
++++||||+..
T Consensus 259 ~ll~h~~~~~~ 269 (284)
T 2vgo_A 259 GVMEHPWVKAN 269 (284)
T ss_dssp HHHTCHHHHHH
T ss_pred HHhhCHHHHhh
Confidence 99999999764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=361.62 Aligned_cols=262 Identities=25% Similarity=0.418 Sum_probs=210.8
Q ss_pred CceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE--
Q psy11727 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW-- 182 (437)
Q Consensus 105 ~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~-- 182 (437)
.....++|++.+.||+|+||.||+|.+..+++.||||++.........+..|+.++..+. .||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS----HHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHC----CSTTBCCEEEEEEECC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhcc----CCCCeeeeeeEEeecc
Confidence 344578999999999999999999999999999999999766555677888999888874 68999999999987
Q ss_pred ----CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 183 ----KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 183 ----~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
.+.+++||||+++ +|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~NIl~--~~~~~~kl 170 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH--KVIHRDIKGQNVLL--TENAEVKL 170 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEE--CTTCCEEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCcHHHEEE--cCCCCEEE
Confidence 5689999999976 899999876545689999999999999999999964 89999999999999 67888999
Q ss_pred EeCCCceecCCc---cccccccccccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q psy11727 258 IDFGSSCHVGQT---LYQYIQSRYYRSPEVLL-----GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVL 329 (437)
Q Consensus 258 ~DFG~s~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 329 (437)
+|||++...... .....||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.+.......+....
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 999999765432 23457899999999997 5678999999999999999999999999888766555443210
Q ss_pred CCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHH
Q psy11727 330 GMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILR 409 (437)
Q Consensus 330 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 409 (437)
.+... . ......+.+||.+
T Consensus 251 --~~~~~---------------~--------------------------------------------~~~~~~l~~li~~ 269 (326)
T 2x7f_A 251 --APRLK---------------S--------------------------------------------KKWSKKFQSFIES 269 (326)
T ss_dssp --CCCCS---------------C--------------------------------------------SCSCHHHHHHHHH
T ss_pred --cccCC---------------c--------------------------------------------cccCHHHHHHHHH
Confidence 00000 0 0001257899999
Q ss_pred ccccCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 410 MLTYDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 410 ~L~~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
||..||.+|||+.++++||||++...
T Consensus 270 ~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 270 CLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp HCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred HhccChhhCCCHHHHhhChHHhhCcc
Confidence 99999999999999999999987653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=358.45 Aligned_cols=253 Identities=30% Similarity=0.506 Sum_probs=183.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||+||+|.+..+++.||||++.... .....+..|+.++..+ .||||+++++++.+.+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-----KHPSILELYNYFEDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-----CCTTBCCEEEEEECSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-----CCCCeEeEEEEEccCC
Confidence 468999999999999999999999999999999996432 1224556677766655 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
..++||||+++ +|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+||++ +.++.+||+|||++
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nili--~~~~~~kl~dfg~~ 159 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH--GILHRDLTLSNLLL--TRNMNIKIADFGLA 159 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHT--TEECSSCCGGGEEE--CTTCCEEECCCTTC
T ss_pred eEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEE--cCCCCEEEEeecce
Confidence 99999999965 8888887643 4689999999999999999999964 89999999999999 67888999999999
Q ss_pred eecCC---ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 264 CHVGQ---TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 264 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|++||...+..+.+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------- 226 (278)
T 3cok_A 160 TQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------- 226 (278)
T ss_dssp EECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-------------
T ss_pred eeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-------------
Confidence 87642 22346789999999999998999999999999999999999999987654322221100
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
..+ ..|. .....+.+||.+||+.||.+|||
T Consensus 227 ------------~~~-----------~~~~---------------------------~~~~~~~~li~~~l~~dp~~Rps 256 (278)
T 3cok_A 227 ------------ADY-----------EMPS---------------------------FLSIEAKDLIHQLLRRNPADRLS 256 (278)
T ss_dssp ------------SCC-----------CCCT---------------------------TSCHHHHHHHHHHSCSSGGGSCC
T ss_pred ------------ccc-----------CCcc---------------------------ccCHHHHHHHHHHcccCHhhCCC
Confidence 000 0000 00125789999999999999999
Q ss_pred HHHHhcCCCcCcCC
Q psy11727 421 PTNVLRHEFFLKHS 434 (437)
Q Consensus 421 ~~e~l~Hp~~~~~~ 434 (437)
++++++||||++..
T Consensus 257 ~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 257 LSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHTTSTTTC---
T ss_pred HHHHhcCccccCCC
Confidence 99999999998754
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=376.39 Aligned_cols=301 Identities=24% Similarity=0.325 Sum_probs=209.6
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
+...++|++.+.||+|+||+||+|.+..++..||+|++.... .....+..|+.++..+ .||||+++++++.+.
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-----NSPYIVGFYGAFYSD 103 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-----CCTTBCCEEEEEEET
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-----CCCCEEEEeEEEEEC
Confidence 444678999999999999999999999999999999997542 1223444555555444 799999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+.+++||||+++ +|.+++.... .+++..+..++.||+.||+|||+. .||+||||||+|||+ +.++.+||+|||+
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~--~~~~~~kl~Dfg~ 178 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILV--NSRGEIKLCDFGV 178 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEE--CTTCCEEECCCCC
T ss_pred CEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHh-CCEEcCCccHHHEEE--CCCCCEEEEECCC
Confidence 999999999965 8999987753 489999999999999999999963 279999999999999 6788899999999
Q ss_pred ceecCC-ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 263 SCHVGQ-TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 263 s~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
+..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.......+........
T Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 179 SGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp CHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred CcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 865432 2335688999999999999999999999999999999999999999887765544332211111111100000
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
.....+......... .......+..+.... + ....+......+.+||.+||++||.+|||+
T Consensus 259 ~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~---~------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 319 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRP----------PMAIFELLDYIVNEP---P------PKLPSGVFSLEFQDFVNKCLIKNPAERADL 319 (360)
T ss_dssp -------------------------CCCHHHHHHHHHHSC---C------CCCCTTTSCHHHHHHHHHHHCSSTTTSCCH
T ss_pred cCCCcccccccCCCC----------cccchhhhhHHhccC---C------CCCCcccccHHHHHHHHHHhhcChhhCCCH
Confidence 000000000000000 000000011111100 0 000001112368999999999999999999
Q ss_pred HHHhcCCCcCcCCC
Q psy11727 422 TNVLRHEFFLKHSV 435 (437)
Q Consensus 422 ~e~l~Hp~~~~~~~ 435 (437)
+|+|+||||++...
T Consensus 320 ~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 320 KQLMVHAFIKRSDA 333 (360)
T ss_dssp HHHHTSHHHHHHHH
T ss_pred HHHhhChHhhcchH
Confidence 99999999987543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=385.07 Aligned_cols=251 Identities=16% Similarity=0.199 Sum_probs=196.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC----cccchHHHHHHHHHHHhhhcCCCCCcEEEec-------
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----KPFLNQAQIEVQLLEKINKADIHSRYIVKLK------- 177 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~----~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~------- 177 (437)
.++|.+.+.||+|+||+||+|.+..+|+.||||++... ......+.+|+.+++.+. .+.|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR--GIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGST--TCCSHHHHHHHHCBCCCS
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhcc--ccCCHHHHHHHhhhhhhh
Confidence 46899999999999999999999899999999999632 222355667776665553 45899999998
Q ss_pred ceeeECC-----------------EEEEEEEeccCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHhcCCCCCe
Q psy11727 178 GHFTWKN-----------------HLCLVFELLSYNLYNLIRNTNF-----HGVSLNLTKKFAQQLCCALAFLSSPELSI 235 (437)
Q Consensus 178 ~~~~~~~-----------------~~~lV~E~~~~~L~~~l~~~~~-----~~ls~~~~~~i~~qi~~aL~~LH~~~~gi 235 (437)
+++.+.+ ..|+||||++|+|.+++..... ..+++..++.++.||+.||+|||++ ||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~i 227 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GL 227 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT--TE
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC--Ce
Confidence 5554443 3899999998899999876421 1123488888999999999999964 89
Q ss_pred eeCCCCCCcEEEecCCCCCEEEEeCCCceecCCccccccccccccChhhhcCC-----------CCCCcchHHHHHHHHH
Q psy11727 236 IHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGI-----------PYDLAIDMWSLGCILV 304 (437)
Q Consensus 236 iHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlG~il~ 304 (437)
+||||||+|||+ +.++.+||+|||+|...+......+| +.|+|||++.+. .++.++|||||||++|
T Consensus 228 vHrDikp~NIll--~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 228 VHTYLRPVDIVL--DQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp ECSCCCGGGEEE--CTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEE--cCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 999999999999 67789999999999988777777788 999999999987 8999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCC
Q psy11727 305 ELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGG 384 (437)
Q Consensus 305 elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (437)
||++|++||.+.+.......+.. . ..
T Consensus 305 elltg~~Pf~~~~~~~~~~~~~~-----------~-------------------------------~~------------ 330 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSEWIFR-----------S-------------------------------CK------------ 330 (377)
T ss_dssp HHHHSSCCC------CCSGGGGS-----------S-------------------------------CC------------
T ss_pred HHHHCCCCCcccccccchhhhhh-----------h-------------------------------cc------------
Confidence 99999999976543211111000 0 00
Q ss_pred CCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 385 PGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
. ....+.+||.+||+.||.+|||+.|+++||||++.
T Consensus 331 ---------~----~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 331 ---------N----IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp ---------C----CCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred ---------C----CCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 0 01257899999999999999999999999999764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=359.78 Aligned_cols=256 Identities=28% Similarity=0.452 Sum_probs=206.6
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ .|+||+++++++.
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~ 76 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-----RHKNVIQLVDVLY 76 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-----CCTTBCCEEEEEE
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-----CCCCeeEEEEEEE
Confidence 35689999999999999999999999999999999996432 1234455677666555 7899999999984
Q ss_pred --ECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 182 --WKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 182 --~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
+.+..++||||++++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--~i~H~dlkp~NIl~--~~~~~~kl~d 152 (305)
T 2wtk_C 77 NEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ--GIVHKDIKPGNLLL--TTGGTLKISA 152 (305)
T ss_dssp CC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE--CTTCCEEECC
T ss_pred cCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCcccEEE--cCCCcEEeec
Confidence 55689999999999998888876666799999999999999999999964 89999999999999 6788999999
Q ss_pred CCCceecCC-----ccccccccccccChhhhcCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy11727 260 FGSSCHVGQ-----TLYQYIQSRYYRSPEVLLGIP--YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332 (437)
Q Consensus 260 FG~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p 332 (437)
||++..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~ 232 (305)
T 2wtk_C 153 LGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI 232 (305)
T ss_dssp CTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred cccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCC
Confidence 999976532 223456899999999998754 3779999999999999999999999988777666654321000
Q ss_pred ChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc
Q psy11727 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412 (437)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 412 (437)
+. .....+.+||.+||+
T Consensus 233 ~~---------------------------------------------------------------~~~~~l~~li~~~l~ 249 (305)
T 2wtk_C 233 PG---------------------------------------------------------------DCGPPLSDLLKGMLE 249 (305)
T ss_dssp CS---------------------------------------------------------------SSCHHHHHHHHHHTC
T ss_pred CC---------------------------------------------------------------ccCHHHHHHHHHHcc
Confidence 00 001257899999999
Q ss_pred cCCCCCCCHHHHhcCCCcCcCC
Q psy11727 413 YDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 413 ~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
.||.+|||++|+++||||++..
T Consensus 250 ~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 250 YEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp SSTTTSCCHHHHHHSHHHHSCC
T ss_pred CChhhCCCHHHHhcCcccccCC
Confidence 9999999999999999998643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=368.63 Aligned_cols=248 Identities=29% Similarity=0.467 Sum_probs=204.9
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---------cchHHHHHHHHHHHhhhcCCCCCcEEEe
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---------FLNQAQIEVQLLEKINKADIHSRYIVKL 176 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---------~~~~~~~e~~~~~~l~~~~~~h~~iv~l 176 (437)
..+.++|++.+.||+|+||+||+|.+..+++.||||++..... ....+..|+.++..+ .||||+++
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~Iv~~ 94 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-----EHANIIKV 94 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-----CCTTBCCE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-----CCCCEeeE
Confidence 3467899999999999999999999999999999999975431 223456688888776 68999999
Q ss_pred cceeeECCEEEEEEEec-cC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCC
Q psy11727 177 KGHFTWKNHLCLVFELL-SY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA 254 (437)
Q Consensus 177 ~~~~~~~~~~~lV~E~~-~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ 254 (437)
+++|.+.+.+++|||++ .| +|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.
T Consensus 95 ~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll--~~~~~ 168 (335)
T 3dls_A 95 LDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLK--DIIHRDIKDENIVI--AEDFT 168 (335)
T ss_dssp EEEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE--CTTSC
T ss_pred EEEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CeEEeccCHHHEEE--cCCCc
Confidence 99999999999999998 44 7888887653 589999999999999999999964 89999999999999 67889
Q ss_pred EEEEeCCCceecCCc--cccccccccccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy11727 255 IKIIDFGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPY-DLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331 (437)
Q Consensus 255 ikL~DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 331 (437)
+||+|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||..... .......
T Consensus 169 ~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~ 242 (335)
T 3dls_A 169 IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIH 242 (335)
T ss_dssp EEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCC
T ss_pred EEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccC
Confidence 999999999876433 345679999999999998876 7899999999999999999999975211 0000000
Q ss_pred CChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 332 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
.|. .....+.+||.+||
T Consensus 243 ------------------------------------~~~---------------------------~~~~~l~~li~~~L 259 (335)
T 3dls_A 243 ------------------------------------PPY---------------------------LVSKELMSLVSGLL 259 (335)
T ss_dssp ------------------------------------CSS---------------------------CCCHHHHHHHHHHT
T ss_pred ------------------------------------CCc---------------------------ccCHHHHHHHHHHc
Confidence 000 00125789999999
Q ss_pred ccCCCCCCCHHHHhcCCCcCcC
Q psy11727 412 TYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 412 ~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
+.||.+|||+.++++||||++.
T Consensus 260 ~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 260 QPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp CSSGGGSCCHHHHHHCTTTTCC
T ss_pred cCChhhCcCHHHHhcCccccCC
Confidence 9999999999999999999874
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=370.97 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=200.6
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+|.+.+.||+|+||+||+|.+.. ++.||||++.... .....+.+|+.++..+.+ .|+||+++++++...+.+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~---~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ---HSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT---TCTTBCCEEEEEECSSEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHccc---CCCeEEEEEEEEecCCEE
Confidence 469999999999999999998765 8899999996433 223567789999998864 478999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
|+|||+.+++|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+|||+ + ++.+||+|||++...
T Consensus 132 ~lv~E~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~--~ivHrDlkp~NIll--~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 132 YMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLI--V-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEEEECCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT--TCCCCCCCGGGEEE--S-SSCEEECCCSSSCCC
T ss_pred EEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHEEE--E-CCeEEEEecCccccc
Confidence 9999976779999988754 589999999999999999999964 89999999999999 3 467999999999766
Q ss_pred CCc-----cccccccccccChhhhcC-----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh
Q psy11727 267 GQT-----LYQYIQSRYYRSPEVLLG-----------IPYDLAIDMWSLGCILVELHTGEPLFSGKNEV-DQMTKIIEVL 329 (437)
Q Consensus 267 ~~~-----~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~~ 329 (437)
... ....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.... ..+..+....
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~ 284 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc
Confidence 432 234679999999999975 36889999999999999999999999875432 2333222100
Q ss_pred CCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHH
Q psy11727 330 GMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILR 409 (437)
Q Consensus 330 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 409 (437)
..+ ..|.. ....+.+||.+
T Consensus 285 ~~~----------------------------------~~~~~---------------------------~~~~~~~li~~ 303 (390)
T 2zmd_A 285 HEI----------------------------------EFPDI---------------------------PEKDLQDVLKC 303 (390)
T ss_dssp SCC----------------------------------CCCCC---------------------------SCHHHHHHHHH
T ss_pred ccC----------------------------------CCCcc---------------------------chHHHHHHHHH
Confidence 000 00000 01257899999
Q ss_pred ccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 410 MLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 410 ~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
||+.||.+|||+.|+|+||||+..
T Consensus 304 ~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 304 CLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp HTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HcccChhhCCCHHHHhhCcCcccc
Confidence 999999999999999999999754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=364.88 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=199.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
.++|++.+.||+|+||+||+|.+ .+++.||||++..... ....+..|+.++..+.+ +|+||+++++++...++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~---~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ---HSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT---TCTTBCCEEEEEECSSE
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhh---cCCceEEEeeeEeeCCE
Confidence 46799999999999999999987 4688999999974332 23556789999998864 44899999999999999
Q ss_pred EEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 186 LCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 186 ~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
+++|||+.+++|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||++ ++.+||+|||++..
T Consensus 84 ~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~--~iiHrDikp~NIll~---~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 84 IYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIV---DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEEEECCCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEE---TTEEEECCCSSSCC
T ss_pred EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCcceEEEE---CCcEEEeecccccc
Confidence 9999998788999999875 3589999999999999999999964 899999999999994 46799999999976
Q ss_pred cCCc-----cccccccccccChhhhcC-----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHH
Q psy11727 266 VGQT-----LYQYIQSRYYRSPEVLLG-----------IPYDLAIDMWSLGCILVELHTGEPLFSGKNEV-DQMTKIIEV 328 (437)
Q Consensus 266 ~~~~-----~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~ 328 (437)
.... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.... ..+..+..
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~- 235 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID- 235 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC-
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc-
Confidence 6432 224679999999999964 67889999999999999999999999875432 22222211
Q ss_pred hCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHH
Q psy11727 329 LGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLIL 408 (437)
Q Consensus 329 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 408 (437)
..... ..|. .....+.+||.
T Consensus 236 --~~~~~-------------------------------~~~~---------------------------~~~~~l~~li~ 255 (343)
T 3dbq_A 236 --PNHEI-------------------------------EFPD---------------------------IPEKDLQDVLK 255 (343)
T ss_dssp --TTSCC-------------------------------CCCC---------------------------CSCHHHHHHHH
T ss_pred --CCccc-------------------------------CCcc---------------------------cCCHHHHHHHH
Confidence 00000 0000 00125789999
Q ss_pred HccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 409 RMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 409 ~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
+||+.||.+|||+.|+|+||||+..
T Consensus 256 ~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 256 CCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp HHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HHcCCChhHCCCHHHHHhCcccccc
Confidence 9999999999999999999999753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=375.98 Aligned_cols=259 Identities=31% Similarity=0.471 Sum_probs=198.0
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---------cchHHHHHHHHHHHhhhcCCCCCcEEEe
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---------FLNQAQIEVQLLEKINKADIHSRYIVKL 176 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---------~~~~~~~e~~~~~~l~~~~~~h~~iv~l 176 (437)
..+.++|.+.+.||+|+||+||+|.+..+++.||||++..... ....+..|+.++..+ .||||+++
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l 205 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-----NHPCIIKI 205 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-----CCTTBCCC
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-----CCCCEeeE
Confidence 3456889999999999999999999999999999999974321 122466788888887 78999999
Q ss_pred cceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC-CCCC
Q psy11727 177 KGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP-KRSA 254 (437)
Q Consensus 177 ~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~-~~~~ 254 (437)
++++. .+.+++||||+.+ +|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+ ....
T Consensus 206 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~--~ivHrDlkp~NIll~~~~~~~~ 280 (419)
T 3i6u_A 206 KNFFD-AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCL 280 (419)
T ss_dssp CEEEE-SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSSSCC
T ss_pred EEEEe-cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChHhEEEecCCCcce
Confidence 99875 5668999999965 888877654 4589999999999999999999964 89999999999999532 2346
Q ss_pred EEEEeCCCceecCCc--cccccccccccChhhhcC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHH
Q psy11727 255 IKIIDFGSSCHVGQT--LYQYIQSRYYRSPEVLLG---IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMT-KIIEV 328 (437)
Q Consensus 255 ikL~DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~-~i~~~ 328 (437)
+||+|||++...... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+......+. .+...
T Consensus 281 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~ 360 (419)
T 3i6u_A 281 IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360 (419)
T ss_dssp EEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT
T ss_pred EEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC
Confidence 999999999876543 245689999999999864 568889999999999999999999998754432222 22211
Q ss_pred hCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHH
Q psy11727 329 LGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLIL 408 (437)
Q Consensus 329 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 408 (437)
....+...+. .....+.+||.
T Consensus 361 ~~~~~~~~~~-----------------------------------------------------------~~~~~~~~li~ 381 (419)
T 3i6u_A 361 KYNFIPEVWA-----------------------------------------------------------EVSEKALDLVK 381 (419)
T ss_dssp CCCCCHHHHT-----------------------------------------------------------TSCHHHHHHHH
T ss_pred CCCCCchhhc-----------------------------------------------------------ccCHHHHHHHH
Confidence 1111110000 00125789999
Q ss_pred HccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 409 RMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 409 ~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
+||++||.+|||++|+|+||||++.
T Consensus 382 ~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 382 KLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp HHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred HHccCChhHCcCHHHHhCCcccCCh
Confidence 9999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=351.12 Aligned_cols=255 Identities=23% Similarity=0.366 Sum_probs=199.7
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE----
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW---- 182 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~---- 182 (437)
..|.+.+.||+|+||+||+|.+..++..||+|++..... ....+..|+.++..+ .||||+++++++..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-----QHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEEESSS
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-----CCCCeeeeeeeeccccCC
Confidence 358999999999999999999999999999999874322 123345566666554 78999999999876
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
..++++||||+++ +|.+++... ..+++..++.++.||+.||.|||+++.+|+||||||+|||++ +.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~-~~~~~~kl~Dfg 177 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT-GPTGSVKIGDLG 177 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES-STTSCEEECCTT
T ss_pred CceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE-CCCCCEEEeeCC
Confidence 4679999999955 899998765 358999999999999999999996522399999999999993 267789999999
Q ss_pred CceecCCc-cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 262 SSCHVGQT-LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 262 ~s~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.............. ..+.....
T Consensus 178 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~-- 253 (290)
T 1t4h_A 178 LATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKPASFDK-- 253 (290)
T ss_dssp GGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCCGGGGG--
T ss_pred CcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhcc-CCccccCC--
Confidence 99765433 334678999999998875 58999999999999999999999998855544433222111 01100000
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
.....+.+||.+||+.||.+|||
T Consensus 254 ---------------------------------------------------------~~~~~l~~li~~~l~~dp~~Rps 276 (290)
T 1t4h_A 254 ---------------------------------------------------------VAIPEVKEIIEGCIRQNKDERYS 276 (290)
T ss_dssp ---------------------------------------------------------CCCHHHHHHHHHHSCSSGGGSCC
T ss_pred ---------------------------------------------------------CCCHHHHHHHHHHccCChhhCCC
Confidence 00015789999999999999999
Q ss_pred HHHHhcCCCcCcC
Q psy11727 421 PTNVLRHEFFLKH 433 (437)
Q Consensus 421 ~~e~l~Hp~~~~~ 433 (437)
++|+++||||++.
T Consensus 277 ~~ell~h~~f~~~ 289 (290)
T 1t4h_A 277 IKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHTSGGGC--
T ss_pred HHHHhhCcccccC
Confidence 9999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=352.29 Aligned_cols=256 Identities=29% Similarity=0.426 Sum_probs=203.7
Q ss_pred cCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 104 HGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 104 ~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
.+....++|.+.+.||+|+||.||+|.+..+++.||||++.... .....+..|+.++..+ .||||++++++
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~ 79 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-----RHPHIIKLYQV 79 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-----CCTTBCCEEEE
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-----CCCCEeEEEEE
Confidence 34556789999999999999999999999999999999986422 2234556677777665 68999999999
Q ss_pred eeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 180 FTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 180 ~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
+...+..++|||++++ +|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+||++ +.++.+||+
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~--~~~~~~~l~ 153 (276)
T 2h6d_A 80 ISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRH--MVVHRDLKPENVLL--DAHMNAKIA 153 (276)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH--CSSCCCCCGGGEEE--CTTSCEEEC
T ss_pred EecCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCChhhEEE--CCCCCEEEe
Confidence 9999999999999965 8999987653 489999999999999999999964 89999999999999 678889999
Q ss_pred eCCCceecCCc--cccccccccccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 259 DFGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPY-DLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 259 DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
|||++...... .....|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.......|..
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (276)
T 2h6d_A 154 DFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY 233 (276)
T ss_dssp CCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred ecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchh
Confidence 99999766433 234578999999999988765 589999999999999999999999887766666554321111000
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
....+.+||.+||+.||
T Consensus 234 ---------------------------------------------------------------~~~~l~~li~~~l~~~p 250 (276)
T 2h6d_A 234 ---------------------------------------------------------------LNRSVATLLMHMLQVDP 250 (276)
T ss_dssp ---------------------------------------------------------------SCHHHHHHHHHHTCSSG
T ss_pred ---------------------------------------------------------------cCHHHHHHHHHHccCCh
Confidence 00157899999999999
Q ss_pred CCCCCHHHHhcCCCcCcC
Q psy11727 416 KKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~~ 433 (437)
.+|||+.|+++||||++.
T Consensus 251 ~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 251 LKRATIKDIREHEWFKQD 268 (276)
T ss_dssp GGSCCHHHHHHSHHHHTT
T ss_pred hhCCCHHHHHhChhhccC
Confidence 999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=351.86 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=209.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|.+.+.||+|+||+||+|.+..+++.||+|++..... ....+..|+.+++.+ .|+||+++++++.+.+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-----AHQHVVGFHGFFEDND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-----CCCCEeeeeeeeccCC
Confidence 5689999999999999999999999999999999864321 223445566666554 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
..++||||+++ +|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dl~p~Nil~--~~~~~~kl~dfg~~ 162 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFL--NEDLEVKIGDFGLA 162 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEE--CTTCCEEECCCTTC
T ss_pred EEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChHhEEE--cCCCCEEEEeccCc
Confidence 99999999975 8888877653 589999999999999999999964 89999999999999 67888999999999
Q ss_pred eecCC---ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 264 CHVGQ---TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 264 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+.......|.
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 236 (294)
T 2rku_A 163 TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK------ 236 (294)
T ss_dssp EECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT------
T ss_pred eecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc------
Confidence 77532 233467899999999999989999999999999999999999999988876665554321100000
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
.....+.+||.+||+.||.+|||
T Consensus 237 ---------------------------------------------------------~~~~~~~~li~~~l~~~p~~Rps 259 (294)
T 2rku_A 237 ---------------------------------------------------------HINPVAASLIQKMLQTDPTARPT 259 (294)
T ss_dssp ---------------------------------------------------------TSCHHHHHHHHHHTCSSGGGSCC
T ss_pred ---------------------------------------------------------ccCHHHHHHHHHHcccChhhCcC
Confidence 00125789999999999999999
Q ss_pred HHHHhcCCCcCcCC
Q psy11727 421 PTNVLRHEFFLKHS 434 (437)
Q Consensus 421 ~~e~l~Hp~~~~~~ 434 (437)
++|+++||||+...
T Consensus 260 ~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 260 INELLNDEFFTSGY 273 (294)
T ss_dssp GGGGGGSHHHHTSC
T ss_pred HHHHhhChheecCC
Confidence 99999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=359.35 Aligned_cols=259 Identities=26% Similarity=0.402 Sum_probs=203.6
Q ss_pred cCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccc----hHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 104 HGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFL----NQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 104 ~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~----~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
....+.++|++.+.||+|+||+||+|.+..+++.||||++....... ..+.+|+.+ ...+.||||++++++
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-----l~~l~hp~iv~~~~~ 80 (311)
T 3ork_A 6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQN-----AAALNHPAIVAVYDT 80 (311)
T ss_dssp CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTT-----CCCCCCTTBCCEEEE
T ss_pred CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHH-----HHcCCCCCcceEEEe
Confidence 34567889999999999999999999999999999999997543221 122333333 344589999999999
Q ss_pred eeECC----EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCC
Q psy11727 180 FTWKN----HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA 254 (437)
Q Consensus 180 ~~~~~----~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ 254 (437)
+...+ ..|+||||+++ +|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.
T Consensus 81 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~--~~~~~ 154 (311)
T 3ork_A 81 GEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN--GIIHRDVKPANIMI--SATNA 154 (311)
T ss_dssp EEEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEE--ETTSC
T ss_pred eeccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CCCcCCCCHHHEEE--cCCCC
Confidence 87654 45999999964 8999887653 589999999999999999999964 89999999999999 56788
Q ss_pred EEEEeCCCceecCCc------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q psy11727 255 IKIIDFGSSCHVGQT------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV 328 (437)
Q Consensus 255 ikL~DFG~s~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 328 (437)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+...
T Consensus 155 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 234 (311)
T 3ork_A 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 234 (311)
T ss_dssp EEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC
T ss_pred EEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC
Confidence 999999999765332 22356899999999999999999999999999999999999999998887776666553
Q ss_pred hCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHH
Q psy11727 329 LGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLIL 408 (437)
Q Consensus 329 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 408 (437)
...++....... ...+.+||.
T Consensus 235 ~~~~~~~~~~~~-----------------------------------------------------------~~~l~~li~ 255 (311)
T 3ork_A 235 DPIPPSARHEGL-----------------------------------------------------------SADLDAVVL 255 (311)
T ss_dssp CCCCHHHHSTTC-----------------------------------------------------------CHHHHHHHH
T ss_pred CCCCcccccCCC-----------------------------------------------------------CHHHHHHHH
Confidence 333322111000 015789999
Q ss_pred HccccCCCCCCCHHHHhcCCCcCc
Q psy11727 409 RMLTYDPKKRISPTNVLRHEFFLK 432 (437)
Q Consensus 409 ~~L~~dP~~R~t~~e~l~Hp~~~~ 432 (437)
+||+.||.+||++.+++.|+|++.
T Consensus 256 ~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 256 KALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHhcCHhhChhhHHHHHHHHHHH
Confidence 999999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=352.53 Aligned_cols=257 Identities=22% Similarity=0.288 Sum_probs=200.0
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
..+.++|++.+.||+|+||+||+|.+..+++.||||++..... .......|+..+..+. .||||+++++++.+
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~----~h~~iv~~~~~~~~ 82 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG----QHSHVVRYFSAWAE 82 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSC----SCTTBCCEEEEEEE
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhC----CCCCeeeeeeeeec
Confidence 4457889999999999999999999999999999999974322 2234445555555542 78999999999999
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC---------
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTN--FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP--------- 250 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~--~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~--------- 250 (437)
.+..++||||+++ +|.+++.... ...+++..++.++.||+.||+|||++ ||+||||||+|||++.+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dikp~NIl~~~~~~~~~~~~~ 160 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEE 160 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEC-----------
T ss_pred CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC--CEeecCCCHHHEEEcCCCCCcccccc
Confidence 9999999999965 9999887642 24589999999999999999999964 89999999999999432
Q ss_pred --------CCCCEEEEeCCCceecCCccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy11727 251 --------KRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ 321 (437)
Q Consensus 251 --------~~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~ 321 (437)
....+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+.....
T Consensus 161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 161 GDEDDWASNKVMFKIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp ---------CCCEEECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred cccccccCCceEEEEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 34479999999998776543 35689999999999876 566899999999999999999988765432
Q ss_pred HHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhh
Q psy11727 322 MTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYM 401 (437)
Q Consensus 322 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (437)
...+... ..+. .| .....
T Consensus 237 ~~~~~~~--~~~~---------------------------------~~---------------------------~~~~~ 254 (289)
T 1x8b_A 237 WHEIRQG--RLPR---------------------------------IP---------------------------QVLSQ 254 (289)
T ss_dssp HHHHHTT--CCCC---------------------------------CS---------------------------SCCCH
T ss_pred HHHHHcC--CCCC---------------------------------CC---------------------------cccCH
Confidence 2222110 0000 00 00012
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 402 KFKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 402 ~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
.+.+||.+||+.||.+|||+.|+++||||++..
T Consensus 255 ~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 255 EFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred HHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 578999999999999999999999999998754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=358.94 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=210.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ .|+||+++++++.+.+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-----AHQHVVGFHGFFEDND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEecCC
Confidence 568999999999999999999999999999999986432 1223445566666654 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~--~~~~~~kl~Dfg~~ 188 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFL--NEDLEVKIGDFGLA 188 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEE--CTTCCEEECCCTTC
T ss_pred eEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC--CCEecCCCchhEEE--cCCCCEEEeeccCc
Confidence 99999999975 888888765 3589999999999999999999964 89999999999999 67888999999999
Q ss_pred eecCC---ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 264 CHVGQ---TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 264 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
..... ......||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.......+.
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------ 262 (335)
T 2owb_A 189 TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK------ 262 (335)
T ss_dssp EECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT------
T ss_pred eecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc------
Confidence 77542 233467899999999999999999999999999999999999999988877666655432110000
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
.....+.+||.+||+.||.+|||
T Consensus 263 ---------------------------------------------------------~~~~~~~~li~~~l~~dp~~Rps 285 (335)
T 2owb_A 263 ---------------------------------------------------------HINPVAASLIQKMLQTDPTARPT 285 (335)
T ss_dssp ---------------------------------------------------------TSCHHHHHHHHHHTCSSGGGSCC
T ss_pred ---------------------------------------------------------cCCHHHHHHHHHHccCChhHCcC
Confidence 00015789999999999999999
Q ss_pred HHHHhcCCCcCcCC
Q psy11727 421 PTNVLRHEFFLKHS 434 (437)
Q Consensus 421 ~~e~l~Hp~~~~~~ 434 (437)
+.|+++||||+...
T Consensus 286 ~~ell~~~~~~~~~ 299 (335)
T 2owb_A 286 INELLNDEFFTSGY 299 (335)
T ss_dssp GGGGGGSHHHHTSC
T ss_pred HHHHhcCccccCCC
Confidence 99999999998754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=351.85 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=206.6
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
...++|++.+.||+|+||.||+|.+..+|+.||||++... .....+..|+.++..+ .||||+++++++...+.+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-SDLQEIIKEISIMQQC-----DSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-SCCHHHHHHHHHHHTC-----CCTTBCCEEEEEEETTEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-HHHHHHHHHHHHHHhC-----CCCCCccEEEEEEeCCEE
Confidence 3457899999999999999999999999999999999754 3456677788888776 789999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++||||+++ +|.+++.... ..+++..++.++.||+.||.|||+ .||+||||||+||++ +.++.+||+|||++..
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dl~p~Nil~--~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHF--MRKIHRDIKAGNILL--NTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTCCEEECCCTTCEE
T ss_pred EEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCCcCCCcCHHHEEE--CCCCCEEEeecccchh
Confidence 999999976 8988887443 468999999999999999999995 489999999999999 6778899999999976
Q ss_pred cCCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 266 VGQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 266 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+... .++....
T Consensus 175 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~----- 247 (314)
T 3com_A 175 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN--PPPTFRK----- 247 (314)
T ss_dssp CBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCCCCSS-----
T ss_pred hhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC--CCcccCC-----
Confidence 6433 23457899999999999999999999999999999999999999987766554433221 1100000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
.......+.+||.+||+.||.+|||+.
T Consensus 248 -----------------------------------------------------~~~~~~~l~~li~~~l~~dp~~Rpt~~ 274 (314)
T 3com_A 248 -----------------------------------------------------PELWSDNFTDFVKQCLVKSPEQRATAT 274 (314)
T ss_dssp -----------------------------------------------------GGGSCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred -----------------------------------------------------cccCCHHHHHHHHHHccCChhhCcCHH
Confidence 000012578999999999999999999
Q ss_pred HHhcCCCcCcCC
Q psy11727 423 NVLRHEFFLKHS 434 (437)
Q Consensus 423 e~l~Hp~~~~~~ 434 (437)
++++||||+...
T Consensus 275 ~ll~~~~~~~~~ 286 (314)
T 3com_A 275 QLLQHPFVRSAK 286 (314)
T ss_dssp HHTTSHHHHTCC
T ss_pred HHHhCHHHhcCC
Confidence 999999998754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=352.59 Aligned_cols=260 Identities=30% Similarity=0.458 Sum_probs=207.4
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
....++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+..|+.++..+ .||||+++++++...+
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~ 89 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-----DHPYIVKLLGAYYHDG 89 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECC-
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-----CCCCEeeeeeeeeeCC
Confidence 345678999999999999999999999999999999986443 2345667788888776 6899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
..++||||+++ +|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++
T Consensus 90 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~--~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK--RIIHRDLKAGNVLM--TLEGDIRLADFGVS 164 (302)
T ss_dssp CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEE--CTTSCEEECCCHHH
T ss_pred eEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcC--CcccCCCCHHHEEE--CCCCCEEEEECCCC
Confidence 99999999976 7777776543 4599999999999999999999964 89999999999999 67788999999987
Q ss_pred eecCC---ccccccccccccChhhh-----cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 264 CHVGQ---TLYQYIQSRYYRSPEVL-----LGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 264 ~~~~~---~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
..... ......||..|+|||++ .+..++.++|||||||++|+|++|.+||...+.......+.... ++..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~ 242 (302)
T 2j7t_A 165 AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD--PPTL 242 (302)
T ss_dssp HHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CCCC
T ss_pred ccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC--Cccc
Confidence 54321 12345789999999998 36678999999999999999999999999988776665554321 1100
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
..+ ......+.+||.+||+.||
T Consensus 243 ~~~----------------------------------------------------------~~~~~~l~~li~~~l~~dp 264 (302)
T 2j7t_A 243 LTP----------------------------------------------------------SKWSVEFRDFLKIALDKNP 264 (302)
T ss_dssp SSG----------------------------------------------------------GGSCHHHHHHHHHHSCSCT
T ss_pred CCc----------------------------------------------------------cccCHHHHHHHHHHcccCh
Confidence 000 0001257899999999999
Q ss_pred CCCCCHHHHhcCCCcCcCCC
Q psy11727 416 KKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~~~~ 435 (437)
.+|||+.++++||||+....
T Consensus 265 ~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 265 ETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp TTSCCHHHHTTSTTTTTCCC
T ss_pred hhCCCHHHHhcChHHhhhcc
Confidence 99999999999999998654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=353.25 Aligned_cols=263 Identities=35% Similarity=0.489 Sum_probs=213.2
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
..+.++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+..|+.++..+ .||||+++++++.+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~ 92 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-----DHPNIMKLFEILED 92 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-----CCTTBCCEEEEEEC
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-----cCCCccEEEEEEeC
Confidence 345689999999999999999999999999999999986432 2234566788877766 78999999999999
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC-CCCEEEEeC
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK-RSAIKIIDF 260 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~-~~~ikL~DF 260 (437)
.+..++|||++.+ +|.+.+.... .+++..++.++.||+.||.|||++ ||+||||||+||+++.+. .+.+||+||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred CCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCChhhEEEecCCCcccEEEecc
Confidence 9999999999965 8888887653 589999999999999999999964 899999999999995422 457999999
Q ss_pred CCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 261 GSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 261 G~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
|++...... .....||+.|+|||++.+ .++.++||||||+++|+|++|.+||.+.+..+....+......++...
T Consensus 169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 245 (287)
T 2wei_A 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ-- 245 (287)
T ss_dssp TGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG--
T ss_pred CcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchh--
Confidence 998765432 234568899999999876 489999999999999999999999999888777666654211110000
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
+. .....+.+||.+||+.||.+|
T Consensus 246 --------------------------------~~-------------------------~~~~~~~~li~~~l~~dp~~R 268 (287)
T 2wei_A 246 --------------------------------WR-------------------------TISDDAKDLIRKMLTFHPSLR 268 (287)
T ss_dssp --------------------------------GT-------------------------TSCHHHHHHHHHHTCSSGGGS
T ss_pred --------------------------------hh-------------------------hcCHHHHHHHHHHcccChhhC
Confidence 00 001157899999999999999
Q ss_pred CCHHHHhcCCCcCcCCCCC
Q psy11727 419 ISPTNVLRHEFFLKHSVDN 437 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~~~~~~ 437 (437)
||+.|+|+||||++...++
T Consensus 269 ps~~ell~hp~~~~~~~~e 287 (287)
T 2wei_A 269 ITATQCLEHPWIQKYSSEE 287 (287)
T ss_dssp CCHHHHHHSHHHHHHCCC-
T ss_pred cCHHHHhcCHHHhccccCC
Confidence 9999999999999877653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=363.84 Aligned_cols=257 Identities=28% Similarity=0.439 Sum_probs=204.1
Q ss_pred ccCeeeeceecccCceEEEEEEEc---CCCeEEEEEEecCCc-----ccchHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDH---EEKCQVAIKIIKNKK-----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~---~~~~~vaiK~i~~~~-----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
.++|++.+.||+|+||+||+|++. .+++.||||+++... ........|+.++..+. .|+||+++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~~ 128 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR----QSPFLVTLHYAF 128 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH----TCTTBCCEEEEE
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHcc----CCCceeEEEEEE
Confidence 478999999999999999999984 589999999986422 22345567888888885 588999999999
Q ss_pred eECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 181 TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 181 ~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
...+.+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dlkp~NIll--~~~~~~kl~D 202 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL--GIIYRDIKLENILL--DSNGHVVLTD 202 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEE--CTTSCEEESC
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEE--CCCCcEEEee
Confidence 999999999999965 8999887653 589999999999999999999964 89999999999999 7788999999
Q ss_pred CCCceecCCc----cccccccccccChhhhcC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCC
Q psy11727 260 FGSSCHVGQT----LYQYIQSRYYRSPEVLLG--IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVL-GMP 332 (437)
Q Consensus 260 FG~s~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~p 332 (437)
||++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... ...
T Consensus 203 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 282 (355)
T 1vzo_A 203 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282 (355)
T ss_dssp SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred CCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC
Confidence 9999765322 234679999999999986 357899999999999999999999997643222222221110 000
Q ss_pred ChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc
Q psy11727 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412 (437)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 412 (437)
+. . +......+.+||.+||.
T Consensus 283 ~~---------------------------------~---------------------------~~~~~~~~~~li~~~L~ 302 (355)
T 1vzo_A 283 PP---------------------------------Y---------------------------PQEMSALAKDLIQRLLM 302 (355)
T ss_dssp CC---------------------------------C---------------------------CTTSCHHHHHHHHHHTC
T ss_pred CC---------------------------------C---------------------------CcccCHHHHHHHHHHhh
Confidence 00 0 00001257899999999
Q ss_pred cCCCCCC-----CHHHHhcCCCcCcCCC
Q psy11727 413 YDPKKRI-----SPTNVLRHEFFLKHSV 435 (437)
Q Consensus 413 ~dP~~R~-----t~~e~l~Hp~~~~~~~ 435 (437)
.||.+|| |++|+++||||++..+
T Consensus 303 ~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 303 KDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp SSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred hCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 9999999 9999999999998653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=349.05 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=205.1
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
+.++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+..|+.++..+ .|+||+++++++.+.+.
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-----NHENVVKFYGHRREGNI 79 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEETTE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-----CCCCceeeeeEEEcCCE
Confidence 4678999999999999999999999999999999996433 2234566677777665 78999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
.++|||++++ +|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+||++ +.++.+||+|||++.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nil~--~~~~~~kl~dfg~~~ 153 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLL--DERDNLKISDFGLAT 153 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE--CTTCCEEECCCTTCE
T ss_pred EEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCChHHEEE--ccCCCEEEeeCCCcc
Confidence 9999999976 888877543 3589999999999999999999964 89999999999999 678889999999997
Q ss_pred ecCC-----ccccccccccccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChhhh
Q psy11727 265 HVGQ-----TLYQYIQSRYYRSPEVLLGIPY-DLAIDMWSLGCILVELHTGEPLFSGKNEVD-QMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 265 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~p~~~~~ 337 (437)
.... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+... ....+.......+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 229 (276)
T 2yex_A 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN---- 229 (276)
T ss_dssp ECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTST----
T ss_pred ccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccC----
Confidence 6532 1234678999999999988765 678999999999999999999998765432 2222211000000
Q ss_pred ccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCC
Q psy11727 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKK 417 (437)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 417 (437)
.. ......+.+||.+||+.||.+
T Consensus 230 --------------------------------~~-------------------------~~~~~~~~~li~~~l~~~p~~ 252 (276)
T 2yex_A 230 --------------------------------PW-------------------------KKIDSAPLALLHKILVENPSA 252 (276)
T ss_dssp --------------------------------TG-------------------------GGSCHHHHHHHHHHSCSSTTT
T ss_pred --------------------------------ch-------------------------hhcCHHHHHHHHHHCCCCchh
Confidence 00 000125789999999999999
Q ss_pred CCCHHHHhcCCCcCcCC
Q psy11727 418 RISPTNVLRHEFFLKHS 434 (437)
Q Consensus 418 R~t~~e~l~Hp~~~~~~ 434 (437)
|||+.|+++||||++..
T Consensus 253 Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 253 RITIPDIKKDRWYNKPL 269 (276)
T ss_dssp SCCHHHHTTCTTTTCCC
T ss_pred CCCHHHHhcCccccChh
Confidence 99999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=356.44 Aligned_cols=277 Identities=20% Similarity=0.285 Sum_probs=207.8
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.+.++|.+.+.||+|+||+||+|.+..+++.||||++.... .......+|+.++..+ .||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~ 80 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-----NHKNIVKLFAIEEETT 80 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECTT
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-----CCCCcceEEEEeecCC
Confidence 44678999999999999999999999999999999997433 2234566788888877 6899999999998765
Q ss_pred --EEEEEEEecc-CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec--CCCCCEEEE
Q psy11727 185 --HLCLVFELLS-YNLYNLIRNTN-FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS--PKRSAIKII 258 (437)
Q Consensus 185 --~~~lV~E~~~-~~L~~~l~~~~-~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~--~~~~~ikL~ 258 (437)
+.++||||+. ++|.+++.... ...+++..++.++.||+.||+|||++ ||+||||||+|||+.. +.++.+||+
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHEEEeccCCCCceEEEc
Confidence 8899999996 58999887643 23489999999999999999999964 8999999999999743 345569999
Q ss_pred eCCCceecCCc--cccccccccccChhhhc--------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH
Q psy11727 259 DFGSSCHVGQT--LYQYIQSRYYRSPEVLL--------GIPYDLAIDMWSLGCILVELHTGEPLFSGKNE----VDQMTK 324 (437)
Q Consensus 259 DFG~s~~~~~~--~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlG~il~elltg~~pf~~~~~----~~~~~~ 324 (437)
|||++...... .....||+.|+|||++. +..++.++|||||||++|||++|++||..... .+.+..
T Consensus 159 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 159 DFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred cCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 99999876433 34567899999999986 57889999999999999999999999975332 333444
Q ss_pred HHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHH
Q psy11727 325 IIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFK 404 (437)
Q Consensus 325 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (437)
+... .|+ ..+..... .....+.... ..| .....+......+.
T Consensus 239 ~~~~--~p~-~~~~~~~~-------~~~~~~~~~~-------~~~---------------------~~~~~~~~~~~~l~ 280 (319)
T 4euu_A 239 IITG--KPS-GAISGVQK-------AENGPIDWSG-------DMP---------------------VSCSLSRGLQVLLT 280 (319)
T ss_dssp HHHH--CCT-TCCEEEEC-------STTCCEEEES-------SCC---------------------TTCSSCHHHHHHHH
T ss_pred HhcC--CCc-ccchhhhc-------ccCCccccCc-------cCC---------------------cccccchhHHHHhH
Confidence 4332 222 11111100 0000000000 000 01122344455789
Q ss_pred HHHHHccccCCCCCCCHHHHhcCC
Q psy11727 405 DLILRMLTYDPKKRISPTNVLRHE 428 (437)
Q Consensus 405 dli~~~L~~dP~~R~t~~e~l~Hp 428 (437)
+||++||++||.+|||++|+|+||
T Consensus 281 ~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 281 PVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHHHHhccCChhhhccHHHhhhcc
Confidence 999999999999999999999997
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=356.81 Aligned_cols=259 Identities=32% Similarity=0.456 Sum_probs=202.3
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---------cchHHHHHHHHHHHhhhcCCCCCcEEEe
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---------FLNQAQIEVQLLEKINKADIHSRYIVKL 176 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---------~~~~~~~e~~~~~~l~~~~~~h~~iv~l 176 (437)
..+.++|.+.+.||+|+||.||+|.+..+++.||||++..... ....+..|+.++..+ .||||+++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~ 80 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-----NHPCIIKI 80 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-----CCTTBCCE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-----CCCCCceE
Confidence 3456789999999999999999999999999999999864321 123456788888876 68999999
Q ss_pred cceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC-CCC
Q psy11727 177 KGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK-RSA 254 (437)
Q Consensus 177 ~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~-~~~ 254 (437)
++++...+ .++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+. .+.
T Consensus 81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~~~ 155 (322)
T 2ycf_A 81 KNFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCL 155 (322)
T ss_dssp EEEEESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSSSCC
T ss_pred eeEEcCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEEecCCCCCe
Confidence 99987655 8999999965 898888654 4589999999999999999999964 899999999999994322 335
Q ss_pred EEEEeCCCceecCCcc--ccccccccccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHH
Q psy11727 255 IKIIDFGSSCHVGQTL--YQYIQSRYYRSPEVLL---GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ-MTKIIEV 328 (437)
Q Consensus 255 ikL~DFG~s~~~~~~~--~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~-~~~i~~~ 328 (437)
+||+|||++....... ....||+.|+|||++. +..++.++|||||||++|+|++|.+||.+...... ...+...
T Consensus 156 ~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (322)
T 2ycf_A 156 IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235 (322)
T ss_dssp EEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT
T ss_pred EEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC
Confidence 9999999998765432 3467899999999974 56789999999999999999999999987544322 2222221
Q ss_pred hCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHH
Q psy11727 329 LGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLIL 408 (437)
Q Consensus 329 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 408 (437)
.......... .....+.+||.
T Consensus 236 ~~~~~~~~~~-----------------------------------------------------------~~~~~~~~li~ 256 (322)
T 2ycf_A 236 KYNFIPEVWA-----------------------------------------------------------EVSEKALDLVK 256 (322)
T ss_dssp CCCCCHHHHT-----------------------------------------------------------TSCHHHHHHHH
T ss_pred ccccCchhhh-----------------------------------------------------------hcCHHHHHHHH
Confidence 1111110000 00125789999
Q ss_pred HccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 409 RMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 409 ~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
+||+.||.+|||+.++|+||||++.
T Consensus 257 ~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 257 KLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred HHcccCHhhCCCHHHHhhCcCcCCH
Confidence 9999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=363.23 Aligned_cols=280 Identities=20% Similarity=0.329 Sum_probs=214.6
Q ss_pred eecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc----c--------------hHHHHHHHHHHHh
Q psy11727 102 IKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----L--------------NQAQIEVQLLEKI 163 (437)
Q Consensus 102 ~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~----~--------------~~~~~e~~~~~~l 163 (437)
...+..+.++|.+.+.||+|+||.||+|.+ +++.||||++...... . ..+..|+.++..+
T Consensus 23 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 100 (348)
T 2pml_X 23 VKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100 (348)
T ss_dssp ESSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred hhhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence 345566789999999999999999999998 8999999998643211 1 6677788887766
Q ss_pred hhcCCCCCcEEEecceeeECCEEEEEEEeccC-cHHHH------HHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCee
Q psy11727 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNL------IRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSII 236 (437)
Q Consensus 164 ~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~-~L~~~------l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~gii 236 (437)
.||||+++++++.+.+..++||||+++ +|.++ +.......+++..++.++.||+.||+|||+. .||+
T Consensus 101 -----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~i~ 174 (348)
T 2pml_X 101 -----KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE-KNIC 174 (348)
T ss_dssp -----CCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT-SCEE
T ss_pred -----CCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhcc-CCEe
Confidence 689999999999999999999999976 88887 5554346799999999999999999999961 4899
Q ss_pred eCCCCCCcEEEecCCCCCEEEEeCCCceecCC-ccccccccccccChhhhcCC-CCCC-cchHHHHHHHHHHHHhCCCCC
Q psy11727 237 HCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ-TLYQYIQSRYYRSPEVLLGI-PYDL-AIDMWSLGCILVELHTGEPLF 313 (437)
Q Consensus 237 HrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlG~il~elltg~~pf 313 (437)
||||||+|||+ +.++.+||+|||++..... ......|+..|+|||++.+. .++. ++|||||||++|+|++|.+||
T Consensus 175 H~dl~p~Nil~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 252 (348)
T 2pml_X 175 HRDVKPSNILM--DKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252 (348)
T ss_dssp CCCCCGGGEEE--CTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred ecCCChHhEEE--cCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999 6788999999999987533 34456789999999999887 6666 999999999999999999999
Q ss_pred CCCCH-HHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCC
Q psy11727 314 SGKNE-VDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNE 392 (437)
Q Consensus 314 ~~~~~-~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (437)
.+.+. .+....+.......|.. ...+...... . ..
T Consensus 253 ~~~~~~~~~~~~i~~~~~~~~~~-------~~~~~~~~~~----------~---------------------------~~ 288 (348)
T 2pml_X 253 SLKISLVELFNNIRTKNIEYPLD-------RNHFLYPLTN----------K---------------------------KS 288 (348)
T ss_dssp CCSSCSHHHHHHHTSCCCCCCCS-------SSSSTTTTCC----------------------------------------
T ss_pred CCCCcHHHHHHHHhccCcCCccc-------hhhhhccccc----------c---------------------------cc
Confidence 98776 55555443211110000 0000000000 0 00
Q ss_pred CCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 393 PGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 393 ~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
..........+.+||.+||+.||.+|||+.|+++||||++...
T Consensus 289 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 289 TCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp -----CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred ccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 0000111226789999999999999999999999999998653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=353.78 Aligned_cols=250 Identities=20% Similarity=0.218 Sum_probs=204.6
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+.++|++.+.||+|+||+||+|.+..+++.||||++... .....+..|+.+++.+. .|+||+++++++...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~----~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK-SRAPQLHLEYRFYKQLG----SGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETT-CSSCCHHHHHHHHHHHC----SCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccc-cchHHHHHHHHHHHHhh----CCCCCCEEEEEEecCCccE
Confidence 457899999999999999999999999999999999744 33456888999999885 6789999999999999999
Q ss_pred EEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCC-----EEEEeCCC
Q psy11727 188 LVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA-----IKIIDFGS 262 (437)
Q Consensus 188 lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~-----ikL~DFG~ 262 (437)
+||||++++|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++. +||+|||+
T Consensus 82 lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~--~iiHrDlkp~Nill--~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 82 MVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSK--NLIYRDVKPENFLI--GRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEE--CCGGGTCTTSEEECCCTT
T ss_pred EEEEeCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHeee--ccCCCCCCceEEEEEccc
Confidence 999999779999988653 4699999999999999999999964 89999999999999 55555 99999999
Q ss_pred ceecCCc----------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHh
Q psy11727 263 SCHVGQT----------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN---EVDQMTKIIEVL 329 (437)
Q Consensus 263 s~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~---~~~~~~~i~~~~ 329 (437)
+...... .....||+.|+|||++.+..++.++|||||||++|||++|++||.+.+ ..+.+..+....
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~ 236 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK 236 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence 9865322 135679999999999999999999999999999999999999998843 334444443321
Q ss_pred CCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHH
Q psy11727 330 GMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILR 409 (437)
Q Consensus 330 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 409 (437)
...+...... ....+.+||.+
T Consensus 237 ~~~~~~~~~~-----------------------------------------------------------~~p~~~~li~~ 257 (330)
T 2izr_A 237 RATPIEVLCE-----------------------------------------------------------NFPEMATYLRY 257 (330)
T ss_dssp HHSCHHHHTT-----------------------------------------------------------TCHHHHHHHHH
T ss_pred ccCCHHHHhc-----------------------------------------------------------cChHHHHHHHH
Confidence 1111110000 00147899999
Q ss_pred ccccCCCCCCCHHHHhc
Q psy11727 410 MLTYDPKKRISPTNVLR 426 (437)
Q Consensus 410 ~L~~dP~~R~t~~e~l~ 426 (437)
||+.||.+|||++++++
T Consensus 258 ~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 258 VRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHCCTTCCCCHHHHHH
T ss_pred HHhCCCCCCCCHHHHHH
Confidence 99999999999998875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=343.96 Aligned_cols=253 Identities=19% Similarity=0.183 Sum_probs=206.0
Q ss_pred CceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 105 ~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
+..+.++|++.+.||+|+||+||+|.+..+++.||||++... .....+..|+.+++.+. .|++++++++++....
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~e~~~~~~l~----~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLA----GCTGIPNVYYFGQEGL 79 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTT----TCTTCCCEEEEEEETT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC-CccHHHHHHHHHHHHHh----cCCCCCeEEeecCCCc
Confidence 456678999999999999999999999999999999998643 34456778998888875 5788999999999999
Q ss_pred EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCC-----EEEEe
Q psy11727 185 HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA-----IKIID 259 (437)
Q Consensus 185 ~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~-----ikL~D 259 (437)
..++||||++++|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||++ .++. +||+|
T Consensus 80 ~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~NIl~~--~~~~~~~~~~kl~D 154 (298)
T 1csn_A 80 HNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK--SLVYRDIKPDNFLIG--RPNSKNANMIYVVD 154 (298)
T ss_dssp EEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEEC--CSSSTTTTCEEECC
T ss_pred eeEEEEEecCCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEec--cCCCCCCCeEEEEE
Confidence 999999999889999998654 4599999999999999999999964 899999999999994 4443 99999
Q ss_pred CCCceecCCc----------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHH
Q psy11727 260 FGSSCHVGQT----------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGK---NEVDQMTKII 326 (437)
Q Consensus 260 FG~s~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~---~~~~~~~~i~ 326 (437)
||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|++||.+. .....+..+.
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234 (298)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence 9999765432 23457899999999999999999999999999999999999999874 3444444444
Q ss_pred HHhCCCCh-hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHH
Q psy11727 327 EVLGMPPG-YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKD 405 (437)
Q Consensus 327 ~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 405 (437)
.....++. ..... ....+.+
T Consensus 235 ~~~~~~~~~~~~~~-----------------------------------------------------------~~~~l~~ 255 (298)
T 1csn_A 235 EKKQSTPLRELCAG-----------------------------------------------------------FPEEFYK 255 (298)
T ss_dssp HHHHHSCHHHHTTT-----------------------------------------------------------SCHHHHH
T ss_pred hhccCccHHHHHhh-----------------------------------------------------------CcHHHHH
Confidence 33221111 11000 0015789
Q ss_pred HHHHccccCCCCCCCHHHHhc
Q psy11727 406 LILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 406 li~~~L~~dP~~R~t~~e~l~ 426 (437)
||.+||+.||.+|||++++++
T Consensus 256 li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 256 YMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHhcCCcccCCCHHHHHH
Confidence 999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=348.52 Aligned_cols=251 Identities=27% Similarity=0.460 Sum_probs=209.5
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+.|++.+.||+|+||+||+|.+..+++.||||++.... .....+..|+.++..+ .|+||+++++++.+.+.+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-----CCCCEeEEEEEEecCCeE
Confidence 467999999999999999999999999999999997442 2345667788887776 789999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++||||+++ +|.+++.. ..+++..+..++.||+.||.|||++ ||+||||||+||++ +.++.+||+|||++..
T Consensus 96 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~--~~~~~~kl~Dfg~~~~ 168 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE--KKIHRDIKAANVLL--SEHGEVKLADFGVAGQ 168 (303)
T ss_dssp EEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEE--CTTSCEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCChheEEE--CCCCCEEEeeccccee
Confidence 999999976 88888765 3589999999999999999999964 89999999999999 6788899999999976
Q ss_pred cCCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 266 VGQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 266 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+... .++. .
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~-~------ 239 (303)
T 3a7i_A 169 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--NPPT-L------ 239 (303)
T ss_dssp CBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CCCC-C------
T ss_pred cCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--CCCC-C------
Confidence 6432 23467899999999999999999999999999999999999999988776655544321 0000 0
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
+ ......+.+||.+||+.||.+|||+.
T Consensus 240 --------------------------~---------------------------~~~~~~l~~li~~~l~~dp~~Rps~~ 266 (303)
T 3a7i_A 240 --------------------------E---------------------------GNYSKPLKEFVEACLNKEPSFRPTAK 266 (303)
T ss_dssp --------------------------C---------------------------SSCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred --------------------------c---------------------------cccCHHHHHHHHHHcCCChhhCcCHH
Confidence 0 00012578999999999999999999
Q ss_pred HHhcCCCcCcC
Q psy11727 423 NVLRHEFFLKH 433 (437)
Q Consensus 423 e~l~Hp~~~~~ 433 (437)
++++||||.+.
T Consensus 267 ~ll~~~~~~~~ 277 (303)
T 3a7i_A 267 ELLKHKFILRN 277 (303)
T ss_dssp HHTTCHHHHHH
T ss_pred HHhhChhhhcC
Confidence 99999999654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=361.71 Aligned_cols=262 Identities=27% Similarity=0.383 Sum_probs=179.6
Q ss_pred eeccCeeeec-eecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE---
Q psy11727 107 KFLDRYEIDT-LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--- 182 (437)
Q Consensus 107 ~~~~~y~i~~-~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--- 182 (437)
.+.++|.+.+ +||+|+||+||+|.+..+++.||||++.... ....|+...... ..|+||+++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~----~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQA----SGGPHIVCILDVYENMHH 96 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHH----TTSTTBCCEEEEEEEEET
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHh----cCCCChHHHHHHHhhccC
Confidence 4578999965 6999999999999999999999999997432 233333332222 278999999999986
Q ss_pred -CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC-CCCCEEEEe
Q psy11727 183 -KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP-KRSAIKIID 259 (437)
Q Consensus 183 -~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~-~~~~ikL~D 259 (437)
...+++||||+.+ +|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.+ ..+.+||+|
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~--~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH--NIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEEecCCCceEEEec
Confidence 5579999999966 899999877656799999999999999999999964 89999999999999542 256699999
Q ss_pred CCCceecCCc-cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 260 FGSSCHVGQT-LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 260 FG~s~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.........+......
T Consensus 175 fg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------- 247 (336)
T 3fhr_A 175 FGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL------- 247 (336)
T ss_dssp CTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred cccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc-------
Confidence 9999766433 34567899999999998888999999999999999999999999876544332111110000
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
+.+. ...+. +......+.+||.+||+.||.+|
T Consensus 248 --------------~~~~---------~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~R 279 (336)
T 3fhr_A 248 --------------GQYG---------FPNPE-------------------------WSEVSEDAKQLIRLLLKTDPTER 279 (336)
T ss_dssp -----------------C---------CCTTT-------------------------STTCCHHHHHHHHHHSCSSGGGS
T ss_pred --------------cccc---------cCchh-------------------------hccCCHHHHHHHHHHCCCChhHC
Confidence 0000 00000 00011267899999999999999
Q ss_pred CCHHHHhcCCCcCcC
Q psy11727 419 ISPTNVLRHEFFLKH 433 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~~ 433 (437)
||++|+|+||||++.
T Consensus 280 pt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 280 LTITQFMNHPWINQS 294 (336)
T ss_dssp CCHHHHHHSHHHHTG
T ss_pred cCHHHHhcCcccccc
Confidence 999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=353.25 Aligned_cols=256 Identities=30% Similarity=0.414 Sum_probs=196.2
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE-----
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW----- 182 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~----- 182 (437)
+.++|++.+.||+|+||+||+|.+..+++.||||++.........+..|+.++..+ .||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-----NHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEECCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-----CchHHHHHHHHHHhhcchh
Confidence 46789999999999999999999999999999999975444445566677776655 78999999998865
Q ss_pred --------CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC
Q psy11727 183 --------KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS 253 (437)
Q Consensus 183 --------~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~ 253 (437)
.+.+++||||+++ +|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dlkp~Nil~--~~~~ 153 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ--GIIHRDLKPMNIFI--DESR 153 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEE--CTTS
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC--CeecccCCHHhEEE--cCCC
Confidence 4678999999965 8999987643 4578899999999999999999964 89999999999999 6788
Q ss_pred CEEEEeCCCceecCC-----------------ccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy11727 254 AIKIIDFGSSCHVGQ-----------------TLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSG 315 (437)
Q Consensus 254 ~ikL~DFG~s~~~~~-----------------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~ 315 (437)
.+||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++ ||..
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 899999999876532 12345689999999999865 68999999999999999998 5543
Q ss_pred C-CHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCC
Q psy11727 316 K-NEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPG 394 (437)
Q Consensus 316 ~-~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (437)
. +..+....+.......|. .
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~-----------------------------------------------------------~ 251 (303)
T 1zy4_A 231 GMERVNILKKLRSVSIEFPP-----------------------------------------------------------D 251 (303)
T ss_dssp HHHHHHHHHHHHSTTCCCCT-----------------------------------------------------------T
T ss_pred chhHHHHHHhccccccccCc-----------------------------------------------------------c
Confidence 2 222222222211000000 0
Q ss_pred CChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 395 HSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 395 ~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
.+......+.+||.+||+.||.+|||+.++++||||+....
T Consensus 252 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (303)
T 1zy4_A 252 FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQ 292 (303)
T ss_dssp CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCH
T ss_pred ccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCCh
Confidence 00111125789999999999999999999999999987543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=348.92 Aligned_cols=211 Identities=28% Similarity=0.380 Sum_probs=176.2
Q ss_pred cCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 104 HGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 104 ~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
.++.+.++|++.+.||+|+||+||+|.+..+++.||+|++..... ....+.+|+.++..+ .||||++++++
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~iv~~~~~ 79 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-----SHQNIVSMIDV 79 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-----CBTTBCCEEEE
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-----CCCCCceEEEe
Confidence 356678899999999999999999999999999999999854322 223445566665554 78999999999
Q ss_pred eeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 180 FTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 180 ~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
+.+.+.+++||||++| +|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+
T Consensus 80 ~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~Dlkp~Nil~--~~~~~~kl~ 153 (294)
T 4eqm_A 80 DEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDM--RIVHRDIKPQNILI--DSNKTLKIF 153 (294)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEE--CTTSCEEEC
T ss_pred eeeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEE--CCCCCEEEE
Confidence 9999999999999965 8999987653 589999999999999999999964 89999999999999 678899999
Q ss_pred eCCCceecCCc----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy11727 259 DFGSSCHVGQT----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKI 325 (437)
Q Consensus 259 DFG~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i 325 (437)
|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+........
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~ 224 (294)
T 4eqm_A 154 DFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH 224 (294)
T ss_dssp CCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH
T ss_pred eCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 99999765432 23457899999999999999999999999999999999999999998876654444
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=344.43 Aligned_cols=256 Identities=25% Similarity=0.356 Sum_probs=208.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE--C
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--K 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--~ 183 (437)
.++|++.+.||+|+||+||+|.+..+++.||+|++..... ....+..|+.++..+ .||||+++++++.+ .
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~ 79 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-----KHPNIVRYYDRIIDRTN 79 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEEGGG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-----CCCCCCeEEEEEecCCC
Confidence 5789999999999999999999999999999999974322 234456677777776 68999999998854 6
Q ss_pred CEEEEEEEeccC-cHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHhcCCCCC-----eeeCCCCCCcEEEecCCCCCE
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTN--FHGVSLNLTKKFAQQLCCALAFLSSPELS-----IIHCDLKPENILLCSPKRSAI 255 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~--~~~ls~~~~~~i~~qi~~aL~~LH~~~~g-----iiHrDiKp~NIll~~~~~~~i 255 (437)
+.+++||||+++ +|.+++.... ...+++..++.++.||+.||+|||++ | |+||||||+|||+ +.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~~~ivH~dl~p~NIl~--~~~~~~ 155 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR--SDGGHTVLHRDLKPANVFL--DGKQNV 155 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--C------CCCCCSGGGEEE--CSSSCE
T ss_pred ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc--cCCCCeeEEeccchhhEEE--cCCCCE
Confidence 799999999975 8999886532 24489999999999999999999964 6 9999999999999 678889
Q ss_pred EEEeCCCceecCCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy11727 256 KIIDFGSSCHVGQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332 (437)
Q Consensus 256 kL~DFG~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p 332 (437)
||+|||++...... .....|+..|+|||++.+..++.++||||||+++|+|++|.+||.+.+..+....+......+
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~ 235 (279)
T 2w5a_A 156 KLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 235 (279)
T ss_dssp EECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred EEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc
Confidence 99999999765433 234578999999999999999999999999999999999999999988776666654421100
Q ss_pred ChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc
Q psy11727 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412 (437)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 412 (437)
. | ......+.+||.+||+
T Consensus 236 ~-----------------------------------~---------------------------~~~~~~l~~li~~~l~ 253 (279)
T 2w5a_A 236 I-----------------------------------P---------------------------YRYSDELNEIITRMLN 253 (279)
T ss_dssp C-----------------------------------C---------------------------TTSCHHHHHHHHHHTC
T ss_pred C-----------------------------------C---------------------------cccCHHHHHHHHHHcC
Confidence 0 0 0001257899999999
Q ss_pred cCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 413 YDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 413 ~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
.||.+|||+.|+++|||+++...
T Consensus 254 ~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 254 LKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp SSGGGSCCHHHHHTSTTCCGGGS
T ss_pred CCcccCCCHHHHHhChhhhhhcc
Confidence 99999999999999999998654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=354.26 Aligned_cols=267 Identities=27% Similarity=0.406 Sum_probs=186.6
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
...++|++.+.||+|+||+||+|.+..+++.||||++.... .....+..|+.++ ..+.||||+++++++...+
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l-----~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAM-----SQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CC-----CCCCCTTBCCEEEEEESSS
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHH-----hhcCCCCEeeEEEEEeecC
Confidence 33578999999999999999999998899999999986432 1122333444433 3457999999999999999
Q ss_pred EEEEEEEecc-CcHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 185 HLCLVFELLS-YNLYNLIRNT------NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 185 ~~~lV~E~~~-~~L~~~l~~~------~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
..++||||++ ++|.+++... ....+++..++.++.||+.||.|||++ ||+||||||+||++ +.++.+||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dl~p~Nil~--~~~~~~kl 162 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN--GQIHRDVKAGNILL--GEDGSVQI 162 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEE--CTTCCEEE
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC--CCCCCCCChhhEEE--cCCCCEEE
Confidence 9999999995 4898888641 234589999999999999999999964 89999999999999 67888999
Q ss_pred EeCCCceecCCc--------cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q psy11727 258 IDFGSSCHVGQT--------LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV 328 (437)
Q Consensus 258 ~DFG~s~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 328 (437)
+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.............
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 242 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence 999998654321 234578999999999976 56899999999999999999999999887765444332211
Q ss_pred hCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHH
Q psy11727 329 LGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLIL 408 (437)
Q Consensus 329 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 408 (437)
.++... . . .. .+.........+.+||.
T Consensus 243 --~~~~~~-~-~---------~~----------------------------------------~~~~~~~~~~~~~~li~ 269 (303)
T 2vwi_A 243 --DPPSLE-T-G---------VQ----------------------------------------DKEMLKKYGKSFRKMIS 269 (303)
T ss_dssp --SCCCTT-C-------------------------------------------------------CCCCCCCHHHHHHHH
T ss_pred --CCCccc-c-c---------cc----------------------------------------cchhhhhhhHHHHHHHH
Confidence 110000 0 0 00 00000000125789999
Q ss_pred HccccCCCCCCCHHHHhcCCCcCcCCC
Q psy11727 409 RMLTYDPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 409 ~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
+||+.||.+|||+.++++||||++...
T Consensus 270 ~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 270 LCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp HHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred HHccCChhhCcCHHHHhhChhhhcCCC
Confidence 999999999999999999999987643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=354.02 Aligned_cols=255 Identities=26% Similarity=0.408 Sum_probs=206.7
Q ss_pred ecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-------cchHHHHHHHHHHHhhhcCCCCCcEEE
Q psy11727 103 KHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-------FLNQAQIEVQLLEKINKADIHSRYIVK 175 (437)
Q Consensus 103 ~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-------~~~~~~~e~~~~~~l~~~~~~h~~iv~ 175 (437)
..++.+.++|++.+.||+|+||+||+|.+..+++.||||++..... ....+..|+.+++.+.+ .|+||++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~---~~~~i~~ 112 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS---GFSGVIR 112 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS---SSCSBCC
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhcc---CCCCceE
Confidence 3455678899999999999999999999999999999999974321 12455678999988864 5789999
Q ss_pred ecceeeECCEEEEEEEecc--CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCC
Q psy11727 176 LKGHFTWKNHLCLVFELLS--YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRS 253 (437)
Q Consensus 176 l~~~~~~~~~~~lV~E~~~--~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~ 253 (437)
+++++...+..++|||++. ++|.+++... ..+++..++.++.||+.||+|||+ .||+||||||+|||++ .+++
T Consensus 113 ~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll~-~~~~ 187 (320)
T 3a99_A 113 LLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN--CGVLHRDIKDENILID-LNRG 187 (320)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEEE-TTTT
T ss_pred EEEEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcEeCCCCHHHEEEe-CCCC
Confidence 9999999999999999995 5899988765 358999999999999999999995 4899999999999994 2567
Q ss_pred CEEEEeCCCceecCCc-cccccccccccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy11727 254 AIKIIDFGSSCHVGQT-LYQYIQSRYYRSPEVLLGIPY-DLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331 (437)
Q Consensus 254 ~ikL~DFG~s~~~~~~-~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 331 (437)
.+||+|||++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+. +... .
T Consensus 188 ~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~--~ 259 (320)
T 3a99_A 188 ELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--Q 259 (320)
T ss_dssp EEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--C
T ss_pred CEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc--c
Confidence 8999999999876543 334678999999999987665 6789999999999999999999975321 1110 0
Q ss_pred CChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 332 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
.. + + . .....+.+||.+||
T Consensus 260 ~~-------------~---------------------~-----------------------~----~~~~~~~~li~~~l 278 (320)
T 3a99_A 260 VF-------------F---------------------R-----------------------Q----RVSSECQHLIRWCL 278 (320)
T ss_dssp CC-------------C---------------------S-----------------------S----CCCHHHHHHHHHHT
T ss_pred cc-------------c---------------------c-----------------------c----cCCHHHHHHHHHHc
Confidence 00 0 0 0 00025789999999
Q ss_pred ccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 412 TYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 412 ~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
+.||.+|||++|+++||||++..
T Consensus 279 ~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 279 ALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp CSSGGGSCCHHHHHTSGGGSSCC
T ss_pred cCChhhCcCHHHHhcCHhhcCcc
Confidence 99999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=340.91 Aligned_cols=246 Identities=22% Similarity=0.312 Sum_probs=205.9
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.++|++.+.||+|+||+||+|.+. ++..||+|++.........+.+|+.+++.+ .||||+++++++.+.+..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-----SHPKLVQLYGVCLEQAPICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-----CCTTBCCEEEEECSSSSEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC-----CCCCEeeEEEEEecCCceEE
Confidence 468999999999999999999986 467899999986655566788898888877 68999999999999999999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
||||+++ +|.+++.... ..+++..++.++.||+.||+|||+ .||+||||||+||++ +.++.+||+|||++....
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~--~~i~H~dikp~Nil~--~~~~~~kl~Dfg~~~~~~ 157 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLV--GENQVIKVSDFGMTRFVL 157 (269)
T ss_dssp EEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--CGGGCEEECCTTGGGGBC
T ss_pred EEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHh--CCeecCCcchheEEE--cCCCCEEecccccccccc
Confidence 9999965 7888887654 468999999999999999999995 489999999999999 667889999999997664
Q ss_pred Ccc----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 268 QTL----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 268 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
... ....+|..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+......+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------- 230 (269)
T 4hcu_A 158 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR------- 230 (269)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT-------
T ss_pred ccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCC-------
Confidence 332 23455678999999998899999999999999999999 999999988877776664421111000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
.....+.+||.+||+.||.+|||+.
T Consensus 231 -------------------------------------------------------~~~~~~~~li~~~l~~~p~~Rps~~ 255 (269)
T 4hcu_A 231 -------------------------------------------------------LASTHVYQIMNHCWRERPEDRPAFS 255 (269)
T ss_dssp -------------------------------------------------------TSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred -------------------------------------------------------cCCHHHHHHHHHHccCCcccCcCHH
Confidence 0012578999999999999999999
Q ss_pred HHhcC
Q psy11727 423 NVLRH 427 (437)
Q Consensus 423 e~l~H 427 (437)
++++|
T Consensus 256 ~ll~~ 260 (269)
T 4hcu_A 256 RLLRQ 260 (269)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=352.77 Aligned_cols=203 Identities=13% Similarity=0.192 Sum_probs=170.6
Q ss_pred ccCeeeeceecccCceEEEEEEEcCC-----CeEEEEEEecCCcccchHHHHHHHHHHHhh----------hcCCCCCcE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEE-----KCQVAIKIIKNKKPFLNQAQIEVQLLEKIN----------KADIHSRYI 173 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~-----~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~----------~~~~~h~~i 173 (437)
.++|++.+.||+|+||+||+|.+..+ ++.||||++.... .....|+.+++.+. ...+.|+||
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC---HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc---hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 45899999999999999999998765 5789999987543 34555666665553 356789999
Q ss_pred EEecceeeEC----CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec
Q psy11727 174 VKLKGHFTWK----NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS 249 (437)
Q Consensus 174 v~l~~~~~~~----~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~ 249 (437)
+++++++... .+.||||||++++|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~--~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEH--EYVHGDIKASNLLLNY 187 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEES
T ss_pred CeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC--CeEEecCCHHHEEEec
Confidence 9999998875 5789999999779999987753 5699999999999999999999964 8999999999999964
Q ss_pred CCCCCEEEEeCCCceecCCcc----------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy11727 250 PKRSAIKIIDFGSSCHVGQTL----------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN 317 (437)
Q Consensus 250 ~~~~~ikL~DFG~s~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~ 317 (437)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|++||.+..
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 478899999999997653221 23459999999999999999999999999999999999999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=346.18 Aligned_cols=269 Identities=23% Similarity=0.343 Sum_probs=203.0
Q ss_pred CCCCCcceeecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCC
Q psy11727 94 DDENYDYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHS 170 (437)
Q Consensus 94 ~~~~~~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h 170 (437)
+....++.+.......++|.+.+.||+|+||.||+|.+. +++.||||++.... .....+..|+.++..+.+ .|
T Consensus 12 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~---~~ 87 (313)
T 3cek_A 12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ---HS 87 (313)
T ss_dssp --------CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGG---GC
T ss_pred cCCCCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccc---cC
Confidence 333344445555555678999999999999999999875 58899999996432 233566789999988864 46
Q ss_pred CcEEEecceeeECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC
Q psy11727 171 RYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP 250 (437)
Q Consensus 171 ~~iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~ 250 (437)
+||+++++++...+.+++|||+.+++|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+|||+.
T Consensus 88 ~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~-- 161 (313)
T 3cek_A 88 DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIV-- 161 (313)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEE--
T ss_pred CceEEEEEEeecCCEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCcccEEEE--
Confidence 89999999999999999999977789999998753 589999999999999999999964 899999999999994
Q ss_pred CCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcC-----------CCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy11727 251 KRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLG-----------IPYDLAIDMWSLGCILVELHTGEPLFS 314 (437)
Q Consensus 251 ~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlG~il~elltg~~pf~ 314 (437)
++.+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 162 -~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (313)
T 3cek_A 162 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240 (313)
T ss_dssp -TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchh
Confidence 3789999999997654322 24578999999999976 468889999999999999999999998
Q ss_pred CCCHH-HHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCC
Q psy11727 315 GKNEV-DQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEP 393 (437)
Q Consensus 315 ~~~~~-~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (437)
..... ..+..+......+ ..|.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~----------------------------------~~~~----------------------- 263 (313)
T 3cek_A 241 QIINQISKLHAIIDPNHEI----------------------------------EFPD----------------------- 263 (313)
T ss_dssp TCCSHHHHHHHHHCTTSCC----------------------------------CCCC-----------------------
T ss_pred hHHHHHHHHHHHHhccccc----------------------------------CCcc-----------------------
Confidence 75432 2222221100000 0000
Q ss_pred CCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 394 GHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 394 ~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
.....+.+||.+||+.||.+|||+.|+++||||+...
T Consensus 264 ----~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 264 ----IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp ----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred ----cchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 0012578999999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=343.44 Aligned_cols=254 Identities=25% Similarity=0.301 Sum_probs=197.5
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
...++|++.+.||+|+||+||+|.+ ++..||||++..... ....+.+|+.++..+ .||||+++++++.+.
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-----RHPNIVLFMGAVTQP 106 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEECST
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEEC
Confidence 3467899999999999999999976 678999999975432 223566788888777 689999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhcCCCCC--eeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNF-HGVSLNLTKKFAQQLCCALAFLSSPELS--IIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~-~~ls~~~~~~i~~qi~~aL~~LH~~~~g--iiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
+.+++||||+.+ +|.+++..... ..+++..++.++.||+.||+|||++ | |+||||||+|||+ +.++.+||+|
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~~~ivH~Dikp~NIll--~~~~~~kL~D 182 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR--NPPIVHRNLKSPNLLV--DKKYTVKVCD 182 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS--SSCCCCTTCCGGGEEE--CTTCCEEECC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC--CCCEECCCCChhhEEE--eCCCcEEECC
Confidence 999999999965 89998876431 2389999999999999999999965 7 9999999999999 6788999999
Q ss_pred CCCceecCCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 260 FGSSCHVGQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 260 FG~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......++
T Consensus 183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--- 259 (309)
T 3p86_A 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE--- 259 (309)
T ss_dssp CC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC---
T ss_pred CCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC---
Confidence 9999755433 3346789999999999999999999999999999999999999999887766655532111000
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
.| ......+.+||.+||+.||.
T Consensus 260 -------------------------------~~---------------------------~~~~~~l~~li~~~l~~dP~ 281 (309)
T 3p86_A 260 -------------------------------IP---------------------------RNLNPQVAAIIEGCWTNEPW 281 (309)
T ss_dssp -------------------------------CC---------------------------TTSCHHHHHHHHHHTCSSGG
T ss_pred -------------------------------CC---------------------------ccCCHHHHHHHHHHccCChh
Confidence 00 00012578999999999999
Q ss_pred CCCCHHHHhc--CCCcCc
Q psy11727 417 KRISPTNVLR--HEFFLK 432 (437)
Q Consensus 417 ~R~t~~e~l~--Hp~~~~ 432 (437)
+|||+.++++ +++++.
T Consensus 282 ~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 282 KRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp GSCCHHHHHHHHHHHHC-
T ss_pred hCcCHHHHHHHHHHHHHh
Confidence 9999999987 555543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=349.71 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=186.1
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCe---EEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKC---QVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~---~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
....++|++.+.||+|+||+||+|.+..++. .||||+++... .....+.+|+.++..+ .||||++++++
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~ 93 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-----DHPHVAKLVGV 93 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-----CCTTBCCCCEE
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-----CCCceehhhce
Confidence 3446789999999999999999999877765 89999997432 2234555676666655 78999999999
Q ss_pred eeECCEE------EEEEEeccC-cHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEe
Q psy11727 180 FTWKNHL------CLVFELLSY-NLYNLIRNTNF----HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLC 248 (437)
Q Consensus 180 ~~~~~~~------~lV~E~~~~-~L~~~l~~~~~----~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~ 248 (437)
+...+.. ++||||+.+ +|.+++..... ..+++..++.++.||+.||+|||++ ||+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--~ivH~Dikp~NIli- 170 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR--NFIHRDLAARNCML- 170 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE-
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC--CcccCCCCcceEEE-
Confidence 9877655 999999965 89988865321 2489999999999999999999964 89999999999999
Q ss_pred cCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy11727 249 SPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQM 322 (437)
Q Consensus 249 ~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~ 322 (437)
+.++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+..
T Consensus 171 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~ 249 (323)
T 3qup_A 171 -AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249 (323)
T ss_dssp -CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred -cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH
Confidence 678899999999997653322 22345778999999999999999999999999999999 99999998877666
Q ss_pred HHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhH
Q psy11727 323 TKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMK 402 (437)
Q Consensus 323 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (437)
..+......+.. ......
T Consensus 250 ~~~~~~~~~~~~--------------------------------------------------------------~~~~~~ 267 (323)
T 3qup_A 250 NYLIGGNRLKQP--------------------------------------------------------------PECMEE 267 (323)
T ss_dssp HHHHTTCCCCCC--------------------------------------------------------------TTCCHH
T ss_pred HHHhcCCCCCCC--------------------------------------------------------------CccCHH
Confidence 655432110000 000125
Q ss_pred HHHHHHHccccCCCCCCC-------HHHHhcCCCcCcCCCC
Q psy11727 403 FKDLILRMLTYDPKKRIS-------PTNVLRHEFFLKHSVD 436 (437)
Q Consensus 403 ~~dli~~~L~~dP~~R~t-------~~e~l~Hp~~~~~~~~ 436 (437)
+.+||.+||+.||.+||| .++++.|||+.....+
T Consensus 268 l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 268 VYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 789999999999999999 8889999999876543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=361.21 Aligned_cols=254 Identities=24% Similarity=0.301 Sum_probs=194.1
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
.+|.+.++||+|+||+||.. ...+++.||||++.... .....+|+.+++.+. .|||||++++++.+.+.+|+|
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~----~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPEC--FSFADREVQLLRESD----EHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTT--EEECHHHHHHHHHSC----CCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHH--HHHHHHHHHHHHhcc----CCCCcCeEEEEEecCCEEEEE
Confidence 36999999999999997643 45678999999996432 344567888888763 689999999999999999999
Q ss_pred EEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec---CCCCCEEEEeCCCceec
Q psy11727 190 FELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS---PKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 190 ~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~---~~~~~ikL~DFG~s~~~ 266 (437)
||+++++|.+++..... .+++..+..++.||+.||+|||++ ||+||||||+|||++. +....+||+|||+|...
T Consensus 97 ~E~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 97 IELCAATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSL--NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp EECCSEEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHT--TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred EECCCCCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHC--cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 99999999999987653 355666789999999999999964 8999999999999943 23346889999999766
Q ss_pred CC------ccccccccccccChhhhc---CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 267 GQ------TLYQYIQSRYYRSPEVLL---GIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 267 ~~------~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
.. .....+||+.|+|||++. +..++.++|||||||++|||++ |.+||........ ..+ .+......
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~---~~~~~~~~ 249 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NIL---LGACSLDC 249 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHH---TTCCCCTT
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHH---hccCCccc
Confidence 42 233467999999999998 4567889999999999999999 9999976544322 111 11000000
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
..........+.+||.+||+.||.
T Consensus 250 --------------------------------------------------------~~~~~~~~~~~~~li~~~L~~dP~ 273 (432)
T 3p23_A 250 --------------------------------------------------------LHPEKHEDVIARELIEKMIAMDPQ 273 (432)
T ss_dssp --------------------------------------------------------SCTTCHHHHHHHHHHHHHSCSSGG
T ss_pred --------------------------------------------------------cCccccccHHHHHHHHHHHhCCHh
Confidence 000011122578999999999999
Q ss_pred CCCCHHHHhcCCCcCcC
Q psy11727 417 KRISPTNVLRHEFFLKH 433 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~~~~ 433 (437)
+|||+.|+++||||...
T Consensus 274 ~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 274 KRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp GSCCHHHHHTSTTTCCH
T ss_pred hCCCHHHHHhCccccCh
Confidence 99999999999999753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=339.76 Aligned_cols=256 Identities=26% Similarity=0.432 Sum_probs=198.1
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
+|....+||+|+||+||+|.+..+++.||||++.... .....+..|+.++..+ .||||+++++++...+..++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-----KHKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-----CCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-----CCCCEeeEeeEEEeCCcEEEE
Confidence 3444558999999999999999999999999997543 2345566788777766 789999999999999999999
Q ss_pred EEeccC-cHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 190 FELLSY-NLYNLIRNTN-FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 190 ~E~~~~-~L~~~l~~~~-~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
||++++ +|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+||+++. .++.+||+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~-~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN--QIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEET-TTCCEEECCTTTCEESC
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC--CEEccCCChhhEEEEC-CCCCEEEeecccccccC
Confidence 999964 8988887643 23467899999999999999999964 8999999999999942 36789999999997764
Q ss_pred Cc---cccccccccccChhhhcCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 268 QT---LYQYIQSRYYRSPEVLLGIP--YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 268 ~~---~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.. .....|++.|+|||++.+.. ++.++|||||||++|+|++|+.||...................+.
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------- 246 (295)
T 2clq_A 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE-------- 246 (295)
T ss_dssp C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCC--------
T ss_pred CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccc--------
Confidence 32 23457899999999997643 889999999999999999999999765433221111111111100
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
.| ......+.+||.+||+.||.+|||+.
T Consensus 247 -------------------------~~---------------------------~~~~~~~~~li~~~l~~dp~~Rps~~ 274 (295)
T 2clq_A 247 -------------------------IP---------------------------ESMSAEAKAFILKCFEPDPDKRACAN 274 (295)
T ss_dssp -------------------------CC---------------------------TTSCHHHHHHHHHTTCSSTTTSCCHH
T ss_pred -------------------------cc---------------------------ccCCHHHHHHHHHHccCChhhCCCHH
Confidence 00 00012578999999999999999999
Q ss_pred HHhcCCCcCcCC
Q psy11727 423 NVLRHEFFLKHS 434 (437)
Q Consensus 423 e~l~Hp~~~~~~ 434 (437)
++|+||||+...
T Consensus 275 ~ll~~~~~~~~~ 286 (295)
T 2clq_A 275 DLLVDEFLKVSS 286 (295)
T ss_dssp HHHTSGGGCC--
T ss_pred HHhcChhhhhcc
Confidence 999999998654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=345.24 Aligned_cols=257 Identities=27% Similarity=0.384 Sum_probs=185.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccch--HHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLN--QAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~--~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.++|++.+.||+|+||+||+|.+..+++.||||++........ +...|... ......||||+++++++...+.+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~----~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV----VLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHH----HHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHH----HHHhcCCCceeeEEEEEecCCcE
Confidence 5789999999999999999999999999999999975432111 11112211 12234899999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
++||||+++.+..+.... ...+++..++.++.||+.||.|||++ .||+||||||+|||+ +.++.+||+|||++...
T Consensus 100 ~lv~e~~~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dlkp~Nil~--~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 100 FIAMELMGTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILL--DERGQIKLCDFGISGRL 175 (318)
T ss_dssp EEEECCCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHH-HCCCCCCCCGGGEEE--CTTSCEEECCCTTC---
T ss_pred EEEEeccCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhh-CCEEeCCCCHHHEEE--CCCCCEEEEECCCchhc
Confidence 999999965555555443 35689999999999999999999952 279999999999999 67889999999999765
Q ss_pred CCc--cccccccccccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCChhhhc
Q psy11727 267 GQT--LYQYIQSRYYRSPEVLL-----GIPYDLAIDMWSLGCILVELHTGEPLFSGK-NEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 267 ~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||... ...+.+..+.... ++.
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~---- 249 (318)
T 2dyl_A 176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE--PPL---- 249 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC--CCC----
T ss_pred cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC--CCC----
Confidence 332 23457899999999995 457889999999999999999999999874 4444444443311 100
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
.|... .....+.+||.+||+.||.+|
T Consensus 250 -----------------------------~~~~~-------------------------~~~~~l~~li~~~l~~dp~~R 275 (318)
T 2dyl_A 250 -----------------------------LPGHM-------------------------GFSGDFQSFVKDCLTKDHRKR 275 (318)
T ss_dssp -----------------------------CCSSS-------------------------CCCHHHHHHHHHHTCSCTTTS
T ss_pred -----------------------------CCccC-------------------------CCCHHHHHHHHHHccCChhHC
Confidence 00000 001257899999999999999
Q ss_pred CCHHHHhcCCCcCcC
Q psy11727 419 ISPTNVLRHEFFLKH 433 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~~ 433 (437)
||+.++++||||++.
T Consensus 276 ps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 276 PKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCHHHHTTSHHHHHH
T ss_pred cCHHHHhhCHHHHhc
Confidence 999999999999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=336.47 Aligned_cols=246 Identities=22% Similarity=0.298 Sum_probs=205.3
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.++|++.+.||+|+||+||+|.+. ++..||+|++.........+..|+.++..+ .||||+++++++.+.+..++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-----SHPKLVKFYGVCSKEYPIYI 80 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhC-----CCCCEeeEEEEEccCCceEE
Confidence 578999999999999999999775 567899999986665566788899988887 58999999999999999999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
||||+++ +|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+||++ +.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~Nil~--~~~~~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH--QFIHRDLAARNCLV--DRDLCVKVSDFGMTRYVL 155 (268)
T ss_dssp EEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT--TEEESSCSGGGEEE--CTTCCEEECCTTCEEECC
T ss_pred EEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCcCcceEEE--CCCCCEEEccCccceecc
Confidence 9999965 7999887653 3589999999999999999999964 89999999999999 678899999999997664
Q ss_pred Cccc----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 268 QTLY----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 268 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.... ...+|..|+|||++.+..++.++||||||+++|+|++ |.+||.+.+..+....+......+...
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------- 228 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH------- 228 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT-------
T ss_pred hhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCC-------
Confidence 3322 2345667999999999899999999999999999999 999999988877666654321111000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
.....+.+||.+||+.||.+|||+.
T Consensus 229 -------------------------------------------------------~~~~~l~~li~~~l~~~p~~Rps~~ 253 (268)
T 3sxs_A 229 -------------------------------------------------------LASDTIYQIMYSCWHELPEKRPTFQ 253 (268)
T ss_dssp -------------------------------------------------------TSCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred -------------------------------------------------------cChHHHHHHHHHHcCCChhhCcCHH
Confidence 0012578999999999999999999
Q ss_pred HHhcC
Q psy11727 423 NVLRH 427 (437)
Q Consensus 423 e~l~H 427 (437)
++++|
T Consensus 254 ~ll~~ 258 (268)
T 3sxs_A 254 QLLSS 258 (268)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=357.67 Aligned_cols=256 Identities=20% Similarity=0.246 Sum_probs=204.3
Q ss_pred eeccCeeeeceecccCceEEEEEE-----EcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAF-----DHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~-----~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
...++|.+.+.||+|+||+||+|. +..+++.||||+++... .....+.+|+.++..+ .||||++++++
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~ 142 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-----NHQNIVRCIGV 142 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEE
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-----CCCCCCeEEEE
Confidence 345789999999999999999999 45678899999996432 2223456677777776 78999999999
Q ss_pred eeECCEEEEEEEeccC-cHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC-CC
Q psy11727 180 FTWKNHLCLVFELLSY-NLYNLIRNTNF-----HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP-KR 252 (437)
Q Consensus 180 ~~~~~~~~lV~E~~~~-~L~~~l~~~~~-----~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~-~~ 252 (437)
+...+..++||||+.+ +|.+++..... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+ ..
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~ 220 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPG 220 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTT
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChhhEEEecCCCC
Confidence 9999999999999955 89999876532 3489999999999999999999964 89999999999999422 23
Q ss_pred CCEEEEeCCCceecC-----CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy11727 253 SAIKIIDFGSSCHVG-----QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKII 326 (437)
Q Consensus 253 ~~ikL~DFG~s~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~ 326 (437)
..+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+.
T Consensus 221 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp CCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 459999999996542 22234567889999999999999999999999999999998 999999998877776664
Q ss_pred HHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHH
Q psy11727 327 EVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406 (437)
Q Consensus 327 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 406 (437)
.....++.. .....+.+|
T Consensus 301 ~~~~~~~~~--------------------------------------------------------------~~~~~l~~l 318 (367)
T 3l9p_A 301 SGGRMDPPK--------------------------------------------------------------NCPGPVYRI 318 (367)
T ss_dssp TTCCCCCCT--------------------------------------------------------------TCCHHHHHH
T ss_pred cCCCCCCCc--------------------------------------------------------------cCCHHHHHH
Confidence 422111100 001157899
Q ss_pred HHHccccCCCCCCCHHHHhcCCCcC
Q psy11727 407 ILRMLTYDPKKRISPTNVLRHEFFL 431 (437)
Q Consensus 407 i~~~L~~dP~~R~t~~e~l~Hp~~~ 431 (437)
|.+||+.||.+|||+.++++|.++.
T Consensus 319 i~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 319 MTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 9999999999999999999987653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=339.96 Aligned_cols=246 Identities=21% Similarity=0.289 Sum_probs=203.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.++|++.+.||+|+||+||+|.+. ++..||+|++.........+..|+.++..+ .|+||+++++++.+.+..++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-----SHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-----CCTTBCCEEEEECSSSSEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcC-----CCCCEeeEEEEEecCCCeEE
Confidence 568999999999999999999875 677899999986655566778888888876 68999999999999999999
Q ss_pred EEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
||||+. ++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++....
T Consensus 97 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~Nili--~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK--QFLHRDLAARNCLV--NDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCSGGGEEE--CTTSCEEECSTTGGGGBC
T ss_pred EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC--CccCCCCccceEEE--cCCCCEEEcccccccccc
Confidence 999995 58999887643 4599999999999999999999964 89999999999999 678899999999997664
Q ss_pred Ccc----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 268 QTL----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 268 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
... ....+|+.|+|||++.+..++.++||||||+++|+|++ |++||.+.+..+....+......+....
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 245 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL------ 245 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTT------
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCc------
Confidence 332 22345678999999998899999999999999999998 9999999888777776654321111000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
....+.+||.+||+.||.+|||++
T Consensus 246 --------------------------------------------------------~~~~l~~li~~~l~~~p~~Rps~~ 269 (283)
T 3gen_A 246 --------------------------------------------------------ASEKVYTIMYSCWHEKADERPTFK 269 (283)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred --------------------------------------------------------CCHHHHHHHHHHccCChhHCcCHH
Confidence 012578999999999999999999
Q ss_pred HHhcC
Q psy11727 423 NVLRH 427 (437)
Q Consensus 423 e~l~H 427 (437)
++++|
T Consensus 270 ~ll~~ 274 (283)
T 3gen_A 270 ILLSN 274 (283)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=353.95 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=201.9
Q ss_pred ccCeeeeceecccCceEEEEEEEc-------CCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDH-------EEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~-------~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
.++|.+.+.||+|+||+||+|.+. .++..||||+++.... ....+..|+.++..+. .||||++++++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~hpnIv~~~~~ 155 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG----KHKNIINLLGA 155 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSC----CCTTBCCEEEE
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhc----CCCCEeeEEEE
Confidence 578999999999999999999874 3566899999975422 2345667888887763 68999999999
Q ss_pred eeECCEEEEEEEeccC-cHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q psy11727 180 FTWKNHLCLVFELLSY-NLYNLIRNTNF--------------HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPEN 244 (437)
Q Consensus 180 ~~~~~~~~lV~E~~~~-~L~~~l~~~~~--------------~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~N 244 (437)
|...+.+|+||||+++ +|.+++..... ..+++..+..++.||+.||+|||++ ||+||||||+|
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~N 233 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--KCIHRDLAARN 233 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGG
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--Ceeccccchhh
Confidence 9999999999999965 89999876431 3489999999999999999999964 89999999999
Q ss_pred EEEecCCCCCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy11727 245 ILLCSPKRSAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNE 318 (437)
Q Consensus 245 Ill~~~~~~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~ 318 (437)
||+ +.++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+.
T Consensus 234 Ill--~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 234 VLV--TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp EEE--CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EEE--CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999 77889999999999866432 223456788999999999999999999999999999999 9999998876
Q ss_pred HHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChh
Q psy11727 319 VDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398 (437)
Q Consensus 319 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (437)
.+....+......+. | ..
T Consensus 312 ~~~~~~~~~~~~~~~-----------------------------------~---------------------------~~ 329 (370)
T 2psq_A 312 EELFKLLKEGHRMDK-----------------------------------P---------------------------AN 329 (370)
T ss_dssp GGHHHHHHTTCCCCC-----------------------------------C---------------------------TT
T ss_pred HHHHHHHhcCCCCCC-----------------------------------C---------------------------CC
Confidence 665554432111000 0 00
Q ss_pred hhhHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 399 DYMKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 399 ~~~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
....+.+||.+||+.||.+|||+.|++++
T Consensus 330 ~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 330 CTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01257899999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=335.49 Aligned_cols=203 Identities=26% Similarity=0.327 Sum_probs=172.3
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+.++|++.+.||+|+||+||+|.+..+++.||||++... .....+..|+.++..+.+. +++..+..++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~e~~~l~~l~~~----~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-TKHPQLHIESKIYKMMQGG----VGIPTIRWCGAEGDYN 80 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESC-SSCCHHHHHHHHHHHHTTS----TTCCCEEEEEEETTEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCC-cchhHHHHHHHHHHHhhcC----CCCCccccccCCCCce
Confidence 4568999999999999999999999999999999998743 3446788899999998643 3444555556788899
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec-CCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS-PKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~-~~~~~ikL~DFG~s~~ 265 (437)
++||||++++|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||++. +.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 81 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEEecCCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 9999999889999987543 4699999999999999999999964 8999999999999931 2567899999999976
Q ss_pred cCCc----------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy11727 266 VGQT----------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN 317 (437)
Q Consensus 266 ~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~ 317 (437)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 5432 234578999999999999999999999999999999999999998743
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=356.90 Aligned_cols=259 Identities=27% Similarity=0.357 Sum_probs=194.5
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+.+.|.+.+.||+|+||+||.+. ..+|+.||||++... .......|+.++..+. .|||||++++++.+.+.+
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~----~HpnIv~~~~~~~~~~~~ 84 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID--FCDIALMEIKLLTESD----DHPNVIRYYCSETTDRFL 84 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHT----TSTTBCCEEEEEECSSEE
T ss_pred hhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH--HHHHHHHHHHHHHhcc----CCCCcCeEEEEEecCCeE
Confidence 345668888999999999998764 567899999998643 2355677888887663 789999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCC-----CCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC-----------
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHG-----VSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP----------- 250 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~-----ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~----------- 250 (437)
|+||||++++|.+++....... .++..++.++.||+.||+|||++ ||+||||||+|||++.+
T Consensus 85 ~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 85 YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC--CccccCCChHhEEEecCcccccccccCC
Confidence 9999999999999997654211 13334578999999999999964 89999999999999642
Q ss_pred CCCCEEEEeCCCceecCCc-------cccccccccccChhhhcC-------CCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q psy11727 251 KRSAIKIIDFGSSCHVGQT-------LYQYIQSRYYRSPEVLLG-------IPYDLAIDMWSLGCILVELHT-GEPLFSG 315 (437)
Q Consensus 251 ~~~~ikL~DFG~s~~~~~~-------~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~ellt-g~~pf~~ 315 (437)
.++.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|||++ |.+||.+
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 3457999999999876432 224579999999999976 578999999999999999999 9999987
Q ss_pred CCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCC
Q psy11727 316 KNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGH 395 (437)
Q Consensus 316 ~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (437)
..... ..+.......+. . ..-.
T Consensus 243 ~~~~~--~~i~~~~~~~~~------------------------------------~--------------------~~~~ 264 (434)
T 2rio_A 243 KYSRE--SNIIRGIFSLDE------------------------------------M--------------------KCLH 264 (434)
T ss_dssp TTTHH--HHHHHTCCCCCC------------------------------------C--------------------TTCC
T ss_pred chhhH--HHHhcCCCCccc------------------------------------c--------------------cccc
Confidence 65432 222221100000 0 0001
Q ss_pred ChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCc
Q psy11727 396 SLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLK 432 (437)
Q Consensus 396 ~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~ 432 (437)
.......+.+||.+||+.||.+|||+.++++||||..
T Consensus 265 ~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 265 DRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred cccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 1122236799999999999999999999999999964
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=347.66 Aligned_cols=249 Identities=20% Similarity=0.280 Sum_probs=200.8
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCC---eEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEK---CQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~---~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
+...++|.+.+.||+|+||+||+|.+..++ ..||||+++... .....+..|+.++..+ .||||+++++++
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~ 119 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-----DHPNIIRLEGVV 119 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEE
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEE
Confidence 344678999999999999999999998554 459999997532 2233455677776655 789999999999
Q ss_pred eECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 181 TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 181 ~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
.+.+.+++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||+ .||+||||||+|||+ +.++.+||+|
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~--~~ivH~Dlkp~NIll--~~~~~~kl~D 194 (325)
T 3kul_A 120 TRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSD--LGYVHRDLAARNVLV--DSNLVCKVSD 194 (325)
T ss_dssp CGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--CTTCCEEECC
T ss_pred EeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH--CCeeCCCCCcceEEE--CCCCCEEECC
Confidence 999999999999965 8999887653 469999999999999999999995 489999999999999 7788999999
Q ss_pred CCCceecCCcc------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Q psy11727 260 FGSSCHVGQTL------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMP 332 (437)
Q Consensus 260 FG~s~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p 332 (437)
||++....... ....+|..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 195 fg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 274 (325)
T 3kul_A 195 FGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP 274 (325)
T ss_dssp CSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred CCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC
Confidence 99998764321 12344678999999998899999999999999999999 999999988887777665432211
Q ss_pred ChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc
Q psy11727 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412 (437)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 412 (437)
... .....+.+||.+||.
T Consensus 275 ~~~--------------------------------------------------------------~~~~~l~~li~~~l~ 292 (325)
T 3kul_A 275 APM--------------------------------------------------------------GCPHALHQLMLDCWH 292 (325)
T ss_dssp CCT--------------------------------------------------------------TCCHHHHHHHHHHTC
T ss_pred CCC--------------------------------------------------------------CcCHHHHHHHHHHcc
Confidence 100 001257899999999
Q ss_pred cCCCCCCCHHHHhc
Q psy11727 413 YDPKKRISPTNVLR 426 (437)
Q Consensus 413 ~dP~~R~t~~e~l~ 426 (437)
.||.+|||+.++++
T Consensus 293 ~dp~~Rps~~eil~ 306 (325)
T 3kul_A 293 KDRAQRPRFSQIVS 306 (325)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=335.79 Aligned_cols=203 Identities=26% Similarity=0.330 Sum_probs=167.6
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+.++|++.+.||+|+||+||+|.+..+++.||||++... ........|+.+++.+.+ ++++..+..++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~e~~~l~~l~~----~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-TKHPQLHIESKIYKMMQG----GVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTT----STTCCCEEEEEEETTEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc-ccchHHHHHHHHHHHhcC----CCCCCeeeeecCCCCce
Confidence 3467899999999999999999999999999999987643 334567889999998863 33455566666788999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEe-cCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLC-SPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~-~~~~~~ikL~DFG~s~~ 265 (437)
++|||+++++|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+. .+.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 81 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEECCCCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEEccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 9999999889999987543 4599999999999999999999964 899999999999993 12467799999999976
Q ss_pred cCCc----------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy11727 266 VGQT----------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN 317 (437)
Q Consensus 266 ~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~ 317 (437)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 5432 124578999999999999999999999999999999999999998754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=345.67 Aligned_cols=256 Identities=29% Similarity=0.417 Sum_probs=195.0
Q ss_pred CceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-------cchHHHHHHHHHHHhhhcCCCCCcEEEec
Q psy11727 105 GEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-------FLNQAQIEVQLLEKINKADIHSRYIVKLK 177 (437)
Q Consensus 105 ~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-------~~~~~~~e~~~~~~l~~~~~~h~~iv~l~ 177 (437)
.+.+.++|++.+.||+|+||.||+|.+..+++.||||++..... .......|+.++..+... ..|+||++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~~h~~i~~~~ 104 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG-GGHPGVIRLL 104 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSS-CCCSSBCCEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhccc-CCCCCeeeEE
Confidence 45667899999999999999999999999999999999964432 123344688888877532 3789999999
Q ss_pred ceeeECCEEEEEEEe-cc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCE
Q psy11727 178 GHFTWKNHLCLVFEL-LS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAI 255 (437)
Q Consensus 178 ~~~~~~~~~~lV~E~-~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~i 255 (437)
+++...+..++|||+ +. ++|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+||+++ ..++.+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~-~~~~~~ 179 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSR--GVVHRDIKDENILID-LRRGCA 179 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH--TEECCCCSGGGEEEE-TTTTEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCChhhEEEe-CCCCeE
Confidence 999999999999999 54 58999987753 589999999999999999999964 899999999999994 167789
Q ss_pred EEEeCCCceecCCc-cccccccccccChhhhcCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy11727 256 KIIDFGSSCHVGQT-LYQYIQSRYYRSPEVLLGIPYD-LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333 (437)
Q Consensus 256 kL~DFG~s~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~ 333 (437)
||+|||++...... .....||..|+|||++.+..+. .++|||||||++|+|++|+.||.+... +.......
T Consensus 180 kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~- 252 (312)
T 2iwi_A 180 KLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHF- 252 (312)
T ss_dssp EECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTCCCC-
T ss_pred EEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------HhhhccCC-
Confidence 99999999876443 3456789999999999876664 589999999999999999999975321 11100000
Q ss_pred hhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
+ ......+.+||.+||+.
T Consensus 253 -----------------------------------~---------------------------~~~~~~~~~li~~~l~~ 270 (312)
T 2iwi_A 253 -----------------------------------P---------------------------AHVSPDCCALIRRCLAP 270 (312)
T ss_dssp -----------------------------------C---------------------------TTSCHHHHHHHHHHTCS
T ss_pred -----------------------------------c---------------------------ccCCHHHHHHHHHHccC
Confidence 0 00012578999999999
Q ss_pred CCCCCCCHHHHhcCCCcCcCCC
Q psy11727 414 DPKKRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 414 dP~~R~t~~e~l~Hp~~~~~~~ 435 (437)
||.+|||+.|+++||||+....
T Consensus 271 ~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 271 KPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp STTTSCCHHHHHHSTTTCC---
T ss_pred ChhhCcCHHHHhcChhhcCchh
Confidence 9999999999999999998653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=340.56 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=209.6
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
+...++|++.+.||+|+||+||+|.+..++..||+|++.........+..|+.+++.+ .||||+++++++.+.+.
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTREPP 83 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSS
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEccCCC
Confidence 3446789999999999999999999999999999999986665567778899988887 68999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+++||||+++ +|.+++.......+++..++.++.||+.||+|||++ ||+||||||+||++ +.++.+||+|||++.
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dikp~Nil~--~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLV--GENHLVKVADFGLSR 159 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH--TCCCSCCSGGGEEE--CGGGCEEECCCCGGG
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC--CccCCCCCcceEEE--cCCCCEEEccCccce
Confidence 9999999975 899999876666799999999999999999999964 89999999999999 677889999999997
Q ss_pred ecCCcc----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhcc
Q psy11727 265 HVGQTL----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 265 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 339 (437)
...... ....+|..|+|||++.+..++.++||||||+++|+|++ |.+||.+.+.......+......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 234 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP----- 234 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC-----
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCC-----
Confidence 664332 23445778999999998899999999999999999999 99999987766555544321110000
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
......+.+||.+||+.||.+||
T Consensus 235 ---------------------------------------------------------~~~~~~l~~li~~~l~~dp~~Rp 257 (288)
T 3kfa_A 235 ---------------------------------------------------------EGCPEKVYELMRACWQWNPSDRP 257 (288)
T ss_dssp ---------------------------------------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ---------------------------------------------------------CCCCHHHHHHHHHHhCCChhhCc
Confidence 00012578999999999999999
Q ss_pred CHHHHhc
Q psy11727 420 SPTNVLR 426 (437)
Q Consensus 420 t~~e~l~ 426 (437)
|+.++++
T Consensus 258 s~~~~~~ 264 (288)
T 3kfa_A 258 SFAEIHQ 264 (288)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=339.15 Aligned_cols=198 Identities=22% Similarity=0.341 Sum_probs=171.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.++|.+.+.||+|+||+||+|.+..+++.||+|++.... .....+..|+.++..+ .||||+++++++.+.+..+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-----EHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCcCcccEEEEEecCCeeE
Confidence 468999999999999999999999999999999886432 2334566677777665 6899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+.+ +|.+++.... ..+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~dlkp~Nil~--~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSM--NIIHRDLNSHNCLV--RENKNVVVADFGLARLM 158 (310)
T ss_dssp EEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSTTSEEE--CTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCCcCeEEE--CCCCCEEEeecccceec
Confidence 99999965 8999887743 4699999999999999999999964 89999999999999 67888999999999765
Q ss_pred CCccc-----------------cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy11727 267 GQTLY-----------------QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGK 316 (437)
Q Consensus 267 ~~~~~-----------------~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~ 316 (437)
..... ..+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 33221 457899999999999999999999999999999999999998753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=349.97 Aligned_cols=260 Identities=28% Similarity=0.392 Sum_probs=179.9
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccc--hHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFL--NQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~--~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.++|++.+.||+|+||.||+|.+..+++.||||++....... .+...|... ......||||+++++++...+..
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~----~~~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDV----VMRSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHH----HHSSCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHH----HHHcCCCCcEeeeeeEEEeCCce
Confidence 578999999999999999999999999999999997542211 122222221 22345899999999999999999
Q ss_pred EEEEEeccCcHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 187 CLVFELLSYNLYNLIRN---TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~---~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
++||||++++|.+++.. .....+++..+..++.|++.||.|||+. .||+||||||+|||+ +.++.+||+|||++
T Consensus 97 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~ivH~dlkp~NIll--~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 97 WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN-LKIIHRDIKPSNILL--DRSGNIKLCDFGIS 173 (327)
T ss_dssp EEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH-HSCCCSCCCGGGEEE--ETTTEEEECCCSSS
T ss_pred EEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc-CCEeECCCCHHHEEE--cCCCCEEEccCCCc
Confidence 99999999998887763 2235689999999999999999999953 379999999999999 56788999999999
Q ss_pred eecCCcc--ccccccccccChhhh----cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhh
Q psy11727 264 CHVGQTL--YQYIQSRYYRSPEVL----LGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEV-DQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 264 ~~~~~~~--~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~p~~~~ 336 (437)
....... ....||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.+.. +.+..+.. +.++
T Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~--- 248 (327)
T 3aln_A 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPP--- 248 (327)
T ss_dssp CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC--SCCC---
T ss_pred eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc--CCCC---
Confidence 7664332 234789999999999 4567899999999999999999999999864321 11000000 0000
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
..+ ..........+.+||.+||+.||.
T Consensus 249 ------------------------------~~~-----------------------~~~~~~~~~~l~~li~~~l~~dp~ 275 (327)
T 3aln_A 249 ------------------------------QLS-----------------------NSEEREFSPSFINFVNLCLTKDES 275 (327)
T ss_dssp ------------------------------CCC-----------------------CCSSCCCCHHHHHHHHHHTCSSGG
T ss_pred ------------------------------CCC-----------------------CcccccCCHHHHHHHHHHhhCChh
Confidence 000 000000112679999999999999
Q ss_pred CCCCHHHHhcCCCcCcC
Q psy11727 417 KRISPTNVLRHEFFLKH 433 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~~~~ 433 (437)
+|||+.++++||||++.
T Consensus 276 ~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 276 KRPKYKELLKHPFILMY 292 (327)
T ss_dssp GSCCHHHHTTSHHHHHH
T ss_pred hCcCHHHHHhChHHHHh
Confidence 99999999999999753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=349.66 Aligned_cols=198 Identities=27% Similarity=0.314 Sum_probs=162.3
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC----
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN---- 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~---- 184 (437)
.++|++.+.||+|+||+||+|.+. ++.||||++............|+.++ ..+.|||||++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l-----~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSL-----PGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTS-----TTCCCTTBCCEEEEEEEECSSSE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHH-----hcCCCCCchhhcceeccCCCCCc
Confidence 357999999999999999999864 78999999975433233333344443 3447999999999998744
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCC--------CCCeeeCCCCCCcEEEecCCCCCE
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP--------ELSIIHCDLKPENILLCSPKRSAI 255 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~--------~~giiHrDiKp~NIll~~~~~~~i 255 (437)
.+++||||+++ +|.+++... .+++..++.++.||+.||+|||+. ..||+||||||+|||+ +.++.+
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill--~~~~~~ 170 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL--KNNLTA 170 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE--CTTCCE
T ss_pred eEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE--CCCCeE
Confidence 58999999965 899998764 389999999999999999999953 1289999999999999 678899
Q ss_pred EEEeCCCceecCCc-----cccccccccccChhhhcCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy11727 256 KIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGI-----PYDLAIDMWSLGCILVELHTGEPLFSGKNE 318 (437)
Q Consensus 256 kL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~elltg~~pf~~~~~ 318 (437)
||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|||++|++||.+...
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 99999999765432 2335789999999999873 456788999999999999999999987543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=335.88 Aligned_cols=202 Identities=24% Similarity=0.330 Sum_probs=170.1
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccc--------hHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFL--------NQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~--------~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
..++|++.+.||+|+||+||+|.+..+++.||+|++....... ..+.+|+.++..+ .||||++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~ 91 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-----NHPNIVKLYGL 91 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-----CCTTBCCEEEE
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-----CCCCchhhhee
Confidence 3578999999999999999999999999999999986433221 4556677777665 68999999999
Q ss_pred eeECCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCC----
Q psy11727 180 FTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA---- 254 (437)
Q Consensus 180 ~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~---- 254 (437)
+.+.. ++||||+. ++|.+.+.... ..+++..++.++.||+.||+|||+++.+|+||||||+|||++ .++.
T Consensus 92 ~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~--~~~~~~~~ 166 (287)
T 4f0f_A 92 MHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ--SLDENAPV 166 (287)
T ss_dssp ETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES--CCCTTCSC
T ss_pred ecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe--ccCCCCce
Confidence 87666 69999996 58988887654 469999999999999999999996522299999999999994 4444
Q ss_pred -EEEEeCCCceecCCccccccccccccChhhhc--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy11727 255 -IKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLL--GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEV 319 (437)
Q Consensus 255 -ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~ 319 (437)
+||+|||++...........||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..
T Consensus 167 ~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 234 (287)
T 4f0f_A 167 CAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234 (287)
T ss_dssp CEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC
T ss_pred eEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc
Confidence 99999999988777777788999999999994 456789999999999999999999999876543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=346.04 Aligned_cols=257 Identities=14% Similarity=0.203 Sum_probs=191.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcC---CCeEEEEEEecCCcccchHHHHHHHHHHHh----------hhcCCCCCcEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHE---EKCQVAIKIIKNKKPFLNQAQIEVQLLEKI----------NKADIHSRYIVK 175 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l----------~~~~~~h~~iv~ 175 (437)
.++|.+.+.||+|+||+||+|.+.. ++..||||++.... .....|..+++.+ ....+.|+||++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~---~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN---GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC----CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCC---cchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 4689999999999999999999987 78899999987543 2233344333332 224458999999
Q ss_pred ecceeeE----CCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC
Q psy11727 176 LKGHFTW----KNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK 251 (437)
Q Consensus 176 l~~~~~~----~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~ 251 (437)
+++++.. ....|+||||++++|.+++.... .+++..++.++.||+.||+|||++ ||+||||||+|||++.+.
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN--EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEESSS
T ss_pred eecccccccCCCcEEEEEEeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCcCHHHEEEccCC
Confidence 9999988 78999999999779999887654 689999999999999999999964 899999999999996555
Q ss_pred CCCEEEEeCCCceecCCc----------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC--CCHH
Q psy11727 252 RSAIKIIDFGSSCHVGQT----------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG--KNEV 319 (437)
Q Consensus 252 ~~~ikL~DFG~s~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~--~~~~ 319 (437)
.+.+||+|||++...... .....||..|+|||++.+..++.++|||||||++|||++|+.||.+ .+..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 458999999999765322 1345789999999999999999999999999999999999999965 2333
Q ss_pred HHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhh
Q psy11727 320 DQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLAD 399 (437)
Q Consensus 320 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (437)
.............+..+....+. ...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~------------------------------------------------------~~~ 294 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWAPS------------------------------------------------------GSS 294 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHSCT------------------------------------------------------TSC
T ss_pred HHHHHHHhhcccccHHHHhhccc------------------------------------------------------ccc
Confidence 33322222222222222110000 000
Q ss_pred hhHHHHHHHHccccCCCCCCCHHHHhc
Q psy11727 400 YMKFKDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 400 ~~~~~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
...+.+||.+||+.||.+|||++++++
T Consensus 295 ~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 295 CCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp CHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 126799999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=350.60 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=201.6
Q ss_pred eeccCeeeeceecccCceEEEEEE-----EcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAF-----DHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~-----~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
...++|++.+.||+|+||.||+|. +..+++.||||+++.... ....+..|+.++..+. +||||++++++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~hpniv~~~~~ 94 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG----HHLNVVNLLGA 94 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEE
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhc----CCcceeeeeee
Confidence 346789999999999999999998 456779999999975332 2345778898888885 68999999999
Q ss_pred eeECC-EEEEEEEeccC-cHHHHHHhcCC---------------------------------------------------
Q psy11727 180 FTWKN-HLCLVFELLSY-NLYNLIRNTNF--------------------------------------------------- 206 (437)
Q Consensus 180 ~~~~~-~~~lV~E~~~~-~L~~~l~~~~~--------------------------------------------------- 206 (437)
+...+ .+++||||+.+ +|.+++.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 88755 59999999965 89999876532
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc----
Q psy11727 207 -------------HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT---- 269 (437)
Q Consensus 207 -------------~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~---- 269 (437)
..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++......
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~--~ivH~Dikp~NIll--~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILL--SEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE--CGGGCEEECCCGGGSCTTSCTTCE
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChhhEEE--cCCCcEEEEeccceeeecccccch
Confidence 1289999999999999999999964 89999999999999 67888999999999765322
Q ss_pred -cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhh
Q psy11727 270 -LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYF 347 (437)
Q Consensus 270 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~ 347 (437)
.....||..|+|||++.+..++.++|||||||++|||++ |.+||.+....+.+.........++.
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~------------- 317 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA------------- 317 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC-------------
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC-------------
Confidence 234567889999999999999999999999999999998 99999887655444444332111100
Q ss_pred cccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 348 DRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
| ......+.+||.+||+.||.+|||+.|+++|
T Consensus 318 ---------------------~---------------------------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 318 ---------------------P---------------------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ---------------------C---------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------C---------------------------CCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 0 0001257899999999999999999999976
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=349.40 Aligned_cols=251 Identities=24% Similarity=0.311 Sum_probs=205.0
Q ss_pred eeccCeeeeceecccCceEEEEEEEcC-------CCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEec
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHE-------EKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLK 177 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~-------~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~ 177 (437)
...++|.+.+.||+|+||+||+|.+.. ++..||||+++.... ....+.+|+.++..+. .||||++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~hpnIv~~~ 141 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG----KHKNIINLL 141 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhc----CCchhhhhe
Confidence 345789999999999999999998754 336799999975422 2345667888888874 689999999
Q ss_pred ceeeECCEEEEEEEeccC-cHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCC
Q psy11727 178 GHFTWKNHLCLVFELLSY-NLYNLIRNTNF--------------HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKP 242 (437)
Q Consensus 178 ~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~--------------~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp 242 (437)
+++...+.+++||||+++ +|.+++..... ..+++..++.++.||+.||+|||++ ||+||||||
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp 219 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--KCIHRDLAA 219 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCc
Confidence 999999999999999965 89999976542 3589999999999999999999964 899999999
Q ss_pred CcEEEecCCCCCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q psy11727 243 ENILLCSPKRSAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGK 316 (437)
Q Consensus 243 ~NIll~~~~~~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~ 316 (437)
+|||+ +.++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 220 ~NIll--~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 220 RNVLV--TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GGEEE--CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEE--cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999 67889999999999765432 233456788999999999999999999999999999999 99999998
Q ss_pred CHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCC
Q psy11727 317 NEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHS 396 (437)
Q Consensus 317 ~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (437)
+..+....+.........
T Consensus 298 ~~~~~~~~~~~~~~~~~~-------------------------------------------------------------- 315 (382)
T 3tt0_A 298 PVEELFKLLKEGHRMDKP-------------------------------------------------------------- 315 (382)
T ss_dssp CHHHHHHHHHTTCCCCCC--------------------------------------------------------------
T ss_pred CHHHHHHHHHcCCCCCCC--------------------------------------------------------------
Confidence 877766655432111000
Q ss_pred hhhhhHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 397 LADYMKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 397 ~~~~~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
......+.+||.+||+.||.+|||++|+++|
T Consensus 316 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 316 SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0001257899999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=354.91 Aligned_cols=246 Identities=21% Similarity=0.319 Sum_probs=200.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.++|.+.+.||+|+||+||+|.+..+++.||||+++... .....+..|+.++..+ .||||+++++++...+.+
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-----SHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-----CCTTBCCEEEEECSSSSC
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEecCCCc
Confidence 468999999999999999999999999999999987432 1223455677777665 789999999999999999
Q ss_pred EEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++||||++ ++|.+++.... ..+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++..
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~--~ivHrDlkp~Nil~--~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK--CCIHRDLAARNCLV--TEKNVLKISDFGMSRE 262 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE--CTTCCEEECCGGGCEE
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC--CcCCcccCHHHEEE--cCCCcEEECcCCCcee
Confidence 99999996 58999887653 3589999999999999999999964 89999999999999 6788999999999987
Q ss_pred cCCcccc-----ccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhcc
Q psy11727 266 VGQTLYQ-----YIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 266 ~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 339 (437)
....... ..++..|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+......+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 338 (377)
T 3cbl_A 263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPE---- 338 (377)
T ss_dssp CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCT----
T ss_pred cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC----
Confidence 6543322 224667999999998889999999999999999998 999999988766655443321111000
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
.....+.+||.+||+.||.+||
T Consensus 339 ----------------------------------------------------------~~~~~l~~li~~cl~~dP~~Rp 360 (377)
T 3cbl_A 339 ----------------------------------------------------------LCPDAVFRLMEQCWAYEPGQRP 360 (377)
T ss_dssp ----------------------------------------------------------TCCHHHHHHHHHHTCSSGGGSC
T ss_pred ----------------------------------------------------------CCCHHHHHHHHHHcCCCchhCc
Confidence 0011578999999999999999
Q ss_pred CHHHHhc
Q psy11727 420 SPTNVLR 426 (437)
Q Consensus 420 t~~e~l~ 426 (437)
|++++++
T Consensus 361 s~~~i~~ 367 (377)
T 3cbl_A 361 SFSTIYQ 367 (377)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=354.97 Aligned_cols=245 Identities=21% Similarity=0.295 Sum_probs=201.1
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC-EE
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN-HL 186 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~-~~ 186 (437)
-.++|++.+.||+|+||+||+|.+. ++.||||+++... ....+..|+.++..+ .|||||++++++...+ .+
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQL-----RHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTC-----CCTTBCCEEEEEECTTSCE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhc-----cCCCEEEEEEEEEcCCCce
Confidence 3578999999999999999999874 7799999997543 456778899888876 7899999999987665 79
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++||||+++ +|.+++.......+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++..
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivHrDlkp~Nill--~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLV--SEDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEE--CTTSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCCHhhEEE--CCCCCEEEeeCCCccc
Confidence 999999965 899999877655589999999999999999999964 89999999999999 6788999999999987
Q ss_pred cCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc
Q psy11727 266 VGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344 (437)
Q Consensus 266 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 344 (437)
.........++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+......+...
T Consensus 339 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~--------- 409 (450)
T 1k9a_A 339 ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD--------- 409 (450)
T ss_dssp CC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCT---------
T ss_pred ccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC---------
Confidence 6555445577889999999999999999999999999999998 999999877666655554321111000
Q ss_pred hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHH
Q psy11727 345 KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNV 424 (437)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~ 424 (437)
.....+.+||.+||+.||.+|||+.++
T Consensus 410 -----------------------------------------------------~~~~~l~~li~~cl~~dp~~Rpt~~~l 436 (450)
T 1k9a_A 410 -----------------------------------------------------GCPPAVYDVMKNCWHLDAATRPTFLQL 436 (450)
T ss_dssp -----------------------------------------------------TCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -----------------------------------------------------cCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 001257899999999999999999998
Q ss_pred hc
Q psy11727 425 LR 426 (437)
Q Consensus 425 l~ 426 (437)
++
T Consensus 437 ~~ 438 (450)
T 1k9a_A 437 RE 438 (450)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=330.69 Aligned_cols=246 Identities=22% Similarity=0.302 Sum_probs=204.5
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.++|++.+.||+|+||.||+|.+. ++..||+|++.........+..|+.++..+ .||||+++++++.+.+..++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-----SHPKLVQLYGVCLEQAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-----CCTTBCCEEEEECSSSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-----CCCCEeeEEEEEccCCCeEE
Confidence 468999999999999999999986 677899999986655556777888888776 68999999999999999999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
|||++++ +|.+++.... ..+++..+..++.||+.||+|||++ ||+||||||+||++ +.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nili--~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLV--GENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp EECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCCGGGEEE--CGGGCEEECCTTGGGGBC
T ss_pred EEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCchheEEE--CCCCCEEEcccccccccc
Confidence 9999965 8999887653 4589999999999999999999964 89999999999999 677889999999997654
Q ss_pred Ccc----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 268 QTL----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 268 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
... ....++..|+|||++.+..++.++||||||+++|+|++ |.+||.+.+..+....+......+...
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~------- 228 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR------- 228 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT-------
T ss_pred cccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCc-------
Confidence 322 23456778999999998899999999999999999999 899999988777666654321110000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
.....+.+||.+||+.||.+|||+.
T Consensus 229 -------------------------------------------------------~~~~~l~~li~~~l~~~p~~Rps~~ 253 (267)
T 3t9t_A 229 -------------------------------------------------------LASTHVYQIMNHCWRERPEDRPAFS 253 (267)
T ss_dssp -------------------------------------------------------TSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred -------------------------------------------------------cCcHHHHHHHHHHccCChhhCcCHH
Confidence 0012578999999999999999999
Q ss_pred HHhcC
Q psy11727 423 NVLRH 427 (437)
Q Consensus 423 e~l~H 427 (437)
+++++
T Consensus 254 ~ll~~ 258 (267)
T 3t9t_A 254 RLLRQ 258 (267)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=331.69 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=188.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-----cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.++|++.+.||+|+||+||+|.+ ++..||||+++.... ....+..|+.+++.+ .||||+++++++.+.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-----KHPNIIALRGVCLKE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHC-----CCTTBCCEEEEECCC
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-----CCCCEeeEEEEEecC
Confidence 56899999999999999999987 478999999864322 234566788887776 689999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCC-CeeeCCCCCCcEEEecC------CCCCE
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPEL-SIIHCDLKPENILLCSP------KRSAI 255 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~-giiHrDiKp~NIll~~~------~~~~i 255 (437)
+..++||||+++ +|.+++.. ..+++..++.++.||+.||+|||+++. +|+||||||+|||++.+ .++.+
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred CceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence 999999999965 77777753 358999999999999999999997531 29999999999999532 26779
Q ss_pred EEEeCCCceecCCc-cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 256 KIIDFGSSCHVGQT-LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 256 kL~DFG~s~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|++||.+.+.......+......++
T Consensus 156 kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 234 (271)
T 3dtc_A 156 KITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP- 234 (271)
T ss_dssp EECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC-
T ss_pred EEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC-
Confidence 99999999765433 2346789999999999998999999999999999999999999998877655544432110000
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
.+ ......+.+||.+||+.|
T Consensus 235 ---------------------------------~~---------------------------~~~~~~~~~li~~~l~~~ 254 (271)
T 3dtc_A 235 ---------------------------------IP---------------------------STCPEPFAKLMEDCWNPD 254 (271)
T ss_dssp ---------------------------------CC---------------------------TTCCHHHHHHHHHHTCSS
T ss_pred ---------------------------------CC---------------------------cccCHHHHHHHHHHhcCC
Confidence 00 000125789999999999
Q ss_pred CCCCCCHHHHhcC
Q psy11727 415 PKKRISPTNVLRH 427 (437)
Q Consensus 415 P~~R~t~~e~l~H 427 (437)
|.+|||+.|+++|
T Consensus 255 p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 255 PHSRPSFTNILDQ 267 (271)
T ss_dssp GGGSCCHHHHHHH
T ss_pred cccCcCHHHHHHH
Confidence 9999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=362.51 Aligned_cols=248 Identities=22% Similarity=0.310 Sum_probs=208.1
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
-.++|.+.+.||+|+||+||+|.+..++..||||+++........+..|+.++..+ .|||||++++++...+.++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSCE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-----CCCCEeeEEEEEecCCcEE
Confidence 35679999999999999999999999999999999986655567788899999887 6899999999999999999
Q ss_pred EEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+. ++|.+++.......+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++...
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll--~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHRNLAARNCLV--GENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE--CGGGCEEECCTTCEECC
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChhhEEE--CCCCcEEEeecccceec
Confidence 9999996 5899999876656799999999999999999999964 89999999999999 67888999999999876
Q ss_pred CCccc----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 267 GQTLY----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 267 ~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
..... ...++..|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+......+..
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 441 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP------- 441 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC-------
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC-------
Confidence 43322 2344678999999998899999999999999999999 99999988766555544321111100
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
......+.+||.+||+.||.+|||+
T Consensus 442 -------------------------------------------------------~~~~~~l~~li~~cl~~dP~~RPs~ 466 (495)
T 1opk_A 442 -------------------------------------------------------EGCPEKVYELMRACWQWNPSDRPSF 466 (495)
T ss_dssp -------------------------------------------------------TTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -------------------------------------------------------CCCCHHHHHHHHHHcCcChhHCcCH
Confidence 0001257899999999999999999
Q ss_pred HHHhc
Q psy11727 422 TNVLR 426 (437)
Q Consensus 422 ~e~l~ 426 (437)
.++++
T Consensus 467 ~el~~ 471 (495)
T 1opk_A 467 AEIHQ 471 (495)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=345.74 Aligned_cols=196 Identities=16% Similarity=0.149 Sum_probs=166.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCC--------CeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEE-----
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEE--------KCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVK----- 175 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~--------~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~----- 175 (437)
.++|.+.+.||+|+||+||+|.+..+ ++.||||++... ..+..|+.+++.+. ||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~-----h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAA-----KPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHC-----CHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhc-----ccchhhhhhhh
Confidence 36899999999999999999999874 789999999744 46778999998884 555555
Q ss_pred ----------ecceeeE-CCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q psy11727 176 ----------LKGHFTW-KNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPEN 244 (437)
Q Consensus 176 ----------l~~~~~~-~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~N 244 (437)
+++++.. .+..++||||++++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dikp~N 189 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN--EYVHGNVTAEN 189 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCCGGG
T ss_pred ccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCCHHH
Confidence 6777776 7899999999977999999876445699999999999999999999964 89999999999
Q ss_pred EEEecCCCC--CEEEEeCCCceecCCcc----------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCC
Q psy11727 245 ILLCSPKRS--AIKIIDFGSSCHVGQTL----------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPL 312 (437)
Q Consensus 245 Ill~~~~~~--~ikL~DFG~s~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p 312 (437)
||++ .++ .+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 190 Il~~--~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 190 IFVD--PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EEEE--TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred EEEc--CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9995 455 89999999997653321 234789999999999999999999999999999999999999
Q ss_pred CCCCC
Q psy11727 313 FSGKN 317 (437)
Q Consensus 313 f~~~~ 317 (437)
|.+..
T Consensus 268 f~~~~ 272 (352)
T 2jii_A 268 WTNCL 272 (352)
T ss_dssp TGGGT
T ss_pred cccCC
Confidence 98764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.42 Aligned_cols=198 Identities=23% Similarity=0.321 Sum_probs=162.4
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE---
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--- 182 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--- 182 (437)
..+.++|++.+.||+|+||+||+|.+ +++.||||++.... ......|..++.... +.||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~---l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVM---LRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTC---CCCTTBCCEEEEEEEEET
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhh---ccCcCeeeEEEeeccccC
Confidence 45678999999999999999999986 68899999996432 344455666655532 489999999998764
Q ss_pred -CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCC------CCCeeeCCCCCCcEEEecCCCCC
Q psy11727 183 -KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP------ELSIIHCDLKPENILLCSPKRSA 254 (437)
Q Consensus 183 -~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~------~~giiHrDiKp~NIll~~~~~~~ 254 (437)
...+++||||+++ +|.+++... .+++..+..++.||+.||+|||.. ..||+||||||+|||+ +.++.
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill--~~~~~ 151 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV--KKNGQ 151 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE--CTTSC
T ss_pred CCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE--cCCCC
Confidence 3578999999965 899998543 589999999999999999999932 3489999999999999 67889
Q ss_pred EEEEeCCCceecCCcc-------ccccccccccChhhhcCC------CCCCcchHHHHHHHHHHHHhC----------CC
Q psy11727 255 IKIIDFGSSCHVGQTL-------YQYIQSRYYRSPEVLLGI------PYDLAIDMWSLGCILVELHTG----------EP 311 (437)
Q Consensus 255 ikL~DFG~s~~~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~elltg----------~~ 311 (437)
+||+|||++....... ....||+.|+|||++.+. .++.++|||||||++|||++| .+
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 9999999997653322 234789999999999886 455789999999999999999 88
Q ss_pred CCCC
Q psy11727 312 LFSG 315 (437)
Q Consensus 312 pf~~ 315 (437)
||..
T Consensus 232 pf~~ 235 (301)
T 3q4u_A 232 PFYD 235 (301)
T ss_dssp TTTT
T ss_pred cccc
Confidence 8855
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=343.43 Aligned_cols=250 Identities=24% Similarity=0.328 Sum_probs=202.4
Q ss_pred eeccCeeeeceecccCceEEEEEEEc-----CCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
...++|++.+.||+|+||.||+|.+. .+++.||||+++.... ....+.+|+.++..+ .||||++++++
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~ 118 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-----DNPNIVKLLGV 118 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEE
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-----CCCCEEEEEEE
Confidence 34678999999999999999999987 4558999999975322 234566777777766 68999999999
Q ss_pred eeECCEEEEEEEeccC-cHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCee
Q psy11727 180 FTWKNHLCLVFELLSY-NLYNLIRNTN----------------------FHGVSLNLTKKFAQQLCCALAFLSSPELSII 236 (437)
Q Consensus 180 ~~~~~~~~lV~E~~~~-~L~~~l~~~~----------------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~gii 236 (437)
+.+.+..++||||+++ +|.+++.... ...+++..++.++.||+.||.|||++ ||+
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--~iv 196 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFV 196 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--TCC
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC--Cee
Confidence 9999999999999965 8999987642 14689999999999999999999964 899
Q ss_pred eCCCCCCcEEEecCCCCCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CC
Q psy11727 237 HCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GE 310 (437)
Q Consensus 237 HrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~ 310 (437)
||||||+|||+ +.++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 197 H~Dlkp~NIl~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 197 HRDLATRNCLV--GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CSCCSGGGEEE--CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred cCCCCcceEEE--CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 99999999999 67888999999999765322 223567889999999998899999999999999999999 99
Q ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCC
Q psy11727 311 PLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRR 390 (437)
Q Consensus 311 ~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (437)
.||.+.+..+....+......+. |
T Consensus 275 ~p~~~~~~~~~~~~~~~~~~~~~-----------------------------------~--------------------- 298 (343)
T 1luf_A 275 QPYYGMAHEEVIYYVRDGNILAC-----------------------------------P--------------------- 298 (343)
T ss_dssp CTTTTSCHHHHHHHHHTTCCCCC-----------------------------------C---------------------
T ss_pred CcCCCCChHHHHHHHhCCCcCCC-----------------------------------C---------------------
Confidence 99999887776665543211000 0
Q ss_pred CCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 391 NEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 391 ~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
......+.+||.+||+.||.+|||+.+++++
T Consensus 299 ------~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 299 ------ENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 0001157899999999999999999999863
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=335.78 Aligned_cols=245 Identities=22% Similarity=0.330 Sum_probs=195.8
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCC-------eEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEK-------CQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~-------~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
..++|.+.+.||+|+||+||+|.+..++ ..||+|++.... .....+..|+.++..+ .||||++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~ 80 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-----SHKHLVLNYGV 80 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-----CCTTBCCEEEE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-----CCCCEeEEEEE
Confidence 3578999999999999999999988877 579999986433 2335566788777776 68999999999
Q ss_pred eeECCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCC----
Q psy11727 180 FTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSA---- 254 (437)
Q Consensus 180 ~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~---- 254 (437)
+.+.+..++||||+. ++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++. ++.
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~--~~~~~~~ 155 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEEN--TLIHGNVCAKNILLIR--EEDRKTG 155 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEEE--CCBGGGT
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhC--CeECCCcCcceEEEec--CCccccc
Confidence 999999999999996 58999987653 3489999999999999999999964 8999999999999954 444
Q ss_pred ----EEEEeCCCceecCCccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHH
Q psy11727 255 ----IKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTG-EPLFSGKNEVDQMTKIIEV 328 (437)
Q Consensus 255 ----ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg-~~pf~~~~~~~~~~~i~~~ 328 (437)
+||+|||++...... ....||..|+|||++.+ ..++.++|||||||++|+|++| .+||...+...........
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234 (289)
T ss_dssp BCCEEEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred ccceeeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc
Confidence 999999998765443 34568899999999988 6799999999999999999995 5666665554433322211
Q ss_pred hCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHH
Q psy11727 329 LGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLIL 408 (437)
Q Consensus 329 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 408 (437)
...|+. ....+.+||.
T Consensus 235 ~~~~~~----------------------------------------------------------------~~~~l~~li~ 250 (289)
T 4fvq_A 235 HQLPAP----------------------------------------------------------------KAAELANLIN 250 (289)
T ss_dssp CCCCCC----------------------------------------------------------------SSCTTHHHHH
T ss_pred CCCCCC----------------------------------------------------------------CCHHHHHHHH
Confidence 100000 0014689999
Q ss_pred HccccCCCCCCCHHHHhcC
Q psy11727 409 RMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 409 ~~L~~dP~~R~t~~e~l~H 427 (437)
+||+.||.+|||+.++++|
T Consensus 251 ~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 251 NCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHSCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhHCcCHHHHHHH
Confidence 9999999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=342.36 Aligned_cols=204 Identities=26% Similarity=0.370 Sum_probs=155.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceee------
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT------ 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~------ 181 (437)
..+|++.+.||+|+||+||+|.+..+++.||||++.... .....+..|+.++..+. .||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS----GHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHT----TSTTBCCEEEEEEECTTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhc----cCCChhhcccccccccccc
Confidence 458999999999999999999999999999999885433 22345667888888774 5899999999984
Q ss_pred --ECCEEEEEEEeccCcHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 182 --WKNHLCLVFELLSYNLYNLIRN-TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 182 --~~~~~~lV~E~~~~~L~~~l~~-~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
....+++||||++|+|.+++.. .....+++..++.++.||+.||+|||+++.+|+||||||+|||+ +.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~--~~~~~~kl~ 180 (337)
T 3ll6_A 103 DTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL--SNQGTIKLC 180 (337)
T ss_dssp TTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE--CTTSCEEBC
T ss_pred ccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE--CCCCCEEEe
Confidence 3456899999999999998865 23345999999999999999999999652239999999999999 678889999
Q ss_pred eCCCceecCCcc---------------ccccccccccChhhh---cCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy11727 259 DFGSSCHVGQTL---------------YQYIQSRYYRSPEVL---LGIPYDLAIDMWSLGCILVELHTGEPLFSGKNE 318 (437)
Q Consensus 259 DFG~s~~~~~~~---------------~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~ 318 (437)
|||++....... ....||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+...
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 999997654321 144689999999998 566789999999999999999999999976543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=335.11 Aligned_cols=244 Identities=26% Similarity=0.445 Sum_probs=186.8
Q ss_pred eeccCeeee-ceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE---
Q psy11727 107 KFLDRYEID-TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--- 182 (437)
Q Consensus 107 ~~~~~y~i~-~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--- 182 (437)
.+.++|.+. +.||+|+||.||+|.+..+++.||+|++... .....|+.++..+. .||||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~----~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS----QCPHIVRIVDVYENLYA 85 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT----TSTTBCCEEEEEEEEET
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhc----cCCCchhHHhhhhhhcC
Confidence 346778887 7899999999999999999999999999743 45667777775543 78999999999987
Q ss_pred -CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC-CCCEEEEe
Q psy11727 183 -KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK-RSAIKIID 259 (437)
Q Consensus 183 -~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~-~~~ikL~D 259 (437)
...+++||||+++ +|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++.+. ++.+||+|
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEEecCCCCCcEEEec
Confidence 7789999999965 999999887656799999999999999999999964 899999999999995322 67899999
Q ss_pred CCCceecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhcc
Q psy11727 260 FGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 260 FG~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 339 (437)
||++.... +..++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 164 fg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~------------ 212 (299)
T 3m2w_A 164 FGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT------------ 212 (299)
T ss_dssp CTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC------------
T ss_pred cccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH------------
Confidence 99986443 23578899999999999999999999987654321110000
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
.+..+.+ ..| .... ......+.+||.+||+.||.+||
T Consensus 213 ---------~~~~~~~-----------~~~----~~~~-------------------~~~~~~~~~li~~~l~~dP~~Rp 249 (299)
T 3m2w_A 213 ---------RIRMGQY-----------EFP----NPEW-------------------SEVSEEVKMLIRNLLKTEPTQRM 249 (299)
T ss_dssp ---------SSCTTCC-----------SSC----HHHH-------------------TTSCHHHHHHHHHHTCSSTTTSC
T ss_pred ---------HHhhccc-----------cCC----chhc-------------------ccCCHHHHHHHHHHcccChhhCC
Confidence 0000000 000 0000 00112689999999999999999
Q ss_pred CHHHHhcCCCcCcCC
Q psy11727 420 SPTNVLRHEFFLKHS 434 (437)
Q Consensus 420 t~~e~l~Hp~~~~~~ 434 (437)
|+.|+++||||++..
T Consensus 250 s~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 250 TITEFMNHPWIMQST 264 (299)
T ss_dssp CHHHHHTSHHHHTGG
T ss_pred CHHHHhcChhhcccc
Confidence 999999999997653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=342.62 Aligned_cols=246 Identities=20% Similarity=0.252 Sum_probs=195.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeE----EEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQ----VAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~----vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
.++|++.+.||+|+||+||+|.+..+++. ||+|.+.... .....+..|+.++..+ .||||+++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~- 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-----DHAHIVRLLGLCP- 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-----CCTTBCCEEEEEC-
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-----CCCCcCeEEEEEc-
Confidence 46899999999999999999999888765 7778775332 2234556677777665 7899999999887
Q ss_pred CCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
.+..++||||+. ++|.+++.... ..+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dikp~Nil~--~~~~~~kl~Dfg 160 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEH--GMVHRNLAARNVLL--KSPSQVQVADFG 160 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHT--TCCCSCCSSTTEEE--SSSSCEEECSCS
T ss_pred CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhC--CCCCCccchheEEE--CCCCeEEECCCC
Confidence 466889999996 58999887653 4589999999999999999999964 89999999999999 678889999999
Q ss_pred CceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 262 SSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 262 ~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
++...... .....++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+......+...
T Consensus 161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
T 3kex_A 161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ 240 (325)
T ss_dssp GGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCT
T ss_pred cccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCC
Confidence 99765332 233456789999999998899999999999999999999 999999877666555543311110000
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
. ....+.+||.+||+.||
T Consensus 241 ~--------------------------------------------------------------~~~~~~~li~~~l~~dp 258 (325)
T 3kex_A 241 I--------------------------------------------------------------CTIDVYMVMVKCWMIDE 258 (325)
T ss_dssp T--------------------------------------------------------------BCTTTTHHHHHHTCSCT
T ss_pred c--------------------------------------------------------------CcHHHHHHHHHHcCCCh
Confidence 0 00135799999999999
Q ss_pred CCCCCHHHHhcC
Q psy11727 416 KKRISPTNVLRH 427 (437)
Q Consensus 416 ~~R~t~~e~l~H 427 (437)
.+|||+.++++|
T Consensus 259 ~~Rps~~el~~~ 270 (325)
T 3kex_A 259 NIRPTFKELANE 270 (325)
T ss_dssp TTSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=332.50 Aligned_cols=201 Identities=23% Similarity=0.368 Sum_probs=162.7
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc----chHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~----~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
..++|++.+.||+|+||+||+|.+..+++.||+|++...... ...+..|+.++..+ .||||+++++++...
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~iv~~~~~~~~~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-----QEPHVVPIHDFGEID 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEET
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-----CCCCeeEEEEEEeeC
Confidence 357899999999999999999999999999999999744222 23455566666554 789999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+..++|||++++ +|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dlkp~NIl~--~~~~~~kl~Dfg~ 180 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAA--GATHRDVKPENILV--SADDFAYLVDFGI 180 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEE--CTTSCEEECSCCC
T ss_pred CeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC--cCCcCCCChHHEEE--cCCCCEEEecCcc
Confidence 999999999976 8999887653 589999999999999999999964 89999999999999 6778899999999
Q ss_pred ceecCCc----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy11727 263 SCHVGQT----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEV 319 (437)
Q Consensus 263 s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~ 319 (437)
+...... .....|++.|+|||++.+..++.++||||||+++|+|++|++||.+.+..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 241 (309)
T 2h34_A 181 ASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS 241 (309)
T ss_dssp ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH
T ss_pred CccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH
Confidence 8765432 23457899999999999999999999999999999999999999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=339.02 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=199.1
Q ss_pred ccCeeeeceecccCceEEEEEEEc-----CCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|.+.+.||+|+||.||+|.+. .++..||||++..... ....+..|+.++..+ .||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-----NHPHVIKLYGACS 96 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-----CCCceeeEEEEEe
Confidence 578999999999999999999873 4568999999974321 223455666666555 7999999999999
Q ss_pred ECCEEEEEEEecc-CcHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeC
Q psy11727 182 WKNHLCLVFELLS-YNLYNLIRNTNF----------------------HGVSLNLTKKFAQQLCCALAFLSSPELSIIHC 238 (437)
Q Consensus 182 ~~~~~~lV~E~~~-~~L~~~l~~~~~----------------------~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHr 238 (437)
+.+..++||||+. ++|.+++..... ..+++..++.++.||+.||+|||++ ||+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~ 174 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM--KLVHR 174 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT--TEECC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC--CCccc
Confidence 9999999999996 589999876532 2389999999999999999999964 89999
Q ss_pred CCCCCcEEEecCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCC
Q psy11727 239 DLKPENILLCSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPL 312 (437)
Q Consensus 239 DiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p 312 (437)
||||+|||+ +.++.+||+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |.+|
T Consensus 175 dikp~NIli--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 175 DLAARNILV--AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCSGGGEEE--ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccchheEEE--cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999 567789999999997664321 23456788999999999889999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCC
Q psy11727 313 FSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNE 392 (437)
Q Consensus 313 f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (437)
|.+.+.......+......+. +
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~-----------------------------------~----------------------- 274 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTGHRMER-----------------------------------P----------------------- 274 (314)
T ss_dssp STTCCGGGHHHHHHTTCCCCC-----------------------------------C-----------------------
T ss_pred CCCCCHHHHHHHhhcCCcCCC-----------------------------------C-----------------------
Confidence 998877655544432110000 0
Q ss_pred CCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 393 PGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 393 ~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
......+.+||.+||+.||.+|||+.++++|
T Consensus 275 ----~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 275 ----DNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0001257899999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=341.98 Aligned_cols=246 Identities=19% Similarity=0.272 Sum_probs=191.9
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeE----EEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQ----VAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~----vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
.++|++.+.||+|+||+||+|.+..+++. ||+|.+.... .....+..|+.++..+ .||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-----DNPHVCRLLGICLT 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-----CBTTBCCEEEEEES
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-----CCCCEeEEEEEEec
Confidence 46799999999999999999998887765 4777775322 2345677788888877 68999999999987
Q ss_pred CCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
.+ .++|+|++. |+|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~Dikp~NIll--~~~~~~kl~Dfg 162 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAARNVLV--KTPQHVKITDFG 162 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEE--EETTEEEECCTT
T ss_pred CC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC--CeeCCCCChheEEE--CCCCCEEEccCc
Confidence 65 678888885 58999887754 4699999999999999999999964 89999999999999 567789999999
Q ss_pred CceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 262 SSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 262 ~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
++....... ....+|..|+|||++.+..++.++|||||||++|||++ |++||.+.+..+....+......+..
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~- 241 (327)
T 3poz_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP- 241 (327)
T ss_dssp HHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC-
T ss_pred ceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCC-
Confidence 997654322 23345778999999999999999999999999999999 99999987766554444321111100
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
......+.+||.+||+.||
T Consensus 242 -------------------------------------------------------------~~~~~~~~~li~~~l~~~p 260 (327)
T 3poz_A 242 -------------------------------------------------------------PICTIDVYMIMVKCWMIDA 260 (327)
T ss_dssp -------------------------------------------------------------TTBCHHHHHHHHHHTCSCG
T ss_pred -------------------------------------------------------------ccCCHHHHHHHHHHcCCCh
Confidence 0001257899999999999
Q ss_pred CCCCCHHHHhcC
Q psy11727 416 KKRISPTNVLRH 427 (437)
Q Consensus 416 ~~R~t~~e~l~H 427 (437)
.+|||+.++++|
T Consensus 261 ~~Rps~~ell~~ 272 (327)
T 3poz_A 261 DSRPKFRELIIE 272 (327)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCCCHHHHHHH
Confidence 999999999865
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=350.67 Aligned_cols=204 Identities=25% Similarity=0.322 Sum_probs=175.0
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+.++|++.+.||+|+||.||+|.+..+++.||||++... ....++..|+.+++.+.+ ++++..+..++...+..
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~E~~il~~L~~----~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLLYESKIYRILQG----GTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETT-CSSCCHHHHHHHHHHTTT----STTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccc-cccHHHHHHHHHHHHhcC----CCCCCeEEEEEeeCCEE
Confidence 4568999999999999999999999999999999998743 334567889999998863 34566677777889999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec-CCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS-PKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~-~~~~~ikL~DFG~s~~ 265 (437)
+|||||++++|.+++.... ..+++..++.|+.||+.||+|||++ |||||||||+||||+. +..+.+||+|||++..
T Consensus 79 ~lvme~~g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~--gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 79 VLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEECCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 9999999889999997643 4699999999999999999999964 8999999999999942 2567899999999976
Q ss_pred cCCcc----------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy11727 266 VGQTL----------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNE 318 (437)
Q Consensus 266 ~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~ 318 (437)
..... ....||..|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 64322 156789999999999999999999999999999999999999987543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=334.03 Aligned_cols=248 Identities=25% Similarity=0.333 Sum_probs=188.5
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCC---CeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEE---KCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~---~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
...++|++.+.||+|+||+||+|.+..+ +..||+|++.... .....+..|+.++..+ .||||+++++++.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-----DHPHIVKLIGVIT 86 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCccceEEEEEc
Confidence 3467899999999999999999998653 5679999987432 1223455666666655 7899999999875
Q ss_pred ECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 182 WKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 182 ~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
.+..++||||+++ +|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+||
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~--~~~~~~kl~Df 160 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK--RFVHRDIAARNVLV--SSNDCVKLGDF 160 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE--EETTEEEECC-
T ss_pred -cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC--CeecccccHHHEEE--CCCCCEEECcc
Confidence 5678999999976 8999887653 4589999999999999999999964 89999999999999 55778999999
Q ss_pred CCceecCCcc----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 261 GSSCHVGQTL----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 261 G~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
|++....... ....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+......+..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~- 239 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP- 239 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC-
T ss_pred ccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCC-
Confidence 9997664322 23456778999999998899999999999999999997 99999988776666655432110000
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
......+.+||.+||+.||
T Consensus 240 -------------------------------------------------------------~~~~~~l~~li~~~l~~~p 258 (281)
T 1mp8_A 240 -------------------------------------------------------------PNCPPTLYSLMTKCWAYDP 258 (281)
T ss_dssp -------------------------------------------------------------TTCCHHHHHHHHHHTCSSG
T ss_pred -------------------------------------------------------------CCCCHHHHHHHHHHccCCh
Confidence 0001257899999999999
Q ss_pred CCCCCHHHHhcC
Q psy11727 416 KKRISPTNVLRH 427 (437)
Q Consensus 416 ~~R~t~~e~l~H 427 (437)
.+|||+.+++++
T Consensus 259 ~~Rps~~~l~~~ 270 (281)
T 1mp8_A 259 SRRPRFTELKAQ 270 (281)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=355.33 Aligned_cols=248 Identities=22% Similarity=0.340 Sum_probs=204.9
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
+...++|.+.+.||+|+||+||+|.+. ++..||||+++........+..|+.++..+ .|||||++++++. .+.
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-----QHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTC-----CCTTBCCEEEEEC-SSS
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhC-----CCCCEeeEEEEEe-CCc
Confidence 344678999999999999999999875 467899999986655566777888887766 7899999999886 667
Q ss_pred EEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+++||||+. |+|.+++.......+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++.
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivHrDlkp~Nill--~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--NYIHRDLRAANILV--SASLVCKIADFGLAR 332 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCSGGGEEE--CTTCCEEECSTTGGG
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCCHHHEEE--CCCCcEEEeeCCCce
Confidence 899999995 5899999765434589999999999999999999964 89999999999999 678899999999998
Q ss_pred ecCCccc----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhcc
Q psy11727 265 HVGQTLY----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 265 ~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 339 (437)
....... ...++..|+|||++.+..++.++|||||||++|||++ |++||.+.+..+....+......+....
T Consensus 333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~--- 409 (454)
T 1qcf_A 333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN--- 409 (454)
T ss_dssp GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTT---
T ss_pred EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC---
Confidence 7644322 2345678999999998899999999999999999999 9999999888877777655332221100
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
....+.+||.+||+.||.+||
T Consensus 410 -----------------------------------------------------------~~~~l~~li~~cl~~dp~~RP 430 (454)
T 1qcf_A 410 -----------------------------------------------------------CPEELYNIMMRCWKNRPEERP 430 (454)
T ss_dssp -----------------------------------------------------------SCHHHHHHHHHHTCSSGGGSC
T ss_pred -----------------------------------------------------------CCHHHHHHHHHHccCChhHCc
Confidence 001578999999999999999
Q ss_pred CHHHHhc
Q psy11727 420 SPTNVLR 426 (437)
Q Consensus 420 t~~e~l~ 426 (437)
|++++++
T Consensus 431 t~~~i~~ 437 (454)
T 1qcf_A 431 TFEYIQS 437 (454)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=341.40 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=201.3
Q ss_pred eccCeeeeceecccCceEEEEEEE-----cCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFD-----HEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~-----~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
..++|.+.+.||+|+||+||+|.+ ..++..||||++.... .....+..|+.++..+. .||||+++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~~ 118 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG----SHENIVNLLGAC 118 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC----CCTTBCCEEEEE
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhc----CCCCeeeEEEEE
Confidence 357899999999999999999997 3467789999997432 33456778999988874 689999999999
Q ss_pred eECCEEEEEEEeccC-cHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeC
Q psy11727 181 TWKNHLCLVFELLSY-NLYNLIRNTNF---------------------HGVSLNLTKKFAQQLCCALAFLSSPELSIIHC 238 (437)
Q Consensus 181 ~~~~~~~lV~E~~~~-~L~~~l~~~~~---------------------~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHr 238 (437)
...+..++||||+++ +|.+++..... ..+++..++.++.||+.||+|||++ ||+||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~ 196 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHR 196 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT--TEEET
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC--CcccC
Confidence 999999999999965 99999876532 2379999999999999999999964 89999
Q ss_pred CCCCCcEEEecCCCCCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCC
Q psy11727 239 DLKPENILLCSPKRSAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPL 312 (437)
Q Consensus 239 DiKp~NIll~~~~~~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p 312 (437)
||||+|||+ +.++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|+| |.+|
T Consensus 197 Dikp~NIll--~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 197 DLAARNVLV--THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp TCSGGGEEE--ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCChhhEEE--cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 999999999 56788999999999765322 123456788999999999899999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCC
Q psy11727 313 FSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNE 392 (437)
Q Consensus 313 f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (437)
|.+......+..+......++. |
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~----------------------------------~----------------------- 297 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGFKMDQ----------------------------------P----------------------- 297 (344)
T ss_dssp STTCCCSHHHHHHHHTTCCCCC----------------------------------C-----------------------
T ss_pred cccCCcHHHHHHHHhcCCCCCC----------------------------------C-----------------------
Confidence 9887655444444331100000 0
Q ss_pred CCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCC
Q psy11727 393 PGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHE 428 (437)
Q Consensus 393 ~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp 428 (437)
......+.+||.+||+.||.+|||+.++++|-
T Consensus 298 ----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 298 ----FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 00012578999999999999999999999763
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=350.59 Aligned_cols=276 Identities=21% Similarity=0.315 Sum_probs=204.7
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
..+.++|.+.+.||+|+||+||+|.+..+++.||||++.... .......+|+.++..+ .||||+++++++...
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~ 79 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-----NHKNIVKLFAIEEET 79 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECT
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-----CCCCCCeEEEeeccC
Confidence 345678999999999999999999999999999999997432 2234566788888877 689999999999876
Q ss_pred C--EEEEEEEeccC-cHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec--CCCCCEEE
Q psy11727 184 N--HLCLVFELLSY-NLYNLIRNTN-FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS--PKRSAIKI 257 (437)
Q Consensus 184 ~--~~~lV~E~~~~-~L~~~l~~~~-~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~--~~~~~ikL 257 (437)
+ +.++||||+.+ +|.+++.... ...+++..++.++.||+.||+|||++ ||+||||||+|||+.. +.++.+||
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (396)
T 4eut_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKL 157 (396)
T ss_dssp TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC--CEEECCcCHHHEEEeecCCCceeEEE
Confidence 5 88999999965 8999887643 23489999999999999999999964 8999999999999843 34556999
Q ss_pred EeCCCceecCCc--cccccccccccChhhhcC--------CCCCCcchHHHHHHHHHHHHhCCCCCCCCC----HHHHHH
Q psy11727 258 IDFGSSCHVGQT--LYQYIQSRYYRSPEVLLG--------IPYDLAIDMWSLGCILVELHTGEPLFSGKN----EVDQMT 323 (437)
Q Consensus 258 ~DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlG~il~elltg~~pf~~~~----~~~~~~ 323 (437)
+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||.... ..+.+.
T Consensus 158 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp CCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred ecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 999999876443 235678999999999875 467889999999999999999999996532 233333
Q ss_pred HHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHH
Q psy11727 324 KIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKF 403 (437)
Q Consensus 324 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (437)
.+.. +.|+.. +..... ...+.+.... ..| .....+......+
T Consensus 238 ~~~~--~~p~~~-~~~~~~-------~~~~~~~~~~-------~~~---------------------~~~~l~~~~~~~l 279 (396)
T 4eut_A 238 KIIT--GKPSGA-ISGVQK-------AENGPIDWSG-------DMP---------------------VSCSLSRGLQVLL 279 (396)
T ss_dssp HHHH--SCCTTC-CEEEEC-------STTCCEEEES-------SCC---------------------TTCSSCHHHHHHH
T ss_pred HHhc--CCCccc-chhhee-------ccCCCcccCc-------cCC---------------------cccccchHHHhhc
Confidence 3332 233322 111100 0000000000 000 0112234445578
Q ss_pred HHHHHHccccCCCCCCCHHHHhc
Q psy11727 404 KDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 404 ~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
.+||.+||++||.+|||++|+++
T Consensus 280 ~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 280 TPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHHHHHSCCCTTTSCCHHHHHH
T ss_pred hHHHHHhhccChhhhccHHHHHH
Confidence 99999999999999999999854
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=335.29 Aligned_cols=249 Identities=26% Similarity=0.339 Sum_probs=203.1
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE---
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--- 182 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--- 182 (437)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.++..+ .||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKL-----DHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHC-----CCTTBCCEEEEEEEEEE
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhC-----CCCCEEEEeeeEecccc
Confidence 456788999999999999999999999999999999997543 4567788888877 68999999998865
Q ss_pred -------------CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEe
Q psy11727 183 -------------KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLC 248 (437)
Q Consensus 183 -------------~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~ 248 (437)
...+++||||+++ +|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dlkp~Nil~- 155 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK--KLINRDLKPSNIFL- 155 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE-
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCCHHHEEE-
Confidence 4568999999976 899999876555799999999999999999999964 89999999999999
Q ss_pred cCCCCCEEEEeCCCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy11727 249 SPKRSAIKIIDFGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326 (437)
Q Consensus 249 ~~~~~~ikL~DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~ 326 (437)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... .....+.
T Consensus 156 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~ 232 (284)
T 2a19_B 156 -VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLR 232 (284)
T ss_dssp -EETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHH
T ss_pred -cCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhh
Confidence 56778999999999776432 344678999999999999999999999999999999999998875321 1111111
Q ss_pred HHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHH
Q psy11727 327 EVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406 (437)
Q Consensus 327 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 406 (437)
. +..+. .....+.+|
T Consensus 233 ~--~~~~~---------------------------------------------------------------~~~~~~~~l 247 (284)
T 2a19_B 233 D--GIISD---------------------------------------------------------------IFDKKEKTL 247 (284)
T ss_dssp T--TCCCT---------------------------------------------------------------TSCHHHHHH
T ss_pred c--ccccc---------------------------------------------------------------cCCHHHHHH
Confidence 0 00000 000157899
Q ss_pred HHHccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 407 ILRMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 407 i~~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
|.+||+.||.+|||+.|+++|.+.-+.
T Consensus 248 i~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 248 LQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 999999999999999999999876443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=335.89 Aligned_cols=250 Identities=26% Similarity=0.354 Sum_probs=202.5
Q ss_pred ccCeeeeceecccCceEEEEEEE-----cCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFD-----HEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~-----~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|.+.+.||+|+||+||+|.+ ..+++.||+|++..... ....+..|+.++..+. .||||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~i~~~~~~~~ 97 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG----NHMNIVNLLGACT 97 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEEEC
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcc----cCCCeeeEEEEEe
Confidence 57899999999999999999985 45778999999975432 2345677888888874 6899999999999
Q ss_pred ECCEEEEEEEeccC-cHHHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q psy11727 182 WKNHLCLVFELLSY-NLYNLIRNTNF----------------HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPEN 244 (437)
Q Consensus 182 ~~~~~~lV~E~~~~-~L~~~l~~~~~----------------~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~N 244 (437)
+.+..++||||+++ +|.+++..... ..+++..++.++.||+.||+|||++ ||+||||||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~N 175 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARN 175 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCccce
Confidence 99999999999966 89999876542 2489999999999999999999964 89999999999
Q ss_pred EEEecCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy11727 245 ILLCSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNE 318 (437)
Q Consensus 245 Ill~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~ 318 (437)
||+ +.++.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+...
T Consensus 176 il~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 176 ILL--THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EEE--ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EEE--cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999 567889999999997764432 23456778999999999999999999999999999999 9999988765
Q ss_pred HHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChh
Q psy11727 319 VDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398 (437)
Q Consensus 319 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (437)
......+......++. + ..
T Consensus 254 ~~~~~~~~~~~~~~~~----------------------------------~---------------------------~~ 272 (313)
T 1t46_A 254 DSKFYKMIKEGFRMLS----------------------------------P---------------------------EH 272 (313)
T ss_dssp SHHHHHHHHHTCCCCC----------------------------------C---------------------------TT
T ss_pred hhHHHHHhccCCCCCC----------------------------------c---------------------------cc
Confidence 5544444332111000 0 00
Q ss_pred hhhHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 399 DYMKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 399 ~~~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
....+.+||.+||+.||.+|||+.|++++
T Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 273 APAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 01257899999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=338.31 Aligned_cols=258 Identities=22% Similarity=0.315 Sum_probs=205.2
Q ss_pred cCceeccCeeeeceecccCceEEEEEEEc-----CCCeEEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEe
Q psy11727 104 HGEKFLDRYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKL 176 (437)
Q Consensus 104 ~~~~~~~~y~i~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l 176 (437)
..+...++|.+.+.||+|+||+||+|.+. .+++.||||++...... ...+.+|+.++..+ .|+||+++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~ 93 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-----NCHHVVRL 93 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-----CCTTBCCE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-----CCCCEeee
Confidence 34555789999999999999999999876 46788999999743321 22345566666554 78999999
Q ss_pred cceeeECCEEEEEEEeccC-cHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q psy11727 177 KGHFTWKNHLCLVFELLSY-NLYNLIRNTN--------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILL 247 (437)
Q Consensus 177 ~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~--------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll 247 (437)
++++.+.+..++||||+++ +|.+++.... ...+++..+..++.||+.||+|||++ ||+||||||+|||+
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~NIli 171 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMV 171 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCSGGGEEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC--CCccCCCccceEEE
Confidence 9999999999999999965 8999886532 23579999999999999999999964 89999999999999
Q ss_pred ecCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy11727 248 CSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQ 321 (437)
Q Consensus 248 ~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~ 321 (437)
+.++.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+.
T Consensus 172 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 249 (322)
T 1p4o_A 172 --AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249 (322)
T ss_dssp --CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred --cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH
Confidence 678899999999997653321 23456788999999998899999999999999999999 8999999887766
Q ss_pred HHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhh
Q psy11727 322 MTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYM 401 (437)
Q Consensus 322 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (437)
...+......+. + .....
T Consensus 250 ~~~~~~~~~~~~-----------------------------------~---------------------------~~~~~ 267 (322)
T 1p4o_A 250 LRFVMEGGLLDK-----------------------------------P---------------------------DNCPD 267 (322)
T ss_dssp HHHHHTTCCCCC-----------------------------------C---------------------------TTCCH
T ss_pred HHHHHcCCcCCC-----------------------------------C---------------------------CCCCH
Confidence 665543110000 0 00012
Q ss_pred HHHHHHHHccccCCCCCCCHHHHhcC------CCcCc
Q psy11727 402 KFKDLILRMLTYDPKKRISPTNVLRH------EFFLK 432 (437)
Q Consensus 402 ~~~dli~~~L~~dP~~R~t~~e~l~H------p~~~~ 432 (437)
.+.+||.+||+.||.+|||+.|+++| |+|++
T Consensus 268 ~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~ 304 (322)
T 1p4o_A 268 MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 304 (322)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcc
Confidence 57899999999999999999999986 66654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=338.73 Aligned_cols=249 Identities=26% Similarity=0.323 Sum_probs=199.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEE--EEEEecCC--cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQV--AIKIIKNK--KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~v--aiK~i~~~--~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||.||+|.+..++..+ |+|.+... ......+..|+.++..+. .||||+++++++.+.+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG----HHPNIINLLGACEHRG 99 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC----CCTTBCCEEEEEEETT
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhcc----CCCchhhhceeeeeCC
Confidence 478999999999999999999999888865 99998642 223455667777776653 6899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTN--------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS 249 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~--------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~ 249 (437)
.+++||||+++ +|.+++.... ...+++..++.++.||+.||+|||++ ||+||||||+|||+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~-- 175 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILV-- 175 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE--
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCccceEEE--
Confidence 99999999955 8999987643 24689999999999999999999964 89999999999999
Q ss_pred CCCCCEEEEeCCCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy11727 250 PKRSAIKIIDFGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKII 326 (437)
Q Consensus 250 ~~~~~ikL~DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~ 326 (437)
+.++.+||+|||++...... .....++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+.
T Consensus 176 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 176 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 67788999999999754322 223456788999999998889999999999999999998 999999988766655442
Q ss_pred HHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHH
Q psy11727 327 EVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406 (437)
Q Consensus 327 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 406 (437)
.....+. + ......+.+|
T Consensus 256 ~~~~~~~-----------------------------------~---------------------------~~~~~~l~~l 273 (327)
T 1fvr_A 256 QGYRLEK-----------------------------------P---------------------------LNCDDEVYDL 273 (327)
T ss_dssp GTCCCCC-----------------------------------C---------------------------TTBCHHHHHH
T ss_pred cCCCCCC-----------------------------------C---------------------------CCCCHHHHHH
Confidence 2110000 0 0001257899
Q ss_pred HHHccccCCCCCCCHHHHhcC
Q psy11727 407 ILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 407 i~~~L~~dP~~R~t~~e~l~H 427 (437)
|.+||+.||.+|||++++++|
T Consensus 274 i~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 274 MRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=320.47 Aligned_cols=246 Identities=20% Similarity=0.220 Sum_probs=195.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc---chHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC--
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF---LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK-- 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~-- 183 (437)
.++|.+.+.||+|+||+||+|.+. +..||+|++...... ...+..|+.++ ..+.||||+++++++.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l-----~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRL-----RIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGG-----CCCSCTTEECEEEEECTTTS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHH-----HhcCCCchhheEEEEccCCC
Confidence 578999999999999999999874 889999999754321 12233344333 445799999999999877
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+..++||||+++ +|.+++.......+++..++.++.||+.||+|||+++.+|+||||||+|||+ +.++.++|+|||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~--~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI--DEDMTARISMADV 159 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE--CTTSCEEEEGGGS
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE--cCCcceeEEeccc
Confidence 789999999965 9999998766556999999999999999999999653339999999999999 6788899998888
Q ss_pred ceecCCccccccccccccChhhhcCCCCCC---cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhcc
Q psy11727 263 SCHVGQTLYQYIQSRYYRSPEVLLGIPYDL---AIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 263 s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 339 (437)
+..... ....||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+..+....+......++.
T Consensus 160 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 232 (271)
T 3kmu_A 160 KFSFQS--PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI----- 232 (271)
T ss_dssp CCTTSC--TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC-----
T ss_pred eeeecc--cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC-----
Confidence 754332 3457899999999998866554 799999999999999999999998877766655432111100
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
| ......+.+||.+||+.||.+||
T Consensus 233 -----------------------------~---------------------------~~~~~~~~~li~~~l~~~p~~Rp 256 (271)
T 3kmu_A 233 -----------------------------P---------------------------PGISPHVSKLMKICMNEDPAKRP 256 (271)
T ss_dssp -----------------------------C---------------------------TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred -----------------------------C---------------------------CCCCHHHHHHHHHHcCCChhhCc
Confidence 0 00012578999999999999999
Q ss_pred CHHHHhc
Q psy11727 420 SPTNVLR 426 (437)
Q Consensus 420 t~~e~l~ 426 (437)
|++++++
T Consensus 257 s~~~il~ 263 (271)
T 3kmu_A 257 KFDMIVP 263 (271)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=338.75 Aligned_cols=207 Identities=22% Similarity=0.296 Sum_probs=172.2
Q ss_pred eecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 102 IKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 102 ~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
........++|++.+.||+|+||+||+|.+ .+++.||||++..... ....+.+|+.++..+ .||||+++++++
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~ 104 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFC-----RHPHLVSLIGFC 104 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-----CCTTBCCEEEEC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhC-----CCCCEeeEEEEE
Confidence 334455678999999999999999999986 4688999999864432 234455666665544 799999999999
Q ss_pred eECCEEEEEEEeccC-cHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 181 TWKNHLCLVFELLSY-NLYNLIRNTNF--HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 181 ~~~~~~~lV~E~~~~-~L~~~l~~~~~--~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
...+..++||||+++ +|.+++..... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~ivH~dlkp~Nil~--~~~~~~kl 180 (321)
T 2qkw_B 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR--AIIHRDVKSINILL--DENFVPKI 180 (321)
T ss_dssp CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCSTTEEE--CTTCCEEE
T ss_pred cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC--CeecCCCCHHHEEE--CCCCCEEE
Confidence 999999999999965 88888765432 3489999999999999999999964 89999999999999 77889999
Q ss_pred EeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy11727 258 IDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNE 318 (437)
Q Consensus 258 ~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~ 318 (437)
+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|++||.+...
T Consensus 181 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp CCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred eecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 999999764321 2234689999999999988999999999999999999999999986543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=336.96 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=201.9
Q ss_pred ccCeeeeceecccCceEEEEEEEc-------CCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDH-------EEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~-------~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
.++|.+.+.||+|+||+||+|.+. .++..||||++.... .....+..|+.++..+. .||||++++++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~ 109 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG----KHKNIINLLGA 109 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEE
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhh----cCCCEeeEEEE
Confidence 578999999999999999999875 467789999997432 22345667888888874 68999999999
Q ss_pred eeECCEEEEEEEeccC-cHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q psy11727 180 FTWKNHLCLVFELLSY-NLYNLIRNTNF--------------HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPEN 244 (437)
Q Consensus 180 ~~~~~~~~lV~E~~~~-~L~~~l~~~~~--------------~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~N 244 (437)
+...+.+++||||+++ +|.+++..... ..+++..++.++.||+.||+|||++ ||+||||||+|
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~N 187 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--KCIHRDLAARN 187 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGG
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCccce
Confidence 9999999999999965 89999876532 2489999999999999999999964 89999999999
Q ss_pred EEEecCCCCCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy11727 245 ILLCSPKRSAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNE 318 (437)
Q Consensus 245 Ill~~~~~~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~ 318 (437)
||+ +.++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+.
T Consensus 188 Ill--~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 188 VLV--TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp EEE--CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EEE--cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 999 67889999999999876432 123456788999999998889999999999999999999 9999999887
Q ss_pred HHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChh
Q psy11727 319 VDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398 (437)
Q Consensus 319 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (437)
.+....+......+.. ..
T Consensus 266 ~~~~~~~~~~~~~~~~--------------------------------------------------------------~~ 283 (334)
T 2pvf_A 266 EELFKLLKEGHRMDKP--------------------------------------------------------------AN 283 (334)
T ss_dssp HHHHHHHHHTCCCCCC--------------------------------------------------------------TT
T ss_pred HHHHHHHhcCCCCCCC--------------------------------------------------------------cc
Confidence 7766655442111000 00
Q ss_pred hhhHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 399 DYMKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 399 ~~~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
....+.+||.+||+.||.+|||+.|++++
T Consensus 284 ~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 284 CTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01257899999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=328.19 Aligned_cols=247 Identities=20% Similarity=0.300 Sum_probs=201.9
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
...++|++.+.||+|+||+||+|.+. ++..||+|++.........+..|+.++..+ .||||+++++++. .+..
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~-~~~~ 82 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-----QHQRLVRLYAVVT-QEPI 82 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEC-SSSC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhC-----CCcCcceEEEEEc-CCCc
Confidence 34578999999999999999999875 567899999986655566778899988887 6899999999876 4568
Q ss_pred EEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++|||++. ++|.+++.......+++..+..++.||+.||+|||++ ||+||||||+||++ +.++.+||+|||++..
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~Nil~--~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--NYIHRDLRAANILV--SDTLSCKIADFGLARL 158 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE--CTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHhhEEE--cCCCCEEECCCccccc
Confidence 99999995 5899988754333589999999999999999999964 89999999999999 6788899999999987
Q ss_pred cCCccc----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 266 VGQTLY----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 266 ~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
...... ...++..|+|||++.+..++.++|||||||++|+|++ |++||.+.+..+....+......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 232 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP------ 232 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC------
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCc------
Confidence 654322 2345678999999998889999999999999999999 99999998877666655332110000
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
......+.+||.+||+.||.+|||
T Consensus 233 --------------------------------------------------------~~~~~~l~~li~~~l~~~p~~Rps 256 (279)
T 1qpc_A 233 --------------------------------------------------------DNCPEELYQLMRLCWKERPEDRPT 256 (279)
T ss_dssp --------------------------------------------------------TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred --------------------------------------------------------ccccHHHHHHHHHHhccChhhCCC
Confidence 000125789999999999999999
Q ss_pred HHHHhc
Q psy11727 421 PTNVLR 426 (437)
Q Consensus 421 ~~e~l~ 426 (437)
++++++
T Consensus 257 ~~~l~~ 262 (279)
T 1qpc_A 257 FDYLRS 262 (279)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=339.81 Aligned_cols=256 Identities=20% Similarity=0.246 Sum_probs=200.2
Q ss_pred eeccCeeeeceecccCceEEEEEE-----EcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAF-----DHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~-----~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
...++|.+.+.||+|+||.||+|. +..++..||||++.... .....+..|+.++..+ .||||++++++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~ 101 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-----NHQNIVRCIGV 101 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEE
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-----CCCCCCeEEEE
Confidence 346789999999999999999998 55678899999996432 2233456677777766 78999999999
Q ss_pred eeECCEEEEEEEecc-CcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC-CC
Q psy11727 180 FTWKNHLCLVFELLS-YNLYNLIRNTNF-----HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP-KR 252 (437)
Q Consensus 180 ~~~~~~~~lV~E~~~-~~L~~~l~~~~~-----~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~-~~ 252 (437)
+...+..++||||++ ++|.+++..... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+ ..
T Consensus 102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--~i~H~dlkp~NIli~~~~~~ 179 (327)
T 2yfx_A 102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPG 179 (327)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTT
T ss_pred EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC--CeecCcCCHhHEEEecCCCc
Confidence 999999999999995 589999976532 3489999999999999999999964 89999999999999432 34
Q ss_pred CCEEEEeCCCceecCC-----ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy11727 253 SAIKIIDFGSSCHVGQ-----TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKII 326 (437)
Q Consensus 253 ~~ikL~DFG~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~ 326 (437)
..+||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+.
T Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 259 (327)
T 2yfx_A 180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259 (327)
T ss_dssp CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred ceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence 5699999999865422 1233567889999999998899999999999999999998 999999888776665554
Q ss_pred HHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHH
Q psy11727 327 EVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406 (437)
Q Consensus 327 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 406 (437)
.....++. ......+.+|
T Consensus 260 ~~~~~~~~--------------------------------------------------------------~~~~~~l~~l 277 (327)
T 2yfx_A 260 SGGRMDPP--------------------------------------------------------------KNCPGPVYRI 277 (327)
T ss_dssp TTCCCCCC--------------------------------------------------------------TTCCHHHHHH
T ss_pred cCCCCCCC--------------------------------------------------------------CCCCHHHHHH
Confidence 32111000 0001257899
Q ss_pred HHHccccCCCCCCCHHHHhcCCCcC
Q psy11727 407 ILRMLTYDPKKRISPTNVLRHEFFL 431 (437)
Q Consensus 407 i~~~L~~dP~~R~t~~e~l~Hp~~~ 431 (437)
|.+||+.||.+|||+.++++|.|+-
T Consensus 278 i~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 278 MTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999998763
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=343.37 Aligned_cols=207 Identities=24% Similarity=0.306 Sum_probs=171.9
Q ss_pred ceeecCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEec
Q psy11727 100 YIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLK 177 (437)
Q Consensus 100 ~~~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~ 177 (437)
+.........++|.+.+.||+|+||+||+|.+ .+++.||||++..... ....+..|+.++..+ .||||++++
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~ 93 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-----VHRNLLRLR 93 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTC-----CCTTBCCCC
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-----cCCCccceE
Confidence 44445556678999999999999999999974 4688999999874322 223566677666554 789999999
Q ss_pred ceeeECCEEEEEEEeccC-cHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHhcCC-CCCeeeCCCCCCcEEEecCCCC
Q psy11727 178 GHFTWKNHLCLVFELLSY-NLYNLIRNTNF--HGVSLNLTKKFAQQLCCALAFLSSP-ELSIIHCDLKPENILLCSPKRS 253 (437)
Q Consensus 178 ~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~--~~ls~~~~~~i~~qi~~aL~~LH~~-~~giiHrDiKp~NIll~~~~~~ 253 (437)
+++...+..++||||+.+ +|.+++..... ..+++..+..++.||+.||+|||++ ..||+||||||+|||+ +.++
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~--~~~~ 171 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL--DEEF 171 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE--CTTC
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE--CCCC
Confidence 999999999999999965 89999876532 3489999999999999999999964 1289999999999999 6788
Q ss_pred CEEEEeCCCceecCCc----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy11727 254 AIKIIDFGSSCHVGQT----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFS 314 (437)
Q Consensus 254 ~ikL~DFG~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~ 314 (437)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|++||.
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 9999999999865422 233568999999999998889999999999999999999999996
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=331.77 Aligned_cols=197 Identities=31% Similarity=0.461 Sum_probs=159.1
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.++|++.+.||+|+||+||+|.+ .++.||||++... .....+..|+.++..+ .||||+++++++. +..++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~--~~~~l 76 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-SERKAFIVELRQLSRV-----NHPNIVKLYGACL--NPVCL 76 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-THHHHHHHHHHHHHHC-----CCTTBCCEEEBCT--TTTEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-hHHHHHHHHHHHHhcC-----CCCCcCeEEEEEc--CCcEE
Confidence 46899999999999999999986 4788999999643 3345677788888776 6899999999887 34789
Q ss_pred EEEeccC-cHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHhcCCC-CCeeeCCCCCCcEEEecCCCCC-EEEEeCCCce
Q psy11727 189 VFELLSY-NLYNLIRNTNF-HGVSLNLTKKFAQQLCCALAFLSSPE-LSIIHCDLKPENILLCSPKRSA-IKIIDFGSSC 264 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~-~~ls~~~~~~i~~qi~~aL~~LH~~~-~giiHrDiKp~NIll~~~~~~~-ikL~DFG~s~ 264 (437)
||||+++ +|.+++..... ..+++..+..++.||+.||+|||+.+ .||+||||||+|||++ .++. +||+|||++.
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTAC 154 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE--TTTTEEEECCCCC--
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe--CCCCEEEEccccccc
Confidence 9999965 89999876532 24789999999999999999999732 5899999999999994 4554 7999999998
Q ss_pred ecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy11727 265 HVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN 317 (437)
Q Consensus 265 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~ 317 (437)
..........||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 155 DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred ccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 77666666789999999999999999999999999999999999999998643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=333.47 Aligned_cols=200 Identities=26% Similarity=0.389 Sum_probs=165.6
Q ss_pred eeccCeeeeceecccCceEEEEEE----EcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAF----DHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~----~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
...++|++.+.||+|+||+||+|. +..+++.||||++..... ....+.+|+.++..+ .||||+++++++.
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-----QHDNIVKYKGVCY 81 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEC
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEe
Confidence 346789999999999999999998 567899999999975432 234566788887776 6899999999886
Q ss_pred E--CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 182 W--KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 182 ~--~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
. ..++++||||+++ +|.+++.... ..+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dikp~Nil~--~~~~~~kl~ 156 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK--RYIHRDLATRNILV--ENENRVKIG 156 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE--EETTEEEEC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcC--CcccCCCCHhhEEE--cCCCeEEEc
Confidence 4 4578999999955 8999987654 3589999999999999999999964 89999999999999 567789999
Q ss_pred eCCCceecCCc------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy11727 259 DFGSSCHVGQT------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGK 316 (437)
Q Consensus 259 DFG~s~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~ 316 (437)
|||++...... .....++..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 157 DFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp CCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred cCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 99999765432 12234677899999999999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=346.13 Aligned_cols=246 Identities=22% Similarity=0.296 Sum_probs=189.4
Q ss_pred ccCeeeeceecccCceEEEEEEEc---CCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDH---EEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~---~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.++|.+.+.||+|+||+||+|.+. .++..||||+++... .....+..|+.++..+ .||||+++++++.+.
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-----DHPNIIRLEGVVTKS 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEeeC
Confidence 568999999999999999999876 467789999997432 1223455677666655 799999999999999
Q ss_pred CEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+.+++||||++ ++|.+++.... ..+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||+
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll--~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILI--NSNLVCKVSDFGL 193 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEE--CTTCCEEECCC--
T ss_pred CceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCcceEEE--cCCCCEEECcCcc
Confidence 99999999995 58999987653 4589999999999999999999964 89999999999999 7788999999999
Q ss_pred ceecCCccc------cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 263 SCHVGQTLY------QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 263 s~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
+........ ...++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+......++..
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~ 273 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCT
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 976643211 1234678999999999999999999999999999998 999999888777666554322111100
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
.....+.+||.+||+.||
T Consensus 274 --------------------------------------------------------------~~~~~l~~li~~cl~~dp 291 (373)
T 2qol_A 274 --------------------------------------------------------------DCPAALYQLMLDCWQKDR 291 (373)
T ss_dssp --------------------------------------------------------------TCBHHHHHHHHHHTCSSG
T ss_pred --------------------------------------------------------------cccHHHHHHHHHHhCcCh
Confidence 001257899999999999
Q ss_pred CCCCCHHHHhc
Q psy11727 416 KKRISPTNVLR 426 (437)
Q Consensus 416 ~~R~t~~e~l~ 426 (437)
.+|||+.++++
T Consensus 292 ~~RPs~~~i~~ 302 (373)
T 2qol_A 292 NNRPKFEQIVS 302 (373)
T ss_dssp GGSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=355.51 Aligned_cols=253 Identities=17% Similarity=0.189 Sum_probs=191.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcC-----------CCCCcE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKAD-----------IHSRYI 173 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~-----------~~h~~i 173 (437)
...|.+.+.||+|+||+||+|.+..+|+.||||++.... .....+.+|..++..+.+.. +....+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345889999999999999999999999999999987322 22456677887777665411 000112
Q ss_pred EEec------ceeeE-----CCEEEEEEEeccCcHHHHHH-----hcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeee
Q psy11727 174 VKLK------GHFTW-----KNHLCLVFELLSYNLYNLIR-----NTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIH 237 (437)
Q Consensus 174 v~l~------~~~~~-----~~~~~lV~E~~~~~L~~~l~-----~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiH 237 (437)
+.+. ..+.. ...++++|+++.++|.+++. ......+++..+..++.||+.||+|||++ ||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~iiH 234 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVH 234 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT--TEEC
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC--Cccc
Confidence 2221 11121 23578999999999998885 22223478889999999999999999964 8999
Q ss_pred CCCCCCcEEEecCCCCCEEEEeCCCceecCCccccccccccccChhhh----------cCCCCCCcchHHHHHHHHHHHH
Q psy11727 238 CDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVL----------LGIPYDLAIDMWSLGCILVELH 307 (437)
Q Consensus 238 rDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlG~il~ell 307 (437)
|||||+|||+ +.++.+||+|||+++..+......+| +.|+|||++ .+..++.++|||||||++|||+
T Consensus 235 rDiKp~NILl--~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 235 TYLRPVDIVL--DQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp SCCCGGGEEE--CTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred CCcccceEEE--ecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999 67888999999999988877777888 999999999 5666889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCC
Q psy11727 308 TGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGG 387 (437)
Q Consensus 308 tg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (437)
+|+.||.+.+.......+ +.. ..
T Consensus 312 tg~~Pf~~~~~~~~~~~~---------------------~~~---------------------~~--------------- 334 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWI---------------------FRS---------------------CK--------------- 334 (413)
T ss_dssp HSSCCCCTTGGGSCSGGG---------------------GSS---------------------CC---------------
T ss_pred HCCCCCCCcchhhhHHHH---------------------Hhh---------------------cc---------------
Confidence 999999875432110000 000 00
Q ss_pred CCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 388 RRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 388 ~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
.. ...+.+||.+||+.||.+|||+.++++||||++.
T Consensus 335 ------~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 335 ------NI----PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp ------CC----CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ------cC----CHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 00 0257999999999999999999999999999753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=327.72 Aligned_cols=247 Identities=23% Similarity=0.296 Sum_probs=198.1
Q ss_pred ccCeeeec-eecccCceEEEEEEEc--CCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 109 LDRYEIDT-LLGKGSFGQVVKAFDH--EEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 109 ~~~y~i~~-~lG~G~fg~V~~~~~~--~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.++|.+.+ .||+|+||+||+|.+. .++..||||+++... .....+..|+.++..+ .||||+++++++ ..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-----DNPYIVRLIGVC-QA 81 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEE-ES
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-----CCCCEeEEEEEe-cC
Confidence 45677776 9999999999999854 468889999997532 2344566788888776 689999999998 55
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+..++|||++++ +|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+||++ +.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nili--~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK--NFVHRDLAARNVLL--VNRHYAKISDFGL 156 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEE--EETTEEEECCCTT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHC--CEeeCCCchheEEE--cCCCCEEECcccc
Confidence 679999999976 8888886543 4699999999999999999999964 89999999999999 5677899999999
Q ss_pred ceecCCcc------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 263 SCHVGQTL------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 263 s~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
+....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |++||.+.+..+....+......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~-- 234 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-- 234 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC--
T ss_pred eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC--
Confidence 98764321 22345788999999998889999999999999999999 9999998887666655533110000
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
| ......+.+||.+||+.||
T Consensus 235 ---------------------------------~---------------------------~~~~~~l~~li~~~l~~~p 254 (287)
T 1u59_A 235 ---------------------------------P---------------------------PECPPELYALMSDCWIYKW 254 (287)
T ss_dssp ---------------------------------C---------------------------TTCCHHHHHHHHHTTCSSG
T ss_pred ---------------------------------C---------------------------CCcCHHHHHHHHHHcCCCh
Confidence 0 0001267899999999999
Q ss_pred CCCCCHHHHhcCC
Q psy11727 416 KKRISPTNVLRHE 428 (437)
Q Consensus 416 ~~R~t~~e~l~Hp 428 (437)
.+|||+.++++|.
T Consensus 255 ~~Rps~~~l~~~l 267 (287)
T 1u59_A 255 EDRPDFLTVEQRM 267 (287)
T ss_dssp GGSCCHHHHHHHH
T ss_pred hhCcCHHHHHHHH
Confidence 9999999999764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=328.77 Aligned_cols=202 Identities=26% Similarity=0.447 Sum_probs=160.4
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
....++|++.+.||+|+||.||+|.+..+++.||||++..... ....+..|+.++..+ .|+||+++++++.
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~ 102 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-----NHPNVIKYYASFI 102 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEE
Confidence 3446789999999999999999999999999999999974321 223455677776665 7899999999999
Q ss_pred ECCEEEEEEEeccC-cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 182 WKNHLCLVFELLSY-NLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 182 ~~~~~~lV~E~~~~-~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
..+..++|||++.+ +|.+++... ....+++..++.++.||+.||.|||++ ||+||||||+||++ +.++.+||+
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dl~p~NIl~--~~~~~~kl~ 178 (310)
T 2wqm_A 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR--RVMHRDIKPANVFI--TATGVVKLG 178 (310)
T ss_dssp ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEE--CTTSCEEEC
T ss_pred cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC--CeeCCCCcHHHEEE--cCCCCEEEE
Confidence 99999999999976 898888642 234589999999999999999999964 89999999999999 678899999
Q ss_pred eCCCceecCCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy11727 259 DFGSSCHVGQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGK 316 (437)
Q Consensus 259 DFG~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~ 316 (437)
|||++...... .....|++.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 179 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 179 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp CC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred eccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 99998765432 23457899999999999999999999999999999999999999764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=333.59 Aligned_cols=249 Identities=19% Similarity=0.269 Sum_probs=194.7
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCC----eEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEK----CQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~----~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
...++|.+.+.||+|+||+||+|.+..++ ..||||+++.... ....+..|+.++..+ .||||+++++++
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~ 115 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-----SHHNIIRLEGVI 115 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEE
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEE
Confidence 34578999999999999999999876553 4699999974322 123455677766655 789999999999
Q ss_pred eECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 181 TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 181 ~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
...+..++||||+++ +|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIl~--~~~~~~kl~D 190 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM--NYVHRDLAARNILV--NSNLVCKVSD 190 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEE--CTTCCEEECC
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChheEEE--CCCCcEEECC
Confidence 999999999999976 8988887643 4699999999999999999999964 89999999999999 6788999999
Q ss_pred CCCceecCCcc------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Q psy11727 260 FGSSCHVGQTL------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMP 332 (437)
Q Consensus 260 FG~s~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p 332 (437)
||++....... ....+|..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 270 (333)
T 1mqb_A 191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 270 (333)
T ss_dssp CCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred CCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC
Confidence 99997654321 12345678999999999999999999999999999999 999999888777666654321111
Q ss_pred ChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc
Q psy11727 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412 (437)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 412 (437)
... .....+.+||.+||+
T Consensus 271 ~~~--------------------------------------------------------------~~~~~l~~li~~~l~ 288 (333)
T 1mqb_A 271 TPM--------------------------------------------------------------DCPSAIYQLMMQCWQ 288 (333)
T ss_dssp CCT--------------------------------------------------------------TCBHHHHHHHHHHTC
T ss_pred Ccc--------------------------------------------------------------cCCHHHHHHHHHHcC
Confidence 100 001257899999999
Q ss_pred cCCCCCCCHHHHhcC
Q psy11727 413 YDPKKRISPTNVLRH 427 (437)
Q Consensus 413 ~dP~~R~t~~e~l~H 427 (437)
.||.+|||+.+++++
T Consensus 289 ~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 289 QERARRPKFADIVSI 303 (333)
T ss_dssp SSTTTSCCHHHHHHH
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999998763
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=336.11 Aligned_cols=245 Identities=19% Similarity=0.266 Sum_probs=190.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEE----EEEEecCC--cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQV----AIKIIKNK--KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~v----aiK~i~~~--~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
.++|++.+.||+|+||+||+|.+..+++.| |+|.+... ......+..|+.++..+ .||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-----DNPHVCRLLGICLT 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-----CBTTBCCCCEEEES
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-----CCCCeeEEEEEEec
Confidence 468999999999999999999998887755 66766432 22345666787777665 68999999999987
Q ss_pred CCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
.+ .++|+|++. ++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIl~--~~~~~~kL~DfG 162 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAARNVLV--KTPQHVKITDFG 162 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEE--EETTEEEECCTT
T ss_pred CC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC--CCcCCCCCHHHEEE--cCCCCEEEccCc
Confidence 65 778888885 58999887754 4689999999999999999999964 89999999999999 567789999999
Q ss_pred CceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 262 SSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 262 ~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
++....... ....+|..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+......+..
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 241 (327)
T 3lzb_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP- 241 (327)
T ss_dssp C----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC-
T ss_pred ceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC-
Confidence 997653321 23445778999999999999999999999999999999 99999988776655544332111110
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
......+.+||.+||..||
T Consensus 242 -------------------------------------------------------------~~~~~~l~~li~~~l~~dp 260 (327)
T 3lzb_A 242 -------------------------------------------------------------PICTIDVYMIMRKCWMIDA 260 (327)
T ss_dssp -------------------------------------------------------------TTBCHHHHHHHHHHTCSSG
T ss_pred -------------------------------------------------------------ccCCHHHHHHHHHHcCCCh
Confidence 0001157899999999999
Q ss_pred CCCCCHHHHhc
Q psy11727 416 KKRISPTNVLR 426 (437)
Q Consensus 416 ~~R~t~~e~l~ 426 (437)
.+|||+.|+++
T Consensus 261 ~~Rps~~ell~ 271 (327)
T 3lzb_A 261 DSRPKFRELII 271 (327)
T ss_dssp GGSCCHHHHHH
T ss_pred hHCcCHHHHHH
Confidence 99999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=335.00 Aligned_cols=196 Identities=22% Similarity=0.259 Sum_probs=160.1
Q ss_pred cCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 104 HGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 104 ~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
....+.++|++.+.||+|+||.||+|.+. ++.||||++.... ......|..++.. ....|+||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~e~~~~~~---~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE--EASWFRETEIYQT---VLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG--HHHHHHHHHHHTS---TTCCCTTBCCEEEEEEES
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc--cchhhhHHHHHHH---HhhcCCCeeeEEEEEccC
Confidence 34456789999999999999999999874 8899999986432 2333344444333 235899999999999987
Q ss_pred ----CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCC------CCCeeeCCCCCCcEEEecCCC
Q psy11727 184 ----NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP------ELSIIHCDLKPENILLCSPKR 252 (437)
Q Consensus 184 ----~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~------~~giiHrDiKp~NIll~~~~~ 252 (437)
..+++||||+.+ +|.+++... .+++..++.++.|++.||+|||++ ..||+||||||+|||+ +.+
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill--~~~ 178 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV--KKN 178 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE--CTT
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE--CCC
Confidence 799999999965 899999765 489999999999999999999965 2389999999999999 678
Q ss_pred CCEEEEeCCCceecCCcc-------ccccccccccChhhhcCCCCCCc------chHHHHHHHHHHHHhCCC
Q psy11727 253 SAIKIIDFGSSCHVGQTL-------YQYIQSRYYRSPEVLLGIPYDLA------IDMWSLGCILVELHTGEP 311 (437)
Q Consensus 253 ~~ikL~DFG~s~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlG~il~elltg~~ 311 (437)
+.+||+|||++....... ....||+.|+|||++.+..++.. +|||||||++|||++|..
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~ 250 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV 250 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccC
Confidence 899999999997653322 24578999999999988777665 999999999999999933
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=333.34 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=199.2
Q ss_pred ccCeeeeceecccCceEEEEEEE-----cCCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFD-----HEEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~-----~~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|++.+.||+|+||+||+|.+ ..+++.||||++..... ....+..|+.++..+. +||||+++++++.
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~~~ 101 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG----HHLNVVNLLGACT 101 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEEEC
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcc----cCCCeeeEEEEEe
Confidence 57899999999999999999985 35778999999975432 2335667888888874 6899999999988
Q ss_pred ECC-EEEEEEEeccC-cHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcE
Q psy11727 182 WKN-HLCLVFELLSY-NLYNLIRNTNF--------------HGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENI 245 (437)
Q Consensus 182 ~~~-~~~lV~E~~~~-~L~~~l~~~~~--------------~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NI 245 (437)
..+ .+++||||+++ +|.+++..... ..+++..++.++.||+.||.|||++ ||+||||||+||
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~i~H~dikp~Ni 179 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNI 179 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC--CcccccCccceE
Confidence 754 59999999975 89999876542 1288999999999999999999964 899999999999
Q ss_pred EEecCCCCCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy11727 246 LLCSPKRSAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEV 319 (437)
Q Consensus 246 ll~~~~~~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~ 319 (437)
|+ +.++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+....
T Consensus 180 l~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 257 (316)
T 2xir_A 180 LL--SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257 (316)
T ss_dssp EE--CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred EE--CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence 99 67788999999999765332 223467889999999999999999999999999999998 99999887644
Q ss_pred HHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhh
Q psy11727 320 DQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLAD 399 (437)
Q Consensus 320 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (437)
+.+.........++ .+. ..
T Consensus 258 ~~~~~~~~~~~~~~----------------------------------~~~---------------------------~~ 276 (316)
T 2xir_A 258 EEFCRRLKEGTRMR----------------------------------APD---------------------------YT 276 (316)
T ss_dssp HHHHHHHHHTCCCC----------------------------------CCT---------------------------TC
T ss_pred HHHHHHhccCccCC----------------------------------CCC---------------------------CC
Confidence 44333322211000 000 00
Q ss_pred hhHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 400 YMKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 400 ~~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
...+.+||.+||+.||.+|||+.++++|
T Consensus 277 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 277 TPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1257899999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=351.74 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=202.8
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
..++|++.+.||+|+||+||+|.+.. +..||||+++........+.+|+.++..+ .||||+++++++.+ +..+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECS-SSCE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhC-----CCCCEeeEEEEEcC-CceE
Confidence 35789999999999999999999865 46799999986554456788899999887 68999999999876 6789
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+.+ +|.+++.......+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++...
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivHrDlkp~Nill--~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILV--GENLVCKVADFGLARLI 330 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE--CGGGCEEECCCCTTC--
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChhhEEE--CCCCCEEECCCccceec
Confidence 99999965 899999764434589999999999999999999964 89999999999999 67788999999999766
Q ss_pred CCcc----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 267 GQTL----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 267 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
.... ....++..|+|||++.+..++.++|||||||++|||++ |++||.+.+..+....+......+...
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~------ 404 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP------ 404 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT------
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC------
Confidence 4322 22345678999999998899999999999999999999 999999988877776664432211100
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
.....+.+||.+||+.||.+|||+
T Consensus 405 --------------------------------------------------------~~~~~l~~li~~cl~~dP~~Rpt~ 428 (452)
T 1fmk_A 405 --------------------------------------------------------ECPESLHDLMCQCWRKEPEERPTF 428 (452)
T ss_dssp --------------------------------------------------------TSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred --------------------------------------------------------CCCHHHHHHHHHHccCChhhCcCH
Confidence 001257899999999999999999
Q ss_pred HHHhc--CCCcCc
Q psy11727 422 TNVLR--HEFFLK 432 (437)
Q Consensus 422 ~e~l~--Hp~~~~ 432 (437)
+++++ +.+++.
T Consensus 429 ~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 429 EYLQAFLEDYFTS 441 (452)
T ss_dssp HHHHHHHHTTTSC
T ss_pred HHHHHHHHHHhcc
Confidence 99986 466654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=329.50 Aligned_cols=244 Identities=21% Similarity=0.307 Sum_probs=189.8
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC-CEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK-NHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~-~~~~ 187 (437)
.++|++.+.||+|+||+||+|.+ +++.||||+++.. .....+..|+.++..+ .||||+++++++... +..+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-ATAQAFLAEASVMTQL-----RHSNLVQLLGVIVEEKGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-C--HHHHHTHHHHTTC-----CCTTBCCEEEEECCC--CCE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch-hHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcCCCceE
Confidence 57899999999999999999976 4889999999743 3445667788777665 689999999986544 5789
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|.+++.......+++..++.++.||+.||+|||++ ||+||||||+||++ +.++.+||+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~--~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE--CTTSCEEECCCCC----
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCcceEEE--eCCCcEEEeeccccccc
Confidence 99999976 899998765433479999999999999999999964 89999999999999 67889999999999877
Q ss_pred CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccch
Q psy11727 267 GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSK 345 (437)
Q Consensus 267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 345 (437)
........++..|+|||++.+..++.++||||||+++|+|++ |.+||...+..+....+......+.
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 235 (278)
T 1byg_A 168 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA------------ 235 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC------------
T ss_pred cccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC------------
Confidence 665556678899999999998899999999999999999998 9999988776555444422100000
Q ss_pred hhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHh
Q psy11727 346 YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVL 425 (437)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l 425 (437)
+ ......+.+||.+||+.||.+|||+.+++
T Consensus 236 -----------------------~---------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 265 (278)
T 1byg_A 236 -----------------------P---------------------------DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 265 (278)
T ss_dssp -----------------------C---------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred -----------------------c---------------------------ccCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 0 00012578999999999999999999987
Q ss_pred c
Q psy11727 426 R 426 (437)
Q Consensus 426 ~ 426 (437)
+
T Consensus 266 ~ 266 (278)
T 1byg_A 266 E 266 (278)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=339.98 Aligned_cols=202 Identities=23% Similarity=0.307 Sum_probs=170.1
Q ss_pred ccCeeeeceecccCceEEEEE-----EEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKA-----FDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~-----~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.++|.+.+.||+|+||+||+| .+..+++.||||++... ....+..|..+++.+.. ..|+||+++++++...
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~--~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKP--SMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCG--GGGGGBCCEEEEEECS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhh--hhhhhhhhhheeeecC
Confidence 568999999999999999999 46778999999999743 34567788888888753 2588999999999999
Q ss_pred CEEEEEEEecc-CcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec---------C
Q psy11727 184 NHLCLVFELLS-YNLYNLIRNT---NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS---------P 250 (437)
Q Consensus 184 ~~~~lV~E~~~-~~L~~~l~~~---~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~---------~ 250 (437)
+..|+||||++ |+|.+++... ....+++..++.++.||+.||+|||++ |||||||||+|||++. +
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~--~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC--EIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCSGGGEEECGGGTCC-----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC--CeecCCCCHHHEEecccccCcccccc
Confidence 99999999996 5899988642 235699999999999999999999964 8999999999999942 1
Q ss_pred CCCCEEEEeCCCceecC-----CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy11727 251 KRSAIKIIDFGSSCHVG-----QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGK 316 (437)
Q Consensus 251 ~~~~ikL~DFG~s~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~ 316 (437)
.++.+||+|||+|.... ......+||+.|+|||++.+..|+.++|||||||++|||+||++||...
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 17889999999997542 2334567999999999999999999999999999999999999999653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=336.43 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=202.2
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCe-----EEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecc
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKC-----QVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKG 178 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~-----~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~ 178 (437)
+...++|.+.+.||+|+||+||+|.+..++. .||+|++.... .....+..|+.++..+. .||||+++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~ 117 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG----QHENIVNLLG 117 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhc----CCCCeeeEEE
Confidence 3346789999999999999999999877654 79999997543 22345677888888874 6899999999
Q ss_pred eeeECCEEEEEEEeccC-cHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcE
Q psy11727 179 HFTWKNHLCLVFELLSY-NLYNLIRNTN------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENI 245 (437)
Q Consensus 179 ~~~~~~~~~lV~E~~~~-~L~~~l~~~~------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NI 245 (437)
++...+.+++||||+++ +|.+++.... ...+++..++.++.||+.||+|||++ ||+||||||+||
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~NI 195 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNV 195 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGC
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC--CcccCCcccceE
Confidence 99999999999999966 8999886532 23579999999999999999999964 899999999999
Q ss_pred EEecCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy11727 246 LLCSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEV 319 (437)
Q Consensus 246 ll~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~ 319 (437)
|+ +.++.+||+|||++....... ....+|..|+|||++.+..++.++|||||||++|+|++ |.+||.+....
T Consensus 196 l~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 196 LL--TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp EE--EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred EE--CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 99 567789999999997653221 23456778999999999899999999999999999999 99999887655
Q ss_pred HHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhh
Q psy11727 320 DQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLAD 399 (437)
Q Consensus 320 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (437)
.....+......++. | ...
T Consensus 274 ~~~~~~~~~~~~~~~----------------------------------~---------------------------~~~ 292 (333)
T 2i1m_A 274 SKFYKLVKDGYQMAQ----------------------------------P---------------------------AFA 292 (333)
T ss_dssp HHHHHHHHHTCCCCC----------------------------------C---------------------------TTC
T ss_pred HHHHHHHhcCCCCCC----------------------------------C---------------------------CCC
Confidence 555444432111100 0 000
Q ss_pred hhHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 400 YMKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 400 ~~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
...+.+||.+||+.||.+|||+.|++++
T Consensus 293 ~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 293 PKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 1257899999999999999999999863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=326.78 Aligned_cols=247 Identities=23% Similarity=0.298 Sum_probs=196.6
Q ss_pred eccCeeeeceecccCceEEEEEEEcC---CCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHE---EKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~---~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
..++|.+.+.||+|+||+||+|.+.. ++..||+|++.... .....+.+|+.++..+ .||||+++++++.+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-----DHPHIVKLIGIIEE 84 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-----CCTTBCCEEEEECS
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-----CCCCcceEEEEEcC
Confidence 35789999999999999999998654 34569999987542 2235567788888887 68999999999875
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
+..++|||++++ +|.+++.... ..+++..+..++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~--~~~~~~kl~Dfg 158 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI--NCVHRDIAVRNILV--ASPECVKLGDFG 158 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEE--EETTEEEECCCC
T ss_pred -CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCccceEEE--CCCCcEEeCccC
Confidence 456899999965 8999887654 4589999999999999999999964 89999999999999 557789999999
Q ss_pred CceecCCcc----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 262 SSCHVGQTL----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 262 ~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
++....... ....++..|+|||++.+..++.++|||||||++|+|++ |++||...+..+....+......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 237 (281)
T 3cc6_A 159 LSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPD- 237 (281)
T ss_dssp GGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCT-
T ss_pred CCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCC-
Confidence 997654322 23456788999999998899999999999999999998 999998877666655554321111100
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
.....+.+||.+||+.||.
T Consensus 238 -------------------------------------------------------------~~~~~l~~li~~~l~~~p~ 256 (281)
T 3cc6_A 238 -------------------------------------------------------------LCPPVLYTLMTRCWDYDPS 256 (281)
T ss_dssp -------------------------------------------------------------TCCHHHHHHHHHHTCSSGG
T ss_pred -------------------------------------------------------------CCCHHHHHHHHHHccCCch
Confidence 0012578999999999999
Q ss_pred CCCCHHHHhcC
Q psy11727 417 KRISPTNVLRH 427 (437)
Q Consensus 417 ~R~t~~e~l~H 427 (437)
+|||+.|++++
T Consensus 257 ~Rps~~ell~~ 267 (281)
T 3cc6_A 257 DRPRFTELVCS 267 (281)
T ss_dssp GSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=326.97 Aligned_cols=197 Identities=27% Similarity=0.391 Sum_probs=166.5
Q ss_pred ccCeeeeceecccCceEEEEEE----EcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAF----DHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~----~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
..+|++.+.||+|+||.||+|. +..+++.||+|++.... .....+..|+.++..+ .|+||+++++++..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-----YHENIVKYKGICTE 94 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-----CCTTBCCEEEEEEC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-----CCCCeeeeeeEEec
Confidence 5679999999999999999998 56789999999997432 2235667788888776 68999999999987
Q ss_pred C--CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 183 K--NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 183 ~--~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
. +.+++||||+++ +|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dikp~Nil~--~~~~~~kl~D 169 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSR--QYVHRDLAARNVLV--ESEHQVKIGD 169 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE--EETTEEEECC
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcC--CcccCCCchheEEE--cCCCCEEECc
Confidence 6 679999999965 8999986654 4589999999999999999999964 89999999999999 5677899999
Q ss_pred CCCceecCCc------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy11727 260 FGSSCHVGQT------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG 315 (437)
Q Consensus 260 FG~s~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~ 315 (437)
||++...... .....||..|+|||++.+..++.++|||||||++|+|++|..|+..
T Consensus 170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 9999876432 2234677889999999998999999999999999999999998753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=327.37 Aligned_cols=252 Identities=27% Similarity=0.363 Sum_probs=187.4
Q ss_pred cCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc---chHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 104 HGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF---LNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 104 ~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
.++...++|++.+.||+|+||+||+|.+.. .||+|+++..... ...+..|+.+++.+ .|+||+++++++
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~ 89 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-----RHVNILLFMGYS 89 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEE
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhC-----CCCcEEEEEeec
Confidence 345567889999999999999999997533 5999999744322 23455677666655 789999999954
Q ss_pred eECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 181 TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 181 ~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
..+..++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|
T Consensus 90 -~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~--~i~H~Dlkp~Nil~--~~~~~~kl~D 163 (289)
T 3og7_A 90 -TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK--SIIHRDLKSNNIFL--HEDNTVKIGD 163 (289)
T ss_dssp -CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEE--ETTTEEEECC
T ss_pred -cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC--CcccccCccceEEE--CCCCCEEEcc
Confidence 56678999999965 8888886543 4689999999999999999999964 89999999999999 5678899999
Q ss_pred CCCceecCC-----ccccccccccccChhhhc---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Q psy11727 260 FGSSCHVGQ-----TLYQYIQSRYYRSPEVLL---GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGM 331 (437)
Q Consensus 260 FG~s~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 331 (437)
||++..... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 164 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (289)
T 3og7_A 164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 243 (289)
T ss_dssp CC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSC
T ss_pred ceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccccc
Confidence 999975532 223457899999999997 567889999999999999999999999987766665555543222
Q ss_pred CChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcc
Q psy11727 332 PPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411 (437)
Q Consensus 332 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L 411 (437)
++... . ........+.+||.+||
T Consensus 244 ~~~~~------------~---------------------------------------------~~~~~~~~l~~li~~~l 266 (289)
T 3og7_A 244 SPDLS------------K---------------------------------------------VRSNCPKRMKRLMAECL 266 (289)
T ss_dssp CCCTT------------S---------------------------------------------SCTTSCHHHHHHHHHHT
T ss_pred Ccchh------------h---------------------------------------------ccccCCHHHHHHHHHHc
Confidence 21100 0 00000126899999999
Q ss_pred ccCCCCCCCHHHHhc
Q psy11727 412 TYDPKKRISPTNVLR 426 (437)
Q Consensus 412 ~~dP~~R~t~~e~l~ 426 (437)
+.||.+|||+.++++
T Consensus 267 ~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 267 KKKRDERPSFPRILA 281 (289)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred cCChhhCCCHHHHHH
Confidence 999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=340.12 Aligned_cols=193 Identities=23% Similarity=0.295 Sum_probs=154.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE-----C
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW-----K 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~-----~ 183 (437)
.++|++.+.||+|+||.||+|.. +++.||||++.... ......|..+.. ...+.|+||+++++.+.. .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~---~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN--RQNFINEKNIYR---VPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG--HHHHHHHHHHHT---STTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc--hhhHHHHHHHHH---HHhccCcchhhheecccccccCCC
Confidence 57899999999999999999965 68999999996432 233333433322 334589999999975542 3
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCC-------CCCeeeCCCCCCcEEEecCCCCCE
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP-------ELSIIHCDLKPENILLCSPKRSAI 255 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~-------~~giiHrDiKp~NIll~~~~~~~i 255 (437)
..+++||||+++ +|.+++.... .++..+..++.||+.||+|||++ ..||+||||||+|||+ +.++.+
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill--~~~~~~ 159 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV--KNDGTC 159 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE--CTTSCE
T ss_pred ceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE--cCCCcE
Confidence 478999999954 8999987654 58999999999999999999964 1289999999999999 677899
Q ss_pred EEEeCCCceecCCc-----------cccccccccccChhhhcC-------CCCCCcchHHHHHHHHHHHHhCCCCC
Q psy11727 256 KIIDFGSSCHVGQT-----------LYQYIQSRYYRSPEVLLG-------IPYDLAIDMWSLGCILVELHTGEPLF 313 (437)
Q Consensus 256 kL~DFG~s~~~~~~-----------~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~elltg~~pf 313 (437)
||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 99999999765321 224578999999999987 35667899999999999999996554
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=324.84 Aligned_cols=244 Identities=23% Similarity=0.324 Sum_probs=194.0
Q ss_pred ccCeeeec-eecccCceEEEEEEE--cCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 109 LDRYEIDT-LLGKGSFGQVVKAFD--HEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 109 ~~~y~i~~-~lG~G~fg~V~~~~~--~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
.++|.+.+ .||+|+||+||+|.+ ..+++.||||++..... ....+..|+.++..+ .||||+++++++ .
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-----DNPYIVRMIGIC-E 88 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-----CCTTBCCEEEEE-E
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEE-C
Confidence 46799988 999999999999954 56788999999975422 234566677777766 689999999998 5
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
.+..++|||++++ +|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dikp~Nil~--~~~~~~kl~Dfg 162 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNVLL--VTQHYAKISDFG 162 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE--EETTEEEECCCT
T ss_pred CCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhC--CeEcCCCCcceEEE--eCCCcEEEccCC
Confidence 6788999999975 899988765 3589999999999999999999964 89999999999999 557789999999
Q ss_pred CceecCCcc------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 262 SSCHVGQTL------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 262 ~s~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
++....... ....++..|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+....+......+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~- 241 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC- 241 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-
Confidence 997764322 12345688999999998889999999999999999999 9999999887666555432110000
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
| ......+.+||.+||+.|
T Consensus 242 ----------------------------------~---------------------------~~~~~~l~~li~~~l~~d 260 (291)
T 1xbb_A 242 ----------------------------------P---------------------------AGCPREMYDLMNLCWTYD 260 (291)
T ss_dssp ----------------------------------C---------------------------TTCCHHHHHHHHHHTCSS
T ss_pred ----------------------------------C---------------------------CCCCHHHHHHHHHHcCCC
Confidence 0 000125789999999999
Q ss_pred CCCCCCHHHHhc
Q psy11727 415 PKKRISPTNVLR 426 (437)
Q Consensus 415 P~~R~t~~e~l~ 426 (437)
|.+|||+.++++
T Consensus 261 p~~Rps~~~l~~ 272 (291)
T 1xbb_A 261 VENRPGFAAVEL 272 (291)
T ss_dssp TTTSCCHHHHHH
T ss_pred hhhCcCHHHHHH
Confidence 999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=327.76 Aligned_cols=249 Identities=17% Similarity=0.252 Sum_probs=189.5
Q ss_pred eccCeeeeceecccCceEEEEEEEcC---CCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHE---EKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~---~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
..++|.+.+.||+|+||+||+|.+.. ++..||+|++..... ....+..|+.++..+ .||||+++++++.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~ 106 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-----SHPNVIRLLGVCI 106 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEEE
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-----CCCCeeeeeEEEe
Confidence 35689999999999999999998765 566899999874322 223455677776665 6899999999998
Q ss_pred ECC-----EEEEEEEeccC-cHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC
Q psy11727 182 WKN-----HLCLVFELLSY-NLYNLIRNT----NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK 251 (437)
Q Consensus 182 ~~~-----~~~lV~E~~~~-~L~~~l~~~----~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~ 251 (437)
..+ ..++||||+.+ +|.+++... ....+++..++.++.||+.||.|||++ ||+||||||+|||+ +.
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dikp~NIli--~~ 182 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR--NFLHRDLAARNCML--RD 182 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT--TCCCCCCSGGGEEE--CT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCcceEEE--cC
Confidence 655 45999999965 899888532 234589999999999999999999964 89999999999999 67
Q ss_pred CCCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy11727 252 RSAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKI 325 (437)
Q Consensus 252 ~~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i 325 (437)
++.+||+|||++...... .....+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+.......+
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 262 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence 888999999999765332 123456788999999999999999999999999999999 99999988776665555
Q ss_pred HHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHH
Q psy11727 326 IEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKD 405 (437)
Q Consensus 326 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 405 (437)
......+.. ......+.+
T Consensus 263 ~~~~~~~~~--------------------------------------------------------------~~~~~~l~~ 280 (313)
T 3brb_A 263 LHGHRLKQP--------------------------------------------------------------EDCLDELYE 280 (313)
T ss_dssp HTTCCCCCB--------------------------------------------------------------TTCCHHHHH
T ss_pred HcCCCCCCC--------------------------------------------------------------ccccHHHHH
Confidence 332110000 000125789
Q ss_pred HHHHccccCCCCCCCHHHHhcC
Q psy11727 406 LILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 406 li~~~L~~dP~~R~t~~e~l~H 427 (437)
||.+||+.||.+|||+.++++|
T Consensus 281 li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 281 IMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=324.27 Aligned_cols=244 Identities=20% Similarity=0.263 Sum_probs=193.0
Q ss_pred CeeeeceecccCceEEEEEEEcCCCe---EEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKC---QVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~---~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
.|.+.+.||+|+||+||+|.+..++. .||+|++..... ....+..|+.++..+ .||||+++++++.+.+.
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-----NHPNVLALIGIMLPPEG 96 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEECCSSS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEecCCC
Confidence 57788999999999999998765544 799999974332 234455677777665 68999999999987665
Q ss_pred E-EEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 186 L-CLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 186 ~-~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
. ++|||++. ++|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||++
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dikp~Nili--~~~~~~kl~Dfg~~ 171 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQ--KFVHRDLAARNCML--DESFTVKVADFGLA 171 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE--CTTCCEEECCTTSS
T ss_pred CcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCcceEEE--cCCCcEEeCcCCCc
Confidence 4 99999995 58999887643 5689999999999999999999964 89999999999999 67889999999999
Q ss_pred eecCCc-------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 264 CHVGQT-------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 264 ~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
...... .....++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..+....+......+...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 3pls_A 172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPE 251 (298)
T ss_dssp CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCT
T ss_pred ccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCc
Confidence 755332 223466889999999999999999999999999999999 567777766655555443321111000
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
.....+.+||.+||+.||
T Consensus 252 --------------------------------------------------------------~~~~~l~~li~~~l~~~p 269 (298)
T 3pls_A 252 --------------------------------------------------------------YCPDSLYQVMQQCWEADP 269 (298)
T ss_dssp --------------------------------------------------------------TCCHHHHHHHHHHTCSSG
T ss_pred --------------------------------------------------------------cchHHHHHHHHHHccCCh
Confidence 001257899999999999
Q ss_pred CCCCCHHHHhc
Q psy11727 416 KKRISPTNVLR 426 (437)
Q Consensus 416 ~~R~t~~e~l~ 426 (437)
.+|||++++++
T Consensus 270 ~~Rps~~~ll~ 280 (298)
T 3pls_A 270 AVRPTFRVLVG 280 (298)
T ss_dssp GGSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=325.40 Aligned_cols=245 Identities=20% Similarity=0.272 Sum_probs=192.9
Q ss_pred cCeeeeceecccCceEEEEEEEcCC---CeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEeccee-eEC
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEE---KCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHF-TWK 183 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~---~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~-~~~ 183 (437)
.+|++.+.||+|+||+||+|.+..+ ...||+|.+..... ....+..|+.+++.+ .||||+++++++ ...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-----SHPNVLSLLGICLRSE 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEECCSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-----CCCCEeeeeeEEEcCC
Confidence 4699999999999999999986543 34689999874322 234456677777665 689999999985 456
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+..++||||+++ +|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||+
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~--~i~H~dikp~Nil~--~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASK--KFVHRDLAARNCML--DEKFTVKVADFGL 174 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE--CTTCCEEECSCGG
T ss_pred CceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCchheEEE--CCCCCEEECcccc
Confidence 688999999966 8999987643 5689999999999999999999964 89999999999999 7788999999999
Q ss_pred ceecCCc-------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 263 SCHVGQT-------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 263 s~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
+...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+......+..
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 254 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC
Confidence 9765332 223456788999999999999999999999999999999 67888887766655554332111100
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
. . ....+.+||.+||+.|
T Consensus 255 ~----------------------------------------------------------~----~~~~l~~li~~~l~~~ 272 (298)
T 3f66_A 255 E----------------------------------------------------------Y----CPDPLYEVMLKCWHPK 272 (298)
T ss_dssp T----------------------------------------------------------T----CCHHHHHHHHHHTCSS
T ss_pred c----------------------------------------------------------c----CCHHHHHHHHHHcCCC
Confidence 0 0 0125789999999999
Q ss_pred CCCCCCHHHHhc
Q psy11727 415 PKKRISPTNVLR 426 (437)
Q Consensus 415 P~~R~t~~e~l~ 426 (437)
|.+|||++|+++
T Consensus 273 p~~Rps~~ell~ 284 (298)
T 3f66_A 273 AEMRPSFSELVS 284 (298)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCcCHHHHHH
Confidence 999999999885
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.38 Aligned_cols=253 Identities=22% Similarity=0.320 Sum_probs=206.9
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
...++|++.+.||+|+||+||+|.+.. +..||||+++........+.+|+.+++.+ .|+||+++++++.+ +.+
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECS-SSC
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhC-----CCCCEeeEEEEEee-ccc
Confidence 345789999999999999999999865 46799999986554556788899999887 68999999998876 678
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
||||||+.+ +|.+++.......+++..+..++.||+.||+|||++ |||||||||+|||+ +.++.+||+|||++..
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll--~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILV--GENLVCKVADFGLARL 412 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE--CGGGCEEECCTTSTTT
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCCHhhEEE--cCCCcEEEccccccee
Confidence 999999965 899999764334589999999999999999999964 89999999999999 6778899999999976
Q ss_pred cCCccc----cccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 266 VGQTLY----QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 266 ~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
...... ...++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+.....++...
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~----- 487 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP----- 487 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCT-----
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC-----
Confidence 643321 2345678999999998899999999999999999999 999999988877776664422211100
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
.....+.+||.+||+.||.+|||
T Consensus 488 ---------------------------------------------------------~~~~~l~~li~~cl~~dP~~RPt 510 (535)
T 2h8h_A 488 ---------------------------------------------------------ECPESLHDLMCQCWRKEPEERPT 510 (535)
T ss_dssp ---------------------------------------------------------TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ---------------------------------------------------------CCCHHHHHHHHHHcCCChhHCcC
Confidence 00125789999999999999999
Q ss_pred HHHHhc--CCCcCc
Q psy11727 421 PTNVLR--HEFFLK 432 (437)
Q Consensus 421 ~~e~l~--Hp~~~~ 432 (437)
++++++ ..+|+.
T Consensus 511 ~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 511 FEYLQAFLEDYFTS 524 (535)
T ss_dssp HHHHHHHHHTSSCC
T ss_pred HHHHHHHHHHHhhc
Confidence 999986 356553
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=328.40 Aligned_cols=198 Identities=24% Similarity=0.293 Sum_probs=163.9
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE----C
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW----K 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~----~ 183 (437)
.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.++..+ .||||+++++++.. .
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-----NHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEEEEEETTE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-----CCCCeeeEEEEEEeccCCC
Confidence 457999999999999999999999999999999986432 2334566777777665 78999999999873 3
Q ss_pred CEEEEEEEeccC-cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
...++||||+.+ +|.+++... ....+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~dlkp~NIl~--~~~~~~kl~df 178 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK--GYAHRDLKPTNILL--GDEGQPVLMDL 178 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEE--CTTSCEEECCC
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEE--cCCCCEEEEec
Confidence 489999999966 899888753 235689999999999999999999964 89999999999999 67888999999
Q ss_pred CCceecCCcc------------ccccccccccChhhhcCCC---CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy11727 261 GSSCHVGQTL------------YQYIQSRYYRSPEVLLGIP---YDLAIDMWSLGCILVELHTGEPLFSG 315 (437)
Q Consensus 261 G~s~~~~~~~------------~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~elltg~~pf~~ 315 (437)
|++....... ....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 9987653211 2345789999999998654 68999999999999999999999953
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=331.66 Aligned_cols=199 Identities=27% Similarity=0.382 Sum_probs=168.4
Q ss_pred ccCeeeeceecccCceEEEEEE----EcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceee--
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAF----DHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT-- 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~----~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~-- 181 (437)
.++|++.+.||+|+||.||+|. +..+++.||||++..... ....+.+|+.++..+ .|+||+++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-----HSDFIVKYRGVSYGP 96 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEECS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-----CCCceeEEEEEEecC
Confidence 3689999999999999999998 567899999999975432 234467788887776 7899999999886
Q ss_pred ECCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 182 WKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 182 ~~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
+.+.+++||||++ ++|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dikp~NIl~--~~~~~~kl~Df 171 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR--RCVHRDLAARNILV--ESEAHVKIADF 171 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE--EETTEEEECCG
T ss_pred CCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCChhhEEE--CCCCCEEEccc
Confidence 4568999999995 58999887643 3589999999999999999999964 89999999999999 56788999999
Q ss_pred CCceecCCcc------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy11727 261 GSSCHVGQTL------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN 317 (437)
Q Consensus 261 G~s~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~ 317 (437)
|++....... ....+|..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 234 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence 9998764322 23457788999999999889999999999999999999999997643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=325.91 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=196.0
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
|...+.||+|+||+||+|.+ +++.||+|++.... .....+.+|+.++..+ .||||+++++++.+.+..
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~ 105 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-----QHENLVELLGFSSDGDDL 105 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSC
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-----CCCCeEEEEEEEecCCce
Confidence 44558999999999999975 67899999986432 2235567788888877 689999999999999999
Q ss_pred EEEEEecc-CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 187 CLVFELLS-YNLYNLIRNTN-FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 187 ~lV~E~~~-~~L~~~l~~~~-~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
++||||++ ++|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+||++ +.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dlkp~Nili--~~~~~~kl~Dfg~~~ 181 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN--HHIHRDIKSANILL--DEAFTAKISDFGLAR 181 (307)
T ss_dssp EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEE--CTTCCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEE--cCCCcEEEeeccccc
Confidence 99999995 58999887432 34589999999999999999999964 89999999999999 678899999999997
Q ss_pred ecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhcc
Q psy11727 265 HVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 265 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 339 (437)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+..+.+........
T Consensus 182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 256 (307)
T 2nru_A 182 ASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT---- 256 (307)
T ss_dssp ECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC----
T ss_pred ccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh----
Confidence 65432 223578999999999876 58999999999999999999999998765443333333221110000
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
+.+.+. .............+.+||.+||+.||.+||
T Consensus 257 ----------------------------------~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 292 (307)
T 2nru_A 257 ----------------------------------IEDYID----------KKMNDADSTSVEAMYSVASQCLHEKKNKRP 292 (307)
T ss_dssp ----------------------------------HHHHSC----------SSCSCCCHHHHHHHHHHHHHHTCSSTTTSC
T ss_pred ----------------------------------hhhhcc----------ccccccchHHHHHHHHHHHHHcCCCcccCc
Confidence 000000 000111223344689999999999999999
Q ss_pred CHHHHhcC
Q psy11727 420 SPTNVLRH 427 (437)
Q Consensus 420 t~~e~l~H 427 (437)
|+.+++++
T Consensus 293 s~~~l~~~ 300 (307)
T 2nru_A 293 DIKKVQQL 300 (307)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=363.63 Aligned_cols=280 Identities=22% Similarity=0.260 Sum_probs=201.4
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE---
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--- 182 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--- 182 (437)
..++|++.+.||+|+||+||+|.+..+|+.||||++.... .....+..|+.++..+ .||||+++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-----~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-----NHPNVVSAREVPDGLQK 86 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-----CBTTBCCEEECCTTTCC
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-----CCCCCCceeeeeccccc
Confidence 3578999999999999999999999999999999986432 2234566788888877 68999999988765
Q ss_pred ---CCEEEEEEEecc-CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC-CCCEE
Q psy11727 183 ---KNHLCLVFELLS-YNLYNLIRNTN-FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK-RSAIK 256 (437)
Q Consensus 183 ---~~~~~lV~E~~~-~~L~~~l~~~~-~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~-~~~ik 256 (437)
.+..++||||++ ++|.+++.... ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ ...+|
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~--gIVHrDLKP~NILl~~~g~~~~vK 164 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN--RIIHRDLKPENIVLQPGPQRLIHK 164 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT--TBCCCCCCSTTEEEECCSSSCEEE
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCCHHHeEeecCCCceeEE
Confidence 678899999995 58999987643 23589999999999999999999964 899999999999995432 22489
Q ss_pred EEeCCCceecCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 257 IIDFGSSCHVGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 257 L~DFG~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+............. .
T Consensus 165 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~---~-- 239 (676)
T 3qa8_A 165 IIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE---K-- 239 (676)
T ss_dssp ECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-------
T ss_pred EcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc---c--
Confidence 9999999876433 34467899999999999999999999999999999999999999876543211100000 0
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
... .........+.+.+ +. ........+......+.+||.+||++|
T Consensus 240 -----~~~-~~~~~~~l~g~~~~---------------------------~~-~lp~p~~l~~~ls~~L~dLI~~mL~~D 285 (676)
T 3qa8_A 240 -----SNE-HIVVYDDLTGAVKF---------------------------SS-VLPTPNHLSGILAGKLERWLQCMLMWH 285 (676)
T ss_dssp ----------CCSCCCCSSSCCC---------------------------CS-SSCCSCCCCGGGHHHHHHHHHHHSCSS
T ss_pred -----cch-hhhhhhhhcccccc---------------------------cc-ccCCchhhchhhhHHHHHHHHHHccCC
Confidence 000 00000000000000 00 000011223334457899999999999
Q ss_pred CCCCCCHHHHhcCCCcCcC
Q psy11727 415 PKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~~~~ 433 (437)
|.+|||+.|+++||||+..
T Consensus 286 P~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 286 QRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp CC---CCTTCCCCTTHHHH
T ss_pred HhhCcCHHHHhcCHHHHHH
Confidence 9999999999999999753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=342.70 Aligned_cols=197 Identities=21% Similarity=0.240 Sum_probs=160.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---------cchHHHHHHHHHHHhhh---------cCC--
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---------FLNQAQIEVQLLEKINK---------ADI-- 168 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---------~~~~~~~e~~~~~~l~~---------~~~-- 168 (437)
.++|++.+.||+|+||+||+|++ +|+.||||++..... ....+.+|+.+++.+.. .++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46899999999999999999987 789999999975421 22677889999998862 221
Q ss_pred ----------CCCcEEEecceeeE-------------CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHH
Q psy11727 169 ----------HSRYIVKLKGHFTW-------------KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCA 224 (437)
Q Consensus 169 ----------~h~~iv~l~~~~~~-------------~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~a 224 (437)
.||||++++++|.+ .+.+||||||+.+ ++.+.+.. ..+++..++.++.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 16677777777665 7899999999955 46666543 358999999999999999
Q ss_pred HHHhc-CCCCCeeeCCCCCCcEEEecCC------------------CCCEEEEeCCCceecCCccccccccccccChhhh
Q psy11727 225 LAFLS-SPELSIIHCDLKPENILLCSPK------------------RSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVL 285 (437)
Q Consensus 225 L~~LH-~~~~giiHrDiKp~NIll~~~~------------------~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~ 285 (437)
|+||| ++ |||||||||+|||++.+. ...+||+|||+|+..... ..+||+.|+|||++
T Consensus 174 L~~lH~~~--~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 174 LAVAEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHH--CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCSGGG
T ss_pred HHHHHHhC--CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEeecccChhhh
Confidence 99999 65 799999999999996432 127999999999876543 45899999999999
Q ss_pred cCCCCCCcchHHHHHHH-HHHHHhCCCCCCC
Q psy11727 286 LGIPYDLAIDMWSLGCI-LVELHTGEPLFSG 315 (437)
Q Consensus 286 ~~~~~~~~~DvwSlG~i-l~elltg~~pf~~ 315 (437)
.+.. +.++||||||++ .+++++|..||.+
T Consensus 250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred cCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 8876 899999998777 7788889999954
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=327.60 Aligned_cols=199 Identities=29% Similarity=0.376 Sum_probs=166.6
Q ss_pred ceeccCe-eeeceecccCceEEEEEEE----cCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecc
Q psy11727 106 EKFLDRY-EIDTLLGKGSFGQVVKAFD----HEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKG 178 (437)
Q Consensus 106 ~~~~~~y-~i~~~lG~G~fg~V~~~~~----~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~ 178 (437)
..+.++| ++.+.||+|+||+||+|.. ..+++.||||++.... .....+.+|+.++..+ .||||+++++
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~ 100 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-----YHEHIIKYKG 100 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-----CCcchhhEEE
Confidence 3455666 9999999999999988753 4578999999997543 2234567788888877 6899999999
Q ss_pred eeeE--CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCE
Q psy11727 179 HFTW--KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAI 255 (437)
Q Consensus 179 ~~~~--~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~i 255 (437)
++.+ ...+++||||+++ +|.+++.... +++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+
T Consensus 101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~--~ivH~Dikp~Nil~--~~~~~~ 173 (318)
T 3lxp_A 101 CCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQ--HYIHRDLAARNVLL--DNDRLV 173 (318)
T ss_dssp EEEETTTTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE--CTTCCE
T ss_pred EEecCCCceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhC--CccCCCCchheEEE--cCCCCE
Confidence 9998 4689999999965 8998887653 89999999999999999999964 89999999999999 678889
Q ss_pred EEEeCCCceecCCc------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy11727 256 KIIDFGSSCHVGQT------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGK 316 (437)
Q Consensus 256 kL~DFG~s~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~ 316 (437)
||+|||++...... .....++..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 174 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 174 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp EECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred EECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 99999999876442 22345778899999999989999999999999999999999999764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=327.92 Aligned_cols=201 Identities=21% Similarity=0.277 Sum_probs=166.7
Q ss_pred cCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 104 HGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 104 ~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+..+.++|.+.+.||+|+||+||+|.+ +++.||||++.... ......|..++.... +.||||+++++++...
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~---l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVM---LRHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHSC---CCCTTBCCEEEEEECC
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh--HHHHHHHHHHHHHhh---cCCCcEEEEEeeeccc
Confidence 3455678999999999999999999987 58899999996432 345566777766532 4899999999999877
Q ss_pred C----EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCC------CCCeeeCCCCCCcEEEecCCC
Q psy11727 184 N----HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP------ELSIIHCDLKPENILLCSPKR 252 (437)
Q Consensus 184 ~----~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~------~~giiHrDiKp~NIll~~~~~ 252 (437)
+ .+++||||+++ +|.+++... .+++..++.++.||+.||+|||.. ..||+||||||+|||+ +.+
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll--~~~ 183 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKN 183 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE--CTT
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE--CCC
Confidence 6 89999999976 899999764 489999999999999999999942 3489999999999999 678
Q ss_pred CCEEEEeCCCceecCCc-------cccccccccccChhhhcCCC------CCCcchHHHHHHHHHHHHhC----------
Q psy11727 253 SAIKIIDFGSSCHVGQT-------LYQYIQSRYYRSPEVLLGIP------YDLAIDMWSLGCILVELHTG---------- 309 (437)
Q Consensus 253 ~~ikL~DFG~s~~~~~~-------~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlG~il~elltg---------- 309 (437)
+.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 89999999999765432 23457899999999998752 33689999999999999999
Q ss_pred CCCCCCC
Q psy11727 310 EPLFSGK 316 (437)
Q Consensus 310 ~~pf~~~ 316 (437)
..||...
T Consensus 264 ~~p~~~~ 270 (342)
T 1b6c_B 264 QLPYYDL 270 (342)
T ss_dssp CCTTTTT
T ss_pred ccCcccc
Confidence 7787654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=333.47 Aligned_cols=245 Identities=20% Similarity=0.275 Sum_probs=182.8
Q ss_pred cCeeeeceecccCceEEEEEEEcCCC---eEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee-EC
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEK---CQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT-WK 183 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~---~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~-~~ 183 (437)
..|.+.+.||+|+||+||+|.+..++ ..||+|.++.... ....+..|+.++.. +.||||+++++++. ..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~-----l~hpnIv~~~~~~~~~~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD-----FSHPNVLSLLGICLRSE 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTT-----CCCTTBCCCCEEECCCS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHh-----CCCCCcceEEEEEEcCC
Confidence 35889999999999999999875432 4689999864321 22334445554444 47999999999865 45
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+..++||||+++ +|.+++.... ..+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|||+
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll--~~~~~~kL~DFG~ 238 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK--KFVHRDLAARNCML--DEKFTVKVADFGL 238 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEE--CTTCCEEECCC--
T ss_pred CCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC--CEecCccchheEEE--CCCCCEEEeeccc
Confidence 688999999965 8999987654 4589999999999999999999964 89999999999999 6788999999999
Q ss_pred ceecCCc-------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 263 SCHVGQT-------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 263 s~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
+...... .....++..|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+......+..
T Consensus 239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p 318 (373)
T 3c1x_A 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 318 (373)
T ss_dssp -------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC
T ss_pred cccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9755322 123456778999999999999999999999999999999 78999887665554444321110000
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
. .....+.+||.+||+.|
T Consensus 319 ----------------------------------------------------------~----~~~~~l~~li~~cl~~d 336 (373)
T 3c1x_A 319 ----------------------------------------------------------E----YCPDPLYEVMLKCWHPK 336 (373)
T ss_dssp ----------------------------------------------------------T----TCCHHHHHHHHHHTCSS
T ss_pred ----------------------------------------------------------C----CCCHHHHHHHHHHcCCC
Confidence 0 00125789999999999
Q ss_pred CCCCCCHHHHhc
Q psy11727 415 PKKRISPTNVLR 426 (437)
Q Consensus 415 P~~R~t~~e~l~ 426 (437)
|.+|||+.|+++
T Consensus 337 p~~RPs~~ell~ 348 (373)
T 3c1x_A 337 AEMRPSFSELVS 348 (373)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCcCHHHHHH
Confidence 999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=321.90 Aligned_cols=246 Identities=24% Similarity=0.291 Sum_probs=188.6
Q ss_pred ccCeeeeceecccCceEEEEEEEcC-CC--eEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHE-EK--CQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~-~~--~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|++.+.||+|+||+||+|.+.. ++ ..||||+++... .....+..|+.++..+ .||||+++++++.
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~ 91 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-----DHRNLIRLYGVVL 91 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEC
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-----CCCCcccEEEEEc
Confidence 4689999999999999999998643 33 368999986432 2334566788887776 6899999999998
Q ss_pred ECCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 182 WKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 182 ~~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
..+ .++|||++. ++|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+||
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dikp~Nili--~~~~~~kl~Df 165 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK--RFIHRDLAARNLLL--ATRDLVKIGDF 165 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEE--EETTEEEECCC
T ss_pred cCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC--CcccCCCchheEEE--cCCCCEEEccc
Confidence 765 889999996 58999887653 3589999999999999999999964 89999999999999 56778999999
Q ss_pred CCceecCCcc------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Q psy11727 261 GSSCHVGQTL------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPP 333 (437)
Q Consensus 261 G~s~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~ 333 (437)
|++....... ....+|..|+|||++.+..++.++||||||+++|+|++ |++||.+.+..+....+......++
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC
Confidence 9997764322 23456778999999998889999999999999999999 9999999887766665533111100
Q ss_pred hhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
. . ......+.+||.+||+.
T Consensus 246 ~------------------------------------~-------------------------~~~~~~l~~li~~~l~~ 264 (291)
T 1u46_A 246 R------------------------------------P-------------------------EDCPQDIYNVMVQCWAH 264 (291)
T ss_dssp C------------------------------------C-------------------------TTCCHHHHHHHHHHTCS
T ss_pred C------------------------------------C-------------------------cCcCHHHHHHHHHHccC
Confidence 0 0 00012578999999999
Q ss_pred CCCCCCCHHHHhc
Q psy11727 414 DPKKRISPTNVLR 426 (437)
Q Consensus 414 dP~~R~t~~e~l~ 426 (437)
||.+|||+.++++
T Consensus 265 ~p~~Rps~~~l~~ 277 (291)
T 1u46_A 265 KPEDRPTFVALRD 277 (291)
T ss_dssp SGGGSCCHHHHHH
T ss_pred CcccCcCHHHHHH
Confidence 9999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.31 Aligned_cols=245 Identities=22% Similarity=0.282 Sum_probs=193.3
Q ss_pred ccCeeeec-eecccCceEEEEEEEc--CCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 109 LDRYEIDT-LLGKGSFGQVVKAFDH--EEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 109 ~~~y~i~~-~lG~G~fg~V~~~~~~--~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.+++.+.+ .||+|+||+||+|.+. .++..||||+++... .....+..|+.++..+ .|||||++++++..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-----~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-----DNPYIVRLIGVCQA- 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-----CCTTBCCEEEEEES-
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-----CCCCEeeEEEEecc-
Confidence 34566666 8999999999999875 356779999997532 2345677788887665 78999999999876
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+.+++||||+++ +|.+++.... ..+++..+..++.||+.||+|||++ |||||||||+|||+ +.++.+||+|||+
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~--~iiHrDlkp~NILl--~~~~~vkL~DFGl 482 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK--NFVHRNLAARNVLL--VNRHYAKISDFGL 482 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE--EETTEEEECCCST
T ss_pred CCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC--CEEcCcCCHHHEEE--cCCCcEEEeeccC
Confidence 569999999965 7888886543 5699999999999999999999964 89999999999999 5678899999999
Q ss_pred ceecCCcc------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 263 SCHVGQTL------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 263 s~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
+....... ....++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.....++...
T Consensus 483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~ 562 (613)
T 2ozo_A 483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 562 (613)
T ss_dssp TTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCT
T ss_pred cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 97653321 12234578999999998899999999999999999998 999999988877776664422111000
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
.....+.+||.+||+.||
T Consensus 563 --------------------------------------------------------------~~~~~l~~li~~cl~~dP 580 (613)
T 2ozo_A 563 --------------------------------------------------------------ECPPELYALMSDCWIYKW 580 (613)
T ss_dssp --------------------------------------------------------------TCCHHHHHHHHHTTCSST
T ss_pred --------------------------------------------------------------cCCHHHHHHHHHHcCCCh
Confidence 001257899999999999
Q ss_pred CCCCCHHHHhc
Q psy11727 416 KKRISPTNVLR 426 (437)
Q Consensus 416 ~~R~t~~e~l~ 426 (437)
.+|||+.++++
T Consensus 581 ~~RPs~~~l~~ 591 (613)
T 2ozo_A 581 EDRPDFLTVEQ 591 (613)
T ss_dssp TTSCCHHHHHH
T ss_pred hHCcCHHHHHH
Confidence 99999999753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=349.77 Aligned_cols=238 Identities=23% Similarity=0.324 Sum_probs=191.1
Q ss_pred eceecccCceEEEEEEE--cCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 115 DTLLGKGSFGQVVKAFD--HEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~--~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
.+.||+|+||.||+|.+ ..+++.||||+++.... ....+..|+.++..+ .|||||++++++.. +..++|
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~-~~~~lv 447 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-----DNPYIVRMIGICEA-ESWMLV 447 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-----CCTTBCCEEEEEES-SSEEEE
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEec-CCEEEE
Confidence 34899999999999954 45678999999975322 235677899998887 68999999999864 568899
Q ss_pred EEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 190 FELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 190 ~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
|||+.+ +|.+++... ..+++..++.++.||+.||+|||++ |||||||||+|||+ +.++.+||+|||++.....
T Consensus 448 ~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~--~iiHrDLkp~NILl--~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNVLL--VTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE--EETTEEEECCTTHHHHTTC
T ss_pred EEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHC--CEeCCCCChHhEEE--eCCCCEEEEEcCCcccccc
Confidence 999965 899998764 3589999999999999999999964 89999999999999 5677899999999976533
Q ss_pred cc------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 269 TL------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 269 ~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
.. ....+|..|+|||++.+..++.++|||||||++|||++ |++||.+.+..+....+......+...
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~------ 595 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA------ 595 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT------
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC------
Confidence 21 22345778999999999999999999999999999998 999999998877766664422111000
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
.....+.+||.+||+.||.+|||+
T Consensus 596 --------------------------------------------------------~~~~~l~~li~~cl~~dP~~RPs~ 619 (635)
T 4fl3_A 596 --------------------------------------------------------GCPREMYDLMNLCWTYDVENRPGF 619 (635)
T ss_dssp --------------------------------------------------------TCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred --------------------------------------------------------CCCHHHHHHHHHHcCCCHhHCcCH
Confidence 001257899999999999999999
Q ss_pred HHHhc
Q psy11727 422 TNVLR 426 (437)
Q Consensus 422 ~e~l~ 426 (437)
.++++
T Consensus 620 ~~l~~ 624 (635)
T 4fl3_A 620 AAVEL 624 (635)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=321.06 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=191.4
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
+...++|++.+.||+|+||+||+|.+.. .||+|++.... .....+..|+.++..+ .|+||+++++++.+
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-----RHENVVLFMGACMS 100 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-----CCTTBCCCCEEEEC
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-----CCCCEeEEEEEEec
Confidence 3346789999999999999999998754 39999986432 2223444566665554 78999999999999
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
.+.+++||||+.+ +|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ + ++.+||+|||
T Consensus 101 ~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~--~i~H~dlkp~NIl~--~-~~~~~l~Dfg 174 (319)
T 2y4i_B 101 PPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK--GILHKDLKSKNVFY--D-NGKVVITDFG 174 (319)
T ss_dssp SSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSTTEEE--C---CCEECCCS
T ss_pred CCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCChhhEEE--e-CCCEEEeecC
Confidence 9999999999965 8888886643 4689999999999999999999964 89999999999999 3 5689999999
Q ss_pred CceecC--------CccccccccccccChhhhcC---------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy11727 262 SSCHVG--------QTLYQYIQSRYYRSPEVLLG---------IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTK 324 (437)
Q Consensus 262 ~s~~~~--------~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~ 324 (437)
++.... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 254 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 976542 12233468899999999975 4578999999999999999999999999887766655
Q ss_pred HHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHH
Q psy11727 325 IIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFK 404 (437)
Q Consensus 325 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (437)
+......+.. . ......+.
T Consensus 255 ~~~~~~~~~~-----------------~--------------------------------------------~~~~~~l~ 273 (319)
T 2y4i_B 255 MGTGMKPNLS-----------------Q--------------------------------------------IGMGKEIS 273 (319)
T ss_dssp HHTTCCCCCC-----------------C--------------------------------------------SSCCTTHH
T ss_pred hccCCCCCCC-----------------c--------------------------------------------CCCCHHHH
Confidence 5332110000 0 00001478
Q ss_pred HHHHHccccCCCCCCCHHHHhc
Q psy11727 405 DLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 405 dli~~~L~~dP~~R~t~~e~l~ 426 (437)
+||.+||+.||.+|||+.++++
T Consensus 274 ~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 274 DILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHH
T ss_pred HHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=321.78 Aligned_cols=197 Identities=26% Similarity=0.403 Sum_probs=165.8
Q ss_pred ccCeeeeceecccCceEEEEEE----EcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAF----DHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~----~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.++|++.+.||+|+||.||+|. +..+++.||||++.... .....+.+|+.++..+ .|+||+++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-----QHDNIVKYKGVCYSA 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-----CCTTBCCEEEEECC-
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEEec
Confidence 5679999999999999999998 46689999999997543 2234566788887766 689999999988754
Q ss_pred C--EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 184 N--HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 184 ~--~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
+ .+++|||++++ +|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+||+||
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dikp~NIli--~~~~~~kL~Df 189 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK--RYIHRDLATRNILV--ENENRVKIGDF 189 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEE--EETTEEEECCC
T ss_pred CCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC--CEeccCCCcceEEE--cCCCcEEEecC
Confidence 4 78999999965 8999987754 4589999999999999999999964 89999999999999 55778999999
Q ss_pred CCceecCCcc------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy11727 261 GSSCHVGQTL------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG 315 (437)
Q Consensus 261 G~s~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~ 315 (437)
|++....... ....++..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 9998764332 123467789999999988899999999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.30 Aligned_cols=248 Identities=25% Similarity=0.333 Sum_probs=197.9
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCC---CeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEE---KCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~---~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
+...++|++.+.||+|+||+||+|.+..+ +..||||.++... .....+..|+.++..+ .||||+++++++
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~ 460 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-----DHPHIVKLIGVI 460 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEE
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEE
Confidence 34457899999999999999999988643 5679999986432 1224566677777766 789999999988
Q ss_pred eECCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 181 TWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 181 ~~~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
. .+..++||||++ ++|.+++.... ..+++..+..++.||+.||+|||++ ||+||||||+|||+ +.++.+||+|
T Consensus 461 ~-~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDikp~NILl--~~~~~vkL~D 534 (656)
T 2j0j_A 461 T-ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK--RFVHRDIAARNVLV--SSNDCVKLGD 534 (656)
T ss_dssp C-SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE--EETTEEEECC
T ss_pred e-cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC--CccccccchHhEEE--eCCCCEEEEe
Confidence 5 466899999996 58999887654 4589999999999999999999964 89999999999999 5678899999
Q ss_pred CCCceecCCcc----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 260 FGSSCHVGQTL----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 260 FG~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
||++....... ....+++.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+......+..
T Consensus 535 FG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 614 (656)
T 2j0j_A 535 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 614 (656)
T ss_dssp CCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCC
T ss_pred cCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 99997664332 22456788999999998899999999999999999997 99999999888777776543211100
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
. .....+.+||.+||+.|
T Consensus 615 ~--------------------------------------------------------------~~~~~l~~li~~~l~~d 632 (656)
T 2j0j_A 615 P--------------------------------------------------------------NCPPTLYSLMTKCWAYD 632 (656)
T ss_dssp T--------------------------------------------------------------TCCHHHHHHHHHHTCSS
T ss_pred c--------------------------------------------------------------cccHHHHHHHHHHcCCC
Confidence 0 00125789999999999
Q ss_pred CCCCCCHHHHhc
Q psy11727 415 PKKRISPTNVLR 426 (437)
Q Consensus 415 P~~R~t~~e~l~ 426 (437)
|.+|||+.++++
T Consensus 633 P~~RPs~~el~~ 644 (656)
T 2j0j_A 633 PSRRPRFTELKA 644 (656)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhHCcCHHHHHH
Confidence 999999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=345.00 Aligned_cols=245 Identities=21% Similarity=0.342 Sum_probs=191.9
Q ss_pred eecCceeccCeeeeceecccCceEEEEEEEcC-CCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecc
Q psy11727 102 IKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHE-EKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKG 178 (437)
Q Consensus 102 ~~~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~-~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~ 178 (437)
+..++.+.++|++.+.||+|+||+||+|.+.. +++.||||++..... ....+..|+.++.. +.||||+++++
T Consensus 72 ~~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~-----l~hp~iv~~~~ 146 (681)
T 2pzi_A 72 LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAE-----VVHPSIVQIFN 146 (681)
T ss_dssp SCTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGG-----CCCTTBCCEEE
T ss_pred CCCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHh-----cCCCCcCeEee
Confidence 34567788999999999999999999999976 789999999864321 12234455555544 47999999999
Q ss_pred eeeECCE-----EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCC
Q psy11727 179 HFTWKNH-----LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR 252 (437)
Q Consensus 179 ~~~~~~~-----~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~ 252 (437)
+|...+. .||||||++| +|.+++.. .+++..++.++.||+.||.|||++ |||||||||+|||++ .
T Consensus 147 ~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~--giiHrDlkp~NIll~--~- 217 (681)
T 2pzi_A 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI--GLVYNDLKPENIMLT--E- 217 (681)
T ss_dssp EEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEC--S-
T ss_pred eEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC--CCeecccChHHeEEe--C-
Confidence 9987665 7999999976 77776544 489999999999999999999964 899999999999994 3
Q ss_pred CCEEEEeCCCceecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Q psy11727 253 SAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMP 332 (437)
Q Consensus 253 ~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p 332 (437)
+.+||+|||++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.... +.+
T Consensus 218 ~~~kl~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~ 285 (681)
T 2pzi_A 218 EQLKLIDLGAVSRINSF-GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLP 285 (681)
T ss_dssp SCEEECCCTTCEETTCC-SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCC
T ss_pred CcEEEEecccchhcccC-CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc----------ccc
Confidence 37999999999877654 556799999999999765 489999999999999999999998752110 000
Q ss_pred ChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc
Q psy11727 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412 (437)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 412 (437)
.. .. .......+.+||.+||+
T Consensus 286 ~~-------------------------------------~~----------------------~~~~~~~l~~li~~~l~ 306 (681)
T 2pzi_A 286 ED-------------------------------------DP----------------------VLKTYDSYGRLLRRAID 306 (681)
T ss_dssp TT-------------------------------------CH----------------------HHHHCHHHHHHHHHHTC
T ss_pred cc-------------------------------------cc----------------------ccccCHHHHHHHhhhcc
Confidence 00 00 00011257899999999
Q ss_pred cCCCCCCCHHHHhcCCCcC
Q psy11727 413 YDPKKRISPTNVLRHEFFL 431 (437)
Q Consensus 413 ~dP~~R~t~~e~l~Hp~~~ 431 (437)
.||.+|||..+++.|+|+.
T Consensus 307 ~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 307 PDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp SSGGGSCSSHHHHHHHHHH
T ss_pred CChhhCCCHHHHHHHHHHH
Confidence 9999999999999888763
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=308.66 Aligned_cols=179 Identities=13% Similarity=0.060 Sum_probs=149.4
Q ss_pred ecCc-eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccc----hHHHHHHHHHHHhhhcCCCCCcEEEec
Q psy11727 103 KHGE-KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFL----NQAQIEVQLLEKINKADIHSRYIVKLK 177 (437)
Q Consensus 103 ~~~~-~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~----~~~~~e~~~~~~l~~~~~~h~~iv~l~ 177 (437)
..+. .+.++|++.+.||+|+||+||+|.+..+++.||||++....... ..+..|..++.. +.|+||++++
T Consensus 23 ~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-----l~hp~iv~~~ 97 (286)
T 3uqc_A 23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSR-----IDKPGVARVL 97 (286)
T ss_dssp CTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHT-----CCCTTBCCEE
T ss_pred CCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhc-----CCCCCcceee
Confidence 4455 56788999999999999999999999999999999997543322 445556665544 4899999999
Q ss_pred ceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEE
Q psy11727 178 GHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIK 256 (437)
Q Consensus 178 ~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ik 256 (437)
+++.+.+..|+||||+.| +|.+++... .....+..++.||+.||+|||++ ||+||||||+|||+ +.++.+|
T Consensus 98 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~--givH~Dikp~NIll--~~~g~~k 169 (286)
T 3uqc_A 98 DVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA--GVALSIDHPSRVRV--SIDGDVV 169 (286)
T ss_dssp EEEEETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEE--ETTSCEE
T ss_pred EEEEECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC--CCccCCCCcccEEE--cCCCCEE
Confidence 999999999999999965 899888542 46667889999999999999964 89999999999999 5678899
Q ss_pred EEeCCCceecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy11727 257 IIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNE 318 (437)
Q Consensus 257 L~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~ 318 (437)
|+++|. ++ +++.++|||||||++|+|++|++||.+.+.
T Consensus 170 l~~~~~-----------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 170 LAYPAT-----------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp ECSCCC-----------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred EEeccc-----------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 985543 33 378999999999999999999999987653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=286.15 Aligned_cols=183 Identities=17% Similarity=0.045 Sum_probs=128.0
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCc-----------ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-----------PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-----------~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
...+.|++|.+..++....|+.||+|++.... ....++.+|+.+++++. .|+||+++++++++++
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~----~~~~i~~~~~~~ed~~ 315 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPP----AGFDAPAVLAHGENAQ 315 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCC----TTCCCCCEEEEEECSS
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcC----CCCCeeEEEEEEEECC
Confidence 34677888888887777789999999997432 12245677888888774 6889999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+||||||++| +|.+++.... .++. ..|+.||+.||+|||++ |||||||||+|||+ +.+|.+||+|||+|
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~--~l~~---~~I~~QIl~AL~ylH~~--GIIHRDIKPeNILL--~~dg~vKL~DFGlA 386 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGE--EIDR---EKILGSLLRSLAALEKQ--GFWHDDVRPWNVMV--DARQHARLIDFGSI 386 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTC--CCCH---HHHHHHHHHHHHHHHHT--TCEESCCCGGGEEE--CTTSCEEECCCTTE
T ss_pred EEEEEEecCCCCcHHHHHHhCC--CCCH---HHHHHHHHHHHHHHHHC--CceeccCchHhEEE--CCCCCEEEeecccC
Confidence 99999999977 8999998753 4655 35899999999999964 89999999999999 67889999999999
Q ss_pred eecCC---ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCC
Q psy11727 264 CHVGQ---TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPL 312 (437)
Q Consensus 264 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p 312 (437)
+.... ...+.+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 387 r~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 387 VTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred eeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 76643 3456789999999999987 467889999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=239.18 Aligned_cols=179 Identities=17% Similarity=0.140 Sum_probs=138.6
Q ss_pred eeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc---------chHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 113 EIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF---------LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 113 ~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~---------~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
...+.||+|+||+||+| ...+..+|+|....+... ..++.+|+.+++.+ .||||+++..++...
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-----~h~nIv~~~~~~~~~ 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-----KDFGIPAPYIFDVDL 411 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-----GGGTCCCCCEEEEET
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-----CCCCcCceEEEEEeC
Confidence 44678999999999999 445778999987543211 23357788888888 578888666666677
Q ss_pred CEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+..||||||++ ++|.+++.. +..++.||+.||.|||++ ||+||||||+|||+ +. .+||+|||+
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~--gIiHrDiKp~NILl--~~--~~kL~DFGl 475 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN--DVIHNDLTTSNFIF--DK--DLYIIDFGL 475 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT--TEECTTCCTTSEEE--SS--SEEECCCTT
T ss_pred CccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC--cCccCCCCHHHEEE--CC--eEEEEECcc
Confidence 88899999996 589888765 568999999999999964 89999999999999 44 899999999
Q ss_pred ceecCCcc----------ccccccccccChhhhcC--CCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy11727 263 SCHVGQTL----------YQYIQSRYYRSPEVLLG--IPYDLAIDMWSLGCILVELHTGEPLFS 314 (437)
Q Consensus 263 s~~~~~~~----------~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~pf~ 314 (437)
|+...... ...+||+.|+|||++.+ ..|+..+|+||..+-..+...++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 98876531 35689999999999987 568889999999999888888877664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-23 Score=201.12 Aligned_cols=154 Identities=23% Similarity=0.331 Sum_probs=116.7
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-------------------cchHHHHHHHHHHHhhhcCCCCC
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-------------------FLNQAQIEVQLLEKINKADIHSR 171 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-------------------~~~~~~~e~~~~~~l~~~~~~h~ 171 (437)
.|.+.+.||+|+||.||+|.+ .+|+.||||+++.... ....+..|+.++..+.
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~------- 162 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ------- 162 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-------
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-------
Confidence 466779999999999999999 8899999999964321 1234678999988875
Q ss_pred cEEEecceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC
Q psy11727 172 YIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP 250 (437)
Q Consensus 172 ~iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~ 250 (437)
| +++.+++.. +..|+||||++| +|.+ +. ......++.||+.||.|||+ .||+||||||+|||+ +
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH~--~giiHrDlkp~NILl--~ 227 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLV--S 227 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEE--E
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHHH--CCCEeCCCCHHHEEE--E
Confidence 2 444554443 556999999976 7876 31 12355799999999999995 489999999999999 4
Q ss_pred CCCCEEEEeCCCceecCCccccccccccccChhhhcC----------CCCCCcchHHH
Q psy11727 251 KRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLG----------IPYDLAIDMWS 298 (437)
Q Consensus 251 ~~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~DvwS 298 (437)
++.+||+|||+|+. +..+.|||++.. ..|...+|+|.
T Consensus 228 -~~~vkl~DFG~a~~----------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE----------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp -TTEEEECCCTTCEE----------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred -CCcEEEEECCCCeE----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 78899999999863 345788998753 34455566664
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.8e-21 Score=183.12 Aligned_cols=138 Identities=17% Similarity=0.190 Sum_probs=109.0
Q ss_pred eeeeceecccCceEEEEEEEcCCCeE--EEEEEecCCccc-------------------------chHHHHHHHHHHHhh
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQ--VAIKIIKNKKPF-------------------------LNQAQIEVQLLEKIN 164 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~--vaiK~i~~~~~~-------------------------~~~~~~e~~~~~~l~ 164 (437)
|.+.+.||+|+||+||+|.+..+|+. ||||+++..... ...+..|..++..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78899999999999999998778989 999997543211 025678999999998
Q ss_pred hcCCCCCcEEEecceeeECCEEEEEEEeccC------cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhc-CCCCCeee
Q psy11727 165 KADIHSRYIVKLKGHFTWKNHLCLVFELLSY------NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLS-SPELSIIH 237 (437)
Q Consensus 165 ~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~------~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH-~~~~giiH 237 (437)
+.++.+|.++.. +..+|||||+++ .|.+.... .++..+..++.||+.+|.||| .+ ||||
T Consensus 129 ~~~i~~p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~--givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY-------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA--ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE-------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS--CEEC
T ss_pred hCCCCCCeEEEc-------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC--CEEe
Confidence 887777766542 245899999953 45554332 235677899999999999999 75 8999
Q ss_pred CCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 238 CDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 238 rDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
|||||+|||+ +. .++|+|||+|....
T Consensus 195 rDlkp~NILl--~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 195 ADLSEYNIMY--ID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SSCSTTSEEE--SS--SEEECCCTTCEETT
T ss_pred CCCCHHHEEE--cC--cEEEEECcccccCC
Confidence 9999999999 44 79999999997653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2.9e-17 Score=161.60 Aligned_cols=139 Identities=18% Similarity=0.219 Sum_probs=99.2
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc----------c-------------hHHHHHHHHHHHhhhcCC
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----------L-------------NQAQIEVQLLEKINKADI 168 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~----------~-------------~~~~~e~~~~~~l~~~~~ 168 (437)
|.+.+.||+|+||.||+|.+. +|+.||||+++..... . -....|...+.++....+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 999999999999999999874 6899999998632110 0 012346667777766555
Q ss_pred CCCcEEEecceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q psy11727 169 HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILL 247 (437)
Q Consensus 169 ~h~~iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll 247 (437)
..|..+.. .. .+|||||++| .|.++. .......++.||+.+|.+||. .|||||||||.|||+
T Consensus 176 ~vp~p~~~------~~-~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~--~gIVHrDLKp~NILl 238 (397)
T 4gyi_A 176 PVPEPIAQ------SR-HTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAK--HGLIHGDFNEFNILI 238 (397)
T ss_dssp SCCCEEEE------ET-TEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEE
T ss_pred CCCeeeec------cC-ceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHHHEEE
Confidence 44433221 12 2799999987 554321 223456789999999999995 489999999999999
Q ss_pred ecCCCC--------CEEEEeCCCceecCC
Q psy11727 248 CSPKRS--------AIKIIDFGSSCHVGQ 268 (437)
Q Consensus 248 ~~~~~~--------~ikL~DFG~s~~~~~ 268 (437)
..++++ .+.||||+-+.....
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred eCCCCcccccccccceEEEEeCCcccCCC
Confidence 654332 388999998876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=1.3e-11 Score=115.51 Aligned_cols=141 Identities=16% Similarity=0.103 Sum_probs=106.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.+.|.+...++.|+.+.||++.. .+..+++|+..... .....+..|..+++.+.. +..+.++++++.+.+..|
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~----~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEG----KLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT----TSCCCCEEEEEEETTEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhc----CCCCCeEEEEEecCCceE
Confidence 45788999999999999999964 36789999986421 223468889999999864 234666777788888999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP----------------------------------- 231 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~----------------------------------- 231 (437)
+|||+++| +|.+.+. +......++.+++.+|+.||+.
T Consensus 87 lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 99999988 6665421 1223457888999999999961
Q ss_pred ----------------------CCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 232 ----------------------ELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 232 ----------------------~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
..+++|+|++|.|||+. +...+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~--~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK--DGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE--TTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE--CCcEEEEEEchhcc
Confidence 04589999999999994 44446799999873
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=1.4e-10 Score=107.71 Aligned_cols=138 Identities=17% Similarity=0.069 Sum_probs=97.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
...|.+..+.+.|..+.||++.. .+|..+++|+.... .......|..+++.+...++. +.+++++....+..++
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~---vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVP---CAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCC---BCCEEEEEECSSCEEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCC---CCeEEEeccCCCCCEE
Confidence 34566655545666799999953 55678999997643 335678899999998754332 4556666777778999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCC-----------------------------------
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPE----------------------------------- 232 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~----------------------------------- 232 (437)
|||+++| ++ + .. ..+ ...++.+++..|+.||...
T Consensus 93 v~e~i~G~~l-~-~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 93 LLGEVPGQDL-L-SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEECCSSEET-T-TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEecCCccc-C-cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999988 45 3 11 111 2356777888888888532
Q ss_pred ---------------------CCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 233 ---------------------LSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 233 ---------------------~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
.+++|+|++|.|||+. +++.+.|+|||.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~--~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE--NGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE--TTEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE--CCcEEEEEcchhcc
Confidence 1399999999999994 44456799999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.06 E-value=2.7e-10 Score=108.98 Aligned_cols=186 Identities=19% Similarity=0.133 Sum_probs=118.1
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhh-cCCCCCcEEEecceeeECC---EEEEEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINK-ADIHSRYIVKLKGHFTWKN---HLCLVF 190 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~-~~~~h~~iv~l~~~~~~~~---~~~lV~ 190 (437)
.+.++.|....||++. ..+++|+... .........|..+++.+.. ..+..|.++. .....+ ..|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~-~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~---~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH-SRGSTNLFNEVNILKRIHNKLPLPIPEVVF---TGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS-HHHHHHHHHHHHHHHHHTTSSSSCCCCEEE---ECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC-cchHHHHHHHHHHHHHHHhcCCCCCCceEe---ecCCCCCCCcceEEE
Confidence 3458999999999873 3588998653 2334567889999988843 3344444432 222222 458899
Q ss_pred EeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q psy11727 191 ELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP-------------------------------------- 231 (437)
Q Consensus 191 E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~-------------------------------------- 231 (437)
++++| .+.+.... .++......++.|++..|+.||..
T Consensus 96 ~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 96 TKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp ECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99988 55443221 256777777888888877777741
Q ss_pred ------------------CCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCccccccccccc---cChhhhcC---
Q psy11727 232 ------------------ELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYY---RSPEVLLG--- 287 (437)
Q Consensus 232 ------------------~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~~~~~gt~~y---~aPE~~~~--- 287 (437)
...++|+|++|.||+++.+....+.|+||+.+..-.. .........+ .+|+....
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~-~~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP-DNDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT-THHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh-HHHHHHHHhhccccCHHHHHHHHH
Confidence 1358999999999999533245578999999865322 1111111111 23332211
Q ss_pred -CC-C---------CCcchHHHHHHHHHHHHhCCCCCC
Q psy11727 288 -IP-Y---------DLAIDMWSLGCILVELHTGEPLFS 314 (437)
Q Consensus 288 -~~-~---------~~~~DvwSlG~il~elltg~~pf~ 314 (437)
.+ . ..-.+.|++|.++|.+.+|.++|.
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 00 0 122689999999999999987763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.03 E-value=6.9e-10 Score=108.70 Aligned_cols=143 Identities=14% Similarity=0.213 Sum_probs=100.5
Q ss_pred eeceecccCceEEEEEEEcCCCeEEEEEEec--CCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC---CEE
Q psy11727 114 IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK--NKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK---NHL 186 (437)
Q Consensus 114 i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~--~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~---~~~ 186 (437)
..+.|+.|.++.||++... +..+++|+.. ... .......+|..+++.+....+ .+.+++.++.+. +..
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~v---pvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDV---PVAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSS---CCCCEEEEECCTTTTSSC
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCC---CCCcEEEECCCCCccCCe
Confidence 3567899999999999653 4578888775 322 123467789999999976444 355555666555 458
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP---------------------------------- 231 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~---------------------------------- 231 (437)
++|||+++| .+.+. ....++......++.+++.+|+.||..
T Consensus 117 ~~vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 999999988 44321 123467888889999999999999962
Q ss_pred ----------------------CCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 232 ----------------------ELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 232 ----------------------~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
..++||+|++|.|||+..++...+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 2469999999999999432223368999999864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.3e-06 Score=81.55 Aligned_cols=133 Identities=15% Similarity=0.190 Sum_probs=89.8
Q ss_pred ecccCce-EEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccC-
Q psy11727 118 LGKGSFG-QVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY- 195 (437)
Q Consensus 118 lG~G~fg-~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~- 195 (437)
+..|..| .||+......+..+++|+-... ....+..|...++.+.. .+. +.+++.++.+.+..++|||+++|
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~-~vP---VP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTA-FMP---LPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTT-TSC---CCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhcc-CCC---cCeEEEEEEECCeEEEEEEeeCCc
Confidence 3445555 6999877777778999987532 23567789999988864 232 55666778888999999999988
Q ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCC--------------------------------------------
Q psy11727 196 NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP-------------------------------------------- 231 (437)
Q Consensus 196 ~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~-------------------------------------------- 231 (437)
++.+..... ......+..+++..|+-||.-
T Consensus 106 ~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 106 TAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp EHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 555543321 122234445555555555531
Q ss_pred ------------CCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 232 ------------ELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 232 ------------~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
...++|+|+.|.|||+ ++.+.+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~--~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIF--DEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEE--ETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEE--ECCeEEEEEECcccc
Confidence 1237999999999999 445556799999874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=1e-06 Score=84.24 Aligned_cols=139 Identities=19% Similarity=0.153 Sum_probs=85.4
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhc-CCCCCcEEEecceee-ECCEEEEEEEe
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKA-DIHSRYIVKLKGHFT-WKNHLCLVFEL 192 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~-~~~h~~iv~l~~~~~-~~~~~~lV~E~ 192 (437)
.+.++.|....||+. +..+++|+-. ..........|..+++.+... .+. +.+++.+.. ..+..++|||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~---VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVN---IPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSB---CCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCC---CCCeEeecccCCCceEEEEec
Confidence 345788888899988 4568888853 223345778899999998753 222 333333332 34567899999
Q ss_pred ccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q psy11727 193 LSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSS----------------------------------------- 230 (437)
Q Consensus 193 ~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~----------------------------------------- 230 (437)
++| .+.+.... .++......++.+++..|+.||+
T Consensus 95 i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 95 VQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred cCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 988 44432111 12333333444444444433332
Q ss_pred -----------------CCCCeeeCCCCCCcEEEecC-CCCC-EEEEeCCCceec
Q psy11727 231 -----------------PELSIIHCDLKPENILLCSP-KRSA-IKIIDFGSSCHV 266 (437)
Q Consensus 231 -----------------~~~giiHrDiKp~NIll~~~-~~~~-ikL~DFG~s~~~ 266 (437)
....++|+|++|.||++..+ .++. +.|+||+.+..-
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 12357999999999999421 1344 489999987543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.30 E-value=8.1e-06 Score=78.53 Aligned_cols=75 Identities=16% Similarity=0.185 Sum_probs=47.4
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEec-c--eeeECCEEEEEEEe
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK-G--HFTWKNHLCLVFEL 192 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~-~--~~~~~~~~~lV~E~ 192 (437)
+.|+.|..+.||++... +..+++|+.... ......|..+++.+...++..|.++... + +....+..++||++
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 45666778999999653 345899998742 2445567888888876665445444421 1 12456788999999
Q ss_pred ccC
Q psy11727 193 LSY 195 (437)
Q Consensus 193 ~~~ 195 (437)
++|
T Consensus 113 i~G 115 (346)
T 2q83_A 113 IEG 115 (346)
T ss_dssp CCC
T ss_pred ecC
Confidence 977
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=7.1e-06 Score=81.14 Aligned_cols=77 Identities=19% Similarity=0.176 Sum_probs=48.9
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCc--------ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--------PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--------~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+.||.|.++.||++....+++.++||...... ....+...|..++..+.... +..+.+++.+ +.+..
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~--~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV--PHLVPRVFYS--DTEMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTC--GGGSCCEEEE--ETTTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhC--CCCcCeEEEE--cCCcc
Confidence 457899999999999765567789999864321 12345677999988875421 1123334332 44556
Q ss_pred EEEEEeccC
Q psy11727 187 CLVFELLSY 195 (437)
Q Consensus 187 ~lV~E~~~~ 195 (437)
++|||++++
T Consensus 111 ~lvmE~l~g 119 (397)
T 2olc_A 111 VTVMEDLSH 119 (397)
T ss_dssp EEEECCCTT
T ss_pred EEEEEeCCC
Confidence 899999976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=1.1e-05 Score=78.33 Aligned_cols=79 Identities=4% Similarity=0.059 Sum_probs=52.6
Q ss_pred eecee-cccCceEEEEEEEc--C----CCeEEEEEEecCCc---c-cchHHHHHHHHHHHhhhc-CCCCCcEEEecceee
Q psy11727 114 IDTLL-GKGSFGQVVKAFDH--E----EKCQVAIKIIKNKK---P-FLNQAQIEVQLLEKINKA-DIHSRYIVKLKGHFT 181 (437)
Q Consensus 114 i~~~l-G~G~fg~V~~~~~~--~----~~~~vaiK~i~~~~---~-~~~~~~~e~~~~~~l~~~-~~~h~~iv~l~~~~~ 181 (437)
..+.| +.|....+|++... . ++..+++|+..... . .......|..+++.+... .+.-|.+ +.+..
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v---~~~~~ 100 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRV---RWIET 100 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCE---EEEEC
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcE---EEEcc
Confidence 35677 88889999988643 1 15678899865332 1 135678899999998765 5444444 44444
Q ss_pred EC---CEEEEEEEeccC
Q psy11727 182 WK---NHLCLVFELLSY 195 (437)
Q Consensus 182 ~~---~~~~lV~E~~~~ 195 (437)
+. +..++|||+++|
T Consensus 101 ~~~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 101 TGDVLGTPFFLMDYVEG 117 (357)
T ss_dssp SSTTTSSCEEEEECCCC
T ss_pred CCCccCCceEEEEecCC
Confidence 33 356899999977
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.0004 Score=65.66 Aligned_cols=69 Identities=12% Similarity=-0.010 Sum_probs=47.0
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEec-
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELL- 193 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~- 193 (437)
.+.|+.|....+|++ ..+++|+........-....|..+++.+...++. |-++. . +.+.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~-P~~~~---~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVS-PEVLH---V--DPATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSS-CCEEE---E--CTTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCC-CceEE---E--ECCCCEEEEeecC
Confidence 567888999999999 3588998864433233346799999998877765 55542 2 233346899999
Q ss_pred cC
Q psy11727 194 SY 195 (437)
Q Consensus 194 ~~ 195 (437)
+|
T Consensus 91 ~g 92 (301)
T 3dxq_A 91 GA 92 (301)
T ss_dssp TC
T ss_pred CC
Confidence 66
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00031 Score=69.85 Aligned_cols=75 Identities=15% Similarity=0.057 Sum_probs=45.5
Q ss_pred CCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCcc--ccccc--cccccChhhhcCCCCC---CcchHHHHHHHHH
Q psy11727 232 ELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL--YQYIQ--SRYYRSPEVLLGIPYD---LAIDMWSLGCILV 304 (437)
Q Consensus 232 ~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~--~~~~g--t~~y~aPE~~~~~~~~---~~~DvwSlG~il~ 304 (437)
...++|+|++|.|||+ +.++ +.|+||+.+..-.... ..... ...|++|+......-+ ...++.++...++
T Consensus 231 ~~~liHGDl~~~Nil~--~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMV--TQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEE--CSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEE--eCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 3579999999999999 4444 9999999986543211 11111 2346777665421111 1234456777777
Q ss_pred HHHhC
Q psy11727 305 ELHTG 309 (437)
Q Consensus 305 elltg 309 (437)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.0011 Score=62.99 Aligned_cols=146 Identities=14% Similarity=0.190 Sum_probs=81.8
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEec-c--eeeECCEEEEEEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK-G--HFTWKNHLCLVFE 191 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~-~--~~~~~~~~~lV~E 191 (437)
.+.|+.|....+|++... ++ .+++|+.... ........|..+++.+...++.-|.++... + +....+..++||+
T Consensus 27 ~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 456788888999999653 33 6889988642 233567789999999987766555444322 1 1234567899999
Q ss_pred eccCc-HH-----------HH---HHhc--CCCC-----CCHHHHHHH---------------HHHHHHHHHHhcC----
Q psy11727 192 LLSYN-LY-----------NL---IRNT--NFHG-----VSLNLTKKF---------------AQQLCCALAFLSS---- 230 (437)
Q Consensus 192 ~~~~~-L~-----------~~---l~~~--~~~~-----ls~~~~~~i---------------~~qi~~aL~~LH~---- 230 (437)
+++|. +. .. +... .+.. ......... ...+...+..+..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 99762 10 01 1111 1110 111100000 0112333444321
Q ss_pred -CCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 231 -PELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 231 -~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
...++||+|+.+.|||+. ++..+.|+||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~--~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFL--GDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEE--TTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEe--CCceEEEecchhccC
Confidence 134799999999999994 344457999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0013 Score=62.62 Aligned_cols=78 Identities=17% Similarity=0.165 Sum_probs=51.3
Q ss_pred ceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecc--eeeECCEEEEEEEec
Q psy11727 116 TLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKG--HFTWKNHLCLVFELL 193 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~--~~~~~~~~~lV~E~~ 193 (437)
..++ |....||++.. .+|+.+++|+.............|..+++.+...++.-|.++..-+ .....+..++||+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3456 78889998853 3456799999864322345677799999998876554343333211 123466788999999
Q ss_pred cC
Q psy11727 194 SY 195 (437)
Q Consensus 194 ~~ 195 (437)
+|
T Consensus 110 ~G 111 (328)
T 1zyl_A 110 GG 111 (328)
T ss_dssp CC
T ss_pred CC
Confidence 77
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00081 Score=64.43 Aligned_cols=142 Identities=14% Similarity=0.147 Sum_probs=71.6
Q ss_pred eecccCceE-EEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccC
Q psy11727 117 LLGKGSFGQ-VVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY 195 (437)
Q Consensus 117 ~lG~G~fg~-V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~ 195 (437)
.|+.|+... +|+... .++..+++|...... ......|..+++.+...++.-|.++.. ....+ ++|||.+++
T Consensus 25 ~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~---d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 25 PLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAE---EHARG--LLLIEDLGD 96 (333)
T ss_dssp C--------CCEEEEC-TTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEE---ETTTT--EEEECCCCS
T ss_pred ECCCCCCCceEEEEEc-CCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeee---cCCCC--EEEEeeCCC
Confidence 455554443 666642 225567777654221 144566888888888766555544432 22223 689999976
Q ss_pred -cHHHHHHhcC------------------------CCCCCHHHHH-------H-HH------------HHHHHHHHHh--
Q psy11727 196 -NLYNLIRNTN------------------------FHGVSLNLTK-------K-FA------------QQLCCALAFL-- 228 (437)
Q Consensus 196 -~L~~~l~~~~------------------------~~~ls~~~~~-------~-i~------------~qi~~aL~~L-- 228 (437)
.+.+.+.... ...++..... . +. ..+...+..+
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 5544332110 1112211110 0 00 0111112222
Q ss_pred --cCCCCCeeeCCCCCCcEEEecCC--CCCEEEEeCCCceec
Q psy11727 229 --SSPELSIIHCDLKPENILLCSPK--RSAIKIIDFGSSCHV 266 (437)
Q Consensus 229 --H~~~~giiHrDiKp~NIll~~~~--~~~ikL~DFG~s~~~ 266 (437)
......++|+|+.+.|||+..+. .+.+.|+||+.+..-
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 12235799999999999994321 156899999988543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0034 Score=59.77 Aligned_cols=74 Identities=22% Similarity=0.212 Sum_probs=55.2
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhc-CCCCCcEEEecceeeECCEEEEEEEec
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKA-DIHSRYIVKLKGHFTWKNHLCLVFELL 193 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~-~~~h~~iv~l~~~~~~~~~~~lV~E~~ 193 (437)
.+.|+.|....+|+... ++..+++|+.... ....+..|...++.+... .+ .+.+++.+....+..++|||++
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v---~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSI---NVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSS---BCCCEEEEEECSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCC---CcceEEEEeecCCceEEEEEec
Confidence 45689999999999964 4667889987532 245678899999998764 23 3555556666678899999999
Q ss_pred cC
Q psy11727 194 SY 195 (437)
Q Consensus 194 ~~ 195 (437)
+|
T Consensus 114 ~G 115 (312)
T 3jr1_A 114 NK 115 (312)
T ss_dssp CC
T ss_pred cC
Confidence 76
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0017 Score=63.12 Aligned_cols=73 Identities=16% Similarity=0.125 Sum_probs=44.7
Q ss_pred eceecccCceEEEEEEEcC--------CCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHE--------EKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~--------~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+.|+.|....+|++.... .+..+++|+.............|..+++.+...++ .|-++ +.+ .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~-~P~~~---~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKI-APQLL---NTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTS-SCCEE---EEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCC-CCceE---Eec--CC--
Confidence 3466788888999987543 13678899876433222234679999999887665 44443 222 22
Q ss_pred EEEEEeccC
Q psy11727 187 CLVFELLSY 195 (437)
Q Consensus 187 ~lV~E~~~~ 195 (437)
++||||++|
T Consensus 110 ~~v~e~i~G 118 (369)
T 3c5i_A 110 GRIEEWLYG 118 (369)
T ss_dssp EEEEECCCS
T ss_pred cEEEEEecC
Confidence 589999976
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00072 Score=66.29 Aligned_cols=142 Identities=14% Similarity=0.214 Sum_probs=79.7
Q ss_pred ceecccCceEEEEEEEcC-------CCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDHE-------EKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
+.|..|-...+|++.... +++.+++|+............+|..+++.+...++. |-+ ++.+. + .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~-P~l---l~~~~--~--g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLG-PQL---YGVFP--E--GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSS-CCE---EEEET--T--EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCC-CeE---EEEcC--C--cc
Confidence 355667777788886532 346899998643222345566899999999887763 444 34443 2 28
Q ss_pred EEEeccC-cHH--------------HHH---HhcC--CC-CC--CHHHHHHHHHHHHH-------------------HHH
Q psy11727 189 VFELLSY-NLY--------------NLI---RNTN--FH-GV--SLNLTKKFAQQLCC-------------------ALA 226 (437)
Q Consensus 189 V~E~~~~-~L~--------------~~l---~~~~--~~-~l--s~~~~~~i~~qi~~-------------------aL~ 226 (437)
||||++| .+. +.+ .... .. .. -+..+.++..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999976 221 111 1111 01 11 13455555554422 122
Q ss_pred ----Hhc--CCCCCeeeCCCCCCcEEEecC--CCCCEEEEeCCCcee
Q psy11727 227 ----FLS--SPELSIIHCDLKPENILLCSP--KRSAIKIIDFGSSCH 265 (437)
Q Consensus 227 ----~LH--~~~~giiHrDiKp~NIll~~~--~~~~ikL~DFG~s~~ 265 (437)
.|. .....++|+|+.+.|||+..+ ..+.+.|+||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 123569999999999999643 136799999998853
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0075 Score=60.58 Aligned_cols=73 Identities=16% Similarity=0.187 Sum_probs=46.7
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEecc
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLS 194 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~ 194 (437)
.+.|+.|-...+|++....++..+++|+........-....|..+++.+...++. | ++++.+. +. +||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~-P---~ll~~~~--~G--~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIA-K---KIYVFFT--NG--RIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSB-C---CEEEEET--TE--EEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCC-C---CEEEEeC--Ce--EEEEeeC
Confidence 4567888889999997654457899998754322222236799999999876542 3 3444442 32 5999997
Q ss_pred C
Q psy11727 195 Y 195 (437)
Q Consensus 195 ~ 195 (437)
|
T Consensus 185 G 185 (458)
T 2qg7_A 185 G 185 (458)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0048 Score=57.70 Aligned_cols=77 Identities=9% Similarity=0.024 Sum_probs=53.3
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhc-CCCCCcEEEecceeeECCEEEE
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKA-DIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~-~~~h~~iv~l~~~~~~~~~~~l 188 (437)
+..-++.+|.|..+.||+... .+|+.|.+|+-..... ....+..|...++.+... .+..|-++. + +. -++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~---~--~~--~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAG---W--DD--RTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEE---E--ET--TEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEe---c--cC--ceE
Confidence 345578899999999999975 5678899998754332 234577899999998653 344444432 2 22 368
Q ss_pred EEEeccC
Q psy11727 189 VFELLSY 195 (437)
Q Consensus 189 V~E~~~~ 195 (437)
|||++.+
T Consensus 88 v~e~l~~ 94 (288)
T 3f7w_A 88 AMEWVDE 94 (288)
T ss_dssp EEECCCC
T ss_pred EEEeecc
Confidence 9999854
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.012 Score=56.61 Aligned_cols=70 Identities=13% Similarity=0.189 Sum_probs=45.4
Q ss_pred cccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCC-CCcEEEec-c--eeeECCEEEEEEEecc
Q psy11727 119 GKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH-SRYIVKLK-G--HFTWKNHLCLVFELLS 194 (437)
Q Consensus 119 G~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~-h~~iv~l~-~--~~~~~~~~~lV~E~~~ 194 (437)
|.|....||++.. .+| .+++|+..... ...|..+++.+...++. -|.++... + +....+..++||++++
T Consensus 32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~-----~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADS-ESK-SYFIKLKYGYH-----DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEEC-SSC-EEEEEEEECSS-----CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEe-CCC-CEEEEEecCcc-----chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444678999964 344 89999876433 24678888888776654 34333321 1 1234678899999997
Q ss_pred C
Q psy11727 195 Y 195 (437)
Q Consensus 195 ~ 195 (437)
|
T Consensus 105 G 105 (339)
T 3i1a_A 105 A 105 (339)
T ss_dssp C
T ss_pred C
Confidence 7
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.027 Score=56.00 Aligned_cols=72 Identities=13% Similarity=0.093 Sum_probs=48.3
Q ss_pred eceecccCceEEEEEEEcC-------CCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHE-------EKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.+.|+.|....||++.... ++..+++|+.... ........|..+++.+...++. |-+ ++.+. + .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~-P~l---~~~~~--~--g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLG-PKL---YGIFS--G--G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSS-SCE---EEEET--T--E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCC-CcE---EEEeC--C--C
Confidence 4567888889999997643 2578999998432 1114556799999999877653 433 33333 2 2
Q ss_pred EEEEeccC
Q psy11727 188 LVFELLSY 195 (437)
Q Consensus 188 lV~E~~~~ 195 (437)
+|+||++|
T Consensus 149 ~v~e~l~G 156 (429)
T 1nw1_A 149 RLEEYIPS 156 (429)
T ss_dssp EEECCCCE
T ss_pred EEEEEeCC
Confidence 89999976
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.01 E-value=0.028 Score=50.09 Aligned_cols=100 Identities=13% Similarity=0.012 Sum_probs=63.9
Q ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHh-cCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCcccccc
Q psy11727 196 NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL-SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYI 274 (437)
Q Consensus 196 ~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~L-H~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~~~~~~ 274 (437)
+|.+.|...+ .+++++++|.++.|.+.+|.-+ +... -..+=+.|..|++ ..+|.|.+.+ +.+. .
T Consensus 34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l--~~dG~V~f~~-~~s~---------~ 98 (229)
T 2yle_A 34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRV--WRDGAVTLAP-AADD---------A 98 (229)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEE--ETTSCEEECC-C-------------
T ss_pred cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEE--ecCCceeccc-cccc---------c
Confidence 6888887765 6899999999999999998776 2111 1234455788999 5677776653 2211 1
Q ss_pred ccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCC
Q psy11727 275 QSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEP 311 (437)
Q Consensus 275 gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~ 311 (437)
....+.|||... ...+.+.=|||||+++|..+--..
T Consensus 99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 233467888763 244677889999999999987443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.71 E-value=0.081 Score=52.39 Aligned_cols=73 Identities=12% Similarity=0.166 Sum_probs=49.1
Q ss_pred eceecccCceEEEEEEEcCC-------CeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHEE-------KCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~-------~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
++.|..|-...+|++..... +..+++|+........-...+|..+++.+...++ .|-++ +.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi-~P~l~---~~~--~~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINI-APNII---ADF--PE--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTS-SCCEE---EEE--TT--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCC-CCCEE---EEc--CC--C
Confidence 45667788888999976521 5789999875443333345679999999987776 34444 222 23 6
Q ss_pred EEEEeccC
Q psy11727 188 LVFELLSY 195 (437)
Q Consensus 188 lV~E~~~~ 195 (437)
+||||++|
T Consensus 147 ~I~efI~G 154 (424)
T 3mes_A 147 RIEEFIDG 154 (424)
T ss_dssp EEEECCCS
T ss_pred EEEEEeCC
Confidence 89999977
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.26 E-value=0.67 Score=45.25 Aligned_cols=33 Identities=30% Similarity=0.447 Sum_probs=26.4
Q ss_pred CCeeeCCCCCCcEEEec----CCCCCEEEEeCCCcee
Q psy11727 233 LSIIHCDLKPENILLCS----PKRSAIKIIDFGSSCH 265 (437)
Q Consensus 233 ~giiHrDiKp~NIll~~----~~~~~ikL~DFG~s~~ 265 (437)
..++|+|+.+.|||+.. ++...+.++||..|..
T Consensus 244 ~vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 244 VVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 34789999999999953 3456799999999854
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.35 E-value=2.3 Score=37.55 Aligned_cols=114 Identities=11% Similarity=0.139 Sum_probs=76.5
Q ss_pred CCCcEEEecceeeECCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q psy11727 169 HSRYIVKLKGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILL 247 (437)
Q Consensus 169 ~h~~iv~l~~~~~~~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll 247 (437)
.||+++.. ..-+..+.+.+.++.-+ +.-+..++ .++....++++.+|+....++++ =+|--|.|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEE
Confidence 66777755 44556677777776654 32232233 36789999999999998877774 3889999999999
Q ss_pred ecCCCCCEEEEeCCCceecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy11727 248 CSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLF 313 (437)
Q Consensus 248 ~~~~~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf 313 (437)
+.++.+++.-.|.... ++|. .++...=+-.+=|++..+++++..|
T Consensus 113 --~~~~~p~i~~RGik~~--------------l~P~-----~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 113 --TRDGLPIAKTRGLQNV--------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp --CTTSCEEESCCEETTT--------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred --cCCCCEEEEEccCccC--------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 8888899877665311 2221 1222222334677888888887776
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.76 E-value=3.7 Score=36.37 Aligned_cols=112 Identities=16% Similarity=0.185 Sum_probs=74.4
Q ss_pred CCCcEEEecceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HhcCCCCCeeeCCCCCCcEE
Q psy11727 169 HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALA-FLSSPELSIIHCDLKPENIL 246 (437)
Q Consensus 169 ~h~~iv~l~~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~-~LH~~~~giiHrDiKp~NIl 246 (437)
.||++ -...-.+.+.+.+.++.-++ .-+..++. ++....++++.+|+.... +++. -+|--|.|+||+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-----~~~~eKlrll~nl~~L~~~~~~~----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-----TTLLSRIRAAIHLVSKVKHHSAR----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-----SCHHHHHHHHHHHHHHHSSCCSS----SEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-----cCHHHHHHHHHHHHHHHHHhhhC----ceeEEEeCceEE
Confidence 55666 22333667888888877633 34444432 688999999999999887 6664 488899999999
Q ss_pred EecCCCCCEEEEeCCCceecCCccccccccccccChhhhcCCCCCCcch-HHHHHHHHHHHHhCCCCC
Q psy11727 247 LCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAID-MWSLGCILVELHTGEPLF 313 (437)
Q Consensus 247 l~~~~~~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-vwSlG~il~elltg~~pf 313 (437)
+ +.++.++|.-.|.- .-++|.- .+ ..| +-++=|++..++.++.-|
T Consensus 117 f--~~~~~p~i~hRGi~--------------~~lpP~e-----~~-ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 117 F--NRALEPFFLHVGVK--------------ESLPPDE-----WD-DERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp E--CTTCCEEESCCEET--------------TTBSSCS-----CC-HHHHHHHHHHHHHHHTTCSSCH
T ss_pred E--eCCCcEEEEEcCCc--------------ccCCCCC-----CC-HHHHHHHHHHHHHHHHcCCCCH
Confidence 9 78888999877753 1223321 11 223 334667777777776655
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 437 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-61 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-59 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-56 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-05 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-54 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-53 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-53 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-53 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-52 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-05 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-06 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-50 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-49 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-48 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-05 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-05 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-05 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-46 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-46 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-05 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-04 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 0.002 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-05 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-43 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-04 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-04 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-05 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-42 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 0.001 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-37 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-37 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-36 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-36 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 0.001 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-34 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-33 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-33 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-32 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-32 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-32 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-31 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-31 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-31 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-30 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-29 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-29 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-29 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-28 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 5e-61
Identities = 72/328 (21%), Positives = 123/328 (37%), Gaps = 33/328 (10%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKINKAD 167
D +E + LG G+ G V K +A K+I K NQ E+Q+L + N
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN--- 62
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
S YIV G F + + E + + + + + K + + L +
Sbjct: 63 --SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTY 119
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL-YQYIQSRYYRSPEVLL 286
L + I+H D+KP NIL+ S IK+ DFG S + ++ ++ +R Y SPE L
Sbjct: 120 LRE-KHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQ 176
Query: 287 GIPYDLAIDMWSLGCILVELHTGEPLFSGKN-EVDQMTKIIEVLGMPPGYLLHGASKTSK 345
G Y + D+WS+G LVE+ G + + ++ +V G +
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 346 YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKD 405
D+ P + + + N P F+D
Sbjct: 237 LSSYGMDS--------------RPPMAIFELLDYIVNEPPPKLPSGVFSLE------FQD 276
Query: 406 LILRMLTYDPKKRISPTNVLRHEFFLKH 433
+ + L +P +R ++ H F +
Sbjct: 277 FVNKCLIKNPAERADLKQLMVHAFIKRS 304
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 194 bits (494), Expect = 7e-59
Identities = 105/352 (29%), Positives = 159/352 (45%), Gaps = 43/352 (12%)
Query: 100 YIIKHGEKFLD-RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQ 158
+ GE + D RY + LG G F V A D VA+KI++ K + A+ E++
Sbjct: 2 HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK 61
Query: 159 LLEKINKADI------HSRYIVKLKGHFTWKN----HLCLVFELLSYNLYNLIRNTNFHG 208
LL+++N AD + +I+KL HF K H+ +VFE+L NL LI+ G
Sbjct: 62 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG 121
Query: 209 VSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILL----CSPKRSAIKIIDFGSSC 264
+ L K+ ++QL L ++ IIH D+KPEN+L+ IKI D G++C
Sbjct: 122 IPLIYVKQISKQLLLGLDYM-HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180
Query: 265 HVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGK------NE 318
+ IQ+R YRSPEVLLG P+ D+WS C++ EL TG+ LF +
Sbjct: 181 WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240
Query: 319 VDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTIL 378
D + +IIE+LG P YLL T +F+ + K ++ L +
Sbjct: 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300
Query: 379 GVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
+ D + ML DP+KR ++ H +
Sbjct: 301 AKE---------------------ISDFLSPMLQLDPRKRADAGGLVNHPWL 331
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 3e-56
Identities = 97/329 (29%), Positives = 147/329 (44%), Gaps = 50/329 (15%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK---NKKPFLNQAQIEVQLLEKINK 165
++ ++ +G+G++G V KA + VA+K I+ + + A E+ LL+++N
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN- 59
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCAL 225
IVKL +N L LVFE L +L + + G+ L L K + QL L
Sbjct: 60 ----HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTL---YQYIQSRYYRSP 282
AF S ++H DLKP+N+L+ AIK+ DFG + G + + + +YR+P
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLI--NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
Query: 283 EVLLGIPY-DLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341
E+LLG Y A+D+WSLGCI E+ T LF G +E+DQ+ +I LG P + G +
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYM 401
Y P R++
Sbjct: 232 SMPDYKPSF----------------------------------PKWARQDFSKVVPPLDE 257
Query: 402 KFKDLILRMLTYDPKKRISPTNVLRHEFF 430
+ L+ +ML YDP KRIS L H FF
Sbjct: 258 DGRSLLSQMLHYDPNKRISAKAALAHPFF 286
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-54
Identities = 87/333 (26%), Positives = 140/333 (42%), Gaps = 49/333 (14%)
Query: 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQ-VAIKIIK---NKKPFLNQAQIEVQLLEK 162
+ +YE +G+G++G+V KA D + + VA+K ++ ++ EV +L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 163 INKADIHSRYIVKLKGHFTW-----KNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKF 217
+ +V+L T + L LVFE + +L + GV K
Sbjct: 64 LET--FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR 277
QL L FL S ++H DLKP+NIL+ S + + L + +
Sbjct: 122 MFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL 179
Query: 278 YYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337
+YR+PEVLL Y +D+WS+GCI E+ +PLF G ++VDQ+ KI++V+G+P
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSL 397
+ + K TD +
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDEL------------------------------- 268
Query: 398 ADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
KDL+L+ LT++P KRIS + L H +F
Sbjct: 269 -----GKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 181 bits (461), Expect = 4e-54
Identities = 62/249 (24%), Positives = 109/249 (43%), Gaps = 11/249 (4%)
Query: 102 IKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF-LNQAQIEVQLL 160
IKH LD Y+I LG G+FG V + + A K + + E+Q +
Sbjct: 19 IKHDH-VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTM 77
Query: 161 EKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQ 220
+ +V L F N + +++E +S + +S + ++ +Q
Sbjct: 78 SVLR-----HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 132
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRY 278
+C L + E + +H DLKPENI+ + + + +K+IDFG + H+ Q++ +
Sbjct: 133 VCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAE 190
Query: 279 YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338
+ +PEV G P DMWS+G + L +G F G+N+ + + +
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS 250
Query: 339 GASKTSKYF 347
G S+ K F
Sbjct: 251 GISEDGKDF 259
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 43.5 bits (102), Expect = 3e-05
Identities = 9/28 (32%), Positives = 14/28 (50%)
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEFF 430
KD I ++L DP R++ L H +
Sbjct: 256 GKDFIRKLLLADPNTRMTIHQALEHPWL 283
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 4e-54
Identities = 83/319 (26%), Positives = 131/319 (41%), Gaps = 45/319 (14%)
Query: 117 LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINK-ADIHSRYIVK 175
LG+G F V KA D VAIK IK + I L +I ++ I+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 176 LKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSI 235
L F K+++ LVF+ + +L +I++ N ++ + K + L +L I
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHW--I 121
Query: 236 IHCDLKPENILLCSPKRSAIKIIDFGSSCHVG---QTLYQYIQSRYYRSPEVLLGI-PYD 291
+H DLKP N+LL +K+ DFG + G + + +R+YR+PE+L G Y
Sbjct: 122 LHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 292 LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLS 351
+ +DMW++GCIL EL P G +++DQ+T+I E LG P Y S
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 352 DNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRML 411
L + DLI +
Sbjct: 240 FPGIPLHHIFSAAGD-----------------------------------DLLDLIQGLF 264
Query: 412 TYDPKKRISPTNVLRHEFF 430
++P RI+ T L+ ++F
Sbjct: 265 LFNPCARITATQALKMKYF 283
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-53
Identities = 95/327 (29%), Positives = 150/327 (45%), Gaps = 46/327 (14%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI- 168
Y ++G GSFG V +A + VAIK + K F N+ E+Q++ K++ +I
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNIV 76
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNL--TKKFAQQLCCALA 226
RY G + +L LV + + +Y + R+ + +L + K + QL +LA
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRYYRSPEV 284
++ S I H D+KP+N+LL P + +K+ DFGS+ + G+ YI SRYYR+PE+
Sbjct: 137 YIHSFG--ICHRDIKPQNLLLD-PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 285 LLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343
+ G Y +ID+WS GC+L EL G+P+F G + VDQ+ +II+VLG P + +
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR---EM 250
Query: 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKF 403
+ + T + R P
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPE-------------------------------A 279
Query: 404 KDLILRMLTYDPKKRISPTNVLRHEFF 430
L R+L Y P R++P H FF
Sbjct: 280 IALCSRLLEYTPTARLTPLEACAHSFF 306
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-53
Identities = 91/343 (26%), Positives = 144/343 (41%), Gaps = 38/343 (11%)
Query: 97 NYDYIIKHGEKF---LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQA 153
N Y ++ G+ L RY+ +G G+ G V A+D VAIK + +PF NQ
Sbjct: 1 NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQT 58
Query: 154 QIEVQLLEKINKADIHSRYIVKLKGHFTWK------NHLCLVFELLSYNLYNLIRNTNFH 207
+ E + ++ + I+ L FT + + LV EL+ NL +I+
Sbjct: 59 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----M 114
Query: 208 GVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267
+ Q+ C + L S IIH DLKP NI++ S I +
Sbjct: 115 ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
Query: 268 QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
+ Y+ +RYYR+PEV+LG+ Y +D+WS+GCI+ E+ + LF G++ +DQ K+IE
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232
Query: 328 VLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGG 387
LG P + T + + L P + +
Sbjct: 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ------ 286
Query: 388 RRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
+DL+ +ML DP KRIS + L+H +
Sbjct: 287 ---------------ARDLLSKMLVIDPAKRISVDDALQHPYI 314
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-53
Identities = 77/336 (22%), Positives = 138/336 (41%), Gaps = 50/336 (14%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK---NKKPFLNQAQIEVQLLEKINK 165
+ +YE +G+G+FG+V KA + +VA+K + K+ F A E+++L+ +
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68
Query: 166 ADIHSRY---IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLC 222
++ + K + K + LVF+ ++L L+ N +L+ K+ Q L
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQMLL 127
Query: 223 CALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG-------QTLYQYIQ 275
L ++ + I+H D+K N+L+ + +K+ DFG + +
Sbjct: 128 NGLYYIHRNK--ILHRDMKAANVLIT--RDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 276 SRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPG 334
+ +YR PE+LLG Y ID+W GCI+ E+ T P+ G E Q+ I ++ G
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT- 242
Query: 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPG 394
E P + ++ R+ +
Sbjct: 243 ------------------------------PEVWPNVDNYELYEKLELVKGQKRKVKDRL 272
Query: 395 HSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
+ DLI ++L DP +RI + L H+FF
Sbjct: 273 KAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 175 bits (443), Expect = 3e-52
Identities = 91/329 (27%), Positives = 143/329 (43%), Gaps = 52/329 (15%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINK 165
+++Y +G+G++G V KA ++ + A+K I+ +K + E+ +L+++
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELK- 58
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCAL 225
IVKL K L LVFE L +L L+ G+ K F QL +
Sbjct: 59 ----HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGI 113
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG---QTLYQYIQSRYYRSP 282
A+ ++H DLKP+N+L+ +KI DFG + G + I + +YR+P
Sbjct: 114 AYCHDR--RVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
Query: 283 EVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341
+VL+G Y ID+WS+GCI E+ G PLF G +E DQ+ +I +LG P +
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYM 401
+ KY T E LP L +
Sbjct: 230 ELPKYDPNF------------TVYEPLPWESFLKGLD----------------------E 255
Query: 402 KFKDLILRMLTYDPKKRISPTNVLRHEFF 430
DL+ +ML DP +RI+ L H +F
Sbjct: 256 SGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (448), Expect = 4e-52
Identities = 59/250 (23%), Positives = 112/250 (44%), Gaps = 13/250 (5%)
Query: 102 IKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF-LNQAQIEVQLL 160
+K G + D Y+I LG G+FG V + + K I P + E+ ++
Sbjct: 22 VKQGSVY-DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIM 80
Query: 161 EKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQ 219
+++ ++ L F K + L+ E LS L++ I + + +S + +
Sbjct: 81 NQLH-----HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMR 134
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSR 277
Q C L + SI+H D+KPENI+ + K S++KIIDFG + + + + +
Sbjct: 135 QACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA 192
Query: 278 YYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337
+ +PE++ P DMW++G + L +G F+G+++++ + +
Sbjct: 193 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF 252
Query: 338 HGASKTSKYF 347
S +K F
Sbjct: 253 SSVSPEAKDF 262
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 1e-51
Identities = 86/333 (25%), Positives = 150/333 (45%), Gaps = 48/333 (14%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK--NKKPFLNQAQIEVQLLEKINKAD 167
RY + +G+G++G V A+D+ K +VAIK I + + + E+++L + +
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 168 IHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
I + + LV L+ +LY L++ +S + F Q+ L +
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKY 124
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG------QTLYQYIQSRYYRS 281
+ S +++H DLKP N+LL + +KI DFG + L +Y+ +R+YR+
Sbjct: 125 IHS--ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 282 PEVLL-GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340
PE++L Y +ID+WS+GCIL E+ + P+F GK+ +DQ+ I+ +LG P L+
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADY 400
LS K ++P ++
Sbjct: 241 INLKARNYLLS----------LPHKNKVPWNRLFPNA----------------------D 268
Query: 401 MKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433
K DL+ +MLT++P KRI L H + ++
Sbjct: 269 SKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 5e-51
Identities = 63/245 (25%), Positives = 104/245 (42%), Gaps = 11/245 (4%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINK 165
++ ++Y I LG+G FG V + + K K +K K + E+ +L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR- 59
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCA 224
R I+ L F L ++FE +S +++ I + F ++ + Q+C A
Sbjct: 60 ----HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEA 114
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYIQSRYYRSP 282
L FL S +I H D++PENI+ + + S IKII+FG + + G + Y +P
Sbjct: 115 LQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172
Query: 283 EVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342
EV A DMWSLG ++ L +G F + + I+ S
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232
Query: 343 TSKYF 347
+ F
Sbjct: 233 EAMDF 237
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (105), Expect = 1e-05
Identities = 7/31 (22%), Positives = 16/31 (51%)
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433
D + R+L + K R++ + L+H + +
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 6e-51
Identities = 76/335 (22%), Positives = 141/335 (42%), Gaps = 44/335 (13%)
Query: 101 IIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK---NKKPFLNQAQIEV 157
+ K + Y +G G++G V A D +VAIK + + F +A E+
Sbjct: 9 VTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 68
Query: 158 QLLEKINKADIHSRY-IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKK 216
+LL+ + ++ + LV + +L L+++ + +
Sbjct: 69 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL---GEDRIQF 125
Query: 217 FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQS 276
Q+ L ++ + IIH DLKP N+ + + +KI+DFG + + Y+ +
Sbjct: 126 LVYQMLKGLRYIHA--AGIIHRDLKPGNLAVN--EDCELKILDFGLARQADSEMTGYVVT 181
Query: 277 RYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335
R+YR+PEV+L Y +D+WS+GCI+ E+ TG+ LF G + +DQ+ +I++V G PP
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP-- 239
Query: 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGH 395
+++ RL + E+ + L
Sbjct: 240 --------AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA------------------ 273
Query: 396 SLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
+L+ +ML D ++R++ L H +F
Sbjct: 274 ----SPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 7e-51
Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 17/234 (7%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLLEKIN 164
L+ +EI LGKG FG V A + + K +A+K++ K +Q + EV++ +
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL- 63
Query: 165 KADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCC 223
I++L G+F + L+ E +Y ++ + T + +L
Sbjct: 64 ----RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELAN 117
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT-LYQYIQSRYYRSP 282
AL++ S +IH D+KPEN+LL S +KI DFG S H + + Y P
Sbjct: 118 ALSYCHS--KRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSSRRTTLCGTLDYLPP 173
Query: 283 EVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336
E++ G +D +D+WSLG + E G+P F + +I V P ++
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 227
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (108), Expect = 4e-06
Identities = 11/32 (34%), Positives = 18/32 (56%)
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434
+DLI R+L ++P +R VL H + +S
Sbjct: 231 ARDLISRLLKHNPSQRPMLREVLEHPWITANS 262
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-50
Identities = 67/227 (29%), Positives = 104/227 (45%), Gaps = 18/227 (7%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADI 168
D +EI LG G+FG+V KA + E A K+I K L +E+ +L +
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD---- 67
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228
IVKL F ++N+L ++ E + + + ++ + + +Q AL +L
Sbjct: 68 -HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---GQTLYQYIQSRYYRSPEVL 285
+ IIH DLK NIL IK+ DFG S Q +I + Y+ +PEV+
Sbjct: 127 --HDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 182
Query: 286 LGI-----PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
+ PYD D+WSLG L+E+ EP N + + KI +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK 229
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 167 bits (423), Expect = 7e-49
Identities = 77/360 (21%), Positives = 149/360 (41%), Gaps = 45/360 (12%)
Query: 83 KEKKYVHNDGHDDENYDYIIKHGEKF--LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAI 140
+ + Y + H Y H ++ D Y++ LG+G + +V +A + +V +
Sbjct: 6 RARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 65
Query: 141 KIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNL 200
KI+K K + + E+++LE + I+ L N +
Sbjct: 66 KILKPVK--KKKIKREIKILENLR----GGPNIITLADIVKDPVSRTPALVFEHVNNTDF 119
Query: 201 IRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260
+ + ++ + + ++ AL + + I+H D+KP N+++ R +++ID+
Sbjct: 120 KQ--LYQTLTDYDIRFYMYEILKALDYC--HSMGIMHRDVKPHNVMIDHEHRK-LRLIDW 174
Query: 261 GSSCHV--GQTLYQYIQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGE-PLFSGK 316
G + GQ + SRY++ PE+L+ YD ++DMWSLGC+L + + P F G
Sbjct: 175 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234
Query: 317 NEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDT 376
+ DQ+ +I +VLG Y K + R +
Sbjct: 235 DNYDQLVRIAKVLGTEDLY-------------------------DYIDKYNIELDPRFND 269
Query: 377 ILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHSVD 436
ILG + R + L + D + ++L YD + R++ + H +F ++V
Sbjct: 270 ILGRHSRKRWERFVHSENQHLVSP-EALDFLDKLLRYDHQSRLTAREAMEHPYF--YTVV 326
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 4e-48
Identities = 84/337 (24%), Positives = 144/337 (42%), Gaps = 54/337 (16%)
Query: 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK---KPFLNQAQIEVQLLEKI 163
+ +RY+ + +G G++G V AFD + +VA+K + + E++LL+ +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 164 NKADIHSRYIVKLKGHFTWK------NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKF 217
++ L FT N + LV L+ +L N+++ + +
Sbjct: 75 K-----HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT---DDHVQFL 126
Query: 218 AQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR 277
Q+ L ++ S IIH DLKP N+ + +KI+DFG + H + Y+ +R
Sbjct: 127 IYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCE--LKILDFGLARHTDDEMTGYVATR 182
Query: 278 YYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336
+YR+PE++L + Y+ +D+WS+GCI+ EL TG LF G + +DQ+ I+ ++G P L
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242
Query: 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHS 396
L S S S + P
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANP--------------------------- 275
Query: 397 LADYMKFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433
DL+ +ML D KRI+ L H +F ++
Sbjct: 276 -----LAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 7e-48
Identities = 85/330 (25%), Positives = 140/330 (42%), Gaps = 52/330 (15%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK---NKKPFLNQAQIEVQLLEKINK 165
+ +YE +G+G++G V KA + E VA+K ++ + + + A E+ LL+++
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK- 59
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCAL 225
+ IV+L L LVFE +L + N + + K F QL L
Sbjct: 60 ----HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGL 114
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---GQTLYQYIQSRYYRSP 282
F S +++H DLKP+N+L+ +K+ +FG + + + + +YR P
Sbjct: 115 GFCHSR--NVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 283 EVLLGIP-YDLAIDMWSLGCILVELHTGE-PLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340
+VL G Y +IDMWS GCI EL PLF G + DQ+ +I +LG P
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADY 400
+K Y Y + +T + +P
Sbjct: 231 TKLPDY------KPYPMYPATTSLVNVVPKLNAT-------------------------- 258
Query: 401 MKFKDLILRMLTYDPKKRISPTNVLRHEFF 430
+DL+ +L +P +RIS L+H +F
Sbjct: 259 --GRDLLQNLLKCNPVQRISAEEALQHPYF 286
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 5e-47
Identities = 65/234 (27%), Positives = 104/234 (44%), Gaps = 13/234 (5%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINK 165
+K + ++ +LG+GSF VV A + + AIKI++ K+ + + ++ E+
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVTRERDVM 62
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCA 224
+ + + VKL F L L IR T+ + ++ A
Sbjct: 63 SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSA 120
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ-----TLYQYIQSRYY 279
L +L IIH DLKPENILL I+I DFG++ + ++ + Y
Sbjct: 121 LEYLHGKG--IIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 280 RSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
SPE+L + D+W+LGCI+ +L G P F NE KII++ P
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP 230
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (97), Expect = 9e-05
Identities = 8/32 (25%), Positives = 15/32 (46%)
Query: 402 KFKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433
K +DL+ ++L D KR+ + + H
Sbjct: 236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (409), Expect = 7e-47
Identities = 76/251 (30%), Positives = 112/251 (44%), Gaps = 15/251 (5%)
Query: 103 KHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI--EVQLL 160
K E D Y+ +LG G+F +V+ A D + VAIK I K + + E+ +L
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 161 EKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQ 219
KI IV L + HL L+ +L+S L++ I F+ + +
Sbjct: 62 HKIK-----HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIF 114
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILLCS-PKRSAIKIIDFGSSCHV--GQTLYQYIQS 276
Q+ A+ +L I+H DLKPEN+L S + S I I DFG S G L +
Sbjct: 115 QVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGT 172
Query: 277 RYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336
Y +PEVL PY A+D WS+G I L G P F +N+ +I++
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY 232
Query: 337 LHGASKTSKYF 347
S ++K F
Sbjct: 233 WDDISDSAKDF 243
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.7 bits (100), Expect = 4e-05
Identities = 9/28 (32%), Positives = 15/28 (53%)
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEFF 430
KD I ++ DP+KR + L+H +
Sbjct: 240 AKDFIRHLMEKDPEKRFTCEQALQHPWI 267
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 1e-46
Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 15/221 (6%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKII-KNKKPFLNQAQIEVQLLEKINKADI 168
+Y +G+G+ G V A D +VAI+ + ++P E+ ++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN----- 74
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228
+ IV + + L +V E L+ L + ++ AL FL
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGS--LTDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---GQTLYQYIQSRYYRSPEVL 285
S +IH D+K +NILL +K+ DFG + + + Y+ +PEV+
Sbjct: 133 HS--NQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 286 LGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
Y +D+WSLG + +E+ GEP + +N + + I
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (103), Expect = 2e-05
Identities = 11/28 (39%), Positives = 17/28 (60%)
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEFF 430
F+D + R L D +KR S +L+H+F
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (404), Expect = 1e-46
Identities = 67/259 (25%), Positives = 105/259 (40%), Gaps = 29/259 (11%)
Query: 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----------FLNQAQIEV 157
F + YE +LG+G V + + A+KII EV
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 158 QLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKK 216
+L K++ I++LK + LVF+L+ L++ + +S T+K
Sbjct: 61 DILRKVS----GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRK 114
Query: 217 FAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV--GQTLYQYI 274
+ L + L L+I+H DLKPENILL IK+ DFG SC + G+ L +
Sbjct: 115 IMRALLEVICALHK--LNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKLREVC 170
Query: 275 QSRYYRSPEVLLG------IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV 328
+ Y +PE++ Y +DMWS G I+ L G P F + ++ + I+
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230
Query: 329 LGMPPGYLLHGASKTSKYF 347
S T K
Sbjct: 231 NYQFGSPEWDDYSDTVKDL 249
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-46
Identities = 56/236 (23%), Positives = 109/236 (46%), Gaps = 19/236 (8%)
Query: 107 KFLDRYEI-DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINK 165
+D Y++ +LG G G+V++ F+ + + A+K++++ + ++ +
Sbjct: 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRAS----- 62
Query: 166 ADIHSRYIVKLKGHF----TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQ 220
+IV++ + + L +V E L L++ I++ + + +
Sbjct: 63 ---QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 119
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSA-IKIIDFGSSCHV--GQTLYQYIQSR 277
+ A+ +L S ++I H D+KPEN+L S + +A +K+ DFG + +L +
Sbjct: 120 IGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 177
Query: 278 YYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
YY +PEVL YD + DMWSLG I+ L G P F + + + + M
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (105), Expect = 1e-05
Identities = 8/32 (25%), Positives = 18/32 (56%)
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434
K LI +L +P +R++ T + H + ++ +
Sbjct: 248 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-45
Identities = 57/228 (25%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQI--EVQLLEKINK 165
F++ +++ LG+G++G+V A + + VA+KI+ K+ I E+ + + +N
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN- 61
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLSYNL-YNLIRNTNFHGVSLNLTKKFAQQLCCA 224
+VK GH N L E S ++ I G+ ++F QL
Sbjct: 62 ----HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAG 115
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG-----QTLYQYIQSRYY 279
+ +L + I H D+KPEN+LL R +KI DFG + + L + + Y
Sbjct: 116 VVYLHG--IGITHRDIKPENLLLDE--RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 280 RSPEVLLGIPYD-LAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
+PE+L + +D+WS G +L + GE + ++ Q
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 219
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 4e-45
Identities = 54/229 (23%), Positives = 99/229 (43%), Gaps = 15/229 (6%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
+ YE+ +G GS+G+ K + + K + + +A+ ++ + E ++
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELK 61
Query: 170 SRYIVKLKGHFTWK--NHLCLVFELLSY-NLYNLIRNTNFHGVSLN--LTKKFAQQLCCA 224
IV+ + L +V E +L ++I L+ + QL A
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 225 LAFL---SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT---LYQYIQSRY 278
L S +++H DLKP N+ L + +K+ DFG + + ++ + Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTSFAKAFVGTPY 179
Query: 279 YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
Y SPE + + Y+ D+WSLGC+L EL P F+ ++ + KI E
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (91), Expect = 6e-04
Identities = 7/27 (25%), Positives = 11/27 (40%)
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEF 429
++I RML R S +L +
Sbjct: 242 LNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 156 bits (395), Expect = 8e-45
Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 6/219 (2%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
L ++I LG GSFG+V A+K++K K+ + Q+E E++ + +
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLSIV 61
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228
+I+++ G F + ++ + + + + + K +A ++C AL +L
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYL 120
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGI 288
S II+ DLKPENILL IKI DFG + +V Y + Y +PEV+
Sbjct: 121 HSK--DIIYRDLKPENILLDK--NGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTK 176
Query: 289 PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
PY+ +ID WS G ++ E+ G F N + KI+
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 9e-45
Identities = 61/232 (26%), Positives = 104/232 (44%), Gaps = 10/232 (4%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
++ + + +LGKGSFG+V A + AIK +K ++ + +++
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
++ + F K +L V E L+ +L I++ H L+ +A ++ L F
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQF 118
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---GQTLYQYIQSRYYRSPEV 284
L I++ DLK +NILL IKI DFG + + Y +PE+
Sbjct: 119 L--HSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174
Query: 285 LLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336
LLG Y+ ++D WS G +L E+ G+ F G++E + I P +L
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL 226
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.4 bits (86), Expect = 0.002
Identities = 8/29 (27%), Positives = 17/29 (58%), Gaps = 1/29 (3%)
Query: 403 FKDLILRMLTYDPKKRISPTN-VLRHEFF 430
KDL++++ +P+KR+ + +H F
Sbjct: 230 AKDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 2e-44
Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 18/229 (7%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLLE 161
+ + +G GSFG V A D VAIK + EV+ L+
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 162 KINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQL 221
K + ++ +G + ++ LV E + +L+ +
Sbjct: 71 K-----LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGA 124
Query: 222 CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRS 281
LA+L S ++IH D+K NILL P +K+ DFGS+ + ++ + Y+ +
Sbjct: 125 LQGLAYLHS--HNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAPA-NSFVGTPYWMA 179
Query: 282 PEVLLGI---PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
PEV+L + YD +D+WSLG +EL +P N + + I +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.2 bits (104), Expect = 2e-05
Identities = 8/31 (25%), Positives = 16/31 (51%)
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEFFLKH 433
F++ + L P+ R + +L+H F L+
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-43
Identities = 54/228 (23%), Positives = 104/228 (45%), Gaps = 12/228 (5%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSR 171
+ D +G+GSF V K D E +VA ++++K L +++ + E +
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQHP 68
Query: 172 YIVKLKGHF----TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
IV+ + K + LV EL++ L ++ F + + + + + +Q+ L
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQ 126
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ-YIQSRYYRSPEVL 285
FL + IIH DLK +NI + P S +KI D G + + + I + + +PE+
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGS-VKIGDLGLATLKRASFAKAVIGTPEFMAPEMY 185
Query: 286 LGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
YD ++D+++ G ++E+ T E +S Q+ + + P
Sbjct: 186 EE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 232
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (97), Expect = 1e-04
Identities = 8/29 (27%), Positives = 16/29 (55%)
Query: 402 KFKDLILRMLTYDPKKRISPTNVLRHEFF 430
+ K++I + + +R S ++L H FF
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-43
Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 15/228 (6%)
Query: 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-------PFLNQAQIEVQLL 160
+Y++ LLG G FG V + VAIK ++ + P + +EV LL
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 161 EKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQ 220
+K++ +++L F + L+ E T + L + F Q
Sbjct: 62 KKVSSGFSG---VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLY-QYIQSRYY 279
+ A+ ++H D+K ENIL+ R +K+IDFGS + T+Y + +R Y
Sbjct: 119 VLEAVRHC--HNCGVLHRDIKDENILI-DLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 175
Query: 280 RSPEVLLGIPY-DLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKII 326
PE + Y + +WSLG +L ++ G+ F E+ +
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF 223
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (97), Expect = 1e-04
Identities = 6/28 (21%), Positives = 10/28 (35%)
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEFF 430
+ LI L P R + + H +
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 5e-43
Identities = 61/248 (24%), Positives = 103/248 (41%), Gaps = 9/248 (3%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINK 165
E D Y+ LG G F V K + Q A K IK ++ ++ + + +E+
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 166 --ADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCC 223
+I ++ L + K + L+ EL++ ++ +F +Q+
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILN 124
Query: 224 ALAFLSSPELSIIHCDLKPENILLCS--PKRSAIKIIDFGSSCHV--GQTLYQYIQSRYY 279
+ +L S + I H DLKPENI+L + IKIIDFG + + G + +
Sbjct: 125 GVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 280 RSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339
+PE++ P L DMWS+G I L +G F G + + + + V
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 340 ASKTSKYF 347
S +K F
Sbjct: 243 TSALAKDF 250
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (102), Expect = 2e-05
Identities = 12/28 (42%), Positives = 18/28 (64%)
Query: 403 FKDLILRMLTYDPKKRISPTNVLRHEFF 430
KD I R+L DPKKR++ + L+H +
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 9e-43
Identities = 50/228 (21%), Positives = 96/228 (42%), Gaps = 15/228 (6%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
+ ++ +GKG FG V+ K VA+K IKN E ++ ++
Sbjct: 6 MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDA-TAQAFLAEASVMTQL----- 57
Query: 169 HSRYIVKLKGHFTW-KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALA 226
+V+L G K L +V E ++ +L + +R+ + + KF+ +C A+
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 227 FLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLL 286
+L + +H DL N+L+ + + K+ DFG + T + +PE L
Sbjct: 118 YLEGN--NFVHRDLAARNVLVS--EDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALR 173
Query: 287 GIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPP 333
+ D+WS G +L E+++ G + D + ++ + M
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA 221
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 149 bits (376), Expect = 2e-42
Identities = 59/246 (23%), Positives = 95/246 (38%), Gaps = 22/246 (8%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIK----NKKPFLNQAQIEVQLLEKINK 165
DRYE+ +LG G +V A D VA+K+++ F + + E Q +N
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN- 65
Query: 166 ADIHSRYIVKLKGHFTWKNH----LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQ 220
IV + + +V E + L +++ ++ +
Sbjct: 66 ----HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIAD 119
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT----LYQYIQS 276
C AL F IIH D+KP NI++ + + + I +
Sbjct: 120 ACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 277 RYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336
Y SPE G D D++SLGC+L E+ TGEP F+G + V + + +PP
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 337 LHGASK 342
G S
Sbjct: 238 HEGLSA 243
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 9e-41
Identities = 60/236 (25%), Positives = 97/236 (41%), Gaps = 26/236 (11%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKA 166
+ + +G GSFG V K H + VA+K++ P L + EV +L K
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-- 62
Query: 167 DIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCAL 225
I+ G ++ L +V + +LY+ + + A+Q +
Sbjct: 63 ---HVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGM 117
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG-----QTLYQYIQSRYYR 280
+L + SIIH DLK NI L +KI DFG + Q S +
Sbjct: 118 DYLHAK--SIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 281 SPEVLLGI---PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
+PEV+ PY D+++ G +L EL TG+ +S N DQ+ ++ + P
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (363), Expect = 2e-40
Identities = 46/237 (19%), Positives = 86/237 (36%), Gaps = 21/237 (8%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
Y++ +G+GSFG + + + QVAIK ++ Q + E + + +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-RRSDAPQLRDEYRTYKLLA----G 59
Query: 170 SRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLS 229
I + H LV +LL +L +L+ S+ A+Q+ + +
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSI- 117
Query: 230 SPELSIIHCDLKPENILL---CSPKRSAIKIIDFGSS----------CHVGQTLYQYIQS 276
E S+++ D+KP+N L+ S + I ++DFG + +
Sbjct: 118 -HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 277 RYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
Y S LG D+ +LG + + G + G K +
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 142 bits (360), Expect = 2e-39
Identities = 52/232 (22%), Positives = 100/232 (43%), Gaps = 15/232 (6%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
++ + + ++G+G FG+V + A+K + K+ + Q E L + +
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR--IKMKQGETLALNERIMLSL 60
Query: 169 ----HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCC 223
+IV + F + L + +L++ +L+ + S + +A ++
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIIL 118
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT-LYQYIQSRYYRSP 282
L + + +++ DLKP NILL ++I D G +C + + + + Y +P
Sbjct: 119 GLEHMHNR--FVVYRDLKPANILLDEHGH--VRISDLGLACDFSKKKPHASVGTHGYMAP 174
Query: 283 EVLL-GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
EVL G+ YD + D +SLGC+L +L G F D+ L M
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (354), Expect = 4e-39
Identities = 54/235 (22%), Positives = 92/235 (39%), Gaps = 19/235 (8%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
+RY + +G GSFG + D +VAIK+ K Q IE ++ + +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQ----G 61
Query: 170 SRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLS 229
I ++ ++ +V ELL +L +L + SL A Q+ + ++
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH 120
Query: 230 SPELSIIHCDLKPENILLCSPKRSA-IKIIDFGSSCHVG----------QTLYQYIQSRY 278
S + IH D+KP+N L+ K+ + IIDFG + + +
Sbjct: 121 S--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 279 YRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333
Y S LGI D+ SLG +L+ + G + G + K +
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (350), Expect = 5e-38
Identities = 62/228 (27%), Positives = 106/228 (46%), Gaps = 6/228 (2%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
LD+++ LG GSFG+V+ E A+KI+ K+ + QIE L EK +
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAV 98
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228
+ ++VKL+ F ++L +V E ++ S + +A Q+ +L
Sbjct: 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGG-EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGI 288
S L +I+ DLKPEN+L+ I++ DFG + V + + +PE++L
Sbjct: 158 HS--LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSK 213
Query: 289 PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336
Y+ A+D W+LG ++ E+ G P F + KI+ P +
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-37
Identities = 53/223 (23%), Positives = 100/223 (44%), Gaps = 11/223 (4%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
++ ++ LLGKG+FG+V+ + A+KI++ K+ + + ++ + E +
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNT 62
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAF 227
++ LK F + LC V E + L+ + + + + ++ AL +
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEY 120
Query: 228 LSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---GQTLYQYIQSRYYRSPEV 284
L S +++ D+K EN++L IKI DFG G T+ + + Y +PEV
Sbjct: 121 LHSR--DVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 285 LLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
L Y A+D W LG ++ E+ G F ++ I+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (88), Expect = 0.001
Identities = 11/33 (33%), Positives = 16/33 (48%), Gaps = 5/33 (15%)
Query: 403 FKDLILRMLTYDPKKRISPTN-----VLRHEFF 430
K L+ +L DPK+R+ V+ H FF
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 4e-37
Identities = 48/228 (21%), Positives = 93/228 (40%), Gaps = 15/228 (6%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
+ ++ LG+G FG+V + +VAIK +K E Q+++K+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKL-----R 70
Query: 170 SRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLS 229
+V+L + + + + +L + ++ + L A Q+ +A++
Sbjct: 71 HEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 230 SPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR----YYRSPEVL 285
+ +H DL+ NIL+ K+ DFG + + Y Q + +PE
Sbjct: 131 RM--NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 286 LGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMP 332
L + + D+WS G +L EL T G + G + + ++ MP
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 234
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 8e-37
Identities = 47/230 (20%), Positives = 98/230 (42%), Gaps = 17/230 (7%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
+ ++ LG G FG+V + + +VA+K +K + E L++++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLAEANLMKQL-----Q 66
Query: 170 SRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228
+ +V+L T + + ++ E + +L + ++ + +++N A Q+ +AF+
Sbjct: 67 HQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR----YYRSPEV 284
+ IH DL+ NIL+ KI DFG + + Y + + +PE
Sbjct: 126 EER--NYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 285 LLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPP 333
+ + + D+WS G +L E+ T G + G + + + M
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (334), Expect = 3e-36
Identities = 51/227 (22%), Positives = 96/227 (42%), Gaps = 14/227 (6%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINK 165
E + LG G +G+V + + VA+K +K + + E ++++
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE--- 69
Query: 166 ADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCA 224
I +V+L G T + ++ E ++Y NL + +R N VS + A Q+ A
Sbjct: 70 --IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR----YYR 280
+ +L + IH DL N L+ +K+ DFG S + Y +
Sbjct: 128 MEYLEKK--NFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183
Query: 281 SPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIE 327
+PE L + + D+W+ G +L E+ T ++ Q+ +++E
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 230
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 4e-36
Identities = 50/229 (21%), Positives = 86/229 (37%), Gaps = 15/229 (6%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
+G G FG V + K +VAIK I+ E +++ K+
Sbjct: 5 SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-----S 58
Query: 170 SRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLS 229
+V+L G + +CLVFE + + + T + +C +A+L
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 230 SPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ----SRYYRSPEVL 285
+IH DL N L+ IK+ DFG + V Y + SPEV
Sbjct: 119 EA--CVIHRDLAARNCLVGE--NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 286 LGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPP 333
Y D+WS G ++ E+ + G+ + ++ + + I +
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 223
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 3e-35
Identities = 46/229 (20%), Positives = 87/229 (37%), Gaps = 15/229 (6%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
LG G FG V + VAIK+IK ++ E +++ +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQY-DVAIKMIKEGSMSEDEFIEEAKVMMNL-----S 57
Query: 170 SRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLS 229
+V+L G T + + ++ E ++ H + + +C A+ +L
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 230 SPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQ----YIQSRYYRSPEVL 285
S +H DL N L+ +K+ DFG S +V Y + PEVL
Sbjct: 118 SK--QFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 286 LGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPP 333
+ + D+W+ G ++ E+++ G+ + + I + L +
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 222
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 8e-35
Identities = 54/239 (22%), Positives = 89/239 (37%), Gaps = 24/239 (10%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHE---EKCQVAIKIIK----NKKPFLNQAQIEVQLLE 161
+ LG GSFG V + + VA+K +K ++ ++ EV +
Sbjct: 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 162 KINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQL 221
+ R +++L G + +V EL + L ++A Q+
Sbjct: 67 SL-----DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 222 CCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR---- 277
+ +L S IH DL N+LL + +KI DFG + Q Y+
Sbjct: 121 AEGMGYLESK--RFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 278 --YYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPP 333
+ +PE L + A D W G L E+ T G+ + G N + KI + P
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-34
Identities = 64/263 (24%), Positives = 115/263 (43%), Gaps = 26/263 (9%)
Query: 101 IIKHGEKF-LDRYEIDTLLGKGSFGQVVKAFD---HEEKCQVAIKIIK-----NKKPFLN 151
+ H EK ++ +E+ +LG G++G+V H+ A+K++K K
Sbjct: 14 LTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE 73
Query: 152 QAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLS-YNLYNLIRNTNFHGVS 210
+ E Q+LE I S ++V L F + L L+ + ++ L+ + +
Sbjct: 74 HTRTERQVLEHIR----QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ--RERFT 127
Query: 211 LNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV---- 266
+ + + ++ AL L +L II+ D+K ENILL S + + DFG S
Sbjct: 128 EHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADE 183
Query: 267 GQTLYQYIQSRYYRSPEVLLGIP--YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTK 324
+ Y + + Y +P+++ G +D A+D WSLG ++ EL TG F+ E + +
Sbjct: 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 243
Query: 325 IIEVLGMPPGYLLHGASKTSKYF 347
I + S +K
Sbjct: 244 ISRRILKSEPPYPQEMSALAKDL 266
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.001
Identities = 14/33 (42%), Positives = 17/33 (51%), Gaps = 5/33 (15%)
Query: 403 FKDLILRMLTYDPKKRISPTN-----VLRHEFF 430
KDLI R+L DPKKR+ + H FF
Sbjct: 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 3e-34
Identities = 63/278 (22%), Positives = 113/278 (40%), Gaps = 50/278 (17%)
Query: 92 GHDDENYDYI----IKHGEKF---LDRYEIDTLLGKGSFGQVVKAFDHE-----EKCQVA 139
G D Y Y+ ++ K+ + E +LG G+FG+V+ A + QVA
Sbjct: 12 GSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVA 71
Query: 140 IKIIKNKKPFLNQAQI--EVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-N 196
+K++K K + + E++++ ++ IV L G T + L+FE Y +
Sbjct: 72 VKMLKEKADSSEREALMSELKMMTQLG----SHENIVNLLGACTLSGPIYLIFEYCCYGD 127
Query: 197 LYNLIRN---------------------TNFHGVSLNLTKKFAQQLCCALAFLSSPELSI 235
L N +R+ + + ++ FA Q+ + FL S
Sbjct: 128 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SC 185
Query: 236 IHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR-----YYRSPEVLLGIPY 290
+H DL N+L+ K +KI DFG + + ++ + +PE L Y
Sbjct: 186 VHRDLAARNVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243
Query: 291 DLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIE 327
+ D+WS G +L E+ + G + G K+I+
Sbjct: 244 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 281
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-33
Identities = 58/239 (24%), Positives = 97/239 (40%), Gaps = 15/239 (6%)
Query: 99 DYIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQ 158
DY I+ +R E+ +G+G FG V + + IK K + + E
Sbjct: 1 DYEIQR-----ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF 55
Query: 159 LLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFA 218
L E + +IVKL G T +N + ++ EL + + + L +A
Sbjct: 56 LQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 114
Query: 219 QQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQ--- 275
QL ALA+L S +H D+ N+L+ S +K+ DFG S ++ + Y
Sbjct: 115 YQLSTALAYLESK--RFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGK 170
Query: 276 -SRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMP 332
+ +PE + + A D+W G + E+ G F G D + +I +P
Sbjct: 171 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 229
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 125 bits (314), Expect = 2e-33
Identities = 45/242 (18%), Positives = 93/242 (38%), Gaps = 23/242 (9%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDH---EEKCQVAIKIIKNK--KPFLNQAQIEVQLL 160
E + +I+ ++G G FG+V + + VAIK +K+ + E ++
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81
Query: 161 EKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQ 220
+ ++ L+G T + ++ E + + N ++ +
Sbjct: 82 GQ-----FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136
Query: 221 LCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG--------SSCHVGQTLYQ 272
+ + +L+ + +H DL NIL+ S K+ DFG +S +
Sbjct: 137 IAAGMKYLADM--NYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 273 YIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGM 331
+ +PE + + A D+WS G ++ E+ + GE + D + I + +
Sbjct: 193 GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL 252
Query: 332 PP 333
PP
Sbjct: 253 PP 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-32
Identities = 53/240 (22%), Positives = 97/240 (40%), Gaps = 26/240 (10%)
Query: 108 FLDRYEI---DTLLGKGSFGQVVKAFDHEEKC--QVAIKIIKNKKP---FLNQAQIEVQL 159
+LDR + D LG G+FG V K + +K VA+KI+KN+ ++ E +
Sbjct: 2 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 61
Query: 160 LEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQ 219
+++++ + YIV++ G LV E+ N N H V +
Sbjct: 62 MQQLD-----NPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVH 114
Query: 220 QLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG------SSCHVGQTLYQY 273
Q+ + +L + +H DL N+LL + KI DFG + + +
Sbjct: 115 QVSMGMKYLEES--NFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHG 170
Query: 274 IQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMP 332
+ +PE + + D+WS G ++ E + G+ + G + + + M
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG 230
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-32
Identities = 51/341 (14%), Positives = 104/341 (30%), Gaps = 77/341 (22%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIH 169
+ +GKG FG+V + E+ VA+KI +++ + E+ +
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFREAEIYQT-----VMLR 55
Query: 170 SRYIVKLKGHFTWKN----HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCA 224
I+ N L LV + + +L++ + + V++ K A
Sbjct: 56 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASG 112
Query: 225 LAFL------SSPELSIIHCDLKPENILLCSPKRSAIKIIDFG-------SSCHVGQTLY 271
LA L + + +I H DLK +NIL+ I D G ++ +
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPN 170
Query: 272 QYIQSRYYRSPEVLLG------IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKI 325
+ ++ Y +PEVL D++++G + E+ + G +E Q+
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYY 229
Query: 326 IEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGP 385
V P + K + +
Sbjct: 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRW------------------------------- 258
Query: 386 GGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVLR 426
S ++ + R++ + +
Sbjct: 259 ---------QSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-32
Identities = 51/243 (20%), Positives = 91/243 (37%), Gaps = 22/243 (9%)
Query: 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI 168
+ + ++G+G+FGQV+KA ++ ++ I + K+ + ++
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFH--------------GVSLNL 213
H I+ L G + +L L E + NL + +R + +S
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 214 TKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS--CHVGQTLY 271
FA + + +LS + IH DL NIL+ KI DFG S V
Sbjct: 129 LLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYV--AKIADFGLSRGQEVYVKKT 184
Query: 272 QYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLG 330
+ + E L Y D+WS G +L E+ + G + G + K+ +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244
Query: 331 MPP 333
+
Sbjct: 245 LEK 247
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (297), Expect = 5e-31
Identities = 58/254 (22%), Positives = 102/254 (40%), Gaps = 45/254 (17%)
Query: 110 DRYEIDTLLGKGSFGQVVKA-----FDHEEKCQVAIKIIKNKKPFLNQAQI--EVQLLEK 162
+ E +G+G+FG+V +A +E VA+K++K + QA E L+ +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 163 INKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGV------------ 209
+ + IVKL G +CL+FE ++Y +L +R+ + H V
Sbjct: 73 FD-----NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 210 ----------SLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259
S A+Q+ +A+LS +H DL N L+ +KI D
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGE--NMVVKIAD 183
Query: 260 FGSSCHVGQTLYQYIQSR-----YYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLF 313
FG S ++ Y + PE + Y D+W+ G +L E+ + G +
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 314 SGKNEVDQMTKIIE 327
G + + + +
Sbjct: 244 YGMAHEEVIYYVRD 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 9e-31
Identities = 55/236 (23%), Positives = 95/236 (40%), Gaps = 24/236 (10%)
Query: 110 DRYEI-DTLLGKGSFGQVVKAFDHE--EKCQVAIKIIK--NKKPFLNQAQIEVQLLEKIN 164
D I D LG G+FG V + ++ VAIK++K +K + E Q++ ++
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL- 66
Query: 165 KADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCC 223
+ YIV+L G L LV E+ L+ + + ++ + Q+
Sbjct: 67 ----DNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSM 120
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR------ 277
+ +L + +H DL N+LL + R KI DFG S +G Y
Sbjct: 121 GMKYLEEK--NFVHRDLAARNVLLVN--RHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 278 YYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMP 332
+ +PE + + D+WS G + E + G+ + + M I + M
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 232
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 9e-31
Identities = 55/256 (21%), Positives = 95/256 (37%), Gaps = 34/256 (13%)
Query: 106 EKFLDRYEIDTLLGKGSFGQVVKAFDH-------EEKCQVAIKIIKNK--KPFLNQAQIE 156
E DR + LG+G+FGQVV A +VA+K++K+ + L+ E
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 157 VQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLT- 214
+++++ I + I+ L G T L ++ E S NL ++ G+ +
Sbjct: 69 MEMMKMIG----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 215 -------------KKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS---PKRSAIKII 258
A Q+ + +L+S IH DL N+L+ K + +
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASK--KCIHRDLAARNVLVTEDNVMKIADFGLA 182
Query: 259 DFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKN 317
+ + +PE L Y D+WS G +L E+ T G + G
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242
Query: 318 EVDQMTKIIEVLGMPP 333
+ + E M
Sbjct: 243 VEELFKLLKEGHRMDK 258
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-30
Identities = 46/230 (20%), Positives = 93/230 (40%), Gaps = 12/230 (5%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKI-IKNKKPFLNQAQIEVQLLEKINKADI 168
++ +LG G+FG V K E +V I + IK + + + L E A +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 169 HSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFL 228
+ ++ +L + + L+ +L+ + + + + Q+ + +L
Sbjct: 69 DNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 229 SSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR-----YYRSPE 283
++H DL N+L+ +P+ +KI DFG + +G +Y + + E
Sbjct: 128 EDR--RLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 284 VLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMP 332
+L Y D+WS G + EL T G + G + + + + +P
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 233
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-29
Identities = 59/248 (23%), Positives = 99/248 (39%), Gaps = 38/248 (15%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKIIKNKKPFLNQAQI--EVQLLEK 162
+R LG G+FG+VV+A + + VA+K++K + + E+++L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 163 INKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGV------------ 209
+ + IV L G T ++ E Y +L N +R +
Sbjct: 83 LG----NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 210 ----SLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265
L F+ Q+ +AFL+S + IH DL NILL + KI DFG +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHGRI--TKICDFGLARD 194
Query: 266 VGQTLYQYIQSR-----YYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEV 319
+ ++ + +PE + Y D+WS G L EL + G + G
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 320 DQMTKIIE 327
+ K+I+
Sbjct: 255 SKFYKMIK 262
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 4e-29
Identities = 42/237 (17%), Positives = 87/237 (36%), Gaps = 23/237 (9%)
Query: 111 RYEIDTLLGKGSFGQVVKAFDHE---EKCQVAIKIIK--NKKPFLNQAQIEVQLLEKINK 165
+ ++G+G FG V + +K A+K + ++Q E +++ +
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS- 86
Query: 166 ADIHSRYIVKLKGH-FTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCA 224
++ L G + +V + + H ++ F Q+
Sbjct: 87 ----HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 142
Query: 225 LAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSR------- 277
+ FL+S +H DL N +L +K+ DFG + + + + ++
Sbjct: 143 MKFLASK--KFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
Query: 278 YYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPP 333
+ + E L + D+WS G +L EL T G P + N D +++ +
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ 255
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 5e-29
Identities = 54/250 (21%), Positives = 107/250 (42%), Gaps = 31/250 (12%)
Query: 100 YIIKHGEKFLDRYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKIIKNKKPFLNQAQ 154
Y+ E ++ + LG+GSFG V + E + +VAIK + + +
Sbjct: 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 69
Query: 155 I--EVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY-NLYNLIR--------N 203
E ++++ N ++V+L G + ++ EL++ +L + +R N
Sbjct: 70 FLNEASVMKEFN-----CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 124
Query: 204 TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263
SL+ + A ++ +A+L++ + +H DL N ++ +KI DFG +
Sbjct: 125 PVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFT--VKIGDFGMT 180
Query: 264 CHVGQTLYQYIQSR-----YYRSPEVLLGIPYDLAIDMWSLGCILVELHTG-EPLFSGKN 317
+ +T Y + + SPE L + D+WS G +L E+ T E + G +
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240
Query: 318 EVDQMTKIIE 327
+ ++E
Sbjct: 241 NEQVLRFVME 250
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-28
Identities = 45/236 (19%), Positives = 90/236 (38%), Gaps = 22/236 (9%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDH----EEKCQVAIKIIKNKKPFLNQAQI--EVQLLEKI 163
++G G FG+V K +++ VAIK +K + E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 164 NKADIHSRYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCC 223
I++L+G + + ++ E + + S+ + +
Sbjct: 67 -----SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 224 ALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ------TLYQYIQSR 277
+ +L++ + +H DL NIL+ S K+ DFG S + T
Sbjct: 122 GMKYLANM--NYVHRDLAARNILVNS--NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 278 YYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMP 332
+ +PE + + A D+WS G ++ E+ T GE + + + M I + +P
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 233
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 1e-25
Identities = 55/245 (22%), Positives = 100/245 (40%), Gaps = 33/245 (13%)
Query: 110 DRYEIDTLLGKGSFGQVVKAFDHEEKC-----QVAIKIIKNKKPFLNQAQIEVQLLEKIN 164
DR ++ LG+G+FGQV++A VA+K++ K+ + + KI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKIL 70
Query: 165 KADIHSRYIVKLKGHFTWK-NHLCLVFELLS-YNLYNLIRNTNFHGV------------- 209
H +V L G T L ++ E NL +R+ V
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 210 -SLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268
+L ++ Q+ + FL+S + IH DL NILL ++ +KI DFG + + +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSE--KNVVKICDFGLARDIYK 186
Query: 269 TLYQYIQSR-----YYRSPEVLLGIPYDLAIDMWSLGCILVELHTG-EPLFSGKNEVDQM 322
+ + +PE + Y + D+WS G +L E+ + + G ++
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246
Query: 323 TKIIE 327
+ ++
Sbjct: 247 CRRLK 251
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.7 bits (193), Expect = 1e-17
Identities = 37/200 (18%), Positives = 67/200 (33%), Gaps = 16/200 (8%)
Query: 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHS- 170
I L+G+G V + + + +K K + + + +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 171 -----RYIVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCAL 225
R + KL+G K + + L LI + V + + + +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAV----LMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 226 AFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVL 285
A I+H DL N+L+ I IIDF S VG+ ++ I R R+
Sbjct: 117 AKFYHRG--IVHGDLSQYNVLVSEEG---IWIIDFPQSVEVGEEGWREILERDVRNIITY 171
Query: 286 LGIPYDLAIDMWSLGCILVE 305
Y D+ S +++
Sbjct: 172 FSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 437 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.34 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.02 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.74 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.46 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.09 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.99 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-59 Score=439.26 Aligned_cols=252 Identities=29% Similarity=0.451 Sum_probs=215.5
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC----cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~----~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||+||+|+++.+++.||+|++... ......+.+|+.++..+ .|||||++++++.+++
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-----RHPNILRLYGYFHDAT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-----CCCCCCeEEEEEEECC
Confidence 46899999999999999999999999999999998632 22345567788888776 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+|+|||||++ +|.+++.... .+++..++.++.||+.||+|||++ |||||||||+|||+ +.++.+||+|||+|
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~--~ivHrDiKp~Nill--~~~~~~kl~DFG~a 153 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK--RVIHRDIKPENLLL--GSAGELKIADFGWS 153 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEE--CTTSCEEECCCCSC
T ss_pred EEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC--Ceeeeeecccccee--cCCCCEeeccccee
Confidence 99999999965 8999887654 589999999999999999999964 89999999999999 67888999999999
Q ss_pred eecCC-ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 264 CHVGQ-TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 264 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
..... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+.......|..
T Consensus 154 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~------- 226 (263)
T d2j4za1 154 VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF------- 226 (263)
T ss_dssp SCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTT-------
T ss_pred eecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCcc-------
Confidence 77643 3456789999999999999999999999999999999999999999998888777765421111100
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
....+.+||.+||+.||.+|||++
T Consensus 227 --------------------------------------------------------~s~~~~~li~~~L~~dp~~R~t~~ 250 (263)
T d2j4za1 227 --------------------------------------------------------VTEGARDLISRLLKHNPSQRPMLR 250 (263)
T ss_dssp --------------------------------------------------------SCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred --------------------------------------------------------CCHHHHHHHHHHccCCHhHCcCHH
Confidence 012578999999999999999999
Q ss_pred HHhcCCCcCcCC
Q psy11727 423 NVLRHEFFLKHS 434 (437)
Q Consensus 423 e~l~Hp~~~~~~ 434 (437)
|+|+||||+..+
T Consensus 251 eil~hp~~~~~s 262 (263)
T d2j4za1 251 EVLEHPWITANS 262 (263)
T ss_dssp HHHTCHHHHHHC
T ss_pred HHHcCcCcCCcC
Confidence 999999998644
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-57 Score=446.58 Aligned_cols=261 Identities=25% Similarity=0.437 Sum_probs=222.0
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
+.++|++.+.||+|+||+||+|++..+|+.||||++..... ....+.+|+.++..+ .|||||+++++|.+.+++
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~ 98 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-----RHPTLVNLHDAFEDDNEM 98 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-----CCTTBCCEEEEEEETTEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEE
Confidence 46799999999999999999999999999999999975432 234566788888877 689999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
|||||||+| +|.+++.... ..+++..++.++.||+.||+|||++ |||||||||+|||++.+.++.+||+|||+|+.
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~--~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhc--CCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 999999965 8999886543 4599999999999999999999964 89999999999999766678999999999987
Q ss_pred cCCc--cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 266 VGQT--LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 266 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.... ..+..||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..|......++......
T Consensus 176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~---- 251 (350)
T d1koaa2 176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG---- 251 (350)
T ss_dssp CCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGG----
T ss_pred cccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC----
Confidence 6533 3457899999999999999999999999999999999999999999999888888866433222111100
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
....+++||.+||++||.+|||++|
T Consensus 252 -------------------------------------------------------~s~~~~~li~~~L~~dP~~R~t~~e 276 (350)
T d1koaa2 252 -------------------------------------------------------ISEDGKDFIRKLLLADPNTRMTIHQ 276 (350)
T ss_dssp -------------------------------------------------------CCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred -------------------------------------------------------CCHHHHHHHHHHccCChhHCcCHHH
Confidence 0015799999999999999999999
Q ss_pred HhcCCCcCcCCC
Q psy11727 424 VLRHEFFLKHSV 435 (437)
Q Consensus 424 ~l~Hp~~~~~~~ 435 (437)
+|+||||++...
T Consensus 277 il~hp~~~~~~~ 288 (350)
T d1koaa2 277 ALEHPWLTPGNA 288 (350)
T ss_dssp HHHSTTTSCTTC
T ss_pred HhcCcccCCCCC
Confidence 999999987653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-58 Score=441.77 Aligned_cols=262 Identities=30% Similarity=0.402 Sum_probs=205.4
Q ss_pred cCceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 104 HGEKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 104 ~~~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
..+.+.++|++.+.||+|+||+||+|+++.+++.||||++.... .....+.+|+.++..+ .|||||+++++|.
T Consensus 3 ~~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~ 77 (307)
T d1a06a_ 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-----KHPNIVALDDIYE 77 (307)
T ss_dssp ECSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-----CCTTBCCEEEEEE
T ss_pred CCCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-----CCCCCCcEEEEEE
Confidence 34556788999999999999999999999999999999997443 2224456788888776 7899999999999
Q ss_pred ECCEEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec-CCCCCEEEEe
Q psy11727 182 WKNHLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS-PKRSAIKIID 259 (437)
Q Consensus 182 ~~~~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~-~~~~~ikL~D 259 (437)
+++.+|||||||+ |+|.+++... ..+++..++.++.||+.||+|||++ |||||||||+|||+.. ++++.+||+|
T Consensus 78 ~~~~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~--~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 78 SGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred ECCEEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhc--eeeeEEecccceeecccCCCceEEEec
Confidence 9999999999996 5899999765 4599999999999999999999964 8999999999999964 3568899999
Q ss_pred CCCceecCC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 260 FGSSCHVGQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 260 FG~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
||+|..... ...+.+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+....+......++....
T Consensus 154 FG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (307)
T d1a06a_ 154 FGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 233 (307)
T ss_dssp C------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTT
T ss_pred cceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccc
Confidence 999976643 334678999999999999999999999999999999999999999999888887777553221111000
Q ss_pred ccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCC
Q psy11727 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKK 417 (437)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 417 (437)
+ .....+.+||.+||+.||.+
T Consensus 234 ~-----------------------------------------------------------~~s~~~~~li~~~L~~dP~~ 254 (307)
T d1a06a_ 234 D-----------------------------------------------------------DISDSAKDFIRHLMEKDPEK 254 (307)
T ss_dssp T-----------------------------------------------------------TSCHHHHHHHHHHSCSSGGG
T ss_pred c-----------------------------------------------------------CCCHHHHHHHHHHccCCHhH
Confidence 0 00125799999999999999
Q ss_pred CCCHHHHhcCCCcCcC
Q psy11727 418 RISPTNVLRHEFFLKH 433 (437)
Q Consensus 418 R~t~~e~l~Hp~~~~~ 433 (437)
|||++|+|+||||++.
T Consensus 255 R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 255 RFTCEQALQHPWIAGD 270 (307)
T ss_dssp SCCHHHHHHSTTTTSS
T ss_pred CcCHHHHhcCHhhCCC
Confidence 9999999999999863
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-58 Score=435.10 Aligned_cols=256 Identities=24% Similarity=0.360 Sum_probs=207.6
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
+.++|++.+.||+|+||+||+|+++.+|+.||||++.... .....+.+|+.+++.+ .|||||++++++.+++.
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~~~~~~~~~~~ 77 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-----NHENVVKFYGHRREGNI 77 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-----CCTTBCCEEEEEEETTE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-----CCCCEeeEeeeeccCce
Confidence 4678999999999999999999999999999999997442 2234577888888776 78999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+|||||||+| +|.+++... ..+++..++.++.||+.||+|||++ |||||||||+|||+ ++++.+||+|||+|+
T Consensus 78 ~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~--~IiHrDiKp~NILl--~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 78 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLL--DERDNLKISDFGLAT 151 (271)
T ss_dssp EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEE--CTTCCEEECCCTTCE
T ss_pred eEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc--CCccCcccHHHEEE--CCCCCEEEccchhhe
Confidence 9999999965 899888654 4699999999999999999999964 89999999999999 677889999999998
Q ss_pred ecCC-----ccccccccccccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 265 HVGQ-----TLYQYIQSRYYRSPEVLLGIPY-DLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 265 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
.... ...+.+||+.|+|||++.+..+ +.++|||||||++|||++|++||.+.+...............+.
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~---- 227 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN---- 227 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTST----
T ss_pred eeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC----
Confidence 6532 2345689999999999998876 57899999999999999999999876544333222221110000
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
.+ ......+.+||.+||+.||.+|
T Consensus 228 -------~~-------------------------------------------------~~~s~~~~~li~~~L~~dP~~R 251 (271)
T d1nvra_ 228 -------PW-------------------------------------------------KKIDSAPLALLHKILVENPSAR 251 (271)
T ss_dssp -------TG-------------------------------------------------GGSCHHHHHHHHHHSCSSTTTS
T ss_pred -------cc-------------------------------------------------ccCCHHHHHHHHHHcCCChhHC
Confidence 00 0001257899999999999999
Q ss_pred CCHHHHhcCCCcCcCC
Q psy11727 419 ISPTNVLRHEFFLKHS 434 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~~~ 434 (437)
||++|+|+||||++.-
T Consensus 252 ~t~~eil~hpwf~~~l 267 (271)
T d1nvra_ 252 ITIPDIKKDRWYNKPL 267 (271)
T ss_dssp CCHHHHTTCTTTTCCC
T ss_pred cCHHHHhcCHhhCcCC
Confidence 9999999999998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-57 Score=434.25 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=214.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ...+.+.+|+.+++.+ .|||||+++++|.+.+++|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDELW 93 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-----CCCCEeeEeEEEEECCEEE
Confidence 357999999999999999999999999999999987433 2335677899988877 7899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
||||||+| +|.+++... .+++..++.++.||+.||+|||++ |||||||||+|||+ +.++.+||+|||+|+..
T Consensus 94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~--~iiHrDiKp~NILl--~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILL--GMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCcHHHeEE--CCCCcEeeccchhheee
Confidence 99999965 788877653 489999999999999999999964 89999999999999 67789999999999876
Q ss_pred CC---ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 267 GQ---TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 267 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.. .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..+......+...
T Consensus 167 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------- 238 (293)
T d1yhwa1 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN-------- 238 (293)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSS--------
T ss_pred ccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC--------
Confidence 32 3345689999999999999999999999999999999999999999998887777765532111100
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
.. .-...+++||.+||+.||.+|||++|
T Consensus 239 ---~~-------------------------------------------------~~s~~~~~li~~~L~~dP~~R~s~~e 266 (293)
T d1yhwa1 239 ---PE-------------------------------------------------KLSAIFRDFLNRCLDMDVEKRGSAKE 266 (293)
T ss_dssp ---GG-------------------------------------------------GSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred ---cc-------------------------------------------------cCCHHHHHHHHHHccCChhHCcCHHH
Confidence 00 00125799999999999999999999
Q ss_pred HhcCCCcCc
Q psy11727 424 VLRHEFFLK 432 (437)
Q Consensus 424 ~l~Hp~~~~ 432 (437)
+|+||||+.
T Consensus 267 il~Hp~~~~ 275 (293)
T d1yhwa1 267 LLQHQFLKI 275 (293)
T ss_dssp HTTCGGGGG
T ss_pred HhcCHhhCC
Confidence 999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-57 Score=435.49 Aligned_cols=254 Identities=29% Similarity=0.453 Sum_probs=215.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC----cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~----~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||+||+|+++.+++.||||++... ......+.+|+.+++.+ .|||||+++++|.+++
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-----DHPFFVKLYFTFQDDE 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-----CSTTBCCEEEEEECSS
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-----CCCCeeEEEEEEEECC
Confidence 46899999999999999999999999999999999632 22345677899998887 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+|+||||++| +|.+++.... .+++..++.++.||+.||+|||++ |||||||||+|||+ ++++.+||+|||+|
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~--~iiHrDiKp~NIll--~~~~~vkl~DFG~a 155 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK--GIIHRDLKPENILL--NEDMHIQITDFGTA 155 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE--CTTSCEEECCCTTC
T ss_pred EEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccc--cEEcCcCCcccccc--CCCceEEecccccc
Confidence 99999999975 8989887653 599999999999999999999964 89999999999999 77889999999999
Q ss_pred eecCC-----ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 264 CHVGQ-----TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 264 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
+.... ...+.+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+.+|.......|.
T Consensus 156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~---- 231 (288)
T d1uu3a_ 156 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE---- 231 (288)
T ss_dssp EECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT----
T ss_pred eecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc----
Confidence 87642 223568999999999999999999999999999999999999999999988888777542111100
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
.....+++||.+||+.||.+|
T Consensus 232 -----------------------------------------------------------~~s~~~~~li~~~L~~dP~~R 252 (288)
T d1uu3a_ 232 -----------------------------------------------------------KFFPKARDLVEKLLVLDATKR 252 (288)
T ss_dssp -----------------------------------------------------------TCCHHHHHHHHTTSCSSGGGS
T ss_pred -----------------------------------------------------------cCCHHHHHHHHHHccCCHhHC
Confidence 001257899999999999999
Q ss_pred CCHHH------HhcCCCcCcCCCC
Q psy11727 419 ISPTN------VLRHEFFLKHSVD 436 (437)
Q Consensus 419 ~t~~e------~l~Hp~~~~~~~~ 436 (437)
||++| +++||||+..+++
T Consensus 253 ~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 253 LGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp TTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred cCHHHHcCCHHHHcCCccCCCCHH
Confidence 99998 5889999998765
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-58 Score=446.90 Aligned_cols=297 Identities=24% Similarity=0.325 Sum_probs=209.8
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
..++|++.+.||+|+||+||+|++..+|+.||+|+++... ....++.+|+.+++.+ .|||||+++++|.+.++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-----NSPYIVGFYGAFYSDGE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-----CCTTBCCEEEEEECSSE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCE
Confidence 3578999999999999999999999999999999997432 2234566777777665 79999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+||||||+.| +|.+++.+.. .+++..++.++.||+.||.|||++ .|||||||||+|||+ +.++.+||+|||+|.
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl--~~~~~vkl~DFGla~ 153 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILV--NSRGEIKLCDFGVSG 153 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEE--CTTCCEEECCCCCCH
T ss_pred EEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHh-CCEEccccCHHHeeE--CCCCCEEEeeCCCcc
Confidence 9999999976 8999887653 589999999999999999999963 379999999999999 678899999999998
Q ss_pred ecCC-ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhhccCCc
Q psy11727 265 HVGQ-TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ-MTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 265 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.... ...+.+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+. ...+....+.+..........
T Consensus 154 ~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 154 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred ccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 6533 33467999999999999999999999999999999999999999988665432 222222222222111000000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
..... .......+.......+-......|... .+......++|||.+||++||.+|||++
T Consensus 234 ~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~s~~~~dli~~~L~~dP~~R~ta~ 293 (322)
T d1s9ja_ 234 GRPLS--------------SYGMDSRPPMAIFELLDYIVNEPPPKL------PSGVFSLEFQDFVNKCLIKNPAERADLK 293 (322)
T ss_dssp --------------------------CCCCHHHHHHHHHTSCCCCC------CBTTBCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred ccccc--------------ccccccccchhHHHHHhhhhccCCccC------ccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 00000 000000000000000000000011100 0001123689999999999999999999
Q ss_pred HHhcCCCcCcCC
Q psy11727 423 NVLRHEFFLKHS 434 (437)
Q Consensus 423 e~l~Hp~~~~~~ 434 (437)
|+|+||||++..
T Consensus 294 e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 294 QLMVHAFIKRSD 305 (322)
T ss_dssp HHHTSHHHHHHH
T ss_pred HHhhCHhhCcCC
Confidence 999999998744
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.7e-57 Score=443.41 Aligned_cols=258 Identities=25% Similarity=0.426 Sum_probs=218.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc-chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF-LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.++|++.+.||+|+||+||+|++..+|+.||||++...... ...+.+|+.++..+ .|||||+++++|.+++++|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-----HHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-----CSTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEE
Confidence 57899999999999999999999999999999999754322 23455677777665 7899999999999999999
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
||||||+| +|.+.+.... ..+++..++.|+.||+.||+|||+ .|||||||||+|||+.....+.+||+|||+|...
T Consensus 103 ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~--~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHE--HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccccccccccccCCCeEEEeecccceec
Confidence 99999965 8888776543 469999999999999999999995 4899999999999996557789999999999877
Q ss_pred CC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccc
Q psy11727 267 GQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTS 344 (437)
Q Consensus 267 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 344 (437)
.. ......||+.|+|||++.+..|+.++|||||||++|+|+||++||.+.+..+.+..+......++......
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~----- 254 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS----- 254 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTT-----
T ss_pred CCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC-----
Confidence 53 34457899999999999999999999999999999999999999999999888888866433222111100
Q ss_pred hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHH
Q psy11727 345 KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNV 424 (437)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~ 424 (437)
....+.+||.+||+.||.+|||++|+
T Consensus 255 ------------------------------------------------------~s~~~~~li~~~L~~dp~~R~s~~ei 280 (352)
T d1koba_ 255 ------------------------------------------------------VSPEAKDFIKNLLQKEPRKRLTVHDA 280 (352)
T ss_dssp ------------------------------------------------------SCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred ------------------------------------------------------CCHHHHHHHHHHccCChhHCcCHHHH
Confidence 01257999999999999999999999
Q ss_pred hcCCCcCcC
Q psy11727 425 LRHEFFLKH 433 (437)
Q Consensus 425 l~Hp~~~~~ 433 (437)
|+||||++.
T Consensus 281 l~Hp~~~~~ 289 (352)
T d1koba_ 281 LEHPWLKGD 289 (352)
T ss_dssp HTSTTTSSC
T ss_pred hcCHhhCCC
Confidence 999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-57 Score=438.95 Aligned_cols=260 Identities=26% Similarity=0.417 Sum_probs=225.0
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+.++|++.+.||+|+||+||+|.++.+++.||||+++........+.+|+.++..+ .|||||+++++|++.+++
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-----~HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-----RHRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-----CCTTBCCEEEEEEETTEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-----CCCCCCeEEEEEEECCEE
Confidence 457899999999999999999999999999999999986655445677899888876 789999999999999999
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
|||||||+| +|.+++.... ..+++..++.|+.||+.||+|||+ .||+||||||+|||++.++...+||+|||++..
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~--~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS--HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH--cCCCcccccccceeecCCCceEEEEcccchhhc
Confidence 999999965 8999887654 358999999999999999999995 489999999999999766677899999999987
Q ss_pred cCC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 266 VGQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 266 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
... ......+|+.|+|||.+.+..|+.++|||||||++|+|++|.+||.+.+..+.+.+|......++...++..+
T Consensus 154 ~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s-- 231 (321)
T d1tkia_ 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEIS-- 231 (321)
T ss_dssp CCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSC--
T ss_pred cccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCC--
Confidence 643 3456788999999999999999999999999999999999999999999999988887754433333221110
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
..+++||.+||+.||.+|||++|
T Consensus 232 ---------------------------------------------------------~~~~~li~~~L~~dp~~R~s~~e 254 (321)
T d1tkia_ 232 ---------------------------------------------------------IEAMDFVDRLLVKERKSRMTASE 254 (321)
T ss_dssp ---------------------------------------------------------HHHHHHHHTTSCSSGGGSCCHHH
T ss_pred ---------------------------------------------------------HHHHHHHHHHccCChhHCcCHHH
Confidence 15789999999999999999999
Q ss_pred HhcCCCcCcC
Q psy11727 424 VLRHEFFLKH 433 (437)
Q Consensus 424 ~l~Hp~~~~~ 433 (437)
+|+||||++.
T Consensus 255 il~hp~~~~~ 264 (321)
T d1tkia_ 255 ALQHPWLKQK 264 (321)
T ss_dssp HHHSHHHHSC
T ss_pred HhcCHhhccC
Confidence 9999999753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-57 Score=429.43 Aligned_cols=254 Identities=30% Similarity=0.450 Sum_probs=213.4
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC-cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK-KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
+.|++.+.||+|+||+||+|++..+++.||||++... ......+.+|+.++..+ .|||||+++++|.+.+.++|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-----DHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-----CCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEeeCCeEEE
Confidence 5699999999999999999999999999999999754 33456788899999887 68999999999999999999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
|||||++ +|.+++.... ..+++..++.++.||+.||.|||++ |||||||||+|||+ +.++.+||+|||+|....
T Consensus 87 vmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~--~ivHrDiKp~NIll--~~~~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN--KIIHRDLKAGNILF--TLDGDIKLADFGVSAKNT 161 (288)
T ss_dssp EEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEE--CTTSCEEECCCTTCEECH
T ss_pred EEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC--CEEEeecChhheeE--CCCCCEEEEechhhhccC
Confidence 9999966 7888776543 4699999999999999999999964 89999999999999 678899999999997654
Q ss_pred Cc---cccccccccccChhhhc-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhcc
Q psy11727 268 QT---LYQYIQSRYYRSPEVLL-----GIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 268 ~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 339 (437)
.. ..+.+||+.|+|||++. +..|+.++|||||||++|||+||++||.+.+..+.+.++.... ++...
T Consensus 162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~~~~~--- 236 (288)
T d2jfla1 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--PPTLA--- 236 (288)
T ss_dssp HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--CCCCS---
T ss_pred CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CCCCC---
Confidence 32 34578999999999984 4568999999999999999999999999988887777765421 11000
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
.. ......+.+||.+||+.||.+||
T Consensus 237 ------~~-------------------------------------------------~~~s~~~~~li~~~L~~dp~~R~ 261 (288)
T d2jfla1 237 ------QP-------------------------------------------------SRWSSNFKDFLKKCLEKNVDARW 261 (288)
T ss_dssp ------SG-------------------------------------------------GGSCHHHHHHHHHHSCSSTTTSC
T ss_pred ------cc-------------------------------------------------ccCCHHHHHHHHHHccCChhHCc
Confidence 00 00012579999999999999999
Q ss_pred CHHHHhcCCCcCcC
Q psy11727 420 SPTNVLRHEFFLKH 433 (437)
Q Consensus 420 t~~e~l~Hp~~~~~ 433 (437)
|++|+|+||||+..
T Consensus 262 t~~ell~hp~~~~~ 275 (288)
T d2jfla1 262 TTSQLLQHPFVTVD 275 (288)
T ss_dssp CHHHHTTSGGGCCC
T ss_pred CHHHHhcCcccCCC
Confidence 99999999999853
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-57 Score=432.36 Aligned_cols=283 Identities=33% Similarity=0.549 Sum_probs=228.0
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
++|++++.||+|+||+||+|++..+|+.||||+++... ....++.+|+.+++.+ .|||||+++++|.+++++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-----~Hp~Iv~~~~~~~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHPNIVKLLDVIHTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-----CCCcEEEeccccccccce
Confidence 68999999999999999999999999999999996432 2345677888888766 799999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
|+||||+++++.+++......++++..++.++.||+.||+|||++ |||||||||+|||+ +.++.+||+|||.|...
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~--~IiHrDiKpeNIl~--~~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--RVLHRDLKPQNLLI--NTEGAIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEE--CTTSCEEECSTTHHHHH
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC--CEEccccCchheee--cccCcceeccCCcceec
Confidence 999999999988888776667899999999999999999999964 89999999999999 67889999999999766
Q ss_pred CCc---cccccccccccChhhhcCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
... .....||+.|+|||++.... ++.++|+|||||++|+|++|++||.+.+..+++.++....+.|....+.....
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 432 33458999999999988766 47899999999999999999999999999999999999888887655543322
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
...+....+. ......... .......++|||++||++||.+|||++
T Consensus 233 ~~~~~~~~~~----------------~~~~~~~~~------------------~~~~s~~~~dll~~mL~~dP~~R~t~~ 278 (298)
T d1gz8a_ 233 MPDYKPSFPK----------------WARQDFSKV------------------VPPLDEDGRSLLSQMLHYDPNKRISAK 278 (298)
T ss_dssp STTCCTTSCC----------------CCCCCHHHH------------------STTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred cccccccccc----------------ccccchhhh------------------ccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 1111100000 000000000 001113679999999999999999999
Q ss_pred HHhcCCCcCcCCC
Q psy11727 423 NVLRHEFFLKHSV 435 (437)
Q Consensus 423 e~l~Hp~~~~~~~ 435 (437)
|+|+||||++..+
T Consensus 279 ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 279 AALAHPFFQDVTK 291 (298)
T ss_dssp HHHTSGGGTTCCC
T ss_pred HHhCCHhhccCCC
Confidence 9999999998653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-56 Score=427.62 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=217.9
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-------ccchHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-------PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-------~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
+.++|++.+.||+|+||+||+|+++.+|+.||||++.... .....+.+|+.+++.+ .|||||+++++|
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~ 82 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-----QHPNVITLHEVY 82 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-----CCTTBCCEEEEE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-----CCCCCCcEEEEE
Confidence 4678999999999999999999999999999999996432 1235678899999887 689999999999
Q ss_pred eECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCC--CCCEEE
Q psy11727 181 TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPK--RSAIKI 257 (437)
Q Consensus 181 ~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~--~~~ikL 257 (437)
.+.+++|||||||+| +|.+++.... .+++..++.++.||+.||+|||++ |||||||||+|||++.++ ...+||
T Consensus 83 ~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~--~ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 83 ENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred EECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhc--ceeecccccceEEEecCCCcccceEe
Confidence 999999999999965 8999987753 599999999999999999999964 899999999999995332 235999
Q ss_pred EeCCCceecC--CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Q psy11727 258 IDFGSSCHVG--QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGY 335 (437)
Q Consensus 258 ~DFG~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~ 335 (437)
+|||+|.... ....+..||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+......++..
T Consensus 159 ~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 238 (293)
T d1jksa_ 159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 238 (293)
T ss_dssp CCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHH
T ss_pred cchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCch
Confidence 9999998764 33456789999999999999999999999999999999999999999999988888776543222222
Q ss_pred hhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 336 LLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
..+.. ...+++||++||+.||
T Consensus 239 ~~~~~-----------------------------------------------------------s~~~~~li~~~L~~dP 259 (293)
T d1jksa_ 239 YFSNT-----------------------------------------------------------SALAKDFIRRLLVKDP 259 (293)
T ss_dssp HHTTS-----------------------------------------------------------CHHHHHHHHTTSCSSG
T ss_pred hcCCC-----------------------------------------------------------CHHHHHHHHHHccCCh
Confidence 11100 0157899999999999
Q ss_pred CCCCCHHHHhcCCCcCcCC
Q psy11727 416 KKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~~~ 434 (437)
.+|||++|+|+||||++..
T Consensus 260 ~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 260 KKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp GGSCCHHHHHHSTTTCC--
T ss_pred hHCcCHHHHhcCcccCCCC
Confidence 9999999999999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.1e-57 Score=434.61 Aligned_cols=253 Identities=30% Similarity=0.482 Sum_probs=218.8
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC----cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~----~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.+.||+|+||+||+|+++.+|+.||||+++.. ......+.+|+.+++.+ .|||||++++++.+.+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~ 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-----THPFIIRMWGTFQDAQ 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CBTTBCCEEEEEECSS
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-----cCcChhheeeeEeeCC
Confidence 46799999999999999999999999999999999632 22335566788887766 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+|+|||||.| +|..++.... .+++..++.++.||+.||+|||++ |||||||||+|||+ +.++.+||+|||+|
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~--~iiHrDiKp~NILl--~~~g~vkL~DFG~a 151 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK--DIIYRDLKPENILL--DKNGHIKITDFGFA 151 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEE--CTTSCEEECCCSSC
T ss_pred eeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccC--cEEccccCchheeE--cCCCCEEEecCccc
Confidence 99999999966 6777766553 589999999999999999999964 89999999999999 77889999999999
Q ss_pred eecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 264 CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
+.......+.+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+.++.......|..
T Consensus 152 ~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~-------- 223 (316)
T d1fota_ 152 KYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF-------- 223 (316)
T ss_dssp EECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTT--------
T ss_pred eEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCC--------
Confidence 998888888999999999999999999999999999999999999999999999988888876532111100
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC----
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI---- 419 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~---- 419 (437)
....+.+||.+||+.||.+|+
T Consensus 224 -------------------------------------------------------~s~~~~~li~~~L~~dp~~R~~~~r 248 (316)
T d1fota_ 224 -------------------------------------------------------FNEDVKDLLSRLITRDLSQRLGNLQ 248 (316)
T ss_dssp -------------------------------------------------------SCHHHHHHHHHHTCSCTTTCTTSST
T ss_pred -------------------------------------------------------CCHHHHHHHHHHhhhCHHhccccch
Confidence 001578999999999999996
Q ss_pred -CHHHHhcCCCcCcCCC
Q psy11727 420 -SPTNVLRHEFFLKHSV 435 (437)
Q Consensus 420 -t~~e~l~Hp~~~~~~~ 435 (437)
|++++++||||++..+
T Consensus 249 ~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 249 NGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp TTTHHHHTSGGGSSCCH
T ss_pred hhHHHHHcCcccccCCH
Confidence 9999999999998754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-56 Score=437.53 Aligned_cols=253 Identities=26% Similarity=0.428 Sum_probs=216.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC----cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~----~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++++.||+|+||+||+|+++.+|+.||||++++. ......+.+|+.+++.+ .|||||+++++|++.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-----RHPFLTALKYAFQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CCTTBCCEEEEEECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-----CCCCEEEEEeeecccc
Confidence 56899999999999999999999999999999999743 22345567788887765 7899999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
++|+|||||+| +|.+++.... .+++..++.++.||+.||+|||++ |||||||||+|||+ +.+|.+||+|||+|
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~--~iiHRDlKP~NILl--~~~g~vkl~DFG~a 152 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR--DVVYRDIKLENLML--DKDGHIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEE--CTTSCEEECCCTTC
T ss_pred ccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhc--CccccccCHHHeEe--cCCCCEEEeecccc
Confidence 99999999965 7888887764 589999999999999999999964 89999999999999 77889999999999
Q ss_pred eecC---CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccC
Q psy11727 264 CHVG---QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGA 340 (437)
Q Consensus 264 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 340 (437)
+... ....+.+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+....-..|..
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~----- 227 (337)
T d1o6la_ 153 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----- 227 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT-----
T ss_pred cccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCcc-----
Confidence 7653 33456789999999999999999999999999999999999999999999888877775532111100
Q ss_pred CccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC
Q psy11727 341 SKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS 420 (437)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t 420 (437)
....+++||.+||+.||.+|++
T Consensus 228 ----------------------------------------------------------~s~~~~dli~~~L~~dP~~R~~ 249 (337)
T d1o6la_ 228 ----------------------------------------------------------LSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp ----------------------------------------------------------SCHHHHHHHHHHTCSSTTTSTT
T ss_pred ----------------------------------------------------------CCHHHHHHHHhhccCCchhhcc
Confidence 0015789999999999999994
Q ss_pred -----HHHHhcCCCcCcCCC
Q psy11727 421 -----PTNVLRHEFFLKHSV 435 (437)
Q Consensus 421 -----~~e~l~Hp~~~~~~~ 435 (437)
++|+++||||++..+
T Consensus 250 ~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 250 GGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp CSTTTHHHHHTSGGGTTCCH
T ss_pred cccccHHHHHcCcccccCCH
Confidence 999999999987643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-56 Score=426.02 Aligned_cols=284 Identities=31% Similarity=0.489 Sum_probs=228.5
Q ss_pred ccCeeeeceecccCceEEEEEEEcCC-CeEEEEEEecCC---cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE--
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEE-KCQVAIKIIKNK---KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW-- 182 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~-~~~vaiK~i~~~---~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~-- 182 (437)
.++|++++.||+|+||+||+|++..+ ++.||||+++.. ........+|+.+++.+.. ..||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~--~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET--FEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHH--TCCTTBCCEEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhh--cCCCCcceeeeeecccc
Confidence 47899999999999999999999765 678999998632 2234467788888888764 379999999999863
Q ss_pred ---CCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 183 ---KNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 183 ---~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
..+++++||++++++..+........+++..++.++.||+.||+|||++ |||||||||+|||+ ++.+.+||+|
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~--~ivHrDiKp~NILi--~~~~~~kl~d 159 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILV--TSSGQIKLAD 159 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEE--CTTCCEEECS
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CEEecCCCccEEEE--cCCCCeeecc
Confidence 3579999999999877777666667799999999999999999999964 89999999999999 7788999999
Q ss_pred CCCceecC--CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 260 FGSSCHVG--QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 260 FG~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
||++.... .......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++.++.+..+.|+...+
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 99987653 3334678999999999999999999999999999999999999999999999999999999998887665
Q ss_pred ccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCC
Q psy11727 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKK 417 (437)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 417 (437)
+............ .. . ...... .......+.|||++||++||.+
T Consensus 240 ~~~~~~~~~~~~~-------~~-------~----~~~~~~------------------~~~~s~~~~dli~~mL~~dP~~ 283 (305)
T d1blxa_ 240 PRDVALPRQAFHS-------KS-------A----QPIEKF------------------VTDIDELGKDLLLKCLTFNPAK 283 (305)
T ss_dssp CTTCSSCGGGSCC-------CC-------C----CCGGGT------------------CCSCCHHHHHHHHHHSCSSTTT
T ss_pred cccccchhhhhcc-------cc-------c----cchhhc------------------cccCCHHHHHHHHHHCcCChhH
Confidence 4333221110000 00 0 000000 0011125789999999999999
Q ss_pred CCCHHHHhcCCCcCcCC
Q psy11727 418 RISPTNVLRHEFFLKHS 434 (437)
Q Consensus 418 R~t~~e~l~Hp~~~~~~ 434 (437)
|||++|||+||||++..
T Consensus 284 R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 284 RISAYSALSHPYFQDLE 300 (305)
T ss_dssp SCCHHHHHTSGGGTTCC
T ss_pred CcCHHHHhcChhhcCch
Confidence 99999999999999763
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-56 Score=421.61 Aligned_cols=252 Identities=24% Similarity=0.394 Sum_probs=201.5
Q ss_pred cCe-eeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE---
Q psy11727 110 DRY-EIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--- 182 (437)
Q Consensus 110 ~~y-~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--- 182 (437)
++| ++.+.||+|+||+||+|.+..+++.||+|++..... ....+.+|+.++..+ .|||||+++++|.+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~ 82 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-----QHPNIVRFYDSWESTVK 82 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEEESS
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEeeccc
Confidence 345 677889999999999999999999999999875432 223456677776655 79999999999876
Q ss_pred -CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeC
Q psy11727 183 -KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDF 260 (437)
Q Consensus 183 -~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DF 260 (437)
...+|+||||+++ +|.+++.... .+++..++.++.||+.||+|||+++.+||||||||+|||++ ++++.+||+||
T Consensus 83 ~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~-~~~~~~Kl~DF 159 (270)
T d1t4ha_ 83 GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT-GPTGSVKIGDL 159 (270)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES-STTSCEEECCT
T ss_pred cCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee-CCCCCEEEeec
Confidence 4578999999965 8999887653 58999999999999999999997644599999999999994 34678999999
Q ss_pred CCceecCC-ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhhc
Q psy11727 261 GSSCHVGQ-TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQ-MTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 261 G~s~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~p~~~~~~ 338 (437)
|+|+.... ...+.+||+.|+|||++.+ .|+.++|||||||++|||++|++||.+...... ...+.. +.+|..+..
T Consensus 160 Gla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~--~~~~~~~~~ 236 (270)
T d1t4ha_ 160 GLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--GVKPASFDK 236 (270)
T ss_dssp TGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT--TCCCGGGGG
T ss_pred CcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc--CCCCcccCc
Confidence 99976543 3456789999999999876 699999999999999999999999987654443 333322 111111000
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
. ....+.+||.+||+.||++|
T Consensus 237 ~-----------------------------------------------------------~~~~~~~li~~~l~~dp~~R 257 (270)
T d1t4ha_ 237 V-----------------------------------------------------------AIPEVKEIIEGCIRQNKDER 257 (270)
T ss_dssp C-----------------------------------------------------------CCHHHHHHHHHHSCSSGGGS
T ss_pred c-----------------------------------------------------------CCHHHHHHHHHHccCCHhHC
Confidence 0 00157899999999999999
Q ss_pred CCHHHHhcCCCcC
Q psy11727 419 ISPTNVLRHEFFL 431 (437)
Q Consensus 419 ~t~~e~l~Hp~~~ 431 (437)
||++|+|+||||+
T Consensus 258 ~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 258 YSIKDLLNHAFFQ 270 (270)
T ss_dssp CCHHHHHTSGGGC
T ss_pred cCHHHHhCCcccC
Confidence 9999999999996
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-56 Score=437.94 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=219.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC----cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK----KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~----~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++++.||+|+||+||+|+++.+|+.||||++... ......+.+|+.+++.+ .|||||+++++|.+.+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFLVKLEFSFKDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-----CCCcEeeccccccccc
Confidence 46899999999999999999999999999999998632 12234566777777665 7999999999999999
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||++ |||||||||+|||+ +.++.+||+|||+|
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~--~iiHRDIKP~NILl--~~~g~ikL~DFG~a 188 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLI--DQQGYIQVTDFGFA 188 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEE--CTTSCEEECCCTTC
T ss_pred ccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC--CEecCcCCHHHccc--CCCCCEEeeeceee
Confidence 99999999965 7888887654 599999999999999999999954 89999999999999 67889999999999
Q ss_pred eecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 264 CHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 264 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
+.......+.+||+.|+|||++.+..|+.++|||||||++|||+||++||.+.+....+.+|......+|..
T Consensus 189 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~-------- 260 (350)
T d1rdqe_ 189 KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH-------- 260 (350)
T ss_dssp EECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--------
T ss_pred eecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCcc--------
Confidence 998877778899999999999999999999999999999999999999999999888888876532211110
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC----
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI---- 419 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~---- 419 (437)
....+.+||++||+.||.+|+
T Consensus 261 -------------------------------------------------------~s~~~~~li~~~L~~dP~kR~~~~r 285 (350)
T d1rdqe_ 261 -------------------------------------------------------FSSDLKDLLRNLLQVDLTKRFGNLK 285 (350)
T ss_dssp -------------------------------------------------------CCHHHHHHHHHHSCSCTTTCTTSST
T ss_pred -------------------------------------------------------CCHHHHHHHHHHhhhCHHhcccccc
Confidence 001578999999999999995
Q ss_pred -CHHHHhcCCCcCcCCC
Q psy11727 420 -SPTNVLRHEFFLKHSV 435 (437)
Q Consensus 420 -t~~e~l~Hp~~~~~~~ 435 (437)
|++++++||||++.++
T Consensus 286 ~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 286 NGVNDIKNHKWFATTDW 302 (350)
T ss_dssp TTTHHHHTSGGGTTCCH
T ss_pred ccHHHHHcCccccCCCH
Confidence 9999999999998754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=429.11 Aligned_cols=276 Identities=31% Similarity=0.539 Sum_probs=220.2
Q ss_pred eeceecccCceEEEEEEEcCCCeEEEEEEecCCc------ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 114 IDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK------PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 114 i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~------~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
.+++||+|+||+||+|+++.+|+.||||+++... .....+.+|+.++..+ .|||||+++++|.+++++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~~~~~~~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-----SHPNIIGLLDAFGHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-----CCTTBCCEEEEECCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-----CCCCEeEEEeeeccCCcee
Confidence 4678999999999999999999999999986432 1235677899998887 6899999999999999999
Q ss_pred EEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 188 LVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 188 lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
|||||+.+++...+.... ..+++..++.+++||+.||+|||++ ||+||||||+|||+ +.++.+||+|||+|....
T Consensus 77 ivmE~~~~~~~~~~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~--~iiHrDiKp~NIli--~~~~~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH--WILHRDLKPNNLLL--DENGVLKLADFGLAKSFG 151 (299)
T ss_dssp EEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEE--CTTCCEEECCCGGGSTTT
T ss_pred ehhhhhcchHHhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhcc--ceecccCCcceEEe--cCCCccccccCccccccC
Confidence 999999887776665543 5699999999999999999999964 89999999999999 778899999999997664
Q ss_pred Cc---cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 268 QT---LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 268 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
.. ....+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+++.+|.+.++.|+...+......
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 42 3356899999999999754 6899999999999999999999999999999999999999998887655433322
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
..+... ...+. ..+..+.. .....++|||.+||++||++|||++|
T Consensus 232 ~~~~~~----------------~~~~~-~~~~~~~~------------------~~s~~~~dll~~~L~~dP~~R~sa~e 276 (299)
T d1ua2a_ 232 PDYVTF----------------KSFPG-IPLHHIFS------------------AAGDDLLDLIQGLFLFNPCARITATQ 276 (299)
T ss_dssp TTCCCC----------------CCCCC-CCHHHHCT------------------TCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred chhhhh----------------ccCCC-CChHHhcc------------------cCCHHHHHHHHHHccCChhhCcCHHH
Confidence 111000 00000 00111100 01136899999999999999999999
Q ss_pred HhcCCCcCcCC
Q psy11727 424 VLRHEFFLKHS 434 (437)
Q Consensus 424 ~l~Hp~~~~~~ 434 (437)
||+||||++..
T Consensus 277 ~L~Hp~f~~~p 287 (299)
T d1ua2a_ 277 ALKMKYFSNRP 287 (299)
T ss_dssp HHTSGGGTSSS
T ss_pred HhCCHhhCCCC
Confidence 99999998743
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-55 Score=417.48 Aligned_cols=257 Identities=29% Similarity=0.450 Sum_probs=216.7
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----------cchHHHHHHHHHHHhhhcCCCCCcEEEec
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----------FLNQAQIEVQLLEKINKADIHSRYIVKLK 177 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----------~~~~~~~e~~~~~~l~~~~~~h~~iv~l~ 177 (437)
|.++|++.+.||+|+||+||+|++..+|+.||||++..... ....+.+|+.++..+. .|||||+++
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----~hpnIv~~~ 76 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS----GHPNIIQLK 76 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT----TCTTBCCEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhc----CCCCeEEEE
Confidence 46899999999999999999999999999999999975421 1234667888888884 489999999
Q ss_pred ceeeECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEE
Q psy11727 178 GHFTWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIK 256 (437)
Q Consensus 178 ~~~~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ik 256 (437)
++|.+++++|||||||++ +|.+++.... .+++..++.++.||+.||+|||+ .|||||||||+|||+ +.++.+|
T Consensus 77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nill--~~~~~~k 150 (277)
T d1phka_ 77 DTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHK--LNIVHRDLKPENILL--DDDMNIK 150 (277)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--TTEECSCCSGGGEEE--CTTCCEE
T ss_pred eecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH--cCCcccccccceEEE--cCCCCeE
Confidence 999999999999999965 8999997754 59999999999999999999995 489999999999999 7788999
Q ss_pred EEeCCCceecCC--ccccccccccccChhhhcC------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Q psy11727 257 IIDFGSSCHVGQ--TLYQYIQSRYYRSPEVLLG------IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV 328 (437)
Q Consensus 257 L~DFG~s~~~~~--~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~ 328 (437)
|+|||+++.... .....+||+.|+|||++.+ ..++.++||||+||++|||++|++||.+.+..+....+...
T Consensus 151 l~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~ 230 (277)
T d1phka_ 151 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230 (277)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred EccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence 999999987754 3455789999999999863 35788999999999999999999999999988888877664
Q ss_pred hCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHH
Q psy11727 329 LGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLIL 408 (437)
Q Consensus 329 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 408 (437)
...++..... .....+++||.
T Consensus 231 ~~~~~~~~~~-----------------------------------------------------------~~s~~~~~li~ 251 (277)
T d1phka_ 231 NYQFGSPEWD-----------------------------------------------------------DYSDTVKDLVS 251 (277)
T ss_dssp CCCCCTTTGG-----------------------------------------------------------GSCHHHHHHHH
T ss_pred CCCCCCcccc-----------------------------------------------------------cCCHHHHHHHH
Confidence 2211110000 00126799999
Q ss_pred HccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 409 RMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 409 ~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
+||+.||.+|||++|||+||||++.
T Consensus 252 ~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 252 RFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp HHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred HHccCChhHCcCHHHHHcCHHHHHh
Confidence 9999999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-56 Score=428.44 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=208.9
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc----chHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF----LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~----~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
...|++.+.||+|+||+||+|++..+++.||||++...... ...+.+|+.++..+ .|||||+++++|.+++
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~~~~~~~~~~ 88 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-----RHPNTIQYRGCYLREH 88 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETT
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-----CCCCEeeEEEEEEECC
Confidence 34699999999999999999999999999999999744321 23455677777655 7999999999999999
Q ss_pred EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 185 HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 185 ~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
++|+|||||.+++.+.+.... ..+++..++.++.||+.||.|||++ |||||||||+|||+ +.++.+||+|||+|.
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~--~iiHrDiKp~NILl--~~~~~~Kl~DFG~a~ 163 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNILL--SEPGLVKLGDFGSAS 163 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEE--ETTTEEEECCCTTCB
T ss_pred EEEEEEEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhC--CEeccCCCcceEEE--CCCCCEEEeeccccc
Confidence 999999999876555443333 4699999999999999999999964 89999999999999 567889999999998
Q ss_pred ecCCccccccccccccChhhhcC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 265 HVGQTLYQYIQSRYYRSPEVLLG---IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 265 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
..... ...+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+..+......++..
T Consensus 164 ~~~~~-~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------ 236 (309)
T d1u5ra_ 164 IMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS------ 236 (309)
T ss_dssp SSSSB-CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC------
T ss_pred ccCCC-CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCC------
Confidence 76543 45789999999999975 358999999999999999999999999988887777765421111000
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
......+.+||.+||+.||.+|||+
T Consensus 237 -------------------------------------------------------~~~s~~~~~li~~~L~~dP~~Rpt~ 261 (309)
T d1u5ra_ 237 -------------------------------------------------------GHWSEYFRNFVDSCLQKIPQDRPTS 261 (309)
T ss_dssp -------------------------------------------------------TTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred -------------------------------------------------------CCCCHHHHHHHHHHCcCChhHCcCH
Confidence 0001257999999999999999999
Q ss_pred HHHhcCCCcCcC
Q psy11727 422 TNVLRHEFFLKH 433 (437)
Q Consensus 422 ~e~l~Hp~~~~~ 433 (437)
+|+|+||||++.
T Consensus 262 ~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 262 EVLLKHRFVLRE 273 (309)
T ss_dssp HHHTTCHHHHSC
T ss_pred HHHHhCHHhcCC
Confidence 999999999764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-56 Score=419.13 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=196.6
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc---chHHHHHHHHHHHhhhcCCCCCcEEEecceeeE--C
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF---LNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--K 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~---~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--~ 183 (437)
.++|++.+.||+|+||+||+|+++.+|+.||||++...... ...+.+|+.++.. +.|||||++++++.+ .
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~-----l~HpnIv~~~~~~~~~~~ 77 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE-----LKHPNIVRYYDRIIDRTN 77 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTS-----CCCTTBCCEEEEEEC---
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHH-----CCCCCEeeEEEEEEeCCC
Confidence 46899999999999999999999999999999999754321 2234455555544 489999999999864 4
Q ss_pred CEEEEEEEeccC-cHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHhcCCC---CCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNT--NFHGVSLNLTKKFAQQLCCALAFLSSPE---LSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~--~~~~ls~~~~~~i~~qi~~aL~~LH~~~---~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
+.+|+|||||++ +|.+++... ....+++..++.++.||+.||+|||+++ .+||||||||+|||+ +.++.+||
T Consensus 78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll--~~~~~vkl 155 (269)
T d2java1 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQNVKL 155 (269)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE--CTTSCEEE
T ss_pred CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc--CCCCcEEE
Confidence 578999999965 899988642 2356999999999999999999999642 249999999999999 67889999
Q ss_pred EeCCCceecCCc---cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 258 IDFGSSCHVGQT---LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 258 ~DFG~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
+|||+|...... ....+||+.|+|||++.+..|+.++|||||||++|||+||++||.+.+..+....+....-.+.
T Consensus 156 ~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~- 234 (269)
T d2java1 156 GDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI- 234 (269)
T ss_dssp CCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-
T ss_pred eeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-
Confidence 999999765432 3457899999999999999999999999999999999999999999988887777755211000
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
| .. -...+.+||.+||+.|
T Consensus 235 ----------------------------------~-----------------------~~----~s~~l~~li~~~L~~d 253 (269)
T d2java1 235 ----------------------------------P-----------------------YR----YSDELNEIITRMLNLK 253 (269)
T ss_dssp ----------------------------------C-----------------------TT----SCHHHHHHHHHHTCSS
T ss_pred ----------------------------------C-----------------------cc----cCHHHHHHHHHHcCCC
Confidence 0 00 0015789999999999
Q ss_pred CCCCCCHHHHhcCCCc
Q psy11727 415 PKKRISPTNVLRHEFF 430 (437)
Q Consensus 415 P~~R~t~~e~l~Hp~~ 430 (437)
|.+|||++|+|+|||+
T Consensus 254 p~~Rps~~ell~hp~i 269 (269)
T d2java1 254 DYHRPSVEEILENPLI 269 (269)
T ss_dssp GGGSCCHHHHHTSTTC
T ss_pred hhHCcCHHHHHhCCcC
Confidence 9999999999999996
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-55 Score=426.31 Aligned_cols=281 Identities=28% Similarity=0.511 Sum_probs=226.0
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
+.++|++++.||+|+||+||+|.+..+|+.||||+++... .....+.+|+.+++.+ .|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-----~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-----RHENVIGLLDVFTPDE 90 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-----CBTTBCCCSEEECSCS
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-----CCCCeeEEEEEeccCc
Confidence 5789999999999999999999999999999999997432 2234567788888876 6899999999998654
Q ss_pred ------EEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 185 ------HLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 185 ------~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
++|+||||++++|..+++.. .+++..++.++.||+.||+|||++ |||||||||+|||+ +.++.+||+
T Consensus 91 ~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~--~IiHrDiKp~NIL~--~~~~~~kl~ 163 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA--GIIHRDLKPGNLAV--NEDCELKIL 163 (346)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEE--CTTCCEEEC
T ss_pred cccccceEEEEEecccccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhC--CCcccccCcchhhc--ccccccccc
Confidence 67999999987888877654 499999999999999999999964 89999999999999 778899999
Q ss_pred eCCCceecCCccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 259 DFGSSCHVGQTLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 259 DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
|||+|...........||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+....+..+....+.|+..++
T Consensus 164 Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 164 DFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 999999998888889999999999999874 5789999999999999999999999999999999999999999998887
Q ss_pred ccCCccch--hhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCC
Q psy11727 338 HGASKTSK--YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDP 415 (437)
Q Consensus 338 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP 415 (437)
........ +....+.. ....+..+ .......++|||.+||++||
T Consensus 244 ~~~~~~~~~~~~~~~~~~----------------~~~~~~~~------------------~~~~s~~~~dli~~mL~~dP 289 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPEL----------------EKKDFASI------------------LTNASPLAVNLLEKMLVLDA 289 (346)
T ss_dssp HTCSCHHHHHHHHHSCCC----------------CCCCGGGT------------------CTTCCHHHHHHHHHHSCSST
T ss_pred hhhcchhhhhhhccCCcc----------------cccchHHh------------------ccCCCHHHHHHHHHHCcCCh
Confidence 65543221 11111000 00000000 00111257899999999999
Q ss_pred CCCCCHHHHhcCCCcCcCC
Q psy11727 416 KKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 416 ~~R~t~~e~l~Hp~~~~~~ 434 (437)
.+|||++|||+||||++..
T Consensus 290 ~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 290 EQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp TTSCCHHHHHHSGGGTTTC
T ss_pred hHCcCHHHHhcChhhCcCC
Confidence 9999999999999998754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.6e-55 Score=415.79 Aligned_cols=278 Identities=32% Similarity=0.536 Sum_probs=221.1
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
++|++.+.||+|+||+||+|+++ +|+.||||+++... ....++.+|+.+++.+ .|||||+++++|.+.++.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-----KHSNIVKLYDVIHTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-----CCTTBCCEEEEEECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-----CCCcEEeeeeecccCCce
Confidence 68999999999999999999985 78899999996542 2345677888888776 789999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+++||++.+++...+.... +.+++..++.++.||+.||+|||+ .|||||||||+|||+ +.++.+||+|||.|...
T Consensus 76 ~i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~--~~IvHrDiKp~NIll--~~~~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD--RRVLHRDLKPQNLLI--NREGELKIADFGLARAF 150 (286)
T ss_dssp EEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE--CTTSCEEECCTTHHHHH
T ss_pred eEEEEeehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhcc--CcEEecCCCCceeeE--cCCCCEEecccccceec
Confidence 9999999998777776544 569999999999999999999995 489999999999999 67889999999999776
Q ss_pred CCc---cccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 267 GQT---LYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 267 ~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
... .....+++.|+|||++.+. .++.++|+|||||++|||++|++||.+.+..+++.++....+.|+...+.....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence 443 3345689999999999765 578999999999999999999999999999999999999999887666544332
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
...+...... ....+ ... ........+.|||.+||++||++|||++
T Consensus 231 ~~~~~~~~~~------------~~~~~----~~~------------------~~~~~s~~~~dli~~~L~~dP~~R~s~~ 276 (286)
T d1ob3a_ 231 LPKYDPNFTV------------YEPLP----WES------------------FLKGLDESGIDLLSKMLKLDPNQRITAK 276 (286)
T ss_dssp STTCCTTCCC------------CCCCC----GGG------------------TCCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhccccccc------------ccCcc----hhh------------------hcccCCHHHHHHHHHHccCChhHCcCHH
Confidence 2211110000 00000 000 0001112678999999999999999999
Q ss_pred HHhcCCCcCc
Q psy11727 423 NVLRHEFFLK 432 (437)
Q Consensus 423 e~l~Hp~~~~ 432 (437)
|+|+||||++
T Consensus 277 ell~Hp~f~~ 286 (286)
T d1ob3a_ 277 QALEHAYFKE 286 (286)
T ss_dssp HHHTSGGGGC
T ss_pred HHhcCcccCc
Confidence 9999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=425.70 Aligned_cols=252 Identities=28% Similarity=0.445 Sum_probs=211.4
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|++.+.||+|+||+||+|+++.+++.||||++++.. ........|..++... +.|||||+++++|.++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~----~~hp~Iv~~~~~~~~~~~ 77 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA----WEHPFLTHMFCTFQTKEN 77 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHH----TTCTTBCCEEEEEECSSE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHh----CCCCcEEEEEEEEccCCc
Confidence 68999999999999999999999999999999996421 2223444555554432 389999999999999999
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
+||||||+++ +|.+++.... .+++..++.++.||+.||+|||++ |||||||||+|||+ ++++.+||+|||+|+
T Consensus 78 ~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~--~iiHrDikp~NiL~--~~~~~~kl~DFG~a~ 151 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK--GIVYRDLKLDNILL--DKDGHIKIADFGMCK 151 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEE--CTTSCEEECCCTTCB
T ss_pred eeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCcccceee--cCCCceeccccchhh
Confidence 9999999965 8999887654 589999999999999999999965 89999999999999 778899999999997
Q ss_pred ecC---CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 265 HVG---QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 265 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++.++....-..|..
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~------ 225 (320)
T d1xjda_ 152 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW------ 225 (320)
T ss_dssp CCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT------
T ss_pred hcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc------
Confidence 653 23345689999999999999999999999999999999999999999999888887775421110000
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
....+.+||++||+.||.+|||+
T Consensus 226 ---------------------------------------------------------~s~~~~dli~~~L~~dP~~R~s~ 248 (320)
T d1xjda_ 226 ---------------------------------------------------------LEKEAKDLLVKLFVREPEKRLGV 248 (320)
T ss_dssp ---------------------------------------------------------SCHHHHHHHHHHSCSSGGGSBTT
T ss_pred ---------------------------------------------------------CCHHHHHHHHHhcccCCCCCcCH
Confidence 00157999999999999999999
Q ss_pred H-HHhcCCCcCcCC
Q psy11727 422 T-NVLRHEFFLKHS 434 (437)
Q Consensus 422 ~-e~l~Hp~~~~~~ 434 (437)
+ ++++||||++.+
T Consensus 249 ~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 249 RGDIRQHPLFREIN 262 (320)
T ss_dssp BSCGGGSGGGTTCC
T ss_pred HHHHHhCchhccCC
Confidence 6 899999998864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-54 Score=421.55 Aligned_cols=279 Identities=32% Similarity=0.533 Sum_probs=221.2
Q ss_pred CeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE------CC
Q psy11727 111 RYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW------KN 184 (437)
Q Consensus 111 ~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~------~~ 184 (437)
+|...++||+|+||+||+|++..+|+.||||++...... ..+|+.++..+ .|+|||+++++|.. ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l-----~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKL-----DHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHC-----CCTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhc-----CCCCCCcEEEEEEecCccCCce
Confidence 699999999999999999999999999999999765433 23688888876 68999999999854 34
Q ss_pred EEEEEEEeccCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCC-CCEEEEeCC
Q psy11727 185 HLCLVFELLSYNLYNLIRN--TNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR-SAIKIIDFG 261 (437)
Q Consensus 185 ~~~lV~E~~~~~L~~~l~~--~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~-~~ikL~DFG 261 (437)
++|||||||++++.+.+.. .....+++..++.++.||+.||+|||++ |||||||||+|||+ +.+ ..+||+|||
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~--~IiHrDiKp~NILl--~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLL--DPDTAVLKLCDFG 168 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEE--CTTTCCEEECCCT
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc--CCcccCCCcceEEE--ecCCCceeEeccc
Confidence 6899999999887766643 2345699999999999999999999964 89999999999999 544 479999999
Q ss_pred CceecC--CccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 262 SSCHVG--QTLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 262 ~s~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
++.... ....+.+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..+.+.+|.|+..++.
T Consensus 169 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 169 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp TCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred chhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 998763 34456789999999999876 468999999999999999999999999999999999999999999887775
Q ss_pred cCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCC
Q psy11727 339 GASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKR 418 (437)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R 418 (437)
....... ...+..... .+ +..+ ........+.|||.+||++||.+|
T Consensus 249 ~~~~~~~------~~~~~~~~~-------~~----~~~~-----------------~~~~~s~~~~dLl~~mL~~dP~~R 294 (350)
T d1q5ka_ 249 EMNPNYT------EFKFPQIKA-------HP----WTKV-----------------FRPRTPPEAIALCSRLLEYTPTAR 294 (350)
T ss_dssp HHCC---------CCCCCCCCC-------CC----GGGT-----------------SCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred hhccchh------hcccccccc-------Cc----hhhh-----------------cccCCCHHHHHHHHHHccCChhHC
Confidence 4332100 000000000 00 0000 000111257899999999999999
Q ss_pred CCHHHHhcCCCcCcCCC
Q psy11727 419 ISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 419 ~t~~e~l~Hp~~~~~~~ 435 (437)
||++|||+||||++...
T Consensus 295 ~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 295 LTPLEACAHSFFDELRD 311 (350)
T ss_dssp CCHHHHHTSGGGGGGGC
T ss_pred cCHHHHhcCHhhccccC
Confidence 99999999999987543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-55 Score=427.00 Aligned_cols=262 Identities=26% Similarity=0.438 Sum_probs=207.6
Q ss_pred eeccCeeeec-eecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE---
Q psy11727 107 KFLDRYEIDT-LLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--- 182 (437)
Q Consensus 107 ~~~~~y~i~~-~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--- 182 (437)
.+.++|.+.. +||+|+||+||+|++..+++.||||+++.. ....+|+.++.++. .|||||+++++|++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~----~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRAS----QCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHT----TSTTBCCEEEEEEEEET
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhc----CCCCCCeEEEEEeeccc
Confidence 3467899875 699999999999999999999999999743 56677888776553 78999999999976
Q ss_pred -CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC-CCCCEEEEe
Q psy11727 183 -KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP-KRSAIKIID 259 (437)
Q Consensus 183 -~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~-~~~~ikL~D 259 (437)
+.++|||||||+| +|.+++.......+++..++.|+.||+.||+|||+ .||+||||||+|||++.+ ..+.+||+|
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~--~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--INIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH--cCCccccccccccccccccccccccccc
Confidence 4689999999965 89999987665679999999999999999999995 489999999999999542 356799999
Q ss_pred CCCceecC--CccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 260 FGSSCHVG--QTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 260 FG~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
||+|+... ......+||+.|+|||++.+..|+.++|||||||++|+|+||++||.+.+.......+.....
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~------- 230 (335)
T d2ozaa1 158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR------- 230 (335)
T ss_dssp CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC-------
T ss_pred cceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh-------
Confidence 99998653 334567899999999999999999999999999999999999999988765444443322100
Q ss_pred ccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCC
Q psy11727 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKK 417 (437)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 417 (437)
.+.+ ..|.. ........+.+||++||+.||.+
T Consensus 231 --------------~~~~-----------~~~~~-----------------------~~~~~s~~~~~li~~~L~~dP~~ 262 (335)
T d2ozaa1 231 --------------MGQY-----------EFPNP-----------------------EWSEVSEEVKMLIRNLLKTEPTQ 262 (335)
T ss_dssp --------------SCSS-----------SCCTT-----------------------HHHHSCHHHHHHHHHHSCSSTTT
T ss_pred --------------cCCC-----------CCCCc-----------------------ccccCCHHHHHHHHHHccCChhH
Confidence 0000 00000 00001126799999999999999
Q ss_pred CCCHHHHhcCCCcCcC
Q psy11727 418 RISPTNVLRHEFFLKH 433 (437)
Q Consensus 418 R~t~~e~l~Hp~~~~~ 433 (437)
|||++|+|+||||++.
T Consensus 263 R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 263 RMTITEFMNHPWIMQS 278 (335)
T ss_dssp SCCHHHHHHSHHHHTT
T ss_pred CcCHHHHHcCHHhhCC
Confidence 9999999999999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-54 Score=427.69 Aligned_cols=259 Identities=23% Similarity=0.373 Sum_probs=208.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc----ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
.++|++.++||+|+||+||+|++..+|+.||||++.... ........|...++.+.+ ..|||||+++++|.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~--~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSS--SCCTTBCCEEEEEECSS
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhc--CCCCcEEEEEEEEEECC
Confidence 468999999999999999999999999999999986322 112334455555555543 47999999999999999
Q ss_pred EEEEEEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+|+|||||+ |+|.+++.... .+++..++.++.||+.||+|||++ |||||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~--~iiHrDlKP~NILl--~~~g~iKl~DFGla 154 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR--FVVYRDLKPANILL--DEHGHVRISDLGLA 154 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEE--CSSSCEEECCCTTC
T ss_pred EEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHC--CccceeeccceeEE--cCCCcEEEeeecee
Confidence 9999999996 58999987753 589999999999999999999964 89999999999999 77889999999999
Q ss_pred eecCC-ccccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 264 CHVGQ-TLYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 264 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
+.... .....+||+.|+|||++.+ ..|+.++|||||||++|||+||++||.+.+..+...........++.
T Consensus 155 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~------- 227 (364)
T d1omwa3 155 CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------- 227 (364)
T ss_dssp EECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCC-------
T ss_pred eecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC-------
Confidence 87644 3456789999999999974 56899999999999999999999999876544333222111111100
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCC-
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRIS- 420 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t- 420 (437)
.| .. ....+.+||.+||+.||.+|||
T Consensus 228 --------------------------~~-----------------------~~----~s~~~~~li~~~L~~dP~~R~t~ 254 (364)
T d1omwa3 228 --------------------------LP-----------------------DS----FSPELRSLLEGLLQRDVNRRLGC 254 (364)
T ss_dssp --------------------------CC-----------------------SS----SCHHHHHHHHHHTCSSTTTSTTT
T ss_pred --------------------------CC-----------------------CC----CCHHHHHHHHHHcccCHHHhCCC
Confidence 00 00 0125799999999999999999
Q ss_pred ----HHHHhcCCCcCcCCC
Q psy11727 421 ----PTNVLRHEFFLKHSV 435 (437)
Q Consensus 421 ----~~e~l~Hp~~~~~~~ 435 (437)
++|+++||||++.++
T Consensus 255 ~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 255 LGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp SSSTHHHHHTSGGGTTCCH
T ss_pred cccCHHHHHcCccccCCCH
Confidence 799999999998653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=418.13 Aligned_cols=299 Identities=31% Similarity=0.519 Sum_probs=223.9
Q ss_pred ceeecCc-e--eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcE
Q psy11727 100 YIIKHGE-K--FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYI 173 (437)
Q Consensus 100 ~~~~~~~-~--~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~i 173 (437)
|.+..++ . +.++|+++++||+|+||+||+|++..+|+.||||++.... ....++.+|+.+++.+ .||||
T Consensus 4 ~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-----~hpnI 78 (355)
T d2b1pa1 4 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKNI 78 (355)
T ss_dssp EEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-----CCTTB
T ss_pred EEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-----CCCCe
Confidence 4556666 3 3489999999999999999999999999999999997542 2234566788888776 78999
Q ss_pred EEecceeeE------CCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEE
Q psy11727 174 VKLKGHFTW------KNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILL 247 (437)
Q Consensus 174 v~l~~~~~~------~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll 247 (437)
|+++++|.. ..++|+|||||.+++.+.+. ..+++..++.++.||+.||+|||+ .||+||||||+|||+
T Consensus 79 v~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~--~giiHrDlKP~Nil~ 152 (355)
T d2b1pa1 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVV 152 (355)
T ss_dssp CCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCSCCCGGGEEE
T ss_pred eEEEEEEecccccccCceeEEEEeccchHHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhh--cccccccCCcccccc
Confidence 999999963 47999999999998887664 348999999999999999999995 489999999999999
Q ss_pred ecCCCCCEEEEeCCCceecCC--ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy11727 248 CSPKRSAIKIIDFGSSCHVGQ--TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKI 325 (437)
Q Consensus 248 ~~~~~~~ikL~DFG~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i 325 (437)
+.++.+|++|||++..... .....+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+...+..++
T Consensus 153 --~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i 230 (355)
T d2b1pa1 153 --KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230 (355)
T ss_dssp --CTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred --ccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHH
Confidence 6788899999999876543 334567899999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCChhhhccCCccc-hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHH
Q psy11727 326 IEVLGMPPGYLLHGASKTS-KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFK 404 (437)
Q Consensus 326 ~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (437)
...++.|+...+....... .++....... . ........ .................++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~------------~~~~~~~~------~~~~~~~~~~~~~~s~~~~ 288 (355)
T d2b1pa1 231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYA----G------------LTFPKLFP------DSLFPADSEHNKLKASQAR 288 (355)
T ss_dssp HHHHCCCCHHHHTTSCHHHHHHHHTSCCCC----C------------CCHHHHSC------GGGSCCSSHHHHHHHHHHH
T ss_pred HHhccCCCHHHHHHhhhhHHHHhhcCcccc----c------------cccccccc------cccccccccccccCCHHHH
Confidence 9999988888776554332 2222111000 0 00000000 0000000111122334689
Q ss_pred HHHHHccccCCCCCCCHHHHhcCCCcCcC
Q psy11727 405 DLILRMLTYDPKKRISPTNVLRHEFFLKH 433 (437)
Q Consensus 405 dli~~~L~~dP~~R~t~~e~l~Hp~~~~~ 433 (437)
|||++||.+||++||||+|||+||||+..
T Consensus 289 dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 289 DLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=408.24 Aligned_cols=250 Identities=25% Similarity=0.408 Sum_probs=204.6
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc-------cchHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP-------FLNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~-------~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
+.++|++.+.||+|+||+||+|++..+|+.||||++..... ...++.+|+.+++.+++ .|||||+++++|
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~---~h~nIv~~~~~~ 78 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS---GFSGVIRLLDWF 78 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS---SSCSBCCEEEEE
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhcc---CCCCccEEEEEE
Confidence 45789999999999999999999999999999999964321 12345679999998863 589999999999
Q ss_pred eECCEEEEEEEeccC--cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEE
Q psy11727 181 TWKNHLCLVFELLSY--NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKII 258 (437)
Q Consensus 181 ~~~~~~~lV~E~~~~--~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~ 258 (437)
.+.+.+++|||++.+ ++.+++... ..+++..++.++.||+.||+|||++ |||||||||+|||++. +++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~--~iiHrDiKp~NIll~~-~~~~vkl~ 153 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC--GVLHRDIKDENILIDL-NRGELKLI 153 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEET-TTTEEEEC
T ss_pred eeCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC--CCccccCcccceEEec-CCCeEEEC
Confidence 999999999999954 677777665 3599999999999999999999964 8999999999999952 45689999
Q ss_pred eCCCceecCCc-cccccccccccChhhhcCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 259 DFGSSCHVGQT-LYQYIQSRYYRSPEVLLGIPY-DLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 259 DFG~s~~~~~~-~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
|||+|+..... ..+.+||+.|+|||++.+..+ +.++|||||||++|||++|++||.+.+ .+....-.
T Consensus 154 DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~----- 222 (273)
T d1xwsa_ 154 DFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF----- 222 (273)
T ss_dssp CCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCC-----
T ss_pred ccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccC-----
Confidence 99999876544 345789999999999987765 567999999999999999999997632 12111000
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
+ + . . ....+.+||.+||+.||.
T Consensus 223 ----------~---------------------~--~---------------------~----~s~~~~~li~~~L~~dp~ 244 (273)
T d1xwsa_ 223 ----------F---------------------R--Q---------------------R----VSSECQHLIRWCLALRPS 244 (273)
T ss_dssp ----------C---------------------S--S---------------------C----CCHHHHHHHHHHTCSSGG
T ss_pred ----------C---------------------C--C---------------------C----CCHHHHHHHHHHccCCHh
Confidence 0 0 0 0 002579999999999999
Q ss_pred CCCCHHHHhcCCCcCcCC
Q psy11727 417 KRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~~~~~ 434 (437)
+|||++|+|+||||++..
T Consensus 245 ~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 245 DRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp GSCCHHHHHTSGGGSSCC
T ss_pred HCcCHHHHhcCHhhCCCC
Confidence 999999999999998753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=410.40 Aligned_cols=283 Identities=27% Similarity=0.440 Sum_probs=221.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCC---cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE---
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK---KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW--- 182 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~---~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~--- 182 (437)
.++|++++.||+|+||+||+|++..+|+.||||++... .....++.+|+.+++.+ .|+||+++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-----~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-----KHENVVNLIEICRTKAS 83 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-----CCTTBCCEEEEEEC---
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-----cCCCccceEeeeecccc
Confidence 58999999999999999999999999999999998533 23445678899999887 68899999998754
Q ss_pred -----CCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 183 -----KNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 183 -----~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
.+++|+|||++++++........ ..+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~~-~~~~~~~~~~i~~qil~~l~~lH~--~~ivHrDlKp~NILl--~~~~~~kl 158 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHR--NKILHRDMKAANVLI--TRDGVLKL 158 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHTCTT-CCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCCGGGEEE--CTTSCEEE
T ss_pred cccccCceEEEEEeccCCCccchhhhcc-cccccHHHHHHHHHHHHHHHHhcc--CCEEecCcCchheee--cCCCcEEe
Confidence 35689999999988877665443 569999999999999999999995 489999999999999 67889999
Q ss_pred EeCCCceecCC-------ccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Q psy11727 258 IDFGSSCHVGQ-------TLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVL 329 (437)
Q Consensus 258 ~DFG~s~~~~~-------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 329 (437)
+|||++...+. ...+.+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+....+..+....
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~ 238 (318)
T d3blha1 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238 (318)
T ss_dssp CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999976542 22346799999999999865 68999999999999999999999999999999999999999
Q ss_pred CCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHH
Q psy11727 330 GMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILR 409 (437)
Q Consensus 330 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 409 (437)
+.++............+... .. .........+.+. .......++|||.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~-~~--------------~~~~~~~~~~~~~----------------~~~~~~~~~dLl~~ 287 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKL-EL--------------VKGQKRKVKDRLK----------------AYVRDPYALDLIDK 287 (318)
T ss_dssp CCCCTTTSTTCCCC--------C--------------CSSCCBCHHHHHH----------------HHHCCHHHHHHHHH
T ss_pred CCCChhhccccchhhhhhhh-cc--------------cccccccchhhhc----------------cccCCHHHHHHHHH
Confidence 88877665544332211100 00 0000000111100 00112357899999
Q ss_pred ccccCCCCCCCHHHHhcCCCcCc
Q psy11727 410 MLTYDPKKRISPTNVLRHEFFLK 432 (437)
Q Consensus 410 ~L~~dP~~R~t~~e~l~Hp~~~~ 432 (437)
||++||++|||++|+|+||||+.
T Consensus 288 mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 288 LLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp HSCSSTTTSCCHHHHHHSGGGSS
T ss_pred HCcCChhHCcCHHHHHcChhhcc
Confidence 99999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=408.65 Aligned_cols=280 Identities=30% Similarity=0.540 Sum_probs=219.5
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC---
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK--- 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~--- 183 (437)
.++|++++.||+|+||+||+|++..+|+.||||++.... ....++.+|+.+++.+ .||||+++++++...
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-----~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-----RHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-----CCTTBCCCCEEECCSSTT
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-----CCCCCCcEEEEEeecccc
Confidence 478999999999999999999999999999999997432 2344667899998887 688999999998754
Q ss_pred --CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 184 --NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 184 --~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
.++|+++++++++|.+++... .+++..++.++.||+.||+|||++ |||||||||+|||+ ++++.+||+|||
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~--~iiHRDIKp~NILl--~~~~~~kl~DfG 154 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA--NVLHRDLKPSNLLL--NTTCDLKICDFG 154 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEE--CTTCCEEECCCT
T ss_pred ccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCCCcceEEE--CCCCCEEEcccC
Confidence 357788777788999999764 489999999999999999999964 89999999999999 678899999999
Q ss_pred CceecCCc------cccccccccccChhhhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 262 SSCHVGQT------LYQYIQSRYYRSPEVLLG-IPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 262 ~s~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
+|...... ....+||+.|+|||++.. ..++.++||||+||++|+|++|++||.+.+..++...+...++.|..
T Consensus 155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (345)
T d1pmea_ 155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234 (345)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred ceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCCh
Confidence 99765332 334678999999999854 46789999999999999999999999999999999999998888877
Q ss_pred hhhccCCccc--hhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc
Q psy11727 335 YLLHGASKTS--KYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412 (437)
Q Consensus 335 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 412 (437)
.......... .++...+.. ....+..+. ......+++||.+||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~------------------~~~s~~~~~li~~~L~ 280 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHK----------------NKVPWNRLF------------------PNADSKALDLLDKMLT 280 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCC----------------CCCCHHHHC------------------TTSCHHHHHHHHHHSC
T ss_pred hhhhhhhhhhhhcccccCCcc----------------CCCCHHHhC------------------CCCCHHHHHHHHHHcc
Confidence 6654433221 111111100 000000000 0001257899999999
Q ss_pred cCCCCCCCHHHHhcCCCcCcCC
Q psy11727 413 YDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 413 ~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
+||.+|||++|||+||||++..
T Consensus 281 ~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 281 FNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp SSTTTSCCHHHHHTSGGGTTTC
T ss_pred CChhHCcCHHHHhcCHhhccCC
Confidence 9999999999999999999754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-52 Score=395.69 Aligned_cols=280 Identities=29% Similarity=0.491 Sum_probs=218.3
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
++|++++.||+|+||+||+|++..+++.||||+++... ....++.+|+.+++.+ .|||||+++++|.+.++.
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-----~h~niv~~~~~~~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-----KHKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-----CcCCEEeeccccccccce
Confidence 68999999999999999999999999999999996433 2345666788777665 789999999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
++|+|++.+++...+.... ..+++..++.++.|++.||+|||. .|||||||||+|||+ +.++.+||+|||.|...
T Consensus 77 ~iv~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~--~~IvHrDiKP~NIli--~~~~~~kl~DFG~a~~~ 151 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHS--RNVLHRDLKPQNLLI--NRNGELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--CTTCCEEECCCTTCEEC
T ss_pred eEEeeeccccccccccccc-cccchhHHHHHHHHHHHHHHHhhc--CCEeeecccCccccc--ccCCceeeeecchhhcc
Confidence 9999999875544443332 568999999999999999999995 489999999999999 66788999999999876
Q ss_pred CCcc---ccccccccccChhhhcCCC-CCCcchHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 267 GQTL---YQYIQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPL-FSGKNEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 267 ~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~p-f~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
.... ....+++.|+|||++.+.. ++.++|||||||++|||++|+.| |.+.+..+.+.++....+.|+...++...
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 5432 3456788899999998765 68999999999999999998866 67788888889888888877765443322
Q ss_pred ccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCH
Q psy11727 342 KTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISP 421 (437)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~ 421 (437)
....+... . ..+.. .............+.|||.+||++||.+|||+
T Consensus 232 ~~~~~~~~------~----------~~~~~------------------~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa 277 (292)
T d1unla_ 232 KLPDYKPY------P----------MYPAT------------------TSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277 (292)
T ss_dssp GSTTCCCC------C----------CCCTT------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred hccccccc------c----------ccccc------------------chhhhccccCCHHHHHHHHHHccCChhHCcCH
Confidence 21111000 0 00000 00000111112367899999999999999999
Q ss_pred HHHhcCCCcCcC
Q psy11727 422 TNVLRHEFFLKH 433 (437)
Q Consensus 422 ~e~l~Hp~~~~~ 433 (437)
+|+|+||||++.
T Consensus 278 ~e~L~Hp~f~~~ 289 (292)
T d1unla_ 278 EEALQHPYFSDF 289 (292)
T ss_dssp HHHTTSGGGSSC
T ss_pred HHHhcChhhcCC
Confidence 999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=410.45 Aligned_cols=281 Identities=30% Similarity=0.568 Sum_probs=222.7
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC--
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK-- 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~-- 183 (437)
.++|++.+.||+|+||+||+|++..+|+.||||+++.... ...++.+|+.+++.+ .|+|||+++++|...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-----~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-----KHENVIGLLDVFTPARS 91 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSCSS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEeeccc
Confidence 5799999999999999999999999999999999974322 234566788888887 689999999998643
Q ss_pred ----CEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 184 ----NHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 184 ----~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
.++++++++++++|.+++... .+++..++.++.||+.||+|||++ ||+||||||+|||+ +.++.+|++|
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~--giiHrDiKp~NILi--~~~~~~kl~d 164 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA--DIIHRDLKPSNLAV--NEDCELKILD 164 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEE--CTTCCEEECC
T ss_pred cccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC--CCcccccCCccccc--cccccccccc
Confidence 345666555567899988553 599999999999999999999964 89999999999999 7788999999
Q ss_pred CCCceecCCccccccccccccChhhhcCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhhc
Q psy11727 260 FGSSCHVGQTLYQYIQSRYYRSPEVLLGIP-YDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYLLH 338 (437)
Q Consensus 260 FG~s~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 338 (437)
||+|........+..||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......+....+.++..+..
T Consensus 165 fg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 165 FGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp C----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred cchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 999998888888889999999999987764 6889999999999999999999999999999999999999998887776
Q ss_pred cCCccch--hhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 339 GASKTSK--YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 339 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
....... +...... .+.. .+.... ......++|||.+||++||.
T Consensus 245 ~~~~~~~~~~~~~~~~---------------~~~~-~~~~~~------------------~~~s~~~~dli~~mL~~dP~ 290 (348)
T d2gfsa1 245 KISSESARNYIQSLTQ---------------MPKM-NFANVF------------------IGANPLAVDLLEKMLVLDSD 290 (348)
T ss_dssp TCCCHHHHHHHTTSCC---------------CCCC-CHHHHS------------------TTCCHHHHHHHHHHSCSSGG
T ss_pred hccchhhhhhhhhccc---------------CCCc-chhhhc------------------CCCCHHHHHHHHHHCcCChh
Confidence 5443211 1111000 0000 000000 01112579999999999999
Q ss_pred CCCCHHHHhcCCCcCcCCC
Q psy11727 417 KRISPTNVLRHEFFLKHSV 435 (437)
Q Consensus 417 ~R~t~~e~l~Hp~~~~~~~ 435 (437)
+|||++|||+||||++..+
T Consensus 291 ~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 291 KRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp GSCCHHHHHTSGGGTTTCC
T ss_pred hCcCHHHHhcCHhhCCCCC
Confidence 9999999999999998653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.3e-52 Score=404.35 Aligned_cols=286 Identities=25% Similarity=0.427 Sum_probs=214.9
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC--CEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK--NHL 186 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~--~~~ 186 (437)
.++|++++.||+|+||+||+|++..+|+.||||+++.. ...++.+|+.+++.+. .||||++++++|... .++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~----~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR----GGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHT----TSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhcc----CCCCCcEEEEEEEecCCCce
Confidence 46899999999999999999999999999999999743 3467888999999885 589999999999854 579
Q ss_pred EEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 187 CLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 187 ~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
++|||||++ +|..+ .+.+++..++.++.||+.||+|||++ |||||||||+|||++. +++.+||+|||+|..
T Consensus 108 ~~v~e~~~~~~L~~~-----~~~l~e~~i~~i~~qil~aL~~LH~~--gIvHrDiKp~NILi~~-~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 108 ALVFEHVNNTDFKQL-----YQTLTDYDIRFYMYEILKALDYCHSM--GIMHRDVKPHNVMIDH-EHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEEEECCCSCBGGGT-----TTSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEET-TTTEEEECCGGGCEE
T ss_pred eEEEeecCCCcHHHH-----hcCCCHHHHHHHHHHHHHHHHHHhhc--ccccccccccceEEcC-CCCeeeeccccccee
Confidence 999999976 55433 24589999999999999999999954 8999999999999953 344699999999977
Q ss_pred cC--CccccccccccccChhhhcCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHHhCCCChhhhccCC
Q psy11727 266 VG--QTLYQYIQSRYYRSPEVLLGI-PYDLAIDMWSLGCILVELHTGEPLFSGK-NEVDQMTKIIEVLGMPPGYLLHGAS 341 (437)
Q Consensus 266 ~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~p~~~~~~~~~ 341 (437)
.. ......++|+.|+|||++.+. .++.++|||||||++|+|++|..||... +..++...+...+|.|.........
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred ccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 64 334567889999999998875 4799999999999999999999998654 4556777777777654333221111
Q ss_pred cc--chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 342 KT--SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 342 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
.. ...+. .+++......... .............++|||++||++||.+||
T Consensus 260 ~~~~~~~~~---------------------------~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 311 (328)
T d3bqca1 260 NIELDPRFN---------------------------DILGRHSRKRWER-FVHSENQHLVSPEALDFLDKLLRYDHQSRL 311 (328)
T ss_dssp TCCCCGGGG---------------------------GTCCCCCCCCGGG-GCCTTTGGGCCHHHHHHHHHHSCSSGGGSC
T ss_pred ccccCcccc---------------------------hhcccccccchhh-cccccccccCCHHHHHHHHHHccCChhHCc
Confidence 00 00000 0000000000000 000000111123689999999999999999
Q ss_pred CHHHHhcCCCcCcCCCC
Q psy11727 420 SPTNVLRHEFFLKHSVD 436 (437)
Q Consensus 420 t~~e~l~Hp~~~~~~~~ 436 (437)
|++|||+||||+.+.+|
T Consensus 312 ta~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 312 TAREAMEHPYFYTVVKD 328 (328)
T ss_dssp CHHHHHTSGGGTTSCCC
T ss_pred CHHHHhcCcccCCCCCC
Confidence 99999999999998765
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-52 Score=398.89 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=208.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.++|++.+.||+|+||+||+|.+..+++.||||+++......+++.+|+.++..+ .|||||+++++|.+.+.+++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-----CCCCEecCCccEeeCCeeEE
Confidence 4689999999999999999999999999999999986666667788999999887 68999999999999999999
Q ss_pred EEEecc-CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLS-YNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~-~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
||||++ |+|.+++.......+++..+..++.||+.||+|||++ |||||||||+|||+ +.++.+||+|||+|+...
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--~iiHrDlKp~NILl--~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLV--GENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE--CGGGCEEECCCCCTTTCC
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC--CcccCccccCeEEE--CCCCcEEEccccceeecC
Confidence 999996 5899998876667799999999999999999999964 89999999999999 678899999999998664
Q ss_pred Ccc----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 268 QTL----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGE-PLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 268 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~-~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
... ....|+..|+|||++.+..|+.++|||||||++|||++|. +||.+.+.......+......+.
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~--------- 237 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER--------- 237 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC---------
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCC---------
Confidence 332 2235788899999999999999999999999999999965 55556555544443322111000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
| ......+.+||.+||+.||.+|||++
T Consensus 238 --------------------------~---------------------------~~~~~~l~~li~~cl~~dP~~Rps~~ 264 (287)
T d1opja_ 238 --------------------------P---------------------------EGCPEKVYELMRACWQWNPSDRPSFA 264 (287)
T ss_dssp --------------------------C---------------------------TTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred --------------------------C---------------------------ccchHHHHHHHHHHcCCCHhHCcCHH
Confidence 0 00012579999999999999999999
Q ss_pred HHhc--CCCcCc
Q psy11727 423 NVLR--HEFFLK 432 (437)
Q Consensus 423 e~l~--Hp~~~~ 432 (437)
|+++ ..++++
T Consensus 265 ei~~~L~~~~~~ 276 (287)
T d1opja_ 265 EIHQAFETMFQE 276 (287)
T ss_dssp HHHHHHHHTTSS
T ss_pred HHHHHHHHHHHh
Confidence 9976 344443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.9e-52 Score=393.89 Aligned_cols=256 Identities=26% Similarity=0.410 Sum_probs=201.2
Q ss_pred ceeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcc----cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 106 EKFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKP----FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 106 ~~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~----~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
..+.++|++.+.||+|+||+||+|++..+|+.||||+++.... ....+.+|+.++..+ .|||||++++++.
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-----~hpniv~~~~~~~ 77 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-----NHPAIVAVYDTGE 77 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEE
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-----CCCCCCcccceee
Confidence 3567899999999999999999999999999999999974322 223456677777664 8999999999998
Q ss_pred ECC----EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEE
Q psy11727 182 WKN----HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIK 256 (437)
Q Consensus 182 ~~~----~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ik 256 (437)
..+ .+||||||++| +|.+++.... .+++..++.++.||+.||+|||+ .|||||||||+|||+ +.++.++
T Consensus 78 ~~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~--~~iiHrDiKP~NIll--~~~~~~~ 151 (277)
T d1o6ya_ 78 AETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ--NGIIHRDVKPANIMI--SATNAVK 151 (277)
T ss_dssp EECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH--TTEECCCCSGGGEEE--ETTSCEE
T ss_pred eccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHh--CCccCccccCccccc--Cccccce
Confidence 754 48999999976 7888877653 58999999999999999999995 489999999999999 5677899
Q ss_pred EEeCCCceecCC------ccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Q psy11727 257 IIDFGSSCHVGQ------TLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLG 330 (437)
Q Consensus 257 L~DFG~s~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 330 (437)
|+|||.+..... .....+||+.|+|||++.+..|+.++|||||||++|||+||++||.+.+..+.+.++.....
T Consensus 152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~ 231 (277)
T d1o6ya_ 152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 231 (277)
T ss_dssp ECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC
T ss_pred eehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCC
Confidence 999999865432 23456899999999999999999999999999999999999999999998888777765333
Q ss_pred CCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHc
Q psy11727 331 MPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRM 410 (437)
Q Consensus 331 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~ 410 (437)
.++....+. ....+.+||.+|
T Consensus 232 ~~~~~~~~~-----------------------------------------------------------~s~~l~~li~~~ 252 (277)
T d1o6ya_ 232 IPPSARHEG-----------------------------------------------------------LSADLDAVVLKA 252 (277)
T ss_dssp CCGGGTSSS-----------------------------------------------------------CCHHHHHHHHHH
T ss_pred CCCchhccC-----------------------------------------------------------CCHHHHHHHHHH
Confidence 222111100 002578999999
Q ss_pred cccCCCCCCCHHHHhcCCCcC
Q psy11727 411 LTYDPKKRISPTNVLRHEFFL 431 (437)
Q Consensus 411 L~~dP~~R~t~~e~l~Hp~~~ 431 (437)
|+.||.+||+..+.|.|+|++
T Consensus 253 L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 253 LAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp TCSSGGGSCSSHHHHHHHHHH
T ss_pred ccCCHhHCHhHHHHHHHHHHH
Confidence 999999999544455566653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-52 Score=389.63 Aligned_cols=245 Identities=22% Similarity=0.319 Sum_probs=199.1
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
++|++.+.||+|+||+||+|++. ++..||||+++.......++.+|+.++..+ +|||||++++++.+++.+++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-----SHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-----CCCCcccccceeccCCceEEE
Confidence 57999999999999999999876 567899999987666667788899998887 789999999999999999999
Q ss_pred EEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 190 FELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 190 ~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
|||+++ +|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||+ ++++.+||+|||+|+....
T Consensus 79 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~--~iiHrDlKp~Nill--~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLV--GENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT--TCCCTTCSGGGEEE--CGGGCEEECSCC-------
T ss_pred EEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc--ceeecccchhheee--cCCCCeEecccchheeccC
Confidence 999965 8888887654 4689999999999999999999964 79999999999999 6788999999999976543
Q ss_pred c----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 269 T----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 269 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
. .....||..|+|||++.+..|+.++|||||||++|||+| |.+||...+..+.+..+......+.+.
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~-------- 225 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR-------- 225 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCT--------
T ss_pred CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCcc--------
Confidence 2 223568899999999999999999999999999999999 678888888877777765532211100
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
.....+.+||.+||+.||.+|||++|
T Consensus 226 ------------------------------------------------------~~~~~l~~li~~cl~~~p~~Rps~~~ 251 (263)
T d1sm2a_ 226 ------------------------------------------------------LASTHVYQIMNHCWKERPEDRPAFSR 251 (263)
T ss_dssp ------------------------------------------------------TSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ------------------------------------------------------ccCHHHHHHHHHHccCCHhHCcCHHH
Confidence 00125789999999999999999999
Q ss_pred HhcC
Q psy11727 424 VLRH 427 (437)
Q Consensus 424 ~l~H 427 (437)
+++|
T Consensus 252 il~~ 255 (263)
T d1sm2a_ 252 LLRQ 255 (263)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=395.11 Aligned_cols=251 Identities=20% Similarity=0.308 Sum_probs=207.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.++|++.+.||+|+||+||+|..+ ++..||||+++......+.+.+|+.++..+ .|||||++++++.+ +.+++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-----QHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhC-----CCCCEeEEEeeecc-CCeEE
Confidence 468999999999999999999875 578899999986666667788999999887 68999999998764 56789
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
||||+++ +|.+++.......+++..+..++.||+.||+|||++ ||+||||||+|||| ++++.+||+|||+|+...
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~--~ivHrDiKp~NIll--~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--NYIHRDLRAANILV--SDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE--CTTSCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCccchhheee--ecccceeeccccceEEcc
Confidence 9999965 788877655444689999999999999999999964 79999999999999 778899999999998764
Q ss_pred Ccc----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 268 QTL----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 268 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
... ....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+.+..+......+...
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~------- 233 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD------- 233 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT-------
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcc-------
Confidence 322 23567889999999998899999999999999999999 567778777777666664321111000
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
.....+.+||.+||+.||++|||++
T Consensus 234 -------------------------------------------------------~~~~~l~~li~~cl~~~P~~Rpt~~ 258 (272)
T d1qpca_ 234 -------------------------------------------------------NCPEELYQLMRLCWKERPEDRPTFD 258 (272)
T ss_dssp -------------------------------------------------------TCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred -------------------------------------------------------cChHHHHHHHHHHcCCCHhHCcCHH
Confidence 0012578999999999999999999
Q ss_pred HHhc--CCCcCc
Q psy11727 423 NVLR--HEFFLK 432 (437)
Q Consensus 423 e~l~--Hp~~~~ 432 (437)
|+++ |+||+.
T Consensus 259 ei~~~L~~~fts 270 (272)
T d1qpca_ 259 YLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHhhhhhhc
Confidence 9998 899874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=386.26 Aligned_cols=245 Identities=21% Similarity=0.298 Sum_probs=207.8
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLV 189 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV 189 (437)
++|++.+.||+|+||+||+|+.+ ++..||||+++......+.+.+|+.++..+ .|||||+++++|.+++.+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-----~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-----SHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTC-----CCTTBCCEEEEECCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhc-----CCCceeeEEEEEeeCCceEEE
Confidence 57889999999999999999974 788999999987666667788899888877 789999999999999999999
Q ss_pred EEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCC
Q psy11727 190 FELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQ 268 (437)
Q Consensus 190 ~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~ 268 (437)
|||+++ +|.+++.... ..+++..+..++.||+.||+|||++ ||+||||||+|||+ ++++.+||+|||+|+....
T Consensus 78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~--~iiH~dlk~~Nill--~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK--QFLHRDLAARNCLV--NDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT--TBCCSCCSGGGEEE--CTTCCEEECCCSSCCBCSS
T ss_pred EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhc--CcccccccceeEEE--cCCCcEEECcchhheeccC
Confidence 999965 6777766554 4589999999999999999999964 89999999999999 6788999999999976533
Q ss_pred c----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCcc
Q psy11727 269 T----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKT 343 (437)
Q Consensus 269 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 343 (437)
. .....||..|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..+....+......+.+..
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~------- 225 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL------- 225 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTT-------
T ss_pred CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCccc-------
Confidence 2 223568899999999999999999999999999999998 8999999998888777754322211100
Q ss_pred chhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHH
Q psy11727 344 SKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTN 423 (437)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e 423 (437)
....+.+||.+||+.||.+|||+++
T Consensus 226 -------------------------------------------------------~~~~l~~li~~cl~~dP~~RPt~~e 250 (258)
T d1k2pa_ 226 -------------------------------------------------------ASEKVYTIMYSCWHEKADERPTFKI 250 (258)
T ss_dssp -------------------------------------------------------CCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred -------------------------------------------------------ccHHHHHHHHHHccCCHhHCcCHHH
Confidence 0025789999999999999999999
Q ss_pred HhcC
Q psy11727 424 VLRH 427 (437)
Q Consensus 424 ~l~H 427 (437)
+++|
T Consensus 251 il~~ 254 (258)
T d1k2pa_ 251 LLSN 254 (258)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-50 Score=399.62 Aligned_cols=311 Identities=32% Similarity=0.525 Sum_probs=242.1
Q ss_pred eecCceec-cCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCC------CCCcEE
Q psy11727 102 IKHGEKFL-DRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADI------HSRYIV 174 (437)
Q Consensus 102 ~~~~~~~~-~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~------~h~~iv 174 (437)
+..|+.|. +||++++.||+|+||+||+|++..+|+.||||+++......+...+|+.+++.+.+.+. .|+|||
T Consensus 4 ~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv 83 (362)
T d1q8ya_ 4 AFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 83 (362)
T ss_dssp CCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence 34577776 46999999999999999999999999999999998665556778889999999987654 478999
Q ss_pred EecceeeE--CCEEEEEEEeccC--cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC
Q psy11727 175 KLKGHFTW--KNHLCLVFELLSY--NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP 250 (437)
Q Consensus 175 ~l~~~~~~--~~~~~lV~E~~~~--~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~ 250 (437)
++++++.. ....+++|+++.. +............+++..++.++.||+.||+|||+. .||+||||||+|||+..+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~-~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECSCCSGGGEEEEEE
T ss_pred EEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh-cCcccccCChhHeeeecc
Confidence 99999864 4577777777643 455555555556799999999999999999999963 589999999999999543
Q ss_pred CC----CCEEEEeCCCceecCCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC------HHH
Q psy11727 251 KR----SAIKIIDFGSSCHVGQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN------EVD 320 (437)
Q Consensus 251 ~~----~~ikL~DFG~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~------~~~ 320 (437)
.. ..++++|||.|..........+||+.|+|||++.+..|+.++|+||+||++++|++|++||...+ ..+
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcccccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 32 23999999999988877778899999999999999999999999999999999999999997543 446
Q ss_pred HHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhh
Q psy11727 321 QMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADY 400 (437)
Q Consensus 321 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (437)
.+..++..+|.++..++........+|+........ .......+...+. .....+....
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~-----------~~~~~~~~~~ 301 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNI----------SKLKFWPLEDVLT-----------EKYKFSKDEA 301 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSC----------CCCCBCCHHHHHH-----------HTTCCCHHHH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhcc----------ccccCCchhhhcc-----------cccccCcccC
Confidence 678888899999999988777766666543211100 0000001111111 0122344556
Q ss_pred hHHHHHHHHccccCCCCCCCHHHHhcCCCcCcCC
Q psy11727 401 MKFKDLILRMLTYDPKKRISPTNVLRHEFFLKHS 434 (437)
Q Consensus 401 ~~~~dli~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 434 (437)
..++|||.+||++||.+|||++|||+||||++..
T Consensus 302 ~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 302 KEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp HHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 6899999999999999999999999999999653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=396.34 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=201.8
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCe-----EEEEEEecCC--cccchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKC-----QVAIKIIKNK--KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~-----~vaiK~i~~~--~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|++.++||+|+||+||+|++..+++ .||+|.+... ......+.+|+.++..+. .|||||+++++|.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG----SHENIVNLLGACT 111 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHC----CCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhc----CCCcEeEEEEEEe
Confidence 3689999999999999999999876543 6999998643 233456777888888774 6899999999999
Q ss_pred ECCEEEEEEEeccC-cHHHHHHhcC---------------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCC
Q psy11727 182 WKNHLCLVFELLSY-NLYNLIRNTN---------------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCD 239 (437)
Q Consensus 182 ~~~~~~lV~E~~~~-~L~~~l~~~~---------------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrD 239 (437)
+.+.+++|||||++ +|.+++.... ...+++..++.|+.||+.||+|||++ ||||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~--~IiHRD 189 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRD 189 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT--TEEETT
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC--Ceeecc
Confidence 99999999999954 8999987643 13489999999999999999999964 899999
Q ss_pred CCCCcEEEecCCCCCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q psy11727 240 LKPENILLCSPKRSAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLF 313 (437)
Q Consensus 240 iKp~NIll~~~~~~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf 313 (437)
|||+|||+ +.++.+||+|||+|+..... ..+..||+.|+|||++.+..|+.++|||||||++|||+| |++||
T Consensus 190 lKp~Nill--~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 190 LAARNVLV--THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp CSGGGEEE--ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred Cchhcccc--ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99999999 67889999999999765332 224567999999999999999999999999999999998 89999
Q ss_pred CCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCC
Q psy11727 314 SGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEP 393 (437)
Q Consensus 314 ~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (437)
.+.+....+.+++..-..++. |
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~----------------------------------p------------------------ 289 (325)
T d1rjba_ 268 PGIPVDANFYKLIQNGFKMDQ----------------------------------P------------------------ 289 (325)
T ss_dssp TTCCCSHHHHHHHHTTCCCCC----------------------------------C------------------------
T ss_pred CCCCHHHHHHHHHhcCCCCCC----------------------------------C------------------------
Confidence 987766666665542111100 0
Q ss_pred CCChhhhhHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 394 GHSLADYMKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 394 ~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
. .....+.+||.+||+.||++|||++|+++|
T Consensus 290 ~---~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 290 F---YATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C---cCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0 001257999999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.3e-51 Score=390.72 Aligned_cols=247 Identities=19% Similarity=0.302 Sum_probs=192.6
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCe---EEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKC---QVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~---~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.++|++.++||+|+||+||+|.++.+++ .||||.+..... ....+.+|+.++..+ .|||||++++++.+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-----DHPNVIHLEGVVTKS 99 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-----CCCCCccEEEEEeeC
Confidence 4679999999999999999999877654 589998864322 234566777777665 799999999999999
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+.+++|||||++ +|.+++.... ..+++..+..++.||+.||+|||++ |||||||||+|||| +.++.+||+|||+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~--~iiHrDlKp~NILl--~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADM--NYVHRDLAARNILV--NSNLVCKVSDFGL 174 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEE--CTTCCEEECCC--
T ss_pred CEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhC--CCccCccccceEEE--CCCCcEEECCccc
Confidence 999999999976 6877776543 4699999999999999999999964 89999999999999 7788999999999
Q ss_pred ceecCCcc--------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Q psy11727 263 SCHVGQTL--------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPP 333 (437)
Q Consensus 263 s~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~ 333 (437)
|+...... ....||+.|+|||++.+..|+.++|||||||++|||+| |++||.+.+..+.+..+......|+
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 254 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP 254 (299)
T ss_dssp ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 97653321 12456889999999999999999999999999999998 8999999988877777654322221
Q ss_pred hhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
.. .....+.+||.+||+.
T Consensus 255 ~~--------------------------------------------------------------~~~~~l~~li~~cl~~ 272 (299)
T d1jpaa_ 255 PM--------------------------------------------------------------DCPSALHQLMLDCWQK 272 (299)
T ss_dssp CT--------------------------------------------------------------TCCHHHHHHHHHHTCS
T ss_pred Cc--------------------------------------------------------------cchHHHHHHHHHHcCC
Confidence 10 0012578999999999
Q ss_pred CCCCCCCHHHHhcC
Q psy11727 414 DPKKRISPTNVLRH 427 (437)
Q Consensus 414 dP~~R~t~~e~l~H 427 (437)
||.+|||+.|++++
T Consensus 273 ~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 273 DRNHRPKFGQIVNT 286 (299)
T ss_dssp STTTSCCHHHHHHH
T ss_pred CHhHCcCHHHHHHH
Confidence 99999999988764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-51 Score=386.89 Aligned_cols=248 Identities=26% Similarity=0.333 Sum_probs=193.8
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc---ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK---PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~---~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
.++|++.+.||+|+||+||+|+.. ..||||+++... .....+.+|+.++..+ +|||||++++++. .+.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-----RHVNILLFMGYST-APQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-----CCTTBCCEEEEEC-SSS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCCCEeeeeEEEe-ccE
Confidence 467999999999999999999643 359999996432 2234566677777665 7999999999765 456
Q ss_pred EEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCce
Q psy11727 186 LCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSC 264 (437)
Q Consensus 186 ~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~ 264 (437)
++||||||++ +|.+++.... ..+++..+..|+.||+.||+|||++ |||||||||+|||+ +.++.+||+|||+|+
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~--~ivHrDlKp~NiLl--~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK--SIIHRDLKSNNIFL--HEDLTVKIGDFGLAT 152 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEE--ETTSSEEECCCCCSC
T ss_pred EEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcC--CEeccccCHHHEEE--cCCCCEEEcccccee
Confidence 8999999964 8999987654 4599999999999999999999964 89999999999999 668899999999997
Q ss_pred ecCC-----ccccccccccccChhhhcCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 265 HVGQ-----TLYQYIQSRYYRSPEVLLGI---PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 265 ~~~~-----~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
.... ...+..||+.|+|||++.+. .|+.++|||||||++|||+||+.||.+.+....+..++.....+|...
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 232 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 232 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGG
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcch
Confidence 6532 22346789999999999753 589999999999999999999999998877666655554322222100
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
... ......+.+||.+||+.||.
T Consensus 233 ------------~~~---------------------------------------------~~~~~~l~~li~~cl~~dp~ 255 (276)
T d1uwha_ 233 ------------KVR---------------------------------------------SNCPKAMKRLMAECLKKKRD 255 (276)
T ss_dssp ------------GSC---------------------------------------------TTCCHHHHHHHHHHTCSSGG
T ss_pred ------------hcc---------------------------------------------ccchHHHHHHHHHHcCCCHh
Confidence 000 00012578999999999999
Q ss_pred CCCCHHHHhcC
Q psy11727 417 KRISPTNVLRH 427 (437)
Q Consensus 417 ~R~t~~e~l~H 427 (437)
+|||++|+++|
T Consensus 256 ~RPt~~~il~~ 266 (276)
T d1uwha_ 256 ERPLFPQILAS 266 (276)
T ss_dssp GSCCHHHHHHH
T ss_pred HCcCHHHHHHH
Confidence 99999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-51 Score=394.57 Aligned_cols=258 Identities=28% Similarity=0.447 Sum_probs=208.7
Q ss_pred ccCeeeeceecccCceEEEEEEE---cCCCeEEEEEEecCCc-----ccchHHHHHHHHHHHhhhcCCCCCcEEEeccee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFD---HEEKCQVAIKIIKNKK-----PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHF 180 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~---~~~~~~vaiK~i~~~~-----~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~ 180 (437)
.++|++.+.||+|+||+||+|++ +.+|+.||||+++... .....+.+|+.+++++. +||||+++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~----h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR----QSPFLVTLHYAF 98 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH----TCTTBCCEEEEE
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhcc----CCCeEEEeeeee
Confidence 47899999999999999999987 4478999999986432 23456778999999996 457999999999
Q ss_pred eECCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEe
Q psy11727 181 TWKNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIID 259 (437)
Q Consensus 181 ~~~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~D 259 (437)
.+.+.+++||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .|||||||||+|||+ +.++.+||+|
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~--~~ivHrDiKp~Nill--~~~~~vkL~D 172 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK--LGIIYRDIKLENILL--DSNGHVVLTD 172 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCGGGEEE--CTTSCEEESC
T ss_pred ccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhc--CCEEeccCCccceee--cCCCCEEEee
Confidence 999999999999965 8999887764 47899999999999999999995 479999999999999 6788999999
Q ss_pred CCCceecCCc----cccccccccccChhhhcCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Q psy11727 260 FGSSCHVGQT----LYQYIQSRYYRSPEVLLGI--PYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEVLGMPP 333 (437)
Q Consensus 260 FG~s~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~p~ 333 (437)
||+|...... ..+..|++.|+|||.+.+. .++.++|||||||+||+|++|++||.+.+..+....+......+.
T Consensus 173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~ 252 (322)
T d1vzoa_ 173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 252 (322)
T ss_dssp SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred ccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC
Confidence 9999765332 3356789999999999765 467899999999999999999999988776655555544211000
Q ss_pred hhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHcccc
Q psy11727 334 GYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTY 413 (437)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~ 413 (437)
. ..| ......+.+||.+||++
T Consensus 253 ~--------------------------------~~~---------------------------~~~s~~~~~li~~~l~~ 273 (322)
T d1vzoa_ 253 P--------------------------------PYP---------------------------QEMSALAKDLIQRLLMK 273 (322)
T ss_dssp C--------------------------------CCC---------------------------TTSCHHHHHHHHHHTCS
T ss_pred C--------------------------------CCc---------------------------ccCCHHHHHHHHHHccc
Confidence 0 000 00012679999999999
Q ss_pred CCCCCC-----CHHHHhcCCCcCcCCC
Q psy11727 414 DPKKRI-----SPTNVLRHEFFLKHSV 435 (437)
Q Consensus 414 dP~~R~-----t~~e~l~Hp~~~~~~~ 435 (437)
||.+|| |++|+++||||++..+
T Consensus 274 dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 274 DPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp SGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred CHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 999999 5899999999998653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=385.59 Aligned_cols=249 Identities=23% Similarity=0.318 Sum_probs=200.9
Q ss_pred cCeeeece-ecccCceEEEEEEEcC--CCeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC
Q psy11727 110 DRYEIDTL-LGKGSFGQVVKAFDHE--EKCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN 184 (437)
Q Consensus 110 ~~y~i~~~-lG~G~fg~V~~~~~~~--~~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~ 184 (437)
++|.+.+. ||+|+||+||+|.++. ++..||||+++... .....+.+|+.++..+ .|||||++++++.+ +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-----DNPYIVRLIGVCQA-E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEES-S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-----CCCCEeeEeeeecc-C
Confidence 56888885 9999999999997754 45689999997432 2235677788888876 78999999999865 5
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCc
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSS 263 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s 263 (437)
.+|||||||++ +|.+++.... ..+++..+..++.||+.||+|||++ |||||||||+|||+ +.++.+||+|||+|
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~--~iiHrDlKp~Nill--~~~~~~Kl~DFGla 156 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK--NFVHRDLAARNVLL--VNRHYAKISDFGLS 156 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEE--EETTEEEECCCTTC
T ss_pred eEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhC--CeecCcCchhheee--ccCCceeeccchhh
Confidence 68999999976 7888876543 4699999999999999999999964 89999999999999 56788999999999
Q ss_pred eecCCcc------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 264 CHVGQTL------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 264 ~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
+...... ....||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..+....+......+..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p-- 234 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP-- 234 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC--
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC--
Confidence 8764321 23467899999999999899999999999999999998 99999998877777666442211100
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
+. -...+.+||.+||+.||+
T Consensus 235 --------------------------------------------------------~~----~~~~l~~li~~cl~~~p~ 254 (285)
T d1u59a_ 235 --------------------------------------------------------PE----CPPELYALMSDCWIYKWE 254 (285)
T ss_dssp --------------------------------------------------------TT----CCHHHHHHHHHTTCSSGG
T ss_pred --------------------------------------------------------Cc----CCHHHHHHHHHHcCCCHh
Confidence 00 012578999999999999
Q ss_pred CCCCHHHH---hcCCCcC
Q psy11727 417 KRISPTNV---LRHEFFL 431 (437)
Q Consensus 417 ~R~t~~e~---l~Hp~~~ 431 (437)
+|||+.++ |+|+|+.
T Consensus 255 ~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 255 DRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp GSCCHHHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHHHH
Confidence 99999887 6788873
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=385.34 Aligned_cols=252 Identities=21% Similarity=0.307 Sum_probs=203.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCL 188 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~l 188 (437)
.++|++.+.||+|+||+||+|++..+ ..||||+++......+.+.+|+.++..+ +|+|||++++++.+ +.+++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l-----~h~nIv~~~g~~~~-~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEKLVQLYAVVSE-EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECS-SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhc-----ccCCEeEEEEEEec-CCeEE
Confidence 46899999999999999999998765 5799999986665567788899998887 78999999999865 55789
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
||||+.+ +|..++.......+++..++.++.||+.||+|||++ ||+||||||+|||| ++++.+||+|||+|+...
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~--~ivH~DlKp~NIll--~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILV--GENLVCKVADFGLARLIE 164 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE--CGGGCEEECCCCTTC---
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh--heecccccceEEEE--CCCCcEEEcccchhhhcc
Confidence 9999965 677777655445699999999999999999999964 89999999999999 678899999999997653
Q ss_pred Cc----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 268 QT----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTG-EPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 268 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
.. .....||+.|+|||++.+..++.++|||||||++|||++| .+||.+.+..+.+..+......|...
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~------- 237 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP------- 237 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT-------
T ss_pred CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc-------
Confidence 22 2235689999999999999999999999999999999994 67777777777766664322111100
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
.....+.+||.+||+.||++|||++
T Consensus 238 -------------------------------------------------------~~~~~l~~li~~cl~~dP~~Rps~~ 262 (285)
T d1fmka3 238 -------------------------------------------------------ECPESLHDLMCQCWRKEPEERPTFE 262 (285)
T ss_dssp -------------------------------------------------------TSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred -------------------------------------------------------ccCHHHHHHHHHHcccCHhHCcCHH
Confidence 0012679999999999999999999
Q ss_pred HHhc--CCCcCcC
Q psy11727 423 NVLR--HEFFLKH 433 (437)
Q Consensus 423 e~l~--Hp~~~~~ 433 (437)
++++ |+||+..
T Consensus 263 ~i~~~L~~~~~~~ 275 (285)
T d1fmka3 263 YLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHHHTTTSCS
T ss_pred HHHHHHhhhhcCC
Confidence 9988 9999764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=382.08 Aligned_cols=242 Identities=24% Similarity=0.350 Sum_probs=192.2
Q ss_pred ceecccCceEEEEEEEc--CCCeEEEEEEecCCcc---cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEE
Q psy11727 116 TLLGKGSFGQVVKAFDH--EEKCQVAIKIIKNKKP---FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVF 190 (437)
Q Consensus 116 ~~lG~G~fg~V~~~~~~--~~~~~vaiK~i~~~~~---~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~ 190 (437)
+.||+|+||+||+|... .+++.||||+++.... ..+++.+|+.++..+ .|||||++++++.. +..+|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~g~~~~-~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-----DNPYIVRMIGICEA-ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEES-SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-----CCCCCceEEEEecc-CCEEEEE
Confidence 47999999999999754 4567899999964322 234567788888766 79999999999865 4578999
Q ss_pred EeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecCCc
Q psy11727 191 ELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVGQT 269 (437)
Q Consensus 191 E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~~~ 269 (437)
||+++ +|.+++... ..+++..+..++.||+.||+|||++ |||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 87 E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~--~iiHrDlKp~Nill--~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 87 EMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNVLL--VTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp ECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE--EETTEEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhC--CcccCCCcchhhcc--cccCcccccchhhhhhcccc
Confidence 99965 798888765 3599999999999999999999964 79999999999999 56788999999999765332
Q ss_pred c------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCc
Q psy11727 270 L------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASK 342 (437)
Q Consensus 270 ~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 342 (437)
. ....||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..+....+......+.+
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p-------- 232 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP-------- 232 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC--------
T ss_pred ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC--------
Confidence 1 23468899999999999999999999999999999998 89999998887766665432111100
Q ss_pred cchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHH
Q psy11727 343 TSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPT 422 (437)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~ 422 (437)
.. -...+.+||.+||+.||.+|||+.
T Consensus 233 --------------------------------------------------~~----~~~~~~~li~~cl~~dp~~RPs~~ 258 (277)
T d1xbba_ 233 --------------------------------------------------AG----CPREMYDLMNLCWTYDVENRPGFA 258 (277)
T ss_dssp --------------------------------------------------TT----CCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred --------------------------------------------------cc----cCHHHHHHHHHHcCCCHhHCcCHH
Confidence 00 012578999999999999999999
Q ss_pred HH---hcCCCcC
Q psy11727 423 NV---LRHEFFL 431 (437)
Q Consensus 423 e~---l~Hp~~~ 431 (437)
++ |+|+|+.
T Consensus 259 ~i~~~L~~~~~~ 270 (277)
T d1xbba_ 259 AVELRLRNYYYD 270 (277)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHhhCHHhh
Confidence 98 5676653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=374.80 Aligned_cols=246 Identities=19% Similarity=0.265 Sum_probs=191.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCC----eEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEK----CQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~----~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
.+.|++.++||+|+||+||+|....++ ..||||++..... ...++.+|+.++..+ .|||||++++++.+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-----~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-----SHHNIIRLEGVISK 80 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEECS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-----CCCCEeeeeEEEec
Confidence 457999999999999999999877654 4799999964322 223456778777766 78999999999999
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
.+..++||||+.+ ++.+.+.... ..+++..+..++.||+.||+|||++ +|+||||||+|||| +.++.+||+|||
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~--~iiHrDlKp~NILl--~~~~~~Kl~DFG 155 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM--NYVHRDLAARNILV--NSNLVCKVSDFG 155 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEE--CTTCCEEECCCC
T ss_pred CCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccc--ccccCccccceEEE--CCCCeEEEcccc
Confidence 9999999999976 5666665543 5699999999999999999999964 79999999999999 778899999999
Q ss_pred CceecCCc------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 262 SSCHVGQT------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTG-EPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 262 ~s~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg-~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
+|+..... .....||+.|+|||++.+..++.++|||||||++|||++| .+||.+.+..+.+..+.+....+..
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~ 235 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 235 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCc
Confidence 99765322 1234578999999999999999999999999999999995 5667777766666555432211110
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
. .....+.+||.+||+.|
T Consensus 236 ~--------------------------------------------------------------~~~~~l~~li~~cl~~~ 253 (283)
T d1mqba_ 236 M--------------------------------------------------------------DCPSAIYQLMMQCWQQE 253 (283)
T ss_dssp T--------------------------------------------------------------TCBHHHHHHHHHHTCSS
T ss_pred h--------------------------------------------------------------hhHHHHHHHHHHHCcCC
Confidence 0 00125789999999999
Q ss_pred CCCCCCHHHHhc
Q psy11727 415 PKKRISPTNVLR 426 (437)
Q Consensus 415 P~~R~t~~e~l~ 426 (437)
|.+|||+.|+++
T Consensus 254 p~~RPt~~eil~ 265 (283)
T d1mqba_ 254 RARRPKFADIVS 265 (283)
T ss_dssp TTTSCCHHHHHH
T ss_pred HhHCcCHHHHHH
Confidence 999999999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=382.93 Aligned_cols=245 Identities=19% Similarity=0.270 Sum_probs=194.6
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCe----EEEEEEecCC--cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKC----QVAIKIIKNK--KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~----~vaiK~i~~~--~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
++|++.++||+|+||+||+|.+..+|+ .||+|.++.. ......+.+|+.++..+ +|||||+++++|.++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-----DNPHVCRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-----CCTTBCCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEecC
Confidence 469999999999999999999988776 5888888633 23345678899998887 789999999999876
Q ss_pred CEEEEEEEec-cCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELL-SYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~-~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+ .+++||++ +++|.+.+.... ..+++..++.++.||+.||+|||++ |||||||||+|||+ +.++.+||+|||+
T Consensus 84 ~-~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~--~iiHrDlKp~NIll--~~~~~~kl~DFGl 157 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAARNVLV--KTPQHVKITDFGL 157 (317)
T ss_dssp S-EEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEE--EETTEEEECCCSH
T ss_pred C-eeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHc--CcccCcchhhccee--CCCCCeEeecccc
Confidence 5 45666666 568988877654 5699999999999999999999965 79999999999999 5678899999999
Q ss_pred ceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhh
Q psy11727 263 SCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYL 336 (437)
Q Consensus 263 s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~ 336 (437)
|+..... .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..+....+......+...
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~- 236 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP- 236 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCT-
T ss_pred ceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc-
Confidence 9765332 223467999999999999999999999999999999999 899999888776666554432211100
Q ss_pred hccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCC
Q psy11727 337 LHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPK 416 (437)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~ 416 (437)
.....+.+||.+||+.||.
T Consensus 237 -------------------------------------------------------------~~~~~~~~li~~cl~~dP~ 255 (317)
T d1xkka_ 237 -------------------------------------------------------------ICTIDVYMIMVKCWMIDAD 255 (317)
T ss_dssp -------------------------------------------------------------TBCHHHHHHHHHHTCSSGG
T ss_pred -------------------------------------------------------------ccCHHHHHHHHHhCCCChh
Confidence 0012578999999999999
Q ss_pred CCCCHHHHhcC
Q psy11727 417 KRISPTNVLRH 427 (437)
Q Consensus 417 ~R~t~~e~l~H 427 (437)
+|||+.|+++|
T Consensus 256 ~RPs~~eil~~ 266 (317)
T d1xkka_ 256 SRPKFRELIIE 266 (317)
T ss_dssp GSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-48 Score=374.46 Aligned_cols=258 Identities=23% Similarity=0.285 Sum_probs=203.1
Q ss_pred eccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 108 FLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 108 ~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
+.++|++.+.||+|+||+||+|++..+|+.||||++... ....++..|+.+++.+. +|++|+.+.+++.+.+..+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~E~~i~~~l~----~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-TKHPQLHIESKIYKMMQ----GGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC-TTSCCHHHHHHHHHHST----TSTTCCCEEEEEEETTEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchh-ccCHHHHHHHHHHHHcc----CCCcccEEEEEEecCCEEE
Confidence 346899999999999999999999999999999998754 33456788999998875 3456777788888999999
Q ss_pred EEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEec-CCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCS-PKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~-~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++++.+.+.... ..+++..+..++.|++.||+|||++ |||||||||+|||++. +.+..+||+|||+|+..
T Consensus 80 ivme~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~--~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 80 MVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEcCCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHC--CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 999999999888776544 5699999999999999999999964 8999999999999853 23557999999999875
Q ss_pred CCc----------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH----hCCC
Q psy11727 267 GQT----------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKNEVDQMTKIIEV----LGMP 332 (437)
Q Consensus 267 ~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~~~~~~~~i~~~----~~~p 332 (437)
... ....+||+.|+|||++.+..++.++|||||||++|||+||++||.+.........+... ...|
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 321 23457999999999999999999999999999999999999999887655444333221 1111
Q ss_pred ChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccc
Q psy11727 333 PGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLT 412 (437)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~ 412 (437)
+....+.. ...+.+||.+||+
T Consensus 237 ~~~~~~~~-----------------------------------------------------------p~~~~~li~~cl~ 257 (299)
T d1ckia_ 237 IEVLCKGY-----------------------------------------------------------PSEFATYLNFCRS 257 (299)
T ss_dssp HHHHTTTS-----------------------------------------------------------CHHHHHHHHHHHH
T ss_pred hhHhccCC-----------------------------------------------------------CHHHHHHHHHHcc
Confidence 11111100 0157899999999
Q ss_pred cCCCCCCCHH---HHhcCCCcCc
Q psy11727 413 YDPKKRISPT---NVLRHEFFLK 432 (437)
Q Consensus 413 ~dP~~R~t~~---e~l~Hp~~~~ 432 (437)
.||.+|||++ ++|+|+|.++
T Consensus 258 ~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 258 LRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp SCTTCCCCHHHHHHHHHHHHHHH
T ss_pred CChhHCcCHHHHHHHHHHHHHHc
Confidence 9999999976 5578887654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-50 Score=375.01 Aligned_cols=245 Identities=22% Similarity=0.311 Sum_probs=192.9
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE-CCEEE
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW-KNHLC 187 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~-~~~~~ 187 (437)
.++|++.+.||+|+||.||+|.. +|..||||+++. ....+.+.+|+.+++.+ +|||||++++++.+ .+.++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~-~~~~~~~~~E~~~l~~l-----~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN-DATAQAFLAEASVMTQL-----RHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCC-CC--HHHHHTHHHHTTC-----CCTTBCCEEEEECCC--CCE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECc-HHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEecCCcEE
Confidence 46799999999999999999987 477899999974 34456778888887765 79999999998854 46789
Q ss_pred EEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceec
Q psy11727 188 LVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHV 266 (437)
Q Consensus 188 lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~ 266 (437)
+||||+++ +|.+++.......+++..++.++.||+.||+|||++ +||||||||+|||+ +.++.+||+|||++...
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~--~ivH~dlkp~Nil~--~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE--CTTSCEEECCCCC----
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC--ceeccccchHhhee--cCCCCEeecccccceec
Confidence 99999965 899998765444589999999999999999999964 89999999999999 77889999999999887
Q ss_pred CCccccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhhccCCccch
Q psy11727 267 GQTLYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSK 345 (437)
Q Consensus 267 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 345 (437)
........++..|+|||++.+..++.++|||||||++|||+| |++||.+.+..+....+......+.
T Consensus 154 ~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~------------ 221 (262)
T d1byga_ 154 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA------------ 221 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC------------
T ss_pred CCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC------------
Confidence 776667788999999999999999999999999999999998 7999998877766666532111000
Q ss_pred hhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCCCHHHHh
Q psy11727 346 YFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRISPTNVL 425 (437)
Q Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l 425 (437)
| ......+.+||++||+.||.+|||+.+++
T Consensus 222 -----------------------~---------------------------~~~~~~~~~li~~cl~~dP~~Rps~~~l~ 251 (262)
T d1byga_ 222 -----------------------P---------------------------DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251 (262)
T ss_dssp -----------------------C---------------------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred -----------------------C---------------------------ccCCHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 0 00012578999999999999999999998
Q ss_pred cC
Q psy11727 426 RH 427 (437)
Q Consensus 426 ~H 427 (437)
++
T Consensus 252 ~~ 253 (262)
T d1byga_ 252 EQ 253 (262)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=375.49 Aligned_cols=246 Identities=25% Similarity=0.355 Sum_probs=190.4
Q ss_pred ccCeeeeceecccCceEEEEEEEcCC---CeEEEEEEecCCc--ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeEC
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEE---KCQVAIKIIKNKK--PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWK 183 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~---~~~vaiK~i~~~~--~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~ 183 (437)
.++|++.+.||+|+||+||+|++..+ +..||||.++... .....+.+|+.++..+ .|||||++++++. .
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-----DHPHIVKLIGVIT-E 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEC-S
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEe-c
Confidence 46899999999999999999988654 4568999986432 2234466677777665 7999999999986 4
Q ss_pred CEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCC
Q psy11727 184 NHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGS 262 (437)
Q Consensus 184 ~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~ 262 (437)
+.+++||||+++ +|.+++.... ..+++..++.++.||+.||+|||++ |||||||||+||++ +.++.+||+|||+
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~--~iiHrDlKp~NIll--~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK--RFVHRDIAARNVLV--SSNDCVKLGDFGL 154 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE--EETTEEEECC---
T ss_pred CeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhccc--Ceeccccchhheee--cCCCcEEEccchh
Confidence 678999999976 6777766543 5699999999999999999999964 79999999999999 5678899999999
Q ss_pred ceecCCc----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhhh
Q psy11727 263 SCHVGQT----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPGYLL 337 (437)
Q Consensus 263 s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 337 (437)
|+..... .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||.+.+..+.+..+......+..
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~--- 231 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP--- 231 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC---
T ss_pred heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC---
Confidence 9765432 234567899999999999999999999999999999998 89999998888777776542211100
Q ss_pred ccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCC
Q psy11727 338 HGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKK 417 (437)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~ 417 (437)
+ .-...+.+||.+||+.||.+
T Consensus 232 -------------------------------------------------------~----~~~~~~~~li~~cl~~dp~~ 252 (273)
T d1mp8a_ 232 -------------------------------------------------------P----NCPPTLYSLMTKCWAYDPSR 252 (273)
T ss_dssp -------------------------------------------------------T----TCCHHHHHHHHHHTCSSGGG
T ss_pred -------------------------------------------------------C----CCCHHHHHHHHHHcCCCHhH
Confidence 0 00125799999999999999
Q ss_pred CCCHHHHhcC
Q psy11727 418 RISPTNVLRH 427 (437)
Q Consensus 418 R~t~~e~l~H 427 (437)
|||++|+++|
T Consensus 253 Rps~~ei~~~ 262 (273)
T d1mp8a_ 253 RPRFTELKAQ 262 (273)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=373.66 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=188.0
Q ss_pred ccCeeeeceecccCceEEEEEEEcC-----CCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHE-----EKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|++.+.||+|+||+||+|.+.. +++.||||+++.... ....+..|..++..+. +|+|||.+++++.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~----~h~~iv~~~~~~~ 87 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG----HHLNVVNLLGACT 87 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHC----CCTTBCCEEEEEC
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhc----CCCeEEEeeeeec
Confidence 3689999999999999999998754 457899999864321 2234445556655553 6889999999876
Q ss_pred EC-CEEEEEEEecc-CcHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcE
Q psy11727 182 WK-NHLCLVFELLS-YNLYNLIRNTN--------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENI 245 (437)
Q Consensus 182 ~~-~~~~lV~E~~~-~~L~~~l~~~~--------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NI 245 (437)
.. +.+++|||||+ |+|.+++.... ...+++..+..++.||+.||+|||++ |||||||||+||
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~--~ivHrDlKp~NI 165 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNI 165 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC--CCcCCcCCccce
Confidence 54 57899999996 58999886532 23489999999999999999999964 799999999999
Q ss_pred EEecCCCCCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCHH
Q psy11727 246 LLCSPKRSAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTG-EPLFSGKNEV 319 (437)
Q Consensus 246 ll~~~~~~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg-~~pf~~~~~~ 319 (437)
|+ ++++.+||+|||+|+..... .....||+.|+|||++.+..++.++|||||||++|||+|| .+||.+.+..
T Consensus 166 Ll--~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 166 LL--SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp EE--CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred eE--CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99 67889999999999755322 2345789999999999999999999999999999999996 5789887655
Q ss_pred HHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhh
Q psy11727 320 DQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLAD 399 (437)
Q Consensus 320 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (437)
+.+..++..-..++. | ...
T Consensus 244 ~~~~~~~~~~~~~~~----------------------------------~---------------------------~~~ 262 (299)
T d1ywna1 244 EEFCRRLKEGTRMRA----------------------------------P---------------------------DYT 262 (299)
T ss_dssp HHHHHHHHHTCCCCC----------------------------------C---------------------------TTC
T ss_pred HHHHHHHhcCCCCCC----------------------------------C---------------------------ccC
Confidence 555444332111100 0 000
Q ss_pred hhHHHHHHHHccccCCCCCCCHHHHhcC
Q psy11727 400 YMKFKDLILRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 400 ~~~~~dli~~~L~~dP~~R~t~~e~l~H 427 (437)
...+.+||.+||+.||.+|||++|+++|
T Consensus 263 ~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 263 TPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1257899999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=371.19 Aligned_cols=248 Identities=24% Similarity=0.322 Sum_probs=196.2
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCC-------eEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecce
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEK-------CQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGH 179 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~-------~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~ 179 (437)
.++|++.+.||+|+||+||+|+...++ ..||||+++.... ....+..|...+..+. .|||||+++++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~----~HpnIv~~~~~ 87 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG----KHKNIINLLGA 87 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEE
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhc----CCCeEEecccc
Confidence 478999999999999999999876554 4799999964432 2344555666666663 79999999999
Q ss_pred eeECCEEEEEEEecc-CcHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q psy11727 180 FTWKNHLCLVFELLS-YNLYNLIRNTN--------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPEN 244 (437)
Q Consensus 180 ~~~~~~~~lV~E~~~-~~L~~~l~~~~--------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~N 244 (437)
|.+++..++||||+. |+|.+++.... ...+++..++.++.||+.||+|||++ |||||||||+|
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~--~ivHrDiKp~N 165 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--KCIHRDLAARN 165 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC--CEEeeeecccc
Confidence 999999999999995 58999987543 23589999999999999999999965 79999999999
Q ss_pred EEEecCCCCCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy11727 245 ILLCSPKRSAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNE 318 (437)
Q Consensus 245 Ill~~~~~~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~ 318 (437)
||+ +.++.+||+|||++...... .....+|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+.
T Consensus 166 iLl--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 166 VLV--TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp EEE--CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eee--cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 999 77889999999999766332 233578899999999999999999999999999999998 7999998888
Q ss_pred HHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChh
Q psy11727 319 VDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398 (437)
Q Consensus 319 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (437)
......+......+.. ..
T Consensus 244 ~~~~~~i~~~~~~~~p----------------------------------------------------------~~---- 261 (299)
T d1fgka_ 244 EELFKLLKEGHRMDKP----------------------------------------------------------SN---- 261 (299)
T ss_dssp HHHHHHHHTTCCCCCC----------------------------------------------------------SS----
T ss_pred HHHHHHHHcCCCCCCC----------------------------------------------------------cc----
Confidence 7666655432111100 00
Q ss_pred hhhHHHHHHHHccccCCCCCCCHHHHhc
Q psy11727 399 DYMKFKDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 399 ~~~~~~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
....+.+||.+||+.||.+|||+.|+++
T Consensus 262 ~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 262 CTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 0015789999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-46 Score=359.88 Aligned_cols=203 Identities=22% Similarity=0.244 Sum_probs=175.7
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+.++|++.+.||+|+||+||+|++..+|+.||||++... .....+..|...+..+. +|+|++.+++++....+.
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~e~~~~~~l~----~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLA----GCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTT----TCTTCCCEEEEEEETTEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc-cCcHHHHHHHHHHHHhc----CCCCCCEEEEEeecCCcc
Confidence 3457899999999999999999999999999999998643 33456777888888885 457889999999999999
Q ss_pred EEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC---CCCCEEEEeCCCc
Q psy11727 187 CLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP---KRSAIKIIDFGSS 263 (437)
Q Consensus 187 ~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~---~~~~ikL~DFG~s 263 (437)
++||||++++|.+++.... ..+++..+..++.|++.||+|||+ .|||||||||+|||++.+ ..+.+||+|||+|
T Consensus 77 ~~vme~~~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~--~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 77 VLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEEEecCCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHH--CCceeccCCccceeecCcccccCCceEEccccee
Confidence 9999999999999887654 469999999999999999999996 489999999999999532 3567999999999
Q ss_pred eecCCc----------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy11727 264 CHVGQT----------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSGKN 317 (437)
Q Consensus 264 ~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~~~ 317 (437)
+..... ....+||+.|+|||++.+..++.++|||||||++|||+||.+||.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence 765321 234579999999999999999999999999999999999999998654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=372.41 Aligned_cols=248 Identities=25% Similarity=0.291 Sum_probs=200.3
Q ss_pred cCeeeeceecccCceEEEEEEEcCCCeE--EEEEEecCC--cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHEEKCQ--VAIKIIKNK--KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~~~~~--vaiK~i~~~--~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
++|++.++||+|+||+||+|+++.++.. ||||.++.. ......+.+|+.++..+. +|||||++++++.+.+.
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~----~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG----HHPNIINLLGACEHRGY 85 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCC----CCTTBCCEEEEEEETTE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhcc----CCCCEeeEEEEEecCCe
Confidence 6899999999999999999999888874 677877532 223456778888887763 68999999999999999
Q ss_pred EEEEEEecc-CcHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecC
Q psy11727 186 LCLVFELLS-YNLYNLIRNT--------------NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSP 250 (437)
Q Consensus 186 ~~lV~E~~~-~~L~~~l~~~--------------~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~ 250 (437)
+++||||++ |+|.+++... ....+++..+..++.||+.||.|||++ |||||||||+|||+ +
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~--~iiHrDlkp~NIL~--~ 161 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILV--G 161 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE--C
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC--CccccccccceEEE--c
Confidence 999999996 5899988643 235699999999999999999999964 89999999999999 6
Q ss_pred CCCCEEEEeCCCceecCCcc--ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHH
Q psy11727 251 KRSAIKIIDFGSSCHVGQTL--YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTG-EPLFSGKNEVDQMTKIIE 327 (437)
Q Consensus 251 ~~~~ikL~DFG~s~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg-~~pf~~~~~~~~~~~i~~ 327 (437)
.++.+||+|||+|....... ....||..|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..+.+..+.+
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 78899999999997654332 245689999999999999999999999999999999996 578998888777666543
Q ss_pred HhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHH
Q psy11727 328 VLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLI 407 (437)
Q Consensus 328 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 407 (437)
....+.. . .....+.+||
T Consensus 242 ~~~~~~~-------------------------------------~-------------------------~~~~~~~~li 259 (309)
T d1fvra_ 242 GYRLEKP-------------------------------------L-------------------------NCDDEVYDLM 259 (309)
T ss_dssp TCCCCCC-------------------------------------T-------------------------TBCHHHHHHH
T ss_pred cCCCCCC-------------------------------------c-------------------------cCCHHHHHHH
Confidence 2111100 0 0012679999
Q ss_pred HHccccCCCCCCCHHHHhcC
Q psy11727 408 LRMLTYDPKKRISPTNVLRH 427 (437)
Q Consensus 408 ~~~L~~dP~~R~t~~e~l~H 427 (437)
.+||+.||++|||++|+++|
T Consensus 260 ~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 260 RQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9e-48 Score=369.27 Aligned_cols=247 Identities=23% Similarity=0.303 Sum_probs=200.6
Q ss_pred ccCeeeeceecccCceEEEEEEEc-----CCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|++.+.||+|+||+||+|+.+ .+++.||||+++.... ...++.+|+.++..+ .||||+++++++.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-----~h~niv~~~~~~~ 86 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-----DNPNIVKLLGVCA 86 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-----CCCCcccceeeec
Confidence 568999999999999999999875 3567899999964322 234567788887766 7899999999999
Q ss_pred ECCEEEEEEEecc-CcHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeC
Q psy11727 182 WKNHLCLVFELLS-YNLYNLIRNTN----------------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHC 238 (437)
Q Consensus 182 ~~~~~~lV~E~~~-~~L~~~l~~~~----------------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHr 238 (437)
..+..++|||+++ |+|.+++.... ...+++..+..|+.||+.||+|||++ +||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~--~ivHr 164 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHR 164 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCS
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC--CeEee
Confidence 9999999999996 58999886432 23478999999999999999999964 79999
Q ss_pred CCCCCcEEEecCCCCCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCC-CC
Q psy11727 239 DLKPENILLCSPKRSAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGE-PL 312 (437)
Q Consensus 239 DiKp~NIll~~~~~~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~-~p 312 (437)
||||+|||+ +.++.+||+|||+|...... ..+..|++.|+|||++.+..|+.++|||||||++|||++|. +|
T Consensus 165 DlKp~NILl--d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 165 DLATRNCLV--GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CCSGGGEEE--CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EEcccceEE--CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999999999 67889999999999754322 23456788999999999999999999999999999999985 88
Q ss_pred CCCCCHHHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCC
Q psy11727 313 FSGKNEVDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNE 392 (437)
Q Consensus 313 f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (437)
|.+.+..+.+..+.+....+..
T Consensus 243 ~~~~~~~e~~~~v~~~~~~~~p---------------------------------------------------------- 264 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRDGNILACP---------------------------------------------------------- 264 (301)
T ss_dssp TTTSCHHHHHHHHHTTCCCCCC----------------------------------------------------------
T ss_pred CCCCCHHHHHHHHHcCCCCCCC----------------------------------------------------------
Confidence 9999888887776542211100
Q ss_pred CCCChhhhhHHHHHHHHccccCCCCCCCHHHHhc
Q psy11727 393 PGHSLADYMKFKDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 393 ~~~~~~~~~~~~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
......+.+||.+||+.||.+|||+.|+++
T Consensus 265 ----~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 265 ----ENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 000015789999999999999999999964
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-48 Score=363.98 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=189.1
Q ss_pred cCeeeeceecccCceEEEEEEEcC-C--CeEEEEEEecCC----cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE
Q psy11727 110 DRYEIDTLLGKGSFGQVVKAFDHE-E--KCQVAIKIIKNK----KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW 182 (437)
Q Consensus 110 ~~y~i~~~lG~G~fg~V~~~~~~~-~--~~~vaiK~i~~~----~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~ 182 (437)
++|++.+.||+|+||+||+|+... + ...||||+++.. ....+.+.+|+.++..+ +|||||+++++|.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-----~H~nIv~~~g~~~~ 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-----DHRNLIRLYGVVLT 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-----CCTTBCCEEEEECS
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEee
Confidence 579999999999999999998643 3 246899998643 22345667888888877 78999999999975
Q ss_pred CCEEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCC
Q psy11727 183 KNHLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFG 261 (437)
Q Consensus 183 ~~~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG 261 (437)
+.+++||||+.+ ++.+.+.... ..+++..+..++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~--~iiHrDikp~NIll--~~~~~vkl~DfG 156 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK--RFIHRDLAARNLLL--ATRDLVKIGDFG 156 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEE--EETTEEEECCCT
T ss_pred -cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhC--CEeeeeecHHHhcc--ccccceeeccch
Confidence 467899999964 7888776543 4599999999999999999999964 79999999999999 557789999999
Q ss_pred CceecCCcc------ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCh
Q psy11727 262 SSCHVGQTL------YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNEVDQMTKIIEVLGMPPG 334 (437)
Q Consensus 262 ~s~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~p~~ 334 (437)
++....... ....|+..|+|||++.+..++.++|||||||++|||+| |++||.+.+..+.+..+......++.
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 236 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC
Confidence 998764332 23456788999999999999999999999999999998 89999999998887776542111100
Q ss_pred hhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccC
Q psy11727 335 YLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYD 414 (437)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~d 414 (437)
.. .. ...+.+||.+||+.|
T Consensus 237 ------------------------------------~~---------------------~~----~~~l~~li~~cl~~d 255 (273)
T d1u46a_ 237 ------------------------------------PE---------------------DC----PQDIYNVMVQCWAHK 255 (273)
T ss_dssp ------------------------------------CT---------------------TC----CHHHHHHHHHHTCSS
T ss_pred ------------------------------------cc---------------------cc----cHHHHHHHHHHcCCC
Confidence 00 00 015789999999999
Q ss_pred CCCCCCHHHHhc
Q psy11727 415 PKKRISPTNVLR 426 (437)
Q Consensus 415 P~~R~t~~e~l~ 426 (437)
|.+|||+.|+++
T Consensus 256 p~~RPt~~ei~~ 267 (273)
T d1u46a_ 256 PEDRPTFVALRD 267 (273)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhHCcCHHHHHH
Confidence 999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=364.42 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=204.8
Q ss_pred ccCeeeeceecccCceEEEEEEEcC-----CCeEEEEEEecCCccc--chHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHE-----EKCQVAIKIIKNKKPF--LNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~i~~~~~~--~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|++.+.||+|+||+||+|.+.. ++..||||+++..... ...+.+|+.++..+ .|||||++++++.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-----~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-----NCHHVVRLLGVVS 93 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-----CCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-----CCCCEeeeeeEEe
Confidence 5789999999999999999998753 4578999999743221 12345566665554 7899999999999
Q ss_pred ECCEEEEEEEecc-CcHHHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCC
Q psy11727 182 WKNHLCLVFELLS-YNLYNLIRNT--------NFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR 252 (437)
Q Consensus 182 ~~~~~~lV~E~~~-~~L~~~l~~~--------~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~ 252 (437)
..+..++||||+. |+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+|||+ +++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~--~ivHrDlk~~NiLl--d~~ 169 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMV--AED 169 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCSGGGEEE--CTT
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC--CeeeceEcCCceee--cCC
Confidence 9999999999995 5788877532 123478999999999999999999965 79999999999999 788
Q ss_pred CCEEEEeCCCceecCCc-----cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHH
Q psy11727 253 SAIKIIDFGSSCHVGQT-----LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTG-EPLFSGKNEVDQMTKII 326 (437)
Q Consensus 253 ~~ikL~DFG~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg-~~pf~~~~~~~~~~~i~ 326 (437)
+.+||+|||+|...... .....||+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+..+.+..+.
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 89999999999765332 2234678999999999999999999999999999999998 59999998888887775
Q ss_pred HHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHH
Q psy11727 327 EVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDL 406 (437)
Q Consensus 327 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 406 (437)
+....+... .....+.+|
T Consensus 250 ~~~~~~~p~--------------------------------------------------------------~~~~~l~~l 267 (308)
T d1p4oa_ 250 EGGLLDKPD--------------------------------------------------------------NCPDMLFEL 267 (308)
T ss_dssp TTCCCCCCT--------------------------------------------------------------TCCHHHHHH
T ss_pred hCCCCCCcc--------------------------------------------------------------cchHHHHHH
Confidence 422111000 000257999
Q ss_pred HHHccccCCCCCCCHHHHhc------CCCcCcC
Q psy11727 407 ILRMLTYDPKKRISPTNVLR------HEFFLKH 433 (437)
Q Consensus 407 i~~~L~~dP~~R~t~~e~l~------Hp~~~~~ 433 (437)
|.+||+.||.+|||++|+++ +|+|++.
T Consensus 268 i~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 268 MRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence 99999999999999999997 8998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=363.21 Aligned_cols=249 Identities=26% Similarity=0.359 Sum_probs=201.9
Q ss_pred ccCeeeeceecccCceEEEEEEEc-----CCCeEEEEEEecCCcc--cchHHHHHHHHHHHhhhcCCCCCcEEEecceee
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDH-----EEKCQVAIKIIKNKKP--FLNQAQIEVQLLEKINKADIHSRYIVKLKGHFT 181 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~i~~~~~--~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~ 181 (437)
.++|++.+.||+|+||.||+|+.. .+++.||||+++.... ....+.+|+.++..+. +|||||++++++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~----~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG----NHMNIVNLLGACT 97 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhcc----CCCCEEEEEEEEe
Confidence 478999999999999999999863 4678999999974332 2334667888888773 6999999999999
Q ss_pred ECCEEEEEEEeccC-cHHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCc
Q psy11727 182 WKNHLCLVFELLSY-NLYNLIRNTN----------------FHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPEN 244 (437)
Q Consensus 182 ~~~~~~lV~E~~~~-~L~~~l~~~~----------------~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~N 244 (437)
+.+.+++|||||++ +|.+++.... ...+++..+..++.||+.||+|||++ |||||||||+|
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~--~ivHrDLKp~N 175 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARN 175 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC--Ceeeccccccc
Confidence 99999999999965 7888886532 23589999999999999999999965 79999999999
Q ss_pred EEEecCCCCCEEEEeCCCceecCCcc-----ccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy11727 245 ILLCSPKRSAIKIIDFGSSCHVGQTL-----YQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHT-GEPLFSGKNE 318 (437)
Q Consensus 245 Ill~~~~~~~ikL~DFG~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~pf~~~~~ 318 (437)
||+ +.++.+||+|||.++...... ....||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+.
T Consensus 176 Il~--~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 176 ILL--THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp EEE--ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccc--cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 999 667889999999998664322 23577999999999999999999999999999999998 7788888777
Q ss_pred HHHHHHHHHHhCCCChhhhccCCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChh
Q psy11727 319 VDQMTKIIEVLGMPPGYLLHGASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLA 398 (437)
Q Consensus 319 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (437)
.+.+.+++..-..++. +. .
T Consensus 254 ~~~~~~~i~~~~~~~~----------------------------------------------------------~~---~ 272 (311)
T d1t46a_ 254 DSKFYKMIKEGFRMLS----------------------------------------------------------PE---H 272 (311)
T ss_dssp SHHHHHHHHHTCCCCC----------------------------------------------------------CT---T
T ss_pred HHHHHHHHhcCCCCCC----------------------------------------------------------cc---c
Confidence 6666666543111110 00 0
Q ss_pred hhhHHHHHHHHccccCCCCCCCHHHHhc
Q psy11727 399 DYMKFKDLILRMLTYDPKKRISPTNVLR 426 (437)
Q Consensus 399 ~~~~~~dli~~~L~~dP~~R~t~~e~l~ 426 (437)
....+.+||.+||++||.+|||+.|+++
T Consensus 273 ~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 273 APAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0125789999999999999999999985
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=361.89 Aligned_cols=196 Identities=22% Similarity=0.257 Sum_probs=159.6
Q ss_pred ccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECC----
Q psy11727 109 LDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKN---- 184 (437)
Q Consensus 109 ~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~---- 184 (437)
..+|.+.+.||+|+||+||+|+. +|+.||||+++... ......|.. .+....++|||||++++++.+.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~--~~~~~~e~e---i~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAE---IYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHH---HHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc--hhHHHHHHH---HHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 46799999999999999999975 68899999996432 233333433 23334568999999999998754
Q ss_pred EEEEEEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCC------CCCeeeCCCCCCcEEEecCCCCCEEE
Q psy11727 185 HLCLVFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSP------ELSIIHCDLKPENILLCSPKRSAIKI 257 (437)
Q Consensus 185 ~~~lV~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~------~~giiHrDiKp~NIll~~~~~~~ikL 257 (437)
.+|+||||+.+ +|.+++... ++++..+..++.|++.||+|||+. +.|||||||||+|||| +.++.+||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl--~~~~~~Kl 149 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--KKNGTCCI 149 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE--CTTSCEEE
T ss_pred EEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE--cCCCCeEE
Confidence 78999999955 899999764 489999999999999999999973 3589999999999999 77899999
Q ss_pred EeCCCceecCC-------ccccccccccccChhhhcCCC------CCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy11727 258 IDFGSSCHVGQ-------TLYQYIQSRYYRSPEVLLGIP------YDLAIDMWSLGCILVELHTGEPLFSGK 316 (437)
Q Consensus 258 ~DFG~s~~~~~-------~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlG~il~elltg~~pf~~~ 316 (437)
+|||++..... ......||+.|+|||++.+.. ++.++|||||||++|||+||.+||...
T Consensus 150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~ 221 (303)
T d1vjya_ 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred EecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcc
Confidence 99999976532 123467899999999997643 567899999999999999999888653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=355.69 Aligned_cols=246 Identities=20% Similarity=0.261 Sum_probs=188.3
Q ss_pred eceecccCceEEEEEEEcCCC---eEEEEEEecCC--cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeE-CCEEEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEK---CQVAIKIIKNK--KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTW-KNHLCL 188 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~---~~vaiK~i~~~--~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~-~~~~~l 188 (437)
.++||+|+||+||+|....++ ..||||+++.. .....++.+|+.++.++ .|||||++++++.. +..+++
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-----SHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEEEETTTEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-----CCCCEeEEeEEEEecCCceEE
Confidence 578999999999999986543 36999999642 22335577788888776 78999999999876 468999
Q ss_pred EEEeccC-cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCCCCEEEEeCCCceecC
Q psy11727 189 VFELLSY-NLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCHVG 267 (437)
Q Consensus 189 V~E~~~~-~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~~~ 267 (437)
|||||++ +|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||+ ++++.+||+|||+++...
T Consensus 107 v~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~--~iiHrDLK~~NILl--~~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK--KFVHRDLAARNCML--DEKFTVKVADFGLARDMY 181 (311)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEE--CTTCCEEECSSGGGCCTT
T ss_pred EEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhccc--CcccCCccHHhEeE--CCCCCEEEecccchhhcc
Confidence 9999965 7777776543 4578889999999999999999964 79999999999999 778899999999997653
Q ss_pred Cc-------cccccccccccChhhhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHHhCCCChhhhcc
Q psy11727 268 QT-------LYQYIQSRYYRSPEVLLGIPYDLAIDMWSLGCILVELHTGEPLFSG-KNEVDQMTKIIEVLGMPPGYLLHG 339 (437)
Q Consensus 268 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~pf~~-~~~~~~~~~i~~~~~~p~~~~~~~ 339 (437)
.. .....||..|+|||++.+..++.++||||||+++|||+||..||.. .+..+....+......+.
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~------ 255 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ------ 255 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC------
T ss_pred ccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence 22 1234678999999999999999999999999999999997666554 333333333322110000
Q ss_pred CCccchhhcccCCCcceeccccccccccCCCCCchhhhhccCCCCCCCCCCCCCCCChhhhhHHHHHHHHccccCCCCCC
Q psy11727 340 ASKTSKYFDRLSDNSYVLKKSTDTRKERLPGSKRLDTILGVDNGGPGGRRRNEPGHSLADYMKFKDLILRMLTYDPKKRI 419 (437)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~~L~~dP~~R~ 419 (437)
| . .....+.+||.+||+.||++||
T Consensus 256 -----------------------------p------------------------~---~~~~~l~~li~~cl~~dP~~RP 279 (311)
T d1r0pa_ 256 -----------------------------P------------------------E---YCPDPLYEVMLKCWHPKAEMRP 279 (311)
T ss_dssp -----------------------------C------------------------T---TCCHHHHHHHHHHTCSSGGGSC
T ss_pred -----------------------------c------------------------c---cCcHHHHHHHHHHcCCCHhHCc
Confidence 0 0 0012578999999999999999
Q ss_pred CHHHHhcC------CCcCc
Q psy11727 420 SPTNVLRH------EFFLK 432 (437)
Q Consensus 420 t~~e~l~H------p~~~~ 432 (437)
|+.|+++| .|+.+
T Consensus 280 s~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 280 SFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp CHHHHHHHHHHHHHTCCSC
T ss_pred CHHHHHHHHHHHHHhhhhh
Confidence 99999988 66554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=7.6e-25 Score=194.66 Aligned_cols=161 Identities=20% Similarity=0.233 Sum_probs=110.7
Q ss_pred eeeeceecccCceEEEEEEEcCCCeEEEEEEecCCccc-------------------chHHHHHHHHHHHhhhcCCCCCc
Q psy11727 112 YEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPF-------------------LNQAQIEVQLLEKINKADIHSRY 172 (437)
Q Consensus 112 y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~-------------------~~~~~~e~~~~~~l~~~~~~h~~ 172 (437)
+.+.++||+|+||+||+|.+. +|+.||||+++..... ......|...+..+ .|.+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~ 75 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-----QGLA 75 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-----TTSS
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-----cCCC
Confidence 467899999999999999885 6889999987632110 01112344444444 4556
Q ss_pred EEEecceeeECCEEEEEEEeccCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHhcCCCCCeeeCCCCCCcEEEecCCC
Q psy11727 173 IVKLKGHFTWKNHLCLVFELLSYNLYNLIRNTNFHGVSLNLTKKFAQQLCCALAFLSSPELSIIHCDLKPENILLCSPKR 252 (437)
Q Consensus 173 iv~l~~~~~~~~~~~lV~E~~~~~L~~~l~~~~~~~ls~~~~~~i~~qi~~aL~~LH~~~~giiHrDiKp~NIll~~~~~ 252 (437)
++..+++. . .++|||++++... ..++...+..++.||+.+|+|||. .||+||||||+|||++ ++
T Consensus 76 v~~~~~~~--~--~~lvme~~~~~~~--------~~l~~~~~~~i~~ql~~~l~~lH~--~giiHrDiKP~NILv~--~~ 139 (191)
T d1zara2 76 VPKVYAWE--G--NAVLMELIDAKEL--------YRVRVENPDEVLDMILEEVAKFYH--RGIVHGDLSQYNVLVS--EE 139 (191)
T ss_dssp SCCEEEEE--T--TEEEEECCCCEEG--------GGCCCSCHHHHHHHHHHHHHHHHH--TTEECSCCSTTSEEEE--TT
T ss_pred cceEEEec--C--CEEEEEeeccccc--------cchhhHHHHHHHHHHHHHHHHHhh--CCEEEccCChhheeee--CC
Confidence 66655432 2 2799999987432 124556678899999999999995 4899999999999994 33
Q ss_pred CCEEEEeCCCceecCCccccccccccccC------hhhhcCCCCCCcchHHHHHH
Q psy11727 253 SAIKIIDFGSSCHVGQTLYQYIQSRYYRS------PEVLLGIPYDLAIDMWSLGC 301 (437)
Q Consensus 253 ~~ikL~DFG~s~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DvwSlG~ 301 (437)
.++|+|||+|.....+... .|.. .+.+ ...|+.++|+||+.-
T Consensus 140 -~~~liDFG~a~~~~~~~~~-----~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 140 -GIWIIDFPQSVEVGEEGWR-----EILERDVRNIITYF-SRTYRTEKDINSAID 187 (191)
T ss_dssp -EEEECCCTTCEETTSTTHH-----HHHHHHHHHHHHHH-HHHHCCCCCHHHHHH
T ss_pred -CEEEEECCCcccCCCCCcH-----HHHHHHHHHHHHHH-cCCCCCcccHHHHHH
Confidence 4999999999877543221 1111 1222 356889999999654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.34 E-value=1.4e-06 Score=78.49 Aligned_cols=86 Identities=12% Similarity=0.045 Sum_probs=58.0
Q ss_pred eeccCeeeeceecccCceEEEEEEEcCCCeEEEEEEecCCc-ccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCE
Q psy11727 107 KFLDRYEIDTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKK-PFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNH 185 (437)
Q Consensus 107 ~~~~~y~i~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~ 185 (437)
.+.+.|++.+..+-++.+.||+.. .++..+++|+..... ........|...++.+.. .+. +.+++.+..+++.
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~-~vp---vP~vl~~~~~~~~ 84 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEG-KLP---VPKVLHFERHDGW 84 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT-TSC---CCCEEEEEEETTE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhc-cCC---CCcEEEEEecCCc
Confidence 345677777765555567899884 455567888875332 233457788888888753 223 3445566778889
Q ss_pred EEEEEEeccC-cHH
Q psy11727 186 LCLVFELLSY-NLY 198 (437)
Q Consensus 186 ~~lV~E~~~~-~L~ 198 (437)
.++||++++| .+.
T Consensus 85 ~~lv~~~l~G~~~~ 98 (263)
T d1j7la_ 85 SNLLMSEADGVLCS 98 (263)
T ss_dssp EEEEEECCSSEEHH
T ss_pred eEEEEEeccccccc
Confidence 9999999988 443
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.02 E-value=2.4e-05 Score=74.98 Aligned_cols=77 Identities=19% Similarity=0.187 Sum_probs=48.8
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCC--------cccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNK--------KPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHL 186 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~--------~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~ 186 (437)
.+.||.|....||++.+..+++.++||.-... .....+...|...+..+... .+..+.+++. .+.+..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~--~p~~vP~v~~--~d~~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEH--VPHLVPRVFY--SDTEMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTT--CGGGSCCEEE--EETTTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhh--CCCCcceEEE--EcCCCC
Confidence 34579999999999988777889999965321 12245667788888776532 1123445543 345566
Q ss_pred EEEEEeccC
Q psy11727 187 CLVFELLSY 195 (437)
Q Consensus 187 ~lV~E~~~~ 195 (437)
++|||++++
T Consensus 107 ~lvmE~L~~ 115 (392)
T d2pula1 107 VTVMEDLSH 115 (392)
T ss_dssp EEEECCCTT
T ss_pred EEEEeccCC
Confidence 799999975
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.74 E-value=9.6e-05 Score=65.64 Aligned_cols=73 Identities=14% Similarity=0.015 Sum_probs=51.5
Q ss_pred eecccCc-eEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEEEEEEeccC
Q psy11727 117 LLGKGSF-GQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLCLVFELLSY 195 (437)
Q Consensus 117 ~lG~G~f-g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~lV~E~~~~ 195 (437)
.+..|.. +.||+... .++..+++|..... .......|...++.+....+. +.+++.+..+.+..++||++++|
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~--~~~~l~~E~~~l~~L~~~gvp---vP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVP---CAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCC---BCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc--CHhHHHHHHHHHHHHHhcCCC---CCceeeecccccceEEEEEeeec
Confidence 3455554 67898864 45666888987543 235678899999988876554 44455666777889999999976
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.46 E-value=0.00018 Score=66.79 Aligned_cols=71 Identities=14% Similarity=0.148 Sum_probs=51.5
Q ss_pred eEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEec--ceeeECCEEEEEEEeccC
Q psy11727 124 GQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLK--GHFTWKNHLCLVFELLSY 195 (437)
Q Consensus 124 g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~--~~~~~~~~~~lV~E~~~~ 195 (437)
-.||++.. .+|..|++|+.+.......++..|+..+..+...++..+..+..- ..+...+..+.++++++|
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 57999964 567889999987654455778889999999987766544333332 234567789999999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.09 E-value=0.0024 Score=58.29 Aligned_cols=146 Identities=12% Similarity=0.102 Sum_probs=81.7
Q ss_pred eceecccCceEEEEEEEcCCCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecce---eeECCEEEEEEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHEEKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGH---FTWKNHLCLVFE 191 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~---~~~~~~~~lV~E 191 (437)
.+.|..|---+.|+.... +| .+++|+.... ........|+.++..+...++..|..+...+- .........++.
T Consensus 23 ~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~ 99 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 99 (316)
T ss_dssp EEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eecCCCCcccCeEEEEEC-CC-cEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeee
Confidence 344567777888998653 34 4899998643 34567788999999998887766654443221 223556677777
Q ss_pred eccCc-H-----HH---------HHHh--cCCC-----------------------CCCHHHHHHHHHHHHHHHHHhcCC
Q psy11727 192 LLSYN-L-----YN---------LIRN--TNFH-----------------------GVSLNLTKKFAQQLCCALAFLSSP 231 (437)
Q Consensus 192 ~~~~~-L-----~~---------~l~~--~~~~-----------------------~ls~~~~~~i~~qi~~aL~~LH~~ 231 (437)
++.+. . .. .+.. ..+. ..........+..+...+.-.+..
T Consensus 100 ~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 179 (316)
T d2ppqa1 100 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 179 (316)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred ecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcc
Confidence 66431 1 00 0000 0000 001111122233333344443322
Q ss_pred --CCCeeeCCCCCCcEEEecCCCCCEEEEeCCCcee
Q psy11727 232 --ELSIIHCDLKPENILLCSPKRSAIKIIDFGSSCH 265 (437)
Q Consensus 232 --~~giiHrDiKp~NIll~~~~~~~ikL~DFG~s~~ 265 (437)
..|+||+|+.++||++ +++...-|+||+.++.
T Consensus 180 ~L~~giIHgDl~~dNvl~--~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 180 DLPAGVIHADLFQDNVFF--LGDELSGLIDFYFACN 213 (316)
T ss_dssp SSCEEEECSCCCGGGEEE--ETTEEEEECCCTTCEE
T ss_pred ccccccccCCcchhhhhc--ccccceeEeccccccc
Confidence 3579999999999999 4555567999999864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.99 E-value=0.0017 Score=61.61 Aligned_cols=72 Identities=15% Similarity=0.123 Sum_probs=47.7
Q ss_pred eceecccCceEEEEEEEcC-------CCeEEEEEEecCCcccchHHHHHHHHHHHhhhcCCCCCcEEEecceeeECCEEE
Q psy11727 115 DTLLGKGSFGQVVKAFDHE-------EKCQVAIKIIKNKKPFLNQAQIEVQLLEKINKADIHSRYIVKLKGHFTWKNHLC 187 (437)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~-------~~~~vaiK~i~~~~~~~~~~~~e~~~~~~l~~~~~~h~~iv~l~~~~~~~~~~~ 187 (437)
++.|+-|-.-.+|++.... ..+.|.+++.-.. .......+|..+++.+...++. | +++++|. + .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~idr~~E~~i~~~ls~~gl~-P---kll~~~~--~--g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLG-P---KLYGIFS--G--G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSS-S---CEEEEET--T--E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chhhHHHHHHHHHHHHHhCCCC-C---eEEEEcC--C--c
Confidence 3567777788899887543 3456888887533 2334456799999998877653 3 3444443 2 5
Q ss_pred EEEEeccC
Q psy11727 188 LVFELLSY 195 (437)
Q Consensus 188 lV~E~~~~ 195 (437)
+|+||+.|
T Consensus 118 ~I~efi~g 125 (395)
T d1nw1a_ 118 RLEEYIPS 125 (395)
T ss_dssp EEECCCCE
T ss_pred eEEEEecc
Confidence 78999875
|